>KALACAFP_00006 hypothetical protein
MASGDYIGYSKVVKTEKDAQNNINSSIERNYSNIPDFHYFFQEGVIPINMPSTKSPNSTE
NGKVLSEVVYDSSMNKIQQTDNTYSEVYSNVYYGTSLSRNSRSVWNFVSVNSSLIPQQHG
VTVLGYYPIFSKESLLTQSIKKEYLNNKIFTTQTSFGYNTYNNLKEESTTLPNGEVDRVY
LSYALDLYQLNLYNANMHSIPLQKVIYRNQDYSAFRTKYDDTSHLNPTSVQETSQVQPPN
YIAEAKTVINYTLYDNKGNLLEYTDGQNIPTTIVWGYNQTLPIAKIVGAFYSSISQFLQD
IINKSNLDTDTTSEQTLIDALDELRKKPEMSNYQITTYTHNPLVGVTSITPPSGIRETYI
YDSSNRLKQVIDSNGKILKENEYNYKH
>KALACAFP_00007 hypothetical protein
MKKILIPFNILFVAVLFHAQTTTENYIQTRTYLEPVTSGSSTAKQIQTVQYFDGLGRPKQ
VVNVKASPSGRDVVTHIEYDGFGRQVKEFLPVPQSQSLNGAIIPDPLTNATQPDIYGAEK
IYSEKILESSPIDKILQQKQVGNAWDNKPIQFTYDLNIDGEVKNYTVITVWTNKTTVNTI
SLTGTYNSNQLYKNTVTDEDGNATIEFKNGRGQTILVRKNDGTKNVDTYYVYDNYQNLAY
VIPPLASASSTIDQTVLDNLCYQYRYDIWDRLIEKKLPGKGWEYMLYDKQDRLVATQDTE
LKNKGQWLYTKYDQFGRVAITGIGTGYQRSVEQTTVDTYTSNNVNRLASPLFNRQGMDVY
YGNQDSTYPNSTKWVTLLSLHYYDSYPQYSFNPAFPSTILGEPTLTETPTTEGLSTKSLP
VMSLVKNIEDDNWTKSYSYYDKKGRAIGTYSINHLGGYTKTESKLDFAGVALQTKTYHKR
LSTDTERIITENFEYDAQNRLKKHYHQVDSQPQELLTENSYNELSQLTNKKVGNNLQSID
YAYNIRGWMTKINDPANLAGKLFGYKIKYNEVEGLQTPNSDYPGLQVKPRYNGNIAEVDW
KTATDPNDYLRRYGYVYDGLNRLSAGFYQREDNPSAQEYFEKIDYDLNGNILNLKRSAAK
GANTVASLIDNLTYTYARSNRLNTVTDSSTDYRGYPDTSGGTIGYNDNGSMTSQPDKGIL
QIDYNVLNLPKYIKFNQFIEGRGGAVYVNSTYSYRADGSKTGKVYTYKDPLISNALATTT
TDYLDGFQYEAKSGGMGATPVTLQFVPTAEGYYNFENNKYIYSYTDHLGNVRLSYFKNTS
GSAEVLEENNYYPFGMKHEGYNNALVGNPAYKYQYNGKEYQTETGWNDYGARMYMSDIGR
WGVVDPLAEKMRRYSPYNYAFNNPLRFIDPDGRAPLDDHFNKNGRFMYRDDKKTNNIIVH
TDQGNAKLSQLDYSKKGTRMAVSNIIAHYATQKGLTGYYGVSTKIKNEDTGAVTSGRSNN
VFYNSKQLAKGSYNNLYDLRNTLDHEAGKDGHKNENKNGEYTFLAHAKVYLGQSKTSDYE
NSTEANQYSVAFGFAQRLWNAYKKDEISWEGMDPYLEDFNRNNTGGVQISTIGGYEGDPM
EVVIKNDTKQSIAKPVKKMTNPHD
>KALACAFP_00008 hypothetical protein
MIKFLKYLFVAIVLTSCSSPSDKIKNVILYQDSIGYWNYEWPRERAEFYGFTFKFFKDNK
LSKYSYSKVKNRRWPFSDEGIDQRLEWGIADDSILTLMNYNSQIKVTKYNKDTIWLYDKK
DKENSMLIKVKGDLNIEK
>KALACAFP_00009 hypothetical protein
MIKFLKYLFVTFALTSCLSPSDKIKDVILYQDSIGYWNYEWPRERADFYGFTFKFGKDGS
ISKYSFDKIEDRRTLFSDYGIEPRLKWGVANDSIFTIMNYNSQIKIMRYNKNTIWMYDKE
RKRSTMLIKVKGDLNIEK
>KALACAFP_00010 hypothetical protein
MKTGGGGAYFGAGKYQNYKYNGKELQETGMGDYGSRMYMADIDRWGVVDPLAEKMKRHSP
YNYAFNNPIRFIDPDGRQGKDILIPYGTDPKDVPSIVSNLQKLIRDKLMTMKGVNGNIYV
FIDKFQKDGKYDAGTQYSFLLSPKSLEITLNDFAGYYNITRYNEKDWRK
>KALACAFP_00011 hypothetical protein
MSASDPDDFEIHNADDDSSTRSQYFTNYLSPEKNWGVQVLDKPFTIGFGGEATVGAGVGF
EVGYFSGNYDSGLYINLYKSYGLNAGAGFAYNEYTTKNGYDPLTASNMNGKYWNASGGVG
PISGNYGETALNDKKQNVSMGGASLSSDIWNFLKRPKVSAGGSVQFGTTYSSRLKKFGN
>KALACAFP_00012 hypothetical protein
MAKFKNIAGFVGFILFIIGYFLYKDYQKKEPQRRIESNLNVSFQGKIDSLYIDSQNHGWL
IIILSNRQILRFNGSDKYIYQKNDSIVKNKGKDSIYLYRNGEVKTYKY
>KALACAFP_00013 hypothetical protein
MSLNYNTKPTAIAVGSLLLLTDYKSARMVLFFYI
>KALACAFP_00014 hypothetical protein
MNIPREEKAIFGTNSLYNYKYNGKELQETGMYDYGARFYMPDLGRWGVVDPLAEKMTRHS
PYNYAFNNPLSFIDPDGREGTGWIKSVVDGQTSWTYDKDVHSLQDAKDKKYTGVQEYQDA
LTITGISNGQQNYQYTLDTSGVVTDSSGNLMAESFKTGAGTNIGVNPDSSMLFSIRNMPS
IGLGGMGGEIKFSQIYGVGYSIAIGYVSADGNNGSSFYVTPSFGVGYDVGPSFSLYSVNQ
PAGHDFKIGDFQGQGMSYGVSAFFLNGSYGGSDYNGSFQFSDTNPSNFGLSKQGAKGYTT
TGGGINPFGFGASYQYGKTHLFWTTPAKK
>KALACAFP_00015 hypothetical protein
MKKSNVIMILIAFVGFIILFTYYNSEKTETSDFFKSDEELFMKSFLPIEMNKEKYLGEVA
DSSNHMNAYMNFGNVCLPMLDQWKDKIRIGDYVSKKKDSLSLFIQGKTKKYYLHFDSKNF
DGAPLPCNCSKLSKNF
>KALACAFP_00016 HTH-type transcriptional regulator ImmR
MVFILTRYTINFLTVDYFMKSITFGKRLTEVRKDKKMSQDEVGKLVNVHGAVIGRYEREE
VKPSIEVVIQLAEVLEISLDYLVGSTDVLLEKNIVSKILDIKNCRKLPNLQKKTRITFF
>KALACAFP_00017 hypothetical protein
MKQVLSSLLLIVGFWGTSQLKSTGVMTCTVGTRSVTANITLNNTTNKVRLDLTGPSDRWF
GFTFRSAANSGMSGAPTDALTYSDVGFNDRNLGGIGVYNSDTQDWTVINAPSISAGTVSM
SYERNLTTADGANDYQFNYATANSITTKCVITNSAGLSISPHGGAANTAVTNGTFATVLA
TNDVAAESKKIVLYPNPAKETVSFKNADKIKLVDIFESTGRKVRSVKMNGNEINVSDLKS
GNYYFEITLKDGSTSFEQLIKE
>KALACAFP_00018 Phosphocholine transferase AnkX
MMSLFLSFGFVSAQEKAKSIFDIARTGTVTEVKELMKQNPDIINQTNDQGFSPLILACYR
GNVEVAKFLMDNVKDINYGSAQGSALTASVFKSNKELTQKLLANGANANLADSNGVTPLI
YAVQLQDKDLVKILLEYKANKDLADKQGKTAFEYAIFSKNHEIINLLKN
>KALACAFP_00019 hypothetical protein
MKKLVLLIVSLLFTNLALAQKYMSKTGKVTFEASVPLFEDVYAQDDNNVAVINADTGDFA
SVSVVKNFHFKTKLMEEHFNESYAETAKYPKTTFTGKVVNFDKNKLSASPQKYTVQGTLN
FHGVEKAYTSTATIYAKDGKIYMTGGFVARPADHNVKIPKMVTKKIAESVNVQYNYVLSK
Q
>KALACAFP_00020 hypothetical protein
MYIFSSAVLLVACESRTYEEISDNTPIVEQVTYTKDVKPIIEANCIGCHSAGGPASFQPW
TSYDQVKTHIDNILDRIQRPNGDPLKMPQGGALSPSQINIFTKWKADGLIEN
>KALACAFP_00021 hypothetical protein
MTKTLLFLSMFASGLTFAQEDLLKDIDTIKTNTETSQPAFKALQIVTGQSTKLTAKNEWY
IVVAHRFGDVSKGFKDFFGLDDASTKLGVIYGVTDGLSLSLSRETNLKTFEGGAKYKLVK
QSENFPVDIVGYNVLAVNTDLSKDNYPHLQFGDRLSYLTQALISRRFSDNFSLQLSPSYV
HKNLYDPAIEDKNQFLTGLGGRYKVSKRISINAEYFVNFDNHSFYKNPLSLGMDIETGGH
VFQLLFTNSQLNSDIGYLTNATGRWGKGQIFFGFNLYRVF
>KALACAFP_00022 Cyclic AMP receptor-like protein
MINNQFILNKFGFLGEDFSKELNKHAVITDIKAKTEIIREGQKNKFVPFLIKGSIKVFTL
NDGRELIYYYIRMNDSCLMTFSSIFTDCVSRVYAVAEEDSEVLLIPVSVVHEWLIKFPEI
NKLFYYEYDKRFSDIMNMVNDAVFHRLDKRVINYIKQQILITGNNPVKLTHREIASNLGT
SREVVSRVLKKVENEGELIQTKEGIKIPVNENVRLG
>KALACAFP_00023 hypothetical protein
MDNNQNPQDGNINIELNEMVAAGIYANLALVNHSPSEFVVDFIQLMPGVQQAKVRSRVIL
APLHAKRVLSALQQNIANYEQQFGEIKEVEPFVLGGNNVNA
>KALACAFP_00024 DNA-directed RNA polymerase subunit beta'
MSNKNKSSRFNKITIGLASPESILQESRGEVLKPETINYRTHKPERDGLFCEKIFGPVKD
YECACGKYKRIRYKGIVCDRCGVEVTEKKVRRERIGHINLVVPIAHIWYFRSLPNKIGYL
LGIPSKKLDMIIYYERYVVIQQGIAKKLDGSDFEHMEFLTEEEYLDIMETLPVENQYLDD
SDPNKFIARMGAEAVEDLLKRIDLDALSFDLRHKAHNEGSKQRRTEALKRLNVVEALRGA
NTRMINKPEWMIMRVLPVIPPELRPLVPLDGGRFATSDLNDLYRRVIIRNNRLKRLLEIK
APEVILRNEKRMLQESVDSLFDNTRKSSAVKSESNRPLKSLSDSLKGKQGRFRQNLLGKR
VDYSARSVIVVGPNLQLHECGIPKDMAAELYKPFIIRKLIERGIVKTVKSAKRIIDRKEP
VVYDILENVMKGHPVLLNRAPTLHRLGIQAFQPKMIEGKAIQLHPLVTTAFNADFDGDQM
AVHLPLGPEAILEAQLLMLGSQNILNPANGSPITVPSQDMVLGLYFMTKEASSTEDYKVK
GEGLAFYSPEEAEIAYAEGRVSLNAKVRCRLPVKEDGELVTRLIETSVGRILFNQIVPKK
VGYINELLTKKSLRNVIGKILAETDFPTTVKFLDAMKDLGYSNAFRGGLSFSLGDIVVPV
EKKQMIAQAVENVDEIRANYNMGLITDTERYNQVIDVWTNTNAGLTEMIMSRMKSDQGGF
NSVYMMLDSGARGSKEQIRQLSGMRGLMAKPQKAGSTGAEIIENPIVANFKEGLSILEYF
ISTHGARKGLADTALKTADAGYLTRRLVDVAQDVIVTEDDCGTLRGTEVTALKKNDEIVE
RISERILGRVSLHNIYDPESDELIIEADQVIIEAFAKRIEEAGLEAVEVRSPLTCEAKKG
ICAKCYGRNLATGKTIHMGEAVGVIAAQSIGEPGTQLTLRTFHQGGTAGNVSENPSIVAR
RDGIVEMDEVRTITSEDENGKTAEVVVSRSTEFRLVADNESRTPLMIANVPYGSILAVKP
GDKVKKGDVICRWDPYNAVIIAETAGKVEYEDIIQGISFQLEIDEQTGFEEKVISESRNK
KAVPTLKVVDSKGVEQKAYNLPVGAHLMVNDGEKIKAGKVLIKIPRKSAKAGDITGGLPR
VTELFEARNPSNPAVVTEIDGVVSYGKIKRGNRELIVEAKTGERKIYLVKLSNQILVQEN
DFVRAGAPLSDGSITPEDILRIKGPTAVQEYLVNEIQEVYRLQGVKIDDKHFEIIVRQMM
TKVSIVDGGDTQFLEGALEHKYDFLEENNRVFGLKVVVEAGDSKIFKPGQMITARELRDE
NSKLKREDQALVEVREALPATATPVLQGITRAALQTKSFMSAASFQETTKVLNEAAVAGK
VDELNGLKENVIVGHRIPAGTGLKEYQSVIVGSKKEFEDLN
>KALACAFP_00025 DNA-directed RNA polymerase subunit beta
MSKTTVTTKGTPRINFSSAKGKIITPDFLDIQIESFKEFFQLDTLPEDRRDEGLYKTFQE
NFPITDSRNQFVLEFLDYLVDSPRYSIDECVERGLTYSVPLKARLKLYCTDPEHEDFQTV
VQDVYLGPVPYMTPSGSFIINGAERVIVTQLHRSPGVFFGQTYHANGTKLYYSRIIPFKG
SWMEFTTDINSVMYAYIDRKKKLPLTTLLRAIGYESDKDILQIFDLAEEVKVSKAALKKV
EGRTLAARVLNTWFEDFVDEDTGEVVSIERNEIILDRETILEKEHLDLILDAGVKSILIH
KENSNEFSIIQNTLQKDPTNSEKEAVEYIYRQLRNADPPDEETARGIIEKLFFSEQRYSL
GEVGRYRLNKKLGLNIPTTTEVLTKEDIIAIVRHLIELVNSKAEVDDIDHLSNRRIKTVG
EQLAGQFGVGLSRIARTIKERMNVRDNEIFTPLDLVNAKTLTSVINSFFGTNQLSQFMDQ
TNPLSEITHKRRLSALGPGGLSRERAGFEVRDVHHTHYGRICPIETPEGPNIGLISSLGI
YAKINNLGFIETPYRKVDNGKIDLNADPIYLNAEDEEAKVIAQANVELSDNGEFETDRII
ARLDGDYPVVEPQQVDLIDVAPNQISGISASLIPFLEHDDANRALMGSNMMRQAVPLLKP
QAPIVGTGLEQQVAKDSRILINAEGTGTVEYVDADRIVIKYERSEDEDLVQFESATKTYN
LTKFRKTNQSTTITLRPNVRVGDVVEKGQVLCDGYATENGELALGRNLVVAFMPWKGYNF
EDAIVINEKVVREDWFTSIHVDEYSLEVRDTKLGMEELTADIPNVSEEATKDLDENGMIR
IGAEVKPGDIMIGKITPKGESDPTPEEKLLRAIFGDKAGDVKDASLKADSSLRGVVIDKK
LFSRNIKDKKKRTEEKLKLEEIENTYKAKFDDLRNTLIEKLNTLVSGKTSQGVKNDLDEE
IIGKGVKFTHKLLTSVEDYVNVSGSDWTVDADKNELIKQLIHNYKIKYNDIQGVKNREKF
AISIGDELPAGIMKLAKVYIAKKRKLNVGDKMAGRHGNKGIVSRIVREEDMPFLEDGTPV
DIVLNPLGVPSRMNIGQIYETVLGWAGQKLGMTFATPIFDGASLDQITEYTEKAGLPKFG
NTHLYDGGTGERFTQPATVGVIYMLKLGHMVDDKMHARSIGPYSLITQQPLGGKAQFGGQ
RFGEMEVWALEAFGASNILREILTVKSDDVIGRAKTYEAIAKGESMPEPGIPESFNVLLH
ELQGLGLDVRLEE
>KALACAFP_00026 hypothetical protein
MTKKLFGKITALLMLLAMSVVAFGQGYTPIRGMGVEAKPVNGSGICLACYNGSMNPVIDA
NLDNSVSMGSFATLVSGNGISVKNTNTTYPAGFITGFNVDLGTSVITASFLSNLRISTYK
AGVLQESSNSSTLLSVPAFGGTKTRIFLHFKTTKAFDEVRLYQVNVLSVFSALNIYYAFA
FDPNKVPVDNNGICDDIIAGSGVDGNVSGSSSFLAPLSYVNNREKIGDGDKNSYGSIVLP
AGLLGSYSVGVLDKNQVYPAGNKAGFVIEPDDQGKLLSAEFLKNITIETYLFGQLQDSKN
LSDGGGLINIKVLRFGSNKQKISLTTTKPFNEVRLKVTQTIGVNFGSLKVFYAFEEPQGC
DCNEYIQTSGTSRLGDIVPGASWTGASGTLFGLTNITNTGNVVDTNTSNFSTVNFSPINL
LIPTVRLTVKSNTGDYPAGTFGGFTLTKSANLFTINALDYITITFYKGTTATESRTAGGL
FSGQFITSASNQFYVGFMATKPFDRMKIEINPGIGITLAQQYYIYNAFVQLDDDQDGVPN
CNDQCPNGNDSIDNNGNGIPDCAEGCSAVNDKSPILDGDGDGIADACDGDSDNDGIPDAL
EDLNGNGKFEDDDVDGDKLIVAELGDGVSSYLDLDSDNDGILDLFESGIPTSVINQIDTD
HNGVIDANVATGNNGIADILETSPDSGIMKYPLKNTDGDDKPDFIDLKSNAVDFDLYAIG
KDNLDDLGGGFISRINDADADGIQAVVDTDLVKKGSPDSPLSPYASFAKNSGLMAKSVSE
SEVKSVVNDIKVYPNPVKAGENLNIKSGEEGTYTMFSAQGQLIKSGKFSGDAEVNTSSLP
TGMYIIKVETKTTVKSYKVIVK
>KALACAFP_00027 hypothetical protein
MKNKLFGFTALVFTGFLVNAQVGINTNLGQATLDVVGFPTNIAKLDGIIAPRLTGNQLRA
KNYTTAQTGALVYVTAADTSPAGQTINVTASGYYYFDGAVWIQSTPAQSSDWRTTGNSGS
IGTTTTTAALGTAISSGNFLGTTDNQNLVIATNNSVKAILDVNGTLRGGNANASTPYASI
TWGSNNTLSNTTSSNVALGRENTVAAQAANFPGVAIGAGNTAASGAKVIGNSNFATGANT
VVLGNNNGTSGANVSGINVGNSNVNSGGFAFGTGNNVSTNNYAFGNANTASGAAGAIAFG
LSASATIANQTVYANTAHAFSGQGAIGTAITDVGINMTPSATNIPDLEVSKGILIKPATA
NPPTSTDCNASNEGTIVYGKTGTTGNFYGCKISAGVYAWQQL
>KALACAFP_00028 50S ribosomal protein L7/L12
MSDLKNLAETLVNLTVKDVNELATILKDEYGIEPAAAAVVMAGPGAGEAAEEKTEFDVIL
KSAGASKLAIVKLVKDLTGAGLKEAKDIVDGAPAPIKTGISKDEAEALKKQLEEAGAEVE
LK
>KALACAFP_00029 50S ribosomal protein L10
MTKDQKVVAIQEIKDLLQDAKVVYVADLEGLNAAKSSEFRRQAFKQNIKVKVVKNTLLQK
AMEQMEGVDYSEMFQTFKGNSALMISETANGPAKLIQGFRKKEEKPALKSAFVQETFYVG
DNNLDALANIKSREEMIGEIIGLLQSPIQRVVSALQNKPETVEAKAEEAAPAVEETPAAE
APEAPAAESTEETPSAE
>KALACAFP_00030 50S ribosomal protein L1
MAKLTKKQKEALSKVEKGRIYNLAEGSALVKEVNTAKFDASVDIAVRLGVDPRKANQMVR
GVVSLPHGTGKDVKVLALVTPDKEAEAKAAGADYVGLDEYLDKIKNGWTDVDVIVTMPAV
MGKLGPLGRVLGPRGLMPNPKSGTVTMEVGKAVSEVKSGKIDFKVDKYGIIHAGIGKVSF
DADKLRENAQELIQTLIKMKPTAAKGTYVKSIYLSSTMSPGIAIDTKSVN
>KALACAFP_00031 50S ribosomal protein L11
MAKKVFKMVKLQVKGGAANPSPPVGPALGSAGVNIMEFCKQFNGRTQDKPGQVLPVVITV
YEDKSFEFVIKTPPAAIQLMDAAKIKGGSGEPNRNKVGSVSWDQVKKIAEDKMADLNCFT
MDSALSMVAGTARSMGLRVTGTKPTNA
>KALACAFP_00032 hypothetical protein
MNKKLFSIISIMLANIVFAQVGINTTNPQGIFHIDGGRDNPISGPPTPVQQSNDFTVVAT
SGVGQGTLSVGVGTTNPTERIDIANGNVRIRDINNLTGVGSDRLLVADSNGVLKVAGGEA
FSVLNSGNRILNATNGPTLTAANDWNNNEFTTLTLDEQYDAMNAYNPTTGEFLVPQDGLY
FMYGVCGFNTPANGSGTFDGTSGDAFTALVVDGGRVSTAHNVIYKGTKNPGMTANLFFLV
TNSTLWLKAGQKVTLQFLTYGTSNMVDSLSDLKIDKASSKFIINKIL
>KALACAFP_00033 Transcription termination/antitermination protein NusG
MSELKWYVLKAISGQENKVKNYIETEIKRLGFEQYVTQVVIPMEKVIQIRNGKKVPKERP
YYPGYLMIEADLMGEIPHIIKNIPGVISFLSLTKGGDPVPMRKSEVNRMLGRMDELSEFA
SDVEIPYIVGENVKVIDGPFNGFNGTVEKILEDKKKIEVSVLIFGRKTPMELSYMQVEKV
>KALACAFP_00034 Protein translocase subunit SecE
MSSFIDFLKGSYNEFRHKVEWPKWSDLQSSTIVVTIATVILALFTFGVDELFSKAISNII
GMLINLFN
>KALACAFP_00036 Elongation factor Tu
MAKETFNRNKPHLNIGTIGHVDHGKTTLTAAISSVLANKGLAEKKDFSSIDSAPEEKERG
ITINTAHIEYETENRHYAHVDCPGHADYVKNMVTGAAQMDGAILVCAATDGPMPQTREHI
LLCRQVNVPRIVVFMNKVDMVDDAELLELVELELRDLLSTYEYDGDNSPVIQGSALGALN
GDEKWVKTVEELMDAVDTWIEQPVRDQDKPFLMPIEDVFSITGRGTVATGRIEAGVINTG
DPVDIVGMGDEKLTSTITGVEMFRKILDRGEAGDNVGLLLRGIEKTDIKRGMVIAKKDSV
KPHKKFKAEVYILSKEEGGRHTPFHNKYRPQFYVRTTDVTGEIFLPEGVEMVMPGDNLTI
TVELLQPIALNDGLRFAIREGGRTVGAGQVTEILD
>KALACAFP_00037 Cobalt-zinc-cadmium resistance protein CzcA
MNKFIKNIIAFSLKNKAFTFIWVAILAVSGFISFKNMPIEAFPDVTNTQIVIITQWNGRS
AEEVERFVTTPIELAMSPVQKKTSVRSTTMFGLSIVKILFDDGVDDTFARNQVNNQLRTV
SLPDDVDPEVQPPYGPTGEIFRYTLQSKTKDSRELLTLQNWVIDRALRGVPGVADINVFG
GQDKVFELSIDPRALDKYNLTPLQVYDAVTKSNLNVGGDVIEKNGQAYVVRGIGLVKSIN
DIGNITIQNDSGNPVLVKNVAEVHESSMPRVGQAGLNNQEDTVEGIVVMRKGENPREVLV
GVKAKIKELNEKILPKDVKMVTFYDRDNLMDFTTHTVMHNLIEGIVLVTVIVLIFMADWR
TTLIVSIIIPLSLLFAFLCLKLAGMSANLLSLGAVDFGIIIDGAVVMVEGLFVMLDHKAH
QYGEEKFNKMAKGGWIKQTGTGLGKAIFFSKLIIITSLIPIFSFQKVEGKMFSPLAFTLG
FALMGALIFTLTLVPVLSHILLNKNVKEKNNPFVSFWDRIVLKGFNYTFKHKKMSLIVAI
SFLAVTLFSGKFLGTEFLPQLNEGSLWITAEMPMSSSLKESLKTADLLKKDIMSFPEVTD
VLAQTGRSNDGTDPNGFGFVQFAVNLKPKEDWKRKITYEELIEEIDKKLRNYQGITFNYS
QPISDNVAEAVAGFKAENGIKIYGDNLETLDRLAEEVLKQIKDIQGVKDAGIIKNIGQPE
VSVVLDRDKMAAYGVMPDDAQSVLEMAFGGKTASEMFDGERKFPIRLRYSQEYRKDENDI
AALMVPTQDGSKIPLKEISNIVKDNGAAFIYRDDIKRYIGIKFSIRDRDLGSTIADAQKA
VSKIELPDGYSVGWTGQFENQQRASKRLAQVVPISILGIFFLLFILFGNMKDSLLVLANV
PFALIGGIIALHVTGINFGISAGVGMIALLGICIQNGVILITEFHQNVKNGLSLDDAILQ
GVKSRTRPVIMTALMASIGLMPAALSTGIGSESQKPLAIVIIGGLITATVLTLLIFPIIF
WIFNRTKKSLQI
>KALACAFP_00038 Cobalt-zinc-cadmium resistance protein CzcB
MKKYIVLVMVALSVLSCSKKEEKTKPQAKKGFELSNTMLQSISLAKVEKKYIEDNYNFYG
KISADKNSYIDVYPLVGGNVLSVNVELGDHVTKGQVLATIRSTELAEVQKDVSDAKTDLV
VAQNNLRVAKEMYEGKLNTEREVLEAKSQLQKAQDQMQRANAVSTVYNVKKGNIYSVVAP
ISGYIVQKNINKDMQLRSDRSDNIFDVANTSNVWAIMNVNESDIDKISLGMKAQVSTLSY
PDKFFDGKIDKIFKIIDPETNAMQARVVLDNQNGLLIPDSKATIKVTSSENAMALTVPSK
AVIFDDNRSFVVVYKSRTDVKVKEIKVLKQVGDITYVSEGLSEGEEVITNNQLLIYRSLN
S
>KALACAFP_00039 Cobalt-zinc-cadmium resistance protein CzcC
MNKIAGLFIVISSFMTAQQQMTLLDCEEAFQKNNLQLLAEQYNINMADADILQAKIWELP
QLSGQINAYNPEDRKFFDIGHAKGAQITQLIYMGGKKKNEIAFAKSSKELAQLQFSQLLV
DLKAQLHTTYYNLYYEKLKLENTEKQLGYMNDLLAAYKVQAAKGNVSLKDEVRLQSIVIQ
LNNDKLGINKNIIEFEQNLKILTGITDDIEPQLSDADAKNILAAQPFGDETELQRKALEN
NADYQYNLKLIDNSKLYAQWQKSLNVPDLNVGAGWDQNGGTFKNEVNLMVGIPLPLWKSN
RGNVDKANFAIQQNQKNADFQKLNLETKVQAAYKTWKNQYDQLTGITLTDLNNMDLVYNG
MLKNFRNGNVSLIEFTDFMESYRQTALQIYDMKNEIMQSAEQLNQLVQTKIFY
>KALACAFP_00040 Signal transduction histidine-protein kinase ArlS
MSLKRKIALNLSIAFSLLFGIVMAVIYMSFNDFRRDEFKERFRQRLEFTSHFIAKSKDFE
EEAPVFFNENSDNILLNETILIFNNKKELIYSTIKDRNVTWDDGLLKELDEKKVIYSEKT
VPEIYAALRTINGENYYILTSALDSNGKSKLSYLKYLLITAYVMSTLLIGFFSYYFMGQF
LKPLEDLNQEISEVTAHKLTTKVPVRDSNDEINVLARSFNTMIGRLDDVFQSQKDFTASA
SHEIRTPITRMAFQLENLIKLEQHSPETLSSLKQIQQDVYQLSDLTNSLLLLTKFDKENI
QSIYEEVRIDEVIFESFEAVEKSYPNLKMDFLISEETSENALLTIKGIQSLLDIVFINLF
KNAAVYSQDTEVDVLITETNENLTVDVISRGETIPQDEQTKLFEAFKRGNNSQNISGSGL
GLRIVKRILEYHSAKITYLSPNENVNQFSVIFNK
>KALACAFP_00041 Response regulator MprA
MNILLLEDDLILSAELCKFLESNNFTCDKIYDGETFLRQIKNNTYNMYLLDINVPKINGL
DVCQTIRSFDKNTPIIIISAYGDLSDKKDAFTRLADDYLVKPFQFEELLLRINSLLRRKA
PSENNDQDIIRIDDLIINKTEQKVYRGGNEITLTLKEFQLLVYLAEAQGRTVSKQQITEH
VWEHNFNTNTNTVEVYINFLRKKIDKDFKIKLIHTRSGFGYYLSPL
>KALACAFP_00049 hypothetical protein
MKITVHSIGLTPHEPLESHIDKKVSKLDTFYDKIQECKVFLKVENNADKLNKTSEIILVV
PGDDIVVKKTCATFEESLDLCVDTAKKLLIKKKELA
>KALACAFP_00050 Tyrosine recombinase XerC
MRSEFLFLYSETMLNKFLEYLQFEKRYSPHTITSYKKDLEDFSHFYLKTESSEDISKADK
KVIRNFIVELSENNISKRSINRKLSSLRSFYLFLLKIGEIKVSPTESISSLKFYPEKQIP
ISKEEMQTLTDKVFEQMHDILEKCIMEVLYQTGIRKAELCGMMFENVNLDGNELKIIGKG
NKERVIPISADLSDLLKSYLEIRQPQTEYKSYFFVNKKGKKLTEKFVYVVVNKYLSLITT
KEKRSPHILRHSFATHVLDNGAEISKVKKILGHSSLASTQVYTNANIEQLKKVFNQAHPR
ASKKEEL
>KALACAFP_00051 30S ribosomal protein S21
MLIIPVKDGESIDRALKKYKRKFDKTGTVRQLRSRQQFIKPSVTLRQARLKAAHKQRALS
KEEQA
>KALACAFP_00052 hypothetical protein
MVFEQKSYLCIYFIHGVDWFRQQGQWVSKHAENRSAISLIPCYKILTGNEEFALAA
>KALACAFP_00054 hypothetical protein
MFSKFNLIELLKDGFSEIRVSPKIFYTIFWHLFFPIMLSIIFLLFSVTIDNDIISNIISA
ISIFSGLLFSVIFVVTENYSKRKNQMSRNQSDEAQSYLKRYKDFTEQITTLILFSVAIAI
ISIVFLLLYIFLMKANLQGLQVVKEVKEFIETGDIDYSKVKSIVLLFLQTLSFIFLYNYL
LTIITLVKEVYAMVFDDINYD
>KALACAFP_00055 hypothetical protein
MAQNLKLEIFKIAIKKRNSRSKEFLNFKDLFKSIGEEKEEAYLQFISDYRGLFDGKFKTD
GKGTKSISTTNDNNFTPRSTQNIIDGEIFGGSIGNLETIYDLNNAIEEKGKIGLDQIASV
PFFVKLWTPFDHNSGILMIQSYSDYTVSELFKIVLRKFITGYGFTLVYSPFTPKDIKDQY
LKNSHVYEMKIIKDNISRGKRKIINPIFADEKNLKITVTVSGFKHNVTDFWSKLKGQGIN
KLIGANLEDLDISEQNGYDLKAYYKDEDGHLANVGINKTLDITPTIFLPDEIKSNETHHY
DYVKIKKFTDGILNKIKREIGYKN
>KALACAFP_00056 hypothetical protein
MINSEETILNQNNREEVIKILDEKKIKVELEDLFLYDLSPYYKENLDNSFFSKQLEFIQE
TNQLSHNSKISFTSEQLKIYNGILENRRCIVSAPTSFGKTMLIKEFIFNNQPNKVVFIVP
TNSLADELLDDFKLLFTALDYIIFDSVKSLEVISEKSIFIGTQEKYYNLKGFYKEKIDLF
VIDEAYKLTDSIKGSREVILNRSFIDTIENSEKIILLMPLVNSITGLENFTFQVLKSDYA
PVAKSFNSIKKLDQTIYQEISKNEITNLVYFNSPKELERIYLSKLKSIKNSIELNDSWIQ
RVQEDFHSEWLPIQALKSGIGIHYGPMPKFIQKKVIDLFKSNQLKNVLATNSVIEGVNTP
TKNIYIYSSRDILGDKNLVKYKNLIGRAGRLGEHKVGNIYYFEKHQKQFENANVSYENIN
IEFLLENKSDIIEINRDENFDKEKNTEGKTSHEDKLQKHLENSSYSNVPSKEIISLLNNH
GFTVNQFTILLEYIANTKNVLLLGIIGKLIGGTDINSLNTILSSRFNTFGSMVNELHSKN
KQKFKSQIISILIDMIYSFLPFKIIPLINFIIDVDDLYKKHTNKNLIPTEVIVEAKRKKA
QFYSKFIGIDNPTHETLVIMNKLFEYGIPYQRANPFLERIADNLPNKFSIHDIRKIIFQN
ENMSDLRVYFE
>KALACAFP_00057 hypothetical protein
MSFSIAEKKKSSCGKYNFSIYEHSLTFEDLDSYILDIMYEETNLNYLFQKDRPLSRKDRL
RQLRRFIETSFENREKDVDDDEIRKFISDNKNETYYSFFAEALLARLNIDYIDKDLVTGV
ISVNENLTKISTGADVCMFSNSSLVLGEAKFYSLLYGGVGKIIKDVSFKSKLEDYIKNIL
NTDSVIILKGITGEISEKTSEDIKKMPLTLSGFVLHTSETDIKKYDTSYNLIDKVAISNF
PTHYKIHLYHLPIESKNELIFKAQRKALDLIIKEIIS
>KALACAFP_00058 hypothetical protein
MNESLDEIERYVIKRVKEIRESKNITQEELSLSIGKNIGFISQIEAPSKKAKYNLIHLNL
IAIALGCSIKDFLPNEPIPDKKYDIKEIKSKKS
>KALACAFP_00059 hypothetical protein
MKTTNSQPKKLTDFQLYVQLKKGNPASLEHIHLRYKRLLFWIGKQMLDDDFVVETLVQDT
FLKLWLHRDSIETPNHILGFLRFVLKRDCITYFNTPKNKFARLTASLENFENYQDYLIGF
DPQNDKENLLNQESEQKKFDEVKKVVNVLDPKRKHLIELCLEYGFQYKPIAEAMGSSVTS
ISNEVSRAINDLRKILNRSSLELPTEKASGNKEQTEKLSSQQIDIINRRFEQKSSFAVIA
RELKLSEKEVHQEFLCAYQYLQNRNNSEITT
>KALACAFP_00060 hypothetical protein
MEESTITLTRKIQLLIDVPSDQKNEMWEKLYRYQNRCFRAANLISSHLYIQEMIKDFFYL
TEEIQYKLVDEKKDQMGMFNRSKTGTTARMVFDRFKGEIPTDILGSLNNTIQSTFSKNKA
DYWQGAKSLRNYKRDIPIPLPVKCISKMKYDPDKKAFCFNMFAIPVKTYLGKDYTDKRAI
MERLLKGDIKLCTSQIQLKDRKIFWLAVFEFEKEEHLLNPEIIAEAYLSLEHPIVAKANN
TRINIGSKEEFLYRRLAIQASQKRIQEGIAYSRSGNGVKRKQKALYKTENLESKYVSHRL
HLYSRKLIDFCIKQQAGTLVLKNQEDKIGIAKEQEFVIRNWSYYELQTKIKYKAEKAGIE
LIIG
>KALACAFP_00061 TonB-dependent receptor SusC
MRKITFKIGLLQSTLFCLGLYGQNSDSIKTTKIDEVVVTAYGVKKEKKALGYSFQDVKGQ
TLVDAKETNVTNALVGKVAGLQVIKGGFGPASSSKINLRGLNSFKGDNQPLIVVDGVPLS
NNLGTKPKQNDGYYNNDFWNPDLDMGNGLSDINPDDIESVSVLKGGAASALYGSRGGNGV
ILITTKSGKRKGGLGITYSTSLGFETIFMKPDMQHSFAQGSNGVANPPNDPNGTTSSWGP
AFAGSDMTVYDNLKSFFKTGINSQHTLSFQENLGEGSSLYTSANYLHDNSQIPNSKYERF
NFMAKMNSTFGANKRWTSEMKAQYISTKANNRPSGGSGDGNYYPRILLMPQNIDINDYRE
GQMQNGVNSRWITSNGINPYWSAYNSLNSDKKDRFLLNGYLKYQFNDWLSADVRLGTDFY
SLNADAKVWTGSSRKNSYGTSEEKFYENNYITSLTAKKDNLFGKWGGSLSVYGQMMESRT
KAIYFSTQNLIIPNVFSVDNTSDLAAVATNEVDFRKKINSVFAAAEINYDGYWYINATAR
NDWSSTLNIENRSYFYPSISTSLVLTEMLNKLNGTTSKILTFAKLRAAYAVTGNSLNPYE
LYNTYTLSTDPNGHIILSRKKILYNSNLQAEKLKTFEVGADLKFFNKVSLDVSYFNNNAT
GQLIDLPMNPLSGYEQAKISSGGLHNSGIEVVLNTDIFKKENFIWNINANFSKLKSIIDK
IDGTVSKYPLAGFDNVGIFAEVGRPYGAIYGTKFLRVEDVNSPYYGKLIVDQNGLPQATP
DQHYLGDQSPKALFGFTNSFVIKNFGLSFLIDGRIGGEFFSATQSALQRVGLAEDTAPGG
RRDNIVLDAVVQGGSGYTANTKEITQQDYWTAVTTGNLGITEQNIYDATNIRLRNVQLSY
NFPKSIFEKLALQSAKVAFTANNVWMIYSKAKGVDPESVFAINSNAVGFENLAFPTTRSY
LFTITLGF
>KALACAFP_00062 hypothetical protein
MKKYILSFLAVTVLSVSCNDFEDINNDPFSVDINKAEPEYFLNNSILGAQQDPNIAERVF
VLYWKTAARQHLTTGIAGGTYDDSWTSEYWKYISEWLNNANAAIQIANEKKALGQGKPYY
DNIIQVSRIWRAYLMSEFSDNFGPQPIQAFQGTNPTFNSEKEVYYFILDELKDAADKMDL
NQAAPSNPNAYDMVYGFSWGKWVKYANSMRMRIAMRISEVDPVKAKTEFEAAANSNMFIA
SSTDNFTVAEKPGWDALTGVMSREWNSQILSATLNNIYIGLGGINTTSQLPAAQHPAVKA
ADYVGIKYDQQFTTMTNDPSAGYWLDGLPNKIDPRAYKTFYIPGDLTNPIYSLYPTYTNE
ATTNYGNLTFADNSQITINTVNTWNAYTIGNWGVKGQRNGLRNVIGCMPALGKQYRESKN
SRIFFASWESYFLIAEAALKGWATPMNDEAAYNKGIQDSFTYNNVSQFYGQYIASTDYNR
DGTSVAYNHTTEPGASHTMQYKDPSTNNLVSVEIKYPVNTIYKNGAFKNDKLTKVITQKY
IANMPWLPLESWSDHRRLGLPFFENPAIEAPLVNLPNLNAGNYMTNSIKNFPQRLRYPST
FRNTDQTGYDKAVQLLGAEDAVLTPLWWAKH
>KALACAFP_00063 hypothetical protein
MKLKTYFFNTKFFVKSAFFVLLISFCHLQSQRTLTVGGTNWTVTIPSITEAGSNYTGTYE
SATNQILLAASVPLLLGSGKVSVHYEANPTWNSNLILHARRTGNGTTACLTCSITGGTIY
ITVPLTTDVELFRIQAIVALASYTNIPVQLELSGVSVTIPATTYNSRVVFTISAL
>KALACAFP_00064 hypothetical protein
MKLFKLLFLIFLGFSCTIFSQTTGNRTVAVTLPVVTLMDVEPAGTIAINFVAPTDAGRPV
TAPAANTAKWINYTSAIAPGGLSRRITASINQVLPGIDIKIQAATASGSGGGTLGTPSAQ
VTLTTTAQTIISGIGGAFTGTGANNGHRLTITLSANTYANLSARTNTPVVITYTITE
>KALACAFP_00065 hypothetical protein
MIKNWILYLILLFPVLIFAQKKDFVNKKDSLLPGTSTSISFTIENTAPESKIYDLKVETS
SSHITPILTNGELKISANEKSVYIVPLKIATETPQGKYSVFLSGIEKNTGEKFVKSSAFF
VSGTRKISLTTLHYPEFVKAGETIKATFLLKNNGNLSENLILESKNAVVEENTSLVLPPG
ESKIITINKITNPDLGKNEYQNLNLSVYSLDNPSENQTAYTSVKIISVKPVEEDIFHRFP
VAASISFIGMRNRGEYDDGFQGEIYGKGSLDKDNKNLLEFHAITKNPVEFNSFTQYEEYF
VNYKRDNFFVHLGDKNYSSSFLTEYARYGRGAEIRFDLKKISFGGFYNHPRFFRDIKDEF
NVYSKFKIAKESEITTGYLYKIPRTENVDVSFSNFRLDSNAHLPYVAGKFQLTKNFEISG
EASYSKTDKTDGNAFMLQAIASFEKISGNVMYMKASPEYAGYFNNTSTFNGNLQYNLSKK
INVLATYVQDARNFQRDTLFLAAPYRKFLQYGIQYRYMKSGSVMLYNGFQRYEDRLMPKE
FDYKERFFKVSIDQQIGIFQLNLEGQFGKTDNYLTGFSGNSSFYTANIGFEKFKTSFNIY
GSYAITSRYQLQNQKQVYYGARILSRFSDTTSFSLFYQNNYMPEDYYTDRNLFEILFHQQ
IFRGHEIDLSGRYTLQRGELGNKDFIFSLRYTLRMNVPTQKIAEYTTLSGNIKNLGVKKV
DGIRLMLGNHLSITDRSGNFIFKNVIPGDYVLEMDRSTTEIGDIPDVNVPASLVLTEKEN
IFNFGLTSAANIEGNIQYSENQASFAQLAIKKDKKKKENLIIEASNGDQTYRKMAVIGEN
FDFTYLRPGEWKVKIYRNGLDKRYKIPIDEFRFNLKPSEIKKLTIHVIKQQTEVKYQQET
IKVSYNETKKRK
>KALACAFP_00066 hypothetical protein
MLIFLLPVCLLRANIVILNGLTHNYKVENGQVYKGKISLENTSSQPQSVKLFLQDFTYQS
DGSISYTAPNTNVKTNAEWIKLNTNLITLKAKEKTEVFYEITVPKQLSNAGSYWSVIMVE
PVENIKPSNEKEGINITSIVRYAIQVITDFDSEKAKPDLKFEGLKIERENGSQILKVAIA
NNGNLYCKPTATIEIYKKDGQKLGVFSSQPMGLLPQTSKSFHIDISKMPAARYNAVLIAT
DEDENAFALNVELEVKND
>KALACAFP_00067 hypothetical protein
MMNFTNFTLPNHNIMKRIKFTLALSIVAVAISANLSAQDTNTDNHTVTISVPEVALVDIE
PAANKNITLGFTAPTEAGLPVTPTGTNNTLWLNYSSIKSVADATRNVSVKVNAIIPGIDI
RVTAAAATGAGGGTLGTPSAQLTLSAADQTIISGIGSAYTGDGANNGHNLTYALAPGSGP
GTVASYADLEATATAVATVTYTISDN
>KALACAFP_00068 Non-hemolytic phospholipase C
MKRREFLEKSGLLLAGLGTSNVLHPSILKALTIAPAAESTFYDAEHVVILMQENRSFDHA
FGAMKGVRGFLDQRTFIKPDGHSAFFQKGDSGKYAAPARLDLRNTKSTWMSSLPHSWSDQ
QKALNKGKYDQWLQAKASGNKDYKDIPLTLGYYNREDLPFYYQLADAFTIFDQYFCSSLT
GTTPNRLFHWSGTIREQKNGKVKANVYNENIDYDKNHQARWKSFPEILEENTISWKIYQN
EISLPKGMSGEQEAWLSNFTDNPIEWFSKFNVKFSRGYYQNIPNIISYLKKEIEKNPKQK
ERFETLIAELEEDKIKYHPDNFAKLSPTEKNLHEKAFTTNINDPDYWNLEEGQDENGDKL
VVPKGDVLFQFRKDVEDKKLPLVSWLVAPEHFSDHPGSPWYGAWYISEVLNILTKDPETW
KKTIFIINYDENDGYFDHVLPFAPPMNPSQLVDFDGKEGVEYVSINQEYMASPNIKDKEK
IEGTVGLGYRVPMIIASPWTRGGFVNSEVSDHTSVLQFLEKFIQKKFNKNVTVDNISDWR
RAICGDLTSSFNSSNVKIPQIDYLNQKDYAKTINSAKNKPVPNLKWYSENELNNNLLEIQ
ERGLKPSNPLPYNYHVNFGSGKISMINVKERAVPLLIYDRTQFNNDNFHFSYALYSKQEL
SHAVKPGKYDMEVFGPNGFYRHFKGEDDPQLEISLNNISSKNQLELLIKKNKKESADIRL
DLENGYEKKKTEITLTMIQEKIIIDLNKMKGWYDIKLVSGKNSWHFAGRIESGKPTVSDP
HWA
>KALACAFP_00069 hypothetical protein
MKNIIKSIFVVGLLALTSCESNLDTINENPNDQASVDPKYLLTYVSSNAFQVNGDNMYAS
RMMIGTDGENTYQYMKWSDASFDVYTKGLLNTVKMMQEAEKLNNKNYQAIGKFYRALYFF
NLSLKFGSIPYSEAVKGESGITQPKYDSQETVMAGILTELKEANDLINQNDKIEGDIIYN
GDATKWKKLINSFRLKILITMSKKATIGSYNVATEFASIAGSQTLMTSIADNGELKFVDA
ADSRYTMFNNSGYGSSLYMANYFIDLFKTRQDPRLFTFAAQTTGAKEAGKPITDFTGYNG
GNPTSPYSDNAALITAKNISKVNDRFYKDATNEPSSVLSYSELEFILAEATARGWISGSA
KTHYDNAIKASFSFYQTYVKNPGLYFSGFDVNNYLATPLVVYDNSAPLATQLERIMTQKY
MTMFHQSQWTSYYDYLRTGYPNFPLQTGVSAPFRFRYPQSEYNYNNANLKAALASQYGGN
DNINSKPWWLQ
>KALACAFP_00070 TonB-dependent receptor SusC
MKKTLATFAVFLLPLYLTAQEINISGNVKSENGSGVSGVNVTDKNTGKTATTDENGNFTI
SANPKDVLEFFSPEFSTYTIEVSNKRNYSVVLKKVNEKQIEGVVITALGIAKKKEKIGYS
TQEVGTKQFETITTPSIGNLFSGQVAGLNVSNPTGMQQAPQFTLRGNSNLVFVIDGVIVE
KEVFQNLDPNNIDNINVLKGATASALYGSRGRYGAVLITTKSAKKKGFTVEFSQNTMVTA
GFTNLPKTQTEYGNGSHGKYEFWDGADGGVNDGDMIWGPKFTPGLKIAQWNSPIRDKVTG
QVTPWYGAVTGTQYDDKSRYERVPIDWKYHDNLDTFLKPAVINNNNFSISYKNNKDVYRL
SGNFMNYDDRVPESYLQRYGVNFSSENHLGEKLIFDTKFNFNQTFTPNIPNYDYNPSGHM
YTILIWMGGDVDGRDLKNHMWIPGKEGTAQANWNYAWYNNPWFGAEYYKNKNRTNIINAQ
TGLEYKATKDFSVKGKISIVENHNKQEILSPYSYFNYSAPRSGGYILNDTKTWNLNYDVL
ATYKKKISENFDFTINAGGSAFYYKNDVDNASTDGLKIPELYTLDNSVGAVKYYDYLKEK
LIYSAYTTIDVGLYNAFFLNVSGRNDWSSTLPKANRSYFYPSASLSAVVSNLIKMPESIS
LLKLSASWAKVAYDFQPYSIRNYYVNNGGITFNGNPTYYYPTTLNVENTLKPEQTKSYEL
GLSAGFFDNRITLDATYFRTLDYNNILQFPSAQPSGFTSKYVNGNEYTTKGLEISLGLTP
VKTSDFTWKSLINWSTYEQKLTSIYDNMPVYNNIKLGERMDSYYDYTWQKSPDGKVILNA
ETGMPTRANTPTNLGHFNPDWTFGFNNTFKYKKFTLNIGIDGSVGGVMRSQVVEKMWWGG
KHPNSTQYRDLEYANPGTYYFVPDGVNYNAATGTYTPHTKAISFQDWAQNYPYQARVTED
ESEEFANVFDRTFVKLRSVVLEYDFSYLLNPRGMVKGFTANISGYNLAMWKKSKNLYSDP
DYKIGTGNDIQDPSSRWIGVGFNLKF
>KALACAFP_00071 hypothetical protein
MKLILKIFFVLFCVFVQAQKKHYFLIDSETKVKKKVKDSLSAAKFLDSLAQNNYFFTQLK
EVNIKGDSTEIIYDKGKNFNETYVSLTDSIVQKTKNQKEFFTKNLDSTKKNINKQYIDDG
FAFSRIKSKYKGQKNGYPIVELDINKNDKRTINGFVVKGYTNVPKRFIKNLEKEFKGKTY
DDKNLIAINKSFQSHQFITLERPPQTLFTKDSTSIYLFMEKKKTNSFDGVIGFGNDKSDK
FTLNGTLNVNFKNIFNSFESINLYWQRNPDKGQTFDLQTDIPYLFKSNVGLNMKVNIFRQ
DSTFANVKALPALYYHLNSRNKIGLRGTFESSSIIDTLYVQGKDYNKKGIGIWFEMIEPT
DIDLFLYKTKINAGYDYLTTTYTKDNIKSPQNQFYFFGEHNYHINGNHFLNIKAEGAMMD
SKIEFSANELYRFGGWNSMRGFNENSLAADFYYYGSLEYRYLIGNQAFFDVFGQYGQLNN
KSLNVKPKLYSVGLGFNFFIPIGLMSFQLSNGNEFGNPFKFNDIKIHWGILSRF
>KALACAFP_00072 Fatty acyl-CoA reductase
MVIIITGTSSGIGFVLAEYFGKKGHHVYGLSRKHTESQHFKSIPTDVTDNDAVQNAIAEV
LKTETRIDVLINNAGMGMVGAVEDSSKEDILKLFNLNLVGAVQMMSAVMPKMRENKFGKI
INVSSIGSEMGLPFRGFYSASKSALDKVTEAMRYEVYPWNIDVCSLHLGDIKTNIAENRV
RTKVSEPYKNVFDKVYALMNSHVGDGTEPLEVAEYIDTLLAKNKWKAHYYFGKFGQKIGV
PLKWILPQGTYENLMKKYNKLA
>KALACAFP_00073 hypothetical protein
METSIHTFIHLLFTGIIALFPVVNPIGSAFMVNPYLQHLSNEDKKAAVKKITLYAFCVCV
MSLLAGHYILELFGISIPVIQLAGGIMICKMGWEFLSAKNDEKSDVDKNDMQNDMGAQSD
ISNKLFYPVTFPVTTGAGTISVLFTLSAHSKALSINNYLINILAIIAAVLFMCILIYIFY
LNTKKIITFLGSSGEKIVNRLTSFLIFCVGLQIAVSGIQTLVMEHIGK
>KALACAFP_00074 3-phosphoshikimate 1-carboxyvinyltransferase
MKTLEKSKLTGNKTIQISGSKSISNRLLILESLFKNIKIGNLSNSQDTQLLKKALSEDTE
IVDIHHAGTAMRFLTSYYSIMEGKTTILTGSKRMKERPIKNLVTALQNLGVEIEYLENEG
FPPLKITGRKITQTTVDVPSNISSQFITSLLLIAGKLENGLEINLVGEVTSRSYIEMTLD
ILTKFGIKNSFTGNTIKVEPFTHNHSSIIDYEVESDWSSASYFYSFAALGRETIYLKSFY
KESTQGDSAIAKIYEDFFGIKTIFTEEEHKLSLIPQPNFQFPEKIVLDMNNCPDIAQTLC
VTAAALKIPFEISGLGTLRVKETDRLQALYNELKKLGTETEITDLTIQSVSFNEPKKNIS
IKTYQDHRMAMSFAPFCLIKELNIEDEDVVEKSYPDFWKDLDSLLET
>KALACAFP_00075 hypothetical protein
MEITNLQQQVDEWIKTIGVRYFNELTNMAMLTEEVGEVARIIARRYGEQSEKESDKSKDL
GEELADVLFVTLCLANQTGVNLQEAFDKKMKVKTDRDKDRHQNNEKLK
>KALACAFP_00076 hypothetical protein
MDFNIIKIVGLISLIICYIFVRRFFKRVANYTETAGESLETKQEKEGEIKRLNNKIASLE
EQLKK
>KALACAFP_00077 hypothetical protein
MKFKLLLAFSFWMLIMAVSCNKDDISFDAPSQELSFSKDTVFCDTVYHQVRSETYAVKVY
NNEDKDILIPRIHLEKGATSLYKINVDGKPGYDFKDVPLRKKDSLYIFIEIAPEATGPEA
IAEDKVLFESPAGNQQVVLFSVVQDAEFFIETPTNPNVISADATWTNNKVKIIYGDLTID
QNVNLDIQPGTKVYFHKNSGMKVLSGASLNINGTLANNVVLRGDRNDPAYDTIPKNWNSI
RMEAGSNLTMNYARLLGGTRGLDMKQTNAVISNSFIHTFQEYGIYAVASTVNAKNLVMNN
CGESAIGIFKGGTHNYIHSTIANYSNLLHSYNRNGIFATNEWTNTSGQTEQGALILNVRN
SIIYSDRDNSVNFEQTPGQLFNFVFENCLLKYSNTSEAGFPFDSNPSVIQSIKNQDPLFV
NYFAAQMQLRVKQNSPAIGKGSPAVAATVPTDIANVSRTSNPTLGAYQYQ
>KALACAFP_00078 50S ribosomal protein L31 type B
MKNGIHPENYRLVVFKDMSNDEVFLCKSTAETKDTIEYEGQEYPLIKMEISSTSHPFYTG
KTKLVDTAGRVDKFMNKYKKFAK
>KALACAFP_00079 hypothetical protein
MQLVFSDAQYWEDFLPLTFTRPVAEMRCGILTFSERWQKILDNTEISYFTENYLQNKFRN
PEEKESLFLVTNFLPTQQVIQQIKDLKQGEALVYEDELIAARINMKDFSLNQIEKMTDIK
EELTFFKKPTDLFTYNDKAIDFDFELLTKGKTSQELSSTNGFLGDKKDLFIEEGAQIEFS
TLNTKTGKIYIGKNADVMEGCNLRGPIALCEDSQLKLGAKVYGATTVGPHSKVGGEVNNI
IIFGYSSKGHDGFLGNSVVGEWCNFGADTNSSNLKNNYSNVKLWNYRTKSFEDTGLQFAG
LIMGDHSKTAINTQLNTGTVVGVASNIFKEGFPPNLVENFSWGGFKDDERFKLDKAYEVA
ERAMARRKVALTDDDKAIFKYIFDTY
>KALACAFP_00080 ECF RNA polymerase sigma factor SigH
MTQETFKNTVFILKNEMYRFAKRFVMSSDEAEDVVQDLMIKFWQKKDELEQFGNLKSYAL
KAVRNECLNRLKHHDVKRGFADMQLHRSELYSMEVNNLKEHIISFINQLPEKQKMVIHLK
DVEEYEVSEIAEMLEMEENAVRVNLMRARQKVKEQISQLMSYEQRQISK
>KALACAFP_00081 hypothetical protein
MDWDFEDFLKKAEGKEDEVQKDETPIIPIDTKTKPSFPKWFWMAAGVILLLSIGLIFNIN
KNSDVEDQAQLVENQIKDQKNDFIEENSEHQEQVAVNNTTDSISGTKKDSIFQENTVAEK
DVLDEILPKRGRLKKERKPKYVDNSSYRKYKKASDSTGYKDSYVIVNGKRIDNVEEAINV
TKYSFQIFANNVSEKLVQPKVVDDDY
>KALACAFP_00082 hypothetical protein
MKKIILIFALAFSHFFNVYGQKDKDKLDQLFEKYQEVEGVTSIKIAKPMFGMLSNLDLGD
AELDQIKPLLAKITGLKILIAERPANATNAKEQKLTQINKDISSYLSNLNYSEIMTVNSN
GAKIKFLSAEEKNGILDDLLLSIDSGGEENILMKLDGKLSMDDINKIINSSETNTNPITN
TRSSLTSENTSSYLSGESRSVGEFSGIQVSTGVNVVFKQESPTNVKVIADADKLQYIVTK
VDNGVLKVYVDNKGQKNLKFKNISVNVSSPRMDNIKTSSGSTFTTINSVRENNLSIDASS
GSIVKGKFNIANDTKVEATSGSDIKIDINSKNFDFKGSSGSSTKFDGQAGMANFDISSGA
LCKADNLRTNQVEAESTSGGSLSINVVDKLKARASSGGLIKYRGNPEITSDINKISGGTL
KQID
>KALACAFP_00083 hypothetical protein
MKILKNIFLIACMMLLLQSCVVSERPNMAFFSESGHDFKGAKFVSINVPMLLAKPYIKKA
LKEDGESEEIINLVKKVSKIKVMTVENGDRQMLKDFASYLNDNNYEEWATIKHDGDNVNI
RVKQKGDAIKNMLITVNSDKELVFVDVKGSFTADDISKMIASATDK
>KALACAFP_00084 Inosine-5'-monophosphate dehydrogenase
MSIHNKIVETAITFDDVLLVPSYSEVLPNQVSLKSRLTDKITLNVPIVSAAMDTVTEAEL
AIALARVGGLGFIHKNMPIAEQAAQVNRVKRSENGMISDPVTLSKDHTLGEAREMMAKFK
ISGLPVVDAENTLIGIITNRDVKYQEKLDMKVEEIMTKDNLITSDKNTNLEQAKEILLKN
RVEKLPIVDKNNKLVGLITIKDIDNQLEYPNANKDGSGRLIVGAGVGVGEDTLDRIAALV
QAGVDIIGIDSAHGHSKGVLDKIAEIRRTYPDLDIVGGNIVTAEAAEDLIKAGANVLKVG
VGPGSICTTRVVAGVGVPQLSAIYNVYEYAKSKNVAVIADGGIKLSGDIVKAIASGAGAV
MLGSLLAGTDEAPGEEIIFQGRKFKSYQGMGSLSAMKRGGKERYFQSEAKKFVPEGIEGR
VPHKGKLEDVIFQLTGGLRAGMGYCGAKDIEALQKDTKMVMITGSGLKESHPHDVIITQE
APNYSL
>KALACAFP_00085 Disulfide bond formation protein D
MSTLRIPVGSNDHVQGNLETAKIVLVEYGDYQCPYCGHAYPLVKRFVEEYGDEVAFVFRN
FPLTDSHQYAMAAATIAEAAGKQGKFWEMHDLIYENQNHLNEEMLKESVKSLGLDFNKIE
NDINTADLQDKIENDFEGGVRSGVNGTPSFFVNNQKWEDYDGTYDSFVELIS
>KALACAFP_00086 Putative peroxiredoxin
MILEKGTPAPEFELHSTPDQKLKRSDFLGKNLILVFYPADWSPVCGDQVTLYNEMLSIFH
KYNADILGISVDSSWCHDAFMGDRKLHFPLLADFNPKGEIAKKYGVYNEENGTSKRALFV
IDKEGTIQWSYLSPDGINPGADGIIDALENLK
>KALACAFP_00087 hypothetical protein
MKKITQIILIISLIYTALLLYFQYDYFLKLTPIIIILLTINFYLIYRYNSKILNYIFNGL
LFIFLIICFSFGVALRQDW
>KALACAFP_00088 hypothetical protein
MKKYITEKITTVLSVLLVSNTLIAQASNTENYISEKTCFDADCVKNTETINYFDGLGRSK
QTVGVKASPTEKDVVTHFEYDAFGRQIKNYLPVPQSGTQNGAIYTSPLLNASTVYGPEKI
YSENVPENSPLDRIKQRIQFGNDWTSHPENYTYGANTVADGVRKFTTSTTWENNATKSTL
GTAGNYIANQLSKETVIDEDGYSTIEFTNTNGQLILERREITVGDYVDTYYVYNEYDQLV
FIIPSQANIYSDLVTNTTRQADLCYQYKYDGRYRMVEKKLPGKGWEFILYDKQDRVVATQ
DANLRAQGRWLYTKYDKFGRVAITGIGTGATTRLAEQNIVDGLNSNNVERTGSSVFNREG
MDVYYNNQDSTYPNSTKWFKILTLNYYDQYPAYDFNPTFPTSILGEPTLTQNEVSENVST
KSLPVLNLIKNIEDDRWTKKYTYYDKKGRVIGLNTINYLDGYTRLENELDFIGQTKQTKT
FHKRSTTDTEVVIKEDFEYDNLKRLKKHWHQVNNGIPELLTDNTYNERSLLSNQKLGNNL
QSIDYEYDVRGWLTKINDPANLGGKLFGYKIKYHNPDPLLGIQEAKYNGNISEVDWKTAT
DGILKRYTYKYDGLNRLIYGKSYQPLSTTLNIDYYEDIEYDNNGNIANLVRGKKGTGNTS
ITEVIDNLTYNYEGNKLITITDETGNTSGYPGGGNIITYDTSGNMTSMLDKRIKQIDYNF
LNLPNSIQMNAAIGVGYTLNHIYRADGVKHQKQYMRGSTFITTDYLDGFQYEHSSLLPTT
PDLKFVPTTEGYYSFENNKYIYQYKDQVGNIRVSFYKDTNGNAVIDDAVDFYPFGLEHGT
IATSIVTPSYKYSFQGQEKQIHTGWSSFKWRNYDPSIGRFFNVDPLSEKYAYQSHYNFSE
NRVIDARELEGLEAVDFRKNDGYKNLVVVVQGHSGDTVKGHTQARNRGDGSVDKNGLGAL
NQLSSKDTRVVIFDSSQNENTKDDINSTISSFNKNHPDGDVTAVGHSLGGDNLIEKTNEN
KDLKINLMITLDIMDFYSDTTIKSKNVSKVMNYYQTKDFYGGEKVTVSEDNKKTKVTNIH
APKSTHKSIDNDLSKKIVKTVKDEINKPK
>KALACAFP_00089 hypothetical protein
MKKRLILVSALLASLLNAQGIQNYQNFGGNFFPQSPNSTPFAVAGKYPINMYRGVPIINV
PLFNEEHGESNFTMSLSYNVKSVKPSTVPTWVGLGWNLDIGGSITRIVNGGVDEVYVSGV
VPNNRYSYLDNYSTLDNSNWDSQSALQNYYSANLQVILQSEPNVVPNPDEFIVNVGGLTG
SFYLNEKGKWIGRTRDGRTLKIEHQYKFDYVLPEKTILGSSYIGTTSHNLKRMLYGFAVT
TDDGTKYIFGLDDTAIEFSSNPETVDLSFNPHIVPSAWNIKEIIYPTGKSTKFTYERDER
SVFVVNRSGNRSYYSQGSSSGSIGNSASSGNLLALHSNRLNNVFLKKVEGEDFIVNLNRS
LANQKEYEQFDVPTNEWVPPYTHHISAYYNFKHWYKLDNVTVTDKAGKIIKNIVFNYNND
PTDRLMLNNVTINTIEKYNFAYNSQKLPKYISDATDHWGYYNGTSFYESNVNLNVPQDQM
KNIFLNVYPTYKVPNLNLSKAQTLEQITYPTGGTTTFEYELNDYSKYGDKDINETYLKIY
PTSTNEIAGGLRIKKIKSCNENNNCINKTYSYLNDDGITSSGVLPYKPIYLLDGYEPSVN
LSFWEFNYNSFQSLKNEDNSIGYSKVTEIDDNGGKKETYYTNLEQTDYKDKSGNRYYGWL
SPILFKQLPYLSYSLMRGKPLKEIVYSDTNKISETTYTYTQQTDYLRAYAFNSKQFGQVQ
AWGPWSNAGGVSYGALLDAHNINFNSSFLSQKKTVFENVESTVQNFYNYTYNTPTSTWKT
QSDGTIYVTNYKYASDTNNTAMLNAYMVGVPVGQEIKKNNIVLSKTETVYPTSLPTTQTG
NLLLPLSETYFDPQNIAPSTEITYDKYDTDGNVVQFTTKDDVPTTIIWGYSKTQPIAKIE
GATYDQVQPYITGILTASENDFMPPAGMTSDQTETAMVEALNIFRKNPALLGYQITTYSY
DPVIGVRSITPPSGVKEVYKYDSNSRLERIEDVNGKLLKEFKYNYKP
>KALACAFP_00090 hypothetical protein
MKKNYTGALFLCTILSTSAQEVVWQKDIKSSTQDFLSQVTTTIDQQYLISGSSIQAGGQK
IGAGSKQNNGYDYHFIKLNQQGEEVWEKYFSGQNHDFLSATVATQEGGFLAAGTSYSGKG
LDKKDDSKGGTDIWLIRLNEFGDELWQKTIGGASDEEARAVIQTTDFGFFVAGSFVSAQD
SKMKGYGSKDVLIVRLDKNGKELSQLTLGGKGLDEVEKMIPTKDGGALLGIYSRSNQEGS
KKTENFGEGDYWIIKLSKDGKVEWEKNFGGKGDDHLRTLALTSTGYLIGGESRSERSGNK
SVGIEEGTDLWLISLDERGEEIWQKSYNFKNRDVLMGMSGISGMMEDGSGKSKGILLGGY
TQAEGRIENDDETFWMLYLDQNGNEQWRKHVKGESRKKEERLSDIKLNKDGSIILAGTSA
EELGKENWKIVKLGDKQIDQLIEKQDIKIYPNPVTDYAYIEIGFDFKEADIVLYDMGGRQ
LQSLKTKNKVTKINTQALIQGAYLITIKTDTNKTANSKLIKK
>KALACAFP_00091 Beta-agarase D
MKSLYLLCLALGSSAFAQTITFNGCHNLFDADNTFIFNKIGVDAYNKNIYMTTPINDQQS
CSGLGICEFKIQWNNALTRWEFLADEGYGTFTNPLLIYYNSTGNNNFVGNPPSITFGTWV
ENTAVTQPAGGCGGNLTPSNSTMTGDVHSTSLAVSDVKADSKIQIFPNPVADVIRISGID
NGQSVQIYNMAGQLVKSEVFDQKINVSQLTSGIYLLKINTKNFQTHEFKFVKK
>KALACAFP_00092 hypothetical protein
MKKLALACTLLISYALAPSLKAQASDPYLGQIAFVPYNFVPKNWAACNGQLLSIAQNQAL
FSLLGTTYGGNGTTTFALPDMRGRVLVHEGQAPGGATNYTMGQTGGAESVTLLVTQMPAH
SHTVNAVTAEGNQNTPTNNLPADTKGLDKEYSDATANTTMKSTMVNPTGGTQPHENRPPF
VTLKCIISLVGVYPSQF
>KALACAFP_00093 hypothetical protein
MKNNQPTINQVNHKINWFQKFLMVCSGGNIHILRKTPSEWNKFSGIGGIVLFTAVFATLS
AGYAMYTVFDNIWASIGFGILWGLMIFNLDRYIVSSIKKTGTWGNQILMAIPRLVLATFL
GIIISKPLELKIFEKEVNKQLNTIIQRNKKQLQGEMNGRILQQSGPFETEKKQISDKIAQ
YQKSYDSAAVELEKEILGKQSGLTSGKEGFGPNAKRKQELKEQRRQDLETYQKQVAPRLE
YLDKEISKVYTNLETERKSTETFEDKFNGFAARLQALDELGKNSAIIGLAAAFIMGLFIC
LEISPVLVKLISHVGPYDYLLEKTENDFRLYSKEKIEKGNALTDFRIDDFKDNLHK
>KALACAFP_00094 hypothetical protein
MKKNVFLFALMIFFNAFSQNTQKYCGFDDVMQKMDSKFPNLKKIRNEADTRFSTMDKNSY
LNKAGATTSWNGLYTGQIYEIPVVVHVIESNASANANLALTDQEIINWIDRANKMYATTY
GNGFYPEGSGPTGGNVIPFKLVLAKRSPSCTPTTGIVRYNGSSLTGYDAYGVKAQGANGA
PDYMIKNQLAPHWPETSYFNIYVVIGFDGQQQLTYGLMGYATFPDTYDYNYESFMKVATI
KNNNDTTLTHELGHAFGLYHTFEGVNYNNQTSCPANNNCATDGDRVCDTSPSRSMYGVAV
PDNTATDPCTGQNYDGTQYNIMNYTNSNKKFTGGQRDRALLMMMEYRKNLLNSLAGKDPS
IVVPSPVSVASAQCNPAGTAHPANNNFAIGPYRVVLGSINSITNGYDSDEPAPIFYADYS
TATCIRPAYYTDIPANTATPLKVYSMNGFPQSDKFKTKVWIDYNNNGAFEASELVVDNTS
AVMTSGATNTVTTNITPPAGAVKNTYLRMRVGVDAATYTSAPLPDFGACSQVQYGQMEDY
AVRIMDVLGTSEVKDHTETKIVFVKAENKLKLFGNKNDIFGDYQILDMSGKIIQKGNSKT
NEVQIIQELPKGGYIVSFSNNNKKESKKFLNN
>KALACAFP_00095 hypothetical protein
MDGNSKKSYPLQECEKKYSLVFEKSNNNIILTKNYAAGKDCKLKSNSGKISIIIEESSFS
YLDLDLKRKDQYKILSKNKFSILYSEILDGKVREIEDLYERQ
>KALACAFP_00096 hypothetical protein
MKNVTRFSLVCLIMVLISCKKEKTIDDELKEAAANMNKMTPQILNEGVRLDSVSVLPNKV
FKYNYTLTDDVKENVTPEEIETFKKEAKEEALKVVRNSGDMQEFRNNDVTLQYSYFDKNG
KPTADFIIAPAEYKGK
>KALACAFP_00097 Crossover junction endodeoxyribonuclease RuvC
MIAEKIILGIDPGTTVMGFGIISVKKGKMEMISIHELLLKKYPNHETKLKYIFDKTLALI
DEFHPDEVALEAPFYGKNVQSMLKLGRAQGVAMAASLYRNIPITEYSPKKIKMAITGNGN
ASKEQVAGMLQNLLNLKEFPTKYLDASDGLAVAVCHHFNSGTIADTKSYTGWESFLKQNP
GRLK
>KALACAFP_00098 hypothetical protein
MKNLMIFLTLPFYFFYSFLQVKEVKDTGENPAMRTLSKSPQIVYLFFKVEKTNSGVEKIT
LQEKKITEGKLKSVPNSDENNGQNGDFIVSFTNANGKEIIKQIVEDPLNPSREVYDRDQI
SRNKISLQNAEFSVRYSHSDEIQMVKIQKISETGKQLLFTQKL
>KALACAFP_00099 hypothetical protein
MKKILLSLFIGSFCFAQVFETVPVLQNGTNDKRINIAVLGDGFTTAQLSTFVTSAQNTVN
YLFTKSPYTEYKNYFNAYAIKVVSPESGVKHPGTASDVTEPVFPVSNPNNYFNSTFDNGV
HRCYYGNTTKVTQVLAANLPDFDVAYVLGNSPEYGGCGGTYAFASLNSSSNEIVVHELGH
SFGKLADEYWFSGSGESANKTQTSNPATIKWKNWIGLNGVGVYAHAESPSWYRPHQSCEM
RYLNQQFCSVCKEAIIEKIHALVSPVDSYTPANSSTVNANSNVTFTVTEILPIPNTLVNS
WTLNGTPLASTSNSVTITPSQLNNGNNTLLFSVNDNNPLLKINNHSTIHFTNVTWTLNKS
TLKTVDIKAKERRFSVYPNPAENEFYIKGKQDFSKNVNVILHDMSGKLIPVKFDLKDAST
LSVDINNLPVGTYSLSVTDDKELIISQKIIKE
>KALACAFP_00100 RNA 2',3'-cyclic phosphodiesterase
MKKMYFIAIYPPQEIIEEVKVFKKDLALNYGNSKALKNDAHITLFPPFSRELDLERDIHE
AFQKIDTNISPFELTLNGFGSFGNPKNPVLFVQPENNNQLKDLYLRVRERFNFMSYSFNP
HMTVGYRDLTYDNYLKAWEVYQEKEYKTRFLVDKILLLRHDQKWVPIAEKKLSIH
>KALACAFP_00101 Putative penicillin-binding protein PbpX
MIIKTLRIFLIISILINLISCKNEVKVKPVDKKAIVDSTITVFQKNLLKNQIDSVFKKYN
FNGSVAVFKDSVQLYRKDQGFSDFKNKIKIDSNTVFAIGSVSKQFTAALVLLQMEQGKLQ
TDDKVSKYLPDFQNKDYQNITIHQLLNHTSGLNTLGEKLHFKSGTDFLYSNEGFNALGKI
IEKVSGKSYDENVMELFKKAGMLHSSTGNLFKGNDFAGAHLRNGKKFVEIQNMPKRLASK
DIGIPAGGILSTIDDLHTWNNALYNGKILTKETLKKFTSQSAERHHPVFGKMGYGYGIMT
NVEKPVTYYHSGYVKGSPSLNIFYPETKTSVIILSNIADEEKGKNLIFKPYADIKKITDA
IENSVVQMKKDTTNVLAVH
>KALACAFP_00102 hypothetical protein
MGDFYFNMKPKAIFNWSSGKDSALALYKTLQEGKFEVTSLLTSINKEFQRISMHGVHVSL
LEKQAESLGFPLIKMELPKEPTMEEYREIMGKTMNEIKSQGVIHSIFGDIFLEDLRKYRE
DQLKTIGMEGVFPLWKIDTTNLIHEFLNLGFKTIVTCVNETYLDKSFAGRIIDKHFIKDL
PENVDPCGENGEFHTFTFDGPIFKNPVQFEVGETVKKTYPKPKSDENDETGEYIFWFCDL
ISK
>KALACAFP_00103 hypothetical protein
MKISFKGISFLITISLSSILFAQKRTEDFTISLPTQKLNRSFYKTITVIDNRIDTASIGI
VQQGALNAKARVVPTSPLSNQFQSVLNSVNGENAEDGSLVLYLKQLYFAEVSKAFTEFGY
CYFQGFLFAKNEDGTYSLLEKTDTVVDHKAADVTKEILRKGSDMLGEFIAKNASRKPETT
EPHYTFDQIKKFDDIDKQSISLFNSSQLKDGVYKDYLSFKSQQPQQEITNVKFYGNMPKI
VRIYETVDGKEREIKKDDIYAIIYKGEPYIYLPIENLFTKAEKRDNDYYFVGKLRSGGPN
MANLSIGMFFGAVGVLLASNPAYPFEQKIDYINGAFIPIKEIQSKKY
>KALACAFP_00104 Fused isobutyryl-CoA mutase
METQKYTPKNKVRIVTAASLFDGHDAAINIMRRVIQGTGCEVIHLGHDKSAEEVVNTAIQ
EDANAIALTSYQGGHNEYFKYIYDLLREKNSPQIKIFGGGGGVILPEEIKDLMSYGIDRI
YSPDDGRELGLQGMIDDLVNRSDFATGKDVTEKDLDSINFENPTSIAKIISAVENFSDEK
PELVQAIDEKSKDLNIPIIGITGTGGAGKSSLTDELVRRFLRSNTDKKIAIISIDPSKKK
TGGALLGDRIRMNAINDPRVYMRSMATRENNVSVSPFIHSALNVLKLAHPDVIILETSGI
GQSGSEVSDFADVSMYVMTPEYGASTQLEKIDMLDYADLVALNKSDKRGALDALQAVRKQ
FQRNHLLWDQQLDEMPVYATKASQFNDHGTTELYNRLVSKVNDKFSGLNLQGFVEQEITD
EVTIIPPKRVRYLSEIVENNRQYDANVEKQAELARKMYHIEGVKNFLSNETLDAEYQKAE
KDLQQENIDFLKSWDDTKKAFHEEFYSYFVRGKEIKVETSTESLSHLRIPKIALPKYNDW
GDLIKWKGQENLPGSFPYTAGIYPFKRTGEDPTRMFAGEGGPERTNRRFHYVSAEMPAKR
LSTAFDSVTLYGQDPALPPDIYGKIGNAGVSIATLDDAKKLYSGFDLVNAMTSVSMTING
PAPMLLAFFMNAAIDQNVEKYIAENNLEAKVEAKLKEKFDDKGLARPRYNGELPPSNNGL
GLKLLGITGDEIIPAEAYAEIKAKTIATVRGTVQADILKEDQAQNTCIFSTEFALRLMGD
VQEYFITEKVRNFYSVSISGYHIAEAGANPVSQLAFTLANGFTYVEYYLSRGMDINDFAP
NLSFFFSNGIDPEYSVIGRVARRIWAKAMKLKYGADERSQMLKYHIQTSGRSLHAQEIDF
NDIRTTLQALYAIYDNCNSLHTNAYDEAITTPTEQSVRRAMAIQLIINKELGLAKNENPL
QGSFIIEELTDLVEEAVYAEFDRITERGGVLGAMETMYQRSKIQEESMHYEWLKHTGEYP
IIGVNTFLGKDGSPTVLPGEVIRSTEEEKQAQIETLHNFQKANESKSEEALRKLQHAAIN
QQNLFEVMMDAVKYCSLGQITNALFEVGGKYRRNM
>KALACAFP_00105 hypothetical protein
MKKALLYFALGTVLSFLINYFFYSSKNIGLDLYYALAFGFAWGIAYYLDTPNFSLPQKLG
LSFLAMGVMVAIGTLIFNLEQAIPSVLKFSTVFVAYYLIASFRANKTLRD
>KALACAFP_00106 hypothetical protein
MSHGKLREEKNCLNCGHLVEERFCPHCGQENIQPKQPFHYLFTHFIEDFTHYDGQFWKTI
KYLLIRPGRLTKEYLEGKRQSYVAPVKLYIFISFITFFLPSLFGDSEEAQDHKKKTHASQ
EIDKEKAREEKIAKFTDSLAQHFSKDQLQKDSLTKVQDIKVSEINGNDIETDALEETEDG
KMMVLGAKNMKQYDSLHNINSRNRPVFVFLKPFAEKIFHMQEQGMNKDQIFDRFSDTFVH
TIPKALFVYLPLFAFFLWIFHNKKKWWFFDHGIFSLHYFSFLLLGTLILIFYSKLSNLLP
DNGFLTILNIIIYTAAILYISLYFFVAHHRVYESSRTMSVFKGIFLFLINSIGIMCMFLI
LMYVSFLMMH
>KALACAFP_00107 50S ribosomal protein L13
MNTLSYKTVSANKATANKEWVVVDAEGQPLGRLASTVAKILRGKHKTNYTPHVDCGDNVI
VLNAGKVTLSGNKWNDKTYIWHTGYPGGQKSMTAAELQKKDSLKVLEKSVKGMLPKNKLG
AAILKNLYLYEGTEHKHEAQQPKTINVNEFK
>KALACAFP_00108 30S ribosomal protein S9
MSTVHKIGRRKTSVARVYVKPGTGNITVNGKDAKEYFSTDVMVYKLNQPFILSETVGQYD
VTVNVFGGGNTGQAEAIRLGISRALCEINAEFRLALKPAGLLTRDARMVERKKPGQKKAR
KRFQFSKR
>KALACAFP_00109 30S ribosomal protein S2
MAKANVKDLLEAGVHFGHMTRKWNPNMAPYIFMEKNGIHIVDLHKTAVKLDEACNALEKL
TSAGKKVLFVATKKQAKEVVAKHASELNMPYITERWPGGMLTNFVTIRKAVKKMNSIDKM
KKDGTFETLSKKERLQVDRQRANLEKNLGSIADMVRLPSAVFVVDILREHIAVTEAKKLG
IPVFGIVDTNSDPRKVDFVIPGNDDASKSIDMILSVVSEAIKEGQSQRKADKEKSKEEGE
KVSADTDADFDGE
>KALACAFP_00110 hypothetical protein
MKKLLPFSTALIAVFLTSCGSTNYNTKQPVRKPSYPTSNTGSSNTSATQVEREYQALIKT
YKSETAEVLTDLLNDSSDSPKTAITVENKSPCNMVLTISGNNYFKKIPIGANKIGSAMVL
KNQNYNLSGMVCNSVYQKTKFVTSSYNITISN
>KALACAFP_00111 hypothetical protein
MKNFKKISREGLKNIVGGIRNPHEAEDQITMCYSLLYCYSTSASDTAPIVWHVGTAQPPA
DANNAHICGWTPNGNMAGCP
>KALACAFP_00112 hypothetical protein
MKKIHVVVSLCLMLISCSTNKNAHKNANILESKNIAEIENFLKTAHPEDPRRRVLKPKLI
ALKNLEWTKGKKDAKPMEARPVISEIPNSVMKNSNSAEAEEFKNLIASTSKEHKDKTVKL
LNAMFNEDISSKEVILLFKNQSDCNLVLRIQGKDFYNMAVPAKGENFIVINKGNYTLTSN
VCDVVYSSKKEINKSIFLTINNPEHIGTKNSLSKK
>KALACAFP_00113 tRNA (guanine-N(7)-)-methyltransferase
MGKNKLARFAENKILPNVIQPTREDALNGFELKGKWRTDFFKNDHPIVLELGCGKGEYSV
GLAKTFPEKNFIGIDIKGARFWFGAKEAVEAGMNNVAFLRSQIELVEYFFGENEVDEIWI
TFPDPQIKYKRTKHRLTHPDFLNRYKKFLKPGGIIHLKTDSEFLHGYTLGLLQGLGYEIL
TAHHDIYGAPEYDPKTEHLRDIRTYYEELFSAKGKTITYIKFRIN
>KALACAFP_00114 hypothetical protein
MKKLLLLFSVIFFAHLSAQSRGKDYSEILKSKSIYEINAFLRDAHPDDPRRSVLKPRVMD
MMKEYIKNAKPGDQKVKQMQDWLAMLKRRPSTKISFEEMNAIIKQKQIAKYQKQLQMGQA
AVVYTPSTPKNVFIEPTTPEVAKPSAAIPDAEASEFNMLMAENPVEHKNKTVKILNSLFD
NDPNTKECIVMIENKSDCNIIVRMDGIGNTKYRLPVPAHGDNSVVVQKGDYLFTSIVCGA
QYASQKTIQKALMVALGSSAKK
>KALACAFP_00115 hypothetical protein
MKKLFTLLLLIFLAKINAQIYSGEVFLRDNSILYLNQVYVTNLTTQKTVLTDYNGDFNIP
ANPGDVIRFTSIVTERKDIKLTPQMMGPKNLIELKIAYREIQEVVISRFKPTGNLRYDVN
SLKKEDKGLAIKKVIGLPEPKGDGTPPQLPVAGLRDGGLTFSLESIYDILSGERKKKQRY
VAYERMNNSITQIKNYLGKDYFTRFKIPENLIDNFLQFVYSSENIEPYVLAGNFEAVKIP
IEKYLPIYQKRLKNSHLQEVIK
>KALACAFP_00116 hypothetical protein
MKKILSFLFIFYFFTSTFAQLDREHWFAPMVDRTGNPNPYQKLYLSTNRTTPFPVSIYNN
NTLIATVNISKGNPQKIDILRNYIITTLQADLFTPITKGLYVKAEFPFYANLRFSVFNHA
EIITSKGIPSTGKLFYAASAPISVTNSILNFMTSVLATEDNTVVTISGYKPTTQFSNGTT
GATTPTITFTLNKGQSYIIDGNGINSGNSDGFIGAKIVATKPVNVTNGNFNGQYAGNFSS
SSDILMDQAVPVERLGNEFALVKGNGNIGSHMEGALVIATEDNTEVRVNNELAPITVLNT
GQYFMIPDSKYQLQGNGHYNLYIRTTKNAYIYQVLAGANNVGNEVATGGFNFIPALNCYL
PKQINELGFIDENFVHSNANPGGILNIPTKLNLITEKGAVVTVNGVTPPATTGPFNMTGT
NNWVTYGIPNTVGTITVVSSKAITAGINAGSDAVGYGGFFAGFPTQPVILKSGGDCIPGI
VLTVDPIIYDTYQWYINGTLIPGATGTSITPTQPGYYTCSVTMGSCAPLVTEQFKVLNCT
KETSTTYDFCTSKTITPAFTNSTQTPVPSTVAILTPPTLGTATVNATTGVITYTPTNPGT
PATDTFTYTFCGNDVNFPDCETVTVTLNIQVLTVNNVAINACNVNGTGQGVFNLTTANVT
GSSPVTITYYTSLINAQNETPGTSIPTPTTYTAANGTIVYAVVKNNIGCKNIAEITLNLF
PYAVVTDNYSGVFCDENVDGTVNVTLSDITAIVLSNPAYFTGVRYYASLTDANAGNTNTL
PNNWSYTTTTTIYIRVDSPDGCPPVIKPLTFNVAGKIPLIRTTLSVTVCDDDLDGIKLMD
LLPYMTQYTIDPLVTFSFHGSLADAQNDLAPIGNPMNLTGVQTIYIRFEKPGECPNVASI
TITIKIPKKSDILVDKIICPKTKTTLDAGPGFDSYLWSTGATTPSISNVGVGSYWVDLTV
NGCTYRQNVTVTESPLPIITTIEINGTTVTVGVGGGTPPYQYSLDGVNWQDTNVFTNVPR
GNHIVHVRDSNRCEEVTRPFVIINLINTITPNSDGYNDTIDYSALMDNDNVEFRIFDRYG
AEVFRGNSANRFIWDGKITGRPVNTATYWYFISWTEFKGSTTVKYTSWLLVKNY
>KALACAFP_00117 hypothetical protein
MKKQLYSLVLFLFTFIAISAQRDTEHWFAPFSAANLSSTAKQAVYLSTDSATPFNVDIYN
NNVIIATVAISKGNPQSYNITAADMIGSTAGDLFTVGTKGLYLKGEKPFFASFRFVVPAH
GEILTSKGKAGVGTKFYAVVAPITNPTQGMNFTTGILATENNTTVTISGYSPNVVFTNGV
TATSTPSMSITLNKGQSYIVEGRGNVTGNSTGFIGSKITSDKPISVTNGNFLGEYNIGTS
LTGGDIVMDQSVPVDRLGKEFVIVKGFGNIAAKTEDVLLVATEDNTEIYVNNNPAPVATI
NEGQHYRVNEPNNVNYIDQGSGHYNMYVRTTKNAYVYQLLAGTATSSATIGFNYIPPLNC
LLPRKIDEIGMIEWLPQAANNIKLNILTEKGAAVTVNGVTPTAAQGPYDVTGTTDWVSYS
LTGVTGNVTIISTKAVTAGIAGGSGVVGYGGYFAGFSSVPAISKSGDCVPGAILETGDSF
ETYQWYLNGNPIPGATTYTYTPMQPGNYTVKVGMGGCFATTPVYEVESCYEQVTKSLIVC
ETQKTIIPKFTNHTVPFIPSTVQIDTAPTNGTATIDAATGTITYTANTNFIGNDLMVYHF
CANPTTGVGCEQVTLHLKVDPNPTVKNVTIQSCYLDSNPNMAAFNLETAPIVTQTGYTIL
YYPTLADLNNGTNVISNASTYISSNTTVYANVTNSNGCSSIAQITLVVLPPVKSTVLSDK
IICIENKATLDAGPGFDGYRWSTGETTQAITVPVGAYWVQLKTGECFTRQDVKVLAAEQP
VISNLEIKNNTITVSVIGGTQPYKYSLDGATWQDSNFFGNLPRGENSIYVKDFYNCEPID
VTVTVPNLLNAITPNGDNKNDYIDYSELAYKKNLIFNIYDRYGNKVYQADRFSAYKWDGT
MYGKKVPTATYWYEITWTEPNKAQTQIKYSGWILVKNLE
>KALACAFP_00118 hypothetical protein
MKRFLSFVLMLCALNTLFAQRDTDHWFAPYYDVSTGGVYNHVLYFSTDATTPFEVKIYNN
NTVIGTVTISKGSPQTFALNANLIRTTAASSAAVPTNLGVYTKGDRAYFVSLRAAVSSHG
EIITSKGKAGIGTKFYAAATPVTVPATDKNFTTGILATEDNTIVTVSGYDPNISFVNVPS
PTPLTLTVTLNKGQSYILTGLSTTTPVNRDGFIGAKIESNKPVSVTNGNANGFYATTTSS
DGADLIMDQSVPTDRLGNEFAMVKSISTSSANMEGGIIVGTENNTDIYLNNGTTPVATID
EGEYYRILANEYKDQGGGHSNLYVRTTKNVYLYQLVGAGSANNTGGFNYIPPLNCFLPRK
IDEIGRINVMPNITSAITLKLNILTEVGAAVTVNGVTPTAAQGPYPLTGNTQWVTYAITG
ITGNVTITSTKAVTAGVNGGYSSAGYGGYFAGFSSIPLIAKQTGDCIPGIVLEVDDSYDT
YQWYLNGTAIPGANSNTYTPAVSGNYTVRITVGSCPPAVTPVYKVYTCLHESTKALTVCE
GYKAIIPEFTNSSQTYVPSTVTIVTPPTNGTVIVDPSGVIGYTPNFGFTGTDTIVYKFCG
NDPDFTDCEQVTLTLTVSESPVVTNATLRSCFIPSNPATALFNLTLAAVTGQTGITKQYY
PSPTDAQNGTNEILNPTNYIAPNGVVYIKVSNANGCYRVAEVTLIVLPPVYSNVLEDKII
CIEDTTTLDAGSGFTAYAWSTGATTQSINNVGVGTYWVDLKTGECITRQTVKVYASEQPV
ISSIDISNNTVTVNTVGGTAPYQYSLDNINWQNSNVFTNVPRGNSKVYVKDDYNCDPIDV
EITVPNLINVITPNGDGVNDILDYSELSYKPNFVFNIYDRYGTKMHEGNKANGYKWDGAV
GGKKVSTGNYWFDLSWNEPNSKKTSIKYSGWIMVKNRE
>KALACAFP_00119 hypothetical protein
MKRFLLSLVLVFLTINTLFAQRDTEHWFAPMMNRTGLTGGTNNQAIYLSTDSTTPFPVDI
YNNNTVIGTVTISKGDPKVFVVPLATIITSSQADLFTPITKGLYTKGTKPYYANLRFSIP
SHGEILTSKGKAGIGKKFYAAAAPITDIGGGGIYNFMAGIMATEDNTVVTVSGYSAGVTF
SNGTTGATTPSMSFTLNKGQSYIIEGRGNITANSSGFIGAKIESDKPVSLTNGNFNGQFS
WGAVGGSSDIIMDQSVPVDRLGNEFVLVKGNGNVTAQMEDALIIATENNTEIQINGGPVV
ATLNEGQFYRVNGPNNGNPANNVNYIDQGNGHYNMYIKTSKNVYVYQLLAGLATSIATLG
YNYIPPLNCFLPRKIDEIAFINDLNGSASPDIKLNILTETGSTVTYSTNGGAPITPTAAQ
GPYPVQGTSAWVSYSIPGLAGNVTVNSTKAVTAGIAGGSGAVGYGGYFAGFSSIPVIAKQ
SGDCVPGIVLEVDDSFETYQWYLNGVAISGATQATHTPTQAGNYTVKVTMGTCPPVTTPI
YKVFSCVKNTTATLNACATKVITPTFSFNTSQTPVASTVTILTYPTHGTATLNPSTGQIT
YIPNAGYLGADQIVYQFCGNAPEFIDCEHVTLNLNVVPFVLNDATIKACQYDGKGFFDLT
TAIVTLYDPVVKKFYPTLADLNAGTNMITNPTNYLSAAGFVYVKVTTNEGCTGNAKITLE
FLPTPTVNEATLSECFLEMDETKAKFDLTIANVSSVTPITKKYYPTFTDANNGTNEIMNP
QAHISGDGAAYVRVYNSNGCYAIAKIILKVIPPKRSPLLVDKTICIDSRTNLDAGPGYAS
YEWSTGATTQVLSGVPVGTYWVILEDNGCFVKQFVNVKKAEDPVIKELEISNNTVTVHVT
GGKAPYQYAVDAPTNWQDSNVFTGLTRGQHIFYVKDSYNCTPISVEVTVPNLINAITPNG
DNKNDFIDYSELAYKNNLSFVIYDRYGNKIFTGDKFNNYKWDGKHYDKKIVTGTYWYHIN
WNEPNKEKTPIKYTGWILVKNID
>KALACAFP_00120 hypothetical protein
MKKLLLTICTFLCLLCNAQLDTDHWFAPMSSKAGTTGLQGYLYLSTNETTPFSVQIYNSN
VLFTTVQVSKGNPAQVSIPNSFLITDNPSDLFAPNAMGMYVKGPKKFFANYRFSLQNHAE
IITSKGLAGLGTTFYAGMAPLTGVAFYVNSMIGVTATEDNTSVVVSGYNPNVVFSDGSSS
PTKTFVLNKGESYILDAVSTDSNYNLNGLVGAKIEATKPISVTNGNFNGIYTNLNFTNND
VLMDQAVPVERLGKDFVVVKGNGSVFSEMETALIIATENNTQLTINGTGTGITLNAGQYY
MVPSSNYIYQGGTDNYNMGISATKNIYVYQFLAGVSGGNEYPTGGMNFIPPLSCFMPNKI
DEIGFINRIGSQNYSTRLNIITQTGATVTLNGNAIAAANGPYPVNGNPNWVTYSVPNVTG
TITVNSTKSVTAGIAAGSGAVGYGGYFAGFSSIPAITKTGDCYTGILLQVDNTYDGYQWY
LNGSPISGATTYSINPEIYGAGTYTCLVTKNNCESKLTTGYDYTLCPPITTTTYNIGACN
TKVISPAFTTSTQTITPSHTSIVAAPTSGTATVNSATGEITYTPNPGLTADATDTFIYYV
EGSGNPADFEYFKIIINIDVLQTTNGALTSCADASGNGTFDLTSVSVSPDPGTTVQYYTN
SALSGTPIATPATYNGPAGTIYANVTSQYGCTKTAQITLTTIPSPNINTNNFNATLCDDN
FDGIVNVNFSNITPVIVTNSASFNVRYYLNQTDANAGNTNTLPANWTYTANTTVYVRVDV
LTGNCPAAFGQINFKIGNRITLLTGTATSDVCDNDISGSESVNLNDYKNLFTTDPGVTLT
FHATLANAQAGTNAISPIQTITSTSTFYIRFTSATECPNTGILTLNLKTPKKSDRLKDQI
VCPNELVTLDAGPGFTSYTWSTGATTQTVTVGAGSYYVDLGFNGCIYRQYVNVTTAQPPT
ITKIEVSGYNATVFASGGTPPYQYSLNGIDYQSSNIFTGLSRGMHTAYVLGADGCSPVVK
EFLILNLINAITPNGDGLNDVLNYSDLRIKQDVSIEVVDRYGALVYRSADKNYIWDGKVN
GRPLSTGTYWYLLRWIEPDTKLPVSYSGWVLIKNRE
>KALACAFP_00121 Elongation factor Ts
MSYTPAAADVAKLRNQTGAGMMDCKKALVEAEGDFEKAVDILRKKGQKVAANRADRESTE
GAVIARVNEDNTLGAIISLNCETDFVAKNEAFIELAYELAEMAIFAATKEELLATDFHGI
TVAEKLVEQTGVIGEKIEIGAFERITGPFLGAYIHAGNKIASITALSAKVDGADEAAKSV
SMQVAAMNPIALDETAVSQETIDRELEIERHKLTEEGKPANIIENILKGKMQRFYKDNTL
VHQDFIKDGSMSVADYVKSINGDLKVTGFVRVSL
>KALACAFP_00122 hypothetical protein
MKKIFLLIFLCIFTLGFSQKKKKAKSKAIVEKETAIIYTESDAETTSEARVIAGFLKQNP
GHAKTDYFKKKLIQIIMADNSPEAKPTIKAVSEDKIKQEILENNSLNSSKTIAANTASAA
APERTVTYASVGGASKKTGPSEQHKKTAAMLTHMFNNDPMDKEAYINIKNRSKCNLIVKI
SGKKYYNLDVPANGQNFLLVDKGEYILTTMVCDAKYSSLKKINKDIEIELNLRED
>KALACAFP_00123 Acetyl-coenzyme A carboxylase carboxyl transferase subunit alpha
MEYLSFELPIKELMDQLQTCSLVGEESGVDVKLACSQIEDKIIEKKKEIYSSLTPWQRVQ
LSRHPDRPYTLDYINGMVDKGSFLELHGDRNFADDPAMIGGLATLDGQKVMIIGTQKGRT
TKERQHRRFGMPNPEGYRKALRLMKLAEKFQIPVVTLVDTPGAYPGLEAEERGQGEAIAR
NIFEMVQLKTPIFTYIIGEGASGGALGIGVGNKVYMLENTWYTVIAPESCSSILWRNWDH
KEDAANALNLTPKDALREKFIDGIIEEPLGGAHYDPEATYLNLKNSILQNIKAFSKFTGQ
ELETQRQDKFIAMGQFKG
>KALACAFP_00124 Glutamate--tRNA ligase
MEKVRVRFAPSPTGPLHLGGVRTALYDYLFAKNQGGEFVLRIEDTDTARYVEGAEEYIEE
ALEWCGIIADESPKKGGKFAPYRQSERRDIYDRYTEQILKTDYAYIAFDTAEELDAIRAE
YEARGDVFSYDNKTRNRLKNSIALSEEEVEMLLLNKTPYVVRFKMPVDRTLNLEDIIRGK
SSVNTNTLDDKVLVKNDGMPTYHFANIIDDHEMEISHVIRGEEWLPSLGLHILLYEAMGW
EAPQFAHLSLILKPEGKGKLSKRDGDKFGFPVFPLNFTDPATGAVSKGYRESGYLPEAFI
NMVALLGWSPADDKEILSLDEMAKEFDLNKVHKAGARFSKEKAEWFNHQYIQMKSDEELL
QMLKSSDLHLNIEDEKLIKIIHLMKERATFPKDIYENGKFFFEAPTSYDEKASKKAWNEE
TSGILGELASNLEAADFNAENLKQIVHDFAENKGLGMGKVMMPLRLALVGELKGPDVPDI
LELIGREESISRINNAINNFK
>KALACAFP_00125 Mannose-1-phosphate guanylyltransferase 1
MLEIGERPWGKYFVLADEPNYKLKRIEVNPGQKLSYQYHHKRQEQWTIIEGDATVVLDGK
EINLKYGESIFIPLGSKHRMMNLSDKPVVFIEVQTGTYFGEDDIVRIEDDYDRS
>KALACAFP_00126 hypothetical protein
MNMSNNISLLIGLKNNLEYSKSCYYSIRENYPDTEIVFVSYGSSDGTHEWLDSLKDENLV
YFSDPEEKTLSDTYNKAIEISTKDYVCFLHNDMVIGRNFLSEIAKALAKNNLVYYKVIEP
PIFASDKRLWKEIQDFGSDFETFRFEDFFRFESEQKKQEGAYTEDVSFFLAAKKELLLKI
NGLDPLFKPMFCEDDDLILRLRMSGEKTFVCPNAIVYHFVSKTSRFSEEFQNKTKKIEEN
SLRNFIRKWGFTNQSRTKKKLKFGLILENPSDEAIKALEIFVDHIYSDFNAEKYIKEEQE
NTSFDLKEKFRAKNADFSDDILIRFDAKKLSEKNMYSFRNLADITDELKQSKKSIIKKLF
SKPNSFKINNLKIEILNDKSYEQQLINKNNV
>KALACAFP_00127 hypothetical protein
MFNFLKPITITYGITVCNEHQELRVLLDILLPLIDKKDEILILRDITNPDQKVGELLDEY
QSKIRVIEAKLNGDFATFKNKLIENSNSRYLFQIDADEYPTEYFIKTLKPYLRKEKSVEV
FSVPRINIVEGITDEYVKEMGWDMNEDGYINFPDYQMRILKNNKKIFWKNKVHEILYGNK
NFTEVPKDYKLSLIHKKNFEKQKKQNDFYGTLED
>KALACAFP_00128 hypothetical protein
MVDLGISVFGFINGEFGIAEATRLNCRSIQSVGIPMSLFNYNVNTNHNNNDFTFTEFSEH
AVHPINLIQVSPSEVLHFFEYFDYSLFKGKYNILYVAWESETIPEDYIVNINLFDEVWTP
SEYCKKCLEKFIALPIKVIPHPINIDLKPTEDEDALNFFTKDFFNFLFIFDYNSSIERKN
VINLIKVFKDTFDKYENNAFLTIKTSKSNRFADEKEQILQAIGDSKKIKIVEKIFDKNSL
NYIISNCDSYISLHRSEGFGLTMAEAMYFGKPTIGTNYSGNLQFMNHENSFLIDAQKVSY
GSDDLNYSSNTIWSEPSLEKASEYLKKVYEGETDVKIIAEKGRETIANDFSLSGIGKLIK
KRCEELISGEKISQNRSGLIKLYIENIYLKKDLRIYKKSKPIEFIYGIKMYFRKRKEKK
>KALACAFP_00129 hypothetical protein
MQLSINYHGFFDGNFGIAEATRLNAIAMESAGIQVNRINYSSDTLEKIKSETEPEFQSYI
NIFHINSNVTHEFFSKNQDINLAGHYNIVYWAWEFPEVSDKTVDFLNIFDELWVPSDFCV
NIFTKYTGIPVMRFSHPIQKMATSEEFDFNTYQIKPNSKVYVTIFDSLSTTIRKNPEATI
ESFIKVFNNDPESVLIVKTHNLERSKDAQKALEKYNNIPNIIIINEHFSKEKLHSLIQKS
DVLISLHGSEGFGLTMAEAMSYGKVVVGTGYSGNLDFMNVNNSFLIQYDFIKTSNTKGLI
AEGLTLARPNIEDAVEKLKYIKDNFNALDNIKNNAEAQIRESFSIESIGNLFKIRLSFID
QFGKKENTGGSNADNVFHLAEIDRLTRKVNYLEKTLYNKIRKKVNIFLKKMKGKK
>KALACAFP_00130 hypothetical protein
MGILKKIKKHFKRKKKLKDLKTRDIVNIHLYDPTKKTILFASRDFPTHDKDSGSNRLKEI
ILIYKELGYNCILFAPNVFEDDSYVKFYQQHNVIVFVENNMYKNIYDFLKSFKNIDYVWF
NGPLALNLFYKKMKNILPRTKFIYDMVDIHFLRYKRAIELEPNRISLKRKYTHFFRLETV
IAPQLDYIIAISDKEKEIMSEYADKNKIITISNIHYPKIDISERKNFRDSKGIIFIGSIH
EPNIDAVKFLYEKIMPLVWKENPDLEVSVIGNVADKLDIKLYPKFRFLGFVESIEDHFMN
SKIMVAPLRFGAGVKGKIGQAFEYFFPVVTTDIGAEGMKLADKKNVLIANDEKTFAEAIL
QLNNNEELWDTLSKNSVDSLRAFSPEEVKEKLKTL
>KALACAFP_00131 hypothetical protein
MKICIISYDFWDYDKYIVETLCQRGIDAHHIKISTVTHSNFNERAVNALSKTFLSKNLKK
EKRQKYVLDSLEKLGHQDQILVLNPDTFDIATLEKIRKYTDRLITYLYDNLERVPVEGRL
HLFDKILSFDIIDVEKHGFEKITNYIYLPFTPKEQQNPQMDLFYITSYDNRRVSLIKKLA
KKLLALGLKFQIMVIGKKSWKHQLTNIFIKVPENLFLIFSIKKIPHDDLPSYYKNSKVLL
DLMREGQYGLSFRVFEAMSLEKKIITDNEAIKSYDFYNPNNILILNENISNLDKSFFETP
YEKIPEEIYYRYTLDSWVNKVFELNNKH
>KALACAFP_00132 SPBc2 prophage-derived glycosyltransferase SunS
MNISGLIITHNEEKNMQEVLECFDFCDEIIVVDSFSTDKTVEIAESFPNVKVIQNTFEDF
TKQRNLALDAAKNDWVLFLDGDERITPKLREEIIEELNKPEKKDAYYFYRKFFFADKPIH
FSGTQSDKNFRLFRKSKARYTAGKKVHETLEVNGTIGILKNKLLHYSVSDYESYRKKMIH
YGILKGKELAAKGKKFNILIQYFKTAFKFFKAYVIRLGILDGKEGYQLSYLQSLSVFETY
ESLKKEQN
>KALACAFP_00133 hypothetical protein
MIPLLILLLLIFFCVFHFRLYLFAFPKNRLIILMYHQVKKETHENLTVSLKQLEQQFEYL
NKKKYKTRFFSELNTLGKKSIILTFDDGYKNNFEYLPSLLEKYNLKATIFIPTKFIQEGY
KNYEMMGFEDIRNLDKKHFEIALHSHAHENFRHLSTECIASDLKTNMLILDNEKIPYSKV
LCYPYGKYPKKSPKKEEVFSAFESLGIDFAVRIGNKVNYFPTKNPYELCRIDIKGKDSLR
KFKLKLIFGRLKLF
>KALACAFP_00134 SPBc2 prophage-derived glycosyltransferase SunS
MPLSLAVITYNEEENIVRLLDSLKNTVDEIVIVDSFSTDKTKEICTQKYPQVKFFERKFN
GYGEQKNHALDLCSHEWILFLDADEVPDEDLKNSIKKITSSDHPEFSVYKTKFNNHLGIH
LIKFGGWGNVYRERLFRKDCARYSNDKVHEYLITNKKSGILGGTLNHYTYKSIQHHITKI
NKYSDLMAEKMFERGKKIKRFKIIVSPIYEFIKVFIFKLGFMDGFPGYYIAKTMSYYTFL
KYIKLYEKIRLREIENTQ
>KALACAFP_00135 Ornithine aminotransferase
MSTVETAKNSQYFIDLEDKFGAHNYHPLPVVLDKGEGVFVWDVEGKKYYDFLSAYSAVNQ
GHSHPKIVNALVEQAKKLALTSRAFYNSKLGEYEQKITTLFGFDKVLPMNSGAEAVETAV
KLARKWSYEVKGISENAAKIIVCENNFHGRTTTIVSFSNDPDANQNYGPFTPGFIKIPYN
DIAALEEVLNREAGNIAAFLVEPIQGEAGVYVPNDGFLKNASELCKKHNVLFIADEVQTG
IARTGKLIACHHEDVQPDILILGKALSGGMYPVSAVLANNEIMNVIKPGQHGSTFGGNPI
ACAVAVAALDVVEEEKLSERAEELGKLFRAEIEKIIEKTDLITKVRGKGLLNAILINDTP
DSSTAWNLCLKLKENGLLAKPTHGNIIRLAPPLVITEEQLLDCVRIIEKTLLEF
>KALACAFP_00136 Biotin carboxylase
MFKKILIANRGEIAMRILRTCKEMGIKTVAVYSTADKDSLHVRFADEAVCIGPAMSKDSY
LKIPNIIAAAEITNADAIHPGYGFLSENANFSRICQKNGIKFIGASPEQIEKMGDKANAK
ATMKAAGVPCVPGSDGLIESYEIAATTAEEIGYPVMIKATAGGGGKGMRAVWKAEDLKDH
WESAIQEAVAAFGNGGMYMEKLIEEPRHIEIQVAGDQYGKACHLSERDCSVQRRNQKLTE
ETPSPFMTDELREKMGEAAVKAAEFIGYEGVGTIEFLVDKHRNFYFMEMNTRIQVEHPIT
EQVIDYDLIREQILLAAGTPISGINYYPKLHSIECRINAEDPYADFRPSPGKITGLNIPG
GHGVRVDTHVYAGYTIPSNYDSMIAKLITTAQTRDEAIAKMRRALEEFYIEGVKTTIPFH
RQLMDNEDYLAGNYTTKFMEDFVMDRKYDNH
>KALACAFP_00137 Biotin carboxyl carrier protein of acetyl-CoA carboxylase
MDIKDIQNLIKFVSKAEVSEVKYKTKDFEITIKTPLAGSEVAYAQPAVYHTAPQQVAAPA
PVAAPAATPAEKAEAASDDSKYIAIKSPMIGTFYRKPSPDKDVFVNVGDEVSIGKTVCVI
EAMKLFNQIESEVSGKIVKILVDDATPVEYDQPLFLVDPS
>KALACAFP_00138 50S ribosomal protein L32
MAHPKRRQSSTRRDKRRTHYKAVVPQLAKDATTGELHLYHRAHWHEGKLYYRGKVVLEKE
VAATEEN
>KALACAFP_00139 hypothetical protein
MHTHFMDKLRNYDVSFSGLKTGKHEFRFEIDKEFFQLFDTEQEFTNPRIVVDVFLHKHST
FLEFEIKIHGLVELVCDITNENFDHPIENQIKVLVKFGEEYDDSEEDVITIPTSDHAFNV
AQLIYENVMLSIPMKKISPNVSDEDLQILEKFSPKEVEEEEEPKGDPRWEALRKLKDKN
>KALACAFP_00140 4-hydroxythreonine-4-phosphate dehydrogenase
MSPKNHKVRVGISIGDFNGIGPEIIMKSLKDKNITDFFTPVIFGSGKLFTYQKNIFKLNL
NFNYINEPSQAQGGKLNMVNLVKDNVTVELGTPTEESTNMAIASLEAATEALMKGEIDVL
VTAPINKDEMMKMGFKHAGHTGYFEEKFSKKGLMFLVTEDLKVAVLTHHIPIAQVAENIS
KEKIKKQIRVLNQTLIEDFNISKPKIAVLGLNPHSGDGGVIGNEEIEIISPAIKELSDNG
ILAFGPFPADSFFQPNKYKSFDAVLAMYHDQGLAPFKTLAYEEGVNYTAGLPFIRTSPDH
GVAYDIAGKNLADEQSFTEAIFTAIKIFKNRSEYNDLMSNRLQPRKMVVDNGIDEDLPEE
IEP
>KALACAFP_00141 Riboflavin synthase
MFTGIIEAVGVIERIETNGSNIDFTLTCPFTNELKIDQSLAHNGCCLTVVKIKGDKYVVT
AINETLEKTNLGKWEVGTVVNLERCMKMDGRLDGHIVQGHVDKTGEVVSIENKDGSYFIT
MKYEDNGSFVTVPQGSITVNGISLTVAKSEDTQFSVAIIPYTWEFTNMKYLKVGDKVNLE
FDIIGKYIARLIKKQNVN
>KALACAFP_00142 Sensor protein ZraS
MSINMYKGYSLRNRVFFGFLLVCLLSVVASSLVPYFVLKENSVQQSEIDMQGKTGAVIRY
LDYAVSRTRVETNDLKTVLENKIFEIADINQHDIILYDLKGNYLLSNKEESLVEQKAIPI
NIVNKILATNARVDIKGYDASKDSVLTSSYLLLKNNDLEPIAIVYIPLYHNESAYFEVLH
VYVKYIVLVDILLILFSIWISWIMSNSLAKNITKFSDMITRITLFENEMRPIRYYKNDEL
NALARAYNRMILQIQDQKERLRFKASEEAWREMAKQVAHEVKNPLTPMKLTIQNFERKFD
PKDPNIGERVKQMSKTMVDQIDLIATVASAFSEFAKLPEKNNEVINLNNEVEDVLRVFND
DSIFMHSNKSNIMINMDRIYLSRIITNLVTNAKQAESDERKLIINVDVEQHQRRVMISVQ
DNGIGIADNMYERIFEPNFTSKNSGMGLGLSMVRKMVEDYKGEITVKSELGKGSTFTITL
PTNL
>KALACAFP_00143 tRNA1(Val) (adenine(37)-N6)-methyltransferase
MKPFTFKQFQIQQSKNVFRVGTDGVLLGSLASVDNVSNVLEVGTGTGLISLMLAQRNPDA
EFLGIDINEEAANLTAINFNNSPFTVRLKNILQDFKNFKTEEKFDLIVSNPPYFEASDSE
KDKIARQTIELNFKQLISKSSTLLSENGIFSVIIPVEAGDDFIEIAKENQLFLIRKINIK
GIENSKTKRLILEFSLSEKSLEESEFTIEKSPRQYSDQYIALTKEFHIFKHN
>KALACAFP_00144 hypothetical protein
MRKLYLFIFFIAFNICFAQQITYFDKNWKETSKEKASYYREVSNEGKLMRIKDFFISGKL
QMEGLASKIENGDEVFEGEVKWYFENGKVEKSSIFKNGTQIGLQKEFDADGKLVEEDLSN
EKGNVYTRKYKYKSETQPFNVFTEWKDDTITETEYDNDIKLIRRVYKGDGNYEYYDEKGA
LIGKLNDDYVDGKSGIEVIYFYNPMKVRTIIEYEKGKYKVIKNYFPDKKLESEIITAGTS
GTLKKFDRQGKLLSSAKVEVDEQKNITPIEGTYISEDFTDETGNKSYISVIAEYKAGEVI
TRKIFYENGKLKNDESQEKVTHYAPDGSLKYTMIYKNGEPFDGTEIIEDAKLFEFKNGKM
ISFRIYLNDMKTLALENIFNPKTQMYEQKIFDENSDYKQIKFVTITKEADSYKTQAEIIT
YQNGQPVAKAVVKNEVLESGKVIFFYPDKKKTIFETKDGSSTQVTSYNENGDMTRNTNYP
VKNVDDYEIPKINEGFLLGNDLTLPTVTSKPKVLYNE
>KALACAFP_00145 Cell division ATP-binding protein FtsE
MPHTNIAGDNIISLQHAKIAQKNFTVLSDVNLNIKKGRFCYLIGKTGSGKSSLLKTLYGH
IPLAAGHGAVVGFDLEKMKTSDIPNLRRKLGIVFQDFQLLSDRTVEKNLKFVLEATGWSD
KVKMEDRINEVLGSVNMKSKKHKMPHELSGGEQQRVAIARALLNHPDLILADEPTGNLDP
ETSNEIMTLLKQVALENGAAVVMATHDYHMIQNFPGEAIRCEDGKVSVLDTAELFE
>KALACAFP_00146 50S ribosomal protein L34
MSKRTFQPSERKRRNKHGFRERMSTPNGRRVLAARRAKGRKRLTVSASRAKR
>KALACAFP_00147 Bifunctional oligoribonuclease and PAP phosphatase NrnA
MFTPAELLEIKALLTPENRIVILTHYNPDGDAIGSSLGLKHYLKAKGIYAEVIVPNDFPK
FLKWMPEAKKALIAEYKRKVASDIINEADVIFCLDFNAPSRIGILGDWLTNARGKKILID
HHQQPEKFDFVYSDTIIPATCQMIYHFIEAMGDENLVNKDIAECLYTGIMTDTGGFRFRS
TSATTHRIIANLIEHGADPAMITSNTWDTNTVSRLHLLALILGRIEVVKDGKVAVLYLTR
EELKEYGFQKGDTEGFVNYGLSIMGVKMAAFFMEDLYEDFIKISFRSKDDMDVNQFSRKY
FSGGGHINAAGGKSYESLQGTIETFKGKIEGEESL
>KALACAFP_00148 putative NTE family protein
MLDFLSFKKKKPIIGLTLSGGGMRGIAHIAVLKALEEYNLRPDIISGTSAGSIIGAFYSF
GKTPDEMMDIVRQTTFFSRSYLKLSKNGIFSSKFIVKLFTDYFPEDDFKILKIPLYVAAT
EMTHGIVDFFSEGELFAPLLASSSVPFVLPPVKIGEKIYVDGGVLDNLPIEPIIDKCDFL
IASHVNSISYDSLEKMSLMKEFDRILHLAIAKSVYSKVSSCDIFLDPPKMTKFSLFNKKF
FDVMFQEVYEYTCKELEDKGCSRGA
>KALACAFP_00149 Dihydrolipoyllysine-residue acetyltransferase component of acetoin cleaving system
MLNFERKGNGKETLVLLHGFMENLSIWDDMEPHLSEKFSLLKIDLPGHGQSEILAEVQTM
ELMAEEVKKVLDDQNLKKVHLLGHSMGGYISLGFAEKHPEYLKSLTLFFSSYLPDDAEKK
EQRIKSYRIIKDAFAHYVRAGVPNLFNPNERDVLEGKIETALEVALSTNNLGALASVKGM
VERTDKKHVLENLDAKILVLAGKHDNAVKTELMIKNLPDKTNIKSYVLDCGHNGHWEKPS
ICAEIINTELLHHMPKHLVF
>KALACAFP_00150 hypothetical protein
MKNFLTAFAIIALLISCSKKESNPTANKTDSTKIIDSINAARTKINDSIRSKNHFKDFSG
KHKFTHNLIKKSGFIDFKKIDGEADHYNVSGDIRSGKDYVHIQGFTAIVSDKHMNFTGSI
SESISENENGKIYIRQGTKTFMSKDGGKTSRLQDKVNGSGFVDYIDIHF
>KALACAFP_00151 hypothetical protein
MAEVIAQEKQGGSKQRKKLIRVDMTPMVDLGFLLITFFMFTTNFTKPNVMDLGLPAKSPH
PPKHVVDTKNQVTFILGKDNRVFYHQEAAEDLNSSNLKETNFSGINITKIISEAYNKAPK
KENFTIIIEPTDDANYKNFVDILDNIAISKKERYGITDIKPWEKKVYEELTK
>KALACAFP_00152 Thiol:disulfide interchange protein DsbD
MKFRNWFLLILLFLATGINAQIKNPVKFKFTINDLGNNQYEAVLNATMESGWHIYSKDIP
EDTGIPTEYKVSGKNIELIGKFTEVGKKHEEFSEAFGGKIIFYSNSAGFKQKFKLKDGTK
PGDVVAEITYQTCDDRVCLAPNTLEFNQKVTPKGATEEAATEEKTEPAKDSAKTVETVVE
NPAKTEMTVTETSKLDPKQLKIQSIDFQKPLTDCGTGSTKVDENYWTYLFLGFIGGLIAL
LTPCVFPMIPLTVSFFTKGNKNKAKGKRDALIYGFFILLIFVLLSLPFHLIDGIAGNIFN
QISTSVWLNIAFFIIFIFFAGSFFGYYDITLPSSIANKSSKAEEAGGIIGIFFMALTLVI
VSFSCTGPILGSLLGSAVTGSANVPMLLTFALAGFGLAWAIVFGLLALFPQALQSLPKSG
GWMNTVKVVLGFVELALALKFLSKADLVSKTFFLKRELFIAIWIIVALGLALYLFGLIRF
PHDDKKPKISIARKILGVLGFGFVIYLIQGLIPSERPKLQLLSGILPPLNVSYFHDEKDG
ILGMHPEHDFFKAVELAKKEDKPILIDFTGYGCENCRKMEEFVWSQPDILPILQNDVVLA
SLYVDDKEELPEDQKTKIDLGDGQVKKVKTIGDRWSLFQQVNFNNNSQPHYVLVTPDGKV
INTPVSGYMPKEDFKKFLECGVNYYKKNK
>KALACAFP_00153 tRNA(Ile)-lysidine synthase
MLNALNFKNQLENLIHSPENHRYLLAVSGGADSMVLAHFFNGLRDSGAEFQVAHINYKLR
CEDSDLDQSVVQDFCEKNHIQFHLYEVSEKDRKPKNSIQLWARELRYRFFKQIQERENLE
FLVTAHHLNDQLETFIINLSKAAGINGLSGIPANENQILRPLLHFSKEEIYKFARENKIE
YREDLSNQKSDYLRNKIRLEIVPKLLETNEHFLENFKKSSSYLNQTKDFVHQQIEEIENR
ISIFNKYHKIVSKEKLERESRFVQFEILKKYGFNQEEEIAKIFKAENGSSFFSKDYQLIV
NYDELIISTKIEDGRWAFDNENKNIKDEILLIENFHFSENQININLGKVIGEIEEINKNF
EWDFDAEKLHFPLRLRRQEDGDEFYPLGFSGKKKVAKFFRDEKISILARQKIWILTDSEN
SVLGIIPYRQDRRNARDEKTNKILKIFNEK
>KALACAFP_00154 putative lipoprotein YiaD
MKIFKMLAVSAMVLGMTSCISKKQYDALSSNYKQCIENVGERQREIQDLKSQNSALTSEN
NLLKSQHDALKSSLDACLSNSGKSSANIDKLVGEINASNSYIKQLISNNAKNDSLNLALS
NKLKRSLDNVTDDDVQVKVLKGVVMISLSDKMLYKTGDYNVLPAAQEVLGKVAKVINDYD
KYSVLIEGNTDNAPLASANLPRDNWDLSALRGTAVAKVLQTQFGVDPARITAGGRSEYNP
KATNMSVSGRAENRRTEIIIMPKLDEFMKLMDIAPKK
>KALACAFP_00155 Putative O-methyltransferase/MSMEI_4947
MSFFEEKNPEMDRYLETHASSEPEILKKLRRETYQKTTQPHMISGYQQGRLLTIISQMMQ
PKNILEIGTFTGYATLCLTAGLAKDGKITTLDVNEDLAYLPKKYFAESEYSGQIDFKLQD
AKEFLKETNEIFDLIFIDADKENYAEYFRLIKPRTKSGSVVLFDNVLWYGKVLEENPKQK
STQVIKELNDLIAKDDDFENLILPLRDGVNFLRRK
>KALACAFP_00156 Gamma-D-glutamyl-L-lysine endopeptidase
MNKGICIVTVAPVRAESSDKAEIVTEILFGESADILEVNKNWTKIKMHYDGYEGWMDTKQ
IKTVTDEELAKRKVTVITEDFSSVLMNDGKILLSMGSEVEFPAVASRRSHDVRESVALTA
REFLNVPYLWGGKSFFAVDCSGFTQLVYKIHDVKLPRDTYQQAEIGEPLTFVEESQPGDL
AFFENEEGRIIHVGIMLENQKIIHASGKVRIDTLDSTGIFNKELNKHTHKLRVIKSVL
>KALACAFP_00157 hypothetical protein
MENIFLIIFDVFNFGLLVFLWQFTIRNYKTLPQTIPIHFDFDGKADNFGTKKYSFLTPVL
LTIFYTVFAFVVRAPEYANYPVKITEDNMHAQFLIMEIFIRWLYALIALIFLNSQDYMFR
YSFDENAKPRVPMTTAILTLFGSLIILFIFVGLFK
>KALACAFP_00158 Oxalate-binding protein
MIKSKNNTEHYIWGNACDSWVLKDSQNLSVKQEIMPAGTAEKLHFHEYSEQFFYILKGEA
VFYCDDEKFSVKTGESISVLPKSKHYIANESLEELEFLVISNPSTNNDRIEI
>KALACAFP_00159 3-deoxy-D-manno-octulosonic acid transferase
MYFFYNIFINLLIFGMKVFSLFNDKTKKGVEGRKKSLQKVKSAFSKTDKVIWMHAASLGE
YEQGLPVLEQLKENFPDHKILVTFFSPSGYEHVVKKKNIADAICYLPFDKKSSVKEFISQ
FDVQLFFTVKYDYWYNLLEELKNKGAKTYVISALFYERQSFFTSYGKWFVKELQKNIDWF
FHQTEMSFALAKSIGLTKSSVTGDTRFDRVKQLRTRNNHVDFIKDFTGDDKVVVFGSSWQ
AEEKVAEEVLQGSPYAKLIIAPHDLKRVQHLKQIFPDAILYSEIKKLVKNFQSRVLIIDS
IGLLSKLYSYADVAVVGGGFHDAGLHNILEAAIFGVPVIFGNHYRKNPEADELISVDGGR
SFENAGLAADFVMFLLNNEEELLKMSENAEKFVTEKPNSTDLIIKKILS
>KALACAFP_00160 hypothetical protein
MEYSKEFKAALSAFSSIEKDRLIFRLLKKDKLLSKKLYFELIDQETTDDKRDAMEENVRE
KVLLASKYIGNQKYFLSIIRKISAEITEHVKITTDKFGEVSLNLLLIDKILDYNEDLSRQ
RFDNVYKLYIYIINKIFRALLLIKKLDEDYWMEIDEYLQSLETKINKNHYLQKLCINNHL
DFKWLRCENIPENIDQIVKEIKNQGFLR
>KALACAFP_00161 UDP-Glc:alpha-D-GlcNAc-diphosphoundecaprenol beta-1,3-glucosyltransferase WfgD
MKDLVSIITPSYNSAEFIEETIQSVLDQTYENWEWLITDDLSKDNTVEIIKKYNDPRIKL
QVLEQNGGAGNARNKSLERAQGRYIAFLDSDDYWYPEYLETMTDYMQENNAELVYCNYSR
CDEHTMEPILKDFLADKVVTFSNLLKTCRLAPVSTIYDTKRVGKFFFPVKSKREDHVMWL
NLLKEIPKGYPVKKTLAKYRMRENSVSRKKKNIIKDQYLVYKDFMKFSTVKSLYYTANWA
VNGFLKYSKIFN
>KALACAFP_00162 hypothetical protein
MQDITKNNFDFLRVLLAFIVFVGHLGTLSASKELKILENSPIEIAVFGFFIVSGFLIARS
YDRSSSLKSYIKKRINRIVPAYLLVVFLCAILLSLVSTLPFREYFSNTQVYKYLFWNSLF
LNFKAPWLPGVFGNQAVNGALWTLKVEMSYYFCVPLLFLLFGKNNKYRNTSLIIIYFLSL
IYLNYFESIGKVSIAKQIPGTLSYFIPGMLIYFNFDQFIKHKNLLFIIAIITVWIDLFTG
IILFSPAMIGIITLYIAYSFKFLNNFGKYGDFTYGIYIFHFPIIRTFTTLGLFQDYNPYV
MAIVCMLVVIAVGVSSWHFYEKRFL
>KALACAFP_00163 hypothetical protein
MKKLALLFAGLSLFVATGCNNDDDTTIEYPLVGTWQPVKEVVTTVPVGGTPVSDEITYTD
CQKQGRWVFNSGNTGKATDKGDGAIPGECVTTFDRNFTYIYNNDTKAIEVKYQGIVEPDK
GKVTGLNETTLNLTIEDTTDPTEYHSVTYTFKRIPQQ
>KALACAFP_00164 Leucine--tRNA ligase
MFYDHQQIEKKWQKYWEDNQTYKTSNNTDKPKFYVLDMFPYPSGAGLHVGHPLGYIASDI
YARYKRHQGFNVLHPVGYDSFGLPAEQYAIQTGQHPAITTEQNITRYEEQLKKIGFSFDW
SREVRTSDASYYKWTQWIFIELFHSWYNKDTDKAEPISTLIKHFEEKGTEDVNANQNDEL
HFTAEEWKEASDIDKEDILLNYRLAYRAETTVNWCPALGTVLANDEVKDGKSERGGFPVF
QKKMMQWSMRISAYSERLLQGLKTLDWPQPLKDSQEYWIGKSQGAQVRFNVEGHDEIIEV
FTTRPDTIFGATFMVLAPENPLVETITTAEQKAEVDTYIEETSKKTERDRMSDVKNVSGA
FTGSYAVNPFSNERMPIYISDYVLMGYGTGAVMAVPAHDERDHRFAKKFNLEIKKVVETD
EDVQEKSFDSKTSVCVNSDFLNGLSYDEAKALIITAIEKRGIGHGTTNYRQRDAIFSRQR
YWGEPVPIYYKDGMPYTLPTSALPLELPEVEKYLPTEDGDPPLGNAKTFAWDEANQKVVA
TDLIDEKTVFPLELSTMPGWAGSSWYFLRYMDPNDDEVFVKKELADYWGQVDLYIGGSEH
ATGHLLYSRFWNMFLKDRGYISHDEPFQKLINQGMILGMSAFVFRIALNMRKKAESQRVG
NGKLTKLNEVEQIVLKNLFISNGYKKYIKTLSSKEEGFTENKNKFFDLLTPYIEKEFKNL
NLDIKEYELDSLIPFQRFVTHVDISLLKGTSDELNIDAFKKWRPEFADAEFILEEDGKYI
TEREVEKMSKSKYNVVNPDDICNEYGADGLRLYEMFLGPLEQSKPWNTQGLSGVYGFLKK
FWNLYFNGENFEVSDEEPTKAEYKVLHTLIKKVVYDIENFSFNTSVSSFMIAVNELQKIK
CNKRNILEPLAVIISPYAPHICEELWSLLGHDTSVEFEKFPVLNEDYLVEDEIEYPVSVN
GRTKFKISLSAQLSPKEVEDLVINDEKMQQILEGKAPKKIIVVPHRIVNIVI
>KALACAFP_00165 hypothetical protein
MLKLRIIAKKRENNYNIESVLKFPCQKKGKCLFKTLAF
>KALACAFP_00166 Biopolymer transport protein ExbB
MNVSKNDEQVVARKAGGLNPALIIPILFIIGVCIYLFVLGNPGNFKDAEKLGGGSVAFSS
VEGKDIHPESFLGIIYKGGVIVPILITFMITVIVFSFERYFVLSKAAGKGNLDNFVVQVR
SLLNQNKIDEALEECDRQQGSVGNVVKEGLTTYKALSHDTTLNKEQKMVALNKAIEEATT
LEMPMLEKNMMILSTLGTVATLVALLGTVIGMIKAFFALGSGGGTPDAAALSTGISEALI
NTALGIGTSAIAIILYNFFTSKIDGLTYKIDEIAMSIQQSFAEFN
>KALACAFP_00167 hypothetical protein
MARVKPKRHGVVTDMTAMCDVAFLLLTFFILTTQFKKPDVEQIKPPSSISEKLLPDASLM
TINATPDGKFYFQPVENASERLQLLDNMGQKYGVTFDNNEKAAFQKVQAIGVPMNQLKSF
LDLPEDEQKNFRSPKGIPMDSTNKQLVDWVEQSLKVNPEYKLAIKGDVSTEYPKVKSLFE
GLRDIDFLKFWLITSQEGKPNE
>KALACAFP_00168 hypothetical protein
MAEVQVQEKGAKGGKVRSKKQSTRVDMTPMVDLGFLLITFFMFTTTFSKPNVMDLGLPAK
PKDKDKKPPPTEIKLSNSISLLLGKNNKIYWHQQDNTSLTDQNLNETSFDREGIRKVIEQ
AKANAADRSKFTVIIKPTDDAVYKNFVDILDEMAITKSEQYGVTDLKPWEKAIYDRKVGN
SGAPAAPATK
>KALACAFP_00169 hypothetical protein
MANENAYDPSLTLDEIVFENRNKEYGAYDLRHQYPKLLTKSFIVGTALFLIAALSPFIYL
TIKRLTEPPKQEVKADLVEILQEDKVLEQPKEEEPPPPPPPPKEEEKIEIIQNVVPEPVK
APKIETPPPPISKQLETTTGLVNQEGVKAPAYTPPPPPPSTGTKASTVEVKPQVTNDVYE
SVDQAADFSSGGINGFRSKFMDNFDNSSVEGEGTLSTEITFVVERDGSLSQVKASGSNSD
FNREAERTVKSIKTKWIPGKVNGQPVRSRFRFPVKMNFEG
>KALACAFP_00170 hypothetical protein
MMFNWLSLVTGLFYIVLGIVVIIYKFFFTILDPGVAYALGALLILYGIFRIYRAILRLKN
SGNEK
>KALACAFP_00171 hypothetical protein
MKNSVKLVILFFLSIIAVSCKNEDKSPSYHKGEMTIFTDESFKSVTEALADGYMINYPET
KIKVVTKKEDLGFIDLLKDKARIIVMSRNLSPEEIKTYEEQVDLKFLPARFAADAVVFIV
PKDSPKESISMEEIAQGMQSDNKEFIFDGANSSNLNFVAQKLKKQPKELKFSVIPGSKNI
IEELSKYPNKIGVIGLNTFSRPYDKESEELRSMVKILPVESKGKLYNTDSENLRKMNYPF
TRVLYFLTNEGNFNIANGFIRYSCTQLGQMIVQKEGLQPYNLYRREVQMR
>KALACAFP_00172 Lipopolysaccharide assembly protein B
MKDIMNMNVKKIAFGAAVVFFTNFTFAQTVQDGINSIDSDKYAQAKTNFTNMIAKEPSAE
NYFYLGNTYLKQVDPDFAAATENFNKGIAADSKSYLNKIGLAAVKLGKGDKNAIAEIQKV
VTDSKEKDAEVLFRAAEALTLFEKNNSPDLAIQFLNKAIERAEKKGVPAHYYYTLGDAYR
LKRMPGDAMTAYEKALPLAKNKASVYTRIGSLWMAAQQWQQAKTNIEKAIATDPSYAPAY
KVMAAYDIRYQQNAKATQDLINYTKYADEDPYTQLEISKLYFTNEDYANSKQVLDKIFDK
INDPIKFKLRAYQLYADGKYAEAKQNMDNFVSQADKARVQPADQGLQGLIAAGLAKTETD
AAKKSALTAEAQQKIAIAKAAKDETMKWDMELAKIAGGGASQADIDAGPTNPTIEGLKQK
VAANAQDTDSLFKLATAYQDAKNWNGAIVTWQKMNTLLPDWAPGYYSLGYSYQQAGNNDA
AKIAYEKFISTVKPAEQEANKQTLAYAYFAVAYMSKDSDMAKAKDYVAKSLQLDPSYQDA
VKLNAEINK
>KALACAFP_00173 N-acetyl-alpha-D-glucosaminyl L-malate deacetylase 1
MGSFCLNLIFENMKTDILAFGAHPDDVELGCGGTIAKMVSEGKNCVIVDLTRGELGTRGT
DETRKVEAMDAAKILGVSARENLGMKDGFLVNSEEYQMKIVKMIRKYRPEIVLANAIDDR
HPDHAKGAKLVSDACFLAGLRKIETVFDGENQEVWRPKHIFHYIQWKNIEPEFVIDISEH
LDKKIEACMAFKTQFYDPTSKEPVTPIATKDFYESLTYRAQDLGRLSGVTYAEGFTSEKL
IALKNFDGIVW
>KALACAFP_00175 hypothetical protein
MSEYKERHENEIFTKVLKAGRRTYFFDVRETKAGDYYLTITESKKNFGENGEATFEKHKI
YLYKEDFKSFQEMFNESTEFIINEKGEDVISEKHDKDFKSKSYTIDSDDEV
>KALACAFP_00176 putative multidrug resistance ABC transporter ATP-binding/permease protein YheI
MKALKTLNPYFWKHKILLFWGLLFIIASNFFNIYKVQFVGKSVDELTKNGNLGFNQQVLM
YVGIIVGCSLLTGFFTFMMRQTIIVASRRIEYELKNKIYRHYQDLSLTDYKQTTIGDLMN
RLSEDVVAVRMYLGPGVMYVANLIVLVLITAIYMIKTDVSMTLWTLLPLPILSYAIYKVS
SIINKKSKIMQKSQSAISTFVQDSFSGIRVVKFFARENYIKKNCGVKVTDYQDKALDLAK
TEAYFFTIILFVIGLLNVAIIWIGGEKYIAGQLSIGKIADFFMYINTLIFPFSMVGWVTS
VNQRAEASMQRINEFMDKKSEIVNKNFENYPIKGNIEFRNVSYVYPNTGIKALDNLSFSI
KAGESLAIMGKTGSGKSTIALLLCRLIDPTEGEILIDGVNLKEHNLENYRNFIGYIPQES
YLFSDSIENNIGFAIDKPTHEKVVEYARIADVDKNIVEFKEQYKTMVGERGVMLSGGQKQ
RICIARALIKDPNIIIFDDSLSALDTETEQNILENIDRKIHNATSIIITHRESSAQRADK
IINLTEITNSVTA
>KALACAFP_00177 N utilization substance protein B 
MLGRRQIREKVVQTVYSYYQNPVKFDVLEKNMFAGIEKIYYLYIYQLNFLVALKELAENQ
IEIGKNKYLKTDADINPNQKFINNQVLIKLEENPERLFFTGQHKQLKWDMHDDLLVKTFQ
RITAGKRYQDFMKQDGYSFEDDQKFIGKLFLRYIAENDDFHDYLGDKELSWYDDIHIANS
MVQKTIGFLKEDEESRTLIKMIKDEDDKDFAGKLLRDTLNNWENNEKKLEERLENWDLDR
VSLMDKVILSTAISELDNFPFTPSRVIINEYIEIAKVFATDRSNIFINGILDKYCKDLNR
I
>KALACAFP_00178 hypothetical protein
MKKTLSIIALSIIGFGLVSCKKENKEVQSTESATTDSTAAPTAPVAGDSTATTVSGETPA
APVSNQPLTTIALSENNFDFGNIKKRDKVEHVYEITNTGTNPLVISEVKPGCGCTAPDFT
KEPIMPGKKGKITLHFDSSNFDGNVQKYADVFANVEKAPIKLTFTANIQP
>KALACAFP_00179 hypothetical protein
MNILTIFLQAPGQGGNSSMMLIMMGVMFVGFYFLMIRPQMKKQKQEKNFQETLKVGTRVV
LTSGLHGRIAQVQDDGFVIETLSGKLKFEKAAVSREFTEARFGDKAKAAEKTADKATDKK
EIEEKN
>KALACAFP_00180 Decaprenylphosphoryl-2-keto-beta-D-erythro-pentose reductase
MNQNTNKTVLILGANSDVAKQCIKQYIEKDFSVIAASRNTQSLEDFIGQNNLHSKVTVLH
FDSVDFDSHQKFYNELPVKPHLVVYAAGFLVDNEKALRDFKGTQQMMLVNYMGAVSILNI
IATDESNKNLERIIGLSSLSGVRGRKSNFVYGSTKAAFTTYLAGLRQELASRDIKVNALV
IGYIRTKINEGLQLNESLIMEPDYVAKFIVNAGNSFTIVPNFKWKMIYLILKILPESLVA
KLP
>KALACAFP_00181 Multifunctional non-homologous end joining protein LigD
MLAKSYEKAFDDEDWVFEIKWDGYRAIADLSKDQPLFYSRNGISFLSKFDKVSQDFKNQK
HKMILDGEIVAYDENGRPNFQLLQQIGDNPNLALVYHVFDILWLNGHPTEELPLIQRKEL
LKEALVETDVIKYCDHIPEKGIDFFEQMKKMQLEGMIAKKADSLYIENHRTSDWLKIKFT
NTEEVIICGFTEPRGSREGFGALILGKYIDEKLIYAGHTGTGFNKTSLNEMYERLKKLAV
KTSPFENKPKTNMPVTWTKPELVCEIKYSEITKDGIFRHPVFVAIREDKNPEEIADSSEK
SKINEKPKEMKAKTPPKSTKSSEKEKEITLNKHTVKLTNQDKIYFPKDSITKGNVVDYYQ
SVADYILPHLKNRPLSLNRFPNGIEEQSFYQKDASDNIPDWIKTTQVYSESNDKYIDYIY
CNDKATLAYLNNLGCIDLNPWNSSLPDLEHPDFLVLDLDPSKKNTYDDVIETALQVNEVL
KSIKIQGYCKTSGSTGIHIYIPMGGKYDFNQVKDFAHILMKQVNEKLPQITTLERSLQKR
DDKKIYLDYLQNRTGQTLASAYSLRPKEGASVSMPLEWEELKPGLKPTDFNIHNALDRIK
EKGDLFKPVLGKGIDMMKALELLQGGE
>KALACAFP_00182 Multifunctional non-homologous end joining protein LigD
MALKDYNEKRKFDETSEPQGKTKKSKDKLIFVIQRHAASRLHYDFRLEMEGVLKSWAVPK
GPSLDPKDKRLAMMVEDHPYDYKDFEGNIPEGNYGAGQVEIWDSGTYEPLDENSKLSDEK
ELLKELKAGSLKFILHGKKLKGEFALVKMKNAENNSWLLIKHKDDFAEENYDAEENTAKN
SQVTKFLEEKKSLKSSKKKS
>KALACAFP_00183 Non-homologous end joining protein Ku
MKAIWNGAIGFGLVNIPVKIYSATETSKLDLDMLDKSDFSNIKFKRVNEKTGKEVKWENI
VKGYLMDDKYIILEEEDYEAASPEKSKILSIDQFVKEVEVDSVYFENPYYLEPQKNGENA
YRLLLKALSETEMVGVGTFVLRESEAIGMIRPYNDDVLILNRLRFAQEIRDYKDLKIPAK
KAPKPAELKMAISLIEQLSQEFDPEMYKDTYTESLLKIIKQKAKGKGVKAKKAEPAKEGK
VIDLMAQLKASLQTPKSKNAS
>KALACAFP_00184 hypothetical protein
MTEEILTYNTPNSEQILRQINQYEFKRIWENNLKKNNKNLFWTVFFLLLAGFMLFYKEHL
GYFFAGLGLMYISIFINYRSIYRKQKEKLNTLLDKEIKDLTTNSKDVIWEFTPTYFRFKN
YKSDFKFNWETISYCLLDDQYLYITVSPYMNFILDKANIDEENFNKTIDYLKNKSHFKAV
>KALACAFP_00185 Aspartate--tRNA ligase
MFRSHTNGELSLKNLNEEVTLSGWVQTIRDKGFMIWIDLRDRYGITQLYFSQEISSNELF
EEVKKLNREFVIQVTGKVIERKDKNKNIPTGEIEILVEKLTVLNESQLPPFKIEDETDGG
EELRMKYRYLDIRRAPVRDKLIFRHKMAQKVRNYLSDEGFIEIETPVLIKSTPEGARDFV
VPSRMNPGQFYALPQSPQTFKQLLMVGGMDKYFQIVKCFRDEDLRADRQPEFTQIDCEMA
FVEQEDVMNVFEGMTKTLLQDITGQKFDKYFPRMTFADAMQKYGNDKPDIRFGMEFVELN
ELVKGKDFKIFDDAELVVGINVEGCADYTRKQIDELVDWVKRPQIGASGMVWVKFQNDGV
KTSSVNKFYNEEDLAKIIEKFGAKEGDLMLILSGNENKVRTQLSALRMELGNRLGLRKGD
VFAPLWVVDFPLLEFDEESGRYHAMHHPFTSPKPEDIHLLETDPGKARANAYDMVLNGNE
IGGGSIRIFDKDLQSKMFDLLGFSKEEAEAQFGFLMNAFKYGAPPHGGLAFGFDRLVAIL
DGNEVIRDYIAFPKNNSGRDVMIDAPAAIAEAQLDELQLQLNLKA
>KALACAFP_00186 Multidrug export protein MepA
MTKYIDFIKKALSGDDVDYTKTSIRTAVLLLAIPMMLEMAMESVFALVDLYFVGHLKESG
YAIQTVGLTESVLSVMYSIAIGMSMAATALVARRIGEKNPEQASRSAAQVLLVSFAVTFI
LSLFGVIYAEEILILMGSKPEAAFYGKDFTRIMMGSSVIIMLLFLINGIFRGAGNAAIAM
KSLWIANIANIILCPVLIKGFGPIPAMGLTGAALATTIGRSIGVIYQLYHLLIADTQIRI
QTKYFKPDFDLIKSVIKIATPGIFQFVIASCSWIFLAQLVATTGGENASAGYQTALRLMM
FFMLPAWGLSNAASTLVGQNMGANEMLRAEQSVMKTVKYNVIFMLTVSLIFFLLGDFLVG
FFTQEIEIKNFAKNALHIMSVGFIFYGIGMVMINAFNGAGDTWTPTWVNVFGFWLFQIPL
AYFLSKHFGMGPKGVFISIPAAETLITIVAFILFKRGKWKTVKV
>KALACAFP_00187 hypothetical protein
MGKGDKKSKRGKINNGSYGKRRPRKASKSIEASAEKAKK
>KALACAFP_00188 hypothetical protein
MSLIDLLTGNTGNQVAEQAENKFGISRNQVIALLAVAAPLIISYLRNKSQDTNEAEALNN
ALDKDHDGSILDDVSQADARQAEGGSILNHIFGGDKQNVENQLSQNTGISIDKIGPILSM
LAPVIMGYIGREKQQNNVGAGGLGDLLGGILGNASNQAQNQQSSPLNDILGSVLGGGQSQ
SSGNPLNDILGSVLGGGNQQKQQGGGGLGDILGGFFGGK
>KALACAFP_00189 hypothetical protein
MSEEFEIRNKVAESGLINFDLTDLVPKGERKGIDLKDFLFMEMILKEKDFREKVADINVE
EYRDTYVYIYNSADAIVPLWAYFLITARLTDVTKKIVFGDREDLEVILMHNAIRNHDFGE
MRGKRVLVKGCSDKEIPENAYIELVEQLKPIVKSLMFGEACSNVPVFKN
>KALACAFP_00190 Lipid-A-disaccharide synthase
MKYYIIAGEASGDLHGSNLMKALKKKDPAAEFRFWGGDLMAAQGGTLVKHYKDLAFMGFL
EVAKNLRTILNNIKYCKQDIKNHQPDILILVDYPGFNLRIAKFAKELGIKVVYYISPQLW
AWKEGRVEIIKKYVDEMMVILPFEEDFYKKHGVHSHFVGHPLLDAISDLQEINTENFKAE
NGLNEKEIIALLPGSRKQEVEKMLEMMLSVRPYFKEYQFVIAGAPSLPKDFYQTYVDDNV
HFVSNKTYDLLRCSKAALVTSGTATLETALLNVPEVVCYRGSKISYAIAKRLVKNINYIS
LVNLIMDREVVKELIQNDLNTKNLVEELKKIIDGDKRAQVLNDYELLRKKLGGSGASDHA
AEVILKV
>KALACAFP_00191 Flavin-dependent L-tryptophan oxidase RebO
MTTRRSFIRQGLLAAGGLMIPSSSFANFILSGKKKVIVIGAGFSGLAAANKLNQRNFDVT
VLESQNRIGGRVFSHQMNDNLVVELGAEWVGNSHNRILELCNELKLDLSENQMDTHLLYK
GIYSPARQWDFSKNWKLKMESLLENYRHLNDKDKLILDKMDWWRYLVNNGCKDRDLDLRE
LMDSTDFGESIRKVSANAALSEYVENTGDTQNQMDKKIIGGNTMLAQRLSEKLGKEKILL
NHAVTRIEQGDKVKVYCANGKVFEADKVICTLPTFALKNIDWKPGLPENKIEALNELQYA
RINKHAMLFDNRFWKSENFDMVTDQLPHYFYHATQGQSGSSGVLISYSIGDKAAVIANQN
DMTNFKSVQETLQPVFGDVKSHLKQQANYYWGNDQRSHGSYAIYGPGQWFRVRPVLKEPF
MHTHFAGEHLADWQGFMEGAIVSGEEAAGEF
>KALACAFP_00192 ComE operon protein 3
MRKHKFFQLNKQPLLILAVCFIVGVLLQDKLSLDKNYIYLVIGICLLVFIATFFKSYFLH
KAKPYLLGIMFFGIGIILHFFNSFSPQSLSVPRNEFIIFKISKKLNSTEKNKKYEAVINV
DKKTVNAVLYVPKDHQELDFNHYYKTKAFITSPKPAKYDFQFDYAKYLKRKSIDYQCYSN
GDILSAGRKDVSFIEKFSQKRLELLQNIDKSEISQKTKDFLKGIILADRTEIDSQTIQDF
NRSGLVHFLAISGTHIVVIFGLFYFLLMKFFPLKFRKYAIILSLIFIWLFALLIGLGNSV
VRSCVMLSVYFVYVLLQRKPDVLHSLALSAFIILIFDTQQIFDVGFQLSFLAVLGIFWLN
QPILKYFPKQNNWFKKLIFNTISISVSAQLATLPLVLYYFHQFSLISIVANFFIVPFSEI
IIVFSFVMTGLIAFSLDFTLINTVYDYIIQILLKVIHWFADFDSVFFENIPMNLAEVFSL
FLIVYLMRFAILKYNFKNLARLMMAVLTFFILRIGFNFYENQKTEILVHDFSKNKVLSIK
EGNKVCFWIKENSDKQKITQFIINPYCSSRRLDNVEMKVAPKSARQVVYDGKIYEIN
>KALACAFP_00193 hypothetical protein
MAGLTSSTIGRKYAMALSALFLLIFLILHLTTNLLSVLPNRDIFNTASDFMGYNPFVQFL
MQPILGFAVLFHFIMGFVLEIKNNKARPVKYAANNPSVNSSWMSRNMIISGAVVLAFLAL
HFYDFWLHEINYKYVEGIAPDAERFWPELHEKFADIWRVALYVIAFVLLGLHLAHGFQSS
FQSVGARHPKYTPVIKAFGKWYSILIPAGFIFIAIFHFVTQ
>KALACAFP_00194 Fumarate reductase flavoprotein subunit
MSKLDSKIPAGPLKDKWKNHKDHMNLVAPNNRDKIDIIVVGTGLAGGSAAATLAEQGYNV
KAFCYQDSPRRAHSIAAQGGINAAKNYQGDGDSTYRLFYDTIKGGDYRAREANVYRLAEV
SANIIDQCVAQGVPFGREYGGQLDNRSFGGVQVKRTFYAKGQTGQQLLLGAYSAMSRQIG
KGRIKMYNRHEMMDLVIVDGKARGIIARNLVTGEIERHSAHAVVIASGGYGNVYFLSTNA
MGSNVSAAWKIHKKGAYFANPCYVQIHPTCIPVHGTQQSKLTLMSESLRNSGRIWVPKKI
EDSVAIREGKLRPENIKEEDRDYYLERRYPAFGNLVPRDVASRAAKERCDAGFGIENNDT
QEGVYLDFSTEIMKKGKEAAIEKHIHNPTEQQIYDLGKKWIEEKYGNLFVMYEKITADDP
YKTPMKIYPAVHYTMGGVWVDYNLQSTIPGCFVIGEANFSDHGANRLGASALMQGLADGY
FVLPYTIADYLSADIRTGAIPTNSPSFDEAEKGIKEKVDFFLNNKGTHSVDHFHKQLGNI
MWNKVGMGRTPEGLREAIKEIEEVRNDFWKNVKVPGDNNGMNTELEKAFRVADFLELGQL
MAIDALHRNESCGGHFREDHSTPDGEAERDDVNYKYVGAWEYQGGDINAEVLHKEELIYD
NIEVKTRSYK
>KALACAFP_00195 Fumarate reductase iron-sulfur subunit
MSAKKGLHLTLKIWRQKNNKSKGQFETYKISDVSTDSSFLEMLDILNENLINEGKEPVAF
DHDCREGICGMCSLYINGRAHGPDTGITTCQLHMRMFKDGETIVIEPWRSAAFPVIKDLM
VDRSAFDRVMAAGGFISVNTSGNTLDANAIPVPKEDADKAMDAAACIGCGACVATCKNGS
AMLFVGAKVSQFALLPQGRVEAKRRVLNMVKAMDEEGFGNCSNTGACEVECPKGISLENI
ARMNREYMAAFVDQG
>KALACAFP_00196 Thiol-disulfide oxidoreductase ResA
MKKYLLLFIIAVFAVSCSKKVEVKGKITGGSPLERIEFIEASGVATLPLINIGVNKDGTF
SGNFEAPKSGMYVISYGGKQNLIYLKGGQKLEISGNALTFPSEYVITGDAKKNNDFFTAT
QKYLSTYAQTVNMNELIMKDEKTFLKGIEKVQADINKNIDENVKKFSPDNEIITWKKNDL
ASTLLTIMNQYELTHKQMGNPSFKVTKAFTDFENKLQENKDVMVKENPYYRQYLLGKMSS
DFQKYAEANSKGKTDITTTELFSEYLKKNQKDLSQTAKDYLLAFVMAQSDMHLGSSEKTV
EKIKKIIDTDIKDATIKEDLKKIQFAINGFKVGELAPEASLVKQDGKAYKLSENKGKPYL
LTFYASWNPYIGESTIPVLKEVVNFYKSKMNFVFVNVDDTKDQFIKTSNSLLKGIAGTNV
YGEGGLNSEIAKKYGVYGFKLPCFIVVDKDGKIASKVFVNLGEQDVITVLDKQTGLSAPK
VNPNVQLQPGMGMDPAVVAAQQAAQQQANPQPAQTK
>KALACAFP_00197 23S rRNA (uracil-C(5))-methyltransferase RlmCD
MKRNKKNLILENIKLLNAGAKGVAIGRTEEGKTVMVSGAIPGDIVNVRVKKAKSKYYEGE
AIEVLERSPDRVEPKCIHFGVCGGCKWQNMSYEKQLAFKQEEVYNNIKRIGGIDDFETVP
ILGSEEHYFYRNKMEFSFSNARWLTQYEISSEENFGNKDALGFHIPGMWSKILDLKECFL
QEDPSNAIRLAVKDYAVKNGLDFFDVKNHEGFLRTLMMRQNSKGEWMVLFQLYREEKENR
EKLFEFLLEKFPQIKTLVYAINPKPNDSIYDLNINTYFGEGFLMEEMDGLKFKIGPKSFF
QTNYKQALELYRKTLEFADLKGDEVVYDLYTGTGTIAQYVARNAKQVIGIESVQEAIDAA
IEHAELNGLTNTTFYCGDMKDIFNDEFLANHPKADVLITDPPRDGMHQKVVEQILKLSPE
KVVYVSCNSATQARDLALMKEHYKVVKILPVDMFPQTHHVENIALLIKK
>KALACAFP_00198 hypothetical protein
MKYFKLLIAICFLGLLFSCGGDDDICESGEGTPRMKVSFKNFDTGKEKTMDSLYVAVDYG
SGKVELGKQTSITSRVIPLRVDDSPFTDVYFRTSKTGAESKVRINYTTKSIYVSPGCGIK
KTYEDLNSVLDPTTTNPVKALEAGQNFIENEDKTNLYLLF
>KALACAFP_00199 hypothetical protein
MSFAQENKEAKKEKWKYKPNFMVGFDVLNTGVSFFSDRKLYQGFISSKVKDNIHGIIEAG
FESNVYNKNSYDAKVNGPFLKLGAFYMLARDPENEFNGFFAGGKIGGSFYTQEYMAVPVR
GYGGSNSSIAFPSSTQSSYWLEGTIGGRVQLFESDFYIDVNLQPRYLVFTTKQDDIQPMI
VPGFGRSSSKFNMGFAWNIAYKF
>KALACAFP_00200 hypothetical protein
MRKSTTSKVFLFMLSFFAAGINAQNTGGKKNAEFNVNKPQSELAKSNGFDRCSTVEYENY
LQEKFPGRMTAEQFESWLAPLIRNAKVEKSQNGNIITIPVVVHVIHNGQAVGVAPNIVDE
QVISQITVMNNDFRRLAGTPGFNTNAVGADTQIQFALAKVDPNGNPTNGIDRVNLCQPSW
TQAQIETFVKPETIWDTTKYMNMWSINFPNSSTILGYAQFPSGSGLPGLNANGGEAYTDG
VVARYTTFGSSDYNNGTFILAAPYDKGRTMTHEVGHFLGLRHIWGDLACGTDYCADTPTA
HTSNYTCNASIASCDSPSIFEMVQNYMDYTNDTCMNVFTVNQKDRITAVMNNSPRRLELK
TSTADMPIALFANDAEVKLERDCSTIGCSTTTAQNVKVSLYNRGTSPLTSAVITYSVNGN
TQTYNWSGNLAQDKFDIVTLPMNAASLGGYMNINVTSANGGADQRASNSNISVNYLGAPT
RMDTNVVFNLQLDSYGTETTWSLKNSAGTVVESGGPYTDVTFPTLPALKTFNWTLNPNEC
YTFTINDSYGDGLYPYGGYYNIKSQSGNVLLSGSHFSSTQSRTLKAQVLATHEVVKKETF
GLYPNPANDVLNITNVSNKAKFEIHNAVGQLVKGGTIDNNQVRVADLVKGTYIITIKDNT
ISESIKFIKK
>KALACAFP_00201 hypothetical protein
MKKLITTLFCSFLGGALFAQWAPTTFAGGTDKTSHIRSYYKLDLNKIRQQLKDAQETGKN
AKPVEISLPTLDGRIEKFAVYSFPVMAKDLADQYQLGSYVGVGIDDPSKYLRFSVAPNDF
QSMIIKNGAYEFIEPVDANKTTYGVHPKTNKGNGDFTCSTTESKVSKDEMKKLYEMGKSF
TNQPTNFAKNSDKKYRTMRLAMSVTGEYTQYFGGTVAGALTAINATMTRVNGVFEKDFAL
HLNMQNYPAIIYTNPSTDPYSPASQMGNWNLQLQQTLTTNVGDANYDIGHLFGASGGGGN
AGCIGCVCIAPTTADPEGKGSGYTSPADAIPQGDNFDIDYVAHEMGHQLGANHTFSQNIE
GTGVNMEPGSGSTIMGYAGIVPGANVQMHSDAYFHVASIEQVQTNLMSKTCDVETTITNN
PPVIGALSNYTIPKGTAFVLTGTATDPENDPMTYTWEEYDSATSPVTTVTGNNTTGALFR
SWTPTATGNTRYFPKLSSVLAGNLTVPADWETVSNVARPTNFKLTVRDNNPVTTSQQTQS
GLVTVTVSNDGPFKVNTPNAPHTVPATIQWTVANTAAAPYNAANVKVDYTTDNGTTWTVL
SASTPNDGTENFTFPAALSGQTIKLRISSIGNVFYAVKPIAIYTMTPCDGSAPTGVTTSN
ITQNTVDVNWMLVSGATYIIRYKKLTDTTWQQTTSTTNSITLSGLEDSTTYEVQVAAVCS
GTPGAYSASSNFTTQGMAYCTLASVDSNYEYISNVTLANVNNNSMASTYTNYTTDPTKVV
NLVKNSTNNVVSVSKSWVSTLYDEAVRVWIDFNKNGTFDASELVMDSPLSKTTPVTATFT
VPSTAVVNKVLRMRVAMSDSASPPTCGTFQYGEVEDYNVMISDVLATNDLNGPKNDIQLY
PNPVSDILNVTKVSDKAAYKIYSAAGQLVESGTINGGKINVSALIKGGYVITIEDKGRDL
FKSKFIKK
>KALACAFP_00202 hypothetical protein
MKKFFTSFFSLCVLGAVSAQWSPTAFKGEKLRKEANIKAYYSLDISALRSQLANAQETGK
GAKAVEISLPTMDGKVEKFAVYSLPVMAKDLADQYQLGSYVGVGIDDPSKYLRFSVAPND
FQSMIIKGGEYEFIEPANTAKTVYGVHPKTNKVAGGFLCSMNESALSKQQMDALYAKGKT
FTNQPTNFAKSSDQKYRTMRLAMSVTGEYTQYFGGTVAGALTAINATMTRVNGVFEKDFA
LHLNLQSFPGVIYTNPATDPYSPAATGAAGAWNLELQNTLTTNVGNANYDIGHLFGASGG
GGNAGCIGCVCTDPTTAEPEGKGSGYTSPADAIPEGDNFDIDYVAHEMGHQLGANHTFSH
NIEGTGVNMEPGSGSTIMGYAGIVPGANVQMHSDAYFHVASILQVEDNLSTTTCDVETNI
INNPPVIGALTDYTIPKGTAFVLTATATDPENDPMTYTWEQFDSASTSVTTVTGNNTTGA
LFRSWTPTATGNTRYFPKLSSVLAGNLTVPADWETVSNVARATNFVLTVRDNNPVATSQQ
TQSDIVTVTVGSQGPFKVNTSQVYHNTPSTVAWDVAGTTAAPYNVANVKIDYTTDNGTTW
TVLSASTPNDGSENFTFPVALNGQNIKLRVSAIGNIFYAVKSILVTAAAPCNGTAPTNVT
FTNITSSSAVVNWNTILNATYIIRYKKSTETAWQQTTSTTNSVTLNTLEEGVRYDVQVAA
VCSGTPGAYSANSQFITLSSVSYCTLTSSDPSEEYISNVTLANVNNTSGSSTYTDYGPDP
AKLINLISGSTNNNVSVTKTWPADIYPEGVRVWIDFDRNGTFDTAEMVLNSAAGTTPTVS
ATFTVPVTAVQNKTLKMRVALRYNTVPAACTSYTYGEVEDYNVMVTPTALATNDLNTPEN
AIQLYPNPVSDILNVTKVSDKAAYKIYSAAGQLVESGTINGGKINVSALIKGGYVITIED
KGRDLFKSKFIKK
>KALACAFP_00203 hypothetical protein
MKKLFTSFFSLCMLGAVSAQWSPTVFKGDKVRKEANIKAYYSLDISALRSQLANAQETGK
GAKAVEISLPTMDGKVEKFAVYSLPVMAKDLADQYQLGSYVGVGVTDPSKYLRFSVAPND
FQSMIIKDGEYEFIEPANTAKTVYGVHPKTNKNGQGFLCSTNESPAAVKQMQELLKQGKT
FTNQPTNFAKSTDQKYRTMRLAMSVTGEYTQFHGGTVAGALAAINATMTRVNGVFEKDFA
LHLNLQSFPGVIYTNPATDPYSAAAAGAAGAWNLELQNTLTTNVGNANYDIGHLFGASGG
GGNAGCIGCVCTDPTTAEPEGKGSGYTSPADGIPQGDNFDIDYVAHEMGHQLGANHTFSH
NIEGTGVNMEPGSGSTIMGYAGIVPGANVQAHSDAYFHVASILQVEDNLSTTTCDVETNI
TNSPPVIGALTDYTIPKGTAFVLTATATDPENDPMTYTWEQFDSATSSVTTVTGNNTTGA
LFRSWTPTATGNTRYFPKLSSVLAGNLTVPADWETVSNVARPTNFVLTVRDNNPVATSQQ
TQSDIVTITVGNNGPFKVNTQYANVNTPAPIEWDVAGTTAAPYNVANVKIDYTTDNGTTW
TVLSASTPNDGSENFTFPSSMNGQIIRLRVSAINNVFYAVGKITVAAFAPCDGSAVTGVT
TSNVTVSGVTVNWTPVSNATYIIRYRKVGETTWQQTTSTTATVTLSGLTDSTNYEVQVAA
VCSGTPGAYSTSATFTTSAIPYCTASTVTAANLYISKVQVANINNNSAGSTYTSYTANPA
LQINLVKGTAYPMTINSNIAAYDAAMVFIDYNRDGVFAATERVLNFPVANVSTFTGSFTV
PTTGVVEGQTLRMRVLLGYAGQDNAGLSAPATWVCGVNFNDGEVEDYNVVVTATPLATDE
VSGPKNDIQIYPNPVSDILNITKVSDKAAYKIYSAAGQLVKHGTINNGQINVTELIKGAY
VITIEDKGKDQFSSKFIKK
>KALACAFP_00204 hypothetical protein
MKKKFTSFFFLFLFAITSAQWSPTTFRGEKNRANADIKGYYSLDISLLKSQLAKAQETGK
NAKPVTISLPTLGGKIEKFAVYSFPVVVKELADQYQLGSYVGVGIDDPNKYLRFSLAPDD
FQSMIIKEGKYEFIEPVDKNKTVYGVHPKTDKSNEGFLCSMNEDRLSKQEIENLYTTGKA
FSNQTMNFSKNSDKKYRTMRLAMSVTGEYTQYFGGTVANALTAINATLTRVNGVFEKDFA
LHLNLQNFPGVIYTDPATDPYSPAAQMNNWNLQLQQTLTANVGSANYDIGHLFGATGGGG
NAGCIGCVCIDPANNTATQKGSGYTSPADGIPQGDNFDIDYVAHEMGHQLGANHTFSHGL
ETAGVNQEPGSGSTIMGYAGITGANTDVQPHSDPYFHIASIKQVQTNLINKNCDVETTVT
NNPPVIAALPAYTIPKGTAFVLTASATDAENDPMTYCWEEVDNASVTINKNNLGTTASGA
SFRSLNPTTSPTRYFPKLSSVLAGVLNNSNNQWESVSTIARNSKFAVTVRDNNPAANQQQ
TQFAEQTITVGNDGPFKVTTTTAYNNGPTNVTWDVVNTTAAPYSTANVKIDYTTDNGVTW
TVLSASTANDGNESFNIAGLTVGNIIKIRVSAIGNVFYAIGSATIASLANCTTAPPTGIT
VTAITQTTATVSWTAAANATYVIQYHPVGSTTWTTVTSTGNSIGLTGLSDGIQYEVQVAT
VCSGVQGPFSASTNFTTLGLTYCTMTSSNFGSEYISNVSVTPIGAAPMSNNSAGSTYTDY
TTTPSALVNLVIGSTGNTISVTKFFPGTQWSEAVGVWIDFNRNGTFEATEQIMNTPANTT
TPVTATFNVPATAYNGPATTRMRVAMRYSTAPVMCQSFGDGEVEDYAVKLIQPIPCTSNA
PLNLNVTSITATSAFVTWDPVTGGTYVLQWRPVGSTTWTTVPLTTPSYVINGLTEQTQYE
VQVAYVCSGVTGTFTAPYQFTTPPVTYCNNTPTANTNGYISNVTITPTGSYVMSNNSAAS
TYTNFSADPAKLVTLVRNSTNNTISVSKSWSGTFQSYIATSAWIDFNRNGIFEASEKVIG
VGTSITTPITATFTVPATSYNGPLTLRMRVIVATSTINDPCATISEGEVEDYAVKIIDPQ
PCTTAPPTPIIVSNVTASTALVSWVSTTGATYTLRYRTGTGAWTVIAAATNPYTIINLNA
STTYEVQVATICGGTTGAWSNSVNFTTPTSTYCNSGTATVTDGYINNITVTGTSTPTMSN
NSGATTYTDYSNDATKIITLARNSTGNILSVGRTILSSTYSTYAWLDFNGDGIFNNNPVT
VPGGERIMNLGYSSTTPVTATFAVPAGAYAGTNKVKMRVIVYFLTPTDACSPLTSNGEVE
DYQVKFIDIQPCTTAAPTGITVTNIAATTATVSWISSTGATYLVRWRTTSPIGAWNVSPA
PITGNTYNITGLTEQTAYEVQVATICGGVQGPWSTSLPFTTTPITYCNMTGTGTTDFISN
VTMTSVNPGLPVMSNTSVQTNYISYTTPATLINLEIGSTGNKISVAKGWSGATQSDAVSA
WIDFNRNGVFETTEQIMASAASTTTPVTALFNVPSTAYNGPLTTTMRVVLKRSSAPVMCQ
NAVNGEVEDYAVKLRPCATTMPTNVAINTITHVSANVNWTVPAGTLTFIVRYRVAGTTTW
TEVTASTLSGNPPIALTGLTPATTYEVQVAASCGTTPGTFTNIQTFTTRCDPTPPNVTIG
TITTNSAVVNWAPIAASSTYVIRYRIVGTTTWTTINVTTPPFGSYTITGLSPYTTYEVQI
ANMCNGETTVNPWSNPKVFTTERTCELPPPGLTITNLTPTTAVVVWDPFPGATYILRYRK
VGIPSWTNVPSSTNTVTLTGLTELTQYEMQVANVCNGTPGTYTLPYFFTTPTVVYCQMAS
TASNSEYISKVNVKPTGKPEMDNPSNASNYTDYTGIPATFIELVQGSSNNQITIEKKLSG
NAQAGVAVWIDFNRNGYFDVNERVLVSSPNNQQTVSGTFSVPADAFISLTDYKYVVMRVA
MSKDAIPVNCTSFPNGEVEDYTVRISKQIVPNPVNQTDILIYPNPVSSVLYVKNISKKAN
YKIYNAAGQLVSSGIILNNKIDVHALINGVYVIDIQDGDAISVQKKFIKE
>KALACAFP_00205 Dephospho-CoA kinase
MEELHSEPQKAEPEPLSASKVIGLTGGIGSGKTTVAKFIEECGFPVYYSDDRAKEIVNDN
DDLKQKIKELLGEEAYDKDDLYDRKFVAEKVFNNKELLHQLNEIIHPAVRIDFEDWVKKQ
TKYLVFKETALLFELKLNLQCYKSILVTAEDNIRIKRVMDRDGKTYREVQAIMEKQMPEK
DKIKLADCIIYNNTNLEDLKHQTEKIIFDIE
>KALACAFP_00206 putative quorum-quenching lactonase YtnP
MKLYPIQCGKFKLDGGAMFGVVPKSLWEKTNPADERNLIELGTRSLLVEDGKKLILIDCG
LGNKQDDKFFGHYSLWGDDNLDKNLKKYGFVREDITDVFLTHLHFDHCGGAIEWNDDRTG
YRPAFKNAQFWTNENHWKWATEPNAREKASFLKENIIPIQESGQLNFLPLPTTGNYGFAP
DLKMDVIFVDGHTEKQMLPVIQYQEKTIVFAADLIPTAGHIPHVYVMGYDTRPLLTLEEK
GKFLKQCVDNEYLLFFEHDAHNELASLKMTEKGVRLDETFSFNDVFGY
>KALACAFP_00207 Protease synthase and sporulation protein PAI 2
MFIPKLYKSEDYDLMKEIIRENSFALLISSVDKIRATHSMMMLNEDDPENVYIESHISRA
NPQAKTLKNGDEVLCDFLGAHTYISSSWYDHINVSTWNYEAVQIYGKVELMNDAELYHHL
EKLTYKYEKVQQCPVMVKDMGREFVEKEMKGAFGLKIIPTEIFIKQKLSQNRKEHDFRNI
ISNLEEGDENARKIAEKMKLIK
>KALACAFP_00208 Holliday junction ATP-dependent DNA helicase RuvB
MPDFLHPDKDNYSREELMQEEQIRPQSFKDFAGQRKTLENLEVFVTAAKKRGGALDHVLL
HGPPGLGKTTLANIIANELGVNCKVTSGPVLDKPGSLAGLLTNLEENDVLFIDEIHRLSP
VVEEYLYSAMEDYKIDIMLETGPNARSVQIGLNPFTLVGATTRSGMLTKPMLARFGIQSR
LEYYTIELLSTIIIRSARVLGVKIYEDAAIEIARRSRGTPRIANALLRRVRDFAEIKGNG
EIEINITKYALNSLNVDEFGLDEMDNKIMRVMIENFKGKPVGISALATSIAENPETLEEV
YEPFLIQEGFIIRTPRGREVTEKAYKHLNIAIPRNPGELF
>KALACAFP_00209 Imidazolonepropionase
MKLIGPFKQVVTLANLPLRGKLSDDQLEIIADGGILVDNNTIQKVGNFETLKSENQNIEI
ESIEGEQIVLPAFVDSHTHICFGGNRANDFAMRNAGKTYLEIAESGGGIWSSVQHTRNAS
EEELLKTILKRIDFLIALGITTIEIKSGYGLDVANELKMLRIIKKAQEQTKATLVPTCLS
AHLKPRDFDGSNEEYLQYILTEILPKVKKENLAKRVDIFIEKSAFQPEESKGFLLKTKDL
GFEITVHADQFTPGSSRIAVEVGAQSADHLEATIDEDIEFLAQSNTVATALPGASLGLGE
KFTPARKLLDAGAILAIASDWNPGSAPMGNLVTQASILATFEKLTTAEVLAGMTFRSAFA
LGLEDRGKLENGLKADFVTFKTNNFQNVLYNQGSLKAERVYIDGNKVLK
>KALACAFP_00210 hypothetical protein
MFELNEGIYKFYVYILTNKNRTVLYTGVTGNLHQRLKEHVNKINPTSFTAKYNTCFLIYY
EKFGWIQQAIEREKEIKLLKRNYKFELIRNVNPNLEFLNHLFQQAV
>KALACAFP_00211 Formimidoylglutamase
MNNNIWQGRLDGEELLYHRIFQRVREESNYDTISTNDFVLHGFAVDEGVRRNKGRQGAKD
APDIIRKNMSNFPVILPDFSLLDFGNITCDDGNLEETQNNLAKNVSKVLLKGGKSLVLGG
GHEVTYAHYLGIKTAFPEQKIGIINIDAHFDNRQPENGIGASSGTGFWQIAQEGEINSLH
IGIQRNSNTLKLFDTAHQYGMKYILADELFFENLPSIYQRIDELLNSVDYVYLTICMDVF
NVSIAPGVSASAYNGIFADATFMHLYRHILKNEKLLALDVAEVNPAYDIQDRTARLAACL
MNEWFMIMP
>KALACAFP_00212 Succinate semialdehyde dehydrogenase [NAD(P)+] Sad
MEQSIENKLIKADKTFSEWKKVPFEDKQKLIAKAAEVIKANSEKFGRIITSEMNKPISQS
IAEIEKSALMMNYYADAENILKPEKIDSEFGYSEIHYAPKGVILGVMPWNFPFWQVLRFA
IPTILAGNTVVLKHASICFGSGNAIEEIFLEAGFPEGVFQNLEVGHKVVKEILEHKTVKG
VSLTGSEKAGGEVASIAGLNIKKSLLELGGSDAFLVLDDADLDEAARVGAWARLQNCGQS
CIAAKRFIIEEKIEDVFLPKFIEEYKKFVAADPMDKETKLGGMARPDLADELEKQFQKAL
ENGAEIIIPLERISSNEFKPGLIRVKEGNPILQEEFFGPLGMVMVAKNDEEALQMANDIP
FGLSNSVWTKDINRQLFFVENLESGTVSVNKMTSSDPRFPFGGTKTSGYGTELSLLALKE
FVTAKMIVGN
>KALACAFP_00213 Pyruvate kinase
MKNFIKLSSIMNKYLKKTKIIATLGPASSSKEVMLGLMKAGVDIFRINFSHADYDLVRKN
IEIIRELNKEYGFSVGILGDLQGPKLRVGVVKEGSYLNPGDVLTFTNEKIEGDSTKVYMT
YQQFPQDVQVGERILIDDGKLVLEVIETNEKDTVKAKTIQGGPLSSKKGVNLPNTNVSLP
ALTEKDIQDANFMLDQEVDWVALSFVRHAQDIIDLKELIAKHPNGKFKTPIIAKIEKPEG
VKNIDEILLECDGLMVARGDLGVEVPMEEVPAIQKTLVEKARFYSKPVIIATQMMETMIN
SLTPTRAEVNDVANSVLDGADAVMLSGETSVGRYPVQVVENMAKIVKNIEMTHFYQHKNE
PIEKDYNCIDDRFITNRVCLAAVRIAKTTNVAAIVTLTHSGYTAFQLAAHRPNSHIIVYS
GNKRVITMLNLLWGVHAYYYDMKKPTDETIIQVNMLTHNYGYIEGGDFVININATPSYEG
GKTNTLRLTTV
>KALACAFP_00214 hypothetical protein
MEIQKLYDLDDIEFEDIAIGLVRLAKNIPDHEFFFNVNQKNDLTFKRIDDLIFHGAYYDY
FFPRFEAYHKFTKTCFTFISNKSSESKQKKIQTELFSEEENIKFLLNNQVDVQYILHSSE
QFPDFSVILLPENLVFPIQDYTLSSDEELYQIIQYYE
>KALACAFP_00215 Ribonuclease 3
MELQKYFSKFLLKNRKRKLTERDYFLSTELSRMLGTEVQNVALYREAFSLKNSSKNQDSN
YERLEFLGDSVLGTIISCHLFQTYPQANEGYLTQMKSKIVNRKNLNKLGEDLKLTDLLQK
SGSVALGENISGNLFEALIGAVYLDFQYDACKKIILERLLTPTEINKLENKIVSYKGLLL
EWSQKKKLNIKYETCEEIQVNKSIVFRCHVWLGEERIANATETSKKKAEEKAAQRAFYIL
NKKENILGNPKTL
>KALACAFP_00216 3-oxoacyl-[acyl-carrier-protein] synthase 2
MELKRVVVTGFGAITPIGNNAKEYWENLVKGESGAAPITLFDATNFKTKFACEVKNFDPL
QHFDKKEAKKMDRNTQLGLVAAREAVTHSRIIEDSVDKNRVGVIWGSGIGGLETFETEVL
GWANTDIPRFNPFFIPKMIADITPGHISIEYGFHGPNYTTVSACASSANALIDSKMLIQL
GKADVIVCGGSEAAVTASGVGGFNAMMALSTRNDDPKTASRPFDKDRDGFVLGEGAGCIV
LEEYEHAVKRGATIYAELKGGGLSADAHHMTAPHPEGLGAYLVMKNCLEDAGLTADEVDH
INMHGTSTPLGDIAESNAISKLLGEHAYDIQINSTKSMTGHLLGAAGVIEAIAALGTIIH
GIVPPTINHFTDDENIDSRLNFTFNEAVKKDVKVAMSNTFGFGGHNACVLFTKI
>KALACAFP_00217 Acyl carrier protein
MSDIASRVKAIIADKLDVEETEVTPEASFTNDLGADSLDTVELIMEFEKEFNIQIPDDQA
EKITTVGHAIAYIEEVVNK
>KALACAFP_00218 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MKKVWFITGSSKGLGKSLVEAVLAKGDYVVATARNPQQLNDLAGKYPEQLLPLELDVQNK
EQIYATVDEAVNHFGKIDVLVNNAGFGITGAAEAFTNEQVRNQLEVNLYAPIEVTRAVLP
YMRKERSGHILQISSIGGRVGNAGLSIYQAAKFGLAGFSESLSKEVAPLGIKVTCIEPGG
FRTEWAGSSMSFAKDIEGYETTVGGVKEHLTSGKFIPMGDPAKAAKVMTEIVENENPPLH
LVLGSEAAAILRATDAKRKEEFEKWLDVTVSTDHDDAVNIFETEYGKQYLAHKGINVK
>KALACAFP_00219 Exoenzyme S synthesis regulatory protein ExsA
MQSHFNYLCITMKSKREDFGNIVYSCYTQVSRQGEHFVSDHVLSYQIAGDLVLNDGFKDY
SATDGSIRFLKRNQLLKFTKQPPPSGEFKSLSVYLDQQILKDFSVEYGLTAEKKYVDKSL
LLLTENPLLQNFMQSLLIYQFSDKLSDSRLVEVKVKEVLILLLQEEPDLKDVLFDFNEPG
KLDIEAFMNKNYHFNVNLDRFAYLTGRSLATFKRDFEKIFGITPGKWLLQKRLKEAHYLL
EKGKMASDIYLDLGFEDLSHFSFAFKKQYGLAPSKIISA
>KALACAFP_00220 Thermonuclease
MKKLIYITLIFISNVFFSQVKGKIVGVKDGDTVVILLTNKTQETLRLADVDCPENGQPFG
KNAKQFTSSQIFGKTVTFYRIGKDRYRRTIAKIFYDNDKYLSAEIIKAGFGWWYYKASRN
TELQKLQDQAKAGNLGLWADKNAVSPWDFRESKKKKKVL
>KALACAFP_00221 hypothetical protein
MKRFYLLTAFLMLNFAYAQLDNLHYLQPIIFGAYTDATIVAEHIYLSTPSTSNITVTVRR
ADGTTIPRLYVYNINAETGSYVASGSVTFSNTTPIRINIVNASNVILDAGTSPMTRPTNT
AGTIIQGSAGGLIFQSTDNFYVNYRGRSESQAGSVMTKGRVALGKNFFWGGTPNEYTTQV
PEVGNMVSIMATENNTSVTINNIDSGTQFINGTNATPLTGTTFTRTLQKGQSFILYAKVK
LNALSLQDRGWLGAKITADKNIAVTVGGLMQQGGATSGTVSDSRDFAVDQLVPVEQLGNE
YVVMQGNGGAQERVIVVATQANTTISMNGSTTPNYTLTNIGDYQIVPASFFTNKNMYIKT
NKAVYVFHKIYGSTALNTNSFMFIPPLSCFGQTSVNMIPDAKRIGSNEYANTQLAVLAAA
GAPPTVTVGGTTANPIAGTANIAVPGNPNWTSYRYNIAAATGGTATIKNVRISSTGAIQA
ELVGADVDAGFGGYYSGFGAAPNVEINITGSPNPARPCTGGTGNSVLTVSSGLGTYQWYK
DGVAISGATTNTYSIPVTDTTAAEYNVIVTVPGGCLVYSNVVTSFACPCYKPGVTGTPEI
TKIGISTRTTASTPNFPADRNNGFIALESNDKGMVISRVAEPEVSITNPVDGMMVYDTDD
NCLKIYNGTQWSCINQTCN
>KALACAFP_00222 hypothetical protein
MKTTYFTIFFFVLNGLLQAQIGVEKESVDGSALMDFPTGTAKGIILPQVQNNTLMTDVTA
GTLVFDGATAKTKYFDGTNWIELFGESGLAESLLSGAEKNVTKGVIIGAADSAAKGVLVF
ESEDKALILPKVIDPVNTVKSPTAGMMCYDPVAKLVCFYNGASWSFWGNIN
>KALACAFP_00223 DNA-binding transcriptional activator DecR
MEHLDNKDLQLLRLLQSDAKLTVKELAKEVNLSPSPVFERVKRLEQEGYIKRYAAVLDAE
KLNLGFTVYCQLKLKSNDSYLAIEFEREIMEIEEVAECYSISGDFDFLLKVHVRDMKQYQ
NFVFNILGAVPSIGSTHSTFVMAQIKNTHGLTI
>KALACAFP_00224 Tyrosine recombinase XerC
MNYTFKLKQPNGTKESLIYFRSFFNNENKNFIYSTGEKIKPSEWDFEGRQPNDLNGRTKR
AEIHRSVKMQLDRYSSFFTEIVNRYKNINEELTVDILKQRFDEKFKKITVKSDFFRIYQE
FLDEKENDYTGNSISNSTLKRYKCNKNLLEDFESNCKVKITLGKFDDKLYNRFLKYCIEE
KKHSANTLHRNVGLLKTFLLWALNKKYTYNNNFITFKKPAKFTTDEIALNYEQVELIYNY
DFSDNKRLERVRDLFVFGCTTGMRFGNYSTISKSDVDGNFIRVIDLKSKSKNLAIPLNSI
SKSILEKYDYNLPSITNQKMNEYIKEVFKKLEFTDEIKKTMKYGDELVDQKAEFWTRISS
HTARRSFITIMKNKRVPDKVIMSYTGHTSLEVFNAYYRPSEDDKINYMNEVFK
>KALACAFP_00225 hypothetical protein
MDQKKLYGRWNFWEEFVGYPMMIYLWIRRPKIHKRLRSRIEKAQQKSSKIVLDEKLRNEF
LIRYDKLDNFFSFHFRDIDASRNHNFEEKIQYCLDQYKKESNSLLSSSNLMKLQGNFLNG
VETTLFLYFALKHKTNREISLSDIMIGDNSSKIFLAFLKDKKFIDENHNLLVDQKSSFIR
IHRFLKDNHIINPDFQDTTIIEAMENEYNTNFDKGTFSRAVTVKANDFEENIYQELSKIF
NIKF
>KALACAFP_00226 hypothetical protein
MGHYDAYLVCENGHGVNDSFYKNPEFNKNFCTTCGAKTLKNCPTCGKEIQGDYHIEGVID
LTAGPTPVPDICKYCGTDFPWKSIRAKIAENVKSTNKDDILILETIMDKFHLVVKQIRQR
YNDRTTLDVEDEYDVQDLLHSLLKIYYDDIRTEEWNPSYAGSSTRSDFLLKNEKIVIEVK
KTRNTLRAKQLGEQLIIDIAKYKTHPDCNLLFCFVYDPDGYINNPIGIENDLKQDRKEEM
QVKVKIIPKGH
>KALACAFP_00227 hypothetical protein
MKKCSYCGKESKLTKEHIWPKCIIKRAPELNMKYLESQKKVFSRELVISDVCSDCNNTKL
SYLDAYICQLYDRYFKFFKDKRETFEFECNYDLLLRSLLKITYNSSRTIVKSNNFFQKYK
DYILEGGRTREDIIVKLDIVIPAIIDGNKVYPKSARCGTLDIGITSENFIMRTVAINSYY
FSILFSKEEQIPDTFLPELNNILQRIPGSIINPYDSITVIKHFSNENTISVHEGLINKIS
EAKKR
>KALACAFP_00228 hypothetical protein
MQATNPFQTILDELEEVKDLLYSLKKEPEIELKKKLYSIKECSEILKLDYQTVRSHILKG
NIKAEQIGRFYRVNHFDLMDALNEVKSLKYRR
>KALACAFP_00229 hypothetical protein
MSEKIPYLRVGTTYYKTIEKPLISGDKISILVRWNRETIISDHGKIYVSKVSKYDGFCCI
PSHLDYKQIIDGFYNIYNEIPYQPINENTNSEDLENKIPFSLKFMEHIFGEQLELGLDYI
KILLEYPTQILPILCLVSKERSTGKSTFIKWLKSIFGLNMTYIKGDSFSSQFNSDWTSML
IVAIDEVFFDKKEITERLKYLSTTDKDKKEAKGKDREEVEFFGKFILCSNNEDNFIQIDE
NEIRFWIIKVKSIKSENTEFLKNLNEEIPYFLRYLIQRPFHSHKQTRMWFTDSQIRTKAL
QRLVWKNNNKLESKIIELLYEFFESNEDSKIHCIPQDIFNMLGKMFSKQYWTVNDVRKIL
KENWKLEPQSNSLAYVKYDLDYGLSFFQQNKAGRYFTIERNFILQRFDEMMS
>KALACAFP_00230 hypothetical protein
MNCKKFNSISLEEVLLSLGHLPTKQNEKEAWYLNPFASESQASFKLDKKINAWYLHSEGI
GGNNTDFMKKYLKTSVNEVLEWAQKQNFSFFHQQQQHFKKSEPNYRIDGILNLENPNLKK
YLQGRGLTSKIYDHIKEIRFTVGEKKLYAIGFENLSGGFELRNSFYKGSLLKKDISIIDL
NNNAMALSNVQDKNIKAVAVFEGFMDALSFIEMQRSFAGDLLVMNSIALLNKSIERLKNY
SDINLFLDNDNAGIKCKSQIIKSFSQAKDYSGIYSNHKDLNEFLIHRIKNDVVNKLGKQS
EKFPEADELQIRHQETELKNLNGFKRKR
>KALACAFP_00231 hypothetical protein
MKTSINFKAVKSDSETHNFRKKTFDYIRKDLTPNNEYWLEQKISIRMQKIEAYCKAKSGR
KLQKNAMPIREAVVVIKENTTMLELQNLAKRLEDELKIRVFQIAIHKDEGHTDKDTKEWK
PNYHAHLVADWQDLETGKTLKHQSYHYSKMQDLTAECLNMERGISGSRGRLEAIEFKIQK
KEEDLKVLEEMYNKMKSEMSLDKSQQLIVKENDFLGFKRLNTDKTIANYEKTFRIYRSTI
QKSKTDLESKSKQIAELSTKVDSLNKEVQSFKNKYSVLLTEPNVFASEKKKYLDSVTNIL
ERKVKFERYKYPNIDRTENQKLISEMGQIAENICKENNIPFSAINEIFKNNEMAVQLFSI
LRFGTNDANYMTEDIPIGKQKRRKRL
>KALACAFP_00232 hypothetical protein
MEKDIITFGFEIPGYSNFEKNITSNVSLMDADIVVICPEIIKPSSHSWVSFSSGGGGCYD
VSASTNFINKLQHLKKELTDMLKLGKTIFILLSEKNTFLIALSTSHPRKGQTTYNTTSSS
NYDFLPISIGKLTSASGDKIIFTGNSIFANFNKEYNKNLVYKAYVENSENCNIVYTGKDT
NKILGSIQKVGNGHLITLPMIEFNKDFTKYDEEKDKYFWTKEGVSFGKNFIQNLLEIDKN
LTSNSNKTPIPDWASLDEFVTSKAKSIEKSIETNNKKILELKESNIKYNDLLLEENKIKD
LLFESGKPLEDAVTNALNILGYEAQNYEDGVLELDQVIVSPEKHRFIGECEGKDTKDINI
TKFRQLLESLNADFARDEVQEKAFGILFGNPQRLSEPNSRTLDFTEKCKIGAEREKIALV
KTSDLFFVIKYLKENDNDNYKKKCRDAIYKGLGKIVTFPPIPKTKSRQT
>KALACAFP_00233 hypothetical protein
MKLSDLTIESIKEFISGDNGLTPGLSGPLILKLFNQVGFKDVYKWEEGGMPRKLSRNAYI
IEKLTEINGQKELIQLLEIVFDPRHFAKDVNKDIATAVEKINVLLQQDGYRLEDIDGKYK
IIGAELPDDIEVEVHFEEIQRQIIEQIRLAKFTIWVAVAWFTDKDLMRELYEQKQKGINV
RLVILDDEINAKNGFQYEKYFETKRVHKTGIYQNIMHHKFCIIDLKTIVHGSYNWTTKAK
WNRETISIENSRELAEKYATEFKQLIK
>KALACAFP_00234 hypothetical protein
MAQRTTLEDFLRRSKEIHGNKYDYSKVVYKTTESRVIIICPEHGEFDMRPRAHYAENRGC
PKCDNSHKSGFHKSIWYDKSKYIYLIECYGNNEKFLKFGVTITDIETRTLKGELPYSYTR
LFSKKIEIGEEAMKIEVKLKKKYASLSYKPLLKFRGSTECLVLGIKENILNYLK
>KALACAFP_00235 hypothetical protein
MTKIERVEQYLHKFFTYNIFEFTDFYRAVNEQREFGIYRLPKGDEILNFLNNIHSNIEEN
LNFEQLIPHRFATPQNLLFYLQRFIDDINGDRHLVDSLYDGEDTDWIISSFVMYIEKILS
AFEYAIEIYDLEDENVLLYQKLRYQLIKHNIDDFITDLKSIFANVSYEIVKQTEGYYHAN
VFLILKLLGFDIVPEESTNIGRIDAVIRFSRKIYIMEFKFSEDSDDSQEALDQILVKDYA
EKFRIDNPDIYGIGISFNSKIRNIRTYKESKL
>KALACAFP_00236 hypothetical protein
MDIEKYKENALKILSPIKPVDVNTKANEELLFFAERSDAGREIHDYYLVYFLFVNLLGFR
DAGRFEKLAWSIPIDFNGKAFLIEHRKMGVGVFIQNKEDEEDARIITKKINGAIKSSRPY
FNYLAEEAIRNSAINIVNNNGYLFERFNYFLKLYKAANKKLSKLSKESIWKDNHLILASK
EYHKVRPNVRWLAISTIESFFSWTEHLFIHLAVITQKIKTGEEVTKLIDAEWKTKFNTVI
SDDKLKEYYDELLLIRNQVRNFVAHGAFGKEGNAFYFHSGAGAVPVRMDFNKTKNRFSFR
GTLEFKDHEVIGLIESFISDVNSSNLKPALTYTQGHGLVTILPYASNGMYESAMHDNDTM
EKFCDHLQGIFDNAANMDW
>KALACAFP_00237 hypothetical protein
MNIEECKELLDLFLARWTVENVLDMTLEEYVGLGNKDTFCQWIETRTRILGSIKGMTSIK
FGIYERKDLTKRPKNYKNDEKYSWLKAYGVSRKTAFENTRNDLINIIKFSECGKFDLIDN
ILLPDLFKWKVAFLYSNERLIPIFKRDVLLKIAHFFGLKADRNTKISDIQNVMMLNKPAD
LDVYSFMRKLYDEFGTEDDKIEIAGRTIRIKEMRTKRRATGSRNIETQVRKGGASYVAQQ
KHNKIQEALVKLLSDTYGRKNVLIEENFIDVKLIQPDYVSFYEVKSSSYASQCVKEALGQ
ILLYSLNDRDERPRKHIIVGQYPANDNDIKYIEYLKQNLKLEFDYINVAIE
>KALACAFP_00238 hypothetical protein
MYEIIYISTTHKQNGQCNADELCKIVEQIHPEVIFLEALRETYSNNQEHLFSDFGILHNK
LEIEAIQKYQYKSTFKYVPVLDSGMSDVFNEKYEIATQNIELQRKIENFNVLSAKYGFQF
LNSDVSIQLQEDMRKLENIILSDTALNKDAINSIDLYEDEMLDNIYSYCKTNQFDKAVFM
CGVAHRKSIINKVEKLNKNKDITLDWNVLRF
>KALACAFP_00239 hypothetical protein
MPNYDIVVRDNKNKICQFFIGISGDYENDITMNVAEIQKKFPEVNMHTIDTAKNYVKHFE
DLGYTIDNDLYSNLLNSK
>KALACAFP_00240 hypothetical protein
MELINHYNDAHPIEKDECRKGLTLLVNLSTEKTNNNLHVKFTPPMDVILGNYLFGKEENF
LKMYSQTITLAQKLAGNDPITPEDNIDDAIEAVGNQLDFEKEMIRQNYENYIKSINEGNV
DWAYFEGKVKREQRRKFLASLRKGELSFLVAQSMIDRAYFNVKETYQKDEGFFRTVVKFM
KDFCPALVMNELLLDNIGNGVIAISDLKDKRWNTILDISLIFGTLYNPQGEDVVLVTEDQ
NIIDSFNKCGFDGKAIKLTDFLALLGLEQ
>KALACAFP_00241 hypothetical protein
MDFSKFIFKLERKNCSDFIYTVFSLAKEGMFSQKQIFNGYKVLFKSELIKVMIYLMDKFI
FCYLNSDDSSDLN
>KALACAFP_00242 Putative HTH-type transcriptional regulator
MFSKTCEYALRALIYIAQQSKNDSRVGIKDISKSINSPEHFIAKILQDLSRKGFVQSAKG
PNGGFYMDEKNLGTNIADIVREIDGDKLFSGCGLGLDQCSEIHPCPLHNQFKSIRQDLRI
MLETSKVQMFVDNLDLKLTYLKA
>KALACAFP_00243 hypothetical protein
MKLYLKNPVILMLFCLMAGMFITVSFVETPLKFQVEGITLSTALGLGKLMFGISTKIQAL
FLTLILIFMTISQSHYTKLDFTITIVLLSILVLEQFWMLPVLDERADLISSGKPLAPTPL
HDYFIYAETAKAIILILAVVLQFRTQPNENRSY
>KALACAFP_00244 hypothetical protein
MKTDPIEKMSAHWLLAKIGKKVLRPGGLALTLEMLAMLNITPDDRVVEFAPGLGFTAKLT
LEKNPASYIGIDAEQESVNLLKKNFKHTSAQFQLGNAAQSSLADQSADKVYGEAMLSMHA
DHRKSEIIQKASRILRPKGFYAIHELALAPDSLDENVKLQIQKELALTLKVNTRPLTIPE
WTHLLEKEGFKVLKTETAPMHLLEIKRIISDEGFSGFLKIAGNVVMQPKIRCRIMQMRKT
FKKFENNLCAVSILAQKV
>KALACAFP_00245 Cytochrome c-551
MILSVLAINLSCSDKSGTTPIPVPGPSTGQAPSQPVSTLEPAVAPNTSGDPGLTLIKRAD
CLACHKIDAKLIGPSYQDVAVKYTEKDIDQLAQKIIDGGKGNWGDIPMTPHEGLSKDDAQ
QMVKYILSLKK
>KALACAFP_00246 Iron-sulfur cluster repair protein YtfE
MNTRTDLIGNMVAEDFRTAAIFKRHGIDFCCKGGRTIEEACSNKKLDPEKIYAELEAIPK
NEGSSIDFNSWPLDLLADYIEKTHHRYVEEKTPVLQAFLDKLCKVHGGRHPELFEINTLF
NESAHDLAAHMKKEELILFPFVRNMIKAKISGSHLSQPAFGTVENPVNMMQHEHTVEGER
FRKIAEITDEYLPPADACNTYKVAFAMLQDFENDLHKHIHLENNILFPKAIQLEKEFTVE
S
>KALACAFP_00247 Nitric oxide reductase subunit B
MTPKKLWIGLAIVMIASFAVLIFYGTEIYRKVPPIPDQIVSADGTVIATGQDIKDGQNVW
QSIGGQTVGSIWGHGAYIAPDWTADYLHREAVLLLDELAKKEGKTYKELPDDEQAKYQVL
LKKELRTNTFNKNKNEIVFSPERAKVQKQLSQYYSRLFMNDPSMSELRDQYAIPKNTIKD
RGRMARMNAFFAWSTWVCITERPGDDVTYTNNWPHDEAVGNVPPPSLHLWSGFSVLLLLA
CVGLLVFYHARNKEEEINEALPLEDPLRNMKPTPSMKATLKYIWVVALLILVQMLAGVIT
AHYGVEGSGFYGIPLDQFLPQSVSRSWHVQLAIFWIATSWLATGLYIAPAVSGYEPKYQK
LGVNVLFGALLIVVLGSLTGQWLGVMQKLGLVDNFLWGHQGYEYVELGRIWQILLLIGLI
LWLILMVRALLPALRRKDGDRHLLLLFTLSSVAIAMFYGAGLMYGRQTHMAIAEYWRWWV
VHLWVEGFFEVFATVVAAFLFTRLGLLRLKSATNAVLFSTIIFLGGGILGTFHHLYFSAT
PTAVLALGATFSALEIVPLVLIGYEAYQNYQLSKSTKWIQAYKWPIYCFIAMCFWNFLGA
GIFGFAINPPIALYYIQGLNTTAVHGHAALFGVYGILGIGLMMFVLRGLYPDRQWNDKLI
GWAFWLTNIGLLVMVTISLLPIGIMQSVASIKEGYWYARSAEFMQTDIMHFLRWMRVPGD
ILLAAGEFLLVVFIIGLKFGWSLKEKR
>KALACAFP_00248 hypothetical protein
MKRNQNIILLSRDHHFGLLCSWKIRQGLKKEIETDRIKKYILHFWHNYLEEHFREEEQIL
CAYLEDEYTERIRSEHAQIKVLASQIEHSEDTRLLSDFAELLEQHIRFEERNWFPHLEEK
LNNAVLNWIGKELDHIHPEKKEVYADEFWK
>KALACAFP_00249 hypothetical protein
MQTDSLLFINPNVVLKPFETIGGQLMNFNKDFYCVEIHDQEVACDGILYNNVFEIPSINL
NQEQSADIQRIIGEI
>KALACAFP_00250 H(+)/Cl(-) exchange transporter ClcA
MKRKSIQRHHYFRLILISIIISICASFLGYSLKLITEYFQKLIFHFAEEENTLIFIFLPT
IGITAIYFLRKYFFLNRKNKGITEIYKTLDQRKNHLPLFKIPSHYFNGFLTVIFGGSTGI
EVSTVVATATLGNTIYEKHFSANIYKLELISAGVVAGVSILFGSPIAGWLFAMEVIARKF
NKTLFISCTASAIISAIFLCFIKSEPLLSFEITGWKWTALPFFVILSLLGGVLSVYFTVL
VIKIKDFFSGISNNFLRVNLGALIVGGLIFCFPFLYGDSYHSLSEILNHPKSYSFLFLLF
LILLKPLASALTLGAGGDGGVFAPSIVAGAFLGLTFALFCNTFFGTSLIYVNFVLVGAAA
TLSASIYAPLTALFLVCNLAPNGYVLFFPVLLGCWASQNLARRIIPYNVYSYDIKS
>KALACAFP_00251 hypothetical protein
MKIKLKRIYETYSPTDGYRVLVDRLWPRGISRENAHIEEWNKELAPSTELRKWFHHDPKL
WKSFSEKYEIELKEKDPGKEFLNRNKKQDIITLVYGAKDEQHCHPLILKKYLENLILNDK
I
>KALACAFP_00252 hypothetical protein
MSKHNAIVFIYIDEESNPIAELQTPIVFNLDTTKLSDGEHTLKIISRFDNKEGLKIIHFN
VRNGPIIHMEGLSDNETVNGTLPLMLNAYDTGRNQSFIIKGSENPRTIPVWVWVIALVFI
AWAAFYIVTNFSL
>KALACAFP_00253 hypothetical protein
MKKLKLIFPVFVFWTGYFQACDACKLQQPKITQDFTHGTGPESNWDWAIVIIIAIITLGT
FFYSFKFLIKPNENNKKHIKNNILDF
>KALACAFP_00254 Cytochrome c-552
MDFFSDHKKLFSSALAFFLFLTLFICIFPALNNQKVYQPLQGSKPFTEEESRGKSIYIRE
GCVACHTQQVRNVDMDQVFGNRPSLAVDYARNKRINLFQNTATLMGTERTGPDLTNIGAR
QSSKDWQYSHLFNPRAVVPQSIMPSYKWLFIVKDQLDPGDKEISLPDAFKKGIKGKIVPS
KDASDLVAYLLSLKQTELPKSIPAREFLYKKEEKKAEGNAGGDNLPDGEALFIANCATCH
QATGEGVPGAFPPLKGDKVVLGDNLELYVTIIMKGYNGLAPQFGEMPAVGTNANFKPEDV
TALINHERTSWGNNGKKVTVEEIKIIMDKIK
>KALACAFP_00255 Cbb3-type cytochrome c oxidase subunit CcoN1
MNELLNEPGLQITIVLFLIPIIFALILILIRVNRMISDTLKKKELKRIYEHLSHLQPGEI
SALEERKKELEFQLSGNELSANKQVKDPRGLIDQANEIHEIRFLQTKREEGRNIKIPDEE
KKLILWFLGTSVFWLFMGTTVGEYLGIKFVAPDADHISWLSFGRLRPVHTNMVFWGWASM
AMVGFSYYVIPRVGNTKIFNLKIGYVTLILMNSAVFLGSVCLMAGINNSGGEYREYIWPV
MLLFATGIIISIYNHINTIAFRKTEEIYVSNWYVVSAMMFVVVILVVAYLPFWQDGLGET
ITQGYFMHQGVGMWFMFFNLGLMYYFLPQELNSPVYSYSLSILAFWTQILFYTLIGTHHF
IFSAIPWWMQTIAIVASVGMVIPVAAGSINFMMTIRGSWHRLKLSYVLPFYVVSIIFYFT
GSLQGTAEAFRTTNLLWHFTDFTVAHSHLTMYGIITFMLWSFTYTLVPRLTSYEPPSITV
GLHFWLALVGVLVYTVSLMIGSTEKGVMWIEKKPFIEGVVHMIPFWLWRAIGGTMMWLSH
IIFAYNFYRMIKPKKEIKLPQTPGDILEIIHNKQVKA
>KALACAFP_00256 cAMP-activated global transcriptional regulator CRP
MISEKHIKDYNYNITQYSSGDFIYEENSTCKSYFQIISGTVKLNNYSEDGKEFIQNIINA
PQGFGEVLLFINEKYPTNAIALTDCDIIQISSKDFFKLLTEYPKYAIEINKSLSRRLYYK
MIMSQHIFSNDPTTRLKTLMNYFKNIYCIENGLNSEYIVPLTRQQMANLTGLRVETVIRT
IKLMEKNNLLKIKKGLIYY
>KALACAFP_00257 HTH-type transcriptional activator RhaR
MKEVYPTFEIEGLSTCNSINEVFTIDRFSEFLDQNPGTTKVHRHSFYHVTYFVKGYGENL
IDFKTYDVAPEKIFFMRPGQVHSWRLDENAEGYVINFSTTFFDQLKINSSLIDQFPFFNL
FESDQMVNISKENQRKLKVCFEDIIEEMTDIQSWSQIMIASLILQICALAGKDTISKTIF
IDTNYNSLILKQFIEILETNFHQYKLPKDYATSLNITPNQLNFICKQQINLSAGEIIRNR
IILEAKRLLVNFDLSITNIAEALNYSDPSYFVKFFKKYTSFTPEAFRKQYYNKY
>KALACAFP_00258 Cytochrome c oxidase subunit 1 , bacteroid
METQKFYYDNTIVRAFLYATIVFALIGFVFGLTAALLLFYPELPEFIFGTDDQSIHILRD
GGIQALIDTNGAFGFGRIRMLHTNTVIFAFVCNSFFIGVYYSVPRLLKTEMFNKTLSWIH
FWTWQLMVVVTFITFFMGINTSKEYAEHEWPIDILLTFSWVIFGLNMFGTITKRRVRHLY
VAIWFYLGTWIAVAMLYIFNNLEVPLSFTGWKSYSAYAGVKDAIVQWWYGHNAVAFILTT
PILGLMYYFLPKAAERPVFSYKLSIIHFWSLIFVYIWAGPHHLQYTAIPAWAQAVGTGFS
IMLIAPSWGGMLNGLLTLRGSWDKVRENPILKFFVVAVTCYGMATFEGPLLATKNINKIG
HFTDWVIGHVHLGALGWNGFMAFGMIYYLIPILWRTKIWSVKLANWHFWLGTLGIIFYAV
PMYISGFTQGLMWKQFNPDGTLLWKNWLDTVTAIIPYFKMRFLGGLFYFSGAILMVINLA
ATIRKGSFQKEVPAEAPALANINNKRKEGEGIHLWLERLPVLFTVLSFIAVSVGGAVEII
PTLMLKQNVPTISAVKPYSPLELEGRDLYIREGCNACHSQIVRPFRDEIVRFNGKNGQYS
KAGEFVYDRPFLWGSKRTGPDLHREGGKNPSSWHYKHMYNPRSTSAGSIMPRYPWLIANN
LDRSKMIDKLKFMKNTFDVPYTKAQIDSADKWADNQASIIVKDIFSEATDLKEAYAKRPQ
GELEKKEIIALIAYLQRLGTDIKTSDIKTAGNN
>KALACAFP_00259 hypothetical protein
MIPQNFKDILANTDYAGFYQTLSMIIFLLFFVILILYVFTRPKKFYHEAERAPLRDDQ
>KALACAFP_00260 Putative electron transport protein YccM
MSEINEEVVRGGQGQVLNPETYRDSIGTMEQSGKRKWVFPKKPKGKYTNYRDLVSYTLLI
IYFVIPFIKINGNPFFLLNVINGEYFIAGQPFYPQDFFILTLGAIASLIFIIVFTIAFGR
IFCGWICPQTIFMESVFRKIEFWIEGDRNKQMRLERQEWNTEKIWKRTLKWSIYIIISLI
ITHVMFMYIVGYEKVFKIISEGPFENITNFIVMILFTATFYFVFAWFREQVCTLVCPYGR
LQGVLIDKETINVFYDFKRGENRSKWRNGEDRKVTGKGDCIDCYQCVSVCPTGIDIRDGQ
QLECVNCTACIDACDEIMEKVGLPKGLIRYASEREIETGTPYKFTSRMKGFAAILILLIG
FLGFLLSSRGDMEAKFIKPAGSTFFVREGKIINTYNYTFLNKTNNKKIVTIKVIEPAHAE
INYSASSKIVVDRDKISKGTINISFPESQMNLSKQNITIGVYDLNGKLIDSYQTYFEGPF
KLQIP
>KALACAFP_00261 hypothetical protein
MEEIRIFSETISELLDSGYLLQNELTEYLNLIQNIKTEGSEIPASGFKVDKIYKCYDDNS
EIIYVFAISNPNNNIKGITTSIRVDENIIEFSELFKKIRKGIEKFGNYVFGINNNKIFYH
L
>KALACAFP_00262 hypothetical protein
MKLKHILIILLILNGLFSCNNDDNTFHLKTVKLLEYSKNLPEQKLYIKAFSDDLPESIAQ
TEEYPSTLPLPATLKMYPSPSMNLYGKNYHLELWGGISGYIGRCDIDMDDYKIVFPIDME
IENDSLSISMQGTWD
>KALACAFP_00263 hypothetical protein
MKTAIPIFKSWIPDWMVKIVLFSMTLPGIVIFFLPLANINAAAGYYGSEPADMQFAVALF
YAGYVGFYSLERRFFTFLAAKEYFIIFTTLQMLACLVCYITKDVYILFPVRFIQGMLFAS
NVNISLSLMFTRLKSERAREIGFSVFFGTLLCALPFNNLVTAELIDSYNFNIVFKSAIFS
FFPGLLFIITGMNSFRLHVKFPLYKLDWQSFVMYSAILSLIGYITIFGQEYYWLDDVRIS
GSVLAIIILLIISIFRQKSLKRPYINLRIFSYRNCKVGLVVLFVMYICRFASGITNSYFT
GVLKFDPFYLSYMNVFNILGIIAGVIISAAMILQKKRIRNIWLLGFCLLFVFHVRMYYLF
DIQADEFNYFLPLFLQGMGVGFIMVPTIVYIIASVPVSLGPSAAAAALAIRYFGYAVSIA
IINYFELFRKSMHYNAFQDHLTKIDPMVKNFLHKQNTKLSTKGMLEGISSKASEKLLIKN
LTMQTQIRFAMDYYEMMAIFLLIIMVLIAIFPYVNRTRVYLRSRRLSPA
>KALACAFP_00264 Multidrug export protein EmrA
MKKKYTVTDRFVTKITGWIASLILLGLIVWGGGSLMDYYKYEQTNDAQIQEYVNPVISRA
GGFIVDVKFEENQNVKKGDTILVIDNREYVLQQEQTQASLAKAEAQLVVLGSTINTLENE
ASSSQAQIAANKAKVWKQGLDYDRYLKLYNEESATKQQVEKVQAQLDVDKSEYRSSQENY
AASVSKIEDIRAERNVVKAEIQRLKSLLNRHKLDVTYTYITAPYNGRMGRRTVEVGQMID
AGETLAFIVNDDTDKWVVANYKETQIKDMRIGDEVKIIADAYPNKEFKGTIISLSPATGS
SFSLLPPDNSTGNYVKIVQRIPIRIRVDGSRKEIDVLKVGMNVNVFASKKHS
>KALACAFP_00265 hypothetical protein
MKNYLTGFLMFGITFSTWAQSSVWNADTLKLSLKDAWNKAEEHSRDIKIKHLEVGISAEE
VKDLRAERLPEVQIKGSAEKASNIPIYENGLFSKPSQHEVIHTLYRAGADFYLNLYNGNK
LNLQIKEEKILHEISEINREQTVSDIHYKTAALYLDLQKILIFRKLIKEDIEDQKKQLKE
IRSLLKNGVVLKSDVLRIELELSRREMALITIENDILIATQKLNIIMGAPDEQIVVPDEP
AYIWNNTTSYEEYLKTALEHSFDYHISEHKTELSKIKIDQIKANVRPKIGMYGEFYYANP
QIFLFPYNPYWYSLGVIGLRASFNLSSFYHNTHKVRAAKIEFEKEEESYKNTEDKVRQQV
KEAYLRYQEALEQIKVAEANQAHAKENARIIKNTYFNQTSLITDLLDADVQLLQTKFELE
AAKIMAQNKYYLLQNIIGIL
>KALACAFP_00266 HTH-type transcriptional regulator NimR
MGLINSLPDIDKNDKSVFVMHEKSEKLIPVHRHTKGQLSYVEGGIAYITINNRTYVVPAR
HFFWIPQGLEHILQIGHSATVLRSLYFFAHDDLSDPFFSRLGIYPATELLIQMIKYTEIW
DERHVISTDENFEFLVALKKILPKTHQQPLPIILPATKNKMTRNIVSYLECTIEEKHSLA
SISKKFGLSERSLSRLFKTDLDISFLQYLKTLRIIKAIELLLNTNKSINEIAYNVGYNSV
SSFSDTFREFTRSRPSDLRKLNN
>KALACAFP_00267 hypothetical protein
MLEDVIDNDEYLEIKVDCKDQIDKLESKPSKVEDKKKIDFPKLLDQALSNLVNLSKVYAD
GDIEVKRKIVGSMFPEKLEFFENHYRTTKANVLLSYIYQINNELGAKKNRKESELSPLSG
LVPITEEISKHLVEDLERISEILPGKYSQKKKN
>KALACAFP_00268 Putative aminoacrylate hydrolase RutD
MAYKVFGLEDRKDNEPVVVFEAGLGSGGGGYGGLLSFVQKKFAGIVYDRNGIADSEIDTS
LKTDADVIKRLHDLLTKLEIKPPYLLVGHSIGGPFIRLYASIYPNDVCGLFFIDPTDFML
TQAEDDKVKLSTLSKTGYRELFIKNYDYILKDTSISNGFRFEVEREKNESTPVFFKRYTS
LSPLKDIPITVMISYNKHIEDYEIEMNKNLNLGINLIPWWKELDYLRIDHYAEMIKNNQH
SRLILLPLYSHGIHQQDPKIVAEALIETYENCLSSTKNKK
>KALACAFP_00269 hypothetical protein
MKKKVSLFASVIFVCTVQAQIGINTPNPQTEFHIDGAKDNPATGAPTVAQQTNDVVVTQQ
GRLGVGTTAPTNNFEVNSRTTGVSGVKITQLPSATVLATDASGNVISGTSESSGVSVTKQ
RLIAPNSAVVLTTGSGNYSFRYAGYNATTFLQGYWQIKVNTGVARQFNVWDTEYAGAGGG
STVWQDRNVTTFTPNVWTALNAANVVGGSNEYNVYHVYDSSTGVIIRFTCTLSNMGSTAA
GVRESMIAEEF
>KALACAFP_00270 hypothetical protein
MKKTSLLLCFLCTQLFFSQIGINTTVPNQSAMLDIVSNNKGVLVPRIALSSRTDAATIPS
PATGLIIYNTTTAGIGGDQITPGLTINTGTPANPIWASLQVITNTQGHTTDKLRYLGLPD
ITKTTSVGGFLEFRVRQSGISYNFEMRLLNPPTSNIIYRYARIGYGIVPTTGEKINNGYA
SNFTFTPTNYNVWQVVDAPFLTTGTLGFHGVLSSPNRDAMHELILNFTYGEFVNCVINTY
>KALACAFP_00271 hypothetical protein
MRTLLATTLLSFGSLAFAQVGINISNPHASSALEISSGNKGFLPPRMTLISNTDGTTIPN
PATGLTVYHNGNAAMDAGLYTNVGTPIAPNWTRGAIINEYQGSLIKKIKYEGTSPDATKT
VQIGPVEFRFSPASYTVPEMRFLSTLTSNTLVNYHSGQFVHSTASPPTIAYQSQNRTYTA
ANWNVWQNVAFHATDGLNTLERNEIWLSIQNDPDAIYCVEFVILNKGTSNIYSIIATRY
>KALACAFP_00272 Tyrosine-protein phosphatase
MKKIVLALAIAAFGATANAQIKDSLRRVVKMEGAYNFRDTGGYKTTDGKEVALGKVFRSD
AIDKLTDKDLKTFKAKKIVTVVDFRGVKEAKKAQDRLPENTSYILCPAGSNNLPTAQDMA
KLLKDKNFLFDMYGDGGIPYFGERYRSLFVQLLTLKPDEALLFHCTGGRDRTGMASALFL
KVLGVPQDMIENDYVASNFYLAKNPTMKTMYSGLSKMSGMTETEIKQQMELRPELIRNFF
AAINKKYGSVENFFQVEMGIGPREITVLKEKYLK
>KALACAFP_00273 Vitamin B12 transporter BtuB
MNNSIGFSKQKSRIIQISAFFLMASFGTIHAQTIKGTVVGKTNGALPGANISIVDAEAKA
VSSLDGDFNLLSPQLGEINIKVEYIGYETKIFPVTIKEGTNDIGYITIAPEEKKNKDKVK
DIEQVVISKPNALTQAKAYEIKKNNNAIMEVIAADAIGKLPDRNAAEAVQRVQGVAVARY
HGEADQATVRGTPFSWTSALFNGNRLPSANVLGNRSFVLDVIPSELIQFVQVSKAVTPDM
DGDAIGGSINFITRTAPAKKTLSISGAGGYNTFSQNATYNGSIVYGDRFFKNKLGVILSG
AIWDRQWGADSFDVTYNTGLANDDQKKSISTIMMKRYMGTRRTIGLNGGLEYKFNANNKI
YFRGMFNKFDDIRPVYESYVDYTNSRYQYNFRYSHYQTELYGMELGGEHSLSSKLNIDWM
LSDYQAKYFLDTPPTNDIKGLPIATFRQKITGGFANLSNDGKRYWGFDSPNGIGGEYLDY
SSDAANPNEVMGANKLLLSQLVIAKLDNNERDKIARVNLKYDINPNISLKIGAKYREKDR
NSTYGYTAVFLPNASLGIPNSPALLTLSQLTTNEPPKGTTFLNGMNGDYSQYIMNPPTKD
QLFQMYSPEFLQKNGFKDFSNAETNATSVYTGEENVFAAYAMAEIKASDKFKIIGGFRNE
TTRLTLNGAKATKSGTPAATVISESIVESNYNAFLPMLHLRYNFSPKANVRFAYTRSFIR
PNFGDMSPGSSIDNTSNPNKITRGNPDLQPTFSHNFDMMGEYYFNNIGILSGGVFYKKIS
DIVFSDTSMMNLNGTDYMVTQAKNLQDSNLLGFEMGINKRLDFLPGFWSGFGVEFNYTFI
DSSVDVPRTANGVQYFDKTTLPNQSKNLFNAILYYESNKVMVRLAGNYRGKSVETINQNL
GPNYYIWSDKNFTIDFSASYDISKKVKLFIELNNLSNESLRLYMGDNKKRITSNEWYGSR
GQMGVRWQIF
>KALACAFP_00274 hypothetical protein
MQYIVIIGAFQALVALWLLQFRERKSPSNYLFICLLSAIAVHLIIKFVIFNFIPDKSIRQ
QMNTFIGASYGPLIYLYALSKTKKEFSVTSKWYAFIPLFILMIGYLTVSCVFFVLNHVDQ
KLLDLYNDFSLIVLFTVNLYYPLKSIVIINKNQFKTLEKTEYNAIARISHCILFMECGVI
ISKTLLYLYPEESQLINISIRTVAYFLLLVICLIIVRKSLTTEISHFQEISSQHNFKIPV
NQYFDKEKPSLNTVDYEIKFSELWQKMDQSVRQKQLYRDCDLNLDQLALKTEINKYQISE
MLNGYKHKPFYRYINEYRIEYFKNMVEKAIQENRNINFLSFAYEAGFKSKSSFNRYFKDI
IGKTPSEYYKNLITINKQQTFEINI
>KALACAFP_00275 hypothetical protein
MKAFFKWIKRIGLGLVTLVILLLIAGFIFERISRNDAEKIKPDGNFVEVDNHRLHYYKKG
NGGPTVVFETAFDPAGHLQWYHIQQKLPISYTSFSYDRSGILWSERGQNPKSGEKMAEEL
HLLLEKSNVPKPYILVGHSFGGTPVRFFVNQYPQDVAGVILVDSQCPDDKKYLSPELFKM
VNQGLPGGFLKFANAFGLARLMFKGMFPAEKQYKYQNSIMPALLYKSADAVLEEQDHMSS
VKKEAEKIESFGNIPLLVLTAADPKRYDSSIQDKKLKLEMISAWDKMQKDFLLLSTDSKQ
ILVPNSGHYINQDNPKVVENAINEMVSKILHQK
>KALACAFP_00276 hypothetical protein
MKKLRTILFLFLLVSQSAYSQKIILDKSNLVPHKVSMQMVNLKGKKVVRVVKDSAVKEAD
EPTFVKIKNTKFKNGSIEVEVLSRLLPTAAPSDRGFIGLAFRIDDMNSKFESIYIRPANG
RAEDQVRRNHSIQYFSYPNFKYDRLRREDPEKYESYADMGLDEWITIKIEVKGSQAKLFL
NKNKYPCLIVNDLKQGSDATGGVGLFVDVGTDGYFRNLKINPSK
>KALACAFP_00277 hypothetical protein
MIKSVTFSLLFFLMNLFCVKAEQLYVNPLTGNDINSGTNTQPLKSLSEAARRVNLNKDQG
ETTIILSEGTHLITETVIFNNDKYTFTNRLTIRAEVMPDDADWTPKKMPVVMTIVPPEPG
VGGEEARGIQPEVSHVTIAGLRFTGSPDYTYLDANNLRRSYPIWRDGKKLNDLLVTQCLF
AGNADVLPLHVGVIANGYGLVIDHCVFFNCKIPVVFWKNEGKNGIRSAMQYSLVYGGYFA
GVWTTQGTNGDDFDFHHNIIANTSTVWIREKGSARRYKASDCIFVNYNKLAGYGSGPLSD
SIPTPTDFLEMKNVQTTGNVIIEKDQSKRNYLQLAEGSLGSNLNAGLFKR
>KALACAFP_00278 HTH-type transcriptional activator RhaS
MVTAAQIKTYHFLPHKYGAELLLDLGRIETLKNYVLDRTVHQLSFYEIVFIEEGSGTLSL
NGTIMSITPGTIIFISPGQVRRWEIEEKIKGYTLFFEKDFLHLFFSDELFLYRFQYFHQY
SHPADIKIDQASFGKCLELLREIEREFRQIQNDSNHLIRSVLYQLLIILNRYYARIYNVQ
RDTYIHADFYRFRSLLEKKFLEDQTVEDYTKMLNVSSGFLNKICRQFSGLSAQQMIHHKL
ISEIKKALHQNKSAKEICYEFGFSDPSNFNRFFKKFTYTTPLQYRKNI
>KALACAFP_00279 Xylan 1,3-beta-xylosidase
MKIFKNILTFSLFIFALNNGFAQVEKSKISLQKEFRYTNPITRDSAISMRDHFIIKVDDM
WYCVGTSNPVWTGSNPGVRMLVSKDLINWKQHSFIIDAKKLPKDTPYNGRFWAPEIHFIQ
GKYWLTVNSGKVTKEDPKGMATHSIWLFSADKVTGPYKLVNGPLTPQYNNDSTLFEDEDG
QVYLYCSGNGLFQAKIDLKTGKLTTPIQKFLDKKQPGWPEWMVGGIEGPFVIKKEGTYFM
FFSTWTRGYEVGLLKSKSPLGPWELASPEPIFGTRKKGYRIEMAKENGYENLFFTDTEDP
YQETGHNALFIGPDGNLWNSCHYFMYEKRPYPYSQTFQPWELGPQMGIEPVHYKDGMFYI
DGPTWTEQIIKYRESKK
>KALACAFP_00280 hypothetical protein
MWEQLQLTYSYGVDKIWILNVGDLKPNEYPMDFFLNMAWNPTSFTQENLDYYSVKFAEDQ
FGKNNAKEIAEIINLYCKYNSRVSAEMMNHKTYNLQSGEFLQVRDAYLALETRALRQFMI
LDKTYQDTYKQIILHPVRAMANLYDMYYAVAMNHKLAEEKDQKANYWADYADECFTRDAE
YTKDYNLNISGGKWNHMMDQTHIGYKSWDEPKEGNIKPTVYRITPAEAKTGGYIFEEKNG
VVTMEAEHFFDVKAPANTKWTVIPDLGRTLSGISLMPYTEKTNGSAISYQFKLKNNPSTV
KVHFFFDSTLPFKKGGHSVKAYFDKNDPKTIGINQDLTWANNYTKMYPAAAARLVEKVET
FTLPPNKNSLQILTVEPLDPGVVLYKIVIDNGGYEETYLKMNESPYKR
>KALACAFP_00281 hypothetical protein
MLRKTLYKIFHLYFIFCLWQNGNVFAQQTSGLTENIISNDNGFPIVSSDGKTANLFYDKS
ENVAVIRAVKDLQSDIQKVTGKLPDLSTSEISGEFEIIIGTIGTNKLIDKLISSKKINAK
DLKGKWESFVITTEENIKSKSKKQQLIIAGSDRRGTIYGIYELSKQLGVSPWHYWNDVPV
QKRSSAYVVPGYYASGEPKVKYRGIFINDEEPAFGTWARTKFGGINSKMYSHMFELLLRL
RANYLWPAMWGKAFNEDDPLNPKVADEYGIVMGTSHHEPMMRAQKEWGNHRKEYGNGEWN
YHTNKEGLLKFWEEGFSRNKNYDNLVTMGMRGDGDEPMSDLGSAEANFKLLEQIMLDQRK
IIQKVTKKQAKETPQLWALYSEVLDYYDQGMKVPDDMTILLCDDNWGNVRRLPYLNGRKH
PGGYGMYYHVDLHGAPRAYQWLNMA
>KALACAFP_00282 Penicillin-binding protein 4*
MEHYKTKLSTLILLFCLIHIQFVWAQKPDINKINQQLKILEKENYLSGVVLIAKNGQSIY
KEAFGFANLADSIRNKTDTKFNLASMNKMFTAMVIMQLAEAGKISLQDKVGKYLTDYPNK
PVADSVTIHQLLTHTSGMGNFWAEHDKLAKEKFKTVEDYLPLFVNQKLAFAPGSDFLYSN
SGYMVLGLIIEKITGKSYFDFVKENIYKPTKMMDTDAYELDEAIPNLATGYTMSLEKPGQ
WKNNIFSNVVKGTPAGGGYATADDLLKFANALQNNILLNKKNTELYTSGKVKYREGMYSY
GIIENKINGHRIIGHTGGHFGIANELMIFPDLGYTVVILTNGEVENYWEISNLVKREIGG
STPAIESFFYTKDVIKEVCNKGYEAAMMKIKNSSKKYPLKENLIERYGYKLLFEKKYNQA
IDLFKLNINNFPDSSYGYYNMSEAYRISNQKEKAIEFLKIYIEKEPDDKDALSKYEMLKI
KTSIDKIN
>KALACAFP_00283 hypothetical protein
MEVQFFKPKNEILKKYIEGYYFISEKDSLKSNKYWTFPSNNSVVTVCKNATVISENNKIS
VLPSDSKKIDSNFYYNISFPVEIFYEKPVNEITMYFKPLGILHFSDDISFEIGKDNVPDF
QPHPDYLNEMERILSIENKENQSSALENYWLSKFRNKDFEIIEDVLNEIKNGTKIGDIAD
KLNISRQYFHKMFYKNIGKSPSDYRKIHRFKGIIEKYKSNEKFIELSNNGSFFDQPHFNK
DFKDLTRINPTLFFKSVDTKLSNLWLFQ
>KALACAFP_00284 hypothetical protein
MKKKMTVPSEGISFTLIHTQNVKVGIDTIQPGSALDVIETTKDVSIKASLLNILKFLILP
SEFLKQSKNSICLLSN
>KALACAFP_00285 hypothetical protein
MKTLSLLVLTFFFSVSYSQTGNVGINTINPGSSLTINGSIAGQYKNVQTSMALGVNDFYM
AYSGSSDGIFTLPAAVAATPASGNILGRIYYIKNVGTGRLTISASGSELIDNQSGAGVSS
VTLTPGGYTMFISKGTLTGTTWEVALLLNKTTPTIAALGATNPVTFTGTAFTDFNNSIPQ
IIPFSSGDVIVNQGGSATWNDGSDYWQIIESGVYKIEGYSYFRSGTAVSGTDPFTGINLN
ITKNGTALSDIIGGNRANLDNQTASQGSSPINVSCIVHLNAGDRVYLTMNWGAYNKPTTN
VSILAPNSLKENRNFSLQQLSTP
>KALACAFP_00286 hypothetical protein
MKKQFIKTICFLVSSFSFAQIGINEINPSATLDIKSKGNTGSTKALEINNSSGTEMFTVL
DNGNVGINVAAPAAKLHTNGQIRYENLPQFTGSVSPLAIDANGYVGTYIPTAAYSYITIN
AAQTLSNFSLYSNSIFYSIPFTTTGITDNALAVTAGQDASATLTRTSGATASAAQVAYIT
IPNPGIYKLNLNYYTSCTGTRSSSSGGANLLGIGTGIYLASSGNTNYQELTTIRHNAFPL
RQDTGALITTAAYNYPFAHNIFSVIQTTSANQKVAFFVNWGTGDQFNTNVCSLSAPSGID
KRVTLIISKL
>KALACAFP_00287 hypothetical protein
MKKLLTIIFLAVFSVAFGQNTGLNTANPSAMLDIVSKGNTAATNALNINNSAAARLLRMT
DQGHLGINTNSPTAVLHVNSSGTANVKHDNLPVLDATGFTPPFNTFGVNSDGNGVNLGGT
VKYLYYQNGDIYPPTYNATTNTGGFSLYTTNQYTNLSIKNDAGLKGNTIGFTFGTDASAT
INGQSANNVNYIIIPEPGVYLFEFYGTARCNRYNNTQNYTFTGQMQVNTIFATASGTSYS
TNTIFRGLMSGMRSDNGSTHVNTYSIANPQTLTVALPTTQPNQKIALFFQYESGETNQFT
NNECYFNVPAGANFSYYFIVTKI
>KALACAFP_00288 Beta-lactamase
MKINVFSVLPIISAGLLLSCSTTKDMIKHENVEPLYLEINKMAQELTAAHNVPGVAVALI
KNGDISLIQSIGYADVASKKRVTPHIIFNVGSVSKVVSAWGFMQLIEKGELSLDSPVCFL
GNIQCLCSF
>KALACAFP_00289 HTH-type transcriptional regulator ChbR
MIRLSSGTYLGENTSRYEGNGIQLVDTVYHQVVSNDWHSHEHTHLTLVLDGGNREQRRGA
DYQLGAGQVIFYHSDEVHRNDHTLFPSRNINLEIGPEFFAKYELTEVQFAEAIKFHNINA
SFILRVFKEAELNEDALTDHVAELLISPLNKKYKVPPKWVRELHQLLNDNWQEIPSLHAL
AALVSVHPTTISKHFTQYFGCTLSQYLRKLKIERAIPMLRDKFSISEISYFCGFADQSHF
IRTFKTETGLLPKAFRKL
>KALACAFP_00290 Penicillin-binding protein 4*
MRTAFQLASLSKPFTAIAILQLADQRKLNLDDKLKKYIPTFPYPGITISQLLSHSSGVSD
QDLGQALATFEKANGHPHTNTELLQFLAGHPVSFKLAPGQKWWYSNLGYELLACLVEKVS
GKSFDRYLARYIFKPAGMKNTYLLSSPKAQQMYQAKNYDYPKIYATDRIRIDQTAADYKE
RAYGHSNIVSTCEDLMKLANHYFNGSLVKLETVSKAIKGTRLENGQPNSVWMNIGGLGNT
VDGLGWFIFTDSENRGQLFHAGGMAGAVTILLYDMEKKQTVIILDNTGSEGIYKNAQNGI
RILNHQQMTPAKRNLAKLYGRWLVSKGEKIAAEMLTSNKQDTTNFTLSENDMNNLGYAFL
GDKLYNNAIAAFKLNCTMFPISDNAWNSYGEALEQIGQTKEAEEMYVKSLHLNPVNIDSQ
KALERIHAASGIKK
>KALACAFP_00291 hypothetical protein
MNYSYNNKISLNLGLGYSFFNKIDLKVSTYDPATNITRTTFENSSKASRLGLDYNLNYPV
TKKLTLSVNGNSAFFFIKGKLDGIEVENNLFTYYIYFSANYQFVNNWNINSSIDINSKMP
AGLQSTTNVFTGSSFSFSKRILDNQLSFSAYINNPFNKFRNGVTEINGIDFYQSNYVRDY
YKSFGFNVTYKFGKLKDEIKSTRRKMQNNDLGN
>KALACAFP_00292 hypothetical protein
MSGNLGLKEKEYVRNQYQDSFLWGSFYNTLNFSLEILVFLSHDIDY
>KALACAFP_00293 hypothetical protein
MVVGSFNFAQEIKSSTVQDSVQLTKDVQEVLIKAQRKKQFVDKAIYTFDDEALKKARYAN
DLLQTLPELQFDPISSSISSIKGGKFLLLINGVESTESQARGIRPENVIRVEYYDNPPTR
PIRHRLVAFNTFIIKVMCFSIGLKIISLPSSPSPFFNLFILFCILYPQFDLKKFTYCNTT
ILLYQLYDRY
>KALACAFP_00294 Lipopolysaccharide assembly protein B
MGKTKFIRTLCTLHFLFVFFQVHAQNTIPEIDSLQKNEAKRLQDIGNLRGKILLEKSLFR
QSKKLKYKKGELRACIGIASTLCGLSRHKESFQLLEYSSRELRNFDDAELKTKLNIVYGR
NYYSLGMYKKAVKSFNEGVKNACEIEDTKNRKKQLFYIYEWKRSSFSMMGMSDSAKIMER
KCMESPIPMLFIEIAQRHMMSGQIDSAEFYLGKAAVLAQDASAESKSNVLRGYGELYMKT
EDYDKALTSLFSSLSISQKAGLKSRDRETYKLIAQVYNRLHHIEKENEYLQKYSTLNDSL
IENEKSALDIPIEILLNQTGEKGIKNNTIPPNYIVLLLAGFTGILLTYAIYSKKQKSKNK
IIREEALPINDDNKKPDISLNEVVQLAINGDPTFIIVFKDFYSDFYTTLTSKHPELTLND
LRFIAMVKLNFSNKEIAQYGNMSIRTVESKKYRLRKKLDLPADLDFNQWVLGQ
>KALACAFP_00295 Sensory transduction protein LytR
MNCIIVDDEELAHHVIEEYISRIPFLNLVKNCYDIQEAIPVLQEKNIDLIFLDINLPNIS
GIEFLKSFNKLPDVIITTAYDDSAVQGFEMGVVDFLLKPFSFERFLKAVYKSYKHYSNSK
MLKEKSTQNFLKDSFIFVRFNNEDVKLNLSEIKRISALKDYIIIYTEDRKLIVHQTMKSI
MEKIDSENFIRVHNSHIISLQHLQTIGKNSLTVGNERVPISEKYKAFLNEVIGKYK
>KALACAFP_00296 Sensor histidine kinase YehU
MDFMTSFFKQIQTPYIYHWIIWSILIFFKLIIDYSIFGNFLLLMNLKIFLVSMILFYINY
YIFLPFIIRQTPKKILVITISFAVIYIALMIVFIPPLPQHPPLLPKDGKIGSFNDDIHFS
DIFFKIGIFSIIFSTLLFFLDKWMENRKKISALEFERQSSELKILREQINPHFFFNALNS
IYSLSITQSKDTPRVILILSDIMRYVLNNKNMQRNNLNDEITNIKKYIEIQSIRFSKFNN
INCEFYGNFDLYEIEPLLLLTFVENAFKYADLRKGPLDINVHLQNGLLDFSIRNFYERKN
HEKTNENKLGVENTKLKLNLLYPGKYQLDINDNGSEYKINLKLQLN
>KALACAFP_00297 hypothetical protein
MIKNFLRLFFLLGIFLVSCEKKNNSLEIKITKQNSGYGYQILKKQKIIINQPFVPAIQGN
KSFKTKTDARKTADLVVSKIDKYSLPKISIHELDSMNIEY
>KALACAFP_00298 N-acetylneuraminate epimerase
MNNKLLVLALTFAGTFLVVSCRNDDDDDELIGNWIRVSDLDGKPRSNASAFVVNGKGYIT
GGYDGDVYYNDLWSYDPNLNAWTQKADFLGSKRSSAVGFATNLYGYVGTGYDGLNKLKDF
YKYDPSSNSWSQIDDFPGTGRYAALAFGIENKGYVGTGYDGSELKDFYKYSESDASWSTI
TSLGGSKRRDGAVFVIDNIAYVGFGSNNNSLVSDFWAFDASSETWTRKVDTSNDDDSQSR
ISTAAFAAGGLGYVSTGSTGGVGNTTWEYNPSTNDWTERTAFEGSARESACAFSLGNYGY
VLTGNSGSSYFDDIWVFHPNESENDDD
>KALACAFP_00299 hypothetical protein
MSRTNGQRENKFFLNSSFLYVCGKKMYKYLLLCVSLLFLFSCEDESNTYEVGSSWIDAQS
KIVMIDTLTMKMSTIMVDSVVTSGRSVMMVGNIKDQTFGKVTSSSLFELTPESYTLTSPS
NAVFDSVVMYLTNTDFYYGDTLKTYKLDVHPLADRIKLNNGYLYNKSNFNYSSNSIGSTE
FYPRPNTDSSYVKIKLDQSYGQTLFNTLKNNDVNNQEYFLNFYKGLALVPSSENNAMLRF
GINSSYQVQISKSTKEKVSNIVRMYYHTISQNGTEPVKYTLDLNPSTSYQYNKIQSDFTG
SDLANLTPANPIPSASLGNKTYLMAGIGVYTKVELPYLKSLKNLYENYKIIDANLSVSPV
AGYYSHQFYNPSPLYYYVGDKLNHIVSAYTSDGSTEITSGLLADSEFQNEHVYNFSLTEY
VKSILSESANSNYNTLIYPSSYMDVLSGKTVLGDQKNTTNPAKLKVYILGY
>KALACAFP_00300 hypothetical protein
MNKKNKILINLFFLSAFASESSAQNSSPYSYFGIGMFNNVDDARNIALGNTGIALDAPDY
INSKNPAAMTAISTRNVILNVSGMLKYNTISSNLGSDRRLSSNFTNFSAALRISKNAFVG
ISMQPATSSDYKISSTIPIEGTASEYPVTYEGSGGISNWGISLGYKINDNWSVGGKVKNN
FGTIVRKETITTTSEVEISRNIRYTGFSYNLGTQFKKDFTENFQLTLGGVVNFGSKLVSK
REVSYTENKDYTNSVISKLSSNDSSLPLELGLGIGLLKNERYRMTFDFTQSNWDDVKNTE
TSEQYYRQNTYGLGVEILPGRKQIEKISEAFIYRFGINYDTGYYKINKAKIDKLEATFGL
GIPLKKVMLNVNYGYGIHGVQKNVSIRENYHMLNISVNILDIWFKKRYLD
>KALACAFP_00301 Sensor histidine kinase YehU
MIKNERKIYLYSALLITLVVNSAKLMALNGDGIIARYWQFNIWEYGFQFLYNMIFCLVLL
HVNLSRGKLFNVFRENRQWFKLYAFNTLLVVAAIILGSVIHSLLFGVVQLPGGRIRGYFA
RFLLSSIMIAVVIRLILLMRESRNKDLINEQLHTSYLQAQLQLLQEQLNPHFLFNTLSSL
SAIVREDPRLAQTYILHLSKVFRYTLVHSGNEMVSLEKELQHLESYIQLVKMRLENTFQI
QININASILGKQILHLSLQPLVENAVKHNRATILYPLMVDIYEENEWLIIRNNLQLTISE
TEGTGLGLANLNERYKLQTHHEIEIHQTKEYFMVKLPLL
>KALACAFP_00302 Sensory transduction protein LytR
MTQNLHIIIIEDEAATARNLEYILQEINPDIKIIITLQSITESVHWLTNNNSDYDLIFSD
IRLSDGLSFEIFRQINIKKPVIFVTAYNDYAIEAFRNNGIDYVLKPFDKEEIQRTLLKYN
TLIAADFKREQTKTAALLQQLQSATKQYKKSFLIHYCGKLIPIEAAKINWFYTANEIVYV
HTADGRQYVTEFTLEQLERELNPALFFRANRQFMINKNA
>KALACAFP_00303 hypothetical protein
MLLKQKKKLLLLVTAFLCTAFTSLSAQTKKLKDSTPEQRAKMQTEWMKTKLALNTTQVQQ
VYALNLQYAQKNDPVIQSNEGKRAKFKKLKAFQKEKSDALSHILDAGQYKKYQELKDQMV
QNFKEKRK
>KALACAFP_00304 hypothetical protein
MKKLVYPWVMIMFITTSACSQSSSNDNDEMALQATPGNSFQGPIQKPTSGYGADGNYEVE
EITFNNPQYAGTQVSIFYPKGITSPRPTIFFSHPFGGEEKDYNIELYNFIAKKGYAVVFV
PYRTIDISVDHRYQTLWEGFIKAAADYPNIIDTQKVGFMGHSFGGGASIDLAYKAFTEKG
WGQNGRFLFTMAPWYSFNWNSPLTTQQQLQSFPANTKMITQVYDEDDVNDHRMAIDIFKN
INITNAEKDFIYFKSSTVNGYNYVTDHAMPSSRKAFDALDYYGVYRLLDAMMDYSFNGNA
NAKNVALGNGSTAQATMPSYNGQSMAPLEVTDNPTPKYLQGKYQFQCGDSTNPRISYCN
>KALACAFP_00305 hypothetical protein
MDKSFFTVKNILIILLLLFIGIQFINVKENISQSRSENAIGNYYKIPAKVQEILKTSCYD
CHSNNTSYPWYSKVQPVKWWLADHVNSGKRHLNFDEFNTYSREKKLEKLDEIVETVKMGE
MPLTSYTVVHRNAKLSASDQSEIERWANGIKKELNN
>KALACAFP_00306 Cobalt-zinc-cadmium resistance protein CzcB
MSRLIQNKYLILLMLVLFFSVQCHKKEEAVIKPTTSKDESIVILTDAQLKNTPIETMSLS
VKNISTVLKINGKIDVPPQNLVSVSVPLGGYLKNTNLLPGMRVNKGQVIAVIENPQFIQL
QQDYLMAKSKLHFAELDYGRQKKLNQSQASSDKVMQQAQSEMNSQRIMMNTLAEQLQLVN
INPGNLTAENIRKSVPVYSTINGFVSKVNVNIGKFVNPSDVLFELINPNDIHLNLKVYEK
DLEMLKIGQRFTAYTNTQPEKKYNGKIILISKDINADGTADVHCHFEQYDQNLIPGIYMN
AEIDTETSFSNALPEESIVSFEGNNYVFVQQKKQTYKLAPVTLGEAENGFVQIKNFEDFK
NKKIVAKNAYTLLMKLKNTASEEE
>KALACAFP_00307 Cobalt-zinc-cadmium resistance protein CzcA
MLTKIIEFSVKNKLIIALLVFGLIGVGAYQVTKLPIDAVPDITNNQVQVITTAPSFGATD
IERLVTFPIEQANSNISGLKEIRSFSRFGLSLVTIVFDDDIDIYWARQQVAERLQQVQNQ
IPPDIGTPTLGPISTGLGEIYQYVVRPKKGYESKYDITELRTLQDWIVRRQLLGVKGVAE
VSSFGGKLKQYEISVNPDKLNAYGVTITDVFDALKTNNQNTGGSYIEKGPTVLYIRSEGL
VGNLDDIKNISIVTKNNDVPLFIRDIADVRYGYATRFGAMTYNDNGEVSGAVVMMLKGEN
SSEVIKNVKAKILQIQKTLPEGVVIEPFLDRTKMVNNAIGTVEKNLMEGALIVVFVLVLF
LGNFRAGLLVASVIPLAMLFAICMMNLFGVSGNLMSLGALDFGLIIDGAVIIVESVMHQF
THNSKFRKALSVSKQEMDTIVIDSAGKMMNSAVFGQIIILIVYLPILTLQGIEGKMFKPM
AQTVAFALLGAFLLSLTYIPMMSSIILNKKISHKMNFSDRLMAKAEIIYRKALLKVLRIP
KIIFSIVIVLFTFSVVVLSRMGGEFIPSLEEGDFAVDTRVLPGSNLKTTTESTQKAAHIL
KTRFPEVQKVVTKIGSGEVPTDPMPMDASDMMVILKDKSEWISAKTFPELSGKMGKALED
VPGVTFGFQYPVQMRFNELMTGARQDVVLKIFGENLETLVKNANQLGKIVNTVKGTQNLY
IEPISGLPQVIIQYNRPVIAQYHLSIGDINRVINTAFAGQSTGLVFEGEKRFDMVVRLNS
NDRKNLDDVRNLLVPTPSGNQIPLSQLANVEIKDGPNQIQRENGQRRIVVGFNIKNRDVQ
GIVEELQAKVDRQLKLPPGYYITYGGSFENLKNAKNRLMIAVPIALVLIFVLLFLAFNSV
KESLLIYTAIPLSIIGGVFLLAARGMPFSISAGVGFIALFGVAVLNGIVLISEFNRLYKG
GIKNIVRIVVDGGEARLRPVLMTAFVASLGFIPMALSNGAGAEVQRPLATVVIGGLLIAT
LLTLFVLPLLYVTIEKGFKMKKIRKNTVTPILIIFFVLTGSVMKSQTKVTLNEAVAIALK
NNRGLKNEKLKSEYAKALIKTSSDIPQTGISADYGQINSAYRDIKFGVSQSIAFPTVYKR
QKNLYTEEWKKSELTISLKEYQLKKGVTLTFYNILYWQEKEKILNESLDFYSQFLEKATL
RLKSGESNILEKTTAANQKSAIEIQIKQVRQELRTLQLQLQWLLNSETEFIPDGEHIFAL
SNLQNDVSDNPSLKILEQQKNIAAQQTALEKSKLLPGLQLAYNLNSFRGMGADDRVYNAS
PQFHSVQVGVSVPLFSGSHKARIEASKIVESVNENDFQNAEFTLKKQYKKLSEIQQKNME
IVSQYEKYELKNADTILETAQKQFINGDINYLEFVMLANQAISIKNNYTDAVWNLNESII
ELEYITLNQ
>KALACAFP_00308 hypothetical protein
MRRLISIVLLSFYLVSTTELYQLLKIPVLIEHFLQHKGQNKNITLIDFLKMHYDHPVKDA
DYQTDQKLPFVSHANLLSVVFIINPSVDFHFTDKIYNAPGIKKTFYKSILYNKEILNSIW
EPPKFYQS
>KALACAFP_00309 hypothetical protein
MNNKSLHSFHIPVMGLAYTIDSPIRVAQYGISSVISIIDDEIVEKMRELYSKKFNLTFWG
ISTNEEDYRARRISAYLDMVDTIVCEKFESFKKEISKNKEALKGFINMLPNASTIKNVLL
RFDRQKEHDALAIKNFVDTHLIPGNIDVNIMTKVDKDNFKNNKQLPAYYNDAHSSLRGFA
QSKLSSSVVLSAGMNPRLYSYLEEFDDFFPDLDGGLRKKIILKVSDFRSAMIQGNFLAKK
GLWVSEYRVESGLNCGGHAFATEGMLLGPIMEEFKQRKEELIQSAHSLMITALEYKGKYL
VSKPLPMKITVQGGVGTSDEHEFLLSHYEADSIGWGSPFLLVPEATTLDSETRQLLMKAK
AEDLFLSNISPLGVPFNAIKGTSNETLKKLKISNNKFGSSCPKKLLALSKEFSPKGICTA
SKKYQKIKLEELEQQKNELSEETFQKNKLSIIDKSCLCVGLSNSAYLEHGMEIKGEKQGV
VICPGPNLAFFDKEVSLSQMVRHIYGNVNILSDGYRPHMFISELKLYVDYFKKEIEAFSG
KITNSQSKKWTGFKENLLAGIAYYNNLFQDSEMFKKDLKMIKHQLHNYRSIISNIKIPTG
A
>KALACAFP_00310 hypothetical protein
MPIVKYGIIEKSFPWLVKAFILSVLLDIANIVLQLNLPVPMLYGMILLFSLSEYRIIKKV
YILHFFPFLSFFIFWIFLKVLSVKDPTLEVWGLFEGVFTGVYIIYTIFYLYLAKLFICKK
DSEERAIIFHVRNLMIFVSLISVGKLLKLFNFSIISFNLAALNGAVDVYTIVFVIAHIFV
LRKKTNAVPAEQKVSKKSTAALSLSPELLEQYKATVEDFFSCSREYTKPNFSITFLAERT
GIPKHHLSFLFNHYLKQNFNEYLAKFRIDYAVEMMSNDSYMNMTIESIAFECGYSSATTF
NKWFKFFMHCLPNEFIKDLNHISKVESTTRL
>KALACAFP_00311 HTH-type transcriptional activator RhaR
MKLSFYLQIVIIIICIFFIIKSNRDSRPVQLDIILYFFYYALLHNIYTSIAYYIYYPTEK
FFFIEIGAPFGTAYGLLLYYAALKTSDRANININLKIHIIPIIFWFLMFFAFFISGIYED
VPTRKRYNGFLYMYMVLSWLFYIVKLYIFLYKSTVNIKLKSILSTISYILGFTACVFISY
LLSVKKYNNDFKRTLIYLAFLFCIIAAIRFYHYKKSILSGKERSKDQNPEENSGDISNEE
EDLKYKELVRIMESEKIYLTPKLTVAEMSRITNISPPILAEILAQRNHTFVTFVNSYRIN
HAIELLSNTDLPIEDIAYRSGFNSRSAFYKQFIKNTTRHPSDYRPAS
>KALACAFP_00312 hypothetical protein
MKPIIKSKPNYKKIFCDIITLKHPDKLEYCREILAKDEILLFDVILLNKIIFGNGEKDTE
FFNQQHKSYDEATINTILNYQKKHHLNNSEVSRHFKLSRNTIARWRKLFP
>KALACAFP_00313 hypothetical protein
MAENSKGNSKFKFKEIHIGNIIRERWEEKNIDMVRTCNFLKTDEDKILEMFTQPGINSEI
LLRWSKLLEYDFFRIYSQHLILYAPSASDNVKDTKLPVFRKNIYTKEIIEFILGRIANKE
KTKSEIIKEYGIPKATLYKWISKYDDTI
>KALACAFP_00314 hypothetical protein
MKHLCTLLLSLYVSLIFSQVGINTPLPNATLEVTGQPSDILKMDGLIAPRITGDQLRAKT
YTTSQNGAIVYVTAKDSAPSGQSVEVLNPGYYFFNGDKWVGMATSNAFVPNVVAAGRSTS
TIVQNSSTNYTKWNFTVTRNDGNWNTATNSYTIPSSGYYQLSLSGKVMPNTTGNAFTWLV
MYGTERFDYSNFVNYAANAEYNRGGVIVLYLIQGTVVHFGGFPCTGCTGSYTVGERTFSI
VSLGS
>KALACAFP_00315 hypothetical protein
MKQKTLFISFLYLLGFGQYESQIGINTTNPQGTFHIDGAKDNAATGVPTLAQQANDVAVT
PSGNVGIGTVSPSVKLEVTSPVLSGAIKIVDGSQGAGKILTSDANGAGTWSSAATATKAI
VTATSTSTATTSGTQGVFTYIPSLRINFPVSGYYSLTLKPFVVNAGAARDTGGYVGGLYL
RNTATLATIQIGVVNINPGWPYGGYGYAFSSYPLEYIPAGNYEVGVITLSTASAQQTTFQ
YTPPVNSVVGILSAQ
>KALACAFP_00316 hypothetical protein
MKKRMLFISSLYLLGFGRYEAQIGIQTSNPQGTFHIDGAKDNAATGVPTLAQQANDVAVT
PSGNVGIGTVSPSVKLEVTSPVLSGAIKIVDGSQGAGKVLTSDSNGVGSWSPAATAIKAV
VTATTTSTVTTSSTQGVITYFPTLRLDFPVSGYYSLSINPHIVDASTARDPNGYVGGLYL
RNTTTLATIQIGAANVNPGWPYGNYGYRFASFPFKYVPAGNYELGVTTLSTASAQQSTFE
YYLPISTVVAVLFAQ
>KALACAFP_00317 hypothetical protein
MKKSKPTIIPMLIITFPIYAQVGINTDLQIPFHIAGNSFNGLPSLLQQENKSAVWAGGNV
GMETFTSSPKLRERLGKNGIFCVERSHTIKDVVPNIAQFGFGVAENVLYQENV
>KALACAFP_00318 HTH-type transcriptional regulator ChbR
MTNITKQKLVAKLDEFEKSGLYLRTNFSLSYLTMYCETNSKYISYLIKTYKGKDFNNYIN
ELRVQYILEKLRTCPHYKNYKMSTLASEAGFSSPNKFSMIFKKHTSYSPSIFIKCMDK
>KALACAFP_00319 hypothetical protein
MKKFFKKMLVSVLTLPGTFILAQIGINSADPKATLDIVAKTTDGSRPEGIIAPRLTGNQI
KLADTQYTGTLAGAIVYASSAVSISSPKTVNITVPGYYYFDGNVWQRFSVTEHTGSVSIP
LNGISFQRAALSGDVTAAANSNTTAVTALQGKPLSAAAPIANDLLAFNGTVWAPLPTSSL
GIPKQVISVSVPGNQNIAGSINALTIVQFTVENYDPHNTWTNNVFTVPANMGGTYTFNFQ
IANTHTASTTSTSAFWTMMHVEKSTDGGIGWTKVITDISVAQFNDVDNGNRLFWTGNLNA
GDKLRIRAQYNGDTSDIISLGNLAITKL
>KALACAFP_00320 hypothetical protein
MSKLFFMLAASCLFSPVNGQIGINTSNPQGTFHIDGAKDNAATGVPTLVQQANDVVITPQ
GKLGVGTVVPAENLEVNSGINNSSGVRLTKLPSAAILATDANGTIISGNTESAGVSVTKQ
KMVSASPSFVLNSGSGAYSFRYTGTATVGGEWQIKVNNGVTRAFNIWDVEYWGQNGVGTS
ATVYQKRTVKSITPNMWTNLDDNYAGGADEYNVYHVYDLETGAILRFTCTLSDVSGIKES
MILEEF
>KALACAFP_00321 hypothetical protein
MKEKFVTLSFIIAPLFIFSQVGINTPNPQNIFHVDGANDNPSTGVPGSLQQANDVIITSA
GSVGIGTTVPAQKLDINNGNVNGAIKITDGTQGANKVLMSDANGVGTWNALAGSWLGLLR
AGAATTVPSKIDFTAGTVVGQGGAVDITADTVSVPVSGLYEITISGWSQGTTSPYLTTWS
IRKNGTEIASPHYGSPIASMGTDVSTTNFFTLNSGDVISLFLSDTFNPAAAAGIAQKVSM
AVKLIR
>KALACAFP_00322 hypothetical protein
MKSIIQIILLVFFSFLYGQKSLKNILKSNNIIEIETFLKAAHPDDPRRNILKKKLIDLKN
SSWTKPGIGPSMAARPIVNNAEFYVDEEKEEFDLLISETSNQHKEKTVQLLNALFATDLE
GESATFLIQNRTKCNIILRIQPKTDDKIVYNLAVKGQAENFITLKKGQYLIKGKICGQLY
SSEKELSKSLLIELK
>KALACAFP_00323 hypothetical protein
MKNKFTLNIAAMLLISTNFYAQDGRIGINTPDPKTTLDVNGKTDASGNVLTMDKTGLQAP
RLTRAELTAKGNTLYGADQKGALVYITDVSGGDTLDQRTNITTIGYYYFDGSIWNGLKNN
TASYTPGDIKHSVKAADHDGWYLLDGRTVSSLPANAQLAANNLGFTVNIPDATNRVLKTK
TSLETLGTTGGSNTLNIAQTNLPNINLSGSISGTAQANGDHSHAFSATTSLAGIHAHGPI
AGTGFLLGGTTIGNNGTGNYQGNGLQSSWGGVGLGGATANAGNHTHTLSGTTANTGSHTH
TVSGTTTVSTGGANTAMNNMQAYLVVNTFIYLGL
>KALACAFP_00324 hypothetical protein
MKTHVELQKDVQDTMTWEPLLNSVVIGVKKRQAEHAVKNVLRVKALVENIEDRLPHPQSK
NDIEIVGKLLLYLKQYVPETTEISILKFDMNTTISTNFKTILI
>KALACAFP_00325 HTH-type transcriptional regulator ChbR
MMTNITEQKLSAKLEEFERSTLYLKNNFSIAYLAVYCGVNSKYLSHLIKKHKNKDFNNYI
NELRINYIIDKLRKCSHHRNYKIATLAEEAGFSSPNKFSAVFKKHTSFSPSFFIKCLEKK
LPEYII
>KALACAFP_00326 Hydroxyacylglutathione hydrolase GloC
MKVEQIYTSCLAHGAYYITSKGEAAIIDPLRETVSYLERLKNDGVKLKYIFETHFHADFV
SGHLDLANETSASIVYGPTARPDFAAHVAEDNEIFKLGDVTIKVIHTPGHTMESSCFLLI
DEEGKETALFSGDTLFLGDVGRPDLAQKAAHMTKEELAGVLYKSIYHKILPLADEIIVYP
GHGEGSLCGKKMMKETSDTLGNQKKVNYALNQLNEESFISAVLDGLSPPPGYFEMNAVMN
RAGYESFENVFSRGMSPLSAEEFEAKANNENVIILDTRDGGEFSKGFIENSINIGLKGSF
APWVGAMIQNVKQPILLVADTEKHEEAITRLSRIGFDNVIGYLEGGFETWKKAGKKICRI
HRISAEEFVTKMNDGVLAIDVRKESEYSEYSFKGTYNKPLADINQWIGEINNQNHFYLYC
QGGYRSMIAASLLYRRGYTNFTEVEGGYAAINQIMSK
>KALACAFP_00327 hypothetical protein
MKKIVLMSALAIAGSFSAQEKNPGLKGTWFATAQMGYQSTKDGTENGKSSSTTILPVVGY
FIAPSTALGVAVGNIGVKSENQLGSDVTLKTNLLVIEPLARKYWNIHGGLFFFGQLAVPM
ITGKTKVTVNGESVADSDIKISQFGLALSGGLDYVMTKHFTVEFSYNLANLSFTTIKNYP
GTTKDIKTTDFALAHVATVTPQYNAAIFGPSGTAIAPLSFGFKFLF
>KALACAFP_00328 hypothetical protein
MLKVGIIGCGWLGSRIAKHLQPEYEISATTRTQEKAEQLQEVGIQPFLVDFPDSKKISEY
FQPTLLSQNPEVIIITVPFSKKMTTESLHNRFENISLYIEGFKGQLFLMSSVGIYPQEPI
EISENTLPDEQLNPSMLNVEKLVKEKFSQVNILRLGGLMGDNRVFSNYNILSPEQIVNHV
HYHDICRIIETMMKQNISSKTYNVVAPWHPMKQEVINYQKGLSVPIDFLPEGRKIISKSL
EKDLGFSYVYPDPKKFTEGV
>KALACAFP_00329 hypothetical protein
MKAKQISGVPQQKNGGFHDTESQKVFENSSVAVQKFEILKEKFFSVNQWKSYCSEKLADF
QLYDSYGNHLSRKPEIGDFIRIDIPGLGDAEAKGYDWVKITSIFSEKEESYEKIIMCCSP
SYIPGQMKNFHIAHFYGARASSCFMIAREGNYIKAAVYGRNERPNFEARFLDKIRNIFIA
LGGMFGFSKIQWKSLTDGLLEL
>KALACAFP_00330 hypothetical protein
MAAQILNSSIIRKVAMGLSGIFLISFLMLHVSLNFTSVISGDLFNQISHFMGYNWLVQYI
GQPILIFGLVFHFVMGFILEIQNRKARPVGYARNASSANSSWSSRNMIISGAVILSYFCL
HWYDFWFQELNYKFIEMNVPNETRYYEELVHKFQSPVRTFLYCCAFVLLGFHLWHGFYSS
MQSVGFNNRYARALAQFGRYFAIVVPSCFIFIALFHHFAH
>KALACAFP_00331 hypothetical protein
MKHQFYREQQLNCDIQTAWKFFSSANNLSEITPKDMNFIVLTHFDNDEIYEGMTIDYYVS
PLFGIKMKWQTEIIQVDFQKSFTDFQKKGPYKLWHHHHEFIENENGVLMKDTVDYELPFG
FLGEIAHSVLVKKKLENIFNYRYKVLEERFNKK
>KALACAFP_00332 hypothetical protein
MKIFSLIFVFLFLFSCKSEKNDTIKTEYNHEVVKIEKKPEINVNKAKSKAGEALKFCLSK
GFNTDFCILIDMSVHSGVKRLLIWDFKNNSVSKKYLVGHGCGANPWSSDGSKNDPEFSNE
DGSHLSSLGKYKLEGRGYSDWGINVKYLMHGLEKTNSNALKRFIVFHSWNLMSDDDVFPE
GSPEGWGCPTISNNAMREIDPMLQNSKKPVLMWIYD
>KALACAFP_00333 hypothetical protein
MTAKKMLFLILKVLGIVVGIVILYAALGYLLPFIEVSAKDDGQKKEVPIYIYTNGVHTDI
VMPVKNDLQDWTAKIPFNNTKSKQTDYSYVGIGWGDKGFYLDTPTWADLKFSTAFKAAFW
LSESAMHCTYYKEMKEGSDCKKIMISRDQYQKLVQFIENKFDRDEKGNFVLIPTNAVYSD
NDAFYDAKGKYSFLDTCNTWANDALKAAGQKAALWTPTDSGIFLHYK
>KALACAFP_00334 Epoxyqueuosine reductase
MNSNAEKYSQLIKSKAKSFGFQSCGISKADFLEDDARHLETWLKNNFHGEMKYMENHFDK
RLDPRLLVEGSKSVISLSYNYFPKEKISALENFKISKYAYAEDYHEVIKEILREMIAELQ
EEIGAFGFRVFVDSAPVMERSWAKKSGIGWVGKNANLITKQNGSFYFLAEIICDLELIPD
HETTDHCGTCRKCIDACPTDAIVSDKIIDGSKCISYATIELKNEIPDYFKDKMDDWMFGC
DVCQDVCPWNRFSVPNLQSRFAPNEALKNFKKGEWKELTQELFSEIFRKSPVKRTKFAGL
KRNIEFLGGSSDKN
>KALACAFP_00335 Thiosulfate sulfurtransferase PspE
MSLSEVLKSGNYELIDVREPMELEMDGNIEGAKNIPLGEVENRQDEILSIEKPVVIFCRS
GNRSGKALEYLNSQGLKDGYNGGGWAELKATIEANQGTF
>KALACAFP_00336 hypothetical protein
MELKEIFSQNCLLFTKDQHLIENLWSEIEQKYSEKSRYYHNLEHLENMFSELDAVKDRLE
NYSFISFSVFYHDVIYDASSKSNEEKSAEFAKIRLEKLHVDSESVKKISEQIIATKTHQK
SEDNDTNYLLDADLSILGKDLKTYMDYTKKIRKEYAIYPDIFYKPGRKNVLQYFLKLKNI
FKTEYFHEKYEVRARANILFEIESL
>KALACAFP_00337 2-hydroxy-6-oxononadienedioate/2-hydroxy-6-oxononatrienedioate hydrolase
MEGRIIDVNGKKLYIEYSNSFKNKPTIVFLHDSLGCTQLWRDFPEKLSEATQCNILVYDR
LGYGKSSPMPTYERDNDYMETEADLLNDLLDELEIKEMILFGHSDGGTIALISASKYPEK
TKAVICEAGHIFVEDVTVKGVSDAFEAYKTTSLPERLQKYHGDKVDMMVKAWTEIWLSDR
FRSWNIESMLKNSKAPLLFIQGENDEYGTLNQVEKTISQVSGSAEKFIIPNVGHTPHKEV
PEVVLGKSAEFINRIVNSQ
>KALACAFP_00338 Nitronate monooxygenase
MGNFIDFNTAKKLQEMQSQQNRITELFSIKYPVIQAGMIWHSGWRLASAVSNCGGLGLIG
AGSMYPDILRENIQKCKQATDKPFGVNVPMLYPNLDEVIQIILEEGVKIVFTSAGNPKTY
TETLQKEGLKVAHVVSSTKFAMKCEDAGVDAVVAEGFEAGGHNGRDETTTFCLIPNVKKH
ISKPLIAAGGIALGSQMKAAMILGADGVQIGSRFAATVEASAHDNWKKKITELQEGDTHL
TLKELAPVRMVKNKFFNELEEIYNIGRNKESLIASLGRARAKRGMFEGDMEEGELEIGQV
SALIDEVLPVETVFRNLLQEFEDAKMPVF
>KALACAFP_00339 Foldase protein PrsA 1
MTNKLKITFLFGIFIMLFATNMVKAQLKQGELVDGIAAVIGDEIVLESDVNEQMNYAKQQ
GASNIDKCEFLENLLNNKLLVYEAKKDTLIENRSAAIKEQANAKYQQLLSQFPDEKTMLA
AYKFRNGYEMKNAIEKIDTDTYYGQAKYQRVTEKADVTPNEVTDFYNTYKAQLPEIKDEV
SLSQIMMYPKLTEAHKQDLINRLKKIKKDIEGGETFESQARIYSEDPGSASNGGLMKNIS
KGQMVKPFEAAALNLQEGEISDPVESEFGYHIIQLVKRSGKIYDARHILLMATPTDEEIK
TAKNKLDSIRTLISNGKITFKDAAFRYSDDKRTKFNAGVIAGSDGSNKIERESVPGTISY
ELAGLNKGDITTAFDDEDERKRKVVKIVKIEDVIPAHQITLETDYDRIKQMALNKKRNEM
VEKFVNSKLPTTFISIDGRYDSCNFKGSWKKDSIKK
>KALACAFP_00340 2-dehydro-3-deoxygluconokinase
MKLLVVGSVAFDAIETPFGKTDKILGGAATYIGITSSILGVKSGIVSVVGGDFPQEHLDM
FTDRDINIEGIEIVKEGKTFFWSGKYHNDLNTRDTLATEVNVLENFDPKIPDSMQDAEIL
LLGNLHPGVQLSVLEKMNNRPKLVILDTMNFWMDSAWDILMDMIAKTDVITINDEEARQL
SGEYSLVKAAKKIHTLGPKYVIIKKGEHGALLFHDNKVFAIPALPLEEVFDPTGAGDTFA
GGFAAYLAKKGKFDFETMKSALIVGSAMASFTVEKFGTERIEEVKESDMFGRLRQFKELT
TFDVEVQ
>KALACAFP_00341 hypothetical protein
MFKNVIFIFVALLLMSCGKDPVPKPYGELRLEYPAPKYQKFENNCAYTFEYSDFAKITNA
KKPCWYYLNYPKMKAKIFVTYYPIQNDFAEHIREAEKMVYEHTIKASAIDTKSFEYPDKK
VYGNFYELKGQSASNLQFYITDSTKHFVTAYLYFNTRPKPDSLAPAVDYIKKDMKHLLDT
FEWKK
>KALACAFP_00342 Adenine DNA glycosylase
MEKTATPTFKHIGSKLLNWYQKNARDLPFRQTKDPYKIWICEIVFQQTRINQGLNHYNNF
IKRFPDVKTLAEAEENEVLLYWKGLGYYSRAINIHRAAQQIMNDYHGTFPHEYEEILKLK
GVGKYTAAAVSSICFDGKIPAVDGNFYRVLSRIFADDFDISNSRAFNYFSELAHLILPDN
VGDFNQAMMDLGSEICKPKNPLCGECPLHEDCLAFSLNKISEFPVKTKKVKAEDLSLKYY
FVHRNGKFLIQQRKDDFIWKKLFEFPPVISDELISFIKSVKTVNHKLTHKNLSIEIFNVE
VDSEDIWKDFIAENNFIVTDVEGSHERSFPKPLENYIQNYDTAYRIL
>KALACAFP_00343 hypothetical protein
MKGGLQHFLPIFLMIFAVSCDDKKVQTDHKIDLFANERKEGKAYIMKPQECFDESDMVVS
TSNIKLIDKSLGRGKSVFIYKVNSGQVLKTTRDSVVSFPFQFLANQELRFKKDSTSYVYL
KKLQGYRFIAKEMNLKYQWLKAAPVYSVKAGK
>KALACAFP_00344 hypothetical protein
MDSKLQAAENQQQQGQQQHAGQPKGNPLAELNKIGGFGFVESVVDGIANMNPTRKARKEI
FLTDANKTDERKELLQKINLWVNLLEGNESADKMADTCKTKAQQAEENLKKNLKNTLDAV
RQMETNYRTVAQFYKNTELDKVDNVSIVNASIDQVSDLDNPIFIEAIAEEFKNYYDRLDL
RDNYSILAIPGYLGSNKVIEKWAKICNENKVMMVTDFANLDKPDDVVDLFHSANLTGGEL
HRSNVIMTCNWLVGRGKAEEVGEEENVELPPSTSLAGKIHKTLMSQVAAGKKHGNINEVD
AVKFELKKSEISQLEKMGLVPMVNEYGKIMAFSAKTLFTGDNIGLQTYSVVRVFDYVTKV
LLDFLNRRAFENWNAKNEDDLRRQIVQFLDSIKGPDKLIEKFKIVRFEQDRVNKDRVWLD
IRLTPYFPTKSFVIKLDGHKGDDGNEWDAEYAQE
>KALACAFP_00345 hypothetical protein
MLQFFFKFKHWIGQLFDADKNNSHQNRKSQNNNNMAMFNYGVGGNEVKVDANEAIQDIQE
NKSLIVSQLTTDESYVPEIVTGLKTVDDVFKHFQPSVAVQHETEDGNVVEEEFRFQNLAD
FTPKSLTQKSNYLQQLSMEQEQYNKIVRQLKTNKILRNMLENDQTRAAFIEVLKEVAQEL
EK
>KALACAFP_00346 Neutral endopeptidase
MKKLNIGILAFSGLVFLNSCGTTKTADTQKPETMKDVVVKPAKEEMKEEGINLSYMDKSV
RPQDDFFSYVNGNWVKITQIPSDKASWGSFNALRENVDDASLDILNKILSETYPAGSEGQ
KIQNLYASFMDTSKRNAEGLVPIKGDLAKIDAIKNLNDLQNYLLEATKLGDNSFYGWRVG
ADMKNSNMNAVYLGGPDLGLGRDYYQKVNEANTKTLAEYQTYVGKLFGVLGYKNSDAAAK
NVVDFEKQLANYLLTLEQNRDANLRYNPKNVSELSGLVKNVNLAKYLKDAGVNTDRVIVG
ELKYYQNMDSFLTQKNLPLLKDYLKYHLINGNASNLDEGLEQIRFDFYSKYLQGQKEQRP
MNKRGLSLVNGVLGEAFGKLYVEKYFTPEAKQQMETYIDYLLKSFKQHINDMDWMSPATK
VKAQEKLSKFTVKIAYPDKWKDYTQLKVDAPAQGATLYSNLQNVAAWQYQRSLDKVGKPV
DKTEWGMTPQTVNAYYSGSNNEIVFPAAILQPPFYNPKADAAVNFGGIGAVIGHEISHGF
DDSGSRFDGDGNLNNWWTDADRKNFDAKVGQLAAQYNSYEPVKGSFVNGKFTSGENIGDL
GGVAVAYDALQMYLKDHGNPGLISGFTQDQRFFMSWATVWRTKSTDQYMVNQVKTDPHSP
GVFRAFGPLVNQDSFIKAFDIKPGDKMYKAPQDRIKIW
>KALACAFP_00347 Neutral endopeptidase
MKKLTLSLFLLAGICSQTVNAQASAVKTAANTDKGLDLSLMDKSVRPQDDFYNYVSGTWM
KTAKIPSDKPTWGSFNKLAEDTDNNSMTILNSLLKDKFADGTEGKKIQDLYATYMDMKKR
DADGIKPIQANISKIDAIKNLTDLQNYLTSVTKEGENTFYGWGVDADLKDSKMNAVYLGN
ASLGLGRDYYQKVNEKNTEALAEYTKYVASMLKELGYKNADAAAKGIVDYEKSIAQTYLT
NEQSRDNTLQYSPKTMTELSGLVKNVNLPAYLKAVGVNTDKVIIGEIGYYKNLDKFISAQ
NLPVIKDYLKFHMIHGSASYLSEKLGDMKFAFYGKYLRGQQEQRALNKRGFELINGTLGE
AFGKLYVEKYFPAEAKAQMVELIDYLKKSFAVHINNLAWMSSTTKEKAMQKLNKFTVKVA
YPDKWKDYSKLTIVPESKGGNLYSNLQNITEWQYNKDLAKIGKPVDKTEWGMTPQTVNAY
YNPVNNEIVFPAAILQPPFFNPKADAAVNFGGIGAVIGHEMSHGFDDSGAQFDADGNLVD
WWTPEDKANFEKATKALAAQYDKYEPVKGTFVNGTFTNGENIADLGGVNIAYDALQMYLK
DKGNPGSISGYTQDQRFFLSWATVWRTLSSEKYMVNQVKTDPHSPGYFRSFGPIINVDAF
YKAFDVKQGDKLYKAPADRIKIW
>KALACAFP_00348 Nicotinamide-nucleotide amidohydrolase PncC
MEKAVLITIGDEILSGNTVDTNSNFIAAELKNIGIRVSQIFTISDEIETIKNTLTSAFET
GDLIITTGGLGPTRDDKTKKAIAEFFNDEIALDEVTFNHLKAYMEKRGRLEILERNREQA
FVPTKSTVFQNHYGTAPCMMMEQDGKLLFSLPGVPYEVKPLIKDQIIPYLQEKFNLNYIS
TRIVSVVGIPESILADTIENWELALPQNLALSYLPVGTRVKLRLTATGENEAVLQQQLEE
EIQKLLPLIKDNVIATSEDKIEKILAELLMERNMTISTAESCTGGELAKMITSNSGSSKY
FVGGIIAYATEKKIEILKVKKETVDEFTVVSEQVASEMAEGCQKLFDTHISLSTTGVAGP
EKGEDGKEVGTVFYTIRVNDKVVTSKLYMPHLDRLDFMYFVSQKIIQDLVGVLISE
>KALACAFP_00349 Outer membrane lipoprotein Blc
MKTFQKIVIPVSLGVLGLIILNSCSVGIPNGAAAVRNFNAQKYLGKWYEIARFDYKFERN
MDNVMATYSQNPDGTIRVDNKGYNYVKKEWKQSVGEAKFVKEKTEARLKVSFFKPIWAGY
NVIDIDDNYQYALVAGSSLKYLWILSRTTEIPESIRTRFLEKAKKIGYNTDELIWVKHNQ
>KALACAFP_00350 Sensory transduction protein LytR
MKIKSVIVDDEIIARDVLRNYLTKYCPQIEILGEAENIKEAVPLIAEHRPQLVFLDVEMP
FGNAFDVLEATKEFSYETIFITAFSQYSLQALNKSASYYILKPIDIQELILAVNKVAESL
EKKEELNRNKILLENLKLKPEKQQLILPTLQGFDVVKTEDIVRLQADGNFTQVYLTDGSK
KMVCRFLKHFDDLLENPFVRVHRSHIINTNFVKSYHKSGTATLSDDTEIEVSGSFKDNFL
KVFS
>KALACAFP_00351 Sensor histidine kinase YpdA
MKLLFKIILIFVLAQGNFSFAQDSARVSNVLKSARKLQKAVDNNDPKGVADTYVGLANNY
YNQGNYAKSEEYFIKARNIYQNLNDKKNLESVTRKLAQSQEKQNKITPAISNYSRAAEVS
YTEKNKTVNSNDAARLSNASPELKAEAIQSNIEISQKSKDKGNLAASYSQMADVNIQQNN
IPKAEENLNNAYKLSKQQAPQQALEINQKLTDFYVENKNFDKAIEAKKKVLKENFVKDNS
QEKVNQIQELADIYIKKNDAEEAITLLKNAYKISLEKGHTLEAQKSVKKLDSLYAISQNT
DASVLLYRDFLGKLPDLVSKDKSLVDQKILEDTEQRISQLEKEKELKDELIRKKNVFNYG
LIGALIVLTALIIFIFRTLKKVQTKNKKIALQSLRREMNPHFIFNSLNSVNHFIATNNEL
EANQYLTKFSKLMRGVMENSTEDFIPFQQELDLLQNYLALEKTRFADKFDYEIEVDESLN
TQSLKVPGMLIQPFLENAVWHGLRYRSTKGFLKLNFEKENQHLKITIEDNGIGIEESKKQ
KTQHQKTREGRGMKNTLERITLLNDLYGQDIQCKITDKKNGEGVFVEISYKLVNK
>KALACAFP_00352 hypothetical protein
MKLKHFLLIGLLTAGSLINAQEIKKNAIEVTGVAEMEVEPDEIIFNVGIKGDNKNQLADN
EKLLFETLKNNGVKNEDIKFKSMYQNIYAKTKTFTKNFQFKINKKTEMGNLFESLNQKWV
TNINIAEIKNTKIADFRKTVKINALKAAKEKAEYLLESLGKKIGNPIEIVEIEDYTSDMI
VPAAYKSRAANVQLEAADAGVDYSFENIENIRLKYSIKTRYEIL
>KALACAFP_00353 hypothetical protein
MTTIKTLTLAMGAAAFLGAQNSPKFECKEPTVQRTIVQNDHQPAGTLGKENKIQVALLLD
TSNSMDGLIDQAKSRLWNIVNTLTTLKYDGQAPQVEIALYEYGNDGLRDENYIRQVTPLT
QDLDLVSEKLFALRTNGGSEYCGAVIRDASMNLNWDGNEKSMKLIYIAGNEPFDQGKINY
KEVISTAKRKNIYTNTIFCGSRDEGIQTFWQNGATIGDGKYFNIDSDRKVIYIETPYDVR
ISQCNAKLNDTYIYYGSHGSEYKTKQIAQDRNAEVQSVSNAVERTVAKAKKNAYKNDHWD
LVDKAEKDKAYISNLKQEELPSELKGKSSTEIQKIVAQKSSERDKIQKEIEELSKKRQDF
IDAEMKKKGSADSDDLGKAIEKSILELAKKNGYSS
>KALACAFP_00354 Gamma-glutamylputrescine oxidoreductase
MDLKSNEPFWLLKNGLIASYPSLKSDEDCDVLIIGGGITGSLIAHQMVTEGYKTILIDKR
ELCNGSTSATTSMLQYEIDVPLFELIEKIGEKGAVMSYKACSDAIDKIEKLSEEIKSSSG
FKRKKSLYFAAKKKDVSWLKKEFKTRKNAGFDVKWLETDEVTKRFEFENTYGAILSKQGA
SIDAFKFAHELFKLNIKEGLKIFDKTEMVKVEYFKGYNLITVDSGYQIKAKKIIYCIGYE
SKNLIKEKFVDLKSTYAIVSEIDKKKFRNITNTLVWNTDKPYIYMRTIDDGRVLIGGGDE
DFYDAKKRDAILDKKEKEILRNLQKIKPDYHFYTDFVWAGTFGKTKDGLPYIGEHENFKN
SYFVLGFGGNGITFSVTGMEMASLFMKGKKHPLSRYFKFGR
>KALACAFP_00355 hypothetical protein
MITIIPEAPENVAAFNATGEVTKEDFENLVIPRVKEKIDQFNELNYLLYLDTDLDQFTMG
AWLEDLLLGLKNLTKWNRTAIVTDKEGVQKFTDIFSVLMPGEFKSFPKENLYNALYWCEN
GNEVEA
>KALACAFP_00356 Lectin MVL
MSTFKINIIAGPLWSNDEAQKLGGRIAAAHLGKFTGQWSTIVEGEMSVIEVELNTQPTGS
SEYTLNVLAGPIWSDEDAKAVCPSICASYGGTWNGQWTTVVEGKMSVCGCVFKF
>KALACAFP_00357 Inner membrane transport protein YdhP
MGIDKRIIPLAIGGLGIGTTEFTVMGLLPDVARSLQISIPEAGHLISAYALGVVIGAPIL
IGYSVKFPPKKVLMALMMIFTLFNALSAVAPDYTTMLIIRFLSGLPHGAFFGVGTVVAAR
MAGKGKEAFYISLMFTGLTIANLAMVPLVTYIGHTFHWRWYFVIVAVIGLLALLFLKLWL
PVLETNQDTHFMEELKFLKRKQAWLVLMITAIGFGGLFTWFSYITPLMTVISGIKESQMA
YVMILAGGGMVVGNLVGGYLSDRLSPEKTCALLLFLMMISLAGVFFLSEYQNIALALTFI
CGALSMSVAAPINIMMMKAAPKSEMMAAAFMQAAFNIANAMGAFLGGIPLEHGFSFNYPS
LVGVGMTSIGLVIAVRYKYLYGSQTIDKEEIATECVSCDQ
>KALACAFP_00358 HTH-type transcriptional activator Btr
MKIQKEIIEFEEDKSFKLFSPSLKNCFFWHYHPEIELVYVEASNGIRHVGKNISDFKESD
LLLIGSNVPHLNFDYKIQTECRQLVLQMRENFLQDLIFPIPEFENIKKLLDRSYLGLSFS
GETKKLVVEKLHHIKDENSFKSFIGLIEILQILAHSTEVKELNNEDTRIKWFLNDKIRMG
TIYDYIHENYDKKTNVNEIAEMVSLSTPAFCRYFKKQTNMTFTDFVNTYRINQAKLLLLQ
NSCVTEVCFQVGFDSLSYFNKLFKKYIGETPSAFKKKHLSKVK
>KALACAFP_00359 Lipoyl synthase
MENLVQDTTVQKPKWIRVKLPTGKNYRELRSLVDKYKLNTICQSGSCPNMGECWGEGTAT
FMILGNICTRSCGFCGVKTGKPLDVNWDEPEKVARSIKLMKIKHAVLTSVDRDDLKDMGS
ILWGETVNAVRRISPGTTMETLIPDFQGITKHLDRLVEVAPEVISHNMETVKRLTREVRI
QAKYERSLEVLRYLKEAGQRRTKTGVMLGLGENKDEVFQTIEDIRNANVDVITLGQYLQP
TKKHLPVKKFITPEEFDEFGDFARSLGFRHVESSPLVRSSYHAEKHIH
>KALACAFP_00360 hypothetical protein
MKTIFCFLSIIFSTFCFAQKEFQPAGSTIIESVDGDLDGDKIPEKVIIYNTKDTTDFGNI
REIQILKNFNGKWKILEKSRNTILESNSGGMMGDPYGDTKIEKGILIISQYGGSSWKWGY
TDKYRFQNGHFELIGYDSTYGKPEEYFSSVEFNLSTGQLNFEKEVENTAEYGKSKKETYI
KKGLKIDLQNRNQKEQRKITLPKTKEDVYL
>KALACAFP_00361 ECF RNA polymerase sigma factor SigW
MNDEQLFLLIGKAKEKDQKAQTKLINIFWVDVFSFVMKKVKDENDADEITVNVFSKVLSK
LDMYDPHFQFKTWVLTIAQNTIIDFWRRKSRENQDPTENLDEVKNQFAKSPEELMISAEE
QKKIIKTIESLDANYQDIIKLRFFEEKSIKEIAEELGISVANTKVRVMRAKKVLAELLKN
NEFEDN
>KALACAFP_00362 hypothetical protein
MKKIIILFHLLIVAIIFSQKKFDVVYEADYKLNYKLSNANNYKKETTFALLINEKSSFFK
DLHRYISDSLLVEKKLNTLEEAMKYNTDFRGYIGTTSAKLYVTDEINYAYFGYEEPNNIN
WKIKNEFKTIAGYKCQRAEATKYGRTWIAWFASEIPFQFGPYKFNGLPGLIAEVYDTKDD
YHYTLYAFRKRKYTCKSANNATNVKNLTKEKVAEIFKNRLAGKLRLNEQFIENAEDREYM
KQNAIKAEKNYNPIELSLY
>KALACAFP_00363 hypothetical protein
MKKSLLLGALLVAGIVSAFPFRTSCGKVVQVSQTIADNMSLDQLSNFLADVNGENCPNAG
AVVIHIYYH
>KALACAFP_00364 hypothetical protein
MNLSDKLFTTRTAKKLSKQEVADLLGMDVTTYGRVEAGKRNLEIDKLKLLPETLGIKAEE
ILDLLEIDKGTTFNITNSENATSNGIGNIENFYNENKDALAEIKKLYTELLQQKDSMIDY
LKKENEELKNLLKK
>KALACAFP_00365 hypothetical protein
MCKDKKFGVIKSGKAQKGILNAKVCLSEYRLMV
>KALACAFP_00366 Tyrosine--tRNA ligase 1
MNSFIEELKWRGLFADMMPGTDEQLDKEMTTAYIGFDPTADSLHIGSLIQIKILAHFQQH
GHKPIALVGGATGMIGDPSGKSAERNLLDEETLLHYVDCLKNQLSRFLDFSGNEPNKAEL
VNNYDWMKNISFLDFAKNVGKNITVNYMMAKDSVKKRLSGEAGVDGMSFTEFTYQLIQGY
DFLHLYQNNNVRLQMGGSDQWGNITTGTELIRRKAQGEAFALTVPLITKADGSKFGKSES
GENYWLDKKKTSPYKFYQFWRNAKDEDAERFIKFYTFLSKEEIETLVAEHKTAEHEWKLQ
KRLAEEITVWVHGREEYEKALKASEILFGRSTAEDLVSLDEETFLDVFDGVSQKEVAKAE
VIGANIVDLLVEKSGFLKSKSEAQRELKGNSISVNKEKVNDTFVATENDLINDKFLVLQK
GKKNYFIVRVV
>KALACAFP_00367 hypothetical protein
MKKDLLVLSGILLVMSTAMQAQTGVGINTVTPGTTLDVNGAITNRETAVAVASNAATIPA
NVTQIQLTGSATATIAITAPAAPNAGQRLIIYNNTGGGFGASLNGFTITNGQAMEFAYSN
GNWRATNNGAGATATSIPWNTLGNSGTNPTTNFLGTTDNQGLALRTNNAEQMRITPTGNV
GIGTTTPNSHLDLGPLVSSTKLAVYNDTAGGDFYGFGLSGGLLHFHTASPTSATAPDMVL
HSTGQLGINIGATNPTANMDVNGTARIRNTPMLAAGNGASIAIPVYHDANGNVVKTAPPG
HGNVMSGIITGAPGASTLIIGNIPDGTYYRLTVTVANACTHHAVAEFWVAANSSGGTAIQ
GRDGFMSLNGVAPPTFSETQTSTGVSWSGVPGCGDGGNTANLDFTMYIVASGGGTYQLNV
VNNGNVNRGYSAVLERVGTY
>KALACAFP_00368 hypothetical protein
MKKDLLLLSGVLLFISTAMQAQAGNVGINTTTPGTTLDVNGAITNRETAVAVAANAATIP
ANVTQIQLTGSATATIAITAPAAPNAGQRLVIYNNTGGGFGATINGFTINNGQAMEFAYS
NGGWRAMNNGTGALPNTIPWNTLGNAGTDPANNFVGTTDNQGLALRTNNTEKVRVTPTGN
VGIGTTAPNSKLDLGTDVSSAKLAVYNAAAGNDFYGFGLSGGLLHFHTASATPTTAPDMV
LHSTGQLGINIGATNPTANVDVNGTARIRNTPMLAAGNGASIAIPIYHDANGNVVKTAPA
GHGNVMSGTITAAPGASTLLVGNIPDGSFHRLTVTVANGCTHHAVAEFWVAANSTGGTAI
QGRDGFVSLSGVNPPTFSETQTSTGVSWSGLPGCADGGNTANLNYTMFIVASGGGNYQLN
VVNNGNVARTYAAVLERIGTY
>KALACAFP_00369 hypothetical protein
MKKKLLLLSGTLLLVCATMQGQAGNVGINTTTPGTTLDVNGAITNRETAVAVTANAATIP
ANVTQIQLTGSATATIAITAPAAPNAGQRLVIYNNTGGGFGATINGFTINNGQAMEFAYS
NGNWRAMNNGTGALPNTIPWNTLGNTGTNPTTNFLGTTDNQGLALRTNNTEKVRVTPTGN
VGIGTTAPNSKLDLGTTFGTTPTDVAGKKLAVYNNASGTDFYGLGIVPGHLAFYSSALNA
DAPEMVIHAAGNVGIGTDPTAAPTAKLDVNGTARVRSTPVIATTGQIPVYMDANGNIGKS
QGNGNNENYYAHTPTLSPGTTGVVGQIPDGGVYKMVVTTYNACSYAAVTEFWVFALATNN
QSSIQGISGSTSNNGVSPPTFTETQTSSAVTFSGVPGCADGSNSTAFNFTVAIDNLAPHN
IRITNNANTAKPYTIRLTRYPFN
>KALACAFP_00370 hypothetical protein
MKQFYKSNLLRLSFLFAVLFSVISVVNSCKDDDKDEYEDHIIQFESKIVNGTGSGTGTFK
TIVTQVGTSQNTIFDPTGTNWASGEQFVSSSQSQLNLAANAVLPNADSKLIVNIWVDGEV
AKSDTVIGSGTKSAAVAHSFLEL
>KALACAFP_00371 Carboxylesterase 2
MNLDYIVREPENITSDTTILFMLHGYGSNEQDLFSFRETLPKDWIIVSFRAPRATQFEGF
SWYDIDFNNPENFVDVPQATESLNSVLESILKIVNHYGITEGKTHLCGFSQGGILCYALA
LKYPEMFNYVACLSSYPEEKLLKDIVKDKKKLEKLRFFISHGTDDAVIPLDWGRKAADLL
YDLGCYFTFREYMNGHGVNQKNYMDLMDFFAK
>KALACAFP_00372 hypothetical protein
MKLKYFFWFVFLSIFLNAQEQNSFELQNEKKTVIPFKLINNLIFIPVNVNGAELTFLLDT
GVAETSIFSLENQELKLASLEKIKFSGLGGNASIDGFRSDNNIARIGKDFVNYTLTLFII
IDQDFNISSHVGIPVNGIMGYHFFKNHPVLIDYTSKKITIYNDKELFKKKVKKFDELPIS
IEKNKPYIFADVEMTREKKSSKLLIDLGNSDPIWLFPTLIKDFVYNRPNIDDFLGRGFNG
DVYGKRSRIHNFYLGNYRFEKPLTAMPDEYSIQHVNLVENRKGSIGGDIMRRFTVGFDYT
NKKLYLRKNRNFDDPFHFNMSGLDFRQDGMEWTKDMVNLPTKNNNNASSGIEVINNSLQY
NFVLKPIFSIAGVRKDSPADKAGLKKDDKLISINGKKTTDMTMEKIMEMMKSEQGKTINM
VIQRKNQEMTLSFTLEDPIPYQEQE
>KALACAFP_00373 hypothetical protein
MNTEETTLDKIRSRPRFKMFTHLTKEEYAENLKKYLSEHKDEFSGNINKEVATICVETEY
DSYWKPRLSLRIEIEDEKTAIRGVFGPSSAVWTFFMFLYFSFSILWMTFFSMYYVEKQIK
SQEFPWALNASFLMLFFIALTYAAARFGQHKGKAEMLKLRRFAEESTLQFEKKDD
>KALACAFP_00374 hypothetical protein
MKNIFVKKSFLYTIFIVFMLVSCKKEIEKISDTIKDTTSSITETEEAEKDSVKKDSVIQK
ESMPPAMQEDGFYNAFIFPKDKKLKDSLFGIFNKKYTEKERYAIYALNRLDAKNKWNADT
LVVPAKIDTTLMEYSPFPMQLDVLSPVKKFVVFSYPIQAYGVYSNGTLVKWGPTSMGKKA
AKTKTGLTFANWKKKLAISTVSSEWKLPYNFNIFNTDGIGWHQYDLPGYPASHSCLRLLL
KDAQWLYGYADTWVLNPGGATTKAKGTAVLVYGDYGWGKRKPWRKLLNDPNANSVSVEEM
TKMIEPNIEKILKEQDNREKVVDSIKAAKAILEQMPEDPKTQAP
>KALACAFP_00375 1,4-dihydroxy-2-naphthoate octaprenyltransferase
MKALYYKSSSLLSRELYIIWKFSNTNIFDAILLIITTSLTAWFYNESSWDSFIPTLFWSV
IFSFLYITTFTTANQLNSIDEDKLNKPYRLIPSGQLNQKQVFKRMIIYSIIYLLISLYLG
ILYISIGWLVLVYLHERFSFNHHWFTKNIVIMPLGAIVLHASAWEIVTPLEPKVWVFYIL
LSTWCALSMNLQDFRDQEGDKNIGRKTLPLLYGDKKARLYQALILFFISPLLYSSIILSQ
TGISEGFTRPFVIIVLIIQTLLNWFIAFRLLRYKTSKQDNITYHCWVIFYWFTIPLICFL
K
>KALACAFP_00376 hypothetical protein
MKKRPIFLLVLVALSSSVYAQVGIHTTTPKSSLDVSGKTDTLGNLLSTDITGLQAPRLTR
SQLTDKGDTLYGADQTGAMIYITDISGGDVLAQRVNITAVGYYYFDGNVWQKISMGNNVA
ATNWSLAGNTGTTAGTNFIGTADATDFVTKANGIEALRVIWDAANNATHLAVGTTTAATV
SSPTSGSTAEKKLAKLTVGNGDASINSITVGLGGGQVATNTVVGNSALNSNTTGSFNTVV
GGNALLANTTGARNTVLGHQAMLNNTTGGFNTAIGRISLQNNTTGLRNIAIGEAALTDNT
TGSGNIGIGITSGQTSGSFTGGNNIFIGKGSNTTMKVTSGTLNITIGDNAGTNIGAGSNN
ISFGTDSMVGVLDGSNQIQMGNFNVTSARVQVAWTITSDKRWKENITRIPYGLDFVKELK
PVAYHRINDKENPNKEMGFVAQEVEELIQKFGWKDQGFLTKDTNGYLAIRYNDFIPLLVR
AVQEQDAKIESQNTKIAELEALVKSLAAKIK
>KALACAFP_00377 hypothetical protein
MKKKCILFIVFTILTCSVKAQTGNVGIGTANPGSKLTVNGSFAAAYTSVTANTYNAGEND
FSIMWDGTANGTITLPASPTSPDRTGRLYFFKNASTAYNLTIEGNGSELIDKDLNTVIQP
GESVLLTKTNINTATGITYRVLSLAQSQQPYMYTINGDATQYVAQGSATQLTFSNVEYST
NGGGDFDPATSSWTCPQSGWYNLEVYAEVTSSTVYSTHTALILVKNGAIQQKLIAIFTPG
YTVNYIAGSGTGSQKLNLMKGDVISISATPCYGCGSDYTLFYTRKLNISRL
>KALACAFP_00378 hypothetical protein
MYNIKYQFVVQNYILSSIILKNACVIMPRHL
>KALACAFP_00379 Autoinducer 2 sensor kinase/phosphatase LuxQ
MSRFLITIFLFVIFQAEGQIASSWYDMDSGLPQNSIKDIIKDKYGFIWLSTDDGIVRYDG
LSFTPYNNLAVTNLHFEDFHGNISHDSIMIGNNNEENKILITKRNVYKIPQKNLNKVESI
LLKEKNGFKKRLVKNIGLEYYPGLQYFIKTKSGDYFFRKNEILYLEKKKVKQKISIPFSN
PDLSHVFVYNEVLYVTDPIKRHTYRIDKGKLSILKEPTILNDPSTRIFWQQISDQTFILN
NDEISLLQHDKNGLQLKFLVKYKDFGRQRFNCIFYDQHFNKLYLGSLTKGLNIIYLGNFF
TAQKKIPFVEEVARASLPFTRNTIIDVSGYELNKYGLVKNHYFDSDNKYFMQYDDSKNIL
FTKDSVLVRMRKSSQYKVRDTVSFIKTFCGIYEKDSLRAVSITYDLKYSYLYIYKNKHIK
KADCIFKFKGSVSSFLKYGNDLLVGHNNGLYRISLSHNTISQLASGISVKSIIQTPDKMV
WVTTNKHGFFLLKDKKLFKIPLDQNAYLSSAHYILADPYGYYWISSNNGLFKASKNLLLQ
SVKSKSPVFYYRFSKSEGLLTNEFNGATLPNAYSLDNGEFVFPSMDGFVFFNPKSIATYY
PDKKNIFIERARINNSKIINFKNHLVLENNYKQADIFIDIPYYSNSYNLRIEAKIEGEDK
DWQQIPIKDERKYTIKSLETGTYTLLLRILVSPDGSYEYKTISFEIKPLFYQTTAFKISL
GLLLLLIIIYIGQKRTKFLRKKNTTLKTKVNHMANELKETSKHLETVKNDMQKESEYRTR
LVEAISHDIATPVKYIALLSQKLNEEKDTDIQKEYFDTIHQSSAQLYSFTLQLKEYTDLY
RTENIFQTEKYPINEILITKKRLFDDIAKSKKNSIIIDDKNEAYSFINKNIIACIIHNLL
DNAVKYTDGGTIHLSAEEGSDFTSINISDTGYGMSDEQMIYYKQVFEHANEDDIVQFKNY
GLGLHMVIHLIKKINSVITFNKNIPHGTIIKIILKNTYE
>KALACAFP_00380 Oxygen regulatory protein NreC
MNNRILIADDHLVVSIGIVSILRSAYPNMVIDIAKSYPEAKNCLLAHKYDVIMLDIHMPG
TQYTQMIPEIKELQNDIKILIFSSFDQNIALQYIRKGAEGYLNKQCSEDDVKNAINTILE
TGFYYPPELIPIIMKGTKETTEVKNLTTREFEVFELLAKGNGNLEISSYLNVQVSTVSTF
KKRIFEKLKITNIAELIEIYKCLH
>KALACAFP_00381 hypothetical protein
MYYVYILYSLSRDVYYKGFSEDVEKRLTYHINSKGKYTSGTEDWKIVYVQSFESKTLALI
EEKRLKKLNRVSIEKLIHE
>KALACAFP_00382 hypothetical protein
MYYVYILYSLSRDIYYKGFSEDVEKRLTYHINSKGKYTSGTEDWKIVYVQSFESKTLALI
EEKRLKKLNRVSIEKLIKQ
>KALACAFP_00386 Thioredoxin
MALEITDSSFQDTVLKSDKPVLVDFWAVWCGPCRTLGPIIEEVAHDFEGKAVVGKVDVDN
NQEISMQYGIRNIPTVLIFKNGEVVDKLVGVAPKEVIAEKLSAHL
>KALACAFP_00387 Cysteine desulfurase IscS
MNKVYLDNAATTPLSEEVIDAMVGTMKMNFGNPSSTHSFGQEAKILIENVRRQIADYLHV
TPAEIIFTSCGTESNNMIIKSCVEHLGVERIISSPLEHKCVSESILDMKNRKGVEVSYIR
PNEKGDIDLNKLEELLKASDKKTLVSLMHVNNEIGNIYDIKKIAELCKANNALFHSDTVQ
TMAHMDLDFSDIHVDFASCSAHKFHGPKGVGFAFIRKSSGLKGIITGGPQERSLRAGTEN
VAGIVGLGKALELSLKNMEAYTNHMQDIKTYAIERLSAEIPGIKFNGRSAEKENSLYTVL
SALLPYKNPLIGLQLDMKGIAISQGSACSSGASKPSMVMMMVLSEDEMDHCTPLRISFSH
MTTKEDIDALVNALKEISKDFVIENTNVEHR
>KALACAFP_00388 hypothetical protein
MKKMLILCLGFIMSCTSTPSQKSSATNKNAEILVSESYGGGNEANFVIIKNEQELQKAIK
GNTAVIDLDKAPVYPQFPKDKKVILYNLGSFTSGDHKITKIKNISVKDNVLYVEVPQYQS
GGMEISVMSNPWFIFTVPSEYQFTSVQLKYSN
>KALACAFP_00389 hypothetical protein
MKKLYCFDFDGTLTYKDTMFMYLKFYDPTKFRLQFLKHVPLFILLKLKLAETEKVKKSFI
GAILKGQTQEKIEKKSRQFFEEHYPKIVRENALDFIQNIDRSNTQSLLVTASLDIWAKPF
ADAFQMQLVSTKAEFRNGVFTGNFIGKNCNGKEKLARIKTEIDGQKYDKIIAFGDTSGDK
PMLKWANEGHYQFFH
>KALACAFP_00390 Decaprenylphosphoryl-2-keto-beta-D-erythro-pentose reductase
MIVLGSTSEVAQAFVEKALQEGEKFEKIYLFTSSKETTERFARHIDVKFFQQAEVIELDL
TKEIDFTQFENINSNLLFCATGYLGEGTEEGLYDNKNTEKIIDINYSKLVPVMNYFAQKF
ESRRSGTIIGLSSVAGDRGRQSNFIYGSAKAAFTAYLSGLRNYLFDKKVHVMTVKPGFMA
TKMTEGLPLNPKLTATPKQAADCIFKAYKKQKNVAYVLPIWGIIMLIIRNIPEFIFKKLK
L
>KALACAFP_00391 Decaprenylphosphoryl-beta-D-ribose oxidase
MKPDFIQKVTNWGNFPIVEKEMKSDDSFKKIKEFILSNNEVIARGNGRCYGDASLGEHIF
STKKLNKFISFDRLNGIIECESGVLLSDVLEIAVPQGYFLYVTPGTKFVSVGGAIASDVH
GKNHHAEGCFSEYVIEFKLMIENGEIITCSREENADKFWATIGGMGLTGIILTAKFKLKN
IESAYIRQESIKAENLDEIFRLFEESESWTYTVAWIDCLQKGKNIGRSILMRGEHAFQHE
LPSNLKDKPLRLKKKFEPTVPFYFPGFVLNALTVKIFNLLYFNKQRSKEIKNFIDYETFF
YPLDAIHEWNRIYGKSGFIQYQMVIPKETGKEGMKRILETIANSGNGSFLAVLKLFGKNN
PEAYNSFPVEGYTLALDFKVNSKLKKLVDQLDQIVQEFGGRIYLTKDSMSRSSLTNYLKN
TQSSKFVSLQHKRIINNN
>KALACAFP_00392 Decaprenyl-phosphate phosphoribosyltransferase
MKKYFKLLRVEQWVKNLFVFVPLFFSGNIKNLDLLTKSIFAFIIFSLAASIVYILNDYND
IEADRQHPEKRRRPLASGAISKSQAIGIFIGLIATDIALVLFAEAYFHQSLWKFATIIGF
YFVMNLAYTFKLKHVPIIDISIIAVGFVLRVLAGGYITGISISQWAILLTFVLALVLAIG
KRRGELINAQVSGKTRRALDGYNVQFADIALSISVTLAIICYLMFTLSPEVQARFHERVF
YTVIFVVFAFLRYLQQTLVYNRTESPTKIVYRDRYIQVTLLLWVAAFLIQIYFKK
>KALACAFP_00393 Outer membrane porin F
MKFTKTYIGALFLSSALLLTSCEAVQNSNHQQRGTAVGVASGAVLGGILGNNVGKGKNAA
LGAVLGGIIGGVAGNVIGSKMDKQAREIKETLPGAQVERVGDGIKITLNESIVNFDFNSS
ALTSTAKTNLDKLAQVLTNNPDTNINIYGHTDNKGTDEYNMGLSERRANSVKAYLAGKGI
SSNRLFALGEGESMPVATNDTEEGRAKNRRVEFAITANEKMINDAQQGQ
>KALACAFP_00394 hypothetical protein
MKKLLLAGMLGTSLFAVSCSSVNNAKTAQNQRSEFLKMKGDWQIVSIDYDKQFKVKPFDD
GVDAQCFVGSHWRLIPNNWTGAYTLSGGGTCGAGYTQPIKIDVVSGNTFNFKKIMAGTKA
KQNTAGYTLTLTNQTTDQFSLEQNIPFDGENVRVVYNFERAGMK
>KALACAFP_00395 Subtilisin DY
MKKVLLAAVFLAGFGFSYAQEAKAGVDPKEDKDLMTWYHKDFGTSKVYGVNTENAYKFLE
SKGLKPKTVVVGVLDSGVQVDHPGLVKNVWSNPNEVPNNGKDDDGNGYIDDIHGWNFIGG
KNGDIDIDNMEVTRVVAKYKPVFEGDDSAKNKANQTKMPEEFAMYMKAKDIFSKKSVEAR
QGFQTYTMINDAIPTMVRLLNGKALTPENVAAIKPTEQKDAMAVQVLSQVAQSPEFKGKS
AAEFEKTMKEQMKEALDYFGPQEKQYNLDYDPRKEIVGDNYDDYSQKNYGNNHYEGPDAE
HGTHVAGIIAGLPQGKEIQYGVASRVAKIMSVRTVPNGDERDKDVANAIRYAVDNGAKVL
NMSFGKPVSPGKNVVWDAFKYAQDKGVLLVKAAGNENEDVAEHIAYPTNFKNVTDEKPFV
NNVLVVGASTNKNDALRASFSNFNKKMVNVFAPGEEIYSTVPHNEYKYLQGTSMASPVVA
GAAAVLLAYMPNLTPAQIIESLVKSSNASTTNQFGDFSQAGGVIDLEKAAEYAYANFYNG
KSGAVKKAEKSVKKAVKK
>KALACAFP_00396 hypothetical protein
MNNVLLPVFYLPPISWFSVFLNPENEIVFEQFESFPKQTYRNRTNIYGANGKLSLIIPIQ
HNGKRELKEIEISHREDWRNLHWKSIKTAYQSSPYFEFYEDKFRKIFDLKEKYLLDFNLK
GLEIIQQILKTEKAHSLNVEYIKNPEEINFREKFSAKLPSEFEMEEYYQTFSDKLGFLND
LSILDLICNKGQESLTYIKNIKQSY
>KALACAFP_00397 Signal peptidase I
MNYFLTYTVYVLILSVLMGISTWKLFKKLGYSPLFAFIPFYNYFIILKETKHPKWWAILS
YLPIVGPIMMSVFHLYLMKKFGKTLFKDQLLTVLLPFIYMATVNYGKDVELEDENELFLT
DEEKNAKKKDSFLGSVTFAVVFATIIHVFVTQPFGIPTGSMERTLLVGDFLFVNKWSYGY
RLPMRPLAIPFLQGTIFDSGEKGNPKDDPKSYVDGIKLPYERILQFNKPQKHDVVVFNYP
QDSVHTAIDRKDPYVKRCVAVAGDTFEMRAGRLFVNGKPETILGDQEIQHAYTVNTGAQL
DIPGLYNIYGFLPVREMQNDKGGFTYMFQGLTDKTAKEIKALPNVIDMEENIFPKDSATV
SYKLNADKTAYTKSIDTTQSIFPINKPWNQDWYGPLKIPKKGDVVTINQETLPEYQWIIS
EYEHNSLENKNGKIFINGKETNQYTIKQDYYMMIGDNRDASLDARFFGFVPEENIVGKPM
FTWMSIEGAFKDSGSSYQADGWRIRWDRMFKATNTGEANKTSYWWIAAMILILFFGWEYF
MKLFGKKKTEDDI
>KALACAFP_00398 4-hydroxy-tetrahydrodipicolinate reductase
MRIALVGYGKMGKIIDEIATKRGHEVVARLKETPTVENLNNPDVVIEFSLPEVAFDNIKA
CLENKIPVICGTTGWLEKKPEIEKLAVENETAFLYGSNFSLGVNLFFALNEKLADLMKNV
DEYSCQLEEIHHIHKLDAPSGTAISIAEGIFKHNPKFDAWKLEETQDNQLGIFAIREDEV
PGTHSVFYRSEVDEIEIKHTAFNRNGFALGAVVAAEWIKDKKGNFAMKDVLGL
>KALACAFP_00399 hypothetical protein
MKKIFFTFFLCLFAIAYSQVNPNDTIRVEHHPKDSVSVEKNNTKTEAKIVSDLEKANGPT
KKTLKLNPTKAGLYSAVLPGLGQFYNKKYWKIPIVWGAVGTGVGIAVWNDKQYRKYREYY
IAKLNGTPNEFVDSHPWLDKVALGNAQDRSKRQRDYAIAITGLIYILNIVDAVVDAHLYE
SRHDPDLSFNPTVIQDQYGFTPPKTGLSLSYRF
>KALACAFP_00400 putative chromosome-partitioning protein ParB
MKDKKRAMGRGLGAILSAESKATINSATDEGADKFVGNIVEIAIEDIYPNPTQPRTYFDE
KALNELAQSIKNLGVIQPITLRKDGEKFEIISGERRYRASKIAGLESIPAYIRLVNDQEL
LEMALVENIQREDLDAIEIALTYQRLMEEIGLTQENLSQRVGKDRSTITNSIRLLRLNPD
IQNAIRSGEISAGHGRAIISLENEEHQQILFDLIIKEKLNVRQAEQAATALKNPKSPAAK
KAKAELSNNYKRAQKTIADILDVKVEIKTSGNGKKGKIVLDFKNEDELEYILSHIK
>KALACAFP_00401 Sporulation initiation inhibitor protein Soj
MAKIIGIANQKGGVGKTTTAVNLAAALGVLEKKILIIDADPQANATSGLGVDDVQYSTYN
LLEHSIDTKSCIKKTATPNLDIVPSHIDLVAAEIELVDKEDREYMLKKALQTVRDDYDFI
IIDCAPSLGLITVNALTAADSVIIPIQCEYFALEGLGKLLNTIKNVQKIHNKDLDIEGLL
LTMYDSRLRLSNQVVEEVNAHFPEMVFETIISRNVRLSEAPSFGESILNYDAESKGAIQY
IQLAEEVLLNNENLVKN
>KALACAFP_00402 hypothetical protein
MKHIHQNQEFRFNEVLFEHRNKEYGAYVLRNESDKILTKALFIGVSLLAAISVTPVIINA
FKSTEIPETGTVFILPPPVDVTTPEKDPPAQVKPQPAPDVKTYDDRLPEPRKIVTNEKNV
TPEEKLNAVASTQTSAGKEITTPTYVPTTPTIGTGPVINTAPPTVVPKEDPNKIVDAKDL
GKEAIFDGGIDSFRNKVMNNFDGSGFDSGDVMKTTITFIVEKDGTISGIKANGNDADFNN
EAIRTIKSIRGKWAPAKNKQGEIVRSYFKFPISMKFDN
>KALACAFP_00403 hypothetical protein
MPTTTLTQQARSNSLMSMLLKQVYDSITNGGDPDSIGPNDFIAFDPIGLTLTEDTFDYAL
NGLFGNAPAPKPMLDGQGKPILDANGNPKTNMEEFQNAMKESKFRKYLQMEQFSAMVDAI
PSNLPPLTDNGNGRQITIFNDSSKRVSKVYEDLMQWSVVVDTPVDPKVEKNLEKLRNKLF
KVKVVKNPDFDENAPVDDLNKPELHQTFVAPMYSKYIEYQMKYYDIVDANNSIRTDADNG
DPDAMAKLSIDGKNMKKREDAALKAWQSLGYKEAVERIQNYLSEIEEKHMLVIKKRLQSE
FRNSQRTRVVDYTNYSPSIPISANALKESKGWPTISMYEGEANRDYSKTIHNWSAGAGFS
LGIFSIGATNSGSTERQSLNTDFSNIRISFKLGKVRVERGWFSEEFVESKYWKLHENSPQ
TLNGDIISDGKGKGLMPMIITELIIAKDVMLDFSENSTAFKAASTKVNSGAAVGIGPFVF
GGSHSYQNQNSQSNAKWSGKKLQSDGIYIIGYKCHVIPKSPNPNPEIKVWTHGKS
>KALACAFP_00404 hypothetical protein
MKYFVAVYQKLRNIYMSQSSMENDLPMICPSLRVYENEELELLKPQSLLNDDQKKALSII
KKQNVAYELNSVPISPNFWDLNPNNALFDIYRDILEKNSLKNLEENLDKAATSQSTILFD
AKGGDTKELKAYKKYQTAYETTANNIAAHLELFDALDTDEEKTNWNDKLITLNNLKALAF
SEWKVKGSKDIIEKELARINKNSDADLYLAMAQNAKNTFEAAEKTDVINNSSIHDINFIP
YDFMENESGWNSIRLEKSELEALHTEAKNSNENLPSEILSIDYDESVIQAVEFDYSFVHL
KRNWFNKNFMLSEIFEWKEPKKISDGQTISSEFKLPAITKTMMLAKNLKIILDPSITNDT
VNNPNQLIYFGPLIMKQQLFVNKSNNQKFLKAVTNVRTIKSDQLNTLTRKTITAESVKIP
TPDVAPKPVAQPVTETPKVNPVFANKINMSVLGSVRNLRPVATAPHPATPVQPQPAPVKP
VTPVVGTPIRVPGIFVPIRVPVVVQPTAANVEFKVFDKINNDPIYKCAISIKGTNNNRIF
EIETNEIGMISQMIPVGEYSIELRVDDYAILNQKFSVTNTNPLNLEYKLQREEVKFKSFF
LIGMICERMPKIPIN
>KALACAFP_00405 hypothetical protein
MKLLKYYTKSPEVTTLCELLYKQGYNIKISDSFSLEVDAAVKDFQRKNSLVVDGIVGMKT
WTVLLQKNSAPAPSNTADKFLKESDLISFADQYGLELAAVKAVNEIESSGKGFLLNNKPK
ILFEGHIFWSELKKRGIDPNSYYNANHKDVLYPKWTKIYYQGGVKEYDRLNEAMTLGADP
KFKDAALSSASWGSFQIMGFHAKPLGYSDVTDFVSKMELNEGEHLKAFGRFLEVNRILVH
LKNKNWASFAKAYNGSGYKLNKYDEKLAKAYAKYSKN
>KALACAFP_00406 Adenylosuccinate synthetase
MSTYVVVGLQYGDEGKGKITDVLSAKSDYVVRFQGGDNAGHTVYVGDEKFVLHLLPSGVL
QCKGKCIIANGVVVNPKSFIKEVNQIESKGLRTDHIFISRRAHVIMPYHILLDTYREEEH
GGTQIGTTKKGIGPCYEDKIARVGIRMIDLLNPEILRDKIEKNLKIKNSLFEKYYGKPTL
DVEEIYNEFLEIGKQLQDRIVDTELELNEAIQDGKNVLFEGAQALMLDIDFGTYPYVTSS
SPSTGGVCTGAGVPPTSLQNLIGVAKAYCTRVGNGPFPSELDNELGESIRQIGGEFGATT
GRPRRTGWLDLVSLKHACMINGINNLVITKLDVLTGIETLKIVTHYKTEDGKIIDYFTSS
TEKLYNYEPIYQDLPGWNEDLTKVRSYDELPDNAQKYIEFIEKYLGINVYLVSVGPERSQ
NIIRKELF
>KALACAFP_00407 hypothetical protein
MNQSQKHHSLPVFYLKGFTEKNGQFKIFNVQRKEFKQKGKYFSPSTHFYILKDNTITTDF
GEDDFMEKLYEKIDNNFAKILQIINANNYENKFGVNENDMPYINNFVSQIYWRSPFNKNI
IQDYIKKYKLKELGLKIVDNQGNHNEELSERFKNEPEFYKTYKLYNSLLDSIRGSNCRTQ
YHIFGRPKELPSICSDFPIIFNKNSAIKVYEDDYIFPLSQNRIFVKRNLTQKFNHQLHYL
IDLISLKQSINYVATSDESYIDFLIKLDKENNCTIEEIYLTNLYKILIQF
>KALACAFP_00408 Antitoxin ParD1
MAKNTSILLGDYFDNFINQQIKSGKYSSASEVIRTALRMFEHEESKKSELINELKKGEKS
GFAENFDRKEFLKNLHQKHSAE
>KALACAFP_00409 Toxin ParE1
MKYKISKEASNDLEKIWLYTFEIWSKEQADHYFDLLMDEIEYLSENPKSGKDYSEIRKGY
FRSRVKSHFIFYKINIKNEEIEIIRILHQQMDISSRLDE
>KALACAFP_00410 hypothetical protein
MINEEIIQRIEINIQNFKDNFKNDYKLLSVASPKSIENFESKFAVKIPDDFKWFLLNISN
GIVNTEQYGFNLIDRIDFSDYYYLPDEFNPSLPFKLNDDFDFETDEYDDFINGTIHLAGY
GCGCYSFIVVNGEEYGNVWIDNYASNSEVSPIKSELKNRLNFHEWLDEKINSMISQKNEK
ENFRQKQLQEEKKQVHQHYEKLKSDFNGKASNVRLSIFEKIKQIFK
>KALACAFP_00411 hypothetical protein
MNKQLKTLILLLLPFFFLNAQNKITEYLNIPGPIMLDSKTYQLVWSSHPNENYFKQEYLS
SNENLQKYNTMVLIDFVKGNFEIKDAINQKVTELEEIKKTNPVVNYQVFENNGEYILDFL
ITENSKDGKEILIAERNVYRYKLINENNNKGVMLFAVSERGYKENMEAFFNNLKENSTKL
VEIVGNYKLPDIKIK
>KALACAFP_00412 putative ABC transporter ATP-binding protein YbiT
MLFLQNISFGFPAGNLLFNSINLTIQTHTKSALVGSNGMGKSTLLKIIANEIEPLEGNIH
IQGDIFYVPQMFGNFNDLTVAECLKIDKKLEALQKITSGEVDEVYFETLNDDWDIEERCQ
NALQYWKLENLKLNQKLESLSGGQKTKVFLAGIQINQPEIILLDEPTNHLDLEGRNLLYD
FIEKTSSTVVIVSHDRTLLNLVDTIFELSNQGISIYGGNYDFYAEQKEIENEALQNDIHS
KERALKKAKEKERETLERKQKLDARGKGKQEKSGVARIMMNTLRNNAEKNSSKLKSIHAE
KINDISGDLRDLRSSVRNSDQMKVNFNDSNLHSGKILISAEEINFKYNEKNLWKENLNLE
IRSGDRISIKGSNGSGKTTLIKLLLGDLQPSVGMISKSDFQMIYIDQEYSLIDKNATVYD
FAQQFNDNAMQESEVKTLLSRFLFGKETWDKKCGVLSGGERLRLLLCGLSISNKAPDMII
LDEPTNNLDLQNVEILTNSIKDYHGTLVVISHDGVFLEEIGVSGEVSLD
>KALACAFP_00413 Hypoxanthine-guanine phosphoribosyltransferase
MESIKVHDKTFVPYLQDAEIQEIVKETALKIYEDYKDEVPVFIGVLNGVIMFFSDLLKHY
PGNCEIAFIQMSSYAGTESTGIVYQKMELTKDVKDRHIILVEDIVDTGNTVESLFKYFNE
TQRPKSVKIASFLLKPEVYKKDFKLDYIGKEIPNKFVLGYGLDYDELGRNLPNLYQLAEG
QINH
>KALACAFP_00414 Adenylate kinase
MINIVLFGPPGSGKGTQAQNLIEKFNLKQISTGDLFRFNMKNDTELGRLAKSYIDKGELV
PDQVTTDMLIDEIRKPTDAAGFIFDGYPRTAVQTEALEKIVKEELNDEIDVCLSLVVEDK
ILVERLLKRGEISGRSDDSNVEIIENRIKEYYAKTAEVAELYKQQGKYVEINGVGDINEI
SEKLFAEVEKVK
>KALACAFP_00415 GTPase Obg
MSNFVDYVKIHCKSGHGGAGSAHLRREKYIPKGGPDGGDGGRGGHVIMKGNANEWTLLPL
RYTRHVKAERGENGGKNQLTGAYGADVYIEVPIGTIAKNEEGEIIGEILEDGQEIILMEG
GMGGKGNEHFKSSTNQTPRFAQPGMDGQEGYVVFELKILADVGLVGFPNAGKSTLLASVS
AAKPKIADYAFTTLTPNLGIVDYRNYKSFVMADIPGIIEGAAEGKGLGHRFLRHIERNSI
LLFLIPADSENHFQEFKILENELKEYNPELLDKDFIISISKSDLLDDELKKEIAAEFPEN
KQPLFFSGVTGEGLVELKDAIWKQLHG
>KALACAFP_00416 hypothetical protein
MKYLLSLCAFILFFSCTSQKSTSKYSKIEYEATPCFGFCPVFKMTINPDRTAVFEAEHFN
FNDKPSKDEFSKPREGTFKGTIKQEDYNKLVALLDGLDVKNLNDKYGEKNVTDLPSSHLR
INFADGTSKHVEDYGKHGSEKLSEVYKFFEDLRKNQQWTKVK
>KALACAFP_00417 ATP-dependent RNA helicase RhlE
MNFTDLQLIEPIAKAIHEQGYVNPTPIQEKSIPEILKGKDFLGCAQTGTGKTAAFAIPIL
QNLTKNKTPNKNIKALILTPTRELAIQIEENIKAYGKYLPLKHLVIFGGVKQGNQEAALK
KGVDILVATPGRLLDFISQGIISLKNLEIFVLDEADRMLDMGFVHDVKRIIKLLPQKRQT
LFFSATMPAEIQKLADSILNNPVKVEVTPVSSTAETIKQSVYMVEREDKINLLVHILKND
ISDSVLVFSRTKHGANKIAQKLQKSNISTEAIHGDKSQNARQNALNNFKSGKTRILVATD
IAARGIDIDELKYVINFELSDVSETYVHRIGRTGRAGAEGTSISFVDGLDLLNLKNTEKL
IGMKIPVVKNHPFHTDDLVAQKRDSNNKPTAAGSGRTPSSNAPRPQKNKKKPGASTPAVG
FKKPKNKNFTRKK
>KALACAFP_00418 Ubiquinone/menaquinone biosynthesis C-methyltransferase UbiE
MMKATISKILRQTRLLFLADKLRFYIQKYKNQAKNKSFQSSHKEFVFPPDYLMYESFNIS
YESYYKSGKAAAERFIKSFRKYNSAENVKVLDWGCGPARVVRHIPGIVPNGSVYGTDYNQ
NSIEWNKKNIADVDFNLNGLQADLPYEDSFFDFIYGISIFTDLSEQLHYEWKNELTRVLK
KDGILLLSLQGNLFKTILTDNEIRDFENGNLVVRGNVKEGHRTYSAFHPENFVKKLFSDY
EILEHTDSFINNNGKPEQDIWILKKK
>KALACAFP_00419 putative metal-dependent hydrolase YcfH
MIDTHTHLYAEEFDEDRKEMIQRAVDKGITEFYLPAIDSESHEKMLQLEAEYPNQIFSMM
GLHPCYVKPETWEKELEIVKDYLDQRAFPAIGEIGIDLYWDKTTLDIQVKAFEQQIDWAI
EKDLPIVIHTRESFDETFEVLERKKHPKLRGIFHCFSGNLEQAKHAIDLNFILGIGGVVT
FKNGKIDQFLHEIPLEKIVLETDSPYLAPVPHRGKRNESSYLDLVAGKLVNIYGKDFSEI
DRITTENAKNMFNNK
>KALACAFP_00420 hypothetical protein
MKFRTEVEIKESKKKIEVEDKIFSIGSCFASEMSDLFQQGQLQTVNNPFGTIFNPFSINN
SIKKLHDSEFYKEEDLIAFSDEYISLDHHTSFDTRYIHQTLNKINANIVEGNHFLQDANW
VIVTYGTSFIYEFIPKQKLVANCHKIPQKFFEKRLLSQQELTDSIYDTILNLKDICKDDV
QILFTVSPVRHTKDGMVENQLSKSKLITAVHDIISQFENCHYLPVYEILMDDLRDYRFYK
EDMIHPNNQAVNYIFDTFGNAYFSEETKDFIKENFKINKALAHRSDDEKDPKYIEFKEKL
NQRIEAQRQKVKHKIFNSYEL
>KALACAFP_00421 (2E,6E)-farnesyl diphosphate synthase
MEFLDRYQQIVADAIGKYTFKDKPAELYEPMNYIISHGGKRLRPIMVLMACDLFGGDLKE
AIKPALAIEFFHNFTLIHDDIMDEAPLRRNKPTIHTLHGINVGILSGDGLMLKAYKFFED
LEPEIFKACIRIFTHTGLLLCEGQQYDINFETQEDVTFDDYIRMITYKTGVLSASSFEIG
ALIAKANFKDAKAIFNFGKHIGIAFQIMDDYLDVFGDQAQFGKKHAGDIYENKKTVLYLM
AREHATEEERKELDYWYSKKTDNIDKVYGVEKIFRRTKVDEKALRLIEKHNEIGQSYLQK
IDIPEEKKKPFAELANYLLRRES
>KALACAFP_00422 hypothetical protein
MKIKLGTLLFLVVNNILYSQSNTLKSQYEAIYRIKSFDDTLSKNNAVEENLSLLIKDQKS
LFRSTQKAISDSIAMSIGKKSVENAINGKVVVDMRNVPRTYFKSEVFSDNGKQTIYKELM
RNKFSFPLEDPIQWKVGSETKMIESYLCKKATGKYKGRHYIAWFTESIPIPDGPYVFKGL
PGLVLEVYDPNDNIHFTMISFKKVVKPMTLMKDVFATKYSTFYKARQNSIDNAAGVLSNQ
TGITLKPVDIARINSNAKRVNNYLD
>KALACAFP_00423 Low-affinity inorganic phosphate transporter 1
MEFPVLLIVIIALALIFDYINGFHDAANSIATIVSTKVLTPFQAVLWAALWNFAAFFLAA
YVIGEFKIGNTIAKTVNENFITLEVIFSGLVAAILWNLLTWWFGIPSSSSHTLIGGFLGA
ALMHAFMMDYHDVAAAQPALGFWDTCKEAFNQVTHQSVVKFEKVIPIFLFIFLAPIIGMI
ISIIITLIIVHLYKKSNPHKADKSFKRLQLVSSALFSLGHGLNDAQKVMGIIGAALIYYH
VEMLHDPIYLDIPAAGRFDYFAEHYLWVPLVSFLAIGLGTMSGGWKIIKTMGTKITKVTS
LEGVSAETAGAITLFITDHFGIPVSTTHTITGSIIGVGLTKRISAVRWGITVSLLWAWVL
TIPISAIVAGVTYLLVTFLT
>KALACAFP_00424 hypothetical protein
MGIGNIFHAFQPKDKIFFVLFEKVTENLVAMSEEFNHGIKDFDLNDDSMLKKMSDYEHKN
DELTHEIFVELGKNFITPFDREDIHTLATGLDDIADYIYASTKYIFLYKSPEMKAYSDFS
LLIHKACLEIQNAMKNLKGFKNMEQVKEACIKVNSIENIADDLLSNSMVELFETNDAINI
IKVSSVLNYLEVVTDKAEDVANTIENIMIKYA
>KALACAFP_00425 ATP-dependent RNA helicase DeaD
MNLFTETNLSPDILKAIGELGYESPTEIQKQTIPFILSDIRDLIALAQTGTGKTAAFSLP
ILDMIDDTSRKIQLLVLCPTRELCLQIAKDIKNYSKYMKDIKTTAVYGGSSIMEQMRSLK
DKPQIIVGTPGRVIDLINRKALDFSAIHWLVLDEADEMLSMGFKDELETILSETPETKQT
FLFSATMNKEVERISKNYLTKPHRISVGSINEVKKNIKHEYYVVGYRQKKEALKRLIDAN
PNQYSIIFCRTRMETQEVADYLMQNGYAADALHGDLSQAQRDTVMKKFRLKNIDILVATD
VAARGLDVNSLTHVIHYSLPDDPEVFVHRSGRTGRAGKDGISMALIKPEESRKLKQIKFS
TKIDIVENIIPSGEEIIKAQVGGVFESLFEVHEDFFEFDDSLIPDLSAFSKEELVHKLLQ
FQLKDLALYYKDRHDLIEQKLSTRDDDPRRDRRDRDRGRDRDRERGGDRDRSAKPRRRNE
NMVRFFFNLGKKDQLKKLDVLDIINKATSGKGKKRAEIGDIEILEKFSFFEVEKSFKDNV
LSNIGSMKFKGKEMRAEVAN
>KALACAFP_00426 hypothetical protein
MQAILSPKVFEFLKKLTKNNNREWFTENKNLYTESQENIVSFLEDLIREMSEFDEELGKI
DAKKSLFRIYRDTRFSKDKIPYKTNFGASLGMGKGSQKGGYYLHLEPGKSFIAGGIYMPE
SSVLKEIRKEISLYGEEFLAILNNKDFKKHFPELDQDDKLKKVPMGFEKEDPMGEYLKLK
NFIVVYSLKDEEVLDKNAVKNLAKVFKLMKPLNDFLNAPFL
>KALACAFP_00427 2-O-methyltransferase NoeI
MSLYRRIAETLQYISPSFYKKRYFKKLNNLNKDNFSAKNVEPELVWIKEYLPKNAVILDI
GANVGTFLYQLENKLNHEHIYGFEPNQKLYRRLKRLFPKMRILPLALSDENTTAEFKVPV
INGKIIASRGTLNTSYKEKGEEMSHTEKVKVIKLDDWAAIEHFKRLDFIKIDVEGNEMKT
LFGARKVIEQFAPTLMVEMEQRHHETPIWNEISEVESWGYEAKYLNRNTFELEKITEEIL
LKNINDEKNKQEYINNIIFIPKNH
>KALACAFP_00428 hypothetical protein
MSVVARQGFKYSIIGYVGFLLGTISAIFIFPNDFEFYGKLRYILPSAEFLVPFVVMGISY
SNVKFFHTVEKDGKEQNMLSLSLLVIFVNFLIFLLIFFLLPYFYPKFRYSEAWKAKEIIL
PMVLILSFCAIFNKYTSNYKRIVVSNIFDNLFPKIANLGAFCLFFYFALSQNIAFAFFFG
MFALMLFGYIYYTNTLKKINLDFSTDYFKKDGFWKEFFNYSFFGFLGTFGNYLAINSLMI
GEFMGMEENGIYAVLYALISLISIPQLGLFNVSAPIISKNLADGDMEGLDKFHKKTSLTL
YFLGAVLFSCIMVGFPFLTQFMPKNGVMLREYEPVVWIWGSAVLVDLATGFNGNIISLSK
YYKFNIVVMLLLAGLTISLNLYFIKNTDLKLIGIALSTAISLTTYNVIKIIFNYVMFKVS
PLTIEMIFVSIICTLAITVAIVLPNFTNNFINLIYKPAVVLLLIFIGNYFTKVFPIEDYL
NKNFIKSILKFK
>KALACAFP_00429 hypothetical protein
MKKIAYIEIDTHAEIAQSFMDIMQDSQKFFVDFYLSEKIRNQVNDGENIFLSDSSMILDQ
LKNKAYDLVIIGTLHRYFNTFQVITQKYNTAVIVHNLNFTRTSGLRLVKNIFKADIIYRL
KLWWKEGLFNASKIYQETKNVLVLDEALSSERFKFLPIFYTQNFERSENQNFVVVIPGGV
SQKRRDYDHIFNMIQNLKTDEKYEFIFLGKAKDHELKKLEKIAIQLPSNVDVTYFSERVS
QKDFDFWMRKANVLWCPIQPETEFFSQKEIYGKSKMTGNLGDAIKYGKLAVFPENYPCQL
DFIIPEKQDILKQFQELKNKDFDFQLKYNKNTVRENLEKVLNSLISI
>KALACAFP_00430 Poly-beta-1,6-N-acetyl-D-glucosamine synthase
MRFLIIIPAHNEENNLPFTLNSLQQQSFKDFKIVVVNDGSTDKTAEVIKKYIDNDTRFET
INLEKSAHQPGSKVVNAFKNGLNTQNMDEFEIICKFDADIILPENYLEILEKSFKSNSNY
GLVGGLLYIEKNGDWVYEGNSNKHHVRGPMKAYRKESFLQMGGLRETLGWDNIDSILLEN
LGWKEVVLPELHVKLIKVKGADYTIRPAEYYGKYFYFLGLNRFLAYIAASKEAMKSKSVS
FFFTIITSYENCRSQKLELKISKEEQEVINNQRWNMLKKKWLKM
>KALACAFP_00431 Aspartate ammonia-lyase
MENFRKESDLLGELDVPMNAYYGVQTQRAINNFKISGQLLSSYPEFIKGLAFVKKAAAKT
NYELGLLDENLYFKIAEVCDEIIAGQLHEQFPVDMIQGGAGTSINMNANEVIANRVLEKL
GKNKGEYEFCSPNDHINLSQSTNDAYPTAIKMGLLQMNTSLVEKLEKIVDAFREKGKEFQ
DVIKMGRTQLQDAVPMTLGQEFEAFAATLEEDISKLNNNANLFVEVNMGATAIGTGINAP
VGYATLCAKNLAQLTGFPVISAPDLVEATPDTGSYVIYSSAMKRLAVKLSKICNDLRLLS
SGPRAGLSEINLPPMQPGSSIMPGKVNPVIPEVVNQVCFKVFGNDLTVTFAAEAGQLQLN
VMEPVLSHAIMENIHFLGNALDTLREKCIKGITANKDVCLNMVKHSIGIVTALNPYIGYK
QSTQIAKEALETGKSVYNLVLEKGILSQEKLDEILDPKNMLKPQTNKINDER
>KALACAFP_00432 N-acetylmuramoyl-L-alanine amidase AmiD
MRKTLYIIGLSALVFSCTSQQNSKKRQYIPRTPVVKPKTAVKTTTTEKPKPQITNDHGVE
FFTTNIADPTKNDNTVSYGSIVSAKPAGYKVVKTYFPAIAQNFRQKYLILHYTALPDDKS
ITVLTQQAVSAHYLVNNTGDNEIYQLVDENKRSYHAGVSAWRADKNLNDTSIGIEIVNMG
YTADSIGKRVFVPFNDAQVKKVAALAKDIITRYQIPPTNVLAHSDIAPTRKQDPGPMFPW
KKLYDEYQIGMWYDEAVKQSFYDLATSTDFQLKYNDPSFIFNVQTQLQKFGYALDLSGKW
DDSTKKTIEAFQYHFRPQNYDGIMDAETFSILQALIQKYPVK
>KALACAFP_00436 hypothetical protein
MINVMNVYGFSTVCNDFAVYYLSNRGLKKLILSQYKGAS
>KALACAFP_00437 hypothetical protein
MKKKVISMLILVIGLTEISAQIGINTAVPQGSLDVAYIASKPTTAQGIIFPKLTGDEIQQ
MTVGAGQNGMFVFATSVPTSPIPRTSLITESGLYYYYSAEDKWRNVNQVISPSSLFSTTY
RNSTMSISAYSGGSGATDYNSGQVSSLRFVNGTEIPFNSTSYIAVRTADNNRGIRFLKSG
IYNVTLQFSFVYKRDVTGDGANDPALTDRLGSQVTYQLIPNFLASPTSAYTTNITHNVDY
NGVRQGSGLFRLSGIAVGNIIVKQDNVVEFVPEINTSGYWISTEELAIGNTGLLNMHIIR
VSDYNP
>KALACAFP_00438 hypothetical protein
MIISEDLLIANGAMPESYLAHEVIFKEGTMPGLTFRL
>KALACAFP_00441 hypothetical protein
MKNLFKLHGGFYLLLIALCFTVVQSCSTDENENNNSGSIGKTQTTQSSKIGGRVFDLTFS
IVEKDNVINYANNMSEEEKLEFIKESENSGYKLTANDEFVVNRFAEYYVKDDFDTAIKKL
QEDILTLDLDDAEFARYNQFVNVMIIMEQHEVEKSTTGKINKRAIGCAVAVAANAVSTLG
LYACAVPTPALPAGCGVAIAGKLLSYAGMLLC
>KALACAFP_00442 hypothetical protein
MNAYIKKILPVFLLGAMAAHAKGQAAGTPYIPMIDIPFSFLYGGASIDSPRTHALSLAAD
GGYFGVGDSQSSASGDVTGVNGGNRDNWVIKWDTTGKIAWQRLVGGNGIELGTSITATPD
GGCIVVTRSGSTNIPGTTFHGGQTDLLAAKLDASGNIQWQRLVGGSGNDEPSKVAIASDG
GYIIAGVSYSVDGDLTGIPKYTGGAFGTDAWLVKLNTDGTINWQKRYGGTDEDSFGGIIA
TNDGGYLVTGTTSSGAVGDFTGLPVFAGPNPFIMKTDALGNRIWIKRFGVSAAANPYILD
TRQTSDDGYILAIRTAGSNTGSLTGIVGFGGNDFWIMKVDATGNLITQKVFGGTGSDTPS
SIYQTSDGGYIVSGGSASSNTGTLTGVISHGGNDSWVFNLDSSLNLVQQKLYGGNGNEGT
TGAYLLPLSSENSYLLLSDSGSSNNGDVTDLNHAAGSGDYWLLKLFPSGDIVWVPDTGQR
>KALACAFP_00443 hypothetical protein
MRKFLLTLTLPFFGIVSAQSGNIGLNTANPGSTLDINGSLAAQYKTVSASTYAMTSSDFY
IAYTGTTNSVFTLPTAIAGVGNFKGRMYTVKNNTAFTVTINSAAPETINGSAGITVPAGQ
SVELISTGLTGAVSAWELSGFRSSAFPLTTASNGLNAVGTDVRLGGTLSQATDIATAGNN
LIVSGTGNVGIGSVAAPVSKLEVNGSSTNAVSYNAAAATTIDFSRSNLAYTTANPGAFTL
QNVKDGGTYTLSVRGATAGTSTFTATGFTVRYINNRTTVANTHTLYTLVVIGTVIYVYIA
TAV
>KALACAFP_00444 NADPH-dependent stearoyl-CoA 9-desaturase
MSQKVKFSSVSGSHFYATVRSRVDQFFSQHQLSQHANAHMWGKTIFFLTGFTGIYLIIIS
GLLPTWMLLPLAALLGMFSAFVGFNVCHDAIHGSLSGNKKVNKVFGFVFNLIGANPYVWS
ITHNVVHHTYTNIPGHDEDIEVAPGLIRIAEEDHVNRIQRYQHWYAFPLYSLASLSWVFR
KDYVKFFQKKIGAHQSKHPKLEYFNLFAYKGLYYFLFIVLPLLILDVSWWQFLIGFLLLH
IAEGLTMGLVFQLAHVVEGTNFPVPNESGQIEEAWAEHQMHTTANFATHNKLAAFFLGGL
NRQIEHHLFPKVCHIHYGKISVIVKKTAMEFNLPYIENKSFLSALRSHFITLKKFGKEAV
N
>KALACAFP_00445 hypothetical protein
MKSLFTIVFLLIIQIFSAQEEVYANGIFNFEENKAQKIFTDWTRVRQEPNINSTIQDSLQ
TNQQILILKKEEKVLQLGERSANWYKISYQKGDKTSEGYVWGGNLAIGYRNKNGYDFLFG
LTKTVDRKDKQFNQNVRQNVASIKVVEGNKLIDEVSFDTGSGESLNFGSFTIESNHKLKN
VEFTLKAAVSGEACGVAGYDQYVLFKDKKLIALPQLMNVGDADVYYHTEEFIFPNDKGGI
PNAFIFKMEEMEKDENDKEKKKSASKTYLWNGNSYQLK
>KALACAFP_00446 Ribosomal protein L11 methyltransferase
MQNYLEFDFKISPLQPWSDILMAELIEIGFDSFTEELEGILGYIQKDLFNEEELKALPLF
QNEEVKIEYTFQEMPNINWNEEWEKNFEPINIDDKVLIRAEFHESVPGMHEIIIQPKMSF
GTGHHPTTHLMIQQMMDIDFNGKKVLDMGCGTSVLAIYAKQIGAGDTKAIDIDEWSVENS
KENATRNSVELDIELGTAENLGKENYDIILANINRNILISDIPTYVSVLNEGGKLLLSGL
CFFDVDDILEVCKENGLELKKQLQREEWVSLLLEK
>KALACAFP_00447 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MNINGKNAIITGGGRGLGKAVALALANEGVNIGITGRNEENLKMTVEEIKDLGVNAFYAV
FSMDNEIHVKAGIESLAEQLGGIDILINNAGIGDFGSIEEMPSETWEQVIKTNLFGVYYA
AKAVHPFMKAKGEGDIVNVASTAGLKGGPNMSAYAASKAAVVSLSQSMMAEWRKQNIRVI
TLTPSTIASDMSIQGGLTDGNPETVLQPEDFAEWVRDILKMNRRALIANGSIFSTNP
>KALACAFP_00448 3',5'-cyclic adenosine monophosphate phosphodiesterase CpdA
MPCLLISAMAFSQASVSGYVYEDSNKNQKKENREKGIEGVAVSNGVQVVLTDKSGRYSLP
IQENQTVFVIKPSGYMTPVNGNNLPQYYYQYKPKGSPADFKYKGTAPTGELPKELNFALN
KQNESKNFDILVFGDPQPYTEKELDYFKRSIVNEVKNTKKNAVLGISLGDLVGDNLSLQK
PYIDVMKEVGLPWYNVMGNHDMNYDAKEDLFSDETFESNFGPANYSFNYGNVHFIILDDI
LYPDPRDGKGYWGGFREDQLKFVENDLKLVDKSKLVVVSFHIPLEHKNEDNFRNADRQKL
FDYLTPFQNALILSAHTHIQQQIFYGKQAGWNGSKDLHEFNAGTTCGDWWSGTADDAGLP
TSTMRDGTAKGYSFISFNDNQYKVKYKTAGKPEDYQIGLFVPKAIPGRTSAKILANFFMG
SKKDKVEYSIDGGQWEAMEYDETLDPNFVMSVFKWDVTPNLFPGRRPSNPEMSKHTWTGA
FPRKISLGKHKVEVRATDMYGNQFSTSEEFEVQNPVLIP
>KALACAFP_00449 hypothetical protein
MKKSIVKYFLLAGLGIASVSCDRTMDEVNVDNSRILDPEVSSFLAPAQYNMASVNYMRAN
DFTFDIMQVSLDFPNEGNSLSRYYITENTGAGFWNNNYKWLKQIYDLKRAAVKSNDKNYE
AIALVMNAWIASNLTDTFGDIPLTEASRLDEGISQPKFDKQKDIYVQLLDDLKRANSLFV
TTKPLTGTDLFYNAGTDTNGITNWKKFCNSLSLRLLTRILSKNGEINVNERIQEIVNNPT
TFPIFQSNAETTKINITGVSPLLPPIARPQDFTTSRAASSFLVETMKSNNDPRMSMFFSQ
AKDLATNTNIGYKGAPSGYNPGMVFTYQPSNMNQNLAKAPLNILIYPYAELQFTLSELAF
KGIISGSAQTYYENGVKATIEQWGATMPANYFSNANVAYNGTLERIMLQKYVALFFVDQQ
QWFEKRRTGFPVLPNNGGLLNNGNLPSRLMYPPNPRVLNTSNYQTVVQQMGGDDINVKVW
WNKP
>KALACAFP_00450 TonB-dependent receptor SusC
MRKETQKLLVLSLLGLVSVNLTAQQKAKKDTIKNIDEVVVTALGIKRQNKALGYSTETID
SEQLLRTQNNNWTGALEGKVAGLKIQTAGAGPLASARITLRGDVSMNGFEDQALIVVDGV
PMNGRTVGSGTPAYGAGSGGDVPIDYGNDLNSINPDDIESITVLKGPTAAALYGSRGAKG
AVMITTKSGKNKDGKLQVSLNSYTSFDSVLKWPDWQYQYGQGTMTKDKNGNYYYSYGASV
DGVSTGGTSSAFGPKFDGQYYYQYDPTVNGQSKERQLWRPYKNNIKDFWQTGSTYSNNIS
IEGSNDKTSYRTSLTYLNNEWMMPNTGLERWNAAVSVDHKLSSKLKANVKLSYSQTKSDN
LPATGYNNQSISYFMIFQNPNVDLEWYRPIWKPGQEQVDQIHPFSSYIDNPYLIAYEMTN
SLNKKNITGNVSLNYQIDKHFDVLLRSGMVWNDELRTQKRPWSSANYLKGYYREQYIDGF
NFNNDLMVNYKTAIGSINLTATGGASSQYEEQKTQDYFAIGLKNPGVYSLTNAVAQDFKI
PKPYDRYVNSLYALLTLNYKEKIFLDFTARNDWSSTLPKANRSYFYPSVASSFILSDIFG
LKSNKLNMWKLRASWSRIGNDTAPYQLENYYSVSSFPGSVELPSLYANPNLRPEMITNIE
GGMDFSLFKNRLTFNATVYQSNSVDQIIRNVPVLWETGYSLRVINSGEVRNRGVELMMNA
YPIKNKNFSWNVSANWSMNRNKILSLPEEFHGEPYTMASVGGVVYYNAVVGGSIGDMYGY
GLMYSPDGQVVFGSDGLTAKPTTMKKVGNAFPKWRAGIQNEFKIKNVTVSFSFDGQYKGM
AYSQSHHKMTEQGKLEHTLVGRDNPDGLIVGQGVVQNADGSYSTNTKGVAVPTYYADYWR
RANVETNTFDTSFVKLRDARIAYSFPKSVTQPLKITDLTLAIFGKNLWMWTKFPLFDPEA
ATLDNATITPGVEMGQLPTARTVGFQLNVKF
>KALACAFP_00451 Glycerophosphodiester phosphodiesterase
MKNFILGLAVLSTVLMKAQTQIIAHRGYFQSQPPTTENSLKSLENAQNLKIYGSEFDVRM
TKDGVLVVNHDEHHAKMEIAETDFKELKKVKLPNGEDFPTLKDYLKQGKKDKSLKLIVEI
KPDKTKEKEDELTAKTIKMIKDMKLESQCEFISFSLNICKEIKKLEPTYKVQYLKGELSP
QQIKDEGLDGIDYHYSIFQKNPTWIADAKALGLITNAWTVNDVAIYEELKNQGIGFITTN
IPDQLKNK
>KALACAFP_00452 hypothetical protein
MKKVKIVLGLLFLSFGTLAYAQTTQASIVGKVTGAGNAAQEKVKVTIVNESTGFRTETET
NSKGEYIFKEIPLGGPYTVIVNDEKKEGYNVNFGDQVTVNVDMSGAEKSIEEVVIAGNLK
NKIGNLGAATAITAKNIGILPVNGRNFTSLTELSPLSGKGGNLSGQLGSSTNFTIDGMTA
KNPTSAGSTTSRSGAPFSISIEAVREFKITTNQYDVTLGRSGGGTVSAVTKSGTNKFSGS
AWEYLRTDWLSSPYDIRGNKRENDFSTSQFGFSLGGPIIKNKLHFFVAWDHQLDSRPLQI
ADIKSHEDELRLNTSTATLNKFLDIARAKYGVGNTPQFGSFDKVRNSDAGFLRLDWQIND
KNLLTLRDNFTNDFNKNGLADNTAINFYESFGNDKNLDNSLLLTLRSNLKPNMTNELKAQ
YLYTFQDSYQNDELGHAVPRAIVENVLTNIDGKDKATNIQIGGHRFGQENFRNNVFQIVD
NLYYNTDKIKYTFGADLMYTKARSVYGSEVNGRFHFKEAASNPDNLYNFNNMTAYRFYRE
VPLMDDPSVKSNIWNIGVYGQIQTKIAKGLDLMAGLRLDYGGYPKAEFNQKLFDEMGIRT
DNQIKSFIIQPRFQFDWNINEGNKDFLKFGAGIFSSDINNYMIINNLVFDGRHLATVDVN
PSQIGLTPDFISYRNDYGTVPTLPQYQLPTINYTGKDAKIPIVYKANISYTHFFNERFRA
GIAGYMALGRNNYFYYDRNMVANPYFTLDNEGGRGVFVPITSVTANGTMNWKDGRINQNF
GRVLELVSDGKVNQFSFVVDTSYRYWKDGEITASYTWSDIKDNTSYNGNVANSATLSTMV
ASDPRDLRMSYSDNQFRNKVVIYGNSPTIAGFTLGIRYAGIGGTRFSVTAGGNVNGDFVD
TNDLAYIFPNLTQTLIDNPEVGKALKSYITDYNNQIAERNGGKNGFYGVWDVRVAKKIKF
EKIGAFELSVDIFNVANLLNKEKGINKSYGNTSLYRITGFDPVTKQLKYSLNTSGLEPLS
GNPYQIQIGAKYSF
>KALACAFP_00453 DNA ligase
MSENIQQKIEQLRKELHQHNENYYLHDTPTISDFDFDMLLEELRDLEAKYPEFYDENSPT
VRVGGAITKVFPTIQHKFRMYSLDNSYDFDDLEDWEKRIIKTIDDPVEFVAELKYDGASI
SILYENGKLAQAVTRGDGFQGDEITGNVRTISDIPLKLKGDFPEHFFMRGEIYLTRKNFD
KINKLREEEGLDPFMNPRNTASGSLKMQDSGEVRKRGLSSVLYQFISEEIPAKTHWELLE
NAKSWGFKTSQQAKLCTTLDEVKEFINFWDVERHNLPFEIDGIVLKVNSLQQQRQLGYTA
KSPRWAMAYKFKAEKVETELQSVSYQVGRTGAITPVANLKPVLLAGTIVKRASLHNEDII
KKLDLHEHDFVYVEKGGEIIPKIVGVNTEKRTEKSKEIEYIKYCPECGTELVKIEDQAIH
FCPNELHCPPQVVGRMIHYVSRKALNIENLGSETIEQLYREKLIENPADFYTLTKEQLLP
LERMAEKSAQNIISGIEKSKEIPFEKVLYGIGIKHVGETVAKKLVKNFPTIEELKNATVE
ELCQVEDIGTKIAVSIVDFFANPENVLMLERLKSYGVQLEKGESTNEVLSNVLEGKTFLF
TGKLSLFTREAAEEMVEKHGGKNISAVSKNLNYLVVGEKAGSKLKKAQDIGTIGILDEQQ
FLDLIENQ
>KALACAFP_00454 Internalin-J
MRKIYLIIFLIMFAVSQAQIVNIPDANFKAKLLAADVTNSIASTGSGNFNMKIDTNNNGE
IEVSEALQVGTLRLYGGGISDITGIAAFANLGALEISGNSVTSVNLSSNTNLGQISFDAA
PSISSLNITNCNNLNRVYLSNTSITSLDLQNRPNLKYLYVFNTPLTSLNVSGSTQIIELD
VENTQLTSFDASNLQNVFAFYLRKNPLLSSINFTNANIELIDINKNNLSTVNIQNQSKLR
MIDCGENHLTSLYAPGCPDMRIIYCDYNLLTSLNTSIYPLLNSLYCNNNSIQSLDLSQNP
EFNTINCTTNGMSFLNLKNGKNQLNNSTGITYNPNLVICCDESELAMIQNMINSAPVFFS
TYQATTYCSFTPGGTFYTVLGNTKYDSNNNGCDVNDLSKAFQKFDITSGTTSGSVIANNS
GNYSIPLQAGNHTITPFFENPGYFTASPASLAVNFPSQASPLTQNFCLTANGTHNDLEVA
IIPVTNARPGFEAKYKIIYKNKGTGTQSGTFSFDYNDNLMNYVTSTTGPASQSTGILNWN
FTHLLPFETREITVTFILNTPTQTPALNGGDILHYTAQVNGATDDTPLDNTFTLNQTVVN
SFDPNDKTCLEGTTIAQAKVGDYVHYLIRFENTGTANAQNIVVKDIIDTSKYDVSSLIAM
NGSHNFVTRVTAPNVVEFIFENIQLPFDDANNDGYVSFKIKTKSTLNLGDSFSNTAKIYF
DYNAPIVTNTYTTTVQNLLATSETGKENGDISIYPNPVKDVLNIQSKTEILKAEIYDATG
RILYSSSVKGNYINVSELTKGNYIIRLFTKDKIFTHKFIKN
>KALACAFP_00455 hypothetical protein
MEFLKDHSIQNELLLIFISVILGILIGAEREYRNKSAGLRTFILICFGSCLFTILSIKIG
VADPDRIAANIITGIGFLGAGVIFKGDNKIDGITTATTIWATASIGMAVGSGYVYLAALG
TVLVLLILSSLTSFEKIIDKEHRIREYKIAVVNYHDIAYCEEIFKRHHLKFTISKQQYTQ
GNLATSWIITGKSVNHEALMKALMEDEKILAYQF
>KALACAFP_00456 Asp/Glu-specific dipeptidyl-peptidase
MTKKILLSVFLLPAVMTFAQQYGGMWIPTELNEKEMKDLGMKISAKEIFNPQKASIKDAV
VQFNGGCTAEIISPKGLLLTNHHCGYGQIQAHSTVQNDLLSNGFWAKNPEGELPNPGVTV
DFIVDIKDVSNQILEGTDNLAEPELSKQIAKNIEIYKNSQKTEPYQSISVKSMYYGNKYY
AYTIETYKDIRLVGAPPQSIGKFGSDTDNWVWPRHTGDFSMFRIYADKNNKPAEYSKDNV
PYVPKHYLPVSIKDKNENDFTFVFGFPGRTTEYLPAIAVEKIMKEIDPARIAVRDVALKT
LDEKMRTDDATRIKYASKYASVANYWKKWIGEVEGLKKSNAVEKKVMYEGSLVAKNHEIK
STLDQLNKLYNDQAPFALNNAYYSETIKNAETLALANLYYTYITAVEAGRMDEKGTIALK
KKLTAFYKDYSAELDAKVTAKLLALYANKTAPQFLPAGFEKYKNEAQNIQSFEEISKNSI
ITGRSEVNGASLAQDIDKAFSNQDKLIKALKKDPVYQPFTSIRDTYMTKADPQFTSLQMK
IDALQKTYMAQQMATDKDRKFFPDANSTLRVTYGKVKGSSPRDAVSYNYQTHLAGVMEKY
VPGDYEFDVPKKLIDLYNKKDFGNYKDKTGDVPVGFTATNHTTGGNSGSPALDANGNLVG
LNFDRQWEGTMSDINYDPRFSRNIMVDTKYILFIIDKYADSKWLIDEMKIVK
>KALACAFP_00457 hypothetical protein
MTEKRYQETIHTDKNNYEYITISHDENKVRIYTLKNGLKVFLSQNFDAPRIQTYIPVRTG
SNNDPADNTGLAHYLEHMMFKGTSKLGSQNWEKESELLNQISDLYENHKAENDPDKKKEI
YRKIDEVSQEASQYAIANEYDKAISSLGATGTNAHTWFDETVYKNNIPNNELEKWLKVEK
ERFSELVLRLFHTELESVYEEFNRAQDNDTRLVQYELMDALFPTHPNGQQTTLGKAEHLK
NPSMKAIHKYFDEYYVPNNYAMVLVGDFDFEETIQLIDQYFGAIPYRELPKKTPIIEKPI
TEIIKRTVKSPTTPRVQLAWRTESYGTREAMLADIVVNILSNRGEAGLLDLNINQTQKLL
WGQAFSVGLRQYGYFSIVAVPKETQTLDEAKNLVLEQVELMKKGEFPDWMLPAIINDFKV
QRMKTLETADGLATNLYDTYIKGRTWEEELNEMDEYAAFTKEDVVAFANEFFKENYVIVY
KEKGVNDKLIRVENPGITPIKINREAQSEFLQEILAEKTEDIQPEFIDYQKEIKTDLVKD
KKLNFVKNKYNEIAQVHFIFPFGSDNDRDLGISTQVLQYLGTEKFSPEDLKKEFFKIGVT
NDFKTTNDQLTISLNGLEENIEKGIELLQHWMYDVKPDQDIYNQFVNTVLENRAAVKKDK
GRIMTALTNYTKLGEFSRFTDIISKEELESSKVEVFTDRMKKLFKFPYQIFFYGKDFENF
KGYIGNYVENESFQIPEPKKYPEPETSGKVYFTDYDMVQMEMSKVGKGHDVNPENFGKIN
VFNEYFGRGLSSIVFQEIRESKSLAYSAYVSYAANSELNHPDYITTYIGTQPDKLQIAVD
TMTELMDELPEVPIQFENAKNAALKQIASTRITRTNIFFNTLRLKKLNIYHDFRKDIYKQ
IESLTLNDLKQFYQTDIKPIHFNTAIIGKKENLNMEAVNQMGAFKEVSLKDIFGH
>KALACAFP_00458 hypothetical protein
MKNLLLGIMILASGLSFAQQREDINLRGERKRVVQGVRSGEINRREAAVIHNQAKDVKQA
KRIAKADGVVTPRERAVVAREDRQLDRTIYRAKHN
>KALACAFP_00459 Transcriptional regulatory protein ZraR
MSGNILIIDDEIKLLKLLGMILSQENFNVKEASTARSAMTMLEQYDFDVVLSDVRLPDAF
GIDLVKSIKTKYPHQEIILMTAFGNITDAVQAMKNGAYDYLVKGDDNEKIIPLVYKALEK
VKDNKSKIVQKNTAQKGFSQIIGNSPLILQAKKLAEKVALTDATVLLTGETGTGKEVFAN
AIHEGSDRKKNNFVAINCSAFSKEILESELFGHKAGAFTGAIKDKKGLVEEANAGTLFLD
EIGEMPIELQAKLLRVLETKEFIKMGETKVSRSDFRLIAATNRDLEEEIKQAHFREDLYF
RLNVFEITLPPLRERKEDLKALAKNFVNVFSQKLHISNVQVTPEYYKTLEKNDWKGNIRE
LRNTVERSLILMNDHILDAESLPHYSEKISTEKDSLSIRSLEKEHILKVLQYTKGNKAEA
ARLLEIGIATLYRKLEEYNLR
>KALACAFP_00460 Potassium-transporting ATPase potassium-binding subunit
MNTEILGIIAMFAITLVIGIFLGKYIADVYGYKKTFLDKIFQPFENLIYKISGINPNKQM
TWKQNMFAMLTINLVWFIIGFFILLNQSWLPLNPDGNPDMSPDLAFNTAISFLVNCNLQH
YSGETGVSYLSQLYLMFLQFVTAATGMAAMAVLFKAFKDKTTTELGNFYDFFTKSIIRIL
IPISIVVAFILSANGTPMTFEGKDHITTLEGQKVDVSRGPAAAFVAIKHLGTNGGGFFGA
NSAHPLENPNYLTNMTEMVTQMIIPFALVFALGFYLKKRKLSWTIFTVMTIGFLALTVPN
IINETNGNPLITQMGTDPHLGAMEGKEIRFGSAASAYWSIATTVISTGSVNAMHDSTMPL
SGMNELLAMMINCFYGGCGVGILNYFIFIILAVFISGLMVGRTPEFLGKKIEAKEMKIAM
IVALFHPFLILVGTALTAYLPEFGTKTLNNPGFHGFSEMLYEFTSSSANNGSGFEGLGDN
TPWWNISTGIILLLSRFIPIIGPIAIAGLLAQKKYIPESSGTLKTDTATFGFMTLAVILL
IAALSFFPALTLGPIAEQLQYFSK
>KALACAFP_00461 Potassium-transporting ATPase ATP-binding subunit
MKNQSQTLFQKDLVSEAIRQSFVKLNPKIMFKNPVMFLVEIGTVVMFIVSLFSLTGDKSQ
GSFSYNFLVFIILFFTVLFANFAEAIAEARGKAQADTLRKTREETPAKVVVDNKQGFQVE
TVLKKSADMKLGDIFLCEAGDQIPMDGEIIEGLATIDESAITGESAPVIREAGGDKSSVT
GGTKVLSDRIKVKVTTKPGESFLDKMIALVEGASRQKTPNEIALTILLAGFTLTFIIVTV
TLKPFADYAQTPITIAAFISLFVCLIPTTIGGLLSAIGIAGMDRALRANVITKSGKAVET
AGDIDVLLLDKTGTITIGNRKATQFHPSNNIQLDEFIKASALSSVADETPEGKSIIELSQ
LKSEDLLVPNPTYIDFTAETRTSGIDFENTRIRKGAYDTIKKLTEKAGNIFPQETQEAVT
KIAENGGTPLVVSVNEKVWGVIELQDIIKTGIQERFQRLRKMGVKTVMVTGDNPLTAKFI
AEKAGVDDFIAEAKPEDKMNYIKKEQQEGKLVAMMGDGTNDAPALAQADVGVAMNSGTQA
AKEAGNMVDLDNDPTKLIEIVEIGKQLLMTRGTLTTFSIANDVAKYFAIIPALFITFIPA
LQKLNIMHLHSPESAILSAIIFNAIIIPFLIPLALKGVAYKPIGASALLRRNLLIYGLGG
IIVPFIGIKLIDLVVSLFF
>KALACAFP_00462 Potassium-transporting ATPase KdpC subunit
MKIYLISALRLSLVMLVVVALYLIFVFAGSKILPTQGNAEIINYNGQKFYANIGQNFTSP
EYFHGRPSAVDYNAAGSAGSNKGPTNEEYLQTVQKRIDTLKIQNPEMENVKVPVELVTAS
GSGLDPDISPEGALYQAKRIAKERNLSLEKIENLIKNQTEKPLFGPAKVNVLKLNIVLNQ
IH
>KALACAFP_00463 hypothetical protein
MKSKTIQAVFLLGLFALSPMNAQEIKQDSISVQPKDSLTTESKIPFDGYDLTWINGQNRQ
TDFPLTLKDKNGETILTGVTYVDAYYNYDFRRPKDNTHTISAAIGRSNEFTINMASIGLE
TNYKNVIGRLWLQFGQMGSIIQDLDGTVNHGKNTSIGNLKYIREAAAGYHFDVMHGLNVE
AGIFMSYIGLESYVLSENWNYQRSLVCDFTPFYFQGARVQAYPSKKYKVELWVLNGWQTY
NSWNTGLGLGVSNYYRPNENLQLVANFYLNGKDTRNNPGVRRFHHDHSIVARYYKNKESK
GLSQAGFSINNHYGFQTGGGLKAKDNYMIGTSIANRLWFYNNKIGLTLRADAVSNPGAYL
AFSPSPVTNNDFNDAIANGEKLKMFQGTATIDIMPNQFFTFRLEYGFRKSNIPYFAGRDG
TTSPDGWIDTPVESWRPDLKKSDSRITLGVIFRL
>KALACAFP_00464 hypothetical protein
MLIISGYQNDQQSQNNCKMKKAIVIGIMLGIIFPKAQSSDSLKSGNKLTVSAYAELFYTY
DFNRPEGSHRQDFLYSYNRHNELNLNLGLIKGSYQNDNFRANLALMAGVYAEDNLSAEEE
ILQYVNEANVGIKISKTKNLWIDAGIMPSHIGWESAIGKDNINLTRSLAADNSPYFETGA
KISYTSDNGKWFVSGLILNGWQRIIQAEGNQSLSFGHQIIYKPNEKITLNSSSFIGNDKA
KEEKKMRYFHDLYGNFQLTKQFSATLGFDIGAEQKEKGSKSYNLWYTPNILMKYQLTDQW
AFGGRLEYYNDKNGVIINTGTENGFQTFGYSFNLDYLIFKKVMLRTEARGFTSKDAVFMK
NNGLKTGNFFITTSLSAWF
>KALACAFP_00465 Sensor protein KdpD
MSSAKDFLELIQKSRKGKFKIYIGMSAGVGKTFRMLQEAHSLLRNGIDVKIGYIETHGRE
ETQALVDGLPEIPRKSVFYKGKNLEEMDVQAIINEHPEVVLVDELAHTNVEGSKNKKRWQ
DVLEILESGINVISAMNIQHIESLNEEVKKITGIEVAERVPDKILALADEVVNIDLTADE
LLTRLKEGKIYKKEKIQTALNNFFQSGHILQLRELALKEVATHVEKKVETEIKTENFKPI
KFLACISSNEKIAKNIIRKTSRLASYYNSPWTVLYIQRPAENPEKIALDKQRYLINNFNL
AQELGAKVMRVKENSVHKGILDYVIEHNITTVCIGKPHAHFLQRIFGYSWIYTLMNRLNE
RQIDIIILS
>KALACAFP_00466 Alginate biosynthesis sensor protein KinB
MKLKTKLTLGVGLLFFLIVLLSVMGSVYINKLKSDTEKILIANYNSIEFSKNMLLALDKI
KSDSLIAIKDFQKNSALQEKNLTEFGEKEATQNLNLHFKNYLQQPSDDKEKLIREDLVTI
MSLNMKGIERKSDIAIITAENATFWIVSLGTVCFLIAFILLFNLPQTIAEPINQLTFSIR
QIANKNYNERVHFKGSEEFNDLANSFNIMAEKLQEYESSTLSKQLMDKKRIETLVNNMHD
AVIGLDENHFIYMINDEALKITNLNKEEIIGKTVHEVAVNNDLVRELLKNMDHPVKEPIK
IVTDNKENYFEQDIIPINIVKTGEKEKKYIGRVILLRNITPFKELDFAKTNFIATISHEL
KTPISAIKMGVQLLGNQKFGELNDQQKELLKSINEDGQRLLDITGELLNLSQVETGNIRL
NIENCSPKEIVHAAIKNVEKLAEQKNISINSQFSINDNDFVSADFDKTVWVMNNFLSNAI
KHSFQDENIHILVEKIDSNIKFSITDTGKGIDEKYHRQIFDRYFQVPGEHQNGTGLGLAI
SKNFIEKQHGEIGVNSSLNQGSTFYFSLPLA
>KALACAFP_00467 hypothetical protein
MKNLKTILIILLTSLINFHIFGQTFTIGELEKFNKMDMSSFKNEIKKLNYSFYDKTESPY
FVLVEYDSPDYQYKIGKFEYVTDKTGDRIEFQFKGKENYSKYEKLIQSLGYKKTETGKIP
GGEAYVDYFKNKAQIRLVSPREELENEFFTILVFK
>KALACAFP_00468 hypothetical protein
MPDTIFLYFLIASILLQTILGVFFFNQKKKIISEFKQTDSIELENINGVIITENGYFRKN
FKWCKFDLMINQNSIFLFPKNFYFIPNRAINLLFSYSDKKNTKRPELLREFNIGKHSIEL
VYYRRFFLAEYKKIYLKNLNPEQLSILENSLNGKSRRFY
>KALACAFP_00469 hypothetical protein
MVRAEDFINMKIELIPVIEITNYDQDMPKFWGGSFAPAPKLFINNHSEQNNKLCNQTF
>KALACAFP_00470 hypothetical protein
MKNTISNFLNLHTGEESPTLVLENVTSNVSFRGANLWILACAILIASVGLNVNSTAVIIG
AMLISPLMGPIVGAGFALATFNFSLLKKSIKNLIIATIVSLAVSSLYFYLSPFKEAQSEL
LARTSPNIYDVLIAFFGGVVGAISITRIEKGNPIPGVAIATALMPPLCTAGFGIATGNFA
FVAGAFYLYTINCFFICISTFLIIKFLKYPSIQSTNKVYEKRIRYGISVLIIIMIVPSCY
LAYNLLTEKKYTQNVEKFINNEFTKNGYTVIYKKVDYHTNPKSIELAFLSKTFDSAEIKK
LNTTLKDFGINNTHLIIKQNTTDLKTEILNEINLQKNNISEKDVQINVLKNELNQYKMND
PELIKEIKILFPEINEIAVGKVQNFYKKDSTAVETALLYNSNSKIDEQKLQSWLENKLKS
NKIILVNTNVQ
>KALACAFP_00471 hypothetical protein
MAATFFATPQEFRKWLEKHHTSEKELLVGFYKVGTKKPSMTWSESVDQALCFGWIDGVRK
SIDEHSYSIRFTPRKPTSIWSAINIKKVEELTKARLMTLEGQKAFDLRKEEKSAIYSHEK
EPATLDPDYEKQFKANKKAWEFFNNQAPSYRKVMLHWIMSAKQEKTRLSRLEKTIRESEL
GKRIL
>KALACAFP_00472 hypothetical protein
MNNDLQNEMNLHSAGATVRHASVFNHLETYKNQFQLSQEFINKWVLPLYMKIRNPHDNSW
IDYIKHHKDEITEEVVLALLGDFNWRTRTVGAYFSAIKNYENQIDIIGIHLLKSEVCYAG
DVYAVVLAFYNTPKTIEYLNQYLEYYLQKPELYFDQERVLETVAYLDSVNKTNHLSKHLD
QWNTMLESRGEISKIRTIQIAKIIEEQEGKTKAQNFLNTLNHVIINPELSTKHISEQIVL
LNKLRDFFA
>KALACAFP_00473 hypothetical protein
MNTDTLDFWVGNFNSEEDFYEFVEEDENFYMEEESDEKYISKFAESQDTIWLDHDFVEYG
FEDGNRTIYEKFAEYSFAEQWLPILINRLNELNLDMNINSIIFLNRGQIPKPVSVEDDLF
SLVYVGGIEYSA
>KALACAFP_00474 DNA polymerase I
MENMDATQDKRLFLIDAYAMIFRGYYALIRNPRLTSKGVDTSAIFGFTNSLIELIRREKP
THLAVVFDVGQASVRTDDFSDYKANRSETPEAIKVAIPYIHRILEAMHIPILGVEGYEAD
DVIGTIACKAEKEGYTTFMVTPDKDFAQLVTDKIKIYKPGLKGGDIEILGVEEVKAKYEI
EDPKQVIDFLAMMGDAVDNIPGLEGVGEKTAMKFLKEFGSIENLLANTDQLKGKLKEKVE
ASAERGILSKKLATIICDAPIEFHQEQYDLEIPDFEKVKEVFDEIEFRRLYENLYRAFAP
AATGTVVVAEVEVTVTETQTPQQKVAQAVGQLDLFATYEELEQATSTKSTIEHNDHLYQF
VNNPKAQKILVDNLLKQKVVCFDTETTSLNELEAELVGMSFSYKKGLAYYIPLSEDKGEV
LQTLEIFKPFFEKEDLIKVAHNLKFDYKILKQYDITVKGAMFDTMIAHYLLNPDGRHGMD
YLSEIYLNYKPVSIETIIGKKGKKQGNFRDADLRTQTDYAAEDADVTFQLYELFAPQLKK
ENLEDLFFTIEMPLMEVLAKMELAGISLDEKWLAQESVDLENDLKQLESKIFELSGEEFN
MNSPKQLGEILFEKMQLDPKAKKTKTGQYATSEDVLQKLASKHEIIKHILEYRTYQKLKS
TYVDALPSQIEKTDNRVHTNFSQTTAATGRLASVNPNLQNIPIRTLRGQQIRGAFVSAEG
KKIISADYSQIELRLIAEISGEDNMIKAFQNGEDIHASTAAKLFKIPLEEVSKTQRSQAK
TVNFGIIYGQGAFALAEQTGLSRTEAKQMIEAYFETYPKLKEYMAEQVNKARQIGYVETI
LGRKRHLKDINSNNFVVRGHAERNAVNAPVQGSAADVVKMAMIKIQKELEKEKLQTKMLL
QVHDELIFEAPIEEVEVASNIIKIEMESAIETQVPLLVEVGVGNNWLEAH
>KALACAFP_00475 hypothetical protein
MGRSKIKNVCLLLPLLLSIIACGHPDFDKLGGTGFSYQISAGKTDIVRVRFTTDEGAPSI
QLFDTKGNLKEEATIAPYSGLGLTAMKNDTIQMTYFVGENDQMFLSWFKKNKYNPTRIGN
YSIRYNYKVRNVYFMDQDPVQVDSLYIDKNTQMMSLFLKQKLIAKKPMYLFRVKSSEITL
YDPSSESNIPYIFADNEGIVEEYLKEILALY
>KALACAFP_00476 hypothetical protein
MKKILIPVSALFVAGLVQAQLSPTENYVYTKTYLSDPTLSNPKTSETVQYFDGLGRPKQV
VNVKASPQGKDVVTHIEYDGFGRQVKDYLPVPQSSTLNGAIVPNPLSNAPNTPYGTEKIY
AEKLLENSPLDRILSQKQVGNDWSNKPVQFGYDANTVADNVRKFTTVTTWENGATKSVLG
ENWLYTDAQLYKNTVIDEDGNKTIEFKNGKGQVVMVRKVVNDTENADTYYVYNEYDQLAF
VIPPLASIRGDIVPNTVKHDELCYQYRYDGRNRLVEKKLPGKGWEYMLYDKQDRLVATQD
TELKNKGQWLYTKYDQFGRVAITGIGTGYQRSVEQVTVDSFGSNNVTRINTPFFNRQGID
VYYNNPDGSYPNSSNWITLLSLNYYDSYPGYSFNPTFPTSILGEPTLTETPTTEGLSTKS
LPVMSLVKNIEDDNWTKNYSYYDKKGRVIGTYSINHLGGYTKTESKLDFAGVPLNTNTYH
LRKQGEIGVTVKERFVYDTQNRLLQHYHQVDSKPEELLAENSYNELSQLTNKKVGNNLQS
IDYNYNIRGWLTDINKDQMSMSDLGGKLFSYKIKYTQKDGIDNPDSAQFPGKNVVPRYNG
NIAEVDWRTSEFNSSLTPKRYGYVYDKQNRLTAGYYQNPNNPYNKESTESLSYDLNGNIT
SLYRTSIPEFGNTTATMIDNLEYIYDSGNQVARINDHSQNTSGYEGGGGTIHYDVNGNMD
IMPDKNINKITYNFLNLPKKIEYTGASIGIDYLYNAGGIKLQKKSPRTECGIINCNTFID
VTDYLDGFQYLSNVTSGSGGGGDPEMRSFSENSSRAMEIQAYSVENLNMTNTLTTLGAKT
PDLQFFPTTEGFYDYKKDLYIYQYQDHLGNVRVSFTRTNAGVLEVMDNNDFYPFGMNHFG
TGSAMFGPGSYKNYKYNGKELQETGMYDYGARFYMADIGRWGVVDPLAEQYRKWSPYNYV
MDNPLRFIDPDGRGTESTHTDKFGNVVAVYKDGDLGVYRHDGNAKETQQELNQNYSKDNT
SGGGERMGRTLVWNSFTQFDGNGAPAGKINFGSYQAREWLKNFSSEISKDLENNFGIGFA
TRQNYALNGGNGDKYDYKTQNGGGLYAGSQIADGVYVSARDVGNFAAGRAAAITGQNKMD
FMLNAGGFNISGNSKMGLIFNNSHWKSEAQKAGFPTYGEDFNSNLFQRLGYENVTTAEGI
IKKSKIIWGDRK
>KALACAFP_00477 hypothetical protein
MFLFLPLLIGTIYKGQINLLDKQMQSVATPEVASLMKYSDFPSLGYIGKTDISIPIYNIN
FGKIKLPLGLSYNTKGNKVADIATSVGLGWSLNAGGNLTVKVNDMNDFTESYTYYTTATF
EPELSLEWYRQSKGYLTKEYSMLVNNNNYGLCINTKIGANDDFFVDAAPDFYYINAPGFN
DKFYLTKINDTQFKANFFNSTNAKLNNTLNLIPRINCAGFESTGFGNKGRAGVYYQVDEF
EIIGENGYIYTFNDFESARLREYPQTIISHDAFQINNWYLTKIKDPYSGREMNFEYESYT
NNYEHPSLTTLGDVNFGNYPMSYNYELGRMGSNFVYPAVFNKVTTSQLYPKRIKKITTDE
EVVDFQYSFNRIDYPGNGLTNIQVKNKNGTIIKQTDFSYDYFNSVNCSSGDYECKRLKLN
SITDSSLGTYRFYYDANSFPPRNSSKVDFLGYYNNNDSDIVFSKDNFHEDQYNYYPGTKI
YFYPDLVRDQLLPFQLINKGTYATTSGVDRSAKTISKLGLLKRLIYPTGGSVELSYENDD
FIYEGEKYILGSTRISKMKLYDSQNIVSKEINYKYVNEDNKSSGQINFIKTPANSAHTEI
SSGIGFSTDAIVGYSRIIEEVAGKGYVERKYSNFNDYPDKFMTSDYNFTDQGTRNFLKFL
KFPSSYVQSFDERRGKPTVENYYKEGIIDPIKKIKYSYNYQVKDSLKVQKVFTSYDNYTH
DATHNYTASNYLLRYFNNTSSNTKEDFFSGNNIKEENFYSYDDTRLTYKKTVSSGDTTEE
YYRNAKDKSIQKLIDVNILDKPVEVEKKKNGKTLSKQEVKYENTSNIFPSSELSYDLSTN
LMGTEVTYDKYDSKGNLLQYTTKNNIPVTVIWGYRQSQPIAKIEGANYTQIIQAFGLNTN
DNNAYLDLDIVKKSDLHFDDTTESELISKLNDFRNKPALKDFTITTYTHTPLIGVKSITS
ASGNKEGYKYDTANRLEKVSDIENKTVKEYKYNYAPVIYYNNEKQQAFMTNNCAPGTLPA
SGTYTVSIGKYSSTISQADADQKAQNDINTNGQNYVNSHFNCTPYVCTITPTYLADIYYS
SFQEISTNHIKAILSLPLTNSSGGAAPNWSNGVLIGTLDTLCRPNSYKSISVSTTNGSWN
VSISPSGGVTLMSTSSSNPSGSTTLNFEYDK
>KALACAFP_00478 hypothetical protein
MNKFYTGALFLCTILSTSAQEVVWQKDIKSSTQDFLSQVTTTIDQQYLITGSSIQAGGQK
MGAGSKQNNGYDYHFIKLNQQGEEVWEKYFSGQNHDFLSATVATQEGGFLAAGTSYSGKG
LDKKDESKGGSDFWLIRLNEFGDELWQKTIGGASDEEARAVIQTTDFGFFVAGSFVSAQD
SKMKGYGSKDVLIVRLDKNGKELSQLVLGGKGLDEVEKMIPTKDGGALLGIYSRSSEFRG
SGSEVQSSDSKTSNPASRYPKSTNNFGEGDYWIIKLSKDGKVEWEKNFGGKGDDHLRTLA
LTSTGYLIGGESRSERSGNKSVGIEEGTDLWLISLDERGEEIWQKSYNFKNRDVLMGMSV
ISGMMEDGSGKSKGILLGGYTQAEGRIENDDETFWMLYLDQNGNEQWRKHVKGESRKKEE
RLSDIKLNRDGSIILAGTSAEELGKENWKIVKLGDKQIDQLIEKQDIKIYPNPVSDYAYV
EIEFDFKEADILMYDMSGRQLQSLKTKNKVTKMNTQNLIQGAYLITIKTDTNKTANAKLI
KK
>KALACAFP_00479 hypothetical protein
MEAYNFETTIKPFFWVASEKTFSVCLNAGSYKPEIFEWRKNEGFEGNGYDWTSLAKVFLN
EKKSGLSGDIKFDPEADMFCAYSSNPESLKEFVLDFKKACEDEMLIQDLFSKAELD
>KALACAFP_00480 hypothetical protein
MNRLKPFKDLKLIYNVVIGKYDFLENGVNVEFDIEDSYTQMEDFTELISDSEKWIRKFSN
ETLGELKSKISKDLIDSAYTDSNYQPVEKDYKNLEKQMKLTEIRFLPETVISLVFKAKKE
YPDKEIYCQISEKFEIEDLFVD
>KALACAFP_00481 hypothetical protein
MDKFKNLKLEDDVVTGKYNYYDGEVDVEFDLEEDDTEMDDFSELISDANNWIENLTQENL
NELKTKIAKELTDSAYSDSDYKPTEKDYKDLENELTLTDVRFFPDQVISLVFKAKKEYPD
MDIYCQIDNEFQVEDLFVE
>KALACAFP_00482 Putative deoxyribonuclease RhsC
MADQNKIKKIKVAKPDMNPDRSLSVSADVTSFSKEKTTQGWKNGMKNNFDSLNPVSMVKS
VAGGDGGESKSSGGGGGGTSVSAENTAPQSKVKLIKVNTPAISPTAIQHTSKHFDIVLAI
DIHWTLIPPPPSFMLIPLPLPHPFIGIVFDVMDYIKFSIPVPQFIRNLKPDLPESIPMGG
SIYVHGRHKATTTTSVMGVVIPFKHVTSLIPVYMIPFPQEAPHEGEVYYGAQTVLGQGSK
MSGNQPQQVLTCMGLPFGMTMLPAMPNKPKKNPLAYFAFYNNFSSLYIQINTGGPVLVGG
AFVPHVYTPGEMLMRFAGMALMRGLTKSLGKGVTKFNHFLQGKFGKTNPVSRVLCKVGLE
PVNFASGAMLFEWDDFEIEAGTSLQWTNVWYSDRPYQHGMLGNGIFNAHDLYIVPDEEDE
VAVWVHPEELQPMPIPVPPVGEELTYYRSQKIWQYRPNSSIWIIRKGTDIYTYKRFHHIT
EGSIFKVIQIEYGDGTIREYEYQGRNIVLKNIKDVKSGFSIETVLHPELKKVSEVYYCYK
NKRDLQVRYNYDERGNLTHVWDIHKKAIVFEYDDQNRVIKRTNRNEMSYHWEYDKKDRVV
HTKGLEGFMEGFLKYNEEEGYTEVIYPKQNNKTERYYYDEDLLVYKQIDGEGGETWFDYT
SHNELKMIGTPEGRVQGYTYDEMGNIKTFHTPDGEEYHYQHNELGQIIARFSPSGTSESW
SYDEMGRITNYTDPNGEMVAYEYNENERLAKSASKQNVTTHYEYNQRLQITKLTSSIGTE
QYWKYDDYGRLLAFSKQPLNRTVWNRDKMGRITEVNEQGQLPLKLRYDAYDLPVYATDGK
AEWLMSYTPMGSLKRQVRRNALTYKKEETLVFGYDAYENLMSITNQKGEIYYFERDNNGN
IIGETGFDGQQKFFVRNKDGMVTQSRTQNGKDIFYEYDLAGRLTQTHYPDGTWEAYQYDT
YGMLIKADNEISSVSFQRNKSGFVTAEKQGDHSINYEYDDLGNLVGLKSSLGAEIDYSYN
DLGQLNYVKAITKGIHQPWQMNLDISRNGQLFSREMTGGIESIFECDHTGMPVSQKVMVN
KTGTAFHKDYHWASGSRLLQVLDRVMGSRTRFDYDAFGSLVAAEYSNGEIQYKNPDEIGC
LYESARQNDRVYDKGGKLMRDKNWFYHYDNEGNLLLKSKRSINNIKPNQKEEENNSHPYY
RSIAAEWLMKPKLQEVDHLPDVYENTPSEIQDPEWESGDWAYFWNANGMLAKVKRPDGKE
ISFEYDAIGRRISKIGNKKITRYIWDGNILLHEWSYDIKEEPKTFVDDEGKVIIQKEPTD
NVVTWVYEADSFVPRAKIFNDKKYTIISDYIGNPIQGFDENGVLIWERELSIYGDIKKEK
GENNFMPFRYQGQYYDEETELCYNRFRYYDVKSGNYISQDPIGLKGGLPNFYGYVVDPNK
YTDVFGLEHHDLDAELVRGGKTIFSDEYISGGEKGGGRLNQQEALLTHTERKFLKDIDGM
VKPGDHLKMTGELNPCRPGCQPAIRDFVHAKGVTAEYTASSTGKIYKWERLDNRFVLQTE
IDAKGNATTYKYNILKRKRTKYK
>KALACAFP_00483 hypothetical protein
MNPVDLELVKLKRQWQNVVSKNGEKPMLICLGEKHETDLFDGFIKSRLSEDYDGEDVFLV
HYQEFNGMDSFGQALFDEWKEYYEMLEKSEKNIPQWELNISDEKFKTDAYKAFFPLLELK
KNFPNIQNSKIFLYIAPVRINDSKELSIWVKEWCEICEKSGNQDIKLVWAEHHSYKTLPE
NASAHSFRVEVDIHQLMQNTAAHTNRKKNSADTDFQQQILTASNHLSKGRFKEAEFALKT
AVKLAKEQKNKQGEISAYFMLTQAYIADKKKERAEDTYRTIFEEVEPDTPLEVQMYMNYG
SYLLGNSKKSRAEKAFEKAAEVAQKIGEYAMAIECYKIIGTLNDTVLTKDKMIEYFEKCM
DIAKLMEPSTRESSSLKFVASMLFIKYEGDNDKKTVLDNEMKNYFGDDWKVSVEKPKYS
>KALACAFP_00484 hypothetical protein
MFQDDNTPKIPSSAAKPSMTKQLGEMKEVAKNQALGKATEKIQQKTKGTVQKTTQKLAQA
QAYTGVVQGASNMLMNQKLQPNSPTLVEDKVWSQQPTSKIHNAKAIPESQIQGINRVVKL
DIVVEGKTVKHFKHFQLKQSATRHHEFSLMLAHDTLGSAENHNLEEAQNFLGKRITVIFK
YKDVEDGPERSFVGVITEVGFSQEKGSLGNIVLTGSSPTVLLDAAPHIQSFGGGQEISLN
SIADQVIKEGLGQGRFDFRVDAQHGNVSYSSQYEETHYNYLARMAEAYGEQFYYDGEVLH
FGKLPPQEKPVKLTYGSSVNDVKIRMKAQHVNPSFYGYNSSKNEKLTTGSSKISHTSDIA
KRAYEISEKTFTTPSLRVAPIKAASFMDVETSQKGTAGSKASDVFVTSGTTTVPFLYPGC
IADIEMRKNDSNETSYFTKLMITEVNHEVDARGYYTGTFDAIASDTGFIPRPEFQTPKAD
SQFAKVISNTDPLNQGRVQVQFDWQNGSTTTEYIRVMTPDGGGSEKVSKNRGFMAIPEVG
DQVVVNFAHQHPDRPFVMGGMFHGGVGGGGGAGNNIKSLSSKSGHTISLDDGGGMTVRDK
DQNSVFLDGAGNISVDSKISITLTCGSSSIFLDKDGNIVIKGKEIMVQGDNIGVGGTASV
GIGVGPEGGDPTSGIGIESTTLDVGTTTLSMGAKTEANLSSAKINIGGGSETNIVSGTVK
LN
>KALACAFP_00485 hypothetical protein
MAANSRGILKFNGGEAQKLLKLNYSVSRSTDVSGRVASDPSNAIIKLTVEATEKSDILES
LLNGKYKPTTGEITFNKSHEEGTLITLTWENGYVIQHEVDFDAVDENSMLISFIVSAETI
DYGNSKYEGLWPGAK
>KALACAFP_00486 hypothetical protein
MPPNTVKEIYRMDKTIKILFFFILLFQNIRCQKMKEEKLPEFNVEISSPNNDMIVTPVED
KIITLEGIPATLPYGSSSGTWGTSGKGWTEQHGTPIGADITYFSRYEDTFYHLKADFPVD
KIKEYMQRAYAQREASLYDKPLEEYKNLGRNERYSNAENPYNSFTTLVFGFAPKGMVVVW
LRFRAVQIELGKFQAEVIKDDKALEQKFFSKLSVTREEMKKNRFMDVKPKEWDDYRRKYS
WKPLFTSENKALKLFESNISYYNGEEEVILRPWIDKIPIKERAIPKELNFTWETAKDEQY
IGRAFFNWLETDDQFENAGENFNVEFKIAPDNKSFEVLVGGYPIKIDSTRIFKTEREFHD
SYK
>KALACAFP_00487 hypothetical protein
MSIEYFVEGKAVMQTGGDNRTFAKEGISHNSTATVEQKGKDTGVSYNKAQTINPNDKPVN
TIDVSLNLFFDGTQNNKTNTQLGGGFEEASSDKDDSYNNDFTNVARGYDTIDPNAQNQVT
WYIEGIGTEDRKSDSVIGGVAQGIGSTGVVAKVAKGCKKGAEAIVDKLKNNLKPINVLTV
NVFGFSRGAAAARHFIHVANSPALISYSRGKEILQVFPPEFINSDNLIIKDKDGSKLQFI
MRYGYFGACLLAQDLEVKEIKFRFAGLYDTVASYGLNHRGGFGIDNDTKQLGLDAVGGGK
VNFVLQLASDDEYRDNFDLTNIDSTGLYGLEFTLPGVHSDIGGSYGEGDQEISVLYCDYY
DPYDNVNTHKECETFKKIVVDEGWYHENQLEIKYFTQKDVNYDRWWNKTSLYYGLVGKRK
LSNKYDKIPLNQMFHYSKQHEVKYLEDLINENHKINDPFLSGIYSQLSSYMNACNQLRNK
YVDDFKAGKKPSAAKYKQDIKAISYLGHISEEDLKKLRNQYLHWSVKANQIGLDAKPNDN
APKKRGALAAQYRKRNIQNG
>KALACAFP_00488 Actin cross-linking toxin VgrG1
MKTESQNILKNPSFRPAQNADGISENHHTGINRLVKLSLVIEGKVIKYYKHFKLTQSSRR
HHEFSVTLAHDALGDRQTHTLEEANKFLGKRLTAVISYKDIENSPERTFVGVITGVGFSQ
EKMSLGNIVLTGYSPTILLDGAPHVQSFGGGSPVNMGIIANEVIKQGIDSSRFDVRVDTN
DYSQIIYSSQYDETHYNYLARMAEAYGEQFYYDGEVLHFGKLPPQNKPIKLTYGSSANDI
KVELKAVHTKPQFYGYNSSKNEKLTSGETPVQHVSDLAKTAYAHNEKIYKTPALQVAPIK
ASTHLDVEYSQKSTSGSQAVNVFSLSGNTTVPFLHPGCVVDVQMRKPDTNESSYFTRIMV
TESTHEIDTIGHYTGSFEGIASDTGFLPKPEFKTPKAEPQIATVISNTDPEGQGRVQVRF
DWQTNDTTHFIRMMSPDAGGTDQITQNRGYVAIPEVGDQVMVNFVHSHPDRPFVMGGMFH
GGVGLGGGVDNRVKSIQTRSGHRVVFTEDESIIITDKSGNEIHLDTTGSNITITAPETMT
LNCKNMNINVGENMTTNVGMNKADTIMANHTESVGSMKYLTTGADFMTNVVGKMSHYVKG
DMEVYGEKEHKLTSLKGVEVSSQGKVEHHAEKEVQNNSGEKSKNH
>KALACAFP_00489 Membrane-bound lytic murein transglycosylase D
MKPNYKNILQVLVVFLFSNVMNAQFLSASDTSGSSVKKYKNIINANKDIVDFIEYSLAEK
GLPRHLRNLALIESHFDRNITSGAGAVGVWQFMTAHANQYGLTEQNRTDLYKSTKTAVTS
LTNLYKKYNNWVTVVAAYNCGEGNIAKAMQAAGSSQYHVFYKYLPTETINHVKKYLNACY
ATGELQNVLSNYNSSRMNTVFFVNGGSKKNNEQLAETDINAGFNLNIIADELDVEVDKLL
SWNPGITEELQQKGESTLYLPTDLMPDFLLRKNKILSRSIKEGNTLTTKQ
>KALACAFP_00490 Chaperone protein ClpB
MGVLVTNETVKQLFHIAQSIARENYNATYGAPHILRALMHKDIGLNEFLKSIDKDPGYFY
EWADVRIEDYPKTTHLPDEVGEDEFVDNIIEEADDIRLKLGLDEITPVCVLTAIVKPQVA
FTLQQLKSLPLREHEIFNLYRKDTPYEISGNGEFSSIFSNGSEYSDNSFPSIKNYCVDRT
AQARKGELENIIGRDKELRMLVEILCRRSKPNVIIIGEPGVGKTALVEGFAIEITKGNVP
DMLKNGTLLELDTGALLAGTSYKGEIEDRLKKVINECKKIEKAILFIDEIHTLLDPKGSI
GNVANLLKPELARGEITVIGATTQEEYRKIIEPEQAFNRRFEVLTVNEPDEKTCVKMIDV
LLEGYKKHHGIEVEKTALPECVRLAKRYAKGKKLPDAAIDLLDRTMAAIKMLDELSEKEL
ESWKTRYDEILQEEFLDEKDKADELIWTYNLLRDKISPILWGSLSEQPQIDNSMPVEQIQ
KIIEDTYAELLQHASVKREKVDRLELAAVMAAKTSIPIGKIQAQEKEKLLNMEGLLMNRV
VGQDHALKILSDAIVENRSGLNKPGQPIGSFFLLGPTGTGKTELAKSMAELLFNDEKAMV
RFDMSEFKEEHSAALLYGAPPGYVGYEEGGMLVNKIRQQPYTVVLFDEIEKAHHSVFDVF
LQIMDEGKVHDKLGKEGDFSNALILFTSNIGSEEIVKQFEEGKIPESNSLMQIMSNSGRF
RPEFLARITEIIPFAPITESIAERIFNIQLKSLHTSLIRLGMTLEISDEAVKNLALGGFS
SKYGARQISGVIRSQLARPISKMIVREEVKAGQTIHVDWNAEEEKLSWKVD
>KALACAFP_00491 hypothetical protein
MAGNSRGILKFNGGEGQKLLKLNYSVSRSTDVSGRVASDPSNALIKVTIEATEKSDILES
LLNGKYKPTTGEITFNKSHEEGTLITLTWENGYVIQHEVDFDAVDENSMLISFIVSAETI
DYGNSKYAGLWPSS
>KALACAFP_00492 hypothetical protein
MIVHFILSGETLESISEEIHLENPKYLKEFHNLHCAKEDIIHDRLIPRKKLLIPDSKTIK
EYNSRNDAPFKDPKLNPELPFKPENFSQIFSVTNTEIEETELDKKNNILLYTVSLKWVAK
EENFHVFHLFKNNFSTEHGSMMNDIAAASIRALNPIVVKTNEKGEVMNVGLKEETIASFG
SIRENLSDLFPDKYAKIYLDEFEFAVLDKKLFDQRMKEDIFIKTYFSSLRNEFKNGKSFI
KQTIGEDNIPIEVIQRVEDEKYTNEITLQHNIQPQPGIDFHGKYVVSTETGMVKNIEIKY
FISQYGVKSTNFFSVKELS
>KALACAFP_00493 hypothetical protein
MIKSNIIGLCLLAGLSVLSCKKDQHKNQKNVKDSAVVSQTVDDSAKSIQKTNPVEKDSAN
ENQTGEKNPKDVNLKNAIEGKYVAKTCDGGIFSIEIKNVNDKPSFKILDQSKIIASGNAS
VEEEAMEGITISMGEIGGLYDGDKITIQNYGNSMNEFEHFIQCGDKYLEFTKQK
>KALACAFP_00494 hypothetical protein
MKFIFCLLFLFQVKNCKSETPAPSKNEGIAAVKVVEKTPDSYIINSVDQNAVGKKIEDKE
TIKSLKKILKNSFQREVERPYMWDIFVGSNDTLLQFYPYKNFMINNVPFKSYYTKINYED
GNYQCILLVNETSTEPYNSMIVFEDLKSEENYQRYAEVKGDKVQVVLKGQDLKNLQFQVK
DGTFLDYFDTPTVDKKWGKEAKDFAYQLKGSTNNHVKNGYWIEKKYSIDYNKNIIEDGNY
VNGLKDGEWNYSPEGPVDKIEVYKLGKVVKVYYP
>KALACAFP_00495 hypothetical protein
MPVKKGVSRISGNPSPKVGEKTLYKIEEWYPGTPKAEQNPALVTWELFKKRSNGSFTTTN
IKKTGDGNFTFGEVSAKNTYRLEAYLHEPEGKGSTTIDITPQLAGIPKIDKVELHYADDS
KGTVFSYNEKLIAKAQCINLTGKKLLFTLWEDDAAGDGHHNANLFVDSKEVLVDRTGTAT
AEFALTKVLMQKAAGGEKDPKKLEFYVTVEYYKDRKHATNNVEVQNPEYKEPAPQPKSDA
KTPASDSGQTATPAKTNNEQPASKKEEKGVGDTSQKPEAVQETKGTVEPEQKPTAQKPEG
KTTSVVEEPKTESLLDAFFAKEEFTKETDETDGQHKYTFAKDNNNINKDNIANIIKGKVN
PAAKKDKKYAKFDDIKNALAKTSYKKGESITFPLYKLGPVMTPINSAPLEEEVFVVAKTM
LLDGKEVSINIKEKEELLLAKDASLPVLEAKENGAELTTLKATAQNGLAKIKIKLRPKSD
ETLKEWREKLSGKKDGTHTYKFGGTNKTATADEKKRIAGVIANKIKDELAKQEKFTKTDA
IVKALTKEVYNKDEEVTFDVFKKVTEFLWLKAECTGNIKKHEGEFLKKDGSYFEIAKKCP
RCEAPITAEEFKQMYPDVAQLFDKGTNSFGSPTIETFLTSLNKTLKEFKINTCVKKAFFL
TQITKETGYFSRADENLYYTTETALHSFWSKDSHPRLYSNPSEFFKSPEKLGNYVYRNIA
ENGDEASGDGYKYRGRGLIQITRKKGYRRFREYAGKDLVADPDLLLSDLDLTTRSAGWYW
KHGVLLNDGSEKDLNTVADKGDFKEVTRLVHGSTNDVAARETILAKIKEVLKTDECQATN
IGDADVEYHIQSTGEIQYKYKNEKRESAAYFYHDSAGNVHDLGKYKLVKVKENYGGVYKD
KLGKDTENIYLIDVRNVKHTYKKDSIGFTMTINTVRYYMNDVTMAALFGALLECNYDDFV
FNGFSNEKGESVGGSKSHKNGMNGDLRYLRTDKKGGMTDLFNDDEATGWKGLDETRQNTF
NDALYKFGWKSMLSQNYGEKSEKILNHCTHDKDKNHNDHLHIQGFAPTLKEI
>KALACAFP_00496 hypothetical protein
MSQQSSPHDGKYFVVQKGKAQCNQGDKFPQYKVTTHQKHFWNDSDGNTDFLGVTENDLQF
NPPGPSFGQCKLKPTSGGYLPCSYAPAGKWQKTYDKVTIMGKKIVTELSELQCVVGGKIT
IKDHGQRGEMSKQNVKNADNKTVQHINPLVKMQDFKETVLESEIDAY
>KALACAFP_00497 hypothetical protein
MKNKLPLAAYYIGVSVLLTSCQVKLPSKRTPEPSQYGQIDNASVVNGFPKKSVPWIAISD
RSRNTAYLDKSDEKSYKEVKFLEPLMVLKNRDGMVKVAEYIPDALMKKVSSKQIKTYGWI
PESDLLLWSNSLKNEKTGFPVRVAVVPSNSEVIRSSERYYKNDSIMVFNSPSLIEQANVK
IPNGQIVYVYKQAENNKRFLVGKKPTIDIDSIGTSLYGWVSSNVVSAWGERSAVKMKNTT
GVTETALGLHEGSPGGNETENRTAILLTDVNKRTPLENIYPVSLSLNETPTPDSKTKYFT
NILDYSKNYVFNVLGEPIYFDRYREITERNKRINIVFALDISAPNAPYAPIVKSLLQDLQ
LRFEKPSYFNQVKYGVVLYKNNSCGDNVAVSNLSTDYSKITTFIDQKTNEMNCASNSGYQ
PVNEGLMAAGNLLTSVPDETNIVVTVGTSANQSGNMYGVINSLTQAQARLIMFQTSARSS
DTYNDFVLMAENVVTNTAKNIAELKKQKIINQNDVLTKNNFSLIEGDEGFFSLAYPKQSM
SQGFVIFPKKGDIATPGYLKKSVDSLIAQVTLDNETLDKSLNDYFHSSVGAGRTDVDLKY
KYLYPGLTNPVPAGIAAQLINYGSPFLVKGYIPKELKDYKPGLEKGILISETEYDNLKLF
YTEVYQKTGAERADFNQSRAIKEYVSLLKKYNPTVKFLDKGDLYEQPMSYAVGISTGFDN
SEEELMSKYNLKGWRKSKIITNETVRTYFRHYKDLADRMLSHRNNPAVKIEQNGQIFYWL
NEYFMPTMLPTEEPEFTKH
>KALACAFP_00498 hypothetical protein
MNYFQKNKKNIIIGVIATLLIAALVALWLQKKVIHSADDIVGVVYPSSVAVGDTLLFEDK
TQFAKTKRWSFGDGTTSDKSSGIHFYNKPGYYQVTLIIDNKYSKSFPVMVSARGLPKPKD
TTKNKTLIDAQTQAMQFENVQFRAVSDAKQFTWKFGETGNIDSKDKLAIYSYKKPGDYIV
TLYTDESEEPILHQIKILPAYDALEEEVSVEDAYAKIDNDFKYHLQQIANGNSFNMHYNY
LLRTYLCNNENTVVKVNDSKVNNFYMYCAGLQFDKNNVIQTVKVNFDDAQNCVTKIDINQ
SK
>KALACAFP_00499 hypothetical protein
MQGQITLSKKERHYQFLYLILMLLAALIFLGIIFLKGFESPFSDEDIISIRNLEEKTKFD
QEQKFTYKLMDSTFSQINRLTDQPPQPFTENNIMNGINDVANQLANDNTTDIRKDAFPQI
AKFYKMYFDDKKIISSKTENIKSFQKQFEECSIGFKEKKNQLFQRETALKSRTQ
>KALACAFP_00500 hypothetical protein
MFFIISLKKLNFVNKLFFYNFTGPNKSQNMSSNREKKLNKSDVRIGIWKFVLSFVALSAV
SFICVFFFFKSYDQQREGIKKQADDYRELLTRSDLLRTHVDSIYYRMNQLDINKVDNDII
LKNYIMDNVQDAKNIMGKDSADNFKHYSILMKQIEPMLALKNQIVKVSYDEQIALRDLSE
CRGKVGIVNNELRVDPTRKFTGSRRRR
>KALACAFP_00501 DNA-binding transcriptional activator EvgA
MIKTLMENPFYMLLNDCNNGHELISRNYRRQEDVFVVELFMPVLSGLEAIKYIRKSNIET
PIITYSGTYQEDMAEILSKIPNIFYCEKKSNVIKDIIKGKIASNSFDYETYTKEWEQQPL
AVMEYMDRQKKSQEELSPTEIQLMKFCYEGFSNKEIGEKLNLSTRTIDTYINRLTEKLGL
KTKLHLIRFCVENGYYNSSM
>KALACAFP_00502 DNA-binding protein HU
MTKAELVNTISNKLGTEKNETQKVVEAFMQEIRTSMYNGDNVYLRGFGSFIIKTRAAKTG
RNISKNTAIEIPAHNIPAFKPSKSFVEKVKTKVAVK
>KALACAFP_00503 hypothetical protein
MPSGKKRKRHKVATHKRKKRRRANRHKKK
>KALACAFP_00504 Ribonuclease E
MKKELIVSHEDDLTKIALLEDGRLCELHEQEDKSDFIVGDLFIGKVKKLAPNLNAAFVNI
GYEKDAFLHYQDLGPQYLTYRKFLRDTISKKQNASSLKNFEIQPEIDKNGTVDKVIAKDD
LVLLQITKEPISTKGPRISTQVSLTGRFLVLIPFDNKVSISKKVKSFEEKERLRTLIESI
KPEGFGVIIRTVAEGKKVADLHNDMNQLIQKWETTFKNIQKNKVPSRVLSEDDKASAILR
DNFNQDFVSITCDDEQMVEEMKNYLEVIAPERKNIVHFYNSHIPLLEYYNVEKQLKQSFG
KHVNIPSSKGAYLVIEHTEALHVIDVNSGNNITTGAAVNKEHALKVNKMAATEIARQLRL
RDMGGIIVIDFIDMQNPDHRRDLYEHLKEEMKRDKARHKILPPSKFGLIQITRQRNRPEK
QIDTKEENPNKDGEIVAPIVIVERMGETLRTIMQKEKGKLYLHVHPFVEAYLTKGINSFQ
MKWFMKYKKWVTVIPRDSFKYLEYRIYNSNKEELIGYSN
>KALACAFP_00505 hypothetical protein
MKKIILLTLLFISGFYFSQQIHVKYLRVLSPFTTSHEDLYIKNNQTISIQDSIVTQNKLT
GDWTMAVNLDNGKKPTKQYFVSDLNDDSERNFFFTANVDSRDFFIYDKVPKPTWKIEEDQ
TKTIAGYKCYKATGTFRGSKIIAYFTKDLPYSAGPFKFYGLPGLILDIRTENKDHDIWKA
ESVNVDDKSTITFKPKFLNKEKISLKDYVEAKEAHMNKIFAKVAENLPKSSKVITNQRFT
VEQKYEWEK
>KALACAFP_00506 hypothetical protein
MMKKTLLLAAFGVAGLVSAKDNGNVAKETGKKEKTEQKADVQQCGVVITYWSGGQVVGQE
TVYSDQPNLASCQAWQNGVKVALQVAGFWLT
>KALACAFP_00507 hypothetical protein
MGLDTKLRKLREQKGWSQMDVAHQLDISQSAYNKWEAGQAKPTLLNLQKIAEIFEVDFFD
LIQEQIPNLDLSNAKFENSPFFVIESTHNTISYDSPELISKILDNQNQMAKLMEMQNKLI
ESLLKK
>KALACAFP_00508 hypothetical protein
MKNHHYKTTIQWTGNRGSGTSSYRDYERSHTISAENKPVIEASSDPAFRGDKTKYNPEEM
LLSSLSSCHMLWYLHFCSEAGIIVTDYVDHATGIMEETNNGSGHFVEVTLHPTVTLQNEE
MTEKAKELHHKANEFCFIANSVNFPVKHIPTVLVK
>KALACAFP_00509 Oxygen regulatory protein NreC
MMKPRLTIFDEPLLYTEGLSKLLDQSEIFTSVHICNCPQALAMILQEDPPEFLMISSNML
ILTDLYKSIENITSNNKGIKIIIIGSDYDVIDIRKLFNKGIKSYLDKNSRYDEFIKSIQA
LLHNEIYICDHAKERMLNFISSEQEQTRAHMRDPLTKREMEILKLICDGLSSKDISEKLF
ISINTVETHRKRILLKLNVKNSVGVVKYAIENHIID
>KALACAFP_00510 Protein TolB
MKTLIKIISIFILSLCLFSCDEELVDQAQTGSMKGKVVKRGTNQPIANVKIFTSPSTQTV
FTGTDGSFEITGMPVGNYSVKAELTGYVTNYQGVNIQNQNQVVTVVFEMDDDTSLNSPPT
APQLLSPIDNATDQPLSVELTWSSTDPDTTDVLKYNLTIKNNINTNVVQVNDLTATHYTL
NNLNYGVSYFWQVSVSDGIHPPVLSPISKFTTNTVPTNRYHYVQKQGGNFVIISSNDTGT
NFQFTNSSYNSWRPRKNNNSGLIAFLRTEGGSNHIYTANPDGSNLFKVTTVPVAGFRNDE
LDFAWRNNGQELLYANFNKLYRINKDGSGLNLVYTTPDGSMISECDWSYDGSKIAIKTND
FSGYNTKIYVIDMTGNVLETVLTGTTGASGGLNFSVDGQMLVYTRDLSGYTDSSGNYRQL
DSHIFVYNLMTDTTYDISSESEKAMGTNDLDPRFSPNNAQVIFMNTSNDNISQKNVMVIN
LNSSMTDLTRAVLFNNAEMPDYE
>KALACAFP_00511 Curli production assembly/transport component CsgG
MRAKTYSRIFFCTILLCITQACSSLLGLPSNPERSTLGENTIYTTELKNMPLPKEKIVIG
VYKFRDQTGQYKPSENGNNWSTAVPQGTTTILIKALEDSRWFIPIERENIANLLNERQII
RSTRQEYLKDADKNSQSLPPLLYAGILLEGGVISYDSNVMTGGLGARYFGIGASTQYRQD
RITIYLRAVSTLNGEILKTVYTSKTILSTSVNGSFFRYIDTERLLEAEVGLTQNEPVQLA
VTEAIEKAVKALIVEGIKDKIWGKSVDNTGNYQVVIDEYEREQDVNKNRLIGNKFPDNYR
QKFAVFGNVEAQKIKDDYVNPKMNIGGKLGFKYFFSPNFNVEINANIFTLENENIVKRNF
FVPEVNLEYLLFPKYRFSPYIYGGGGIMYSNIKPRYKGQFGGGLEFMLAKNIGLRASSQY
DVGFKDDWEGLVNGKRKDQALRFALGLNFYIGNK
>KALACAFP_00512 hypothetical protein
MKTFVIFLTIVAGMFFGKSQQLVYKPLNPAFGGDTFNYQWLLSSANAQNQFDQKNDYDSL
LDNLNSLDSFSNSLNRQVLSELSRKLFEDQFGEGSIQPGNYLFGTMYLQVTTTAQGLLIN
ILDTATGDQSEVIIPK
>KALACAFP_00513 hypothetical protein
MINSYSLILCTFFIFLSALVHAQEDKKVTAKIESSFVENQIKLKAVVSNSTTIYKELNYL
LVSIKKGSSGNLSNNQQSGKFSMNPNEVKVLSEINVNLEKKDALKAFLYIKDEETQKLIA
KDSLELNSDLFKKKVAKIEEEVFYELKGLTIDETKSKIGKDFYDLFYIQYSQSQDKNNSA
ITISELPVRGTNGQINIEIDDKVVYSFMTNPSEDYLKEQLTNTLKYIKDYNAKKNLIKNE
FIY
>KALACAFP_00514 hypothetical protein
MFKLGWSVITLLLFTTLKAQQIDWEKINSNTILNIIAVQNPDLSVSPNILQIGNNNSVEL
SINAKTDIAVRQLGEYNTLYFVNSFTDTENKTTISAQGNNNIIDVTGSNSISDGMQIHVK
GDNKTIFVRNY
>KALACAFP_00515 hypothetical protein
MKNFITSVFTLMAVSFTFAQANIDMSTQTGNMNTATVDQTGLMNVNELTQDGNRNTADID
QIGIMNTNDAESIGNRNSVDVNQLGLGNSNEVSQQGNRNEATTWQIGAFNSTEQTQMGRR
NEVLSIQLGSDNTAVQYQDGRRNNATSLQWGDDNTSAQVQLGRRNDAVGMQIGDDNLLVQ
YQQGNDNSATHAQVGDDNIAAAVQVGDDNVALGGQVGSDNLLVQLQIGDGNSALDSQVGD
GNIAIISQSGDAHVHVGTQIGNNNSLMVNQSN
>KALACAFP_00516 putative Nudix hydrolase NudL
MSFGKDLLRKIKSAELPGENAHGVFSPPYRPVFTYEEALANNPKFAAVNIILYLKNDEWH
FPLIQRTVNEHDRHSGQISLPGGKREEMDRDFAETAIRETSEEIGIEKHYVRIIREMSPI
YIPPSNFYVYPYISYTKKNPQFILQQTEAVETIEFPITCFLNLPDNPEIMALPSAGGKEV
PVINFNGYIIWGATAMILSEFSQLLKKM
>KALACAFP_00517 hypothetical protein
MAKKNIFTDAFGTPYFLKRLIIFILGIVSYRRFNGFNKLKITGTEHLVDLPDSNVLFVSN
HQTYFADVAAMYHAFCAVNNGYLNTIKNPIYLLNPKIDFYYVAAEETMNKGILPKIFKIA
GAVTVKRTWRAEGKNVNRLVDMSEVDNIMKALDNGWVATFPQGTTAAFAQGRRGTAKLVK
NQRPIVIPIKINGFRRAFDKKGLRVKVTGVKPTMEFKAPLEIDYDKENAHEILLKIMTAI
EQTEDFNLLHNYDEELKAKKLEQKDSNN
>KALACAFP_00518 hypothetical protein
MKRIIGILFAIIVLVSCNSQKVYSDFEISYSKSGGYAPVYENLLINGNNAHYSFEGQGKK
YKKDFKISEDDLTKLNNTLSQNNFRKIEEDRKKLYDNITTSINIKKGPNEGSKTDASLIM
PNYKTNWENITKAFQEIINNNVKK
>KALACAFP_00519 UDP-N-acetylmuramate--L-alanyl-gamma-D-glutamyl-meso-2,6-diaminoheptandioate ligase
MKTHFIAIGGSAMHNLAIALKDKGYQVTGSDDAIFEPSKSRLENKGILPAEMGWFPEKIT
SDIDAVILGMHAHQDNPELARAKELGLKIYSYPEFLYEQSKDKTRVVIAGSHGKTTITSM
ILHVLNFHQKDVDFMVGAQLEGFDCMVKLTQDNDFMVLEGDEYLSSPIDLRSKFLLYQPN
IALMSGIAWDHINVFKTFDDYVEQFRKFVASITPGGILVYNEEDAEVVKVVEGAENYFRK
IPYKTPEYEIINGKVHLKTEMGDVPLSVFGAHNLLNMEGARHICHTLGIMDEDFYEAIMS
FKGASKRLEKVEREDKGTLYKDFAHAPSKVKATVKAFQEQFKNEKKYGFLELHTYSSLNP
VFLEQYDHAMDGLDEAIVFYSEDALKIKRMEPISPELIKEKFKNESLKVFTSAEDLHAYW
NTLDKTQGVYLMMSSGNFGGLDLTK
>KALACAFP_00520 hypothetical protein
MNSEKDKKPAENALPEASNEQIEQAGQSSGNTIMEVSAYSTTLLYQNAAHSTGIMYQNSV
SNQNNLNILGQAAANQGVMQIYSINTLTDTVYIDKILNPGNVRLAPTQLENKQPENDNKD
EK
>KALACAFP_00521 hypothetical protein
METDLKLKLEQLHQRVDSLKDQINTEEATKNAFVMPFIQILGYDIFNPTEVIPEFICDIG
TKKGEKVDYVIKKDNEPILIIECKHWKESADAHNSQLHRYYHVSKARFGVLTNGHIYNFY
ADLEKPNIMDEKPFFTLDLSNLKDSSLKILENFTKNGYNLESILDSAEDLKYIKAIRSEF
EKELQNPTDEMVKLLVSKFFDKPITAIRLATFREYTKKAFSNSINESISFRLKNALNMND
IVPSKEKDKAPAIDENVDTPKFITTEEEIEGSQIVKAILREVLPATRIAFRDTQSYFGIL
LDDNNRKPICRLHFNSSNKYIELFQNGKDSGEKKLLNSLDDIYNHKSELLSTLKNYE
>KALACAFP_00522 2,5-diketo-D-gluconic acid reductase A
MQQKTYTGQPVIRLNNGVDIPALGFGVWQMEDLQECENAVIKAIEVGYRMIDTASIYLNE
TAVGNAVKNSGVDREELFITSKLWVQDHGYEKAKSAFQRTLDRLQLDYLDMYLLHWPFGD
FLGAWKALEELYHEGKIKAIGVCNFTIEKMEELKENSKVLPVINQIELHPIFQQKELQVY
DRENNIVTQPWSPLGNGNTGLLDNDKLKEIASKYNKTVAQVILRWHLQEGFCVIPKSVTP
SRIEENFNVFDFELTEDEMNVVRSLDTGKRLFFDPKDPTWEQKMLNSVADI
>KALACAFP_00523 Glycine cleavage system transcriptional activator
MVNLEWYRTFKAIYKTGTLTGAADALFISQPGVSLHLGSLEAYVGYKLFDRTGRKMIPTE
RGKVLFNAISEPLTKLEDVEKNFQKSTEKHTPTISVGMCFETFQTTLEQYVSTLPFNLII
SFGEYPEMLDQLDKGILDLIITPKKGTSPNILHEAFSSEQIILVGGKDVDTGSFLETLNS
KGIEHAEEWLKQEKWYGTTGDMEHLFQFWILNFGHKPNFRPNYIVPNLNSIIRCLKGGAG
LAVVPDFLCKNEIDNGEIKLIWEGEKKLENTLYFGCRKNTMYHEEIDHIKGLFRKMMGNK
ERLEVRS
>KALACAFP_00524 Modulator of drug activity B
MKKVLIINGGQNFGHSGGKYNQTIAENTLEVLKGFENVEVKITNVDNGYNSNEEVEKFVW
ADYIIYHTPIWWFQLPNGLKKYIDEVFTAGHAKGIYMSDGRTAENPKINYGTGGMLGGRK
YMVTTSWNAPETAFTLPGEFFMETSVDDGPLFGFHRMNAFVSLEKMESFHFHDVEKNANI
ERDMKLYREHLTTVFEKELKPQLA
>KALACAFP_00525 Putative monooxygenase YcnE
MKIYLTAIINAKEEYRNEVLEVLQNMVKETRKEEACELYTLHQGIENKNQFVFYEIWKSE
EGLAQHNQQPYIQAFGALVDEKLQEKPQIYLTEII
>KALACAFP_00526 Molecular chaperone Hsp31 and glyoxalase 3
MKKLALLILTLFTIGFIQAQTKKSKNMKKKILFVVTSHDKKGDTGESTGYYLGEVSHPWE
VLHNAGYEIDFVSPKGGTPPVDGFDLKDPVNKEFWENTEYKNKIDNSMKPSQVNPNDYST
IFYAGGHGAMWDLADNTELASIASKIYENGGIVAGVCHGPAGLVNIKLNNGKYLVDGKKI
NAFTNEEESEVKLTNVVPFLLEDKLKERGAKFEKSGLWQNHVVSDQRVITGQNPQSAKSV
GEAILKELNK
>KALACAFP_00527 hypothetical protein
MNLLKTFTLLITIFMMNTFSAQQKDTCRYIKTPTGYLMVLRQGDDVIAHLENMAKTENMP
SASFSGIGFASDVTFGFYDFNAKKFNPKTFNKVEMGSLTGSIAWNEKGPSIHVHGVATDD
KFNAYGGHILDLHVGTGSMEIYVTVHDQKLERKVEQPLNANVLQLNCLK
>KALACAFP_00528 hypothetical protein
MSTRFNMATTDAAAYKALLGLEGYLQTTSLNHTQKELIKIRASQINGCAFCIDMHTKDAL
KYGETPQRIFLLNAWREAKDFFTEEEQVLLQMTEEITLISQKGLTDETYYKAKQLFDEAK
IAQIIMAIITINAWNRIGVSTHLPIAK
>KALACAFP_00529 hypothetical protein
MADKKDIQFPQLFLRLALAVTMLSAVADRFGFWGKNSAWGNWENFEKYTKQITSFLPDIL
SSLSAYFATFFEILFPLMLIFGFKTKMAAYGAGFLLLIFALSMTLSLGIKAPLDYSVWIG
SAGAFLLASQEKYSLTIDNLTKNL
>KALACAFP_00530 hypothetical protein
METFKAHLDKFISINDEELASVLSFFQVMEVKKKQNLMLEGEVCKSMFFVLKGCLRKFFI
NEKGVEQTTDFAIENWWITDTFAYERQTKSNFSVQAVERSIILVIDFHSQELLLEKHPMM
ERYFRMIYQRAYAASERRIRYLYEFSREELYMQFSTQYPGFIQRIPQYLIASFLGFTPEY
LSEIRAKLRS
>KALACAFP_00531 hypothetical protein
MEIVAKILIAVVAIEHIYILWMEMFAWETKGKEVFKSALPAEMFKPTKGLAANQGLYNGF
LAAGLIWSFFIEDPKWQTNIALFFLICVAVAGIYGAVSATKKIFFVQALPAILAIIAVIL
R
>KALACAFP_00532 hypothetical protein
MRLLTIFLFLMLVPCFCLSQMKTGTFSDIETYQKENPKPTIIHIFTDWCSVCKIESFQLK
KDKDLVKMLNESFYLINFEAEKTKEKISFQGQDFSYLPNGNSGIHELALALSKNKNQPIY
PLWIILDKDQNLVYYHEGKFKPDEMKKKLKEISAL
>KALACAFP_00533 Colicin I receptor
MLVLSNNFNFMRRILLSAIFFFGYCFSQETDSLGLNQSKKLDSVSVSDKKEIKTKVIDDV
VITGTIKPISKSKSPVAVEIYSQKFFQKNPTPNIFEAISMVNGVKPQLNCSVCNTGDIHI
NGLEGPYTMILIDGMPIVSSLSTVYGLSGIPNSLVDRIEVVKGPASSIYGSEAMGGVINI
ITKNALTAPKLSVDLMTSTWSENNVDLSTKFNLGKNAASLLSLNYYSFEKKFDFNKDNFT
DAALQNRISVFNKWNFQRKENRQASFALRYLYEDRFGGEMQWNKTYRGSNEVYGESIYTN
RVEAFGVYQWPLKENIITQFSYNFHDQNSFYGSNPFMATQKVAFAQTYWDKKLGNHDLIL
GLTFKKTFYDDNTPGTLSADGFTNEPMRSPIFGAFIQDQWEINEKNTLLLGYRFDYDKIH
HSVHSPRFAWKFSPNPYHTLRFNFGTGFRVVNLFTEDHAALTGSREVVIKSNLKPEKSIN
GNLNYVWKIPVGDRMINLDASAFYTYFSNKIVGDFDTDPEKIIYDNLHGYGISRGASLNV
DYNFSFPLSINLGITYLDVYQKFDGTNEKSQQLHAPKWSGTYNLTYKFPNNLAIDFTGQF
YGPMRLPVLPNDYRPEYSPFYSLANIQVSKSFKSGFEVYCGIKNLFNFTPKDPLMRPFDP
FDKYVDDPVSNPYHYTFDTTYGYAPMQKIRGFLGVKYILK
>KALACAFP_00534 Homogentisate 1,2-dioxygenase
MRYHQSGNIPQKRHTIFKSPEDKFYYEQLFGTEGFHGISSLLYHIHRPTQIKSIGEPKDV
TPKIAVDKNVTPRMFKGMNVTPEDDFMDSRKFLMVNNDLKMGLSKPRKSMDYFYKNAECD
ELLYVHQGSGVLKTFVGNLDFFIGDYLIIPRGTIYQVELHSDDTVFFVLESHSPIYTPKR
YRNEFGQLLEHSPFCERDIIAPTFVEPKDEKGEFLIKVKKENQITDFIYATHPFDVVGWD
GYFYPYKFNIKNFEPITGRIHQPPPVHQNFEGHNFVVCSFCARMYDYHPMAIPAPYNHSN
IDSDEVLFYTEGDFMSRNHIDLMDFTLHPGGIVHGPHPGAMERSIGKKFTEEYAVMVDPF
RPLKITEEALKVEDPSYKTSWLEDQDKTMEDRSQE
>KALACAFP_00535 Succinyl-CoA:coenzyme A transferase
MYNYISAEEAIYTIKSGNRVFFHGSACTPNYLIDELARQSHRLDHIEMVSITQQGNVEIA
KPEYKDKFFINSLFVSGPVRDAVNSERGDFVPVFLSEIPILFRKNILPLDVALITVSPPD
KHGFCTLGTSVDVARSAVDTAKIIVAIVNPLMPRTHGDGMLHISKIHKLVWHEEELPTVD
YGAKVGPEEMEVGKNVAELIEDRSTLQMGIGTIPDAVLKCLGNHKDLGVHTEMLSDGVVD
LIQNDVINNKYKGYHNNKTITSFCFGTRKLYDYVDDNTVFAFNDVSAVNFPINIMRNKKM
VAINSAIEIDLTGQVCADSIGTMQYSGIGGQMDFMRGAALSEDGKPIIAITSRTKKGVSR
IVPFLKQGAGVVTTRGHIHYVVTEYGTAYLYGKNLRQRAQELISIAHPDDREMLERAAYE
RFKH
>KALACAFP_00536 hypothetical protein
MKTIYNSIREEVVKHSKVKNSVLGNVNEWKRSHYIILSEIIKEELSEAEELKGGKKFEIG
STISHVTLQRFFENDYQDKTHNDLRFLKTLDKICIFLGYKDLNAYIQFVKEKKQDNEKSN
NEKFLQMVYDYCATVFEFYKQFPNHKTELFKDLVFDESPFLERASQFSKELCDRDFQLVT
KNNRSNYEVFDINIVTDEPDKKILESQEFWNLLFKVGETGEEHFVNQLNTQIYFIRKIDN
VWKIWDNYNPDAGRLNNIK
>KALACAFP_00537 4-hydroxyphenylpyruvate dioxygenase
MSTLTFAEKIAQAENFLPINGTDYIEFYVGNAKQAAHYYKTAFGFQSVAYAGPETGVRDR
ASYVLQQGKIRLVLTTGLKSDSPINEHVKKHGDGVKILALWVDDAYKAFEETTKRGGKPY
LEPVTLTDENGEVRMSGIYTYGETVHMFVERKNYTGPFMPGYEKWESDYKPEDAGLLYVD
HCVGNVDWNRMIPTVEWYEKVMGFVNILSFDDKQINTEYSALMSKVMSNGNGYAKFPINE
PAEGKKKSQVEEYLDFYEGEGVQHIAVATKDIIHTVTELKKRGVEFLSAPPEAYYEMVPE
RVGHIDEDIKKLQSLGILIDHDEEGYLLQIFTKPVEDRPTLFFEIIERHGAQSFGAGNFK
ALFEALEREQEKRGNL
>KALACAFP_00538 hypothetical protein
MRKFLIGILFFGATFGLKAQYGSLNDILTRLEERKGINQHLETVNIDNKKFVYIKDEADH
TERDFIVIKGNKATYVEVFDDKATGETSSNVFTGDIVRKKNIVSLRADMLENKKVPIPVT
KTLLLTRQDDILYLIDVNTKARWIDEESFSKAKAKSKK
>KALACAFP_00539 hypothetical protein
MKSFVEYSSNSDFSIHNIPFGVAVFNKEYIGCCTRIGDQVIDLATLYDLAYFEDVEGLDD
NVFEAYTLNEFIELGKPVTNAVRLKIQELLQEGSTLSKDEKTIEEAFYDLDKVKMMMPVH
IPNYTDFYSSIEHATNVGKMFRDPANALLPNWKHLPVGYHGRASSIVVSGTEINRPKGQT
KPADVEKPIFGPSKQLDFELEMAFIINKNTEMGESISTKDAEDAIFGMVVFNDWSARDIQ
AWEYVPLGPFLAKNFGSSVSPWVVTLEALEPFRTASPKQDPEVLDYLKFEGDKNYDINLE
VYIQPENGEQNLICQSNYKHMYWNMTQQLAHHTVNGCNVEVGDLYASGTISGSDPKSFGS
MLELTWRGQNPIQLSNGQERKFIDDNDTVTMKAWAEKDGVRVGFGEVSGKIIPAI
>KALACAFP_00540 hypothetical protein
MKTVIPSEISPVQLQLVMQTAVSPRPIALASTVDRNGNSNLSPFSFFNMFSTVPPILIFS
PSRRVRDNTIKHTLENVLEVPEVVIGTVNFPIVQQISLASTEYEGGVNEFIKSGLTMKDA
DLVKPKLIEECPVNFECKVLEVKHLGDQGGAGNLIICEVQKIHIREEYLDEQGNLDQRKL
DMVARLGGNWYSISNENSLFEVPKPLVTKGIGFDLLPDEIKLSKVFTGNDLGMLANVEVL
PSGAYHSEENIHQEAQKLLLESRIEEAWKMLMK
>KALACAFP_00541 hypothetical protein
MNITKKQNIIISNPETRDFLADAFYPETNEKLPLIIFVHGYKGYKDWGAWNLIAEKFAEA
GFFFVKFNFSHNGTTVEDPHNFADLEAFGNNNYSKELSDLGAVIDFFVKDPKVDDQKIVL
IGHSRGGGISMIKTFEDERINGLITLASVDTLDRFPKNDAFEKWQQAGVYYVLNGRTKQE
MPHYYQFYEDFEKDHHRFDVERAAEMAKAHVLIIHGTNDESVSMKNAEHLHILNPLSELL
LIENANHTFGAKEPWEESDLPEDLNVVTEKCIEFINEKIVNE
>KALACAFP_00542 hypothetical protein
MLDLRTVTVMRYILPLREGGSLPALAEADDDFKYVLKFRGAGHGVKMLISELLGGKITEA
LGLKIPELVFVNLDVDFGRTEADEEIQDLLKFSEGLNLGLHYLSGSIAYDSSVKIDPLLA
SKIVWLDAFITNIDRTFKNTNLLMWHKELWVIDNGASFYFHHSWQNFDTAAKTPFKYVKD
HVLLPQAKMLDEADRFAKEVLNESVFREIVNLIPEDWLHWNDADETPEEIREVYFNFLKT
RLENSEIFLNEAKNARG
>KALACAFP_00543 hypothetical protein
MQEDKIYEYAVIRLVPKVEREEFFNIGLVMFSKKEKYIRVEFYLCPDKFRLMHSKLDYDD
IIQNLESFQKIANGEKDAGPIAQLDIPERFRWLTAVRSSVVQTSRPHPGKSKDLDKTFGK
LFEELVK
>KALACAFP_00544 Carboxylesterase NlhH
MKSINNKIIYRFSMNLFFVFFLSFYTLGFSQNQIEPETQKSFVLPEKTSFSENIVYKKSK
TGKSVFLDIYRPKNVSNAKTPVVIYVHGGGWVGGDKIIRADSYIETTILKLVEKQYSVIS
IDYTLVNKDVHFPLPLEDTKDAIRWVRKNADTYNFDVNNIGLFGASAGSHLSMLAAYTKD
NEFVGDPELSSYSAKVKYVVNNFGPTDLNKLLHTRAGKIPVFFIGLLAKNIVDLREKLVL
GLSGYDIKKDKRKVVEYLKTISPVTYVDNGIPTLILQGDKDKIVPINQSKKLHKKLNKED
IENKLTIVEDGNHGFRTTDKAYLDQLTDEMVNFIVAQKK
>KALACAFP_00545 hypothetical protein
MKIKNLLRTSALCFLVISCSSDDSPELPDQNENPSTETMYFPPSNSDVWETKSISALGWH
QDKVQDLLTYLETKNSKSFIILQNGRIVMENYFSGHTSTTPWYWASAGKTLTSTVTGIAE
QEGFLNINNKVSDYIGTGWTSEPLAKENLITCKNLLTMTSGLDDSLGDVVSPANLQYKAD
AGTRWAYHNVYVKLQDVVAAATNQTWSQYFNIKLRDKIGMTGNWVQSGNNSVYWSTTRSM
ARFGLMALNNGNWNGTQIINSNYFQSATNTSQNINLAYGYLWWLNGKSSYHLPQTQIQFN
GKLIPSAPDDMFCALGKNDQKIYVVPSKKLVIIRMGDAADNVNLALSDFDNTLWQKINAV
IN
>KALACAFP_00546 Lipase 2
MARLLIFLLAFLFSTPFFSQEYSLISNVHYYDEKVNQSDVYINERCVLDIYVPKNVKNFP
TVIWFHGGGLTGGQKEIPEALKNKGIAVIGVNYRLSPKVNAPKYIEDATAATAWVFKNIK
NYGGSEDMIFISGHSAGGYLATMVGLNKMYLNKYGINANQLASIIPFSGQMISHFTTRKE
KGIDELDARIDEMAPLHFIRADAPPLLLITGDREKELLGRYEENAYMARMMKLKGHKDTT
LYELDGFDHGGMAQPAFPLLLNEIKRVQKLKNKN
>KALACAFP_00547 Glucosamine-6-phosphate deaminase 1
MKLNLLEETRFEKVPVSVFENSKTASVHVAHRIAEIIRKKQAEKTFAVLGLATGVTPIAV
YAELVRLHREERLSFKNVITFNLDEYYPMQSSSAQSYVTFMNENLFNHIDIPKGNIHIPN
GTIAMSGIPSFCLEYEKKIESLGGLDIQILGIGRTGHIGFNEPGSAPNSGTRLVTLDDLT
RRDAAHDFGGKAFVPTKAITMGIGTIFKAREIILMAWSRKKATVIKKAVEGDISGEVPAT
YLQLSNNVEFILDEAAAAELTRFDTPWLVKDCIWTDDLIHKAVIWLANHLQKPILKLTDD
DYNTHGMAQLATEKGPAYNINIRVFNKLQHTITGWPGGKPNADDSQRPERAEPSKKNVLI
FSPHPDDDVISMGGTFIRLVDQKHNVHVAYQTSGNTAVWDDDALRFVEFNLDFSEKMKID
NKSLKDVYQKMRTFLEHKKPNQTDSPEIQTVKSLIRKGEAIAGARYCGLNDDHIHFQSLP
FYENRENKKNPVSEKDIELTIQLLQEIKPHQVFAAGDFEDPHGTHLVCFNIVLEALQRLR
RTETWAKDCWLWMYRGAWHEFETHEIEMAVPLSPKELEQKKQAIFKHQSQKDKAVFPGDD
SREFWQRAEDRNRETAKAYDKLGLAEYEAMEAFVRWKFE
>KALACAFP_00548 ATP-dependent DNA helicase PcrA
MEDYLKGLNESQFEAVTTLQGPLMVLAGAGSGKTRVLTMRIAHLITNGVDPFNILALTFT
NKAAREMKERIAKVVGQSNARSLWMGTFHSVFARILRSEANYLGYPSNFTIYDQQDALNV
IKKVLKDMNIDADLYKPKKVQARISTYKNNLITVKAYFNNPELMEADEKANMKFIGQIYQ
RYVEQCFKNGSMDFDDLLLKTNELLTRFPEVLAKYQDRFRYILVDEYQDTNHSQYLIVKA
LASKFENICVVGDDAQSIYSFRGANIYNILNFKKDYPDAVTVSLEQNYRSTQNIVNAANV
VIAKNLQQFKKNVFSENEEGEKIKVYRSLSDADEANFVAGNIWEIRNREQRKYSDFAILY
RTNSQTRAFEDALRRKNIPYKVYGGLSFYQRKEVKDLLAYLRLLINESDSEALMRIINYP
ARGIGETTQNKLIVFADAQNVSVAKVLDNLPIYAPHLGFNNGVLNKLNDFWSMIKAFEVL
LKTETAYNVAMEVAKRSGLIKFLKDDQTPEGISRVENVQELMNSMQGFIEEQMQLEDGDP
SLSNFLENIALSADTQDKESEDEMVSLMTIHLSKGLEFPVVHLVGLEENLFPSFMSSATR
EDLEEERRLFYVALTRAEKQVFFSYAISRFQWGKITDAEPSRFLSEIDEQYIEFVNPAIE
KRFINNSGVRSNIFDEHPSEMRSFKKVEKKTIERAEGSKPIAEPRKLKPVATAKIINPSG
ASSQDIEVGDKVRHDRFGIGEVTFLDGTDPQNIKAKVIFQHEGEKNLILKYAKLTKI
>KALACAFP_00549 Bifunctional ribulose 5-phosphate reductase/CDP-ribitol pyrophosphorylase Acs1
MDSKKLKIIVIGSSGTIGKEVSKNLEGNGHEVIRVSRNSGDFHADIQDKNSLEQLFRSVG
NFDAVANAAGDVKFGPLENFTDQDFAFSFESKLMGQINIVRTALPFINDNGSFTLISGVL
TDEPIAGGIIGTTVNGAIEGFVKASSYELPRNIRINCISPTVLVESEDYHPFFPGFIPVE
AWKVAKAYEKSIAGVFNGRIIKV
>KALACAFP_00550 HTH-type transcriptional regulator ChbR
MDYVDINSISELHDFFRYEKPLHPLVTVVDLAKVDRSHRKPDAVYRLDLYSIACKKIEGS
FQYGRTNYDFSEGTMMFTAPHQTLSPGMENKVSGWGIYIHPDFLNATGKGHKLTEYSFFG
YDTSEGLHISEAERLVLEDCVKNIQKEISLNVDKHSYHIILTNLELLLSYCERFYERQFF
TRTKASNDVVANFERLLNDYFAQETLVQSGIPDVAYFAGKLNMSPNYLSDLLKKYTGKSC
QEYIHLKLIDKAKALLWSTDESISGIAYDLGFEHPSHFTKLFKNKTGMSPKSYRNLN
>KALACAFP_00551 3-oxoacyl-[acyl-carrier-protein] reductase FabG
METNNHNQKIAVITGGSRGIGKSIAINAAKRGIAVILTYNNNPEQGKAVAEEINANGGKA
IALKLNVADISTFSGFADEVSKTLKDWGRDSFDYLVNNAGIAQRTLIKDTTEAIFDELIN
VNFKGVFFLTQQLEPLMENGGQIINISSGLARFAFPTVAVYGAIKAGIDSLTRYFAKEFA
DKKIRANSVAPGAIDTEFGGGKGDESHRQQIAGMTALGRLGEADDVGLFVASMLSDDSRF
VNAQRIEISGGIYI
>KALACAFP_00552 putative zinc protease
MKKRLLSVAAAAFFGMALNAQQIKFEEYDLPNGLHVILHQDNSAPVVTTGVMYHVGAKDE
VKGRTGFAHFFEHLLFEGTPNIKRGEWFKIVSSNGGQNNANTTNDRTYYYETFPSNNEQL
GLWMEAERMRHALINQVGVDTQREVVKEEKRLRMDNQPYGNLFTTIQKNLFTNHPYNWPT
IGSMEDLNAAKLDEFQAFYKKYYVPNNATLVVAGDIKPEQTKKWIQEYYGGIPKGTLYPK
NFPKDTPITQEKEVTATDPNIQLPAYVFAYRTPGNKEKDAYVLDMLSSYLSNGKSSVLYK
KLVDQDKKALQVAAFNQGLEDYSIFAFFAIPMGQTTKATLQADIDAEIKKLQTTLISEED
YQKLQNQYENQFVNANSSIQGIAASLATNHVLMGDTNLINKEIDIYRSITRQDLQNAAKK
YLNSNQRIIINYVPEKK
>KALACAFP_00553 putative zinc protease
MKKQLTYIAAAFFFTGMVSAQKIDLNAMPKPGPTPAINIAKPKTFQLSNGLTVMVVENNK
LPRVTANLSMDRPPYYEGSVAGVSDIMAEQFENGTTNMSKDDFNKKVDYLGAGLNFSSNG
ASANALSKYFPEVLGLMADAIINPKFSTEEIQNSKERAIEGLKSSEKNASAIASKVSNAL
MYGKNTSRGEFETVESINKIQLADVQNIYKKYYAPDNAYLVIVGDVKFDQVKPLIEKSFN
GWKKANTPISPLEPASNVAKTEINVVDVPSAVQSVVSVNNLNNLKMKDPNYFAAVMANYI
LGGGGEARLFMNLREKNGFTYGAYSDMSASKYSPDFSASASVRNEVTDKAVKEFMNELNA
ISTVKPEELENAKAKLKGAFILSLEQPATVARFALNQKVQDLPSDFYTNYLKSIDKVTAA
DISNAVKATILPNQSRIFIAGKASDISEGLDKLGYPVKYFDKDANPVAKPTTQKVDANVT
VASIADKYINAIGGKANLEKISSYTMNASMTMQGQTIDFKIIKAQGGKELTTVTAMGQVV
QKQVFDGKAGYSEQMGQKVPMKAEQIAEKQKNPELFEELGFAKSADYKVAGIEKVNNEDS
YVVKGGDTTYYYSVKTGLKTGETKTVKAQGKEMTIPTTFSDYKDVSGVKMPYSISVNQMG
MDMTMNVKSYEVNQAKDADFK
>KALACAFP_00554 hypothetical protein
MDSIFILLMVLIMIASVLLVIIVMAQNPKGGGLSSTFGGASSAQFGVQRTNDFMEKATWT
LGGTIIVLILLSVVLTGKPAQTAPAQQQPVKQEAPAKSAPASSTPAQTPATK
>KALACAFP_00555 hypothetical protein
MISLKNKKILFLSVSFFKYERAIAKRLTEMGNEVDFYDERPSNSNISKGIIRLNKRLYHL
KINKYYNRILDDIKHKKYDYFLLIKGEAIPAFFLEKIKESNPDMEMIYYNFDPLTEYPNL
ISNLKYFDKKFTFEYNDSVKYNLNFRPLFYLDEYKNLRQNQGVPEYDIVFIGSAHTDRYI
VGEKIKVIADQLKLRSYFYYYAMGRFTFRLKKIIDKSLKQFDIDKVSFDKLNHDQIIDFY
KKTKSVLDINKPFQNGLTIRTFEVLASGRKLITTNFDIKNYPFYNPDNILVIDRKNIQLD
PEFFKTDFQELGEDVLYKMSLDSFIECLFIKDQDDYWNSFRKN
>KALACAFP_00556 dTDP-L-rhamnose 4-epimerase
MKILITGGAGFIGSKLSLELRKKGYEVTVLDNLSSQIHGENPEEDSPLYRSILGKVNFIH
GDIINLEDWEKAIEGQEVIVHLAAETGTGQSMYEIEKYTEVNVSGTSKMLDLLVNKPHNV
KKVVIASSRAVYGEGKYLHPELGLIYPKPRNVAEMRSGKFDIIYPDGQTLTALPTDEESK
IHPTSIYGITKYTQEQMVMTACSSMGVAPVAVRFQNVYGEGQSLLNPYTGILSIFSSQIL
NGNNINVFEDGRESRDFIHVDDAVEATIKCIENDAANGEIFNVGTGVSTAVTTVAENLRK
FYNIDFEINISGQFRLGDIRHNFADISKIKSRLNFQPKISFEEGMSKFTNWVLQQNIQDV
KFKESLEEMKVKGLLK
>KALACAFP_00557 putative glycosyltransferase EpsJ
MISVIVPMYNAEQSIVSALDSVKNQTFPLEKFEIIIVNDGSTDKSKAIVENYMKENPQLN
IILLHQNNGGVSKGRNTGLKVAKGDYIALLDADDEWHTDKIEKQIQHFENDLQIDFLATA
RNNNKILFPYHVKNGLAEITFRKLLIRNEAQPSTVMFRKKVLENTGYFDDDQRYAEDVNY
WMKVSLKNKMYILDESLVTVGKGKRTFGVSGLSANLPEMAKGFRKNLKEIYILKKISFLQ
YVTFRLFYKAKYLLLLFRTFYYNIRKTKN
>KALACAFP_00558 hypothetical protein
MDILQFSSNTSLDTIKKYSSFLIYLIINSLFIMKYGENYNMLILTVYLLAVPGVSFFYLK
FNFKEVFYKILFWFGVVLFFFLSVYLNYKIDGNSLNVDRWSAMEIGIKAILNGQYPYNIP
DHMGRESSNLPMLIVLGMPFYLLFGSVGYLQSFCFLLFSYLIFKIFTDYKQRLAVLILLF
LSPSYLWEVYVKSDLFSNFIIVAGFTFLIWNKFLMKNNMKLELVSFLSALFLMTRLSSAI
PLIILLFKKFYDFSILEKLRFTLVFIITVAAVAYFFFHNAPGFDVFIKHNPLMIQGAKQP
LLLSLLYIVAAFVLSFKIQSFSDITFRAGTLLFICVFVPFIMYFAKYGYTDMITNSFFDL
SFFNMCMPFVIITLVLGIFKNKFKEN
>KALACAFP_00559 Recombination protein RecR
MDYPSKVLAKAVDEISGLPGIGRKTALRLALHLLKQPNSRAVSLGNSVINLVNEIKYCKE
CHNFSDFDVCEICSNEKRNDELICVVEDVRDVIAIENTGKYSGKYLILGGKISPMEGVGP
NQLNIPSIEKKLNGGRVKELIFALSATMEGDTTAYYIYKKFKNFNVNFSSIARGISVGDE
LEYADEISLGRSIMNRLPYNEGNS
>KALACAFP_00560 hypothetical protein
MVLNNLNYPLDFKFKITTLASDFNITDKNGNYVAYVRQKMFKLKEDVVIFNDESKSKELF
RIRANKWIDFNASYSINEVATGKNFGRLARKGMRSLWKSTYNILDENDQQKFTITEDNAW
TKFFDGLVSEIPIIGMFTGYFLNPAYTVRGIDGKEYFKLKKMPSFFGRRFQLDRMIDIDD
EDESLVILSFLMMVLLERARG
>KALACAFP_00561 hypothetical protein
MKYVIIFFSAFLLVACKKDQQTVSSSAPVADSLATVQDTAKTEVSSGKILVENFPFPKEI
KECSCYFAKNKKDFEAERYIYADDAGKTAYMKLDGKRVAMNLISSSDMEVDEELNKEIEN
DNYKISVKGKKIKHEEALLFEGTLTIEKPDGTVVTMPIYGECGC
>KALACAFP_00562 Cytosol non-specific dipeptidase
MELSNIEPQIIWKNFSKLNAVPRPSKKEEKVIAFIKEFGENLGLETTVDEVGNVIIKKPA
TTGMENLKSVVLQSHLDMVCQKNNDVNFDFETEGIKMEIDGDWVKAKGTTLGADNGLGVA
TIMSILESSDIPHPALEALFTIDEETGMTGALGLKPGQLTGDILLNLDTEEDDEIDIGCA
GGIDVTITQTYEVEPAKGQIVRFEVKGLQGGHSGMDIHKGLGNSNIILGRLLYTALDKEN
IQLISIDGGGLRNAIPREAVAIVSVRNANEFIEELTTGLKKEILEEFATIEPGIQINIEN
STTSEKAISEADSKKIILTLKALHNGVYRMSPDVKDLVESSNNVARVELKSGALKILNLS
RSSVESTKYSVAEQLKSVAELAGMNTEFSGSYPGWKPKPGSEIVQLMEKIYVEKFTEKPH
VVACHAGLECGIIGANYPEMEMVSFGPTIRGAHSPDEKANIPSTQKFWTFLKDILANIPS
K
>KALACAFP_00563 hypothetical protein
MTKKLLLIFGLLLFSKHFSQSEKLIGEWFLDRTVKSDGNNLEINNPKYSMFLTYKINPNE
LMINNIKFKAKFSVDQIKLDNRNFKYWFEKDYLLIQEGNEISLFLKADNFIKKYPEFEPK
VEIRNNDSVIVANQIIHPIFNNEKTFDDFIIPLMTQESSKNMNDLYFNAEYILTKDNKIT
DIKIINKRTPQYDSQFIQALKKAEKYYENPYKKNLLIVEEKHFLKWYDDLKDNSEKELHN
YIYEGSGFYDNNNFEKAIEKLSKIDQLDIKDNKFMMNIHDAYIKLGISYLALGKNDQACI
NFRKAGNLTDFAVRNYLKDFCK
>KALACAFP_00564 LOG family protein YvdD
MKNITVFCGSSFGSDPIFEEQAILLGQTLAKQNIQLVYGGSNTGLMKAVADGALNEGGKV
TGVLPHFLQSKEIAHKSLTELILVETMHERKTKMNELCDGVIVLPGGYGTLEEFFEMITW
AQLGLHKKPIGILNINGFYDDLIRLVQTMVDKGFLKQINRDMLLISDNIDELLEKMRNYE
APSVGKWISKEEV
>KALACAFP_00565 hypothetical protein
MNLEARKISLVQEFLRIDNEKIISALENVLHKIKSENFDENLKPMSLNQFNEEIDKAIED
ENKDRLINTKDLKDKIQKWD
>KALACAFP_00566 hypothetical protein
MGLEILWSQFAEDKLYDIFHYYKFKAGIKIAKKIVNEIVDKTLILEQNSQAGQIEELLIE
RKQEFRYLVSGNYKIIYYINLKTKRIIIANVFDTRQNPLKLNETK
>KALACAFP_00567 Rhodocoxin
MSDINIKITDREGVTHDVIAPTDMSMNLMEIIRSYELAEEGTIGVCGGMAMCASCQVYVI
NDPGLEPMGDEEDAMLAEAFHVKENSRLGCQLHMAMNMEGLEVEIAPYP
>KALACAFP_00568 Ferredoxin--NADP reductase
MITTDILIIGAGPTGLFAVFEAGLLKMKCHIIDALPQPGGQLAELYPKKPIFDIPGYPSV
NAGELVDNLMEQIKQFQPGFTLGETAVSYTKVDDEWFEVVTNKGTVHRAKAIAIAGGLGT
FEPRKPTIENIADYEEKGLEYFVKEPEHFRNKKVVIAGGGDSALDWSIFLSNVASEVTLI
HRRNEFRGALDSVEKVQELKNQGKIKLITPAEVTAIKGDGKVEGITVEVDGQEAYDIETD
YFIPLFGLTPKLGEIGNWGLNIEKNAIVVNNALDYQTNIDGIYAIGDINTYPGKLKLILC
GFHEATLMCQSVYNRLNPGKKYVLKYTTVSGVDGFDGSRKEAEKAVVKKID
>KALACAFP_00569 hypothetical protein
MKKLLSLLTIFVFYLGFAQIDNIADGESIKFRIHYGFLNAGTATLVTQKTTYKGVPHLYA
KGTGETTGAVKAFFKVEDLYESFINVQTGLPSFYVRNVKEGSYRQHFETVFNHDNNTLIL
TDKKTPANGSKVIKSVKGVQDMLSCFYYLRSKSPSELKPGTVMNMNVWIDDEMFPFQLKV
VGTENLKTKFGTINCLKIIPSVKSGRVFKEKEGVTMWVSNDANHIPMLLKAELAVGSLKA
SIDEIKNVKYPLKFSK
>KALACAFP_00570 hypothetical protein
MKTQLMILFIVLLSVFTFAQKKENDNIVRKKIVITKTASSPKIDGILDDAEWQNAPVATN
FIERNPNNGKPQADSIKTEVKILYDDTGIYFGAQMYDPTPGKIAKELTERDGISNDDFFG
VALNGYNDKQQSLEFVVTAAGVQFDAKLTTDGEDDTWNSIWYSGAKINEKGWSAEIKIPY
SELRFPKSNVQEWGMNIFRRIQRIKASYDWNFVDNAKNSYTLFDGVLQGIENINPPTRLS
FTPYFSTYVNSFDGKTTANFNGGMDVKYGINDAFTFDMTLIPDFGQANFDNSILNLTPFE
QQFSEQRTFFTEGTELFSKGGMFYSRRVGGEPTAYPTISANEEVTEYPSKVKLFNAFKIS
GRTKKGLGIGFFNGVTQRMEATIVNNETGETRKEVVEPWTNYNVLVFDQRFNGNSSVSLV
NTNVTRDGSFRDANATGILWDLNNKKNTYKTFGSLKGSWVMNGETKFGTRGEAGFEKIAG
KHRFSINGNVTTKDWDINDVGFSTKTNFANYNVWYGYRILQPTKTFNNIYLNFNLNYYHR
LEPFIFQNFVFNHNNSFTDKNFRNFGGGIEFTPLGQNDIYEPRTFGRHLKVPGYFDSWVW
FESDTRKKLQYNFTVDYYAFDQKGRNQIFTNFGLRYRFSDKFNVNWSFNPSFSNNETGFA
GKNDTDIFIGRRQRNTYENALTSKYTFNEKIALTLTFRHYFSDVTYKQFYTLNQDGSLTN
TDNFTNNLNGTYNAWNVDLRFSWWFAPGSQLTLLYRNATSNYLDISRLNVTKNYDMLFSE
PTVNNFSLKLTYFLDYNRIKNWTKKKNKS
>KALACAFP_00571 hypothetical protein
MRYISTIFIGIEYCSAPIFVSTKRIKKNYLEKTTKMIFGFSRNTNDEKESKISNTTNDTK
KIKPPKTFGGSFVFNY
>KALACAFP_00572 Response regulator UvrY
MNQPDHKSILLADDHSLIRQGIVFLLEDINPDFEIFHASNLQQALESLKTNPIDLAIIDA
HFPDGNSLSILPEIKKIKPEIKILIFTGIEEDKHALKYLNAGANGFLSKMNEEDEIESAI
RKMLENGEYISPATQALLMNSMHNPKLINPLLSLTERELQIAKLYAEGYGNLEIANNLDV
KQNTVSTIKKRIFEKLDIENLVELIELIKNN
>KALACAFP_00573 Autoinducer 2 sensor kinase/phosphatase LuxQ
MSVKLLNFKVRKIVHYSLILCILLIQVIIAAFFYNEFINKKNLTFIENQLKEVHSLENLT
DNSRKELLNAQDFLQKYMMSEDEKYLDSYFKSLNKLGENLDSISHYEYKYPKLKNISASH
KKDSSQIKKLKVLIDSTYQFSTRPKFKIGNDLPKLERYDVDYNFDKFNVETKTYSDTTVK
KKGLFGRIGDAISGKENVRKDSTVVTVKQGKVPVSKAIKTEFDSIINLVNNHYSGEVKRI
QVDAAEKQDNNDKFYRIFNNLLLYSNGLMNTYELAIKDSKSDLEKEYNKQNSKNNRIRTY
LIFGSIILMIIVSILIMILTRIAFIYEQKLKAANQQISENLKFKNRILGMLSHELRSPLK
IIGIFINRIGKKTDDKNIKEYLKSISFTNNTLLMQANQILEYTKNQQVENKLIPVVFNLK
NEIQSILNSIEPYIETRNNKFIIHENIDPEIVVYSDNTKINQVFMNILGNANKFTENGQI
SVTTTAEPVDENTVALTTIISDTGAGISKTDLEKIFEPYYQGVLSEDIENLGAGLGLSLC
KEIVELYSGKISVASEVNKGTTVTFSINLNLKNESTRS
>KALACAFP_00574 Phenylalanine--tRNA ligase alpha subunit
MQNIFERSTTMIEKIEELLVEVNSFNATSKEDIENFRIKYNGKKGVLNDFYETLKAVPND
QKKEFGQKINTLKQAVNVKLEDLKNSSTSSVVVEKEDLTRPAFPLDLGSRHPINLVKNRI
IEIFKSIGFAVADGPEIEDDWHNFTALNLPEYHPARDMQDTFFIEQNPDILLRTHTSSVQ
IRYMEENQPPIRILSPGRVFRNEAVSSRSHCIFHQIEGLYIDENVSFADLKQTIQFFTTE
LFGKSKIRLRPSYFPFTEPSAEIDVYWGLNSETDYRITKGTGWLEIMGCGMVDPAVLKNV
NIDAEKYSGYAFGMGIERIVMLLYQMSDIRMFFENDIRTLEQFKTL
>KALACAFP_00575 hypothetical protein
MNSYEAGYNMGYITGQILTLGFIVLIIYGIVRLKKIIKK
>KALACAFP_00576 Protein YceI
MFLGKEHFFYYISGYIKKLKIMKRKLFSLVIPAFFATAVVISCKKDKPLSSETNEVTTTK
DGNQYAIDTLNSKVEWKGYKILKSENTSHFGTIKFESGDVTIKDGKLESGKFVADMNSLT
SVDLKDDAEQLGKLNGHLKSGDFFEVEKFPTASYEITKVTPSAEGDYNTLLDGNLTIKGI
TKPVQFKANVSVKEGEASIATEPKDINREEFGVKFQAPAENGVIKNEVTLQINVKALEKK
>KALACAFP_00577 Spermidine/putrescine import ATP-binding protein PotA
MLLEINNLYFSYSKEKPLFQNLNLRFEEGKIVALAGESGCGKSTLLSLIYGLLDWQSGDI
IFDSEKLLGPKGNLVPGEAEMKLVAQNFDLMPYATVAENVGKFISNINLAKKKETVSELL
EVVGLEEFAHVLPKYLSGGQQQRVAIARALSVLPKLLILDEPFSNLDFPRKIELREKLFT
YVKQRNITLIISTHELQDIIPWLDQIIVLQNGRLIQNDNPEETFRNPYNSYVAKLFGEVN
IFNENEMTDFQISKFSYHPKQIKISENGFDADVLESRFAGNHYWNKLKVMNKEVIVYTDN
KIQDAVRISFI
>KALACAFP_00578 hypothetical protein
MSDTILCPKCSSEFTYPSDNMMVCSQCFYEWNPEETVAEASNSGKILDSNGNELQDGDSV
VVIKDLPVKGAPKPVKAGTKVKNIRLRPDSDHNIDCKIDGFGSMALKSEFVKKA
>KALACAFP_00579 hypothetical protein
MRNIRRVFLIISILLFGWIFIQIFNQINLIPNYSRVLIQEDISKVENFTDLNELKQFSKS
KIYSLQRINIERSDLAHKQLFIIFILIGIQLFLYISKNNSKT
>KALACAFP_00580 Ribosomal RNA small subunit methyltransferase B
MELIHRNLAIGIHDALQETFFEKNKYADKVIERLLKANKKWGSQDRAVVSEIFYNIIRWK
KRLEYYMGEGVKPNNIYKLIIAYLLWSKTNYKKFEEFDGIKIADILTKLKKSTVPTKAIE
YSIPEWLAETLEKELGSKWEKEMQALNEQAPTVLRANSLRTTPKELISDLSDENVVAYPI
KNYPDAVQLEEKKNVFLTTAFKEGLFEVQDASSQKIGYFLDVKEGQRVVDACAGAGGKTL
HLAALMGNKGQIIALDIFEWKLAELKRRAKRAGAHNIETRLISDNKVIKRLHEKADRLLI
DAPCSGLGVLKRNPDSKWKIDQEFIDRIKTEQQQILQDYSKMLKIGGKMVYATCSILPSE
NNGQVEEFLKNNPNFKMLKDEKVMPSEGYDGFYMALIERVS
>KALACAFP_00581 hypothetical protein
MHQRILFSFFILLFCLSFGQTYEVQYISSSNGKVLTEQPPTLVWANEKENFILNNKIREQ
KAEYPFTITKIEKPSNTVVSYALLKPNEIISTSDAEAIGKQTFEFTNETKKILGYKCKKA
VIKINSNTIEVWYTNDLKIQGGPSTIGQNLGFVLEIERNKNSLISANSIKKVKKTDIENI
LKGPINSIDKLSYGDLLWKSTFTTLKVFDNETINFSDESKSDEKIKRFANGTIILKKIKF
PKISEGENIFVELKQQSNGDAYDRTGTVFFIPQNKPQSFLDGLEKGVKTLPVYENGNGKQ
YYGITATENYDPPVEMMRFFTAFGINKFNHIQLKDKNWQTISPYREDITDLKPSLSEKEL
WVGAFIGNYDKGGHKVSLEITIHKSDQGTYKNNAVIPLFNTLNIMEMAGQDYSTMFNNDK
GLFVEFTLKKDLKNAQLKYTTTGHGGWENGDEFVPKVNSIFLDGKMTYSFIPWRSECGSY
RLYNPASGNFPDGLSSSDLSRSNWCPGTVTNPNFIPLGDLKAGKHTIQVKIPQGPTEGTS
FSSWNVSGVLLGSE
>KALACAFP_00582 Asparagine synthetase B [glutamine-hydrolyzing]
MCGIVCLFDAKQKTEILRPQVLEMSKKIRHRGPDWSGVFQDEKVIFSHERLAIVDPTSGK
QPLFTKDGKIVLAVNGEIYNHRELKEEFPDYEFQTQSDCEVILALYKKYGKNFIEKLNGI
FAFSLYDIENDVYLIARDHMGICPLYHGWDKNGNYYVASELKALEGICKTIETFLPGHLV
YSKDGSELQQWYTRDWENFDHVKDNETDISKLRKGLEDAVHRQLMSDVPYGVLLSGGLDS
SVISAITAKFARQRIESGDTQEAWYPRLHSFAVGLVGSPDLEAARKAAEHIGSVHHEVNF
TVQEGLDAIRDVIYHLETYDVTTVRASTPMYLLARVIKSMGIKMVLSGEGSDELFGGYLY
FHKAPNAKEFHDETVRKLGKLHLYDCLRANKALMSWGIEGRVPFLDKEFMDIAMTVNPKD
KMVSKAEGKIEKWVLRKAFEDILPDSIVWRQKEQFSDGVGYSWIDTLKAVAEKEVTDEMM
ASAKFRFPLNTPQNKEEYRYRTIFEEHFPSETAAATVPSVPSVACSTPIALEWDEAFKNM
NDPSGRAVKVHETSYDNSDEL
>KALACAFP_00583 hypothetical protein
MENENINYKKMRRNITILFALLAMTFAFGQGKYGKYLSSKKLAMVYKSVKDADKEDFYQQ
YYWLVKAEQLKTFPHLKDVKPVVLYEFVKKVNPQNPTKKLDARGKELRETAELSLNQYFK
NKKLDNNSVLMYNLETYVDPSKGQYYTKVDAEKIKELVPKELFAFNSNNRNTGEEKTYYL
WIDKKKDDFNIVDIIPDEKENKDFYARVKQYLPNYKFSKYVPSVKKGTKTDRTDVDYYYI
MPFEQNTDNIEYKTKDFKTFSLSQYRKAGEEWKGVEKPRK
>KALACAFP_00584 hypothetical protein
MNLKALILDSLCHFDKGDIYLHNRFFTSFKTTN
>KALACAFP_00585 putative transport protein HsrA
MSEVISQPNSIKKILPLILATAIFMQMLDSTILNTSLPSIAKDLHESPFNMQNAIISYVL
TLAVFMPASGFLADRFGTKKVFIFSLVLFSLGSLFCALSQNLTHLVISRVIQGVGGSLMT
PVGKLALIKTFDKNELLKAMNFAIIPALIGPVLGPLVGGYMVDYLSWHWIFLINIPIGIL
GITLGLKYMPNYKSTDVDFDLKGFLIFAAASLLLSISLELFGDLQNTTPVLVVFILGFLF
MYYYYRHAKRDESPIFPLNLFQVRTFRVGIVGNLATRLGISSVPLLLPLMIQIAYNQSAV
TSGWIIAPMAVTAMFGKSYVIKILDKFGYRQTLMVNTFIIGTLICLLAIPNIHTSLYWFI
PIISVLGFFNSIQFTSMNTISIADLRNFQTSSGNSLISVNQQLAIGFGIAFGLIVLKIFE
STDLIKGEIHNAFRYTFLTVGVLTIISGFVFRRLHISDGKNMKSKE
>KALACAFP_00586 Putative quercetin 2,3-dioxygenase
MATKQVQIVISPKPAHFVGDGFRVHNFIPGVQGLDMKRMDPFIMLDYNAKFHFNGTDQPR
GVGVHPHRGFETVTIAYKGRVQHHDSAGGGGIIGEGDVQWMTAAKGVLHKEYHEREWAKE
GGIFQMVQLWVNLPSVYKMSCPKYQAIKNSDMTKIDLGENGFIELIAGEYQQQKGPAFTF
SPVHMMNAKLKKGGKADFNFPADFNTAALVVEGSIIINGEEKAPTNNFVLFKNEGEDFSI
EATEDSIILIISGMPLNEPIYPHGPFVMNSREEIMQAFEDYNLGRFGYLAD
>KALACAFP_00587 hypothetical protein
MKPEFENIPLINTGTRFQIEFNGHSAFIDYREMGSQIALNHTEADILIAGTGAAQAVVEK
TLHYIEEHQKKALPFCPYVVSFIKKNPEWKRVVDQRFHGYEQL
>KALACAFP_00588 Quercetin 2,3-dioxygenase
MSNIGLIIEEKSADIGNFLVGRLLPFREKRAVGPFVFIDHMGPAELKDYQNLDVPPHPHI
GLSTLTYLLEGSIFHRDSVGSALEIQPGAVNWMTAGKGVVHSERTPEHLRHSDKRLHGFQ
IWVGLPKHLEQSEPTFHHIEADEIPVWEEDGIQYKLIAGEAFGRKSPVPVHSKLFFIEIK
TKDAKKISIGKDLYGEAAMYVLDGTVSTDGNSYGSKQLMIAKDTKLCEFDMSENGTVYLF
GGEPFDEERFIFWNFVNSDKELIEKAKVDWNDQNHEAFPLVLGDEEEFVPLPKAILNRK
>KALACAFP_00589 Metallo-beta-lactamase L1 type 3
MKKIILVFLVIISFVSNAQTVTEPKNNPAEWSKPYEPFRIAGNLYYVGTYDLASYLIVTD
KGNILINTGLAGSLPIIKNNIKKLGFKYKDIKILTLTQAHFDHMGAMAEIKKETGAKLYV
DEKDAEELKSGGKSDYELGKYGVTFKPLQPDYLLKNNDKIKLGNTTLTLLHHPGHTKGSC
SFVFETKDKNQTYKVLIANLPSIIIDRKFAEVKDYQDIQKDYAYTFEAMKKIDFDLWVAS
HASQFDLHTKRKTGDAYNPKLFADKEIYFQKLGKLEADYLEKIKKDSSEK
>KALACAFP_00590 NADH-dependent flavin reductase subunit 1
MKILAFAGSTSSTSINRELVKFVLKDFQDEEINLIDLNDFDMPVFSVDREKKGFPDAAHH
FLKVIEECDVIICSLAEHNRSYSAAFKNVFDWASRINVKVFQNKPMLLMSTSPGGYGGGN
VMNTAKTFFPNFGADIKDTFSLPKFYENFDFETGVINPEMLKDLKNKIENFKNQVKNQ
>KALACAFP_00591 hypothetical protein
MTKGRLEAFSDGVLAIIITIMVLELKLPEGDTWASLKPILPKFLAYIFSFIYIGIYWNNH
HHLFQMVKKVNGGILWANLHLLFWLSLMPVATEWIGETHFAKNPVAAYGIGLIMSAVAYT
IMENLIIKNEGENSKLKEAIHSKFKEYISIVFYVLGFATSFFYPYIAIGFYYLVALIWLI
PDRRIEKSLKEN
>KALACAFP_00592 hypothetical protein
METHEYVNGEITVIWQPKKCIHAAVCVKMLPKVYNPKERPWLKPENATPSELRNQIDKCP
SGALSYKFNTEK
>KALACAFP_00593 hypothetical protein
MAIIVKASLGKEKYYTEVVAGENTLITDEPVDKGGGNKGFNPFEILATSLASCTAATLRM
YIDRKEWNVEKINVEVELENFPLTKRAVFKRDISFEGTNLDEEQLKRLHTIADACPIHKI
LINDIEVLTKFS
>KALACAFP_00594 hypothetical protein
MIEVKQNNDAKHGNFAAFIDGNSAGLMTYTWAGEERFIIDHTEVEEAYNGQGVGKEMLLA
AVDFARKNGKTIIPLCPFAKATFQKHEELQDVLVNQTQA
>KALACAFP_00595 Sodium/glucose cotransporter
MSPIILLSIIIVYFALLLWVAYRTGKGSDNESFFIGNRKSNWMLVAFGMIGTSLSGVTFV
SVPGAVGNDKFSYLQITLGYLIGYMVIAYVLLPLYYRLKLTSIYGYLQQRMGQLSYKSGA
WIFIVSRLVGATARLYLVVNILQVSILDNLGVPFIVTTLIILAMIILYTYEGGVKTIVWT
DTLQTSCMLLGLIICTVYMLNHLGLNVGESFAAMNEKGYTKIFDFDPNQKSFFIKQILAG
AFITITMTGIDQEMMQKSLSVTRLKDSQKNMVTLGFILLGVISLFLYMGGLLHLYGAQES
VASAGDQLFPDIALNHMPPFISIIFIIALISALFPSADGAMTALTSSLCIDIFGMRDKTH
WDDGKKEKFRKNVHLLVALAFLVMVIIFKIINDNSMIGLILKLAGFTYGPLLGLFAFGIF
TKYKVKDNLVPFICIIAPVISFFIDKYQEKLFGEFKIGLELLIINGLLTFIGLWLIRKK
>KALACAFP_00596 hypothetical protein
MKKIIQLFLLLFAVSFISAQEFEISTLRIGPYKIFMKNDEADKFGTKLKQTNYELKNVIK
YNGETILIATNPDYDDQGKENGKIVIQGLSTKSKKFKTKSGIGVGSTKDDIINAYKNYPS
YSVYPTYDEKGNKQNNSSNFILNDLDAGTTLTFTIVNNMVTEMSVFINEGC
>KALACAFP_00597 Transketolase 2
MSKSIEELKSLTTQIRRDILRMVHAVNSGHPGGSLGCTEYFTALYGKVMNYSLPFTMEGK
NEDHFYLSNGHISPVFYSTLARFGFFPVDELRTFRKLDSRLQGHPTTHEGLPGVRIASGS
LGQGLSVALGVAEGKKLDGDNALVYTLHGDGELQEGQIWEALMYAAAKKVDNIISTIDYN
GRQIDGDTEDVLSLGNLHAKLEAFGWLVLEEKNGNDLEAVIAILEKAKSETGKGKPVVII
LHTEMGYGVDYMMGTHAWHGKAPNDEQLDTAFKQLYLEAPADY
>KALACAFP_00598 hypothetical protein
MKKFLLICLFFNFILGISQEKKISFTKEIRYTLIEKKKSQVFIKSFASNKGEFLTQANIR
EFPVYFFTDALGTSSVGLEMNNRLNGSNAFASSMFFGYNRSQPENKEECVLESKKLDTKE
TILGVPCSHYIVNFKLKDGESKGKDAMKLCIDDKSDYNNIPVLSGIFTMFERRSKIKNSG
LKGLILKGGPAESYDTEYFVASSMKDSESFVYFDHKKAMMDQQRQMDSLTLAYKKQEEEY
AKADSAAVLIDSAAAVALDSVAMAEAPNGTMSDEYSYYIPDYVSEYKKGSTEDSSLAMTN
IPNQKLWKGLPKHCKNFEKDLPSFNNKDLKSHLKNYVGQVCDMYLTQSEGHNVGIKITLD
EIRREVLYLNEIQEKLDQSDKKKLNTYLKNLD
>KALACAFP_00599 1-deoxy-D-xylulose-5-phosphate synthase
MKYTYTEKKDTRSGFGAGLAELADKNPNVVALCADLIGSLKMEKFIEKAPERFFQVGIAE
ANMMGLAAGLSITGKIPFTGTFANFSTSRVYDQIRQSIAYSGKNVKICASHAGLTLGEDG
ATHQVLEDIGMMKMLPGMTVINPCDYNQTKAATIAIADHEGPVYLRFGRPTVPVFIPEDM
PFEIGKGILLQEGTDVTIVATGHLVWESLVAADELEKEGISCEVINIHTIKPLDEEIILK
SVEKTGKIVTAEEHNYLGGLGESVAGMLARRRPTRQEFVAVNDTFGESATPAELMKKYKI
DSTAVKEAVKRILEK
>KALACAFP_00600 hypothetical protein
MKKATYQDREKVVDILCQAFIDVLIPNSINFVVNKYLKLKSII
>KALACAFP_00601 Transcriptional regulatory protein RcsA
MFVLSMHFSTIIYIIIFVLLIIIASINFVLHWKQRDRIYYLRFLLLSIVGLIYNFIEEIF
PDSKSTIDRNTQYIISYTSGLLSAFYFLFYLYKEYHLKFIKRFDLLLVGSFSFLILICSF
IIPLSITKSISIPRYLFLSIILIILLLNIFSILKNQFLKFKSSKEIFLKVHSIIGVIGFL
SIISLPITILSSSGNQFIVQFCYTLGFFIISTDYFLYPYRKEEIKKTIPFEKLSVRETEV
LKLLLEDPNLKYSEISQMLNISEKTLSTHLSNIYKKIEIKNKKEIHEISKIYKSTIIE
>KALACAFP_00602 hypothetical protein
MSKLFKLTFTLVLFIGTFSFANSKSTDIMIDDLPYLNHISNSPTFKYGCKTFHITVSIKF
IEVETDVTVCAGCTSYMAVTCGGSISKNASEQDFTFGGMDLNQLMKDRRFADAEQITVLA
SSIETDDNTSLTVKRGTYKIIRDENGYGTIVNLEVTK
>KALACAFP_00603 Thiol-disulfide oxidoreductase ResA
MKKIFYITLTICLCIAFGLFLINQNTDIIKNLKIRTADQVKKDEVKYSLKNSPFYKQYFS
KKNLIVFNIWATWCEPCLKEMSVLNKVKKQMNNSDIIFLSYSLDNDSLKIKNFNASKRFD
FKDITLENYSYKNSILLALDANKNEINNSIINISSTELPETFIIKNGKVVYITKGMINYE
DFLEKLKSFNSQK
>KALACAFP_00604 hypothetical protein
MEEYSYFDEDPKKGWGFILAFAALMLFTLMGFGIDLDEYLQHEYLNIPRWYFFIIFSVDA
LMAVSLVLMFFYRKIGIFAFPALLVLHFFMHNYYLSTFLYTDVTNLFLFTGFGMLAIIPK
WKFFR
>KALACAFP_00605 Regulatory protein AsnC
MNYQLDEIDKKILDFLVENTRMPFTEIAKQMDVSAGTIHVRVKKMEDAGIILGSSLNIDY
GKLDYHFTAFIGILLTKSNRTQEVLKELSTIPNVIEASVISGKYNIFCKVKAKNTDDAKR
IIYQIDDIQDVMRTESMISMEEYLSDKNRLINAISV
>KALACAFP_00606 hypothetical protein
MAKLENNNENENKKSVAGNLGDQVQKAVENAEDVVKETVKEASELASDAIHHPVETAEEF
GKQAVKDVTSYSWWAKLLLILFWLGVALVVAVFVIINLPVTKQWAANQALQIVNKDFKAQ
MSTESVEVNFFGNVKIKGLKIKDYKGLDFITAKEFTANSDWFSLATNIGKNNSLSFNSLT
LKNADVKVITYKGDSISNFIRFTQLFDSGKPKDPKKPEFQLNSRLQILDSKVSIVNQNSP
GEAGKWLTATNFNLKAPNVKVNGANISALINNMSFVTKRWGKSHLVDTFSTELSMTPKYL
SLKDLTLNTDHTLLQGDIKFHLNNGSWADFADRVRWDMNLQQGSQLSGYDISYFVTNWDN
FRPFNVSGKMTGPLNSFYLENFLIRNPEVNIATKTMKVKDLLKGKFLIETNNLSTDFTYK
DLKAMMPSFISKKMKNFADDFGKLKYNGAARVNPDQVYVSNGNLMTGIGQAKITKFSLTG
YSTAMPKYSGLAEVKDLNTSVITKNKSVGLISGRFDINGQSFDVNTMRLTTKSQISSIEI
MNKEINNLYLDGLLDHKKYNGLITVNDEQAKATIKGLIDFSTSRISMNVDADVNYLNMNY
FTDKPGNQIVSGKVNGKMAMSSINDLALDVEATNINFATATQKYTIPNAKVKTFVEAGGR
VIDVDAPGAVNGKISGRYNLGDLAGMVENGLNKILVGPAPRKLYRGQNFAMNFDVQQGLV
SYFLPDLKIPQGAKVEGQYDGNSNNLILNVDAASLKYIMTKVQEITEADKALAAANPEYK
INERDKITRDSAMVDSLMVRINTANLNEQIFAKISRAVYNKNILKDITLSGRNENNTVLH
LATKFKHGNAEDELADQMKEYAINVNQSTNAAGDFVFKFEPTEVKFNDVTWAIDTSPDLN
HSITYRKKEGDFDIRNLRVYSDDSALFVKEAQFKSAKDFYVDAEVNNFAIEKLLEMQSGG
NSLNIKGLANGSVQIRMDKSTLQPLVDMTIDDIKMNGNDMGDITISATNGYSLNVYDVNV
QVNSAGVLGNNSLNLTGTVNNNGSSPVLDLTAEMRDFDLAFAQQFVQTVFGNLRGKATGD
LKISGKFSDLDYSGDIALKGFGLKLLFTGVDYSFDDTVIPLTKGLAILNNIEVHDGRTNS
KGNISGAIQFETISSMGVNLVMRADNLLMLNTTQKDFDLFWGRVYGQGDLYVDGPVSGLS
ISTPNMKALNGSTFTFNSGSTSNVEEFKMLRFLKEGKDGLVTLEEKKKTGANMNIDFSLD
VDKGTTVNVLIGDDVGNIMVKGAAEKLRFQMSRQGNIAMNGTYRVDNGTFVSKAILNKTF
QIEKGSSIRWDGDAMKPALDITANYVRMVSNAGEYLNMGSLQPISILLQANITQSLIDPK
VDLNVTALDVSSQVRETLAAKMSQEGEKVLQFGSVLLLSSFNVSNTGGVDVDVAGVAESS
GYNMLLKQLGSVLNTMSNEFQIDLNYVKGDQNSNTGDRANAGVSFALSPRIKVKTGLGIP
LTKTENTETNYLSGEGTIEYDISKKNDGSLILRGYSKPSNIGMVNGAGSNGTANQAYGGG
IVWSKSFNSLFKKKKKDKKVQEPKQEIKTDSTKSGAK
>KALACAFP_00607 tRNA N6-adenosine threonylcarbamoyltransferase
MSDSIILGIESSCDDTSAAIIKGNSILSNIAANQAIHKEYGGVVPELASRAHQQNIIPVV
EKSLTKANIQQNAISAIGFTRGPGLLGSLLVGTSFAKSLAMSLDVPLIEVNHLQAHILAH
FIADANPMPPKFPFLCLTVSGGHTMIVLVKDYFDMEIIGKTIDDAAGEAFDKIGKIFDLD
YPAGPIIDKMAKEGNPDSYKFNKPKLDNYDYSFSGIKTSVLYFIQKEVKKDPDFIKNNIY
DLCASVQKTIIEILMNKLEKAAKDLDIKEVAIAGGVSANSALRKAMQDNQEKLGWNIYIP
KFEYTTDNAAMIAMVAQLKFERGEFTDLRTTATAKYDL
>KALACAFP_00608 hypothetical protein
MKILLEEKILGTHSKKNSKYYWILETITGKNEVFAEAEEDDFLMNSSEQGYIQNVKEEII
EKMNAENVFSFAFEPKEGDYLSIKNNLRKNEYLNLIFMNNKWIEEIYACSYRDCEGDIYT
TIKTGVAFLSENEITF
>KALACAFP_00609 Ribosomal RNA small subunit methyltransferase E
MKLFYGEIEENKITINDEEQQHIVKVLRMKNGEEIHVTDGKGNLASGKLIIEGKKANIEV
AEIKTDLSDFKTKLHIAIAPTKNIDRIEFFVEKAVEMGASEITFLQTEKTERKNINVDKI
RKQAIAASKQSLRFHFPVINDLIKIQDFLKNINPEHTFVAHCHENLERIDLKEIPQTDQI
TFFIGPEGDFSEKEISYLAQNKVKAVSLGNQRLRTETAGIFVAAWNYLRL
>KALACAFP_00610 hypothetical protein
MRYNELTVFNFKVTYYAMRIFGLYWLLMQYLTFKKISQWPKEIYEPFLLIQRFIFPQYPS
EFLYGSILIGCALLLIITIFKQNYILNFLIFVLIAIINFPISLNFSVGHHNHLIIIGYFM
AIFLLPKNLNKENDFKWVQYFYLGILATYSLAGLSKFLGMAKNIILQTGKITWLDKNAAK
INTLDNYWFADIKVPDWILNVYTYENFWVITTVFGIVVQASSFLGAFNRKYLTFIMIFLY
IFHWYTDLFVLADFRDAKNFVLIALFPYHIFYPLFLKFRRKSNVLQS
>KALACAFP_00611 hypothetical protein
MQKYTKYLFFISFFLSLLSLYVIERGGKEIYPFFSWKLFTSPSGSEKFEEQYRLYRVDGN
DTIRILYKPTAIYDENNLALIVGFYGKKIEKNENREGSVEKMKIFMKSYQPEYKNLLLYK
ESFNPWDLGTSVFKIKKTLITRL
>KALACAFP_00612 tRNA (guanosine(18)-2'-O)-methyltransferase
MKDLAQTFEYLKQFLTEERLSKIEYFSQESSDFVLPVMDDVYQFRNAAAIIRSVEACAFH
KVIAMEEENVFNPNLTVTKGAETWVEVEKMPKNLASLKNIKERGYKILAVSLEKNAVMLP
DYQITEPIALVFGTELEGVSQEVIDFADETLAIPMYGFTKSFNVSVAAGICMYELKQKLM
KSGIDYKLNEEKLLKMKIRWAVNSMRSGQQIFEKYIRENNIDFN
>KALACAFP_00613 L-asparaginase 1
MKRKVLLIYTGGTIGMEKDYETGSLRAFDFGNIFEKMPEMKLMECEVFVHPFAKPLDSSD
MGPEEWKIIAHYIQKNYDQYDGFLVLHGTDTMSYTASALSFMLKGLKKPVILTGSQLPIG
DLRTDAKENLLTSLYYASLYENDEAVIQEVAIYFEYKLLRGNRTLKYSAEYFDAYASPNY
PILGQSGVHLNIIKENLHRDDSDVEFHVDDHISEDVLFWRIFPGMQLSHFKEIPTMKVLI
LQVFGSGTIFSSEKTRETLQEIRNNGTEIVVVSQCISGGISFGKYENSNIFSKIGAISGK
DMTAESAITKAMHLIDNPNYQGSFADHFSKSLCGEISE
>KALACAFP_00615 O-acetyltransferase OatA
MKFRNDISFLRAISVIAVLLYHYNFSFFKGGFIGVDIFFVISGYLMTRIILTGFSKNNFS
ILDFYKKRVVRIFPALIVMITFFAVVIYFLLPIQFINYTKLYFSSSLFFSNIYYYLNSGY
FDSSSKFNFLLHTWSLSVEWQFYMIYPLILIIFKRFYLQEKRKFNLIFLALIILSITSML
IHNIFSNSYSFYMFYPRAWEMMFGGLAFLFANSFDDKSSTFKKNIFYVSLSVIALFIVFT
NEHTVKWPSLITLIPVAFTTQILLLNIDIKLFNNKIVKYVGDISYSLYLWHWPFYVLSLY
FALNDRIRYRIIFIILSLIFAIISYHVVEKRNYNNKHRLVLSSTAILFILSFAISKLNAN
YLFNKNMANLISATTDYKYSEQAYKQFSLENKHLAHYQTLKDYNFNNLKINNNKKNIILL
GDSHAAMFSQTINNIFKNDKYNLIQATADATYPMINSETPYEGPKDFFNFFFEDYFPKNY
NKIDLVIISSNYYGYYKDDLIKKIKFTENYFKKYNIPVIYLGQTDNYPTDFPTHFYLKND
YNVESINTPQLQNKVYAANKLLLKILGNRYINLLDYKIAKVNKDGTPYIYDQNHLTYYGT
EQYRSFIVKSLSLK
>KALACAFP_00616 hypothetical protein
MELPFYLSFNEFENKYYDNLEKWFEEYHNTSETDYLKALAEMYSPYLYYNFANDRLQADA
SIQIKDCFFPYHEKIGLSFCTSCENGKTTKKVKGMNHVFELKTITMMEYAQHILDKINRY
FSKNNDKEGKNTLDFINNYEIITSREGAEYCVNYSQHQATLPFLKAYLPVYGQTVNIATY
RDFIFSIVQIAEFIDLKLKEVKAFESMIYSKLKSDAKFKVQMSHQFLTMCN
>KALACAFP_00617 Succinyl-diaminopimelate desuccinylase
MKKLLFILLAILIVLIAVILIKTFTYPFRKANAGNGQGWKAVKNDSAIQRLSGGIKIPTV
SAGELGEFDYSTFDTFKEYLKQTYPLIYQNTENYEVNKYGLVFRLKGSNPSLDPIVFLSH
YDVVPPGDAEIKDKSENIFRPDDQPLAPNSKVAEDWDFGPFSGAVANGRIYGRGTIDMKG
MFFSLMESFNNLIKNKHTPQRDIYLAFGFDEEVGGQKGAAQIANYFKSKNLKFDAVYDEG
GLILQKGSVAGIDADVAVIGCAEKGFLSVKIKVKGLGGHSSMPPLESAIGKAAVIMQRLE
KDQMKPIVTPLMNEFFTNIGGSMSFVNRMAIANQWLLRPVLLSQLTKNNSTNALVRTTTA
LTMMKGSDAPNVLSPEVEFIVNFRLLPGNTVKEVKDHIARATEGFNVEIEEIDNVKEASA
VSSTTTKAFKLIEAGIREIHPTAIATPYLTVGATDAYKYQIVSKNIYRFMPIKITDAEKQ
SIHSTNEYISIENYMKMIHYFEFIMLNYDK
>KALACAFP_00618 hypothetical protein
MVSKLITLVFFCLFLIGCNNYDKKNEITISVKVVDSYTKHPRINDTVTVRQAKWNIPLRK
YVEIGQYVTDSLGMVTLKINKEKRYSFETDGPNFAFGSDEYGEGELKNNQIIVIKVIPPD
KKQFKIE
>KALACAFP_00619 Putative deoxyribonuclease RhsC
MKLFSSFILSLCSVLGFSQTILYQAESTSRTVQDPQTVVLTQGFYASSSSSNPFIAKIGP
ATENPGGGPVDSGAGATNPSGTTAPSGQSFHDTKGNIEVNGAGQLQFTLPVALPPGVKSV
APQVNLVYTSGSGNGIAGYGWNLSGVTSISRVGKNIEKDGEVNGVQLDYSDYYSFNGQRL
ILKSGEYGKDGAEYVTEKYSNIKIKSVGSITGQAWKGPEYWEVTFEDGSQAWYGGTTSGL
SNARTPIEYNIIKWKDGKGNYITYNYLQTGLSNITTISSIQWGGNETLGKPHFNTIDFTY
INRSLAEYSYIAGVRFLQTQLLSEIKVSTNGSQFKKYTIDYLKNGTNYQAVNKITEYNAD
NNATNPVAFTYPAPTQPNLEFSNNNVESFENVKLSGDFNGDSYLDFVMNNGTVKLGGLND
TYTDISTGKTFNAEAKVINALLDEEGQVHNGNGIVQYEAGKVVGYIFRDNTFVKVFEKLV
YTDPNCTYQGGGVGCRIEMASFNEGDINGDGISDVFVKINKEICQFEPIPGCNDLKQTPT
STSDNTINRPPPCQELNCDTYLVGNYIVDLKNANNPLSTYAVDTGINENSYYKQQYLDVD
GDGKVDIIDVSNTTYTVFEFVKTASNQYLKKIRFTGSLAETKAPESPVLFGDFNGDGNLD
FTIPATDTQEKDNWRFYIGTEKGFSNFLKTNFLKYRKPNDYQNSNYPTFNIYQNFYTTSD
INKDGKSDIVHINSFNKAGQVNGSGVILNRYFGYTIAAYTANGTTTNDSPDFFTSYTYGG
YNYVTSDVGNFTLFSPITSQVKVNNNYYDVFLFWKERMHKLKSPSSVGRLSQVQSIIQGG
ITTSADYLEVIPNNTVNPNFYQKVKKEYYPYFSLNRVDQSYAVSQLRQEGRKQDFRYRGM
TGHMQGKGMMGYHQSARSSWYADGFENTKIWSGAEIDPLFDGIPVKEWSISTNDESKIFP
ADISENNTQLLSFKSTVYQKDKLLNGQIVTGVIADTDKPKVVTATVPTSTKTKDFLNGTL
TNTFITYGDYYLPKQSVSNVNNGYAITTSNFEYIHNFSGVGADYFVGRPQSKTDAVQAYG
DTKSAKEEYVYENNLLKTLKTWNRDNTGYLQETYNYDGFGNITGKTISNSVDSQTQTEAS
VYDPKGRFVEKKTDNLGLETNIEYNDWGQIKKQTDPLGNILTNTYDAWGKLLTSKTNLGG
TTTYKYERDDNANITVIQYDPDGNISKKFTNRLGQDYKTSAKAFGQGQFVSKETQYDVLG
RKIKESEPYFEGQSASGWNTIVYDDSVFPITKATATGFNGKQMVTTVSGLITTTKELNGY
GRTTSKTTDALGNVVSSTDKGGTIQFSYNAAGEQIKAQYAENTVTTKYDSWGRKSEFNDP
SNGIYKYEYDGFGQSKKIISPKGTKEYTYNSLGQLISQKELSTTDGGQATNKIISYTYDN
KGRVISRGGTSKGKVYSSNVSYDPQGRLLSSSESSNGKYFIQKGITYDDKGRVISYEKQL
YSSGVLTKVNVENVYSTWNGELYQVKDKVTGKSLWELKETNAKGQVLKAKLGAADVNNTY
DTNGFLTNVNHSSAVKPSILQLSYSFDAIKNELKSRTTGGDFNIVESFDYDDNNRLVNWT
NPVTGIKPSNNRNIYDVKGRIMENDQVGTMKYENSAKIYQPTGMTLNAAGTQNYNNDLIQ
SIAYNENNDPVFIDGEKGDVAFQYGLTSMRQRVTYGGNFSIDGDGKFTKFYSEDGSFEVL
KDNTTGKEKHILYIGGTPYESNIVYLKNFDESSGSYRFLHKDYIGSILAISDEAGNKLEQ
RHFDAWGNFTHLKIGNGAIITDKSIIDNASLLVDRGYTSHEHFAEVGIIHMNGRLYDPLL
RRFLNADENIQDPYNTQNYNKYGYVLNNPLMFNDPSGEFFQFLMIPIVQAIAIAVVGYTA
TVLITGGKFNILNLYSSIVMGMISAGITIVIGDVFSTATASIGNEALRSLVHAGVQGTLS
FMQGGNFFTAAASAFLSSAVSFGYGQAVGAAAYSGTSQFALGMLSGGVGHALAGGNFWEG
VKIGGIVALFNHAMHRITQPKYVVAGIYGAGGREVSDNPRLEKIVEKQGGKMFTSSWGTN
DQEIIDYLVDGYNEGKQIKIYGHSRGGAAAVRIANELGEMNINIAEVNLFDPVSLGGDFI
FTHPNVLRVNNYYQRNSTVKMYGLPYWNLDNPFVGSPVKAKFSFPIINQVDYTGQYYKSG
VPVSHLNIIRKAYGL
>KALACAFP_00620 hypothetical protein
MKRKLLSLFSLFIGFLGFSQTEVYFKYDEAGNQRYRGTNSAGKTAPEEVKKVEKIKAVAA
VVKQEPLMDEKTFWKQIRLYPVPVNDILTIDWTEEVDGLIESVSLYQHSTVHWKFQQQNI
PSLNKQLKINMTGYDWGVYILRFTLKDGRVFGRNVTKR
>KALACAFP_00621 hypothetical protein
MKKKLLLFALLASSFAFSQSWNITGNTGIIESNFIGTTDSKPLIFKTNNVERMRIFSSLS
AIVIGNQSGLTTIDRARLEMANVSCASCFSTWAAPGDFVIRGRETRNLEFNMANNNSADP
NIDTSTPNSPGITRVKFTDIAHNNTLVINNMGKVSVGTDQYDNDPNYIFYVRKGIKAEQV
KVENPATNGWADYVFKKDYKLRTLEEVEKHIEEKGHLPNIPSAKEVEKDGLNLGEMDAKL
LEKIEELTLYSITQNKQIKELQEENKALKSQSKEIEELKKQVQELISTKK
>KALACAFP_00622 hypothetical protein
MEENSPKAFPFIQVYINKAKKEKNYEKLVQGYKDGVFYSSLNEKKLKYADSAVWAAKQSG
NSDLISTAYIEKGVVYYYHYKKYQKALNEYLAAYEYSKNTNNEFLKFQNLYYIGVVKSYL
GYYEESAQLFKQCIDYYSPKSKSNLHPNEIFNNKKGYLNSLHQLIICYRNLGKTKEADSA
IQTGLSEVKNDPDFAQEKGYFLLCKGISDYKKNQYQLTLDHLNPSISLMKKSGDFAWLSV
GYFYVGKSYLDLKNNAKSIIYFKKVDSIFQKHQFILPELRENYELLINHYKKEKNQEQQL
YYTSQLLKADSIISKDFIYLSPKIHKEYDTKTLLDEKNELEKANSWGSFIIAGLIILAVG
LVILLIIRYKNEKEIQQKYILLEEKFMMQQDAVEKNVSAPEEKKTNLDENKVEELLRKLK
SFEDKKEFTQKGLTINKLASQFGTNSNYLSQVINEYKEVNFNKYLSELRIHYITNLLFEN
REYLKYGIETLAKECGIASRQNFSDLFYEINGIRPTDFIRKRKQELDNKGGFSTWNAV
>KALACAFP_00623 hypothetical protein
MKKIISIKIISLLIIAILSPTLKSCREYDEEIYPEKTNASILKMKNAGDQQKLEEDTARN
SPGDPPIKSGTHWKPNKIY
>KALACAFP_00624 hypothetical protein
MKKTIFLAAGVVALSLMSFASSNNLGIIQFDGDVISMKDTDKVTPEELSFLSVNVLGWTY
CDKQSETNQCNTRNRNFPYSASLEVQKRMNLLIAKYQ
>KALACAFP_00625 hypothetical protein
MKKTIFLAAGVVALSLMSFASSNNLGIIEFDGTVITLTDTDKVTPEELSFMSANVVGWTY
CNTRSETNQCYTRNRTFPYTASLEVQKRMNLIIAKYQ
>KALACAFP_00626 hypothetical protein
MKNTFFEYAILGLIILKVIVTGILTTTESFCSFYKYENPFENKENQYDKTFAAYTGFDTG
YGFFAPNVASNFIIISEELKTGNTYLSTDLLSTNEGKLRFCNLNDVYMKNITPENKNDTD
LKINHILLKQVNKAFEAKYGKQFQSTAYLYDHNFLSDPAKKSKLIKIDNVQ
>KALACAFP_00627 hypothetical protein
MKKSLSSYFNKTFTPSFIVFLRISVGFVLLVHFISIWKDFELLYSNQSIIPVEIHGAVYE
YNIIPYSQIENFLSAYFQNPNLTFKYIYITLCIFIITGFFSRISAIILLVLQVSLVKSAT
LFMYGVDFFASMSLFYIILFPTNRYFSLQKRFFPKTITNFPIQSLNICKRILQLHLCVAY
FFSGLDKVIGFNWWSGEAMWKSLNLPNFTRFINLPSIFDEKYSLLYLIGGWVIICIEIFY
PIFININKTRKLWLTLTILMHIGIIVSFNLFFFSSIMIIWNLTSYYFNYYEKDKIFTESS
SAANVYN
>KALACAFP_00628 hypothetical protein
MKKIKFSQRVLLLLMFTISNIFFAQSSYKAFYEMKWRNKKDTVKNHELCTLIINEKGSSY
FQSYENFRRDSAHTKTVNEYFANKAGGLRLRDDTSNAKFRSLIIKNVSQNSMVVEERFFT
SIFSTHYNTTKQNWKLINKTDKILGHAVSMATTDFGGRKWIAWYTTEIPINDGPYKFYGL
PGLILKISDAGNEYSFEIKGIIKEKNDLEQRNFTYDAPVNITPKQWDAFWKKYTKQPSVI
FENLNTDQTTYVINGQDVNSKEVKDAYNRKELEFLKIFENPIELAPTY
>KALACAFP_00629 Outer membrane protein OprM
MTNMKIYNKYIAAIALSLVLASCKAPMATVVKDEVKENIPQNFNQEEQGDANNDTGTTPW
RQFFTDPNLVALIETALKNNQELMITLQEIEIAKSGVLAKKGRLTPTVSAGIGAGVKKAG
RYTSEGAGDASTEIEPGKEVPDILGNFEGGLMANWEVDIWKKLRTEKESAVAHYLSTVEG
KNFVLSNLIEEVADNYYELLALDNQLDIIQQYIKLQQKALEISKIQKEAAAATELAVKKF
EAELAKSKATEYTIRQEITEKENEINALCGRYPQTIIRTKEDFMTTIPQTVYTGIPSQLL
ANRPDIKQAELELKSSKLDVEAARKEFYPSLEISATLGLEAFKPSYLVKMPESIASSLVG
ELAGPLINKSAIKANFQTADARQIQALYEYDKTILNAYLDVANLMSKVKNIDQYYKLKSE
ETKALEQSIDIANQLFRNSRADYLEVLLNQRDALDAKMELVEAKQKQLSTVVDIYKSLGG
GWK
>KALACAFP_00630 Efflux pump membrane transporter BepE
MFKKFIRRPVLSIVISLIIVFMGILSLVKLPVTQFPSISPPKVNITAEYPGANNELLIKS
VVIPLERGLNGVPGMKYMTSDAGNDGEASIQVVFDLGTDPNVAAVNVQNRVSSVVNKLPP
LVVREGVKITREEPNMLMYINLYSDDPKADQKFLFNYADINVMSELKRVSGVGFADILGT
REYAMRIWLKPDRLTAYSISADEVMEALNQQSLEASPGKTGESSGKRSQSFEYILKYPGR
FNNEKDYGNIILKAKPDGEFIRLKDVADIEFGSSMYDIYSTLNGKPSAAITVKQSYGSNA
SDVIKNVKSLMEELQKTTFPKGMHYDISYDVSRFLDASIEKVIHTLFEAFILVAIVVFLF
LGDWRSTLIPAIAVPVSLIGTFAVMSAFGITLNMISLFALVMAIGVVVDDAIVVIEAVHA
KMEEKHLSPLKATEEAMHEISGAIIAITLVMASVFIPIAFMSGPVGVFYRQFSITMASAI
ILSGVVALTLTPALCALILKNNHGKAKRRTPITIFLDKFNNLFTKGAGKYEKMLNKTVTK
KTVTLPLLLAFCACTFFLSNSLPSGFIPAEDQGMIYAIIQTPPGSTLERTNQIAKELLRE
SEDIDGVQSVSSLAGYEILTEGTGSNSGTCLINLKSWEDRKESAAEIIEKLEEKAKNIPG
ANIEFFQPPSIPGYGAAGGFELRLLDKAGSGDYQKMEKVSNDFVKELKKRPELGSAFTFY
SASFPQYMLRVDNDLAEQKGVTIENAMDNLSTLIGSNYETSFIRFDRPYKVIVQAGPQYR
ALPTDLLKLYVKNDKDQMVPYSDFMHLEKVYGLSEITRHNMYNSSEVSGTPAPGYSSGQA
IAAIKEVADKTLPRGFGIDWAGISKDEVSRGNEAIFIFLVCLGFVYLILSAQYESFILPL
PVILSLPTGIFGAFLCLKLLGLENNIYAQVAMVMLIGLLGKNAVLIVEFAVQKKAEEGIP
VAQAAIEGAAIRFRPILMTSFAFIAGLIPLVMATGPGAVGNRTIGTAAAGGMLIGTIFGL
MIIPGLYYIFGTIAEKSKLAKYEEENPLTEQTEPYQHDDKHEDL
>KALACAFP_00631 Efflux pump periplasmic linker BepF
MMKRVVASIALGSLLLFTGCNKKKEEKEEAAVYPVTSPVVMDTVIDKEYVAQIQSVKNIE
VRAQEKGFLEKIFVDEGQYVHQGQTLFRIMPKLYQAELLKAQAEVAQATIELKNATTLAN
NNIVSKNERAMAKAKLDAANAEAKLAQIHLSFTDIKAPFSGIINRLPLKLGSLIDEGDLL
TSLSDNDDIYTYFNVSEPEYLNYQMNAASRGSNQVSLVMANGDIFPQKGEVQTIEGEFDN
ETGNIAFRAKFPNPNKLLRNGETGKVRMTLPLKNALIIPQKTTYEIQDQKYVFVVDKNGV
VKSKNIKVAYELPDVYVVGSGLATGDKILLEGVQKVKDDQKVQTKFQDPKKVLQSLKLKA
E
>KALACAFP_00632 hypothetical protein
MRNYIVYFLTGLFLLFVVESKINVKTLQSTTHTSQNLPKRANRLNQTYEKLSIQQAPDDA
GNAYSLELTEDDFQLSDTLQTIVVFASIFTLVYIFGLKSFKKLKPTIHGYLSEFSSVKRF
ILIRSIRI
>KALACAFP_00633 hypothetical protein
MVNNFTLHFNYSEKNIIIDFPKIRKVPEHRVLQNLKSGLKYINKLIFPFKKPDSSIHLQN
TYCLPGTLKIRAPDKTYA
>KALACAFP_00634 hypothetical protein
MKKTTLLGFAFCSILTFSQVGVHTQNPQNTFHIDGAKDNPATGAPSPTQQANDFIVTNTG
STGIGTTTPDASSILDITSPNKGILGPRISLTSATMQLSANPNATGLLIYNTGPVLASGY
YFWNGTEWRVFNTSSGNNNNGGNTNIANVDQIAVMGPLTATTDNGRAGYALSITTPDGRF
SVRTFIPTGTAFSQVNLQIRNNTTSVVEIISNGHYLWSGAGGYMQNQLRLPIGAWAGDNA
TSSASLVDATTGARIQTASTNPYWGDPETYAGGMPEQRLYSWTTNDGNDKTFYKLYYMMG
SSSPASVGNATTCPSGTCNATKAFFTIDQIKAP
>KALACAFP_00635 hypothetical protein
MKKLFHFTIIGLMAVTATACKHQGKDEIALQNVAKQSTDKITKDVYRDEFGDQLEVAVNE
TQNTVVVRLDGKSYELKKSEELPEYTAADADYQYSDIRGEVTFLKKDYNMVLFHHKKQKQ
TSNTKMASY
>KALACAFP_00636 hypothetical protein
MKNLLTYLSSLFLVAFLASCMSKPSQPAPNTSDITGKTWKLTELNGQPIKLKNPSANPYF
KLNMADMRYEGHGGCNGVGGTFEIKPDAMRIKFNQGMSTMIACDDLDTERAFVDALLASD
NYSVNGNTLTLNKARMAPLAKFVLDKAK
>KALACAFP_00637 hypothetical protein
MVNCILLIFSKLNLKCVIAVMVLFSGGYRFAVEN
>KALACAFP_00638 hypothetical protein
MFPNMLKKIVLSVVILLSLQYKSQLYSVDELDSINNLYWDRGEVAAFVKFNLEMQKKYKD
ANNIDGVVNTSIGLGGAFTHLNRQKEALEYLDKAKENIGNVTNPLLISRLYNQYGELYTL
SDLYKESNKSLDKAIEYAKKINDKKKKDKRLSIANLWKWYNFNQMGMIDSAYAIQRRSLQ
NFPDNPLVYEKIASEYISTKKHLDSAEYYLNKALPLVSGTTAFYNKGLVNATFGDLFVAK
GEGDKALPYYFQSLDIFKKTKNKFVEKEIYNRISKAYQTKNLNDSTKAEYYYKKYSYLND
SISMNEKKVLGAIVEKLVQEKEDEQEHKTILYTVISAIVVLSLILLFFIRKAYLKNQQKK
DRIIREKALKIEEKEQEADELKRKVNDSFEEVMQLVKTNDPFFLTRFKEVYPEFYQKLIN
HQPNLTEHDIKFCAYIRLNLNSKEIAQYDNIAIRSVESKKYRLKKKLELSTETDLTKWIL
EL
>KALACAFP_00639 hypothetical protein
MKNKITLALALSVAGLAQAQIGVNTATPRATFDITSKNPTGTTRTPEGLLIPNVDRQRAQ
SMTGITTSTMIYVNNISTGTATGIAANINAVGYYYYDGSMWVKLLQDIPTQIDQDNNIYN
SNGTLTGNRTVSQAANSLAFTNTATTGTNHFSVDGTTFSVDAVNNRVGLGTSTPKNRLDL
GSDAPKDVTAVEGKKLAIYNNATGTSFYGFGISDNTLQIHTASTPDGAPLMVLTRAGNVG
IGNTEPSQKLTVVDGVDTNQYQGIASFLPKNLTQGVGIGWGGIQSIGTLSNVNLNLNGKG
TGNILLATRDNGNVGIGTTNPTTKLDIAGSVKITDGTQGNNKVLTSDANGVATWKDLPAT
TDTSIYTNNGTLTGNRIVTQGANTLAFTSTAANAFSVDGNTFSVNASTDRVGIGTTTPET
KMEIVTNGSGFQHSNGTVKLKTLLETAEGSVGTSTAHPLSFMTNNTKRMHITAAGLVGIG
TSTPNSLLDLGSGNGRKLAVWNSAAGDDFYGFGASANVLQIYAGASATENPLMTLNQNGR
VGIGTTNPQTNFHTIGTRRFENATAGSVSVGSVLTATDTNGTAEWRKPAVETIVGGIESG
AGIDIPFTTNSAMRYTGRYITLPPGRWAVTITQLAQTSGNLDTDDALFVRSSFAEGTMTI
GATATPSANVNGGPTLMSFRVQGPATSGNPQQFDVFQGTIFINNNTSAAKTYRYIVGNTV
TGGGPNAATFIRSYGGSWSESSIYATAIQ
>KALACAFP_00640 Sugar transporter SemiSWEET
MDENILGIAAGVLTSISMIPQLIKVIKEKDAENLSWVMLSVLITGLSLWVWYGFLKDELP
IIISNSFAVLVNIILLVCFFIFKKS
>KALACAFP_00641 hypothetical protein
MFRTLIILFAVLFLMNSCHSENDNEYFRDIDKEIVDTGNNYSKILAIYKRELKKYQQTHE
LKYLLCSKYVETSLYNNSDPKRISLAYELLRINNDENDYITIACNFFLAVKIEETSPKLS
LQFLNEAIKMDEKKGNHFFLPRLYHAKAKWYYNHKNYSLAKLYYDKALADFKKNDNPIHI
STAYSNFAIYENKMGNVDMAIKMTRYGIKILEGNGTKISQNKLFFINIMKGNLGVFFMEK
KDYAMAEKYFNDQINFMIKTKEYQQIIVRNSEKLFELYAVTNHPEKEEKLIRLLIEIFPN
LTNTRNKIVACSELRKYFAKKNDLKNATFYSNKLDELNEKNNAEISKELDNLSDVLNGYI
IKNINQKYDFAIKDQQRKNMFLICFVLITIIIFVNVILKIRERNRKEKERLEQLNFLLES
SKENLEKDIQLQKGKIKNLHMNLNLKIETEKAFLENLKKIKRSKNIDAEETVKDLFFKIN
NLLQIDEKNNDFISESSEENTAFMQKLSEAYPFLSKHDLKLCVYFRLSLSSKEISLLENI
TPGSVRVYKAKIKSKIGLGKDEELSSFLNTFK
>KALACAFP_00642 hypothetical protein
MKSFKNIHAGALVKLRFLESEMEISRVSNFFNCSEEEIEKMFESKSLDTEILLKWSKLLE
YDFFRIYSQHLILFSPPSNAYSSNKEKKSNMPQFRKNIYTKEVIDFVTELITSGEKNINQ
VVEKYGIPKTTLHRWIVKYRNHGKRIHKEYQPTNV
>KALACAFP_00643 hypothetical protein
MERSQPNYRLIYHDIISIKCPGKKEECSPILNKKEISILDVIKLNMIIFGINDKETQIFN
QKHRSYDESTILEILDYQAKNNLNNTQLANHFKLSRNTVAKWKKHFKNKHLHPVKAN
>KALACAFP_00644 hypothetical protein
MFLNCYFKKTFYALLLFLSIFSHAQTYTVDELDSLTEKYRIEGDIKKSIALNEQAILQYE
KKRNTEGAIGAHINLGGLLWYLHRYKESLKHLENAENQLAKTKNPFLIAKLHGEYGRNYA
SLGLISQSTDNLNKSISYAKKIKNKKQREKLLYFYYTWKLQNFEELSIVDSVNSVYNKRM
ELSAQPLTFVHIAEKLLKNKELDSAESYLNKAMNISGDYSLYQKSMTLLAFGKLYTEKKD
YEKALEYYFGSLAISQKLSRKSDITNAYKVISETYKFMNDDVKKNEYLEKYSDSKDSIDE
SEREALRIPVDKIINSETKKERKERVRSYIIIGVILFLSVIVLVILTRRYVKKQKETEEI
IIETLNETDELKSKLNTAFEELSKLASTNDPFFLTRFKEVYPEFYERLTTTYPNLTANDI
RFAAFLRLNLSTKTIAQYKNISIRTIESRKYRLRKKLSLPSDVDLNKWMMEF
>KALACAFP_00645 hypothetical protein
MNSKYYYRIVFSILFFCCLQFRAQNYSMEELDSVADLHRGKGEHQKLIDLCLTLAEQYKK
SKSTESEINTYIIIANELAHLNRYKESLTYLNKAEKNISIIKNPEIRSKLYGGYGRNYYS
LGLYEQANNFFDKSLKYARQISNKKTKTRRLYVGHVWKLTVFAKMGLTDSVKSMERKCMK
LDPEPLLYTNIAIRFLKNKQHLDSAEYYLNKAISISGTYPVYQKAMALKNFGKLYTEKKE
YGKALQYYFNFLSIVEKSNRKIDRREAYKLISETYKLMHEEDKANEYLVKFSLINDTINE
EEKTALKMPIKRIIREKDAHEREEKNKLYIVISIIVLLSVLLFFYLRKAYLKKQKQKDEV
ITEKLQETHQLKKQINPSFKEVIQLAKNGDQRFLARFKEVYHDFYDTLTSRYPTLTTGDI
KICALLKLNFTTKEISEIEIISIRTVENKKYRIRKKLELPSEVDLSKWMMEL
>KALACAFP_00646 hypothetical protein
MEKFKTYSLSLCSVILMTFFTTFYAQVGINTSSPYSSAILELSSSNKALLLTRVSLLNTL
DNTTVPNPIAGMIILNTSNAGTGGTAVTANTLYQWIGTEWAALVNNKSLPSFNIPTQILS
INVPGTQNIGSGSSTGVVQLTVENRDIYNAWNSNIFTVPITATYIVNYQSSHFHTPEANV
WYVILSFEKSVDGGANWTQLINDTRSGLQGVDGGNSNILFWTGNLNANDLLRVRFATSAS
TPNIVSNGGIAITKL
>KALACAFP_00647 hypothetical protein
MKKTIIFPILLANLFFGQVGIGTAHPRGALDINKGDGSNTSGLVLPANSDVNNILNPQIQ
YQNSVSGMHYKINI
>KALACAFP_00648 hypothetical protein
MLVSVVAGRSLHVATPLASDVNTLLFPCVPSAILTAPLVAELMCSLVDGAFVPIPTLSLT
ALTENVVPSIEKWFAPVVAVLVKAKLFAACETVRFPVRVPLFA
>KALACAFP_00649 hypothetical protein
MPIYWAFLTYMLLKPGEENHEYWFMFSGIDKALHLSIFAALGFCFMAAFPRIKFSYFIQI
ILIYAFLTEILQEEMGLGRSMENLDIIADTIGCLIGYYIYKVLAKRFL
>KALACAFP_00650 Glycine cleavage system H protein
MNTPSELKYTKDHEWIKIEGNVATIGITDFAQGELGDIVYVDVDTVDEDLNGGDVFGSVE
AVKTVSDLFLPISGKVIEFNSELEDQPELLNTDPYGNGWIIKLEVAEGADHSELLSAEEY
QAIIG
>KALACAFP_00651 hypothetical protein
MVANNKYLNIFLFLSFLCMSVTAFAQQRPVRDTAIIKKDYQLADPTQYEAYYDIKTGMYY
VYPKIGNTITGPPTAMSPEDYKEFMMAAQTKAYYKEKSDRYSLMFRKDKSDAARKGLIPS
LTINNKLFETIFGSNKIEIIPSGYASFDFGGLYQKIDNPLILPQNRTSFTFDINQRIQLG
LLGKVGDNLQLKANYDTQSGFAFENRMNLVWQAKGSWKDLQQKGLNDVDKPNSGGEDKII
KRVEFGNVNMPLSTSLIRGSQSLFGVKTEFQLGKTYGTVVLSQQQGEARNITVQGGGVMN
TFKLNAIDYEDNQHYFLGHYFLNNYDNSLLNYPQINSKISITRMEVWVLDQGNTNLQYQK
SIVGIRDLGDGGGLPNNDQTGFNLYSTVSALPGIRDASTAYDAIKGTSLPVATGGGPEPY
VDGEHFIFSKKARRLNQNEYTLQPQLGYISLNQKLNFNQLLAVSFSYTVNGSNQVYKVGE
FSEESTVLVTKVLKPNTTVNTSSPMWNLMMKNIYSLDAGQVNQDGFILNVLYRDPQSGGK
VNYLPVNNMPQVSSIPLIKLLNWDRLNVNGDLQNNGSTTGDGIFDFVNGITIRPETGRVI
FTKVQPFGSYIQSVIGSNDPQYVFSDLYSKQKQSAISSNLAQRYTLEGRYKGIQGQGISL
GAVNVPQGSVKVSANGVQLTEGIDYTVDYMLGTVTIINEQVKQSGQAINISLENQLTFNT
QRKRFLGLNLERRFNENFILGATVVNYSESPLTQKVSYGQEAVNNTMAGINLMYNNQLPF
LTRLTDKIPLVNTEAPSNLNFKMEAAYLLPGLNKGINDQSYIDDFEQTTSKITLKEPTAW
SLASKPEKNQDDPLFQGAGKNNDITEGYGRGLLSWYNIDPRFWGVGGKAPTGITPQSVSN
HASRRVQFSEIYNNRDFVAGEQTFTNTFDISYYPTEKGPYNANSVPESTTQRWAGIMRPV
SVSNFVDSNIEYVEFWLMDPYADGNTLGTTPKLLLQLGNVSEDILKDGQMQYENGLPTPS
APSTTTNSNWGTQPKQPPILYAFSSEGGDRIAQDAGYDGLSSDQEAALFGNTFVNPVTNV
SDPAVDDFVFYMSDKFTGNQASSVIQRYKYFRGPEGNSQSNSLEVASQTPDAEDINKDYN
LDQSESYNEYVVNLDQASLAAGVDNYIVDQKTVQATFQNGQTDDVKWYLFRIPVSDFNNP
NKPNLGGDKNPSILNNVRFARLLLKGFDQTSTLRFGTMDLVRSDWRKYPKNIAKYWINNG
TGIVIPDPAKDEGSTDVNTSNLEVGSVNIEENALNQPPYVLPPGIDRQILSGNAGAQRQN
EASLYLKANNLVIPEARGVFKNTSLDMRRYKKLKLFVHAHDPGNRDPNIGQIDEKTKFFI
RLGSDATDNYYEYEASLKLTPSTATAPLEIWPFENDVDLNIQDFVDAKIRRDKNKSNKIV
ERTKDEVFDPGNTFKSIYIKGRPSLGNVTTIMVGIRNGDQRSTGTSIDRVLWVNEIRLSE
IENDGGYAGNASLNFNLGDFATVNTSASYTSVGFGNIDSKPAERNQSTQSAFSINTAINV
DKFLPEKSGVKIPVNYSYSQTIEDPKYNPLDTDVEFKNAANKEQLKKVARTYTQQRSIGV
VNMHKERMNQNRKPKFYDVENLSVTAVYNDDFYRDIYTKRNYRQYLRGYIDYNYTFKPWV
IKPFNKMISDTAKSTKYLKWVKEFNFNPVPTRFSFRTEVDRNYNELEFRNIDAILSGNYN
DDFGAIKNRNFYFGWQYGLGFNFTKSLKLEINSATRTLNDNVDVNSMDNNSIFGNVFRAG
RPVLYNHRVQLNYKLPFQYLPYLDFIDAEIGYGFTYNWNSRSTVLLSSPDGSLGSIGQNT
NVIQATASADFTKFFGQFKYFKNLSTKLQKRKQEIDSLNNVYTQAWEKNRYAYKKYKFKN
RLTPLQSMAYLLTSIKQLDINYSENNGTVLPGLLSAPNWYGYGQTLGGPTIGFLLGSQAD
IRRAVMENGWVSDSEFMTDPYIRMSTREIRANLQVMPMNDLRIDISALHNYNRNFSHTGF
NYRDPITGIANPDYTFANDLVTYSNSVVLLKTAFKDGAAVYQSIRENARILSQQMPGQLE
SNGFKDGYGISNAYILIPAFRAAVEGKSPKQMTNPKKAGLPIPNWKITYSGLRNIPIING
QFSKFDILHAYQATYTATGIQSSIDYFNRLNSLTSSGRDINDDYINPFTFAQVGYVENFS
PLIGVDVTMRNNMQFGIQYNRLRTLLLGLVNQTLTEDSNSEYVVRVGYIIRNFRLGMTNV
RGRGKAKGSDLNIRGDFSLRDSKTSITNILLDDSQITGGQKLMNIKISADYNVSENLNLR
VFYEQMTSKYKISTAFPLSTIRAGISATFTFGDSGGGF
>KALACAFP_00652 Holliday junction ATP-dependent DNA helicase RuvA
MIFSLQGIVQELTPTYAVINVQGVGYYVGISLMTSQSLNPNQETFLFIQQIIREDAHLLF
GFNTRSEKEMFNLLISVNGVGAVSALILLSTLSLEEIASAILSRNSALIQKAKGIGAKTA
ERIIVDLKDKVQKFSDPEENISTFVNNKIKEESLSALEVLGIPKRMSEKLADKIIKQDPN
ISIEELVKQILKNI
>KALACAFP_00653 hypothetical protein
MFSFHARMIFNLIFVAGFKDLIQKQKTPKSGVFVKLLLFLNYLIKKIL
>KALACAFP_00654 NADP-dependent malic enzyme
MSSKTHRDEKNFNQAALDYHKAEPKGKIEVIPSKPHSSQRDLSLAYSPGVAVPCMEIHEK
PETVYDYTGKGNLVAVISNGTAVLGLGDIGAEASKPVMEGKGLLFKIFADINVFDIEINE
KDPDKFIDIVKGIAPTFGGINLEDIKAPEAFYIEKRLKEELDIPLMHDDQHGTAIISAAA
LINSLQIANKKIEEVKMVVNGAGAAAIACTNLYISLGLKRENVLMCDSKGVINHKRENLT
SEKIDFIANTDIDTLEDAVKGSDVFVGLSKGNVMTPEMLLSMSENPIVFALSNPDPEIAY
DLAIETRKDVIMATGRSDYPNQVNNVLGFPYIFRGALDVQAKGINEEMKLAAVHAIADLA
KEPVPEAVILAYNVQNLQFGREYFIPKPFDNRLITKVSSAVAKAAIDSGIARKTITDFSE
YENSLLDRMGRDEKLVRMMQSRAKSNPKRITLGNAEEYNVLKAAQILYEEGIAYPSLLGN
KKYIQEQMERFGINLDVPIIDPSDDDQKENRKKYRETLWKLRQRKGMNEYKAKRFVRQRD
YFGPLMLRHGDTDGLIVGFSKNYTSVLRPVLEIIEKDKGVDKVAAMMMILSEKKPIFFAD
TSINQNPTAEDLVNIAKMAEFTVKSFAIEPRIAMLGFENFAAISETSKKVAKAVNILHEK
YPKMIVDGEIQPDFAMNADHLSDYPFSKLETTPANTFIFPNLESANLSYKIIRGMKVAQV
IGPILMGLKQPVHVLQMRSSVDEIVNLATIAVLDAQRREKKDKK
>KALACAFP_00655 hypothetical protein
MVAIVDGGSTKCDWVILDDFHKVFLKTETIGFNPNNIEAELIVPEIEKNISLGAVKNSIT
KVFFYGSGCGVASNRAIIQDELQKFFTKAEIIVKEDLTAAAYAAYNGKPAVVCILGTGSN
SCYFDGTDLKVKLPSLGFLMDDGNGCSIGKQLVRRFFMQKLPQDLHQEFEKTYQLTIEEV
LKNMYHTSMPNAYLANFNKFVVERKGHPYFQKMVFDEMISFFDFQVLPYEESKTAEINFI
GSIAYYYEDILRSAAAELNLNVGHIVQKPIESLVNYHIKYIL
>KALACAFP_00656 hypothetical protein
MKRQNKYRKFQLQQKNIEALERENSRFKRVYSEYENMSNELWNLENSSGEPVPDDFINAM
ILQTSYLEDEIEDWLIQFNEKKTEIKH
>KALACAFP_00657 hypothetical protein
MIVCSNHGLQDRKNHQQKELKMNLLSGYIYIILKLKFRNYFESKKIFNNFFYCLTYSYKF
AYHINRMRDILLRQKQVLFFVIAGGLSAIVEIGSFKVFSTYFPHFFPSETDFHGIHYPLS
NIFSTSCGIITNYFLSIWFVFERGKHSKRREFAYFMVVSFISTLLSLGFFQVFYSSIFKD
NIDVIIYTLSPEMISKIAAILLVSILNYSVKKKVIFNG
>KALACAFP_00658 hypothetical protein
MRKILNYLWRFWLLLLAFVFTVLFGIPVFILSFSKKHYKYAYQFIRCWSYCMFFGMGLRY
ELTKLSNQKLEKNQQYVFISNHTSIMDIMLMCILCADHPICFVGKKELVKIPIFGTIYKR
ICVMVDRSSARSRADVYRRCAEKMEEGNSIVIFPEGGVPDDTSIILDEFKDGAFTLSSKH
NSPIVVFTFVGLKEIFPFDNTKGYPGKAKAYLNGILPPSDSPKDLKSEAFDIIKKTLVER
G
>KALACAFP_00659 L-fucose-proton symporter
MESKQQQTKWSQFLSLIVVFFFWGFVAASNDILIPVFKKWFVLSQVQSQLVAWAFYVAYF
VGSVIFFLISLKSDILQKFGYKKTLAVGLGLSALGAFLFVPAAAAANFWFFLTALFIVGL
GFSVQQIVANPLAIKMGSPQTGAHRLTLAGGINSLGTTIGPILVGIALFGMGNKEDSAPK
NQNLSKIEIVKNEYQTHKDELSKNIIELKKDTQDDPVKVNEVISTIEKNIADIDSQITSI
DQNSGASDAQVDQYSAKLGEIKQKSTNITYPLEFVKENLKMVKVPFIVLGVAFILVAIFM
LFSKIEDPAKEEEALIDEPAKFNIFHYPQLYLGMLAIFIYVGVEVSIISNLPALLHTKEF
GGVLEHNIAPFVSLYWGSLMIGRWNGSINVFNTSKTTNLILKFVVPFIAFGIIIFSNELS
GKDVSAFYIYALWIVAFIIMSFIGGKNAGKTLMIFGIAGVVMMFLGLVYPDKDLAKYFFI
SGGLFCSIMWPSIFDLAIAGLGKNTGKASSFLVMMILGGGIIPLVQGWICDFDKSSPDGI
MGITWTHFSYVIPILCFVYLAFYGFVTPKILKKQGIEMGETTSGGH
>KALACAFP_00660 hypothetical protein
MKWVKQHPVVTNMITLYKKKRFWAGLLLAQFLLFYVFSKSGVMISFFERFFELQKAVHQI
IFSWIPFSLGDVLYILLGIFLMYCIIKCFKKTSRNISLLRILLIINVFYFVYQIFWGMLY
FQIPIIKKLSSQEEPTVAKAKVLALKYLTQCKETRKKVKQDHNGIFVVTDLKSIQKEILF
QQSKLPEYISDKKAPQVNSFKPSLFKNVMSFTGILGYYNPFTAEAQYNSELPNTYIPFTS
AHESSHQLGFAREQEANFVGYLIGIHSKNIELRYSTEYFTLKSLLNFIVDEDPEFVKSVL
ANYSPEMKKDRAYEKSFVLKHQGFLNEFFGFTNNLFLKSNQQEGSVTYSYFIDLLLNYEK
V
>KALACAFP_00661 Prolyl endopeptidase
MKKKYFIIFTQLTLGVISAQKNNLASSNPITDEYFGTKVVDEYRNLENLKDTETINWMKR
QADYTDSVLKDLPYKDYYLNERMKFDKKAGFFVNELKITGNDLYFYLKKEAHENIPKLYY
RKSFKGKEEFLYDPSIFISSFDPESKQQHNFVINFISPSWDGSKIAISMSENGKEISEVI
IMDVKTKYIYPQVITNLEPTSVGQVKWLEDNSSFFYTYFPVIDTDSPEYTKNTEVTFYRL
GDDPKNRKNVFSRVNNPELNIDEGRFPGIVQFNQGDPYFIGNLGDVDDYTDTFIIDRKDF
EKGIKSWKPLYHKADKVFDKMPMGKEVYFMSGYNSPNFKLCKTNLEKPDFKNPKILVPEK
KDEVIRSFTLTKDGVYYTTTKNGVEAKFYLYKNGKDIPIKLPFVAGDITIETKGKEYSDV
WIYCSGWANEQRRYKYNLTTNSFVLENLYPLIEYSEFKDIIVEETSIKARDGESIPLTLI
HDKNINKNKQIPVIIQAYGAYGTSYTPFFARSYLMWAKQGGIIAIAHVRGGGEKGDRWHK
AGYKETKPNTWRDLIDCTEFLINNGYTSKDKVAIWGKSAGGITVGRAITERPDLFKVAVI
EVGATNMLRDEITPNGPGNVPEFGTVSKQDEFKALLEMDAFHHIKYGEKYPATLITAGMN
DGRVVSWMPSKFAAKLMANDASQNPILLKIDYEGGHGGSVSYEKAYEEVGKIFAFIGWQL
NLANFQPTNSKN
>KALACAFP_00662 Cocaine esterase
MEKSFLIYFLFAFSFFFPQKIETKDMVVRDSIIIRTKDNATLSLTLVFNKNQQPQNTILV
NTIYPDKKNIDLVKNFVLNGYVGAILHTRGKYLSDNEIEPFEHEADDINEAISWIIKQPW
SNGKVGMIGGSYSGFSQWAAMKRLNPALKTIIPEAATGVGTMSLPMNNNIFICYSLQWLD
FVTSNKMIDAKSFYDQKKWNSIFKKWYESGKSFRKLDSISGKSNAIFQKWLNHPAYDDYW
KKMIPYKEEFSKINIPVLSVTGYYDVDKSGVLYYFKQHYQYNQNAEHYLIIGPYDHWGAQ
GFIKKELRGYKTDSVASSIDLNKIWLEWFDYVLKNKPKPEFLKDKINFQVMSANRWESAH
SLDIFNKNKIKFYLDNDGNNLTLSQSKNKKENFSSLRVDLKDRTDATELLNLKYNILDHF
IYTKNNLLFKTKPFAQPFELTGNFSGSLSFSINKKDVDFYVSLYEETSEGQYFLLSSYVS
RASFAKDNEKRNLLTPGKIETIPINNYDFISKKIKNGSRLVLIVGIVKSPFWQLNYGTGK
DVSDETIADANEPLEIKFYNNSFVEIPILKY
>KALACAFP_00663 Nisin biosynthesis protein NisB
MMKRKFIPGSEWLYFKIYTGIKTADIVLNEGILPLTDWLLEKKYIKKWFFIRYNDPKPHV
RIRFELITIDQYNIVLSQINHFLEKYITSGEISNLVFDTYNREIERYGKQTIEEAEFLFY
KNSRLVLQEYLDFDDEEKIIISVFYIDQILNRLGLSIHEKLSWVEYSNIGFKKEFNADKK
LNSQLDKKYREFKIKYLDFLQAEDYQYFKETIINEITDCHEILESIIEKTDKQSLQRFFE
SIFHMNINRIFISNQRVFEMIIYDYLFRYYKSVRFQNHQIR
>KALACAFP_00664 Nisin biosynthesis protein NisB
MSRFPYHFFEEYIIRTPMFSYKNFKQEFGERKITDDELKNICVDPVFQEAIYLASPYLYE
EIQQWMGGKKLPLKEFQKLKNTILKYYSRISTRCTPFGLFSQVGLGHFENNPTPQNRQLA
TNNQKLTTKNQIRDTKLDMYFLVCLAQSFEKKAEIKNQLLFFPNNTIYRVGDYIRYVEFE
YIHGKRDYIISSAPFSEELHKILEFSRIGKTTTQLTDILVNEHITETEAREFIEELIENQ
VLVSEIEPNVSGDDFLDKLICVLTKINAKKETEILLSIKKKLDKIDQQLGNSISVYSEIE
DLIKDFETDYEKKFLFQTDLYSKNEFIVPSNWKKDLKNAVIFLNKITRAQKETHFEKFKK
AFHERFETQEMPLAYVLDAEVGIGYKKNGSAKGVHPYLDGLDFLGTLKDTIDIKLTSVHK
ILNEKLQEALWKNETVIQLSDEDFKDFEENWDDLPDAISFMAEIISESNQEKLSLEGSSG
SGAANLLGRFCSERSEIQNLTKSIVKKEEELDPDCILAEIIHLPEARIGNVIRRPTLRKY
EIPYLAQSILPKENQILIDDLYVSLKNDTMVLRSKRLNKEVKPFLTNAHNYFSNTLPVYH
FLSDFNSQNRRKGLYFDWDGLENIYHFLPRVEYKNMILSKAQWKLNEKDQDFLIGVISDE
KHFISEIRKWRNERKIPEWIQWVKSDNKLTINLENYDLVKMFIDAVKHEKSIIIEEFLFN
ENDDFKREFIFPMYKVQ
>KALACAFP_00665 Prolyl endopeptidase
MKIKIFIIICFFSIFSYSQKTNLSPSKPVTESYFGTKVIDEYRNLESLEDPNTINWIKSQ
TAYTNSILDQIPKRNYYVEKRLELDKRQGYSVSDLKITGNDKYFYLKKNENEKVAKLYYK
DGLSGKEELLYDPVNYKNNERNHDFVINYISPSWDGSKIAISMSEKGNELADVIIMDVKT
KYIQPEILTNTAPASFDGIKWLNDNTGFFCVAFSTIDSKSKDFYKNTRTVLYKIGTDSTN
LIEIFSAKNNPELKITEDQFPMLLDFDQEDQYYIGMVVDYSYYRKTFIISKKDLLEGKKN
WKPLSDPNDKAKNLEIWNNDIVFVSGYNSSFNKLCKTSINNFNFKNPEVLVPEKKDEIIK
SYRITKDGIYYTTTKNGVEAKLYVYKDGKDSPIQLPYPSGNINLENKGVNYSDFWITCSG
WANEGQRFKYDVKINALKPENLTPITEYPEFKNITVNEISIKARDGEEIPVSLIYNKNLR
KDGKNMVLIDSYGSYGISYTPFFAKMYLLWINQGGMVAVAHVRGGGEKGEKWRLGGYKET
KPNTWRDLIDCTEYLIKEKYTSKDKVAIWGASAGGITVGRAMTERPDLFKAVIAEVGVMN
PLRDETTPNGQPKEFGTIKDPKEFKALLEMDSYHHIKKGVKYPATFISGGINDQRVTVWE
PVKFAAKLMANNASNNPTLLKIDFEGGHGGNIPPAQRYANLGDMFAFALWQLGHPDYQPK
EPTKK
>KALACAFP_00666 hypothetical protein
MKKQVKKEKKLSLNKVRLMKITDMKTINGGSGAQAGLNFNGDDDHNPTIRQTMGQQ
>KALACAFP_00667 hypothetical protein
MKVIFSILLFLSGFIYAQKSIVDALSEFNYSQLKSKFDDYYDNDKVSESKIIAQYYLQKA
KKEKNNLQIAEGYILIHFNEDFPTALKYIDSLEIITKNIKGSLYPTRTYLMKGNLYFKYD
YLKKALDNYIIALQYAKDQKDQKQIAYANINIAYLNNYLGKYAEAAKIFRYYLYNPNNIT
NESQHNQIRVSLINCYIELNKLDSANILIKEGQTSAFTGKSKYSVNQYLYFSGYSNLKQK
KYTIAINELAKTYNFFSSINDNNANYALYSLGKCYDGLNNKEKAVEYFIRLDSNIQKTNI
TFPELREVYTYIIDYYKKKNDKEKQLYYIDRFLKVDKKLDEQFEYLSTELPKKYDTPKLL
QEKEDIINDLKNRKTFLYTSIGLLLIILLILAYLYYNSKKTEKKHKQIAQDLIHSIEHKN
LEVSDKSNVVLLQELESATENLPLDSFENNVIQNNESLTEEVVEKIEIKANKTIPEDVIQ
NILKELRNFEAKELFLKKGITLANLAKSLKTNTAYLSEIINTHKGKNFAAYLNDLRINYA
LNQLVVDRRFRSYKLSVIAEELGYNNEQAFSLAFKKKTGTTLSIYIKEIENSHQY
>KALACAFP_00668 hypothetical protein
MKLTFLTTNELLTIEGGSTGGDPQTINILGNVIYTGTPPLNP
>KALACAFP_00669 hypothetical protein
MNLEKLNLVELEAHETIIVNGGGNGGWWWLAEQVIDNWSEIKDGLSDGWNGHYNPPKK
>KALACAFP_00670 hypothetical protein
MKNLETLTSSELLAVNGGDGFWYDVAYAVGALAHEYVHQVALAGYYASAGH
>KALACAFP_00671 hypothetical protein
MKNLETLTNDELLSINGGDGFWYDVAYAIGAGAHAAANAIVAAADTIASHPVGGPRGGYN
>KALACAFP_00672 hypothetical protein
MKKLVIFFIISFVFAVLNGYFFNYINDMYLHFDVNQNKNPNISKNELNFIAILVAPFIET
FIFQYLPYLILTKWMKVKNELICIIIMSMIFSSMHYYNWLYIVMTFFGGLILNNLYVYYY
KHARKYSFILTAIFHVLFNLYGFLFVM
>KALACAFP_00673 Hemolysin secretion protein D, chromosomal
MFKKSIYIGILILVITLLCILPIIKVPISSSSRGVIRSVQENTKISAIVSGRIIYSKLEK
NNQEIKQGDTLLIVTAEQLDTQKNLQNSQSSDYSAQLQDLNKLTRGQISGLQTGQYQREL
SAMQEKIAQVQTQLSLAQKDFDRAATLYNQGVIPKAEYDKFFYNLQGLKNQIAGIREQQI
AQWQTQKREVERQIRSLGSEVQRINQEQKNYIITAPISGRLVNFSGIQKNNFLTQGQDIG
EISPEVSLVAECLVSPKDIGFIHTGQTVKYQIDTYNYNQWGLLEGRVSEIDQNIKINEQT
GEAFFRVLCQMDKNYLQLKNGYKGQIDKGMTFTARFHLIDRTLWQLLFDRVDDWFNPKLK
>KALACAFP_00674 Lactococcin-G-processing and transport ATP-binding protein LagD
MKKNILIRQHDIKDCGAACLASVAIHYGLKMPIAKIRQICHTDTRGTNVLGLIQGLEQMG
FNAKGVKGGIDALPELPLPAIAHVVVNGQMHHYVVVYKVAKDKITVMDPARGKLEDYKIE
EFSKIWTGVLILLEPNEYFEQRNEKTSLYKRFWNLVQPHKSILIQALLGALVYTILGLST
SIYIEKITDYVLIDGNKRLLNLLSVGMIVILLFQIFIGAMKSILVLQTGQKMDKHLILGY
YKHLLKLPQRFFDTMKVGEIISRVNDAVKIRTFINDVSIQIFVNIFIIIFSFALMFTYYW
KLALITALVIPFYFLVYWITNKLNKKAERQLMEESAELESHLVESITSVKTIKQFGVETF
ANNKTDNTFSKLLKTIYASVMNALFSGNSSEFLSRIFTIVLLWAGSGYVIDRVITPGELL
SFYALIGYFTSPVSQLIGMNKTIQNALIAADRLFEIMDLEREENTEKIDITSENIGDIQF
KDVSFSYGSRTEVFTNFNSLIKKGETTAIVGESGSGKTTLASLIQNLYPLKTGKIMIGDY
DINYISNYSLRNLVSVVPQQIDLFSGNVIENIALGEDFPDIHKILDITKKLGILNFVEKL
PNGFQTYLGENGALLSGGQKQRIAIARALYKNPEILILDEATSSLDTESELVIQNTLQEF
KNQGKTMIVIAHRLSTIANANTILVMKDGQIIEQGSHIELLDKDSVYKSMWEKQGKKLT
>KALACAFP_00675 hypothetical protein
MLLDKLINYLKLDKQEFLFQFSSHPNYPSALAFSDTLNFMGVRNDAYELDKEYWDELPEE
FIAIVDNTFSLVKKTGNNYSIYSDKAKTLNKDELHKKSTDFVLLFEKENADTKTVTSYKP
FIYVTLAIIAIYSLLNHAWYQLVFNILSMIGVYISLEIFNQKFGNTSAVIGSICGDTADR
QTVNSCNKIINQDKTSILGLKFSDFSLIYFIGITILGLFLPATSFIIKGFTFASVIAIGY
SLYIQGFVEKTFCRVCLVIISILVAQLVIAVFFFDNIYFDLKTSLLSLILWITSFSLVLY
LNNTLNEKDSLQKSNTKNLRFKRNYDLFKRELTEKEKITFSDNETFSVGNKDARLKISII
SNPYCGFCKDAHKIMENLLEKYPDEISVQMRFNYSPDKQNEKFTHLISDFTYVYKNKPEK
DFLQTVEYWFETRDEEKIRQKTGATSSHEDLTPLVNMSAENRDAGLNFTPIILLNGYQFP
DKYDREDIYYFIDELIEDEEM
>KALACAFP_00676 Lactococcin-G-processing and transport ATP-binding protein LagD
MKSFPFYRQPDSKDCGPTCLRIVSKHYGKTISLQQIRNLSETTREGSSLLGLSDAAEDLG
FRSLGVQINFETLAEEVPFPCIVHWNKNHFVIVYKIDKNNKVYISDPSYGLITYNREEFI
KLWIGENANEKTEEGIALILETTPAFFQTEFDDHESKASFSFLSKYLLKYKSLVIQLAVG
LLAGSLLSLIFPFLTQSIVDVGIQNQDLNFIYLVLLAQIMLFLGRMGIEVIRSWILLHLS
ARINISIISDFFIKLMKLPISFFDTRMTGDIMQRINDHHRIEQLLTSSSLNTLFSLVNLI
IFSIVLLLYDYRLFIVYLVGAIAYIGWISFFLNKRKELDYKRFSQVSQEQSKVIELINGM
QEIKMHNAEKQKRWDWEFLQVKLFKIRIKSLSLEQWQSVGGNFINQMKDILVSFLSAKLV
LSGNLTLGMMLSVQYIIGQLNSPLLQLIDFIKQTQDAKISLERLGEIHDKDDEESKDEQY
IHDLPQKDIEIDNVSFRYIGSDAYVFENLTLNIPFQKTTAIVGASGSGKTTLLKLLMKFY
EPTQGEIKLGNTKLKNISPRFWRDHCGVVMQEGYVFNDTIANNVAVGEDYVDKQKLRRAV
EIANIKDFIEELPLSYNTKIGNEGLGISGGQKQRLFIARAVYKSPEYIFFDEATSALDAN
NERVIMENLEQFFKGKTAIVIAHRLSTVKHADKIVVLDKGKVVEEGNHAELVALKGEYYR
LVKNQLELGN
>KALACAFP_00677 hypothetical protein
MKNLRKIERKNLREVHGAGPIPVFPCNCFCYINNVKQWNACNRYCPDGDIPGVEPGNNPK
CDYTLPL
>KALACAFP_00678 hypothetical protein
MTQKDILDNIELRSESVQDILTQPPHWMIRWGNSIIFIILVLILIMSYIIKYPEFVPAPI
VVTSQNPPEKLEARTNSKIEKIFIKNHQQVKKNEVLMVMQSTANYKDVLELKRLIDSIAP
NQLASFPLQETSHFKLGELQGDYNNFAKAFQDEALFTRLQPYAPENLAANQSLSEYKIRT
ATLRQQKSLEQAKYELTKKNYQRSQELFNQGVIAAVELENEKIKYLQAQQNLENITISLS
QIEEGISNLNKTKSGTAINTEKDKITYSSQTLQLFEQLRKSLKQWEQSYLIISNTEGLAS
FQQFFGENQFVKAGDVIISILPKNKENLVGRMAVPATNSGKVTPGEKVLIKLDNYRYQEY
GIVEGKVQNISLSPDKDGNYYVDVILPKGLKTSYHKNLPFDKELKGNAEIVTQDLRLIER
FFYQMRKLLGYQS
>KALACAFP_00680 Thiol-disulfide oxidoreductase ResA
MKKIYTISALLAAFSIQAQFTVTIQTPPDFKDQDAILYTLNGSKDIIVSKEQSKNNTWTF
KYPKNYMGMMKVYFPSSNNTFNFISENKNVNVKLETQTNKIKNVVYLDEANDIMSKIQEG
SQKKELILPALSQIKEYYKDDTEFGKALKTEINRLSGGLSGVDQTQHPFIYYYNTNYNKY
LSNDASKKVNQEEIITFIDKSNDMLETSSLLRPILVGYLNSGGNTNVTASVDKLLDRLKV
ETPRGQVVLSELIDIFDVYEMADYKNKYLNLAKDLKCTITDRLASTLKSNANVEMGAGFP
NYKFQAPVNTTAKSLYDIKADKKVVVFWSSTCSHCESELPQLLAKYNDLKTKNVQVVGLS
LDVDKDSYTKKISAFPWVNDSELRGWNSTYVDTYNVHATPTYFILDANNKIISKPDHVGD
VLEYFKLK
>KALACAFP_00681 hypothetical protein
MKTINKLVSALFLLAVLLVNAQPPNPGSGGGGVGPGAPASPIDMYVYVLGMIAVMFIAFF
TKKYSSNKI
>KALACAFP_00682 hypothetical protein
MRKSLFAIGLLAVVSSVQAQNVLVHVDDAATTYVSKGTLLYSGGGLQMKATGKVENHGNI
MVSGAASDSFKTIDASNVDKTEATGGGNFVNMLNEPTAYNQVNTNSSSATPVYTYGQLFI
SGIPQANLTGIVDQEFRAVNHGTYQQIGLPFYDKTASTLSAELGKTFTNTRYSKNEILTW
NNSTVVSENFSTSSKLGVAKPGTAYYMLGGTGLDVSNTTRVVKGRPVADDAATAIPLQGA
GASVNFGTNGNSTNQYNEKYNTYLQDGFETTPWQGSYGKNWYQFSNPFLTNLDLSRIAVN
EGPNGDGVNLTTIQGVRLEVSGVTTTQTGGTGSASYKFITFTSGVPTGDVDYMMVRPMGT
FAIKLLNNTASDSFNFANLRRFNYYSRAAGTDYSVVANKNAAKIGTVKQLGVVALDANGK
EVGRTYYVVYPNGTTGHSSTDAKTQVKATSADLVGTFEEALTGGYDNNYTGQYWLYINEA
NENNFKGKNIKLVNYDMNKVKSYKFEIRENAELVSDGTHALSSGTGFYFKAPNGIAQQAK
QGDVVPASAAEFDLYYGEPSSVVLAVSKPDVTPSRTMVVYNPQITNYVVRFDPNWKKADI
EVYDMSGKLVISKKAVSTSTDFVIELDGKIKNSYVVKIVSDKGETVNTKILK
>KALACAFP_00683 ATP-dependent Clp protease ATP-binding subunit ClpX
MNSNQCSFCGRKRNEVQMLISGQNGFICENCIEQAHAIVKDSSSKAGYSPAENIDELKKP
KEIKEFLDQYVIGQDQAKKQLSIAVYNHYKRLLHAQDENREVELEKSNIIMIGETGTGKT
LLAKTIARELNVPFCIVDATILTEAGYVGEDVESILSRLLMVADYDVEKAERGIVFIDEI
DKIARKSDNPSITRDVSGEGVQQGLLKLLEGSIVNVPPQGGRKHPDQKYIQVNTQNILFI
AGGAFDGIKEIIERRMNKQAIGFSFEKINKTDEEEYILTNINAIDLRSFGLIPELLGRFP
IITYLDKLTKETMVRIMKEPKNSIVNQFIELFKMDGTNLVFTDGAIEKIVEETIEKGLGA
RGLRGTTEKVLEDYMFSIGEEKEIILTEDNIFVNK
>KALACAFP_00684 putative HIT-like protein
MSTIFTKIINGEIPSYKIAEDENFIAFLDAMPLVKGHTLVVPKKEVDLIFDMESEEYKNL
WGFVQEVAKKIKNAIPCVRVGVAVVGLEVPHAHIHLIPLNKMEDMNFRNERLKLSNEEYT
EIQNSIINS
>KALACAFP_00685 Transcription elongation factor GreA
MASYVTKEGLEKMKAELEQLETVERPKITQQIAEARDKGDLSENAEYDAAKEAQGMLEMR
ISKLKDVISTSKIIDESQLDTSKVSILTTVKLKNNVTKQEQVFTLVPDNESDLKTGKISV
NTPIAKGLLGKVVGETAEITLPNGNKLSFEVLDITL
>KALACAFP_00686 hypothetical protein
MKKTFSILTITTLLIFSNLSINSCGSREDTVSCFPNNPINVTLNLNLPAYYSLNQVGGWV
YINEQQSGTRGLIVVRASDNTFKVYDRNAPHICPDNNTTLEVKDNIKVVCPKDNAQWILL
TGQPTAVANVPPKTYLYNYDPAGKILNIYY
>KALACAFP_00687 D-aminoacyl-tRNA deacylase
MKVVIQRVSESHVKVDGKIVGEIGKGLMLLVGIDENDSKADADWIVQKILNLRIFGDDEG
KLNLSVVDIAGEILCISQFTLIADYKKGNRPSFIKAAKPDTAIPLFDYFKEEISKSGLKT
ESGIFGSDMKVSLINDGPVTIVMDSITKA
>KALACAFP_00688 Outer membrane protein MIP
MKKTLITLVLLTATTFSYAQTNYTEDQKASYYIGLDIAQNMKRQGFSIDPNLMAQAIKDE
FSDKPKLLPAGEKDTFLQGFMQKQNEKRQAEAKVKAEENKKKGAEFLAKNKLNKNVKTTA
SGLQYEVLKEGDGKAKPTASSTATVTYTGKLTDGTVFDSTDKNGGKPIEMNLSGVIPGWT
EGIQLMSKGAKYRFYIPSNLAYGDNGAGGVIPPGAPLIFDVELVDFK
>KALACAFP_00689 hypothetical protein
MKNIFLTAAVASVALVSCGTVQSLVQNTFPYTANVLVSTGVPADKEVSSTATASNVQTWF
GGNNNAKIKDVRISDAKVSVVSPSGGNLSAFKSIKVYISSSGTGERLVASRSDISTDASS
LNLDLENTGFLDEVVKSTGVTVRTVYVLKNQTSSDMNLRVALNFSSVPAK
>KALACAFP_00690 hypothetical protein
MKKSLLLIPLIMISCKKDPEVLETQNKDSVAVTEQPAPAEKVDSAALRKKDSIINNAPKT
KEVLRKGVMRSTKDGQIIRTADAEQLPFTLGEEFTKDDQEFILKITDFNKPNIKAKISTK
EKDFNIRFNQIKLPNGDYDGPFGREISYDVKDKGEVWLIIGKSNMASGNTKGSFTVSVE
>KALACAFP_00691 hypothetical protein
MIKKLKENQRFEVTVLLIFMTLFCFSLSMFRYYISETKVFFFLNWNLFLAWIPFIISSFL
LIFNIKSKISLVVAIAVWILFFPNSPYILTDLFHLKIRSSVPIWYDLVVILSYAWTGLFC
GFISLLDIEKLLSAYFKKSTISLITISFLFLTSFGVYLGRFLRWNSWDILNNPFGLFNDI
IVRIIYPMEYTKTWGVTILMGIMLNFMYFMMKSMKNINRTSYFQAH
>KALACAFP_00692 hypothetical protein
MKTHHYIFLTTALFIIVFYDQELALNVGIIGIIYSLLTLFRTPEKNRTKTFFFLFAASIL
SDIAFAWYRDFPSLLAVLSSFLLLGYRSKNRRMKILFLIPVFVTNCFTALCRFFSFDEWL
PRKDVPGLWQKTMAFVLIPLILISIFFGIYSAGSDHFANLFTNIEFDINFWQLLAITVLG
FFIAFNYWNYVVEKIIYKSNHLLNNDFQEKDKIQKSTYSFLDLDAERMSGVISFFALNIL
LIFFIITYNYEQFYEVSKTPAQLSEETHERVNAVIMSIVMAILVIMFYFKSNFNFDTKAG
SMKILAKIWIFLNAILVVSAMVKNSEYIINYGFTYKRLGVYGFLILALIGLIMTFIKIQQ
KKRNAFLFNTMTWYLYGFILVCSYINWGGIITSENMKRKDFVVDYHKDKIHFNEKILLKY
AEEKKDSKLKAEILNKIKPEQKEKFFSKILYYETFK
>KALACAFP_00693 hypothetical protein
MKNIKFSKEGKVTFLASWLLGTILLLGYIFTKSWIFAGIGFYYVLAAIVINVIVFFHEFF
AFIIDVTYKKSHGNSALLILLNIPIAIAYFFIFCSLESLNL
>KALACAFP_00694 hypothetical protein
MKKIRVQFLLFVYEKTQKLYRKYFKKKKRQWQFTEKQLLEFQEDSLGRKLGEFYKKHGFT
MIPKMENHDVHHLITGCGTNFEDEIAMQFLLLGNGKLNAHLLAAVVLGTLILPEYLKMYI
RAFKKGQNMRPFYHWDFEALLWQNFDHLKDFIQQKETAVIY
>KALACAFP_00695 hypothetical protein
MITTKQKSTFIFAVPALLLSAAFLGNLFVEGWDWSPFDFIIAAVLLFGTAFFVNLVVNSK
KEFFSKLMICVGILAALMLIWAELAVGIFGSPFAGS
>KALACAFP_00696 hypothetical protein
MSVLMVNDWVDFSEMKSLLEVTDGNMASHSNALEKAGYIEVKKEFVGKKPRTSYRVTQSG
RQAFTEHLNALEKLLGK
>KALACAFP_00697 hypothetical protein
MYFKVLYMDSKNYHEDLSHIRSMMERSSRFISLSGLSGVFAGMAALIGAGYVYFVFQREG
IDYFDGERNIFGPALVKELVIIGTVILLTAILSGYIFTANKSKKKGLKIWDATTKRLLVT
FAVPLVTGGIFCLGLLYHHLFVLIAPATLIFYGIALVGAERYTLTDIKYLGYCQIVLGLI
SLFFLGWGLLFWAFGFGVLHIVYGLIMHKKYK
>KALACAFP_00698 hypothetical protein
MKNIRKHSKRILVASSVLAVLALSSCHSDYLDTDPTTAVSEQAAFSTAGNLMAIINGMHR
DMYSRQNSNQGQNGQGGIMIMMDALGEDLVFPSTGNGWYISTVRWQDQVNENASNDFYPY
QFYYALIRNANMVIANGPSVPTPTAADAATVKQAIGEAYAFRAFCYYMLVQIYGKRFVPG
ILNTQLGVPLRLIADESPMKRNSVADVYIQINNDLNEAQNRLAGSTRTTKSHFDEKVVLG
LKARVALTQGNYALAASSAKAARAGFNLMDNATYMAGFNNLAGNGEWMWGATIISDQTDY
FGNFGAYMSRNYNSTNIRQAPKAVNSKLYNIFPTTDVRTKIFDPTGAHTSLGLPSNFAKF
PYTSQKFLSASVSDSRVDVPYMRAAEMYLIEAEALVRLGDEANSKIVFNAFTKNRNPSYP
GASTTGTAYINEILNSRRLELWGEGFRFFDLKRLNQDLDRTGANHSSIVDNNVMTVSSTD
KRWEFLIPKAEINANPLIEQNPL
>KALACAFP_00699 TonB-dependent receptor SusC
MKLKFCTLSVATVFFIGQNLSAQKKKSDTLAKEKQIDEVVIVAYGSQKKETLVGSNTEIK
AKQFADRPITNIGQAIDGASPGVKISTGTGQPGSAPSIQIRGISSYAGSNDPLIILDGTP
FTGSLSAINTNDIASFNILKDAASTSLYGSAAANGVILITTKSGRKGGRDILNFNMSTGY
VGRSIPEYDRVNAYQYYPLIWEAIRNGQLAIGSTLANANAYASTNLIPGVLKQNAFDVPN
NLLVVDGILNPNARLKYTDLDWQKPLIRTGFRQNYELNYSGGTNKTTYYSSVGYTNESGY
LVKSDFERFTAKLKVDSQIRDWLKLGTSLNAVSSYGNNAIDGASSNSSYVNPYNWIRNIG
PIYSPFAHDANTFATLYDANGNVIYDNSARGADAASGRNVIQENLLNSDVSKNFYIVSRA
YAEFKIDPYLTLSTNVGYDVRNNRRSRYGNKIIGDAAPAGSAERTSIIEQTLTFNQLLNY
KRKFGSHNFEFLLGHENYKYMYEYLYGYKTGQVVDNNSELINFITPTALTSQTDNYRKES
FFSRLNYDYKSKYLLSGSVRWDASSRFAKDVRWHPFWSIGAGWRVKGEDFLKNSSTISEL
KLRGSYGQVGNDNTNTSDNAQNFYMYQNTFSLGYNNAQEAGILFNVKADPTITWESNNQS
DLALDFGLFNNRITGTVEYYNRITKDMIFPVPQPVSAGIPGNAIYKNVGTMYNRGFEIGL
NADVIKTPNFVWSLNANASTLKNEITQLSDGITEIINGSKKISVGHSVYDYWMKQWYGVD
PADGSPLFLVADAYANTPASDIRTVNGVLVTTNHNKAKLDYSGSAIPKVFGSFGTSLNYK
QWALSTMFTYQIGGKTYDSNYQTLMSSYSQGGALSTDILDRWTTPGQITDVPALNSATYL
NSNATSSRWLVKSDFISLRQATLSYSFNPEEISRYGLTSLKLILSGENLWSKTARKGLEP
GQSFNGTTTNRYTPARIISIGANLSF
>KALACAFP_00700 Carnitinyl-CoA dehydratase
MNEFVVSELKNNIAEITFGTPKSNSLPGAILEKLAQTILDEGVKDEVKAILIKSEGEKAF
CAGASFDELLAIEELEASTKFFGGFAKVLNAMRNCGKIVVVRVQGKTTGGGVGIACGADY
CFATKDSALALTEINLGIGPFVIGPYVERKIGKSQFSAMAIDADFRSAEWAEQHNVYHSV
SATIEEMDAKLEKFLQTLASRSSDALALIKKVSWEGTDHFNDLMPARIHMSASLILEDSA
KKSIESIKERLRVK
>KALACAFP_00701 hypothetical protein
MEEIMGVIKSFSGNFAPVNFMFCDGRLLSIAQNTALFSILGTTYGGDGINTFALPNLNGR
YPLGPGSNGGQSYVLGEQSGTPQTTLMSMNLPTITSQLKVANANATSASPSATSTLAITG
TQSGRDFTAIPSYINNADPSSVTLLNPQSVIFQGQNQPIDNMMPYIGMNYIICVQGIYPS
RS
>KALACAFP_00702 hypothetical protein
MEEYLGTIKMFAGNFAPRGYMYCNGAILSIAQNQALFSLLGTTYGGNGTTTFALPNLNGR
APIGAGIANTGKSVNLGEVGGSPATTLLNTNLPTFASQLRISKSNAATASPSSASSIAVT
GTQSGRDFTAVPSFVDTAPDTVINAGSVTFVGANVPVENMSPYLGMNYIICVEGIYPSRP
>KALACAFP_00703 hypothetical protein
MKRTILFIICSLFISIFSFGQTSTEQFETESHGSASFTDNGVIFNIISHVNTYDIQANYP
GTGWNGTGVDNRYIDNSAPGNQASGTSFSIKTTSNLFKVNRFWVYASAANLDLSVAGTLT
VTGKLSGVTKFTQTKTTGFTTSLATTNGFTLIDMTNLNGQNYSNIIIDELQITGGGGYVY
LSLDAFTWVKDTNVVLAANEVKPSKKDLNIYPNPTSGPLTITTDDQKKLEIYSQSGQLIK
TVEARKGENQTDISELPKGVYILKSSSESYKIIKR
>KALACAFP_00704 1-phosphatidylinositol phosphodiesterase
MATTFNQNWMNRLDGNKKLTEITIPGTHDSATYDTVFMPAQCQKMSFTDQLNSGIRFLDF
RLKRGFDADKDHVLWFYHGSLGLNLHFGQVINMLVDFLQRHPSETILMCVKNESDPSSES
KQEKFYNDFNITISNNYPSFFYRENRIPTLDEVRGKIVFVKRFATGTVDSSKDGLNLFSQ
WPNDSTISFENNGIKYYVQDNYYNWGKEREDKFTQYVKPALIAAANGEQDRLYFNFSSGT
GFSGGVLPDTTRPWDLAKVVNPLFLEYIRQHPKGRYGIIPMDYPEHPDNKNLIISLINSN
EFKTVPAL
>KALACAFP_00705 hypothetical protein
MKTFADQVVEFNQNLKYDGKLPDDFQVLNPYLDNPETMEVMQKFYHKYYNDSNKRKFIVG
INPSRNGAGVTGIPFTDTKRLETVCGIKMQSAHTHEISSVFIYDMIQEYGGAEEFYKDIY
INSPFPLAIIRKSKGNWINANYYDDKELFKDVKDFMIDSLKKHINLNLYTSEVFILGKKN
ADFISKLNQEAKLFDIMTILEHPRFIQQYKLKEKQLYIDKYILALKQ
>KALACAFP_00706 hypothetical protein
MTDIRTTPIEADCFYHIYNRGINGENIFKSDRNYLFFLNKISEFLVPVCDVYAYCLMPNH
FHFLVKIKSNVELESLVKVSNLDKASGRGLHSPQNIFSKQFSRIFNSYSQAFNKENNRHG
SLIESPFKRKLITSEGYLINTIIYIHQNPQNHSVMDDFSLYNYSSYQSILSKSKTLLKRN
EVIELFDNRENFIMSHQKIIDFDF
>KALACAFP_00707 Bifunctional protein PaaZ
MEKLKNYIHGEWVEGTGNGIPLYNAVTGEQVAVSDTEGLNFEQALDYGRTVGYKNLSSMT
FYDRGEMLKKVALYLLERKKKYYELSYKTGATHVDSWVDIEGGFGTFFTYSGLAKRMLPN
TPFWVDGDTQKISANGTHLGTHILTPSEGVSVQINAYNFPVWGMLEKLSTSLLAGVPSIV
KPSPFGSYLTNAVFQDMIESGILPEGAVQLVCGEPGNILDYVKDGDSVLFTGSATTGRKL
KSLPSIAGNAVRFNMEADSLNCSILGLEAKPGTPEFDLFIKEVRNEMTTKAGQKCTAIRR
IIVPENLIGDVQNALSKALDQTKIGNPLNRETRMGSLVGRQQYEEVLRKVNILKTETELI
YDGKHELVDANYENGAFMSPKLFLNDKPFEKNISHDVEAFGPVSTLMPYKDAEEAAALAK
KGKGSLVGSIVSHDNDFVAETSWKMASQHGRIYVLNRDNAKESTGHGSPLPTLMHGGPGR
AGGGEEMGGLNGLHFFLQKTAIQGSPDILTAITKVYQQGAEKKYSDKHPFQKYFEEVEVG
DSLETAGRTVTDADIVNFSNVSWDHFYAHTDATSLTGTIFDKTVAHGYFILSAAAGLFVS
GKKGPVIANYGLENCSFFKPVYAGDTITVYLTAKEKINRGVKGRNIPSGVVKWLVEVVNQ
RDEVVCVATILTLVAKQSPFIDLNLKNIQKALNGLTESTQPSWGKMSPQQMIEHLEHGVL
VSLGEPEADKCFTPEEQLEKWQDSLYNHRKMPKDFPAPFLEEDEKLLDLRHKNLDAAKQS
FMDNLKKFSIYYKENPQAEHMNFVFGKLNKEMWELMHKKHFTHHFEQFGLI
>KALACAFP_00708 hypothetical protein
MEKGKIKSIKDLDNIKKLLLDLPEFKYQKELTEKLDAKKDDFTYETMLEIVLWKTNRFPE
INNDLIVKINELRKGYDEGLSDYILIKLLDSKGFDLPMASTFLRFINPDYFQIIDQRVYR
TIYGENLKMPFSKPKKIELYKKYLVDLKKICANYEIPFSKSDRILYLLDKHPEVNKEQKI
KY
>KALACAFP_00709 hypothetical protein
MKYLFFAIFFSVVMSAQKTENKKINIELKNELAQIDKDDQIFRELVQPTTSTERKQEIMK
EKNLTQEDVTTGISKIMNKQDEENLAKIEKMIAKYGYPGKSLVGEPENKTAWLVIQHSSK
INQYMPVIKKAADEKELPFRLYAMMLDRQLIQDKKEQIYGTQACTFKTMKDGKPVVEWMI
WPIKDIKNVNRLREEAGFGQTVEDYAKDLLGHDFVFKNYTLEEALKLQNKK
>KALACAFP_00710 Ferri-bacillibactin esterase BesA
MIKKLLIFCSILFTFQFMVLAQTGNIKPLTIGEIRTIKSKILNEDRTVNIYLPQNFDKTK
SYPIIYLLDGSMNEDFIHVTGLVQFFNLMYSVPETIVVGIANIDRKRDFTFHTDLKDLQK
DYPTTGHSDKFINFLEKELKPYIESQFKTTDKYLFGQSLGGLLATEILLKKPEMFNNYFI
ISPSLWWDDESLLKQANQLLTKIPDSKKFIYVSVGKGEHPVMVKDAEDLYDILKKSNKKN
WTVEYKMMETDNHATILHRSLYEGLVKLFPYKEPK
>KALACAFP_00711 hypothetical protein
MINTESFEFDSVYHIFSHVNGKELIFREETNYQFFLKQLDKYILPIADIYSYCLLPNHFH
VLLRFKNIEGVNVENEHQSLMKNFGNFLNSYAKAFNKRYNRKGALFLNAVKRKKISDEKY
LLKVVHYIHNNPVNHGFVNNIDQWKHSSYNSYLNPEKESKLNRKEIMQYFDSLDVFKNYH
HSNVEYDFLNLD
>KALACAFP_00712 Putative acetyltransferase
MNIYSYHGIRPIIKPSAYVHPQAVIIGNVEIGEEVYVGPNAVIRGDWGKIIIKDGANVQE
NCTLHVFPGIETILEESAHIGHGAIIHSGHIGKNCLVGMNAVVMDKAVIGDECIIGALAF
VPANFRCEPRKLIVGSPAKIIRDVSDEMIKWKTEGTKLYQELAREGKDAILPCEPFTEYV
QQIPTKIVDYSIWDDVK
>KALACAFP_00713 Beta-ketoadipyl-CoA thiolase
MNNVYIIDYIRTPISKLQGGLSEVRADDLAAIVIKEIVARNPEVPVEEIEDVIFGCANQA
GEDNRNVARMGLLLAGLPYKIGGETVNRLCASGMSAVANAFRSIAAGEGEIYIAGGVEHM
TRSPYVMSKPSAAFGRDSQMFDTTFGWRFINPKMKEMYGVDGMGDTAENLADMHTISRED
QDKFALWSQQKATKAQESGRLAEEIVKVEIPQRKGEPKIFDTDEFIKPTSSMEGLGKLRP
AFRKEGTVTAGNASGMNDGAAALILASEEAVKKYGLKPKAKILGSSVAGVEPRIMGIGPV
EATQKLLKRLNLSLDDMDIIELNEAFAAQALAVTRTLGLKDDDSRVNPNGGAIAIGHPLG
VSGARIVGSAAMELQKQDKKYALCTLCIGVGQGYAMVIEKA
>KALACAFP_00714 hypothetical protein
MFSSTFFINGEKMKDYFETNNLENFDEILKEFEEMRIDTFNMIRKESTHLQFTNKEVESL
SKKYLKENYPWINDVGIKVVNNHLLWMCWHEGIIKS
>KALACAFP_00715 Acyl-coenzyme A thioesterase PaaI
MNPRQVAEYMFDQDYFSQWMNIKLIEVKENYCLLEMPIKKEMINGLKTVHGGVTFAFADS
ALAFSSNNTGDAAVALNCIINFTKAGKEGDIFRAESILVNNTRKTAVYDIKITNQNEELI
AKFVGTVYKIGKKVVEL
>KALACAFP_00716 hypothetical protein
MDIDGFRAELETRLLIEKEYIIQELSSVKDYQERLELLGKFNQKYRELIKRLAHENGIDL
NASYQTKDPSNSENLSYEQIILGKTMGVYDKLVEELYEEITRVN
>KALACAFP_00717 3-hydroxyadipyl-CoA dehydrogenase
MKVGIIGAGTMGIGIAQVAATNGCKVWVYDANAKQVETATVGLEKTLTKLVDKQKISAEK
MTEILANISIATELKDFKDCELIIEAIIENKEIKTKVFTELEKHVSESCVIGSNTSSISI
TSLGAELQKPERFIGIHFFNPAPLMPLVEVIPSLLTEKSLPEKIYNLMKDWGKTPVIAKD
IPGFIVNRIARPYYGEGLRIVEENIATPEQVDEAMKTLGNFKMGPFELMDLIGVDVNFSV
TTTVYKDYFYDPKYKPSLLQQRMSEAKLHGRKTGKGFYDYSENAQNPVAEKDDALYQQIF
LRIISMLINEAVEAKRLRVANDEDIELAMQKGVNYPKGLLAWGKEIGYAKISETLQNLYE
EYQEERYRQSPLLRKL
>KALACAFP_00718 1,2-epoxyphenylacetyl-CoA isomerase
MYTQLDIETHFDGKLKIAYLNQPETMNALTKPSLSDLKDFVKECSEDPTVRCVAISGRGR
AFCSGQNLDDVFVNGREHHDHDIIRKIVVDYYNPLVTEITRCKKPVIALVNGPAVGAGAM
LALICDFVLANNKAYFAQAFSNIGLIPDTGGTYFLPKLLGRQLANYLAFTGKKLSAEESK
SYGLVAEIFSEEEFTEKSMEILEKMSNMPTAAIKLTKKAFANSYTNTLKEQLELEGDLQQ
EAGQTEDFIEGVNAFLEKRKPNYKGK
>KALACAFP_00719 Putative 1,2-phenylacetyl-CoA epoxidase, subunit D
MKNPLEILELVPDPEIPVINIVELGIVREAKITGENSCEVIITPTYSACPAMFTIEEDIM
KIMKENGWDAKVVTKMFPIWTTDWLTDEAREKLRVYGITPPEKGADENHIGKPKKCPRCG
SEHTKQISRFGSTLCKASYQCLDCLEPFDYFKCH
>KALACAFP_00720 1,2-phenylacetyl-CoA epoxidase, subunit C
MNPLYNYLLKFADDSFIMGQRLSEWCGEGPYLEEDIALTNIALDELGQANNFYVYASRVI
DNGKNEDDLAFLRYEHEYVNAHWTELPNEDYAQTILKVYVFSVYQKLMYEALSNSADEEL
SAIAQKSLKEVKYHYTHTSSWMKIFAQGTEESRERLINAIENIWEYTKGLFAKVEGEDDL
IALSIAPNVDELYNEFVAITQKDFADFGLEYPSNPFMQPKSRTGYHTEYFGYILCELQYM
QRAYPGCTW
>KALACAFP_00721 1,2-phenylacetyl-CoA epoxidase, subunit B
MANLDMWEVFIQTKPGLSHKHAGTVQAPTAEIALQNARDVYTRRKEGTCVWVVPSKYIIS
SEGMDQDAFFDPADDKLYRHPTFYDIPNDVKNM
>KALACAFP_00722 1,2-phenylacetyl-CoA epoxidase, subunit A
MDLEKFVQYVHDENKVEPKDVMPDDYRKLLVRQISQHAHSEIVGMLPEANWISRAPSLRR
KMALLAKVQDEAGHGLYLYSATETLGNGTIRADRDATYDDMLSGKAKYSSIFNYPTLSWA
DIGAIGWLVDGAAIMNQVMLMGNSYGPYSRAMVRICKEESFHQRQGYEILMALCRGTKQQ
KEMAQASLNRFWWPALMMFGPNDDSSPNSKISMNYRVKRESNDSLRQRFIDVTVSQAEFL
GLTIPDKDLKWNEERGHYDFGELPWDEFMEILKGNGPCNKKRLQTKVKAQQENLWVKEAA
IAFAEKQEKFSM
>KALACAFP_00723 1,2-phenylacetyl-CoA epoxidase, subunit E
MSSFYKLKTVRVQKDTNDAVNVAVEIPEELKDKFRFKQGQYLNFRMMIDGNEERRSYSIC
NAPSEKSNTLEVLVKLLEGGKVSGYFNQHLHMDEVLEVMPPMGGFNTTYHPSNVKTYVGL
AAGSGISPVLSNIKESLYQEPNSNAYLFYSNRSMNHVMKKAEIDKLVEHFGGRLKVVYLV
SREQHEEPIFEGRISPEKLELLFERYADIDVKESTYFICGPAEMIKGIADYLKKDKKVPA
IQVLFEYFTAPDEENSEEMSDEFKAIANIESMVTVIIDDDEYSFHLNSKKESILDKALKD
NLPVPFACKGGVCCTCKAEVLEGEVFMEKNFALTEEEVARGYVLTCQCHPTTNVVMLNYD
V
>KALACAFP_00724 Phenylacetate-coenzyme A ligase
MMDFSVEYIKLDQLRQLQSERLVNLVNYLGEKSEFYKGKFNESGISPQDIRSIEDITKLP
ITYKQDLRDNYPFGLFTVPKNELQRIHCSSGTTGKPTVVGYTKEDVDLFSEVVARSLNAA
GAKPGMQLHNAYGYGIFTGGLGLHYGAEKLGMSVLPISGGMTARQVDLIMDFKPEVICCS
PSYALTIADEFAKRGISAEEISLKYAVLGSEPWTEIIRHHIEERLGVHATNIYGLSEIIG
PGVSMEDFEEKGGAYIWEDHFYPEILDPITKEPVPFGEEGVLVITTLTKKAMPLLRYWTN
DITSLYYDENGKRTMVKMKPILGRSDDMLIVRGVNVYPSQIEEAFSHVEGVVPNYYLTPI
EKEQMCVALDIDLEIDDEFVKAQQIEINTDDYTIFVGNFGKNIENEIKKRVGITTKVKIH
AQDSLPKCEGGKINRILKTK
>KALACAFP_00725 HTH-type transcriptional repressor KstR2
MELKEKQKKILDVAVELFKEKGYMGSSVRDLATKLNIKAASLYAHIHSKEEILEWICFGI
AQEFFDELQEVKSTNIPPKEKLNLFIEKHLSVVLKNRDVTHIYSNEWKHLEERLPEFVEL
RKKYQQEVEQLISEIYQAENWELKSPTFTTRFILHTLNNSYFWFKRNIESTTEIPDEIRD
KILFGLLGNQKQ
>KALACAFP_00726 hypothetical protein
MSSILFNHLIRLPYHKKCSIINFLKITDKISEICILKDFYIDKISDSLDLNKKNMAKQSG
LIEITKL
>KALACAFP_00727 Chaperone protein ClpB
MNLNQYTVKSQEAIQAAQQVAMEFGNQQIEPQHLLEGIFQVDENISPFLLKKSEADATLV
RERNRENLERLPKVQGGNIYLSQSANKVLLDAPNIAKKMGDEYVTIEHLWLSLLETNSEV
SKMLKDMGVTKSLLEGGIKELRKGSKATSASSEETYQSLNKYAKNFNQLAAEGKLDPVIG
RDEEIRRVLQILSRRTKNNPILIGEPGVGKTAIAEGIAHRIISGDIPENLMDKTLYSLDM
GALIAGAKYKGEFEERLKSVVNEVIKSDGQIILFIDEIHTLVGAGGGEGAMDAANILKPA
LARGELRAIGATTLNEYQKYFEKDKALERRFQKVMVEEPDTESAISILRGIKDKYEAHHK
VRIKDEAIIAAVEMSQRYISDRFLPDKAIDLIDEASAKLRMEINSKPEELDVLDRKLMQM
EIELAAISREGSQTKIDHLKEDISKISEERNEINAKWLKEKQKSEDLTQIKKDIESLKLE
AERASRAGDYAKVAEIQYGKLREKDEELKKLEIEMQNHQNELIKEEVTSENISEVIAKWT
GIPVTKLLQSEREKLLNLETELHHRVVGQDEAIQAVADAIRRNRAGLSDEKKPIGSFLFL
GTTGVGKTELAKALAEFLFDDENNMTRIDMSEYQERHSVSRLVGAPPGYVGYDEGGQLTE
AVRRRPYSVVLLDEIEKAHPDVFNTLLQVLDDGRLTDNKGRVVNFKNSIIIMTSNLGSHI
IQENFENITEENQDEIVDKTKIEVFDLLKQTLRPEFLNRIDETVLFQPLRKKEIGKIVQY
QLRGFNDLLAKRNIIMTATQDALDYLMNKGYDPAFGARPLKRVIQQEVLNKLSREILAGN
VNDGDRITLDYFEETGLVFRPTEK
>KALACAFP_00728 hypothetical protein
MKTKPNLDVDTLEAISVPNTMTCEFIQTLVNNYRNNHLVFVKDKLGIDDAHSIHFDLATL
KKFISDIETETQKTNPGIADEDLGIRFYYAAYPKATDWEIMSGTPIGVEYAEKHTLVMVP
TMKMEDEEGEMLPYDFNPLSSGSEGEFLAMASKTTDLEGEIISQNHGNLVPPDSTKTESF
>KALACAFP_00729 hypothetical protein
MADFQKIVQELMFWSEGIAALISLLYYNRIKNQYWKYFVFYLIFVFVSEAIGKWGDTFME
YNKQAFYNYFVIPIEFIFFYWLYAAKSFGRPKLFVILSFIYLLSFIPSEFIFTYDKVMFS
LNYTLGCLILMILVVMEYYKQINSSNILDFDKNRMFYINLGVTLFYIGTLPFWTFFELLK
PYREIYNIYFAYFLISAIVMYLLFSISFIWGKQNS
>KALACAFP_00730 Oxygen sensor histidine kinase NreB
MGKTELLVTIILFNIFFVLFVAAIMVYIRKYKQRKKEYLNEIEVKNEIHKRELLATQLEI
QQATMQQIGRELHDNIGQKLTLVSLYTQQLLYENKVPEVSERIEQVSQIINQSLHDLRSL
SKTLTDDNINQKEIVTLIQEEVDNTNAFKKCKVSFEHNFKQLDLGFVHKNVLLRITQEFI
QNSIKHANCKNIFINLNTSEESLWELNIKDDGVGFDKSNIKSNGIGLTNMKNRAEIIGAN
FSLESQENMGTTLNIILKRQP
>KALACAFP_00731 Oxygen regulatory protein NreC
MKKTIVIVDDHVLIAKALEGIIDNFKEFEVIYVAENGKDLIQKFENNSKIPDIILMDISM
PIMDGFETVLWLKEHHPGIKVMALSMQGDDKSVIKMIKNGAKGYLLKNTHPKELENALTK
LNIDGFFYPEWASKIIFSNMNNDDPVNSVRISDREKEFLKYTVTELSYKEIADKMCCSPR
TVESYRDQLCDKLDLKTRVGLAVFAIKNGFAES
>KALACAFP_00732 hypothetical protein
MKYFNLFSDVLVTKGASRILISDLQRNISEIYPLELYDIIESLKHHSVEDLLKSYDEESQ
EIIHEYLDFFLEKEYGFFSQNDWDKNFLPLSYEYKENDLLSNIFIEMVDLAILHKIKSSI
ENLEIKHIIIFSKKNLSLDELVEIDNLFKNSPVSSIEIYSPYHSSINIDFIQNLNQNTLR
FHNIVFYNCNQEPFKIIKNTFNFTLSFLNENLKISSCGKVSLDYFNTNINKVLEAINYNS
CLYKKIGIDAQGNIKNCPSMCKAFGNIENTTLEEVLNKENFKKYWNITKDNIEVCKDCEF
RYICTDCRAYTERIHSNEDGIDTSKPLKCGYDPYSGEWEEWSTNPLKQKAIKHYGL
>KALACAFP_00733 hypothetical protein
MKPKLKEKNSLPLTFKYIELFKTQNLKKLDANTIFYIPCDKYQTNFYIREKPFKPLVRML
>KALACAFP_00734 hypothetical protein
MILIISKDNEITTTEVIKWLYHLGKNFIRVNEDEFFEIKMSNGKLALQSERNSFLLDDIT
SVWYRRGGIKFKRFHYQNDIVNIHMHETQHWLEDYVIHTLESKNHISKQRKSHVNKLIVL
EVAQKVGLNVPRYFLADNTQDVKIGETIVKSITGNGVLQDIHKNYDGIMYTSVVHEEHPT
NFFISFFQDKIEKDFEVRTFYLKGKIWSFAIISQNDEKTKVDFRKYNTAKPNRNVRYKLP
ADTEERVHQLMQNLDLDCGSIDFIKGVDGMFYFLEINTVGQFTALSSITNYSLEKEIAEY
L
>KALACAFP_00735 hypothetical protein
MKILFFLLFSSFYLGQGVSFIYEVKYRTNVNKSDDYNTTYMSLDLAEKKSIFRENIDKKA
DSIKIAGGNPMLSSGFENQFYVKKDLSSNQVNKILTNGQYNFILPIDDILNWKILSEKKK
IGVYNVQKATVIYGEREWIAWFTSDIPINDGPYVFRGLPGLIVSIKDNTDDYNFNLIQTK
NSTNLFDARVKGSNIDWIKFKELSESYYQNPYPELRQGGTRKVTFIDKDGNSVDVDVQRK
KMTTERQNYINNNNNPIELNHKINY
>KALACAFP_00736 hypothetical protein
MKKLKGLKKNFSSLENKKLKDLTSIQGGKLPGAGSSRSAQSNAVGTGHYDIDYYNDDAAS
GTWVYNGRSIFDDIQPGMS
>KALACAFP_00737 hypothetical protein
MKKVKGLKKNFSSLENKKLKNLTSIQGGKLPGSSTRTAASNAQGASDVDHYSDDSTGNWT
YVGREIYTIGG
>KALACAFP_00738 hypothetical protein
MVMKKLLFGILVLGLVSSCNNDNLSNQSEDVSKTESSNLSKRGCAAEEIRQEALRNNPEL
RQRFAALEANTEKFANDLRLGKVLADGTVEIPVVVNVLYNSASENVSDTRIAEQIAVMNS
DFTATNSDINKIPTEFQPVSSGDTKIKFRLVNTVRKQTNVKSWKTNDAMKKASSGGIDAT
NPTNYLNMWVVGKMTSQGQTILGYATFPESAGLWNDGVVIAAPFFGKTGASSPFNLGRTA
THEVGHYLNLRHIWGDANCGNDLVADTPTQTTANYGKPAYPLYNTCSGVQRSVMFMNYMD
YVDDAAMFMFSGGQKTRMQSVVASSGARAGLRVY
>KALACAFP_00739 hypothetical protein
MGKDFIFNNLKYFNPFLNQKICKTEVLQILDNKRKNDFI
>KALACAFP_00740 hypothetical protein
MKKIFIITTSVISTWAFSQIGVNTPTPAATFDVVAKKNDGTTSEGIIAPRLSGNQIKSAD
ARYTAPQTGALVYATNAVSAPTAKTIKITAPGYYYFDGSIWQKMGDERAFTGDIKHSART
ADHGGWYLLNGRAISTLPVEARTAAAALGFTGNIPNATDRVLKTKTAAEAMGATGGISTI
TIKRVNLPDVNLIGTLTGAMDLAGVHAHRTQGNSGSGGQHNHSLSGSTNNVAGHRHGPNE
SLVSNNGNSEVFIYGNTHTGNNGNGNYASTGHLGQPRAWNGIGAATSTGLAGSHNHSITG
TAAAAGNHNHAINIVSTESGNHRHSMDNVRASVPTGGSGEELDNRSPYLSVNTFIYLGE
>KALACAFP_00741 hypothetical protein
MKRLVLGLLLLGSWQFSAQELYMPRNIKKAYENGTRDLSGAPGKNYWQNKGIYNVEVKVD
ASSKTVSGKETIVYSNNSPNDLNELAIRFVNNLHKPQAPRSGVVSNDFLSSGLHIKSFIV
NGEKYTVNSDDWGTVEKVKLNSALKSKSKAEIKIEWEYPLSVQSGREGQIDPETFYVAYS
FPRVSVYDDYNGWDMLPHSDRQEFYNDFNDYNFAITAPKNYVVWSTGEFLNPEAVLQSEF
LKRYKASLKSDKVIHIANEHEMKAGKVTKPNKWNVWKFKASHITDFCFALSNHYVWDAAS
VQLKTKRASVQAGYKVGAKDFEHYVDWMRYNLDWFSKKWPGVEYPYNAMTAIQGYADMEY
PMMINDSSIPDNFQDARLTADHEIAHTYFPFYMGINETRYAFMDEGWATTLEYLIGIDEN
GEAAAKEFYQNFRVKRWINDPSAEQDQPVITMSTQVSGAGYGNNSYVKASLSYLALKDFL
GDDLFKKALHHYMNNWNGKHPIPWDYFNSMNTGSGKNLNWFFNNWFYTNNYIDVKISSIS
QMNDLLTVNIDNVGGFVIPFDAILTYEDGAVEKLHFSPSLWEKDQKQTMLTIPIKKKVKS
VTLDGGIFMDYTPQDNTKAL
>KALACAFP_00742 hypothetical protein
MNFRFSIVFLMAFVLGFSQDLKVMSFNIRLNVDSDKENSWTNRKQDVADLLTYYHPDYFG
VQEALPEQMKDIKNGLKNYDYVGVGRDDGKEKGEFSAIFYDTDRLQVTKSGTFWLSETPE
KPSKGWDAALNRICTYAVFKDKKSKKEFMALNLHFDHVGNVARVKSSELILKKIKEINPK
NLPVVLSGDFNLTEDSEPIKIISQNLQDTFYHSETKPYGPKGTFTAFNVNEVPKNRIDYI
FVKGFKIKSHRHINDRRENLLYPSDHFPVLVDLQF
>KALACAFP_00743 hypothetical protein
MKTAFTIENFNIKFDLKTKTPGNFPELDLCVKFEPLRFCLRS
>KALACAFP_00744 hypothetical protein
MRIKFPTLVSAVAVMLFSQSAIAQEAPKYDYVEAFKPFFYTQTGTPTRSASGQPGYAYWQ
NSADYNLNVSLNEAKNEISGTAEITYTNNSTDKLGFLWLQLDQNLFAKDSRGNAVVPMSG
SRNGAHGEEFDGGYKIKSVKLDGRDVKYTITDTRMQIDLPTELKAQGGVAKIKIEYSFLS
PKYGSDRMGIQDTKNGKIFTMAQWYPRMCVYDDVMGWNTLPYVGASEFYLEYGDITANIT
VPANHYVVASGELLNAKEVYSKEENSRWEQAKNSDKTVMIRTESELGKNQQTGTKTWKFK
ISQARDFAWASSPAFILDAAKINLPSGKKSLAISAYPAESAGESAWGRSTEYTKAAIEHY
SAKWYEYTYPAATNVAGNEGGMEYPGIVFCHMDSKGGELWGVTDHEFGHNWFPMIVGSNE
RLFAWMDEGFNTFINELSTEAFNKGEYFEKKNIAQMGGYILNDGFEPIMVGPDNMKENSI
GVLAYFKPGMGLQILRESILGPEKFDKAFRTYIQRWAFKHPTPWDFFHTMENVSGEELNW
FWRGWFINKWKIDQSVKNVKYVNGDFKNGAQITVENIGQLPMPTTVQVKFKDGTEQIIKL
PIEIWKRNKEWTFKTNSTKEIDQVKLDPKSEIPDVNSQNNTWTSGDAKTAEKINVKDFTG
TYGSKDIPLKITFSEKNNQLYGQATGQGEFPLEYTGNNTFTFEQAQISMTFSQDKKTITF
NQGGREFKFTKE
>KALACAFP_00745 hypothetical protein
MKTYLAVLKKDINIKDLNEELKKKNIKPAAHYKTIGVVKLESEKPVSQKDFKDYFLSVEE
DRDDLTI
>KALACAFP_00746 Subtilisin DY
MEKERYIVVLEDQQKNSLKKVENELEVTITSSEFLSSENRSYDVIDNDNGVLYKNLGILV
VENMDEAQLKSAVKNESNPIVYFEKEREFFSADELSIINELKKQSAEIADKITELEKYII
NKPLPQKPLVEMEWGLKALGLGNSLYTGKGVDICILDTGLELSHPDFSGREIEGKSFIAG
EDWNRDPNGHGTHCAGVATGNIRLDNGKRYGIAKDANLKIAKVLSDAGKGTTSSVIDAID
WAITKKFRILSLSLASAVKLNEIPSPLFETVGVRALENNCVIIAAAGNDSSRPSVPKPVS
SPANAVSIMSVGAIDGQMKIAKFSNAGLNPTTGGCVNICAPGVDIISSYPKNSKNKSSNY
YAMSGTSMATPHVSGLVALYMEQFPEKSAKEIWEFIETKAKPIEGLKYRDIGSGLIQA
>KALACAFP_00747 hypothetical protein
MQELVHHTIQKIQELLEHFNKVQELYLSKSFDFDGQFEAFLYDFLEYLKTKGNTTYESEV
LKVMNMISTVKRGFNPVQMEKIASGKRELLWGFSFNGMESIHGFLMEMYAKEQKKLDEAE
ELLSGLIVSLYQNGILDDGKVKDLNTIPKIEVFWTSLVNQNTQISGINKKLRLSMISEDI
FLLLEKVLLKL
>KALACAFP_00748 hypothetical protein
MIKLSDYLDYLNNEIIQARKKADENAVMIAKEYAQHEYLKYFKVPRYSLPSVKMDIPIKI
TDIDADADRNFPLNELKLIQDVNERILVVNKERQLNIQPISTRNIQTEDFKTLLNSVRGG
GLETSRLSKTETTTQTPDIKTSPTRAIAATPQKPIEKPIEGTSTEEESTVLRQIYTDVLN
RYSLINSKLNNIYIDPNTNSAEDKDKLFINLHVEMEEEGIRIMSYTDKDGKEIEQIIFE
>KALACAFP_00749 hypothetical protein
METLKSVLDANHAKKTKNELIDLLTGLEKSLTPAVYEKVSGIETSELAALSNKELLSIID
DFKKNYDEKWEKTFANVSTEVLKMIAGRMAADDQVFKTSGAESADFAAELGSIDFAKIIG
GPLNACVTAQSNASISTVNFIKEVGFEKDGDDDKLRMAEFKYKKHVPNPEYKNETDTPNE
EPTIEQEVEISVPFIALLNVPSFRIETCEVDFNVKLNSTYTKDVSDEFGIKAGVSGGFGP
VKFNVDVSYKRTSSTGIKVEKEYSLGVKVKATNDEMPAGLEKVLGLLAQ
>KALACAFP_00750 hypothetical protein
MTLNKTKSRFLMGNLLFLFGGFYGLSLGNLLKYFTVTRHKFAVEIF
>KALACAFP_00751 putative 2,4-dienoyl-CoA reductase
MNLYTQPMLREDALKDKVAIVTGGGSGLGKAMTKYFLQLGAKVVITSRNLEKLQTTAKEL
EEQTGGKVLCVACDVRNWDEVEAMKEATLKEFGKIDILLNNAAGNFISPTERLTHSAFDS
ILDIVLKGTKNCTLSIGKHWIDSKSPGTVLNIVTTYAWTGSAYVVPSACAKAGVLAMTRS
LAVEWAKYGIRFNAIAPGPFPTKGAWDRLLPGDLQEKFDMRKKVPLRRVGEHQELANLAA
YLVSDYSAYMNGEVVTIDGGEWLQGAGEFNMLEDIPQEMWDALEAMIKAKKSN
>KALACAFP_00752 hypothetical protein
MKNLKITALLAVLAFSPFYANVLPTDNSPVVRILADVTWKSESIDVGNIPQGKPKVIRFE
FTNTSKKPIVIENVAPSCGCTTADYTKTPILPGKKGFVEASYNAATAGPFMKTVNVTTSD
SKTPKTLSFKGTVVAS
>KALACAFP_00753 Sensor histidine kinase ResE
MEIKKLNIIITLGFVAIIGILIAQLLWTRQAYNLEDKKFNQTVNIALLEVAEKMSGGKTS
FTESPVQNISNDYYVVNINNEFHPAILEHYLKTEFTRFQINTDYVYALYNCHTDQMIYGK
YISKHQESPDKAIKFPKHKNLVYYFSIRFPDKTTYLISSLRFWYVLTFALIIILLVYVYS
IYTIIQQKKFSELQRDFINNMTHEFKTPLSSILLASEALTKQETVKENPKLQTYTSIITD
QSHKLNSHIEKILNIAKNDASGLSLKPQRIVLLPFIQEIVDTIKQKNENLSAQIDIDDTI
SILADEFHFANIIYNILDNSIKYCETKPSIVISALKDSKGLHLKFKDNGMGIPAKNIPHI
FDKFYRVNTKKSDEVNGFGLGLFYVKKIVQQHNWKISVENNSDKGITITLFLPS
>KALACAFP_00754 Alkaline phosphatase synthesis transcriptional regulatory protein PhoP
MEKSKILYAEDDKTIAFLVQDSLESYYDISFYPDGKSALEAFNTESFDICLLDIMMPEMN
GFELAQCIREKNSEIPIIFISAKALKEDRIKGLKIGADDYLVKPFSIEELILKIEVFLKR
SKKTNNNPTKYKVGKYDFDPKNYTLKDSENTITLTQRESELLLYFILNKNTVLKRQDILK
AIWGDDDYFMGRSLDVFISRLRKVLADEKDVFIENLHGIGFRFSEK
>KALACAFP_00755 hypothetical protein
MKRSGTPIFLFLLFFSLNLKAQKFEKLIQYVNPLIGTEKMGHTYPGATAPFGAVQLSPET
DTISYEMNGKYNGEVYKYCAGYRYEDRTIVGFSSTHFSGTGHSDLGDFLVMPTVGKLQLN
PGTATNPESGYRSRFSHQNEKAEAGYYKVKLDDSNILAELTATTRVGVHRYTFPKSDQAH
IILDLMAGIYNYDGKNVWTYVRVENGNTITGYRQTNGWARTRTVYFAMKFSKSFKSYGQK
NYDGKQVYNGFWRKFDQTKNFPEIAGKNLKMYFDFDTNENEAIEVKLAISPVSQANALEN
LEKEAGNLSFDQVKMQTQENWNKELNKIVVKGSEIEKTNFYTAMYHTFINPTTYTDVNGE
YKGLDQNIHKAEDFTNYTTFSIWDTYRALHPFFNIIQPKRNGDMVKSMMAHYNQFSMKML
PIWSHYANDNWCMSGYHSVSVVADAIIKGNYQGDAKEALKACVETANKRDYEGIGQYIDL
GYIPAEKNGTSVSNTLEYAYDDWAIAQLAKHLGETEIYNQFIKRSENWKNNFDKNIGFMR
PRLADGSFKKDFNALSTHGQGFIEGNSWNYSFFVPQNPDELIKLMGGKKKFASKLDELFT
MHLPDEFFADTEDITREGIIGGYVHGNEPAHHVAYLYNWAGQPWKTQAQIRRILEMQYKA
TPDGLGGNDDAGQMSAWYILSSLGFYPVAPGSEDYAIGSPAIDHAVLNLENGKTFEIEAI
NQSPKNVYVEKIILNGKEIKNFTLKHSDITNGGKLSFYMSAKSKK
>KALACAFP_00756 General stress protein 69
MKLNQVKLGSQGLIIPNIGLGCMGMTGFGDMDTYGKADEKEAIATIHRSLELGGNFLDTA
DLYGPFKNEQLIAKAIEGNRDQYIIATKFGWEIDDNEQITWKINGTKDYVKKSIERSLKN
LRTDYIDLYYMHRLDKNVPVEETVGAMSDLVKEGKIGYIGLSEVSSETVKRAHAVHPISA
VQSEYSLFERTVEEKGVIKTLNELGIGFVAYSPLGRGFLSGQIRTIDDLPENDFRRGIPR
FQEQHFYKNIELVDAIENMAKEKNITSSQLALAWIISKGIVPIPGTKRRKYVEQNIEASK
IVLSEAELQKLESIVPLGTDTGATYDEFGMGLLDY
>KALACAFP_00757 HTH-type transcriptional activator RhaS
MNTIQSISAFHKLLSLPEPKHPMVSVINLYESVFIEDDVWKGFVSRYYCVALKRNAKGKI
KYGQQHYDYDKGVLSFTAPNQVQYLDLQTMDCENTGYLLIFHEDFLLKHSLAKTISSYGF
FSYSVNEALHLSEDEENDLLEILHKIDKECQHIDHHTQEIILSQIELLLNYSKRFYERQF
ITRKSGSHQLLTKFESFLNDYFNTESSEKGLLTVHQIAEAMNLSPNYLSDLLRIHTGQNT
QQHIHEKLISKAKEKLSTTELSVSEIAYELGFEHSQSFSTLFKKKTNMSPLEFRQSFN
>KALACAFP_00758 Allantoinase
MKTLIKNVKIVNEGKIVEGDILIENDLISKIDSNISEEADQIIDGAGKYLLPGVIDDQVH
FREPGLTHKGDIETESRAAIAGGTTSFIDQPNTVPNAVTQELLADKYEIASQKAYANYGF
MMGGTNDNLEEVLKTNPRNVPGIKLFLGSSTGNMLVDNPETLENIFSNTKMLIAVHCEDE
ATIKANTQKYIDEYGEDIPVKFHHLIRSEEACYKSSSKAIELAEKTGARLHVFHLSTAKE
TALFRNDIPLKDKKITAEVCVHHLTFTNEDYETKGGLIKWNPAVKTQKDKDGLWEALLDD
RIDVIATDHAPHTWDEKQNVYTKCPSGAPLVQHSLVVMLENYKNGKISLEKIVEKMAHNP
AILFRVEKRGFVREGYKADLVLVDLNENWTVAKENILYKCGWSPLEGMNFHSKVTHTFVN
GNLVYDNGKINEQKFGERLLFEVQK
>KALACAFP_00759 hypothetical protein
MKKLLNETIIYGIGAIMPRIIVVLLNYLFIKNINVGDFAIFTNLYALISFVNIVLSFGFE
TAYFRFSSDKDNEQKVFNTSFWFLTGLSTVFLILVLLFNQPIADTFGYSQTPEFIRWFAW
IAFFDNILVIPLAWFRFHNRPIKYTAIRVTQAVFQSVFVFALFLFIPQEFSLKLGLKEKV
SYPFYSNLAASFLGVLLVLPIILKVKLQFSKDLFLQMIKYSWPIMIAGLAFMVNENFDKF
IQKFIINDGDAGAYGGCYKMAVLMTLFVTAYRMGIEPFFFKQMQNENAKNTYAKVTEYFS
FFASIVALGIIANVSWLKLLLVPNSSYWVAINIIPIIVIANLFFGIYYNLSTWYKVTDRT
RIGTYISWTGAIITIILNFALLKTYGFMVSAWVTLAAYFSMMVLSYWLGQKYYPIPYRMK
KISFFIVLLAVFSYAIVEFFDYNLWVGNLLFLVYAGILIYSEKNMLLSRIKKN
>KALACAFP_00760 UTP--glucose-1-phosphate uridylyltransferase
MKIIVPMAGRGSRLRPHTLTVPKPLIPIAGKPIVQRLVEDIAKVAGEKIEEVAFIIGDFG
PEIEKSLIQIAEKLGAKGSIYYQNDPLGTAHAIKCAEQSMSGDVVIAFADTLFRADFVLD
KNSDGVIWVKSVEDPSAFGVVKLDNYGFITDFVEKPQTFVSDLAIIGIYYFNSAEKLMDE
INYIMDNDIKNGGEYQLTTALENLRAKGAKFTLGKVNDWMDCGNKNATVETNSKILEYER
EAMLNFPASAVIENSLIIQPCFIGENVKISNSKVGPGVSLGNNTIIVNSNIENSLIQENT
RINHGNLSNSMIGNSAQYFGVAREISLGDYSVLDFLSK
>KALACAFP_00761 hypothetical protein
MKNWIVILLLLFVVTSCKTRNAAKKRNNNVKIDSTFVLENDNSPKDANEPVSDKLTFYEH
VLVPPQFEQIKINSKVNVETGSFIPTLDATIYIEKDKKVWMNLQAFIINVARGIATPEGI
KGQDKTSKTYIDSDFDYLNNLLNVNFIDYKSLEKILMGRTFVKINDSQFTLTRNAQGFKM
ASNVNQKIVTDEKTREYKIVLNYDTNYDLLSVNLKDVLSPDELEVSYSNWEEINGIRLPK
NVKIIIKGSKSSQILMENTKFDFSRMETPYSVPSSYKKIEIK
>KALACAFP_00762 hypothetical protein
MIKKFSFLIGILLFGLYYGQGGKKEQLQKQNAELKKQIAQINTDLAKTRSESKLSVAYLD
NVNKKLMLREKVYNNTQKEKRFIEDEIYLRQLEINRQNRELKVLRDNYAKVLVNAYKNKG
VQNKVTFILSAKNLGEAIRRVQYLKQYSDYQDKKAAEITDAAAQIKRTITQRQNSVKEKA
NLLVSQQKDLVTINAERAQKEQLVADFKKNESKLTAELRQKQTQSKALEGQIRAIIAEEI
RIAKAEEEARKKAEAEKIRLAKIAAEREKARIEAENKARAEALEKERLAAEAEARKTAEL
AAKRAEEERKRSLDAAKAEATARDEARKIAAKKASDEAAARAKEAADKVVAAKAAEAALA
KKKDDDKKAAETKAMTNFGVSTVAGSNFAENRGRMGFPVDKGQITHRFGRQPHPVFKNIM
EENNGIKISVPSGTRAKSVFPGTVSSVLANSDGTKTVMLKHGNYFTIYSNLGSVNVSKGQ
QVSAGTPVGVVGQDFDGSYTLDFQVWNGTTPVDPLGWVSY
>KALACAFP_00763 Sec-independent protein translocase protein TatA
MNTLTILALSWQHILIVALILVLLFGGKKIPELMRGVGSGIKEFKDAVKEEDKPGSENKT
TNNNNSSSN
>KALACAFP_00764 hypothetical protein
MNFTETAWKVFNQSIEDYHVSDDVNTLINNPFEKNTLERILYAKNWIDTVQWHLEDIIRD
ENIDPAEALLLKRRIDASNQHRTDMVEFIDSWFLNKFENITPKPDAKINTETIAWAVDRL
SILALKVYHMSLEANRESASEEHRANCQAKLDVLLTQQEDLSTSINQLLTDIENGDVKMK
VYKQMKMYNDESLNPILYQKGQQK
>KALACAFP_00765 hypothetical protein
MKRLLFFGVLTIITSSCATEKPNFSPLSTSFYSETKGSDSDRGAKNNIEINVKDNVNASE
ISNLIATFPQFKNTALNDEITSLKYSLQNYLYAIDANNASGKNRAIKNFEKSYKKIQKLR
ENLNKDDNEVLNRYLVRLKTNISAIEDSIKRN
>KALACAFP_00766 GTP cyclohydrolase-2
MIKIQAEANVPTEHGTFRMIAFSENENDWMPHMAIIAEHTDFSKPVNVRFHSECITGEVF
HSKKCECGQQLDAAMKYIHENGGIIIYLRQEGRNIGIINKLKAYSLQEKGFDTVAANLEL
GLPADDRNFGVAIEILNLLDVKDINLLTNNPEKVKYVKESNIHLNSRIPLQIPANEISKG
YLQTKKDYFGHLLDDNDN
>KALACAFP_00767 hypothetical protein
MNKKLFALLSVLLLTSCVTNDIVNEQNEDPITAEKALKSNQALVSNKSFDNVVMDLSFEK
GIINEGSGCSFEYMISPNGSTYTSTACYGPNPVDQNGYLIRGYGKPMRASAMRGNPWRGV
KLEAKNKPKEIINGGHTELANSERSNAISIEFPFQANVTYEITLSTRLTDYIKVIKSPSG
LGNTPIADQYDIDKSEAFPTIDLQLVETPVIPGNDPCSNTPVVPSQFLAPPNYTRKQKAE
KSTEWAHEEKTFTFYFSTKENKQAMLIKFLPEISNGRNPSYVPESYFWLDIRNIKIVQKP
FDASYYIAPPPPINNNPCPGFRRCP
>KALACAFP_00768 hypothetical protein
MKKFLPILLLAFVSLFIFSCDDNDNVVGDGDTYSQMRDVTGNFTNANSYAFTQGINIEST
DVVLVYRYLGDSWQLIPKMMYLSGNREFQYNFVFDSQNVQIRIDDENFDLTTLSASEANQ
YLNNQKFRIVLVPASANKNASVNYEDYNSVIKYYNLDDSKVINIKATK
>KALACAFP_00769 Beta-hexosaminidase
MKKLVYTSLFIFLFLSSKITAQYQPKNMSKEDLKKAHQWVDKTYKTLSQDEKLGQLFIVA
LYTNKGENEINNVRNIVLNDKIGGLILMQDDAAREITLVNEFQQKSKIPLMIGMDAEWGL
FQRIATAHKFPWAMTLGAIQDKKLIEQMSAKIAEDCHRMGINWDFAPVVDVNTNPNNPII
GNRSFGSEVNNVISSALAYSNGLQDNNILAAIKHFPGHGDTSTDSHLDLPVVSHNSERLN
NIELAPFKALMNKGIGGVMVAHLYVPALESGKGIPASVSKNIITGLLKDKLGYKGLIITD
ALNMGAVANKYKPGELDAMAFKAGNDIMLFSQGVANGKKLIQKAIDNGEIPQSRVEESVK
KILLTKYFLGLYQYTPKNPENINTDLNNDSHKVLVQNLYSNALTLLKDEKKLLPLTGKQV
YYVPLEEAPYQTFANQLGSNVIIKKADEINTIPANSTVIVGFHKDNSTAYKPYKISAESK
KVLADLTNNQNVILNVFGSAYALKDIDISKVSTVLVSYENNDDSMTATANALNGKTKIWG
RLPVLVNDKLKAGMGMDFNPQTASTGVNSTIFTTSKQQ
>KALACAFP_00770 N-acetyl-alpha-D-glucosaminyl L-malate synthase
MKIGILCYPTYGGSGIVATELGMSLANKGYEVHFISSALPARLDITNPNIFFHRVNVQTY
PLFQYQPYDIALSSMIYRVVNLYKLDLLHAHYAIPYAYAAFTAKQMLKEDNNDIPLVTTL
HGTDITLVGQHPSYKHAVEFSINQSDAITSVSESLKRDTLQFFKIKKEIQVITNFIDNSE
FDECNECQRTQFANPDEKILIHVSNLRPVKRVDEVLQIFKNVEKKVKSKLIIIGEGPDME
KVNQFLEENPDLISKIRLLGKVNDLYRILQLSDVFLLPSEQESFGLAALEAMAANTPVIS
SNAGGIPEVNIQGETGFLAEIGNVEAMSNYCIKLLSNEELLTKMKKNAKEQAIKFDLKNI
LPIYEEMYRTTIENFKKELTKV
>KALACAFP_00771 hypothetical protein
MTEKLLQYLWNFKVFKHFDFKDIEGNPVEILDFGKWNTDSGPDFLTAKIKINNIIFAGNI
ELHVKSSDWIFHNHSQDPNYQNIILHVVFQNDIDIHEFKSNHIPTLELKNYIEENILWKY
EKLVSGNQFIPCENIISSDQIPFNFHEENVLKKLEEKSSDIEKSLEQFKNNFEAVLFHNL
AYSFGLKVNAFIFKQIAESIDFTIINKIRQNETQLEALLFGISGWLENPEDEQMKIWKRE
FDFIKAKFLISDLKFHPKFLRLRPPNFPTIRLSQLANLYHQHQNLFSKIINAKNSGELFE
IFNTIKASEYWDHRFNFGKTSTVDQPKTLSKDFIELIILNTILPLKYTYHRYHNEEIAGE
ILNFYKNIPGEKNSVINDWKKTGLKIKTALESQSLIYHFKNSCEEKNCLNCSIGFKILKE
SSNV
>KALACAFP_00772 hypothetical protein
MFDNIRHKMEREWFGVLTRTGTKLGIPVSKLRVFFIYSTFATAGFFFLIYLGLAFTLWVK
DIFITRRPNVFDL
>KALACAFP_00773 hypothetical protein
MEFLQIDSLEDYRIKEIFSSYSSTFPEDERRDWEEFIALFSNAKVKIISVLHESKNIGYL
ILWELSNYTFVEHFEVFAEYRNQKLGSYITNYLFENYPRIILEIEPDHLGDDAKRRYAFY
QRNGFNLIDEMYVQPSYGKDKKSLDLWLLANYIPENLQDVKDEIYDVVYH
>KALACAFP_00774 hypothetical protein
MNKNIIAIAIAAIGFIIGLGLLGSAIKNRNKSENTISVTGLGTKQFTSDLITWSGSFSKN
NIDLKAAYDELALDRRIINDYLLSKGIKQGEIVFSSVDIQKQFRNYTDSNGNNVQGEFSG
YDLTQKVSIESKEVAKIENLSRNITEIINRGIEFTSSSPNYFYTKLATVKQEMIAAATKD
AKARAEKIAENSGSSLGNLKKATMGIIQITAPNSNEDYSYGGTFNTSSKEKEASITIKLE
YEVN
>KALACAFP_00775 hypothetical protein
MVFCFIFANFFSQQTVTGKISDDNGFDLGAVTVINVSSDKKVLTNASGEFSIEASANDEI
RFIKTNYERASLRVLKNGYNPFLFITMIKIPQEIEEVELQKITGDLSKDSRAVAKVDKGK
IVQDAVGLPQPVGKMREKPAEVKEVLLPMLLGSLNVQGVYDLISGKARRQKRQYRYDDLQ
DDISWIRNRVEDEYFTKEGIPKERISEFIEFSFLTKPQVRTFVKAKNLAGALLRLEETIP
LYVERLKKSKLEK
>KALACAFP_00776 hypothetical protein
MLYKKQPVKLKLFFCLFTLFFININAQDYIFGKITSEDKTEIPDVTVINIRTDERVLTNR
DGHFMISGRAGDELRFVKPGFERANEKVTKENIASPINVTLIRTAILIAEVEIKKGVTGD
IKIDSKNLNPPRKVQKLKSDLGKYMAQKSDPRVLAARPGEFVQPVTKGVFSFGKIKDKWD
DVDLMSYIQTALGDKFFEDLKIDKPQIQHFILYIFRTGFERKTILKYGYCSEADLNRFKS
AVLNRISSYKTP
>KALACAFP_00777 DNA helicase II
MQNSYTVINASAGSGKTYALVQRLLMICLRYPNQQQSIRNILALTFTNKAANEMKERILS
WLGNFTANNFAENADLKNIQKAFEEEGLKITIDELHNRAKKLLDYVLHNYSTLNIGTIDR
FNSRLVRSFSYELGLAKNFNLEIEAEPFLIEAVDKMLDQIGENDVISNSFMDYVDYSLEN
NERINLNKSLYDSAKEFVKDIHYEHLKNNKDFDNTNYENIKNTLRKEIVFNKKQAVDIAT
KSIELFQSKNIEIDDFAQGKNGIGGFFTKVLDFYHQKRPGFPFPTTAEESVVNNYRKGAS
SKSKSKEPEIFEILDQLLENRMQLILLYIETQKKEKILSALLPLKVNKDIQDELKKIEEE
NDLVLLSKFNILINENLRNEPSAFIYEKVGSQFQHYFFDEFQDTSELQWQNFVPLRDHSV
STENTSFTLVGDPKQSIYRFRGGESKLMLDIINKKEISPKEAELLILKDNWRSAKNIVKF
NNDLYKFHSDILEEEHKNIFGTDAEQNPKSGIEGRVKVNLIENLTNEDFYNDTSERMRKD
IQESLDNGFKFSDITILCRGNFDIFSYSQKLGNLKVNYKGEETNIKTISEKGLTLELSNT
LKAVIEFLKWEVNPKNKPNLIMMMYYLNKLGRIHMADFTLEMKEILDIESHEEILQFIQH
TYSLKLKQDHFPKFNLYNFVEYYINEFSVENKETDFLLNFLEMLFNFTQNAGASTKEFLK
YWDEEASTYTIQASENIDAIQIMTIHKAKGLEFPIVFIPMMNKNRDAEFTNWFETSTDAV
LKSVNINQFNKNLEVYDEEIEKFNRLNSYKNFVDRLCLQYVATTRPVEQLFFYIQKANKT
SNNLELLEFLQSRNPENLDEFDLYEINPDMLKKHSKDKTSSFKTKDIRNLKNINEKSTSI
KIATPSKNYQVRNEKVRIGLFVHELLSKINTEKDIAKVLESYVLEGQITTDERNDIKETL
EQIIQTYSEFFDEKWEVINEKDIMISENGESRMYRPDRILKSDEGYIIVDFKTGEETEKN
ERQIENYRRILERLGRKVLKTQLIYL
>KALACAFP_00778 Bacterial non-heme ferritin
MVSEKIAKLINEQIAHEQYAAQYYLSMSAWFSGKDLDGIANYFRVQSKEELMHADKMFDY
LNDVGGEIIIGEIPKPPHEFENAIDIFEKALEHEKKVTKSIFNIVKNANDEGDFATTSFL
QWFINEQVEEEASASQYVTKIKMVSDNPSALYLFDQELSQRVFTPDPTA
>KALACAFP_00779 hypothetical protein
MKKLVLAIAFIGIGSFAMAQQTTPQDKQAKRAEMHQKMQQREQEHLAQMQKDLNLDQGQV
EKIKALHERRKAEMKADFDKNKDQRQAKMEQMKAKRAQMDADMKNILTPEQYDKWQADRK
AKMEQRKTEMKQRGMKGDRMMKKPMNTATPDAN
>KALACAFP_00780 hypothetical protein
MKKILIGFAMSLATLSFAQQYPNNGWGDDDGYNQNDGYYQNDGYYSDEDDQNYFPDDYYY
NYPQDYYPSDYYQTNYNDYRNSIVSINWNVFFNQNRLSRWQIDQILRLNNLYVSFSAWNN
FYRYNPDRWYYDRFYALQRIMGPRVFVVFQNNYYRGYSPVVYFQNYRRTHYASICRPMPR
YRNVNINIYRVDRAKFRRYDNPTFNIVRSQRPNNGFRGSVRDGNNGGFRNQSDNRNNNNS
GFRNDNNGVRNNGGFRGNNDNGVRNEGGFRRNNDNGVRNDGGFRADRNENRGGGFRGGEV
RRESAPRRENNGGGRNEGGFRRGENSAPREQNRGNEGRGNGGFRNGFAKN
>KALACAFP_00781 4-alpha-glucanotransferase
MKLYFNVSYSAKAGEKLLLIINEEGAVSQSHIMFYTENGLWKCEVDYFSKSISYKYQLVD
DKGNILREEFVQHHLNFPHNYKEFIIFDEWNNKNFPENYLNNKILYNKLNQFSPEKISVL
KKHTHLFRIEAPIYNPDWKIVLFGSTPSLGSWDYEKAIHLSQTDFGVWETSVEIPENEFI
QYKYCLYDTNEGRVIDVETGENRFAVPNLLKDVLHVVSNHYFKFKLYQMYHDAGVAVPIF
SLRTKDGFGVGEFSDMKKLADWAKETNLGIIQILPINDTTANYTWTDSYPYAAVSVYALH
PQYISLENLDFNLPKELVEEYEQEKAELNSLELIDYEKMISGKWKYLKAVFNEDKEKIYK
DRNFKKFIKDNESWLIPYAAFCVLRDKYKTPNFNEWKTHKKYIAGKIAPFFTTKSKDYDD
SMLHAWVQYQLHRQLKDAIDYTHNLGISVKGDLPIGIYRHSVEAWTEPELFGMDFQAGAP
PDQFTELGQNWEFPTYNWEAMKANDYKWWKSRFKALEQYFDAMRIDHILGFFRIWRMPIS
ATQGILGYFYPAVPITLEEFNAWHIPFNFDRYCKPFINDQILWNYFGEDSGKALEFINTN
QDGTYSFKEEFNTQRKLSDFFKKKPRGPIEEQLISLCANVLFLIEEKNGQIVYHPRFNVY
RTDSYKYLSDWEKKSIYDLYHDYFFRRQDHLWYEKAMEKLPVLLNATKMLICGEDLGMVP
DCVPVVMDELAIIALKVQRMPSDDIPFYNPKNASYLNVVTASSHDSSTLRQWWQEDPALT
QKYFNQQLTQYGKAPEEMDAHLAEIIMKQHLYNDAMLAIFPIQEFLATDKELANKNLNNE
RINNPAVFPHYWRYRMHLNLEDLKEQKNFNQKIADWIKDSGRL
>KALACAFP_00782 hypothetical protein
MKRHLFPLFLLLLGANASAQQDFFALVGKDTPNIVFNDFRAIDVTNGTSGEKIFTSDSPA
KVFSQARNGTVTEDKNTYNNAQAVNMATLAYDPFNNNLVYMPMFSSNIYVLNAKTKEITL
VDNTVARVTSCDINSHMVRMATGYNGNIYAINNAGTQFLQISRKGNQYVVNDLGIIKDDA
SNGKNSFTIIETGFGGDMIADADNNFYVFSAAGNVFKVSTKELKAKFIGKITGIPENYSV
NGSAVNAKGNVVIASAKGLPLYEVNLETLQAKQMAGEQNLHIYDLASKYFANDKAVSNTT
FANLDIYPTRVDEHFINVNVNDRNVKGNIKMNVFDLSGKNVMKQNLSVKEGSLNQQVYLK
NLVSGAYLVSITDESGKILLNKKILVTE
>KALACAFP_00783 Cysteine--tRNA ligase
MQLKIYNSLTGEKEIFKPILEGNVGMYVCGPTVYSNVHLGNVRTFLSFDFIYRSLKHLGY
KVRYVRNITDAGHLTDDGNVDNDRFVKQTRLEKLEPMEIVQKYTVDFHKVLDMFNLLPPN
IEPTATGHIVEQIELTQKLIERGFAYESNGSVYFDVLEYNRRGLNYGELSKRNIEELFAN
TRDLDGQGEKKNPQDFALWKKASPAHIMRWNSPWGEGFPGWHLECTAMSTKYLGETFDIH
GGGMDLKFPHHECEIAQGKACNDAAPVNYWMHANMLTMNSQRMSKSTGNYILPMQLVTGE
NDFFEKPFHPAIVRFCFLQAHYRSVLDISNDAMLASEKGFIRLMEAIKVLHSITPNDEKQ
SDFNLEEWKNKAYDALTDDFNSPVLIAHLFEAVKYIFALNDGKETISTKDLDDLKSTLDA
LIFDVLGLQAIEENNNEKLDQTLKVLIELRNQARKSKNFELSDQIRDKLLAEGIELKDGR
DGTTYVLN
>KALACAFP_00784 hypothetical protein
MDYQILKNIVEAELQRFENISEEQWSHKISPEKWSKKEILGHLCDSALSNIRRFVITQYK
ENENIVYDQNFWVKAQNYQNVSTSDIINLWKFLNFQIVITVENIPDEALQRTCDMTKTEP
QIFTLEYIINDYIGHLQHHLKAI
>KALACAFP_00785 GTP cyclohydrolase 1
MVDFTDNDDDIFTGKEHTPIREDAFEKSPEEKIEKISELFGEIMETLGLDMTDDSLKDSP
KRVAKMYVQEIFGGLLPENKPGISTFSNKYKYRQMLVEKDITVYSFCEHHFLPIIGRAHV
AYISNGEVIGLSKINRIVDYYAKRPQVQERLTMQIVAALKEALGTKDVACIIDAKHLCVN
CRGIKDTASSTITAELSGIFRTNPITRQEFLHYVGSHAKLDY
>KALACAFP_00786 hypothetical protein
MIIVEEVQNENQKKEFLEFPARLYQHDKNYIRPLDKDIDEIFNPEKNKFFKTGECTRFLF
KNKQDQTVGKVAVFVNHLYEQNQPTGGIGFFDCINNQKTADFIFDHCKNWLQERGMEAMD
GPINFGERDKFWGLLIEGFAEPLYGMNYNSSYYKELFENYGFKIYFEQLCFSRPIFADVS
RVFTVMHAKHKQNPNISARPMTKNNLEKFAKDFTEIYNKAWAAHGEGKCMEEAKTLKMFK
TMKPIINEHISWFVYENEKPIAMWMNIPDTNQWFKYLHGKFGFLEKLKFLWVKKFKKNEK
MVGLVFGVVPEWQRKGIEGYMIWEGTQHLRKHTDFKVTEMQWIGDFNPKMIKIAENLDTT
VTRKLATYRYLFDRNKEFERHPML
>KALACAFP_00787 5,10-methylenetetrahydrofolate reductase
MKITDHIKNANGKTLFSLEVVPPQKGIGIEDLYTNIDPLMEFKPPFIDVTTSREEYIYID
KGNGLMERRITRMRPGTLGICAAIQHKYNVDTVPHLLCGGFTKEETEYLLVDCMYLGIDN
VMALRGDAMKGHQYFEPTPGGHASAMDLVHQINDLGRGKYLHNQDEECDELNKFCIGVAG
YPEKHMEAPSMNYDLKWLKEKVDAGADYIVTQMFFDNKKYIEFVTKAREMGITVPIIPGI
KPIATKRHLKLLPQVFKIDLPEELINEVEAAKNNEAVKQIGIEWSIAQCKELLDFGVPVL
HFYSMGKSDNIKKVAGELF
>KALACAFP_00788 Methionine synthase
MKYLRLSGLEPLIITPESNFINVGERTNVAGSKKFLRLIKEEKFGEALDIARHQVEGGAQ
ILDVNFDDGLIDGKASMIKFLNLIASEPDISRIPIMIDSSKWEILEAGLQVAQGKCVVNS
ISLKGGEEEFIKQAKAVKRYGAAVIVMAFDEVGQADSFDRRVEISKRSYDILVNQLNFPA
EDIIFDLNIFPVATGMDEHRRNAIDFIEATRWVRQNLPYASVSGGVSNVSFSFRGNDTVR
EAMHSVFLYHAIQAGMNMGIVNPAMLEVYDEINKELLELVEDVILDKREDATERLLDYSE
KNKSVKKEKVEELEWRTKPLQERITHSLVKGIDRFIEEDVEEARLQAAKPLHVIEINLMT
GMGVVGDLFGSGKMFLPQVVKSARVMKKAVAYLQPFIEAEKDGTKPANGKILMATVKGDV
HDIGKNIVSVVLGCNNYEIVDLGVMVPAEKIIQTAIEEKVDVIGLSGLITPSLDEMVYIA
QELERQNLDFPLLIGGATTSKAHTAVKIDLKYKNAVVHVNDASRAVNVVSSLLGDRNKEY
VDDLKSEYSEFREKFLNRQIDKNYVSIEDARKDKFKIDWENEEIFTPNNLGIQVFENQDL
NELVPFIDWSPFFRSWDLHGKYPNIFDDEVVGAQAKELFKDAQVILKKILDEKLLTAKAV
FGIFKANANESDDILIFDKNDKEQIKFLTLRQQVQKSKGKEYLALSDFIAPQSSGKTDYI
GAFCVTTGFGTDELAEEYEKANDDYNAIMVKALADRFAEAYAEFLHKKVRTEYWGYANQE
NLSNEDLIAEKYKGIRPAPGYPACPDHLEKHAIWDLLKVKESIGVYLTESLAMFPTASVS
GYYFGSPHAKYFGLGKITEDQLKDYSKRKGISLQEARKWLSPNLAD
>KALACAFP_00789 hypothetical protein
MEKPIYLKDSEDAKLFNELRKKVNQRIEAIPENRDIYIQIKAIILPLVYFGLYVFALFNA
EKPWVYILSFVLMGISLVLIYLNLIHEAAHNNIYKSKKLNGLVLQIFDFVGANSYIWKKR
HIASHHAYPNVDGWDTDIEQSGLLLIVPWIKAKGVQKYQHFFFFLVYPLYLFNWMFIRDF
RDFFDKERVILKTQGAIPMVEKVKMINYKLFYFFYQIAVPVLFFKVSIGLALGAWFLQVI
SASIFALFVLLPLHPLPDNAFPKLDEKNGLPYSWLHHQFEVTNDLQENSWFVRNVLGNFN
FHVAHHLFPNYSYLYYNEITEEIEKFAKEHNLAYKRFPIFTALGKHVDLLKQNANNAYFI
LEE
>KALACAFP_00790 Methionine synthase
MKNSEQLYKALSERILILDGAMGTMLQRYKFEEEDYRGERFKDWEHPVKGNNDLLSLTQP
QAIEEVHKKYLEAGADIIETNTFSGTTIAMADYHMEDLVYELNYESAKIARKVCDEFTAQ
NPGKPRFVAGSIGPTNRTASLSPDVNDPGYRAITFDELRIAYKQQSEALLDGGSDILLVE
TIFDTLNAKAALFAIDEIQEERGIKIPIMVSGTITDASGRTLSGQTAEAFLISISHLNLL
SVGFNCALGANQLTPYLETLAHNSEFHVSAYPNAGLPNAFGKYDETPEDMADQIKEYVEK
GLINIIGGCCGTTPDHIKAIADLVAQYPPRKLKEFV
>KALACAFP_00791 L-methionine gamma-lyase
MENFETLAIRTQTERTQFDEHSTPLYLTSSFIFQDAEDMRASFAEEKPKNLYSRFSNPNV
TEFTDKIAKMEGAEAGYAFATGMAAIYSTFATLLNAGDHIVSCQSVFGSTHTLFTKYFPK
WNIETTYFKAEDAENVEKYIQPNTKILYLETPTNPAIEVLDLEFFGQIAKKHNLIFIVDN
CFATPYLQQPIKYGADIVVHSATKLIDGQGRVLGGVAVGREDLIREIYLFARNTGPAMSP
FNAWVLSKSLETLAIRVEKHCENALKVAEFLESHPNVELTKYPFLPSHPSYEIAKKQMKL
GGNIVAFEIKGGIEGGRNFLDKIKMCSLSANLGDTRTIVTHPASTTHSKLSDEERNEVGI
TAGLVRCSVGLENVEDIIADLKQALD
>KALACAFP_00792 Bifunctional aspartokinase/homoserine dehydrogenase 1
MKNANEIKFLKNRSIIKFEGEDFLGEIGIDGRIFKALTLARISVGVISQQAIENGLSILV
HENDSEKAVNCLIDEFEAERKSGKVSQIYSINNVSVIGFVAEDFNKILAELARNNVFPLL
LNQVASEGRVNIVVTSSQDEKAKNIIESEISKKPKTVHLAIIGHGNVGKTLIEQVLESSD
EIKRRKKIDLKVVAVANSRKIAFNKKGFDNNWNDEVLTAESPSDVQELIKFSKENQLENL
IVVDNTASKDFVHNYHTLAENGFDLVSSNKIFNTLPIEEYRKLRYTLNKNNRRYLYETNV
GAGLPLIDTIKLLHLSGENITRIKGVFSGTLSYVFNNFSLRDDKFSTIINEALEKGYTEP
DPREDLSGNDVARKLLILARELDLINEFEDIKIQNLVPESLLSVSKPEFLSRLEELDEEY
QKIKENQEPGHVLRYVGDLHGDLQKDKGELDVKLISVPATSALGQLKGSDSIFEIYTESY
GEHPIVIMGAGAGAKVTARGVFGDILRVSETK
>KALACAFP_00793 Homoserine O-acetyltransferase
MKTELNYINLSYRTNSNKEYNIPLSYQLFGKDLFSAPIILVNHALTGNSDVSGEKGWWKK
LIGENQVIDTNKYTVLCFNIPGNGYDEFFIDEYEDFTPSDIANIFLKGLEILQIKSLHTI
IGGSLGGGIGWEMLVKKPNLAEVFIPIACDFKTHDWLHAQCLVQKFLLNQNNEPLQKARI
HAMLCYRTPESLNDRFQNKYNQEKQRLDSEDWLIYHGNALNKRFSLKSYKLMNHLLMNIN
TEENQLEKIQARMHMISVDTDLFFPASEIRMCFEKLTKKKENVFYHEIKSIHGHDAFLME
YEQLNNIIKNIL
>KALACAFP_00794 hypothetical protein
MIAEKQRLQDTNWKNWGPYVSNRQWGNVREDYSSNGDAWNFANHNNAESYAYRWGEEGIA
GISDAKQLFCFALSFWNKKDKMIKERFFGLSNPQGNHGEDIKEIFYYLDNTPTHSYMKMV
YKYPINAFPYDDIRTENGRRSKKEPEYEIFDTGIFDKDEYFDIFIEYAKADHNDILIRVT
VCNRSETDAPIVIAPTVWFRNNWKWGYNTYKGQTQASYEGCIDIQHDSVSIKKFYSRNIG
AGSVFCENETNTPKLYGAPYPGNTYFKDGINDYIIYGSNTVNPEKRGTKASFLLDEIIGA
RQSKTFDFRLSPDELDEPFYQFDEIFATRIEEANEFYDEIQHDVASDDEKNVQRQSFAGL
LWNKQFYHYNVGKWLKGDPNYEAPRDFNNYVRNIEWNHLHNKDIISMPDKWEYPWYATWD
LAFHCVPFSIIDAEFAKGQLLLLTKEWYMHPNGQLPAYEWNLSDVNPPVHAWSCFRVFKI
DEKQNGKPDLLFLEKVFQKLLLNFTWWVNRKDKNGKNIFGGGFLGLDNIGAFDRNMILKD
GQHLEQADGTSWMAMYALNMMRISMELAQYYQVYEDMAIKFFEHYLYIAEAMENLGEGTK
GLWNEEDGFFYDVLQLGNGDSVSLKLRSIVGLIPMFAVEIIDHHLLDKMPNFRERMDWVL
KNKPELTKLVSHWEEEGQRRKHLMSILRKNRLSKVLTRMLDEKEFLSDYGIRAMSKVYEE
NPFVFSVHGTENVVYYTPAESDSRMFGGNSNWRGPIWFPINFLIVESLQRFHFYYGNSLK
VELPTGSGDKRNLDEVAQNISSRLCSIFLKDEYGQRPFNGGNAKFNYDENFKDYITFYEY
FHGDNGRGVGASHQTGWTATVAKLMKPRLTL
>KALACAFP_00795 hypothetical protein
MKGKLLPLTAVVLLSATFTSLLKAQEYQPMPVQSGFNADVIANGVGPSASSTNNDVDGVD
YAFISRDFQLTAASTPLTYGLPVNGIINSAVASTAGLSYQMASYSSNNTLRLENTNDNGT
LIFTTPLQAINLYMMATGGSGACTVDVDVNFTDNTSQTFTGLSISDWYYGSNFAIQGIGR
INLTNDNLESGYGTDPRLYQIPLAIDAANQSKSVKSVTITKTGTGGIPNIFAFSADAYNP
CPTPTNITSTTTMDTATLSWTAPASAPSSGYQYYYSTSPTAPTATTPPTGNVTSGTSVTL
NNLTTGQTYYFWVRSNCGGSSQSFWKMKEFTPGQISTTYNLGDINTQFDNSGVTTTSTTN
CAGSVTINVPAGYKIASTSVSYKMSTQSNGWMSEQRSLLVCSSNGNTEASVTSGSGSTTG
TYSYNRTGLTLANDLTGAVNFELRAWRTYGGSDCSVDYNKVDNDTFTVTVTLQPLALATN
EVTAKEKERIAYPNPFIDTLHIEKAENVKKAVVTDLTGITVKTVENPSSSLFLGELKSGM
YILTLTMKDGSVKSMKTIKR
>KALACAFP_00796 hypothetical protein
MKITLNRINDDFLFECTNSHGNSILLDNTSQPGATGVSPMESVLMAVAGCSGIDVVSILK
KQRQEITDFKAEVEGERIPVDDAKPFKSIKVKFLLEGSVDPKKAQKAAQLSFEKYCSVSK
TLEPTVEIGYEVYVNGEIVQD
>KALACAFP_00797 hypothetical protein
MKNLYINTRFFFALIGVGVLYVFAFFFSFLMWVAHGVLLLCFLAAMVDYLFVFNQKNGIL
AQRILPEKLSNGDENPVKIDVKNNYGFRINTKIIDEIPFQFQKRDFLIEKQIEPGKNTFF
QYILEPKERGEYHFGNLNIYVSSPLGFVSKRFTFQKDANLPSYPSFIHLRKYELMALQSE
FLLGGIKKIRKLGHTMEFEQIKDYVPGDDIRTINWKATSKANRLMVNQFQDEKSQRIFML
IDTGRTMKMPFKGLSLLDYSINATMALSHIILKKGDRAGMMTFSKKTENKIAAENKSGQL
RKISEALYNIKTDFFESDFNRLYQDVKYSLNQRSLILLFTNFETLDGLNRQLKYLRGIAK
NHLLVVVFFKNAELQTLIHKKPENMQEIYDEIIAEKFEFEKKLIIQELRKYGIYTVYTLP
ENLNIDVINKYLEIKARGIL
>KALACAFP_00798 hypothetical protein
MENLENQNIENQSSIYFDKKEDQFQSRIDMIELRASLEKVKSEIAQVIVGQESMIEHLLA
ALLSNGHVLIEGVPGVAKTITAKLLAKTIDVGFSRIQFTPDLMPSDILGTSVFSVKNSEF
EFKKGPIFSNFILIDEINRSPAKTQAALFEVMEERQITMDGTRYTMEEPFLVVATQNPIE
HEGTYRLPEAQLDRFLFKINVGYPNLEQEIAIIKNQHESKAEDKTEVVKSVISAQQLKSY
QHLVKEIIVEAQLMEYIAKIIINTRENQFLYLGASPRASLALLTASKAFAALRGRDFVTP
EDIKEASYAVLRHRVIVSPEREMEGLTADEIIRQILEGIEIPR
>KALACAFP_00799 hypothetical protein
MNKTFKIYAVIFIVVMIIIALFEVNKTESTDWRKNFDIQEKSPFGLFVFNAEIKDLFKNK
VKKIEQTPYDFYNQNKEKTHNILVIEHNIDKPSWNKILNEVSNGSDALLIVSEIPKDISD
SIGYYDSKISFEDNNVLKLTDTKFQNDFIKLDKFPSGRGFTFIKPNVEVLGKTVEENNSD
QANFIKVKLGKGNIYVHCEPLFITNYYLLKPGSVKYAQDVFSYLDDRETIWFVEGNSQAS
RYFMRFILSNPALKYAWWVLLGGLLLFIFFNAKRKQRIVPIIEPLKNTSVDFVKSIGNLY
LQEGDFHDMMAKKAQYFLNKVRMDLLIDTQNLDEEFAKKLHLKTGKPMEMINEAIVLIKK
AQDPYASVMKEDLAGMNKVLDEIVKM
>KALACAFP_00800 hypothetical protein
MNKFFLFLLVFFSAGFAYAQTEDDPPPPIEEVYVDSIDTGHYKNMYRADSVLAKNPVTEN
TVYPKKFKENIPSRYKGKDFDYTTVKPRMSFWEKLMGKIMRIIESIFGETVFTKSGNIAG
VLVRLFAIVLVGFLLYFIIKYLIGKDGNFLFGKKNRKLDIKDEELHENIHEINFPESILK
FEKSGDFRSAVRYQFLFVLKKLSDKKLITWNPEKTNKDYVSELKAPHLKNDFYDLSYIFD
YVWYGEFSIDEESYLKFKNQYQSFKP
>KALACAFP_00801 hypothetical protein
MMQFYKKRDFGTFISDSFAFFKLYGKNYFKNFILLNGLLLILMVVVIVLGFREFFGALFG
SNISGQSYYFEQLFTDNLGMFIICGILLFILSTALMTINFLFPVFYMRRLAEGNKDIKTD
DILNDFKTNGRKVLTTYFGLTFLVLPAATILFGFSYFLIIILIGIVLVLFVAPTLFNIIT
FLCYDYFNGNRGFFESLSYAIRSQFSYPNGRENSPYWKYWGSTIIMGILFYIVSGIFSSV
PMILYFTTLTTTTPDAQFEQNPLGGSFGILIFFLYGVSSLVSTLLMNVLYINSGLMYYDS
RTDLHQKMELAEIETIGINE
>KALACAFP_00802 hypothetical protein
MREVYFIKQNKEKWLGIEQVIQGKIKKNPDDLSSLYINLVNDLSFAQTYYPKSNTTVYLN
HLSSQIFQKIYKTKRVEENRFLYFFKTEVPLLVYQYRRYLLYAFLFFTLFTLIGVLSAIY
DKDFANIILGEDYVNQTIENIKKGNAVGIYQSGSTWGSTIGIIFNNIGVGAKLYIYGIAG
GVGTLYALLSNSVMLGSFQYFFYDYGALKDSARGIWLHGVFEIFSMVVEAMCGLILGASI
LFPKTFSRFNSFKNGFRDSFKIFLSTVPFTICAGIIEGYVTRHALKMPLFLNLIIIFGSL
AVIGFYYFVYPSIVNKKINNQINDAIL
>KALACAFP_00803 hypothetical protein
MSQIAINTSQNVNINFNIASVGDRMIAFILDLLIKVAYGVVVMYLFFNVFDLGYILNGLD
QWSIMAIYIILLFPTFIYPVVLESIMEGQTPGKKVMKIRVVKIDGYQAGFGDYLIRWVFR
IIDTSFAGVVGLISMIVSKNNQRLGDIASGTAVISLKNDINISHTILENIHQDYIPTFPQ
VIALTDNDMRIIKDNYTKALKIDDRQIISKLSEKIKSILKLEVDPRKMTERQFIGIIIKD
YNYYTGKDN
>KALACAFP_00804 hypothetical protein
MRFENNRSGNGGVITLNNEIKEIGRLTYTIFPEESKFIISFVLVHPEFEGRGMGKYLVEE
AIKFARENNWKVYPHCSYARSVMMRMSDVDDIFLQR
>KALACAFP_00805 hypothetical protein
MKILYAFQGTGNGHIARAQEIVPILKKHVSVDTLISGHQSQLKADFDVNFHYKGISLLYN
KTGGLSYRKTFTDNNFLEAAKTIKEIDLSGYDLIINDYEPITGWASKLKKYPMIELSHQA
SMLFKETPKPAKKDFLGELVLKYYVPSERRIGFHFENYHPQIKKPVIRRKIRNLNPDKKG
FYLVYLPSFSDENIINVLKQIPVEWKIFSKYSKLQFKDGNVEVFPIDEIQYLKYFENCDG
ILCNAGFETPAEALFMDKKLFVIPIHNQYEQECNACALDKMGIPNSKVLKLEEIRNWVAS
DQHLKVNYPDDIEEILLNEVLTL
>KALACAFP_00806 UDP-2,3-diacylglucosamine hydrolase
MKRNVELVVISDVHLGTYGCKAKELLRYLNSIQPKTLVLNGDIIDIWQFKKSYFPKPHLK
VIKKILSFATKSTDVYYITGNHDEMFRKFTDFELGKLKVCNKICLDINDKKTWIFHGDVF
DASVQHSKWIAKLGGKGYDMLIVINNIVNWFLEKMGREKYSFSKKIKNNVKKAVKYIGDF
ELTASELAIDNHYDYVVCGHIHQPQIREVVNKKGSCTYLNSGDWIENLSALEYHDKEWKI
FYYDEHKHLLKDDGAEEIQDIDSTELLKIVTNFTK
>KALACAFP_00807 putative transcriptional regulatory protein
MGRAFEYRKASKMARWDKMAKTFSKIGKDIALAVKAGGTDPESNPALRRCIQNAKGANMP
KDNVERAIKKASGADAENYEEITYEGYGQGGVAFFVECTTNNSTRTVANVRAIFNKFDGN
LGKNGELAFIFDRKGIFTIELAQIKMDWDDFEMEMIDGGAEDVEKDEEEVMITTAFEDFG
SLSHKLDELGIEAKSAELQRIPNLTKEVNEEQFKANMKMLERFEDDDDVQNVYHNMEITE
ELMETL
>KALACAFP_00808 Alpha-agarase
MKNLKLGISALALTVASTVFAQTTNNPWLIGVGAHAENHLAVRNGFSNTFSAKNLTKTMF
NMNNFSITPPLSKLTVARNIGKGLVIDWQTTVGNVENKRFNMGKEFMLMTGLGFQAKAAG
LLWNEESWFDPYLRVGANYLRHDYTALTFPRTDANGEWVQNGDNGNENGKANFFTLATGA
GANFWVTKNFGLGVQGDYVSTPGDKSTVANFWQASASLLFRFGNRDRDKDGILDKDDLCP
DTPGLPEFQGCPDTDGDGVPDKDDQCPDVAGPVENNGCPWPDTDGDGVIDKDDACPTVAG
PAENNGCPWPDTDGDGILDKDDACPTVPGLPEYNGCPKPKDVTAGEVETKLKSVYFDFNK
ATIRAESTPALDAAAQIIKTDGGNYLLEGRTDAKGSEAYNLKLSRERAAAVVAALDARGV
DPNALKSVGVGKAKATIPATASDADRQVDRKVVVKAITDMNEWNAIAKKDYEDAPVKKAT
KKAPAKKKVVKKKKK
>KALACAFP_00809 SsrA-binding protein
MKIEKTVNILNRKARFEYEILEELEAGMVLTGTEIKSLRSSKASIAESFCQFIDGELYII
NMMIDEYKLGTFYNHKTKRERKLLLHKKEMQKLEKKLKDAGNTIVPLKLYINDRGKAKVL
IALARGKKLFDKRESIKDRENKRNLDRILKKS
>KALACAFP_00810 putative ABC transporter ATP-binding protein YbiT
MLTVSNLSLQFGKRVLFDEVNIMFTKGNCYGIIGANGAGKSTFLKILTGKQDPTTGNISL
EPGKRMSVLEQDHFAYDQYTVLEAVLRGNKKLFEIKEEMDALYAKEDFSDEDGIKAGELG
VIYDEMGGWTAESDAQTMLSNVGIKDDMHWQMMSELENKDKVKVLLAQALFGNPDVLILD
EPTNDLDIDTISWLEDFLADYENTVIVVSHDRHFLDTVCTHIGDLDYAKLNLYTGNYSFW
YQASQLATRQRAQANKKAEEKKKELQDFIARFSSNVAKAKQATARKKMIDKLNIDDIKPS
SRRYPAIIFEMEREAGDQILDVKGLEKTKDGELLFSNIDLNLKKGDKVAVLSKNSLAITE
FFEILAGNVQPDKGTVAWGVTTNQSHMPLDNTSFFQEDLSLVDWLRQFTKNDEERHEEFV
RGFLGRMLFSGDEALKSCKVLSGGEKMRCMFSRMMLQKANILLLDEPTNHLDLESITTLN
NSLSNFKGNILLASHDHEMLSTVCNRIIELTPQGIIDREMTYDEYLADKRVKELKEKMYS
>KALACAFP_00811 hypothetical protein
MNRKITRSLLGLMSIVSFCKLSAQNYQTLNVTSGYNSDLIANGSGAASSTTTASVDDPAN
GYVFMSTDFINGNGIAPTSGLPASGLINSQSTTGLSFQMANYSSNNSLRLTNVGDNGTLS
FASTPKASKLYMLATSGSGTSAADILVTFTDGTTQTFTNTSISDWYGGNSFAIKGIGRVS
RVSDAIENSTTNPRIYEIPLVVSGANQTKNISNIKVTKVVGGSGILCVFGFSYIVANSCI
APDNLAASNITANSATLSWNAVAGSSSYEIYLSTTNTAPTMSTTPTMSGITGATTNLTNL
SPSTTYNAWVRNNCGGGSTSDWSSLSVSFSTLCGAVNVPYMENFNSVTNYSIPPCTSQQV
ITSDGDWAVYDWGGTVPGFSSNTVYTIPPNSSNADTWFYTKGINLQAGVSYTLSFDYGNY
FSPQSLKVAYGTSPVNTSMVNLVNDFGSVNIPAASTATYTITPTSTGIYYFGFNDYTPAS
TDLGALILDNISVTTATLSTVENALSQNTVSIYPNPVSDYLYIKSKQKISEMKIFDVSGK
TVLSSGQAEKIDVSPLVKGAYILSVKNADGTISTHKFIKK
>KALACAFP_00812 hypothetical protein
MKNILVFVCITFCTMILAQNESDKSDLKVRYYMVMAPDSTLLRNENEASVFSYSLLCNAK
KSIYADEGAKKYYDYLHDNAGNYGVLSVNSVPRSKSSVYKDGDQIIATLPIGRKDLYRFE
EPALKWELIKGKKKTILSYSCNLAKTTSDTGKVYYAWYSPSIPISEGPFRFKGLNGLILE
VYNEEKSILITAVEIAKVSELIEPLKYVNIFDVKDKSKFLKKRKEVMEDPNSNNLQSKYR
ATGPDGQEIKIDRRQSTVKVKENNLLD
>KALACAFP_00813 hypothetical protein
MKKMLLILSLGFTGLVSAKSGEVSFKAKAVLQYGYLYQSTCGWTFNMYTDTPIGQMSASQ
YDDYMDELIETNDRICKLHGVKPVENFTFNLKNSFNVITKERI
>KALACAFP_00814 Single-stranded-DNA-specific exonuclease RecJ
MSQKWIYKPEPDEEIVDGLSSSLGFGTFESKLLVLRGIDNYQKAREFFKPNLTDIHSPFL
MADMQNAVERIANAIENGEKILVYGDYDVDGTTAVALMYLYLSKIVEKKYLDYYIPDRNS
EGYGISTEGIDFAKENGFSLIIALDCGIKALDMISYAENLGIDFIICDHHLPGDEIPSAV
AVLDPKRSDCRYPFKELSGCGVGFKLCQGLNTIYKLPEAELFELTDLLAISIAADIVSMT
GENRVLAKMGLKVLRKTRNLGLRLLIPEDKLSHFEISNIVFEIAPKINAAGRISHGKAAV
ELMVSDNLKHANQIVSDIMNLNDERRELDMNSTLSALNQVIESQQETKYTTIVYHPEWNK
GVIGIVASRLIETYYKPTLVFTDGNNGEMVASARSVSDFDVHEALDMCSEYFLKFGGHHA
AAGLSMEKDKFDAFKEKFERVVSEKIKEHQKEPSITIDSEIQIDEINREFINFHRKLAPF
GPHNMKPILALTNQKVSGYIKTMGKDNNHLKFYIKQESTGRNIECVGFKLGQFADDFRTK
NFDLVFTLEENHWKGNVTHYLNIKDVKFRD
>KALACAFP_00815 Nicotinate-nucleotide adenylyltransferase
MKKVGLFFGSFNPIHIGHLILANYILENSDMDELWFVVSPQNPFKDKKSLLKDHNRLDMV
QLAVKNYPKMRASNVEFSLPQPSYTIDTLTYLHEKYPDYSFSLIMGEDNLGSLHKWKNSE
LLIKNHHIIVYPRVFDGEKKDSEYLNHENISLIKAPVIELSATEIRNMIKAGKNVRPMLP
PEVFDYLDGSSFYK
>KALACAFP_00816 hypothetical protein
MKFYLFTFLFFIQLFVFGQNNPQEDSLKREREHREMYENRRKKHHENCTRDSLKAVTDSK
IQNKYYINLVAPNGDNFLPAEELKQILNKHHIIWGGEWMGSDFGGYAPYSCYYVYMTRLT
EEKFGKEFMDGLVKESLLKYIDKNPSVIFKYNDHFDLLYDNDDLSDDKIINEYFLKDFTY
PKGYEVSKEKNQYFTEVKLHFNKDTHKLSVINFKHHIDNNHNKQFIPYFEKKIRNFVKSR
NFVNIDHTIYEVKTYFKIYYK
>KALACAFP_00817 hypothetical protein
MDFIEKFFSKYSQEKIIKWFKQICVAEAITCFLLYGVAMIWKRYDEEGILSTIFIIIIGN
IHGLFFTLYLLFCLPARKIFKWDDEDFVFALLSAFFPFATIWVEKKLARFDRE
>KALACAFP_00818 hypothetical protein
MKTPILIAAIFFSGLTFAQEKKQDTVKTKTIEGVTMTKQVFKKQSDRFVYDVAASPVTKG
NTTFDLLKQTPLLSTTDDKTLKIVGKNNAVIYINGRKTNMDAESLTQFLKNTPAENIQKI
EVITVPGSEFQVESSDGIINIILKKKMSDGTSGNMRMSNTQNKYNSSQASFSVNYRKDKL
GINANLSGGENINPQSYILRNKTGNVQNESIGDIDDPNKNIGGYLNIDYQLTEKSNLALS
WNSWANKSYNSTINLLNTITRYDDNGNLVSTDYTKTKNKEDARNYNNSVNLNYELKLDSL
GSKLNLNAAYLNYKRFQYSDNNTMIKDAAGDFTKNSKKIIQDIPQIINNFSGTVDYIQKF
KNDFTFSAGGNFNKTKTDNDTKNYTYPYDISGNQLPSDNDFNHFIYDENIYGLYVTFEKK
FSDKFSGKVGTRYEITNSLGTADSWKNNVESNQKIERNYNNILPYVSFNYAINDKNNLSY
SFSSRMRRPSFWELNPVKNIITEDNYTQNNPFVKASSTYNQELTYMYKNSYFLILNHTYV
KDQITQVPLQRSYIDPKTNQERIQLAYIRTNFGDKQEMSAMVGIQKTFFKQYLTTNFNVG
VQHNTNDGFLNTDPTTGQVFDDYINKRKSTSLVIQTNNTLRLDKKKTWFLGANFFYVDKQ
QIELGVLKNLMSLDLSLKKNWNDWTFAVNVNDVLRTNIVEIEDLQDNGNYNYIRNDQYRR
NLTVSITYNFGNQKVKKVRDIESASDAIKNRTR
>KALACAFP_00819 hypothetical protein
MTLLGCQQKTVNVGNNISFKVENNVSYGKNPNQKMDIYLPEKPNKKNDIFIIIHGGGWRS
GNKSQLTFFTYSLMEKFPENVFVNMNYRLASKTRFALPVQTEDIENVMDSLEKKLKYKPR
FILLGNSAGGHLSMFYANKSDKNKSVKAVINIVGPVDLNDPGFKNYDEYSFVEKHLIDPK
IVDKNISLMDFGSPVHWINKNSPPALSFYGLHDTVVPLSQKKILDSALAKNSVYYESYEF
NGNHLSWEKETNSTFLISKIVQFMKNINKK
>KALACAFP_00820 D-alanyl-D-alanine carboxypeptidase
MKKLKLLSLSLFLPFIFAGCGDDETEKNYQLELDAAVKNIHTNLQKDLNTDVPSLSVYVV
SPKGTFFSTVKGTNGTAVTPNTYFRFASNTKNFTSTAILKMMQDGWLNLDDKITANIPGT
TVPYVPDVADWNFPHKNEITIRQILQHNAGIYDVTNDASQYNIGGETYADYMLATNPDFQ
FSASDYVKVLTDHNLTYGSPNQVYHYSNTGFSILGEIIARVYSQKVNSVKTYGDFMYDKI
VGPNSKKPLGIKFPELASDKQLPSPYVKGFIKYSDHDEVTDLKNASAHIAEGNGIGTMTM
LTEYIRSVMKGDNVLYASSAELMRTNKGAATTNGYGLGCSNFQGIGYGHNGATEGYLSMM
AYDPKSDVSVIVLLPFWDLSSTSKFERCLNTLNTTAIEAKRTLGY
>KALACAFP_00821 hypothetical protein
MQKYFFWVAIFLGFSLNAQQKTFCNPINIDYGYTPFENFSKQGRHRATADPVIVNFKNKL
FLFSTNQEGYWYSDDMLDWKFVKRKFLRDNKYQHDLNAPAVWAMKDTLYVFGSTWEQDFP
IWKSTNPTKDDWKIAVDTLKVGAWDPAFHYDEDKNKLYLYWGSSNEWPLLGTEVKVNTLQ
SEGFVKPIIRLKPEDHGWERFGEYNDNVFLQPFVEGAWMTKHNGKYYMQYGAPATEFSGY
SDGVYVSKNPLEGFEYQQHNPFSYKPGGFARGAGHGATFEDNYKNWWHISTIFISTKNNF
ERRLGIWPAGFDKDDVMYTNTAYGDYPTFLPQYAQGKDFSKGLFAGWMLLNYNKPVQVSS
TLGGYHSNFAVDEDIKTYWSAKTGNSGEWFQTDLGEVSTINAIQINYADQDAEFLGKTLG
KMHQYKIYGSNDGKKWNVIVDKSKNTKDVPHDYVELEKPAKARFLKMENLKMPTGKFALS
GFRVFGKGDGPAPKKVEDFVPLRADPKKYGERRSIWMKWKQNQDADGYVIYWGKSPDKLY
GSIMVYGKNEYFFTGADRTDAYYFQIEAFNANGISERTEIFKSE
>KALACAFP_00822 hypothetical protein
MKQPWIHNAKTDGWFILSPPFLILFIIFLFQKQIQGLENHYSFYTWLFLIVFVDVAHVYS
TLFKTYFVKEEIQKRKLLYYGIPALSWILGLILYQFGSLTFWSVLALVAVFHFIRQQYGF
MQIYARFEPNNWSKKIDEIAVYSATIFSMLYWFKTPRAFTWFVENEFNWLKNLPDYTNFI
TVLYVLILSVWIIKTVVEFFKTKQINIPKITLITGTYLSWYFGIVYFNNDLVFTFLNVIS
HGIPYVALVYIREIKQKETTKLNKFSVFRSTLGIFLFIAIILGFAFFEEFLWEILIWNEH
FSLNVNLSTNWFQFLVPLLVVPQLTHYLLDGFIWRKPKKVN
>KALACAFP_00823 hypothetical protein
MRSGGKYSRKDFLKTLFLGSLMLPFLQYCSKKGKSLLLKITGTDYVLGHKLWAKDFPKPT
EEIHTKYLIVGGGISGLSACRFFSQNSENDYLLLEMEDHLGGNSSSGQNKFSKFPLGAHY
LPLPNKENTEIIDFLKECNIYQGDDENGEPILDEYQMTFPQQERLFFKNSWQNDIVPQKG
VSAETQKEFDRFFKLMDDFRDGKGADGKYFFAIPVEDSSEDPELIQLEKMLFKSFLATEN
FKSEELLWLLDYSCRDDYGLGIDHVSAWAGIHYFAGRKNNWSKKYKDQVFTWPEGNARLV
KHFSKYTAGKSLTKNLVFDVKINDGVEVLSFDNARKKTRKIFAEKVLFAIPQFVNERIFN
DKQAKYFNYVPWLLTTITLKNQFGGDEELAWDNVIYGSDGLGYIYDQHQNVDQIMGEKVM
TYYKSFSTDDCRKARRKLYSMNESELQNLVLEDLKKAHPLIEDFIVEMQFHKIGHAMIAP
VPNQIFGVKTQEAKQPIDGKIFFAHTDLSGISIFEEAFYQGWRTAEKMI
>KALACAFP_00824 Polyamine aminopropyltransferase
MDKKRIPLELLLLFSVFVIATCGLIYELVAGALASYLLGDSVKQFSFIIGVYLFSMGVGS
YFAKFIKGNLIDKFVEIEILVGIVGGISSVVLFILFNTLAHFEAVLYLFVFFTGCLVGVE
IPLLMNILKDRIQFKDLVSNVFAFDYIGALLASILFPLVLIPNLGIVKTPLFFGLINISI
AIFLCFYLKKELSKPVLLKIKAIGAFVFLLILFIFSDKILSFSEEKLYGENVVYTKSSPY
QRIVLTRNNREFRLYLNNNLQFSSTDEYRYHEALVHPAMSMAKNIDHVLILGGGDGFAVR
EVLKYKEVKDITLVDLDGEMTNFFKTNETMRELNQSSLSNPKVKIINKDAYIWVKENKQK
FGVIIIDFPDPSNYSLGKLYSLQFYKELERLTTPDTKIVVQTTSPYFAPKSFWCIEKTIN
QIFPFTSAYHTYVPSFGEWGFSMASFEPVNNKIYRRIPNLKFYDYNFPQMSYFSKDMITE
DVEVNRLDNQILVRYFDEEWGKVQ
>KALACAFP_00825 hypothetical protein
MDQINFLPVINSLLYSFLGIAILLICYFILEKLTPERTWHEISKNQNVALAIIFGAFIIG
ISIIISAAIHG
>KALACAFP_00826 hypothetical protein
MANIINYIKENWFLCLIGGMFLSWFVYLTYSGNQVCDCAKTETYRDGTTRRHSSGGVGYY
RYYHK
>KALACAFP_00827 hypothetical protein
MHYTCPLCKTENKIDASFHPVEYVCKSCSNLIDVSKNTSTKVVKKPIENVVLEIGQQGVI
DGTAYRVTGIIIRKYGSSIFWREYYLKDDKGNSAFLSESDGHWVFLHLINEMDVKRKQNG
KVAELHGVNYRWYETTQCTIHAAAGFFEDRLNFGIATYKEWVNATQMISQEQSGDSLEYF
FGRHISKYTIKKAFNIPNLPNYTGIGIVQPYYFNIKQLINIFCVVALLICLLQVYVYTTR
SNYPVFEQSIRFEEVKNKEMVSKSFTLSGGSAPMKVKVFSGVDNSWANVQLSLVNEKTNE
IVYTSKDIEEYHGVEGGESWSEGSTTEEFNLCGVSSGTYHFLISAERQETIDTTVPASTY
TSPDGTVTIKRENTGLINVINNNTFESVLFGDLKTLEGDQTGTGNMVKKAFEGKNLDSLL
NINAEPLPAVAEPVTSSNYVDIKATWLPVSFWNFGIILVLMIVFFIGCYWGRHLFNVAKW
KNSSNSPYPQS
>KALACAFP_00828 S-adenosylmethionine decarboxylase proenzyme
MKPLSSKGLHILLTLETESEDLLLNSKGFLSFTEKILATKDVEIVGVTDHIFENHSFTSA
VCLKESHLCIHTWPEFKQLTFDVFLCNYMQDNTEKVEQIADEVIGYFNAKIIQKHKIYR
>KALACAFP_00829 hypothetical protein
MQTADTVLMIEPIAFGYNAETAKNNYFQVEQTGSDIQSKALAEFNTFVGKLKSKGINVIT
IKDTLDPHTPDSIFPNNWVSFHNDGKVVLYPMFASNRRVERREDIIETIKDQGFEVDEID
DWSFPETQGHFLEGTGSMIFDHDNKIAYGSVSLRLDEKLFREFCKKYGFTPVVFHSFQTV
GTERLPIYHTNVMMCVADKFVVICLDCIDDELEREKVIETIKNSGKEIIEISEEQMQQFA
GNMLQVQNKEGKKFLVMSETAYRSLTPEQVSNIEKYCEIIYSDLNTIEVNGGGSARCMLA
EVFLPKK
>KALACAFP_00830 Arginine deiminase
MKLNIKNETGRLRSVVLGQPNSMGPVPTLEESYDAKSYYSIEHNMYPKEADIINEMNAFE
AVLKKYDVEVLRPSIIKDYNQVFARDVAFVIDDKMIISNVIADRADEQEAYKKVFEKVAW
RKIINLPETAHIEGGDVIVWDDFLFIGTCFSEDYRSYKTARTNEYAIEILKEYFPKKRII
DLELKKNDKVPYEGILHLDCTFNPIGKDKCIIYKDGFVDESDYRLIIDIFGEENCFHVTA
EEMFEMFPNIFSISPEVVVSDKTFTRMNNHLRNEWGMTVEEIPYREISKMGGLLRCSTMP
LVRE
>KALACAFP_00831 hypothetical protein
MNTKKAVLKNAQKLGREQQKSIMGGGISAAKRCCEWDFETGACTLWTCDRCQCP
>KALACAFP_00832 hypothetical protein
MNTRVWIFLLLLFLSIFAKSQEIVNRKKSDSLDKKERVKNDSTRHISEVIIQSSRRNLKL
NDGNIVMSVSGNRDFKTSTNILDVLRKTPNVTVDSEDGIFIGGRISPAIFIDGKPVVMSS
QELQFYLRSLSPEMVESIEVNTNPSSKYDAEFKGIIGIRLKKNTNLGWKGNYNGNVSVNR
FNYRENSLNLSYNTQKIAYNLQLGYNSGISTYRYNALQRLANTNVMRTSTFQNDDNKVKN
FQFGVDVRLNDKNRLGLNLRGNFREIDRNRGGSLYTTNKDETELVFNTESENPTLYNQNN
YGITTDYSFQNKNFKLNFLGNYLSVENKQNDDFINRDKPTSQLLSYWKSDLLNKITIYTS
QIDVSQKIKNATFEAGIKYSNSHTNNNIRYDTLAVNNQFVFDPTRSNQFSYKEKILAGYL
AYNQKFNKLQINAGLRFENTKSTSNAITIDSVVSRNYLEWLPSFSANYGFNKDNELSVSY
SRKITRPVFSQLNPFRFYFSPLNYWIGNPYLQPSFTSQIKATYRYKNWVTSFTVGKEKDV
MTRYPLYNPQTNVLEYLGTNLPYRNFAVLETNFPVKIAKWWNINTQLSGFYNHEFRPYLD
EVFALRIYNYEIRLNQVFTLPKGYTVNLFTNYESKTGNSLYIIKPRYTVDFSLQKAWFKN
KLNTKLSFNNIFDSYDQQLEFRHKQIMDNRLRHWWDSRRLIFSVSYQFGSSEYQKNDLQR
TEEENRTR
>KALACAFP_00833 HTH-type transcriptional activator RhaR
MTFGQQMLFFFSAIGAFNGFLLGIYLLFVKKLKYIPHFFLGLILLTLSIRVGISVCIYFY
PEWPRIVPYFGLAALFFTGPALFYYVKSSFLQDQFIFKNCRKSFGILTVILGVVGLLYLF
FPITWDKYFATFVYTVWSVFVFLSVYQYYVYFKQKSKNPNKFILPVLLSNVVIFLVYQLI
STGWIQVYCAGGSLVFSFVLYANFLILFNKKYQPAISKEANKYSNKKISGELADNFVSKL
ERLMHHEELYKNPNLKLNDLAAKMNMSSHQLSQLLNDNLGKSFATYINEYRINEACEMIE
NDSYLKIEEIGYEVGFNSKSTFFSTFKKIKNTTPLLYKQSQMPSEQRFQSSNL
>KALACAFP_00834 HTH-type transcriptional activator HxlR
MYERKIPPNLNCGLDLIGEVLYGKWKIRLLWFINEGFLRPSELQRKIPDASRRVLNIQLK
ELEDHELVTKKIYPVVPPKVEYSLTEFGKTLIPVISALGQWGDEHEERLKNVILSRLEK
>KALACAFP_00835 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MNVPFNFNNELAGKTALVTGGTKGTGKAIAERLSNAGATVIITARNTPETSDEKFHFISS
DLSKPEGTQKVVDEVLSKFGKLDILINTLGGSETKGGGFSVLSDEDWETTIQTNLLAPVR
LDRGFLPQMIDQQSGVIIHIASIQGRLPLYDSTLPYAAAKAGLINYSKGLSQEVSSKGVR
ILTVSPGWIMTDSSTRMMERIAESSNSTIEEATQSVMDALGGIPIGRPAKPEDIAEFVGF
LVSPRASYLTGTEYVVDGGTIPTI
>KALACAFP_00836 hypothetical protein
MNLPIVLKNLLEAQKKSDSLLYSECFTDDAVVFDEGKTHKGKDKIRQWNEKSTEEYQFQM
EPLEFSQEDKNSILKANVSGNFAGSPIVLTYTFQIENDKISSLKISG
>KALACAFP_00837 Citrate synthase 1
MSDNKVILNYDGNSYEYPIVDSTIGDRGIDISKLRDQTGLITLDLGYKNTGATLSDITYL
DGDKGELFYRGYPIEQIAEKSNFTEVMYLLLQGELPTKDQYTSFENNIKKYNFVAEEMKK
LIDAFPRSAHPMGVLSSLTSALTAFNPKAVNVNSKEEMDLAAELMIAKFSHLCAWTYRKT
QGLPLNHGDNNLNYVENFYKMTFRMPNQDFEVNPVVVEALDKLLILHADHEQNCSTSTVR
MVGSAHTGLFASISAGVSALWGPLHGGANQAVIEMLELIEKDGGDVNKWVAKAKDKNDSF
RLMGFGHRVYKNFDPRAKIIKKAADDILNALGIQDKALDIAMQLEKVALEDEYFVERKLY
PNVDFYSGIIYRALGIPTEMFTVMFALGRLPGWISQWKEMRLKGDPIGRPRQVYQGAKQR
DYIDMVNR
>KALACAFP_00838 Enolase
MSYISYIEARQILDSRGNPTVEVDVFTESGAMGRAAVPSGASTGEHEAVELRDGGSEYMG
KGVLKAVENVREVIAPELVGLPVYDQNLIDQIMIDLDGTKNKGNIGANAILGVSLAAAKA
AAAELKMPLYKYVGGVNANTLPVPMMNVINGGSHSDAPIAFQEFMIMPVKADSFSHALRK
GTEIFHNLKSILHSRGLSTAVGDEGGFAPTFKGTEDALDTLLQAIEKAGYKPGDDIMLAL
DCAASEFYKDGVYDYRKFQTPDAAQFSSSEQVSYLAELAAKYPIISIEDGMQENDWEGWK
MLTDKIGDRVQLVGDDLFVTNVERLSRGVKEGIANSILVKVNQIGSLSETMAAVQMAQHN
KFTSVMSHRSGETEDSTIADLAVAMNCGQIKTGSASRSDRMAKYNQLLRIEEALGETAIF
PGLEAFKVKR
>KALACAFP_00839 hypothetical protein
MKTIRYIVWVFFISFPQFYFCQDDEINLDLLRAQSSPAANLLGIANSEIEKPTDVNALMV
SLRESSDNFSTLPSSFAIDVAPFKLGGNYQDLRKKTPSFSEGFKQSFVTSFAFKKIEEDL
EESIEARSRLGLGVKFSLKRGNLNNKTIAALDKIEFYQKKMQEIAITDHEGKISALFEER
KKFVLERNEIKDENSKKYKELSEKIKTIDKQISDETIAASKNERQIYQEKIKEEAGKIKL
DRYGFYLDLSMGTVVDFRNNKFDNSQISKTGAWLTGGWNWEKSSSSLIFITRYLYNPDSP
LANPELKKENLHTLDMGSRYALNFFNKKFLMSGECIYRSILNKSDYESSWKFLLNFEYEV
AKNQRLTFSFGRDFEGEYKKDGNVIVALNLLIGLGKVKL
>KALACAFP_00840 hypothetical protein
MSTKKNQSARILNAQTQLLNFKIQQLSMMNYLTDAVNNNNHYVAIKDIFLSDFNENDNIL
VSIFFGGEDQKGSSTLKILKTAEQPKFISQSTENISIGQCKNLAGQILDIESNITDTNGN
PDQNDTILTVKIKIGSKQVYKDQHTINVGEAGTSSFTHYITFY
>KALACAFP_00841 hypothetical protein
MKTTIDNTFEDFKTALNNNPNLQQEFRENPVKAAENITTNPKDTDSWIYRIIVLSFGLII
LTIVITLTVMSMNEGGNQINAQVLTIFTAISSGSIGALAGLLAPSPSKQ
>KALACAFP_00842 Sensor histidine kinase DesK
MNNENLNEIKLTYIIITIVMLFFVVFIIFVVLMYNRRQLLYIKEKQLKESEHQNQLLQKE
LEKQKLIEQERERISHDMHDDLGAGISALKLQAEFLKQKANDGELKNDIEELLKTSEEMN
LSMREMLWNLNSGNDTLGSFIDYSKIYAHNFLKKTKIWLIIENENAIPETTISAEQRRNL
FLCLKEALNNAYKHSKADQLKLSFIQNDKEFKMEISDNGIGIDHENPEGNGLRNMKRRML
EQNGQCEVTTENGTHLFFRIDL
>KALACAFP_00843 hypothetical protein
MYSIFQLIYLLVLFLVASFSLYLCIKKGGKQQEFLWLYLGISFVLEFVMFIFQIVFGSSS
GFGFLYNIYFLFCPLFFMMYFNREQNKFIVKLNTIVFAVFMLIFLFFIFKEYQEVNQIIG
ISFSLVFILYSLIWFYGKLSHPNEKSIMDDPKFWVSCGFLFWGVFFILRIIPRYLFNEVD
HGTLIISQSFFFVINIFFYISFFVSLLKYSKNHDE
>KALACAFP_00844 hypothetical protein
MKNPEEFDCHQVKLDLIQSIIEMPCIEIEKYSLVDFFFNYRLSEQQVVCMRNKASKVIFG
KDSDVELKDFVIDTTSFKNINLEFDFVHFCFIDTVSLQTELEIPINNLQHTLYYIIINCN
KNDLIDFDFNSVAYNAYIVNDSNVLQKITLTNDDYANIRNRFLTRVGSTIRQNTTFNAIT
EYITFSAKKVKDFRNELPSNSTFNVRLICIDKNCNINSPSQEVTDYLSQSRNQNRLSLAF
QKINTVGPGDYYDIGNMQP
>KALACAFP_00845 Transcriptional regulatory protein LiaR
MSISIAIVEDEKNYNNALKKIINYQDDMKVVAQFFDGNEALKNLSDISPDVVMMDIQLQD
MLGIEIIEKLKKEMPKTQFIMCTSFEEDEKIFNSLKAGATGYLIKGESMDKILSSIRDVY
NGGAPMSFSIARKVLQHFERKLPEVQGFDELTDREKEILELLSQGLLYKEIADKKFISID
TVKKHVGNIYRKLHVNNKVEAINKFNHFKN
>KALACAFP_00846 hypothetical protein
MKKGFLIGFSAIALSVISCKKTESGNKNVLKSDSSGAILADNGKVDSTIHYETDVNGKKY
LKTDYVYKATDGSLVKVVFNYEEKTMSVRSNNKTFILNKIESKGDETTYEKMDMKATVKG
DSLILDQGNNIIQLVKTKI
>KALACAFP_00847 Beta-galactosidase
MEKLKTKTILFFILLWGVFFFSQSTQKSFEIKNGQFLLNGKSIEIHSGEMHYPRVPKEYW
KHRLLMMKAMGLNAVATYVFWNYHEEAPGKWDWSGQKDLRQFIKTAEEVGLYVILRPGPY
VCAEWEFGGYPWWLQNIKGLKIREDNEQFLERNRQYLSQLYDQVKDLQITKGGPIIMVQA
ENEFGLFAFQRKDISEQLHRSYVNKIVKQIKDVGFNVPMYTSDVSDFFESGHIDGALPAA
NGEKNIDKLKTVVNKFHENKGPYMIAEFYPGWLMHWGEGFPRTRIRETVQLTENFLKNGI
SFNYYMIHGGTNFGYTSGANYNKEHDIQPDLTSYDYDAPISEAGWRTPKYDSIRNVMAKY
SKEKLPEVPAPIKTISIQNIKFDKLYNLFDYSKTQETVKAEKPLTFEELNQGYGYVLYRH
HFDEAINGKLNVSGLRDYATVYLNGKKMGELNRFFNSYEMSIEIPKNSNLEILVENWGRI
NYDAQINQNTKGIISPVKIDGKEINGTWEMTKLPFPDHFASSIKTKPINPDAYQQLKNLP
TIYRGEFDVNETGDTFIDMQNWGKGLIFINGKNLGRFWRVGPQQTLYIPGVWLRKGKNEI
VIFDQINESIQKSVSTIEEPILNVLTR
>KALACAFP_00848 50S ribosomal protein L17
MRHGKKFNHLGRTASHRSALLSNMACSLIEHKRINTTVAKAKALRVYVEPLLTKAKEDTT
HNRRIVFSYLQSKEAVTELFRTVAPKIAERNGGYTRIIKTGFRPGDAADMALIELVDFNE
LYNPNAEEKKATRRSRRSTTAKKAETVVAEAPVVEEKAEAPKAEAADSTEEKTEE
>KALACAFP_00849 DNA-directed RNA polymerase subunit alpha
MAILQFIKPDKVILLNSDEFRGQFEFRPLEPGFGLTIGNALRRVLLSSLEGYAISSIKIE
GVEHEFSTIPGVIEDVTEIILNLKQVRLKATAENQANEQVVAKVSGQTVITAGDLGKSIN
GFEVLNPDLVICNLNSDVTFEITFNIEKGRGYVPSEQNKSNNAPVGTIAIDSIFTPIKKV
QYSIENYRVEQKTDYEKLVLDIETDGSISPQNALTEASKILIYHFMLFSDERITLETEAV
KASIQYDEETLHTRQLLKSKLADMDLSVRALNCLKAAEVETLGELVSYSKSDLMKFRNFG
KKSLTELEELVHSKGLNFGFDVAKYKLDADK
>KALACAFP_00850 30S ribosomal protein S4
MARYIGPKTKIARKFGAAIYGDDKNFEKRKNQPPGQHGPNKRRGAKKSEYAVQLAEKQKA
KYTYGILERQFANLFDKAHRSKGVTGEVLLQLCESRLDNVVYRFGFAKTRSAARQLVSHR
HITVNGELVNIPSYLLKAGDVIAVREKSKSLEVVTNALASKANYEWLQFNDEKKEGTFVS
APERIQIPEDIKEQLIVELYSK
>KALACAFP_00851 30S ribosomal protein S11
MAKQTKVVKKRKVKVEAIGEAHIQASFNNIIISLTNKNGEVISWASAGKMGFRGSKKNTP
FAAQMAAENCSAVAHEAGLRRVKVFVKGPGAGRESAIRSIHNSGIEVSEIIDVTPMPHNG
CRPPKRRRV
>KALACAFP_00852 30S ribosomal protein S13
MARIAGIDLPKNKRGVIGLTYIYGIGRSTSSEILKAAGISEDKKVNEWNDDELAAIRTYI
SENVKVEGELRSEVQLNIKRLMDIGCQRGIRHRLGLPLRGQRTKNNSRTRKGKRKTVANK
KKASK
>KALACAFP_00853 Translation initiation factor IF-1
MAKQKHIEQDGVIVEALSNAMFRVELENGHVLIAHISGKMRMHYIKLLPGDKVKLEMSPY
DLTKGRITFRY
>KALACAFP_00854 Protein translocase subunit SecY
MKEFIQTLKNIWSLKELRDKIIFTLGIILVYRFASYISLPAINLAEVGDLLEHYKNQGGN
KQGAGLLGLLSSFTGGAFSHASVMALGIMPYISASIIVQLMGMAIPYLQKLQKDGESGRN
TLNQITRWLTIGVCLVQAPSYLTSITQLFLPYAQFQSAYYVEPNSIMFWLPSIVILVAGS
VFAMWLGEKITDKGIGNGISILIMVGILSRLPEAFVQEMAVQNGKGGMGSIMILIEVLFW
MLVVLLAVILSVAVRKIPIQYVSRAQARGGVNRNLMQGARQWIPLKVNAAGVMPIIFAQA
LMFVPGLLTKVDESNTFLAGFKNVFSWQYNVLFALLIIIFSFFYTAITIPVNQMADDLKR
NGGLVPKVRPGKETADYLDDILSKITLPGAIFLSIFAVLPAIVHGSFVQTDAFALFFGGT
SLLIMVGVILDTVQQINTYLLNHHYDGLMQSKLSRTTGY
>KALACAFP_00855 50S ribosomal protein L15
MNLNNIKPAAGSTFNSKRIGRGQGSGKGGTATKGHKGQKARAGYSQKIGFEGGQMPLQRR
LPKFGFKNVNRKEFRAINLDSIQTLIENKSITGEITKEVLIANGLASKNELVKIMGRGEL
KSAVSISADKFTKSAEELITKAGGKAITL
>KALACAFP_00856 50S ribosomal protein L30
MATIKVKQVRSAIGRTKTQKRTLEALGFKKLHQVVEHEATPSILGMIAAVSHLLEVQK
>KALACAFP_00857 30S ribosomal protein S5
MLGLDNIERVKPGGLELKDRLVAVNRVTKVTKGGRAFGFSAIVVVGNEDGVIGYGLGKSK
EVASAIAKAVEDAKKNLVKVPVMNHTIPHQTTARYGGADIFLRPASHGTGLIAGGAVRAV
LESAGIHDILSKSKGSSNPHNVVKATFKALLDIRRPEEIARMRGVSLTKVFNG
>KALACAFP_00858 50S ribosomal protein L18
MALSKLEKRIRIKRRVRGKISGSSELPRLSVYKSNKEIYAQLIDDKSGKTLASASSREKG
VDANGTKTEVSAAVGKAIAAKAKAAGIENIVFDRNGFVYHGRVKALADGAREGGLKF
>KALACAFP_00859 50S ribosomal protein L6
MSRIGKAIITIPAGVTITENNGVVTAKGPKGELSQELTAGITLEQKDGELNVNRPSDSKQ
HKALHGLYRALIANMIVGVSEGFEKKLELVGVGYRASHSGQKLELALGFSHGIVLELPSE
VKVDTLTEKGKNPIITLTSHDKQLLGMVTAKIRSFRKPEPYKGKGVRFVGENVRRKAGKS
A
>KALACAFP_00860 30S ribosomal protein S8
MVTDPISDFLTRVRNAQSAGHKVVEIPASKIKKEITKILFDQGYILNYKFEDSAVQGTIK
IALKYDKQTNKPAIKSIQRASRPGLRQYKGSGELPRVLNGLGISIISTSRGVMTDKKARE
EKVGGEVICYVY
>KALACAFP_00861 Alternate 30S ribosomal protein S14
MAKESMKARERKREALVAKYADKRKALKEAGDYEGLQKLPKNASPVRLHNRCKLTGRPRG
YMRTFGISRVTFREMANNGLIPGVKKASW
>KALACAFP_00862 50S ribosomal protein L5
MEYIARPKKAYKETIVPAMMEEFGYKSVMQVPRLEKIILSQGLGDATADKKIIDYAVEEL
TNITGQKAVGTISKKDEAAFKLRKGMPVGAKVTLRANKMYEFLDRLTASALPRIRDFSGI
KADGFDGRGNYNLGITEQIIFPEIVIDKVKKIQGMDITFVTTAKTDKEAKALLTHFGLPF
KKN
>KALACAFP_00863 50S ribosomal protein L24
MSKLKIKRGDNVIITTGKKDIKGKTGEVIEVIKKEGKDPRVVVAGLNIIKKHVKPSASNP
QGGIVEREASIHISNVALVGKDGKAIKIGYKIEGDKKVRINKKTGETL
>KALACAFP_00864 50S ribosomal protein L14
MLQTESRLKVADNTGAKEVLVIRVLGGTRRRYASVGDKIVVTIKDSTPSGNAKKGQVSKA
VVVRTKKAVRRKDGSYIKFEDNACVLLNAAGEMRGTRVFGPVARELRDKEYMKIISLAPE
VL
>KALACAFP_00865 30S ribosomal protein S17
MDRNLRKERIGVVSSNKMEKTIVVSETTRVKHPMYGKFVLKTKKYTAHDENNECTEGDTV
LIQETRPLSKNKRWRLVRIIEKAK
>KALACAFP_00866 50S ribosomal protein L29
MKKADIKNLSAGDIQAQLTEAKAQYSKLKLAHAISPVENPIQIRDLRKTIARLNTELTNK
Q
>KALACAFP_00867 50S ribosomal protein L16
MLQPKRTKFRRVHKMKMKGNAQRGSQLAYGTFGIKATEGAWITARQIEAARIAATRYMKR
EGQLWIKIFPDKPITKKPAEVRMGKGKGAVEYWVAVVKPGKIMFEVGGVPYEVAKEALRL
AAQKLPVVTKFIVANDFVKPL
>KALACAFP_00868 30S ribosomal protein S3
MGQKTNPIGNRLGIIRGWDSNWFGGNDYGDRIAEDYKIRRYLEARLSKGGISRIFIERTL
KLVTVTITTARPGLIIGKGGQEVDKLKEELKKLTKKDIQINIFEIKRPELDAVLVADSIA
KQIENRISYRRAVKMAMAGTMRMGAEGIKVQISGRLNGAEMARSESFKEGRIPLSTFRAD
IDYHIGEALTQYGKLGVKVWIMKGEVYGKRELSPLVGQQKKGGQSDRGNRGGDRDNRRPR
KNNNNNNNNN
>KALACAFP_00869 50S ribosomal protein L22
MGSRKQDSAIARKEANKDVVKASLNNCPSSPRKMRLVADIIRGEQVDKALYILKYSKKEA
SNKLEKLLLSAIANWQTKNEGADIEEANLIVKEIFVDSARQLKRLRPAPQGRGYRIRKRS
NHVTLILGNKEN
>KALACAFP_00870 30S ribosomal protein S19
MARSLKKGPFIHHTLDKKVQANIESGKKTVIKTWSRASMISPDFVGQTIAVHNGKSFIPV
YVTENMVGHKLGEFSPTRSFRGHGGNKNKGSR
>KALACAFP_00871 50S ribosomal protein L2
MSVRKLKPITPGQRFRIVNNFEEITTNKPEKSLTVGIKKSGGRNQTGKMTMRYTGGGHKK
KYRIIDFKRNKANVEATVKSVEYDPNRTAFIALLEYADGEKRYIIAPNGIKVDQKVVSGE
SVEPNIGNAMKLKNIPLGTVISCVEMKPGQGAILARSAGSSAQLTSRDGKYAIIKLPSGE
SRMILTECMAMIGSVSNSDHQLTVSGKAGRSRWLGRRPRTRAVVMNPVDHPMGGGEGRSS
GGHPRSRNGKPAKGYKTRKKNKVSNRYIVSKRK
>KALACAFP_00872 50S ribosomal protein L23
MSVIIKPVISEKANYLTDLRGSYSFLVDTKANKIQIKKAVEAAYGVKVADVNTMIYAPKV
SSKYTKKGLQVGKTNKLKKAVIKLAEGEVIDIFAVN
>KALACAFP_00873 50S ribosomal protein L4
MELVVLNTSGKETGRKVTLDETVFGIEPNQHAVYLEVKQYLAAQRQGTHKAKERSEITAS
TKKLKKQKGSGSARYGDIKSPTFRGGGRVFGPKPRDYRFKLNKALKRLAKKSVLSQKMRD
NSIRVLEDLSLNAPKTKDFINVLNALELNGKKSLFVLPEANKNVYLSSRNLAKAQVKKFD
EISSYDLVNAGEIVFFEGAVEKFQENLKK
>KALACAFP_00874 50S ribosomal protein L3
MSGIIGKKIGMTSLFNEEGKNIPCTVIQAGPCPVLQVRTQEVDGYVAVQLGFDDKSEKNV
GKALAGHFKKAGSTPKAKVMEFRNEFEHTVKVGDLVEVNMFAEGEYVDVTGTSKGKGFQG
VVKRHGFGGVMQATHGQHNRLRAPGSIGAGSDPSRVFKGMRMAGRMGGKQVTVQNLQVLK
VDQEQNLLVVKGAVPGAKNSYVIIKKWN
>KALACAFP_00875 Glucitol operon repressor
MEKLLSRHNDILKELEEKDYVLVQDLCEKFNVSSVTIRKDLNYLESLGLLFRNHGGASKH
VRYAYEKNVDEKENINVEAKQNIAKAALSLIQENDCIILASGTTMHYLARMLVNFGPLTV
LTSSLRVAIELCNNPNINIIQLGGEVRKSSTSIVGSISETILKQFSCNKLFLGVDGIDMD
FGISTSNAAEAHLNQLMMECSDKVVILADSSKLNKKGFGKIADLDKIDYLITDKDILQED
KNRLEEIGVSVIVK
>KALACAFP_00876 Glycerol-3-phosphate dehydrogenase 2
MKRNEELSKLTTVKEWDFIIIGGGASGLGSALDAVSRGFKTLLLESHDFAKATSSRSTKL
VHGGVRYLAQGDIGLVKEALKERGLLAKNAAHVVKNQSFIIPNYTWWGGIYYKIGLSIYD
FLAGKLSLGKTKYISKSKTVEKLPTIEQKGLASGVVYQDGQFDDARLAINLTQTIIEKGG
TAVNYVKVINLIKNDSNKITGVVAEDQFTNQRYEIHGKVVINATGVFTNDILNMNNPKHG
KFVVPSQGIHLVLDKSFLKSDDAIMIPKTSDGRVLFVVPWHDRALVGTTDTLLESESFEP
RALEEEINFVLNTARQYLSKKPTREDVKSVFAGLRPLAAPKDGSKSTKEVSRSHKVITSD
TGLVSIIGGKWTTYRKMAEDTINEAMKVHQLGMTTSKTEHLSIHGNVKPETVDRSNHLYV
YGSDIPEIKKLQQNNPEFSEKIHPDHPFTIAEAIWAVRNEMAQTIEDILARRVRLLFLDA
RAAIDSAHKIAAIIAKENGHSEEWANEQEREFIELAKGYLLTPYSPRSI
>KALACAFP_00877 Glycerol kinase
MSEKLILALDQGTTSSRAILFNHSGEIEFVSQKSFEQIYPTPGWVEHDPNEIWSSQVSVA
AEVIAKAGISGREVAAIGITNQRETTVVWDKETGEPVYNAIVWQDRRTSKYCDELKEQGH
TDMIKEKTGLVLDAYFSATKLKWILDNVDGAREKAEAGKLCFGTVDTYLVWKLTRGKMFI
TDVSNASRTMLLNIHTLEWDNDLLELFNIPRGILPEVKQSSEIYGETATTLFSTKIPIAG
IAGDQQAALFGQMCTTPGMVKNTYGTGCFLLMNTGKEAVLSKNNLLTTVAWKINGEVNYA
LEGSVFVGGAAIQWLRDGLKLIHSAEEINTLAQSVEDNGGVYFVPALTGLGAPYWDQYAR
GTIVGVTRGTTNGHIARATLEGIAFQVYDIVKSMEADSGKKSPELRVDGGASASDILMQI
QSDLFGFKITRPKTLETTALGAAYLAGLAVGYWKNIDEIQSQWIVDKDFHPKLEKEKVEK
MVKTWNKAVQRSQNWIED
>KALACAFP_00878 putative glycerol uptake facilitator protein
MTPFIAEIIGTMLLILLGNGVVANVVLKDTKGNNSGWIVITTAWALAVFVGVTVAGPVSG
AHLNPAVTLGLAIAGKFSWDLVPTYIAAQMIGAMLGAFLVWLFNKDHFAITEDESAKLAC
FSTGPAIRKPISNLISETIGTFVLVFVIFYFADPSLTLQHEPTAKIGLGTVGALPVTFLV
WAIGLSLGGTTGYAINPARDLGPRIMHAILPVKGNSDWSYAWIPVAGPILGATIAALLHG
ALS
>KALACAFP_00879 hypothetical protein
MKKVIIFCLVVLGTGNLFAQENIENQEDSRLDFTANIQNNHLWRGLIITDKPVVMGNLSY
ALDKDKKWKVGIWGASALTDDKDGTHYKEINYYVQYSNGRLYIGLWDLFNSRNINTAVAS
DDIFNYSNRRTAHIIDLRTNYTFGPSFPLNIEADIMLYGGANAGEVVLEPDGSYKKNKYS
TYVQASYPVIKNKKVNLDAFVGAGFALNDKTFLYGNGKNSFDIVNVGVKASKTIKITEHY
SLPVSMMAMWNPSNKFARIQLAATVF
>KALACAFP_00880 hypothetical protein
MKKILSVLILCISILSFAQTKAPFTGKRDFNIEQGASGSGTPAYYLDVKNNGDVHFGFVQ
INQADGTETKEEINAGKYNPTVMKVHFKTYNETFYVKFDQEKIYLTDEKGKIMKSDDCCP
VSEMAELNCNCEGTLYQ
>KALACAFP_00881 hypothetical protein
MKVFPFLFLFFIFSCSKKENHPYTFYYWKTKLALDETEKKVLNKASSPYLYTRFFDIDKS
GGKFQPVGVITKDKSFEIQQQIVPTVFITNRTFLYISKEEIAFLAKNIHELIQKKASEYH
LKINNEIQIDCDWTAGTRDDYFKFLKELKKISGKEITCTLRLHQVKDKNLTGIPPVEKVY
LMCYSTSSPLENSDKNSILDVNILKSYLSKIDEYPIKKIEVALPIYSWGIVTNYLGKHKL
INALSEKDLENPNFKRISQHEIEIQKDGFYFGNYLNKGFRIKVEEISDQQLQDVVDFLEK
KINHFNIIYYQLDSKFVIGQNFNF
>KALACAFP_00882 hypothetical protein
MKKYFLSLAVLSLFYTKSNACAWSDPDYEYFNLFTQSIIKDKSYLPFLHSYSTRFYSDFK
PNQIPDENIDSWKKFFNNQLSYSETDYLVNKMNINDLNELKKGNPNNALLKKLGAGFYQK
YREAIDYLIEAKYLEPYMKINYVESPDSFYYRENNTDKNATNLDYNKTISALTSLYNAAK
NPEIKQRYGYQLVRFNHYTRNYDAAVQAFKTYVAPIRLKGAPYLMALDQLAGAQRGLGMN
SEANWNFFQVFKDSKSRKESAFVSMKLSDTASFNNILKRAGTNDEKDMAYFLLGYEDFNN
PIPTMEKMFEINPDSEILKVMAVRSINELERSYLPIYYYNNDDHNSTAQTNNSNKNSDQN
KTQTAAEPKKELSFWQKIVRFFKNLFGGSKDKNSPEGKADQSDDELLDNPNRIPVFTQNN
YYYDEKTKDFLDDLEKFTSKTKEKSKDEYWQIADAYLKFLKKDYKGSTEILEDIKTTNPE
YLEEIKRMKVLNDIVSQPKIDAEYEDHLMKDYAEYFVDKPEPKKDSTETNEYDYYGEVPS
TKDFLKDVLANRYFLQGEDGKSFLMNNKLSDLQYNPNSSLVKSVEDFYRKPNKTQFEQQI
IAKNINDVGNIDAFFAVIYGDRAMRQADFEKAKSYYAKAQNFSGIPRTEWNYDEKKATPL
QYAATSYNGFSNISDLVFGHNVWESYQSTPDESMEKEDYSAFPFIKPTMNKLELAEALIQ
LKKIGAGKDEKSATANQLIGNLLYNTSILGYYRELFVMDIDNTNGGKYDFWSTDKKNPYQ
YYYKNFLDRSYIEPDNFDLAINYYKKALDLSMSKEQKARVLFQMASAEQGKYYQYEAKNP
SKVDYSDPKWSEKSDAYQKQLDQIKNQKYRTYFAMLKTQYAETETAKNLMGSCSYFSYFM
K
>KALACAFP_00883 hypothetical protein
MDKSTKSIFEKFSDWGTKFTGSSYAFFGATTIVVAWALTGPIFDYSETWQLIINTGTTII
TFLMVFLIQKAQNKDSKAIQIKLNELIAANEKASNRIVDIEDLTEKELDQLHCYYEKLAD
FAEEDTDIHSSHSIDAAKRNQNSKHESFKRKHEEWLRQQKKESH
>KALACAFP_00884 hypothetical protein
MKRILLIMVLMSFCFNAQTNRFIYELQFKRDSTQTQLDKLNFVLDVNPKDVKFYEYYYLE
SDSINKVHGNYENQYGGEFPTLKRERNSFKNKNYELINFDMFTYTTEDKINWKLSDETKK
MGDYTLQKATADFGGRKWTAWFNKDINISEGPYKFNGLPGLIFELQDSKSNFIFTLVKNR
KLKETYDTSGIVESFYGRKPLEISEKIRQKKKKEFFNDPLANMRNNFKENMQGQMFVMGT
KITNIEQFNDLSKKLQEMLRKINNPIELDKAIKY
>KALACAFP_00885 Germacrene A synthase
MKTPISNEEFYAGLQELPQPKYPFPDFIHPDFQKQREEYYEMIDKDYFFHSEMARQKHKQ
HNLVDIASRGCPFLKTLAELRPLACYAANGAMMDDYLDLCTPDEMDKINNRIIAILTGEE
PNEPTENGIFYQFWTLRQYTITREMPDRLYQKFLQAIFGILTGYSHERAYYRANAIPPLS
IYLIIRNNTSGALPFCKYVAMQKDYRLLPDEILEDPYILRLHTLCSLMIGIHNDIISLPK
ELHREGDTMNLVKVLQQENKITLKEAYMDALELHDSYLNEFLLLHENLPQFGKWQDMTYN
YVQDLGIMVAGVFAWHTNDTSRYVNGGYVEGEYKPT
>KALACAFP_00886 Carbonic anhydrase
MQMRKKENNALGFRSSVRKAAIAFGLIPLLAISCHNDSAIMELNSYPSNIISTPIITTNI
PAAVAESQTPINIEPSKAVPFRSIDPTIHYGAVTLNSVVNNAGENLKVNVSGADNFNNYI
TVGGKKYNLVNFHFHYSSEHTVDGKYSTMEIHFVNVASDNSYAVVSVLVDLGSGNSSLQN
LFALSPTTSNGVNSPNTTYDISNLLPSNTNQYFTYSGSLTTPNFGANSSTPNGGPVTWFV
FKNKQQLSTDQFNSYKSIYAEPNFRAIQPLNGRTVYVNPGF
>KALACAFP_00887 30S ribosomal protein S10
MSQRIRIKLKSYDYNLVDKSAEKIVKTVKATGAVVNGPIPLPTNKRIFTVLRSPHVNKKA
REQFQLSAHKRLMDIYSSSSKTVDALMKLELPSGVDVEIKV
>KALACAFP_00888 Elongation factor G
MGRDLKFTRNIGIAAHIDAGKTTTTERILFYTGVNHKIGEVHDGASTMDWMEQEAERGIT
ITSAATTCNWNFPTDQGKKLPETKPYHFNIIDTPGHVDFTVEVNRSLRVLDGLVFLFSAV
DGVEPQSETNWRLADNYKVARMGFVNKMDRQGADFLNVVKQVKEMLGSNAVPIVLPIGAE
EDFKGVVDLIKNRAIIWDEAGQGATYEVVPIPDDMKDEVMEYREKLVEAVADYDETLMEK
FFEDPDSISEEEINEALRKATIDLSIIPMTCGSSFKNKGVQFMLDAVCKYLPSPLDKDNI
AGTDPRTDAEIERKPSVEEPFAALAFKIATDPFVGRLAFFRAYSGRLDAGSYVLNTRSGN
KERISRIYQMHANKQNPVEYIEAGDIGAAVGFKDIKTGDTLSDEKNPIVLESMIFPDPVI
GIAVEPKTKADQDKMGNALAKLAEEDPTFQVKTDEASGQTIISGMGELHLDIIVDRMRRE
FKVEVNQGQPQVEYKEALTQKANHREVYKKQSGGRGKFADIVFEIGPADEGKTGLEFVNE
IKGGNIPKEFIPSVEKGFREAMKNGPLAGFEVESMKITLKDGSYHQVDSDQLSFELAAKL
GFKESGRAAKAVIMEPIMKLEVVTPEEYMGDIVGDLNRRRGTVNGMDDRNNAKVIKAFVP
LSEMFGYVTSLRTLSSGRATSSMEFERYEAAPTNVAEEVIAKAKG
>KALACAFP_00889 30S ribosomal protein S7
MRKTKAKKRPLLPDPKFNDQLVTRFVNNLMLDGKKSIAFKIFYDALDIVETKKGDTEKTS
LEIWKDALTNVMPHVEVRSRRVGGANFQIPMPIRADRKISMAMKWLIKYSKARNDKSMAL
KLANEVVAASREEGAAFKKKTDTHKMAEANKAFSHFKF
>KALACAFP_00890 30S ribosomal protein S12
MPTIQQLVRKGRATLAKKSKSAALDSCPQRRGVCTRVYTTTPKKPNSALRKVARVRLSNG
KEVNAYIPGEGHNLQEHSIVLVRGGRVKDLPGVRYHIVRGALDTAGVNGRTQRRSKYGAK
RPKPGQAAAAPAKGKKK
>KALACAFP_00891 hypothetical protein
MSFSSNVSVKSFLMSLIIFFAVCLGYYLNVLAKTDGHYVYLIDDAYIHLAMAKNFALYDV
WGITRYEFSSTSSSPLFTYLLSVLIQFFGNNDQLPLYFNAIFGLGIVYFLNQYYSEFFKN
VKNIVAAVLFTLFFAVLHLQLLSGMEHVFHVFLLVVNIFCLSNFKNKTAVFGFYFSLLLM
GVVRFESMFYFVSLAFGFILIKKWKEAAAVLLIGFIPVAIFCYINYQHDGYLFPNSVVVK
GTKFTFDSNLPHQLKSMLLDNFLFNKSFYKIGFLPIIMCAIFIVKDFKKKNYNDLVKDNF
LLIVISLLMICHSMFADLRGNFRYEAYILTGFSMALIPKMKALFEDFKNYIKKEKLISVL
VLMNIFLLIYKFSFAHQMLDNGGKNIYEQQIQSAKFLHTYYNTSKVVANDIGAITYFTNI
HLLDIVGLGSKEMIPFNENKKQLDQHFEDFLTKYTSNKKYDVAVIYDEWFQGYVPKTWKK
AAVLKIKNRITVSKDEVSIYSVDADNFQQLKQNIRQFKWNRNVEVLTVD
>KALACAFP_00892 DNA protection during starvation protein
MKNANIIGLKETDCKKIAEKLNILLANYSVFYQNTRGSHWNIKGDQFFTLHPKFEELYNS
LVLKIDEIAERILTLGATPAHNYSDYLKVATIKESKEVTDATKSVENILSSFKVVIDLQR
ELLDITDQAGDEGTNSQMSDYITEQEKEVWMYNSYLGK
>KALACAFP_00893 Nicotinate phosphoribosyltransferase 2
MHDVRLNSILDNDFYKITMQNAVVKLFPGSIVKYEFINRGKHQFPEGFDVALREAVNKMA
ELKLTKDEKKFMARTCPYIDLPYLDFLEGYHYDPSEVKIHQDGTELSVTVEGLWYRTILW
EVPLLALISELHYEMNHMERDSNEVVMSKTLEKADSLAKLGVNFAEFGTRRRHSYKVQNL
VMEALTHKKESTFIGSSNVHFAMKYGVKPIGTHAHEWFMFHAAEYGFKMANELALEHWVD
VYRGDLGVALSDTYTTDVFFQQFDKKFAKLFDGVRHDSGDALEFADKTIAHYQRHGINPL
FKYIIFSDALNLEKVEEITNYCRGKIGISFGIGTNLTNDVGLKPMNIVMKLIGVQAPNHE
WIPTVKLSDERGKYTGDPKMIELAKEFLRIKE
>KALACAFP_00894 hypothetical protein
MKKFILIVWLFAATFSLAQKTTEQPKYNQELATKQGADKYGMKAYTIVMLTTGPTKIEDK
AKMGELMKGHLGNIGKLADEGKIVVAGPFLEKNKENYRGMFIFNTKSKEEAEQWVKTDPA
VQAGVFSYEIFPWYGSAALPTYLEHHKEIAKENP
>KALACAFP_00895 hypothetical protein
MGFYSKFSHNDLIESYKNQVDYQGKPSNELLEEISKRGSIDDFKKEIENQKQILNERNKI
IREIHQHYLNKSSKEEALSLLSSDILSRQEIRILVEEKYADIHYTTENLKVDSNTVINSF
FGAIIASVVSTMIMFLLLASINSLLVFNFFLLIPIYIINYLIIKFFTNKTRDNLAVFIAT
FMATILNCIYFFLFIYFSE
>KALACAFP_00896 hypothetical protein
MKTIEEVLKKLDEIIIWAKENQSPAGYFACTYRIMTAQVLKGIQQKKFEDNPRMTQLDIA
FAQRYLEAWDAYSKGKKCTNSWYLAFEATKNKNLLILQHIFLGMNAHINLDLGISAASVM
PYRKINPLKKDFENINNVIASINQKVQDSLNKICYPVGLIDKISNGKDNAVLDFAISKAR
DTSWATAVIASNTPNFLRESVIGIVDYAAAKVATQILNPKILTPALTKELKKCESSDVVK
NIEILSSTKNV
>KALACAFP_00897 hypothetical protein
MEMTYLIIGCIAGGVIGAVILYFALKSSMVSRSSYDELNNLHIKNNSDLENSNLKIQELT
QNINKEKELSLQQTDLLNDLKNEFAKISAEHSSLNTQFLEQKQINSKQTAQIESLLTEKQ
NIFAKNSELSAINESLQKSLETQKEEITKIQEEAKLQFKNLANEILEEKSEKFTEQNQLN
IKNLLNPLQEKINNFEKKVETTHKESIDYHAALREQIIGLKDLNAQMSKETLNLTKALKG
DSKIQGNWGELVLERVLEKSGLEKGREYEIQKSHLTEEGNRVQPDVIINLPDGKKMIIDS
KVSLVAYEKYINEENDDIKIQFLKEHIISLRRHIEQLGTKNYHNLYEMESPDFVLLFIPI
EPAFAIAINDDNQLYNKAFEKNIVIVTPSTLLATLRTIDSMWTNQKQQNNAIEIARQAGA
LYDKFEGFVANLLKVGKKMEEAKSEYEGAMNKLIDGRGNLVTAAQRLKVMGAKATKNLPE
NLITRAKANEEISELKLIDNPKDTSELQEE
>KALACAFP_00898 23S rRNA (uridine(2479)-2'-O)-methyltransferase
MLIESFQNEKVKYITKLLADNRFRKKSDVFVVEGQQENERAQKFGFEPVEFFISENIFQK
ELPKGKVHLVSEKVYEKIAYRGSSEGIIGVYKTKEEDLSSFKPQDNSTVIIVEGVEKPGN
LGAILRSCEAFGIDALIVSDGKTDFYNPNVIRSSVGCLFGMKVFQADNQKTLEFLQENNF
NIYTTIMDETAEDLYKRDFKEKSAVLFGTEHSGLSDFWIGKGKNTLIPMAGSIDSLNLSN
AVAITCYEALRQKKG
>KALACAFP_00899 hypothetical protein
MKKSLFVAAIAAISLVACKKTEATATEGADSAAAATTDSAAVVVDSAAKVVDSAATTAVD
ATKDAAAATTAAGTEAAKDATKGAADAAKGAADAAKGAADAAKDATKEAAKK
>KALACAFP_00900 hypothetical protein
MTDLDILHFEQLKRDVQAQYLKEYTPSYDDISKWKGIDIIYFQEDLRKKAKGNISEKSFY
TYFKTSPVTKLPRIDMLNLLSIYAGYDSWYEFKKQHLFAGELLTDDDDLSDEEIQELEKT
VSNSPELPKNEILPQKIEFKAPENTDLQKSITESQTVNQKSELSQNLNSEGSKPKKNFFR
KNAWAIVTSILIIITGILGFKDEIFSKTYKYCFTDADRGVGVINTLEIKVIKENESPILF
KIKPGECFYYSTKDKNLKMQISAPFYEYLEVNRSLENAPDEEMIELKPDDYKMAAYYFSI
KDVTGAPKEEQLSLIKQKRNQLENLISNNAVIYQVYDNNTYGIERLDKQKYITLVTTPTT
SLKNLSVIEMKKDSKGKIISIKFKIATTDEKNN
>KALACAFP_00901 hypothetical protein
MKRIINFLLFTLLLLAFVSCNNKKTEVSDLDKLRNSNNTASYPAVKMDSAQAINLITKQK
VQELLDLSTLYLSGNRNTEIDTVIYSQMQSYFHKPDSLTFKKLFHELDSLKVKSVKVNSL
EVYKDFYKKDTLDFAKFNVEYFDSKNKSLGSFEKNAQYILVSTPNTNNEFKFFFLDFYSN
PFKKDSTSVGVTK
>KALACAFP_00902 5-formyltetrahydrofolate cyclo-ligase
MLKAEIRKKYMQKRKALSTDEAFLLSEKIFKNFINYFQPKEGEKVHVFIPILERNEINTQ
IFIDYFLKQNIRVFVPKIVADELINIEIFADTLFETSAWGIPEPVSNEDSGESYFHYVIT
PLLYCDDKGNRVGYGKGFYDAFFESVSSEVKKIGVNYFNPDEMIDDVWENDIPLDYLVTP
TDVLSFLNGLE
>KALACAFP_00903 putative adenylyltransferase/sulfurtransferase MoeZ
MQLYNTLSAEERAQLIDEAGKERLTLSFYAYAKIEDPKKFRDELFIAWNALDALGRIYVA
HEGINAQMSVPADNFEAFRDTLEAYDFMRGIRLNVAVEQDNHSFLKLTIKVRHKIVADGL
NDETFDVTNKGTHLKAQEFNNLLEDPNTIVVDFRNHYESEVGHFEGAITPDVENFRESLP
IIKEQLQDFKEDKNLLMYCTGGIRCEKASAYFKHQGFKNVYQLEGGIIEYTRQIKEEGIE
SKFIGKNFVFDHRLGERITDDIIAQCHQCGKPCDNHTNCANDACHLLFIQCDECKAAMEN
CCSTECLDIIHLPVEEQVKLRKGLQVGNKVFRKGKSEALKFKKSGDLPNKPLAKATPAGS
KDIRQKIKVKKTLIGKAEHYYSKSKIAQFLIENKELSVGDKVLISGPTTGDQEITITQIF
VNGGPCETAKPGDQITFELPFRVRLSDKLYKILQSENA
>KALACAFP_00904 Periplasmic pH-dependent serine endoprotease DegQ
MKSTLKKLLPFAVVGVISGATTVGTLQYFGHDSNSGDQSYFTKSASNVTFAGMNSAAVGD
DFVKAAKTTVPAVVTIKNYQSRSTNRASEQDLFDFFFGDPFGGRGQQRQKQQQQAPDNMP
SGMGSGVIISPDGYIISNNHVVAGANKLEVVLSNKKSYIATLVGTDPNTDISLLKIEEKG
LPYLNFANSDNIEVGQWVLAVGNPLGLNSTVTAGIISAKGRGIGILSSQGKAANPIESFI
QTDAAINPGNSGGALVNTNGDLIGINSAIQSTTGYYQGYGFAVPSNLARKIVEDIKKFGI
VQRGFLGVTSIDLSDDQLVASYNKQYKTNIKTGNGVYITGFGENSGAEDAGLKKGDIITS
IDNTPVTDFADLSIAVGSKRPGDKVAVTYQRNGKEATTTVTLKDQKGGTSTRTKADLSVT
EKIGAEFEPLSDRFKTDYGLNSGVIAKNVSEGSEIAKIGIVDNYIVIEINGKPVNSQKDV
EKILDKYSGNVSVKFVDAYGQIYTRGFKMP
>KALACAFP_00905 hypothetical protein
MKENIKNHFVVKLKYFKFAKVNNTKNTTMNKKILYHGCIS
>KALACAFP_00906 hypothetical protein
MKKLYLSVLLVGTFVSLSAQEVVWQRDIKSDTQDFLSQVTTTIDGQYLITGSSIQSDKLQ
ASGSKQNNGYDFKLIKLNQQGEEIWKKYFVGGNHDFLSTTVATQEGGFLLAGTSYSGKGF
DKKEDSKGGSDLWLIRLNEFGDPIWQKTIGSTADEEVRSVIQTTDLGFFVAGNVQNSPKN
YGSKDVLIVRLDKDGKKLSQTIFGGRGLDEVERMIPTRDGGALLGIYSRGGIGGSKKTEN
YGEGDYYIIKLDKNNKVQWEKNYGGKGDDHLRTLALTSTGYLIGGESRSERSGNKSVGIE
EGTDLWLISLDERGEEIWQKSYNFKNRDVLMGMSVLHSSDDKTSKGILLGGYTQAEGRIE
NDDETFWMLYLDQNGNEQWRKHIKGESRKKEERLSDIKLNRDGSIVLAGTSAEELGKENW
KIVKLGDKQIDQLIEKQDIKIYPNPVSDYAYVEIGFDFKEADILMYDMSGRQLQSLKTKN
KVTKINTQSLIQGAYLVTVKTDTNKTASAKLIKK
>KALACAFP_00907 hypothetical protein
MKKIFLLLPFLFFYSKFYTQNSVPSAAATSAYIDDPSSIASGEPNINFPVVKLPTLNKNI
GLEFSLDYKVNNHANGSYKNDIIGDYWKLFGGGVISRETPYMYFDGWSDDTSSCYAASCY
RDIYFYSFLGKSGKFKFTKSATTNAFQLINLSPNNLKFEYLTTGDGSKINNISSFIITDD
DGIRYTFSDYSTSVLVTDKGTANEKRKEYKSAFYLSKVTDALNNELLNFTYQKNIHNEPY
TTKLKYTSCELQKAYSPSYGTVSLNYAYSPNQGAPNEPYEYKLLKFTLTDTENHVISSSN
LVYDSEYLKALEKTDKNSQIIEKTSFEYGLTTEPSYFPAGAIPGWTDPNSNFLLKKVILP
TGGVIKYTFQANQYFRDKSGSDYGLNYALYSGSEGNIGDPEVQFYKYINLSFNSQQNPSS
TAQLKYPFNIVTSDGKPTMVKIPEFYINEFQGYLFDPPYPGIWGMKEFTTLSYDSKFLGQ
KPKFEFRILNSNNALVYEAQTGSKYYSLAPGQYTLEIILPQQLEYTIDNDNNNIPSQADN
KFLLKGGKGGATLRYIDRILPPYKNAVSTNNSGVRVKNIEFYENNNTSTPIKSLNYEYTE
FNNSMNSSGKEFKREDYGIYNYNNDSRIPPHILYKNVKISENNKGHIKYYFKTTADNLKY
FEDETGTIINLNNFNSYPNDSNYPMYDLIKEGILDKKEIYDSDNKLLESIECDYVFASLP
AGDVSRKYKVVGDITAEPSIIKQKKIITKTYDTATSAFINKISESTNSTVNLAPTLMKET
FSDGTNVETSYQYAKDKNIVHLLAANMIATPLETQVKNNGELVSKTEIKYDNPANLFPTS
MLSLDLQSNNMSTEVTFEKYDSKGNIVQYTTKEGISTTIIWGYHQTLPIAKIEGAKLSDI
QQSMIDSIVNSSNADATAAANNDETSFLAVLDSFRKNNSNYIVTTYTYDPLIGIRTTTPP
SGIREIRMYDSAGRPEKVLDINGKVLNQLKYNYKH
>KALACAFP_00908 hypothetical protein
MKRHLIIKALSIAGLLLVGKMGYAQTNTENYVQSKTCLDADCVKKAENVQYFDGLGRPKQ
EISIKTSPLGKDIVTHIEYDQYGRQTKDFLPIPQSGTQNGEIYTSPLGNAFSTYGSEKIF
AEKVLENSPLDRIQQQIQVGNDWTGKPVKFDYQFNTAADKVRKFTTTTIWENGATKTTLG
ENWLYADAQLYKNSVKDEDGNQTIEFRNGQGQTILVRKVIANDEYADTYYVYNKYNQQAY
VIPPLASIRGDIATSVDRQEELCYLYRYDRRNRLVEKKIPGKGWEHMVYDNADRLIFTQD
EAMRPSSKWFFTKYDKLGRVIITGIVAGSTRTNMQTMIGNGIITESPNSNGFTKNGMQIY
YSNDFFPSFEKALTVNYYDTYPAGAPAMPLPIFGQEILSQDAQNSSISTKSLPTASYVKN
IEDDIWTKNYSYYDTKGRVIGTHSINHLGGYTKTEIELDFAGVPQRMNTYYARKNGENGV
TVQERFVYDSQNRLLKHYHKVDDKPEELLADNTYNELSQLKSKKVGNNLQSIDYAYNIRG
WLTDINKNEMPLADLGGKLFSYKIKYTQKDGIINPDNTLFSGKDVKARYNGNITEVDWRA
VETLGVNPSSTPKRYGYAYDSLNRLTAGYYQNPNNPYSKESTESLSYDLNGNISNLYRTS
VTEFGSNTATVIDNLNYAYAGNQVKTINDASQNPTGYEGGGNTITYDQNGNMLSMPDKGI
NSIQYNYLNLPNNLHLNRYGNEDVTISTKYRADGTKLRKENTTVTTGFSGSTTTVSVTDY
LDGFQYFSSGTLTPPSGGFDMFSMRAMQPQAFSIDTPITVQDPTIQPIDGSTFALKTPDL
QFFPTAEGFYDYQKDQYIYQYVDHLGNVRVSYTRNSAGALEITDSNDYYPFGMNHLKSGT
AFFGQTSYKNHKYNGVELQETGIYATDWRGYMPDIGRFVGMDALAEDYADQTPFHFAMNN
PANYADPTGLYSVSQGGDRIDLDPSEFGAFFKKYKNGINGPIGSVFNEIQTNTNDYSLTQ
NIPELVLTGNSSGWGSQMQSHYNSFMKNWQADQNLSEARTRLYGAIEDTKVGQSVSAAEN
FLFLELPASMVGGEFLAAGWRAAGLSRYLCGPLGRVSNGLLKICFTEGTLVATEKGSKKI
ENIKEGDLVWSYNEETGKKELKKVVELSRNTSSSLVKISVNGTEITCTPEHPFYVNGNWV
EAKNLTKGTLLTTLDGTTSPVESIKFLDKKVKVYNFEVEGNHNYYVSEKGILVHNDCSLM
TEFMGHFGKYVSNIDASINMGWFTGDVMELQVNAILRSSSAPRNGVMKALTETAEGMARK
HGMSEVRIQFNMVHNSFLKHGGWADELGYYFSREGDTVFWEKVLH
>KALACAFP_00909 hypothetical protein
MKAKEFKKEVLEITLRSVDKKPEDWTTFNDKMHTILLEDNYVPTKASLLSNELPILECDL
HDSYLLVTSDRVISIINNKYDEIYPNDFYELCNDYEKFNYKKEGNYPKTNFICIQKIDGF
KVLLKIDSNYPAFFTKILIYNIMLYKKEGRWFLNPRNRMY
>KALACAFP_00910 hypothetical protein
MVREATVGQAKNWISTELGMQSVKAIDDIAGKLAKNDPFVFSQPIKVVQAEGKTFILNGH
HRIEAAIKMGYEGSIPYQRIPASQISQHSGFSNISELLKAFGH
>KALACAFP_00911 hypothetical protein
MDNSKIYNFIQSYGAKCIKLNFALISNFKLNEILDLQDINHFILPLRASKLKIISHEGNF
ILENEDVEYHIHGTGVTFTINEIKYSFNIEPINESVLPVFSISSLYDYITLVYTKMSHND
FTAVINQLVEKRLLINIHENVLSYYIPQLEFSKNNYQ
>KALACAFP_00912 hypothetical protein
MNHLKSGTAFFGQASYKNHKYNSKELQETGIYATDWRGYMPDIGRFVGMDALAEDYADQT
PFHFAMNNPANYADPTGLYYESPGKDRIDLDPSEFGAFFKKYKNGINGPIGSVFNEIETN
TNDYSLTQNLPELVLSAPKSYQGNAALTGLTLSFGIQQHLSTYLGMQQQPFDRMAWVRND
RGVDMIGGLNDPIGIFDIAGQIMSNWEPENRYLAMGVGILAAVALKKPQLALAEEKATYY
SVAYEMKLSEGSYPGIYRGGHFREANKALEAAMVSDAKFASGIENLGITIPRSPAGSILG
KSPTNWVWHHHVDEGIMQLVPKPQHTVGSSFWSIMHPGNKGGFSIWGK
>KALACAFP_00913 hypothetical protein
MNLIDLISNIDEVDEDSIIFLKDLNDYKSDIILSYPEDGDNGIKKENDTEYYYLIEVFLA
KEFISDWIDSLDYSPSIEDIAKRLYEYGINDA
>KALACAFP_00914 hypothetical protein
MHSYDKLHFNVTGFSKYQFSKFKAGSFVGNRNVTNWEMHEVFSNPTLLNKTQFYRKVGNN
YEILSNFSPYGY
>KALACAFP_00915 hypothetical protein
MKTLYKSNRKFRIWAYMVSHSSLILRSEMKYPDQDDYAESISSNIDIEFWAVSYINLPSD
LLGINIREITSEALPKEINKDLLIFDMRIFELKSDESKYYVIAGGILIGENKWINQDRIF
NYDSNLKHDKILFQS
>KALACAFP_00916 hypothetical protein
MNHLKSGTAFFGQASYKNHKYNGVELQETGIYATDWRGYMPDIGRFAGMDALAEDYADQT
PFHFAMNNPANYADPTGLYSVSQGGDRIDLDPSEFGAFFKKYKNGINGPIGSVFNEIQTN
TNDYSLTQNLPELTIQGSKLKHAFTGDYFFNSDKNAIFNHLNKHIGVMTTFSEHKLDKVE
QWANSDNFALKFSYKTVNDAYTFAQVFDGGLMERPEWESPFGGNYGNLDGTPNYHQEEGF
ANTLSTIYSTVRSLKVVKEFAVEGLNIASKMNAAQFSRVFKGTAIARATPATRGLLNRNL
NKGIGYVNGQVESGMKAPAIVKFFGNMFKSKDKK
>KALACAFP_00917 hypothetical protein
MEILFEIFIRGLVIGFLGVNTRYYFFRIFNKNVKKKDFETDQEDIGASFSQGFYNFFIGL
FVFSILAYGIVSILYVFDLL
>KALACAFP_00918 hypothetical protein
MEIFEVIFQIIFTTLIGNNIYYLVRKIIGDKRSYKEIVNSEKEDGWRYGTGMFVMFAFVI
FLVKCTS
>KALACAFP_00919 hypothetical protein
MNHLKTGTAFFGQGSYKNNKYNSKELQETGMYSYGWRDYMPDIARWNGIDQLSEKFHAAS
PYAYVLNNPISFTDPDGRDIHREGENWSLNGSDAERAFSYMQGGGKLSYLENALSSWETG
GGNFVGDNMSFWDNFGGIDAIVPEVTINARGNKNTWNIGNNLDFNQFLMMSLFTGAQMDW
NLQQNRAFYYSEVTRTGADKIERNFYLMFGGALVAPFAGSYIATLGGETVASYLQGALIR
GVTDMALQQTIKGSIDWKQTGINAFIGGGKGFGAIKVGWLNYTGNMVNNFGTSYYDGGKK
GFMNDFGINSMKALTGIFGMGVGNYNGLTNGSLNGYFGTVLLPGVYFNTTDVVIENKIKK
>KALACAFP_00920 hypothetical protein
MKKIIDKNFHLILISLVIIVIGYWYLSSSDGLKDISKRKKYTIALTVSDWHHKDTNGIGV
DYEYFVNSIKYSNTINLDLKKGQKYLLVFDSIIPENNVLLDIYPINSFSLVPLNGWKINE
LPIKVDSSKINNIILER
>KALACAFP_00921 hypothetical protein
MISKHKLFVIGIFTSFSIYAQKTNEYKFLTKGQYNSKIYEKFETKDGDKVNLWHKVEESL
ENSPGIAFTEFYLQIDCKAKASILKTSITHWRDGTVQKLDDPSNKEVPITDLKSIPGLSY
KKYCRK
>KALACAFP_00922 hypothetical protein
MNFFRNTLAVIVGLGIAGLIITLGIRVFPQWVTFEAFAPFEHWQRFLQSMRNNDAFFGFL
LFISGLGTTIGGVATAMIVKYAKVAYAILIGFIMLFIAMLDVIVFPYHPTFYKISIFLTF
FPFSWIGGKIVSIIYERKRKRRIAEKMNKS
>KALACAFP_00923 2-iminobutanoate/2-iminopropanoate deaminase
MKKIINTVNAPAAIGPYSQANMANGVLYISGQIPVDPATGKLVEGIEKETHQVMKNLEAI
LTEAGMTFKNVVKATIFLKNMDDFAVMNDIYASYLDAESYPARETVQVSCLPKNVDIEIS
MIAHQD
>KALACAFP_00924 LPS-assembly protein LptD
MVKTVFKNILQILIILIFNNFLAQETPEKLPKNAVNDTISKKDTIVLKKEALDDVLQTKA
DYNRRDFQKKMIYLNKNAQVKYQDVQIDADYISIDEEKNLMFARGKQDSLGKFIEPAVIT
QAGKKYETDQFQYNTKTKQAIAFNARTEESEGVIVAEKTKKYNDSVFAMRRAIYTTDDYF
IKKKDTAADYYLKASNIKLVKTKNKSSIISGPIQMYIENVPTPLIMPFAILPFSDKRSAG
ILIPSFGERQDVGFFLNGLGYYQPIGEHFDLKVLADLYTKGSWNLRPEMNYVKKYRYSGN
FSADFGTMVRGIKGLDDYSKTGTYRIAWRHTQDTKANPFLTFSASVDIVSTKFYNNTLNN
NYILNQNVLNTQQNSTVTITKRFLKLPITITGTASYSQNFATGLSDLRLPQMNIAINQFY
LFKSKTGVRQGLLENLTVNTGINLTNYVQTDEGELFKAAMWDKMQTGLKNNIALGTNTTI
AKYFTFSLGANIDNALTTKTVNKFYDPLQNKVVTETDKGVTGYSTFSTTASIQTTLYGML
KFRKGSTIEAIRHMMTPSIGFTYSPDFGGSGFGYYRNYYDANGALTPYSIFEGGIVGSPS
SGMVGALGFNIGNNIEMKVKSKSDSTGVKKIKIFESLGLSGSYNFAAKDHPWSIFTINGQ
SSFFNNKLSVNTSLSLDPYKIIYLPGQETGIRTEEFGYFSIQGFNVQLSYPLSSELFGEK
TDYAKKYKAKGEIRNENYYFDDDNYAHFDQAWTLNVNANYAYTRSTASRTPTRLASIGLD
GSLKLTPFWNINGSTHYDLVTKELAYTRIGFSRDQRSFTINFNWVPFGQYKVYDFFIGIK
ANILSDALKYKDRSFTQPNAPF
>KALACAFP_00925 N-acetylmuramoyl-L-alanine amidase AmiB
MHKVNFRIILSFLFILLSNFIFSQKKFIIVLDAGHGGSDHGANRTYADIGRIAEKDVTLA
ITLKVGAMLEKNKDFKVIYTRKIDEYPSLSDRTNLANRSKADLFVSIHCNSAVRNSAYGT
ETYVQGPDQNDTNLEVAKRENDVIFLDEKDKQTFGSYDPSSPESLIALKLQQSKYLESSL
LLGGLVEDNFVNKDKRFSRGVFQKNLHVLRMNAMPSVLIETGFINHPEESHYLASDKGQT
EIAESIFNAIIDYKKAVDRKSGGPVITKKPEPDRLAEIALKNDFRILLLSSPTKYNEGDP
ALKGLNYILPIKENGQYKYYYGVTNLASVRDINIKTAKDAGFRNAYAVGFMPNQKFNSGY
YTLEVYAGDKLNGNSFILQTLKDVERNKEDGVFYYTYGKVYTLEDAVKLQKDIEAKGIKN
SVIQKVSK
>KALACAFP_00927 hypothetical protein
MRKLFVLAMVSFSVQIFAQVGVNTTAPSASFDITAKEPTGTSTTVDGVLVPRVDRQRAQS
MTSVPTSTMIYVNNIATGSATGTTANVDTIGFYYFDGTVWVKMATGNGVNIYNADGSLAG
VRNVNLNGNNLGFTGTGNVGVGIATPTAKLEIASGTNGTSGLKFSNINNSTAATANASAL
GIDAAGNVVVQSAAPIQTRFVSYPVNATVTESPTLQIGTLEFKVIPGQCSSPGTGPYTTI
QARSITGANNIGIVHGQYGTSQATGQGGFQLNYPITVGTSFSTVPATYIDCYNDGHSQFM
YFSYTDQTYYRINYHIADGDSLGFGGQGYIFVEYQK
>KALACAFP_00928 hypothetical protein
MPDLKIQEAKLLFKKIHSNPKSYDLKINEDGITGRDDKISFRLYRTGERVAFEVTIDGLT
FTNTTGEWNNAMIMLTSTIKKIEREEENFKIEQAIDKLRKYLSEEN
>KALACAFP_00929 30S ribosomal protein S20
MHSHLNDMANHKSALKRIRQNEVRKLRNRYYHKTARTAMKVLRNEEDKAAAAEQLPKVIS
LLDKLAKKNIIHKNKAANLKSKLTKHVNKLA
>KALACAFP_00932 hypothetical protein
MKKVYFLAAVFLSTCFANAQSVFTDGFFMVNEDWFGHTNGSVNFINNNGNVNYRVYSTVN
NNQAFGATTQYGAIYGDKFYFISKQAADGGDTQYTPGGRLVIANAQTMQKIAGFNTIGGG
DGRSFVGVNEHKGYIGTSNGIYVFNIDNLQVGSLIPTTGGGSQYAGQIGNMIRTSQYVFA
VKQSAGILVINPNTDTVVTTISGSFHSIVQAKDGSVWAIQDQKVVNINPSNFATTAYNIP
TTKYLGSWGAWNAGSFSASNQNNTLYWINSVNSFVSGTQIVKFDVTNKTFNENFAVIPGQ
TGTYKQIPYGAALRVNPITDELILNTTESGFGAHYLNNWIHTYNNSGVLTNTKKLDDYYW
FPAMAVFTDNAAPVVSNAFPAEVNVNSVTTIDLKTVVSDTDNLAAAVVKSVKSNTKPSIV
SAAINANDELVLTPHGNGNSEIVIGFNSNGKVVEKTITVTSLSSVLSTAEVKKLEFSIYP
NPATDILNIRTQEKVLSISVYDMAGKLVNVQFSNGQINVGMLPKGVYILTAKTDKAVYQQ
KLIKN
>KALACAFP_00933 hypothetical protein
MKKDSINMMKIALLSTALVGTIACKSDRDEEEWSFSGLEESYTIDRFKVLNIDTKGEGNF
TWSINDSIISQDSQLDFISPVVKTYPLRLKIEINGSVKTYNSSIIVKQEAETYSKYISNV
FDFRPAVGQFTNEIPEFQNGDSYSQMLQKAKESLIGGSSSMLTLGGFGGYVVFGFDHTIP
NMNGRDFKILGNAFWGNDASQPRAGSCEPGIVMVAYDRNKNGKPDENEWYEIAGSEYFKN
TTIKDYSITYFKPDENKPPVAGSEFWEADVEYIKWQDNLGNSGYKTKNAFHAQSYYPLWL
SDTSYSFTGTKLQNNFYDQSGTGVYWIGKSYDFGYADNAPNNDEASNIDISWAVDRNGKY
VKLPGIDFVKVYTGINQEAGWVGEVSTEVAGAYDLHLN
>KALACAFP_00934 hypothetical protein
MKKLNFYLIIFAFISLISCRTDEYITREETESGLAAPENTAIKGFYLLNEGNMGSNKATL
DFFDYTTGTYHRNIYAEINPNVIKELGDVGNDIQIYGNKLYAVINVSNKIEVLDAKTAKR
IKTINLENCRYITFKNGKAYATSYAGPVVLDPNAPLGKVVEIDTASLAIQRQVTVGYQPE
EIEVVGNQLFVANSGGYKFPNYDRTVSVVDLNSFTETKKIDVAINLHRIKKDNYGDLYVT
SRGDYYGIPSSLFLLDAATGTVKKDFHVSVSEMTVVNDKLYYYGNEFNYTTHTYKKSFGI
IDVKTEEIISNKIIDQEYVDMIKTPYGIAVNPITEDIYITDARNYVSTGFVYCFDKNGHF
KWKTEGGNIPAHFTFLYK
>KALACAFP_00935 Vitamin B12 transporter BtuB
MVTKFFTSQLHKVAITVFVLAAQLIFSQSKDSLKEHTIIPVNIQKKNFKEILPAQVLSGE
ELERLNSQSVADALRYFSGVQIKDYGGIGGLKTINIRSMGSQHVGVFYDGIQIGNAQNGV
VDLGRYSLDDLEEISLYNGQKSEIFQPAKDFGSSGSIYLQPKIPIFKGNRKTNLVVRFKN
SSIDLFNPSFRLEQKISENISASFSSEFIQSDGVYKYRYTKKYPDGEIAYDTIAKRMDSD
IHAKRFETSLNGTVNNGSWNVRGYGYLSNRGIPAAIVNNRFDGRGQRQADENYFVQGTFK
KKIFPKLETQLKAKFAYDYTHYVDTVSSIKIQNQYIQRELYVSSSNLYSITPNWDISASV
DFQYNNLNADLVNFSFPTRYTTLAAFATTYEWKRIKFLGSVLGTFVSEDVEKNSKSPDRT
EWTPAAFLSYKPFNAHDFTVRAFYKRIFRMPTFNDLYYTMIGNVALKPEFTNQYNFGFTY
QKRFKSEVFQRIYAKVDGYFNKVEDKIIAAPNGSMFRWTMLNLGNVEILGTDVNIQGDFK
FGNVKIRPLLSYTFQRARDFSDREESYFGHQIPYTPWHSGTFSLMSDYKDWSFNYSFVYV
GERYDVNQNNIQYNYIQPWYTHDLSIQKRFNLKSHQFKASFEVNNIFNQYYDVVLNYPMP
GRNFKLIVSFTL
>KALACAFP_00936 SCO1 protein 
MSKNKKTNNTKSKVIIPIVIIALLFVGIGVGMGYFKKNLYTVMKVPDFELTDQNNKKITN
KDMLGKVYLVEFFFSRCPTICPVMNTNMRAIEDEINSPDFGIISISIDPKNDTPQLLKEH
AKKIGAKSPNWHFLTGNRDYIGKIADQFNIYVGDKEDEGESLNHSGMIALVDKDGNIRCR
YNKDNMPILYYSGLNYEDQEGKSPKLTGKYHPDREILIEDIKKLLK
>KALACAFP_00937 hypothetical protein
MKSKIILTAFLSISLMACAQETPKVKHKKNTSSKSNTKKIKFANAEDPICHMPTEPDMKD
TAVYKNKTYGFCSAGCKDEFKKNPEKYVQK
>KALACAFP_00938 Zinc-transporting ATPase
MEECCSTKPKKEHDHNHEGHDHDHSHEIGDKSTFQMFLPAIISFALLLIGIALDYYIKPD
WFTGWIRLVWYLIAYIPVGLPVLKEAYESIVHGDVFSEFFLMGIATVGAFAIGEYPEGVA
VMLFYSVGEVFQGMAVTRAKRNIKSLLDQRPDEVTIIKDGKPETIKAEKVNIGEIIQLKS
GDKLGLDGELLSETASFNTAALTGESKPDTKTKGETVLAGMINLNTISQVKVTTAYKDSK
LSKILELVQNATAQKAPTELFIRKFAKVYTPIVVFLAVGITLLPYFFVEDYQFRDWLYRA
LIFLVISCPCALVISIPLGYFGGIGAGSRNGILFKGSNFLDVLANIQNVVMDKTGTMTEG
VFKVQEVDFKSEFDKNEILKFVNALESKSSHPVATAIHEYVGEIDHSIQLENVEEIGGHG
LKAIINGKELLVGNFKLLDKFNINYDIKPENIVYTLIAVAYDKKFVGYLTIADSIKPDAQ
LTIKKLKSLKVKTTMLSGDKTSVVKYVADQLGIQNAYGDLLPEDKVNKVKEIKAKNQTVA
FVGDGVNDAPVIALSDVGIAMGGLGSDATIETADVVIQDDMPSKIPMAINIGKQTKKIVW
QNIILAFAVKAVVLILGAGGLATMWEAVFADVGVALLAILNAIRIQKMKF
>KALACAFP_00939 Zinc uptake regulation protein
MKKDIENKLIDKNTKPTSMRILVYDFLSSQEAALSLSEIENHFENADRTTIYRTLKTFEE
KGIVHSIQENTTTKYKLCHDGCDEKTHKDWHLHFYCKICKQTTCKEDISFPENIQTNFRI
DEIRLFAKGICESCLESLQ
>KALACAFP_00940 Cobalt-zinc-cadmium resistance protein CzcB
MKLKLNIIILILLSIFLASCNKSEKAQEANEKTEEHSENENSTTASLTEDQMNAVGISLG
QIEMKELTATIKANGALSVPNNNKANATSLYGGVIKTLNVQVGDFVKKGQVIATIANPEF
IQLQEEYLTAGSRITFAEQEYRRQRELFDNDAGAKKNLQNAEAELKTLRTKRASLQRQIQ
MMGINPGSVSNRNLKSGLVVTAPISGTISNILLQIGSYIDVSSPVAEIVDNSSLHLDLQV
FEKDLPSIKVGQKIHFTLTNNPVEEYDAEVYSIGTAFENQSKTIPIHCKVKGNKNGLIDG
MNTTAVVSLNNQLMPAVPNTAITSADGKDYIFIVIAPKEEEHTDGKTQEKHNEKTTNFER
VEVVKGTSEMGYTAITPVKSIPEGAKIATKGAFFINAKLTNSGEHEH
>KALACAFP_00941 Cobalt-zinc-cadmium resistance protein CzcA
MKTDNHKLNLNLLDKIIKFSIKNKIVIGIMTLLLIIWGVWSATKLSIDAVPDITNNQVQI
ITVCPTLAGQEVEQLVTFPIEQSIATVPDIEETRSISRFGLSVITVVFKDKVDVYFARQL
INERLKQAEENIPKGIGTPELAPVSTGLGEVYQYILHPKKGSEKKYNAKDLRTMQDWIVA
RQLNGTEGVAEVNSFGGELKQYEVAVNPDRLKAMGVSVSDIFLALEKNNQNTGGAYIDKK
PNAYFIRGIGLATSLEDVKNIAVKNSGVVPIFIKDVADVRFGHATRYGAMTYNGQTDAVG
GVVMMLKGANSNDVVNRIKEKIPTIQKSLPEDIVIEAFLDRTDLVDRAIGTVEKNLIEGA
LIVIFVLVLFLGNFRAGLIVASAIPLSLLFALGMMNVFGVSANLMSLGAIDFGLIVDGAV
IIVEATLHHLGLRKSIQKLTQSEMDEEVFLSASKIRGSAAFGEIIILIVYIPILTLAGIE
GKMFSPMAKTVGFAILGALILSLTYIPMMCALFLSKKISHKENFSDKLMNRLQKIYQPLL
QKAITIKYFIVGITVILFSISVLIFTRMGGEFIPQLQEGDFAFHCILPQGSSLSQSIETS
MQASRIIKQFDEVKMVVGKTGSAEVPTDPMPPEASDLIIVLKPQNEWKSKKSYTELSEEM
LEKLEIIPGVFFEANQPIQMRFNELMTGIRQDVAVKIFGENMDSLSVYADKVSKVIQNVE
GATSPQVERVGGLPQINVTYDRTRIANYGLNVEDVNDVLSTAFAGKTAGQIFENERRFDL
VVRLDSVYRTDIDDVSNLIIPTKTGTQVPLSQIANIEYKLGPAQISREAGKRRIVIGFNV
KGRDIESVVKDIQQKLEKEVKLPSGYYFTYGGQFENLKEASQRLTIAVPVSLLLIFMLLY
FTFHSFKQAALIFTAIPMSAIGGIFALLLRGMPFSISAGVGFIALFGVAVLNGIVLIGTF
NQLEKEGISDVLKRVIEGTKTRLRPVLMTATVASFGFLPMAVSTSAGAEVQKPLATVVIG
GLISATFLTLFVLPMLYIIFNSKINLKNKFSGKPLTIVVLIGFLCLSQNVEAQNSSEISL
QEAIEMMQKNNPLIKSKELNIQSSEALKPTAKELPKLDFNAQLGQYNSPKFDQSFAISQS
IPFPTLFKARKELIQEEIKSKKLEKQLTENELIKQIRSYFYQIEYLQYNQAKLQYLDSLY
GDFIRIATVRFKVGDIKKIEINTAETQKGEINLLFQQNKVYLNNAYKNLKVLLNIDEEIS
VPFSQNYEPLKIENLLDHATVANHPSIQIFKQNMEVLEKNKNVEKAQGLPDFSIGYTNQS
LIGFHTLNGQEKYFGAGDRFNSVTVGVAIPLTFGATKARIKSLELQKQMEESNAKFQQQQ
LDAQLKNSLNQYQQDVQQYQYYLNQAVPNAQRIVKAAQLGYKTGEISYVEYLFALQTATD
IELKYLQSIQQVNQTVVNINSLINQ
>KALACAFP_00942 hypothetical protein
MPCNDVHQQSGSSKTEQFSNIEESHSKDKGDICSPLCICNCCQITVTAFKIEPLIAFPEQ
IQFYFSKKILFQKNNFAYQVYDHIWQPPKI
>KALACAFP_00943 hypothetical protein
MKKLKYLSFAFITALSLISCENDLETAPTNQANEAEVFKTAESAETVINGTWAKFNDDGT
TYANIGYSTVLRTSDAMGSDVAVLTNKYGFPGAYAFTDLVNNTGSRPLFIWSLLYSTINN
MNNVLARIDSVEGSQEKKNQVKGQAKALRAFCYFNLASFYQFSYLKDKDALTAPIYTEPT
TTSSVGKKKASLEEIYTLIKSDLTDADNLLQNYSRNNKDKIDRSVVNGLLARVYLNTGDW
TKAIVSAKIARNGYALMTAEKYKEGFNDISNGEWIWGHGQTQEQSGESYAFHFLDVSSSG
SYYYSFMADPYFKDLFDTNDIRYSLFSWDGNPGREGLLRYAKFKFKANLIADIVYMRAAE
MYLIEAEAEARNGNITNAVTVLNQLKSARNANQYSGSLAQNDVIKEVLIERRKELFGEGF
SLSDIIRTQGTVVRKPYTNANGQPIQVQITTPDGIVKNVNGRGHTIFAFPDQSAFVANSR
YYLFSIPQKEVENNPNL
>KALACAFP_00944 TonB-dependent receptor SusC
MVNKNLINSKNWIPPVAAFFLGIAQVNGQETKKDTLQEREIDEVVVVAYGKAKKTSYTGS
VATISSEKINNRPVTNITKALEGQVPGLQAVSSSGQPGSTASIRIRGIGSVSASSNPLFV
VDGIPFDGNINSISPNDIESISVLKDATASSLYGSRGANGVIIVTTKSGKKGEARVNFNI
SQGFSSRAVKDYEQVSTDQYYELYWEALRNGYKSGQISSQQAAQMATDNLVNALGINPYG
TNYAKPVGTDGKLLPGATPLWNDNWKDILQRVASRNQVDLDFSGGNEKSNYYFSLGYLDD
KGIAIESGFRKYSTRLKINSEVKKWLNVGANLAYTNSLQEAPPSSDSRTDNVINAARVIP
SFYPYYERNSDGSYKLDANGNYIYDFGKYRPTSALQNENAAATLPLDKNENREDNFSGKG
FAEFTFLPELKFKTSFSVDLVNYNGHYYTNPLLGEGAEIGGSVTKTNSRTLSYTTSNILT
YDKKFGQHHINILGGQEFYHYEYQTISGSRSQFSLPYYYEPDAAALLGGFSGNSDKLGLL
SFLGKAEYDYQNKYFVSGSVRADGSSRFSPENRWGTFWSVGGSWKASNEDFIKSLNFFNQ
LTLRASYGGQGNDKLSTYYAYQSLYAFYNNLGEGGTVASKLPTPDLKWETNLNLNVGLEF
AILKNRIKGNIEYFQRQSKDLLFDMPLAPSLGFSGFQANIGELKNTGFEFSLFTTPIKTK
DFEWNVDVNLSTLKNEITKLPKGSIVSGTKLLQVGGSIYDFFIPEWVGVDPSNGNPLWKT
ITTDANGNTVEGTTSEYAKATKTLQGSSLPKVMGGLTTSLAYKNFDFSTLVSFAIGGKIL
DTDYTMIMHNGSSAGRAWSAEMLNRWTPENTNTDVPKLSTTTNNWTSTSSRFLYSGTYAR
VKNVSLGYTLPSDYFEKIGLKKFRIYVQAENLLTFYKHKGMDPEQTLDGTTYYRYPAMRT
ITFGLQATL
>KALACAFP_00945 3-dehydroquinate dehydratase
MKVLIVNGPNLNLLGTREPEIYGTTSMEDYLENLRSEFPSHELKYYQSNIEGEIINKLQE
DDFDALIINPGAFTHYSYAIADCLKNIQKQKVEVHISNIYKREEFRQKSVTAANTDAVLS
GFGMDGYRLAILSLKS
>KALACAFP_00946 Phosphoenolpyruvate carboxykinase (ATP)
MLNRKKEIENISKMKHAKIIQDLEKLGIKGNYEVVYNPSYEELYQAEVSPENQGFEKAEL
TESGAVSVKTGIFTGRSPKDRYIVKDDVTKDTIFWDGKVNLPTTPEIFQSCKELVLNQLA
TAKKIYVVDAFCGTNADTRLKVRFIVEVAWQAHFVTNMFIRPSHYELENFGEPDFVVMNG
SKTTNPNWEAQGLNSENFVMFNLTEKLQIIGGTWYGGEMKKGMFAMMNYYLPLKGMASMH
CSANVGEEGDVALFFGLSGTGKTTLSADPKRYLIGDDEHGWDNNGVFNYEGGCYAKVIDL
SAEKEPDIFRAIKRDALLENVVVNNGIADYTDGSITENTRVSYPIYHINKIVLPSKAGHA
KKIVYLSADAFGVLPPVSILDENQAQYHFLCGYTSKLAGTERGITEPEPSFSPAFGEAFL
TLHPTMYSKTLIGKMKEHGAKAYLVNTGWNGTGKRISLKDTRAIIDAIIDGSIEDAPKTR
IPIMNLEVPTTLPNVSEGILDPRNTYSDVSEWEEKAKDLAAKYIKNFDQYCNTEEGKKLI
ACGPQLQQQTTN
>KALACAFP_00947 hypothetical protein
MGEIFSPGKLMLTSEYFAMDGALVLAVPTKLGQEFSFEEKDDEKSLIFWEAYHQNKLWLK
AVIDYKNWQILETNIPSSAEFILKTLKNVQSLSTIKFKNNFTYHLTTNLQFPADYGLGSS
STLMNNLAEWAEIDPFHLNSISLGGSGYDIAVAKEKSAVLFQSKPEIRYERVNFNPSFKN
ELIFIHLNQKQDSREGINFYRSKNKSQKLVDEFSNLTRNILVCNELENFSELMLIHEQKI
SNFLEIPTVKARFFADCPVFVKSLGAWGGDFVMSSKFDGFRDYFWGKGFTTIFNWSDIIN
L
>KALACAFP_00948 Malonyl CoA-acyl carrier protein transacylase
MKALVFPGQGSQFVGMGKELYDSRKDIKDLMESANEILGFDILSVMFNGTDEDLKKTEVT
QPSIFIHSVAALKAVNGLGAEMVAGHSLGEFSALVANGVLSFDDGLKLVSERAKAMQAAC
DANPSSMAAILGLEDAKVEEICAQISGIVVPANYNCPGQLVISGETTAVEEACIKLKEAG
AKRALLLPVNGAFHSPLMQPAQERLAAAIEQTKFRKATIPVYQNITTTAISDPDEIKKNL
IAQLTGPVKWTQSVQNMIKDGATNFVEVGPGKTLQGLIKKIDSSVDVASAI
>KALACAFP_00949 Muramidase-2
MIKRFFILSSLCMVLGVSAQKSHTVVKGDTPYNIAKKYGLTVDELLKLNPKVKDGKLAVG
DVLTVKNDKTSASVPKAAVSTKPVNNSQVGKIVLQPKQTIYGITKQYRISESDLRKLNPE
LDSHMKIGDEITLPLESIKKYGGDQQQTVVASTTTVKPVETAIETPVAATVSEGEYIVQA
KDNYYRISKQFDITKEELFALNPGLEDKGLKPGEKISVKKSNKNTVSESVVNSKEKMDSG
NEKSSASTNVVAGDDYVTYTVQQGDTVFSIVNKFGITIDELIALNPDLSHGLKTGMVLKI
KKLDPAYVKKSGDALSVVLMLPFGYSTNETQYRTMALDFLTGAKLAIERNARNGQKLDIK
IVDSGNEASFQNSLTQINPDNTDLIIGPFFKSNVVDVLNFTKNQKIPIVAPFANSPELYN
YSNLIIVETSDNTYADKIVEEVKAAYSDQKIYIVADSKKENAGYIKAGLEKIIKNPSVVI
VDSPADIKLDQNMMTGQSAPVIAILASDNDAIGEAFANKVIALSKEVQGVKAFSMHYVPV
FEKKVDDLSQANLVYLMDRKINTEGSFEKEILADYKSKYCKTPPRYAIVGFDVVNDMLTR
ENKKGEIFKQMNKVQTQLATKFEFVKSKANGAYVNTGYRVIRLVP
>KALACAFP_00950 Putative cysteine ligase BshC
MKTINKISFHGIESIPQLIKDFLNHNIEGFEESTFSLEHFRKQIHVKQNSFTSGQRNILA
DTFESQLSGLKLSSGQKENIENLRLPNTFTITTGHQLNLFSGPVFFVYKILQTIKTCTYL
KDNFPDFNFVPVYWMASEDHDFAEINHFKTENNYYEINEKSGGAVGRIQINDTFFISEFE
KEFKDFVFGTELILMVKEAYKAGNTLTDAIKTLVNRLFSEFGLLILDGDSKELKNQIKET
FKDELLNYSLQENSKEKVDFLTKKYGKVQVNPREINLFYLSETRDRIDFDGKNYIIVDKN
IQFTQEEILHELENHPEKFSPNALMRPVYQETVLPNLAYIGGNAEIMYWLELKDYFSKIN
IPFPILIPRNSMLFLKEKTIGKIDKLNLNIEDFFQNFTTITNAKILEDNTIFNLLEEKEN
LLINNFSELKTAAETTEKSFGNMVKAEEVRQLKSFKRMKKRLLHAEKIKQSELLERLENL
FLDVHPSKTWQERVYNFSVFFADYGYSWLETCLEEMEITESKLIIVAI
>KALACAFP_00951 hypothetical protein
MKYILSIILFLSLTAQAQVVNKTDSNKLPKEGDTLVIDSGKKDSLKIFKPTINDYQYQTQ
FSEKKVFDTVMTFDKTYIFSQYNNKDNFGKAQVANIGAGFNPLSYEVNAEQNLALLPTNK
SYGILGVNDIHYYDVKTPTATFIYHNAMKNGAALRSSYTQNIGKRFNFALEYMGLRSQGM
YRNSLASNNNTLFSGHYVSKSGNYELFAHYLHQNVNNQENGGISVDSLFQNGDSNSRNRQ
NMQVNLAGSSSQFSYRRYYLTHQFAPFKSEKIPFKIRHTISHQGNKYYYTENSPEPYWYN
TPAELINTGSALPTKKYSDNFSNTVSLVWDNEKFKLDAGVRYQMLKFGATEVAVPNLTIP
AEIKENRIGAVGNLQIKLFDKVQVNSFLEFSNGSEFGTYLKTTNNLKFEPIKDYFVNAKV
NFQSVYPSFNYLINTSNYTNFNYYLQNAKNQAITEIGGSINLKWFKTELFANYFRIDNYT
YFDAMAMPRQSDSSVNISQIGGDATFSYGNFHLNTRLQFQNVLTNKDLLPMPDFIGRANI
FYQSKAFKNAAEIQAGIKVYYFSKFASREYFPILNEYILPNANSFSIGGQPMIDLYFNMK
VKKMFFFIEGQQIGTVLSHNKAYAFPSYPVYDFRLNIGIVWYLFN
>KALACAFP_00952 hypothetical protein
MKNKILKITILSVFTLGILSSCERELDQASYSQIPLDEAMDGSSQANFTQAINGAYTAIK
GTGYFSVDTGNQIIVPDLTTDNLIYNPQGRSSNFTAYNWSFSPNNGSVTGLFTQAYFVIS
RANMPLSYINNLPVGAFRNNIEGHARAVRAAAHFDLVRAYCKIPTQSADANTSLGIPYIT
QFNPLDNSVTRNLTVAQVYDNIINDLNFAVNNITDTPADKSKFSKAAIYGLLSRVYLYKG
DYNNAVSAGNSSIALSPSVGAIGTFTNIWASNNVDGVLFKVLNSTQENITVGVAYQQGAT
ATGGNIRSEYVVPKSLNDLYTANDIRKTAYIRTSAYQGVQRNHVIKWAFNTGGATPLNVV
EVKYLRTAEVYLNVAEAAYKLGNETLTNTVLNTLKTQRYSGYAPVTLTGTALWNEIMLQR
RLELAFENDRYYTFKRLGLTMQRTGEGPNIDGSGTASVVQTILPSDTRWQWPIPQSTINV
TPTFQQNPGY
>KALACAFP_00953 TonB-dependent receptor SusC
MNVKLRVLSAGVLFFLGQTTFAQKTKTDTLPNEKQIEEVVVTGYRTKKADEITQAQSVIG
SEEMKQQSNTLSLTNMLQGKAPGVFVQTLSGQPGSAGSITIRGFSNFSNTGALVVIDGQY
SSFAQLNALNPSDVESQVILKDAAATAQYGSRAAGGVIVVTTKRGTRGKTNYSFESRYGT
SWKVSDKEMNFQMMDAGQKLAWENAIAPQVGNTPWTDAEVAELTALNHNWEKDVLRNSSE
ESYFFTANGGTDKSLFYYSLGYDSNTGIIQHLNALKRYSARFNFENQLSDKIRIGINSSV
QYQQTQNQRDLNNAQNPFNFMYSANPYEPVFLADGSYNPTSAGFPVLEALQRNRSNNSNL
RINANIFGEYKFTDWLKFRSSLFNTFAQLKGKSILEPGSYLDVILGLNGQVSQSNNDLYY
LTANQRLDFDKKFGLHKVSATAFFEYSTEDTNTMTATGRNYRTPGLDILSNMVTPFATTG
GRTQTRRTSLAMLADYNYDSRYILSGSIRRDGSSRFGLDNQYGVFWSASAAWNIAKESFI
NIPNLNALKLRASYGIAGNDAPIPDYVNQPYVGFGLYGPGATTVVPTTVGNKLLEWEKVK
ITNFGLDFNYLNRFRGSVEYFINKRSDFLQLIPNATVQGSYTVYDNAGELENKGIEVDLS
ADVIRKQDWGFQLRGNYSNIKNKILALREGETSRNIGNNNKLEVGEMPYYFRMVRNAGVN
PDTGEALYYTTRTTANPGETFYDLPGGRATNVYSTADIQDIKDKSPYPKYFGGFGATFTY
KKFSVIADFTYKFGGYAVNNEALNRLDPSQYNTNKSVDAINYWRNPGDTNVLPAPTPDGI
WMTDYFLQKTDYIRFRSLNVGYTFDKDFLGEKIPLNSIRVYAQAQNLVLWTKFQGDPEVA
VGSGEGNTDVPGSYTLYTYPTQKTVTFGVELQF
>KALACAFP_00954 hypothetical protein
MLSCYKLVDKHIIFNFISLTYDEIKGSPYLDKAFYKAKVANDYEEVPVRYNSYKDEIEFQ
KEGKILVLPKESKFSRIEIKSPKQTFILFENKDDLGGYSIELVNGKNSLYKKIKTVFKDF
VSAANSYASDTPASFKTQDPIYFIKKEDGSIKKLKNQKETLEQFPDKKEVLSTFFKSNKI
KFDRDEDLIKLTNFINQN
>KALACAFP_00955 Translation initiation factor IF-2
MPKIRLNKAVKEFNISMSRLVEFLQSRGFEVESNPNAQLEEAAYSALEAEFAKDGEQRKA
SHEVVITKVPEEKLEIEEKKTPEVIRAKANKPETKILGKIDLEPKAPEVEETPAPEPAPQ
PKPETTPVVEEKKEEAAPAPEVKAAPEKQEFKVLDKIDLSQIESRNRPVKKDKPKVEEKK
AEEKPTAEPVKEAPKPVVETPAKPVEVKAEPAKAEEVSQEPQKIETVYQKLDGPKIVGEK
IDLSQFADKSKGAGAKKKRKRIEKPGGQNNQQGGNNNQQGGNNNNNQGGGQGNRPNNGGQ
GGNRNQGQGGQGNRPQGQGGQGGGNRFGNNNQGNRPPGQGGNRPPGQGGGNRFGNNRPGQ
RTMPVELTDEQVKNQIKETLEKLTNKGGKSKSAKHRKDKRNFRREQDERQQELEAQDRTL
KVTEFITVGELASLMNVSPTEVISACFSLGVMVTMNQRLEADTLLLVADEFGYKIEFSDA
DLEETDAEEEVDTEESLLQRAPVVTVMGHVDHGKTSLLDYIRKTNVIAGESGGITQHIGA
YNVKLENGQRITFLDTPGHEAFTAMRARGAQITDIAIIVIAADDDVMPQTKEAIAHAQAA
QVPMIIAINKVDKPNANPDNIRQQLSGLNPPVLVEEWGGNVQAQEISAKFGNNVDVLLEK
VLLQAEMLELKANPERSANGVVIEASLDKGRGYVATMLVQTGTLRVGDYVVAGKNHGKVK
ALLDERGKNLTEAGPSIPATILGLDGAPTAGDKFRVYADESEGKAIANKREQLQRELSIR
TKKHTTLEELGRRIALGEFKELNIILKGDVDGSVEALSDQLQRLSTEEISVKILHSGVGQ
ITESDINLAAASDAIIIGFNVRAGANAKELADREEIEIRTYSVIYKAIDEVKEAMEGMLS
PEIQEQVIGNVEIREVFKISKVGTIAGCMVLSGKVTRNSKVRVLRDGIVKFDGELESLKR
FKDDVKEVTKGYECGLNLKGYNDIEIGDILEVYEEVAVKKKLK
>KALACAFP_00956 Transcription termination/antitermination protein NusA
MDNIALIESFGDFKDEKGISKIDLMAIIEDSLKTLLRKRYDSDDHFDVIVNPDKGDFQIF
LNKTIVEDEMSEDDDLEIEISEAKKIDPTFEVGEDFTMEIPVAQLGRRNILTLKQILATK
LQEHNNAMLYEQFKDRIGEIVVGEIHHIRHKHVILLDDEGNEFILPKENQIPSDFFKKGE
NIRAIVETVDFKGSKPQIIISRTAPKFLEKLLELEIPEIQDGTIMLKKVVRIPGEKAKIA
VDAYDDRIDPVGACVGVKGSRIHGVVRELRNENIDVIQWSKNPEILVKRALGNVTINKID
INEQQEYALVYTPVEEISKVIGKQGQNIRLASWLTGYEIDVHRESNEDDDVELTEFNDDI
EEWILDEFKKVGLTTAKSVLDKETESLLNMVDLEEETIEEVKRILREEFED
>KALACAFP_00957 Ribosome maturation factor RimP
MEFRKRIEELLNEFLETRKDLFLIDLKISAGDDITVILDGDNGVSLQDCLDASRAIEFNM
DREEHDFSLQVMSAGLSEPLSTPRQFAKNMGREIEVLLNDSTKIEGELAKIDEEKITLIL
RYRKPKDIGKGKVDVEEEKEIPYSEIKKALVTIKF
>KALACAFP_00958 UDP-glucose 6-dehydrogenase TuaD
MNITIVGTGYVGLVTGTTLAELGNSVYCVDIDEKKVEGMKNGVVPIYEPNLEEMFLRNIQ
AERLFFTTDLKEALDKSEVIYLALPTPPGGDGSADLSYVIKVANDIGEMMTGYKVVVNKS
TVPVGTADKVREVIASKTQIPFDVVSNPEFLREGFAVEDSMNPARVVVGCSSDKAKEIMA
KIYQPFTNTGVPIIFMDEKSSELTKYAANSFLAVKITFMNEIANYCEKVGADVDKVRLGM
GSDDRIGHRFLFPGIGYGGSCFPKDVKALIKSGKQEDFNFQILEATENVNIAQKVILVSE
IEKYFGGNIEGKTIAMWGLAFKANTDDIREASSLDNIDLLLKKGAKIVAYDAIAEDNVQK
ILGDKIQYAKSMYEALENADALFIATEWPEFKNPNFSLMAEKMKNKVIFDGRNMYPLEIP
EQNGFFYKSIGRRTIGR
>KALACAFP_00959 dTDP-glucose 4,6-dehydratase
MKNIIITGGAGFIGSHVVREFVKNNPNTTIINLDALTYAGNLENLKDIENEPNYVFEKAD
ITKPEELRKVFEKYNPDAVVHLAAESHVDRSITDPMAFINTNVNGTANLLNLCKEFWTLN
PDHTHGRFPDEKRTNLFYHVSTDEVYGSLGETGFFLETTSYDPQSPYSASKAASDHLVRA
YGNTYGMPFIISNCSNNYGPNHFPEKLIPLCISNIINERPLPIYGDGKYTRDWLFVIDHA
KGIHQIFNEAKTGETYNIGGFNEWQNIDLVKELIKQMDAKLGRPEGYSEKLITFVKDRPG
HDKRYAIDATKLNQELGWKPSVTFEEGLGKTIDWYLENKEWLEHVTSGDYQKYYASQYTN
EPN
>KALACAFP_00960 hypothetical protein
MNEKILYKDESYKIIGICMEIHNTLGNGFAEAVYSEILEKEFIKNNIPYEKEKLLKIFFK
GEELSKKYKADYVCYNEIIIELKSATFLHDNFSSQLLNYLKATNKKLGILINFGEKSLKY
KRIINL
>KALACAFP_00961 Glucose-1-phosphate thymidylyltransferase
MKGIILAGGSGTRLYPLTIAVSKQLMPVYDKPMIYYPLSTLLLAGIKDILIITTPHDQPG
FVKLLGDGSQIGCNIEYVVQPSPDGLAQAFILGDKFIGDDAAALVLGDNIFYGSEMGTLL
KDKTNPDGGVVFAYHVSDPERYGVVEFDDDFKAVSIEEKPLTPKSNYAVPGLYFYDNEVV
EIAKNIKPSARGELEITDVNNVYLQKGKLEVGVLDRGTAWLDTGTFDSLNDASEFVRVIE
KRQGFKIGCIEEIAFRNKFINEEKLLETATKYGKSGYGEYLKQLINK
>KALACAFP_00962 Teichoic acid translocation permease protein TagG
MNEPQQKWTETIEANHSLFDLKLKEVWRYKDLVYMFVKRDFVSSFKQTILGPIWFFVNPI
LTTIVYLIVFGRIANLPTDGAPPLLFYLAGVTLWNYFSACLLGTSSTFIGNASIFGKVYF
PRLVSPLSIVLSNLMRFGVQFLLFILGWAYYYSQGDIQPNIWILATPFLIILMALFALGV
GMIFSALTTKYKDLSMLLGFGVSLYMYATPVIYPTSALPGFFKKLAFYNPLTGIFECFKY
AWLGVGDFSPMMLVISTAIILILLAIGTVIFNKVEKTFMDTV
>KALACAFP_00963 Teichoic acids export ATP-binding protein TagH
MLALKAENISKQYRLGQVGTGTLSHDLNRFWHRVRGKEDPYLKIGEANDRTKKGTSEYVW
SLRDINFEIEQGDAIGIIGRNGAGKSTLLKLLSKVTKPTTGQIYTNGRIASLLEVGTGFH
PEMTGRENVFLNGAILGMTRKEIKRKFDEIVDFSGVERYIDTPVKRYSSGMYVRLAFAVA
AHLESEILIVDEVLAVGDADFQKKCLGKMNDVAKGEGRTILFVSHNMTAVKELCNKGILL
NQGMLEYQGDMLSTIIEYQKSSATASSYRYNGNINEALGNENIRIKEFSVTPIHGDLLDI
DSGVHVKLVFENYCPDITLDTTFELKNYEELVIFHVGTFVADSNNSKVGEYTVEYDIPAG
LLNAGNYYFKLFFGKDQTILLYGIDNFVGFEVENVKVGSKMHIYPGVTRPHFDYNIQTP
>KALACAFP_00964 TDP-4-oxo-6-deoxy-alpha-D-glucose-3,4-oxoisomerase
MIPKIIELPKIYDKRGNLSFFQYPSNLPFEIERTYWVYDVPGGEKRGSHAFKEQQEFIIA
LSGSFDVIIHDGKEEKSFSLNRSYYGLYVPKMYWRRLENFSTNSLALIVSDKPYNENDYI
RDFEEFKTLANEK
>KALACAFP_00965 TDP-4-oxo-6-deoxy-alpha-D-glucose-3,4-oxoisomerase
MKNSISVFDCSVIDLGKISFDEGNLTVVENNSSFPFNVKRVFYLYDIAGGESRGAHSHKE
CHQFLIAASGSFEVSLDDGKFKRQVFLNRPDIGLHIPPGIWASEINFSSGAICLVLASHT
YNEEDYVRNYDDFLSLNKLQIVDYTESILEKSWNWLNDPEIKHLTSTPDFSKEDQQKWFS
GLENNTKYWVKGIQYNNKTIGVAGLKKIDTDNKTAEYFGYIGEKEYWGKGLSSDLFTLIF
TIAKNQFDLKSLYLNVIPENIRAIKAYEKAGFTISENTDSNVMMSINL
>KALACAFP_00966 hypothetical protein
MNFEIKKYTQEYFDDWNKFIKESKNGLFFFDRDFMEYHSDRFQDHSLLIFNNNKIAAVFP
ANESGKEIISHGGLTFGSLVLSHYVKASEVLEIFEEIKKYYQKLSFHEIIYKAVPHIFHK
YPSEEDLYALFRSQASLFRRDISSVIDLSSPIRFSETKRQLVRKCEEKQIIVSENENFEE
YWTLLSEVLQKFDTKPVHTVTEISLLKEKFPENIRLFEARKDNILFAGIVIFDFENVVHT
QYMAASQEGRKLGALDFINHTLLHKFEDRKYYSFGISTENQGTFLNEGLIQQKENMGARG
IALDFYSIKL
>KALACAFP_00967 dTDP-3-amino-3,6-dideoxy-alpha-D-galactopyranose transaminase
MIKFLDLQKINLQYQNEIEAKLLEVFRSGWYLMGSQLSNFEKNLSDYIGAKHSIGVANGL
DALRLILRGYIELGIMNPGDEIIVPSNTYIASILAISDNGLVPVLVEPEIETYNIDISKI
EEKITSKTKGILIVHLQGRVVFSDQLKEIAEKYQLKIIEDNAQAIGAEWNGKKTGNLGDA
SGFSFYPGKNLGALGDAGAVTTNDDELAKTIRALANYGSNQKYVNIYKGLNSRLDEIQAA
VLDVKLKYIDQENKIRREIAKRFINEINNPTIVLPEYPSDENEHVWHVFVIRSEKRDELQ
AYLTENGIQTLIHYPIPPHQQQAYKEWNELSFPISEKIHDEVLSFPISPVMSEDEIKQII
EVVNKF
>KALACAFP_00968 hypothetical protein
MSRLLENKKYLLKTLKIATLLYNSGKYDDCLKYIEKISYSAWYNFAGYYTLNHFESIIRN
IAAKSLHFKDQIISEKEDTTLHIFSEINQVGGHTKLLFNWIENDRDSKHYLLSTWQDAKE
ITDIATSYNCNIDDRLYTFNKESNHLSKAQKIIDILAEKNFSRIVLHIHPHDAIPSLVFS
SDRLTSPVFFLNHAEHTYWLGAPVIDYLLQIRESNIKKDSKNRNIPVEYQFFLPIPVDES
FSLNKKEKETFNILSIGRESKYEPNVEYNFYEAALNIVKEFDHVVFTIVGISQNNPNRKI
YEHDRLVFVEPTRDIKGFIENTDLYLEGFPVPSFTSLLEPAMAGIPFVLHYNPSDIYKVF
EEDRENGIFYPENLENWHETVGKMISDESYRHEINTKQESYLKNNFSLQAWKNKLKNCKE
NTKNKTHKVRAIPQNETYVEGTDEKIVSLIEIKNVNHYTFTENLGIVSKLKVVALSFDNP
SWVKVLSKKRTLGYLLGK
>KALACAFP_00969 hypothetical protein
MKLRPIAIHLPQFHPFPENDEWWGKGFTEWTNVTKAKPLYEGHYQPQLPADLGFYDLRLA
DCRLEQEKLAKEYGFYGFCYYHYWFNGKLLMERPLEEKLNNPKEDFPFMLCWANENWTRI
WDGGENNILMAQDYNMEDHIAHINYLMPFFKDERYIKIDGKAVFAVYRTTKIPEFDKVAE
IWKQEAKKNGVELYITRFESFGERGEEFMSENIDASIEFQPHSGLKVFNDKEYQKSLASK
QSHKSLRDEISMATIKQSYDHWSKKLKLKNTAEAENSDGKIIEYSDFIEFDIEHGKSEKV
YHKFYKCACPGFDNTARKSKNYVILKDSTPELFKHWVEEKIKLFTPYSEEENLFFINAWN
EWAEGNYMEPNRKWGRAYLEAVKDIFK
>KALACAFP_00970 hypothetical protein
MLSIIISSYQQNYYDQLVKNINETIGDGFQYEIIQMWNPNLMSITKAYNLGAEKSKFQNL
LFLHEDIVFHTKGWGEKLSDHLDKENTGIIGVAGSSYVPAAPSSWTVDEKYNFANILQGN
KQNTDFFHIQSTKANKTKVFAVDGVFLAIKKENFIQFKFDENLPGFHGYDLDFSLRVSKK
YQNYVVDDILIQHFSGGNLDKVWFDANVKVKEKLGSQFGKQIDPEVEKKVFLGFLYNFFQ
HYPVSRKNILLTLKFYPKKLNFKDHLKIVKKYFNYIRYSNNINKKFNTNY
>KALACAFP_00971 hypothetical protein
MIVGSGLIANSLKNIDSEDHLFFASGVSNSLETKDSEFEREFTLLKNNLENNNGSKFIYF
STLSVNDLSKQESPYVLHKLRLEDYIKNNCEKYLILRIGNIVGKGGNPNTLFNFLKNQIM
QDKKFVVHTKARRLLLDIDDISKFLTSSCAAVKNETINFAYPYYYDLNEIINAIEAKMEK
KAQYEKSDEGDFYKVAFEETANEFFTGIQPNEYLKILTDKYI
>KALACAFP_00972 N-acetylglucosaminyl-diphospho-decaprenol L-rhamnosyltransferase
MPKIYFIIVTYNAMKWAERCFTSLRQSSVPLHSIVIDNGSTDGTQEYIKTHFPEVDFIQS
DSNLGFGKANNIGIEKAYKEGADFFYLMNQDAWLYEDSLEKLLEAFNAYPNKDEIGIISP
MHIDGSEKKLDIFLDKYISYNCDKTRLISDLYFQTLKPFYELDFINAAHWLLPRNTIETV
GGFNPFFFHYGEDNEYVNRVHFHKKKVLLAPKSKVVHDGKQSLQKVDYNKYADLRIETNI
MNPNLPNAFQLEKKALLQSMIKNFILLNIKKSKKLFSKYQDISKKSDIFQDIINKVRKKD
TTFLKT
>KALACAFP_00973 putative glycosyltransferase
MDRKISLIIPVYNSSQFLHKTVKAVDDQKKESNWDLELILIEDGSPDNSFEVIEKLAEEY
HYIKGIKLSRNFGHQIAVRTGLSYATGDYIAIIDDDLQDPPSLLPRFFEQLDQGYEVAYG
IRKKRKEDRLKKIAYVSFYRFLNMISDTKIPLDSGDFCVMTKNVKDKMLTLHEQNPYLRG
IRAWVGFKQIGLEYERSGRIEGESGYSLKKLIKIAKDGIFSFSSLPLQIISLLGNTGLLI
SILFTLFTIFRYFNNEIEVAGYTTIIILMMFFSSVLLISLGIIGEYIYRIYNEVRNRPHT
IIEKTIN
>KALACAFP_00974 Ubiquinone/menaquinone biosynthesis C-methyltransferase UbiE
MKEKIQSIIDPHFTYEYKDGKFVFLEFDEEIVSDSLDKIKTFFKKYIWLYELLIYIIAPL
YPSRYFYLKKVLKETKNTDKIVVNLGSGYTDLRDDIINVDLIPYSPVNVLCDITKLPFKD
NSVDQIINIAVLEHVPNPQAVIAEIHRVLKPGGKLLCEIPFMQAFHASPYDFQRYTYEGI
KVQFKDFNNLKIHSISPTGGMLWPLQEWFVMLFSFGIRPLHNILLIIVMCLTFPIKFLDV
ILQYHPLSKNIASAFIFECEK
>KALACAFP_00975 hypothetical protein
MKKVLQNPVYFLSCLIFLIATAFLAYLTYSNLDKGFIFNDEAYYLSYYSNNGGYLSFDRT
NFFRIFRFLYTPNIYHFRVISITTLVVSNFLLCYSTFKYLRFNNYLVLYSLLGIFIGFES
WSISNLIIQQYIGNTILVNIGVSLMLISLIVRKQFFIVLSGFVLSFVLFNGNSHSIIIFP
ILAFFILSDAKNRRSNLLYFFMGFIAGIVVYFTFLDTFDNFIYQFKFLKEYLSFHRKQHS
KSFMVLWCVYLFLNAILPVAIAYFLLWRAKFSESSLKVLDKILAVIGIITVLSFYFYYEY
YIFSFIIFTHLLALRFWVEKTETKNSKYIIILLLIIPYCLAFGSQTWFHLRLNAYKFYYF
LLIFICLVKLYKNNLWMIGYLVHIVTMTIIFPRIIHDKGWKDFVFTEQTEKVKVNGYDLY
LDKGRKKDLEDLRPYLENQDNVIYSSNHLMGYLYILKANPPIYYYFTLKDYIRFIIKKVG
KTPDDFIYIESNDYPFYPKEIVPLKFVSHPENYKVVKTGRFTIYLPSNFKKK
>KALACAFP_00976 Asparagine synthetase [glutamine-hydrolyzing] 1
MCGIAGIIANNARNYQEELKRMTDSIAHRGPDSADFEFYENAALGHRRLSIIDLSDTGKQ
PMLSSTKNECIVLNGEIYGYQNIKAQYPEYPYRGTSDTEVILAMYQRKKENLIHDLPGMF
AFAIWDNEKQELFCARDRFGEKPFFYAIGKNNEFIFASEIKAILASGLIQPKVNQEAISY
YLQYGYVSTYHSIYENIYTLPPAHQLIWKNGKINISRYYSLPAKDRVLSLSDAKDEFIYL
LKNAVQKQLIADVEVGSFLSGGLDSSSIVALVAEFLPRQTTISFGYDHEDSELKYAKEIA
DKYQTNHVEVHEKKEDLATSLLKISPFFDEPFADISFIPHFEICRNARKNLTVVLSGDVG
DELFGGYNFYRVENQLRNHFSYKNIVAKFGLQLYQKLKPVSFITQKNLAHENILDFHQNF
VRNSFNKEEKNALGITAAYEQPYSFTPDPHSLNDIMRVDLEGYVPGNMMVKSDRMAMANS
LEVRTPFLDIDFAEFCIQLPEQLKLDNENDKIILREAMGSYWTETIRNRHKQGFGMSVKS
WFEEENLISLSNDLLKNPNQKVFNYIDFKATQKFLNKDHKHWNLLQLALWAHNNQNVL
>KALACAFP_00977 putative glycosyltransferase EpsJ
MLDISVIIPVYNAGQFLEKSVESAVHFDEVKEIILVEDKSTDNSLEICRKLASENPKIKL
FQHPDQGNHGAGATRNLGIEKATGSFITFLDADDYYLPNRFDAEKEIFNDPKIEGVFGAI
GVEYLTEKGKQEYQTKFKDAALTTVNYPAEGEEVFRGLLSLTPKAFGTFFHLNALTIRKS
ALDRAQLRFNKDLRVHQDSDFNIKLAYHCHLKSGIIDKAIAIRGIHDDNRITKIVQYSPQ
YNQRQYLYWKSLYDWASSKGLPAEYQKRIYLSYKSFDLSQKKGLAKYSNIVLEGLKNPEI
LKTKYRFNYYK
>KALACAFP_00978 putative glycosyltransferase EpsJ
MNISVIIPVYNAEKYVAQAVESALQFEEVYEVILIEDKSPDNALIICEELTQKYDRVKLF
QHPDKGNHGASTSRNLGIEKSTGDFIAFLDADDYYLPNRFDAEKELFKDPKVEGVYGAMG
VHFYSEKAKEQYYKVFRSSLTTVYKKYHPKDVFPGQLYLLGSFGMFSIVALTIRKDSLIN
KMHPFFRPNLKLHEDSEFLFRLSYYLDLYPGSIDKPVAQRGVHEENRITKVGINKKKPVL
SRYIFWKHVNEWASKEKNMPENIKIHIKRMERSFEIAHTPNPKKWAMILKYLILDYPSIR
SGLYNINFRNTII
>KALACAFP_00979 Putative glycosyltransferase EpsE
MKISVIVPVYNAEKYVTQAVESALQFEEVYEVILIEDKSPDNALEVCQQLAQKHDRVKLF
QHPDKGNHGAGPTRNLGLENATGDFIAFLDADDYYLPNRFDAERELFKDPKIEGVYGALG
VHYYSEKAKEQYYKVFGDRLTTVHKRHDPKDVFPGQINMKGSFGLFSIDTLTIRRDALVK
KLKPFFKTHLRLHQDTEFLFRLSYYLDLYPGILDKAVAMRGVHENNRITKVDTKKVKPAT
TKVLLWREINNWAKDENTLPQDVKVHIRRMHRSYEIALAPPAKKWGMIAKYLITDYPSIR
SGLYNINFREYLF
>KALACAFP_00980 hypothetical protein
MKKFLFKISFYIIGVVAVLLFLGTFADGNTDDSYRHFTGPKPSNMIMGDSRGVQAVVPDI
LDAKFKDRKFTNFAFNIADSPYGKVYFEAIKKKLNPNTQNGIFILTVDPWSVSIDKGQEE
KDLPETRSPLASMHFYDINPNYEYLLRNYPRSWFNIYKDREEVAKSNTYLHKNGWMEVTV
DVHPDTVAARTVKKVEEAILSSKKQEISTYRLKSLENIIDFLKTKGSVYIVRIPPSEKVL
EIEKKYSPDFSKRIKAIAEKQGIGFFDFSPEAKKYTYTDGNHMYKESGKVFTAQIADSIL
LHTKTLK
>KALACAFP_00981 Peptidoglycan O-acetyltransferase
MQFTSIAFILFFVTVFGLYWLFQKNVKIQNILLLLASYVFYAFWDWRFLALLIGSSAAAY
FLGIKIGGNEGNKKRLYLNLGLILAIGTLFYFKYFNFFIDSFADLFGIKNTLTVSIALPL
GISFYTFRIISYFLDIKNRKLKPEPDALVFFNYIAFFPSMTSGPIDRGGLLLPQLRKERV
FTSENGADAVRQILYGAFKKLVIANSITPITQGIFQNYEHLSGSTVAFGAILFLFEIYAD
FSGYSDMAIGLAKLLGLKITKNFAFPLFAQNIAEFWRKWHISLTSWLTDYVFTPLVIQFR
DYEKKGLIAAIVLNFVLIGIWHGPRYTFVLFGLLHGLYYIPLILTNKLNKKKKFSKSFPT
IPEMGNIFLTMVMVCFAFILFAAPTLTDAVGMYGRVFSLSFFSIPQFIKVKILGFIFILV
LIDWMNKDQEHGLEISRFNPIMRRALYVFLIFMIMYFGVFGNGNFIYEQF
>KALACAFP_00982 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MNKVILTGGSSGIGKAINIFLLEKGYEVLFTYCHSKESAQEIENQFPNAKAYQIDFTSES
EMAGFSAEIEAFSPDILINNYYNGTFIDTYFHKTESEKILNDFKNNIIPTLQITQECIKI
FRKKKEGRIINILTSSMQSPAMGTSVYNSNKAYLLQMSKSWALENVKFGITCNSISPSFI
PTDFHKDMDERMKETILSGYPLKENLESKDISNVIDLCLNGGKHFNGNHIFLDASHY
>KALACAFP_00983 (R)-specific enoyl-CoA hydratase
MVLQLNQKFQHQFQIDDKIYNGFITVFNDRNALHTNEEFAQNKGFRSKVMHGNILNGFLS
FFIGELLPTENVMILSQHINFKNPVYLDDVLNFEAVVDEQSEAVQVNTFKFKFINAENKT
VAAGKIQIKELT
>KALACAFP_00984 Acyl carrier protein
MDKNEILSKLTTIFHDELDNDEIVLHFETTAEDIEEWDSLSHIQLIVAVEKAFGVRFTSS
EIQSWNNVGEMIDCILTK
>KALACAFP_00985 hypothetical protein
MYKTFSELKKEIRRNTKELKNIKVALLGDTATQFLNIALKGTAIQEGFNLEIFEADFGQI
SRQVLDPTSELYEFNADYTIIFESSHKLLTQYYKSYDAQLDFAENKIKYIEELYSTIQNR
TKSRVIYCNFPVINNQIFGNFSNKVESSFVFQQNKLNYLLSADIATKKDNFFIADLLSIQ
NKWGRDFMFTPNIYVNTEMVLSLDALPIVAHHIFSIISSLEGKFKKCLILDLDNTTWGGI
IGDDGLGKIQIGSLGIGKAFTEFQYWVKALQKRGVILAVCSKNDEDKAKEPFEKHPDMVL
KMEDIAVFVANWDNKADNIRKIQNILNIGFDSMVFLDDNPFERNLVRENLPDICVPELPE
DPAEYLEYLYGLNLFETASFSENDAERTKQYQVEAQRATDLESFTDVTDFLKSMNMISDV
QAFNNFSKPRVSQLTQRSNQFNLRTVRYTEQEVENLMNSEDHHTISFTLEDKYGDNGLIC
VIVLEKKDPETLFIDTWLMSCRVLKRGMEDFTLNTIIDTAKKNGFKYVMGEYLPTAKNQM
VKDHYERLGFRSHEDKWLLNVEEYEPKDVFILAK
>KALACAFP_00986 hypothetical protein
MCPKFNTVSEISRVLKTFVAYLKRPDLYPELGRKIIKNTVNRGNAFKGKEKTNSWAASKA
ISQKEAVSKLFGIDIDPFKNNFAEILKEAERRQNECPIKMGGAGALELIYYSCEFANAKN
AVETGVAYGWSSLAALLSLEKRGGTLYSSDMPYLAQDGDQYVGYVVPENLKPHWKLFRFA
DKESLPKIFADSASFDVVHYDSDKSYNGRFWAYTELYKHLRTGGVFISDDIGDNSAYQDF
CEKNNIDTTVVEYEGKYIGVFVK
>KALACAFP_00987 Putative glycosyltransferase EpsE
MKFSLLIANYNNGKFFKDCYDSILAQEYKNWEVVIIDDRSTDDSVEVIKKIIGSDERFKL
YENDANYGVGVTKAKLIEDASGDVCGYLDPDDIIKPNALKSAVQVLEKKKDVVLTYSRLA
KCDQNLNIIKEFRAAMQVPNRQKTFFNFPIQIAPFVAFRRDAYLNGPKINPELKIAEDQD
LYFKMYEVGKVHFINQTDYLYRAHSGGISQNANKEKSYSYYARSIWEAMQRRNLKQINGK
PVPESYTDPKEIFALLEYQNKIPFRIKKKFIILLQKIFG
>KALACAFP_00988 Alpha-D-kanosaminyltransferase
MPDKKKIKVLFRHRSMEMGGVEKVVLSMLNHLNKDKFELTICLNINQGELRNEFPKYVRK
VYLTDGREDLSKNSVIQKIQLAKRNLKLKSALKNPKIADKLLNETYDVEIAPTYAAFSAV
LNSLNKNSKKIGWFHSDITLPKLQPLVPEILKQIPQFDYFIFGSQQTKDILVETYPDLKI
PENQVILNAIPIDELKQKALAFKPELPNKPVFVSVARLHSRKGFHKLMDAHARLLKDGFD
HHIIVIGDGEEMENLKKQAENLGVTESFKLLGSSMNPYPHVKNADFFILPSESEGWPLII
ADTLILQKPIISTNVGGIPEMIEHEKTGYLINYETDEMYESMKRFLTEPDLVSQIKENLK
NIEKQFDNQKIFDAVEDIIINLSKK
>KALACAFP_00989 Galactoside O-acetyltransferase
MLLLYRAILKIHTTYQFMIQKIYLKICLAKGLKVGKNVRFVEVPQFGTECFLIEIGDQTT
FSNNVRFVNHDGGQNALHFFDKYKDVRTFGRIKIGKQCLIGADTIIMLGVEMGDNCVLGA
GSILTTSMPSGTVYAGVPAKYICTIEEYGDKLLANNVMYPRELEKDRPKLEAYIKEHLPH
TYKPVKK
>KALACAFP_00990 N-acetylgalactosamine-N,N'-diacetylbacillosaminyl-diphospho-undecaprenol 4-alpha-N-acetylgalactosaminyltransferase
MTEKKKILIRIGSLRHGGAEKVLVTFLKNLPQDKYEIDLLLNLYSGKYLSEVPSWINILY
LNKGEMITTNRPHEIPRKAARVIYQGALKKFPNLLYKGKLKNKKYDIEFAAIHGMRDEIL
GSPIKSSKKIVWIHNDLSQVKGYTNDEIRKFFGFDKIMVISEKIEHLFHSLAKNETEKQK
IVKIYNPLDTEEFIAKADQPVLHYEFDHSVPTFISVGTVFPQKGFDRLLKVHKKLLDEGF
KHKILIVGDGYDFENIKKLKSDLGVDETATMLGFTDNPYPYFKNADFYILSSRYEGFPTV
LFEAITLKKRIISTEVSGANEMLNNGELGLIVENSEDGIYEGIKKALTQPASFETYSEKL
KNYEMPFNLENSVNKITSILDEL
>KALACAFP_00991 Serine acetyltransferase
MAEQYSTLQKDFYRESGKWLSTFEIWAKCINPNLHFIYILRQTQKYKKKSLPGLFWRLVL
RRHQIKYGFQIYPETEIGEGFYLGHWGSLVINPKAKIGKNCNIAQGVTIGQQNRGKNAGY
PVIGNEVWIGTNAVIVGAITIGNNVLIGPNSYVNFDVPENSVVLGNPAKIIPAEDATEGY
INNRV
>KALACAFP_00992 Carbonic anhydrase 2
MSQSYKVIFENNKKWVESKLAEDPDFFHELAKTQHPDYLYIGCSDSRVTAEELMGTKPGE
VFVTRNIANVVNTLDMSSTAVIQYAVEHLKVNHIIVCGHYNCGGVKAAMTPQDLGLLNPW
LRNIRDVYRLHQAELDAIEDEAKRYDRLVELNVQEQCINVVKMACVQERYILEEFPVVHG
WVFDLRTGKIIDLEIDFEKILKDIQKIYNLTSSDWVMSRKKN
>KALACAFP_00993 hypothetical protein
MKMKFWSIITLLFFLNFTALPGIASVFGWDLTRTNVVINEEEPHSHPSSFIVYEKTLPKP
LDVFDYLKFFEPSIEGKSFVLVDDSFHLSPLLTIFSPPPEA
>KALACAFP_00994 C4-dicarboxylic acid transporter DauA
MKKTTLIGGIKENFPSGLVVFLVALPLCLGIALASGAPPLSGVIAGIVGGIVVGTMSNSN
ISVSGPAAGLTAIVLTAITDLGAFELFLCAGMVAGVIQLILGFVRAGSISNYFPNNVIEG
MLAAIGIIIILKQIPHALGFDKDYEGHQSIFDNGLNFGYFDELFGAIHPGAIIVTLVSVG
ILITWDKVQALKRIKMLPGALVAVVTGILLNEIFKMTGSSLAIGSQHLVSLPVPQSVDDF
KNLITLPDFAGFTNPKVWIVGATIAIVASIETLLCIEASDRLDQQRRITDTNLELKAQGI
GNLISSFIGGLPMTSVVVRSSANANAGATSKSSTIIHGILLLICVLSIPVVLNLIPLATL
AAVLILVGYKLAKPATFKHFWHLGKFQFIPFVATVVAVVATDLLKGVGIGLAISIFYILQ
GNMKRAYYLSREKLDDADGINIKLAEEVSFLNKAAIKKTLKNIKPNSTVTIDARGTSYIA
TDVLEMIQDFANIRAKEEDIEVELLGFKTSYRDYETDEDSHILVTHRRAM
>KALACAFP_00995 Carbonic anhydrase 2
MKAHTYETQSTITPEKALNFLKEGNQRFVNNLKANRDLLEQVNATREGQWPFAVILSCID
SRTSAELIFDQGLGDVFSIRIAGNFVNQDILGSMEFGCNVAGSKLIVVLGHTKCGALKGG
LDAAQIEGMGMDNLNHLINHFDPIITEVIEEGEERSSKNSSLLERLNQQNVKNAIEDIRK
QSSTLKNLEEEGKIKIVGANYDVETGVVTWL
>KALACAFP_00996 hypothetical protein
MITFDIQKNVADQLMKIQINIILVILLLFLNGILKAQKTVSDTLAYAKKFETNKEKYIGK
PFSLLLKDMTQMQPKKAKSDLRDNPSNPLPSTLFRFSDKDINSANEVTLVITWKADDTPT
TPIEFFEQEHNYRFTVSEKNFFEKKIVKDILVYK
>KALACAFP_00997 Peptidyl-tRNA hydrolase
MKYLIVGLGNKGPEYENTRHNIGFKVAEKVAETLEAPFNTTNFGWMADGKYKGRRVLILK
PDTYMNLSGNAVRYWMQKENIPLENVLIVTDDLALPFGTLRLKGKGSDAGHNGLKNINEV
LQTQNYARLRFGISADFSEGRQVDYVLGTWNEEEKEKLSERIDKFSKACLSFVFAGINNT
MSAFNGK
>KALACAFP_00998 hypothetical protein
MKRLFYFVLLLVGVSTIHSCKDLLDEDGNPLLDVNNNTGLNGPRALYREITDSDTLATYY
YNGLQLSKVITDSASVTDIAWSGDKVSKIDFKGFLDLDGDGDLDKDSIVFTQLFTYGNTG
RLESISENRSFFKRTVTPPAPPSPQTLYKKTKTLYKLTYSAATAKLDSIIMKNGPDASGT
PFAYTDYSKTKYEYLGDNISKVTRHYGPMSGGVFGPAVTKFAYDYSNYDAKLSPFTLIPT
AYKISRLLSTDINDVESWILSPNSPKRFSITDLTPPVPVPTVFSTDYNYDPQTYMTKGFG
VNYIYKPL
>KALACAFP_00999 hypothetical protein
MTKKYFLSTFAALALGFVVSCDNSTDDPPNQNNNNPGGSTITGPRILSKVNNGTKDTEEY
VTTIGGVLSDAYIRDAGSTNTLTASITYTGDKITKIKYQDNVNPHVVDNLYTISYTNGKM
SAISMDQTAMSTTNHSDFTIFYDAGGQLYRIVEKKKMGGSASYTHYVEHKFTFSASNVAK
VDYTTMPMSGGNPDTSTASTITYSYDNYDSKINPYTTLPKEYFMVTGTLFPINFYMLSSN
NTGKITIQNPSGPPISVPKGYLYDSQNYPVSDPSQTIKYIYKPL
>KALACAFP_01000 hypothetical protein
MKKLLLITNLLITFLYNGQVGINTTTPVNMLDINGDLNARKELRTGGTNTVKGSAGAVGT
IFHNNASLTVNDWKSIKVANGLTSMSLYQMSTLEDKTGASFSGNNGETLPYDEGSTMTSA
WTVLSGTQGTFSITNATNKVTFNFQTTAQKTGNGNASTSFACGIFVDNKLRAVRTDVIIG
GDGTNKIFNLNATLANLTPKNNYTVKAACTKRNINSNTLGIGRAVNTTYLNSDMSESVLT
LSVLQPY
>KALACAFP_01001 hypothetical protein
MKNIFSILFIAIGLSLSAQIGIKTESPKSTLDVNGDTNLRGKIAVLDVTENKLSEGTDTQ
VLVSQGEGYPPIWKTLRIPEYEPNKFYLIFNNSFSDETGVSFTSADESTITSRSTTFTKN
NTYTNFAKFKKIPGLTQTINVYSTISKAYFQFETVAQATFSAAGSTDSSIDYACGIFVDD
RLINLRQGNLKASSASNPFLTHNQIGLVENLAKGSHTVTVSCSRLDSYNVANGTVLGIGK
AVASNIDSFISQSSLKVDVYEVPQVFNTITN
>KALACAFP_01002 hypothetical protein
MKKTVYCCVAGLLSIQAYAQVGVGTSTPNSVLDVNGKTTLRKELRVGGTSAQAGNPGLNG
QVLVSQGEGLPPVWKSLNVTFMEEGQYKLVNSYLSTDQTGITTLSNGTLGDSVYKNSVGD
DVTDTSKGKWIKIAGLENNFTIKDGRNRLTYQFQTGVEMKSSSPTTSQNISFTCGVFRNG
KLVAVRPDKISSTNNSEKGGIQDYIFTLNYTEQNVPIGAHKVEVACRKINASSSSAQFAI
GRNVSNTNNVSNAFTLESMMKIDLLEYVTYEIN
>KALACAFP_01003 Transcription-repair-coupling factor
MWKSNGFGKLPKSLLSFIFLLFMQLKTINEKFLPDLLQQEFGKEIFTQLDTHQHISVKGS
AGSAVSIFAAELFLTQKKTILYVVDDKEDALYANTEMEDLLGKDKVLYFPATHLEPYQVE
KTQNANLVLRTEVIHKITSEKSPKVIVAYAGALSEKVLKKEDFKAISHHIKVGDQLDFDF
VDELLNHYNFQQADFVSEPGEFSVRGGIVDVFSFSNEKPYRITFFGNEVESIKTFDIETQ
LSIDKIKEFQLVSNMNFSVSGSRVSLLQLLPKESFVVSKNAIIGMQKLKAFYEKSLEKYE
TLSKDIAHRAPQELFISDQEFLFDYKKFKTVDFGSVAIDGVIELAEIKIDQTSQPSFHKN
FELLIEDLEGRQNEGFDTWISFSTEKQKERLESIFEELEHELPFKSFKSELHEGFVDNDH
KILVYTDHQIFDRYQRYKAKNTFAKSEQLTLKDLMSLKVGDYIAHIDHGIGKFMGLVKVN
NDGKIQECFKLTYKNGDLLYVSIHSLHKISKYNGPEGREIVLSKLGSPSWKSLKQKTKAK
VKQIAFDLIQLYAQRKTAKGFAYTPDSYLQNELEASFLYEDTPDQEKATIDVKKDMEADT
VMDRLVCGDVGFGKTEVAIRAAFKAATDGKQVAVLVPTTILAFQHYRSFKERLKDFPVNV
AYINRFRTAKQKSETLEGLKNGKVDIIIGTHQLASSSVKFKDLGLLIIDEEHKFGVSVKD
KLKTLKSNVDTLTLTATPIPRTLQFSLMAARDLSVIKTPPPNRQPVDTQLIGFNEETIRD
AVSYEIQRDGQVYFINNRIENLKDIAGLIQRLVPDARVITGHGQMEGKQLEKNVLDFMEG
KYDVLVSTTIVESGVDVPNANTIFINDAHRFGMADLHQMRGRVGRSNRKAFCYLITPPYD
MMTSDARKRLEAIEQFSDLGSGFQIAMKDLEIRGAGDLLGAEQSGFINEMGFETYQKLMQ
EALEELKDDQEFENLFENEEERNKLFKTTKDVNIDTDLELMLPDWYISNTEERLLLYQKI
AEIDNEKDLEKFESELIDRFGDLPKEVINLLKSVSLKWLAADIGFEKIVMKNGVFLGYFP
GNPQDKFYQTNKFRTIINYLTKNPAEAQLKEKIGKDGNQLMMRKDKVINVDEVNDLLKSI
LKSEV
>KALACAFP_01004 hypothetical protein
MKKAIRILGLFLLVFFAVTSFASCSDDDDPANNDFFAGTYRGNISYNDADNDISTDNGSV
FVTKIASGTKYNFAFSNGIPDLNGIEFNQEGDHTLVMVGSTATSYIRIDNDELKILYLKD
GRTWTANCTR
>KALACAFP_01005 hypothetical protein
MKKLLSALSIVLGLGLATAQQTAPATTAAPHPTAKTVKAAKPAKPAATATTAKPATAPAA
AKMKKDGTPDKRYKANQKLKKDGTPDKRYKENK
>KALACAFP_01006 hypothetical protein
MKLYFMLREANLFAFATDVNNIFALENLNKEY
>KALACAFP_01007 hypothetical protein
MLNFLKKNVALAWAKKHVRKAEEFKKNSEKNQEELLLSLVNTAQKTLFGREHDFENIKTI
KDFQERVRISDYEDLKPYIERVKKGQANILWTETPEYFAKTSGTTSGSKYIPISKEGMPY
QIKGAQSALFHYIAKKNNADFVKGKMIFLQGSPELEEIFGIKTGRLSGIVAHHIPNYLQK
NRLPSWETNLMEDWEAKVDKIVEETEKENMTLISGIPPWLIMYFEKLIEKHGKKIKQIFP
NLQLIVTGGVNYEPYRDKMEELLGGKVDIVQTFPASEGFFAFQDDYTKEGLLLLTNHGIF
YEFIPLEEYGKPDAKRLTLKDIELNKDYALILTTNSGLWAYSIGDVVRFIDKKPYRILVS
GRTKHFTSAFGEHVIAFEVEEAMKATLEKFPAQITEFHLAPQVNPIEGLPYHEWFIEFEK
EPENLDLFKNELDDQLRKRNTYYDDLISGNILQKLHIALLKKNAFHEYAKSQGKLGGQNK
TPRLANDRKIADLLEIYKL
>KALACAFP_01008 hypothetical protein
MKASVLLKSSLLTSLFVISSCATTKYTQDVAKNDYSNLQAGRMYVVTMRDGSKNQRMLFR
NVDGDNLIGTAGKKDSTAVIIPKANVAAVRDSRKARTTAGAVVIGAAGVAALVLSSTRAD
N
>KALACAFP_01009 Enterobactin exporter EntS
MISFTPLQTLQNVEFRNLLTGRFFIVLAFRMLATLLGWWVYQLTKDPFSIGLIGLSEVIP
AVSCALYAGHVIDMNEKKRLLLICNYAYIFLIGLLLIPAFLNVEMHFTGHQITYFIYGVI
FFTGIARAFIGPIVPSMIPKIVQKENLPNAVTLNQATFLISSVCGHAVGGFLIGFFGVKW
TLIVIISLIFLASLFFFQLKKQYSEYKKDQINVIDSMREGISYIFRTKEILGALCLDMFA
VLFGGAVAMIPVYATDILKVGAEGFGLLNAASDIGSMCIITILSVIPLRKNQGKILLGVV
TGFGLCIIGFGLSHLYWLSFMFLVLSGMLDGISVVIRGTIVQLKTPDNIRGRVLSVNSIF
IMSSNEMGQFESGLMAKLLGVVRSVVFGGSMTILVALIVGSTNSKLRKMQY
>KALACAFP_01010 hypothetical protein
MKKTLLIFLSLIAQIFYAQSDCTSALAVCGNSNISYTPSGFGTIQEAPLGGGCLNTEHFS
VWYTFTVSTSGTLTFLITPNAQADYDWAVFGPNKQCGNLGAPIRCSYASTASGILTGLNM
TATDTTEGAGGDGFVKYMDVVAGETYYLIIDNFSANANGFVLSWGGTATLSSPFTSAIQP
NPFVPPGTPSATPGGPNEVIICSDPATFDFTTLSAGIINGNPNFQVSYHTSSNDALTGNN
PITAPQVVNTTTVYYYSISYVDPTNPNSPISKCKQTGTFKFKQGNIVASDVTLTTCNNNN
AGTGIYDLTSANVLPSDPTAIKKYYPTMADLLAGTNEITNPANFTSSTGNIFVNVTTLQG
CSDNAQITLNFYPEVVVTEATLRSCFIPANPSTASFNLTLAAVTTQSGVTKKYYPSLADA
VAGTNEILNPNTYISPNGVIFIKVTNGNGCYGVAKVTLIVLPPVYSNVLEDKIICMEDTT
TLDAGPGFTGYTWSTGATTQTINNVTVGTYWVDLKTGECVTRQTVKVYPSEQPVISSVDI
TNNTITVNVVGGTAPYKYSMDNINWQDSNVFTNVPRGDNMIYIKDSYDCDPITITVVVPN
LVNVITPNGDGVNDVIDYSALAGKQNLVFSIFDRYGGKVGQADKFTGFKWDGTSAGKKVP
TGTYWYSVTWNENDKKNTPFKFSGWVLVKNRE
>KALACAFP_01011 hypothetical protein
MKKLLLLVVVFLSQMAFSQSDCVSAIPVCGNSDISYNPNSSGTVQENTSPSCLDVEHYSV
WYVFTAATSGTIEFTINPNTVPNVNHYDYDFAVYGANIDCATWDFGNAASCNFSGLSGPT
GLSSTETGAQWNPPLTVNAGETYYLLIDNYIPSNPYGFSLTWGGTATLSSAFTDPTLAPN
PFIAPGDPNPAGGPNLVSTCPLPGQFNFNTLSAGILNGNPNFIITYHTTANDALFGTSPI
TTPITVNATDTYYYSMHYQDPADPNNPLNACRQTGSFKFKLGTITPENVTIKACNNNGAG
TATFNLLSANVYFDNTAIKKFYLTLNDLNAGTNEIQNPANYVSGEKTVYVKVITTGQCVG
HSTITLQFYPLVEAYDATIESCFIDSNITTASFDLTLANVTSQNGTTKKFYKTQADAVAG
TNEILNPNAYISANGVVYVRVISENNCYAISKITLKVLPPVHSNVLKDQTICMEDTTTLD
AGPGFDGYEWSTGATTQSITNVGVGSYWVKLKTGECWTLQPVKVLSSQQPVITTIDITNN
SFTVNVAGGKAPYKYSIDGINWQDSNVFTNLPRGENKVYVKDAFDCTPIEVQVTVPNLLN
AITPNGDNKNDFIDYSALAYKKNLVFTVYDRYGNMLYQADKIRNYTWDGTSGGKKIITGT
YWYTITWNENDKNNTETKYSGWVLVKNIE
>KALACAFP_01012 Replicative DNA helicase
MAQKETLSSLTNGNFAKELSIADGKMPPNAVDFERLVIGTFLIDKKGLDHSIDLLTPEVF
YDPRHTVIFSTILKLYEGNQPVDLMTIIQDLKKEGKLSLAGGDSYIIDLTLGVSSSAHIE
YHVRVILEKYILRSLINVSANVIDAAYKESTDVFELLDKAEQSFFEITNGTIKKGFDTAN
SLVKQAIDTIKSLKDKQGLSGVPSGFRDVDKETGGWQNSDLIIIAARPAMGKTAFLLSMA
RNIAVGHKIPMALFSLEMASVQLITRMIASETRISSEKLRKGTLDDDEWQRLFSNVSELE
NAPLYIDETPSLSIFDFRAKCRRLVMQHGVRLIMVDYLQLMTAGGGGKGVGNREQEISMI
SRSLKAIAKELNVPVIALSQLSRSVETRPGKRPQLSDLRESGAIEQDADIVSFIFRPEYY
KITVWDNDEEGQETSTENQAELIIAKHRNGATADVRLSFLKHFAKFGDIEAALDGGSAGG
YPSNFGSKEQSGFDKIKTTIQPGAAFDLPDSSKLSGSSMNDFDDEDDFPF
>KALACAFP_01013 Ribonuclease HI
MRIEIYTDGACSGNPGKGGYGILMRVPEKKYQKTFSKGFRKTTNNRMELLAVVTALEKLK
SPDNDIHIYTDSKYVADAINQDWLSGWIKRGWKNVKNPDLWQKFAALYNIHKPKMHWVKG
HAGHFENELCDKLAVAAASSPNLEIDTYFENLENNSLF
>KALACAFP_01014 hypothetical protein
MNRNNYFLFLLILLLCLPQHFTSQTYQLSGNPVNTTGWTMVSPTVVNTDFVQLTPDTNNQ
SGSIRLNDPINLKYCDKWKVEFDFRMDSNQTANGDGIAFWYLANPPVASVLGSGLGVSQN
AVGLVVGFDTYNNTTTAVMSKVHVGYGLIQNTTDTNNVEFFNVPGSSFHSPDMNTTLPFQ
GATFKHVEVTSQVDPAAPANWIIKIMIDGNVICNQSFAPSGAAASMTVGYFGFSASTGGN
RSRHSIKNVKVYVDKVAINTPTVTDTFCPNPTTGQGTVNLTSYQNQFVANPSNYTFSYSV
SGTPITNPTNYQFSASTTVSVLIRDNSGVLCDNPDGKIQLNLSPFTATPATLTACNNNNV
GSATYNLTLANVGEPSGSTKVYYKTMADLNAGTNPITNFMNYVSPAGTVYVKVTTPLGCT
GSAPITLAYFPQIPTTDAALESCFIESAPNTASFDLTQANVTSAQSITKVYYKTLADALA
GTNPIGPTTNYITTTGVVYVKITNVAGCFMIAKINLKVLEPVYSTILKDKTICIDSRTTL
DAGPGFDSYLWSTGDTTQSIQGVPVGLYWVQLKTGKCTARQIVKVNPAPQPVISTIDITN
NTITVNVNGGKAPYQYSLDGINWQDSNVFTGLQRGEVVVYVRDSYNCEPIHVQITVPNLI
NAITPNGDNLNDVIDYSALAYKKNLVFTIYDRYGNKLYEANKLRNYKWDGTAGGKKVVTG
TYWYTITWNENDKNNTQTTYNGWVLVKNRE
>KALACAFP_01015 hypothetical protein
MNSTNLLQMKKNLLYCLFIIFVSVSGRLSSQTYQLAGNPVNTTGWDLVSSATVSGDFIQL
TQDIGNQYGAIKLSTPINLKYCDKWKVEFDFRIDGNGTTQFGRGDGFTFWYLANPPTGFV
SGGGLGIPANANGLMVGFDIFNNTTEGQMSKIHLLYGTNNLPVGNNNIEYNNTPGSTFHS
PDLNPTQPFVGPTYKHVEVNGETDLTNPANWIIKIRLDGVLIVDQSFAPSGGAIGMTTGY
FGFSAATGGASARHSIKNAKIYIDKVPILTNTVTPFVCVNPATGNGTVDLTSFQNQFVTN
PANYIFSYFGPGGTPITNPSNYQYSGPVNISVVVQDPSSTLCDNGDGQIVLNPTPFEATD
ATLTGCNNNNAGGAIFDLTTAAVSTVPGVTKQFYNTMYDLNNNLNQITNPTAYLSPAATL
YCKVTTPQGCTDAAAVTLALYPEVTVQEATLRSCSIESNPSMASFNLTLAAVTTQSATKK
YYPSATDAANGTNEILNPTTYISPNGVVYIKVTNANGCYAIAKVNLIVIAQVFSNVLQDK
IICIEDKTTLDAGPGFTSYEWSTGATTQAINNVTVGTYWVKLKTGECVATQTVKVYPSEQ
PVITNVDISNTTVTVYVTGGTAPYQYSMDGINWQVSNEFKNVPRGDAKIYVKDAYDCEPI
DISIVVPNLINVITPNGDGINDVIDYSALAGKQNLVFNVFDRYGAKIHQADKSNKYRWDG
TVAGRKVPTGNYWYSVSWNENDKKNTPIKYSGWILVKNRD
>KALACAFP_01016 hypothetical protein
MEKKLPFLFFILLFCLPKQLFSQTYQLAGNPVNTTGWTMVGPTVVSGDFVQLTPDVNDNS
GSIRLNEPINLKYCDKWRIEFDFRMDSSQTYNGDGIAFWYLANPPVASVLGSGIGVSQNA
IGFIVGFDTYNNATGSTGMSKVHVAYGQVQNTTDTNNVEFFNIPGSSFHSPDLNSTLPFQ
GSAYKHVEVTAEVDPAAPANWIVKITINGTVICNQSFAPSGAAAAMTVGYFGFSASTGGA
RSRHSIKNVKVFVDKIPLLESAITKSICPDLAGMSTVDLTTFNSQLTATPSNYNFTYYIT
GSGTPIANPTNFQYNSDTNISVVIKDPSSVLCDNNDATITLKVAPTVTATDASLRTCFIE
TKPSTGLFNLTTAPVIGTSTGITKTYFPSLTDAQNGTNPIANPNNYIAPNGVVYIKVTNS
FGCYDIAKVTLEVIPPVFSKILEDKIICIEDKTTLDAGPGFTGYEWSTGATTQTINDVGV
GTYWVKLKSGECVATQTVKVYASEQPVISSIDISSTTVTVYAVGGTAPYQYSLDGINWQD
SNEFKNVARGDTKIYVKDAYDCEPIDFTIVVPNLINVITPNGDGINDGIDYSALAGKQNL
VFNVFDRYGAQIHRADKSTKYRWDGTVGGRKVPTGSYWYSVSWNENDKKNTPIKYSGWVL
VKNRD
>KALACAFP_01017 Putative NAD(P)H nitroreductase YfkO
MNYLEALSRRYSVKKFNKEIIPQEKLFNILESGKLSASSLGLQPYKILVVESEEMKQKLI
PAFYNPSQISTCSHLIVIISKKTLDENYVNGYFRHISEVRETPLEKLELFRNSINQHISQ
KTQDEIFNWAEKQSYIVLANLMYAAAIENVDSCPMEGFRQELIEEILDVNPETEKVTVTL
ALGYRSEEDYFQHMKKVRKPNEKLFKFI
>KALACAFP_01018 L-aspartate oxidase
MIKADVLVIGSGISGLSYAIKVSEQLPDAKIIIVTKSDEDESNTKYAQGGLAVVTDSKND
NFDKHIEDTMRAGDGENKRDIVKMVVTEAPKRFKEIVEWGANFDMKNGEFALGREGGHTE
NRIVHHKDITGFEIERALLETAKNSPNIEILDHHYVIDIITQHHVPGKELNEGDIHCYGA
YILDEKSKKIKKITSKITLVATGGAGHVYKNTTNPTIATGDGIAFVARAKGKVSNMQYYQ
FHPTALYSKMDGMLFLISEAVRGDGAKLRTKRGEKFMHKYDEREELASRDIVARAIDAEM
KITGDEYVGLDCREMNHDKFLEHFPNIYKKCKDEGIDPFTQLIPVVPACHYLMGGIEVDS
DGQSSIRNLFGVGECTNSGLHGANRLASNSLLEGLVFGHNAAMKTVDLLNENNFNFDDLK
AVPEWDEEGMKIMDEMVIVSYLRKQLQEMMSDLVGIVRSNRRLNMALQKHQEIAAAVDEI
YHYSILSPQLSELRNLTTVAHLIITQSMEMTENKGAFYNKDLA
>KALACAFP_01019 putative nicotinate-nucleotide pyrophosphorylase [carboxylating]
MKRPAYVTDKVLKQFIKNALEEDIQDGDHSTLSTIPKDLVQSAKLLVKQNCILAGVELAE
IIFKTFDKNLKVETFVKDGDAVKVGDVAFIVTGSARSILSTERLVLNCMQRMSGIATLTH
DWDSRLIGTKTKLLDTRKTTPNFRVCEKWAVAIGGGTNHRYGLYDMIMLKDNHIDYNGSI
TNAVKMAKDYIKKNKKKLKIEVETRNLEEVQEAIKAKVDRIMLDNMDVKTMKQAVKMING
ICETEASGGITREQLKEIASTGVTYISAGALTHSAENMDLSLKAVK
>KALACAFP_01020 Ferric enterobactin receptor
MKLINKSMLTAIITLSTASVYYAQQVQDTASKSKDIEEVVLTGVADIAKDRKTPVAVSTI
KEAQIVERLGNQEFPEILNTTPSVYATKAGGGFGDSKINIRGFAQENIAVMVNGVPVNDM
ENGAVYWSNWSGLSDVTSAMQVQRGLGSSKLAIASVGGTINVLTRAADKKQGGIVSLGLG
NDDYFKTLFAYNTGKSAKGWSSSFLMSRTAGSMYADGTQFEGYNYYFALGYQPNKKHDLQ
FTITGAPQWHNQRSSYSTIQNYIRYNEDQDGTPDRRYNPDWGWRNGEVLSNRVNYYHKPV
MSLNWDWNISSKSKLNSVVYASFGRGGGTGDVGRVGNKFVSGYVDVNGQVDYDAIFAANS
AVNVNSAAAGSTLVRRSSINSHNWFGAIVSFNHKINDNLNFTIGTDDRYYYGYHYQVISD
LYGASGYKDITNKNFYTAPGNLYTVTPRVVSNVFAPNPNWNPFGGKLNNQDDMIAYNNDG
EVLWYGGFGQLEYTNDKLSAFVSGALSNQSFQRIDHFIIDGVTLLNGQQAGFINTAGGTV
AQPTATNPVLNEKTGFKDILGYNVKAGANYNINDHHNVFANIGYYSKQPFLNAVYPNNKN
YLNPNLTNEKIFGIEAGYGFRSGIFTANVNLYRTEWKDRFLRRGNLTVTYPDPTNPSTNI
TTNTAYANLQGITEIHQGVEVEATANVHKMISVYGMLSVGDWYYKGNAQGNIFSETNEQI
GADSQTLYLDKVKVGGAAQTSAAVGFTFKPTDWFSFDGTYRGIKNLYANLNLLNFTNQAS
ADRGALELPSYGLVDLGISFKIKLNNPKQFFTIRGNVYNVLDKTYIAESNTNIHANLTKS
EYAAVNPTLTPAQVDTNYATYQAAGNWNGVSQQNQVYFGYGRTWSATLSFNF
>KALACAFP_01021 hypothetical protein
MDFYNILLNAHKGFGYLEILLVTLFVIALLATMFGYSGKVNNFLKKTTLFTMIFFHVQFL
LGVVMLIINFSKGMDMGSIMKNADLRFQYVEHPFSMLIAAVLMTIINKKVKTNPTISLGI
VIMGLIAVGLFAFAFPWARVFGA
>KALACAFP_01022 Aspartate-semialdehyde dehydrogenase
MKVAVVGSTGMVGQVMLKVLEERNFPITELIPVASERSIGKKVKYKQEEFTIVSMKDAIA
AKPDIAIFSAGGGTSLEFAPLFAEVGTTVIDNSSAWRMDPSKKLVVPEINADVLTKEDKI
IANPNCSTIQLVMVLGPLNKKYDLKRVIVSTYQSVTGTGKAAVDQLNSEITGDDSIAKVY
PYQIFKNALPHCDVFADDDYTKEEIKLMKEPKKILGDDTFNLTATAVRVPVQGGHSESVN
IEFENEFDLDEVRKILSETPGVVVMDNVKNNEYPMPLYSEGKDEVFVGRIRRDLSQPKTL
NLWIVADNLRKGAATNAVQIAEYIVANNLV
>KALACAFP_01023 Ferrous-iron efflux pump FieF
MNLQKNKIKDKLGFQKLIAVFGIILFIGKIVAWKLTNSDAVFSDAMESIVNVISAFMGLY
SLHLASKPKDEDHPYGHGKVEFVTSGIEGALIAIAGLMIIYEGVNSLITGKVLNKLDIGI
WIIAATAIINYLLGYISIKKGEHENSLVLISSGKHLQSDTITTLGVVISLVVVYFTKIYW
LDSVVALIFGVYIIFVGYKIVRKSLSGIMDEQDPELLNQIIKVLEENRRTEWIDVHNMKI
QQFGASLHIDAHITLPWYYSLRDAHNEMEKMIVLLAKNTRRSVEFNFHMDDCKPISCAVC
QIKDCPVREKDFVKRIKWTPENATRVQKHTVD
>KALACAFP_01024 hypothetical protein
MKILSWFLVIIGIFGLIGVRALEDRIFYDPFLTYFHEADKKLAFPSFEWGKLILNYLFRF
ILNLFFSCLIIYFWFKNKEWTIQGAVLITIIFAITFPIYLYCIYDQFEIGYLFSFYMRRF
VIQPLILLLIIPMFYYRKQMNKQA
>KALACAFP_01025 hypothetical protein
MLKDFKPVLSILLRFIIVYLVLLFAYQFYLNSFQNTGLDPFSRMIAEQVRHIQNSLSFPT
QLYNDVKGEQVFFYVKTGYATRMVEGCNAVSVMILFVAFVFAFYKGSKTFLFVLAGLVLL
YIMNLLRIVGLNIVMTDYKQYGKISHDFIFPAIIYGTVVLLWLIWIKFFALKHENS
>KALACAFP_01026 hypothetical protein
MNSENAKQFFENYSDKKPSEFIILAQSGSARVNFLAKTDNEEYIITYNENVRENESFLYY
SKIFTDLDLNTPKIFKISDDRKMYIQEFLGKQTLSEVISKEGLSENVKSLVKQTLEKLYQ
LQITTQGKIDFTKTFEYENYDELPVTHDLYYFKNFVADVLELEYHKSTLLKEFKHIVNLI
ENLEPKGLMIRDFQARNIMVNEKNEVSFIDYQSAMKGPLIYDVISFLFQAKANFPEDFKN
EMLDFYINLFENKDIQLQLKNSVKPIQLMRFLQVLGAYGFRGLIQRKQHFIASINKGIEN
ITEFAQNWDHMKQYPELENVIRQLSLEKTKLKIEEILNN
>KALACAFP_01027 Nucleotide-binding protein YvcJ
MLHIDIHSFSYKKGGIPKDESGNGGGFTFDCRGILNPGRIEEYKIQTGNDIGVQEYLETK
TEMPKFLELIKSLVSINIDNYLERGFENLQINFGCTGGQHRSVYSAIKIAHFIQEKYGDK
VEISLHHDEQHQLNISNQ
>KALACAFP_01028 D-glycero-alpha-D-manno-heptose 1-phosphate guanylyltransferase
MKALIFAAGKGTRLKPFTDHHPKALAKVNGVPLLERNIKYLKSFGIKDFVINIHHFGNQI
VDFLKQNNNFDCHIEISDETDELLETGGGLVFARKLLDHGEDFLIMNADILTNINITDFV
EYHKKIKDFATLAVSDRESSRKLLFNDEMVLRGWLNVQTGEQRLAEFNKGFKALAFSGVH
CINPAIFDKIKRTGKFSVMEEYLDLMQTEHIHGFLHDSILIDVGRPESIAEAEKHFK
>KALACAFP_01029 hypothetical protein
MGIEGMRDESLVNPELDINETKLQNSLRQKTWDETITKDSWMVFKVMAEFVDGYEKLAKI
GPCVSIFGSARLKPQSKYYKMAVEIAEKITNLGFGIITGGGPGIMEAGNKGAFNAQGKSI
GLNIDLPFEQHFNPYINKSYSMNFDYFFVRKVMFVKYSQGFVVMPGGFGTLDELTEALTL
IQTNKIGRFPIVLVGSDFWSGLLDWFKETLLKEKMIHEEDLELYRVVDTADEAVAHIKAF
YDKYSVNVNF
>KALACAFP_01030 hypothetical protein
MIANLLFKMKKFLYISGILTFFMLMSFTYVDFYSSMTKVDYIDGSKTLKFTTKMNTNHIS
DAIKINPNTAGFEAEVKKYVNNNFDVYVNGSPKTITFTGSQVSGETVWVYFEAGGVSDIN
TLKIKNTILLSAFPKQINLVNIAYKGSQKTMNFQRGKEVNEVSF
>KALACAFP_01031 hypothetical protein
MNNIANFLKTTFLAVGVLSVVSSCVKNDEWETPPIECSNKFPAPNISMADFVAQSPATGF
KLITTDQIFDGYVVSSDEQGNFYKTISFQDKTSNPTVGLQIEVDKASNFADFPVGAHIRI
NAKGLRLGTDRGAIKLGSEDPIYAIGRIPQALVGRYMSGVCGGNGLDIQAIVPTPLASLA
DAKNPGLINTLVTVPDVQFNIAEIYPTVKKFIDYDAAGQGLDTDRNIEDKLGNATVIRNS
GFFKTGGELLPTGNGSLTFVVSRYNTSWQMLIRSISDIKFTGARVDATPPKGGTAITYSG
SFLENFESYPTSPANLEVYPKYVNDPVLGNRYWQLKTFSGNKYIQLGANSGSGPYVTYFA
VPVDFTAANTLKFDVNVGFWNGNALKVYYTTNYTPLGDITQATKTDITSAFTIPQTPTSG
YGVLAPAGTYNIPASLTGNGFILFEYTGNGSGVTTTIQLDNIQVQ
>KALACAFP_01032 hypothetical protein
MIKKLSLVSLFTLLPASYYFAQTTVFAYLKDADGKPVERAEVDLKGNDNDVTADKIGYFQ
FVDLQPGHYQIVITKPNYETKVMEFDVANEKKKDLGTITLYSTLTSADQGLAIIDGDGDD
DESSNSQVSTVGLLQSSQDVFSRIAAFDLGFYWFRPRGIDGRSGETMMNGVSMVKSDNGN
VDFSNWGGLNEITRYPEIASNHSPSEYAFGGNSGVIYKNTKASEYRKGFQFTQSLTNRNY
RYRTSLRYSSGMSKKGWAFTLMGARRWAEEGIQEGTFYDAYGTYLGVEKKFSDKHTMTFN
FIGSPYRRSTASPSTQEVYDYRGVHYNSYWGWQDGEKRSERVRRGFQPIFQLQDFWKINK
NSGLWTTASYQFGKDRGSRLDWNGVSNPSPTYYRNLPSYYINSIMYNVVNNPLFTPDQFT
TLIDGYNTSLNSWVNGDPNVTQINWGRLYANNQQNDVVDQQEMARLYGLNGRRSKVYLVD
DVSDDKIFNAGTHYTYNFNDRTKFILNVSYQNYKSELYREMKDLLGGDYAINVDPFKESA
KPGSTGYYNTLDPNVQVKVGDRMTYNYILRRQEAKVNPGLKFSTGNFDIFVSALAGYSSS
NREGLFKHYLYENSYGKSKDFNFWNFGLKGQIVYRINGRNFLVYNGAVYNQAPFLEDLFI
NPRVNALVNPNIKSTVFTANDLSYVISTPFLKLRATGYLVDTQNETNVQRFFADGIQLNN
TNPDGSVSQVQSAFVTQVMSNVEKRNMGAELGVDVKILPTLSVQGLASYGQFVYRNNPDV
YLVSDASGSNVTSFGKAYIKNYKQGGTPQQAFSLGFRYNNPKYWWVGANWNYLDDNYLDP
APALRTNNFIQNVYSSTPYLGLTEADVRDMLKPVKLPSSFFLNANAGKSFVFGKYYLLIT
ASVNNILNNKKYITGGFEQTRETKAMDFAMDYYSPTPSFGPKYWYTQGRSYFVNLQFRF
>KALACAFP_01033 hypothetical protein
MKKFSSLLAIIISIMAFSQQQGKLRKVATVGFLNVENLWDTIRSADYIDGTKDIKNPAFH
RSIPLDSIKFLEAEKYDGTWSDEALKGKKAVRYQSGSDEFTPSSPKNYNTKIYKAKLANE
AKVISEMGAQYTKTAPAVVGLIEVENRQVIEDLVKEPALKKYDYGIIHYNSYDYRGIDVA
LIYQKRRFTPTNSLKKELKVFGDDGKREYTRDILVVTGFLDNEKVAFFMNHWPSRRGGEA
ISLPKRNAAAALLKQQMDSIRAADPSTKLFAMGDFNDDPVSSSLKNYLKAQPSPKDLSDN
TPYLNLMYPLYKKGVASLAYQDAPNLFDQIIVSKNLVSDQVTKEYSVYKAEIFAPPYLVN
KEGNYKGYPFRSWNGDQFTGGYSDHFPAFVVLQKEP
>KALACAFP_01034 hypothetical protein
MKNLILILIVSLLSFNCSAQTEPKNDKEKSEMKPSKNEDGEWDLTVIDTQFDYFLNAIAK
PISQYSESYLKTKNTLLVSEWNSYYFSGKYRNIIESSIDYDPKENYGIKFEYKLYQVFAY
VNWKYGLRMNGLSGSDVTRY
>KALACAFP_01035 Superoxide dismutase [Mn]
MSFELPKLGYAYDALEPTIDARTMEIHYTKHHQAYIDNLNNAIKGTDLEGKTIEEICQTG
TDKPAVRNNGGGHFNHTLFWEILTPGGSKEPVGNVKAAIENYGGFDKFKTDFSDAAKTRF
GSGWAWLIKNADGSVSVSSTPNQDNPLMPVADVKGTPVLGIDVWEHAYYLNYQNRRPDYV
AAFFEVVNWDKVEELFNK
>KALACAFP_01036 Transcription termination factor Rho
MHNSKISVDLHYTNVLENKSHRTYFSYSQLITFFTLNMFNIETLRSKSVTELTKILKDLG
VKVARNSNENDKIFAILDFQASNPKVAKDYFNVTETPMNGEEKEAEKPAKAPAKKPAPKK
TAAKPKAETKTPTDIKPQAEEKPRVEATEQVSEEPKPAEVKAETAEEAAASAAKKKRKRV
SATNTANTEMSQERPEAPKNTEPQESAPAEEKPANPQPQQARPQKGQHNNPHNAGNQHKN
QHQNQNQNQNQNQNKQQQQQQHSERNEEQHHEKKEFNFDGMVSIEGVLEILPDNYGFLRS
SDFSYISSPDDVYVSTAQIRNFGLKTGDTVKGIVRLPKEGEKYFSLLRPTEVNGRDLAFI
KDRVAFEYLTPLFPEEKFNLAGKGSTISTRVVDLFAPIGKGQRAMIVAQPKTGKTMLLKD
IANSIAANHPEVYMMVLLIDERPEEVTDMERSVNAEVIASTFDEAAEKHVKVANLVLAKA
QRMVECGHDVVILLDSITRLARAYNTVTPASGKVLSGGVDANALHRPKRFFGAARKIEGG
GSLTIIATALIDTGSKMDEVIFEEFKGTGNMELQLDRKIANRRIYPAIDLVASSTRRDDL
LLDEVTSQRMWILRKYLSEMNPVEAMEFVDKNIKGTLNNEEFLMSMNK
>KALACAFP_01037 hypothetical protein
MLQRIQTIWTFLAVLAAVFLFVTGQDVIISDSFPVLNIGCIVLVLVGLLSVFSFKNRKRQ
ILLNNISIIINALLIGVLIYWLLKLSGGIQIPEKGIEPIFPLIAIICLFIANIYIKKDER
LVKSVDRLR
>KALACAFP_01038 hypothetical protein
MIKNNFSKVLFLIGFLASGFIILPLLDKSRQKEDDKKPSFYDAEINANVNESLEIGYLFE
VNNKTYKPGLYHYVIQAKRNDERIEFLEDEPSNFENMIVFNWRQTKPPYKVIKKAKADTL
YIIKRGRKIAFSKYLDEDN
>KALACAFP_01039 hypothetical protein
MQHFRLTCDRLSKILFKMKKLTYLTFSLFSIFSFAQEVSKERIQTVLATLASDEMKGREI
GTQENENAANYIAKLFKENDLEYCTGNSYLVPFDYKGKTAYNVCGIKKGKTDKFLGFSGH
FDHIGTSNNANDNIYNGADDDASGITTLVGISDYFKDKKPEFSMVFMAFNGEEKGMLGSK
AISQDKNLDKIYNNLTTLFNFEMVATESAFGKNALFMTGNEFSDLDELFNKNAENGLKIN
PDPYASEQLFYRSDNVNFVKKKIIAHSFSTVDMTKATHYHNESDDLHVVDFDNLTQIVNN
FGKTLEKLTPKNFTPKYNEKVEF
>KALACAFP_01040 Lipid A export ATP-binding/permease protein MsbA
MNQYLKILKFARPHRKYIYGSLFFNIMYSVFQIASLGTILPVLGMLFGTIKPEKYEKAPE
YSGDITDFFNYLKEYSNYYVQNLVTEHGALKVLAWLCIVTAFMFLLRNLFRYLGSFLLIN
YRVGVTKDLRSAMYNKILSLPVSFFTERRKGDLMSRMSNDVGEVEGNILGSLIELINAPF
MLISTLLTLFFLSPEMTLFSLLVLPVMGTMIALVGKSLKKNSHEAQHEMGTIFSIVDETL
KSSKVIKIFNAEKIMGNRFSQSMQRWINSSISLGRKKELASPMSEFLGSITFLIIAWYGG
KQIIVEQSISPADFLVFLGMFFQILPPAKSLSTSIGNVQKGEASLERVLDILDADVKIDE
AANPVTISTLNNQIEFNNIGFFYDKDHTILKNFSLIIPKGKTVALVGQSGSGKTTIANLL
ARFYDVSEGEILIDGIDIKNLKLKEYRQLLGMVTQESVLFNDSVYNNILMGKPDATREEV
IAAAKIANADSFITNLPEGYDSNIGDDGGKLSGGQKQRVSIARAVLKNPPIMILDEATSA
LDTESERFVQDALEKMMENRTSLVIAHRLSTIQKADWIVVMEKGVIVEQGTHHDLIAKRG
MYHKLVELQNFD
>KALACAFP_01041 hypothetical protein
MNPIQEYFYRIEEPDRSTLLFLRKKILESDTENITETLSFGLPFFKYKKKMLCYFYYSKK
YKKHYVSFYHGDRLDDPQLLQEDRKKFKILLIDMNEDLPVELILKLINEVKQYIKA
>KALACAFP_01042 Isonitrile hydratase
MMNKMNFDPEIKINVGFLIYNQVEAMDLNGPIDVFTKANRFDNRYNLYTVSETSQLVPSE
GGTIHMKASYSFENAPQADILIIPGAAVATISEICNNDNIINWIIQQDQNTKLTVSICTG
SLILSKAKILDGKSATTHHLALDLLRQNPTIKVVEKVRYAEDGKFLTSAGITSGLDVALH
IIEMISGKEVAEEIAQTMVYNRSANMDFIK
>KALACAFP_01043 Phosphatidylserine decarboxylase proenzyme
MKLHRESKGTITVATILFIVLGALAIYFLEMWSLVIILPLLVVYSLIFWFFRVPDRDILE
HRENVIAPVDGKVVMIKEVEEDEFIKGKAIQVSIFMSPLNVHICRYPVSGKVIYKKYHPG
KYLVAWHEKSSTENERTTVAVESLTNHQVVFRQIAGYVARRIVFYCNEGDEAKAGHEFGF
IKFGSRMDVFLPLDTEIICKIGDITKGGLDVIARMKD
>KALACAFP_01044 Phosphatidate cytidylyltransferase
MDKNLIQRTLSGIVYVAIIILCTTPLGAQLINSISPDLVKQEYLYYGLITLLLGVGSWEC
FKIMKFGNGYERWIVLPLIIFIFFIFSKRYFHFDFFFDFRISEILAMLLIVIAVVTLFKY
PNELYYDSGKLIFTVIYVALPFCFALGLPKFSRFDDRFSLEVLFLFILIWSSDTFAYLTG
KFFGKHKMAPKISPKKTWEGYIGGVVLTLILSYFIEQYHPDLRGNWIVVGFLVATFAPIG
DLVESQLKRNFGVKDSGNLIPGHGGVLDRLDSFLICVPVVYLYFILEKFI
>KALACAFP_01045 hypothetical protein
MNLFKRIVSKLTNQPEEEESQSLEKLGDSLKNADLDYKFAQLFTHSGGFFNYCADEAEAL
QTLNQIIKIEGINKVFCWDKDLQNFLNVVKSPYTAELQTDNDAAFITCEYLIAYDGRIML
SHNNILHYHSSRLPNKIIIMANVSQIVNNLNDAMGKIKRNGNIKNLTSISGSQSKLDTSS
HANTKLFLLLLED
>KALACAFP_01046 ATP-dependent zinc metalloprotease FtsH 4
MNNKGFNWFFPIAIIALLLFFVPNFFGDSSAKTIDEDGFFKEMQAGKVQNIIIYKDTEKA
DVFLTQAAKTAMVSKTKENDPLSAFSMAPKADFTVKYGDLQLFLQKFDQVRAANPAIKTT
KDYGAGKSPFMDILVSALIWIAILGLFYFLLFRKMGGGGGPGGQIFSIGKSKAKLFDEKE
RIQVTFKDVAGLEGAKEEVQEVVDFLKNSEKYTKLGGKIPKGVLLVGPPGTGKTLLAKAV
AGEAKVPFFSLSGSDFVEMFVGVGASRVRDLFAQAKAKSPAIIFIDEIDAIGRARGKNNF
SGGNDERENTLNQLLTEMDGFGTDTNVIVMAATNRADILDKALMRAGRFDRSIYVDLPEL
HERRQIFDVHLKKIKLDDTVDREFLAKQTPGFSGADIANVCNEAALIAARNNHTSVNKQD
FLDAVDRIIGGLEKKNKAIKPSEKKRVAYHEAGHATISWLVEHASPLLKVTIVPRGRSLG
AAWYLPEERQLTTTEQMLDEMCATLGGRAAEQVIFNNISTGALSDLENVTKRAQAMVTIY
GLSPNIGNISYYDSSGQSEYSFGKPYSEETAKKIDIEIKAIIENQYDRAVQILTENKDKL
DALASKLLEKEVIFREDLEEVFGKRAWDPELTEKPVTNTVGEQAETIVIKDKEREEESEI
QAPESPTQL
>KALACAFP_01047 Ribosomal silencing factor RsfS
MNKTAEKQELLDKIVEAIQDVKGEDIMIFDLSNIENSVAETFVICSGNSNTQVAALAGSV
EKKVRNELKERPWHVEGTENAMWVLVDYVSVVVHIFQKQVREYYDIEELWGDAVITKVEN
EF
>KALACAFP_01048 Bifunctional ligase/repressor BirA
MSQLFYLKECSSTNDEISKFLLYENSDFVTLYTFNQTKGRGQYGNTWSSTAEKNLAYTLA
VKTEHFMLSDFMFNYYTAIVIRDYLANLTENDVKIKWPNDIILKNKKIVGILIEKKKINQ
NNYFIIGAGFNILQEDFDEISNAGSLLTQTGRHFDLEEFTLNLNDFLIKRLQNIPSEEEI
MRLFNAHLFRKDEISVFELDKTRQNGIIRYADEKGELWIELEDGICSFYHKEIKLFY
>KALACAFP_01049 Lipopolysaccharide export system permease protein LptG
MLKIIDRYIVKKYLGTFSFMLILLSIVVLVIDVQQKIPRIENATAIDAKLNLTYFLVHFY
PFWIINLVMTFLSILVFISVIYFTSRMANNTEIVAVISSGASFHRFARPYLLTSLFIATI
SLGVNHFVLPWANIQKNQLEAYTYNATNKEKVLGTAPVSAQLSKTEYIFINSWNKREKRG
SGFVYQKFDKNRRLTYELKASDVTWDKDKKLFVLNSYAEKTINKNDTEKLANGFDLKKSF
GHNPEELFPNELLGQNKTTPELLKFIKREKEKGNSNLNAHLNELHQRTAMPISIIILTFL
ALSLSSQKKRGGLGINLALGISLAFVFVFSFEALKVVSENKSISPALAMWLPNIAFFPLA
AYLYLKRANQ
>KALACAFP_01050 Queuine tRNA-ribosyltransferase
MQKFFTIEKTSEGKARAGELTTDHGKIQTPIFMPVGTVASVKTVHQRELKEDIKAQIILG
NTYHLYLRPGMETMQDAGGLHKFMNWDLPILTDSGGFQVFSLASSRKMSEEGARFKSHID
GSYHMFSPEKSMEIQRQIGADIFMAFDECVAYPCEYNQAKLSMELTHRWLKRCIEWTENN
PELYGYKQRLFPIVQGSTYSDLRKISAEVISEAGAEGNAIGGLSVGEPEEEMYRITDEVT
DILPKEKPRYLMGVGTPWNILESIGLGIDMMDCVMPTRNARNAMLFTWKGVMNLKNEKWK
KDFSPLDEFGTSFVDKEYSKAYLRHLFVSKEYLAKQIASIHNLAFYLDLVKVAREHIMAG
DFYEWKNSVVPVLRQRL
>KALACAFP_01051 hypothetical protein
MEINNQQVMKKLIFIFLLIFVVSCGGDYIDKPKNLIPKDQMAEILADLSINDQATFMYPN
SNLEAGTRYVLKTHNVKPDDFVQSFKYYVVKEKMNGIAEEAQKIVLEKDPKADKYVKEKL
KKNQNLPTFAR
>KALACAFP_01052 Undecaprenyl-phosphate mannosyltransferase
MKKLVIIPTYNEKENIENIISAVFALDDDFHVLVVDDTSPDGTAEVVKDLQRRFPHYLHL
SIRHVKDGLGKAYIHGFKWAIENQYDYIFEMDADFSHNPNDLPKLFEACKNADMAIGSRY
SKGVNVVNWPMGRVLLSYFASKYVRFILGLPIHDTTAGFVCFSRRVLEEIGLDNVRLKGY
GFQIEMKFRAFKKGFRIVEVPIIFTNRILGESKMNGGIIHEAVFGVLNLKWKSIINRL
>KALACAFP_01053 hypothetical protein
MPLSQNITNHIRIPENNDWVIFILLGCIFLYLFMMNVIEREANLKDFLLQKYFDASNNLP
SWVITSCVTVLTLSVLISQYIPIVPKYIADLHILGYQLNKFGFCLIAIVFFYLIKSTLGF
LFFQSIGDGKRWSIFYFTSTKFYFILSFLLIILCVTHYYFPIDRNKMFLYYLIFFSFVFI
FKVFFYLFHKNNILPEKWYYKFLYICTLQIAPLLLLWKLLFF
>KALACAFP_01054 hypothetical protein
MRIKSILVSQPAPSESSPYLDIAKKEKIKIDFRPFIHVEGVDNKELRTQKIDLTQYTGII
FTSKNAIDHYFRLAEELRFTVPDTMRYICQSEAIANYLQKHIVYRKRKISFGEKNFSDLL
PLFKKFPTEKYLLPSSDVLSPDIVKTMDTANVDWTRAIMYRTVCSDLTDITIKDYDMLIF
FSPQGIKSLQQNFPDFKQEETKIGVFGNTTLAAAEEAGLKVDLMAPTKETPSMTMALEKY
IKALHK
>KALACAFP_01055 Protease 2
MEAPQAKKIEKTLEIHGDKRIDNYFWLNERENPKVIKYLEEENAYADFIMKDTEQLQEDL
FEEMKARYKKDDESLPYFFNEYWYIVRYEEGKEYPIFCRKYKSLDNEEEIVVDVNILAEG
ESYFEVGSVAVSPNNELASFSSDNVSRRIYSINFKNLKTGEILPDTIENTTGKAVWANDN
EHVFYIRKDASLRAFQVYRHKLGTDSSEDILIFHEEDETFDVNVFKTKSLEYIFIASSST
ISDEHRFIPSDNVFAEWTIIQPRIDDLEYSVEHYEDEFYIITNADDAFNFKIVKTKINNC
GMENWVDVIPHRPEVLLEGFEIFRHYLVLEEREEGLLQIKIIAETTQESYYLPFSDPTYT
AYIGVNLEFDTEVLRYGYTSLTQPSSTYEYNMKEKTTVLLKQQEVLGGKFFPENYISERI
WADSRDGETKIPISLVYHKDTKRSADTPLLLYGYGSYGHTVDASFSNVRLSILDRGFIYA
IAHIRGGEYLGREWYEDGKMLFKKNTFFDFIDAGKHLIKANYTSSKHLYAMGGSAGGLLV
GAVVNYEPALFHGIVAQVPFVDVVTTMLDETIPLTTGEYDEWGNPNDKEYYEYMKSYSPY
DNVEAKDYPHMLITTGLHDSQVQYWEPAKWTAKLRELKTDNNILIFKTDMSAGHGGASGR
FESLKEDALEYAFLLMIDKK
>KALACAFP_01056 hypothetical protein
MINEAEYWQKIEQFFIENFDTEKNAPIETYLFLIGLQELGSGQQKYTKDDKVNLLHIAVC
RLLEPFGYYKFSHYDDDGYPHFEPLEELPELKPNEQQILMKKAIIQYFQDEELI
>KALACAFP_01057 hypothetical protein
MESNIIFNKDFESNTVYVMKIYHADVSKVWNYFTKAELLDQWWAPKPWKCETKKQDFKEG
GVWLYSMVGPEGERHYAQVKYREIMEHRSFDGTDTFCDENGNVNPDFPEAKWLFGFTGVE
EGTKVTVNIHFSSTEAMKQLLEMGFEEGFKMGLNQLEEILK
>KALACAFP_01058 Sensor histidine kinase ResE
MNNKFIPIISVFMTISLIVFVTLQFYWLKGYYGALEQDFSNKTYSALESISKNINEIETD
KYLNQNFRGFRDNIVANSNQPSLTAIQQVEDSGTQRQIIYSKNIIEKTQLPISQKGDSIK
LTTLYTDEAAYKIKRDTTNRELLTAEINHDIESGDYTVKEFAKVYGNNLPIAKRVDGKVL
DSVITKELRIRGISAKFGYGIIDKNNKLTSVVNKDYKEKKDYNTYSYPLFTDQKERTLYS
LALVFPKKEYSLAKDNWPMLLGTFLSLLTILGIYIISINYMMKQKKLAEVKTDFINNMSH
EFKTPLATISVATDSLANDKIATNPDKVKYYSELIKQENLRMKKQVENVLNMSKLERNEV
KLFLKETNVRELIRKTTESFNLIVKQRNGTLTQEFNATDYIFKIDEFHISNMLVNLLDNA
NKYSPEAPEISIKTRNEGHYYVMEISDKGMGMETQNKTKIFEKFFREETGNIHNVKGQGL
GLSYVKKIVELHKGLIIVDSHKGKGSTFTIKLPMS
>KALACAFP_01059 Response regulator MprA
MSNRILLVEDDQSFGAVLKDYLTINNFEVTLATDGEQGLKEFTENEFDICIFDVMMPKKD
GFSLAEDVKKIDKNTPIIFLTARNMREDILKGYQLGADDYITKPFDTELLLYKIKAILQR
SSTLENEEQEQFKISNIFFDSMLRQLRVGDNEYKLSPKENELLKLLCIHRNDFMPRDLAL
RKIWKKENYFTARSMDVYIAKLRKLLKDDEGLEIINVHGEGFRLLVKN
>KALACAFP_01060 hypothetical protein
MKNTFLGIIAISILTISCKKDERATYIEEEAAIQQPNVAVNNTPKPSLLDQAGIQNTQNP
TAATATAPGMNPPHGQPGHRCDIPVGQPLNSKPAPAQQQGTQNVTVNANQGQTIQIDPNA
LQPGKFQVDNNGKAKTIKTAKGMNPPHGEPGHRCDIPVGQPLNSKPAPAPQPVQTVTQNT
PAPAPAPTGPKPAVNPPHGEPWHNCAVKVGEALP
>KALACAFP_01061 hypothetical protein
MLRFHRKTVVNPNPEWIAAKPITTSTLKTVTTKKNKNLLATTIAVQAVWLVTPS
>KALACAFP_01062 hypothetical protein
MKLYISRITLGIFLLSAQFIFAQNLSKSQFTVKGNCEMCKERIETTAKKAGAKEARYSID
SQTLTLETDTHTSTDDILKKVAEAGHDNEKYKATDATYEALPGCCHYDRDLQMSVAENHD
HHSKKENEFYVKGNCKSCKARIEKAAKDAGADSAEWSAEKQMVTLNFDPKKTSSDKILKK
IADVGHDNEKYKSSDNTYKNLPACCLYDREIPFGEANPKVHLEEGTTAEHTDHIDHNAAN
ENHEDHEKSIESVTVSGTKGSTVLSKKDAGLVFNIDKKELLKAACCNLSESFETNATVDV
SFSNAVTGTKQLKMLGLDQKYTSLTKELLPEIRGLASAYGLNFIPGRWIESIQLTKGGST
VTNGYESITGQINTELLKNAEKPETSLNLFSDFNGRAEANITSVAPINDKWSQTFLLHGN
GTFGDTDMNDDGFLDRPKGTQLNAAYLLNYNDLEKSGLGSHFGINFIKDERTSGQIGFDK
KIPQDKQSLYGVGIDILRFQVWNKTGYVFKGKPYQSLGWMNQYTYHQQDSFFGLRNYSGK
QQTYYSNLIFESILGNTNHKYKAGASFMYDGYDETYLTTNFKRNEIVPGAFAEYTLTGLK
YTLVAGARVDFHNLAGTQFTPRLNFKYDFTPQTILRLSAGRGFRTANIFAESQQYFASNR
NIQILQNGGNIYGLKPEIAWNYGASLQQEFKIFGRKSTIIADFFRTDFQDQVMVDLDRSP
QQLTFYNLEGKSFANSFQTQWDFTPFKNFDVRLAYKYYDVQADYLDGRREVPFMAKHRGF
VNLAYSTNKNNKGGFWSFDTTLNLVGKQRLPDTSSNPEEFQLPTYSQSYAILNAQISRNF
NKKIRAYLGGENLTSYYQKNAIVDFKNPFGNYFDGGMVYAPIMKANFYIGLDVTF
>KALACAFP_01063 HTH-type transcriptional activator Btr
MSQTLIFEDHYKKLGFEIFSEDNLQTLKDTRYKSEIKVFYVPEGYELTVDFKQYSTENPA
LFFLTNQHLQVEKGSKESNLLYYNRDFYCIQIHDKEVACDGLLFHNVFEIPFVELDEDEN
LIIKNLFQSIKDELEWKDSSAEEMIRTYVKQIIIRATRKWKKQNLDNDTIKIPSNELDVF
RDFSRHLEIHFREKHNVADYADLLHIAPKTLTHKFKSLNLESPNQFIINRILLEAKRLLF
YTDKPVKEIAYDLGYEDPAYFNRLFTNKIGSTPTNFKKNYTSGKKYNI
>KALACAFP_01064 Peroxiredoxin OsmC
MRRNATAVWNGTIKEGNGHITTQSTTLNQTQYSFNSRFADGVGTNPEELLAAAHAGCFTM
KLSAELSQAGFTPEELTTKSVITLDPNIGKITKSELTLTAKVPGISEEEFQKYAKIAEEG
CPVSAAFNFEITLEATLAN
>KALACAFP_01065 putative HTH-type transcriptional regulator YxaF
MSKAEKTKQFIIEKTASLFNTKGYLSTTLSDIAQATNLTKGSIYGNFANKDELAIEVYKY
NSGVLSKSMSRSFSDEFPTTMKKLHAFVDFYRKNWRSVFSNGGCPLMNAATESDDIFPTL
KNQVKKSFEDWSGKISSVIIQGQKNGDLNEKANAEEYASIFIMLLEGGILLSKTTGDEKF
LNLALDKITHMIDKELNILPS
>KALACAFP_01066 3-ketoacyl-CoA thiolase
METKKVAIVGYNRIPFARMNTAYADKGNQDLLLPTLNGLINRYNLKGKLLGEVAGGATIK
HISESNLIRETVMNTSLDPATPACDLQQACDTGIEAAVYIANKIALGQIESGIACGVEAM
SNIPFESSPRLRKALLKANKEKSVFGKIKQLLSPKLKDWMPIPYKGQEPKTGLVMGGHTE
ITAKYYQISREDQDELAFRSHQNMAKAYDEGFFDDMITPAYGLDKDNNLRRDTSLEKLAT
LKPAFDKQNGTLTAGNSTPFTDGASAVLLASEEWAKANNLEILAYITFSEIAGIEYVENK
QNLLLAPVFATERMLKKAGMNLQDFDYYEIHEAFAAQVLATLKIWENDDLAKKFGLEKAL
GKIDRNKLNVKGGSLAVAHPFAATGGRIIGTLAKLLHEKGSGKGFISICAARGQGVTMIL
EK
>KALACAFP_01067 hypothetical protein
MDRLAQLKQFIGKEFDQSPSPFMKWLNPIILSAEEGQLEFQYTIRPEWLNPIGNLHGGVT
AAIIDDVIGATMFSLNENSFVTTINNVIDYFSTAKENDNIVAETKIIKRGKQFVNAQCEI
WNADKTRLIARGTSNLFKINN
>KALACAFP_01068 3-oxoacyl-[acyl-carrier-protein] synthase 2
MKRVVITGLGAVTPLGNNVEEFWQNSINGVSGANTITHFDTEKFKVHFACEVKNFDPKVH
LTHNEIKKSDLFSQYAMYSTAEALKDSGLELENMDPFDTGVIWGTGQGGMWTFESEVMNF
AAGDGTPRFNPFFVPKFIANMASGMISMKFGLQGINYTTISACATGNTAIMDAFNYIRLG
KAKVIVSGGSEAAISPASIGGFSIMKAMSTRNDDFATASRPYDADRDGFVMGEGAGALIL
EEYEHAKARGAKIYAELVGAAMTADAYHMTAPHPDGVGAIKAMQLALKEAEINTDDIDYI
NPHATSTPMGDLVELNGINKLFKGSKNLDISATKSMTGHLLGAAGAAEAILSIKAIENGI
IPPTINLHNIDENIPKDIHIVFGEAKEKDINYALSNAFGFGGHNATLIFKKFS
>KALACAFP_01069 hypothetical protein
MKDNSEFISAVRLFNDADGSCRFEKGKLPLLKPMNTTTFWLNNKTEEWERVDHPAPRRQY
VVTLKGKIRFKVTDGSTFLIEPGVILLAEDVEGKGHSWEIEDGDQWERLYIPLAENAESF
FIADSM
>KALACAFP_01070 hypothetical protein
MKGFYSLLGIVYMVTTSFYLSPKKAIVKNEISTKKIERLTDTKSETTTENKVSSSEELYR
SIAFEPGHELNEEVFFKALTGFENLKKAGLLKQDSHLLTICDFSMSSNSKRLWVIDTEER
KVLFNSLVAHGKNTGEEFATNFSNTDSSLQSSLGFYITDATYDGDNGYSLRLLGMDKGFN
DAAYRRAIVMHGADYVSEDFAAMHKRIGRSWGCPAVPRDLTQPIINTIKGRNLLFIYYPD
QNYLSKSEWLKSSI
>KALACAFP_01071 Peptide methionine sulfoxide reductase MsrB
MENEAKNNPYYSKTDAKKLDISNEEWKKILAPDLYAISREAATERAFTGKYNEFDEVGEY
YCAVCGNHLFRSTSKFSSSCGWPSFFEADKEGVYYKRDLAYGMDRVEVLCKRCDSHLGHV
FDDGPKPTGLRYCMNSISLEFVPDSQK
>KALACAFP_01072 hypothetical protein
MNDEAKRKQLRKYKAFATGLFLLMAVIFVITTILQKNNDSHWIGYVRAFSEAAMVGALAD
WFAVTALFRHPLGLPIPHTNLIENSKQRLGDNLGSFVVNNFLSPQNIRPYIQKIKISGFV
GEWLGKEKNQEVLIKNLSDIVLDILNKLDDSTVSEFISKKVTDMTDNIKLNKIVGNGINY
ILEKNDHQKIITNLSSQIKNYIIENDEMIQDRVKKGSYSFIPAFVDNKIADKIASGLADF
FKEIEEDPEHEIRMLITKKIHEFSTDLKEDPKWDDEFKTIKNDLLKGDKLDEYSIDIWIS
IKETLTKELQEKNSSLKNYISKNLNEFSQNLKTDENLQNKIDHWVRVTAYKYILKNTHQF
GNLISSTVGNWQGKELSEKLELEVGKDLQFIRVNGTLVGGLVGLLIYTIAHFFL
>KALACAFP_01073 hypothetical protein
MKKILTLLFCLNLTFFLCQKVELKKITDSSQVFKGEIAGVPVTLQLKFSGIVDCHQYQHF
VDGWYYYDKYQKKIPLTGVYNLGNLYLFNFGDKQKKASKAFKEKITRDLIEKSDSIAKTL
KSKESLIFDRNDSKKDVSGNFHFANKTLSAKLFTKDTRIYRYNNYLSIPNNKRINTYDFI
NAAGGNELISYISDSTGNRVLLYFEEPSNFNYCGMCGASDGEKGYRVLYFTKDWNYKSYE
EFLTESCLENIYDTKFTKSKDSKILKFNIQKNTTSPAYTLTVDVKNASVKKLR
>KALACAFP_01074 Dihydroorotate dehydrogenase (quinone)
MYKSLIRPILFKFDPEEVHHFTFSMLKNFGFLTKLFFPKPIEDKRLEREVFGLKFKNPVG
LAAGFDKNAVLFNELGDLGFGFVEIGTVTPRAQAGNPKKRLFRLIEDGGIINRMGFNNDG
LQAAIEKLKGNKGKIIIGGNIGKNTDTSPENYTQDYLDCFEGLHPYVDYFVLNVSCPNVG
SHAKLEDVEYLRELITEVKKINQSKAVQKPILLKIAPDLNNNQLDEIIELIAETKIDGIV
VSNTSVNREGLKTPPEVLEQIGNGGLSGKPIRERSTKMIKYLSDRSNRAFPIIGVGGIHS
AKDAIEKLDAGATLVQLYTGFIYEGPELINDINKEILKRASRLPR
>KALACAFP_01075 tRNA pseudouridine synthase C
MLEILYRDEHLIAINKPSGLLVHKSFYSGEADTYAIQELKKQIGQKVFPVHRLDRKTSGV
LLFTLDKETLRAMSDQFATREVEKKYLAILRGWTKEEETIDYDLVNENEVKQNAVTYYHR
LQTSEIDLPFLKHQTSRYCLVEAIPETGRFHQLRKHFKHILHPILGCRKHGCNKQNKLWL
QTFSINKMTLHAHQLVFNHPISNERITVNATIDDEFKRVGDILNFDLSSYS
>KALACAFP_01076 hypothetical protein
MEEYSNFFESLIIISIIMAALTLAATDPKKHKIIRITLFVIAAIFLIAGLGGYFLITVSN
VGSYRY
>KALACAFP_01077 Glycine--tRNA ligase
MAKQEDVFKKVISHAKEYGFIFPSSEIYDGLSAVYDYGQNGAELKNNIKQYWWKAMVQLN
ENIVGIDSAILMHPTTWKASGHVDAFNDPLIDNKDSKKRFRADVLVEDYCAKIEDKEKKE
IEKAAKRFGDAFDKAQFEATNPKVLEYRAKREAILSRLAKSLENEDLADVKALIEELEIA
DPDTGSKNWTEVKQFNLMFGTKLGASADSAMDLYLRPETAQGIFVNFLNVQKTSRHKLPF
GIAQIGKAFRNEIVARQFIFRMREFEQMEMQFFVAPGTELEFYEQWKQKRLNWHLALGLG
DDNYRFHDHEKLAHYANAAADIEFNFPFGFKELEGIHSRTDFDLKAHEKFSGRKLQFFDP
ERNESYVPYVVETSVGLDRLFLSIFSHCLKDEILEDGSERTVLSLPPALAPIKAAILPLM
KKDGLAEYAENIFNDLKYDFNLFYEEKDAIGKRYRRQDAIGTPYCITVDHDSLTDNTVTI
RDRDTMQQERVPVSELRRIIDEKTNFRNLLSKI
>KALACAFP_01078 6-aminohexanoate-dimer hydrolase
MVILIYFLTFIILAALLFYLLGYGYLFSGISKTYLRGKTSANIDDGKFFTSNLIATESPK
LWEEAPEYNKTELPKNIVEDLIHSNTASFLVVKNGKLVHEQYWKGYHQLSKTNSFSMAKA
VTVMLLGKALEEGKIKNINDKFSDYFDEFNTKEFGKEVTLKNLAQMESGLNWDEDYKNPF
LPNAKAYYGKSLMKATFSRNFKENPGNRFEYQSGSTQLLGFAVRKAVDQSLASYLSEKFW
IPLGMEQNAEWSTDESGMEKTYCCIHSNARDFAKLGQLFLDNGKVGDQQILNLDFIEQMR
TPTQKSGEIYGMGFWINNDNPIKHYYFLGLQGQYIVMIPEHQMVIVRTGSYNNLPKNDRG
RPDQVKFLVNETVKLFA
>KALACAFP_01079 hypothetical protein
MEKYDTKVDEYIEKSPDFAKPILQYLRETIHEVCPDAEEAIKWKFPTFMYKGKILCSITS
FKQYCSMGFWLHGEMKTIKELETNAEKSSMFSLGKITKMEDLPAKPLLKKAILEAMELTD
MGVTMKKAVPSKTETPIPDYFKEVLQHNKKAWEVFEKGSPSFRKEYINWITEAKTEATRN
KRMEQAIEWISEGKGRNWKYEKK
>KALACAFP_01080 DNA polymerase IV
MYALVDCNNFFVSCERTLDPTLEGKPVVVLSNNDGCVVSRSKEAKDLGIPMAAPAFKYKE
LFKEHDVKSFSAKFELYNARSQQVIDIASSFVAEYEVYSIDELFLNLTGFKYINIHDYCM
EIKNKIKTEVNIPVSIGIAPTKTLCKVANRIVKDFPGNFDGVYILDTPEKIEKALKWLNI
GDVWGIGRRLAVKMQDNGVYKAWDLLQKPEMWVRKVMGIHGVRMINELKGIRQLELDTPS
PKKSIAVTRSFMEMLTKKEDVRERVETFGMYCSERLRKQNTCCKMVTVFVQTNRFRKDLP
EYRNAITQILPNPTNSSILIGRVVNELFEAIFKEGFHYKKAGVIVNDFVPEDQRLINLFE
EDTQNQHLPVMKAMDAMNKKFGKDKVRLGSMSGENTYGRKQLSPEYEAFLKNNTLKEANF
RFH
>KALACAFP_01081 Peptidoglycan L-alanyl-D-glutamate endopeptidase CwlK
MDKVTLQRIERLHPLVREEVKQIIKECDEALTGRAKVRITQGLRSFEEQEKLYAIGRITN
AKKVTNAKAGQSIHNYGLAVDICMMIDGKTASWDTVKDWDNDKVADWYECVKIFAKHGWD
WGGNWKTFKDLPHFEKKNIVTQKGLVKTSWRTLLKMKADRDGYVIL
>KALACAFP_01082 hypothetical protein
MKKTTILSLDGGGIRGIITCIILRYIEEQLQFYDNPSAKLGDYFDLVAGSSTGGLIASII
LCPDEHRKAKYSIQKGLELYAEKGGDIFQVSFWERLVNPFGLINEKISQQELEKNLNAFF
GNLELKELIKPCLITSYDIENRRAKLFNSWKANLSTDNFYVRDVCRATSAAPTYFSPVQI
KSMYGQIFSLIDGGMFANNPALCAYAEARKIPFAEILKNHQKANHPNVNDMIVVSIGTGI
EARPYSFKKLEKAGKIGWVNPIIDILMSANAETVDYQLCQMFQTLGLRNQKNYYRLNPSL
KNASPAMDNVKRSNIENLIQAGLTYIDDNREVLNQIVQKLIKNKI
>KALACAFP_01083 hypothetical protein
MNSTFINAGQPEIRSKFKSNPQAQNMETPNHNPDTIFDEELYTIEWSDIENAEIDYDNYL
NDIENFFREDFENDLLEEGMY
>KALACAFP_01084 hypothetical protein
MKTKQELKLYFENGDKPIQEHFWEWLDSYWHKDEKIPQTSLDAIEKVVPFLVNNNLQGSA
MQLTVPMNTKKILNSAYVYTGMPYQIVKVMFNEGLEEIEPSAFHSQNIKSIETPSTLKVI
GAYAFANQGNNINGMDSIEEIILNEGLITIGDYAFSSGRVTLVKNLYIPSSVQSVGLGSF
NIPSLQTVSAPAGLDLSNAGIPATATITYR
>KALACAFP_01085 hypothetical protein
MKTKQEIKKYFENGDIPNQEQFWDWQDSYWHKDEIIPSDKIDIDLSNKADIVGGKVPATQ
LPSYVDDVIEFASFSALPSQGEQGKIYITTDNDKLFRWTGTRYVDITQGDVGTLQAVTER
GNETTENVKLQGIYFGGLASAENIIIGDESSYVNNRAGGTIAIGKGAKPQGTDHLVIGNN
AVAINESGSIGNTVVGHFSMAQSTSSSENTVFGYNAFSSADYAFANTVCGSYAGLFSGDN
LTQNIILGYSSGCGLGTLSTNNIIIGAQSAFGNAVLQNKLYIHSSTTTPIKTVSDALISG
DFNDRYVNINGKLSVTPGQMPSADSSFTKNLVAKPDGTFGWENKNEALPLSGTDANKPLT
GSIEYKGNDTTGINSFGFYSKLSNEKSGFDIQNDGTLTPTMYLIGDTKTDLYLSSDHVGI
GSSKPDFSGLKGNIYYGDYYQDESYVQKKYVDKKISYSSTEEKTGGRWINGKPIYKKTVV
YNTIPSDGEIDITAAFTDMEVIVSNQMFTDWQAMGTAFAGNQWKAETFITLAMNSVKIHS
IKFPDYDFSLLDSFTLTLEYTKTTD
>KALACAFP_01086 hypothetical protein
MATENTQNNSSQTLFRFVSLRNPQLTETKKENLGFIQRPSTLPSVFDGKVNPNDSALAKF
QALEREAKNFDSTGYESELIIEQGALSEALKIGRKIAKRETLSLSDENTAISLYNSSSIQ
SKVAAVWDNLMYQTVTEKNFYVKEALVHILKALHFGYVCNLPVTEELTKINGTDLKAKAL
EARVVLPMKFFGDGYEGENSDPGSGGSGSTNNAFQVNVSQIGNGVINGTDIPLSIQHQLV
AEGDKISELSKLNFEKEGLTKLKSELEKIQVVYVKSKNKAQETAYSAYKEEYKDEFDAYN
SQIRQIKSQITEDMTQQEIDQLYEALQPLNVPPFEFAYKDQLNFEDFKTKLSLDSLKLFV
SLFTELESGEIPADGYDFSIITVLTDRKLQLGNVVVEMIDFYDTYVEVFEKLDQELSANI
QQLFQKSPLQEQKYLNLGNVLVPVSNSRSNLSQVISRTYYLKASYNPVYSRTPASLTFYY
QAESSSWGLGSAKILATTDIGNFEETYSNISIVDNKVTFPPILVDKFAKLIRSLRIQIFF
NNGKQATVEYTDLIIDQPYTGVLYTEEKITEDPENPEQGGQTPQPGAFFPKHFGVKRLGI
ADYLKVVQTTHAYVPGEVTHIENVMAKEFKQKSTRRLRRSEIQTTTSKSTERETLSDTTT
TTRNDMQSEVANIIQQDINAEAHFSYGNNKTFQVGGSFASHNSKENSTRQAIAKSQEITE
KATERLLTKVAEERIEKIIEEFEENNAHGFDNRNGDKHVIGVYRWVDKKMKNQIYNYGKR
TMFEFMIPEPAKLHRLATAATVTETLTAPVDPRTSPAPWTMADPKSASVDQLQHWASIYN
VKLTELIESTKKFTTGKTWVKLDGSNEYQHIAINIPDNYQASHVKMWYGFEKDVKGIARL
FTSNFVGGFNQIVETYSQSVDLIADFDPQNITGSYDFMYQGHNIDSVNFTFEVTCKLSDA
YMNAWKQENFDAIITAYQDAYAEFQEKKKELEAAAKEQEEANKEKLSNFYRDMERVILKH
NCIAFLLQDYSALGKNLTNNAKAMQDFSIILDENLDQYTALAKFMEQAFEWTIMDYTFYP
YYWANREEWQNMYLSESADPLFRSFLQAGMARVIVTVNPGFEDAVQFFLTTGRIWNGGEV
PVIGDPMYMSIVDEMREPLGLKQGKAWITTLPTSLNILQKDSAGLVTTTALPFTQENPDE
FEIPEDVVTETEFSIVDSQLNSGDDRFVDNIELNNGFLQLTTDDNPKEVVAQLPLADLKD
ALQ
>KALACAFP_01087 hypothetical protein
MNFQEYLNEIGYSDNPQEEFQNFLKNKNNVTFPKYGNTKRGMDNVNSFLKSAPLDNSLNS
QFTEQIYFMDSHTADYNSVKTVTDVGSDPEEMKIKSEEFYYYPNSENKKFAFGVKIYTSK
SAKKLEEAYKVTKPGTKEILFFIEDNTGDKTDFTFGAVRVGEYVQESLLSTYDAHVKKNE
SLKDFLIKAFKENTGQDIDRGFVDELLRFGKAQYPLLRGISGVYKVVDFITFGAFTQFTM
DGLSNLLEVAIEYVNKVKISEESWNPDAEKGFSPLFYPKEAEKAFDNIDDDALNKQVQSI
VRRYSDDLKAIDKYIVDKLKIDNLRSKNNGILGVNDIVYSAFSSVHTKCLNIINDLGNFD
LSEILKTGIRSINAFACGIWNSLVDTIASLLGMIKMIVDTSITYKTLMKNLETQLPKLIE
RIEEALQAWEKIDFKQCVLHFIQKTLESNLTISIVKVAYYLGCFYGFIISVIIEVIIGIV
ISGGALSVEEVARRVFQELFGLISGITKDAKKAFDFTRKLTAKSFAKMVEGLDALIELME
KGTAGIMKLIDEMYEIGSRLKEFIIEAYQKLFNTNARKKLESLGLHPTRYEKGVFDLCPI
S
>KALACAFP_01088 hypothetical protein
MGDIKKCIKLATKAIDEENFCTIIRNNVEIFEDIPEKELDNFFLEIENEAKRAGRKIDDQ
LDYIVDLKKIAKQLSFGKNKLVKYRKHAQQIRKLAKRLNIEIPSKVSNPNTQKVIDDYIS
KVISEGHVRKGPYMTLGDCVYCKLDDAIIIQRLDGEFVTFLEHSLGGVAKMWDQI
>KALACAFP_01089 hypothetical protein
MNKLKNKTFNGIYRINILEEGTKYELEDSIVLKGIETYQLFTTQESLDVLKINNAYHIDG
EYSSNHIDIVPIIEEVINVNKISIVYDKDIDQIAAFSIKSNAKNYFFIRYSDELNVVEKN
EYEKLTSNIKKIETIEI
>KALACAFP_01090 hypothetical protein
MNYSFKKHDWDGTTVYGVESSDKKILSNFGSWGWTPVKIQNIINGVEASKIKAYGKEYNW
SSEELELYANKKGVLLIDMMAQRAGQKDPSSSTLKLSHNEILKFLNDFKIFVENN
>KALACAFP_01091 hypothetical protein
MEYKVIYRDEYYNQHYPKIVSNVNILHPLEISWHYENKIFSLLSSSDDYIGNAYVSDNFL
IIRYTENSNTLHFANNLIVYNLNKEIIHIIPPPKPKKWSKSNSIYSLGDKKIIEGKEHIA
VSIFKADYNDNHSGQEEIHYLNLENLEYHPSYFESHYDSGR
>KALACAFP_01092 hypothetical protein
MKKDFYLTRYALIIKRLESSPATYSQLEDYLLNSFEFQDAGIKSYSIRTLQRDIREISDL
FNLSIHNKKKGDNRYYIESRPTMEVDEYNQKQPQQEKD
>KALACAFP_01093 hypothetical protein
MKKITIKREYNQGITILKVLSYFRDKNIIQSIEEIGNYLDSYEKYDKVEINGDSDKINLV
IEELNEYGVIYEVN
>KALACAFP_01094 hypothetical protein
MKKDFYLTRYALIIKRLESSPATYSQLEDYLLNSFEFQDAGIKSYSIRTLQRDIREISDL
FNLSIHNKKKGDNRYYIESRPTMEVDEYNQKLLESFQVSNALNLHPDFSDFIFFESRKPT
GVENFYDLFFAIRNKRIVSFEHYNYKNKLMTSRKVHPLALKESKDRWYLIAIDTKDKALK
SFGLDRINYLDVSDKKFREKYNYNFREHFKNAFGVMNLTEQNPQKIVLKCSRHQGEYIKS
FPLHQSQNSIKETPEEIFFEFFLHPTYDFMQEILSYGKEVQVLEPKGLVDDIRNHLQESL
NRYLES
>KALACAFP_01095 hypothetical protein
MKSLILCLFCLISSFCFSQQTEEFKNVKNYYNHHRVLINNEFQKKYRTEPNVASKDAIKK
DFLLFMKKMDSIENVALIGALLKVKNLEDLNKIQTKTSTAENQSDMVTTTDKAADYPGGI
NALRQEVANLFYSDGVYAEEKTVKTDVAFIVEKDGTISNVHAQGNNFTFNRQAEIALYSI
SEKFSPATLKGNTVRYHFRLPLTINLE
>KALACAFP_01096 tRNA-specific adenosine deaminase
MFTDEYFMKMALNEAEIALEKDEVPIGCVVVSNNRVIARAHNLTETLNDVTAHAEMQAIT
SAANFLGGKYLKDCTLYVTLEPCVMCSGALSWAQISKVVIGARDEQRGFINKNLSLHPKT
EIVTGIMENECSSIVKEFFKSKR
>KALACAFP_01097 Putative ribosomal N-acetyltransferase YdaF
MLLNLNLSLNLRFNLNTMHNFPKIETERLILSQLKEEDLPFVVDYLQDKIFSDLTSNIPY
PYRQEDAEFWLKMSKEAFEKGSGFTFAIRDKDEKIIGAIGLHDRGEGKAELGYWMAKTYW
NQGFVTEAAKAVLDFGFKELTFNKIFATHFLHNPASGKIMEKIGMKKEEILHQHIKKDGK
YFDIALYSVLKKFN
>KALACAFP_01098 Type III pantothenate kinase
MNSIVINIGNSNIRFGLFDDDNCDISWVINTKPYRTADELYAQMLMLYQTYKIEPQEISK
IIIGSVVPQLTKVMSSAIKKIHGILPVIVDRNTPSGVAAKSKQMGTDIYANLVAAHNMYP
NRKKIVLDFGTALTASCVAEDGETLGVIIAPGIVTALNSLISQTAQLPEIELKKPKTVLG
LDTVTCMQSGMVYGFLGMVEGFIDRINEEVKDDCFVVATGGVSHVYKPLTDKIHVMDRLH
TLKGLYFLGKDL
>KALACAFP_01099 hypothetical protein
MKKLALLLLFLLSVHSFAQSAETIRTLFQKMKKDANIDKNDKAVYNLLDEFYNKSLQADN
DEMTAETVEKIQMLASDKNTKNLHILMLFLMYQQHISQTAMVGKPSNPEFQIETMRLLED
ETKDVYGKIPAIIYIYKYEALDSGKEEDQARATIAQGLKEYPDSVPLKVYSYLNTKDEKI
KNDLIKNHANHWMVKQFEIQ
>KALACAFP_01100 hypothetical protein
MKKSVAILFAFIISQFQAQQGAYYQQSAKYKMDIDVNAEKFTYQGNQTLEYTNNSPDELN
VVYFHLYWNAFKPNSMMDQRVAGQGKNGDSRLQKDGVSRLASIPKNEEGAQNIHWIKQNG
KDLKFEIQETIMKVYLAEPIKPNSTTTFTMNWDAVIPQQIRRSGRNNKEGVDMTMTQWYP
KIAEYDYDGWAAFDYIGREFHAPFADFDVTIKINKDYVIGAGGILENPTEVKGYDANAKI
KAEKNKATWRWTAKNMLDFAWSADKDYVVKSFDVPQGPKVFLVYQNNDKTKVWEQAQPYI
TKYFQIMNSHFGKYVYPTYAFIQGGDGGMEYGMCTMILGEAKDINGLMGLMAHEGAHSWY
QQMLATNESMRPWMDEGFTSYAETYVMSQLFPEDLPNPFANSLNAYRNFIKKGIEEPAVW
LGDHHDNGNSYTYASYVKGELYLVELGYIMGEQNLAETLKQYYDQWSMKHPSDRDFLHIA
QKVSGMDLKWFQNYWINTTKTIDYGIKDVKYEAKSTTITLVNNGQIPMPIDFSVMTTDKK
IVTYQIPMNMTHTWKEKDAYGEFKTMPYWPWTQKEYTITVPYTKSQLSVLGIDFSQRLAD
VNLEDNFVEVK
>KALACAFP_01101 hypothetical protein
MSSTLQLAKRFREVLLDGLWIANTNFKDQLKDVTWEQATTKIGTLNTIAMLTFHIDYYIA
GLVNVFEGGNLEIKDKYSFDLPPIESQEQWETLLNKLWNDAKKFASLLEQMPDSKMNEVF
VDEKYGTYLRNIDGMIEHAYYHLGQITLIKKLLN
>KALACAFP_01102 hypothetical protein
MQGDFVYLCEIYFMTNSRARETTEAIERLYISMRHLFYRGFFKPAGVSGESIRSLLKTIN
PEIYGSMNIPSKLELNGLMYVLDRLPEGIEECAFIHLTSDEGFDKGSFEPIVPKKRRRNC
YRIDEHQMNIEVLLGRSEIYDILTHLTFLFIEADKVRNLAFIQDENWKPTRAFKIIEEVV
KGEKKFSRKEKEVALIHLSSLIGRTFDETLNAYNTFGDDKNPDRLFKIIYNLAKVSLEDA
KQTREREIHFSAILKERVGHHYFGEKWANKVKEVLFENDLHMRPLHIISANMHSVKNMLY
ANDALKKKDPKEVDYKLYGEISDKKELRDKVSKYALEEGMIYINDKSGSNIDVQIIDLSK
TNLKNTPFSGIKFGGDDVIMVFDYAFGEQAYEVMDELLRPYEHKGEVYMMKVKSVSIMGK
AGILAGGKGDIMIPTSHIFEGTADNYPFENALKLDDFKDDELKAFEGPMITVLGTSLQNR
DILSYFMNTSWKAIGLEMEGAHYQKAIQVASKIRHHISPDLFVCYAYYASDNPLETGSTL
SSGGLGLTGVKPTYLITLRILEKILQSGKKEVSSKK
>KALACAFP_01103 Glutamine synthetase
MSTLRFKALETLPFKDFRRDNSVEVPVKLSELFCQNVFSEETMREYLTKEAFQSIMDAVK
KGTKIQRHIADQVAVAMKDWAMSKGVTHYTHWFQPLTGSTAEKHDSFFTPIEGGRAIERF
SGNLLIQQEPDASSFPNGGIRNTFEARGYTAWDPTSPAFIMGTTLCIPSIFISYTGETLD
YKAPLLRALNAVDEAATNVMQYFDKNVTKVTPTLGWEQEYFLVDSALYQSRPDLVLTGKT
LLGHSPAKGQQLDDHYFGSIPTRVMNFMKELEIECMKLGIPVTTRHNEVAPNQFELAPMF
EEVNVAVDHNSLLMDIMARIAHKHHFHILFHEKPFAGVNGSGKHNNWSLATDTGENLLSP
GKNPKKNLQFLTFFVNTIKAVHEYADLLRASIASASNDHRLGANEAPPAIISVFIGSQLF
RVLEELEKVTEGKLSPDEKTDLKLNVVGKIPEILLDNTDRNRTSPFAFTGNKFEIRAVGS
SANCAESMTVMNTIAAKQLNDFKKEVDALIETGLKKDEAIFNVLREYIKQCKNIMFEGDG
YSDDWAKEAKKRGLNNLKTTPEALKQEMDKKFLALYEEMGIFTHREVEARNEIKLEKYST
VIDIEARVLSDIARNHIIPSALNYQNRLIENVKGLKEIFGDKEFKTLAKEQMSLITNISE
NVSKIKLGVEDLIKAREAAKAVSDSQKQAEAYCNKVKPLFDGIRDASDDLEMMVDDELWP
MTKYREMLFTK
>KALACAFP_01104 Murein DD-endopeptidase MepS/Murein LD-carboxypeptidase
MKKRVLFYLVAFVSTVSLQSCVTNYVVSKPATYTKEYKTDAKLASIDTKKMEQDKQQLIN
SFLAEKATSLANAKNTIKNSEIAKSIRHNKTIDNILTEASTYLGTPYRYGGMTRNGIDCS
AFVLSVFGAAAGLSLPRVAASQAQEGEKIEKESLQKGDLIFFSHGRRISHVGIVESVSED
GEVKFIHAATSRGVMISSLNDSYWGPKYRFGKRVINENGEAYNNLATTTPASNGTSF
>KALACAFP_01105 Pentapeptide repeat protein
MKQAYFSDQTFENTDFSQFEKGEYENCIFRNCNFEYADLSFSSFNDCEFIGCNLSMAKLV
STAFREVIFKECKMFGLHFDDCNAFGLSFRFDGCSLNNSIFYKTSIKKTVFKNSKLIEVD
FAECDLSNSIFNSCDLSGAVFDNTNLEKADFRTSVNYSIDPSQNRLKKAKFSLSEVYGLL
HTFDIEIDRNS
>KALACAFP_01106 Peptidoglycan glycosyltransferase MrdB
MKWTEGIDKLGLGLYFLLCVFAIANIYSVDQKLGEKQLIFFCISLFVGLIIFVGRSKFFE
NMAGIIYIGGVLLLIGLFPFGKEILGQKNWYKFGSFTMQPVEFAKIGTALMVANYVSGPE
FNLSNKKSLYTTLAIVGIPAAVVLAIPDVGSMLVFIAFFIALYREGLSGLLFGIGFLFAG
VFLISLAINPIYVAAAIVLIIGGWIAMNYYKMSWNVISISGIVGSVVILCGLAFGSPYIL
EKMPKHQRERIEVLYKGEKAFRDTSGYNLLYSKTAIGSGGLLGKGYREGSVTQGKFVPEQ
ETDYIFCTVGEEWGFVGSATLILCYMIYIGRIYYLAEQQKSTFNRVFGYCFASILLMHFT
INLGMVMGLFPTVGIPLPYFSYGGSSLLAFSIMTFIFFKLNYSDKNSLV
>KALACAFP_01107 Peptidoglycan D,D-transpeptidase MrdA
MNTRYLKIFSVLVIVALIFVTRLAYLQLFTDRYALNAANTSIKIEYVIPQRGVIFDRNGK
ILVGNQPAYEISFTQALMKPDFDTLGFCNLMKISKTDFIKRINIIKKEKYYSKLNPMTFM
KDLSREDIARVQEIIFKYPAFSIVQRPQRQYEVSTSGNLLGYTSEVNEREIKKDSTYYLP
GDFIGKTGVEKSYEKELRGVKGMKYIQKDIKLRNIGSYKNGSLDKDVITGKDITLTIDYD
LQRMAEEMLVNKHGAIVAIDPNNGEVLVAATGPDIDPNIFTGPNKSKNLYALSKDTIYEN
KPTFDRSLQAAYPPGSTFKLLTALSAMQMGVMDENTVFPCGGGFYYRGLRIKGHGGADPL
IPAIQISSNCYFSYAYLAILNKYPGNPSKGVDEWKKIMSSFGVGEFLNNDFAVGAKGRIP
SGEFYEKRMKSILKASGSKKDPKNWDPLATGAVFNGMGQGDVLVTPLQLANYVAAIANKG
WYYTPHIVKSIDGKPNPDPRFKKKHQTLVDKKHFEPVLKGMEAVVLRGTAHGLKSNDFTQ
LAKTGTAQVPQGKDNSIFVLIAPADKPKIVVAAVMEHAGFGATWAGPAATVIAEKYITGD
LKREHLYKKMTSSSFMPEYKRQWIADLKRKGLYVEPKPDSLKQKRIQDSLNFIKTQKEKL
QKQIEIETKNKKSKPVTQ
>KALACAFP_01108 hypothetical protein
MISRTLFTDILIMIFLVALQIFVLNRITFFGKYTPVLYPVFVMFYPFFRNKFQFLILSFL
IGLSVDAFLYSWGINAFATTLIAYFRTLIFRTSTDTSTDFFSFQSLQWAQFLLFLFSSIF
LHQLLVQYIEFFKFSRFFEILLNVSITSIISFIFIVIYALIFKIKQKV
>KALACAFP_01109 Cell shape-determining protein MreC
MQKSWIAGQSAALNSWVSGYIDEGVSYLKLKQINEDLVAQNKALMVELYGRQGAKNPQFR
KVHDTLGGGQIYTFVDGEIVFNSINRRNNYFTINRGRRDGVFPQMGVMAPRGVAGIVINS
TDSYALVQSVLSVNKIRINAALKNSGYFGTLTWNGDNSRVMHLADIPKYVALKIGDTVVT
DGKSAIFPKGVMIGTIAGYSVDNKTGFWDISVELSEKMGSLNKVFVVKNLKKAEVQKIQD
TMQAVIKKEND
>KALACAFP_01110 Rod shape-determining protein MreB
MSLFDMFTQEIAIDLGTANTLIIHNNKIVIDQPSIVAIERSTGRPIAVGEQAKHMQGKTH
EDIKTIRPLKDGVIADFHASEHMIKEFIKKIPGIKGKFIQPALRIVICIPSGITEVEKRA
VRDSAQKVNAKEVRLIYEPMAAAIGVGIDVQKPEGNMIIDIGGGTTEIAVVALGGIVCDK
SVKIAGDVFTNDIAYYLRTHHNLYIGERTAERIKIEVGSAVEDLDVDIEDIPVQGRDLIT
GKPKEIMVGYKEIARALDKSIIRIEDAVMETLSLTPPELAADIYKTGIYLAGGGALLRGL
ADRLHKKTGLPVFVAEDPLRAVVRGTGIALKNMDKFNFLIK
>KALACAFP_01111 Glutamyl-tRNA reductase
MKKNVNLRLLMLQYSNIHQTSNFAVLSISFEKADVETRGKFAFFDENIKNFVTRIHDEDL
GDAFVVSTCNRTEIYTTSPNYLLVAEEYCKTIGVNLMDFLQFANILTKEEALIHLFRVAA
GLESQIIGDFEIIGQIKKAYNRFKKERQNSNPFLERAINSAIQISKRIKNETGISNGAAS
VSYAAVHYILNNQKRITEKNILLLGVGEIGQNTVENLVKHVYQPKIKIANRTQETAAKIS
EKYNIPHIDYADFDQELKNTDILIVATGARHPIVNKSHFPNGKETLVIDLSIPNNVDKNV
IENENVTLIDVDELSKQIQETIQQREKEVPKAEKIIKELAKDFLEWEKKRRLAPNIHHFK
AVLKNMERNEMHNFYKKNKYINITDMELSDKMIQKITNRFAKYIIDNPLKAEEISKLMHE
ILVEQPNNEFNEKH
>KALACAFP_01112 Porphobilinogen deaminase
MKSIRIGTRNSALALWQAREVARHLQNNNYLTDIVPIVSSGDKNLNQPLYSLGITGVFTR
DLDTALLNDEIDIAVHSLKDVPTVLPENIELIAHLERDFPQDVLIRKESSRNKEFHELKL
ATSSLRRRAFWLRNFPNAEFSDIRGNIQTRLQKLEEQDFDATILSLAGIKRMKMDIDYEM
LPMMISAPSQGVIAVAGHSHKQEINDIVRKINHKKTQICVEIERNFLNTLEGGCTAPIGA
FAEIFDDQIRFKAALCSLDGKNCIATDENFVYNEEENYGKKFAKIVLENGGKELMTEIKG
QIK
>KALACAFP_01113 hypothetical protein
MKILFTKNIDQAIISKELGEDILVDCVEVIKTNSIKVNPFDLKNYSLIFTSANGVNAFFK
NRFKPNEDFTAKNYNKIYCVGEKTKRELRKHGFGTFKVLKNAETLSKFIISHCQHEKFLH
FCGNMALDVLDRNLPLQNIKYKKVTVYNTEELNPLITEKYHAAVFFSPSGVRSFAKQNSF
DDMMLFSIGETTSSEIKKYVSKQIFTSEENTLASVLNLIRRTIKKT
>KALACAFP_01114 hypothetical protein
MKKLALLLLLITITFSCTQHTGNNASHQVPYTEAQRYFIKNTINTDVVTFKKLTSQEEFD
EVCGAATVMGPNGSPTKIDFTKSYAIALYGPLTNKNPILTITSLIKDDGNIVLSYTLKEG
ETLSYTTRAAKVLIVSKQYAGNISLNKL
>KALACAFP_01115 Uroporphyrinogen decarboxylase
MIKNDLYLKALRGETVERPPVWMMRQAGRYLPEFIALRDKYDFFTRCQTPELASEITVQP
IRRYPLDAAILFSDILVVPQAMGIDFKMKESVGPWLDNPIRTMEDVQNVVVPDVNDTLGY
VFDAIELTLQKLDNEIPLIGFAGSPWTILCYCVEGKGSKAFDIAKSFCFQQPEAAHLLLQ
KITDTTIAYLKRKVEKGVAAVQVFDSWGGMLSPADYQEFSWKYINQIVEALSPLTHVVVF
GKGCWFALEEMTMSKASALGVDWTITPEFARTLTNHTMTLQGNFDPARLHSTPETIKKMV
HEMISRFGKDRYIANLGHGILPNIPLENAEAFIRAVVDWKPNN
>KALACAFP_01116 Cysteine desulfurase SufS
MFDIQEIRSQFTILDRQVNGKPLVYLDNAATSQKPNSVLEVCHKYYTELNANVHRGIHTL
SQLATEEMELSRRKIQKFINAKHDFEVIFTKGTTEGLNLIAYILTQKLKKDDEIIISYLE
HHSNIVPWQLLCERTGAKLRVIPMDENGILQLDTFDEFLSEKTKIVSVNQVSNALGIVNP
IEEIIAKTRKNTNAYIVIDGAQSAPHFTIDVQKLDCDFFVFSGHKMYAPMGTGILYGKQE
ILEDLPPFHGGGEMIATCSFDGTTYAGLPFKYEAGTPNVGGNIALGAAVDFIQRVGQENI
QNHENALLEYAQRHLLELEGIKIYGEKAKRTGVVSFNLEGIGIASDVGMILDKMGIAVRT
GHHCTQPIMDFFNIAGTVRASFAVYNTFEEIDALIEGVKKAQRMLS
>KALACAFP_01117 General stress protein CTC
MKSITIQGTKRESVGKKSTKALRDAELVPCVVYGGGEPLNFSAEEKAFKGLVYTPEAHTV
SIEVDGQTIPAVLQDIQFHPITDKILHADFYQLADDKPVIMEVPVRITGRSKGVVAGGVL
RQSFRKLKVKAIPANLPDEVVVDVTPLRIGNKLYVGGIKAEGYSFMHPDNAVVVAVKMSR
NAMKGGAAAMDDEDEEEVATEGAAPAAEEAAAE
>KALACAFP_01118 Ribose-phosphate pyrophosphokinase
MADQLSYLFCTRTSKDLAEKIAQYYGQELGKINFQEFSDGEFEPVLDESVRGGRVFLIGS
TFPPADNLLELLLMIDAAKRASAKSITVVLPYFGLARQDRKDKPRAPIGAKLVANLLTAA
GATRIMTMDLHADQIQGFFEIPVDHLYASTIFVDYIRDLNLENLTIASPDMGGAKRAKNY
AGHLGAEVVIAYKERKKANVVEEMFLIGDVEGKNVILIDDMIDTAGTLCKAADILMEKGA
KSVRAMATHGVLSGKAYENIQNSKILEVIVTDSIPVKNNLSSKIKVLSCAPLFADVMKMV
HEHQSISSKFVI
>KALACAFP_01119 hypothetical protein
MKKIIISTFAISALLFTTSCEDDFDTDVKDIAVTAGEANFSNYVSIGNSLTSGYRDNALY
IDGQNESYPNIIAGQMKLAGGGNFVQPLMADNNGGLILAGNVIQATKLYIKSFTNGSPDI
VNVNATPTTDVMNKITGPLNNFGVPGAKSFHLVAPGYGNPGGILLGTANPYYVRFSSSNT
STVVDDAVAKQPTFFSYWIGNNDVLSYATSGGMGVNQAGNTNPATYGANDISDPNVVAGS
IKAGLDKLKAGGATKGVIANIPYVTSIPYFTTVPYNPLTPAALGANLTTLNTSLYGPLKQ
ALTAFGAGDRINLLSSTASNPVLIKDTSLTDLSAQLTVALTPSLGLPTATAFGQIFGQAR
QSTADDYILLTTRAVIGTTAPGAPAPVNVYGISYPLQNQHVLSKTEAAAVKTAVDAYNAS
IKGLADTYGLAFVDANKKMVELNGQSGISWDGVKYTARFVTGGTFSLDGVHLTGRGYAIV
ANEFIKAINGKYKSTLPQVDPNKYSGVRFP
>KALACAFP_01120 Putative outer membrane protein
MKKILVSTALLAGVLSYAGGFRVSLQGVRQLAMAHTSAHAEDASVAFFNPAGMSFIPSKL
SIAAGGFGASNKITFQNLNTLQSTETDNPMGTPIYAAIAYKPIDKLSVGFSFSTPFGSTI
EWPNDWEGKEMVQKLELKAFYFQPMVSYKFNDWFAFGASYIYARGKVNWDRAVTQFGGEL
NLDSKASGHGYGFGFYFRPDPKLDVSIAYRSPVDMKAKKGKATFQFPSASIYPLLGLDAS
GTDDFKATLPLVEEYTIGLTYKITPKWLVSADFNYHGWERYSKLTLDFATAPVGNQADPT
VSVSPKNFRNSKTFRLGTQYAFTNMIYGRLGAYYDESPYTDENFIPETPSFNTYVVTGGV
GFKLKQFGVDIAGGYAMPQARDVKNANLGFYGQAKATAFYLGLGLSYNPF
>KALACAFP_01121 hypothetical protein
MSCGCKTSGDSAHSCGPKKTANGCENVNTCGNSYKLSVFDWLSNINNPAPNRCDYVEVRF
KNDRKSFYKNVNNIPLHIGSVVTVESSPGHDVGVVSLTGELVKIQMKKKKFSEESPLKIY
RLANQKDLEVWQEARKKEDNVKIEARKIAHKLGLEMKITDVEYQGDASKVTFYYTADNRV
DFRQLIKDYAAAFRTKIDMKQIGFRQEAAKVGGIGSCGRELCCSTWLTDFRSVNTNVARY
QQLSINPQKLAGQCGKLKCCLNYELDSYLDALSDFPSSSTTLETEKGKAFCIKIDVFKKK
MWFAYVESSIAWYDFDIDLVKKLISKNKRGEKTLPLEELKQPDTSFQSIDLIQENNVDRF
EKKNRGPKNKNQNRPHNNQNNPNQAQKKSRPDNNRTDRPERQERPANANSNNQPKQQKPQ
QPKAQLEKVEAAAPSDSEKKPTPNKKKFKKKFPPKKDNNA
>KALACAFP_01122 Gliding motility lipoprotein GldH
MRKILGLFSLILFFSCNSSSEGEVIMNSVDNKWNKKSEQKYNLEISDPQNPKNIIFVVRN
NNEYPYSNLRFIVNFTDLQSKKKQTDTLNYVLAKPNGEWLGTGFGDTKEILFQYKLNYKF
PAKGKYEIGLKQAMRNDNLPGIEDIGVKIETAKP
>KALACAFP_01123 Penicillin-binding protein 1A
MEENKQNAGSKGKTFPLPPKKKNTAWKKWVKIIWVGFIALVLGISGLFFAVSQGFLGEMP
DVKELENPDIYVASEIYSSDGILLGKFEKEKTQPIIYKDLPPYLVYALQAKEDERFKEHS
GIDLQSVARAVVYGGGRGGGSTITQQLAKLLFTGGASQNKMQRAFQKLKEWVVAVSLEKR
YTKEEIVTLYFNKFDFLYNANGIEMASRVYFNKTTSQLTLPEAAMFVAMLENPVKNNPMR
NPERAKARRDVVLDQMLKTGYIDQATFDKAISTPITLDYHPIKNINDDYSAYYKFYLKKE
IDAYLKDYEKENGKKLNLYKDGLKIYVTLDSKMQKYAEEAIREHLTDLQKRFDAEQRGRK
NRPFYYLNDKQINSLMLQAMKRTGRYKQLKAAGVSEDSIMLEFKKPIKTSRFTWAGEEEV
EMSPWDSIRYHKQIAQAGLMSMVPGTGEIKAWVGGIDWQHFQYDHIKQGKRQVGSTFKPF
VYATAIMKLGMTPCSVVSNASFNKGTYHVPGRGGMLTLKDALAHSQNPVALRLAEMTGTQ
SVIQTARDLGVTEEISTSLPMALGSSDITIYEMVGAYSTFANYGNYNKPEMIWRIEDANG
RVIKEVNVEPKEVMNPMYAYTMIELMKGVAQYGTASGELGRKGISKDIEIAGKTGTTQNN
SDGWFMGIVPKLATGAWVGWEDRATHFFGTGEGQGAKMALPIWAIFMKKVWADKTLGISP
DDKFVKPSEWKDGCTNLKGLGAGYGDDGGLQTIDEIKNPKPVDPTPKNNSGKKEENVNEN
LNTGEEIDFNK
>KALACAFP_01124 hypothetical protein
MNIENITQPFIKIFPGDFSGNPMQRTTPKVLFAAIAPVGFDQPELIAFNEKLSEEIGLGK
FEEKDLDFLVGNKLPENIKTYSTAYAGHQFGNWAGQLGDGRAILAGEITNNKGEKTEIQW
KGAGATPYSRHADGRAVLRSSVREYLMSEAMFHLGVPTTRALSLAFTGENVVRDMMYNGN
PQDEKGAVVIRTAESFLRFGHFELMSAQREYKTLQELTDFTIKNYYPEITSEGTQKYKDF
FESVCQRTADLMVEWYRVGFVHGVMNTDNMSILGLTIDYGPYSMMDEYNLNFTPNTTDLP
GRRYAFGKQGQISQWNLWQLANALHPLIQDEKFLEVILNDYGSYFWESHDKMLCKKFGFD
QLLTSDEKFFIEWQRLMQELQLDYTLFFNELEKYDDQKDLREQFENVSYTFLNDEKLSQL
DNFIKTYHSRLERNIISREKSLELMRKTNPKFILRNYLLYQCIEEINEGKTDMLNKLTHA
LENPYEKIYPDFSVKRPSNYDDISGCSMLSCSS
>KALACAFP_01125 hypothetical protein
MSKFKTKFIYFFKLIFPATGIELIVFLFFLVCYGYLGSYIAIHYKIIFDNRIPWDAYFSF
DNKSIVMSGGSFERHPFSYYFFNWIRELALLFSDGKMDGNFRFALAWMSNIAISLSVLQI
FKYLKNIIGLPLILNLLLILFFGSFSTTLLLSFTPENFTYTLFLLALFHHYSAIKLKKEE
KIPALALAFSGIAIGGITITNIAKIFIPVAFEKDVFKSWKKFGNAVFRTIFTVVCFVSIY
LYRIDFKYKNIFNKTNEQYEKFSNVKSTPTWDMILSYFFGGNILFSNFIIRDKHNMQGFN
YKGLVMDVYSSVVPYIFIGVLLVLIFWSYFKNFKNKLVQVIMISFLVDIVIHCIMKFGLH
TSYIYGGHFVFVYPLLLGWLFYSYRQSPKILSLLTAVFCILFAYLVSNNYLRMTEFFWFM
DKYY
>KALACAFP_01126 hypothetical protein
MRNLIKIISVLSLFGFYNIDAQQIVKKDTLAGTELVMTMDSKVNGALESLEEKCSRTSGS
TSYRDNDEDNTSTKPTKIYVPNRELTNAEICRKNPRILGYKIQITTVKSNEEANEVKSYF
RKRFPNLKVETDASLRPNYKILAGSYFTKQSAASDLAKVREYFKSAIAVQYRIFCAEAK
>KALACAFP_01127 Menaquinone reductase, multiheme cytochrome c subunit
MISWRKHYRQTLIAIGLLLSTSASIYGQDGDPKNGEKLFKANCTACHALDKQVVGPPLKG
VVERVKTEGGVDKDWLHKWIKNNKELRASGDKYANEIFEKFNKTEMQVFPNLTDKDIDDI
LAYTTNPPAPEPAPAAGTAAPAGNNAQAAPASSTTTNVVIISLLAIAALLVWILIKLRQL
VKLGQSEDLAGLNETRVKSFSEIYQKYHYVGKGLIAILALLATYGIWNWIMWIGVYKGYK
PEQPIYFSHKIHAGEQKIDCQLCHSSAKYGKVSEIPSMNVCMNCHRTISEYNAAHYMEPG
KDKAFYDGEIQKIYAATGWDPAKQQYTGKTQPVEWTRIHNMPDFVYFNHSQHVVAGEQAI
INSFNKKNPNNKIDVVCKACHGKIDTMNVVQMANDFTMGWCIECHRTTEVDMNNGYNKEY
FKNLHDKLKKQYPKDGGKITVDAIGGLECGKCHY
>KALACAFP_01128 Menaquinone reductase, iron-sulfur cluster-binding subunit
MASNKIQFRSIHELKDPALNNKLAQKEFQEEIPVEDFLGDAEQNESGTSRRDFLKLLGFS
TAAVTLAACEAPVIKTIPYVVKPHDIIPGVPNYYASTYFDGFDFASVLVKTREGRPIKIE
PNPAAGDLGKTNARAQASVLSLYDNDKVKQPKFEGKDETFDKVDSFVIKGLDEAKAAGKR
IVLLSHSFASPTFKKLFAEFKAKYPTAELVTYDAFPYAAALDAAQEVFGTRALPVYDLNG
TELVVAFQADFLGDYNASSLETSYASARKPGENMLRHIQVESNMSLTGANADSRIRLKPS
QVNKTLVEVYNAIVGGGTSDKTASEIAKELQAKGSKAVVFADGSKGAQVLAHLINQKLGS
VAFTGKANFLRDFDKARFQEFLGWVNAGQVGVLIANNVDPIYSYHKGEDFKKSLSKVPYV
IAVADKKNEMYKAAKAVIPVANWLESWGDIEPQTGVYSLMQPTIQKIYKSRQIEESLLVW
KNGKNNAANNYYDYLKASASSILGGTSFNKALYNGISVSPNATTLSYAGGNAAQAIAEVS
GFKPSDLELVLYTTTAMGDGTQANNPWLQELPDPITRMSWDNYLTISPKDAERLGIENDL
NARMQLDGSIVNLTVNGVTIKDVPVFIQPGQAEGSVGLALGYGKKNSGATADTGVNAYPL
FDGSNLVVSNVKIEKTGEDHQFAGIQLQNTLMGRYEIAKEVPLADFLNVAFDDEHKGWNK
PLEYHTISGALPARKIDLWDAFDDTDGPHFNLSIDLNSCTGCGACIIACQAENNVPVVGK
EEIRMSRDMYWLRIDRYYSSRQKVEVYEGLKEGMAVPELYGTAFGDGGALNHPADNPDVI
FQPVMCQHCNHAPCETVCPVAATSHSKQGQNHMAYNRCIGTRYCANNCPYKVRRFNWFTY
NLNDKFDFNMNNDLGRMVLNPDVVVRTRGVMEKCSMCIQMTQNTILEAKKEGRKVKDGEF
QTACSKACSTGAMTFGDMNDKDSAIREQYASNRRYYLLEEIGTKPNVFYHTKVRNRVEK
>KALACAFP_01129 hypothetical protein
MSGHYEAPIREPLIIGHKTYHDITEDIARPIEERAGKLWWISLYAALVLFIYGFGCIAYT
IGTGIGAWGLNRTINWGWDITNFVWWVGIGHAGTLISAVLLLFRQRWRMSVNRSAEAMTI
FAVVQAAIFPVIHMGRVWVGYWVFPLPNQFGSLWGNFNSPLLWDVFAISTYFSVSTVFWF
MGLIPDFAMIRDRAKTPWTKKIYTFLAFGWGGKAKHWQRFEELSLVLAGLATPLVFSVHT
TVSFDFATSVIKGWHSTIYPPYFVAGAIFSGFAMVQTLLLVARKVCHLEEYITMYHIEIM
NIVIILTGGMVTVAYATEYFIGWYSGSRFEDFTYLSPGAAVGPYWWAFWALITCNLIIPA
SFWFKRLRTNIIWTFIVALIINIGMWFERFDIIVINLSRDYLPGSWTMFKPTIIDVGVYL
GTIGFFSVLFLLYARTFPVIAQAELKSILKISGETYKAKEGDEHH
>KALACAFP_01130 hypothetical protein
MSTTKIVYGLYADDDDLMNGVKAFNDKGIAINEVYTPFPVHGLDKALGLKKTRISDAAFI
YACYGVTIGATLTWYVMNHDWPQNIGGKPAFDWGHNMPAFVVPMFELMVFCAAHMMSLTF
LVRNKMYPGAPAQNPDPRTTDDKFMMEFVTDDVESVKQLLIETGVEEITVKDA
>KALACAFP_01131 Cytochrome c6
MKKNVLKITAILGLTTVLLNSCGPKENVPLVYFPDMYFPVAYDPLMKAQDAYSDHENEIP
AFVKNNGATGLTPVEGSVPQNKDGIFEEGLLPKNVDEYNAGYDASKNITTSPLNPANAEK
DIERGKMLFDKTCAACHGTGGDGQGPIVQSGAFSGVPNYADREITVGSVHYVLTNGRNAM
GSYAGQLNAGDRWRVAMYVMSAFKKGAAAPAAATAATTEAKPETTTETKK
>KALACAFP_01132 hypothetical protein
MYSFSPKLKSTSIILLVVGLVLFGIGFFMNKGISTDRIKEMMDAVHASGHTAPTHSSEMV
GPQDEAAHLEHATLQVHNQPLASLHFVAVFFFGVSCAVLFFYCIQHAAHAGWPIIITRVM
EAIASYIPYGGAILIILMILNITHNGHLFHWMDPDLTDPNSAHFDVILFEKKKFLNIPFY
AFRTFLYVIGASFFAWKLKAQSKKVDETKSKVDYQMLYRWAVGYIVFFGFCSAAWAWDWL
MSIDPHWYSTMYIWYSMVSCLSSGIAVIILLSVYLKKNGFLPQFNDNHLHDLGVFLFATS
MLWTYTWFAQFMLYWYANVPEEVNYFFGRFQHYSPTFLPMLIINFLLPLLVLVSSSIKRN
YKVVTTMAIVVILGHILDYFNMVMPGTVGPYWNTPEVFILILGAILFIVGLFMFTVLTAL
SKLKLIPTGNPFLHESEIYEYPF
>KALACAFP_01133 hypothetical protein
MKRNYFLFLFVLILSSFNAQTITFVSERTNKPLPKVSVFGKDGSILAYSDIDGKIDKQTL
KPEQEKFQLVYNNFPVATLAYADFDKDVIKIIDNVKDIETVVIKNNKPAKYITLKGNFNS
YVTVNNKLNCYADGIVTYIFDNKTKKLKSTNVEQYRVYRLEDAKFEKKQTAMWDYDGTLE
VPDLKEVGNILDFKRRNSTIKELKGEQKDQIEITGEALQKKEFALFGYRFFDMKSILNAS
YEKSTQKTLRDLLEFNEIGFIKLKHKTEPDYNQLVLYTNFYPTEFSFSNNNDIEKVKFKT
DHSSYKTKYWEDSSFPNMQTVFSSFFKENLKEQQNEK
>KALACAFP_01134 hypothetical protein
MANRIKMKKLSFLLVFSLLLFTACKKDSVDATNTKTLQSSINDMTASLSTIKQIKFNEAL
YILKTFGVEADGDVAELKALGQLINGKKVPEIMSMADQVAQKNGIEWASTAPPSLGEMNI
FGDEKAKESDPNDVKASSLSVITRPTGDDGTGAPTALQIVPRLVDNTGNPVSFTGAGLEA
TLEVFSNGVKLSTAKNLMQDNNFKGFNLKFSSIPAAKVIDNKIDITVSVKTTAKTFKMSK
IGLDVNPALLKVPAPPKVDSTAVNTDPAVIDPNNPGATTPTTDPNATPSPATTPATPKQP
AADPKNVVSAFLNNVSSQNLKAAYNSSSNPNWGSYESFSNSTSGFGSVKSVSVKNITTSA
SNPNAASVNATYDVTDKSGKTTSLKVTFGLKNVNGDWKISSYKTNP
>KALACAFP_01135 Adenine phosphoribosyltransferase
MASQELIKNLEETIENIPDFPIPGIQFKDISPIFLNPKLYEDVIADLVAFSKGKVDAVCG
IESRGYLFGIAIAVALEVPFILIRKSGKLPPPVISEKYDLEYGSAIIETREGQIKPGQRV
LIHDDLLATGGTTEAAAKLVEKQGATVSQFSFLIGLKSLNGEEKLKKFNAEVYHILEY
>KALACAFP_01136 hypothetical protein
MAKLTKNAHNEQEGKETVEFFKDLDREALNTERFLERYSKPLGIVFGVLVLGVLGFFGYK
QFVVAPKNAEAVKSFLAAQKNLADGKDKEALGGKSAANPGFLGTYNEYSGTNIGKLSAYN
AGILKFKEGKFQEAYDLLDKFSSDNKTMMAMKYGAMADAQSGLNKNDDALQLLDKATSAS
DDPYTMYYFTRKAGILALGLNKKAEAKKYFATIDEKYQDYDNGMSDSYIEMTKYY
>KALACAFP_01137 6,7-dimethyl-8-ribityllumazine synthase
MATVNLSDYKPLNITNADEFSIGIVFSEWNDFVTYNLRDAALEILQKEGIKSENIKLFPV
PGAFELNYASMQLCKERKYDAIIAIGCVIRGETPHFDYVCSAVAQGIKDCNILTDTPTIF
CVLTDDTKEQSIERSGGDLGNKGVEAAVTALRMIDFRKNLSSKKGNIGFGHS
>KALACAFP_01138 Lipoteichoic acid synthase 2
MFLQKIKPFLYLGVFYLIISLIVRIIFFFHPITTTSFGFFEIIKILLIGIVNDSFVFVLT
CPFLALYFLFLSDSKYQKPYGHIILGVLMLLFLYILLIPNNIFKQYGGSIAEIALAFIGL
KIIFFGLMLFLPEKRIKIRNTLYFITVFLYVLLIVFNAVSEYFFYNEFGLRYNFIAVDYL
IYTNEVIGNIMESYPVVPLFLGIFAVAILITLFIYRKTKNELQELPNLKQKLILLGSFVA
LVGISLLGLNFTTKIKPADVFEEEIQANGLPKFYWAFTHNELDYFQFYPEINEKQAERNF
LSQFSEPKLQRSITSDQPELKKNVVLISIESLSADFLQHYGNKQNLTPFLDSLADQSLMF
TNLYATGNRTVRGLEALTLCIPPTAGESIIKRENNKNKFTTGSVFKSKGYDVKFLYGGYS
YFDNMQDFFAGNGYGIVDRNNFKPEEITFANVWGVSDEDMAKKAIQTMNAEAKSGKPFFN
HWMTVSNHRPFTYPEGRVDIPGNAKSREGGVKYTDYSLRKFFEMAKKQDWYKNTVFIIIA
DHCASSAGDTELPMDKYRIPAMIFSEGFIKPQKFTKTMSQIDVMPTLFGLLNFNYQSKFL
GQDIFKKEFQPKAYVATYEDLGFIKDNYLTIISPVRKVKQYVLTQQKNMQAPDFNIYFDE
TNVPAPNQNKKLVEETISAYQSTSYWLKKNQLNR
>KALACAFP_01139 hypothetical protein
MKWTDDRGGNVEDRRGLGGGAVVGGGLGTLIIAAIIFFLGGDPSSVLSSGGSGSVNTEQR
ELNENDKKIGEMVDMMGKWNIITWDQVFKENGMTYTPPKIILFENTTQSGCGTAQSAMGP
FYCPADQSVYMDMSFFNELQSRFGAKVTEFTVAYVLAHEVGHHVQTLLGTTQKVDALRRS
GRYSEEQMNRVSVATELQADFYAGLWARRTDSREHILEPGDIQSAIDAAEAVGDDNIQKR
SQGYVNQESFTHGSSAQRKEWFMKGYNSGDIRQGDTFNQLLK
>KALACAFP_01140 hypothetical protein
MKKLGIIALALFMQTAFAQVNRFVYQVTMKPDASNKSDIKTENAYLDISPEKSVFYSENR
IKRDSIMQKAFQSGGGRGSINREQMEGLRSNINYSIEKDKKNQKTFFKDRIGRDVYTYEE
DRPINWKISSETMKIGEYKVQKAETDFGGRKWTAWFTTDLPYQDGPYKFGGLPGLIVKVE
DDKGEYSFDLMKNYKIADFPSMNQFGNTIKVKRADFAKQQKKFMEDPMSFMTQGGGGFGQ
TRVMGGGGISAPRGGGGGNQNPADMRKRMEERIKDEAKRNSNPIELQ
>KALACAFP_01141 hypothetical protein
MRQKLLGFFVLFLASLSYGQTTRYIYETAVNPDSINLVSMKIEKTFLDVKGNRSFFISEN
KLIKDSLFASFKPEEKEERKKDKKDLSKTEVRKHAEPTFFEFFITKNIPEQKVYYYDRVG
GKQVYYQEDRPLKWEISDVTEKQNGYPAQKAVANFGGRIWTAWFTKDINISDGPYKFSGL
PGLIVKLEDDKGDYKFDLVKKITIQNAFEEPMKSDVKQSTRRDFNGDKAALELEFNKNRK
AIAGSKSPEM
>KALACAFP_01142 Iron-binding protein IscA
MIKVSDQAKAKAIQLMTEEGFNPAEDYIRVGVKSGGCSGLEYVLRFDNEKTDTDQIFEDN
NIKIIVDKKSILYLAGTTLEFSGGLNGKGFVFNNPNASRTCGCGESFSL
>KALACAFP_01143 FeS cluster assembly protein SufB
MSKYTEDDLRVDLENKKYEFGWETKIDYEDFPTGLNEDIVRAISAKKEEPEWMTEWRLES
FRIWLKMVEPTWANIKYEKPDFQAIKYYAAPKAKPELESLDEVDPELLATFAKLGINIEE
QKRLSGVAVDIVIDSVSVKTTFQDTLMEKGIIFCSISEAIKNHPDLVRKYLGKVVPRGDN
FYAALNSAVFSDGSFCYIPKGVRCPMELSTYFRINQAGTGQFERTLVIADEGSYVSYLEG
CTAPSRDENQLHAAVVELIALDNAEIKYSTVQNWYPGNEEGKGGVFNFVTKRGLCERNAK
ISWTQVETGSAVTWKYPSCILKGDNSIGEFYSIAVTNNHQYADTGTKMIHIGKNTKSTII
SKGISAGKSQNSYRGLVKVMPTAKGARNFSQCDSLLMGNECGAHTFPYIEIKDPSAQLEH
EATTSKIGEDQIFYCNQRGIDTERAIALIVNGFSKEVLNKLPMEFAIEAQKLLEISLEGS
VG
>KALACAFP_01144 putative ATP-dependent transporter SufC
MLEIKNLHAQIEDGAEILKGINLEIKPGEVHAIMGPNGAGKSTLSSVIAGKEDYEVTDGE
IIFDGENIIEDAPEERAHKGIFLSFQYPVEIPGVSVTNFIKAAMNENRKANGLGEMPAKE
MLAMIRDKSEKLGIKKDFLSRSLNEGFSGGEKKRNEIFQMMMLNPKLAILDETDSGLDID
ALRIVADGVNAFKNEGNAVLLITHYQRLLNYIQPDFVHVLANGKIIKTGDKSLALELEEK
GYDWLLN
>KALACAFP_01145 FeS cluster assembly protein SufD
MVQTTDIPVMALKEQITENHGEFLESLRHRFLDDDRKAALQRFENLGFPTKKDEEYKYTN
LKEITEKGYNFFPKESHNITKEQLDELHLGEENFDWITFVNGKLHKELSNVSIENVEFLS
FNYALNDEKHRDVFDQYFNTIASDKSAFTNLNQAYCKYGFFLKVPKNVVIEKPIHIFYIS
QNQEENTFYNTRNLLIVEEGAKVEIIESHHNFDSTYVLTNSVTEIFTHPNAKADWHKLQN
DNDTSYLIDNTFAKQEKDSLTTVNTFSFGGKLVRNNLDFIHNGSNINSFMNGITIIGKDQ
LVDHHTAVHHNQPNCESYQNYKGIFDGKSHGVFNGKVFVNKIAQKTNAYQQNNNVLLSEG
ATIDTKPQLEIFADDVKCSHGCTVGQLNEDAMFYLRARGISKKEAQALLLYAFANDAMQN
IDIEPLKEKISKLLAEKLEVDIEF
>KALACAFP_01146 hypothetical protein
MKKFLLILSISIGVFAFAQEEIKKDSVVVDTVKHWSVLGKQSLMINQAAFSNWVGGGANN
VGWLAGVDYNITYEKDKDLWENIILLNYGQNDTKGLGVRKTQDVINVSTNYGRKVSKSWY
MSVGAGFQSQFMAGYEDGNNPAAKKISNFMAPGYLNVGMGITYRPNDNINVTLRPTNARW
TFVLDKDLQTAGTYGLRADGDSSLLQFGFLGTAYYKVKLMENVSVTNTASVFSNYLDHPE
RLVLAYGMVLNLKVNKFISSNITVDVLYDHNQIQKTQLKQTLGVGLAYTLNNGVKRSDRK
DSQWWIKK
>KALACAFP_01147 hypothetical protein
MLKNNVISKRAIIYPLLMLAAMWFGYFLQLHGFFESCFGAIIPLLPEGLLGVITSPLLHG
NLDHIVGNSIPIGVLMFLLYQFYPLVANKVFIFGWIFTGLLVWLLPPIDIMTGEYLYTCT
IGASGVVYVLAFFLFFSGVFKWNMTLLTISLLVVLYYGSLVWGMLPEELFSELQEPSKIS
WQAHLAGAVVGIILAFMFKKVGEKRKRYIWEFPNYYSEKDDKLWQEYKENHPEDFMELPY
KKRDDIWEHLDELRKR
>KALACAFP_01148 DNA processing protein DprA
MYSEEHLYAIALRECNLIGDINFYKLVRIFGSAKNAWEKTPKEYKNLDGIGKKIVSDIGN
PEHLKFAEKELKFCEANNIRINLRHLNELPKLLNECDDAPAILYQKGNFDDSKPKISIVG
TRNMTSYGKQFIHDFFEETKSCQYVSVSGLALGVDKEVHEQSIHYQIPTTAVLAHGFHLL
YPAKNKKLSEKILEEGGTLFTEFNSSRKPDRENFIQRNRVVAGISPSTIVVETAFGGGSI
STATFANTYNREVFALPGKITDKQSQGCNHLIFQHKASPISTMKDLIDSLGFNKAKVKTE
ELFPSSEISIQLTESQELIFKTIFNNPQISLDDLAEKIDLSSHKILPIILELELLGKVKS
FSGRQFVTI
>KALACAFP_01149 NAD-specific glutamate dehydrogenase
MEQYNIDQKIQEFIAKIEAKNPNEPEFLQAVKEVAVTVIPFIMTKKEYTGMKLLERMAEA
ERIIIFRVPWVDDKGEIQVNRGFRIQMNSAIGPYKGGIRFHPTVNLSVLKFLAFEQVFKN
SLTTLPMGGGKGGSDFDPQGKSDMEVMRFCQAFMTELCKHVGPETDVPAGDIGVGAREIG
YLFGQYKKIRNEFTGVLTGKGLAYGGSLIRPEATGYGVVYFAEQMLKTIGQTFKDKTVTV
SGFGNVAWGVIKKVSELGGKVVTISGPDGYVYDKDGIDGEKIDYLLELRASGNNRAEDYA
KKYPSAEFHAGKRPWEVKCDVAMPSATQNELDLEDAKKLVENGCICVTEAANMPSTLDAI
NYFLDNKVLFSPGKASNAGGVATSGLEMTQNSIRLNWTSEEVDARLKEIMIGIHKACRDY
GKEEDGYVNYVKGANIAGFVKVAEAMLAQGVV
>KALACAFP_01150 hypothetical protein
MKNTFENIDDYILLFPEEVQEKLQEIRKVIHTQNPEIEEYIGYQMPAFKYKKKPLVYFAG
YKKHIGFYPGAEGIRRFETDFKERKYKFSKGAVQFPVNDEVPVDLITKMVKFRMEEIENK
KS
>KALACAFP_01151 hypothetical protein
MKKFILATAFAFVGTIAVSAQVTPQKTDTVRPDTTRTHRDMKKDDKNWDKSKSDTTKWKN
KDTVEGDKKMKRKEKTN
>KALACAFP_01152 hypothetical protein
MKKLVLTAAFTLVGVIAVSAQTGTPENSTQNSNNQTTTQTQQNTQATSNWGTTSGTAAQN
QNTTATTATTATVDTTPATAATDATASVSAEAAVDATKPAEATKEEKKSKKKKSK
>KALACAFP_01153 hypothetical protein
MDLELYKKQALQKQKEHKKFLDGLKKKPPKNLDYIVQETHEEVFEKVDCLQCANCCKTTG
PLYTEKDIERISKHLRMKQVDFEAKFLRVDEDNDKVLQNLPCFFLNEDNTCSIYEVRPKA
CREYPHTDRKKIYQINNLMIKNTVICPAAFEFVEKIMKNLGK
>KALACAFP_01154 Inward rectifier potassium channel Kirbac3.1
MARGFRQKIRQTNTENSGFGDNASGRFINKDGLPNVHRKGVDILNRFSWYHTMLDLSTFQ
FLSYLVVAYVMVNILFALIYYLIGVEHLTGIDKSDPMNEFIDVFFFSSQTFTTVGYGRIA
PIGFMASLVATFEAFLGLLTFAIATGLFYGRFSRPRAYLKFSDIAVIAPFKNASALMFRL
APYKNNSLTDADVIVSTAIEVIEESVPKSKFYTLKTQLSKINTLALNWTVVHKIDEDSPF
YGFSEEDFKNTDIEIIVHVRAFDEVFSNTVVQRTSYVTKEIIYGAKFVPMYYPDKENLST
ILDLGRINHHQKTDLPVFMEEDK
>KALACAFP_01155 Group 3 truncated hemoglobin ctb
MKKLESREDIEHLVNSFYAKVVKDETISFFFNDVAKVDWDKHLPKMYSFWETILFGQMSY
KGNPMAVHFPVNEMQAMEQKHFNRWLELWRMTVEENFVGENADMAIYKSENIAKLMAFKM
ESARKL
>KALACAFP_01156 Sodium-potassium/proton antiporter ChaA
MKLKELLHYTYIFPFLTVGYYFSGLMGTGVVFDVIAGILLTGSVLSAVHHAEVVAHKVGE
PFGTIILAICITIIEVALIISLMIAGGDQAITLARDTIFAAVMLILNGILGICILVGGVK
YYEQFFARTSATTYLVSIVSILILTLVLPNFTSSINGPFYNEAQLIFVSIACLVIYGIFL
MVQTVRHRNYFIVPDEHPEEHYIPSRKKTVISFIFLVICLTIVVMMAKGLSSTIESMVQS
LGAPKSLVGVIIAAVVLLPEGVAAIRAARANQIQSSLNLALGSALASIGLTIPAVAVVCV
VYDIPLVLGLDKKDIILLSLSVFIVMLSLSRGKTNILYGTVLLVNLAAYIFTVIVP
>KALACAFP_01157 hypothetical protein
MDCFFWKTCVHYFLHFIFPVFIALIFYRENWKKVYLILLATMLVDLDHLFANPIFDPNRG
SIGFHFLHSYYAIAVYFLMLFFKGNIRIIGIGLLFHMLTDFQDFNLWCH
>KALACAFP_01158 hypothetical protein
MSNNIIKEIQEALAVLSIPEKAAFFPKFFKTGKGEYGEGDLFLGVKVPDQRAVAKEYYSK
ISLDELSELLSSKYHEHRLTALFILILKFEKTKDKAVRDEIVEFYLNHLPYVNNWDLVDS
SCYKILGRYAFENKKEDLLKELSDSEEMWHKRIAVVGTMHYVKKGSFDLTKEFVTQNLKH
THDLMHKANGWLLREMGQKNEKELIDYLNKYYKEMPRTCLRYAIEKLDEDLRQDYLKGRI
>KALACAFP_01159 Germacrene A synthase
MKTPTFTIEYPFELRHNPHLESLEKQVSTWIDDYKCLPESLKKRYRKSNFGKFTTSFFPA
ANAEQSTIIGRWILAAFAFDDLYGSNSLENLRLQCQKVIDILEGKATEFENEIFEAFGTV
RKEILSAVTENWMKRFVAHHQFWFEGMEEETIYSYNDKVSYPSLEEYKIIREKVSGGRTL
CDFLEVISGFIMPDEIFSHPAIFRIRQLVTLMLSWFNDIHSVPWELERGEATNLVLVIKN
ENSCTMEEAYDKAIEIHDDDLAEFIRIKENLPDFGRYNEQVRKYIDHAELLLKGQEIWYF
GGTERYTSAEK
>KALACAFP_01160 Na(+)/H(+) antiporter NhaP
MELYYSFSALIVLASIFSYLNYRFLKLPSTIGIMVIAIVVSIFLVSFGETVLPRTFGHLN
KLMISIDFTEVLMGAMLNFLLFAGGIHINIDDLKEQFWPVVIFSTAGVVISTFVVGFGVY
YLLPLVGLQLPFIYCLLFGALISPTDPVAVLSILKQANVSKALETKVAGESLFNDGMAVV
VFTVVLQLAIGNEVDLGVESIGLLLLKEAGGGLLLGVVLGWITSRLMREVDDYIISVLVT
LSVVMGGYLIARQMHISGPLTMVAAGLFMGNFNMKFKMKSVTQDYLIKFWELIDEILNAV
LFLFIGFELLMIKDLRHFMIPGALAIVVVLLARFISIWGPTKFMSFKTRFSPQTVKVLVW
GGIRGGVSIALALSIPKNEYSTIVLSITYCVVVFSIIVQGLTIAKVANPNKIAKEEEELE
SVASNTTK
>KALACAFP_01161 hypothetical protein
MKYHFFLLLLLVSVFGFSQKSKIDFKAVEKDLKNDKSPYNYDKLIFKYKAYPRSLDTIEA
QHLYYGRNFRKDVVSTTDEDFKTLAEAFKTGNFDECIKQGKVLYEKDPTNLDVLLILLKA
YDSKKDGDNFMHHLSQFRILTDAIKSSGDGKTEKMPYLVNSVGDEYILLNILNLGKDYTR
GSKSVRDGILDIWEKDNDKVYIKVLYIDY
>KALACAFP_01162 GTPase HflX
MLEKKEHNYEKAVLVGLITKDQDEEKLTEYMDELEFLAYTAGATVEKRFTQKLSQPDSRT
FVGSGKAIEIKDYVKEHEIGTVIFDDELSPSQLKNLERELEVKILDRTNLILDIFAQRAQ
TSYARTQVELAQYEYLLPRLTRMWTHLERQRGGIGMRGPGETEIETDRRIIRDRISLLKE
KLKTIDKQMATQRNNRGKMVRVALVGYTNVGKSTLMNSLSKSEVFAENKLFATLDTTVRK
VVIGNLPFLLTDTVGFIRKLPTQLVESFKSTLDEVREADLLIHVVDISHESFEDHIDSVN
QILQEIDAHRKPMVMVFNKIDDFSYEKKDEDDLTPATRKNVSLEEWKKTWMAKSKYPTVF
ISALTKENFPEMKRMIYDEVMKIHISRFPYNDFLFEYFDNDEEEEENND
>KALACAFP_01163 Transcriptional regulatory protein NatR
MITNIRCMIIDDDELDRLVLLHHLKQYDNIEVVASFDSAEKAIPYLDLPIDLLVAETKLK
GMNGLEFRKLAHKIPACIFISSHPEMAINTFEIDTLDFIPKPLKTERFHISMQKLFDFFE
MKEKCECFDALLGENCIKIKEGSNIYQVKITDILYLEALKDYTRIVTPEKKHCILDSIGN
ILHKSYFDSFVRIHRSFAVPRHLIRSKNNHEVELVHQIKLPIGRAYKENLSFFTPHG
>KALACAFP_01164 hypothetical protein
MKRTSIQCFFLILLTVPIILLKAQSAVLATGANATGSNGSVSYSVGLPAYIVKGSNNEIM
EGLQHAYEIITLATNETSTTEEGILLYPNPFKDFLYLDFTTNNFKGSEYQLFDAQGKLIK
RDKITQSKSEFNFSSLPSAMYIIRIIQNGENLKTFKIIKK
>KALACAFP_01165 hypothetical protein
MKKILFAVGIVLGSHLAFAQVPEKMSYQAIVRNTGGQILANQSVGIRASILQGSPAGAAV
YSERLTGNTNANGLLTLEIGSGTVLTGTFNTINWSTGSYYLKTETDPTGGTNYTITGTSQ
LLSVPYAMYAKTAGGGGGSFAIPYTNTVNNAGTLFSLINDGDGTSVEGVNNTTTSSVASV
RGIVSNTAPGGFSSGVRGINNGTGGLGVGVWGSQAGSGWGVYGVTPDGLGVYGNSSANGY
GVYANSNTGTGLNATSNNGIGANIAIFNNANNNNVLNANTVGNGTVVNVTTTGNGAGVRS
STGSGFAIHGITSAQTSAGVIGDNNGAGEAVVGRTTSDIAGAVVGRNDGGGYGVRGFIAT
NTSGTAVGVLGQVGLNNSMGRAGRFENFNASNNINNTFEVESNGNGNIPDNTQGNAASFL
LDNTNSVGAAVRGEVNTIFGNFGAAGIFGISSGTGGRAGLFYASNPAGNGASLIALTDGN
GNAITANAGKDGNGIETNIDGAGNALYAWVPTFSTGRAGRFNIFNDANTSDVITVTTVGN
GIAGNFKVDRVTGTSAAVKGEVNSQFANFGTAGIYGISSGTGGYAGLFHASNPSGNGPAL
IAIADGNGNGITANASNTGDGVETTADGTGSAIYAWIPNFGTGRAARFVNYNTANTNPPL
TAETRSGGSIAVFRSGNPGAVNVARIGNDGRGFFNGGTQSSGADVAEAFDVEGNISSYEP
GDILVISTTKDRSVEKSSTPYSNLVAGVYATKPGVLLTEEHIDADLSGKVPMGVIGVIPT
KVCLEGGKIKRGDLLVTSSKSGVAMKGNLKKVKIGQVLGKALQDYDQNGIGKINVLVNIK
>KALACAFP_01166 hypothetical protein
MKSLYIIAFLALSVNIYAQQDKKVSETQEAANFKESKEFEAKMMKEAQDRAKQTPSTTLP
SEQGLEVKKQAPKQEVGNNSGKLLPNTASLDEIRATIPGRQPHKATNSRNTNNNVQGLLS
TPELTIYDIKKTIPKN
>KALACAFP_01167 hypothetical protein
MNCTSAAKQNTQPAARDYKIQREWMLVAFGNYSKPDLIKKGAKIDLTANMEDGKIRGGAF
MGCNNVFFTSEFKDKGKVKISGIGSTLKACPDMSLEDDFSKSFKNMTKYSVEGHFLTLSD
DQGNQMKFVAADWD
>KALACAFP_01168 Dipeptidyl-peptidase 7
MKRLFLLFTFLLGFAQMRADEGMWLLMLIKRLNGVDMQKEGLHLTPEEIYSVNNSSLKDA
IVSFGGFCTGEIVSNQGLIFTNHHCGYGAVAAASTPEKDYLKNGFWAMKQKDEFNAKDLY
VRFLVRMDDATQRINSKLNNNMTAAERKAVIDAETKAIQTENSENGKYTVVVRDFFNGNE
FYYFVYQDYKDIRLVGAPPSSLGKFGGDTDNWEWPRHTADFTVFRVYADAAGNPAEYSPS
NVPLKPKHFLPVSLKGIKPGDFSMILGYPGRTNRYLTSYGIQQMVGKDYPAWVEASKLAM
DVMKKYMDKDKATQLNYASQYASVANYWKNRQGTIDAVIKNGTITDKQGIEEKFRTWALQ
PANITDYETVLDDIAIYYKQTSDRNVERNYMSQLSRNAKYFTLALQVGAVLKSYAEQDMQ
GRVAMKPKVEAALKSAYENINTNLEGEMLNSMVNLYKTKVKPDVASPTLMGLDANTLSNV
AYSSIFANKTSATNFMLNPDRLKLDADPLWKIANALVADQKASAERFVKIDDNFAKNNRL
FLAGLMKAMPEKKFYPDANSTMRLTYGTVDKLPIRTDRNYFGITDNYYTDMTGLVGKYKK
GDEEFDLPQRVIDLYNMKDFGQYADAKGYMPVNFLSNNDITGGNSGSPVIDGDGNLIGIA
FDGNSEALSGDIVFEPEWQKTINVDVRFVLWTIDKYAGARRLVDELQLVRDENTPADTKT
KAARPDHVKAAKKAK
>KALACAFP_01169 hypothetical protein
MKKNLFKITAITAGIFATFSLSSCDDRDNMMENLSQQRTITFENVVVPKDFVQSGRFQGA
GTPIIAPGQSVTIKFSAGKAQSLMFATMYGASKDWFFAFKQPGIKLFDNNGNAITGDVSS
EVLLWDNGTKNNATGQAENNPIAQVPGVNASQLMKLDLAFDDASSEFTLTITNTSGGTAN
ETPFSPGVWAVSNYNGSQLLNPAPFFTPNALSNPEITDIAQMGNTDKMVTKLNANTGIMT
GLSPALVVVYRGEKNPIYELGQLDAGKGLKEISQSGDVSKLQNSLQSLPNVKGVYVAGNA
PVSPGQKISTSFEANSEDKIAYVTMFGFSNDWFFANEEVINTNTIGDISTKTSLFDSGTG
VNQYPGAGNHQALFGGMPQPENIVISKVGNEYPVPPVQNVIKVTIN
>KALACAFP_01170 Thiol:disulfide interchange protein DsbD
MKKILLILSVFLVFVSVYSFKTIHENKINSEVNFYNGSLKEAVIKAKKEKKMIFLDIYAT
WCGPCKLLKKTTFKDPELSDYLNKKFISLEINGEEGEGKEIVQKYQLKGYPSLLFIDTNG
NIVNKTLGYYDGKQLLEIVKEIK
>KALACAFP_01171 Linear gramicidin synthase subunit D
MSNTLSTQALSSGAIVSLSPEDRAKLLTDFNKTGWDYPEAETLVSLFQKQVKRFPENTAA
VFQNQQISYQELDERSNQIANVLLAQGIKEGMYVPVWLDRSLEWVAAILGVLKTGAAYVP
IDPAYPAKRVEFILSDTSAKVLITNSLLAGTLTRKENTGFFIVDTMEDLSDLAADPKDIT
IHQEALAYTIYTSGSTGNPKGVMISHHSIQHLVTWHNEYFHVDHTSKLSLVAGLAFDISV
WETWSALTSGATIFIADNEERTEASALVNYYRNNKITHGFVPTVLAPAVVEKTKSYNDLD
LKYLFTAGEKLKPVLTSELSYELVDYYGPTECTVYATFKKVKDINGQYISSIGKPIANAQ
AYILSENLELLPVGATGELYIGGNLLAKGYLNNEELTNTKFISNPFKEKEKIYRTGDLAR
WTPEGDIEFLGRIDNQVKIRGFRVELGEIERALAKINDVKEVSVITKDNHGGNKYLVAFI
VLNDGAEKNVSFIRTQLKEELPGYMIPAQIIFIDKIPLTANGKTDGNLLKEIADKEAKDL
VSHEPPTNETERIIADIWAEELERPVINITDNFFDIGGNSLLVAIAAVSLQEKLGVKVYI
RDVYQYPVLRDFANTLIARAKAEREAIPVEDVEPYVELQNDVYLNPGTVFEGTFDPKQLE
NPKSIFLTGVTGFVGIHLLQELLDTTDADIYCLVRAQDEFHALEKISKCYQQFNVPRKTE
QTSRIIPVIGDLALPSLGFSDEKFKELAGTLDLIYHSGSSVNFIEPYSYMKAPNVEGLRE
IIRLAGAKKTKCLALLSTISVYSWGHIFTGKTVMLESDDIEQNIISVSKDIGYVRSKYVM
EAIADLAAKEGLPLITYRLGYAMCHSKTGASAPYQWWSGLVKNCIEFKSYPMLTELREGL
ITVDYMTKSMAHITKNKEAIGKKFNLIARPETNLTLENFFGLIKKYYPFVLEGLSYKDWR
KQWENDSKNRLYPLTSLFKDNMHEGLSTVELYQNTYVWDCSNVIQFLEGSGIEEPVFDKS
LLDSYLNYLGIPIS
>KALACAFP_01172 Competence protein ComM
MLIKVFGSAIHGVAAQTITIEVNVDTGGIGYHLVGLADSAIKESSYRISAALKNVGYKIP
GKKITINMAPADLRKEGAAYDLSIAIGILAASDQILAENIQDYIIMGELSLDGTLQPIRG
VLPIAIQAREEGFKGIILPKQNTREAAIVNNLEVYEAENIKEVIDFFNEGKPLHRVTIDT
RKEFQEKVNDFPFDFSEVKGQETAKRAMEVAAAGGHNIILIGPPGSGKTMLAKRVPSILP
PLSLKEALETTKIHSVAGKMGAVTSLMTVRPFRAPHHTISDVALVGGGGYPQPGEISLAH
NGVLFLDEMPEFKRTVLEVMRQPLEDREVTISRARFTVNYPASFMLVASMNPSPSGFFPD
DPNNTSTTYEMQRYMNKLSGPLLDRIDIHIEVQKVEFEQLAEKRKGEKSEEIRKRVLIAR
EIQRERYKDLKISYNAQIGPREIEKFCELDEVSFNLIKLAMEKLNLSARAYDRILKVART
IADLEESENILSQHVSEAIQYRSLDREFWNA
>KALACAFP_01173 hypothetical protein
MKTKLIFLSLLFLSLLNLKAQCTPEITSPRLGTMFPGSVVFCNSESETLSTTQTYASYQW
YKQEWYWQNPNPNPWVPIAGATSQTLTINGTDDMLYNFKVEVTQGDCTAESQSILADGYA
YGLPFLMANFTPGTYEEVNGEYNVCEGASVELQDGFGGVYGLHTWFKCLPSSNPPSPTDP
CIISGATGDTYTATVSGVYGFYACTEYCPSQCEMLSDIAFIKLNFGNFSFCNLATGETKP
KENTLSLYPNPTTQLLYIGKESDKKYPEVSIIDMSGKLVQQKRDHKFSEPIDVSSLVPGT
YMVVSKSADGKVYKNKFIKK
>KALACAFP_01174 hypothetical protein
MSNDWLNDLRRKMEDHTEEVPDGLWEDIKNELFEENDAKGVVGFNDLKAREKAVSKTNYK
TFFYRAGGIAAAVAMFFVADKLIDFNGKKATSQDPTYSSDQIKANIDETISYHQKISNEK
EKQAVENAVKERNELIAANSNIINVLKENVFNNILNKTKNAALDLWNNKTSENQSKNQSE
NILSKSNENLAQGQNKDAIEGEKTNGEEVEKYELLTKEEKEWKEKFEETKKLKLTNKSKK
SWMVGILSGNASSNSTEQFPGYATLNGTTLSLPDVWGLEYGDDPLMAILIANQDKKVDAK
IKHKTPITFGASVYHGLGKKWGIATGINYTKLSAELTTGTSSNFITSEQNIHYVGVPVQV
NYNVIQKGAFTGYVTGGGLVEKAVSGDIKTKYIVDGVLKEETKEEISEKPVQVSVNSAVG
LQLKVIKNIGIYAEPGVSYHFNDNSSLNTVYKEKPLNFNLKFGIRVLLD
>KALACAFP_01175 ECF RNA polymerase sigma-E factor
MEESKEQILAHRLLQKEEAAWKELFGAYSGSLSYVCSRYILDKEDVHDVLQNSFIQMFRS
IDSFEYRGSGSLRAWITRIVVNESLKHIKQNPDFKTVSDDFEIPDEANEEEPNFEEISQN
TIMMMIRSLPDGYRTVFNLYVFEEKSHKEIAETLGIAENSSASQFHRAKALLAQKIKEYK
MSKTAQYE
>KALACAFP_01176 hypothetical protein
MKKLTVLKSLVVAMIVFLGFSLTSCNDERYEPIPVKLSDVDGSYKARLVTSQGNKFNEKI
IEFQAKDTIITFKDFPVREIVKTIITDPVKADTALAHIGKVEYKLEYTSKINASQNLVEL
TFEPKTLALQIPVDGVTKNAVVKLAAKQKGFFVGYDWSLRFGLEAEKITVDGVELTPYQT
IKYDVPISVKN
>KALACAFP_01177 hypothetical protein
MNFEQINLHLDAYKEHDQIIDAAEYLIRSFELEHENFAGFGFREELSPNSMLLTAEGELG
GPQKVMIPKNLFDFDLNLVLNMVAHEMLHVRQKAPGQVIEDKNEREFQAYYEMLFHKVFP
QIPDVSDFHRKFFGNKALEYYRRMGEGSELQHQYAEQKTEVEHLINSLP
>KALACAFP_01178 putative chaperone CsaA
MIIKPEITWADFEKIDIRCGTIISVNDFEKARNPSYQLEIDFGDLGIKKSSAQITTLYQK
EELIGQQVLAVVNFPKKQIANFFSECLVLGVYSEDKKDVTLLTPSLPTKNGMPVG
>KALACAFP_01179 hypothetical protein
MIQNIPLERILFLDIETVPGFGSWEDLSETEQMLWDKKTRFQRKEDFTAEEFYSERAGIM
AEFGKIICITIGMVEKNDTLKIKSFADDDEKKLLLEFGEIFNSPRLRDVILCAHNGKEFD
FPWISRRFLINGMQPPTPFQMFGKKPWEIPHIDTMELWKFGDYKSFVSLELLAHLFGIPT
PKDDIDGSMVSSIYYIEKDLQRIVDYCEKDVLTLANIFRRMRQEDLLKRYINLD
>KALACAFP_01180 Iron-sulfur cluster carrier protein
MKFTDDQIADIGEEIIRVLKTVYDPEIPVDIYELGLVYDVQISDDADVKIIMTLTTPNCP
VAETLPQEVKDKVAEVEHVKSVDLELTFEPSWNKDMMSEEAKFELGML
>KALACAFP_01181 Putative thiosulfate sulfurtransferase SseB
MKPIISPFELKNLPSENLIILDARVGKDVHQNYLNKHIKGARFIDLDKDLAEIGEDAAFG
GRHPLPNVEKFAETLSNLGISEGSHVVVYDDKNGSNAAARAWWMLKSFGLKNVQVLDGGF
QNAEKEDIEFSSGEESFEKSDLIKKDNWLLPTSTLEVVENELTNLSSAVIDVRDAYRYKG
ESEPIDLVAGHIPGAINIPFSENLDENGNFLSPEILKEKYSKLLQDKPQNLIIHCGSGVT
ACHTILALDYAGFPIPNLYVGSWSEWSRREGKEIAREI
>KALACAFP_01182 3-hydroxy-3-isohexenylglutaryl-CoA/hydroxy-methylglutaryl-CoA lyase
MFLTECPRDAMQGWGEFIPTDKKIDYINSLMDVGFDVLDCLSFVSPKAIPQMADSDEVAE
NIDKSRSNTKVSAIIGNYRGAEKALKHQSVDILGFPFSISETFQHRNTNKSQDEAFQEIV
KMLELVKSEGRQLNIYFSMAFGNPYGEMWKWEDVDFWAQRFSEIGVKDILLSDTTGVATP
ETIALLFEKIPSKYPEINFGGHFHNRYEDSYSKLKAAYDKGCTRFDSAIKGIGGCPMAKD
DLVGNMPTEQVINFMSVEKIDHKLNLLNFESSYNKAKDIFHF
>KALACAFP_01183 Peptidase T
MSAIEFNQLWKEKLLNRFINYVKIYSTSDAESETTPSTERQWDIANYIVEELKTIGLENV
SIDDNGYIMGYVPSNLENDDKPTIGFISHYDTSPDFSGENVKPQVWENYDGNDLVLNQTT
GFTLSPSKFESLKKYIGQTLITTDGNTLLGADDKAGCAEIVTAAEYLIAHPEIKHGRIAI
GFTPDEEIGRGAHKFDVAKFGAEFAYTMDGGEVGELEYENFNAAGAVVKIHGLSVHPGYA
YGKMVNAALLASEFAQMLPADETPATTKGFDGFYHLMDLNADISEAKLQYIIRDHDADKF
EARKKFMEEKVAEFNQKHGAGTAEIEIKEQYRNMKQQFEGKMHIIDLAAQAMKEAGIEPK
IKAIRGGTDGAQLSYMGLPCPNIFAGGINFHGPYEYVALESMEKATEVIINIVKA
>KALACAFP_01184 hypothetical protein
MKKRLYSTAVVLLFGIGVSAQKTDSVKQEIKKDAKKVETAVKDGAEWTGKTAEKGYDATK
KGVKNAVKWTKKTAKKGAKAVDKTYQDVKTDIKKD
>KALACAFP_01185 Thiamine-monophosphate kinase
MFEDKEPELTPISKLGEFGLIKHLTEHFPLSNESSELGVGDDAAVINPGSKKVVLTTDVL
AEGVHFNLGYVPLKHLGYKAVVVNLSDIAAMNATPTQILVSLAVSNRFPVEALEEIYSGI
QAACARYKVDLIGGDTTSSNAGLVMSITAVGIENDENIVKRSGTKPNDLLVVTGDLGGAY
MGLQILEREHAVFLADPNMQPEMEGYDYILERQLKPEARTDVKEILEQLDIKPTSMIDIS
DGLASEILHLSDQSKVGFRLYEEKVPMDNLTITTADEFNLNPVMAALSGGEDYELLFTIS
PNDFDKIKNHPDFTIIGHAVEKEEGNFMVARGSNQLVALTAQGWDAFLGNQQI
>KALACAFP_01186 hypothetical protein
MIFYHKFEVRWSDLDANKHLANSSYVQYCAQTRMAFMKQEKMGVTQMSRWGIGPVIMHER
FSFFKEIFADQTVIVSLEIDGCAEDSSIYRFVHKFYTPEGEHCATSEATGVWIDTMLRKM
TTPPDDVVEAMNKYKGPNTVILTKEDFKKLPFRPENIDPAQLI
>KALACAFP_01187 hypothetical protein
MKQIIIIGGGAAGFFCAANLDETKYKITILEQNSDVLQKVKISGGGRCNVTHACFDPREL
VQFYPRGNKELLSVFTKFQPGDTMDWFDQRKVSLKIENDNRIFPESNSSQTIINTFLHEI
QQKNVEVKTKCSVKEIEKLDGKYSVKTSLGDFEADFVIYTTGSSPKSLKMIENLGHKIID
LVPSLFTFNIKDDLLKDLAGTSFEMAETSIPKLKTEESGPLLITHWGLSGPAILKISAWE
AINLAKVKYNFEIQVNFISKDIGDAEELFQSFKQSNPKKTIGQSKIFDVTNRFWQRILEV
SKVDLNKQVANISGKEMQTILENICKKKFQVTGKSTFKDEFVTAGGVDLKEINFKNMSSK
ILPNFYVAGEVLNIDAVTGGFNFQACWSEAWLIAQDLNSK
>KALACAFP_01188 hypothetical protein
MLLAKKNILNAFKILLTIGFGYFFWLMLKITLEYIPLKTDVSFLMIKQTEVGERPEYLYF
FYTHVYTSIFVLLSGFLALIRKDFGVKNFHKNAGNIYIFLILIFAAPSGIYMGIFANGGI
LSKTSFVILGCLWWFSTFKAYQLARQKKFKEHKQWMWRSFALTISAISLRMWKVIIVYLF
HPNPMDVYQIIAWMGWIPNIILIEYLITKKYI
>KALACAFP_01189 hypothetical protein
MKILKLTLISLFAISFIACKKDAKTTSSSKDSLTAKKDSVVVPEIYKEYYGIYMGDFAGK
EMITPEIGEEYEGEVYKKISLKINRITKDSVYGQSIVNGNQRPFRGVFNESTKSFILDEP
GNDKTDGRFEVKLNNDSLTGNWNAFNKSAVKAPVKTLKLIKKEFVYNPNFMLSEDNDLID
WENPKNFVEKYTDEETGKTESYTASKNRIASDAVFKLNASKQKLTEKDLKNLRKLDLEII
KNSVFARHGYSFKKATYRNFFEQTDWYIPVSNNVDNDLSPMEKENVALLNRFIKYAEDKY
DSFGR
>KALACAFP_01190 hypothetical protein
MKFRFSLKYFVATLLIFLVEVLIATALKDIFFIRAYLGDVIVVMLLYTFIKSFIEINDQK
LIVGILIFSCMVELAQYFKIADRLGLEPGSVMYIVVGNSFSWIDILCYAVGCLLLYVFVR
LQLKKINPSTASHSG
>KALACAFP_01191 Thiol-disulfide oxidoreductase ResA
MKNFKILVMIFMVGLGLLSFTTINQDKNKPQKENISSAKGYEIGDEATDFKLKNVDGKMV
SLSDFKTAKGFIVVFTCNHCPYAKKYEDRIIELDKKYKSQGYPVIAINPNDPSVQPEDDY
QKMIERAKQKGFTFPYLVDEGQKIFPQYGATKTPHVFLLQKEDGKNIVKYIGAIDNNYEN
PNDVSEYYVQDAVNALIKNEPIKMTKTVAIGCTVKVKK
>KALACAFP_01192 Thiol:disulfide interchange protein TlpA
MKNVIKILFLMLCFTISKAQQTTVSAVKYEELEKRIQEEKNKLLVVNFWATTCAPCVKEL
PHFMEINKKYSENPNFKMILVSLDRLVDKERVIKFIKNKNLTAEVILLDDIKRMNTWIPR
FEKNWDGNIPVTIFYKNSEKVHFNDGEMSKEDLEKTIVKNLP
>KALACAFP_01193 hypothetical protein
MKKIILFLGLFFSAAVFAQEYSNVTQLPDYAILRTKMKLDDAVYTKADVPAEFPGGMATF
KRKFAESMDVIDVKSNKIDTRVYFIVEKTGYVRYVVATGSDEKHSHAAEIAVRRLFVKWK
PATINGEPVRYLYTFPLSLKKYD
>KALACAFP_01194 DNA mismatch repair protein MutS
MAKATKKETPLMTQYNTIKAKYPDALLLFRVGDFYETFGQDAVRTSQILGIVLTKRANGE
GHIELAGFPHHSVDSYLPKLVRAGMRVAICDQLEDPKTVKGIVKRGVTELVTPGVTFNDQ
VLNSKKNNFLLSLHKEKEKFGIALVDISTGEFLVSEGNLEKLLHIVNTFDPSEIIYQRSV
QIPEQIKNKNAFKLEDWAYQYNFAYEKLTNQFKTNSLKGFGVENQPLAITAAGAIFAYLV
EDTHHNLLAHITKIQVIPQEDYLMMDNFTLRNLEIVYPSNPQGKSLLDIIDKTSTPMGGR
LLRRRIILPLKSVDEINRRLSLIDFLNENDHLKYEISQLLKSISDLDRLMGKLAAEKISP
KELGYLRQSLINIHKIKALLHPHADVLAWLDPLYDQDELIKCLQNHLNDELPVNLAKGNV
IKEGISEELDRLRGLQSKGRGFLDEMCQREIERTGISSLKIDFNNVFGYYIEVRNTHKDK
VPSDWLRKQTLVNAERYITEELKEYENQILGAEEKIGVLENELYRNVCSETMIYIDQIQE
NSNIIAQLDVAVGLSELAVSESYTKPVLNESFSIDLKEARHPIIENALPLGEKYIPNDIF
LDKDSQQIIMVTGPNMAGKSAILRQTAIVCLLAQIGSFVPAKHAEIGILDKIFTRVGATD
NISAGESTFMVEMNEAANILNNISERSLILLDEIGRGTSTYDGVSIAWAIAEYLHQHPTQ
AKTLFATHYHELNEMTVNFERVKNFHVSIQENKGNIIFLRKLISGGSEHSFGIHVAKLAG
MPAKVVNRANEILKTLEASRSQSGSSEKIKRVTEENMQLSFFQLDDPVLENIREELTKID
INTLTPIEALMKLNSIKKMIGG
>KALACAFP_01195 hypothetical protein
MILENVDVVTDISKEDFQKNYFKKHRPLLIKNFASRWDAFDKWNFDFIREKAGDQEVPLY
DNKPADASKSSDAPVTHMKMRDYIDTIKSKPSDLRIFFYIITDRLPELLKNFTYPDLGMK
FFKRLPTLFFGGSEAHVLMHYDVDLGDFLHIHFEGKKRILLFDQKQSAFLYKVPLSVHTI
YELDYENPDYEKFPALKHAKGFEIFMEHGDALFIPGAFWHFNRYLEPGFSMSLRALPNKP
NVFASMLYHVFVMRYTDKLMRKVFKAKWVNYKQKWAYKKSSKAMDKYSE
>KALACAFP_01196 hypothetical protein
MRVYNTKNFLKILFSLHKSDTMKILFPTMVLVGLYSWGIEFLEVEYFHLSSKSTVSNVSL
IHSLLGFVLSLLLVFRTNTAYDRWWEGRKLWGKLVNDTRNFAIKINAILENDRQDAEQIA
RYLKYFPHFLAKHLSKESTRLALDEDYSEIEEYIKHHGPSEIIILLTHKLNQLKKEGKIS
DVEMLYLDTQLSGFLDVCGGCERIKNTPIPYSYSSFVKKFIILYVLALPVAYVISIGFFI
IPLTVFVYYVLMSLEMIAEEIEDPFSNDENDIPMEAIAQNIEKSVHQIMDLK
>KALACAFP_01197 Putative TrmH family tRNA/rRNA methyltransferase
MVHKLKLEELNRIDVETFKNVEKIPLVVVLDNIRSMHNVGATFRTADAFLIQKIVLCGIT
PQPPHREIHKAALGATESVDWSHESDINTAINDLKSQGFEIVGIEQTTDSRMITDFVIDQ
SKKYAIILGNEVEGISDEALQNIDSFIEIPQLGTKHSLNVSVCGGIVMWEFAKALK
>KALACAFP_01198 hypothetical protein
MTHTFQLISIQKIKGTLSKKTNNVKLYPIDQKQYKKLYKEYRENPNKNFQGMDILETQDG
KSSSEFKKNMERYYKNKIKKENNIIEIDLFDD
>KALACAFP_01199 hypothetical protein
MYLDVYKEGSVFYDIQNYKNDSIASLQGYKLSLFVDRVYKEYPQKVFLITSINNDFYSVS
DVRNLNWDISSEKKEINKINAQKATVNFGGRV
>KALACAFP_01200 hypothetical protein
MFIKEYISKDYPCFSLTDSIESARDMLEAFGYSHVFIKKSHHFYGALAEDFLYEEEGTLK
DLEHQIERFAILEDNNIMDSIRLFYTFNANVIPVINKAEKYLGYISCEDIFQDLSKYPLF
SESGAILTVEVPSRKYSMTEIANIVESNNSKFYGAFISFMSDEVIQVTIKIGNENLSSID
ETFDRYDYRIVEKYYSDEKSDLFKDRFGFLQKFIEI
>KALACAFP_01201 NAD kinase
MKAAIYSQKKDLDTFLYLSKFISELENRGVKSVLYDEMAEALQFSKIFETFNCKQDLLDK
EVDLFFTFGGDGTIVNSLTFIEDLEIPIVGVNTGRLGFLASFTKEEAFAELDSILKGDVK
TSRRSVIEVVSPQLEDFFPYALNDVTVSRKETTSMVTVDSYINGEFLNVFWGDGVIVSTP
TGSTAYSLSCGGPIISPNNENFVITPIAPHNLNVRPLVVNDRVEIKFKVESRVSQYSLSL
DSRLIHIETDKEIVIRKANFQILLVQPNNLSFYETIRQKLLWGRDKRN
>KALACAFP_01202 Fructose-bisphosphate aldolase class 2
MSRIFPAGVATGQLVTDIFQHAKENKFALPAVNVIGSSNVNAVLETAAKLNSPVIIQFSN
GGAAYNAGKGLSNDGQKAAILGGIAGAKHIHTLAEAYGATVILHTDHCAKKLLPWIDGLM
DANEEFFKQTGKSLYSSHMLDLSEESLEENLEVSAKYFERMAKMQMTLEVEIGVTGGEED
GVDNSDVDNSKLYTQPEDVAYTYEKLKAISDNFTIAAAFGNVHGVYKPGNVVLTPKILDN
SQKYVQEKFGTAAKPVNFVFHGGSGSTLEEIREAIDYGVIKMNIDTDLQFAYTEGIRDYM
VNKIDYLRTQIGNPEGEEAPNKKFYDPRVWMRKGEETFSTRLVKAFEDLNNVNTLK
>KALACAFP_01203 Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta
MAFDWFKRKAKNITTSTDEKKDVPKGLWHQTPSGKVVEHDELKRNNYVSPEDGFHVRIGS
AEFFDILFDEGKFTELDANVESIDMLNFKDTKSYTDRLKEVKAKTKLTDSIRNAVGTVKG
TEMVVSCMDFAFIGGSLGSVMGEKIRRAVDYCIKNKLPYMIICQSGGARMQEATYSLMQL
AKVQAKLAQLSEAGLLYIAYLCDPTFGGITASFAMTADIIMAEPGALIGFAGPRVIRETI
GRDLPEGFQTSEFLQEKGFVDFIVKRTEIKDTVAKTVNLLAVNA
>KALACAFP_01204 hypothetical protein
MRLLSLILPHPLFSLLSFHATVQAFAIAQKKFPDTASNNGIGNSFRHALWCCFIMMYCCK
VSSPKKALDFCKRITDMHEDLFPNQPLETKMDLHNNKVGMDYFMELLPGVHRQFFEKSFF
IDGLEKKMKDAKVLKNLDDDFEGFLVYLDEK
>KALACAFP_01205 Spore maturation protein A
MVLSRIWSAFIIVAIAIASIKYISSSHYKTIFNDMVVGKGGDTVQIATQKMNTLSPIVRD
SLMKKPDFADSRIHYKTDSLRQDVKVYRVQEADGVIGTSETAVKICLGLIGIMTLFMGFM
SIAEKAGGINLLSRLIQPFFSKLFPEIPKNHPAFGHMLMNFSANLLGLDNAATPFGLKAM
ESLQTLNPNKETASNSQIMFLCLHAGGMTLIPVSIIAIRASMGSKTPTDIFLPCMIATFA
ATLAAMIIVSLYQKINLLRPIVITYVGGISAVIALLVLYLVQLSKDELDDFSKVLSNGLI
LFIFLAIILGAVYKKINVFDAFIEGAKEGFTTCVKIIPYLVGMLIAISLLRTSGVFDVII
DGMKWVAYNANLDARFVDGLPTALIKPLSGSGARGMMVDTMSTFGADSFQGKLAAVLQGS
SDTTFYVIAVYFGAVAVKNTRYTVIAMLLADLVGIITSVALAYLFFA
>KALACAFP_01206 hypothetical protein
MSYTKLDIYNTSFELFIETHQLTFKLPTYETYELGSQLRRSSDSIVTNIVEGYGRKVYKG
ELIRFLVYSQGSCDETVSHLSKLSRLYPELNSDFENKAEQYKLLGGKINNFIKYVQLNWR
T
>KALACAFP_01207 hypothetical protein
MITDKEFTLRLIRQLSQALEKLILDKPEESLMQKELDFDSLMRDIFKFDFTVLSSKTKEE
IIEIVNERQERDHKDYYEMLGNLFYFTGKQTNNTDFLDKAKTFYELYLQTSGIFALPVIN
RISEIKKALE
>KALACAFP_01208 hypothetical protein
MPLQRLKINNKPENFGKDHFKMRSQIINKDEQNKDRLKSALLSILIWSAILLFVFLYKLK
PELEQQPEVVTTMLVNFGDNRNGNGAEEPAEQPGSLAAATEEVTPEPVETPVPETKTAIK
PEPQPETKKSEAKEKIITGNNAKVSVPKKEESKKSDKATATSTSASKNTKKSGATTANSK
TGNGDGKGTAAIGNLIKGRGTKAGSQGDGTGIGNAGDPLGGDGNGDSKVGIDRKLVGFIP
GTMGRGGAQPANSCTASGTITVAYTVDKAGNVVSARRSGGTSDPCITSNAVSWVKKYVKA
EKANTSSTGTYKITF
>KALACAFP_01209 hypothetical protein
MKIQRRNKANPEFSLAAMTDVILLMLIFFMITSSAANQSAIDVKLPKAGAVDDNIPNPLT
VSIKPDGSYFVDDVPVTKDQLEATIVNKLTNQTNKSFTIRADENTMHKDVVFAMEIAEKN
KFNIAIATVKDK
>KALACAFP_01210 Biopolymer transport protein ExbB
MLLTELTQILFAQVAAPAVAVDDLEFSFWKIMFHGGAFAKIVMVTVLLLGVFSVYLFFER
FFFIKRITSKTDSNFMDNIEDFIKEGKIESAADYCKRQNSPEGRILEKGISRLGRPVSDI
VSAMESQAQVEVANMEKNLNLLAVVPSIAPMLGLLGTVIGMIIAFFNLSHASGSFSPKTL
SEGIYTALGQTAVGLAVAIPANFFYNILLTRIDKFVLRAQNMSGEFLDLINKPL
>KALACAFP_01211 hypothetical protein
MKGILKIYHPDETLKYNIRNTYCKAVYSNQQHFLEVEIITDDGLDHVEDDSLQYNFPQLS
LEVFDFPIESAEIEGKTITIADTEEDTYTEVDLFDDEEAFIYDNELLFEKNEEGELQVIW
KGTIDDFYTGSGTPIPFRLKCEFKQDDIEVDED
>KALACAFP_01212 hypothetical protein
MRNILSKSILGLGLIVSLASCKKSDSPLTKVTPTNLDSIAANY
>KALACAFP_01213 hypothetical protein
MLRAEMEKVKQQVGFTGTLEEFINYVKTDPKAMPYKTSKEVLAGFNGILTKITPKLKTMF
SVTPKTGFEIRQTEKFREASASAEYIQGTPDGKRPGIFYVPLPDPSKFNVTSGMESLFLH
EAIPGHHYQVSLQQENTKLPKFMRFGWFGAYGEGWAHYCETLGPEFGLYTDPYQKMGYLS
DQMLRAVRLVVDTGLHTGKMTREEAIKYFLNNISYDEAGATAEVERYMAMPGQALGYKIG
SLRIRELREKYQKQLGSKFNLAKFHDEVLSQGCLPLDVLNRKMELWAKKQK
>KALACAFP_01214 hypothetical protein
MISQNLKSLFTRDLNKLKTEIEAYQDEANIWKTDKSVSNSAGNLCLHLVGNLSHFVGAIL
GNSGYVRTRELEFSLKDVPRAELIKKIEETLHIVTSTLDNLSTEELEKEYPLEPFGYAMT
TEYFLMHLFGHLSYHLGQINYHRRLLDVE
>KALACAFP_01215 Endonuclease III
MTKKQRAELVQTELEKLYPQVPIPLDHTDPYTLMVAVALSAQTTDKKVNQVTPELFAVAG
TPQRMAKLEVFEIKELIKEIGLANTKAKNLKRMAELLLERHNGVVPQTYEELEALPGVGH
KTASVVMSQAFGFPAFPVDTHIHRLMTQWKLTSGKNVVETEKDAKSIWPESVWNKLHLQI
IFYGREYSPARGKGEKDFITKMMFDKD
>KALACAFP_01216 Putative peroxiredoxin bcp
MLKVGDKLPQFEGTNQDGKTVKSEKLIGKKLIIFFYPQANTPTCTVEACNLSDNYSKLKK
NGFQLLGISGDSVKKQKNFHSKFAFPYDLIADENREIIEKFGVWQEKTTFGKTYMGIVRT
TFIFDEQGVCTRVIEKVTSKTAAEQILEG
>KALACAFP_01217 hypothetical protein
MSLKNQPNQQNADKIYETERLIIRPMSLEDGDFILDLYNRPKFIQYIGDRHIKTVSDAEN
YITNRFLPQFERLGYGNYLILTKEGNHKIGGVGIFEREGLDVVDIGFSLLDEYEGKGYAY
EAALKVKSIGMDDFGLKKLSAITTKDNFSSQKLIEKLGLKFQKYITIPDDNEELMYYETE
>KALACAFP_01218 hypothetical protein
MLSGVLSYAQQKRQFSSVASILQNITPNMRTDSWLLIQKSYGKDNIIKQSGVPKDYVSQN
SGFNIGIAEEGNFYYIVYSSAGKTEYITDLEGLKKFVGKIDDVQDAAVFAATEGYIVDED
FKDVAGNYYEDISNYYLDLGKLISKECPYQKKHYTLTISKVTGTINFVKDNGSYIELYNK
KCTNNPRLLKIEKKEEPKDEPKKPAKSTKRR
>KALACAFP_01219 Mannose-1-phosphate guanylyltransferase RfbM
MSKSDRYCVIMAGGIGSRFWPMSTQKFPKQFQDILGVGRTMIQQTYDRISKIIPKENIFI
ITNKEYVELSHQQLPEVPQENIVGEPLLKNTAPCNLYMANKIAEINPNATMIVLPADHLI
LKEQTFLDKVELAFDLAAKHEYLVTLGITPTRPDTGYGYIQFVDKKDSDYYKVKTFTEKP
ILEIAKSFLESGDFLWNAGIFIWSVKSIHHAFETYLPEMTQHFMACEYNADSEKSCIELI
YPKVQKISIDNGILEKAKNVYVIPADLGWSDLGTWTSVYENTEKDENRNAVKLKHILTYN
SKGNVIRLKNSNKAVIIDGLKDYIIVDTDKALLICPRDHDQLIKEYVLDLKNLKKGDKFM
>KALACAFP_01220 Protein SprT
MSIQSLEKYLPQNTLQYLKIWFSDYYIHIKITRNRNSKLGDYRKLPDHSHEITINSTLVP
QLFFFVLTHELAHLIAFEKYGRRISPHGNEWKETFRQMLLQSLDVYEEELRPIIIKFSKS
PKANFMASPDLVKYFHIERQDDTLQFIEKLQKGDFFIYRNEKYLLEGLIKKNYLCKNLAT
GRKYSFKPLARVEKCT
>KALACAFP_01221 Outer membrane protein TolC
MKKVLTVILGLSCLAVNAQKKWSLRECVDYATKHNLQVIQNEYSKQTQDLNLKIAKRNYL
PSVSASVGNSVSFGQASLGTGSIRNDRFSNNSNIGADILVYNNGRLEKTVRKTEFDVEAS
QYDIETIKNDISLQIAQQYLTTLLNKEIVKISQAAVENAQKQYNRSKITTEVGTTAQTVL
AEAEAGLAREKQNLKTAEINVGRSLFALAQLLQLQEYKDFDVEDVDVPDQLAPQLKDVDE
VLTTAYETQPQVKAAESRIRSAEAQTEVSKTAFWPTVTASAGIGSFYNNILTRYDQYGNP
IIDPTFFSQYNDNFGQNVGISVNIPIFNKGITKLQVEQSKLNESIAKITLLQQKQAVREN
VQKAQFDVDANYEIYLSAVQAEKSTKLALEFADKSYAAGRSTIYDVNVARNNYANAQGSV
AQAKYNYLFSLKLLNFYAGIPLSL
>KALACAFP_01222 Folylpolyglutamate synthase
MTIEQYQEAVDWLFVQAPNYQIDGQKAYKPGLDNIIRLCDFFGNPQEKIKCIHIGGTNGK
GSSSNMLASVLQESGYKTGLYNSPHLIDFTERIKINGENCDKEFVYHFIQKLKDLPEDIQ
PSFFEFTTIMAFEYFYQQNVDIAIIEVGLGGRLDSTNIIKPLVSAITNVQLDHQNILGDT
LEEIAGEKAGIIKNSIPVIFGDENEVAKNIIKNKAERENAPFIDATLLKTDLKSDLKGNY
QEKNIKVVLALIEELKKLNFNISDANIEKGLLHVHENTGFIGRWFEFSKNPLTICDTGHN
QAGLEHVFEQLNSIKKHKHVILGFVNDKKIDEVMKILPENSEFYFAKPSIHRGRHPEDYE
NLLVEAKISYKIFDSVQEAYLSAKEQCTNEEMIFIGGSNFVVGEFLEKNLEISE
>KALACAFP_01225 hypothetical protein
MKKLKKIGAVILVGLFVISCAPRLKPNGNNGLPPGQVKKVTGAKSAKYYAPGHRK
>KALACAFP_01226 hypothetical protein
MTRILAYRFSAFGDVAMTAPVFREFLEQNPDVEIVMVSRKNFESLFSDIPNVIFKGVNLD
DYKGFFGLTRLANELVKEFHPDLIANLHDVIRTKVLDKIYRRKGLKVFKINKGKEEKEHL
TDIWNLHKTQLKKTVERYADVFREMGFKVELSHQLRPFSVIKSGIGFAPFAQHRGKMLPL
EKSYELAKILAQKHKIYFFGGGKNETETLGKWEREIPNTQSLSGKLSLTEELNKISELEL
MISMDSANMHLASLVGTRCVSIWGQTHPYAGFLGFGQSEDDVVQIKDLSCRPCSVFGDKE
CYRGDWACLEELAIQKIVNKIL
>KALACAFP_01227 Cysteine desulfuration protein SufE
MTIKEKQQEIIDEFAFLDDWEQKYEYIIDLGKELKGLSEDKKTDENLIKGCQSKVWIDAE
YKDGKLFFNADSDGILPKGIVSLLVSIYSGHSTQEILDSDFEFISEIGLQEFLSPSRANG
LMAMTKQIKFYAVAYQLKS
>KALACAFP_01228 hypothetical protein
MNRKKVITSAFSNLYTDQRIEKVCRTLHENGYGIELIGNDWGGSEKISRPYAFNRIKLIS
TSLKTAYFEFNWKLYHELKKKADKNTILHANDLDALLPNYLISKKLNIPLVFDSHEIFSE
MPAIQGKMSQKLWRYLEKNVIPKIQFMMTASSGYANWFKNQYGILPVVVQNAPRKLDFTG
EILENNPKILLYQGVINPFRGIDKAILAMHHLENVIFKVAGDGPKKKEYEDLVIKENLQQ
KVQFLGKLLPEDLRKITPTVDCGMSIEENGGDSYYYSLPNKVLDCIQARVPLILSNLPEM
QNLKAQFDIGEIIRDHRPESIAEAIKRVLNKGRRSYLPELEKAANILCWENEEIKLLEVF
EKASL
>KALACAFP_01229 hypothetical protein
MNPETATYIGYSASLFIVLSFILKDVRKIRIVNMVGCICFVIYGIFSGMLWPVIIPNGMI
CFIQIYHLLADKKK
>KALACAFP_01230 ATP-dependent Clp protease ATP-binding subunit ClpC
MDYKFSQGLSQVFKQSKSEAKRLKSEFLNTEHLLLGIIKTENSAKEILQNLNADLTQIRR
KIETLNTASLNPISEEVTNISFTKMADHAIKRAELECRQYKSNEINTVHLLLGILYKYED
PTSNILGAYDIDYEGVSKEYQTMLKNSGQAPQMSAYDDDDEREEFEQMRKPTGNLGSGKS
KTPTLDNFGRDLTSLARDGKLDPVIGREKEIERVSQILSRRKKNNPLLIGEPGVGKSAIA
EGLALRIQQKKVSRVLYGKRVITLDLASLVAGTKYRGQFEERMKAIMTELEKNRDVILFI
DELHTIVGAGSSTGSLDASNMFKPALARGEIQCIGATTLDEYRQYIEKDGALERRFQKVM
VEPTSIEETVQILNQIKDKYEEHHNVIYTPEAILACVNLTSRYITDRFLPDKAIDAMDEA
GSRVYIKNMKVPTEIIDFEKKIEDIKEMKQKAVKAQDYLEARKLKDEEERLQMELNAAQD
KWDKDVKEKKETVTEENVAEVVSMMSGVPVTKVGKNELDKLAQMDGKLNGKVIGQEDAVK
KVVKAIQRNRAGLKDPNRPIGTFIFLGTTGVGKTELAKVMARELFDSDEALIRIDMSEYM
EKFAVSRLVGAPPGYVGYEEGGQLTEAVRRKPYAVVLLDEIEKAHPDVFNILLQILDEGH
VTDSLGRKIDFRNTIIILTSNIGTRDLKDFGDGVGFGTSAKKSNTDTRARSTIENALKKA
FAPEFLNRIDDIIIFNSLVQDDIKKIIDLELNKLYSRLEKLGYKVELTEEAKDFISEKGW
DKDFGARPLKRAIQKYIEDLLAEMLVNKQLNEGETVVLDLNEAKDALTGKASKTKKSAAE
KSSQS
>KALACAFP_01231 hypothetical protein
MKKFIISLFVMISGVLFSQVSVGASPESTNRWTFGGGIGVGFGSQSAFYLQASPRVGYRL
TNDLEGGVVGSVSWQTSDYYRSTMFGVGPFLNYYIARTFYLSANYQHYFINYKHKYYDYK
TNAEEDALYLGGGYMQRIGNNSFMQIGLMYNVLWKENESIFSTGLVPSIGFVVGL
>KALACAFP_01232 tRNA-specific 2-thiouridylase MnmA
MKVVVGLSGGVDSSVTAYLLQQQGHEVVALFMRNWNDASVTLEDECPWIEDSNDALMVAQ
KLGIPFQVIDMSELYKERIVDYMFDEYQKGRTPNPDVLCNREVKFDVFMKTAMSLGADKV
ATGHYAQVTSTFDENGKEIFHLLAGKDNNKDQSYFLCQLSQDQLSKALFPIGELTKPEVR
EIAKEIGLVTADKKDSQGLCFIGKVSLPQFLQQQLVPKEGEIVEIFRDSPIFAEETPVFS
SKQEELEFLSKKINYKKSGGKVIGKHQGAQFFTIGQSKGLGIGGHKESCFIISRDMENNI
LFVGEGHSFPGLYKKALKIDNSEVHWVREDLALKNGETMEVMARIRYRQPLQKATLHQFE
DGFYIEFEDAQSAIAEGQFASWYIGDELLGSGVIA
>KALACAFP_01233 hypothetical protein
MINKKYFIISAFMLLLLSCGDRDADIPLDNMSGRIVIEGNISDQNGQSFVAVSRTVKISS
GDDEYSPVANAIVTVSDSQGHVDTLKYENGVYKPVNLVSNYGEIYTLSVTVDGVTYKATS
KMPEYVNLDDVKQSKIFDGFNNVSGLIPIFTDPAAKGNYYLFKSKLKDDDNNDTSYTVMS
DEIGNGEVNGKPISIDVQYGVNQYVTVELQCIDASVYNYFKAFPQAVLHNSGATITPTNP
PSNISNGALGYFSAHTSSSKTITIQE
>KALACAFP_01234 hypothetical protein
MMRITTMAVFLSVCSYAQKNYSINGVVKDQDTGELISGAVIKIKEKPEISIETNEYGFYS
LSLPENDYTLIISHDKHKDAAQNIHLDSTKKIDWTLKKDEYLIEEINLKDVKRSKAFSTQ
SKMGAEKLDIQGISKLPVLLGEKDIMKTLQFLPGVSSQEGSSGFSVRGGNLDQNLILLDE
APVFNNSHLAGFFSTFNSDALRSVTLYKGNIPSQYGGRLSSVVDVKMKEGNNQNFGVAGG
IGLISSRISFEGPIQKGKSSFIVSARRTYLDLFLNSTGENGGNTKLYFYDLNAKFNYQIN
KNNSIHFSSYLGRDIMSFDKFKNNWGNLVGTLRWNSIINSNLFSNTSLTYSNYDYRTNII
GYTGNIVEINPNVRNWGFKQDFSNYVGTSHTFNYGLQASYYDFFTNKLPDYINSEFLKKE
RTMWESALYFNDDYKISEKLFMNYGVRLSMLNRGKDIEKDGETSKRYINFEPRLMLNYEF
NKNNSIRAGYTRLTQNLQTLSNGGYGQFINNDIWLNLKKPLTMDQVNLAYTKKFNKGYEV
TSEVFYKKMANLVDYKDGLVVDVLDNVENNLLYNGIGRAYGFELLAKKTKGRLTGWVSYT
LSKTERKIDGINEGNWYNANSDKTHNLSVVASYELTPAITFSGAFVYSTGNAVTFPVGVY
NIDGQTVFQYGARNSNRMPAYHRLDLNVTYEPKTTKRFKSSWSFGVYNIYGKQNPYTISF
EKDMFTNTIRAKQETLLSIVPNVAYNFKF
>KALACAFP_01235 hypothetical protein
MKNILIHSVSVVISFFWLVTEKETYNPISLKGPDFLKFYLILLLCFYTSVFVLNFLKERV
TKVTILFIILIFVLGMVKLIKGMILDKPVGYLLLILFFEGVFYIYFMLFYFNKKLKLSSK
>KALACAFP_01236 hypothetical protein
METKMLLQNDSLWSRLQEFSLDTPNVDFPFSKKLAKEEKWTLDFTKKAIEEYKKFVYLCC
VLPNGASPSEIVDKVWHMHLIYTQNYWEEFCPNILQKKLHHHPSKGGFAEKEKHQNWFSD
TLKSYREIFQQEAPEEIWKEKPKVKSWLKRMAVFSPLIILLLMYSCSDGEGFISVMFMVV
VCASIFIFGIVESILGDNEVSDPHKKDKGNNDGGGCSGGGSGCSGGGGCGGGCGGCGGCG
G
>KALACAFP_01237 hypothetical protein
MKKEDILHLEKLMNFLSLHFLKKNHWHDVTKTEWSYIVAEINDLIVADHAEKNIKKNPDL
LGSNYLYEHLIINKLKKYYQDEKIVLSKPNLAKLSLIVKVLGYSNYIDFINTNTESFNFN
DLRIDMNNAKQNTKLLDRLVGSWYSYNRNLPDNPLQAKDNRIWRSAMEIYKSETSGEYFI
ERSGGDHHKYFGKVTAYSDYVFIIMNSNTFIRQRHFISRIKDIKEKLKNPDYKLHELHFI
STCISFNQEPIALFEIFQKADRKTFLPDSISFPIDSDEIPKSIIKQLEDTESNRIDYR
>KALACAFP_01238 Sensory transduction protein LytR
MIKTVIIEDEKPASRKLERMLSEFPEIEVVAKIESVEEGVEWFSNNEHPQLIFSDIVLGD
GLSFDIFEKVPTKGFIIYTTAFDQYTLKAFKLNSIDYLLKPILDEDLSGAIEKFKSFLPS
DNSVNSKEIKELIKKDKTTLSRILVKIGYNLKIVQTQEVSCFYSENKIVYLQTQDRAYPS
DFTLDELEDVLDEKKFFRVNRQFIVNSDYIKNIHTSPNYKVELEFQPQEEITVSRDRVKD
FKDWLVN
>KALACAFP_01239 hypothetical protein
MDYNQAQERVNQLKKFYKSLLWFGIVSAIIFFNDIFEQGKLDFSLFKGSIILTIWGIILT
VKAVKLFILDSEWERKVIQKEMGKSKEPIQF
>KALACAFP_01240 hypothetical protein
METTSFNKENLAYERATRRVKELKGFYGNLTSYCLVIPFLVFLNLLTSPDQLWFYWPMLG
WGIGLVAHGINTFGIGRNWEEKKIRELMEEERKNTKTL
>KALACAFP_01241 hypothetical protein
MNTLGIIFTISMIAWFLSEFLYKNILKSGEKDKKGKDKSTLNLLWIAIPLSVALAVTFSY
ITEFPITNELWILYVGEAFILIGIILRVFIIRSLGKYFTVDVTIRENHKIKKEGFYKYLR
HPSYSFSLLTSLGLGLYLNNWLSLLFAFIPPFVAFSYRIRIEERTLIEQFGEEYLEYRRK
TKKLIPFMY
>KALACAFP_01242 hypothetical protein
MENIDKDDIRYREAERRVKKIKNFYVFTFIYFAVNIFILFLNYRGLKPNESIWRLKYFSL
PLFWGIGVMGYGMSVFLPGFVLGNKWEEKKIKELMEKEKSSK
>KALACAFP_01243 Sensor histidine kinase YpdA
MKRKGIIILLWISLGTALFFFFVFNDEKTFKNFALTLLVSTMYSFILGFGNALINDFLNK
KFPWSETTRTRAILSVISILIANFILVYFCNYMNFVVIQKTATTEEFFSSKYNTSNWFMI
NIALLISAFLHAKSFMEELRKTSKKEVVEQKLIAKSANAQFESLKNQLDPHFLFNSLNVL
SSLIDENPKQAQKFTASMSKIYRYVLEQKDKELVTVEDELEFAKTYCDLLKTRFEDSVDF
VFDVKKEDYRRFVVPLSLQLLLENCIKHNFATSSKPLIIKIFSENDTLCIENNLQVREQI
KESSGIGLANIVQRYSLLTKRNVFIEKSEDYFKVKLPVLADKPNVVSVKIEDKDKAYERA
QKRVKEIKSFYGNLISYCIIIPFLMIINLTTNPKNIWFYFPMLGWGIGLAAHGMSVFAIG
KSWEEKKIREILEKQNKR
>KALACAFP_01244 hypothetical protein
MKKYLLSFALAFVSLTAFAQSDYEKAMKENIAKIETSKTVEEYTTVANNFHRIAGKDENN
WLPFYYAALANIQKGRVLMREGKTQDLDFIAGQAQKYIDAAAHVAPTDNAELHLLTKMAY
SLKMMVNPQQRYMTDGAKAAEEMKIAEKLDPNNPRVALIKAEDTYFTPEQYGGSKTKGIE
QFKDALAKFNSYTPKSALDPSWGKAEAEYFANGAKK
>KALACAFP_01245 hypothetical protein
MIRKLTAMKTRGKKLLFLISFLSFSLSFAQVKISGKVAYRNKGIGEVNVTLKDTYDGATT
DSNGNFSFETSEKGNKVLTFTHPKYIDVEKSITIDNQDVSVNAELKEQINEIDAVVVSAG
SIEASDKKRATALLTPIDIYTTAGADGQISSALTYLPGVQKVGETEGLFIRGGTGTESKI
FMDGSLINNYFSNSVPGIAGRDRFNTSLFKGNVFSSGGYSALYGQALSGALMLESVDLPD
QSSYDFGISPIFLNAGFQKLNDNKNSSFGATVGYSNLKLMQEVFNFNTNFSDAPQGLNTD
FNVRIKTKSGGFFKYYGMYDSNRMSVKVESLEPENDFSLVNLKGKNTYHNLSFKQKFGKY
LLNAGTSYSYNKSDLDFSTQKNDIETGNTKLLNDGNYINFKAVLDRKINKISALRGGFEL
NSASEKLNFNDVANKHYKDLISAVFVETDLGFSNQLSAKIGVRAENSSYLKKSNIAPRFA
LAYRLAKDWTTSFAYGLFYQNPESKYINGPANLDFQKSQHYIFQLQRATEGRSLRLEAFY
KKYDDLLKVKNLPYVDGQNQYVQTADNNSGYGYAKGLELFWRDKKTFENIDYWISYSFLD
SKRDFMNYPLSLKPNFASEHTISAVAKRFVPKWKTGFNISYTYAKGRPYYDIATKDVNGD
SVYYVRNEGQLKDYNALNFSVNYLPNLGKKDAKAFTVFVLSVSNILGTKNVYGYNFSMDG
SRNSAVVPPVNTFVFVGAFISFGVDKTQDAINNNL
>KALACAFP_01246 Superoxide dismutase [Cu-Zn]
MNSKTLALLAGCALFAVSCGTTKTYQVLSKSNTQTGGTAKFTQKGDEVIMKLDVTNLTPG
IHAVHIHEKGDCSAADGTSTGGHWNPAKDDHGKWGAEHFHMGDIGNLVANQEGVATLTFK
TDKWCLGCADESKNIIGKGLIVHAAADDFHTQPTGNAGGRVGCVEIK
>KALACAFP_01247 Antitoxin HipB
MAKKEIKKYTLAEMKDRYVGKEGSGERHTYEYELRMDVLGHLIKAARKERKLTQVELGNL
VGVQKAQISKIENNINNVTIATILKIFEALNADVSFNVKLDDKKLELQAG
>KALACAFP_01248 hypothetical protein
MKYFDTIFLEEAERFISKLDNKSARKIIYNIDLAEQTNDPKLFKKISDEIWEFRSKYLGN
QYRLLAFWDKRDHKNTLVIATHGFVKKDQKVPQKEIDKAKKIREIYLK
>KALACAFP_01249 Tail-specific protease
MWKNFKLNKFLLLIPLTSLMFCFNSPQNDDEKMQTIMVSVKNTLSYLHYSPKPINDAYSK
DVYKHYFELVDPAKRYFLQSDMDEFSKHENKLDDYINVGDLTFYKLTIDRLYQRVDEIDK
MTQDIFSKPINLEEDEALTLEPKLKKVPVNKQEQYNEWKKFIKYNILQEIESMNSKEEAQ
KEKKDSVQKYNLKDTIKYQPLNQEAKIKKATNEVKDLVKETFTRFKKRKKMDWFTVYMNA
YTEVFDPHTNYYSPKDKEDFDTNFTGKVIGIGAIIQEKKGNLYLGALTIGAPAWKSKQLS
EGDKILKVKSKPKEDAVNVVGMLSDEAVRLIRGEKGTPVTLTVQKKDGTIKDVTMIREEV
AIEDTFARSIVVNSPNGKKYGFINLPSFNADFENPNGRNASDDIKNEVLKLKEQNIEGIV
LDLRNNGGGSLTEVGDIMGLFMNAGPYVQVKDGNGKIQTLKNKNDVPIWTGPLVIMQNEL
SASASEILAGVMQDYGRAMVIGSPQSFGKGTVQTFVDLNRFLNTEDDFGSLKLTIQKFYR
ITGESTQRKGIVSDIQMKDFFTYAEIGERYDEFALAWDKIPATNFQKLNYFDIKALEAKS
TGRMAKNNNYQLLLESAQWREKLDKEETITLNINKFNELMKQRKAQIEKFKVLTKFDNGL
KFMMYPSEIEREKKDEAFKKKSEMWIKNLRKDTYLQEAMNIIADMSVKS
>KALACAFP_01250 hypothetical protein
MTHQRKLSSTSAHMNAKKGFRIHFLVFLLTTPLIWLVWYLTDRTYIWPLWSTLAWVVGIL
FHFLGVYFFKNFKNK
>KALACAFP_01251 hypothetical protein
METPTKTFRRIVTGHDPEGKATIICDAPPVNTHLVGGKGGATFFEVWHTVETPVLIHPQP
DETDENGLILPPPKNGTRIRVIDFPPEGDEIRNLTEKEAAEKFRSMGDENASTSSQGAPH
PLMHRTETLDYGIVLEGEITMILDKGETTIKAGDIVIQVGTNHAWSNRSGKNCRMAFVLI
DGQFTNNFNLKN
>KALACAFP_01252 hypothetical protein
MRLQPLPPENLTSELRFVHDEISNLITKSQGQASMINDEGALLGPFPAMLHFPKFGIPAL
SFIRTLDTYATLDKKVREVAILTVGSTFGARFELYVHEIMAEAFGFSKSIVASLSAGIRP
EGLNEQEAITYDIAYTLTHGKIVSNSTYRHAVDVLGKEAVGELFFLIGSYSLIAMILNGF
DIPAPENNE
>KALACAFP_01253 Pyrethroid hydrolase
MFLTLLLAAFTLLTSSSCSTDDDNTTTVPPQTYVLVHGAWQAPYVWNTVRANLEKQGQKV
IVVELPGHGADNTPTHTLTLDVYRDKVIEAMNKAEGKVILVGHSMAGMVISNVAEKVPSK
IQKLVYIGAFLPESGQSLGDLALLDPGSQLGGSLVQSADHLTFDVKSENLTHLFIGDGSQ
AAKDLVVSNYRPEPAIPLDDKVTLTSQNFGSVQKVYIKTLQDIVISPAFQDQMISKAGIS
KVYEVNTSHSPFLSKPNDVSDLLIKIGK
>KALACAFP_01254 hypothetical protein
MTKTNRTLGYVLHHLIVAFSAFLLFSGMSIKAQEITVKLTRFEVKADYQNQLKETLSLYV
KNAISKDGNIMAEAYYEREKPSVLWLIERWKNVSELENFNMGPQAKKINSLAKKALTEPL
KTIQVKDLEPLSKEEWRRTSKKEDNQLTIMLFVDAKAGTEQTFKDVYHAAMPQFRSEPGV
VTYQLSQFENDPTQFVTYEKFRGDDAFQYHLKFPPIQPVIDFLNSSIKKQPFQTGIHNLI
EFAPLIRE
>KALACAFP_01255 General stress protein 18
MKTIYKTIVAAIIGIFAINNLNAQKTSHELEVVNQLASQPAVVNMPVSQLLNAPGNEALR
DFFFKPVKDKTVLKGKKIAVIAADGFEEIELLGPVWYFKQLGAQVDIVAPKFNPAPARYG
LVYPEMSKTHIMAIQYLQPVGWIKFDKTADQINVNDYHAVFIPGGAWNPDNLRYDKDVIK
FLQDFNKSGKLIAAICHAPVVLASADILKGRKLTGYWNIQVDLKNAGATVVDEPVVTDGN
IVTSRHPIDVADFSRAVESWLVKH
>KALACAFP_01256 5'-nucleotidase SurE
MERPLILVTNDDGITAPGVRNLVNFMNEIGEVVVVAPNSPQSGKGHAITINSTLSYEEVH
LEGPQRDFSCSGTPVDCVKMALDKILPRRPDIVVSGINHGANSSINVIYSGTMSAAVEGG
VEGLPSIGFSLLDFSWEADFTQAKDYIQNIVRRTLEKPMPKGIVLNVNIPKLPKEEIKGV
KVCKQANAKWEESFDERVNPHGKKYYWLTGYFNNMDDSEDADETALANGYISIVPVKFDL
TAYEYMKTLEEVMNFD
>KALACAFP_01257 Antilisterial bacteriocin subtilosin biosynthesis protein AlbA
MPVRNYTYYDYTISLCPECLKRVGAKIIIEDEAVFMTKRCPDHGFFKTKIASDVHYYKNI
RNYNKASEMPVHFGTDVEYGCPYDCGLCVDHEQHSCLSIVEVTDRCNLTCPTCYAMSSPH
YGSHRSLEEIEAMFDIIVKNEGEPDVVQISGGEPTIHPEFFKIMDIAKSKPIKHLMLNTN
GVRIANDPGFAEKLATYAPEFEIYLQFDSFKPEVLEDFRGKDLTDVRMKALEKLNALNLS
TTLVIVLQKGKNIDEIGKIIDFALKQKCVRGITFQPVEIAGRNRDDSAHEKITLTEVRQE
ILNQFPLLNSDDIIPVPCNPDALAMGYILKLEGETIPLTRYINPADLLNNETKNTIVYEQ
DTGLQMQLLDIFSTGISVDKVQPKVNQLLCCLPEASAPNLDYDNLFRIIIMNFMDAHDFD
VRAVKKSCVHIVNKDLKLIPFETMNLFYRDDKIKYLEELRKEDKVLF
>KALACAFP_01258 hypothetical protein
MKSLTLLEVGNLGGLFAMIIIIFLVVALFISFIITMIVKVSYEWKGDKKFSRKQFIQTML
ISLLLCGLISGAICGGGL
>KALACAFP_01259 Prolipoprotein diacylglyceryl transferase
MDFPVTFHIFDTTVLAHPVFEALGMFIGMRYYFFLKRKSKEKLSFNTSAAVLIGATAGAL
IGSKLIGNLENPYKLFEHFDFKTIWTNNTIVGGLAFGLMGVELAKKIVGHKESTGDLIVF
PLMLAMIIGRIGCFLTGIYEETYGLPTKSIFGMHLGDQYLRHPVALYEIAFLIVLWIVLK
MIQRQKKHPSGFVFQSFMLSYFAFRFLLDFIKPRLELVGNLGTIQLVCLCVIIYYIFKIK
NIKTVHSH
>KALACAFP_01260 GMP reductase
MRIEYEIKLGFKDVMFRPKRSTLKSRSEVDLEREFTFRHTQKKWNGVPVIAANMDTVGTF
EMAVELAKDKIITAIHKHYSVDEWSEFLNNQPENIHQYIALSTGTGKADEEKIRTILEKH
PKIEFLCIDVANGYSEHFVQFVKKARTNFPDKIIIAGNVVTGEMVEELLLVGADIIKVGI
GPGSVCTTRVKTGVGYPQLSAIIECADAAHGLGGHIIADGGCKVPGDVAKAFGGGADFVM
LGGMFAGHDESGGEMIEENGKKFRLFYGMSSKTAMDKHSGGVAEYRASEGKTVKVAYKGP
VSETVKDILGGVRSTCTYVGASKLKELSKRTTFIRVQEQENQVFKD
>KALACAFP_01261 hypothetical protein
MNNILNITNGDYLADQLKETSIEGEMIMCREALVTGPLQADNLEDFWKIRSEFILKDYKA
SQNSYYKKVVSEFEKIMQIADGSEVNLWFEDDLFCQVNLWFCVSLLQHKDIKIYRIFPKK
GKEDHWKGFSVSKNSDLEDALQSRVLFQEKDIKLALNLWKAYQNNDRESLKKLSENQSDC
FHYLDEVIDAYLHTDPEVFIKNLMEKGITDFNDIFEKFRDELGIFGFGDLQVKTFYDKIV
AEKQN
>KALACAFP_01262 hypothetical protein
MKLAKNILVFLSILLYIGLIYIAFFNVYQTDDYIYSYGTKKLGIIGNSLDFYKNWGGRYF
GYTINTLNPVSNDPENILPKVYPALLFSIFIGISALNFKQYFKYSLSESLLKGFLLFFFY
TVILVSLPEHFYWITGSNIYFLPVILSGILLYSYGKFQESGKKIWFFLSAIFVAVIMGSN
EILALLLLGVLIVLNFQIKSKENRILLIVGLIGLLLSFLAPGNFKRLADSTDVFYIKWLK
RIGIFGANSIYISFKIILILPLFLTIFGKELKGIIEKISFKKAILIWLISFVPLLFTGYI
LNTIGRQFENIIFFYLLTFSLVMMFRFEKIRKFWWISIIIVFLPETHIFPEKYANFNIDF
NVNNIFKEIFLTDLKTYDQEIENRIYTIKNSKEDSLILDKIKTVPKVLYFDEMSSVHEDK
KYVNDQLQKYFDKKYIRTK
>KALACAFP_01263 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MKLLEGKVAVITGATRGIGKGIAEMYAQHGAKIAFTYAGSVDKAKELEAALSSVTQIKGY
QSDASDFDAAQKLIDDVIAEFGQIDILINNAGITKDNLLLRMSKEDWDKVIKVNLDSVFN
LTKAVIKPMMKAKAGSIINMTSVVGISGNAGQANYAASKAGVIGFTKSVALELGSRNIRC
NAIAPGFIETEMTAALDEKATQKWNDSIPMKKLGKPQDVANACVFLGSEMSSYVTGQTLN
VDGGLLT
>KALACAFP_01264 hypothetical protein
MLLSSVCLGQTDQYKQILLTKKLGKEVRSYSKGYGMITDPKTGNAGIVDSLGNITFDYPF
KSEISHLWKDRFILKVKTGNSNAKTALIDEKGNQLIPLDNFKFRTWENKDRMIYSRQGKD
CVYDFNGKQIIPFSDKIEFGSENRFFVKNNNIWLIYDFDGKQVSDRQFTEDLRFYKGRAY
ISKGEKSGEVIDNNGKTLSSISNHNIDNINAFPYLVTLDTSKNRYGIVDEKENVISDEIY
EQAFVGREYIYLTKDDKVSIFSKKEGKVYDLDYHYVNPLFNGLFKTSQDQTNPKAAVIRL
NGEIVFPKEYDRIEGLNIAGDKYLYLRKDDVETLLDKNLKSILNDSYEIEKIFPNALILS
KDGVYYSFSPKNNTYKELKGFKEMKPFELYPLLIGKNIDNFYGILDEEGNEVVPFIYDDI
ETFLGANEFVVKKDNKFGVTNHKNEPLTEVVFDKYVQDKKGIKLTKGKETEFIYFTEQKE
RNFIE
>KALACAFP_01265 Ribosomal RNA small subunit methyltransferase I
MSGILYFVPTPIGNLEDMTFRAVNVLKEVDYILCEDTRTSGILLKHFEISKPLKSYHLHN
EHQTTEKVITDLKNGQNIAIITDAGTPGISDPGYLLGKAGADNNIDMICLPGATAFVPAL
VVSGLPNNEFLFAGFLPQKKGRQTKLKQLAEEKKTVVLYESPHKINTTLEQIKEFFGEET
KVSLSREISKKFEETKRGTINELIEFSKSKTLKGEIVLIVNNSI
>KALACAFP_01266 hypothetical protein
MQNIQDLKEKIFFESKNIIAILDKISNVDELLSKQDLVDELANRISFLRLLEKNIEYFGN
ENPQNPENDEKSSAIGNTAENEDLSNEVTEEEAIFNNELNEINENENESYSSEVTEEEAI
FNNQLNEIVEGEFHESIVNLVEENSEPEIVENHEEIKSNDVTEEEAIFNNQLNEIDNDEA
SDYSGNALNFVDEERILADSEPENDDDIHEEMFNDKTTEEEAIFNNQLNEIDEFENEVSD
DEGDVLNDFDEEEKIQDNFESPIKNDEIPEVTETIPSIFDTEILEYEEEILVEENEEQFV
VSNVAIEQGEMATETSNVDHIVSEIKNEPAEEEKQEQSILAEINDRRKIVEIDKPQVEKE
IHPSDESFENLEEYHQEKKIRLANIKGLKAVQTLFDDDPLEREFPEEKPAPATKEDAGSI
LKTNIPTDFMEAEKPKPEFKLDLNDRIAFSKTLFGGSQSELNEVVSNLNSFRTLEEAKEY
LSDLYYQKKWSKVDEYAQRLWILVENKFL
>KALACAFP_01267 Thymidine kinase
MFLENTINHSKQSGWMEVICGSMFSGKTEELIRRLRRAEMAGQNVEIFKPKLDTRYSEED
VISHNQNKIRSTPVENPNEILLLASNCDVVGIDEAQFFDQGIVDVANQLANSGIRVVIAG
LDMDFLGRPFGPMPNLMATAEYVTKVHAICMRTGNLANYSMRTSPGKDLVELGETESYDA
VSRRVFVDEVLNKKDI
>KALACAFP_01268 hypothetical protein
MISEIKNYIKISNSIDEILKNSPFKLKYIIEKSGISEPTFFRKMKEKKFLPEELLKIAEI
IKPEESFLKSLEEAENDFKNEVYYSHDEVMKISEDRFLKKYGNKVV
>KALACAFP_01269 hypothetical protein
MEIRSSKFALQDLEQIEDYIGNRFTYREYQIFMNIFNHKIGLILDRKVIFQKLEKYPEYN
KLLITEQTTLIYRLELNNLKIFRLYNNFQDEDKKFIVEDL
>KALACAFP_01270 Alanine racemase 1
MNYTVEDIAKITNSKVIGDDSLTIKNIAFDSRIIYSTKNTAFIAINTHKNSGEKFIEAAI
DRGINVIISEHQFPQFENITWIIVQNSVDFLQKLAKYHFENSHLKSIGITGSNGKTILKE
WLYQCVWNEFPTVKSPKSFNSQIGLPLSLLQINDSHELGIFEVGISKPNEMEKLEYIFHP
QIGLLTHIGTAHLANFESEEELIDEKIKLFKDSKVIIYNGDNILVDKKIKELYSSKKLIS
YGFKKENQVFITNNISKDENVIVQYFDEEISFPVHQRDEATLTNALALVTVLKELGIENQ
KIVEKINALKAVEMRLEAIEGIKNNIVINDSFNLDLDSLKTALQFLNEYKKPKKSLVLTD
IVGVNSNSKELYEEVSELVNEQKFDSLFLIGSEISKFSELFKAKTFTFINTQELIDSKHL
TEIENQIILLKGARKFEIEKLKDLLELRKHDTVLEINLNAILHNINYHKSLLKPTTKMMA
MVKANSYGLGSYEISEFLQHHHIDYLGVAFVDEGVELRKKGITVPIVVMNPEQHSYETVI
EYNLEPEIYSFRVLELFYQAVQKSGYDKKYPIHIKLETGMHRLGFKEYELDQLSQTLENK
NLKVQSIFSHLSSSDIPTEKEFTLHQLKTFEKNSSYLIEKLGYSPIRHILNSSGITGYTD
HQYDMVRIGIGMLGESPNSEIQKQLRSVVSFKTVISQISMVENGESVGYSRKFKTDHKTK
IATIPVGYADGIPRLIGNEVGNVGINKTLAPIVGSICMDMMMINVDHVPNVKEGDTVTVF
NAKPSLKEFAEYCKTITYEVLTSISPRVKRIYVKD
>KALACAFP_01271 putative NTE family protein
MRKLLIILFVFQLLLIQSQVKKDLVIPKNPKIGLSLAGGGAKGFSHVGVLKVLDSLGVKV
DYIAGTSMGAIVGGLYASGYSGKEIEKIVMDTDFYSLILDPKATRQETTFFNKSVDKYLL
SIPLKNGKITLPSSISTGQKNVYLLKELFKNVSNINDFSKLPIPFMCVATNLESGNMQIF
EKGDLVQSIMASSAFPSLMDPVKIGDSIYIDGAMTVNYPSKPLKDKGIDIVIGVDLNQDL
AKREDLNNIIAILNQIIDMGIKKDTRKQYKYTDINIKPNLKGMTATSYDDKKKILDSGYA
EGLKYTHILNELPKRPFDRLREKVNPIYSNVYKIDSIEVVGSRIYGKNYVLGKMGLRLPS
MQTYGSINKKIDKLVATNNYKFINYDIIPENESNYLKLYVTEDDTRHFLKFGLHYDEIFK
TGLLLNYSAKRLLFKNSNLSLDVIVGDKPRYYLNYFIDNGYIPGFGIYSSGMSFNIMDEN
NYDIDKWEWFRNEAYIQSIWRDKFAIGGGISHDYFDAEDNGNNKRYSRFLNPYVFLKSDT
QNDKDFPTRGIYINAEGKVIDLMKSEVDKRLVQVKADIRINIRVAKHFTYRLNLYGGITI
GENLPQFYQYRLGGIFEQNVVNFKSFSGFYFGQLNTNNVVLVSNDLQFRFNKNYFISGNF
SFANLSDDLTFEDAVKLNYSSFGITAGYKSPFGQIKINFSHSLKNNQKGIFSVILGHWF
>KALACAFP_01272 Endoribonuclease YbeY
MIQFFYENLPETVNTNYKTWLEDIILSEGKKTGEINYIFCDDEYLLKVNQDYLQHDYYTD
IITFDYVKGKTISGEIFVSLQRISDNASTLSKEYEEELRRVLAHGILHLCGFKDKTEEEE
LLMRSKEDFYLAKYN
>KALACAFP_01273 tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG
MISEIYDVIVVGAGHAGCEAAAAAANLGSKTLLITMNMQTIGQMSCNPAMGGIAKGQIVR
EIDAMGGYSGIVADKSAIQFKMLNLSKGPAMWSPRTQNDRMLFAEEWRLALENTPNLDFF
QDMVKQLIVEDNKVVGVVTSLGIEIKGHSVVLTNGTFLNGLIHVGDKQLGGGRMGEPRAF
GITEQLVSLGFEAGRMKTGTPPRVDGRSLDYSKMEEQKGDENPQKFSYLDTPKLTKQLSC
HITYTNEIVHDILREGFDRSPMFNGTIQSLGPRYCPSIEDKINRFAERTRHQLFVEPEGW
KTIEIYVNGFSSSLPEDVQVKAMKHIPGFENVKVFRPGYAIEYDYFPPTQLKRTLETKLI
NNLYFAGQINGTTGYEEAAGQGLIAGINAHNKVHEKDEFILNRDEAYIGVLIDDLITKGT
EEPYRMFTSRAEYRLLLRQDNADIRLTEKAYKLGLAKEDRLKRVEEKITKSEELESFLRE
TSLKPGVINPILETIESSPVDQAFRAAQILTRPNMTLEKLDGIDFINEVSSTYDDEVREQ
AEVNIKYRGYIEKEKENVAKLNRLENIKIPEDFDYSKLSSLSSEAKQKMANVKPKTIAQA
GRISGVSPADINVLLVYLGR
>KALACAFP_01274 Ubiquinone biosynthesis O-methyltransferase
MKIKDHFLSQEIFEIKEIETKGVFKTSPIPSNISKYYESEDYISHHQDSGSIKEKLYKFL
QSFNLQYKKTILLDRINKGSKVLDYGCGAGEFVKYIENDFQTLGFEPDADARKAAQSKIT
KAQILDNINDIEDESLDAITLWHVFEHVENQDEMLEIFNKKLKEKGLLIIAVPNPTSYDA
KHYKEYWAAYDVPRHIYHFSKKGMENLISKKPNWKMRKIKPLILDSYYISMLSEKYKKSP
LFWLKAVVYGTISNVKALFSNEFSSLIYIIEKK
>KALACAFP_01275 hypothetical protein
MTNYFFIFKRFLLFLDLQKLLNVSTPLNMTRVDHIDKIKLLALVMSC
>KALACAFP_01276 Phosphoglycerate kinase
MKTINDFNFKDKKALVRVDFNVPQDDQLKVTDNTRIVAVKPTIDKILKDGGSVILMAHLG
RPKGEVKDEFSLKHIVEEVSNVLGQEVKFVDECIGEKAEQASSELKPGEILLLENLRFHN
EEEKGDEAFAEKLSKLADAYVNDAFGTAHRAHASTAVIAKFFPSTKFFGLLMAKELQAID
RVLKSGERPVTAILGGSKVSTKITIIENILPAIDNLIIGGGMAFTFIKALGGKIGNSLVE
EDKLPLAIEILGKAKEHNVKVYLPSDTIIAESFSNDADRKEVDIYAIPEGWMGLDAGQKS
RDQFNDVLLNSRTILWNGPIGVFEMSNFAAGTIALGESIAEATRQGAFSLVGGGDSVAFV
KQFGYGDKVSYVSTGGGAMLESLEGLELPGVAAINN
>KALACAFP_01277 Ribose-5-phosphate isomerase B
MKRKIAIAADHAGFEYKEIVKKHLSENFDVQDFGTFSTDSVDYPDYVHPAATSVENGENE
LGILICGSGNGVQITANKHQKIRCALCWMPEIASLARQHNDANMISIPARFISKELAIEI
ADKFLSTDFEGGRHQNRVDKIAFC
>KALACAFP_01278 hypothetical protein
MVKTILIFILNFTLLFNNINFPSKYFTMEALLLYKNTTNMEKRGEKPSVKYLLNISIGLH
GNNRLVNSIERYKDTK
>KALACAFP_01279 Ribonuclease R
MPKKRKYISHKNDLKLMEIGRLILRFMNENATKIYNYKQIADGIDYKNPRQRELVVQALH
KLQASEKIKEAEKGKYIVNLNIAGTLTGIIDFNQSGNAYVAVEGLEDDIFIHSKNVKDAL
QGDKVLIITYNYKGKKLEGSVLEVLERGRTEFVGTFQKVAHKDFGFVVCDKKTINTDIFI
PKTKFNSAEDGDKVIVKMTEWRPGDKNPEGEIIQVLGAPGEHETEIHSILAEYGLPYEFP
EEVERDADKIDRRITDEEVAKRWDMRNICTFTIDPKDAKDFDDALSIRKLENGNWEIGVH
IADVSHYVIPGTMLDDEAYQRATSVYLVDRVVPMLPEVLSNDVCSLRPNEDKFTFSAVFE
LDDNAKIQKQWFGRTVIHSDRRFTYEEAQERIETKQGDLQEEINVLDRLAKIMRAERIRK
GAITFDRSEVRFNLDENNEPVGVYFKISKDSNHLIEEFMLLANKKVSEFVSLNRKGDITQ
NTFIYRVHDDPDPAKLESLRDFVSTFGYKMDLANTKKVAESLNKLLHDVKGKGEENMIET
LAMRSMSKAVYSTEPIGHYGLGFEYYTHFTSPIRRYPDLIAHRLLQHYLDGGKSPNKPEL
EEKAKHCSSMERLAADAERDSIKYMQVKFMEKYLGETFNGVISGVAEFGFWVEIPENGAE
GLIKLRDLVDDSYMFDAKTHAVYGMRHGKRYQLGDKVQIKVVKANLIQKQLDFKIVD
>KALACAFP_01280 hypothetical protein
MFELILSAIVLGFMLSLVFIGPIFFLLIETSFSRGPRHALALDIGVISADLLCILAAYYA
SADIVTLIDKHPGFYRITAILIFIYGIVMMVTKTKMHMPGEEKIINQNYFKTFINGFFFN
LLNVGVILFWLVTVISVRNQYPDTGNFILYIGVVIATYLCIDLAKIFLAKQFHDKLTQKL
ANQIRRIVGGILIIFSFFIFLQSFKKFNQFDKRLEEAEKTEVKYQKAK
>KALACAFP_01281 putative murein peptide carboxypeptidase
MKKIIFPKSLKKGDKIAIISPAGAVDETQLTKGIEMIKNKGFEPVLGEHLYTKFSNGYNY
AGTEQERIKDINWALNDHEISAIWASRGGYGCQHLVEHLKLKNFTKNPKWYIGYSDNTVI
QSYLLKKGFASIHGQTVKTSSFGVTDESYDLIFDILKGKTPKYSLKSHQFNKTGSAEGEL
VGGNLALIYALLGTKYAFDCKNKILFIEDIGENFYALDRMIMSLELAGVFTKISGLIIGG
MTNMGDEKENKQYEDSFDEFAYKLISDRISKYHFPVVFGFPNGHIKDNRPLIIGGNVKLQ
GKDKVKIEF
>KALACAFP_01282 hypothetical protein
MINKENIEPIHVTKNVIKGILYILFLLILAVYFIFFDRSLKLEHTEECPCADSKYTLYQY
KDRGTLLERNKYDLKDFKTFKLENRLGFTVDKLTHLDIMKLNDTISRRKQRGTKPFGMQF
YWDCKNKEVWISEKHKLSFQ
>KALACAFP_01283 hypothetical protein
MATHNDLGKLAEDLAAEFLLKNGYKILVRNFRFQKAEIDIIAEKDNLIIVTEVKARSTDA
FMLPQEAVTKTKIKSIVSAANHYLEEFNKNQEVRFDIISVLPDEKGKLIIEHIPDAFEAF
DAN
>KALACAFP_01284 NADP-dependent 3-hydroxy acid dehydrogenase YdfG
MKTILVTGATSGIGKSTAELFAKQGNRIIICGRRSEVLESLKTELSAFTEIFSLKFDVRN
LEEVETAITSLPEEWKNIDVLINNAGNAHGLDPLSAGKTDDWDSMIDGNVKGLLYVSKMI
IPGMKERNSGHIVNISSVAARQTYANGVVYCATKKAVDVISEGMRIELTEFGIKVTNIQP
GAVETDFSMVRFKGDSEKASTVYAGYEPLKAEDIADSIAYCVNAPKHVCVSDMTIYPTAQ
SEPRTIYRK
>KALACAFP_01285 tRNA threonylcarbamoyladenosine biosynthesis protein TsaB
MKILYIETSSKNCSVAISDNEKLLCLTEEVSENYKQSESLHTFVEWALEGAGISMKDIEV
VSLGKGPGSYTGLRIGASSAKGFCYGLKVPLIAINSLETMIEPFLGQNYDFVIPLIDARR
MEVYTAVYDGKTGKEISETEAKILDETSFEEFKDKKILFVGDGAKKAKEILQLPNADFNE
DVYPSAQYLIRKTMEKIDKKEFEDVAYFEPFYLKDFHGVKKKKSED
>KALACAFP_01286 Lipopolysaccharide assembly protein B
MKKNILFLLTLCIVASCATKTKRPDQRSKFMKGFSTYYNTLFNAKDALNYEFESRDKAHK
DNFYAPYIPILTYEDQPLGSDLGQSSAFAENSMKMAEVNRPQNNTPGRGGPPGMPGNPMS
GGTGAPTLSGAVNGAMDKMGLGKDSEEQPEQTGATSLEIAEAKALKAINKYSVIKHGEEQ
NKKIFDAYMILAQARIYRGKSLEALDALNYVFTHMKDDKRLPLARIYQGLAYDQIKNYHK
AHETFAKLKGEKIDKDYQKLLSIYYAESLLDAGKKEEAVRELDNAYELNSNRKLKSRIAY
LRGQVLTNLNQPERARESFMAAYKYANDFEFEVKSQIETAKTFNGKGDYSGAKKYLEDIS
KKGTYASRKNEFYYALGLMANKAGKKDEAQDYFRKSLKEKVSDPQIRGLAYYEIGKGFLD
KNDYIGAGVYYDSALAVMTYEPSKVLLADQSTYIKKISRNYYLIKKNDSILNLAKMTTEQ
KTDFFSKYIAKIKAKEEKEELERRRAERSKGFDTGDYSSTSIFANSSNAFEDFGVTTKGF
YFANTGTVSKGTSTFKQTWGDRALVDNWRFSKKMSTIDDMKNEALGTTDVPNPRRFEPAF
YIEQIPADAGKLSQLKKDRDTASLGLGVMYQNYFTNTPLATKTLYDLVDVKPEEKVMLQA
LYEIFAMNYLKNPQAAERAKQILLTDYPYTSYAEFARNPKNTTFVKSSEDVENQYKQAFA
LYESEKFGESKDIIEQAIQKYPKDALVPKLYLLNAFNAGKASGKEVMILQLEQIALNYGK
TPEGEKAKEMLNYLKSDLSFQATDNKGNSIPQTAVNTANNTPQQPQQPNSIGVPENSAGQ
MNNPQPMQPSSGNSNKPPKKQNNNQQQILNPATMPSKPQ
>KALACAFP_01287 Septum formation protein Maf
MKLLLASQSPRRKELLSSLGFAFEVVKIDCEEIVPEHIKVGESAAYLSELKADAFRKLEE
DEVLLTADTVVAIDNQFLGKPQNEDDAKNMLKLLSGKTHQVYTGITIKTLEKTITETDVA
DVEFDEITDDEIEFYIKNYKPFDKAGSYGIQEWLGMAKIKKMNGSFYTIMGLPTHLVYKI
LKEI
>KALACAFP_01288 3-deoxy-D-manno-octulosonate 8-phosphate phosphatase KdsC
MSYKEKLKDIKAFVFDVDGVFTDGSVYLMPGGNMSRVMNVLDGYAVVKALKNNYLIGVIT
GGNDEMVKHRINYLGIQDYYPKSHNKMADFEDFKAKYNLKNEEILTMGDDLPDLHIMENS
AIAACPENAVPEIKGIATYISPKQGGSGAVRDVIEQVMKVQGNWHDDNTQSV
>KALACAFP_01289 hypothetical protein
MQIVIIGSGNVAYHMAKAFVLNNIPLTQIFGRNEKELNKISDELKIPFSTEKLEDADLYI
ICVSDNAVETVSKIITKKDSLVAHTSGSLPKEILAGEYRKSSFYPLQTFSKSKELEYSNI
PFFIETENEEDKKTLFEIASKISKNVMESTHEKRKYIHLTAVFACNFVNHLFSRAKEISD
SQEIPFNYFLPLIDETVQKIHEIDPKSAQTGPAVRNDKRILELHEQLLKDESLEIYKTMN
HSIQKMYEL
>KALACAFP_01290 ECF RNA polymerase sigma-E factor
MKIKDAEIISLMQSPRTQEKGVRALMDAYQSRLYWHIRRIIVDGDLAQDTLQETFIKAYQ
NFHQFKNDSQLYTWLYRIATNEALQQINKLKKMQKTDEDPEYHMQNLVADNTDGDAEEIQ
ILLQNAIHSLPEKQKLVFMMRYYDDLPYEEISKIVDMSVGTLKTNYHYAKQKIEEYIKEN
YER
>KALACAFP_01291 hypothetical protein
MKDFDLEKLERKNIYKVPENLFEDIQGKVLSGINDFDLEKLERKNIYTVPENLFENIQEK
VMTHVQPAKKAPIFKLNWGYAVAASLALVFGSTFVFNSVNDTKDPAESQASYASKSQEPK
TESEVAYETLKSDLTSVENNNQTVESQDNNRSFAQDNTTVEQKAETKTVKPVSKQQETQI
NEYLDSFSNSEITELASNSTQDVYLDLYN
>KALACAFP_01292 hypothetical protein
MKKILFTLFIIYGFGLNAQRTDYDWKKMDPKQRKEVINNLSPEERKALLTKFRNNMVMDN
LDIDPSDKAEFTDIYNEYLESQKQIKSQFNSNFNPESLSDEEAKAKLQQSFEVGQKLLDN
RKKYADKMQQVIPCQKVLKLFQSEGMMRDKMNERKPRGNGSNSSNALRPRQNP
>KALACAFP_01293 hypothetical protein
MKKIIVFFLFSVFLSAQKTEIIELKENIKDRKGLTKSLTLIDNRADKEIGKVSNKKGEVE
IELPEGDLKSFIEAWFAQDNKVKGNNDIVLMLEDLKVYDEQAENDIIMYAKAKIKISSFL
KRNDKYYFINRFDNVIVCDPKRTASVSKYLSLTIEEILAEFIKTSYSGPVLSQYIVENDI
ANYNADFSKNNKSLNQELKNGVYLNFKSFSDQKPAEGYYFEKNKKGKVVRIKNQEDLTIS
LGETFGYVDGGIAYRLIPTGFQEMKKDEKGYYIITSRAQLFTEKSGNGAMIGAIAGGLVG
AAIGAAIDSGSNIAAVKGFGFKSPTMTKVYIDSLTGAYIFTK
>KALACAFP_01294 hypothetical protein
MKKTFFFLLLSFLLSAQKTETIDLSKSIKDSKNSIKTFTVIDQRPNQEIGKVMYHKDSVR
IIFENNASKDLQDWFYKNNPVRGQNDMVLLLENLNISEDKKEKYSIGKLELRASTFIKKD
DGYHFVYRIDTAATVSSRTTPYLAQSLAKKATLIFTDLFKSSYKLEPWEYTVSENELPNY
TSLLKDKLDILKTDSLKDGVYKNYYSFFTHNPEPGFTIETNSKGVVTKAVNGEKKEPIRN
FYAFVHNGIPFKVIPVGYVEIFRDDQGLFIEVKKEELFPESNSSFIMIGGGVAGLVGSIV
ANVAIVAIDSGAAKKRKAMAGTEVSLDPLTGHYILPENFNKSK
>KALACAFP_01295 hypothetical protein
MKKVLLLLFIVPFTQLKSQWVENAIQNPEEFVNPLIGTLSKPSLSNGNTYPAVAVPHGMN
LWTPQTGKNGNGWQYTYDADKIRGIKQTHQPSPWMNDYGMFSIMPVTGKMRFNEDERASW
FSHKSEVSKPYYYSVYLADHNVTAEVTPTERAAQLRLTYPDSENSWFVVDAFDKGSSITI
IPSQGKIVGYSTRYSRGKLVGFKNYFVIYADKPFTKYSTWKDKDFVKDALEITGDHCGAV
VGFATKKGEKVNLKVASSFISLEQAELNLARELNKDSFDDTFKKAKSAWNEKLKKVEVAG
GTIDQMRTFYSSLYRMLCFPHKMYEINKAGEVVHYSPYSGKTEAGYRFAGTGFWDTFRAL
YPFLNLVYPSINVEMQKGLINDYKEGGWLPEWSSPSYSDIMIGNNSASVVADAYMKGLRG
YDIETLYQALLHGANNEGPQATGRLGIEYYKKLGYVPYDVKINENAARTLEYAYDDFAIA
QLGKALGKPESEWGEYYRRSQNFQKVIDPETKLARGRNQDGSFQAPFNPFKWGDAFTEGN
SWHYTWSVFQDIEGLAKLMGGKKEFSKNLDKVFEMPPVFDDSYYGSTIHEIQEMVNANMG
QYAHGNQPAQHIIYLYNYSGEPWKTQYWVRETMNRLYQPTPDGYCGDEDNGQTSAWYIFS
ALGFYPVTPATDQYVLGAPLFKKATIHLENGKTIEIKADNNSDENRYVKSLNMNGQTYSK
NWLSHAELLKGATLQFNMDDKPNKNRGTNEKDFPYSYSTDKK
>KALACAFP_01296 Elongation factor 4
MKNIRNFCIIAHIDHGKSTLADRLLEYTNTVTQRELQSQTLDDMDLEKERGITIKSHAIQ
MDYEYKGEKYILNLIDTPGHVDFSYEVSRSIAACEGALLIVDAAQSIQAQTISNLYLALE
NDLEIIPILNKIDLPSANPEEVTDEIVGLLGCKPEDVLRVSGKTGEGVLHLLEQIVERIP
APVGDPKAPLQALIFDSVYNPFRGIEAYFKVVNGSISKNEKIKFFATGKEYAADEVGTLK
LKQVPKKTIECGDVGYIISGIKDAREVKVGDTITSFENPAAEAIDGFEEVKPMVFAGIYP
IDSEDFEELRFSLEKLRLNDASLVFEPESSAALGFGFRCGFLGMLHMEIVQERLDREFNM
NVITTVPNVSYHGYSKKDPETAILINNPSEMIDPNLLDRVEEPYIKASIITKSDFVGAVM
TLCIEKRGEIVNQSYLTADRVELTFNMPLAEVVFDFYDRLKSISKGYASFDYSPIGMRAS
KLVKMDILINGDMVDALSSLIHDSNAYHIGKKMCEKLRELIPRQQFDIAVQAALGAKVIA
RETIKALRKDVTAKCYGGDISRKRKLLEKQKEGKKKMKQIGRVEVPQSAFMAVLKLND
>KALACAFP_01297 hypothetical protein
MKTLLKVFIVVIIIIGGVLIIIVGKKPFPEPECLVCGPNLVRILGIAEVILGLGALVIQG
NLIEKQRNL
>KALACAFP_01298 hypothetical protein
MKNLLFVAALAFLFVACDKVKMDVKTTNSEEWKPVDSATATKAWMDYATPGDMHKMLAKS
DGAWTGENTMWMENGKKPTTSTSEANNKMIFDGRYQLSEHKGNFMGMPFEGMSITGYDNA
KKKFVSTWIDNMGTGIMSMEGDWNPSTKSIEFKGKMTDPTRPGKDCEVREIYTFVDDNTQ
KMEMFGPDAKTGKEFKTMEIKFTRKK
>KALACAFP_01299 Bifunctional NMN adenylyltransferase/Nudix hydrolase
MESPKKLQDIKVAVDAVIFGYFDKKDLQILLIKRNIEPFKGGWALPGGLVLDNENLDDAV
RRELHEEAGIKPDFLEQLYTFGNVGRDPRNRVVSIAYLGLVNPSYHELFADSDAEDAQWF
SVNDLPKLAFDHQNIIDIALKRLRTKIQYQPIGFNLLNEEFPFSDLENLYKTIIGQEIDR
RNFRKKIMSYGLLNETNNVKKEGSGRPGKLFTFNQEKYKELEQEGFYFEIK
>KALACAFP_01300 hypothetical protein
MKKIYVFGNGNLSWESFNEFYIEPLKKVNLSECEFIIGDFNGTDTLMMEFLKNKSENVTI
IHMDEKARYFVNTFKTKAQNWKRIGGFTSDLERDTFGIVNCTHFLAIDFNSDEKRKSGTL
KNIENCQNLNKIKIE
>KALACAFP_01301 hypothetical protein
MNAIKYLKGDATNPKIEGNKIIIHICNDRGGWGKGFVMAISKRWKEPENQYRKWFSSDEN
FNLGEIQMVQVENDIWVCNMIGQHKIISNSEGVPPIRYEAVEKCLEKLVNKALDINASIH
MPRIGCGLAGGKWEEIEPIIARTLLQGNMKVYVYDFN
>KALACAFP_01302 hypothetical protein
MKLKLKKYKEQLQSWPQKGHYIMAQYDDKKIIVYQSYRKEIGNFAVQNQYFGGAFSLERM
TWIKPNFLWMMYRNGWGTKEGQECVVAIHLKMDAFKGYLENAVYSSYDETCKISKEEWQN
QIKESSVRLQWDPDHDPFGNKLERRAIQIGLRNDFVKSFAKEDIILIEDISDFVKEQHQF
VLKNDLESLFIPEEKPLLFNEEKLNKKLKLNEI
>KALACAFP_01303 hypothetical protein
MKSDKQFLASESLNGIAIGDAFGESFFGEEGLINSYIHQRILPEKFIDFTDDTIMAIAVF
KSLEKLGEINQDFLSEEFTKNYYLDINRGYGPSMHQYFRAVKGGENWKKVSYSKFEGQGS
MGNGGAMRASVIGAYFYDDLDKLRLNAELSCEVTHANKEAIEGTKAIALAAAFAVQEKLG
IKQLNQQEFIQKIQNELDDSDIKSKLNKCLYLDGNPSIELLVKTLGNGTKMTAQDTVPIV
IWMLSRYRSNFEECIWNTVSALGDRDTTCAMAGGISILCCEENTVPEWTKNVENWKNSSF
YNEL
>KALACAFP_01304 hypothetical protein
MKKTILLAAFISFSNAFSQENDSIRDIQEVKIQSEAGRLQAVNFHNVDPAKSSKNVGQEP
SFLLSELVPSVTAYSDTGGNNGYSYYRIRGIDQTRINVSIDGAPMNEPEDQGSYFSNYPD
IFNSFDKIQIQKGVGLSKNGTASYGGSIQLFSPDLKEKNLEFGANYGSYNSLRVYGKYTS
GIKNDMGIHVRLSEIYSDGYKYNSSNHGQSAFISGGIFKDKSIWKFNALMGNQRNQLAWL
GVTQEQIEKDPRTNGNRDEKDQFFQTFLQVFNQTKLGESSSLQSSIHYTYLNGNYDFNWN
NFIGLPENGEMYNYAFTSKFLGFYTNFQNKFKNGKVTAGINGNLYHRNHKGSELSLGELY
RNTGYKNDVSAFAEVELKAGKWIFSGDIQYRFADFRYKGDLSMDQLEWNFLNPKVGVNYL
INNHSNVFFSLGRVGREPTRNDIFMGNDNLMPDENNQLTLGTTMPEYVTDYEIGYRFNKE
KIKLELNLFYMDFKDEIVLNGNFGPNGLALTNKVDKSYRLGAELSFNYQINEHWSLKNNS
SFVYSKIKEDNISFSPVLTPKIIVNQEVNYKINNFKINISSRFQDSSYMDFSNSAKLPSY
IIFNSGILYDWKQWQIGFFVNNITNKRYYNYGYTETDGAGKYFIQMPRNYMASLKFKVF
>KALACAFP_01305 Trifunctional NAD biosynthesis/regulator protein NadR
MKGFVFGKFYPFHTGHQKMIEFALEKGSVTVLVCEEEKEKIDGNIRKEWIKETFRNNKNL
KVKVFKYKEADFPNTSVSDWEVSKIWSQVFREYFKDEDFLVTSEEYGEMLSVMMDIDHFM
FDENRENIRISASEIRENIFKYWNYLPLAVQKYFALKVVFLGTESTGKTVMTNNLSEYFK
ANKVSEAGRDLISDSKQFAFEDLEKVYTTHAGQIENVNYEKSFLTLIDTDIHITKSYSEF
IFGKKLSVPNEIIEKNKADLYLYSTKDAEYIQDGTRLEFEERNQLDESHRKILKEEKIDF
LELSGSWLEREKRAIHFIENLILKRQVMFKN
>KALACAFP_01306 NAD-dependent protein deacylase
MKKLTILSGAGISAESGIKTFRDGDGLWENHNVTDVASPEGWRKDRALVLEFYNQRRRQL
HEVEPNEAHKLIGNLEKYFDVQIITQNIDDLHERAGSTNILHIHGELFKSCSCNNKSLIY
EQKGDINIGDKAEDGAQLRPFIVWFGEDVPLYQTAREKVKDADILLVIGTSLQVYPAAGL
IHEIKDDCLLIVINPNETGFGYGQRAVVMKETATQGMKLLFDKLVNLA
>KALACAFP_01307 ADP-ribosyl-[dinitrogen reductase] glycohydrolase
MKNMVKAGIFGVCVGDALGVPVEFKNRETLKQFPVTKMQEFGSWNQPKGTWSDDSSLTLC
LAEELTKGYDLEKIGESFVKWVKYGHWTAHGRLFDIGGTTRHSIARLIKGESARFSGNIF
EEDNGNGSLMRILPLAFYLKDEENIEKVYQTVKEVSSITHGHFRSVFACFLYVIFAIELI
KGKDKKEAYNHIQNAALKFAEFQGFNPKEIQLFERILKNDISKYDEDTISSSGYVLHSLE
ASLWCFLNSESYSEAVLKAVNLGEDTDTTGAITGGIAGVYYGFENIPEEWVSELVRKEDI
EKLCIKLENKLIN
>KALACAFP_01308 RNA 2'-phosphotransferase
MNEQQKKKISKFLSLILRHQPEIINLTLDKNGWANVDELKEKCSKNNMDFTLEELDEVVE
NNDKKRFIFNEDKTKIRANQGHSIDIDLALKPQQPPEFLYHGTAQNNVDSILEKGIEKRS
RQHVHLSLDKETATKVGMRHGKPVILTIRTGKMYEDGVLFYLSENKVWLTDFIESKYISR
>KALACAFP_01309 Bis(5'-nucleosyl)-tetraphosphatase PrpE [asymmetrical]
MKRTLAIGDIHGGFKALKQILERADVTENDTLIFLGDYVDGWCESSEIIRFLMELSQRQE
RIFIKGNHDAWCEDWLSFGKNEDVWLFNGGKSTVEGYSDYSLQDMDLHLEFFQRMKNYHI
DEDNRLFIHAGYSSMHGPEKEVYTSNYRWDRTLWETAVAMDKKLSRNSELYPKRFLLYKE
IFIGHTPTLHLGIKEPVNKANIWNLDTGAAFTGALSIMDVDTKKFWQSDPLPSLYPDEKG
RNNYL
>KALACAFP_01310 hypothetical protein
MKLKYLLFSLTSSLLFAQHNFQTTFERGNGNQTVTYDEMNAYYQNLAKNFNTIQYVKKGE
DDNGKPIYVVVYNPFPEKDLNQVRKEKAILFVNNGIHPGEPDGIDATMMLMRDLATKKIK
TPQNFIVAAISAYNVSGMLNRGSFSRANQNGPEQYGFRGNAKNYDLNRDFIKADSKNARS
FQEIYQWLKPDVFIDNHVSNGADYQYTFTYISTFKERLGSILGEYFYNNFQAKNLKDLQK
LGYKSTPYVNIHGDVPEVGFAAFEDSPRYSTGYTSLFNSLGTVPETHMLKPYDKRVDATY
KYMLVNLENLDKEYKTIKRLRIENLKQYQAGKPYGIRWKIDSTRYSTMDFKGFEGKYKPS
EISGKPRLYYDRNKPFTKNIKLFTTAVPTGYIMIPKYYVIPQSQYRVIEEFKRNQIQMKP
LQKDSIIAVESYKINDFKTVKNPYEGHYLHFETTVDKSNKSITFSAGDYIVPTNQEGVKY
IIETLEPEALDSFFNWNFFDGILAQKEYYSAYIFEDTAAELLKKDKELKQKFEAKKASDK
KFADDGTAQLDWIYRNSPYFEEKTFRQYPIYRIL
>KALACAFP_01311 hypothetical protein
MATKKQFFVSLEGVDLTDEQLKNIDRGIQSVVLSELSKMDNTQAFGAHRDFRGLLKPLRV
KDWFPWGIIIFKPGIDIQSQIKDIQSQIKSYGG
>KALACAFP_01312 hypothetical protein
MEASFNSSKKMCPSYLGKVGAQLFGVVNKDGKVQFITPLTVTEEFVQQNDHLEQRFRFTG
KCVEKGCAQWNNEESKCSLSKKVQNLDLNQNKELSYCPIRSQCRWFSQDGNEACFSCNEV
TRNMEELLLTM
>KALACAFP_01313 hypothetical protein
MNSSTQSESNNSHFNREIERQKALKALEKAKSIKRKVVFLPQGATGNLNFID
>KALACAFP_01314 hypothetical protein
MGINLKPIDIVDDITQEEFIEKYLKQRKPVVIKNMARKWPAYQKWTMEYMKEIVGDVEVP
LYDSSKADPAAPINASAAKMMFKDYIDLIQREPTDLRIFFFDPIKHAKKLLEDYIAPKDL
MGGFLDKYPSMFFGGKGSVTFLHYDIDLAHIFHTHFNGRKHVLLFDYKWKERLYQIPYAT
YALEDYDIENPDFTKFPALDGVEGIECFLEHGDTLFMPTGWWHWMKYLDGSFSISLRAWD
KSWAVKAHSLWNLTVQRKFDDIMKKNFKKKYMDWKEKVAVKRAEIALKRGLPR
>KALACAFP_01315 hypothetical protein
MEKKISLFLLIFFSILSFAQKTVSGKITDQDGVAIPSASVTVEEPGKDAILAYAITNSKG
EYKVSFTSAEPNVDLKVKAFNQRPLTKQISNSDQTLNFNMEGEATEIKEVQLKTKLITAR
GDTIAYDLKAFDSKSDRTLADVMKKIPGIEVNTDGTILYQGNAINKFYVNGKDLMEGGYG
TINNSLPKDAVQKVEVLENHQPVKILQDKVPSDQAAINIKLKNSVTMTGRGEVGTGFGDP
WLWNVKLTPMFFGQKSQWVVNYKTNNMGEQVENEGNILAFGSGWEGRRINAAQNDWLNVE
TASTPNTPVKRYLMNNVHYLSANYLTNIDNKKEWELKANANYTNNAVEREDYRETTYQNG
AKVINSTRNNFYTDKVKGELIFTKNAKKGFFKNTTSFSQFWNGDRAVAVREGRTGNESVE
SPTSSFQNSLSTIIPWKEKMVNFKSFINYQDDRQTLQISPANYMQIPFKVSADSIGRINF
APGSIAEQRFRLKTLDTSHSANISFSTKGWTFTPQIGFDFSSDKLDTNFDGLAIPSDPGD
IQPDFNTPAYENSLRFTEINPNASVGVNYKSESWSLFANFPVNFNNIKADDDLRGVSKSL
NRTTFTPNIFAQYTFASFWKASVNGNISNNFGDIQSAYAGYMLLSPTGFNVMDPKNPIPQ
TTTSSAGSRIEYRNPLNNLFFNVNYSLSDSKRNLLGAPILDPTTGFTLMQYRDQENHSKS
NRLSVEVGKYFPKFKTNASVSYGNTTSISDAFLDDEEFKNKNNSQTYGFKLNNTYFSWMS
VDYNMSFSRTKQDSRGGTLGINKGYNHNLALFFYPIENHTIGFNWDQVNTTNGTNKYNNP
FYDISYQFSWAKKKVDFEIKWMNVGNRRVFETYDLDGQFNAIRYTRIQLRPSQVMFTVKF
NFK
>KALACAFP_01316 hypothetical protein
MDTLSQLKDELQDEYQTTRKFFEIFPEGKNDYAPHEKSMKMMPLATHIAEVFGWADTMLK
TSDLDFANTDYQPKKLSTKEDLLKALDENYKLSNEALSNATEDDLNQSWALKNNGQELAK
WSKYGSIRHSLNQATHHRAQLGVYYRLNDIPLPGSYGPSADYQGF
>KALACAFP_01317 hypothetical protein
MKQLFSIFFIALFAIANAQDKDSKETANRFFYELTFKPKNDSAKLEKVMSVLDIVKDRSV
YRDYTVIGQDSIIKVQIEAMQKSGVFKDMSKSIRMPKFSEKIVKIYPDMKVQYIERIASG
FSPMGIAYNETIKFDWKISNEKEKIGAYNAQKATAEFGGRKWTAWFSTELPFQDGPYKFS
GLPGLIVKIEDDGKNYSWVLQGNKKVPNWEELSYAEKISNMSLKVTEMPREKFEKTFNDF
KKDPFASVRPMMNQEMMSKSIPGMDGTIGDMMKKQEKMYKDFFNSNDNPIELNQPSSDKK
KK
>KALACAFP_01318 hypothetical protein
MKKLLLTLAIIGFITSQAQQKANRFFYELTFKPKKQSELTDKVMTALDILDKKSVYEDFT
ERAQDSIVKNVVETAEKSGQHYDLANFIKDKKFDHKITKPYPNMEKEIINDFTGSEFYQY
TENIKFNWKVLNEKEKIGEYNTQKATTEFGGRQWTAWFSTEIPFQDGPYKFYGLPGLIVK
IEDTGKNYSWVLQGNKKIENYDEVSYTRRMIENQGLSFTPIITTKEKFEKARESYQSNPL
RGLRERLTPEMMNEMVPGENKTMGEMFREEEKKEKERINALNNPIELPSKK
>KALACAFP_01319 hypothetical protein
MKDKDLHKLSRFPKNKIGKIIGYDNDSLRMPNKIIEMGLLPETAFRVLYQAPFNGPMYVE
FGDEKSRIALREEEGEFIIVEELN
>KALACAFP_01320 Fe(2+) transporter FeoB
MQENKKKQVLLVGNPNVGKSTVFNALCNKKQKTGNYAGVTVASHSGNYTFKNEEVEVIDL
PGSYSIYPSSEDEAIFSKFLIDEQKNYAGVIYILEALSLKRGLLLFQQIQDLGIPMILVV
NQIDQAERRGITIDIEKFSEALGIKIIQTNAKENVGIDAIKEAVLHNQFVKSEKISFETP
NEHKDFIQKVASHKGIDNEYKAWMSLSLGTDLGRIETVMELMNEPDSKSLVPKRLQVQET
VRRYQHVDKILSNVISKKPQFKELLTEKLDKVLVHKFWGYAVFLMILLIIFQSVFFLAEY
PMNWIDDLFSWLATFTAEHLPEGPINSLISNGIIPGIGGIVVFAPQIGILLYFLYLLEDS
GYMARVVFLMDRLLRPFGLNGKSIVPLVSGTACAIPAVISTRNIENLKERLLTILVTPFM
TCSARLPVYSIIIGLIISDGTFLGIKYKALVLMGMYLLGFIVALLSASILKKFIKSKGKT
YLVMDLPTYKKPLFGYDFKMVLGKVWEFITGAGKIIFIVSIIIWFLSYFGPKQKPDQFVA
ANVELDHSYLAKMGKGIEPVIAPLGYDWKMGVGILTSFVAREVFVGTMSTLYSLEDDAPE
VKVIDKMRRDVKPNGEKVFSFATGVSVLLFYAFAMQCVSTLAVVYRETKSWRWTGLQVAM
MTGLAYFVSMIAYQILK
>KALACAFP_01321 hypothetical protein
MRIYFLIIAFLCTKINAQIDTAKITSYEHQVMVRVNFDTNLEDFVFNSKSEGIEEVIKIS
VNNKIKTSLSLDYRIISASVSFAPNFIPGNNQNELKGKSSYTNLEFRFFPKSFIQEVYYK
NVKGFYIRNTEDFIPRWRRKIDPYIQFPDLRVQSFGGLTSYVFNKDFSLKGIYTQREWQK
VSKGSLVAAIDYDLTIFSNQMDEYESKEQQYTLGLNLGYYYNWVISKKVSIAPYTWLGSG
GKWGVSQGTFSDGTKDEKETYRSLTFRWGSGIHIGYNSDRFLYGTKIDVTSHNYRIDSES
RVRNNNIYGLIYVGYRFAPPKAVSENYDKIQKKIPIL
>KALACAFP_01322 Phosphomannomutase/phosphoglucomutase
MSLIKSISGIRGTIGGKVNDNLTPLDVVKFASAFGTWLQNQKNKKDLTLVIGRDARISGQ
MVSSLVTATLQGLGINVVDLGLSTTPTVEVMVPELNADGGIILTASHNPKQWNALKLLND
KGEFISGENGAEVLALAESEDFNYAEVDDLGKYETRDDVFDIHIQQILDLPMVDVEAIKA
KNFKVVLDAVNSTGGIAIPMLLDKLGCETVKLYCEPTGHFPHNPEPLKEHLGDICELVKK
ENADLGIVVDPDVDRLALIDEKGEMFGEEYTLVAVADYLLKNKNGVAISNLSSSRALRDV
AQTHNSEYFASAVGEVNVVTLMKEKNAVIGGEGNGGIIYPDLHYGRDSLVGVALFLTHLA
KENKTVSELRAGYPSYFMGKKKIELTPEINVDDILTKMEKEYQNEEVSTVDGVKIDFENN
WVHLRKSNTEPIIRIYTEAKSQEEADTLGDEMIAKINSLI
>KALACAFP_01323 TPR repeat-containing protein YrrB
MEEYFGNELVKKFEEMMENNDEFYFDTEELEDIIIYYLELGDFNYADTAVNYGLKLHPNS
LDIKIKKLEILLEWEDYNTAKELIDELKGSSMENTDFLVCYAKYYSNLGNPRKSIEICKK
ALELKEEENFLHNFIADEYVNLGDPFNALKHYKKALKEDPTDEYALENCMVCFSDLNKSE
EAIAFLNEYLDEFAYSEVAWLEYGQYYFNRKNYEEAIKGYDYLLAINSSSVGVYANKAAC
YEALGQYKKAIEVYEEMLELEYTKAFTFYKIGLCYKALKQPIVALNAFQKSLREDPQFYL
AMMEQSYLYEEMGGMTEALHFAKEATQLNENNLDYQKRLAFLFIDSGKFEESLSCLKKLV
DVEPSRFYNWYAYSEVLMLLGEYEEAIIILNKALKAHHRAELYYQLSNCYFNLKDQENGI
ESLKKALELDPSLVTDMQKKYPFIKDEVKKVKAKVKKKNS
>KALACAFP_01324 putative inner membrane transporter YedA
MNADKEKWILLIILSIIWGSSFILIKKSLEHFTPYQVGALRVLIAGIILMPIAISKYKLF
PKKHLKWLLLAAFTGNFIPMFLFPIAETEVSSSIAGIINSMMPIFVIIVGALIWKFQTTK
PQIVGTLISFTGVCLLAFGGDGEGGKFKLIPILLLLLATLCYAVSTTTVKSKLMEVSSTV
LSAFVFAFVLFLPSLIALIFTGFFSTFSLDENNLTGLMFVSLLSIFGTGLAMMMNYRLLK
VSSPLFASTVTLLMPIVAIVWGFLDGDRLSVMQFVGAGIIIAGLIFLRTKPNVIKK
>KALACAFP_01325 Leucyl/phenylalanyl-tRNA--protein transferase
MVRLDENEISFPDPEIYDGHEGLIAFGGDLSIERIWFAYQLGIFPWYNPGEEILWWCPDP
RFVLFPDELKVSKSMRKILHQNVFSFTENQNFRGVIKNCQQISRKGQTGTWLSDELMETF
ITLHEFGLAKSIEVWQNEELVGGFYGLQIGNVFCGESMFAKVSNASKAGFIHFVETHKND
IELIDCQSHTSHLESLGARMISKKEFLKILHKNNERR
>KALACAFP_01326 hypothetical protein
MELQGTVKKLFETQTFASGFQKRELVILTQEQYPQPINIEFLSDKINLLDNLSEGENVKI
GINIRGREWVSPQGETKYFNSITGWRVEKVLDNGSEPTQAAPSQSASPVSNENPFAGDDD
DDLPF
>KALACAFP_01330 hypothetical protein
MEVKRDLEELEKILKTEFKINKTMNDSSNEVKIIDYSPEYQQDFRNLNEEWINKFFKMEE
SDYKMLDHPEEYILNKGGHIVFALLDNEVVGTCALIKSSEDPLKFELAKMAVSPKAQGKK
IGYLIGQSLLEKAKKANAKEVFLETNSSLIPAIKLYEKLGFQHICVTDSPYERCDTKMKL
EF
>KALACAFP_01331 Transcriptional regulatory protein CusR
MKKIILIEDETSVVSFIKKGLQENGYEVSVAFDGKTGVQLVQSNDFDLVILDIMLPEMNG
LDVCKEIRKTNQYVPILFLTALGTSENIVLGLESGGDDYLVKPFKFIELVARVKSLLRRS
NNGNHQEIVEPEIDSEHVFQFSDLILNDYTKKVTRAGEEISLTSTEYKLLLYFMNNPEKV
ISRAEILDAVWGVNYELGTNVVDVYVNYLRKKLDNQDDNKLIHTVIGMGYVLKKP
>KALACAFP_01332 Sensor kinase CusS
MFNRVVTNQTKTMVLLMLVFTAIILLFSGLVYFSIVNFSHQRFYELLKIRTTTIIQIEKS
KDDLDLPENYILNGLNDEELPMERDYVFAIPTDSNFNKISQEVHIPSYFFKSIVKNGEAN
YNDKEFYYIGQTFKYDDKDYIAIASAKNHYVVYYLGFLKRTLITCIVLSLFFSMIFSFYL
SKTLFKPILKITGKVKEISSENLHLRLESQPDNKELNELVDTFNDMLNRIETSFETQNHL
IGNVSHELRTPLTSIMGEADVALSISRTNEEYKETLGIILDEAEKLDKKIKALLMIAQTG
FDGKIQKMDKVRIDQLLWDVIETLRRIDSRNNIYLDISMLPENPKKLKVQGNEQLLHLAV
TNIIQNGCKYSNFQQVKVSLGATDTDVYIIVKDNGIGIPEEEMNKIYDPFFRASNTKNYE
GYGIGLPLARNIVRMHHGELIVSSHENQGTTVQLRFPNFYSTQQEII
>KALACAFP_01333 hypothetical protein
MIKTILIATDYSLESLNILKKVLREKDASEDQNQYNILLVSGYDMGDSIRDLLFNTKSMI
FNKLRPLEFCEAYEIIRNKYPHLINKIVCDIFTGNFQRTFNNYVKVENIEEAYYSPSIRS
TGKRKFDLIPYIKKCEDLESYEISVEVRESLPEKGRLAEIFVEA
>KALACAFP_01334 hypothetical protein
MLRNYSNSRTLGDNIRLGTLTAFTAGTINIASLLIFLSFTSNVTGHYAILAAEISKGNWS
QVAVVGLWIFLFFFGSFVSNFIVINFNKKSKYFAHAMPLVLEIICLLFVGVYGQFYYQKT
LEETEYLVALMLFATGLQNGLTASISNFSVKTTHLTGTTTDLGILFSMFTQKKFRKNGEL
VGRAKLLMSIMVAYVLGAVFSGLTYYILEFRVFYVISLCLLMVIGYDAYKINIRHFNTQY
RYNKIYKKPNFLAFLYDKIHGIPEIKEKREKKRKLVFDD
>KALACAFP_01335 hypothetical protein
MKKNIFPLLIAVFGFSNLACAQTGNVGIGTDTPSSKLSVSGNHSVGSGYTGVAAPANGAI
IEGNVGIGTSSPNTKLDVNGQTKISDGTITPATAPAAGSLVELESTNKGLRMPQIALTNT
TTWAPLQGLGTALSSRGMSVYNTNTAIASSSTTYPANGVGEYYWDGTGWVNKSSTGAQNA
EVLFSVRGPNQAAVDGSYVIYNFTIKNYDKNNNFNLATDTFTVPPKGAGFYQINGLLVTT
AETTTQGGYLSLFVNGIFSRYITIGNAGVGAGIAASGTIAVPLAVNDTVSIRYLANTAGQ
TISNITVDIYQLSK
>KALACAFP_01336 hypothetical protein
MRKFILPLLLATAYCSNFQAQTSNVGIDTPNPGSKLTVNGSFAAAYRAVTGNYTMTVNDY
YLVSNSAANSTVTLPAAQVGSGNFKGRLYEIKNTHTTSTLTVAANGTELIDDVGATGLAS
ISIAPGDGVLLVNNGNTAGTTWEVVSFHSATPTKSYDWLKAGNQFPINPADNSTTIYHLG
GNVGIGTDTPTAKVDVETGNIELTQGNSLRWGPDDTGERIYSALNLGGSGNNLYLESREY
MYFIADRNNTSDGNTVGFVWASDTSWADGTPKELMRLTDIGNVGIGTDNPTEKLHVNTSV
INEGIALSQTSLTNTVMLNSNGGGGYLGFINNSTSTDAGLTAYIQQREPNATGGAGNDLV
YVASGGTHHFLQAVGINTPTPAAGFWLDVAGNIQCNNIQLTAYAGASNREIGVNTAGSII
IYPSDQRLKKDVTDVNDGLSKVMKLRPVYYNWIDQKEYGKQREVGFIAQELNKIIPEVAS
TFNKDGEEYNSVNYSRIVAVLTKAIQEQQTLIEAQNKRIAELEAKEKTAKSLEERVKKME
ELIGTQLHK
>KALACAFP_01337 DNA mismatch repair protein MutL
MSDIIQLLPDHVANQIAAGEVVQRPASIVKELLENAIDAEATKIELIIRDAGKNLIQVVD
DGKGMSETDARMAFERHATSKIRGTEDIFKISTKGFRGEALASIAAVSQVELRTKQKDAT
IGTNIYIEGGVFQFQDPIQTADGSNFLVKNLFYNVPARRKFLKNNNIEFRHVIDEFQRVA
LAHENLEFSLFHDDEAVFRLRKGSQMQRIVDIFGRKLQPQLIPIKEDIIWCKLHGFVAKP
EGAKKTRGEQFLFVNGRYFKSPYFNKAVQEAFEGLLLPGYIPTFFLYLELDPEKIDVNIH
PQKTEVKFEDEHLIFALLRSTIKRALGIYNVAPSLDFERDPQLDEIMQKSFPSKSNSGGS
GVIKMPEIIVDKDYNPFLEEREVKQAEIQNLAEMYHQNIAAEPSKINLFEDEDFDEDLMR
LPNGYWLFNKGDKTLMLDLGRMHRLWVSENTKPVKKGTTNSHALLFSLEYHMNEIEKNKY
KSIKKYLPELGFEMSIAHESVLRIDAVPEGLKETQVMKFLENLFEILEYKTEEEFLQFYQ
NQWNKMHSKSRFDFIYKKDAEQLIKDFTALGFPEFLPNGKRCFFEVPFNDFKNKF
>KALACAFP_01338 hypothetical protein
MFNNLPPLTRNIIIINIIVYIITNFFLYALQKPELYYVLSAYYPFSPFFKSWQIITSMFM
HAPIAGGPGLMHIFFNMFILYNFSFLENILGGKRFLILYFLSGIGAYILFNVWEFIQVEM
FARQLERLGFNIYDYFSGTNKQLKGSAQEIKNQQTLINNIIKIISSPLLGASGAVFGVVS
TFATIFPNARMGILFIPFQIKAKHFLIFSVVISIYFGYSGSDSGTAHFAHVGGAVVGFIL
AKIWKKHLNRFNPQ
>KALACAFP_01339 hypothetical protein
MKILRLILLIAHIGIFFLLVGMLLNAYVPPKVFPWFNLLSLGFPFLIISYVILTIFWIIS
WKKRAFVFFFLGLLFFNPVLRWVNFSGDKSSDKPDNTIKVVSFNARNGTFGVKDVEAFVN
NQNADVVLLQEYGGNKEYHFENLNEAPQTPIIAIFSKHKIIGHKQLINSDYEYNNAYATQ
TDIEIKGKTYRFINLYLQPYKFEKSMVKLNGSSDEDEKKVKNIIKRLIPTFKMHQEQIVE
VRKAIDHSPYPVILAGDFNSVPNSYEYYHLVDGLQDAFVEAGNGSATSFHDYKLPIRIDY
IFTSKSISPTSYKVDRSVKISDHYPIIASFNLSK
>KALACAFP_01340 hypothetical protein
MKLRQILLFAHLTVVVLLLCTLGNAWIPPNFVGNLNLLSLGFPYLMALHVLFTLIWVFKR
KKIAIAFVLGSFLFYNPVRRWINFSPKTENLKSIRDIKVLTFNVKYGDFGWEKVKKYIHD
QDADIILVQERDTNRALRQDLVKYPSVILKTKHKIVRQQELITDKSRGNSFYADVDINGK
IIRIVNVYLEPFRLHKSMLQFDGFKKEGGKISTLLAHMIPTFKAHEDQIKKIRKVIDLSP
YPVILAGDFNSVPNSYEYYSLGKDLQDAFLEAGNGSSSSFHDYKVPLRIDYIFSSKTIIP
LSYKVDNSVQLSDHYPVIAEFLLN
>KALACAFP_01341 hypothetical protein
MKNLLFAAFSFLGLLISCSKKEPADLYPTDSAKANYDTAAVDSFSAGATSIDVVRQIRMS
SQQYQDSVKEAIKLQEEEKKLKEELEKENKKKAEEEKKKTGEEDKKKKTETPAATDTKTE
>KALACAFP_01342 hypothetical protein
MKKNILSALMIAALVVSCTKSTTKTEKVENPDGSVTTTTTTVSENGVGVDTSKINKTKEE
VQTKVDEAGNKIDQAAEKAKNQIDATADKTKEDLHKAGQDIKTEANKVGKDVKDAAAKGA
SKVEEGAKKLKEDLSK
>KALACAFP_01343 hypothetical protein
MATKALFNTVVNWFIRQRIDQIQNFMNHPIETQKGILFSQLFHAEDTEYGKKYGFNSISS
YQDFKNKVPVVTYEDMEPYIEKARQGHKDVSWPGYIKHFAKSSGTTNAKSKFIPISDESL
EYCHMKAGKDMVSIYANNHPENQLFTNKNLRLGGSSELYADFNTKFGDLSAILIDNLPFW
VEITTTPSKKVSLMGEWESKLKAIVSEVKNEDVGSILGVPSWMMVLLQRVLKETDVKNIS
ELWPNLEVFFHGGISFKPYRDQYKQIIGKNINYYEIYNASEGFFGIQDRSNSDEMLLMLD
YGIFYEFIPMDQFHFSNPKVLSLEDVEVGKNYAMIITTNGGLWRYLIGDTVVFTSINPFR
IKITGRTKHYINAFGEELMITNVESALSKACEETNASVSDFTGAPVFMKENEGGAHEWIF
EFCKKPDDLDRFIDIFDRHLKAVNSDYEAKRYNNMTLKRPIVHIAKEKLFYHWLESKGKL
GGQNKVPRLSNDREYIDPLLELNRSLKFN
>KALACAFP_01344 hypothetical protein
MYPTDLVMPMKAELTDKGFEDLTSPAQVEEALKQSGTTLLVINSVCGCAAGAARPGVVYS
LTGDKKPDHLTTVFAGFDTEAVAEARKHLAPFPPSSPCVALFKDGELVHMLERHHIEGNP
AGAIAANLQAAYDEYC
>KALACAFP_01345 hypothetical protein
MSLENTINEAIKTAMRAKDKVALDSLRAVKSQILLLKTEAKGAEVSAEQEIAILQRMVKQ
RKDSYDQFAAQGRNDLAEVEEAQMKVIEQFLPKQLSPEELEAEMKNIIAETSAESMKDLG
KVMGIASKTLAGKSDGKSISEMAKRLLS
>KALACAFP_01346 Cell division protein FtsZ
MENLGTQGFSFDLPKGNSSIIKVIGVGGGGNNALKHMYEKGIHGVDFVICNTDAQTLDNN
PVANKVQLGTTITEGLGAGADPEVGEKSAIESIEDIKAAMGQNTKMVFITAGMGGGTGTG
AAPVIAKVAKDMGILTVGIVTVPFSFEGKRRLEQAENGLDKLRNNVDSLIVINNDKLRQQ
FGNLGFKQGFSKADEVLTNAAKGMAEVITGYFDVNIDFRDAKSVLQNSGTALMSTGVASG
ENKAEEAVKKALDSPLLNDNKITGAKNVLLLIRSGAEEVTMDEIGVIMDHIQKEAGNTAD
IIFGVGSDEELGDSVSVLVIATGFSNDNKKFSGPTEKIKISLNDSFDYPKESPFKTRDER
EAHTEPSHDFGGKNLFRLDDEDNEAPQFSSSPAEKKMIIEEEEVKTEIKFFDKEEDTLDN
PAQSWRNEDESQEQSFNLFSLDDEGEDPNDLEIESFKFDFEQKKEEPQTNSFTNSFSQEK
PVEFSFFVNEPSNNEPKSDPGQPKAELTSINTVNQLTEEPLQKVEHFFQNLKEEPKAETQ
PIVENKTEIETPKTTESEFTFVNKTVDQDRVIERRNKLKEFNSRYQSFDSSSEFESVPAF
KRKNISIDGTNASDQNINTYLSDNNGSMQIRENRFLNKDVD
>KALACAFP_01347 Cell division protein FtsA
MENQEYSVGLDIGTTKIVAIVGRRNAHGKIEVLGVGKAKSLGVHKGIVNNISQTINSIKA
AVSEAQSSAGVPIRKVTVGIAGKHIRSLQHSDYIMREHPDKFITDDDIEALKDQVKKLVM
LPGEEIIHVLPQEYKVDSEGEIQEPIGMHGKRLEANFHVVVGQMGSIRNIARCVREAGLE
MEALTLEPLASSEAVLTKEEKEAGVAIVDIGGGTTDIAIFKDNIIRHTCVIPYGGGIITE
DIKEGCSIIEKHAEQLKVKFGSAVPELEKDSTYVTIPGLHGRPDKEISLKTLAQIINARV
EEILEMVNTELKAYGAFEQKKKLIAGIVLTGGGSNLKHLRQLANYTTGFDSRIGFANEYI
ANDKNQYLKGPEFATSIGLLMESLKIRDKKQNIVVEEAIQEQAQPKAETTSTPAETLQQP
IQQTETIQHQELSEQQKENKRVAKLTFGQSLMEKVKKFFEEVE
>KALACAFP_01348 Cell division protein FtsQ
MKNKYRILKIAITVIILGFLLSFSLKKFSGQKIVDNKISVKMNEKTPVYFIDEKDIREIV
KKENPSGKVGDLNIPALEKKINDLPAVDSANVYLNLNGKLNLDIKQRVPVFRLNKDGRDF
YVDEKGIEFPISKTYSHPCMLVTGNVKKDEYQKLAELVEKIDKDDFSKKYFIGISKDNNN
DYNLLTSEGNYKVEIGDLDHIDFKVKGFKTFVEKYLVYQDPQKYSMVSVKYQNQIVTTLN
PYYKENDSILKAGNKELAKVPAPTPVRKTAEPKLKAAPKKETKKPATTSSKPKESTKPKV
VTKPKETKKTEKKPTAAKPKTKAKVKIE
>KALACAFP_01349 hypothetical protein
MTENEISNIVFDAGMKVHRKLGIGKFSFHPI
>KALACAFP_01350 UDP-N-acetylmuramate--L-alanine ligase
MNNLETYQNFYFVGIGGIGMSALARYFHASGKKVSGYDKTNTKLTQALMSEGIDIVFEDV
IDERITSLQKENTLVIYTPAIKVLGILDYFNEKQFDVLKRAKVLGLITENTDCIAVAGTH
GKTTTSTLVSHLCKEADLPFSCFLGGISENFKSNFLYNGSQYSVVEADEYDRSFLNLSPD
WAVITSTDADHLDIYGDKNTIEEGFRQFAALVPNDKQLFVRKGIEIGRPSLTYAVNEVAD
YYSDNLRMENDKIYFDFHTPTETIKDFIWEIPGIHNVENATVALAILNNLGVDFETLKKA
IANFKGIKRRYTKHRYQNGKIYIDDYAHHPTEINAVMSSIRTFYPGKKLLVAFQPHLFSR
TRDFADGFAESLSQSDELILLDIYPARELQENFKGITSSWLLEKVTLDKKEVSTLNEAFN
KIKEKDFDILLTVGAGNIDTLYDPICEWMGGN
>KALACAFP_01351 hypothetical protein
MSTELSTYRKFIYKDDALELIKILEEHHIAYELANNSSQLDSSFGGDINTKQFELKIQKE
DFNQVEKLEEDLVKKEIENVEEDYHLFDYSDEELIEIVTKKEEWNKFDYLLAQKILKQRG
KEINPELLKIINKQRIKDLSTQEESPTWLIIIGYASALVAGFLGVFVGAYLMYYKKALPN
GDRIYGFTKKDRSHGQNILIISAVAFFVWIGIRFFS
>KALACAFP_01352 UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase
MRLGCMLILLTYLRIYRQHNINKMSKKLKILLSGGGTGGHIFPAIAIADEIKKRFPDAEF
LFIGANGKMEMEKVPQAGYKIEGIDIAGIDRGNMLSNLGLPFKILKSLSKSKKIIKSFAP
DFAVGTGGFASGPALYEASKLGIPIFIQEQNAHAGVTNKILSKKAKAVFTAYPKVEGFPA
EKIKFLGNPIRSTIVSGMQDTAQAKEKMGLDKDKLTILSVGGSLGSRTLNNGWKENLENL
KAKGYQLIWQTGKLDFSELSNESRISDLGSQIQLKEFIKDMETAYSAADVIVSRAGAIAI
SELAVAQKPVLLVPFPFAAEDHQTKNAMNLVEKNAARMVKDSEMQEKFWNTLSEICENEN
VRKEMSENLKYFAKPNAAKEIVDEIFKIIK
>KALACAFP_01353 hypothetical protein
MEIKLIRFIDNKSLEDLSVFDTDEQMISFLKSYNLEFTEIIELNDSVYNVREISIKLIED
KIEAWVYVDFIDLLENLPTA
>KALACAFP_01354 putative peptidoglycan glycosyltransferase FtsW
MNEQDTESRFEFLKGDKVLWMVILVISIFSIFPVYSASSNLEYIVNNGTTTGHVIKHMFF
VVLGLGIMRLAGTVKYEYIGKLSSILLGLMIVLLVVTMFTGQTIDGASASRWLKIPGTPI
SFQPSSFAFLMLIIYLCRYLTKKITRERLPIENIMYIFGPILLVFVLVAKDNGSTALMIL
MVSVVVLIIGQLHWKYIAGFISSSFVAIVLFLIIALNTNLIGGNRVHTWMSRIETFTSAK
AKTADVDDESVKAKNYQVMQAKAAIVHGGITGMGPGKSALKQMLPQSASDFIFAVIVEEY
GVIGAAFLISMYLIMMIRIVMIASKMPAFFGSLLVLSLGVMIFMQLSVNIAVAVNLIPVT
GQPLPLISYGGTSMLVTYLQLGIILNISSRIQIYDEEGMGKKQSVAEINDIA
>KALACAFP_01355 UDP-N-acetylmuramoylalanine--D-glutamate ligase
MKIVVLGGGESGCGAAYLAKKQGMEVFLSDKGAIKDNYKQFLLHNEIEFEEENHDEEKIL
NADWIVKSPGIPKKAEIIHKIHEKGIRLSSEIEFASEFTNAKIIAVTGSNGKTTTTSLIY
YILKNDGLNVGLGGNIGYSFAKQVADENYEYYVLEVSSFQLDDIQNFRPYISLLLNLSQD
HLDQYNYNYEEYALAKFRITENQENDNFFIYNKDDEMSKNILEKLEVKAKMIPFSTKEKL
SEGGFIDDDKIVIKMKDEFSMKIEELSLLGNHNVANSLAASIAGKILEISNESIRNSLMT
FQAVEHRLEFVTEIDGVKYINDSKATNVNATYYALESMKTPTVWIVGGLDKGNDYTEIED
LVKRKVKAIVCLGIDNQKIINFFKDKKEFIYDTSSMEEAVKISKSLAKKGDTVLLSPCCA
SFDLFKSYEDRGRQFKEQVLKN
>KALACAFP_01356 Phospho-N-acetylmuramoyl-pentapeptide-transferase
MLYYLYEYLTSQGIHVPGLGMLKYISFRAGMAVLLSLIIALIYGKRVINYLRTKQMGELV
RDLGLDGQKQKEGTPTMGGLIIILATIIPVLLFTRITNIYIVLLLVSMLWMGAIGFLDDY
LKKIKKNKDGLSGKFKIVGQVGLGLIIGVTMYFHPDITVKRKYADAKVVNRNNVEQNFMP
TEKITVSTVPFAKNNEFDYSGILFWMNDKDAHEWAWIVFIPIVIFIVTAVSNGANITDGI
DGLAAGTSVVILLTLALFAYLSGNIIFADYLNIMFLPNMGETTIFAVAMVGAVIGFFWYN
TYPAQVFMGDTGSLMLGGVIAVLAIILRKELLIPVLCGIFLIENLSVMLQVAVFKYRKKK
YGLEYAQNNRLFRMSPLHHHYQKGGFHESKIVNRMIIIGVILAIVCLITLKMR
>KALACAFP_01357 UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--2,6-diaminopimelate ligase
MQLIELLKRIPVLEIHGDDAREVSELVFDSRKVTENSLYIAMRGTVVDGHSFIASSVEKG
AKTIVCEEFPENLDENVTYVKVKDSSKALGQLASNFYGNPSEKLKLIGVTGTNGKTSVST
LLFDVFKNLGYDSALLSTVEIRIGEKVIPATHTTPDVITTNKILAQAVEEGCEFAFMEVS
SHGIAQNRIEGLHFKIAGFTNLTHDHLDYHKTFDEYLKTKKRFFDELQDTAVAITNVDDK
NGNVMLQNTKATKKSYALKTMADYHGRLLEVDFNGMLLNFNGKEFWTTLTGKFNVYNLLL
VFGIASELGFESDEILQAISKLKRVSGRFETFKSDGGIFFIVDYAHTPDALENILDSIND
IRTKNERLITVFGCGGDRDHAKRPEMGNIATKKSTLAIITSDNPRTEDPAAIIKEIEAGV
EPQNFSKYTSIPDRREAIKMAIKFAEPKDIVLVAGKGHENYQEINGVKQHFDDKEVINEL
WKLMSK
>KALACAFP_01358 putative peptidoglycan D,D-transpeptidase PenA
MQKPNEYDNKRKKTLRWGYLFAVVALCVFVMFLARIVILQNTNVQEIKDDYINKNYREAT
LKAARGNLFASDGSILATTVMRYDIYLDFKTMKDTVYTNNIGALTDSLSKMFGKSRGEFR
KKFDEQRKKKNQYYALAKGLDFDQYDRIRKFPIFKKGKNKGGFIVDRNYKRELATSEIGA
GTIGMDNGEYSSGLEGAFSKYLRGTDGKRLEQRINSSQWKPIDFWKVQEPVDGEDVYTTL
DLRIQDIAHSALEKQLINFEAKHGTVIVMEVETGKVRAMVNLRRTEDGEYEDSYNYGLKD
NIEPGSTFKTISLLAAMDDGFIDENTTVNVGNGVWVYAKQRISDGHGGGTYDISDVLAKS
SNVGTAKLITKYYADKPQIFLDHLKRWKLFDKMDIELPGITKPKIVTPENKRWNAATLAS
IAYGYSSNINLLQLTTFYNGVANGGKMLKPLFIDKIMKDGKVIYNAKPEVIVNKMASEKA
IKMMTSALTKAVEKGTGKSIFTPNLKMAGKTGTARFEYWLPGPMKYRASFAGFYPADNPK
YTCYVMISEPNTAKGFYGGTVSAPVFKEIAGKTFLKTPQNIEKEMLVDKKVNLNKMVEPN
VKVAVNNKQMPNVVGLIGKNVIPQLENLGYRVDYKGVGRIKEQFPLEGTTISKNQRIYLS
LQN
>KALACAFP_01359 hypothetical protein
MIYSNHLVNKKIKIVNALKEETEEYKSRNAYAQSKLIKVKMESELGKEVAKDSLMTLENH
PHKLLIKLDSTDAKTK
>KALACAFP_01360 Ribosomal RNA small subunit methyltransferase H
MYHNPVLLKQSVDDLVTNPDGTYVDCTFGGGGHSREILGRLSDKGRLFSFDQDLDALKNT
IDDPRFTLINQNFRFLENSLLMYGVSQVDGILADLGVSSHQFDEAERGFSTRSNAPLDMR
MNVMQNLDAKRVINEYEEGELADIFYHYGELREARKLARDIVHHRKTKSIETTEDLKKLF
SYIPPHKVNKFYAQLFQAIRIEVNQELEVLKEMLVQAYQVLKPGGRLVVISYHSLEDRLV
KRFLKNGMFEGEPERDIYGNYKKAFELVKSKAIIPDDREIEENSRARSAKMRTGIKVG
>KALACAFP_01361 Transcriptional regulator MraZ
MKSFIGTYECKIDDKGRLKVPSSLIKQMENFDDKAFVVKRSVFQPCLEVYPMNAWDKVMG
KINKLNRFIKKNADFIRMFTAGVKTVELDNAGRLQISKDLTHFANLQKDIVITSAGELFE
IWDKDAYEKVISINETDFASLAEDVMGTFDEE
>KALACAFP_01362 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase
MIFSTKKEKKYTFVEAGEGHPLVLLHGLMGGLSNFDKMVDFFSDRGFKVYVPQLPIYDLP
VLNTNLTTIAKYIAKFIETHVEGPATIVGNSMGGHIGLILTLARPDLIKNLVLTGSSGLY
ERTFGDSFPRKNDRSYIRKKTEEVFYDPSIATEDLVDEVFSVVNDRMKGIKTVMLARSAI
KHNMLNDLPKILTPTCLIWGKQDNVTPPEVAEDMHKFIPNSDLFWIDKCGHAAMMEKPDE
FNEILYSWLKNKV
>KALACAFP_01363 putative GTP-binding protein EngB
MVIKTATFVKSSGKWQDCPEPTIPEYAFIGRSNVGKSSLINAMMNHKDLAKTSQTPGKTQ
LINHFLVNEQWYLTDLPGYGYAKVSKSIRKDFEKLITNYILNRRNLVNLFVLVDSRHTPQ
KIDLEFIQWCGESGVPFSIVFTKADKLKPNVVIKNVEDYKMELHKTWEDLPELYVTSAEK
KEGGDEILAFIQKTNDFLIQNNVHFDE
>KALACAFP_01364 Acetyltransferase
MSNIIWKIKTFDEFTVPELYAVLKARIDVFVIEQNCPYPDLDNYDQKAIHIWAEEDGKIL
ANCRVFDKGIKYDEASLGRVLTTEAARGKNIGRQLMKYAVETIENRFHTSEIRISAQDYL
LKFYSEFGFEDTGKKYLEDDIPHTEMVRK
>KALACAFP_01365 hypothetical protein
MKKIFYFLIASVLFIQCSKAKEQGKGVSAPISNTSNLKNLNVSVLIDLSDRIDPEKNPNP
TMEYFQRDIEYIKSIDKGFLDHIKGKRVIQLNDQMQVFFNPEPSDPKMNDLTKELKISFD
KNTTKDNIDLVDKKYSALPSQIYESAIKDKQYVGSDIWEFFKNKVQDYCIKDDHRNILFI
LTDGYIFHKDSKFSEGKKTSYLTPELVRSLKLNTSNFKTKIQDKELGFIKANDDLDNLEV
IVLGINPAKGNPFEGDVIKEYWENWFKEMKIKKYQIKSADLPSNIEPIILKAISGK
>KALACAFP_01366 hypothetical protein
MNVMTNNIKNLFRLKPVPIESPKDDIVKFDVDANSETSEENRKRSYHENGYRDSSRNNGN
HTALSICLDAIYSKFQNEEKELVDKQNKLKEPYLNEQKNKETEIKGLSVSLDNKEDHLKN
IGQDIESVQDKIEKIKFEINDLPRNPEIYNVKATKGASTKFWIGLIILIPISLYLFTFYI
STSYSAFFKSFDTNGNIIQNVLDAQAFNKAWDEGPLEGAFVTLIPFVFLGLGYLIHMFGE
NKSFVNYSKVALLFIITFVFDAILAYEIESKLYELNKTFNSPPFDLSIAFTKNQFWGIIF
AGFIVYIIWGLVFDFVMKEHKEKDKIKHEQTKRQKDILVYQEKIGDFEKQKEEVRNTIGS
IKELIAKAKGRIEELQNIIDGTIIPTKDYKLYASEYMQGWITFISEKLAVSHPVKQDMIE
ECKKQYMYNLNKVGANSDSQNTVYMSVL
>KALACAFP_01367 hypothetical protein
METIQIPENLKAHFLRLYQMAICDDDFSPLELKMLYKTAEERGISPKNLDEILLNPINSK
SLVPETIDEKVESLFDLTVMIWADGVVSENEYSALKKYVAMFGFLEENVQEIADYFIEAV
KQGKTKNDILNDLKN
>KALACAFP_01368 hypothetical protein
MKYLIIIAALLCFIGIFDLPQRFYLLLRIIVSLIALIIIFNEFRSRNFWFLAFILIFILF
NPFFPIYLYLKPFWIVIDIIVGLLFSYYFYTLFPKKTVKEPETIDIKHQEIPKTRDRIIK
>KALACAFP_01369 hypothetical protein
MKKLLFTSLLSLGLLLPATISATTNSTTSTTEFSTKKPKKAKGKKHRKSKRSKAKSSRSY
SRSKGCTYNGHELIVGPRGGCYYYSGNSKEYVDRSYCSGCN
>KALACAFP_01370 hypothetical protein
METQIQNETTFYQDASVTVTQSRFVTQSKTYAMRNISSVYVFEIEKSRVLPILMILLGIP
FIFFKDVFLIGLILICLGLIIIFSIKNEFAVRISTNAGEANSIVSKNRDYIQKIVKALNE
AIIHRG
>KALACAFP_01371 hypothetical protein
MGKFFISKRSNGEYQFVLKADNHEPILTGEGYQTKAGCKNGIESVKMNAPFDQRYDRRVA
TNGQYYFNLKASNGEIIGTSEMYTTSSAREVGIESVKRNAPNAPVIDLTGE
>KALACAFP_01372 hypothetical protein
MNVKHTPTNIVHKGQKGGMTGCGTNTNTLPDHWVNTNDKITCDKNGCKN
>KALACAFP_01373 Transcriptional regulatory protein RcsB
MFKKVLIAEDHEVRNLGVVNTLAELQIQNFDFVNYCDDALQKIKTAATNNVSYDLLITDL
SFDKDHIDQKINSGQKLIEEAKKIQPNLKVIAFSIEKKPKIINDLFKTHNINGFVSKGRN
DGKDLRNTIRKVFSGEVVIPQEILNSIRNNSFEFTEYDVTLIELLAKGWKQSEIEKFFKE
NKITPDSRSAIEKRLNDLRFELGAKNNIELIVICKDIGII
>KALACAFP_01374 hypothetical protein
MKNLLLIILLVLINSCNKENKTKYSRPSTLSTNPYLERAKLFKDRKIPDSAFYYFNLAKN
EFLKDNDSLGAGRSLVNMGIIQTENGDFLGGIESSLEANKYIKLKKDSNVLRTLAANYNN
LGIASNYLKYYDKSVGFYIKAINTAVDKEKKYIYYNNIGDILTTQGKYKEAIQYLEKAIL
SQNKDDYSRALNNLAKAKYLYNKNYNPLPEFNKALEIRKKENIGDGLNSSFETLSTYYLD
KDKSLSLSFAKKMFQVASVNKSPDDQILALQRIIFLDPKNYLQYFQKFNFINDSLQTARN
NDKNQFAFFRYDLEGERAKGEKLKADNEIQQARKNFILGFLVILLIVGFFWYRKRQIQLK
QEKELEVKNTQLKISKKVHDVVANGLYHMMIDVQNNPEMDKTRILNDIEKMYEESRDISH
ENIVEEDFAMRFINMIMSYSSDQQKVLPVGYKESIWENISYNTQLELYYILREILVNMKK
HSQAKLASVRFEKDNDNLKIRYTDNGVGINDSDLHKGTGIRNTENRIESIGGDIIFEKNP
KGGLIIQITIPIQSKYV
>KALACAFP_01375 hypothetical protein
MLIALAFGNNNANTSCNNDNNGQVTTQLADPGGSTDPGTGTGEDGGPVGGNTGQTPPPFT
NP
>KALACAFP_01376 hypothetical protein
MSKFLPQKRKLLEEVFQKASNETTETSFSGILKSLERDLLDDFKINLSYRSFETYYKTIV
ENDGDYNIKAAILDDLSIYLGYENFRNFCMDWKTIEYAVTQTLSKIVINITNKPIFTMPD
FVKKNGLGIMEMVFVLLLVTGGVIFSNGKKKGDTSFNLGFMSNVKPDVDKKYMYWNGERY
IATDSSDLGPQIEIVPMNPNTFRYLRRITREDTLTTDNAMGKVWYDKSNNNVEFFTSPGE
HPENGKTLKDVSETILNHHAGSNTDSLQIEE
>KALACAFP_01377 hypothetical protein
MNKGIFSFLLLIFSLFSAQKPVQIAFLSDVHFQDLYGSFSDNDFKGIINPKTGKPTILRT
MDSQLHSTRIFNENYFAFLKALDDIAAKGIKIVAMPGDFSDDGQAYNLRGLHKILEKYHK
KYGIDFYLTTGNHDPVGPFRQDAGKDDFLGQDGNPLGIYSKENIGKIKNKIITKDIAESG
YLEILDELKDFGFYPKKENLFWSTPFDSNSFKNYSYEKALQNADYSRRMYEVVKGFSVPD
LSYVVEPVKGVWMIAIDGNTYIPKNINENPNNASNYKGASIGYNNVLTNKKHLIEWVKKI
TQEAKINGKTIIAFTHYPMIDFNDGATQEIKNVLGEKKWQMERVPEEEVAKAFAEAGLQI
HFAGHMHINDTGIRKFGDKMLLNVQVPSLAAYLPAYKVLTIKSPNKMEVQTEVLNDVPNF
DELFSLYEKEYEALKKDQNKILWNKDILKSKTYHDFMLFHLKELVRLRMIPDDWPKSFVE
EAKALTGKDLLLLIQNENQLKQKGINSDNFKIWTFEDLLLDVYKFQSADELAKRDIPKER
LQQYQILEKIFDENQSKDPFIIKLKYVFKILSLLSNGDPADHFEIDLKRHSIKRL
>KALACAFP_01378 hypothetical protein
MKKAVLLGLYLSSLNLFWSQSQNLNDLKINEIQVIGSHNSYKKAILPEVYSYLSKKDSLN
FLPRIQYEHIPIPQQLDLGLRNLEIDVYADSKGGKYAHPKILDLVKTTQPFDPEGKMKKP
GYKMIHITDIDYQTWYYTLEDCLKDLKKWSDAHPDHDPVFITLEPKDGKANRFGTEPEHY
TSKLFDDLDNELKKYLGKNKIITPDDIRGSYKTLNEAVLNKNWPKVKDAKGKFLFVLDNN
SENRDLYMKDHSSLKGRMIFTNSTPGTPESAVLFMNDPSPKITELVKQGYIIRTRADADT
MEARKEDYSRFEKAKESGAQVITTDYYQPSKLFKSNYKISFDNNTYERKNPVNGK
>KALACAFP_01379 TonB-dependent receptor SusC
MYHKINFFKFKKLIPIALIFLVANQVHAEGLTTSHPVFSQVNETITGVVQDQEGASVEGA
KITVVETGETATSDALGNFSISASMGQTLSISYDGYATQLVKISSTSISVKLKAKKDATS
IEEVTLVGYGSQKKSDLTGAVSQLKAENFKEGMNISVDNLMQGKIAGVRIVQSSGEPGAG
VNVSIRGIGSIRSGSTPLFVVDGVPLSNDAVSAQSPNVGLGNTSAKNPLNFLNTSDIESI
TVLKDASAAAIYGARGSNGVVLVTTKRGKKGEPMFTYDTYLGFSSVIKKLDLLTADEYRS
AGINKAYDHGGNTDWQDEIYRSAVSSNHSVSFSKSTDTGNYFASISHMDQDGIVLNSGFK
RTTARLNAEESFFDNKRLKVKLNLTASDIKETGIPNGGNAGSDGQVIIHALMANPTRSVY
DENGNYTNFNMNAHYNPLYLLSVYNDKTNTFRVLGNTEATLRILPGLNYKFNLGIDKTMS
ERNTTMYPNVTDRTPKGMYVQANLDSYNVLLEHYLTYDFNLNRHNFNVLGGFSYQKFKST
GTYFGLKDIAAQGAVAPELNPGYSGTAFVPGAGYAQENELQSYFGRVNYNFDKKYLLTAS
LRADGSTRFGKNNKYGYFPSVAVGWTISNENFLKDSQFVNELKLRGSWGQTGNQEVPNKI
TQASSSLTQAAGYYLYDNLNLINGVSINRTVNPDLKWEVVEQTNIGADFSLFKNKLYGSL
EYYHKTTKDPILNIPSTPLSPTSTVWRNVDAKIINKGFEFSLGSEIIKNENFTWNFDVNG
ATVNNVVKDLPVSAIYSGEVSGPGLSGVTANIYRNGYEAGSFYMYNYLGVDANGKYIYED
LNGDGKIDQNDRKIFEGAIPNFTFGINSYMKYKKFDFSFSFIGQTGGYLVNNTALDLNIN
NLASDRNVLKNFYDSGASFTNQPQLSSLYLEKSDFLRLNNVRLGYTFDINQLKFLRSINL
YVSAQNLFTITSYTGYDPLVDTNKQVGGNQSLGIDYTTYPSAKTFILGATVKF
>KALACAFP_01380 Starch-binding protein SusD
MKSKFLIINKIVLSFAVLALVGCTNLDEKVIDEVLGSETGDPEGALAAAYSQLGEGTFVD
HGSVFALQEYSTDEAILPTRGSDWGDGGKWRAMHEFTWDSNSDVVKTTWNQLNFGITRSL
NAIASIEKSNINNKALFLAEAKGLLAYYTYTTIDLFGQAPYRDPSNINAPIQIRKAETTI
DDLIKEVEGLIPNLADIKTQNTHAGRFTKQAAYAFLADMYLNRAVLKNKTASDFNFLEQA
VNGGGTDMDKVIEYSNLLINNPNFNLESNYFHNFDINNDTSKEMIFTIVQKKIASSDKGS
DNDLAYMSMERIQKPSPDNRGTNANCVTPEFYYSWNGNHDDPRFQRTYQYEDGTWFRNDG
TDVSVPSTSKVEGTGKPWFHFNRGLQVGQQYGPKILANGNFDMTADGRIKVYKLFTEKNT
TLAADFTPELNFDNPSEAVFTQAQINRGVRNFKFEFDPGYGNNGTSGMDVPLYRLGTIYM
MRAEAYFRSGNVSAALTDVNKLRTSRTNDALKGNAPGVALASLDANALFRESGFELYWEM
YRRKAMIRFKKFDLPGTAKPASQPYRRIFPIPQATLDASKDFSQNPGY
>KALACAFP_01381 Peptide methionine sulfoxide reductase MsrA 2
MDNNNLEQITFGGGCFWCVESCFNMLKGVQSAISGYSGGHKDNPTYEEVCTGETGHAEVV
QITYDPSVISYEQLMDVFFFLHDPTQLNRQGNDIGTQYHSVIYYKDDAEKAKAEEAIEKS
KQSGRWQGTYVTELTKFDKFWPAEQYHQGYYNENPTQPYCSAVVGPKIHKFKKYFGELGM
LNEE
>KALACAFP_01382 Glucokinase
MSLIDLSKNVALGIDIGGTNTKFGVVNHRGEVLEKGSIRTDAYEKVEDFIDALYETVHPL
IEKYGKEKNFDGIGVGAPNGNYYKGTIEQAPNLPWKGVIEFGDLMKAKFNLPCTVTNDAN
AAAIGEMLFGAARGMKDFIMITLGTGVGSGIVAGGKLIYGHDGFAGELGHTIVKPGGRKH
WSTGSEGSLEAYASATGIAITAKKMRAEFPESMLNQYPEEEINSKTVHECALKGDPIAIE
VFRYTGQKLGEALANFVMFSSPEAILLFGGVIKAGEFILKPTKLHMERNLLPIFRNKVKL
VFSELDEADAAILGASALVWEK
>KALACAFP_01383 hypothetical protein
MKKKHHHKKKPSTFKKWIGKLHLWLGLGIGFLIFIISITGALYVFKDEIENVTRKDVIYH
NEQNIGQKQVLPIRVLEKAVVEQVKEKYPVHWVNIPIDKKMSYLFYWYEHDPKGWNYFDE
FPIYKVAYVNPYNGKVLKTYDEKNGFFQIVKMIHWSFLLKQEWGTYVVGIPVIIFVIMLI
SGIILWWPKNKAARKQRLSFKWQNVKSWKRKNYDLHNILGFYASIFALIFSLTGLFYAFF
AVQAAFYFIFSGGSTQYPDFSSIKTKAPVELRTEGTLDKISNTVKAKYPDSFGFSIDLGH
EHMDDHEHPNFEVYVKHLSYSYHKSSSLIFDENSGELLHTHDMKDKNFGEKTVGANYDIH
VGSILGLPTKIIAFIVSLICASLPVTGFVIWWGRRKKKTVKIA
>KALACAFP_01384 Ferric aerobactin receptor
MKKIILSVVTLAAITTFAQEKDSLQTKNVDEVVMTASRKKENIKEIPSSVTIVGEKQIQS
QLTVNSDITSILQYTVPSLATSSGQTSNTGQTLRGRQVLVLIDGIPQSTPLRNGARDLRL
IDPSVIERIEVIKGASSIYGNGADGGIINYITRKSNSDKKISGISQVGITGQPYGGTLGF
RASQLLSGSFAKKFDYVASFAYERTGYMKDADGVNLSPTYSTAKMNNYNGMLKLGYNIND
NQRIEASYIGYASKSDLNLGLKTGKYGLIPTIGEGEGKGLETTPQGTPRNHNFKVSYDNK
NLWQGTALNVNLYLQDFRTVYGYSDTFLNGGQSNIISKKYGARVNLDTQLWNAKNSQGEV
IYGVDFLNDQTVQKLEDGRYWTPDMDMTNIAPFMLVKIDLLKKLTIKGGLRYENMKVKVG
DFNTLSTIKNDGTFTKSIFVTGGDLEYNALVANLGLRYNINPMINLFGSFSQAYSINELG
RILRTSTSDTINNLETKPIIVNNYELGATGQITKWINYEITSYVSTSKLGATFIQSPDRA
LTIQRAPEVVYGVEGFVHFTPTRWINFGGSYSWMEGITSPKDDGDYSTKINNSRISAPKV
LAYIQARPTQKLSVGLDMLHAFKQDRFDPNTKTGLYVYGEGEVPEYTVFNFKSSYEVNKN
WKVSLGIENLFNTMYQPAIAWWAARDSDFNNSLGMRGTFMVEYKF
>KALACAFP_01385 hypothetical protein
MKKKHHYKKKPSFTKKWSAKLHLWFGLSIGIIVFIVSGTGTMYVFKDEIQGILRKESMYV
KKESITEKPLSIDVLREKVSLETNEKYPISSVEIPLDKNKSYEFLYYEKDKKAWNYFDEV
KINKLVYVNQYTGEILGIYNEKYDLFPILKAIHWSLLLKSDWGKYVVGIPVVLFIIMLIT
GIILWWPKKSKKGRFWFNWKNVKTWKRKNYDLHNILGFYASFIALLLSLSGIYFAYPWVK
NAFNVALSGSLELPKEKEIKSPDSLLVKNTSVFDLTAQETRKLYAGSSSFKIPVNGKNKK
GKELKNIPVTVYGEDGKFAVRNQIVFDKYSGKLLSNKPHQELNNAEKYANANYDIHTGSY
FGLAGKIIWFIAGLICTSLPVTGFLVWLGKKKKKAIKTL
>KALACAFP_01386 FhuE receptor
MKNVLVCASLLGSMLSFAQEKDSIKSNDIEEVVVNGKYYKKYVEKEGSSSMRLDEELIKI
PQNVSIITNRALEDQQVTTLSDGVLRNVAGAQRLEHWGDMYTRVNMRGSRAAAFMNGVNV
TSNWGPLSEDMSFVDHIEFIKGPSGFLMSNGEPSGIYNIVTKKPTGQSLNGSARVTLGSY
NMYRGETDIDTKITDKVAFRLNLMAQNKNSFRDYEFNDRYIINPSLKVNLSDKTTLTAEY
IYQKAKMSEVGSAYVFSFDGYATRPQSYTQTDPGIDPTKVDNNTVNINLQHKFNENWKLT
SQLTYVNEYTLGSDLWPSMFEGNYMIRRLNYWEADNTMKFGQVFLNGYAKTGIVSHKILA
GLDLGSKKYMADWSQGYNLDKYNATDNYTLPVDHNYWYNLNTNNYDINGTGNYYGPNNTF
VAFDSSKPLSVRAGLGSTIEQNYTGLYLQDELGFLDDKLRLTLAARYTNVKENNYGTKSE
ADKITPRIGISYSINDDMSVYGLYDQAFVPQAAIFRDGSTVKPITGNNLEVGIKKDWFGG
KWNTTVSAYNIIKNNATVADPTNSPIEQFSILLGKTRVQGVEFDLKGEITRGFNAIFNYA
FTENKVTESNDPVNNPVGMRVPGYAKHTANGWLNYTFTEGTLEGFGLSFGGTYLADRSTW
SWASTSTQKELGDYVKFDAGLSWENTKFRVGLNVFNVFNRYLYSGSPYGNYYYYQAEAPR
NFRLSIGYKF
>KALACAFP_01387 Protein translocase subunit SecA
MSFLNKVLKGFLGDKKAQDLKEVKKVVTKIKAVEPTIQQLSDDGLREKTAEFKENIKSAT
SKITAQIEQIQEQIKTSTNVDEKEALFSKIESLKKESYEIEEKILSQILPEAFALVKETA
RRWAQNGEIRVTANDWDRQLAAAGKDFIEIQGDQAVWKNSWDAAGTPVLWDMVHYDVQFI
GGVILHSGKIAEMATGEGKTLVGTLPIFLNALPERGVHVVTVNDYLAKRDSAWMGPLYQF
HGMSIDCIDNHQPNSDGRRKAYNSDITYGTNNEFGFDYLRDNMVTSPSELVQRELNFAIV
DEVDSVLVDDARTPLIISGPVPQGDRQEFDVLKPSIDRIVEVQKKTVSAIFNEAKKLIAA
GNTKEGGFKLLQAYRGLPKNRQLIKFLSESGNRALLQKVEAQYMQDNNRDMPIVDKDLYF
VIEEKNNQVDLTDKGVEYMSQGNSDANFFVLPDIGTEIAELEAKNLSKEEEFEAKEKLFS
DFAEKSERVHTMSQLLKAYTLFEKDDEYVVIDGEVKIVDEQTGRIMEGRRYSDGLHQAIE
AKENVKIEAATQTFATITLQNYFRMYNKLAGMTGTAETEAGELWEIYKLDVVVIPTNRPI
LRHDRQDLVFKTNREKYNAVIEEIERLTEARRPVLVGTTSVEISQLLSKALQLRKIPHQV
LNAKLHKKEAEIVAGAGQPGVVTIATNMAGRGTDIKLTKEVKEAGGLAIIGTERHDSRRV
DRQLRGRAGRQGDPGSSQFYVSLEDNLMRLFGSERIAKMMDRMGHKEGEVIQHSMITKSI
ERAQKKVEENNFGIRKRLLEYDDVMNKQRDVIYKRRKNALFGDHLKYDITNMIFDVANSI
VTKGKANGSFKDFEFEVIKNFTMGSPVSESDFGNKNVQDLTNILFKAAQEDYQMKLNLLK
EKSFPIIENVYQNQGSMFKMIQVPFTDGHKTMTIVADLKEAYETKCESLINDFEKNITLS
IIDENWKLHLREMDDLRRSSQGAVYEQKDPLVIYKQESFHLFSEMIDKLNKEIISFLYKG
EIPA
>KALACAFP_01388 hypothetical protein
MYWTLELASYLSDAPWPMTKAELIDYAIRTGAPMEVVENLQAIEDEGEIYESIEEVWSDY
PTDEDFLWNEDEY
>KALACAFP_01389 UDP-N-acetylglucosamine 4-epimerase
MNYLVTGGSGFIGSHLVEQLLKKGHSVINIDNFDDFYSYQIKIKNTLESIGENSDFEFSD
KENDIKKLISISKSDNYTLYYQDIRDKKGLEEIFKNHKIDLIIHLAALAGVRPSIERPLE
YEEVNVRGTMNLWELCKDLNIKKFVCASSSSVYGNNEKIPFAETDNVDNPISPYAATKKC
GEILGHVYHDLYKIDMIQLRFFTVYGPRQRPDLAIHKFTKLISNSQEIPFYGDGTTARDY
TFIDDIIDGITKSITYLENNSDVYEIINLGESQVITLNEMLSTIENTLGKSAIRKNLPMQ
PGDVQKTNADITKAKTLIGYKPDTNFQNGIKKFVEWFLRK
>KALACAFP_01390 hypothetical protein
MQFQGQILKMTSFNDEPIQYYLNLSGDLIHMNELFGKELTIKHTGFQCVNCQLDKTIYRM
GFCKSCFFESPYASDTIIRPELSTAHLGVAERDLEVEKEIQLQPHTVYLAYTGEVKVGVT
RNTQIPTRWIDQGATFALPIARTENRYEAGMIEVALKQHVPDKTSWKKMLQDDLEDDIDL
ADFQQKIKEYFPEDFQKFYSEGENLWRFDYPFEKPQKVSSFTLDKKPEFTGRLTGIKGQY
LGFEGGDFMNVRGHEGYVIELNVKN
>KALACAFP_01391 hypothetical protein
MKKWVKKILIGFGVLLLIVLVANFGLNIWLKTQLPNYIKNNTDYKVSYKLLEVDLMSGNI
LSTGVSVNSKNPQNTNVIGLQGTIDTLKVSRFGIYDAIFNKQINSSDLLLSKPNLNIVLT
KPVDVKTGKKRNPFLFENIRINSGNISIFRHTKQKFLSVQDLNLFVENLQMTEESVENKL
PVVFDKYDIRGKNFFVRPDNIYALKINKIETSNGQMSIENFQLIPLLNIDQLKRFYPKRT
KLYQFNIPKMEFKDVVLKKNIVSLANAEFEQPYLMVYNTDAVPVKVKKPSDFELNLEDVK
LSNATVQIIKPDGNKLLYARRLNLAVNQLKFNKETREEVIPVGYKSFQFSGKDILYSNHQ
NYNIENFALNQKSGEFRNLSVTPNTANPGRRSMNLKANLVAFNINTFEFIDRKLNLDIKD
VLVDQVNGTIKVGPPRPKKIPKENKVEQILVRKVTLKNSNLTYDKESEPLVFNELNATIN
EIEYKSKSDNHGHTLKVKDYFLTTKNFVYKTRLYNLGVGLLKLNKNKVQINNFTVKPLVS
RAQFIKMIPVEQDLYDIKAGQITADGNWDLFSQNKFINASNVTIQSADANIFRSKIPKDD
PKEKPLYSRMLRSIKIPMIINNLDLKNSILVYEEDTPESVGPGKLTFSNFNMNVKNLNSA
KTKGKPTKVDIKINCSFMNLAPLSVNWGFDVADQRDIFTISGRTLNLPAQGINPFIRPYL
HVTATGTIQEMLFNFTGNPRGLHGRFNLKHKDLKVAILDKNNQEKKGFLTAIANLVVRSD
SGKLPQDVIIEEVERDPTKSFFNLFWRGIEQGLKKTLIGINIDKAKKTVENTKSSIKEMK
QSVKDLKQEIKGSDAKKEEPQPVEEKPKRGFLKGIFKKKERPETE
>KALACAFP_01392 hypothetical protein
MESTGNIDKMTTLSQVMSRLAERGIHREFRMNDNCEVKLENSEKNYLPNELTILKTYRFE
GASSSDDNAVLYVVKDDAGNMGMVIDSYGAESNYPKEFDNFLREIPILESDEFDFD
>KALACAFP_01393 hypothetical protein
MKKEVGVLLAGGVGLLAVLSIIGIKKILHKKGKKYSDTYSDYHRHFDGKNHDDEYHGVEF
YALK
>KALACAFP_01394 hypothetical protein
MQNENIIKGQGAQRNVINRFDRYTYEPEDEDFETVKTSFTEVFPKTIVNQVKSEDLPMEY
SMNPYQGCEHGCSYCFARPTHEYWGYSAGIDFERKIMVKKNAPELLEKFFQKRGYKPAPI
LLSGNTDCYQPAERQFEITRKMLQVCLDYRHPVNVLTKNALVLRDLDILKPMAEQNLVSV
SLSIPTINEDLRRKMEPRTSSAKNKLKAVEILSENKIPVNVMIAPIIPGLNSDEPLTILK
AISEAGAQSFGYTLVRLNDTVEPVFVNWIEHAFPDRAQKVLNLIRSMRGGKLSEKRYFNR
QKGEGNIAEMIHNTFKIGRKKFFDGKEFPKLSTANFTGSKDQQLRLFD
>KALACAFP_01395 hypothetical protein
MKNLKKLSKGQLKSISGAGGIKLPEPEFCMYACNGMVICAACSDDFKCPDDTM
>KALACAFP_01396 hypothetical protein
MDKIPSVDLRDFLSGDPERKQKFVNEIGKAYEEIGFVALKGHFLDDKLVDELYEEVKNFF
ELPTETKQKYEIPGIGGQRGYVGFGKETAKGFKKGDLKEFWHFGQYVSDDSKYKNEYPDN
VIVEELPKFNEVGKEAYQMLEKTGQYVLRALALYLGLDEFYFDDKIAEGNSILRPIHYPP
ITEEPNDAVRAAAHGDINLITLLMGSQGKGLQVQNHKGDWIDAIAEPDELMINVGDMLSR
HTNNKLKSTIHRVVNPPRELWGTSRYSIPFFMHPVSSMSLNALENCVDENNPKLYEDTTA
GEFLHERLIELGLIKK
>KALACAFP_01397 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate synthase
MKKYSSKRSIQILAHLLQQYGISDIIISPGSRNAPLAMHFAEMPGTFHSFSIVDERSAAF
VGLGMAMSEKKPVAITCTSGSAAVNYYPAITEAFYSNIPLLVLTADRPTDYVDIFDGQTI
RQNNLFHQHSYGDFQLLEDSKENAEDINFDIIKKAIELCIEKQGPVHINIPLEEPLYELV
SELPTFPTVEKTIKHKEYEIPSNLVADWNTSQRIMILVGTKDYSPELENQLTQLVKNHSV
VVLSEANSNLYHEKFFRHIDRYVFNFTEEDYKTYAPDLLITVGQNVVSKKVKQFLRKARP
KQHWHLDEVWQPDTYFVLTEKIEVKPEVFFSKLLKFINLEPKPYFNLWDVLRDKKDAKHE
QFLNTVEFSDFYFFNRTSESIPENYNVHFSNSSAIRYAQLFDYGKRRIYCNRGTSGIDGS
TSTVMGFAIKNANPTLLITGDLSFFYDINGLWNQYIPPFVRIMIFNNGEGNIFKIIPGPG
NANPNTLDEFIATKHHKTAEHLAKHFGFSYTKVDEEATLDRVLENFFKPDSQPKILEVNT
YGKNSADVQKAYFNFLKEN
>KALACAFP_01398 hypothetical protein
MSQFIESIKVEDQKIFLLEYHQKRVDQTFAHFGKEGSIDLAKVYKHLEHDEDGLYKLRVV
YDLDKKVRTQMIPYAIPEIDDFQLVENNSFDYSFKFEDRKELEKMKMKSKAEEIIIVKNN
HITDTSFSNLLFLKGKDWFTPTTYLLNGVQRQNLLKHKEIKETEVTLQNIKQFSHFQIIN
ALNDFDENFIYPIDRIINLPGNEEYLDL
>KALACAFP_01399 Aminodeoxychorismate synthase component 1
MDELSLQKVPYFFIIDFLAGNVEVFKENELEKSGLLIDFQYFSNTKTQHDLNKKIEWKSY
PETLESFKSGFDIVQKNIRLGNSYLVNYTRKTKIETNLTLEEIFYHSSAKYKVFYKDFFV
FFSPETFVKIIDGKILTYPMKGTIDASLENAAEILKNDKKEKAEHYTVVDLLRNDLSMVA
DDVRVDKFQHIDFIKTQQKDLYAMSSEISGVLKPEFDGKVGSIMKKLLPAGSILGAPKPK
TLEIILEAEGFPRGYYTGVCGWFDGENLDSCVMIRFIEKEGDTLYFKSGGGITHMSKLED
EYQEMKNKIYVPIY
>KALACAFP_01400 hypothetical protein
MQNKYPQKPGLDFILKQAFFYWNKTLIFQLMFSIVYFGILLTVFFFCDAKYGIMSQYVET
AKYAKDGIQVYTAEIQKMLATESFQSFSLWMVGATIFLYPLNLGFYQIYRKFDLGEKPAL
GDLFVGYNGINFFKYIGYYIFWYFVFAYTFQTIILGVVWVCITVFVAPLMFFMDKRIFEA
ITLNFKALKMYFIEIFVCVIVAIFFKYIGFALFFIGGLFTFPFWNAMIYSLYKTIFSEKR
>KALACAFP_01401 hypothetical protein
MSEFNEFDQQGSVPERNTGSIISHAFEMYKGVFLYAFVAMIIYLIGGFVIQALTGFNSAG
FADDIKSNGGDFSDFNIWAAPGFTSYISLSWLLGLLLAPLYVGLIFMVNKYNTKNPIEFS
DLFIGYRQNFVNILIYSIISGIITSVAAFFCVIPVFFVYPLLMLGYPILLFENATAMDAL
GKTFNIAKENYGTFLGTTVLGILISFAGVILCGFGIILTAPFIMVVMYSLYCAFLGKPRQ
ITFNK
>KALACAFP_01402 hypothetical protein
MNKDQQISSVKIKQVFLLVIILVLTGLICFNLALFIPSVLGAITIYVVCRKYNFYLQEEK
KWKPWASSLLLMLASLIIIILPIYFIGDLLIEKLGNAQVYMTKFNVFLEKIHSYIYSKTG
FDILSQENMTKLKNSVGQVSTKALSSTFNTLTVIISMYFILYFMLEKPRFFERILVSSAP
LKRANVSLIGEKMRKLIMANAIGIPVVALGQGLVALIGYFIFGAPSPVLLFALTAAASMI
PVVGSALVYAPVCIYMIAEGDTGHGLGLAAYCIFVVGLTDNLLRFTLLKKLEDVHPLNTV
FGIIMGMNLFGFMGLIFGPILISLTLLLIQVYRNEFADDDTPPELKLPDSDGDLEQKIDL
IV
>KALACAFP_01403 hypothetical protein
MEDGINPEILKEICVVKMPFGKYEGTVLADLPISYLEWFYRKGMPKGKLGMQLSTIYEIK
LNGLMDLLIPIRGGVVNYEKPKTKIYKF
>KALACAFP_01404 Germacrene A synthase
MKNLMIPRLYCPFDSEINPHVEALKKSSDQWVINFELFSKEGIVKYHSDNYSYFTARFYP
RTDYHRLSVANDLITLLFMVDDLIDSPFIQSRLEKETALRKFIERFLVIIKQKEEPGFID
ENPIFSALKDVWTRLTAIADAAWLASFVKEIERVFAAAVLEYQNSESKKLPTTETYLEKR
RYMGAANITLSLIQPIEKVYLPDFVTLNDKVQELEKAACNAICISNDLFSLSKEQMLGDE
HNLPSIIKNEKNITLEEAILLTAEIHDAEVKKFIALSDELPFFDEEINSKLKYYVNILEL
QMAGNFVWSEFETERYLFVYSDDYKRIKIEN
>KALACAFP_01405 4-sulfomuconolactone hydrolase
MKIFDSHFHIINPKFPLVENNGYLPPEFTVEDYINTTKKYNIQGGAVVSGSFQAFDQEYL
MDALKTLGNNFFGVANIPASITDKELEVLNDANVVAVRFNVKRGGSEKIEHIEKLSNILF
DKFGWHTELYIDSNDLKDLKSVLQNIPKFSIDHLGLSENGLEDLYFWVEKGIKVKATGFG
RIDFNPIPVMKKIYEINPKALMFGTDLPSTRAKIPFSEKDVQLITDNFSTNELDHIFYQN
ALEWYSRKA
>KALACAFP_01406 hypothetical protein
MKRVTGIGGIFFKCADPKALKEWYKTHLGIDVNEYGATFDWKEMAESSPKGSLTWSPSPE
TTKYFEPSTREFMINYTVADLEALVTELKKEGVEILDEIAEYDFGKFIHILDLEGNKIEL
WEPK
>KALACAFP_01407 UvrABC system protein B
MEFKLQSEYKPTGDQPQAIEKLTEGIEIGEKYQTLLGVTGSGKTFTVANVIQNVQKPTLV
LAHNKTLAAQLFMEFKEFFPENAVEYFVSYYDYYQPEAYIATTGTYIEKDLSINEEVEKL
RLSATASLLSGRRDVLIVASVSCIYGIGNPTEFHKSLISVGIGEKVTRTALLHSLVNALY
ARTLNEFQRGTFRVKGDVIDIFPAYADNAVRIQFFGDEIEKIQSFDPVSGNVTSNFEQIQ
IYPANLFVTSKETLNGAIREIQDDMVKQVDFFNSIEKPLEAKRLQERTELDLEMIKELGY
CSGIENYSRYLDGRLPGSRPFCLIDYFPKDFLMVIDESHVTVPQVHAMYGGDRSRKESLV
EYGFRLPAAMDNRPLKFEEFEAMQNQVIYVSATPADYEMEKTGGSYIEQIIRPTGLLDPV
IEIRPTLNQIDDLMEEIHKRSDADERVLVTTLTKKMAEELTKYFTKFGIRTRYIHSDVET
LERIQIMQDLRLGLFDVLIGVNLLREGLDLPEVSLVAILDADKEGMLRSRRSMIQTVGRA
ARNINGKAIMYADRITKSMQATLDETEYRRAKQIKYNEEHGKVPQALNKKISESLVGRTK
DFPDEKYTQKEILQKVAEAKANYSSEDIEKVIAQKQKEMEAAAKNLDFIKAAKLRDEISA
LKG
>KALACAFP_01408 hypothetical protein
MKQNLFSIIFLSLFISLFGKNNVGNPLPPSVVTVYQDAVFYDMYAATVNQPLPTDAVRLS
NSTYTKKMTDAQLDSFGNQVTMNVTIGALCDNYDRLAHVLLALVPKGASSYDTNLVKKLE
IGRFVTPFMNKNISPTSVPYTFQVDNLGAIFKDMNLRSQYDFWIEFTVLGVPYAAQTQVS
GCAGRIDTFKGTLSFTTDNNSSIPPVNNFLLTMAALKSFNNYNATDEPGTTLRMLNFTLP
NTVNNASFYLITSNHGANSGGEEYVRRQHYVYLNDVQIFTYKPGGISCEPFRQYNTQGNG
IYGSSPQSTSWWTSWNNWCPGNSVPIRKISVGNLEPGLHTFTITVPDAQFVGQQGDFPLS
VYLQGEASNVLGVKEMTVTDVKIYPNPASNFIKISSTKKIRETEMYSVDGRLVKTFKGGE
SDISELQTGTYILKVTFEDGISFKHKIIKK
>KALACAFP_01409 Aldose sugar dehydrogenase YliI
MRFNRFYIPVVGLFLVLSCEKNNANAQVGNDGSVETKEPNSNYKPAFAGQTRIKAVKTTT
PYNVEILSKDLGKPWGIINLPDGRFLITDKRGYMNVVSADGKQISKIEGFPKVDSKGQGG
MLDVALDPDFKANNIIYFSFSEPFGKGNLTSVAKGKLAPDLKNISEVKVIFRAEPSYDGD
KHYGSRLAFDKDGNLFVSTGERSDKVTRVYAQKTDNYLGKILKITKDGKPAPGNPFIGKA
GYKPEIYAYGVRNPQGMAIDPNGNLWDVEMGPRGGDEINLIQPGKNYGWGDVTYGIEYSG
EKINNGTTQKTGTEQPVYYWDPVISPSGVTFYTGNIDEWKGNLMIGCLSGEHINRIVMKD
NKVVGEERLLEDQKERFRDVLNGQDGNLYAVTDSGKLYKVSKK
>KALACAFP_01410 Ferrienterobactin receptor
MKIKYLSVIFLSSSSILYSQETKDTISNENKIEEVAITGSRNKKRTVVDTPVPIDVIDIK
QVSQSTGQVEVNQLLQFSAPSFNSNKQSGSDGADAVDPATLRGLGPDQTLLLLNGKRYHQ
SSLINLFGTKGRGNTGSDMNTIPIAAIKRIEVLRDGASAQYGSDAIAGVINVVLNDRNSG
FEGNAFYGMNVFKSPGNKDVVSDHKIDGITFDFSGNLGTKIGSKGGFGNFTVEFVNKDYS
IRNANPEMYEAPRQRFGDAKSQNFYFFGNIEVPLSDNLKLYSRQGFSHRNTNAYAWTRSA
DADGNIPEVYPNGFNPLQDTSITDFTFDNGLKFKVADWDVDFYNVFGSNRFTYQINNTIN
ATLGVNSPTSFNAGGHSLLQNTTGFNASKQFEVLEGLNIAFGSEFRYEKFEIIKGEEGSY
TMYDVNGNVVTASTDPSLLVINPLTGDVRPGGSQGFPGYSQQVDKSRNNLAAYIDTELDI
TKKWMISIAGRFENYNDFGSTINGKFATRYNFTPQFAFRGSVSTGFRAPSLAQKYYSLQF
TNFQGGDLVTIQLASNDSDLARRVGIPQLKQETSLNGSAGFTFNTRKFTATVDGYYIRVK
DRIVLTGNFSRDDLPADVQADYPYIDQAQFFSNAIDTRTKGVDVILSYNENIGKGKLTAT
LAGNYNDMEITAVHTSEKLKGKEEIYLSPRERGFILASAPKTKINLNLNYKINKFNANLQ
LVRFDKVTLLGYGGADDFQIYNPKVTADLSFGYEFTKGLSLTIGSKNLFNRYPTLQKAHV
SDGNTESGGIFDPVQMGFAGRQVFARFNFKF
>KALACAFP_01411 Aspartate aminotransferase
MFTNTNINFEALKRKAYNGRWATLEDGIIPLTAADPDFRMSSEIEQGIIEYIKDGYLSYG
PFSGIPEFKKSVAEHFNTEKKGNFTPENVLAVNSAAQGMFLIAKYVLNPGDEAIIFDPVD
FLFKKTVEAVGGNIKLCAVDSKTGDIDFEMLVSLISPKTKLISVCNPHNPVGRVYSKEIL
KKISEIAAAHDLWVMSDEIWSDIVYDKKEFNTYSSVSEEAKKKSFTVFGFSKSFGIAGLR
IGAVLCNDQELLDDFTEKSNFNSTIEGVSTLSQIAASVAIDKAKPWFNDFLTHLQHNRDL
AHSMLSNSGILTPNLPEATFVIFPKIENGLSSEEFAQHVLQKGKVAIVPGSERWFGKGAE
GHIRICFSTSQELLTEGLHRIINSF
>KALACAFP_01412 2-heptyl-3-hydroxy-4(1H)-quinolone synthase
MSKVAIIGAGVSGLSMANYLEKNNIAYHIYERRTQNDLKGHGFILPKEGIKHLSSIINID
DLYEKGSFLKKYIHYSQNGEVISEKDLDDVFVVSRSALIEILAQGVPAEKISYEKTVNFN
GFSNGKADISLDGNTLDADVVIASDGSRSRIRRNIFQDEIMKAVLENEVVNIIENEELAS
QIESNFLKFHHENGGLTFGVLKLSSSKILWYCQFDITKFFINEDYTPDCIRQFMLDNFGN
WNPLISSIIEGSSYENAHIWRVYELEKLNPFHHENIVFIGDAAHPLIPFTSQGVTSALKD
SFTLTNLLLEGNDLQETFEKYEEERKPEIEIHIKNGRALLEQFLLPLSEQPKNTLPISYK
>KALACAFP_01413 hypothetical protein
MKKLTFENIANFFLKNFFQGLVIIGPIGLTLFVIWYIITSIDNIIPSVAKEIPGLVFIST
ILITALLGFLGNKFVVGRFFFDTMDSLLEKTPGVKHIYTPTKDVMSSFVGDKKKFNDPVW
VKTNENPEIWRIGFLTQKEMADVEKHNYVAVYLPHSYAISGWVIVTEEKNIKPVVGMTAA
SAMKFAVSGGVAGFHSDDNIFKAPE
>KALACAFP_01414 hypothetical protein
MFKLKLPTDPRWANIAEGNIEEILTDHAWCEQKAATNAIGLITMLPEYPEIVTELLAIAQ
EELEHFKQVHEIIKKRGYTFGRTRKDDYVNELVNFIQKGGNRDDLIVDKMLFAAMIEARS
CERFKVLTENIKDEELKNFYRELMISEANHYTTFISFARQLGNPEKVNARWEEWLEYEAK
IIQSYGKGETIHG
>KALACAFP_01415 hypothetical protein
MEPIKTLTTKVTIFLSLAFTMLSSLLVFAQDTTGGVVTKENSTKTTTTTEWYADPMYIIG
GAIILIIIIALIVRGGKKD
>KALACAFP_01416 hypothetical protein
MKRDLYIDFAKGLATLSIIFIHTAFWSGQFYIPAEVRVFSLVFDVALFYALSGITSGSNI
EKTFYRLLKLQITYMIFVTFLFFLDYFFKVLGLSFFSLEWLQRFYSTFGSKYTTVGISSV
PQWQNLGNWYLHQYTNADTFPVVMGSFWYLKVYFILTVFGVLILRFFPKHINWFIGICLA
LTLIFNIFPEIYPTGQVGYVAFYLSLFLIANKMRGKTIPAKIIPLLYGIVAAALIWMFWY
YGSEIFYKINKNKFPPKVPYIIWSLFSLVTLFVFYNRLKVTKENFVTYIGKNAIFFYFAQ
GISSSLVYFLVVPLKEKMSWWILMILIYIINIILAFIISGGLKKIDTLGWKILEFLRIKT
AAK
>KALACAFP_01417 hypothetical protein
MKVNFKFPLLAGALAVFSLSACNDDSMENPALPEQQTENAKIDQPNALEKVCYYVDQYWS
SSSVLTTSLQNSTDTNFMNSQMTKIASLWGRSNPTLRFVNDPSNFNSTYNAISYSTGKIY
YGYAIYYDAKSKGGDIVNAMILAHEYGHQLQYIFGLPSVSESTARPNELEADGFAGYYLR
RPNGYNQSSFAQIAAAYEFAQSIGDYQTTSPGHHGTPPQRRSAVRLGFLLGQYDLSASAF
DYNFFYYYQGVLNGTYKMGKNSQYPEIDAYMSQYIDELKKIQNGEISAEEFKQLK
>KALACAFP_01418 50S ribosomal protein L21
MFAIVEIAGLQYKVEQDQKLFVNRLSGDKGGKVSFDKVLLTVNGAITVGAPAVNGITVEA
EILDHVKADKVIVFKKKRRKGYKVKNGHRQSLTQIQITGITGFEGAPKKAAKKETAKAEI
LSDNETVNFGEDHELNYHLKKNGLSQSKENREALVALGKEVKAELGKDVLTHADVDAAIV
KNVENFKALNK
>KALACAFP_01419 50S ribosomal protein L27
MAHKKGVGSSKNGRESHSKRLGVKIFGGQEAIAGNILVRQRGTQHHPGENVGIGKDHTLF
ALVDGKVVFRKKANNRSFVSVEPNA
>KALACAFP_01420 hypothetical protein
MKNLKKIGRDELKNVMGGVAPEKGCLPCNIYCSIPEGERPPCNIVYIVAHCNGCKDYPSE
S
>KALACAFP_01421 hypothetical protein
MLEEIRMLINNSKYYPLFFLIFFVELVCAQNSAKGRIVDAKTNKEVSGVDVFINENNKPV
LTTTSGNFMVQSDSIIYKLKFLRKNYALETVDVTPENAPNIFVQLSQEKESNIQEVVIHN
EKPKYKNKKENPAYAIMQEVWKRKRNNGLDKFDTYTYKEYEKIQFDANNLDSAFMKKKIF
NKLEFIFEYKDSTAAGKIGLPIFLNEAIYENYGENRPSKKTKRLLIAQKTSGFQDNQIIT
LTAKNLYRDINIYDNTLNYFDIGFPSPVGETGFSTYDYNLLDTISVRGEQAYKIRYQPKR
TEVLAFQGYLYIDTDTYAVLGATLKSTQKINVNFINSISTELEYDNPDEKTFLPRKFVTE
IEMTPFSKKKTSKSIIAKRSVDYSEYDFNKPLEDKVFKRQEEEYDDKFVDKDDAFWTKAR
PDSLSKTEQGVYDMLDKLQQTPKFNRIVKLYETLGSGYYNVVKGIDLGPIFSIYGKNEVE
GDRIRLGARTYFTRNDPWRVQFYTAYGFKDHQVKYGAEGRFMFNRVNRFTVGAGTRRDIL
QLGVQLTNDDGIMARTFASSTIFARGENASLSSVNQTNIFTSIEPWKNFQIRVDGTMQSI
TSANPEGFNLMYYKDGQLRKTANDSHVTVSLIARPGAKFSQTGIDRYEHGTLAPTIVLKY
TRGIQGLFGSDFNYNKLQFMFYKPILIGSWGKTLINFEAGKNFDTVPLALQNVIPGNQSY
SLAANTFAQLNYYEFVADTYTTLHLEHHFNGKILSYIPLIKKLKLREVAFIRGAYGTLSD
ASKAINVEGFKYSAPSEHIYYEYGVGIENIGFGNLRIFRVDFNWRGNYLDRPDISKFGIK
AGFQVGF
>KALACAFP_01422 hypothetical protein
MKKILLSIALVPLAYSAQIGINTPTPTSTLDITAKDPTGTATTVDGVVIPRVDRLRAQNM
SAVPTSTLIYINDISTGTAAGTTIDVTSVGFYHFDGTKWVALITTPSNNDWRTTGNTGTS
PATNFIGTRDNQPLLFKTNNINSGFIGTAPNFSVAYGTGSLPYNAVPNLGNSAFGGSSLG
LTTTGTFNSAFGLSSLGANTSGNLNTAIGYQALLSNTIGVSNTAVGVSALRQNISGQNNT
AVGFQALQDTTGGFNTAFGRDALRTATTGIENIGIGYQAGFDSNAGGTNSQISTGSRNIL
LGMNTGLPNPAGNDQMNIGNIIFGTNVNGTLANPKGNIGLGTSNPTAKVEIASGTTGISG
LKFTNINNTTPTTANAAALGVDASGNVVIQNIAPLTTTFKSFSIDANSATNSLVTIGSLQ
FRYPLTTCTNTNTFVQVRSTTGVNNLGVQHAMFTTAQSGSGFVNTTPLTVTTTFADIAGI
PLNCVQDGHAQFNFFSYTDRTFYRVNVHVADGDSMGFGALGYIFVELQK
>KALACAFP_01424 hypothetical protein
MSSIIVRQAEPKDYPAIIDLQNANTPDQLTEEERKQGFVVSSMTEQTLDGINKNLGVLVA
VENDELAGFVCLATTNPAPVHPVVKAMYESFPNQIFNDKKLTDYRVFIYGPVLINSRWRG
KGILKKLFTAVKDFTEKEYDLGTAFINDKNPHSLAVHIEGLGMTALKPFNYKEETFQLVV
FPV
>KALACAFP_01426 Putative zinc metalloprotease
MELAIKIFQFILSISILVVLHELGHFLPAKWFKTRAEKFFLFFDPWFSIFSMKKINGKWQ
YKLFSKNLPDTEIIEVNGEKKEVAIDISKLPDSDWRKHPEKTKYGIGWLPFGGYVKIAGM
VDESMDTEQLKKPAQPWEFRSKPAWQRLIIMLGGVTVNFFLAWVIFSALVGKNGEHIFDA
DKITIPLHYTEAAKKMGFQDGDKILKVDGKTQKDFKKLALDVLLSDEITVERNGKEVTFP
TSDDGKAMAFQDPEPRSFLTPRMAPVVDTIVTKSTMDAGLKVGDKILAINGKPIQYYDQL
KPLVVPNAGKVTDFQVLRNNQVADLKIPVSKDGTIGILSFKEVQKYYVHNNYDFFGAIKR
GFTLTIESLTYQIKQFKLIFNKKVQGYKKVGGPIAIVKNMPVNKDAKGNVSIDWSAFWGF
TAMFSVWLAFLNLIPIPGLDGGHVLFTLYEMIVGKPVPQKVLENAQMVGVIFLLGLMLLI
FGSDIFKWITGSL
>KALACAFP_01427 hypothetical protein
MISVLFLMRIFFSNNIEKVKFMKKLVFMLMVIFFGATANAQAWTGKGDQKINAGLSAWGY
GTGITGTYDYGLNKLISVGAGLNAYFGNYKDNDDDNRVFVFGRLNFHLKDALQLPEKLDI
YPGIDVGVVGSDFGLGAHIGARYFFSERIGVFAEVGNNGSLGVSINL
>KALACAFP_01428 2-oxoglutaramate amidase
MKIAGLNLDIVWKNKTENFQLIEKELQNQEADLFLLPEMFSTGFCMDASEVADRNQESLE
FLKKMAKEKNAAFCGSASVEEDGKFYNRMYFIQPDSKVDFYDKRHLFSFSGEDKIYTPGR
ERIVVNYKGFRILLQVCYDLRFPVFARNNGDYDMILYVANWPEKRVGAWGHLLKARAIEN
LSFVFGLNRIGTDGNNLFYQESSHCFFADGKEISEKSGNIISAELNMEELKDFRNHFQFL
NDRDSFSIQL
>KALACAFP_01429 Thioredoxin 1
MSQKFQEIIDSERPVLIDFFATWCQPCKVQSSVLNTVKENVGEGARIIKVDVDQYPNLAA
QYGVRGVPTLAIFKNGEMLWKESGVHDVNTLTQLLKQYA
>KALACAFP_01430 Thiosulfate sulfurtransferase PspE
MKVYIFGIIIAATLVLNACTTAAVPEAPKADLREVVNSPDVTLVDVRVAEQYAEGTAKNA
INIPLAEIQNNAESLKGKKVVVFCNKGIQADEAVQILKKNGVEVYDGTSWKNVKAIQDEN
HQKNNNK
>KALACAFP_01431 Beta-lactamase hydrolase-like protein
MYIENNKTVTEEMKVEQIYTGCLAQGAYYIVSENEAAIIDPLREVKPYLDRLEKDNVTLK
YIFETHFHADFVSGHLDLSKKTGAPIVYGPTAQPEFEAIIAEDNQIFEIGKVKIKTLHTP
GHTMESTTYLLIDENGVETAIFTGDTLFLGDVGRPDLAQKATNLTQEDLAGILYDSLHTK
IMPLDDSITVYPAHGAGSACGKNMQKETVDILGNQKRTNYALNQPDKESFIKEVLDGLTA
PPKYFGMNVAMNKSGYESLDNVMNKGLTQISVEDFEAYAEETGALILDTRSAAEFHKGFI
PNSVNIGLKGDFAPWVGTLIVDVKHPLLLVVDEGTEEEAITRLSRVGFDHVLGYLKGGFE
AWKNANKEIDEVKRISPAEFAEQFTENSKVIDVRKLTEYSAEHIDNAYNKPLDTISDWVK
SIDDSEHFFLHCAGGYRSMIAASILNSHGIRNFTEIEGGFNGIKKTEKFPISDFVCQSKT
L
>KALACAFP_01432 hypothetical protein
MADKTQFINELNARYTPKGEHIILGKGMLDGEIVPEVNVTIPLKTINRHGLIAGATGTGK
TKTLQVFAEQLSHAGIPSLVLDIKGDFSGIAEAGTENAAIQERYAKTQLPYNPQAFPVEL
MTISGERGVKLRATVTEFGPVLLSKILQLNETQQSIMSIVFKYCDDKGLPLIDLNDLKKV
LQYVTENPQGKAELASDYGSIASASLGAILRSIVALEQQGAASFFGELSFDVHDLLETRD
GKGVVNILRVADIQSKPQLFSTFMLSLFAEIYMTFPEEGDSGKPKLVLFIDEAHLIFDES
SKALVSQIETMVKLIRSKGVGIYFITQIPGDVPEAVLSQLGLKIQHALRGFTAKDKKEIS
KAVENYPTTEFYDAPTLIQNLGIGEAFITALDEKGIPTPLVHTYLISPESRMDVLNDAEI
TELTNKSALVAKYEKLVDNDSAYEILVRRMEEAAQNVAPDQKSRPVKEEPGVFEQVLKSS
AGRTFTSTLMREGAKAILGMLGLGGGRRR
>KALACAFP_01433 putative ATP-dependent helicase DinG 
MYSIIDIESNGAGYRKECIIDIAIYRYDGQKIVDQFISLVNPESDITPFVQKLTSITPKM
VKTAPKFHEIARRIVEITQNTTLVGHNIDFDYRMLRQSFNRLGYDFKINTLDTIPLAKKL
IPDEVSYSLGKLVKSLGIPLTNHHRAEGDARATLELFKLLVSKDTENEIIQKQHEETNAK
TYINKIKVLTQDLPNEKGFVYFQDEEGKIIFSDHVQDINKFSKKVFNSKSKRWETIQQTV
EQINFELTGTDIIAKLILNSKGIKKREVLPFGLYHRNNKYIVEKNKLNKAEKPILKFKSF
TQGSKATQFFGKIEEYSDLTTFKKKIDFKKRNELWLGQGRKLGEKLFLIIENGKVTSYGF
YELFTQIQTLSKLSKLKIDLLFQSTDLNNELQLALLRGDFETLPLPK
>KALACAFP_01434 Diaminopimelate decarboxylase
MNSKELLQIANEFGTPVYVYDAESIKTQYEKLTSSFLKHTKFFYAAKALTNINILKYVKN
LGASLDCVSINEVKLGLKVGFPKEKILFTPNCVDLAEIEEAMQFGVHINIDNISILEQFG
NKFGNTYPIFVRINPHIFAGGNYKISTGHIDSKFGISIHQLRHIERVMKTTNLNVEGLHM
HTGSEIKDPEVFLQALDIMLELSEHFPNLKYLDMGSGFKIPYQDTEEETDVKTLGKKVEK
VISEFSKSTGKKFELWFEPGKFLVGKSGYLLVKANVIKQTTATVFVGVNSGFNHLIRPMF
YDSYHVIENLSNPKGAERIYTVVGNICETDTFAWDRKLNEVREGDILAFHNAGAYGFEMS
SNFNSRLKPAEVLFLDGKAHLIRKRDEFEDLLRNQIEVL
>KALACAFP_01435 hypothetical protein
MKTLALFIGLFVSNFAFAQFDVEERDDNMITENNKNILKIDIKEPLLQVAVKNCNDFKAA
SFEGGIPVYKETLRKYMYDYLNTEFYILNGDFTFTLTIDQTGKVTNIEGSPKVANSEVFF
DDMKYVVRRIKKNWTPAMCNGQPVTSQVKIKMNLSSIATDV
>KALACAFP_01436 hypothetical protein
MCRNDFLLTMKKYFLILFLLLLSGKAFSQETAVQSQETGNNYQKAEFPGGDEAFQQEFMN
MVYSYIDMALYAIQGQVTFIFNIDTKGKINKIDVLPKFKNNEMFIDDMKYAAKKVKGKWS
PATRNGIPVDSKFVMKVNFKHNTYDHD
>KALACAFP_01437 tRNA-2-methylthio-N(6)-dimethylallyladenosine synthase
MQEKYIDETKQGEAFAIAEKAGNSKKLFLESYGCQMNFSDSEIVASILNEQGYNTTLKVE
EADLILLNTCSIREKAEQTVRMRLSQFKNLKKEKPNMTVGVLGCMAERLKTKFLEEEQLV
DLVVGPDAYRDLPNLLKETEDGRDAINVILSKEETYADINPVRLGGNGVTAFVTITRGCD
NMCTFCVVPFTRGRERSRDPHSILEECKSLWENGYKEITLLGQNVDSYLWYGGGPKKDFA
KASEMQKATAVNFAQLLDLVAKAVPEMRIRFSTSNPQDMSLDVFKMMAKHDNICKYVHLP
VQSGSNNMLEAMNRQHTREEYLELIRKAKEIVPEVAFSQDMIVGFCNESEEDHQDTLSLM
KEVEYDYGYMFAYSERPGTPAHKKMEDNIPADVKQRRLAEVIALQGELSRKRMKSYVGKT
HKILIEGISKKNKNQWKGRNSQNAVCVFDMLEGQKIGDIVDVFVFDNTQGTLLGETVKN
>KALACAFP_01438 hypothetical protein
MEKFHKYCLSVLLVIICSNISAQISNGSVDSEDCKQLYELYNQFLNQNCERPQEFCVKQN
LGYHFAIHDKQNAIDVFGKPSGKPQFNSFNNKTGAGFSEKEKHNQLLQNFEKNSKENLFA
DILYFKTKVSKVRNKDYLEVIG
>KALACAFP_01439 Transcriptional regulatory protein ZraR
MSTELQNIKNRFGIIGNFPALNRALEKAIQVAPTDISVLVIGESGVGKEFIPKIIHSESK
RKHQPYIVVNCGAIPEGTIDSELFGHEKGAFTGATATRKGYFEVADGGTIFLDEVGELPL
QTQVRLLRVLESGEFMKVGSSQVQKTNVRIVAATNVNMMKAIQDGRFREDLYYRLNTVQI
DMPPLRERKGDIHLLFRKFAIDFAEKYRMPELELEPGAVHYIENYTFPGNIRQLRNLVEQ
MTVVERNRHVSVEKLAEYIPMETHLPMVVNTPNSQKQSDFSSEREIMYKILFDMRNDIND
LKSLTSELIKNRGTSDLSNHEKNLINRIYTPETQQNVAPNSLLYFENSSNNDAPVIQNPT
IISSPEESYEDIEDIEIEENRPESLSLQNNEKDLIIKALEKHKGRRNKAADELGISQRTL
YRKIKQYNLEE
>KALACAFP_01440 hypothetical protein
MMKISAKPINFKFNDYLSNGYEFLKNNFGNLFVAFLLCIVMSIIPFCSFLAIGNFYKYCR
NLKAGRQASPGDIFNFDDFMAYFVLQLILIGAVLLLCFPMMIFMPVAAMANGGEPSAGLP
IFVVIYMIAMYIVILIVSLKAFYMIGLISLGGVRDIKTAWQMSSTMSKGNLLSIFLFSLV
VSILGQLGILACGIGLFLTLPFVHTSHYFAYEDALQQVGNDEIKEIGSKNEF
>KALACAFP_01441 hypothetical protein
MNFKVKNIKIKQPKFSWLLLLCLGVLHSCYSFTGSSLTDEKTVQINEFPNNAALVNPTLS
QQFSTDIQNRFLQRTTLKGTKENPDILIEGEITDYSITPTTISSTTVPTNSGGTIQESQN
KLTITVKVHYENKLHPDSSFDRTYSDEAVFNSNLSQSEIESSQVKIATDRIINKIFNDIV
ANW
>KALACAFP_01442 hypothetical protein
MNHRVLELLKAPKNIQSEDLDLLKEEINSFPYIQNIRALYLYGVHLHDKENYQKVLSTTA
AYTTDKKILYQLINGKIQQKPKPEIQPELAKEKIIPTENPLKVLYQSKATGFPIKREEPQ
HTEIQPEIVEEPKAQTADPKEESRIHPDPKPEIKHLYVKGERNRILFEGEEDFLDDDTVE
TIDLESTLESGSIVTQKAEIKQENIQPEEISAEIASKDEAEEIEEFTPETIIEEEKIASE
AEKEEILDESQLSFHETASFMAENQIDEVEEEKVEVKADNIIKAEETADFTPEKIINEDK
ISSEEEEKSVRDDEELSFHGMESFLPEVKINANAEEAKTEIPKTSINKHEDEMRRLIEEV
EKKMKEKAASQEIKKEEESEDIGHDISFAETQSFEVKPIEPEAENRVETVQPEVVEEPQK
EIIAEKKETPKEETPTEAKSTWKPMSFESNLPDSLLNKSAETPQPKAEPVVPKTEIVEKE
TEKKEAPKQEEILPEVEEIPEFTKDKSEKFEELTEELQIDKEAPIIEETSEKQEVPVMNV
SFFGSDIAKWMTPEPAKEEQTEPEENVNTTEEIPAKPEAVQPTPSDSNIPGFINTWQSWL
KIDRTPENEKEKLEVKSKVIETFIENNPKISQLKEESSFVVREKGDDISHLMTETLANLY
FEQKLYTKAIKAFETLIRKTPEKKAYYETRIQEIKDFRTKG
>KALACAFP_01443 hypothetical protein
MNILVITPFEIIFAAIAVIVLYISAITVLFKTKSGILPYLALILFPVIGPLGIIFGNQLN
KTK
>KALACAFP_01444 hypothetical protein
MLDNVPYLPYVISAFIGIGLAAATGFRVFLPMFAVSLASYLHWIPMNEHFEWLAGLPTLI
TTGIATIVEILAYYIPFVDHLLDTVSVPMATVAGSVLFASQFADLGTFPQWALALIAGGG
TAATISSGFAGIRAASTATTGGLGNSVVGTTETAGAGIMSVLAMAAPIIAGICAIALVIV
VIFVGRKAWRKLRRNKDVIDHT
>KALACAFP_01445 Ribonuclease P protein component
MTNFKYPKAEKLKKNAEITLLFEKGKWKTNGNLRIIILKNKPTVPIESTKFAVSVSKKYF
KRAVHRNRIKRLLRECYRLNKDLFKETFGDKTMAMLFWVSPEMPEKFQDVQEQFIKLCQA
QKKP
>KALACAFP_01446 tRNA threonylcarbamoyladenosine dehydratase
MDKYWLERTELLIKEKGLEKLNKATVLVVGLGGVGSFAAEFLARAGVGNMTIVDGDTVDI
TNINRQLPALHSTVGMHKVEVVAERLLDINPKLNLTKINEFLNPERMHQILDEGKFDYIL
DCIDSVTPKLTLLIAARRRKIKVVSSMGAGGKSDPSKVMVRDLSKTHNCYLAKQVRKRLK
KEKINKGIRCVFSNELQNEDSLKMTDGTNYKRSFYGTISFIPAIFGLYAAAEVINHLIKK
D
>KALACAFP_01447 D-aminoacyl-tRNA deacylase
MEFFDFHHHKKNISCGIYNLDWKGIPADSPYSIGIHPKDIEVNDLENQFNWLESNITENC
FAIGECGLDSFVEIDQKIQGDVFLRQITISNEVKKPVIIHCVRKFYEVISFKKFAKQPMI
IHGFNKKQSIAEDLLKNNFYLSFGNAVLYNLSLQNTLKITPLDKIFLETDNEDFNIEELY
RKVSEIKEISLENLNKQILENLETIKNG
>KALACAFP_01448 putative HTH-type transcriptional regulator YttP
MKKKFTEKQIHILDIAEELIAKKGYEGTSVRDICSKANINVAMISYYFGSKEKMMSYLYQ
YRVLKTRENFSEFADTIKDGKPEMQMKEIIKYIVAQLFKYNYFHGFVTQELRHTDNLKDE
LLDFYQLFVKKLDEVIKKGVASGVFTFTPKPEDILTTIIGSTLFVIRNRNFYELYVPNKS
EETYSKEAEKKVRMNLLMSVFAILGYAAD
>KALACAFP_01449 Outer membrane protein assembly factor BamD
MKKYILGLFAVSVVASCVSQQEKAMKSADKNFILKAANENFAKKKWKNALALYDRLPNLV
AGTDDAPNVVFNSAYANYYDKNYKLAGHQFKNFSISFPQDSRKEEAAYMSALCYYEGSMD
YNLDQSSTELAINELQDFLNNYPNSERSKNINTLIEELSYKLEFKSYENARQYFSMGDYK
AANVALENVLEDFPSTKLRPKIYDYIVKSRYELATKSVYDLKDERIENALAFTRQIEKEM
PNTDVAKTALDIREKLEKEKKDFVVVKKQTEARIAALTERQKKLEAKNAEKTKTEQQMKD
QVDAEKKAMQIQRDSAALQTPPPAATFKIQR
>KALACAFP_01450 hypothetical protein
MSVKDTKAEVNTITYDKDKIEDKVGSIYEAIVIMGKRAEQINAEIRTELHNKLDEFAVHN
STLEEVFENREQIEISKHYEKLPKPTSIAIEEWLNEDIYFRKTEERK
>KALACAFP_01451 Coenzyme A biosynthesis bifunctional protein CoaBC
MSLSGKKILIAISGGIAAFKIHFLIRDFVKKGAEVQVIMTPDAEHFVTKLSISTLSKNPV
YTDFYGDNGSWNSHVEMALWADVMVVAPCTANTLAKMVHGICDNLLIATYMSAKCPVFIA
PAMDLDMYAHPSTIKNLELAESYGHIIIPAENGELASGLIGQGRLAEPETIAKAVEDFFD
ANRTKTLEGKTVLITAGPTYEAIDPVRFIGNHSSGKMGFSLAEEAAKRGAKVILISGPSS
QSINNKNVDVHKVTSAKEMLAKVFEFYDKIDIGIASAAVADYAPKDVAKEKIKKDDDNLT
IELVKNPDILRTMGEKKTHQFLVGFALETQNEEENAKGKLAKKNLDMIVLNSLRDEGAGF
KNDTNKIKIFTPTEKKEFDLKSKDDVAKDILDFVEAQLLK
>KALACAFP_01452 hypothetical protein
MKKILSIFLLLFLFNLNFSQELLATVQVNSQQIGGTNQSAYKALEKSLRDFINNTSWTGK
KLQNFEKIKSNFAIVITEREGNRFRGNIVVQAVRPVFNTTYESPLINLQDTRFSFDYVEN
ENLIFNERQFSGKNLIDVISFYIYIILGYDADSFQSMGGTQWFQKAQQIAQNGESQNTYE
GWKLIKEPRGRSVLIKEIMSPNWSQVRATMYTYHRAGLDNLFNQDQAAAKKVIFDALMQL
KMYENTFQQSYYFNLFLDNKSDEIFNIFNSGNNGGIALADLKNEMTILAPKYTEEKWSKW
KQ
>KALACAFP_01453 DNA repair protein RecN
MLSRIYIKNFALIDTLEVSLHNGLQVITGETGAGKSIILGALRLILGERADVKSISNAEE
KSIVETEFALNNQFKKFFIENDLDYELQTIIRREILPSGKSRAFINDVPVTLDILKELSS
QLIDIHSQFETSNLFTSEYQFKIIDGLSGNKQIIEEYQKEFSDFQSLKIQLKKYQTQLSE
TNKESDYKEFLLNELEELKLDDVDYEDLQNQLSIQENAEMISENLVQVLSRFHQEEVGIL
SFFNEAKNKLSKIAEVSNGFAELDGRLETSFVELKDIISELENEAEKIEINPENLAILSE
LNNKINALFLKHNVVGITELKEIRDQLAGEQKGASELEALIAGIEESISKKEKTLQTLAE
KLSKNRKKNIPVFIKKAEELLKKLGLEKAKVDIELQDSPDFNQFGKENIQLLFQANSGFP
LRPIQTAISGGERSRVMLAVKKIIAESDDLPTLILDEIDTGVSGKVAEEIGNLMREMSAD
MQLIVISHLAQVAAKGNNNYKVVKQDVAGKTQSTIVPLSDDEKLNEIAQLLSGSKITEAA
LAQAKELIG
>KALACAFP_01454 hypothetical protein
MFFKFLRLEFKSFFRGSSLGINLAMKILRFIGILYFMACFAGAAFLIFFLTQEKMQQNPV
KIVSRFLIAAWAVDLIIKYLWQELPTQNIKPFLTLNISKKTLVNYMLTKTFLSVFSWLNS
LFFITFCGIALFYGYSFTGILGWFVGVSLLFYLNNFINIIFNDKETVAIVIGCIITAVAG
LTYYNIVPVLDYSERFFFNFYERPYLTVIPIILFFGLWKICFHHIHKVFYLDQGLEAKKA
VGKTENIAFLNKYGAIGTFINNDIKMLKRNKVTKGILLGSFMFLFYGLLMFTSSIYKTPA
MMMFMGLFVTGGFQFMFGQRVPAFDSSYYPLMMTLNVPYKEYLKAKWWLMNIVTAASIVV
ALCYAYFGWNVYLTFFAAGLYNIGVNSQFTLWSGAFNKTQIDLNAKEKRFGQKNSFNIKA
LLLLIPKMFLPMAVFAIVQRFFGIEAGVASVAVMGLIGFLLREKIFDTIVKHYKVEKYST
LEAFKNKD
>KALACAFP_01455 Choline transport ATP-binding protein OpuBA
MITINNLSKTYGKATVLNIEHLEIPNGETFGLVGNNGAGKTTLFSLMLDLIQATTGFVSI
DGIKVSESEAWKNKVSAFVDDSFLIGYLTPEEYFYFIGELRGQNKASVDEFLKQFHDLFN
GEILNSGKYVRDLSKGNQKKVGIVGAIIGNPEIIILDEPFANLDPSTQIKLKNLIKELSK
QDGVTFLISSHDLSHTTEVCNRIVVVNKGLLVKDIQTNPETLKDLEQYFADQISSPLEAV
EVSDLK
>KALACAFP_01456 putative deferrochelatase/peroxidase YfeX
MKIESQNVTDYPNSNTIFMVWRLVDDPKLKEIFQQLSALVLNLNNSVFNRFPDSRASCVM
GIGHNAWKILELPTPLPKELVNFEEIRGDKHTAVSTPGDLHFHLRADDKSIIFDMAIEIS
KLLTPVAESILEIHGFKYWDDRSILGFVDGTENPHNEDRDFFAKIGDEDLQYKGGSYLFT
QKYLHNINAWRSLSVEEQEKVIGRSKENDIEMSDDVKPSNSHIALANIEGENGEELKIVR
DNMPFGSPSMGEFGTYFISYASTFSTTKKMLTNMFIGDPPGNHDRILDFSTAVTGTLFFI
PTKNMLDDFSG
>KALACAFP_01457 Fumarate hydratase class II
MNYRIEKDTMGEVQVPADKFWGAQTERSRNNFKIGPEGSMPHEIIEAFAYLKKAAAFTNT
DLGVLPAEKRDMIATVCDEILEGKLNEQFPLVIWQTGSGTQSNMNVNEVISNRAHVNNGG
TLGDKSEIHPNDDVNKSQSSNDTYPTAMHIAAYKKVVEVTIPAVEKLKNTLAEKSAAFKD
IVKIGRTHLMDATPLTLGQEFSGYVAQLEFGLRALKNTLPHLSELALGGTAVGTGLNTPQ
GYDVKVAEYIAKFTNLPFVTAENKFEALAAHDAIVESHGALKQLAVSLYKIAQDIRLLAS
GPRSGIGEIHIPENEPGSSIMPGKVNPTQNEAMTMVCAQVLGNDTTISFAGTQGNYELNV
FKPVMAYNFLQSAQLIADACISFNDHCAVGIEPNHERIKELVDKSLMLVTALNTHIGYEN
AAKIAKTAHKNGTTLKEEAVNLGLLTAEQFDEWVKPEDMVGSLK
>KALACAFP_01458 Fumarate hydratase class I, aerobic
MEFRYQDPYPIQKDDTVYKKLTSDYVKVEKLGDREILTVDPKGLELLAEEAMADVSFMLR
SSHLESLRRIIDDPEATDNDRFVAYNLLQNAAVAAEGALPSCQDTGTAIVMGKKGENVYT
GVDDGEYLSKGIFNTYQKRNLRYSQVVPLTMFDEKNSGSNLPAQIDIYAKKGDYYEFLFL
TKGGGSANKTFLYQKTKSLLNEKSLEEFIKEKISDLGTAACPPYHLALVIGGTSAEANLA
AVKKASAKYYDNLPTEGNEAGQAFRDLEWEAKVQKICQESAIGAQFGGKYLTHDVRVIRL
PRHAASCPVGMGVSCSADRNIKGKITKEGIFLEQLEQDPKRFLPATPPHLEEAVEIDLNK
PMQEILAELSKYPIKTRLKLNGTLIVARDIAHAKIKEIIDSGKPMPEYFKNHPIYYAGPA
KTPEGMASGSFGPTTAGRMDVYVDEFQSHGGSMIMLAKGNRSKDVTNACNKYGGFYLGSI
GGPAAILAKDNIVSVDVVDFPELGMEAVRKIEVKDFPAFIITDDKGNDFFANLAH
>KALACAFP_01459 hypothetical protein
MIMILSAFWPFYQFLWTIFFFTMFLVGFWCIFMFFGFVIPLWLTEGLKEYFGKVKPFDPE
DIRRKMIYEQEGVEVIFSEPKGNGPFLHDSHGHHH
>KALACAFP_01460 Virulence regulon transcriptional activator VirF
MKNQPDRKILFRSDDIEICLQEDLYPEKFSRSMMIEGKSSFNLLFLLSQNIHLEAQDCGT
RFSFKKNQYILHYSPQESTAELWTENLETLHYLQIQINYDYIFHLINPESNKENADILEN
MIKNNYIFLHKQTPPYMTVEMHMIVKEIVSYSKKGVMQKLFIEAKIIKLLILIFEQFNEK
NTVEESPEIPSMIKKFVDENYHENIKVEEIGKRIGINQNKIRKEFKAQYNITVSDYIAEL
RMLKAKKMIINKKIMIKEIAIECGYEYVQNFTRAFKKKFGISPEKLRNG
>KALACAFP_01461 hypothetical protein
MFGKLHIAVRKMSVGLGVLAIAVSYAYAQQWEDVGGVATISAGGSSYNNLVINNGKYYVS
YYDTSVAKGSVQMFDGASWSYVGGSAGITNGTATFNSLSLDGVGNLYYTNQGTGLEVRQF
NGNSWTQLPSPTTSTINYQASAVSASNVLFTYSTHNSGTVQRYVNGTWEQVGNTGFSNGA
AFAEMVIGTNNKVYTCNTSSGVKVYENTTTATASDNWTLVGGSIVDASSSGEQYTSDIAI
DANNNLYVAYVSNVANGQKLNVKKFDGTNWIQLGNSNFSSGKVQHVAIAVTSTGTPYVIA
SRWENDDYLRNTAYRLDNASQTWTTFGGNFISDGQATFNDLAIDKANNYLAAAYSQNGTK
VKRISLTPACNNTDPGTNTGDLGCVTFNYRGQSVTYTTVRGADGKVWFQQNLGSTKVASS
FDDVDSFGDLFQWGRWDDGHQLRNSATATTPSTNSPDGLSGISAFIIGSGSGSWWATNAT
SDAWNADSAAAISQAIGADPCKAIGSGWKMPSQADWTGLVSAEGIANPATAYSSYLKLPA
GGNRSNTTGSFSYVGQRGYYWSSDTANTGGKYLYIGTTIANPSSGAPRGQGESVRCVKDF
TGLATSDVNSKMNSIGIYPNPTNGILNIKTDSSIENVNVINAVGQKINVQFSNHQINIQG
LPNGMYIVELTLKNGQSFSKKVVKN
>KALACAFP_01462 Organic hydroperoxide resistance protein OhrA
MENNQTLQAKKVLYTGKTHTTGGRDGFSKSSDDNLNVKLSTPGGTEPGTNPEQLFAAGWS
ACFIGALGIAARKRKIRLSSETAVDAEVDLCMEDDAYFLQARLNVSLPGIDNETAKLLTE
EAHQTCPYSKMSRGNIHVEINII
>KALACAFP_01463 Epoxide hydrolase B
MLYNSTPQQIFIIKKYLISAILVLIFSFGLNAQQTKGSLGTLKQIDAGVLNIGYTEAGSS
DGTPVILLHGWPYDIHSYEEVVPMLTAKGYRVITPYLRGFGTTRFLSDKTMRNGQQSAVA
SDIIALMDALKIDKAIVGGFDWGARTADVMAALWPERVKGLVSVSGYLITNLEANKKPLP
PAAELGWWYQYYFSTERGEKGYKDNTYDFNKLIWKIASPLWNFDKATYDQTAQSFNNPDH
VAIVIHNYRWRLSLAKGETKYDALEKKLFTRPVITVPSITISSDFDGAAIDGKAYADRFT
GKYSHKILKGIGHNVPQEDPKSFADAIVEVDGYSK
>KALACAFP_01464 Malto-oligosyltrehalose trehalohydrolase
MKKFYSGVLVFIVALFFGQISYTITPNPFNETDAITLTVPGNQIDESAWGVSNNAIYIWS
WSLDTNYQNSQDCPTNGSWNNSNELNKLNYNSVTDTYSLSFTPTTFYGRTGIGRFGFLLK
DKTGSHQTSPDIFVNVGILNLTMTNPAANSLTSVPTGNSINITATTNVNATFQLKANGTV
VNSTSTATTSYSYNYTVTGDANMELIATDTNSNSKNATFILQVPRNVISEAIPNWIRQGI
NYHPTDNTKVGLALYAPTKDFVHVIGSFNNWAVDDAYLMKRDTTNPDLYWIELSGLTPQQ
LYTFQYRTNDLRKVADPYSPQILSSYDDQWISPATYPNLPAFPAGQGFEVSLFKTGQTPY
NWQMTNFTRPAKENLVVYELLLRDFTQEKNWQSLINKINYLKGLNINAIELMPIMEFEGN
LSWGYNTSFHYALDKAYGTPEKFKEFVDLCHQNGIAVILDVAFNHATGRSPLVRLWNVDP
DGDGYGNVAANNPYFNTVPKHSYNVFNDFNHTSSSTKYYVERCLQQWLTEYHIDGFRWDL
TKGFTQSCSENDETCTNAYQQDRVDIMKYYADKQWAIDPNSYMIFEHLGTDQEEQQWANY
RIAEGKGVMLWNKQTDPYNQNTMGYKENSNYDRMNHALHGFTNMHAVGYGESHDEERLMF
KNLAYGAVNGSYDVKNLNTALERMKTFGATFFTIPGPKMIWQFGELGYEFSINRCADGSI
NSGCRTDEKPIAFTLGYDTNANRKAVYDTWAKIINIRNTYPVFKSKTYSVESNNLANDPD
GLITRIYVYDNTLTNGVKNIVVLANYTTASQNVVPYFPYTGQWQNLKDNSISNITSTTAP
ITLLPGEFRIFGNYVGSLSTIDENVENKLSLQIADNPVKNGLARLIYHKAKNGEITIYDM
SGKKMDSFKLKNEDGTYELKTNYQTGTYLVHLKSETGVAIQKMIVK
>KALACAFP_01465 Ferric enterobactin receptor
MKKLSISILLLGAVFASAQEKEKEQQIEDVIIVGNRNAKRTKVETPVPVDVINIEKIQKS
SPQITVQDLLNYVIPSFNSVRQSASDGTEHIDPVTLRGMGPDQVLVLVNGKRRHTTSLVN
YQNTVGNGSVGTDLSTIPVIAIDRIEVLRDGAAAQYGSDAIAGVINIILKKDIGGSASLN
YGITGRNDGETYQAGVNYGASLGKKGSYINLSLQLNQRGKTIRTQNHNLDIFGSNFAYDF
AADPAAARAADDAIIKERGLTRDDFNFQIGDAQIKQAQLFFNSEYSFNDHLKFYSFGGFS
IKEGEGFGFRRLPSETSNVVAELYPNGFQPVLGSKVYDLSYAIGLKYNKNDWFFDLSNTF
GNNIFNYNVSNTNNASLGIKSPTSFYAGAHSFLQNTINLDVSKNIKNFNVAFGGEFRFEQ
YEIKAGDEASYARYDIYGNLVTASTPSGDIIGAGGSQSFIGFSPKNALSKSRNSTAVYAD
VSYDLDKKLNIDLAGRFENYSDFGSTLNGKLAVRYEFVKNYAIRAAVGTGFRAPSLQQQY
FNNSYADISTTGDGIVTKGIFTNYSKAAEVLGFDKLKQETSVNGSVGFTLKPARGLFITL
DGYWIGVKDRIVITSNITDSRLQDPNIVGAGNEVESARFFTNAVDTETKGVDLVVSYDWK
VGGGNLNINLAGNYTETKITDFHFPANLQTPQNEFFGPDQVNIIETLSPKTKATLGLNYG
MGKFNFLVRNTYFGKVTRDGYPFGGVQEFTPKVVTDVSVGYNFTKNINLTAGANNVFDVF
PDLQIYENSYFGVFKYAPVQMGTLGNYFFGRLNFTF
>KALACAFP_01466 Serine/threonine exchanger SteT
MSTTTSHQIGWKTAVAIVVSNMIGTGIFTTLGFQLVDVTNTYSIFLLWIIGGILALFGAF
CYAELGSHFKGNGGDFIYLKETYHPLLGYLVSWISLIIGFSSPVALAALAMSKYLSAFNY
SFGNGFAIGMIFLVAIFLSFSLKASSRFHNFFTVIKIVFIIVLIILGVGLSEPEIGNSLN
FDNSWQNEIMLPAFATSLVFVTYSYTGWNSASYIAGEIEDVQKNLPKSLIVGTVFVTVCY
LFVNFIMLKHAPLHQLAGKEDVMGEAANNMLGHTFGKVVNIFIALQLVATISGYLWVGSR
LTQAFAKENKLWKTLSASNNKRIPVRAIFAHAVIASLIILTGSFKEIFVYTSFILQLFAS
LAISTAYFIKKDQRKIFKSNLFYIFPTVFLLFSVYILYFTLVHNPKESIIGLGIVAVGIV
LYWIDRKITRSQIDS
>KALACAFP_01467 Peptide chain release factor 1
MSKSLIPKLEAIKQRYNEVADLIIQPDVISDQKRYSSLNKEYSDLGKIVKVYDQYKGALD
SIEESDEIIADGSDRDLVDLAKEEKLEAQARIPGLEEELKVLLIPKDPADDKNVIVELRA
GTGGDEAAIFVEDIYRMYSMYFKTKGWKHEVTDSNEAAKGYKELIMKVEGEGVYGIMKFE
SGVHRVQRVPETESQGRVHTSAITIAVLPEAEEVDVEINPADIEMQTSRSGGAGGQNVNK
VETKVQLTHKPSGIVVVCQQARSQLANRELAMEMLRAKLYDIKLQEVQGDIAAQRKTMVS
TGDRSAKIKTYNYPQGRVTDHRINKSMYNLDAYMNGDISEMIDAVIMAENAEKMKGEEES
L
>KALACAFP_01468 hypothetical protein
MKIFKAILVAMMILCIQNLKSQNILKPETVFSLYFNSFVKYDDDSVKELNSYLINFLGKD
NTYRMNLRDAYNERVEYFTKIFLSNLPPDVASECKKEAQDYFNVLVNNFKEGKYIIKSVK
SVHNKYGQNEDLSEVVYEASFKVPSDISGFEMGNIKTIDAGTIKKYLTDLTDHFKNSDKT
ISVEHTFNLYEVKYGRDTYYWNGGPQELAWKLNEFYFKNIN
>KALACAFP_01469 Prolyl endopeptidase
MNFKPILLTAGVLFSATLYSQKMMYPKALKGSQKDTYFGTAVADPFRDLEKDSDATKKWV
DEEVAYSQNYLSQIPFREDIKKQLTNIWNYEKISAPFKEGDYTYFYKNDGLQAQSVLYRT
DNKTKVTEVFLDPNKFSAKGTTSLSQLSFNKKGNLAAYSISEGGSDWNKIIIIDAISKKQ
IDETLIDVKFSGIAWQGDEGFYYSSYDKPKEGTVLSGMTDKHKVYFHKLGTKQSEDQLIF
GGEKTPRRYLGADVSEDQRYLIISAANATNGNELYIKDLKNGGDFVQINKGFDINANVVD
TQGDDIFIYTDKDAPNGRLVKTTIKNPAPETWKDVIPQTENVLGITTGGGYFFATYMIDA
IDKVKQYDKNGKLVREISLPGKGNVSGFGGKEKEKELYFSFTNYITPGTTYKFNADTGKS
EVYQKPKVMFNPDDYVSEQVFYTSNDGTKIPMMINYKKGTKLDGKNPTILYSYGGFNISL
QPAFSVVNAIWMENGGIYAVPNIRGGGEYGKKWHDAGTKQQKKNVFNDFIAAGEYLQTKG
YTSKEYMALSGRSNGGLLVGATMTMRPDLAKVAFPGVGVLDMLRYNKFTAGAGWSYDYGT
AEDSKEMFEYLKSYSPVHNVKAGTCYPSTMIITSDHDDRVVPAHSFKFGAELQEKQACDN
PILLRIEKNAGHGAGRSTEQVISENADLISFALYEMGIRKLGK
>KALACAFP_01470 Methylmalonyl-CoA mutase large subunit
MRREVQNKTPQFNIIEKHTEVYPFEKDGLQLKSSYKAEDVKNQELTHTAPGIAPYLRGPY
STMYVQKPWTIRQYAGFSTAEESNAFYRRNLAAGQKGLSVAFDLATHRGYDSDHARVVGD
VGKAGVAIDSVEDMKILFNEIPLDQISVSMTMNGAVLPILSFYIVAAEEQGVKQELLSGT
IQNDILKEFMVRNTYIYPPAPSMKIIADIFEYTSQNIPKFNSISISGYHMQEAGATPVLE
MAYTLADGLEYVRTGIKAGMNVDDFAPRLSFFWAIGMNHFMEIAKMRAARYIWAELLKQF
NPQNPKSLALRTHSQTSGWSLTEQEPFNNITRTAIEALSSALGGTQSLHTNALDEAIALP
TDYSAKIARNTQIILQQESGICDVVDPMGGSNLVESLTQQMIEEAMKYIDEVEQEGGMTK
AIEAGIPKMRIEEAAARKQAKIDSGEEFIIGVNSFRSSLKQEAIEILDIDNTEVRRKQIE
RLESIKKNRNSEAVEQILNEIRESAKTGKGNLLALCIEAARRRVTLGEMSDAMEESFGRY
KANIKTISGVYAMNAGKNEYFEKALNLTQKFEEEEGRRPRLMVAKMGQDGHDRGAKVVAT
AFADMGFDVDVAPLFQTPEEVAKQAVENDIHILGVSSLAAGHKTLVPQVVEELKKLGADD
ITIVVGGVIPQQDYEFLYANGADFIFGPGTNLPKCAVDILEKFLN
>KALACAFP_01471 hypothetical protein
MAYTVVSVFPVTVDTEEIKKDLKDKGFDEANIIISKSKVESGLDDYQEDEQTKSFFDYVF
AHDAEMLDAYRKHSIGRNNVVVYADNLEHARLAKTVLNEKGALEVYRRPSDHQDITEGMT
EEEYNGIIAKAKHNIYFLGSERVYHPNVVKGMDDPMDDLGSKD
>KALACAFP_01472 RNA-splicing ligase RtcB
MGNLKLKGKDILKIGYPNNQSVNIALEVMKRNFATKNIHHVKSLLKEILLNPENYEKDLT
FGQIAEALLSSKKTEKRMLNTNRASFQIFGNNISDEAKNQLYTALKLPISTQGALMPDAH
SGYGLPIGGVLAVENAVIPYGVGMDIGCRMSLSILDTPVSYLDGARDKYEKALAEHTKFG
MYETHKSHIEHEIFDRDTFDMIPILRRLKGKAIKQMGTSGGGNHFVEFGEVEITEEDDQI
GLPKGKYLGILSHSGSRGLGAEIAQYYSRVAAEQCPLPKEAQNFAWLDLNTHLGLEYWTA
MNLAGDYASACHDDIHRRLVKAVGGRVKARIENHHNFAWKEIHNGKEVIVHRKGATPANE
NELGMIPGSMTAKGFIVRGKGNPDSLNSASHGAGRAHSRGECRSLFTQNDIKKELKLKNV
TLMGGNTEEAPMAYKDINEVMNAQSELVDILGTFQPRIVRMDK
>KALACAFP_01473 hypothetical protein
MGAPHNIKRYGEVWPEFRIQHGLKILEKLKNKVILSGGWAWHFMSETGHTEYKHAHDHKD
IDVFVKKENVAEVVMILQQEGFQKVWTRYDHLPSEENFRRYEKTIELENGKFHRITIDFF
ERNDLETVATNGFIVVKPDVLLSFYRNIHSSDKCWAVMAAKDLLERGIDPVGHPRLSEMP
K
>KALACAFP_01474 Peptide chain release factor RF2
MEKLIQITSGRGPLECQWVVAKVLKVFLEEAKDNKIDYEIIHRENGDENLTLKSATLLLK
SKNVNEFLQTWLGSICWTGKSTFRKLHKRSNWFIGIFELEGLEKINFNEKDIQFQTTRSQ
GSGGQNVNKVNTAVRATHIPTGQSVFVQDSRSQLENKKLSVTRLKEKVLEQNIIQLQKRM
QETWNNHLQVQRGNPVRTFSGTDFKKNYQEKSFKKQRNQLKNELKNYKNDLN
>KALACAFP_01475 hypothetical protein
MTLTKNKYYFEALDNYPYSLPACLEALNYALSYDPEDADSLCLMGRIYSEMLTDYERAKL
YFEEAMQCNMSNLNTPQYFIKCLLDNEDLDEAEKLIEYSLKIKGIDKCRILIHQSLLFEI
KFEYDKALKPLQEAKKFAYGQSMLDFLSSREKFIKAKMPKKPKKKQIKKKKETK
>KALACAFP_01476 L-Ala-D/L-Glu epimerase
MELRFELKHLQLKETFSIAYGNYNKREALLIELSHQNSKGYGECVAIDYYKIDLQYFVLK
LKEIKGKIEAQKIIHPKEFFHFLLSLDLHPFLLSALDCAYWDLFGKLENKSFIELNQLPS
DNLVESSITISVGDIDKQIQKIEKSSWNKFKVKCKGLDTNTVEKLLELNKNIALDSNASF
TDEDCLWLQENINVQKFTYLEQPRPIDNYKILKKESFANWMADEDCQNLDSLDELIPYYK
SINIKLMKCGGLTPALEMIKKARELNYKIMIGCMTESTVGISAGCVLTGLVDYTDLDGAN
LISNDYATGNSVENGKIMLSQKPGLGIDLK
>KALACAFP_01477 hypothetical protein
MKKLILGMILGSAAMMVSCGPKSVAVTGPKYTSSEQLAQGKTIFENSCNKCHGLPNPEKH
DDQGWIKTLSRMAPRAKLSDDQHQMVYDYLISVNKK
>KALACAFP_01478 hypothetical protein
MKKLIAIASFTAVLLASCTPKTSTATAPIGPATSTAEQIAQGKTIFENSCGRCHKLPDPI
SHTSVQWVGIMNSMAPKAKLTDEQHQWVYDYIVSVKK
>KALACAFP_01479 GTPase ArgK
MKFSTEELIEGIKSGNKRLIAKAITLVESKKAEHRTQAEELLKQIMPLTGNSIRVGVTGV
PGAGKSTFIENFGRLAISNGKKVAVLAIDPSSAINKGSILGDKTRMEELAKEENAFIRPS
PSSGFLGGVANTTFETMMICEAAGYDYILIETVGVGQSEVLVADITDVFLFLKIIGGGDE
LQGIKRGIMEMVDVIFINKVEKENLQKAKNTRLELKRALDFIPPKEKDWKVPVLLGSALY
NEGLGEVFEKINEFISLKKKTHRFEEVRIQQAEKRFEYWVQAYILSMMKKNNSVEEAYIQ
HKKNASTMVSSPSTEAKLFVEKFLRNSESELRDSEN
>KALACAFP_01480 hypothetical protein
MKKYISIIWIFGFLFLFQNCTAQDMDTQTVTNLVNSKDFSFHAQRATPTNYDVINVMNSL
PNSTSTRFLDLSGDNYSIDLRKDKLEVVLPYFGRVFNPTYGNTSQNSYRFTSKDFTVTTT
QGRKGKSIVKIKVNDQSSVDEITIEVFKNGKAFTSIRSNDRQPISYDGYISKNEEEKEKP
>KALACAFP_01481 Beta-barrel assembly-enhancing protease
MKIKHLLGIGAIALSVVACTTNPITGRSSLQLANNSEILTMSAQEYKTTLSKGKVITGTA
DAKRVVNVGTRIKSAAERYYQSIGRSADLANYNWEFNLLQSNELNAWCMPGGKVAVYTGI
LPITKNDNGLAVVMGHEVSHALAGHGNERISQAMVAQYGGAILGGTISNAQWASVFQKVY
PIGSQVALLKYGRNQESEADKMGLYLMGMAGYDPREAIPFWGRMEAASKGARQPEFLSTH
PNPETRISDINKDLPQALEYYKAAGGKI
>KALACAFP_01482 hypothetical protein
MKSLSLTGLVLLAVSALLFYLTTDFTVEKITLSHIMGVMAGVGIGLIIGGLVGYVSKGSA
IKQEQKRKEYKQLQKDKEELEKQAAEIAKREAELRNQQNQNPQI
>KALACAFP_01483 hypothetical protein
MKKVFSIALIGFSMFASAQISLAGKANIIFPTGSPSWKNIKGTVNQAIEGEGKNNVGFNV
GLSLKVGLPTSFYLMPELYYTNFKNEFTADNTTFDVKSSRIDVPILLGYNILGNTLGVFV
GPVASYNLSKEDTFNDFTENARDNFTVGYQFGAQVEISKLILNARYEGAFSKDSRNFINR
VSGEEIRYDNRPNLFMVGVGYKF
>KALACAFP_01484 putative ribonucleotide transport ATP-binding protein mkl
MIEVKNLKKSFDEVEVLKGISTSFDKGKVNLIIGQSGSGKTVFLKSLLNVYQPTSGEILF
DGRDINVMSREEKQHLRSEIGTVFQGSALFDSLTVEENIMFPLDMFTNLTFREKKKRVFE
VIGRVHLDKANRKFPSEISGGMQKRVAIARAIVNNPKYLFCDEPNSGLDPYTSNVIDDLL
LEITKEYNTTTIINTHDMNSVMTIGEKIVYLRLGIKEWEGNKDILITAGNKNLIDFVYSS
ELFKELREYLLENNKTIDNTITKIDENEKGF
>KALACAFP_01485 putative phospholipid ABC transporter permease protein MlaE
MLKKFFTAIGEYIILLGKSIQKPQKMRVFWKLFMREINDLGVNSFGLVIFTSIFVGAVVA
IQMFNNFDASSFPIPPSFVGYATKAVLVLEFSPTIISLILAGKVGSYIASSIGTMRVSEQ
IDALDIMGVNSPNFLILPKIIACVIFNPLLIAISIVFGIGGGYVAGILTGNWTTNDYVVG
IQMYMPNLFIFYAFTKTIVFAFIIASVPAYFGYNVKGGSLEVGRASTQAVVWTMVFIILS
ELLLTQLILS
>KALACAFP_01486 UDP-glucose:undecaprenyl-phosphate glucose-1-phosphate transferase
MQRIRYSRYLKSIIILLDLLVIASIFIFFFVSRNQNLKYNQETWYQNVFSLVLLFLFWML
LSGRTRIYNIPRNLTYTLFLERLLVHFLLFILGVLLIGKVSYNVFFNSDIYWLSFYLFFF
IFLTKSLIYFGIKYVRSLGINHRNIMFLHEDSSTEVLKNILTERRDYGYKIFEYKNPEIK
PEELIEFWKTNGIHTLFIPIENSFNEKTEKEIFKLAEANKVHISLIPSITQSDFFLYDMG
YIQTQPVLNQAKYPLDYYSNFLLKRIFDIVFSSIILVCICSWLFPLIAILIKSSSKGPVF
FIQKRYGFHEEVFDCIKFRTMVVNNESSTKTTSENDSRITRIGKFLRKTSLDEMPQFLNV
LKGEMSIVGPRPHMLAVDNYYKPKIGRYSLRSMVSPGITGLAQVNGLRGDAGDVEVEMNK
RVLADAFYVRNWSFVLDLVIILKTVLLVITGDKNAK
>KALACAFP_01487 7-carboxy-7-deazaguanine synthase
MNLTEEILLKEGKMLPVMEHFYTLQGEGAHTGKAAYFIRLGGCDVGCHWCDVKESWDPNL
HPLMNAEEIAETAAKHCKTIVLTGGEPLMWNLDILTSKLKELGCTIHIETSGAYPMSGQI
DWITLSPKKTGLPKEEIYAKAHELKVIVFNNNDFKFAQEQAAKVSGNCTLYLQSEWSKRD
EMYPKITDFILEHPEWRASVQTHKYLNIP
>KALACAFP_01488 Bifunctional protein FolD protein
MAEILDGLKVSKEIKQEIKAEVEKIVAGKRRAPHLVAILVGNNGASKAYVNAKVKDCEEV
GFQSSLIKFPSTVSESELLEKIEELNKDKSVDGFIVQLPLPDQVDQEKIINAIDPRKDVD
GFHPTNFGKMALEMDTFLPATPFGILTLLERYNIETKGKDCVIIGRSKIVGRPMSILMGR
KDFPGNSTVTLTHSYTKDIEEYTKKADIVITALGDPHFLKGDMIKDGAVIVDVGITRVDD
DSPKGYYLAGDVDFDSCAAKASWITPVPGGVGPMTRAMLMKNTIIAYKTSVYND
>KALACAFP_01489 hypothetical protein
MLNTIHKLKRKIKFIQLSLSPTTNHLKKDISIQKKWLGNDYGGFYVATEFLDKNSIVYSF
GIGEDISFDEEMIKDNNCLVFGFDPTPKSINWIKSRQVPENFKFYSSGIGDKTTVDYFYL
PKNPNYVSGSLVQQNNVDSDSKIEVQLQSLQDIAHMLEHKKIDVLKMDIEGFEYNVIESI
LNSNVEIGQILVEVHERFFENGQQRTIDMLEKLRKHDFLVFGISETFEEISLINKNLINN
KK
>KALACAFP_01490 Glucose-6-phosphate isomerase
MLSKINPTQTNSWKALDEHFGDNDFDLRSLFQYNPNRFSEFSLQRDHFLFDYSKNLIDAR
TKELLLNLAEECQLKDAIAKMFSGDKINETEGRAVLHTALRDFSDREILVDGENIKPQIK
RVLDHMKTFSESIISGAHKGFSGKEITDVVNIGIGGSDLGPVMIVSALKHFKTRLNVHFV
SNVDGNHIAEVVKNLNPETTLFIIASKTFTTQETMTNANSAKDWFLKAGKQEDVAKHFVA
LSTNVQFVKDFGIAEENIFEFWDWVGGRYSLWSAIGLSIVLSVGYENFEQLLKGAYDTDQ
HFQTANFSENVPVLMGLLGIWYRNFYAATSYAILPYSQYLDRFAAYLQQGDMESNGKCVD
RNGEFVEYETGPIIWGEPGTNGQHAFYQLIHQGTELIPADFIAYAKSPNKVSDHQDKLLA
NFFAQTEALAFGKTEEEVEEELKNSGKSDEEIDFLLNYKVFHGNTPTNSILFKELTPFSL
GQLIAMYEHKIFVQGVIWNIFSFDQFGVELGKVLANKILPELESNEPISSHDSSTNGLIN
YYKKNA
>KALACAFP_01491 hypothetical protein
MLSRRNFIKKSSLGVGFLALPGSAKFLYTDDYVSKRPSLEQRKFTSLAVENTIKTIKKSI
GDKELAWMFENCFPNTLDTTVKFYQKNNKFYTYVITGDIDAMWLRDSSAQVYPYLSLANE
DKKLKNLSKGVINKQVECVLLDPYANAFFDDASKISEWKDDSTQMKPGIHERKWEIDSLC
YVMRLSYNYWKTTGDSSVFDADWKKAMLLILQTFKEQQRKDSKGTYSFERANGNPLDTQF
GKGYGNPTKKIGLIHSMFRPSDDATFYPFLISSNMFAVVSLRETAEIFSKVLKDENFSSQ
YKNLAKEVDEAIQKYAILNHPEAGKIYALEIDGFGNALFMDDANVPNLLSIPYLGYASKE
DEVYKNTRKFSLSKANPWFSEGKFAKGIGGPHIGEHKIWPLGLIMQALTTDDDEEILYCL
KTLKATHAGTGFIHESFHVDNPKDYTRSWFSWANTLFGELILHLYKTKPDILKRKL
>KALACAFP_01492 hypothetical protein
MQKLIRKQAHFIEVILQNIDFKIFKTEFFFTKFLPAIFKHYKKFSTNFGISKTLKINSMK
TTYIRLSIAGALLLGIYSCKKGEVSATDLEAYATTDSAAVVASDSISSVATMKVKDKQFI
KTADVNMEVKDVYKATISIEKSVQELGGFVTQSNLHSNVISEDTYNTSNENAVLVKKYQT
ENRMQLRVPTDKLSELLTLINDKKLFLNSRSINAEDVTANIKYSALEAQRNKKTTDNIAQ
LKVNKDKVTLSDENMREGNDQQLESMNMTDQLKYSTIDIYIKEPKIRVAEIGITNTKSID
DKYKFAFVYSAKSAFVEGYYLIQRIIVGLITVWPILLIGAVIVYFLRKRKPAKKQTTTEV
>KALACAFP_01493 Acyl-CoA dehydrogenase
MSNTFSKIRNAIELFRSIDFDQLSAISQKIDLPKLMQNFSKLDDKQLGGLMKMLDPNKKK
KELPPVDGDFYDIYHTLSPEQREIQLKVRAFMEKEVKPLVNHYWLRDEFPHELIPKFQKL
DICGVTYQGYGCPGLPFLMEGVLAMEMARIDASIATFFGVQSGLSMGSIYICGSEEQKQK
WLPQMQKFEKIGAFGLTEPEVGSGAAGGLTVTCKKTPEGWVLNGQKKWIGNATFADIIII
WARDMDDGEVKGFIVEKDNPGYSVEKIKGKMALRIVQNGLITLKDCLVTEENRLQNANSF
KDTAKVLRMTRAGVAWMATGCARGAYESALDYTRKREQFGKPIASFQMIQGHLVEMLSNL
TAMQTMVFRLSEMQDEGILKDEHASLAKVFCTLRTRDIVSRAREVMGGNGILLEYDVARF
VADAEAIYSYEGTKEINSLIVGRSITGFSAFV
>KALACAFP_01494 hypothetical protein
MKIVKFIFALLFGLMFINAGLDKFFHYNPMPKLTPEQMKVYAAFGEIGWLMPLVGAVEVI
GGVLFIFPKTRALGAIIILPVMVGILLHNVCKDQSQMGIIIAVVLFIINIWMIIDNKEKY
KALVS
>KALACAFP_01495 AI-2 transport protein TqsA
MNFIRLPFLVKLTLVVISIIGIVYILALGESILAPFFLAFLMAMLFLPAATFMERKLRFT
RSMSTITSVMIMLVILTGLVYFFGSQLSDFSKDVPHLRVQFTQVFNELQNWVSETFHVKI
DEQLDYLDQGLDKLLSSTGVILGFTFGIFSTGLGFIVFFILFFIFILNYRRILNNFIVTV
FNEKHKASVQEVVNEVRIMTKKYIFGLCLQVVIVSILTSIVLTILGVKYAILLGILTGLL
NVIPYLGICIALLISCFIAFATTTPSTCIYVIIGYIAVHIVDGNIILPFVVGSKVKINAL
FSFIGIVIGEHLWGIAGMFLCIPAIAIIKIVFERVEGLKPWGKLLGEEEKPHKKKKKYKI
SKNITLEEMD
>KALACAFP_01496 hypothetical protein
MKTLLTLFAMIIFSTTEAQHYTQEELSNKEIITKAFQEWHNGNGNFFDLLNDDMHWEITG
STPYSKIYTSKQEFLDEVIIPLNKKLKVKIKPTVRNIFADNDMVIALWDGEATALDDKPY
RSSYAWFMKMKNGKITNVVAFLDV
>KALACAFP_01497 Sorbitol dehydrogenase
MEIKTILITGAGTGFGKGAAIGMAKNGHNIIATVHVSSQVTPLREEVAALGLSDKIRVER
LDLTDQYDIKQALKWDFDILWNNAGMGEAGPVWEIPVDIVRKNYEVNVFLPLILTQGVVQ
KWVREGKKGKVVFTSSMGGLFTPANWGTYVSTKHALEAFAEAMQQELAAYGIKVQTINPG
AYYTGYNETMADNPFRWLDDEVNFTKRADLRKGFDDFFATPEGKMDPQEMIDRMIEIVPA
DEGKFRNVVPKVIEDMLKDHQLKAWENTI
>KALACAFP_01498 hypothetical protein
MEINLNESRQVVQQARAKAIQLNVNVNIAILDTAGHMKSFERMDDAFLGSMDIAIKKAKT
ASLFRTSSENVGEYLKPEAGTYGMTATNDGLVGFAGGLPILKNNEIIGYIGVSGGAVSED
LQIATAGAEILNQTQIQ
>KALACAFP_01499 HTH-type transcriptional activator RhaS
MKTSLDLKEIDLLREFPELTPIYREAHDSKQIKVFNREIVDCRNYLSANRRDFYKILMIT
GGDGIFTLGLNKYIIDKPTMIFIHPNDIISWQKTSGESAGYYLLFKKDFINKHPMLRATI
ERLALFNDKSKSIICVGENDLPGFIRLWESMYNEQENQLGDEAIQAYIQLMMIDSARMSN
FPAPENTGEEYDHIHRFFGLLEEEVSNINYEKPIKLRTAQEFADSLKLHPNYLNRILKKR
TGQNVSKHIKGRLLDECKALLLQTSWTLEQISYAVGFSDQPNFNFFFKKNTGFTPNAFRK
GILE
>KALACAFP_01500 Lon protease 2
MTEFEDISLEEMISDGFDIVAEEINLADLSETEKNSEQKIFPILPVRNMVMFPNVVIPIT
AGRKTSIQLLEEAQKNGDFIGIVSQKNSDLEQPAEKDIFQTGTLAKIIKIIKLPEGNITA
ITKGFHRFKIKKMIETQPYFKAEISKLKDGKPKNKEEYEALLENIKDLALKIIELDPNIP
NAANFAIKNINNNDDLLNFICTNANFPSPEKQKLLEEKNLMERANKCYEMMHEDFRKLEL
RNQIHQKTSKDLDKQQREYFLNQQIRTIQEELGGGPESDVEDLIDKARKKTWSKEVEEHF
QKEINRLQRQNPNSPDYNVQRNYLDFFTDLPWETYTKDVFDIEKAEKILDKAHFGLEDIK
KRILEHMAVLKLKNNMKSPILLLVGPPGVGKTSLGKSIADALGRKYVRLSLGGLHDESEI
RGHRKTYIGAMAGRILQSIKKSGTSNPVIVLDEIDKIGQGLHGDPSSALLEVLDPEQNKS
FYDNFLEMGYDLSKVMFIATANSLSTIQTPLLDRTEIIQIAGYTLEEKIEIAKRHLIKKQ
QEETGLDSKSFKLGNSELKHIIEAHTSESGVRSLEKRIAAIARWVALQTALVKEYDSKIS
IKKIDEILGVPRPKSLSEITGVPGVVTGLAWTSVGGDILFIESILSSGKGTLTMTGNLGT
VMKESATIALEYIKAKHDELGISQDDIEKKNIHVHVPEGATPKDGPSAGIAMLTSMVSSF
KNKKVKPHLAMTGEITLRGKVLPVGGIKEKLLAATRAGIQDVILCEANRKDVEEIKKDYL
KNLKVHYVNRMEEVIDIAIEK
>KALACAFP_01501 Chaperone SurA
MAILGQIRSKPWLLMGVIALALLAFLVNPESIDKVFGKNPDVLGKVNGEKITREEFNDQL
FVLQQQADQQGQPKAGLEEQAWQLLVQSKLIKQQFEKLGFEMTEDYFWNQIQYDQMFAQQ
KQFFDEKGNFKTQELKKQIEEMKATSPEGYNQWLKTRKSIEYRLMARQVFANISTGITTG
KKEAEELMKERDQLADIDFVKIDYASYLQKNNIKVTTEDLANYINQHPIMFKAEESRNLG
IVYFPSQPSAADDAAAQKEITKLFSAGTDASGGTENFQNTKNDSMFVMANSDMPFNNQYL
KPNQLPQTIQAQIPSAAIGQTFGPYKEQNFYVVSKLLDKKTSDSTLSRHILIAFKGSPAG
EGVTRSKEQAKKLADSIGAIVKANPGKFTEFLKLSNDPNSAAQGGSLGWTTPETPFVPEF
LTYLANNPKGATGVVETQFGYHIINIEDKKPGAMGYKVANLVKAVKPSDATEAETDKKAR
RFIQQVQGKSFNDFVNIAKKGNYQFSNPKQAKRFDGQLQGLGTDKDAEILAWAFDKKREK
GDTEFFTVDGTGDKIVVYLNGKQAKGTADPESVRDQIEVVVKNKLAAKQISEKIGKAGSL
DQIAKQFGATKQSAQVNLLNPSVAGSMEPKVAGAAFGAKKGQLSKPVEGGTGVYVLVKKN
EIVNKQPGDLKQFTESVTQRSAGMFGQAWLKSLQDNAKIDDYRIEIWNKLGSQQQ
>KALACAFP_01502 hypothetical protein
MKFSKELKAGVIALIAIVGFVILFQFMKGRSLFTTDNIFYAKYDNVEGLAQSSPVSINGL
KVGQVDKIIPHTAKDGKIDFVVKITVDNNFEFSKNSTLEIFEPGLMSGKEMRVNLAYGGA
TAKDGDTLQGAFKLGTLGSLSSQVGPVKDQLQTVLYRVDSLMSNANQIVDEQNRAEIRAL
LSNLNKTVGALQTTAGSVNTLVGHNDPKLQKVLDDASVTMQTGKVTLDKYGNLAESIDTK
KLNAAISNLDATVGRLNDVIGGINNGQGSLGKLMKDEQLYNNLNSASTNLNSLIEDMKAN
PKRYINFSVFGKNNKD
>KALACAFP_01503 Lactate utilization protein B
MQYIDNIIFLILLIAGFGLFAKSLQKIYRNIRLGREINRNDRKGERWETMARVAMGQSKM
SKRPIAGMLHLFVYVGFIIINIELIEIIVDGIFGTHRFLATILGHGFYNFFTATLEILAL
LVVIGVVTFFIRRNFYGVKRLTMKELFGWPKQDANWILIIEFALMMAFLTMNSSDFILQQ
RGVLPEHGSFPISEMTFVPFLEVFSFDNGFLFLVERGAWWFHFVGILFFMNYLYYSKHLH
IILAFPSTWYANLEKKGKFNNLESVTKEIKLMMDPNADPYAAPAEGNEAEAPSKFGAEDV
FDLNQVQLLNAYSCTECGRCTAVCPANITGKKLSPRLILMKTRDRLEEVGRNIDKNGKFE
DDGKKLLNDYITKEELWACTTCNACTEACPVLLDPLSIIFEMRRFLVMEQSAAPQELNLM
MTNVENNAAPWQYNQADRLNWAND
>KALACAFP_01504 Lactate utilization protein A
MDFNIKTMAEYAAEGKSPEVLFWVGCAGSFDDRAKKITKAFCKILNKIGVEFAVLGQEES
CTGDPAKRAGNEFVFQMMALTNIEVLNAYEVKKIVTACPHCFNTLKNEYPSLGGNYDVVH
HTQFLKTLMEEGRLKVEGGAFKGKKITFHDPCYLGRANDEYEAPRVLLEKLDAELVEMKR
CKTNGLCCGAGGAQMFKEPEKGNKDINIERTEEALSFEPKVIATGCPFCNTMMTDGVKHF
NKNTEVAVKDIVELLAEAEDL
>KALACAFP_01505 hypothetical protein
MKIEESNIVETNDYRVIIYPASRPLETKEAKVITEKLFDFLATWAAHGKPLSSSFKIEKN
QFIIICVDEEKEMASGCSIDALGKVMREIDEEYQLGLFDRMKASFVENGEVKTLKLLDFK
SKVRNGEISKDIQVFDFSKNTYLDFLSHFLLPFEKSWAASII
>KALACAFP_01506 hypothetical protein
MPKILFLTTAHRYDDDRIFYHQAKALKDEGNQVEICSLSSDFQGFVDGIEIESYSILEKS
TEEKTKVFERVYKTFQPDCIICSEPLAVISTKKIKKEKKISVIYDITEWYPSMRMVENFR
FPLNVFQAIKFFLIQLYAGWVSTHFIFGEETKKFPLAYIFWFKKNIISPYYPDDQYIHRN
IKKLESNKITLCYTGQFSEEKGIGNFFAVIDSVKKKKPDLDVSVLLIGGARKEKDEKYFS
DLLSKYRFENMKIEKVTSFETFTESYAEADICFDLRTMNYENHHCLPIKIFYYAASGKPV
IYTDLKATRQHVDVSKFGFLVDPEKADAIAEIVLNYIENPELYSAHAQNARKEYEKKYNW
NGIRNSFVNFIKKSIE
>KALACAFP_01507 hypothetical protein
MKQNTIFKTFVSRFLILILNFGLVIYSTNMWGSEGKGVISIVIADLTIISFFANIFVGSS
MSYFASKYKAEEILPFAYLWSILVGILIPVIFSFNHALEYSNYLIILSVLSSLLAANVNL
FVGQQNIKMFNLYTVLQQIIHIVFIVIIVYIIKITSVNSYFIAQISCFGLLFLISSYQVL
RRCDFKNISFSRQIGSKLFDYGWKTQLSAFLQFLNNRLSFYFLEYFKGIVSVGIFSIGVA
FSEAIWTVSRSLSLVLYADIVNNTNSNEAIEKTKISLRISFLITSLFLGIMLLIPANFYA
MIFGKDFHQTKEIVLFLSPGILAIAVSNIIGYYFAGINKLRILNVKAIVGLIFTIISSFY
IIPKWGIRGACVISSVSYCLSSALLFWRFYQITEFHIHDFILSKKEVDLLLRKVFR
>KALACAFP_01508 hypothetical protein
MRNIVFGFLVVFVAFLSCRTGDDEDLQKIDQIINLYMKNGAGRDLFHKKKDTAYFTYSMN
DVNGNADLAPVSSLLKATADSTLFIEYIAGAKRVGLDTIDPNNKTYHSVIALSLIKRLNN
TVQDTIRDTLEIQYRWTPSVFEVSKIYYNDTLRFTKTPGASNVVTIVK
>KALACAFP_01509 Serine--tRNA ligase
MLQVNFLRDNKERVLEGLKKRQFKNLELVDEAIATDDERKKIQFELDSQLSEINKISKEI
GLLMKEGKKEEAESAKSKTSQFKESSKELQSQLDVKEKDLINILYQLPNIPNELVKSGAS
ADDNEIIYQSHDVEGLGEGAIPHWELAKKYNLIDFELGVKIAGAGFPVYLGKGARLQRAL
VQYFLDKNVEKGYMEVNPPHVVNEASGYGTGQLPDKEGQMYYIQADDLYLIPTAEVPVTN
LYRDVLFDEKDLPIKNTAFSQCYRREAGSYGAHVRGLNRLHQFEKVEIVRIEKPENSYAV
LEEMVEHIKEILSDLELPYRVLRLCGGDTGFASAMTYDFEVWSAAQEKWLEVSSVSNFET
FQANRLKCRYKADGKSQLVHTLNGSAMALPRIMAALLENNQTEEGIKLPKKIAEYARFDL
IN
>KALACAFP_01510 hypothetical protein
MKKILFLLVIGLFTLQSCSINSEVTYHKDSASTTMMDIDMKEAMTMFKSMIPDSAKTDKK
EFGELEKLPRTWTSLYELEKKEGKLKTDNPDSIRIMKKVFMKSNFDNDELAGFSMKMDHF
TKADYTAVGKLSKNEQLPIDQLAMNSWDGKTLTIDTEKLGLNGIKEILADKGISDEKAEM
SMGTLKMMYKKIGTTLKFENKIKSISGKHDWITKADDYSVKINYDLDYLFGEEKDKKPLK
NMDKKIVIVTE
>KALACAFP_01511 hypothetical protein
MEIALIVSAIGLGFASGFHCIGMCGPIALSMGLTKKQATNFYLQNLTYQFGRIFTYSLLG
AILGIIGEGFEMAGFQKYLTIAVGILLIVMAVFSFGGKDFASKIPFFSKFLFKVKSNLGR
LLQKADYRSRFTTGLLNGFLPCGMVYMALTASLASGGIGQGALYMALFGLGTLPFMFAVV
LAGNLMNQAFRIKVLKVIPVVMIVLGGLFIVRGLELGIPYISPRAEAMTISKDNNGQCHL
PGDHSTHSHSNVNCH
>KALACAFP_01512 hypothetical protein
MKNFSWGHGVVIALFAFIVFILSMLFLFPNGQKNSEMVTDNYYEEELKYQDVIDAKKRAD
QLQEKPVYSQNKNGITITFPKDYDNSNTTVKFVLNRTDDQNLDIKKSVQLEANKSFLIPS
KVLRLGNYTLRLNWTKDKTDYRMDYDVIWK
>KALACAFP_01513 Putative electron transport protein YccM
MSDIEETEVRGGQGQVLDPETYRDSIGTMDQSGKRKWVYPRKPKGKYTNYRNLVSYILLV
IYFTVPFMKINGNPLILFNVIDREFFIFGQPFYPQDFFILTLGAIASLIFIIVFTIAFGR
IFCGWICPQTIFLEMIFRKIEYLIEGDRNRQMKLDRQEWNSEKIWKRTLKWTVYLVISLI
ITHFMLMYIVGYKEIFKIISEGPFAHPTNFIIMILFTAAFYFVFAWFREQVCTLVCPYGR
LQGVLIDKDTINVFYDFNRGENRAKWRKGEDRKAAGKGDCIDCHQCVVVCPTGIDIRDGQ
QLECVNCTACIDACDEVMEKVGLPKGLIRYASENEIEKQTEFKFTGRMKGFAIFLVLLVG
FLGYLLYNRGEMEAKFIKPAGSTFFVRDGKITNTYNYTFLNKTNEKKLVTIKVIEPKHGE
VIYSASSKIPVERDKITKGTINISFPEKEMNLSKQNITIGVYDMKGKLVDSYQTYFEGPF
KLQF
>KALACAFP_01514 Cbb3-type cytochrome c oxidase subunit CcoP2
MKQRTPVVVNILIIIGLLIVFYYLFVQSYAFLGSPYFWGTVVIAGILAYIHSAIGDLIEN
NKFKKLSPEEKAAYLAEKKVPYLRRLYDAAFKKQSAAEEKDILIDHGFDGIMELDNQLPK
WWVGLFYFGTAFCIVYICAFSFTNFAHPLSEYEQEYKEQLASIEEYQKTQPPVTIETAKY
SADNIAEGKELFKTNCASCHKEDGSGGIGPNLTDNYWINQPEKTLFKNVFHMDWNGSPTN
PAMRPFGKNGEVSGAEIEKIAAYVYHINQEQPPVTKDKGGAAPQGTEAHWEKE
>KALACAFP_01515 hypothetical protein
MIPQNFKDILSNTDNAGFYQTLALIFFMLFFVALVIYVFSRPKKYYKEEEEAPLQDDEND
DDFNLKN
>KALACAFP_01516 Cytochrome c oxidase subunit 1 , bacteroid
METQKFSYDNSIVRAFLYATIVFGIIGFLFGLTAALMLFYPELPEFLFGTDDETIKSLGG
GIKGLISTHGAFGFGRIRMLHTTTVIFAFVCNIVYVGVYYSLQRLLKTRMYSDTLSWIHF
WTWQIMIVVTYITFFMGINTSKEYAEHEWPIDILIAFSWIIFGANMFLTIAKRRVRHLYV
AIWFYIGTWIAVAMLHIFNNLEVPLSFTGWKSYSAYAGVKDAIVQWWYGHNAVAFVLTTP
VLGLMYYFLPKAADRPVFSYKLSIIHFWSLIFVYIWAGPHHLQYTALPAWAQAVGTGFSI
MLIAPSWGGMLNGLLTLRGAWDKVRENPILKFFVVAVTCYGMATFEGPLLATKNINKIGH
FTDWVIGHVHLGALGWNGFMAFGVIYYLIPILWRTKLYSTKLANWHFWLGTLGIIFYAVP
MYISGFTQGLMWKQFNPDGTLVWKNWLDTVTAIIPYFKMRFVGGLFYLSGALLMVVNLIA
TVRKGSFQKDVPAEAPALANISGKRKEGEGTHLWLERTPVLLGILSLLTISIGSMVEIIP
TLSLKKSVPTISAVKPYSPLELEGRDIYIREGCNACHSQMVRPFRDEIVRFNGKNGQYSK
AGEFVYDRPFLWGSKRTGPDLQREGGKNPSSWHYKHMYNPRSTSAGSIMPRYPWLIATNL
DRSKMVDKMKLMKSAFDVPYTKAQIDSANSWADNQASKIVKDIFSEAADLKDEYAKRPKG
ELEKKEVVALISYLQRLGTDIKTTEIKTASNN
>KALACAFP_01517 hypothetical protein
MDILYLMILCSVSLAAVFLVVFIVNAKKGQFEDDESPAVRILFDSDEIKEKEEDGNKESE
NEKGENNKIEEKSE
>KALACAFP_01518 Copper-exporting P-type ATPase A
MEVSENCFHCGQGIEKERILFDEKTFCCNGCKSVYEILNINNLTNFYELNKRAGIRPSDE
NTTQFDYLDTPEIFEKVTDFSEGNTSLVTFKIPVIHCSSCIWLLESLHTLNKNIKYSQVN
FTRKTLQISFSHNDLKLSELANFLTNLGYKPVISLETADKNVENLDKSLLIKFAIAAFAF
GNGMFLTFPEYIGGEDYWMEHYKGLFRTLMFLLATPVVFYSASDYYKSAWYGLKNKIVNI
DVPIVLGILVLYGRSIYEVVTDYGPGYFDTLCGLLFFMLLGKIFQKRTYNALSYDRDYKS
FYPIAVTKVDFEGKQENILLSDVKVGDRILVRNQEIIPVDAILINGEGNIDNSFITGESE
SISKQPGDKIFAGGKQVGSSLELEVIKNVDQSYLTQLWNKEAFKKHETGLDTLTNTISKY
FTFIILGIALLSGIYWATVDLEKMFQVVSAILIIACPCALALSAPFTFGHIMRILGRNKF
YVKDTLTIEKIAKLNTIVFDKTGTITHRKKSNIKYEGSEIKEFDLLNIKTLLKNSNHPLS
KSLYEFIDVKDDYFPVENFQEISGKGYQGEVRGNLYKIGSAKYNNQESKNLETAVYISKN
AEFIGKFIFKNEYRQNLKDLFKKLTNYKVFILSGDNSSEENQLKELIPNYQGMAFNQSPE
DKLNYIKNLQDQNLKVAMLGDGLNDAGALKQSNVGIAISDDSNSFTPSSDVIMNGEKVVT
LNKYLNVCKGSITIVKMTFIISFLYNIVGLSYAVTGHMHPLFAALIMPASSITVVSFTTF
STWILGRKHFKKQA
>KALACAFP_01519 Global nitrogen regulator
MSQEQQIAIEERFARVFNDKSFKERLSSADFEKYINGKKKLSFQKHDTIFEDGETPKGVY
VLEKGAAKLSKSGAFGKDQILRFIKEGDIIGYRSLLCGENFQAKAEAMTDIEATFLPADV
FMYLLEVDPQLSFVMLQKISYELGESSNTITFLAQKTVRERLAEILLLLEQKLGVDPEGF
IKISLTREEIANIIGTATESAIRLISEFKGDNLIEVDGRNIKILNHDKLMKLGHVVL
>KALACAFP_01520 3-methyl-2-oxobutanoate hydroxymethyltransferase
MSVHSEIKKVTTETLRKMKFDKEKITMLTAYDFTTAKMVDAGGIDAILIGDSAANVMAGF
ETTLPITLDQMIYHAQSVARGTDRALVVADLPFGTYQSNPEKALESAVRMMKEGGAHAVK
IEGGKEISKSIKKIINAGIPVMGHLGLTPQSIYKFGTYKVRAKEEAEAEKLIADAQLLEE
LGCFSVVLEKIPADLAKKVTESISIPTIGIGAGAHCDGQVLVYHDMVGMNKGFSPKFLRR
YLDLYTEITGAVAQYVKDVKDVSFPNENESY
>KALACAFP_01521 hypothetical protein
MKNQQSIQGILSIIALLCLAAGWFNFFSPEINNLLSRKVFYILIGISFFLQAPMLTNKNF
MYAMYAAAAVCVIGAFMPEDSKLSGLKTIGLLAGIILSFTNRPTYRQ
>KALACAFP_01522 Ribosomal large subunit pseudouridine synthase D
MEEQIVYEDNHLLVINKKVGQLVQGDKTGDESLLESIKNFIKKRDDKPGNVFLGLVHRID
RPTSGLVIYAKTSKALSRLTQMVKNREIKKTYWAVVAKEMIPQTQRLVHYLKKNEKNNKA
IVFPKATEGAKEAILTYHIIKNLDNYLLLEVDLETGRHHQIRAQLSKIGTPIKGDLKYGS
PRSNPDGGINLHARKLEFIHPVTKENIEITAPVPQNDAVWRACEE
>KALACAFP_01523 hypothetical protein
MELTINHTIRTFDVLPETLEALMAIEIPQKRKGIAVALNNRIIPQSFWAETFLNDKDSIL
IITATQGG
>KALACAFP_01524 Phosphomethylpyrimidine synthase
MAHNITRSPFPNSKKIYVEGKIHPINVAMREIQLSPTKLSNGTLEENLPVTIYDTSGPYT
DENSDINIEKGLPRIREQWILDRNDVEILDGITSEYGKTRLADSKLDELRFSYNHKPKVA
KEGQEVTQLYYAKQGIITPEMEYIAIRENQRIEQLDSVSKEMAFQHPGNSFGAKTPKSKI
TPEFVRDEIAAGRAIIPNNINHPESEPMIIGRNFLVKINANIGNSAISSSIEEEVEKTVW
ACRWGADTIMDLSTGKNIHETREWIIRNSPVPIGTVPIYQALEKVKGVAEDLTWEIFKDT
LIEQAEQGVSYFTIHAGVLLRYIHLTAKRVTGIVSRGGSIMAKWCLFHHKENFLYTHFEE
ICEIMKKYDVAFSLGDGLRPGSIADANDEAQFAELETLGELTKIAWKHNVQVMIEGPGHV
PMHMIKENMEKQLEVCDEAPFYTLGPLTTDIAPGYDHITSGIGAAMIGWFGCAMLCYVTP
KEHLGLPNKEDVKVGVITYKLAAHAADLAKGHPGAQYRDNALSKARFEFRWEDQFNLSLD
PETARSYHDETLPADGAKIAHFCSMCGPKFCSMKITQEIRESAEKGMFDKSQEFIEKGKE
IYI
>KALACAFP_01525 Thiazole tautomerase
MIIVITPEEMMKNETELINELFQEGLNLLHIRKPFINSEEMADFIQKIDSEFHHQLVLHS
HYDLAKDFNISRFHFREIDRQNDLYKSFADKTISTSVHDIETFNELNEDWEYAFISPVFP
SISKKGYGENSTILNDIKKRTHSNVKLMALGGINENNIHEVFNNGVDGVALLGAIWESDE
PLNVFKKCRQNALS
>KALACAFP_01526 Bifunctional thiamine biosynthesis protein ThiDN
MQTERPFVMSIAGYDPSGGAGLLADIKTFEQLKVQGLGVCTAMTLQTESECLSLNWQPLE
EILSAIDVLMKNYHLEVVKIGVIKDAEFLSEIIKIIKINNSETKIVWDPVLKSTSEFSFF
DLNTISELENVLKQIDLITPNYNEYKVLQKNHLFEKSENTCSVLIKGGHREDKLGTDILI
ENGKEVSIYPTDETSVYYPKHGSGCVLSSAIASYLALGKNVEEACRNGKLYIEKFLTSNS
ILLGFHH
>KALACAFP_01527 Thiamine-phosphate synthase
MEKLQYISQGFTIEDQELNIRKALDHGIKWIQVRWKNAPENEFIKLCEISKKLCSDNQTV
CIINDHVQIAKEIDADGVHLGLKDTSIEIARHILGTNKIIGGTANTISDVLQRMNEPCDY
IGLGPLRFTSTKEQLSPILGFEGYEEIIQNLKERSLEIPKIFAIGGVVLNDIELLQPIGI
YGAAVSGQITNQPSIINQFKTVLQ
>KALACAFP_01528 Thiazole synthase
MKNQPLIIADRTFESRLFLGTGKFGNLSEMTDSIIASGSEMVTMALKRIDSQSSEDDLLN
ALKPTKSHLLPNTSGARTAKEAVLAAQLAREALETNWVKLEIHPDPKYLLPDPIETLYAT
EELAKLGFIVMPYIHADPVLCKRLEDAGTAVVMPLGAPIGTNKGLRTLDFLEIIISQSNV
PVVVDAGIGAPSDAAKAMEMGADAVLVNTAIAVARNPVNMALAFKEGVIAGRRAFEAGLG
AIAQHAEASSPLTSFLFD
>KALACAFP_01529 2-iminoacetate synthase
MKSFKDFFEKYQWEEVRTKLEKVTLSDVESSLQKKNRTIEDFLNFLSPVAAQKLELMAKM
TQQLTQKRFGKTIQLYAPLYLSNECQNICTYCGFSLDNSIKRKTLSDTELMIEATVLKSM
GVNHVLLVSGEANKTVGIDYFLNAIRLLKPHFANISIEVQPLSEEEYQQLHEAGVNAVLV
YQETYHQEVYKEYHPKGKKSNFNFRLETPDRIGKAGIHKMGLGVLLGLEDWRVDSFFNAL
HIDYLQKQYWKSKFSVSFPRLRPAEGIIEPNFIMSDKDLLQLICAYRIWNEDLEISISTR
ENEKFRDNIISLGATAMSAASKTNPGGYAVDKESLEQFETSDERSMDEIKNIIKKAGYDP
IMKDWDAVYSGI
>KALACAFP_01530 putative adenylyltransferase/sulfurtransferase MoeZ
MKNEDIFARYSRQIFIEEIGLEGQRKIMNSKVLVIGAGGLGSPVIQYLAAAGVGTLGVVD
FDEVELHNLNRQIIHNENSIGKLKVKSAGEFVKNLNHQVKYIGIDQKIDDSNAEEIISQF
DIIIDGSDNFKTRYLINDTCIKLKKPLIYGSILGFSGQVAVFNYKGSKNLRDIFSEPPFD
ENLPDCDSLGVLGALPGIVGSMMANLTLKMITDLPLNINQLTLIDTLNWTFQTIDF
>KALACAFP_01531 hypothetical protein
MKHFYTFLSLQAKGKNLFRRTAAGLALLLGASTFVNAQVSTYSFSQSTGSFTGIGGTILD
TATGNTSTTNLNSSVYAVTLPFNFTFNGTSYSSMNVSTNGFVTFGSTAPSTTNTTPISNT
AAYEGAIAAFGRDISSMFDINATTGSITWETIGTAPNREVIVQWKNFRPNNSTSTTSAYA
FSFQIRLHETSNVINTVYETGSYIVGNTSISGTAQIGLRGTSNADYNNRLNATTLEFINS
TAGTANTSSQNFNTVNATPGMPSSGLTYTWTPPTCWVPQAITVTSTTTSTAAITWTAPSS
APSSYDIYYSTSSTPPTSSTPPTIPNVTGTSATLTALAPATTYYVWVRSNCGAGDTSVWS
LQSVQFTTACQPPVISSTTPATVCPGSSATLSAMTTDPTAILTWYDASTGGNVVGAGSTF
TTPALSATTPYYVSASNGTSMFVGPQNPNSLTAPATTGAITTYYIQFEVTNQAVTLVSTD
VFPASAGQSTTLEILQGPTTFNVINTIPFTSTIASDGTTPQTVPINMLLTPGTYRMRISG
GNYYRNYQSNAVFPYSIPNFSITTGSNVASNSYYFMYNLKVNSGCESARTAVTATVDVNC
LSTSEVKAKDMMKIYPNPFTDVIHIDRPEMVKSIQVTDASGKLIKNNMLPESVIKLNDLP
QGLYILILDMKNGTRQSVKAIKK
>KALACAFP_01532 hypothetical protein
MKKTIIASLFLGTIFTYAQEKTNSHTKEKQIEGVTITKTKKAVEQKADRTIFDFSEQPQL
NNGNVLEGIKKLPGLVSTDIAGMMYQGKVLDVYLNGRPLNITSNELNSFLEGMPANSVDR
IEVITQPGAEFPATSGGAIMNIITNKNANKYLTATYSGNYSFTNYDKFRSRTSNSMNLNA
RNKLFGWQLNFGQNYRESMLTTNQNDLLRSNTDRYGRGYFAKSGLTFDLGMDRLLLNYDI
YHNNNDNYTLSDGEGNVKIPIENTDPQEYTYRDFIFNASDAAHTLNTRQEAVVTYQKRFD
DKAQKLDFQFGYTKSSSKFDQDNIFREGKYFDPEESYYIVGGRVLSNRSDMKIANFKVDY
SQPLKILDGGKVSLGGLYENQDFDTESKGLTNLEYKRQTTATYLEFQAKLKKFDFILGTR
AENYDISGVTRVLDSTNAVVQKDLIPFNKFKLFPNASVQYNLMNQVYVSANYNKKISLPS
ISALNPNNTTFQGPNTQVTGNPNLQPTIFDNYELKVSAFDYAFIGYSVSSASNQVAQIIR
KDGKNLFNEQVNISNMKIHNFNVGLPVPFMIFSKPISEIMKFNFNPDKINFMYLYAGYQK
HDIDNLNNKGFWIFNIMTQLILPKDIKLTANYSYLTPKAGYFYFTAEKPFNNSLDITLTK
KFMDNRLTVSVFANDIFNGQVMQVRSNPPSGEAVYMRNKYDTRNFGLSINYKIPTKNKLA
KEDPNILNSTKKEDNGGVMQQGQ
>KALACAFP_01533 Aconitate hydratase A
MTFDIDMIKKVYERYPERIAAARQIVGKPLTLSEKILYTHLWEGNATKVHERGNSYVDFA
PDRVAMQDATAQMALLQFMQAGKAKVAVPSTAHADHLIQARIGAEADLQEGINKNSEVFN
FLSSVCDKYGIGFWKPGAGIIHQVVLENYAFPGGMMIGTDSHTVNAGGLGMVAIGVGGAD
AVDVMAGMAWELKMPKLIGVKLTGKMSGWTSAKDVILKVAGILTVKGGTGCIVEYFGEGA
ESLSATGKGTICNMGAEIGATTSTFGYDDSMRRYLAATGRQDVVDAADKIAEHLTGDAEV
YANPEQYFDQLIEINLSELAPHLNGPFTPDLATPVSEFRAKAEANGWPLEVEWALIGSCT
NSSYEDLSRAASIVEDAVAKGVKPKAILGINPGSEQVKFTAERDGFLDSFRKFENARIFT
NACGPCIGQWDREGAEKGEKNSIIHSFNRNFAKRADGNPNTHAFVASPEMVAAIAISGRL
DFNPITDTLTNESGEQIKLNEPQGFELPAKGFAVDDNGYQAPSADGSSVVVNVSPTSDRL
QLLEEFPAWDGKNITGARLLIKAFGKCTTDHISMAGPWLKYRGHLDNISNNMLIGAVNAF
NMETNKVKNVLTAEYGEVPAVQRAYKAAGVPSIVVGDQNYGEGSSREHAAMEPRHLGVKA
VLVKSFARIHETNLKKQGMLGLTFANEADYDKILEDDVINFLDLDQFAPGKQLTLEFIHA
DGTKDIIIANHTYNDQQIDWFKAGSALNLIKQQEKN
>KALACAFP_01534 Aconitate hydratase B
MNIYQDYIQEIEERKNQGLHPKPIDSAELLSEIIAQIKDTANEHRADSLKFFIYNTLPGT
TSAAAVKAKFLKEIILGESVVEEISPAFAFELLSHMKGGKSIEVLLDLALGNDVAIAKEA
AKVLKTQVFLYEADTNRLKEAYHSGNEIAKEILESYAQAEFFTKLPEVAEEIKVVTFIAG
EGDISTDLLSPGNQAHSRSDRELHGKCMITPEAQAEIKALQAQHPDASVMLIAEKGTMGV
GSSRMSGVNNVALWTGKQASPYVPFVNIAPIVGGTNGISPIFLTTVDVTGGIGIDLKNWV
KKVDENGNPIRNEAGEVVLEEAYSVATGTVLTINTKTKKLYNGDKELIDLTKSFTPQKME
FIKAGGSYAIVFGKKLQTFAAQVLGIEAPLVFAPSKEISHEGQGLTAVEKIFNRNAVGIT
PGKVLHAGSDVRVQVNIVGSQDTTGLMTSQELESMAATVISPIVDGAYQSGCHTASVWDK
KAQANIPKLMKFMNEFGLITARDPKGKYHAMTDVIHKVLNDITVDEWAIIIGGDSHTRMS
KGVAFGADSGTVALALATGEASMPIPESVKVTFKGEMKEHMDFRDVVHATQAQMLKQFGG
ENVFQGRIIEVHIGTLPADQAFTFTDWTAEMKAKASINISEDNTLIESLEIAKGRIQIMI
DKGMDNKNQVLKGLIEKADKRIAEIKSGEKPALTPDANAKYYAEVVVDLDVIVEPMIADP
DVNNEDVSKRYTHDTIRALSYYGGEKKVDLGFVGSCMVHKGDLKIVSQMLKNIEKQQGKV
EFNAPLVVAAPTYNIIDELKAEGDWEFLEKYSGFEFDDNAPKGEARVEYKNMMYLERPGC
NLCMGNQEKAAKGDTVLATSTRLFQGRVVEDSERKKGESLLASTPVVVLSAIIGRIPNID
EYKAAVEGIDLTKFAPPIKELVK
>KALACAFP_01535 hypothetical protein
MKNVVQFLCVFISVFVFSQAKSVKKLPIKNTTKTAGKKTLTAPKTSDLVIINKELPVLIP
KKKDGNFGYVNQKGKFVIPPQYHIAVFFYEDCNLLNSPNEKVRKFGTAEYATVEKDEISY
RIDKKGKRVYQFKQSDLAQCAPKEYTQQLFQAYVLNGFYGIIEKSKFKDPKDYKQFQVYP
QYDYLYILEGDDVVNPMIIASKNDAFGVIDVNNNIIIPFEYSDIKRNFSWKLGRMFDVSK
DGKDYYYIDSKNKTY
>KALACAFP_01536 hypothetical protein
MNKRGRLNNVAIYQFNSLTIKLAHCYIVPSVHLTSLNSITRSRFIGYNLSLLQHPFISAA
KLRKINDMLGIGFWGEEFFGLNGF
>KALACAFP_01537 hypothetical protein
MKGLFFLGLTVGSFAFLRAQNTDSLKVKEIEAVNFTKRLPVAKEIINVAKDVDSRNLGQD
LPILLKNQTSIISTSDAGNGVGYTGFRIRGVAGSAINVMMNGVPYNDSESQGTFFVNVPD
LTSSASQIVIQRGVGTSNNGAAAFGASINVLSKDPEEKFYFKTDDSYGSFNTYKYSAEIG
SGKFWGNRLSVMGRYTHINSDGYIDRAFSKLDSYNFTALYEEGNTKIRLMAFGGKEKTYQ
AWNGIDRKTWETDPKFNYSGAIYDSNWENIVGFYDNETDNYRQSHYQLLWEQKFNDRWNL
ETTLHYTKGKGYYENYKQGDPFARYNLPDFNGEEYSDFIRKKWLNNDFYGIVSTLYGKLG
MVDVNFGAVANQYYGRHFGNVTGVFFPQIDEHEYYRNRSVKNEVAGFAKALVRVNDFEFF
GDLQLRNIDYNTKIITVGDDEGANLDKNWLFFNPKLGVNYKIARGKVFFSYAHAHREPNR
DDLLANNDVKAEKLHDFEAGIERQFGIVSFTANLYYMYYVNQLVLNGELNNVGAFIRTNS
GKSYRSGIELGALAKLSKQWELTGNVSFSNNRNLDFKIENETEVKDLGNTQISFSPDIIA
NLGLKFSPNKNFMFALMNQYVGKQYLDNSEDENLQLKDYLLTDFNAQYQFKIKNNDIALK
LLVNNIFNKKYVNNGAVYDGTPYYFSQAGTNFMFGISWKIQ
>KALACAFP_01538 hypothetical protein
MNISAYILEYLKQFGTVTVPGFGVFSLENSKAIINSENGSILPPASKIVYTPDYEVKSDE
LAAFIASQKQMPLEASKTDLQIQTDFWKKKLQADQILEIQGLGTIFIEDGETHFKGNRLQ
SDHPDFYGLEEIKISDINNKNLKQNVPVNSEKDYTFNKSILWAFLIIIPVLGILYVAYTQ
QELLFGKKSFDKTNISVQTKTHRIEKDTVKVHPYTPPVADSLKKDSVVQQPAQPVTEKGV
KTLTTKNNNTKTKWQK
>KALACAFP_01539 putative acyl-CoA thioester hydrolase
MAKVKKASESLTIMTNIVLPNETNSLRNLFGGELLAKMDRCASISAARHCERRVVTASVN
HVSFNHPIPEGGVVVLESKVSRAFSTSMEVYVDVWLDDPINQKKVHTNEGIYTFVAVDEF
NRPIPIPDMIPETEEEISRHAAAFRRKELSLILSGRMKPLDSVELKKLFQEPQEPKKDKK
>KALACAFP_01540 Hydroxypyruvate reductase
MKILLLDKNHPLITEQLLAKNFILEEDFMSSYDEVCSKIENYDGVIIRSRIPLDKNFLEK
AKNLKFIARVGAGMENIDIPVAEKLGIQLINSPEGNRDSVAEHVVGMLLILMNRLFIASQ
EVKNGIWLREENRGDELLGKTVGLIGYGNMGKATAKRLSGFGCKVIFHDILPDLSDEYAT
QVSLKELKEQAGVLSLHIPLTDVSYYLIDGPFISDMKNDFYFVNTARGKNVETKSLVEAL
KAGKVKGACLDVLEYEKSSFENLETENEDLKYLLESEKVIVTPHIAGWTLQSKEKLAQVI
VDKIVAQFVQ
>KALACAFP_01541 Penicillin-binding protein 4*
MKKCNFVLILTAFLFLFSCKNKSESNETVVGNTTDLPNYGNVDLSKVFTKGDSQISDKAS
LVRYIDQYYNKVWVGSNLSGGILVAKGDDILYENYRGFAREDNQKVIDKNTPLHVASVSK
TLTAMAMLKLIEAGKIKLSDHLTQFFPGFPYPNVTVKTLLDQRSGLPKYEYFITKIQPAP
AELSKQFITNEDVLNMIIKYKPELARETDTGFMYCNTNYALLALLVEKITKKAFPQAMKE
MIFDPLKMKNTFIFQEKDIPTASQSFYYGGNRLYPLDRLDLIYGDKNVYTTPRDLYNFSK
AMFSKDFLNQDLMEMVFTPYSNEKFGMNNYGLGFRMKIFDNGEKLTYHNGWWHGTNSVFA
HLLKSKVTIIAIGNKYSNRVYTALALSGLFEDFPPQKDKLHSIMSEDKDTLNSHSEVYGE
>KALACAFP_01542 hypothetical protein
MKRLLLLFVIGFLLQSCARVGSPVGGPKDSLAPKFLSSNIDTTRINVSRDIRELRLDFDE
YITLKDINKNLIISPPIKSITRIIPSNIANKFILIQWKDTLQANTTYNFNFGNSIADNNE
GNILRYFNFAFSTGDKLDDLYISGEVKDALSIKKGSENKFVVGLYQAKDTIDYKQKPYYI
TKVDDDGYYELNYLSPGKYKIIAFEDENGNSMYDAGKEKVGFQKDPLVLEKSISGLNLKV
YPSRKSLKYVEMKETPGGILMTFEGRPNDVKVLSINDKLQDIKVTHRPKSDSVNIWFDAV
KNNVGQGTTENLKFSYDADKKQDTVSVFYKYNTKNAMDINSDNGGGMLAPKSDFKISSNY
YLDKINTDKWLLRAEGDSVNTIPFTAKISETNPYQILVKSDFISGKKYQLTVPKETVSSF
YAKNYQSKRFDFEVDKVENFGSLTFKLQNAPTSSYWIQLLDTSDKVLFEKYAKGDEVKFN
IIKPGEYIVRILADNNENKYWDEADFQNDVFAEDSYIYYKVVIVRPLWDSVEDWDLKDTR
TLDTSKLTVPKTTAPPQDAKKTDLKSNNTMLTPTR
>KALACAFP_01543 hypothetical protein
MKIFKQILFWSVLGFALIQFIPTDKMNKPVDHKLNFVDAKHTPGKIKGLIKGACYDCHSN
ETVYPKYAYIAPVSWSVKSHVNEGREHLNFSVWETYNKDLKENMLSKTIQTIQGKTMPMP
GYIVYHKQANLSDAERTLLVKYFEEMLKSKTY
>KALACAFP_01544 NADH pyrophosphatase
MKILKYCPSCGKETLHWDGEKKWSCPECNFTLYNNVAGAVAVVIRYQDEIYLTRRNRDPK
KGKLDLAGGFVDPKESAEETCKRELFEELQLGVDISNLKYLTSLPNVYQYKEIDYNTIDL
FYEYHVSEKFEVNLELSEISEAVWIPLKELDLEDIAFDSQKNFFEGYLKNI
>KALACAFP_01545 Tyrosine recombinase XerD
MTWDEKIKDFEIFLRFERNFSENTLDAYIRDIRKLKEYAEEDLANVGPDIIGYENLQEYI
FNLSKQKFSERSQARWISSIKAFFKFLLEDEYREDNPAALLEGPKLGLYLPDTLSLLDIN
KIISAIEVNSDLGKRNQCIIEVLYGCGLRVSELIDLKISNINFKEQYIKVNGKGNKTRFV
PLADYTAELLENYIQDVRSKSKINKKYEDTLFLNSRGTSMSRVIVFLIIKELTDKAGVSK
KISPHTFRHSFATHLLQNGADLRYIQEMLGHSSITTTEIYTHLKTEELRDVILNYHPRNI
NIVQ
>KALACAFP_01546 Riboflavin biosynthesis protein RibD
MNKFDKAYLKMAQEWAKLSYCKRKQVGALIVKDRMIISDGYNGTPSGFENCCEDGDGKTH
WYVLHAEANAILKLAASTQSAKGATLYLTLSPCKECSKLILQAGITRLVYINEYSDDDGI
SFLRNHNIEIEQISDCELKK
>KALACAFP_01547 Short-chain-enoyl-CoA hydratase
MWKMSYENILLNKEDKVSIITINRPESLNALNAQTIKEISSALDELNSDPSCRVIIITGS
GEKSFVAGADIKEFSDFGKEKAEELARNGQNILFNKIENMTKPVIAAVNGFALGGGLELA
MACHIRYASENARLGLPEVTLGLIPGYGGTQRLPKLVGKGIANEMIFSAKMVPAQRAKET
GLVNEVYPIEELLTKTKELANVIAHNSPMAISKAIHAVNLSDTDKGFETEITYFGELFEL
DDKKEGVSAFLEKRKPNF
>KALACAFP_01548 Catalase
MDSKKLTLSSGAPYYEHQDSQTVGPRGPVLLQDFILQENLAHFVRERIPERIVHAKGSGA
YGTFTVTHDISNYTKAKLFSKVGNSCRMFARFSTVGGEKGSADTARDPRGFALKFYTEDG
NWDLVGNNTPVFFIKDAKKFPDFIHTQKRVPKTNLKSATMMWDFWSLNPESLHQVLILMS
DRGTPHGYRHMHGFGSHTFSMINDKNERVWVKFHFKTKQGIKNFTDSEAVKMAGENPDFA
QEDLCNAIENGDFPKWTMYIQVMTEDQARDFRWNPFDVTKVWFHEDFPMIEVGEMELNEV
PVNYFAHVEQSTFSPSNLINGISFSPDKMLQGRLFSYPDAHRYRVGVNSHQLEVNRCPFA
VNNYQRDGFMADSSQYQDKPNYHPNSFDDIKADISYKNYEYELDSAHVASYNRNENDDDH
YTQPGLLYSKAMSPEDRQNLVNNIVGSMRAINGPKKDEIINRQLCHFFRANIELGMKVAS
QLNVIIDPNMMNHSK
>KALACAFP_01549 Hydrogen peroxide-inducible genes activator
MNIQQLEYLIAVDKYKHFGKAAQACFITQPTLSAMIQKFEDELDVKVFDRTTHPIRTTDV
GLQIIDQAKVIIESVNELKNKANLLNNILGGTINIGIIPTVSSFILPTEIFKFLEENPKI
QMNVKEMTTDNIIKALKAGELDAGIISTPYDTADEFYQDFLFNEELMIYSSDTEANKKNS
YVVPEDLNVEKVWLLEEGNCLRNQFENICHLKENTLKPKNLDFLASNIQTLVHMVDKVGG
ISILPELALNQLSDTQKENVFRFKKPFPYREISIIYYKPTFKQKIIDELSHSIRASLEKK
LNYNESPKEFVSIKPQ
>KALACAFP_01550 S-adenosylmethionine synthase
MSYLFTSESVSEGHPDKIADQISDALIDHFLAYDKSSKVACETLVTTGQVVLAGEVKSDA
YLDVQTIARDVINGIGYTKGEYMFNGDSCGVISAIHEQSPDINQGVDRAVNDESFEAKAN
AQGAGDQGMMFGYATNETANYMPLALDLAHTILKELSAVRREDSEIKYLRPDAKSQVTIE
YSDDHKPIRIDSIVVSTQHDDFGTEEEMLNKIREDIKNILIPRVVAQQTEEIKALFNDQI
KYHINPTGKFVIGGPHGDTGLTGRKIIVDTYGGKGAHGGGAFSGKDPSKVDRSAAYATRH
IAKNLVAAGVADEVLVQVSYAIGVAEPCGLYINTYGTAKVDLHDGEIAKKVSTIFDLRPY
AIEQNLKLRNPIYQDTASYGHMGRESYVADKTFNKGQKNELTLKGLEFFTWEKLDKVDEI
KASFGI
>KALACAFP_01551 hypothetical protein
MMNFRFAITFLSIFFLTTFVKAQYTMHKMISVGYTYQNQSFGELGGKLLFLKNDDVIYRL
GASALMGSAHSKFAIMPKLQADVLLNFEKNVDFYHSYYFLIGAEGTNKYVAPKIGVTLFG
ILDLTGGYAFPIGNSGINGKELKGLNVNFTLNIPTVFIHDMFK
>KALACAFP_01552 ECF RNA polymerase sigma-E factor
MKSKSDSLLISLYQKGDEEALSTLIHRHQRELFTFIFYKINDEDLANDVFQDTFMKIIVM
LKEGRYNEEGKFILWAKRIAHNLIIDHFRAKAKNIKVSETTFETDEYSIFDLLREPSENI
EDQLVSNQIQEDLLRMLQFLPLNQQEVIKLRFFDGLSFKEIADHTDMSINTTLGRVRYAL
INLRKIMDENNIILTR
>KALACAFP_01553 hypothetical protein
MRKNDSLKVKTLKPKKQTIEFLLNFSKNLEVVKTKSKNYPISKN
>KALACAFP_01554 Pyrimidine 5'-nucleotidase YjjG
MNIQHIFFDLDNTLWDHRKNAYLTIKDLFETEEITLKYNIDFEEFHSVYHNINESLWEKI
RDGIIDKEYLRKHRFYDTFKHFNVDDLELSMYFEEHFLDKILNHNELVEGAQYILDYLKA
KNYTLHVISNGFKEVTERKCILSRIDKYFQTITSADSVGVRKPNPKIFEYSLQLAEASKE
ESILIGDDWIADVVGAQNFGMDVIFFDVFNENPKEEGLKVIKHLLQIKEYL
>KALACAFP_01555 FMN-dependent NADH-azoreductase
MMKILNIISSPIHEASASTKLGNAIVHKLQGKYPNSTVTVRNLTKQTLPHLEEIQMRSFF
TADENRTPEQKEALKLSDEVVNEVMNADIIVINVPMYNFGISSTLKVWIDHLIRKDVTFK
HSASGAQGMLNDKKVYLAISSGGIYSEGPRKHLDYTENYLRSVLDFIGITDVTVFRIEAQ
SKPDLKEEFAAKAMESISI
>KALACAFP_01556 hypothetical protein
MKTKFLSLIILAIIGLTNLNAQTKNMMKTKSSPILQKENTVLLLVDEQVGLLSGVRDIST
ADLRKNVVAMAKAAQIMGVPVIITAVGSDGLWGPVIPELTAALPNVTVIKRSLINAWDDP
NVVKAIEATGRKQILIAGISLEVCASLPAISATQAGYDARVVLDASGTFNENKRVAGIQR
LTTLGIPLTDYATAAVELLRDNADPKAHDVYGVLGLDFATTVWQLNDAVKKGYK
>KALACAFP_01557 putative HTH-type transcriptional regulator YybR
MINKLNFDDEYLKKLEQNICYNKILNMADTLDVLAGKWKIPIIVCLSFKPKRFSEISKEL
KTITDRTLSKELKYLEENLLISRNIIDEYPLSIEYEITEHGLSLTRILMVLREWGELHRE
KILEHHREDSQSVHKI
>KALACAFP_01558 Tryptophan--tRNA ligase
MSRILTGIQATGTPHLGNLLGAIIPAIELSKQEGNESFLFIANLHALTQIKDAEVMKQYT
YEIAAAWLACGLDTEKTYFYRQSDIAEACELSWHLSCFFPYQRLTLAHSFKDKADRLQDV
NAGLFTYPILMAADILLYDAEIVPVGKDQLQHLEIARDVAARFNNQMGEVLVLPQAELQE
NTKYVPGIDGQKMSKSRGNIINIFLPEKELKKQVMSIETDSKSLEEAKDPETDKVFAIYQ
LIATPEQTEELRAKYLAGNFGYGHAKKELLDLILTRFEKERETYNYYMNNLSELEAKLQE
GATKTRVIATETLKRVRESLGF
>KALACAFP_01559 hypothetical protein
MKKIIKILFKFFLLLLVAGIIFIAWANYSIKENSDSYISYNIADIPETKTALLLGTSKNL
NSGLPNAYFYNRIQAAVDLYKSGKIEYIIVSGDNSRKSYNEPEDMLLTLVHYGIPHDRIF
LDHAGFRTLDSVVRAKEIFGQTKLVIISQKFHNERAVFLAKKNGIDAFGYNAKDVNKYMG
VKTNIREYFAKAKAYYDLILGVKPKFGGKKILIP
>KALACAFP_01560 Lipoprotein signal peptidase
MKKILAVTFLILLIDQASKIYVKTHFNLDDSISVFPGFKLTFVENPGMAYGLHFGGILGK
YFLVFIRIILIGGMIYLFKKWLQRGESNYLLIPMAMIFAGAIGNLIDGMFYGLIFDSGTV
YDQSIDRWIGYGGISKFVPVGEGYSTFMKGCVVDMLHFPLVDWNVPENFPLIGGKHIEFF
KYIFNVADSAITVGAVLLLVFRKKAFPNGLEF
>KALACAFP_01561 hypothetical protein
MSELLILGIIIIAVLAFFNRDWIQKRFFPDRQKNYTIDDKFNSDKREREKEIDKLLSKMG
KNGINDLSEKDRKRLDELSKM
>KALACAFP_01562 General stress protein 16O
MSDERVRYSDADLQEFKAVIKEKIAKAEKDLALINESFINDQNNGTDDTSPTFKAFEEGA
ETLSKEQNAILAGRQEKFIRDLKNALIRIENKTYGVCRVTGKLIPKERLLAVPHATLSIE
AKNMQK
>KALACAFP_01563 Isoleucine--tRNA ligase
MSQFKEYKNLNLIDVAENVAEFWKQNKTFNKSVEIREGKPEFVFYEGPPSANGMPGIHHV
MARALKDIFCRYQTQNGKQVFRKAGWDTHGLPVELGVEKELGITKEDIGQKISIEDYNKA
CREAVMRYTDVWNNLTEKIGYWVDLEDPYITYKSKYMETVWWLLKQLYDKGLLYKGYTIQ
PYSPKAGTGLSSHEVNQPGAYRDVSDTTIVAQFKTLPETLPSFLQGFGDVHFLAWTTTPW
TLPSNTALTVGPKIDYVLVKTFNQYTFEPINIVLAKALVGKQFGKKYAEGADEDFANYTS
ENKVIPYQILAEFKGADLVGIKYEQLLPYALPYQNPENAFRVISGDFVTTEDGTGIVHTA
PTFGADDAKVAKEATPEVPPMLVLNENGNPVPLVDLQGRFTSHMGEFAGKYVKNEYYDAG
TAPEKSVDVEIAIRLKEENKAFKVEKYVHSYPHSWRTDEPLLYYPLDSWFVKMTAVKDNL
VNLNKEINWKPKSTGEGRFANWLENVNDWNLSRSRYWGIPLPIWRTDDLKEERIIGSVEE
LYNEIEKSVEAGLMKENPFKGFIIGNMSEQNYALVDLHKNIVDKVILVSDSGKAMRRESD
LIDVWFDSGAMPYAQLHYPFENKELIDTNKAFPADFIAEGVDQTRGWFYTLHAIGTAVFD
SVAYKNVMSNGLVLDKNGQKMSKRLGNAVDPFETLAIYGPDATRWYMISNANPWENLKFD
IEGIDEVRRKFFGTLYNTYSFFALYANVDGFNYSEKDVENRPEIDRWILSELNLLIKEVK
AFYEDYEPTRVARAINTFINDNLSNWYVRLCRRRFWKGDYTEDKISAYQTLYTCLETVAK
LSAPIAPFFMDQLYQDLNKVTGKESAESIHLTDFPVADESLIDEDLVEKTHLAQSITSMV
FSLRKKENVKVRQPLQKVLVPVMDSKAEGQIMAVAELIKQEVNVKELQLINAEEASHLIV
KQIKPNFKALGPKLGKDMKVVGGEITNFDAEQISKLEKEGKLDVQGYEITLDDVEISTKD
IPGWTVTSDGKTTVALDLTLTDELKSEGIAREFINRIQNLRKDKDFDLTDRITIFLEEDT
PFLNDIKKNEEYISSEVLSNKIEIVSSLSNFNEIEIDEVNFKLNIEKN
>KALACAFP_01564 hypothetical protein
MLTEQQVIEIAEKYVKKRSAKSKYDLVILDNEAIKKPYGIIFFYNTKKYNDTRNDDDNTL
LGNAPFLLENKTGNIVVFGTSKSEEYYIQEYEAGRFTNILGLNSSLE
>KALACAFP_01565 hypothetical protein
MTIEEKEEKMTSTIKLKLDEIDYRITSIISYYHENMKLRDNTYKNTIITSFTEPLLNSET
SIITDSETLEMLYVWTGPTRYMEINDFFIKK
>KALACAFP_01566 hypothetical protein
MLSNEKIDKIAERYVKMISENINVELIIPKDIIIDKPYGRIYFYGAKDYKKHRLAGNGPF
LIKNDTGIVIPFGTAMDVDYYIKGYEDGTWKPASYGVWDPNQN
>KALACAFP_01567 hypothetical protein
MNFKNPLKRMGDFDKISREIWADMRGEKVATNSIEPFFTNLWVDEGKLFRLLASSTDFNT
YVFDAEKNFINYSQEVEKVNLKEIPPAKIDNVKVKAKMIEKLVIQEPKVDPKQFENSFLE
RIDNKVWVNISPGYIDPQNYTHHTEIGIKERKIECTINIPYREYNREVTKTVINEVESTL
TYSSKSPDAIKINLSDVEDYMDTIIYLFPHHREMAQVGLIARFEEAGSSLTTIDDLMFFY
NQLPNFALTGVDYKGKAKKLSDEMLWDHFLKFLNFDSQLTRDVDSISKAAAMAVEPFRDK
SRYAIRILTAISGEFVYKKIKNDPKLILHIYHSLDGESVYMGKGIISDTNQVAYGQMFEN
KELFVISVMAFMQAQHAMDDAHQPLQRGSLFALGVSRDSDTIERHCELTGYFMEGDPDNI
VTLINTVKVFNLKTKEIEAENEIENGEFRPLDMLHLKVYEKVKLRTGKIQTLETDTEVPA
LFLYHIAQKKAAEDALRCLRVAADLIVISASLATIESGVSGLPLYVAYADIGVALSDFYI
ETQLRDELKMTTKGKKLLELWDDIYMVQGATSAMVSMLPKAEKALDATVEVLYTSRFPRQ
QESVQKLIKNTLYSFPLRDYSKNGLKVLLKDGIKNITKHSSDFEKLRVLFVENAAKEIAV
LYKGKKFFHANSARRTGKFLDYLYRKAGGNITKLDQEISRLAGMAENLPPNFSMKAEEFE
AGWKALQEAIVEGKITSENAIDYIYEVLPYFNHHVVNGEVVMISNTNCVNVVKNVIEYLT
TGELKTALPSEGQEVDLLEQIYNNKFKPTTLEDLKAEKGMKEGEIGIIFAYKNISTTIKG
HVFNIVKKNNRLILPDGQFGILARTRDYKYFEYIKVK
>KALACAFP_01568 Murein DD-endopeptidase MepM
MKAFSRLIFAVCFLIGMITQAQNNYPQNYFRNPLNIPINLAANFGAVRSNHFHMGLDIRT
NSQENLQVVAAADGYVSRIKVERYGFGNAVYITHPNGYTTVYAHLNKYFDKLDEYVKERQ
YKDEKWEQDIIFSPDQFPVTKGQLIALSGNTGGSAGPHLHFEIRDTKTEECINPLLFGFA
IPDNVAPIISGLYWYDRRFSTYEPGANGIAVKKAGNVYTSNVVQVNSSQISFAIKAVDKA
NQGFNLGIYDAELLMDGKLIYHFKIDKVHYNDTRYLNGCIDYTKFVRDKMSIQHLSTLPG
MKLKDYSSGSDGIINLQDNEIHNIEIILKDIKGNTSRLTTKIQLAKNSDKVSSGDKTVKP
NEAKTIKTENAEINLSKNAVYDAVNFTMFEKSDPEAVSNAVVLNGSYIPVHDYFTLKIKS
NRRLTDEEKNKTVIELNYGSDKNIIKAKWNGDWAEEEFNRLGTARLLFDNSLPSISPSWK
DGALISSGLLRLKGTTKIGDIESFRAELDGKWLRFARVKDDFVYIFDEKCPKSSGSHTLK
VTTINTAGNTNVQTFTFSR
>KALACAFP_01569 Phenylacetate-coenzyme A ligase
MEFYPSIEKSDIQEIKKFQEQKLQELLMYLETHSPFYQKLFKENNINIADIQTLEDLQKI
PTTTKNDIQQNNDDFFCITPDKIVDYSTTSGTLGDPVTFGLSDNDLERLAYNEAISFACA
GIQKGDVVQMITTIDKRFMAGLAYFLGLRKMGASVVRMGPGIPELQWDSIFRYKPKYLIT
VPSFLLKMIDYAEKHGIDYNNSSVYGAVCIGESIKNQDFTDNILSQKIKEKWNIKLFSTY
ASTEMSTAFTECEFQQGGHHHPELIITEILDDEGNLVKEGESGELTITTLGVEAIPLLRF
KTGDIVKAHYEPCGCGRKTMRLGPVIGRKQQMIKYKGTTLYPPAMNDILNDFNNILCYQI
VIQSNEIGLDEIIIKVSTDKDNENFVNEIRDHFRAKLRVSPKIELIDFDVLSKVVFNPNS
RKPITFIDLR
>KALACAFP_01570 hypothetical protein
MVFMAIATTVFAQSKINFESGNLDILKGQSEVNVQFLFENAKFQTDNYTEEQYLERRKKE
SLEKKTEKFWESWIGEWNNHRNVVFFNKFIDGLNEKAKKIKFGKDLKTKYTLIIDSKWIY
AGWSGFVMQPGKLSTEIRIVETDNPSKVLTKIQTDKIEGTGSKVNYGMEYGRISAAYEKT
GKELGKEIKNALK
>KALACAFP_01571 3-(3-hydroxy-phenyl)propionate/3-hydroxycinnamic acid hydroxylase
MSKEFVDVLVIGAGPSGCVSSSYLKKNNVNVKVVEKTKFPRLVVGESLIPRVMDHFDEAG
LFPALDKMGFEKKLGARFLRGDEVCLFDFSDKFGEGWDWTWQVPRADFDNTLAQEVMNKG
IDLEFETEVIGIEFNGTDSITTVKNKDGETKEIHAKFVIDSSGYGRVLPRLLDLEKPSKL
SPHSAIFAHVEDTNREEGVEGTLISFDIIETEVWLWVIPFSNGNTSLGIVGPTEYIEKLI
ENGDTTEALRKAISLSDYYVKRFGNVDFLFEPRHLKDYSCSVKSLFGDGFALTGNASEFL
DPVFSSGMAFATEGGMTAAKLAIRQLNGEKVDWQKEFADYILYGVDVFTTYVKEWYTGNL
QELFFHRPENPDVKRKICAVLAGYVWNKDNPFVKKHDTVVKNLANLIRMEKQQQ
>KALACAFP_01572 Tyrosine 2,3-aminomutase
MKINNFLELKDFQRIIIENEKIELDDTLLARVDASFQFLKEFSKNKVIYGVNTGFGPMAQ
FKISDEDTHQLQYNLIRSHSSGIGNPLPAAEVKACMLARLNTLSLGNSGVHQSVVNLLKE
LINRDIIPLIFEHGGVGASGDLVQLAHLALVLIGEGEVFYKGERKSTKQVFEIENLQPIQ
VEIREGLALMNGTSVMSGIGAVNAYKANQLTNISIKLSCAINEIVQAYDDHLSEALNGTK
LHEGQQKIAAKMRDHLSDSQLIRKRADHLYTHFEEQEKVFKEKVQEYYSLRCVPQILGPV
LDTLEYTEKVLENEINSANDNPIINVEDQHVYHGGNFHGDYISLEMDKLKIVVTKLTMLA
ERQLNYLLNAKINEILPPFVNLGKLGFNFGMQGVQFTATSTTAESQMLSNPMYVHSIPNN
NDNQDIVSMGTNAAVICRKVIENAFEVLTIEAITIVQAIEYLGFQDKVSSATKELYDEIR
KIIPAFSDDMVMYPYLEEVKKYLKAM
>KALACAFP_01573 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MKCAIVTGGSRGIGRAICIKLAEEKNYHILINYTSNEAAAKETLAKVEELGATGEILKFD
VGNAEETQKVLTEWQDAHPDDVVEVIVNNAGITRDGLFMWMPSEDWNAVINTSLNGFFNV
TNFFIQKLLRNKYGRIINMVSVSGVKGTAGQTNYSAAKGALVGATKALAQEVAKRNITVN
AVAPGFIRTDMTQDFNEDELKAMIPANRFGEAEEVADLVAFLASKKSSYITGEIININGG
IYS
>KALACAFP_01574 3-oxoacyl-[acyl-carrier-protein] synthase 1
MENRVVITGMGIYSCIGTSLEEVKESLFQGKSGIVLVGERKEFGFRSGLTGVVPKPDLKN
LLSRRQRVSMGEESEYAYIATLDALKQANIDQDFLDHNEVGILYGNDSVSQAVVESIDIA
REKKDTTLMGSGAIFKSMNSTVTMNLSTIFKLRGINLTISAACASGSHSLGLAYMMIKNG
FQDMIVCGGAQETNKYSMASFDGLGVFSVREDEPTKASRPFDKDRDGLIPSGGAATLIVE
SLESAQKRGATILAEIVGYGFSSNGGHISTPNVDGPALAMDRALKQSGLAAKDIDYINAH
ATSTPIGDANEAKAIYEIFGSEVPVSSTKSMTGHECWMAGASEVIYSILMMQNDFVAPNI
NLESPDDEAKKINLVAKTKSQKIDVFLSNSFGFGGTNSALIVKKFE
>KALACAFP_01575 Acyl carrier protein
MEREKIVAIVNDFLVNEFEVDGDEISNEANLKTTLGLDSLDYIDMVVVIESNFGVKLGEA
DFKKMITFDDFYSTIENKIAEKKA
>KALACAFP_01576 hypothetical protein
MNKWKGKSKGTILGYKIFVWCIRNIGIRSSYFVLYFVAAYYFIFEKKSNRYISYYFKKRL
SYDSWKTKLSVYKSYFTFGKVLIDKTAISAGLRDKYTYEFDGIENLRNLLAEKKGGVLIS
AHIGNFEIAEHFFAEIDFDCQINLVTTDQEVTVIKEYLESVSVKKSNIKFIYVKGDMSHI
FDINEALSKNELICFTGDRYFEGSKFLEGDLLGKSAKFPAGPFLIASRLGVPVVYVYVMK
EKNLHYHLFARVAQNVKKRDAQGLLNSYTQNLESMIKKYPLQWFNYFDFWDDID
>KALACAFP_01577 Dehydrosqualene desaturase
MVIGSGLGGLVSALVLAKEGLKVCVLEKNNQYGGNLQTFSRDKMIFDTGVHYLGGLSKGQ
NLHQFFSYLEIMDELELQKMDENGYDKITFGNDEIEYSHAQGYENFVEQLSKYFPEEREN
LEDYCEEIQRVCNHFPRYNVVGRDYYSEEILHLNTKRFIESITQNKKLQSVLLGSNFLYG
GDSENVPFYVHALTVNSYIQSAYKCVKGGSQISKLLIRKLRQYGAEVHKHAEVSELIFDE
KDTLTGVKTKAGKEYSAKQFISNIEIRSMIKLIGEERLKKSFLNRVFSWEPVSSCFSVYL
VLKPHSISNFNYNIYHYTSDELVWKAHQYKEETWPETYMLSSTPSKHYPEFAESLTTISY
MDFDEVKKWENTFNTIADEHERGEMYDKFKMEKAEKMIDALEKKIPDLRSFIKKIYTSSP
LSYRDYIGSFEGNMYGYIKSSENPLKTMVSPRTKINNLFLTGQSVNMHGILGCTIGAFNT
CAEILGKELIDERLTQLINKNKGEE
>KALACAFP_01578 hypothetical protein
MKNRGQNMQLVVIQNEAERSEESKQFGIDFSFRRNDRVLILLFFSLSLILNLTSCGVRKS
IRHIPEVQQYSLEIPKVNKINDSTFSFKENYLTKNKQQLWELYIKGNPLQLGYNNGALTQ
DLMQRQEEIFFSKVEGFVPSKFKQNLLRGFLKWYNRKMYLNVREDYQAELYGLSQYSSDK
YDFIAPKYLRNLYLHGAHDIGHAMQDLMMVGCTSLAVWNENTEDGDLLIGRNFDFYVGDD
FAKNKLIEFVEPEIGIPYMSVSWPGMTGVVSGMNEEGITVTINAGKSKIPLTAKTPISLV
TREILQYAKNIDEAIAIAKKRKVFVSESILVGSANDKSAVIIEVSPDNFGVYKAKNTSRV
FCTNHFQSDAYKDDKRNQKHIAESHSEYRYEKLQELLQENKKLNPEKMAAILRDKSGLKG
DKIGLGNEKALNQLLAHHAVIFSPQKKLVWVSSNPYQLGEFVCYDLNEIFSDKRLKNGKF
AKSDLNIAKDSFVDSQEFKNYEEYKKLSTKMEEGIDDKAKMFSEEFINHYQALNPDFWFV
YYQAGKCYFNKKEYFKAKIQFEKALTKEITTVPDKENVEKYLKKTNKKIKN
>KALACAFP_01579 Esterase EstD
MKKILSLFLILTVLFSFAQDKKEAGNLFIKALFSEKNIEEAHTFFDPSVGAQISVAELKS
LPEQLEGQLGKFKNIIEINNENDTYYFYSEFEKSKLDIQITFNQNNKIIGFYFIPHKIFD
KADDKTALQIRSDGIQLKGTLLQPTENNQKKLVILVHGSGPQDRDETIGENKPFKDIAEY
LYKNGISSYRYDKRTYSNPETFNDQSTVEQETINDAVNISNYFKNNENFKGYQIIILGHS
QGAYLMPKIAEKAQVSKYIFMAGNARPLQDLLVDQFEYLHKINPSSISEKDVQDMKTKVD
FLNSKKFNLNAPKSELPLEQSAAYWKYLVDYKPLEEIKSIKAPMFFAQGGMDYQVSAKDY
ALWKNQLKNNKLAEFKFYQPLSHLFMKTSGTPSPKDYETKGNVDEGFLTDLTQFILK
>KALACAFP_01580 hypothetical protein
MRKIYLLFVFCFLILFSCKSDEHIDSVETESPVVNFNIDAVPYSKLSTYAFFKGDLKNLD
PVAKVIPYEPASSLFTDYALKKRFIWMPNDVKASYDADDKSLNFPVGTVLIKNFYYNTIQ
PGNTTKILETRLMIKKSSGWIFAEYLWNDAQIEAELVTGTDFTSGSSKNITFKKENGDII
TTDYRIPSETECYACHKLDNKPVPIGVKPQNLNGSYNYPNGLKNQLQKLVDEGYLQSYPS
NIVSTVNYKDTSKPLDIRLRSYLDINCAHCHQDNARCDYRAIRLSFSQTTNLAKMGVCIL
ADEPIDPSLERIITPGNPNKSVMHFRLSSVNENNRMPLLGRTIVHDEGVDLLKQWISSLN
QNCP
>KALACAFP_01581 hypothetical protein
MKKIFPFFVLLLNSTWVLAQLTCATAVPLSVGTITAPNVTGDAPTTACSLGTPGSKGLWY
KYTPTENKTIKVTTSAAGSNNADTRLIVFTGNCTALSCLIANDDFAGNFSQVTFNAVAGT
TYYIVCDNKYSSLGFNITLSEVVVVPDRLSFIPQSVSSTGSFNNCVVDMNGDYLDDIVSV
ISATQIMISYQQTGGGFTNVSYTVPTTIITPSWSIAAGDYDNNGFNDLVYGSGSGIAFLK
ANSDGTAYTSDRKQQSFLVQRTNFIDINNDGKLDAFICDDNAPNRYYLNDGTNMNHNQGG
LGDFPSGGNYGSIWIDYDNDGDMDLYIAKCSGGGSGPGGNIDELHRNNGNGTFTNVAATA
NMANPTQTWSAAWGDFNNDGWMDAVVGINSTSNGLSKVMKNNGDGTFTDKSAGSGYDTTN
ALSREYVAHDFDNDGFLDVLGAGNTIMFGNGDFTFVPNPTAYNLSYYDRPIGDLNNDGFL
DIQNGNTVMMNAGNTNKWLKVTLKGTQSNRNGIGARVEIYGAWGKQIRDIQSGTGFGNMS
TLNAHFGIGQATAITKVIVKWPSGIVDVINNVTPNTTLNVVEGTFLDTKEVQTSQETFTI
YPNPTHDIISFKTTNDFIPVDAKVYEMSGRMVLQTKVERNSISIKQLNTGNYLLIVMDKN
GKTYSQKVTKK
>KALACAFP_01582 Undecaprenyl-phosphate mannosyltransferase
MTLPEVQNAISEKKICVLIPTYNNEKTLQRVIDGVLDYTENIIVVNDGSTDSTPKILNHY
SQINVINLPENKGKGNALKLGFRKAKELGFHYAITIDSDGQHYPDDIPVFVEALLSEKQD
ILLIGNRNMSQDGIPKKSSFGNRFSNFWFWFETGIKLEDTQSGYRLYPLHKIPKKYFTPK
FEFEIEIIVRTAWRHIPVKNVPIKVLYDPAERVSHFRPFKDFTRISILNTILVTITLFYI
IPRNFVNNFKKKSIRKFIKEDVLESDGTNRTKAFSIALGVFIGLSPFWGFQTLIVISLAV
LFKLNKVLAFVASNVSLPPFIPFIIAASLFLGAPFVHGESNILNQELNFELVKNNLLQYV
IGSAILATTISVISGIATFLFLSKVSPENN
>KALACAFP_01583 hypothetical protein
MKLILSLITAFLFFFQNDLDALRYSYAKANSSAANTAAFINVAEKQTGSDPITLGYKAAA
KIMEAKIAKQNRKQLVKTGATNLESIIKANPNNIELRVIRLSVQENIPKIVGYRGSLKDD
KAFILNNYSKQNIAMKNYVKRFAAQSKTITEAERATLK
>KALACAFP_01584 hypothetical protein
MQTILTDFYTLESYEQAENGSFTANISLNKNHEIFKGHFPGNPVTPGVCMMQIVKELTEE
FTGLKLFLKTASNVKFMAIINPFETPDLKLQLDINQTEEEIKVKNTTYFGETIALKMSVN
YQKLTS
>KALACAFP_01585 hypothetical protein
MKKFTFLLIALISSFSFAQITFTPGIRGGVNFAKFTETDGGIYNWFEASDEYWADQEKVR
TSYITDFYVGAFGTIRFSKLYALQPEINYSRQGTIMKTSKQEIKSELSYISLQAVNKFYL
NKFNLHAGLSIDILISDKNFDPYNKNTTDLGILVGAGYDITKNFGIEARFKKGMISQIKT
TSEDHTNLLFQTGVYYTFNMKK
>KALACAFP_01586 hypothetical protein
MRRFLLQSFLYSLIVLSLASCKTYKLTNVQSIPNSEKTVENLYFSSHEDYVYKCQMDIYK
NHVSGILIIKKINETTHRVAMTSDFGNKLIDFEISENDFKLNYVLPDLDKKIVINFLKND
FQQLLKQKYPVSESFENGNSNIYLSKIDKKAYYLFFNNENGLLKQIIYTKNNKEKIDFTF
DAKKHIFADSLNLQHKDFKINIKLFQITETE
>KALACAFP_01587 Outer-membrane lipoprotein carrier protein
MIKNIAFGAFLLVSGFFFAQNTAMSGAEAKAFVTKVSSETKQIKTLQSDFTQTKKMDFLD
KNIVTYGRMSLKSPNMLSWKYTKPYQYSIVFKDNKIFINDQGKKSSVDAKSKTFEKINKL
IVGSSNGQMFNDPEFSVTYLKNANYNIAKFTPKSAQLLKYIKQIELHFPKNQSTVSQVNM
TEASGDTTNIVFKNTKINAPVSASEFSL
>KALACAFP_01588 Peptidoglycan-N-acetylglucosamine deacetylase
MKHYPFILFYLFCNVFIYAFHGGFLVYFLCFLGFIAVLAWGSFDITLGYFVNSITHKRTK
IKEVALTFDDGPTEFTPKFLDLLKENNTKATFFCIGKQIEKYPETFQRIIAEGHTIGNHT
LSHSNNTGFLSTSKMIEEIEKCDDVMLKIGNIKTNLYRPPFGVNNPNIAKAIKKTQKKSI
GWNVRSLDTITEDEKKIYRKVTKGLKKGSIILLHDTSEKTYNVLVDLLLFLKDKKYSTFT
VDSIIKNQKK
>KALACAFP_01589 3-oxoacyl-[acyl-carrier-protein] synthase 2
MSAVYINSAACISVQDTLNENFFQNLHPENSTQVLKAIEPIYKEFIPPAMIRRMSKTVKM
SSVASHFALKEAEIENPDAIIVGTGMGCSQDSEKFLKNVIDNQEEFLTPTFFIQSTHNTV
AGQIALGLQCHAYNFTYVNTSSSLEFSFLDAKLQINDGEAENVLVGSTDEQTERTMELYK
LNKTIKKEENLPVDYLNSTTDGVIWGEGASFFVVGKDKTENSYAQLKDIQISSRLDLTEI
QQFIEEFLTKNNLKHDEIDAVILGFSGDAKSDVYYTKAMDVFQNSALLYYKHLSGEFNTA
SGFSTFMACHILKNQTIPEVMMINDLKKEEIKNILLYNHLGGNDHSLVLLERI
>KALACAFP_01590 3-oxoacyl-[acyl-carrier-protein] synthase 2
MGQKIAITGMGIISSIGNNVEENLSSLKSGKHGISDIQLFETRHVGNIKTGEIKLSNEEL
VQKLQLNEDNNATRTALLGMIAAKEAVESAGISDINEYKTGLISSTSVGGMDITEKYFYT
YEDFPEKQKYIDAHDAGNSSLLIADYLGLKGMVSTISTACSSAANAIMMGAKLIKNGVLD
RVIVGGTDSLSKFTLNGFNTLMILTDSYNTPFDNERKGLNLGEAAAFIILESDEIVKKEN
KKALGYLSGYGNANDAHHQTASSENGQGAYLAMEKALKVSGLDKKNIDYINVHGTATPNN
DLSEGIAMIRIFGENNVPEFSSTKAFTGHTLAAAAGIEAVYSLLAIQNNIIFPNLNFKTK
MEEFDLTPVTELKEKNINHVLSNSFGFGGNCSTLIFSKS
>KALACAFP_01591 Acyl carrier protein
MENLREELKHKIIEVLNLEDVAVEEIKDTDPLFGGGLGLDSIDALELIVLLDKEYGIKLA
DPKKGKEIFASIDTMAKFIEENRTK
>KALACAFP_01592 hypothetical protein
MKKTDICTVENSKIILNNKIVFETQTENFSDFAKEAYKTLELNYPKFHKMDNLSKLAFLA
SEMILKEEDQSRTALVFANKSSSLDTDFKYQESINSQENYFPSPAVFVYTLPNICVGEIS
IKHKMQTENAFFVLNEFDENFLNDYSEQILQSGKADKVLCGWVELYQESYKAFVYLLTM
>KALACAFP_01593 3-oxoacyl-[acyl-carrier-protein] synthase 2
MRKEVYITDYNCVTPLGFDVSSNWNALLDGKSGVALHKIIENQEPFYASMIDSEKLEEEF
QKKFDNQDFTRLEKMFLLSLKPLVARHSISDETAFILSTTKGNISLLKNQTALPEGVFLS
NLAQKLADFFGFKTKPIVVSNACVSGVMAIAVAKNMIQAGKYKDAVVVAGDEISEFVISG
FNSFQAIGTEICRPYDKNRDGINIGEATAAVYMTSRCEERSDEITSNEKFSFKILGDSAI
NDANHISGPSRTGDGLFASIKNAMTEANVSAGKIDFISAHGTATIYNDEMEAIAFNRMEL
QNVPLNSMKGYYGHCLGASGLLESIISMESALKNTLIPSKNFKETGTSQPLNIIKENQPA
EIKYILKTASGFGGCNAAIVLEKC
>KALACAFP_01594 Acyl-CoA thioester hydrolase YbgC
MQSKENILSCTEEIRVRFNETDPLGIVWHGHYIVYFEDGREAFGRQHGLTYLDIQKAGFV
TPIVKSTCEHFLPLKYGETFKIVTTFVNSTSAKLIYRYELFNEENKLVCSGETIQVFLDS
DNNLCLYNPEFFQAWKDKMGL
>KALACAFP_01595 Inner membrane transport permease YbhR
MLLYKLWRSFVKEILLLKRDIGGIVIIFVMPLLLIVTITLIQDSTFKNLEGSKIPIIFID
KDKSEVSKSIKKELENSKTFQLLTNYNEKSAQNAVFSGDYQLAIVIPENLTKDLNSNIDS
KVQTIVSSFGLETDSASAKKNVQIKAKDIHLYFDPATNAGFKNSVMNSVNKMVFEIENKK
IYKAFQDQLGTTENLEENKSLISFKEITPKKGASEVIPNSVQHNVPAWALFAIFFIVVPL
SINLVKEKSQGTSVRVRVSPTPYFIHILGKTFTYLIICIIQFLLMVAVGIYLFPYMDLPQ
FDVTGKMFHLIIVTIFAGLAAIGFGVLLGTVADTQEQSAPFGATSVVVLAAIGGIWVPVF
LMPEFMQSIAKFSPMNWGLNAYYDIILRNSGIGGIAKELGFLFLFYIAMVTISLFYERKQ
NAV
>KALACAFP_01596 putative ABC transporter ATP-binding protein YxlF
MAENIIEIKNLYKKYKNAEEFSVNDISLNIEKNEIYGILGPNGAGKTTLISMLSGLIKPT
SGNFKINGLSPQKEGFKLRQIIGIVPQEYALYPTLTARENLMFFGSLYGLSHKKLRNTID
ESLEIMGLSKFADKKVEQFSGGMKRRCNLIAGTLHNPKVLFLDEPTVGVDVQSKKAIIDY
LLDLNKKGTCIIYTSHHLSEAEEFCTKIAIIDHGKIHAVGTPEELVNRVASAENLEDVFI
SLTGKELRDVVV
>KALACAFP_01597 hypothetical protein
MKLNFEHHQTAHCENGVASNLLLNKGLKLSEPMIFGIGSGLFFVYLPFLKVNFAPGFSYR
PMPGAIFSKAAKRLGIKIKRIKFSNPQEAQKALEKNLENNIPTGLQVGVFNLTYFPEEYK
FHFNAHNLVVYGKENGRFLISDPVMDYTTSLSEAELEKVRYAKGALPPKGHMYYPTYIPE
DVNLEEAIKKGIRDTCKNMLAPVPLIGVKAIRWVAKSIPKWAEKKGTKVTNHYLGQLIRM
QEEIGTGGGGFRFIYGAFLQEAAVILKNDQLKELSKEITAIGDLWRDFAVDIARVYKNRN
SKSDIYNNLSKSMLHIADLEEAFYKKLRKAI
>KALACAFP_01598 hypothetical protein
MKKQDLPQDESNLKSANMTEVLYVTDENDNYTTANSIGWEAKKAALDESMELITERIEEA
KQNVASNKVSPIIYFMELNKMDLQVLAAYVGMWQWRVKRHAKPKIFKTLSESVLKKYADA
FGISVDELKNFTGK
>KALACAFP_01599 3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ
MEIKEDNIINIHNFLPHREPMLMADYILELTKEKVVTSFEILEDNIFVHNNEFVEAGLIE
NLAQTCSSIVGQSFFENPETETKVIGFITNIKKIEVFTLPKVGDKIISKASLISQFENIC
NIFCEAFNNDELLIRAEINLFIQEVKH
>KALACAFP_01600 hypothetical protein
MENKLPTSNQNFVESLIPQRFPFVMVSSIAEYSENHLISGFEIKKENLFTHDGIFQASGL
IEHQAQSVALHTGYKFYLLGKQAPTGYIGAIKSFQTEALPKVGDILKTEVKILSEIMGVT
LVDAITKLNDEVIASSQMKTVVK
>KALACAFP_01601 3-oxoacyl-[acyl-carrier-protein] synthase 3
MNDVFITKASTYLPNEPVSNDEMETYLGYINDAPSKAKALILRNNKITTRYYALDKEGNP
THTNAQIAAQAVEGLFDDKFKREDMELLSVGTSSPDQIQPSHASMVHGELNVEKPLAINT
ATGLCNSGMNALNYGFLSVKAGVHKNAVCVGSERMSAWMTADKFNHEAENLILLEERPII
AFKREFLRWMLSDGAGAFLLEDKPRENEVSLKIEFIDFYSYAHEIEACMYSGCEKQENGS
LKSWADYPSDEWLKQSIFALKQDTKLLDQYILVKGAESLRSSFDKHNLDPETVDHVLAHI
SSGYFKEGLKNEFANVGLDFPWEKWFYNLSEVGNIGAGSIFIALEQLMNSGRLKKGEKVL
LCVPESGRFAYSCALLTVC
>KALACAFP_01602 hypothetical protein
MKKNILVIYYSQTGQLEDIVKNVARPFEAKKEEYDVTYYNIKLKEDFAFPWSSDVFFNTF
PESYLQIPSEILPPPEEVLNKKFDLILFGYQVWYLTPSIPVISFLKSGYAEGILKDTPVV
TISGTRNMWMLSQEKLKVYLRDLKAKLVGNIALVDRHDNYTSVLTILRWMTTGQKEKSGM
LPAAGVSDEEIAGSIKYGAIIEKHLSGNTLENLQPELVKNGAIEIRAFLVRVEKVGNKIF
TVWSNLIMKKKEKRPLLIKFFKVYLMAAIWIISPVVLVLHLLTTPIFWFKRKKQREYLQG
INLK
>KALACAFP_01603 Siderophore exporter MmpL5
MHRFFIFLYYLIAKNKLLSVFFAVGIAVLCVFFASKINFEEDINQIIPKNEKSDLTAKVL
KQLNFSDKIIVIIENKSKEDNFQLSETADTFLGKIKPLQKYIGSIQGKVNDNEISETFDF
VNQNLPLFLNENDYKEIERKLQRDSIAKQVENNYVSLVSPTSLVTKEFIKKDPLGITFLG
IKKLNALNISKDFKLEDSYIVTKDGKNLLLFIDPKNKSNDTKNNEAFVNQLNEIKDNLNK
QFKGKTEISYFGSPVIAVANAQQIKKDIQNTVMISMTVLLILLIYYFRNIFTPIIVFLPT
VFSVLLALLILYFIKDKISAISLSVGAILIGITIDYALHILTHYKHNNNIEELYKEITQP
IILSSATTAVSFLCLVFVRSEALKDLGLFAAITVILSSITALIIVPQLYKPKQKESGLNT
NFIDKIGSYPYEKNKPLIIVCSIIIVACLFGFRHVGFNEDIGDLNYIPKDLKISEAKLQK
LSDITSKSIYTISYGDSEEQALARNSQLSRFLEKEKKEGKILSYNSLGNVVLSEKDQQKK
IEEWKKFWDANRKNQTIAELVDNGNKFGFNSSAFDQFNENLNKNYSVLSLKDYEKVKALQ
ISEFLSQENGFYTVSNVVKVDDKKRDAFIKDVEKKHNAIAIDRQQMNENFLGLLKRDFNT
LINYSLLAIILTIIVFFRNFELTVLTMFPIVLTGVATAGILYFLGLELNIFSTVVCTLVF
GVGDDFSIFLTKAMQKEHTTGKNELPTYRISIILAVFTTILSIGSLIFAKHPALHSLALV
ALIGMFSVIIITSTLYPFWFRLLITNRAKKGLSPITFRLFLHSVLSFLYYGLGGLFFSFI
GVVFVKNSKGKTLEFIKLIMARFLTSVLFTNPFVKKKVIKNTKEDFSRPAVIIANHTSFL
DTLAIAMTTHKIVYLVNDWVYESPIFGRMVRALGFYPVSQGIENGMEKLKEKVDQGYSLV
VFPEAERSYSNDVKRFHKGAFYLAEQFGLDIVPLYIHGNSEVLPKGDFIIYDGAITVKVG
DRIKKEDLSFGKNYSERTKKVNAYFREKFAELRNELEDENYFKKKLFLSFLYKDTEVVQE
VKKDFNQNKSVYHELNKHIPKDSNILHIADDFGQKDILLTLQQAGRKIFTIIKDEEKREI
AKQNYIVKRRKISYIKDTTEINKPIDILLVSDEHFNIGEVAVLPETIIFVNCKNTIFENM
NYELKSSSESLKIFRTR
>KALACAFP_01604 hypothetical protein
MFKIFDEKINGFLFVIILPLLLFAMSYYGFESSYTRLKTSDRPPSFLFTSVYSYRVIPNY
LSVQMTDLMEYLINNHLSGFRDFLSKNGTPFYHGLFLMNSFFLVICSLVINTILKFKTVD
FLLNINVRRIIHLLCVFFIVITQYAPTNCDTIALCCYLIGVLLTLKYIHTNKNGYYFILI
VLIALSTLVRETACINIAFFAAVLFSVKELKEGNYQFIWKVIPLVIAFLVPYLGLRAVMN
HEHTTFVEGIYISKNFSSPFNLAGLLFAVIVLYFIYKLCVNEESRTVFKKYLFFSLPYLA
MITLVGLFWEVRLFLPLILTGIIMASHQFKNTKQ
>KALACAFP_01605 hypothetical protein
MSLLHPYYIIAIVYMLFFSVQEVFGKKVDKKWFWFLGIYLIILVGLRDNVGPDYGSYRGI
YIYSDTKEYMSIIRKALHIEGSENVEIEWLYALINKILLNVFNAPFYILTLVIAILAITF
KIEYTEDNTFYPFTFTLFMFIPNFFIGESGQIRQNLGTFIIYFAIRYIKERKLWHYLFWV
FIASGIHNVCYIFLPMYWLVRVPLNRTWMLILIIGSIIASPFEIYRVFGDFLSNVASDSM
LVEGFNGYVEETAERLNGGFGIPEAMMAILTFFLFVFDKKMVEKYPYYEYHRVYAVMGIC
MYFIFRNNPVFSSRMAGAFIGFSYVIIPNVMYVVSSNTKKMIYSFIIALVIFNFVVFASF
RNIIGGRFTIDLYKNHILP
>KALACAFP_01606 hypothetical protein
MKKSINNLVALLCCLVTSGIYAHTGFRDSEVKSLVKDLSYVMRSDSLIKNSGGADRRQSI
NKNFTTSLLPDWTKAPNSYIFDPVQNSDGIYIPVRKAYAMWEQDKYIGGRAIPNGKITAD
VLWEDVHGLIKSGPAYSLEVLDSGQSAKIRVPVNKAKKGNAVIAFRVDGQIYWSWHVWVT
DDPSNGSKYKSYPNVKRQRADGITETIPDSDWGWMDRNLGAVGSSITADEWIKNGGLLYQ
WGRKDPIPPLVYKGNDFYEVTGSIGRVRHRGAKNFTGATSFDNLRKFVLLSNANVTNNIR
LAVQNPLSLIYVNKDDNSGIAYYNNNANLMVNWFGKMTGLNDSQLTELNLWSDNSQGKIS
TNYNADASAQPYRSKSSYDPCPNGWRMPSVLVANLASSTYVDDVRIDYSPFGVRTNMGKN
TFEANNYHKIKPTDAGVPSFMTGFRLYPNFGYDLSNVGGMNMGVFPGTGTISFNAHQGQY
TDQHHTVLWTATMAKHFDATPAVLARSLFMIPDKGQPDIPDPSLPNVQGRYWYFPLGSNT
TSDVNACRCVKDPLYVVDSYDFPTEYLVPETEYREGLSNPNTYQAVKTTSAFNIDIPVSK
AFSVQSQLLNNKSILNTTSFNDLKANVLWTTNTNLINKIAMVNPSPSSLADINNSRITVT
VNPNQSGNAVITLHNGSITNPIYWSWHIWVTDTAIGTKNYTTELPEASVTNYVNYVNKAD
NIFQTEFMDRNLGATDAFPAVANPLTPTAAELAKIKASTGMHYQWGRKDPIPIFQHADDR
TSYPIYLGSVTASGSVVYTTLTGATYNDLAGSYIVPYNTYANSTNANVLATDKVSDKITK
VLSYSVRNPLVYMIPSTFAPYNSAIPAYTNGTDWLANEPNLAPDRWGRGGEKSPFDPCPG
GWRIPDLSGVAITSGKDFGLTPWYKKDKNVATSYSIINDYLGQRVRRSATYSYTIGYIFN
NPSYNVGNYPNSGSRGFRSVMINQTPVGTYNFINLQYPGIWTAALNTNYIGRPINVLFDA
ASSANRMIAFHDNNDPYFGMSCRCVKIKYDANGNEEGVIPKLQITSLPAAISSEILNKSE
VEVIVKDTKISLFPIPVKDELHINAPNNNNGYYYQIYSMSGQLVQSGKFEDGKTNVSSLI
SGTYLVRINSSKEIVKIIKE
>KALACAFP_01607 DNA topoisomerase 1
MQKIFRMSKNLVIVESPAKAKTIQKYLGKDFEVKSSFGHIRDLPKKGMGIDLATFSPDYE
VSADKKKLVTELKAAVKKAEMVWLASDEDREGEAIAWHLAEELKLKPENRKRIVFHEITK
NAILKSIENPRDIDQNLVNAQQARRLLDRIVGFEMSPVLWKKVKPGLSAGRVQSVAVRLI
VEKEKEIREFVPKASFKLDGIFLNKTEQEIAAKLKKDFEKEEDAEKFLELAKSTEFKVLN
VETRPGTRSASAPFTTSTLQQEASSRLGYNVTTTMRLAQTLYEEGHITYMRTDSVNLSQE
AIEGAKRQIVGEYGAEYSSPRNYTTKSASAQEAHEAIRPTDFGVKSIGDSQLNKLYQLIY
RRTLASQMANAKIEKTVIEIGNPKLPQNFEAQGEVIIFDGFLKAYGIVKTEEDDEENNDK
LLPKVSVGEVLDYKKITATEKFTRPSARYTEAGLVRKLEELGIGRPSTYAPTIQTIQNRE
YVDKREIEPQTREVVKMSLTKDKIKKEVLDEKFGGDKNKFIPTDIGEVVNDFLTDNFKEI
LDYGFTARVEESFDEIASGDQKWKQMMTDFYSKFHPRIADVEENADRATGDRLLGIDPKT
GKNVHARIGRFGAMIQIGETDDEEKPVFASLMSGQNIATISLEEALELFKLPFDLSQVDG
QPVSVGVGRFGPYVKWGETFISIPKGEDPLSVDQKRAEEIINEKKIADAPIATYKGEPVT
KGTGRFGPFIKYKDIFVNVPKRYNFENLSQSDINELIDAKLEKEANRYIQQWEKEKISIE
NGRWGPFIKFGKAMFKIPKKADDTKYDGEELKEVSLDEVKKWITDQDKNAFAEKKKPAAK
KAATTKKTTTAKKTVAKKK
>KALACAFP_01608 hypothetical protein
MEKTFTRKEFLQTSALGIAAVVLGSSFTSLLDSDDKPYFNLKPIGRQFSLEGYYIWCSSP
IWGEDGKVHLFYSRWKKEKGMGGWLNGSEICRAEADSPFDKFEHKQVILAPRGEGFWDAT
TCHNPLIKKVEDQYYLFFMGNSNGKTNTKRIGLATSKNLNGKWTRPDQPLLLPGKEGSWD
DHCTTNPAFVKGNDGKYWLFYKSWNTHEYETQKGPVRGNRKYGLAKADSPSGPYVKVSEN
PVIDFSSLPNNAQLEDAFVWKQHGKFHMIARDMGFFNHEYGLHLTTKDGQQWTKPEIAYL
NMKHYITEPTPPKHLNRFGRLERPMLLLDKDGKTPKFLFGATQGGVFETSTTFVFEIVNG
KGDWD
>KALACAFP_01609 Formimidoylglutamase
MNFEDFIISPRNFKTETWQIGNRITKDIKEDSIVLLFVSDYRGANGDAEVQDFTGIRKEF
YKLSQLDFEIPIVDLGDLVSGKSVQDSHYILQEVLSACHYKRAIPVIIGGSNDFAFSLFS
ALNFHTKNINYTQISNIISLKQGEIINEHTFLSKIFGAKNFSIKNYHHLGYQKHLNEVDS
VRLIKEVEFDIIRLAEMMNSTEKTEPFFRKADLVTVNCDAIESFSEPFSMNPQVNGLNRR
EICAYMKEIGLSENLKSVGIFNYNIYSENQLNHQLLAQMIWYLIEGINIQKSHPKERQYE
VFYVLVDDRQYAFKRDTFSNLWYFGEDENIENCIPCSRKDFDEAKKGWLNARLTKI
>KALACAFP_01610 putative glycosyltransferase EpsJ
MTNVPSKVSIIVPVYNVENYLAKCLDSLINQTHQNIEILVVNDGSKDNSEQIIQEYAQKY
PEKIKPFSKENGGLSDARNFGIDRATGDYLGFVDSDDYVTSTMFEEMITLAEKHQAKMVI
CNIQKVDQNGNITQRLTQIPNMPEKIDLEKNFSVFSDLSYFACNKLFKKELFHEKRFKKG
AHFEDIQLIPQLLLECKVLAQTQNFHYQYLERTDSITKTHTERGLDILKAVEDVEQVFKT
SQYSKKREELKNFQIFEGVYSFLAYLAFVKDAETFYEMSHKLKLFMKERDIKIKDILKYS
RFDKNYLLSLPLKKKIFYLLFFAGQKKLIRKLI
>KALACAFP_01611 Decaprenyl-phosphate N-acetylglucosaminephosphotransferase
MKNFELFLTQSGIPIFYVKVGLGFLFSFLITFFSVPTIIKISRRKNLMDEPGVRSSHLRK
IPNLGGIAIFYSIGICASIFAYELFDLYKFLFASLIILLYIGVMDDIVVMRAYKKLVAQI
VVAALIVIGSDIRIRSLFGIFGIYEMEYLVSVLFSITTFIILINAFNLIDGIDGLAGGYS
IICSALFGISYYRLGEYNYPLVVLSAVIIGAVLAFLYYNLSNYRTNKIFMGDTGSMLLGC
LLAFTSICFIDIFIDRELPNIPKYHLQSAPVVAVAILILPIVDTLNVIIIRLANKKSPFD
ADKNHIHHKLLKLNLTHRRSSFYIILYYLFVVAVAYYLRHMNVNLLLLIVVSLGFFGAYL
PDFIYLLKNNKKTNN
>KALACAFP_01612 hypothetical protein
MKNFKNLFLLILPFLITTSCITTKDVRYMQPNESLVINEEGLVPYNIPVYRITKNDILNL
NIVTTPKGDAAQFYSSLNTSGSTVTPGTNSVGSGNGMAMGSIGGNNGNTGGNVIFYFNGL
KVDSNGEINIFGIGYVKAEGRTIDEISTEIQDKVNENFQEGKSQVRLNINGITFYVLGDV
ETTGVTGEKVVHKNTLTITEALAISGGLNRTIDRKNIVIHRKLPEGIKIARIDLTREDVM
NSPYYYVQNGDEIYLNTRAKSLNGFGKDPIQTLTTGVSVITTALSIYLLLKNL
>KALACAFP_01613 Putative tyrosine-protein kinase YveL
MIPGKNEALEKNDSQKEKYGSFSLFDIEHFLRRVLKNWYWFVLMLFMGYALSWIYAKYYA
QNIYASDLSLSVSNNTASYFTPTNQSFNFIWGQGGNQDGVYLKKLLLSRSHNEYLVKELD
LFVNYSTKGVIKSTYLDKDDSPVFLQIDKSHPQQLSYPITLIPKSGNTYEVVLPDEGQST
NLYSYVAEGFVNINPYERPANKIIKIGEWYNSPNLRFRLIANPVMPKIQFTNIIVNLNSV
NQSVNDIVSTVGVEFDKEINTIMIITKKGYNLNSTVNFLNKSVSELQKKRLADKLTVDRN
TAVYLQGNLNTIRKKLDSSANLLNYMKTTEKLYDIKDRDEKSLTRIKELEAKKADIESKL
SSLNMIKQSLESQNFDKMISTNAAGFQDGLFTASVSELKALYLKKREMATIYTPNSEPMK
EIDRLINEAKMGSTGSLRTYYNTYYNEINRINNEVANANSDLDSYPEKQRKYLDAERGYN
MIEATYNSLLGRQNETQMRMATNQSDISVIDPAKNVGQPPIGPNIKAAKAGIIGGLLILP
LLFILVGEFLDSKIRNIKELLNATRIPLLGVIGNNTNENMLTVLDQPKSSVAEAFRGIRA
NVRFLSGENGKSKVILVTSSIGGEGKTYVSINLASVLGLSDKKTILLGMDLRKPKIFGDF
QIDNKYGISNYLTGEVEIDQIINKTRIPNLDVATSGPIPPNPSELLMSERNIKFIEDLKE
RYDFIIIDSPPVGLVADSYELMKYSDANMYVVRHEYTEKYMLKMISEKYHNGEIEHLGLV
YNDYNTKQGYGYGYGYGYGYGYGYGYFDEDKNYKEPLLIRIRNKVQSIFNKK
>KALACAFP_01614 hypothetical protein
MQKLIFKITINPYSFMNRKLLFSFLAALGTVVSVKAQRNELGVRLGMSNLVGDIGRTNYI
LQKPLDLSRTSDWGVPFYGGILYRFNFNPHQTVRLDLGYNQIQFSDKVAKEEYRKNRNAF
GKNNVYEASLVFEYNFFPVNNEQKGMVSPYIFGGVGALMFDAPKATLVNDFRRDADGVAQ
APINELDFTTTPVYSTGTKTTMHIPFGVGLKYKFNYSWAIFAEATFRYTMTDQLDHSRIL
SKDVISTYNGDILSPITGGSLLETDAYYVVSKEREAAFLGERNIGDLKSKDWMNTFSLGL
TYSFGRPPCYCD
>KALACAFP_01615 Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific)
MSLIKDKIDPENLPKHVAIIMDGNGRWAKSRGEERTFGHKNAIDAVRNAINACNEIHIPY
LTLYTFSSENWNRPADEVNTLMNLLVETLLLEAEEIFSKGLRMHVIGNLEKLPPLVKDQL
LRVVELTKENTKGNLVLAISYGSQNEILNAIKNISEDVKEGKVAVESIDEKLFESYLYTK
DFPPVDLLIRTSGEIRISNFLLWQIAYAELQFLDVLWPDFTKDIFFQCIVNYQNKERRFG
MTGEQIKIQ
>KALACAFP_01616 Putative outer membrane protein assembly factor
MKFRLLPIIMFVASAHFYGQVTPQDSTKVSNSVHAENQAGTYTLKDIVVDGVKKYTPAQI
LRFTGLSKGETVDIPGQKISNAVKKLWDTQSFSEVEVYVQSIEGETIVLRFYLQDLKDLG
EVKFTGRGIGKSKSEKLAKDNNLKPGTKITQNLVSSLKTNIPKDYIKKGFADAKITIQDK
VNAGDPNLVDWTINVDKGKRIKIDHIEFEGNENVTDRKLRNKAFKETKQKRFGIGGILKS
SKFIEDKYQEDKQNLISYYNSLGYRDAAIVSDSVWRNKRNNYEIDVKLKEGKQYYIGDIT
FTGNTVYSTDYLQRLLGYKKGDIYDAVGFNKKVGEDGGKEDDSDIKSVYMNNGYLFSNVT
PVEKSVNGDKINLEIRINEGEKATWNRVTWEGNTTTHDHVILRALRTKPGSLFAKSDIKR
TYFDLAGMSFFDPQQIGQDIQPNQQDNTVDINWKLVEKGSSQVQLQAGYGGNSFIGTLGL
TFNNFSLRNFLKFKDFKPVPQGDGQTLSIQAQAGQYFQNYGVSFTEPWLFGTRPTALSVS
LNNSRVKYSDAYGASQKLNIFSASVGLNRLLKWPDDYFSLYTGLQYQKYDFSNYPFQFGE
TTEYYGSANNLSINLGLSRNSAGIDPIFPTTGSNLDFSVKFTLPYSAFSNKDYSTMSPMD
KYKWMEFYKVKFKADVYNEIVGKLVLRSSAEMGFMDGYNKQLGAPPFERFYVGGTGLFGG
RYDGRELIPLRGYENASTYGGTSEDITPTGGGTIYNRFTLELRYPISLNQTAKIYALTFA
EGGNVWNSWGSYNPFQLKRSVGVGVRVYMGAFGLIGFDFAYGFDKTIGSSEPSGWKTHFL
MNQSL
>KALACAFP_01617 hypothetical protein
MKNFKIVFSFVLFLLFGLSNAQKIGVVDTDYILNKLPQYKEAEARLNSQIDTWQSELQNL
QSEYERKRSAFESEKVLLIGDQLKLREKEVMDLEKNIKTTTSLRFGATGEIAKLRTNLVQ
PFQDEIWGAIKTMSEKNGLGIVLDKTSNNVLFLQKRYDYSDKVLDILLKGTDKKEKTNTK
K
>KALACAFP_01618 hypothetical protein
MKKLSVLFAAVMMVVSVGMAKAQKIATLDVIGVLNAMPEKKKADADLKAFLDTKQAEIKK
KADAGQAKLKQYSEEAPKKTADENKAREAELAKMQEEIQQMNDKAQKDFVAKQDTAYEPI
EKKLNDAVTKVAKANGYDYIMDANSSAFVYKGGPDATAAVKKELGVQ
>KALACAFP_01619 hypothetical protein
MEREVSTTVKVRFSDCDPIGHLNNVKYLDYMFNAREDHVETFYGFTYEEYTKQTGCTWIA
IQNEIAYLKEVRYNTSVVISSKTIDVQDRTAKVEILMKSSDEKTIHAVLWVTVIYFNVKT
RKSDVHPEDIKETFNKFYVDLEQKDFQARVKFLRSQNAKNS
>KALACAFP_01620 dTDP-4-dehydrorhamnose reductase
MKKILVVGGNGQLGNCIRKIAPDFELDYEFIFTDSQTLDITNEDQVNAFFYENKPDFCIN
ASAYTAVDLAEKEKEKAFAVNADGVAHLAQACKDYKTIFIHVSTDYVFDGETNLCYSEDD
FTNPIGVYGESKLKGEELALEINRKTVILRTSWLYSEFNKNFVKTMLNLFSQKEELGIVA
DQFGQPTNANDLAEAIMEIIEAPQKTYGIFHFSNYPETTWFDFAKKIAEFSKSNIKLNQL
TTEQYPTPAKRPKRSTMCLDKIEEIYKIEPKHWENSLEECINILHNNI
>KALACAFP_01621 hypothetical protein
MKKIIFIVFVFLIQFFNAQNVYLTKVEKTNENTDKFLYRINEEVKDAEYLGEVEVQGFSK
DDAEIFSLLYKKAKEIGANTFSLKPFENIDGSAQNFNPANYKLSLYYLPKEKLLNQTGYL
YVFASSEKDQKINLNKQDYVISPRSYLVVKTIPGVVYTISTKKLLGSTIKIQPKENSSNQ
YFQISSTKVKSDETGVGGLNLKSGDIIGLEKSYAEFLSTIYNKDKQSN
>KALACAFP_01622 hypothetical protein
MTTQQKIIKNKLGVLELAQHLGNVSKACKVMGYSRDSFYRFKELYEQGGELALQEISRRK
PVLKNRVDEVIEKAVVDIAIENPALGQLRVSNELKKKGFIVSPGGVRSIWLRHDLHTFKL
RLKALEAKSAQDGVVLTESQLSALERAKEEKKAHGEIETHHPGYLGAQDTYYVGNIKGVG
HIYQQTFIDTYSKVAFAKLYDRKNALIAADMLNDQVVPFFEQQELRLLRILTDRGTEYCG
IREQHEYQLYLAIEDIDHTKTKAKSPQTNGICERFHRTIQDEFYAIAFRKKIYRSIEELQ
LDLNSWLSYYNNERTHTGKHCYGKTPMQTFSDSKPIAKDKLLETLAEEQKILTFGSKDNI
G
>KALACAFP_01623 hypothetical protein
MYSLKNLKIVLFILLITIFSNNLKSQKIKVGDFTVLAFYTGKNDMAHISFVKEANHYFDS
LSIVKHFEYQSTDDWNRMTFDELSKYDVILFLDTRPEDPDQRKAFQKYMEKGGSWMGFHF
SAFSLEKSAHENNWSWYHDTFLGSGDYKSNTWRPTSAVLKRIAKNKFSPEKFINASPNEW
YAWKNDLRRNNDIEILYAIDERSFPLGTGPKKHEIWTEGFYPIIWKNKNYNMIYSNIGHN
DMDYEHQYGKNSVRTLSFTFRSKDYGDFIINAIYFLAKEKRRRFGL
>KALACAFP_01624 hypothetical protein
MTDITEYDKNPSPDRNGYPAVDVGKFESGRALELGRIGRMERGVKVDSRISF
>KALACAFP_01625 hypothetical protein
MKEHIARGFRFETYKAPELSVFDRLLEIFTDLLTHTSGDFDEAIDWLRMLDEEYQLTTPE
YTIDDFIEDLKKKGYIREEVDPNGGGNGVRLSAKMEQNIRKQALNQIFGNLGKSGNGNHK
TKKSGTGEDTTGEFRNYNFGDPVEKISITESLKNAQINNGIGDFHLTENDLIVEDSIHQS
QMSTVLMIDISHSMILYGEDRITPAKKVAMALAELITTRYPKDTLDIIVFGDDAWPVKIQ
ELPYLQVGPYHTNTVAGLQLAMDILRRKRNTNKQIFMITDGKPSCVREADGTYYMNSYGL
DEYVVQKCYNMAAQARRLHIPITTFMIAQDPYLQHFVSEFTEANQGKAFYTGLNGLGHMI
FEDYEANRKKRIR
>KALACAFP_01626 hypothetical protein
MTAKPDIKTLGSLKASGYTIKSIKDELRDNLRNKILNKESVFEGIFGYENTVIPQLEHAI
LSRHNINLLGLRGQAKTRLARMMTTLLDEWIPFVEGSEINDDPFNPISRFAKELIETEGD
NTPIEWLHRDERFFEKLATPDVTVADLIGDVDPIKAANLRLSYADDRVIHFGMIPRANRC
IFVINELPDLQARIQVSLFNILQEGDVQIRGFKVRMPLDIQFVFTANPEDYTNRGSIVTP
LKDRIGSQILTHYPENIHIAKEITKYELSADERQENKVYVPSLAKDLLEQIGFEARESEY
VDLKSGVSARMSITAFENLLSTAERRSLLAGDEKTTVRLSDFVGVIPAITGKVELVYEGE
QEGAEAVAQMLIDNAVSSLFTTYFPKVEKLEKKGIDGPFSQITDWFLEDDGFLEITDESP
DEAYAKALNRISPLDQIIEKYQPNTKEEDILFMKEFILWGLAVNKKLNKERFRTGVFFS
>KALACAFP_01627 putative propionyl-CoA carboxylase beta chain 5
MDIEFNKREDQNRLKLSEINRLLADIKKGGGEKRLQKLRDEGKMTARERIEYLLDKNSDS
IEIGAFAGYEMYEEHGGCPSGGVVVVMGYVSGRQCIVVANDASVKAGAWFPITGKKNLRA
QEIAMENRLPIIYLVDSAGVYLPMQDEIFPDKEMFGRIFRNNAKMSAAGIIQISAVMGSC
VAGGAYLPIMSDEAMIVDKTGSIFLAGSYLVKAAIGESIDNETLGGATTHCSISGVTDYK
AKDDKDALDRIKNIMKSTGSTEKAGFDRIETALPKEKPENIFGIMPVSRAEQYDTYEIIK
CLVDNSEYEEYKSDYGKSIICATARIDGWSVGIVANQRKLVKSGKGEMQFGGVIYSDSAD
KATRFIANCNQRKIPLVFLQDVTGFMVGSKSEHGGIIKDGAKMVNAVSNSVVPKFTIITG
NSYGAGNYAMCGKAYDPRLIVAWPWADLAVMGGAQAAKVLAQIQESTLKKQGKEITEEEH
NEILDTISKRYQKQTEATYAAARLWTDAIINPVDTRKWISMGIEAANHSPITEKFNLGVI
QV
>KALACAFP_01628 hypothetical protein
MHKLALFRLHLIVFLWGFTAILGKLIHANAQILVFYRMLFAAVFLFVFIRIYKKESIKVS
KKIFFQLAAIGFAMALHWFCFFYSIKVSNVSIALSCLSLSTLFASILEPVIFKRKIDISE
VLMGVVIVACILLIFKTEFQYKEGILYGVLCAIFGTIFSVFNGKMFGKTSSGNIIFYEIF
CGWAILMIIYLFTGQIFQMNEISYRDIALICLLASVFTAFPMLESVNLMKYISPFTLILT
VNLEPVYGIILAFFIFGESEHMSPIFYIASGVMILAIIANGLIKAKKQKTLN
>KALACAFP_01629 hypothetical protein
MMKKYLLLVFSLLFGISQSQIIRKYSNEFLNIGAGARGLAMGGAVVSNQDDVYSPMWNPA
GLMAIEKDWQGAAMHAEYFESIAKYDYLAYAKVLETGVFGVSVVRLGVDNILNTTQLIDT
EGNIDYDKITKFSQSDYAAILSYAFNPAGNTKLDVGVNAKIVYRNVGKFANGYGFGFDIG
AIYKMDNGYKIGGMLRDATTTVNFWSVNQKELSTIVNGEEFNPAPKDKMELTMPKLNVGV
SKNFEINSSVYVLPEAGINVDFAKTAALISTDFASITPYAGAELGYQKMIFVRLGVNRFQ
SITDIEDLKRKVSFQPSAGIGIRYRGLTLDYAITNSGIGGSNFYSNFFSLKLDMGQFRND
>KALACAFP_01630 hypothetical protein
MKKLSIVLLTACSMLAFGQKISDYKYISLPAKFETFKEDFGLSELFTKTLRGKNYTVIPA
DKLQWPAEAKDNPCNVLMGDVKDDSGFLRNKVLVQFKDCNDKVVSSIKGASSIKDFKEGF
QDALKQTFVSISPANPVNQPGGTKIQETVATTQVTTQSTVTNTSSSAPDNSALKFSNGKI
DLQKIQIDNSQFILVNSNSSSPFATFKATTKSDVFRVKLQNGDSTLGYYENGNIVIEIPQ
SNGEFAKEVFLKK
>KALACAFP_01631 hypothetical protein
MKINYSFSKLLASLILSAVGSFVNAQTYCNPTYSSGCTSWRITQVTIPQASFDNTFAAGT
CTSGRDRTSVMVNLNTNTNYTINVSTTNWIACGMAIDFNNDGDFDDAGEVLFLPAYIANQ
NQTYSGDFMVPSSVPVGTYRMRIWNRLANSGAGTPTADSACSTYGYGTWTDYTANVLGPL
ATSEVTKATAKIYPNPVSDVLNIENKNAIESIEIYDANGKLIRTVAQKGNNASVKLSDLV
PGSYVAKIKTGKDNQTVKFIKK
>KALACAFP_01632 UvrABC system protein C
MEFLQLFLCPEIPYFCYMNPSLELQLKTLPSEPGVYRYYDKNEQLLYVGKAKNLKKRVLS
YFNKNLSGYRTKIMVGKIQRLETTIVNSEYDALLLENNLIKEHQPFYNVMLKDDKTYPWI
CIKNEDFPRIFLTRTVIKDGSEYYGPYAKVRPAKILLDTIKHIYKLRTCNLNLSPNKINE
GKYKVCLEYHIKNCEGPCEDLESKQDYDEKIDAIRGIIKGDFRKAKEYLVNQMMKHAANL
QFEHAQLIKERLDVLEDYQAKNTVVNPNIDDVDVFGMTSDETAAYVNFFKIRNGNIIQSF
TTEIKKILEESDEEIMEQALIEIRQKFSSDSKEVLLPFHLPIEIPNVKLIVPKVGDKKRI
VELSEKNAKEYRLEKLKQVQIVDPERHTNRIMAEMQKLLRMPVEPRHIEGFDNSNIQGTN
PVSACVVFKDGKPSKADYRIFHPKTVEGPNDFATMEEVIYRRYKRMLDEGENLPQLILID
GGKGQLSSAVKSLRLLGLYGKITIVGIAKRLEEIFFPEDPIPLYLDKKSETLKILQRVRD
EAHRFGVKHHRTRRKNSTIKSELEEIPGVGEKTIEMLLSKLKSVKRIKESSLETLEEILG
KSKAKIIHDFFNNL
>KALACAFP_01633 hypothetical protein
MKLKTLLLALFLVSTASFAQKVKYSKEEIKKMEQYLFNEGFNAPSPKKTSTVILKDGTTV
KGFCNKIDTKKGQIFEVSIKDSVTKKPTVLEADNISEMYLFPNEAEKFMKVAKYMGNIRN
YQTKKLKNTTTNGRIHFVNQTVSLKNKKDDKEFLMQVINPEFDDIISVYHDPRAKETTGF
SVMGSPQLGGGVIKSYYVKKGDKVMWLHKDDFEDNYDFLFGDNAEFMKKYPKNSVEWDYF
SFLVYEYTSMNNG
>KALACAFP_01634 Histidine ammonia-lyase
MIYGVDVFSFHDVLEICKTPNKAKLNKAAKEQILKSQKNVQKIVESDRCVYGINTGFGPL
CDTKISADETALLQYNLIISHAVGVGKPIDKELSKIMMIAKVHALSKGFSGVSLEVIERM
ILMLEKDIIPAVPEQGSVGASGDLAPLAHLVLPLLGLGQVWEGDKVVETAKVLKKNKLAP
LTLGPKEGLGLINGTQFILAHAIKGLEKFEYLLNLADMTAAMSLEAYRGSQSPFKKELHE
IRPFEGSKKVAARMLKFLKGSENMKAHEDCERVQDPYSMRCVPQVHGASRNAYEHLRMMA
ETELNSVTDNPIVLSAEESISGGNFHGQLMALPLDYATLAAAELGNISDRRSYLLLEGKY
GLPRLLTESSGLNSGFMIPQYTSAALVTENKTLCFPASADSIPTSLGQEDHVSMGSISGR
KFNQVLGNLVNILAVELMFAAQGLEFRRPAKCSKIIEENFTILRSKVAKLEDDRLIGKDM
LAIAELINERKFVVN
>KALACAFP_01635 hypothetical protein
MTIKRTDSSNIDFQNLVKLLDADLAIRNGEDHAFYDQFNKIDMIKNCIVIYIDEKPAACG
AFKKFADDTVEIKRMYTHPDFRKRGLATAIVNELEAWAKEIGYEKTVLESSLEQNEALSV
YEKSGYQRIPNYGQYIGIDKSVCYEKVL
>KALACAFP_01636 Alkaline protease
MKKNVFYLLMLFFVFTACNRDDLQNNPSNIEVTQKDPLTAKEINEKINETIKAKGRFSWK
ESSDHFVWSAIFQGNKIASIGFGSSFDRSLTPDNKVIEEEILKLIEQYEGKTDRILLSSD
QYLTQIDVAIEKQETVIALRKMKNIRYIEPADYRYFENERKFNGAAKSSSSSSGCGFEST
ALNTADYTTVTPNAKAPWSFTKHNIINAWSYSTGAGVTIGVIDSGVSPEQTLLGSSFNNG
LSSGRTISKNGVYVDSVWPWSSGFDGPNDQCGHGTSMASAMGAPRNNLGQPVGVAYNANL
VTYKAASNVVLDGYHEQNGVKIAFTELGNNNNVKIISMSMGHIFSVGKIEDGVKYAYSKG
KLIFCAGGTSTSFTNFVGVIFPAWMSEAQAITGVKENTSNQKCDVCHSGSEIDFTYQMER
ASGNSIPVLSYYNGQTDYVGGSSVATASTAGIAALVWAKNPSWTRDQVLNKMRQSATYYP
TPNSDYGYGNINVLQAVQ
>KALACAFP_01637 hypothetical protein
METQELVVGGWTKYHALTPEDQKVFDEAMRGFVGVKYTPQQVSTQLVNGTNYRYRCIASM
PPSQVVWEAIVEIYAPIEGEPHVVSIHRI
>KALACAFP_01638 4,5-DOPA dioxygenase extradiol
MNLNDLQNISDHFKNTQRMPVLFLGHGSPMNAIEENQFVQGFRKAAAEIPRPNAILCISA
HWFTNGTKVTAMDMPRTIHDFGGFPQALFDVQYPAPGSPELARETAELLAPVLVEEDHQW
GLDHGAWSVIKHMYPDADIPVIQMSIDYTKPPQYHFDLAKKLNKLREKGILIIGSGNIVH
NLRLIDWRNINTVGAGWDWAIEAREKTNNWLLDGNFGNIIDYQNQGTFLQYAVPTPDHYL
PLIYTLGLKEKSENLTLFNDELIAGSLSMTSVKIG
>KALACAFP_01639 Protein YceI
MATKWNLDPAHSEITFKVKHMMISNIKGNFTNFNAEIEADDDTFANAKTNATIQTDSIST
HNTDRDNHLKSAEFFNAEANPTITFESQALNGEVTGNLTINGITKPVTLDVDFNGINVDP
WGNTKAGFSFEGKINRKDFGLNWNAALEAGGVMVSEEVKLAGELQFVKQA
>KALACAFP_01640 Prolyl tripeptidyl peptidase
MLVLGGSALAQTQKFTMAEAVNGLRSNLAVKNISQFSWSNDGKSYIQAVKGGYLITDLKT
NKQDTLVSLTQLNKNLADNKFKAVPQIKFISSSHGYFNSDDKMVWVEKSGSDWKVKNSVA
VDKEASNVKVFGDNQTFAFTVKNNLFVNKNGKTIAVTNDSDENILNGASNVHRNEFGIDT
GIFPAPNSESVAFYRMDQTMVADYPIIDWAVTPAVNHNIKYPMAGQTSHQVTLGVFNIKT
QSTTFLKIDGEKDQYLTAVTWSPDSKYIFVGVLNRGQNHMKMDQYDAATGDLIKTLFEES
NDKYVEPQHPLTFFPNSNTDFIWQSQRTGYNHLFHYSLEKGLIAQITKGDWLVTEILGFN
EKKKEIYFTSTKETPLEKHLYKINWTNFKMQRLDNAEGVHNGILSSDGNYLYDMYSNANT
PRIANIINTNTLKSNNILTAENTLKNYQRPEIKNVELKADDGTPLYGKIILPTNFDANKK
YPVIVYLYNGPHLQLIANTFPASGNLWYEYMAQNGYIIFTMDGRGSANRGLKFEQAVFRN
LGTTEMNDQMKGVEYLKSLPYVDSERMGIHGWSFGGFMTTSFMLRHPEVFKVGVAGGPVI
DWSMYEIMYGERYMDTPQENPQGYATANLLDKVQNLKGKLLMIHGAQDDVVVWQHSVKFI
KAAVDNGVQLDYFVYPGHPHNVIGKDRVHLMQKVTDYFNLYLKK
>KALACAFP_01641 O-acetyltransferase OatA
MNFVKIDRVHFHTFDSLRFLSFLLVFLRHSPVPEDSMLYYFSHEGGIGVSFFFVLSGFLI
TYILILEKINNQGEIPLKKFFKRRILRIWPLYYAMVIFAMCTPFILGFFNISYSNQGYQP
NWFFTLTFLENYVAMFTRQLPNVAPLTVIWSLCVEEHFYIFWGLAFYCISLKNVPKLLVG
CIIFSFIMQIVYEKYEINTLDLFTNIHYFAFGAIPAYLFVFKKNIIEKLSLIPAVYKYLY
AVSIIGVIVIVSNTNLIPDLKVSSLLFSVFFSGLILFTLGEKNVFKISDKSILAKLGKYT
YGLYLIHTICISLFIKIGSKYDMNWIVITLLSFVSTVIFSALSYHLFEKQFLKLKN
>KALACAFP_01642 Alkanal monooxygenase alpha chain
MELGIGMFGDLSFDQTTGQYRDPGVKIREILEQVKFMDEVGIDVFAMGEHHRPDYAVSSP
EIVLAAAASITKNIKLASGVTVLSSSEPVKVYEDFSTLDLISDGRTEIFVGRGSFIESFP
LYGYSLNDYEELFDEKLDLLLKINSEKNVTWSGKLRAPMNNQTVYPRAKNDGKLSIWRAV
GGTPQSVLSAAQLGMPLVVAIIGGMPVQFKNLIEFYKQEYKKAGHDVSKMQIAVHSHTFV
SDDPNIIDGYFDNYKTQVDRIGASRGWAPFTKMQYEGGRSKDGALFIGNPKEVADKIVYL
KEIFGITRFIGHMDVGDPSHDIMMKSIELFGKEVKPVIKNL
>KALACAFP_01643 DNA-binding protein
MQQPSKDPLHGKRLDAILEELVEYYNGFEKLGEQIKIRCFTDNPSINSSLKFLRKTPWAR
EKVESLYLYVLRQKKKNNKPQN
>KALACAFP_01644 hypothetical protein
MVQIKLAFRIVIDQESTMLWDKYIFEDTYFEYRVQHQVFDNEKEPVDNYWELLVKNPNAA
KIPFLLSAVVSNYVAQLNGSIKSLPDVLGTTFFPIETFRLDLISSNVTDASKHKLGITFY
TPILQLIDIIDNKYLLSKSEDTDHLETFMFAFHPQIAIAYYQNS
>KALACAFP_01645 hypothetical protein
MLTKNNSTIFNSNTRSWDKTDFFIINEIELPDEGLKLKKVTEIIINEGQTFYLDYEANSQ
IVVIVLYGKIITDSLPYEIPSDQMIILNPTQKDRLKIKNGFQDECADIIIFEIDNQNNES
FICLEDLNIKKKNELIPLSGSLNFPAFIGLYDGRKKQKYELKQENKSIFGIVINGACEFQ
DRLMETRDAILLYDLDTLEFEALSENLLIIFLEV
>KALACAFP_01646 Chlorocatechol 1,2-dioxygenase
MDRKNFLKNLGLAGVTAIAAPVLIRCENEITRENTNCNLTNYDLEGPFPTKSPSILERVN
IIGDRIGVPFEIHLTVKNKNTECSNLQGAFVDIWHCDKDGYYSEYGGGELQPVDYTHLHF
LRGRQVTNTNGEVKFTSIFPGWYTIGDITRATHLHIHIYNSKGNSLLVTQLAFPDDPNSA
VVKVNQSPGYKGMNGYRYNSEDDFFYDGVSTQLLNISGNINEGYVGAITLIVSA
>KALACAFP_01647 FKBP-type peptidyl-prolyl cis-trans isomerase SlyD
MTIENNHVVAVKYILHTIEEDGSKILVEETTEENPLTFLYGMGMMIPKFEQNILGLKAGD
KAAFVIQPEEAYGERQPDAIAQLPLDMFNESGTPPVGAILPLSDNQGNNFQAFVVEVTPE
AVVVDLNHPMAGKVLDFQVEILNTRPATEEELSHGHAHGIDGNEAH
>KALACAFP_01648 hypothetical protein
MNCPCCSGKSYEDCCKPYHTGEKYAPNAEALMRSRFSAFAIPNGEYLMETTLPSKRKYHN
KKDMQEWGEINEWTKLEIVNKPAPDKVEFKAFYTDEDGQKQVHHELSKFKMIQNRWFYVS
GEFLE
>KALACAFP_01649 Dipeptidyl carboxypeptidase
MKKISSVLLISALALNQSCTTMKKTDIQQEVPSPDASLSSNPFMKKSKLQYEAPEFDKIK
DEHFKPAFDFGLKQHDAEILKIANNPEAPTFENTIVALEKSGEVLKRAMIVFSNLTSANT
NPTLQALDEQYAPVFAAHSDKMYLNENLYKRIKAISDKGLDSESKRLLQYYKQNFEIAGA
NLSAADKEKLKQINQELASLSTQYSNKLLEARKQGGVYFSDAKELDGLSADEIAAAATDA
KNAGKEGQYLLALQNTTQQPLLQNLKNRATREKLFKASWLRAEKGDGNDTRETIEKLAKL
RLKKAQILGKKSFAEWKLQDQMAKTPEAATKLMNQIATPAVETARREAKDIQDLIDQQKG
GFQVEPWDWNFYAEQVRKAKFDLDESEIKPYFEITTVLEKGVFFAAEKFYGLTFKKRTDL
PVYHPDVVTYEVFDHDGKSIAIYYLDFYTRDSKNGGAWMSNFVEQSYLLGTKPVIVNCYN
YQKPAPGKPSLISYDDVTTIFHEFGHSIHGMFASQKYPSLSGTNVPRDFVEFPSQINEHW
ALDPVVLKNYALHYETKQPIPQALVDKIKKAATFNQGYMTTELVSAAELDMDWHTVTNES
QLIPVLDFEKQSLTKHGFTLATVPPRYHTPYFAHIWGGGYSAGYYAYLWSETLDNDAWEW
ISKNGGLTRENGDRFRKYILSVGNSVDLNQAFRDFTGHDPDIKPLLRNRGFIK
>KALACAFP_01650 hypothetical protein
MKSQSLFIFSAFLLLASCNEKHDRKYNDNKDSNWVDKVVNTDHGPVRQKEVSGDFDEIEV
SQAIDAEIIKSDVEKVVISAPENIIDEVLVDNSGGRLHIHYKPGIRVMNTHNVSAKIFAK
DFSKINANSAAKITVKDKFVQDKTDIEVSSAASVSGDLEANDFNISADSSSNFTGKVWAV
DLDVDASSAASIDISGKAKNAEISSSSGSSISANNVVADNVNAEASSGASVDISASSTIK
AEASSGGSVTVYKKGNVTSVTKEENSGGSVSIR
>KALACAFP_01651 Glutathione-regulated potassium-efflux system protein KefC
MESSLAMNTLIFLGVAIIMVPLARKFGLSSVIGYIIGGILIGPYVLKLTGKDVDGIMHAS
EFGVIMLLFLVGLELEPRKFWEMRKKIIGLGLTQMLLTIFLLFLVFIWAGWRIDKAIAIA
ICFALSSTAIVLQTLQEKNNLKTLAGEASFSTLLFQDIAVIPILAILPIIANYKARHHDN
DIQVLIQTLPEWMQAATVILGVVILILLGRYVFVPFLRYVSKSGMSELLTASSLFLVIGV
SELMVAIGLSPALGAFLAGVMLANSEFRHELEAQIDPFKGLLLAVFFVSVGSTINFTVIQ
KDPIFIFSTVFAVLIIKFFVLYVIGKFFKIDTPQSLFYAFALSQVGEFAFVLINYASSLY
LLSKELNSQMMAVTAITMCITPLLLIINDKLITPKFIKDVPEGDHDYNILDSNVSQKKII
IVGFGHFGSTVGRLLKANKISATVLDRDSDRVKLLRSYGFKVYYGDATKLPTLRAAGIED
AEILVLCLDDTDDNKFIADLVREHYPTVKIFVRAKNRIDAYDYLNNGINNIYRETLGTAV
EMAVDVLHEAGMRKYAARRLGQRFMAIDKASIRKLAKTKDKDDEVLLFTTKEILQREEEL
LAYDNLNFDILQWEDSSSDDDEEPEN
>KALACAFP_01652 General stress protein 14
MKKTLVVFAHPYLEHSNSNVELVNFYVRHQHFTLRDLYEEYPDFHIAAFRERKRLKNYDR
FIFQFPLIWFGIPPLLRLWIDEVFDRDWLKEGHNNPLEGKEVYILVTTGGKERSFSKTGT
YKFTVEELISGLIVSLNVFKANIKNIKVVYEANKLSKKDIILHKQEFTELLNK
>KALACAFP_01653 hypothetical protein
MSILHDYLASDGKTQALHSFLELKYIYKYYLLIISLLSLAFIIFAYRKKENKGITFTAIL
SLFIGIASVFLEIWKWFI
>KALACAFP_01654 hypothetical protein
MKLRSLKIVFSFLLICFYNFVSAQYTVPEKPKILYPVYDEANLLSQQEKDDLNKKLIAFA
DSTSTEIEVVIIPSTKGEDVNFLATMFGEKWGIGKKNVDNGVVFLIATEDHTMSIQQGRA
VEQYLTASVAGQILDYIVTPHFKQGEWYEGINRGTSAIMEAVQGKFKPLNNEESGGDGSV
FKILLIAFVIFIIIAIMFGNRGGGKGGGNYDDDDVILSKRGRRNYPGGFFPFPGSFGGGG
FGGGSSGGGGGFGGFGGGGSFGGGGASGGW
>KALACAFP_01655 hypothetical protein
MSKFLTNQQIASLVEAIQSAEQHSTGEIRVHIDSNTEDDNAKIAFKVFEELCMNKTAERN
AVLFHVNFEQKYLTIIGDTGIHEKVHQSYWDHLHDYITSEFAKGNYYKALKSAILETGLE
LKKHFPVTGENHNELPNEITFS
>KALACAFP_01656 hypothetical protein
MKNKGCLSAGTIGIALLIIVAVLFFWGKSGYNSFVTKEQNVNTKWSNVETVYQKRANLIP
NLERTVKSYSKFEQETLTKVIEARSKATSINVDPTNMTEQDLAKFQAAQGELSGALSRLM
AVVEQYPNLKADQQYINFQREYTAIENSIRTETVYYNAAAQDYNTSIKTFPNNILANFTN
FKEKPYFKADAGAQKAPDAFSE
>KALACAFP_01657 Dihydrofolate reductase type 3
MTTIVVAMGEKNEIGFENQLLWHLPKDLKHFKDITSGHPVIMGRKTYESIGKPLPNRTNI
VVSRQKDWFEEGILIVGSIKEAVKFAKKIDEEVFIIGGGNIYEQTMDVVDRLEVTLVKAD
LEADTFFPKINEKVWKKVNEVCHEKDEKNQYDFCFQTYERV
>KALACAFP_01658 hypothetical protein
MKKTRKINTISAFRHMKEFRVLSLAFKVFITLNFNPITLNSES
>KALACAFP_01659 hypothetical protein
MNKYIKIVIAAVLILLGLYMMFFTRNLGWGIVITLLASSPILLFFKNEYILLAFWQLRKQ
NMEKAAVWLNNITNYQAQLHKSQYGYFHYLMGLTQAQDHPAKVEPFMKKALEYGLNMKHD
RAMATLNLAAAAISKGRKQEGQKLLEEAKRLDSAGMMADQIKMMKDQLKMPSMQKHMHNP
NMRNRGKFF
>KALACAFP_01660 hypothetical protein
MHEQFNFLIEVLGTISFSMSGSFAAMQKRLDPFGVLIIAFVTSVGGGTVRDLLLDIPVFW
MHDLLTCALIILTSIFTMIFKSFEKNVRVTLFIFDSFGLGLFTIIGVQKGLNADIHPLIC
IGLGTITGCFGGIIRDILLNRIPLIFRKEIYATACIVGGSAFLLLTKFTTLSFTIIQIFT
ILLIVTIRTLAVKYHWQIPKFYGYNNDGEM
>KALACAFP_01661 Phosphopantetheine adenylyltransferase
MKIAVFPGSFDPITLGHYDIIERAAPLFDKLIIAIGQNSQKKYMFPLEKRMEFIQNSVAE
FPNVEVDYFEGLTVDYCFEKNAQYILRGLRNPADFEFEKAIAHTNRTLAHKKLETVFLLT
SSGKSFISSSIVREIINHGGEYELLVPDSVRVERKK
>KALACAFP_01662 D-alanine--D-alanine ligase
MVMSKKSVAVVMGGYSDEYVVSLKSGQLIYDSLDRDLYDVYKVVILKDEWYFLGENDKKY
EISKGDFSVTLDNNETLKFDVCFNIIHGTPGENGILQAYWDAIGQKYTGCDFYQSALTFN
KKDTLAVLSKYGIPSAKSVYLRKGEEINVDEIVETLGLPVFVKPNQSGSSLGISKVKEKS
ELIAATEVAFKEDDEILIESFLNGMEVSVGVIDYKGETIVLGITEIVPKNEFFDYEAKYE
GASEEITPARIDDETRIRVEEISKRAYNSLGMSGFSRSEFILMDGIPYMLEMNTNPGFSP
ASILPQQAKIYGISIKDLCGNEVEKALNKK
>KALACAFP_01663 Serine/threonine-protein kinase PK-1
MLKSLFNWKVLLNLVVAIGVFVGLVWLTFRWLEYHTNHGQEIPVPNIVNKSVQEAIKILD
DAGLEYEVDSFKYDPKYRPFQVLQVYPAPGSRVKDGRAIQLKVNPRTWARVEVPDVINKY
SGLAFQRLEQVGLKVGDTIFEPSIQKDAVLRILYKGTAVKSKTKLPRFSVVDVVIGSGPM
RNIAIPNVVGLTVKEARAVIAKSMFEVGLVEHEDGGKDESDIIYYQDPAAGDVRDQGMQI
DLWASKKTPAELSAKIEQLNSIYRMKVDTGLPPIEYHEIPAHQEPNYDAQPPAVPAPKRD
IPKPADAVKPDASKTGTAKPTVSGTENKPKTTNSGATSGNNAATGGKTVTTTQKPAEKPK
AKKVVVE
>KALACAFP_01664 Ribosomal large subunit pseudouridine synthase D
MAEDNEDFLDEELLDQNSIDNIDIDEENKGLYEHLNITVDKNQEPLRIDKFLLIYRQNSS
RNKISQTCRAGNVIVNGIPVKQNYRVKPGDQVSVLLAHPPRENVIIPQNIPINIIYEDDD
LVVVDKDPGMVVHPGFGNWDGTLVNALAYHFEQNGEKTDLDRVGLVHRIDKDTSGLLVIA
KNEYALSFLAKQFFDRKTKRLYWAFVWGNVQDDEGTIRGHIGRHPKNRMQMHTYEDGSQG
KHAVTHYKVLERFKYMTWVECKLETGRTHQIRAHFKHIGHTLFNDERYEGHTPLRGVNLP
KYKQFIKNVFEILPRHALHAHTLGFIHPTTKKELYFESPMPKDMADAVKKWRNYLEN
>KALACAFP_01665 hypothetical protein
MRKLYAIVCLALLSNAYKAQETLPYYQQYLLDGEFLFNPAQYGKTDYVQLNLNYQQQFSK
FSESPNVQSIGMNANIFDRVGAGISVFRDSNGPISAGGITAGASYFIPLSSEGDRKDQFS
FGTSVSFYNMNFDYSKINTQDASDPLLQGSESNIFMAYANFGAQATYKNIFAGVSVNDIA
LTNDEAIVNGREPSPIKFFLNLGYDWHVGDNIYFTPSALINLNTNSTRTIDYNLMGTFFN
DINSFSFGVSYRSVQNRFDSQQLQIAPVVKVRFNKFMIGATYNLGLSDIQEYGGNSFMIG
LGYNFDNFINHRGYRY
>KALACAFP_01666 hypothetical protein
MKIAIAAFLLTKRNVNVDHKKSSEKFRAQIYLN
>KALACAFP_01667 Oxygen-independent coproporphyrinogen-III oxidase-like protein
MLAAMKKEIFLRKDELQNKNLQSLYFGGGTPSILSPDEIHSLIDEVLKYFSFEKDIEITL
EANPDDLDKNFLKGLSDSPVNRLSIGTQSFFDEDLKLMNRAHNASEAEGSIKRAQDFGFE
NLSIDLIYGSPTSNLEIWKENLNKTIALEVPHISSYALTVEPKTALENWISKGKVKSPKE
EEQNREFYYLSDFLKDNGFEHYEVSNFAKPGMYSRHNSAYWKYKEYLGIGPSAHSYNGFD
VRSWNVANNQQYIKKLNSNLLAKEEEILSRNDQFNEMIMIGLRTIWGVDLDSLKNKFNEQ
ILEHFQHEIQSKLEEEILIIENNHLKIPEKHWFMADGIASDLFII
>KALACAFP_01668 Glutamate racemase 1
MKTKKQNYSHLSPKQPIGIFDSGVGGLTVAKEIKRLLPNEDLIYFGDTKHLPYGEKSKEA
IIEYSTKITNFLLAQNCKAIVVACNTATANALNEVMESVAGKVPVIDVINPVAEKVSYEI
HNNVGVIATKATVNSGLYKKSIRKHNKWIKVDELATPLLVPAIEEGFKNHPITHAIIYNY
LSNSKLKNIETLILGCTHYPLLIEEIKQYYGNRVRVIDSPNIVANHLKIILDKYNLLNES
NPKPNYHFYLSDLTKNFEKISKKFFGKTIDLELKVL
>KALACAFP_01669 hypothetical protein
MKLKALNYHSKRTLSILLLFLFLNLFSQKITIENKSNTTIEIKYKTNRVKLKEGEKKIIS
EKEINELSIEYNSEKNLIIKYIPILLNSDETLSLTIDNYDKTIEFKGDKVALHNLVVNQQ
HYILYENIGKYQDILYKKRSPKELMNFSEFVLSDYLNKIKTLNTSSLGMEDKIYKRIEKY
VINDWIVSLYLVFTGSKTLDLQSRELVLYYFNKYVKKDVENYSCQYKLQYNIIIELAKYV
DQLNIALPKYTIVENTGDNVINQYLPPSCQRFYFSEKYKYFKNINSSEKEYYNNVLKEKF
NN
>KALACAFP_01670 Oxygen-insensitive NAD(P)H nitroreductase
MNFLEKMKTRYAVKKYNPQGKISDEKIQMLKEILHLSPSSINSQPWNFIFVSNSEIKEQL
AEASYFNKEKVLESSQLVVFQAIKNPEDFEKQIEENLPEGLVEYYRTFVKPQGEAAIKSW
FAHQVYLALGVFLSACVDLGIDSTPMEGIEGDKYDSILNNEKYETLFAVVIGQKSEEDKN
QPIHTPKRRLERKKVIVEM
>KALACAFP_01671 putative HTH-type transcriptional regulator YybR
MYIIDDKHYPCCTTVTMRFIGGKWKAVILYYLIEGPKRYNELRKFMPTITERTLSLQLKQ
LEEDNIINRKVYTKKPPLMVEYTLTEFGETLIPMLKEIARWGIEAVEKSKKVKEEIS
>KALACAFP_01672 Ribosomal RNA small subunit methyltransferase D
MYRIISGKWKAKKIAAPKNFDVRPTTDFAKEALFSILENKYDMQSVSVLDLFAGIGSITL
EFASRGCQDITSVEMNPKHTAFINSTAAELDMALQVNVQRGDVFDWLKKFRNKKSFEIVF
SDAPFETEEKKYYELLSLILNNKYLKPNGTLIVEHQSRMKFDHPNLIDTRKYGNVSFSFF
EPNKEESSEITE
>KALACAFP_01673 hypothetical protein
MNVLNLLFTKDGLTYQIAKNKSIVEEKSYFVDEESPENFIADKLDEVLIKQRFDEIQVVS
ALNHFTLMPEGFSQHETGFELIAYNAPVDSEKEELMLSINEKFKVQFYYTFPKNFYKKIK
ELALPVQFNFSGEKFLNSINNKNNKEIHINLYHNQCEFFAIDNKKVILYNNLDVNSEVDF
LYFIMFTLSKIGFGINETNFFTYGETTENETFISELQKFVKNLRIVFDNVPGKNFILN
>KALACAFP_01674 Endonuclease MutS2
MKIGDKVSVVDEDLSGVVTSVKGNIVVFKDEFGFTYQYPKEKLVPKNADIYENIKVVKKP
EPKKNISKKHQRNHLVLDLHFPNLVKNPNDYDSFERLFIQKEKLLQTIEFCRKHNLKRLE
IVHGIGDGVLQKLVWDTLESQTNIDFYNKEILHHQSGAVMVEFH
>KALACAFP_01675 hypothetical protein
MTKILLLSDSHSYIDDRILDYARQADEIWHGGDFGSMEVIEQLEKIKPVKGVYGNIDNAK
IRSEFPEANRFFCENVEVLMIHIGGYPGRYSPLAKKEIAEKAPKLFISGHSHILKAMFDE
KNNLLHLNPGACGKQGWHKMRTMMRFVVDGEEIKDLEIIELGPKI
>KALACAFP_01676 hypothetical protein
MTTKKLLSVFLLLLSFNLYFSQEVVIKDDKVLLDGKQILKAEKINVAQYSFYTMKDDEEI
LMYRYMDNETPRYQEDDYYVLNFLTEKTKVESTDFTKILNFMNSRKGMEKLVKWLLKERV
INSDGELNPDRVQIFKEKYDENITERTFR
>KALACAFP_01677 Penicillin-binding protein 4*
MKQKLSFFLLLLTVAIFNAQVEEKKLDELIQSTLKTFDVPGMSVGVIKDGKIIYSKGFGV
RSLTSKQPMDDNTLVGIASNSKGFTCTALAILADEGKLNWDDKVSKYIPEFQMYDPYVSQ
NVTIKDLVTHRAGLGLGQGDLMFFPEGGNMTVNDIVHNVRYLKPENPFRTTLDYNNIMFI
VAGEVIHRVSGLSWAEFIEQRIMKPVGMTSSFGSYNRAKAVANKIDAHAPVDGKAIAVPH
DWNETANAAGGIMSNIKDMTTWAEFLLNNFTTKDGKKLVSDKNVQQLWSLQIPSGVAAKN
PYDTSFYGYGLGWFLSDVKGHKQVQHTGGLIGTVTQFTLIPDMKLGIVVLTNQQSGAAFN
TITNTVKDSYLGVADRNWLKTYSERMVKAEEGFNKQKKEAFAKSEAFKKDKNLQPKAEQF
VGTYNDKWFGDVEIAQQGSGYRISCKSSPRLKGELLPYSNNSFIIKWDDRSYDADAYIIF
DYDENGKAQSARVKPISDVTDFSFDFEDLDLRRK
>KALACAFP_01678 hypothetical protein
MSRGKFKLIVKNFSLLSIFILFSCQKKEKTYFETIAINDVQLKKPRYGEWRYNRNEHFQS
FEDFQKLKKIKPEAGKNTIYLQPIGDFNEFQKKQIELTKEYLKTYFQLETKVLPSLSNSI
IPRSVRRMGHDSQEQISAGYVLDSILIKRKPNDAVVFMGITERDLFPKPEWNYVFGLASY
KDGVGVTSMFRFYNGNLTESGSNEGLERLLKISSHEIGHMFGISHCLNANCVMNGTNNLS
ETDSHFARACSLCQQKLNSSLQYDNKKRLIELKKFFEKQHLNSEISRAEEDLKLLK
>KALACAFP_01679 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase
MKKLILVRHAKSDWPEETEDFDRPLADKGLEEAMHMSRFMKNNQISIDYFVSSPAVRALN
TCKIFNQAYHINIITNEKLYNPSESNFESVIYDLDDSHDTVAFFSHNNGISNFANSISED
IFHFPTCGVAGFEIDCNSWAEFDGANKKLLFFYEPGKI
>KALACAFP_01680 Putative pre-16S rRNA nuclease
MGQILAIDYGKARCGIAATDDMQIIASGLDTIQTSVLMEFLKKYFIENKVDEVVVGLPVD
LKGNVSEVETHILKFIEIFQKEFPDVKVNRFDERFTSKMASFFISQSGKSKKQRQEKGLI
DKVSATIILQNFLEQRTR
>KALACAFP_01681 Peptide deformylase 1
MILPIRAFGDPVLRKVGKDIDKDYPDLQQLIDNMFETMYSANGIGLAAPQIGLDIRLFVV
DVSPLAEDEDYEDLKDELTEFKKVFINAKILEESGEEWKFNEGCLSIPDVREDVKRKGTI
VIEYYDENFVKHTETFSDIRARVIQHEYDHIEGILFTDHLSALKKKLVKGKLTKITHGDV
SISYKMRFPK
>KALACAFP_01682 hypothetical protein
MLLEKIISISGKPGLYKLVSQLRNGFIIEDVTSKKKVSIGNSSQVSLLDNIAMFTVDKEV
PLFEVFENIAKNFDYKEAIGHKSSDAELKEFMTASLPNYDKERVYASDIKKLAQWYNILQ
KAGYITPESFIKAEPETLDGEPAEEVSIETEAPKKAPKAEKPATPKVKATSAAKAAPKST
HTKKG
>KALACAFP_01683 Nucleoside triphosphate pyrophosphohydrolase
MFQDKRTFKKIYLKFVSLEFYCMNTKQEKLEAFGRLLDIMDDLREKCPWDQKQTLESLRH
LTLEETYELSDAILQNDLQEIKKELGDVLLHLVFYAKIGSEKESFDIADVINSLNEKLIF
RHPHIYGDTTVKDEEEVKQNWEKLKLKEGNKSILGGVPKSLPSLVKAYRIQDKVKGIGFE
FHDAEDAWKKVDEEIQEFHAETDLDKKEQELGDVFFSLINYARISGINPDSALERTNLKF
ISRFQKMEVLAVEKDLKLADMSLEEMDVLWEEAKILNKN
>KALACAFP_01684 hypothetical protein
MNIFCAVTAIALVACNPKTDQPKTDTLVTEFSLPKKLKEVSGITLSKDKNTIWTIEDQGN
KNVIYGLDQKGNLTNDVLVENTENTDWEDMTTDSEGNIYIGDFGNNENDRQDLSILKVDL
KDASQPTTKVVQTTKFHYEGQKEFPPKKSYWLYDCEAFVEMDGNFYLFTKNRSKGFDGTF
LVFQIPNKEGDFEAKLVGKLKLHGGYSDAAITSAAINGTKDKIVLLTHKNIHVLTGFSVN
DFSKAKIQKISLHHNSQKEAVAFLNDKTLLIADEKDKNMGGNMYKFDLK
>KALACAFP_01685 hypothetical protein
MSKIISTKNKHSMKKQLSYMALFVMSCSLNAQVGILTPTPQHTLHVNGSLQVVKDLNVGG
GPKTTGSSGNPGDFLVSNGSGNAPVWKNIASENFLKVIFVGNKTNINPSSGSYTGTGSNP
VSTHESYTQTYVYNVSNKIDNAYLTYNSTTGLFTVVKAGFYNIVPYITYDLSLNGNGYTA
GTAKSSIQKVSSSTVTLASISTGHGERTLTVNHNLSSISYLNAGETFRVRCVYTQDFRLS
SGNIYITYLTP
>KALACAFP_01686 hypothetical protein
MNLSLKTHLKNTSIVLRVVLSAGVLYSCATYNVKKGKNLSEVENSDIKSENDFKIFLVGD
AGNADEAQAQNTLNLLKGQLETADKNSMLIFLGDNIYPNGMPKESDKEYPLAKQKLEDQL
SIVKNFPGKTLVIPGNHDWYSGLDGRKAQEDFVKNYFNDKKAFLPKNSCPIDDISLTKDI
KLIVIDTEWALLNWDKYPGINKNCDIKTREDLFIEFKDLLNKNQDKQIIVALHHPIISTG
THAGYTSAKSHLFPFKSKIPVPGVASVLNVLRSSSGASPEDINNQHYADLTNRLKSIVQD
KDNIIFVSGHDHNLQYHADRNIRQIISGAGSKVDPATIGERTDFSYGGSGFAVLNIRKDQ
SSDVEYFSTKDNKLEKLSHIQVIEKPKEFVNNYPNSFPATVSSTIYPVKLTKKGKIYRWL
WGEHYRKYYGMPIEAPTANLSELDGGYKPFREGGGNQSNSLRLMSQDGQEYVMRGVKKSA
VRFLNNVAFKKSTFGNELNNTLPEKFLLDFYTANHPFTPFSVGNMADKINIFHSNPRLYY
IPKQQALGNYNMNYGDEMYMVEERFSSDPKTLASLNNAKDIVSTEDVLKNLNKNYKYSID
QESYIRARIFDMLIGDWDRHSDQWKWAEYEEGNKVIYKPIPRDRDQAFSKYDGNAFKIIM
NIPAIRHIKTFKEDLKSVKWLAVEPYPLDLAFLKGSNEEDWIAQAKYIQEHLTDKDIDEA
FNNVPKEVKDETIADIQRKLKLRKAKLQSYATQYFNVLQEKVPLAGTVNPDKFVITKTGK
SVNVKQYKLDKNKENPELVFEKTYDDSKTKELWIYGLEDDDIYEVSGDGNPKMNIRLIGG
YNHDTYNVADGSRVKIYDFKSQKNTYNTHGATKNISDDYDINTYDYKHPKYSFVAGYPNA
DYNPDDGVILGVLANYTVNNFIRDPFTQKHSLKVNFYTATGGFQAVYKGIFKKAISDWDF
NIDAGFTTPRFSENFFGLSNESEYDKEADDRKYNRARISKINFAPSVSKKSWSNIFNQFQ
LTFENNKVQRNGDRFVDVSPDVKPEVFTNQQFGGANYTFSYKNFDNTAFPTLGLEFTVNA
DWKTNLSDFDKNFLILTGTLAFDHRLDSRGNFVFANSSNAMWINNNNFEFYQAASIGGNN
GMRAFRNDRFSGRSYFTNNSEVRWDFGRVKNTIIPANMGILVGYDIGRVWNDHENSRKWH
QSIGGGLWLSILDMFSARLNYFTGSDGGRISGTVGMTF
>KALACAFP_01687 hypothetical protein
MSILQKAKDYVEILFKDKLSSVYFYHNFIHTTYTVNKAEEIMRNTSVSQEDQEKVLLALW
FHDTGYIECAKNHEEKGVSIVKDFLQKENYPENKIEEVTKLILATKLTYEPQNLLEKIVK
DADCSHFASHYFNNISDALRKEWELTNVRCFTNDEWNEENLDMLKNKHRYYTDYAKENWQ
PLKEKNIKKIEKKLEKDKDEDKKENSEGKKDKDKEKEPKSDRSVDTLFRVTLNNHTRLSD
IADSKANILLSVNAIIISVCLSVLVPKLDTPKNSHLIIPSFLLLLSSVLTIIFAILSTKP
NVTKTRFTKQDVADRKVNLLFFGNFNRMLFDDYHDAMKDLIKDRDYIYDSMVKDLYYLGK
VLDRKYKLLSTTYKIFMAGIIISVLSFGYAFLRL
>KALACAFP_01688 hypothetical protein
MSNLYKKDAPFKVYISFKKYLDVLEHIRYNDRLEYRVNYAQSLIDKTKNFQEFKDGFQDI
SLLEKHEELIKLLLADLFPTGLTNNEIKAASIPLSNITFNYTERFKNILKDAGKDFEIEL
RNIDDDEFYVFCCCLILQSYFKRDIRSNLPLYYDIPNKHGIMKHYKITVNSDFTEIFPTE
KAKIPSDEVIDMLLESLDDFKLWKKYFPSESWILRGFTIISLVDCTSEVALSDLKSSMIS
IDPENLSPDENLIEIFKSYFDVSELNFGLMLFNKKDQRLEKVPIYENLFTNHILDFWINT
FDDEIRKTTFDNLNQNSKPIVISNVDNLEHEVKSLPSFDILKRNKINSFMVIPIMKDSEL
LAIMEFTSPIANSFNGLKAKKMEFFTDMILFSLNRFSFEKNYQIEAIIQREYTTIHDSVV
WKFRNEAEKYFNASLSKKIYTLKQISFKNLTPLFGFSDIRSSSEKRLNLMLEDLNQQIDS
LHGIFSLLNSDSEKYLLALDIFENELNNEIKADTEQRFQRLLREEVHPYLQAKLEIKSSS
EVKAKIKDYFMQVFTQSDLFYTNRKSLDDSITLVNRKLADLLDEGQEKAQLIFPHYYERF
KSDGVEHNLYTGQNIAPELHYSSKVVHKLRYWQLKTICNMELEFQNFKRDLPIPLDIASL
IFVYNEKIDIRFRMDEKRFDVDGAYNSYYEIIKKRLDKAHIKDSTERITCPGKITIVYFG
MENQKEYLEYINKLQKKNILQNDVEFLKVEDLQGITGLLALRVSLAQ
>KALACAFP_01689 NADH-quinone oxidoreductase subunit N
MSVLIIVFLTAVVALFSGVFEQGKFARYIGILGLIIALCVSFMPECAFFEQYRHMYDYTA
NTALFTKISIVTTLLLFFLGGFAFSNHRSHQSELYALMLFALCGGIILFGFQNMVTLFLG
VEILSIPLYVMAGANKTDLRSNEASIKYFLMGAFATGFLLFGIAFIYGSVGSFDLYKIHD
FGTSNPKDVMFILGVLLILCALAFKVALAPFHMWSPDVYYGSPSLITAFMASVVKISGFF
ALFRLMTIGFAGVTHEWINVLGVFLIITLLLANVMGLAQTNAKRMLAYSSVSHAGYIGLV
FFGMTSLSTYNLAFYLFAYALSTVGVFMCLIYVEKLKRETSFGAFKGLAKTEPLLATAAA
ISMLSMAGVPLTAGFMGKFALFSQAMNGAAFLVLIAVLGSAVSIAYYLRLIIAMFFFKES
SFKSSEKVTLTYNIVAVVVIASIIVLGVFPDLFARQFGL
>KALACAFP_01690 NADH-quinone oxidoreductase subunit M
MSGLLLTLLLLPLVGSGLVFAWKDKSSKYLALGIALVQMLLTFYILSDFNFTPTVDSVLQ
HEINYPWSQFMKSSLHFGIDGMSMLLLLLTNILSPIIILSSFNENVSYRNTFYGLILLMQ
FGLVGVFTSLDGLLFYIFWEVTLIPIWFIAGLWGQENKRFEFTTKFFVYTFVGSLFMLAG
LIYVYNHSASFALTDLYNAQLNETQQTVVFWFIFFAFAVKLPVFPFHTWQPDTYTYSPTQ
GSMLLSGIMLKMAVYGVMRYLLPITPIPIAGISGQIVIILAIVGIVHGALIAIIQTDMKR
IIAYSSFSHVGLMVAGIFASAVITLRGTFNIEGAEGALVQTFAHGINVVGLFYCCDILYK
RFKSRDIRQMGGLAKVAPKFAVLFLIIILGSMGVPLTNGFIGEFILLKSVYDFNGLAAVI
AGLTVILCAVYLLRFYGKAMFGQGDEAVLSTAKDLSGVEFSVLASLAVFVILLGIFPQPV
IEMVNSSLKFIYQSMVS
>KALACAFP_01691 NADH-quinone oxidoreductase subunit 12
MENLVYAIVLLPLLGFLINGLFGKNLPKILVGSLATAVVFGSFCIAVSLFMNFNSESQPV
IVKAFEWFRVNGVQINFGFQIDQLSLMMVMIITGIGSLIHLYSIGYMSHDKGFYKFFTYL
NLFIFSMLLLVMGSNYLILFIGWEGVGLCSYLLIGFWYTNEEYGKAARKAFIMNRIGDLA
LLIGIFMIASQTNALDYLSVAENAGKFELDGTVIIFITASLFIGATGKSAQVPLYTWLPD
AMAGPTPVSALIHAATMVTAGIYLVVRSNFLFTLAPTVQGGILFIGFLTAALAGFYALRQ
NDIKKVLAYSTVSQLGFMFIALGLGAYTTAMFHVMTHAFFKALLFLGAGSVIHAMSNEQD
MRFMGGLKKYIPLTHATFLIGTLAISGFPLLSGMISKDEILVAAFAKNPIYWVFLFVLAA
VTATYMFRLYYLTFHGEFRGTEEQKHHLHESPSNMTLPLIVLAILSVLGGLINLPHFIGH
GHYAKLMEWLKPVLTEESFKQMETTLSAVPFGTEMTLLAATVLMFFAVWFIVKNTYVNKK
KQALPEEQYTGWEKLSARKLYIDELYNALIVKTVEGLGRGGKMFDKGILDRFVDFVGDGA
EDSGKAMKRIQNGNVENYILIMSLAVGIILIVNFILQ
>KALACAFP_01692 NADH-quinone oxidoreductase subunit K
MGEVNTFIQSIPLNYFIILSSVLFCLGVLGVLLRKNAIVILGCVELMLNSVNLLLAAFSA
YKGNGDGQLLVFFIMVVAAAEVAVGLAIIAMLYRNTRSVDVSIFNKLRG
>KALACAFP_01693 NADH-quinone oxidoreductase subunit J
MDQFLFFLVAFLAVASAVYFVFARNPLYAILSLIVTMFSIAGMYILLNAQFLAIIQIIVY
AGAIMVLFLYILMMLNLNKQDESKKNNTLKFVGVFTAGLLLIGVLGVFRGVQDNHVVVEN
VDKGVGLTKNLGRLLFNEYVLPFELASILILAGIVGAVLIGKKDL
>KALACAFP_01694 NADH-quinone oxidoreductase subunit 9
MKLTNRSKVVSNKEMTLAEKIYLPAIFTGMGITFKHAVRTVLKGAPAVYSYPEVQKPRAD
IWRGQHVLKRDEEGRERCTACGLCAVACPAEAITMTSAERTKEEKHLYREEKYASVYEIN
MLRCIFCGMCEEACPKSAIYLTDRLVDVETNRGSFIYGKDKLVEKINERIDITERQSEKQ
KNAVK
>KALACAFP_01695 NADH-quinone oxidoreductase subunit H
MDLLTFKLILVLALFLLSLTIAAYSTWAERKVASIMQDRIGPNRAGPFGLLQPLADGGKF
FFKEDFTPANAEKFLFVLGPALVMFISLITGAVIPWGKSLNIAGTSYDLQVANIDVGVLF
IIGMASIGVYGIMIGGWASNNKYSLLGAIRASSQMISYELAMGLALLSIIMMTGSLDLKE
ITESQTTGKLWGFIPWVSGLNWNIFYQPIAFLVFFVAALAETNRHPFDLPECESELVTGY
STEYSSMKLGLYMFGEYVNMFISNAFMVVLFFGGYNYPGIEWVTQNWGENTAGILSIVAF
LTKAIIGILIFMWIRWTLPRFRYDQLMHLGWKTLIPMALVNLLITGAVILAFAN
>KALACAFP_01696 NADH-quinone oxidoreductase chain 3
MSEEVKKFKITIDGQTTEVLPGTSILEAARQIGGKSVPPAMCYYSKLETSGGRCRTCLVE
VSKGSEADPRPMPKLVASCRTNVMDGMEVKNLTSDKAQEGRKAVTEFLLVNHPLDCPICD
QAGECHLQDLGYEHGVENTRTEFERNTYEADDLGPHIKLNMNRCILCARCVLAANQLTGE
REHGILFRGDHAEISTYLNKALDNDFIGNVIDVCPVGALTDRTARFASRVWFTKPMNASC
KCDKCSGKATVWMKGDEIVRVTARKDQWGEVEEFICDTCRFERKELSDWNIEGPRHIDRH
SVISLNHYEKPKDELRVLDNPMAKEISEKDEK
>KALACAFP_01697 hypothetical protein
MSVSAQREAFKKGSVMVFWGWNRGWFGDSDIHFTGQDYNFTLQNVSAHDRPTPIKEFDHY
INPLKMSIPQVNYNITYFIKDNLGITLGLDHMKYVMDQDQVVDFNGNISNPEYAAMVKNG
KIDLSDAKFLKYEHTNGLNYLNVGVQQYKQILNKKNFDVFWAYGLGAGALIPKTDATLMG
KEESDHFHLAGFGLDARTGLNVVLWNHIVAKADIKYGYINLPSVRTTVENVKVDKATQDF
TFCELVFGIGYTFNTKKQK
>KALACAFP_01698 NADH-quinone oxidoreductase subunit 1
MSKKLLLKDAHIEGIRYFETYRKQGGYTAAEKALKMTPDEILEEVKASGLRGRGGAGFPT
GMKWSFLAKPEGVPRHLVVNADESEPGTFKDRYLMEFLPHLLIEGMLISSYCLGSNVSYI
YIRGEYSWIPDILEEAIEEAKAAGFLGKNILGTGFDCEIYVQRGGGAYICGEETALLESL
EGKRGNPRLKPPFPAVKGLWERPTVVNNVESIAAVVPIIDITGAEYAKIGVGRSTGTKLI
SACGNINKPGVYEIDMTITVEEFIYSDEYCGGIKDGKRLKACIPGGSSVPIVPANLLLKT
VNGEPRYMNYESLADGGFATGTMMGSGGFIVLDEDQCIVEHTMTLARFYNHESCGQCTPC
REGTGWMYKILKKIEKGEGKMEDIDLLWDIQRKIEGNTICPLGDAAAWPVAAAIRHFRDE
FEWHIKNPELCLTQNYGLANYADPIPAPTV
>KALACAFP_01699 NADH-quinone oxidoreductase chain 2
MSETIAFKPESLEQVHKIIARYPEGRQKSALLPVLHLAQKEFGGWLDVPVMDYVAGLLSI
KPIEVYEVATFYTMFNMKPVGKYVLEVCRTGPCMVCGSEKILDHIRTKLNIKDGQTTEDG
MFTLKPAECLGACGYAPMMQLGKFFHENLTIEKVDEILDLCRQGQIALD
>KALACAFP_01700 NADH-quinone oxidoreductase subunit 4
MKDNSLSNILNQYDSKEQIDGQLYTLNLGPTHPATHGIFQNILTMDGERILHAEQTVGYI
HRAFEKISERRNYSQITTLTDRMNYCSAPINNLGWHMTVEKLIGVEVPKRVDYMRVILME
LARIGDHLICNGVTGMDSGAITGLTYMFIERERIYDMYEQICGARMTTNMGRIGGFERDF
TPKFHELLKDFLKTFPPRFKEFCTLLERNRIFMDRTIGAGAISAERALSYGFTGPNLRAA
GVDYDVRVAQPYSSYQDFDFIIPVGTSGDTYDRFMVRQQEIWESIKIIKQAYENLPEGPF
HADVPDFYLPEKADVYQKMEALIYHFKIVMGETDVPKGEVYHAVEGGNGELGFYLVSDGG
RSPYRLHFRRPCFIYYQAYPEMITGSVISDAIVTMCSMNIIAGELDA
>KALACAFP_01701 NADH-quinone oxidoreductase subunit C
MTNEFVLEAITREFPESVIASSEPYGMLTIEVKKDDIKKIIHYLKDSSLEFNFLTDICGI
HYPEFPEKEIGVIYHLHNMMANFRLRLKIFMSRENIEVDSLVELYAGANWMERETYDFYG
IKFKGHPDLRPILNMEDLGYHPMLKEYRLEDGTRTDKNDSMFGR
>KALACAFP_01702 NADH-quinone oxidoreductase subunit B
MSDNKPVIRTDAPAPEGFEGEGFFATKLSSVIGMARKFSLWPLPFATSCCGIEFMATLNP
TYDASRFGMERNSFSPRQADMLMVCGTISKKLGPVLKEVYTQMAEPKWVVAVGACASSGG
IFDTYSVLQGIDKIIPVDVYVPGCPPRPEQIIEGVMQVQALAESESIRRRDMPEYQKLLD
SYNISN
>KALACAFP_01703 NADH-quinone oxidoreductase subunit A
MNLPESYIPILLQAGVAVAFVAVSLLGAHFLGPKQKKGNSVKNQSWECGVPVEGNARTPF
SIKYFLTAVLFVLFDIEIVFFYPYAVNFREFGMEGFLAVLTFVAIFFMAFFYVWKRGALD
WDK
>KALACAFP_01704 hypothetical protein
MKPHLIIFGILIAGFAIYNFFFQVEDDKTNTLINIIYASILFGFISFMAYSLLKKMKK
>KALACAFP_01705 hypothetical protein
MSKVSVIEVKSNDQLKQFVRFPMDLYSNNPYYVPAFINDEINIWNSGENPAMQYSEAKQF
LAYKDNKIVGRIAVIINHKEEKELGIRKVRFGWIDFIDDEEVSQALIQTAIDYAKEKNID
KIEGPMGFTNLDKAGMLTLGFDKLATMIGIYNHDYYPKHLEKLGLIKEKEWVEFELVFPE
VLPDKIHKFNELISQKYKLKVLNFKSKEQILEYVDPMFDLLDETYKHLSTYTPISDEQRK
TYKEKYFKLIDKDYIVCVADDADQLIAFAITMPSYSKALQKSKGKLLPFGWWHFLRAGKR
NDRANFYLIGIHPDYQRRGVTSIIFKEIWKLFRKKGVKYLETNPELEENKSVQLLWQDYN
PVNHKRRRTYSLTINDN
>KALACAFP_01706 hypothetical protein
MTGYYIIIGISMLISWWVSSRLKSKFEYYSKVHLKNGLSGKEVAEKMLRDNGINDVQVIS
VPGQLTDHYNPENKTVNLSEGVYMQRNAAAAAVAAHECGHAVQHAVGYSMLQLRSRLVPV
VNISSNLMQFVLIAGIAIMAATRTIHDPNGNTTVLAIGVIMFAFTTVFAFVTLPVEYDAS
NRAMKWLKDTGTVTSEEYAGVQDSLKWAARTYVVAAIGSLAQLLYFVSLLMGGRRN
>KALACAFP_01707 hypothetical protein
MREKDISENQIGNLIKVIAFFWLLTKVWSYKTWITERVYPVIPPLDILKNVPDFLHQFLF
GFSLLALLTVLCFKNNLWLLIALFFSEVLSCSLDTVRWQPWEYMYLCFLLMVIINFYKPK
NILLLSHLFLVSIYFFSGLHKFSRDFLSAVWLNMVLVDFFGLSMNFILKYKLFFTGLLIP
FVEIALAILLFISKSKKKISYLLILMHLGILIFIGPLGLKYNSVVWPWNLAMIFILIIIY
SKPVDPVNKNILIPNLYWIVLWFVMPVFSLFGSWYQYFSFNLYSGKGDQMYICISGNEKE
LEPYFEHKKNTLCKGKPYINLQNWALKEIKSAPLPEIEIYRKIGVHMKQKYSKDHLKIIL
YNHQTQKSIEL
>KALACAFP_01708 IMPACT family member YigZ
MVKLNRLVEASNKKTRLKMQFEYKTIEKPIENTLLKEKGSKFIGFAFPVNNEEELKAALE
KIRAEHPKATHHCYAFRMGLNGENYRANDDGEPSGSAGLPIYNQLLAHEITNVLVISVRY
YGGTKLGVSGLVKAYKESAKITLEDANIVTRELETEIEITFNFNQQNIIFTLLSKFDAKI
INFDSQEKASILARIKLKHQDEILELLSNLQFVEYKL
>KALACAFP_01709 Riboflavin biosynthesis protein RibD
MSSLFSFNMQDEFYIKRCIVLAQKAIGKTYPNPLVGSVIVHNGKIIGEGYHHKAGENHAE
INAINSVKDKTLIPESTIYVSLEPCAHYGKTPPCALKIKELGFKRVVIGAMDSHDKVNGK
GKKIIQDAGIEAVSGILEKECIELNKRFFTYHEKKRPYIILKWAESGDGFLDKNFKPVSI
SNSLANQFVHQLRADEHAILVGTQTALNDNPSLTVRNVEGVNPVRILIDFELKVPQDFSI
YNREAKTLVFNTIKEETQNNIQFIKIEKENFLSGLMKALYKEQIQSVIIEGGRFTLQEFI
DAGLWDEAIVIKNENLKLENGTKAPEFDFEPERVENFRDNVVGFYRNR
>KALACAFP_01710 hypothetical protein
MITENNLSENEEKKDSQDVSHEETSENTVSQDENVHEEDTEHEEEHEDVDISLADALKEM
EKIINAPNAGENSKKFNQLKEKANHQIHDEVEDKKHEYVDAGNAPENFSYEHPLQARFSA
LVNIFKEKYDTYQKGQEEEQKKNLEHRQNIIERLKNLYTNSEPGVNLFKSIREIKEDWSK
AGQVAKSEFRILNNNYFHHLNQFYQMLDLNKEFLEQEYSHNLEKRQHIIQRAKELEHEPV
IQKALNELQYLHKLWKEEAEPVAEEFREKTWEEFKEISNKIHERKSELSAAIESEQNANL
EKKNQIIAEIKKLSEPSETPNHNYWQNSIKRVEDLRAEFLKTGSVPRKLSNQNWNDFKTT
LRGFNTTKNTYYKSLKGSQQANLEEKLKLIQTAKDNQNNEEWDIAVPLFKKLQEDWKKVG
HVPKSMTNKIWDEFRDACNAFFNNYREKSNASTDNWKENYKNKKTLLDELKTVSNEEGSI
EKIEAIKTAWNNIGKVPRDKISINTEFNKTLREKLKLNKINELELKEEGLSENQLTDKAR
KIKSQISDLEAEIVKLENNLAFFKKPSRENPMLKDTFDSIDEKKAHLETLKQNLHSIIAG
E
>KALACAFP_01711 Shikimate dehydrogenase (NADP(+))
MDSNKKLGLVGRNISYSFSKKFFEDKFQKLMLKGYSYNIFDLSEIKEVENLFSAPDLLGF
NVTIPYKEKIIDYLDELSDEAQKIGAVNCVLIQNGKKTGYNTDAFGFEKTLLLHKKPHHT
SAIILGNGGAAKAVKYVLDKNGISSITVSRNTEINFENLDKETVENHKIIIQCTPVGTFP
NVEDCLSFPFDGLSKDHLIIDLIYNPNYTQFIINASEKGAKTVNGYYMLEQQAEKAWEIW
NFQKK
>KALACAFP_01712 Extracellular ribonuclease
MSFAFISAFAQIPAGYYDGTSGLTGAPLKTKLKQIITNGHVDHGYNGLWTGYQTTDIDKF
YENDNSVLDIYSENPNGADPYNYTPGSNQCGNYNSEGDCYNREHIVPQSLFNEQPPMVSD
IHFIRPTDGKVNGMRSNYPFGKVSTASFNSQNGSKLGNSASPGYSGTVFEPIDAFKGDVA
RMIFYFVTRYENQLSSFSTGNMLGDSAFPGLQTWELNQLLAWNALDPVSAAEIERNNKSY
VFQGNRNPYIDHPEYVNQIWGTPIVDTEAPSVPTNLATNNPTANSISLSWTASTDNVGVA
GYDIYKDGVFYATVSGTTATVSGLNPSTTYSFYIIAKDAAGNPSTSSNTATGTTLAGQPG
GGSCGTETFESIPNGGNGYGLRTWTNDGITWNATDARTDQTINNKAITLRVGNLTSSSVS
GGIQSLTVTTSLKFGSGAGVLNVEVNGVQVGTVPYSATTNTTTTTTINNINVTGNVVIKI
TNPTTNTNGPRVAIDDLSWTCYSGALGTVETIKEKSFSVYPNPVRNNELFVKGENLKTIS
KAQIYDLSGKLIETIENPFKNSNKINLKGLVKGNYILKTDTFSTKFIVE
>KALACAFP_01713 hypothetical protein
MKNIAFYIASRYLLAKKGSTAVTFITWLAVGAMMVAVTAMFVIISVFSGLEDLNKDLISN
LHADLTIKSSTGKTLKDFNKINAVLKSNKEIRNFSRVIEEKVYINFNGKGDIAYLRGVDS
AYTKVNPIDKDVFYGAYPSFKYSNEVLMENSLDNRLSIPVASNTDYATIFMPKPGTGIIN
KEEDIYNKKDVLVTGVFPGKDQLDNYIISPIELTEELLNLPKHSAYQIVVKLKNSDNTDS
VKQQLLSSLGKNIEIKTKEEENAAFWKMINTEKLFIYLIFALVIFITTFNLAGAIIILQL
DKKEQAKSLISLGFPLSHLRRIYFYTGVLIVVSGIISGLILGTALCYFQQYTEFFKANET
LPFPVKIVGKNYFIVAITASLFGFIISWVFSKISKEYITKN
>KALACAFP_01714 30S ribosome-binding factor
MESNRQRKVAQIIQEDFAELFRKQAAESKQSILVTVSDVKVTADLGIAKIYLSIFPQEFR
AAVMKEIEENKTQYRNFIGQKMAKQVRVIPNLNFYLDTSLDDVEKIEKELRGEGDNPIL
>KALACAFP_01715 hypothetical protein
MKLEHIGIAVKSLGVSDELFAKLLGKESYKKESVEREGVVTSFYAAGESKIELLEASREE
SPISKFIEKKGEGIHHLAFGVENIIEEIERLKKEGFQFISEEPKEGADNKLVVFLHPKST
NGVLVELCQEKP
>KALACAFP_01717 hypothetical protein
MADNKLLFFKEIEDCLTSEGITKSQTNFTESFYKYGINYSHIEEKGDDIILHFSNDSCSS
WLSNFERNIGELFEKAKLLMEEAYIKEEIKGFKDYVEKSLRNILRLDTYGFTKKYIDKLI
NFFQVKYNFEISIASFVANQKVNPYLRLKGGLRKSDITNLYNLSVDDYIEYENLDVNDFF
NVLSGDSNKNIIFKCSTAEMVEYIRNLLPILEKGRIKNIELSGLFYTSGNKILKVNNYQR
YKTSNKKSGISLSIDLLDFFTKLHNKLQ
>KALACAFP_01718 hypothetical protein
MNKTEKNILSFKESIEFMDVSKSFLYKLTSEGRINFFKPNNGKIYFRKEDLENWMMQNEM
KSVESLEKHLLTKNFKSNGKTN
>KALACAFP_01719 hypothetical protein
MERQTKTPLIPNKVYKNLPLILRDVTRDFSGREKDMLLTSSLGVLSSLLPHICGYYDSDI
VYPNLHTFITVPIASGKGVIMKARSLVDITNEAIISVSTSDYEFEMKRNNKVVTPCFDLK
ILPVNINSKDFYSFMARTDGGLLIIESEADIIKFMMDNFSHILKKSFHHEPISFKEEDFY
MNIEKPKLSLVLSSTQEQYKSIMNSAGNDLASMFLTYSFDEVTKFKDVFANKDKNKRGVF
EYYSEMLKDKYSFSRYGDKLEFELTERQKRIFHQHFQDKQTYILNKESLNFTSNNNRLAL
IFFKLCMIISALRFVEERIEPNKLVCTDADFDNCLKLIDIYFQHSLYNFKSLNLKK
>KALACAFP_01720 Tyrosine recombinase XerC
MNNHATIKVVMGSKPLSDGQYLVYLRITKNRRKKEISIGLKGFKEHFDSEQFIKPHPNFK
IENSFIIKQKYEALSIIRNFQLNDEDFTLESFERKFRGMPETNDNFFDFTEEIITEMEQS
DRLGNARAYREAKESLLKFINDNHSGKTTLKFKELTPELLEKYEVYMRSKGNENGGMAFK
MRQIRAIFNKAINRKIISQDIYPFKYYKVSKLKAKPNKRALTVEDFKKLKDVNLLQFPHL
MEAYNYFMFSFYTRGMNFVDMMYLKKSDIVNDRLYYTRAKTKGRFNIEIVDKAQEIIDFY
KDKTKNTSYVFPILLSDDMTPKQIEYRKHKVLSRYNRKLGEIAKIAGVESHVTSYVARHS
FATILKKKGTSTDLISELMGHSNVQITMTYLKEFDDEELDNANRRLLDL
>KALACAFP_01721 hypothetical protein
MNEFPLEEDFHKENGIESNLPSQKLPGEYSEDFEERSEKIELYNHDITLEENFQENNNPK
YILVKVTEDGSMAVENNTPSLTPFDRIVVNMNVYDYSAFENYMIDYDTIFGTRLLTFMKY
DSNFFVCDERVFFEALLIKYKKSDFTSFYWSKEKIFKEVGIKKDRAEKIISRFKELGIIS
VEKKTRTFEGKPQQVNYFFLHPEKVIELLPKMFGEENEEDFIFPGHRDIQKYLKPGLEKK
TGRKRK
>KALACAFP_01722 hypothetical protein
MQLKQSQRQQVKLRLGLSGASGFGKTKSALLLAYGMTQDWSKIAVIDTENSSASLYSDLG
SYNVLDLQAPYSPERYIQAIELCEKSGIEVIIIDSASHEWNGSGGCLEIHEKLGGRFQDW
ANVTPRHQAFINKILQSSCHIITTTRRKMDYSLDIGSNGKTKVVKHGTKEITRDGFEYEL
TINFELVNDNHLAKASKDRTGLFMNKPEFLITSQTGKMILDWCNTGEITKLQVTSSTSEQ
SYLGSNEINNLINKIESCNTIAELLALYKQYPDYQEKLKSEYEVKKSFLIKLSNPQNFST
NGVHR
>KALACAFP_01723 hypothetical protein
MEYTDNTAVMELHNVQRSSHLNLEAVNIQDAEVFYPSRMNEIKEVEPRSVQPLLISNTIS
TITDATVSAYIHKPFIEANTLQVDLSHLKSDCIIPVFSKDNEKTIAHQEFIEIVTNTVMK
MFPHHSVSNPEIRVSHQIKGRTPDAIYKSAKDLLDHEKTIYYERMAFIIQIPSIVDTING
NELALTLGGVRSYNLENLYNKKTFEKFKFFIGFQNKVCCNLCVSSDGFVEEMRVGNYHEL
QEKVTAVIQNYNAQSHLEVMKSLSHSHLTEHQFAQLLGRSRLYQHLPKKEKLAIPSLNFN
DSQLNIVSKDYYEDESFCRNDDGDINLWNVYNLFTQANKSSYIDTFLDRNLNAFEFSKGI
QKALNGNSDYHWFLS
>KALACAFP_01724 hypothetical protein
MKNFERNIKCMNKKFLADIQIIKNAINTNKLVIFAGAGISIDANVPSWSSLIDKIKDELD
LPDDEKDYLKIAQIYFNDRQEKEYIEKVRASLGHKKLRYNEIHEELFELNPEHILTTNFE
DLLEQVITKNSLPYSIIREDKDLPYSNNTKLLVKIHGDLDTGNLVFKEDDYLGYSQNHPL
LDSFIKSVFSTKVVLFIGYSFNDYNLKQIVQYVRNILGNNFQNAYLLSIDKEVHQSHRQY
LKNKGINVINYFDANYIEQKDGESISKNYIDDFLKEDNIYGKKSNYLKEVKSLSEKGQLL
LNFLRFLRFYDKLKISINEENVVDQIYNSLIRFEEVKSLPQDFISKLYPFKSTLEHEHLI
EYNALLLKNTILADLFFDKIEIEGSEIILTDTDSKKKKKIEFILKALNNGLIFYVTKENE
KPDSLGYKGFSDVSKNINYKSVKKCTCSKCKYEKYQLKESLTETNSYSISDTTDITEDMQ
KAFLNYKFGNYFQSFKMFEEVASKAWITQKFITYYIAKTNMKALRTLINWEFQIDDKEKE
SAIEKIDDIDIDKLIFHIPNKSDDEYNLLKIIRDDKVLTKVKDKIDNYYDEILKTYKLFQ
NKYSNSVGPYYPQLIYFELFKLLVFYNENYIINDEFSDFKNIINKAVEALMINYSTDNRY
GGKIKEFDVDFFGLTIPYINTDRFVKVLEEYDIEEIKFKKDNLGMILSYSNNFLKSYFEE
GNIWGIESRSEIMESQLQKSSFEERTRKIFSNIMVFLSLIELNSEQFDSIKSNILLFLSF
NIKLSHNNIKYLKWFLYKNYKSIKIEDCKRLLEISCRDTYNRVKHDILNLVAEICSTNQY
VIIDDIEYAQKLLSDFEYLDKHSDNIIYLWVISNDKVKNFYYQIITERLQNNFDNDLYRS
ATLNKIIDYNIFFDSFISYLNKRNKGNDSEKDGYFMENGKPKFHNHLFYNDLLFFYRLGV
KENDQRLQKLSNLYEFMKFCIFREKYDFSKFKVEWLYLFDHKIFYNEFKKIKPLKKIIET
ALKAKYDEELAKIYAQFFI
>KALACAFP_01725 putative helicase HelY
MAITLYCYHPTYKTISKAVFSKLGNFPAINYLENKNDNNAEIPISRTLEEEFKKIFQKVP
DSDNLYFTDSQYKLFSKLSSSVEFSFSGPTSMGKSFIIKSFIKKVIKNSPPENIVIVVPT
RALINQFSIDLKNELSELFERYKYKVLVNSNITDIALEENYSYVFVLTPERLISYLSQEN
TPPIGFLFIDEAHKLGNLNDARSITLYTCIEKTQKKYKGVKLYFSSPNVSNPDIFLKLFN
RKSRNSFYYTDESPVSQNLYLVDIVGKSIKQYYNGTEIIIGISPSIISVKNDIDFIKKIG
ENQNNLIYCNFKSTTVEKANQFVEFKTDFVPNDAVIKAAKNISDYVHPDYYLTNLLIKGA
AYHHGKLPQAIRNIVEDLYKKEFIRNVFCTSTLLEGVNMPTQNIFILDNRIFNKEFNSID
FWNLSGRAGRLTKELEGNIYCLQYEQSWENVDIFKKEKIELVPTVYNKVDKNLRKIESII
NGNDISGSELEKEILKYIANIIKVDSLETDSNYKSPIINKLIEKNKDKIIQLAKSKSKDY
QIPKFILNNNQNIDFETQNNVFNILSSNPRNIQLPSSGIKYETCLSILTRMYSLYKWDKA
EKKLRDKNSLRYYATLMNQWINGLTLSHIIKESIDWKANNPNSTIKISYKDYIKFDKTDK
KHINIIIEDVIDDIEYVLRFLFEKYFNHYYQVVLKIKGEEKSGENWATLLEYGTQNRVVI
ALQNLGISRNTAIKIYQNHRESLIMVDSKLQSINKNKLLKEFNTNSLEYDEIKKVL
>KALACAFP_01726 hypothetical protein
MVLGSDGVAKQVPADAILNNDDIRVIQYARSFSSPIDSSTPTSSQVSIGNLRVRFNATSP
TSNGFIEYGVNTPNHTTVWYRKRGSLSSMIEQWGQLSISSTTSWNRVPGGSENYVMPSAR
DTTETIITLHNSKEIYRITSNINGNIMASDGVPGVISSATLFVEKLNWN
>KALACAFP_01727 tRNA 5-methylaminomethyl-2-thiouridine biosynthesis bifunctional protein MnmC
MENVDYIIVGDGYAGLFFAHQLIKNNKSFVIFSEGRKSASQVSAGIINPVVLKKFTTFWK
AQEQIDFLKTSLKEIESYTGKNYLIESPIHRIFHDENEQKLWLKKSENEELVNFLDKNFG
HLNVVKNDFNSGKVNQSARLDVNGFFTGLFSFLNEREQFINEKFDYTQLNASDSTYRNFN
FKNILFCEGMGVKDNPYFSNVLVNPNKGHQIKVKLSQPIPENITIKKKHFLFPINDGLYF
YGGTYDREQLHHHIDETAVEQLIKGLSEFYPYDFEVEEVNFGFRPTVKDRRPIIGRHPEH
PNLYVFNGLGARGILNGCYFSKSLYDFIEENIPLHEEVSLARFE
>KALACAFP_01728 hypothetical protein
MKKYISSFLVLVSGFMFSQTILNASSPEEFRQMRAENKMKVGDTIIDKKVKPLEYGFVDE
KDILKSMFVWEVIDMNDKINQPFYYNNPDGLLSTQTKSLYKLLLDGALSGEIKEVYDDEN
FVQRLTPEQIKSRLVDVRVDDEAINILNSGRQLTDQEKKELTDVYETTTEKVKVLKIFGM
WFIDKRDGQMKYRPLGIAAMGPDPKLIGRTTPDGQPLPGANDLIDLFWVYYPNARDILAN
NYVFNRKNSSADLSFDDLINARRFSTVIFKSSTGLGDGIIKDYIPRDADEQIEESDRIKA
QILQMENDMWNY
>KALACAFP_01729 hypothetical protein
MAQGKQTPRQKMINLMYLVFIAMMALNIDAEIIRSYYDSTIALKETRLLTERKNEDIFEK
TLEAKAQQVPDTYAQPWAQYKQLKEKINALVSHADQIKDKLKKESEFVEKDPKTGKLIDV
SENFSALNNNEATTKYFFRDGDENSASKGATDLKAKIDDVRNFINATFGNNPQLKDLVDR
ANKSLIAEYAKGQSPNNKTWLQNKFYHQPLIAALSNLEIIQNDARNVQSDALALLLQEKV
DASIKFSSYEAIVSAPVDVVAGKPAEAVVMLGNYSNSNKIVMSGVSRQENGKGYATLNTS
GIGEHVFSGNITLTDATGKAQNFPFTHTYNVIAGPQEVKLQKGLLLSADKMNVMYRGLDN
PVTGSILGADNAKLSLSAPGATVKSTGPGKWDVRPGSGNILKITLSGTDPYGKSLSQVFE
YRIKNVPPPQGQIRGKNMLTLPATSVENQSLQAVIPDFDFPVSFQVTSFMVRVPGRASMQ
VQGNSLQSVSGMFRNLRPGDGVYIFDIKATATGLGSMQVPNISPVLINIQ
>KALACAFP_01730 hypothetical protein
MFKTKDAWMNFFYSFGAAIVILGAWLKITHINIGPITGNVALTVGLITEAIIFIIFAFDP
PKTEESYAWENVYPELLDKHANPNPLHSNVSSKNNIDHFAELENSLSGKLDKMLQDAKLD
VQLFERLRTGIDKFSSSVDQINQTVDVSASTHKYNDQLNKAAQHMESMNALYAMQLENGQ
RQSDFAKKYVEDMQKSVEHSEKFNQELQGLTSNLNNLNRVYGGMLTAMKS
>KALACAFP_01731 Serine/threonine-protein kinase pkn1
MKRIFLLLLSASVASVSCSGGGTSSVGKPGTKGELIPREKTKSFVAERPYGMVAIPAGSF
VAGLADQDPTNSPEKANLKTVTVSSFFMDEAETTNAEYRVFINYVRDSIARTLLAEAAGE
GGEGKGKGQSIGDYAYLAQKEENLTPYQEYLEGQGGREDDSYDPTKKLDWKVPLNWNTSK
YPDVEYAEVLESMYLPASSRISNERILDVSKLKYTYRWGDMDVALAEKERGVNYLRSESI
AVYPDTTVWVKDFHFAYNEPLFEQYFWHKAYKDYPVVGVTWDQARAYCNFRSKLKSDYNE
SLKRRKQRPLKFRLPTEIEWEYAARGGMENATYPWGGPYLMDDRGCYLANFKPKRGNYME
DDKKGTYTYTAPVKKFKKNGFGLFDMAGNVSEWTESGYNNSTYGFASTLNPTIKDKTDTR
KSVRGGSWKDVGYMLMTGARDWERKDSARSYIGFRTVQDIPEAAVKAKRVNR
>KALACAFP_01732 Glutamine--fructose-6-phosphate aminotransferase [isomerizing]
MCGIVGYTGFQDAYDIVINGLRRLEYRGYDSAGIVLEDTNNTFEVEKTKGKVDDLVNISG
QLRGKAKIGMGHTRWATHGVPSDRNSHPHLSNNNKIAIIHNGIIENYDTIKTMLSEKGFT
FKSETDTEVLVNLIQYFMDLNAETDFPTAVRYALNEVYGAYAITVMHEDYPGVLVVGRLG
SPLAIGIGDKEYFIASDASPFVEFTKEAIYLEEGHMATISLENGVDIRTINDNSKIEAEI
QELKLSLEQIEKGGYEHFMLKEIFEQPKSVHDTMRGRLLVDEGVIKMAGIWDHIERFKNA
NRIIIIACGTSWHAGLIGEYLIEEYARIPVEVEYASEFRYRNPIITDKDVVIAISQSGET
ADTMAALKLAKEKGAFIYGICNVVDSSIARITDAGSYTHAGPEIGVASTKAFTAQLTILT
LIAFKLGKHNGNLGNAEFMSLIAELDAIPKKIEDVLATTHDLVQNIAKDFVHATNFLYLG
RGYNYPAALEGALKLKEISYIHAEGYPAAEMKHGPIALIDENMPIVIIAPKKGHYDKIVS
NVQEIKARKGKVIAVVNNGDTQVREMADYVIEIPETAECFSPIVASVPLQLLAYYIAVYR
GANVDQPRNLAKSVTVE
>KALACAFP_01733 hypothetical protein
MIHTIKKAITVLSLVVFGSVLLYNCEPDADSLGEQLFLDGAAQGNEKSFDVIAFNIDNND
SIRSDAGKLGSAVLGAFNEPQFGKQKASYLTQLRLSTYDPDFGTNAVVDSVVLVMKPIYA
TDSVTTTTDESFVYAGVDGNVDAKKVVNTYPVSKYGKTKINGKTTFNIKVFEVTDFLKSA
SDTVKSNQQFAYNPTALGAKEFKGDVSSVTITKDSDGSSLFTTTTPGIRIKLDKDFFQTK
IIAKKDQPELQDASNFIRYFRGLRIAVDENDGYLFQFSPNDMEMIMYYKYDKTDNGTTTR
PQTTYTFALGSGNAHIGQYEYDRDGSTLKNTVIGNRTTGDQKLFAQGMGGPSIGVIIPKE
KIDSLKLFYNNNKAAIIGARIRIYTDKNSWDNSYIKPTAFTFLQKYKGKYKPDGSLADPN
KTVTNFTDDLLNLSGLAGYTIYKSYDLDKNPAYYEFVVTKSVKDLVEKNDSDSYSTGSYD
PIKRNTLYFRIDMGSFLSNSAGTGLAGYQYTSRAFNTNRAVFVGSDPSNANRVQLKVIYG
TK
>KALACAFP_01734 Glycogen synthase
MPNQKILYITTEMYPYQEDTNMAAVVNKMALKMHNEGNDVRVFMPRFGQISERKFQLHEV
IRLSGMNIIINDLDQPLIIKVASLPGERLQVYFIDNEEYFKRKQYYFDDEGNPFEDNDER
AIFFARGVIETIKKLNWVPDVIHLNGWMASFVPIYLKTYYESDTYFKDAKIVLSLYNEKD
AALASNIDEKLKFDNISGLKALDNPSVKTFVMESMNYVDMVVKGDEFLDEDLDKAFNETT
TPKSEYLDVDSINQLY
>KALACAFP_01735 Pantothenate synthetase
MEVLKSKKVLQDFIERQKEMGKKIGFAPTMGALHKGHLSLYEKAREENDLVISSIFVNPT
QFNNAEDLEKYPRDINRDILILENSHLVDAVYIPEVVDIYPEKTVSQHYDFDGLENEMEG
KSRPGHFDGVGTVVEELFHQVKPDNAYFGEKDFQQLAIIKKMVEKKKLLVNIKGVPIYRA
ENGLALSSRNQRLHEDRREASKVIYETLKKVNEWFRVITIPEIKERVQDIFDEQKGMQLE
YFLIADEETLKETDFFYKDKNFRAFIVVVVDGVRLIDNMHLD
>KALACAFP_01739 Shikimate kinase
MIISLVGYMGSGKSHISKILSEKLDFKLIDLDKEISRRNKLTIPEIFEKKGEIYFRKLER
EALEEILATEENVVLSLGGGTPVYYNNMEIINHNSKSFFLRASINTLSERLSKQKEKRPL
IANISEENLSEFIAKHLFERNEFYSKAQFNINTDNREPEDIVNEIIEKLYL
>KALACAFP_01740 Heat shock protein 15
MRIDKFLWSIRFYKTRSIATEEIKKNRVSIGESTVKSSKEVREGDVIKIRKNQIDYKIKV
IQIPKSRIGAKLVPLHIKDVTDKEQYELLKMRKMSQDYYRIKGEGRPTKKDRRDMDEYVE
NDIASDFTDWDDFFGETGDDSEEKED
>KALACAFP_01741 hypothetical protein
MKKIFLYILAGSLCFSACKKDDDVETFVEPEDIAVRNSYDDQAIQKFMDENYLDTQGNIK
AFSTTDTVDDNYKKLSQLNPVTLPSGVIYIVRDGAQPATGVTIEPDAKTQVKTMIRANYY
LATNTDGNVAFGSVGTLLNTINGSGSPVTDPMFYYVKNAILNNSNNTDIQKQRSYYEIEG
LQEGLKYFKGFQNMSDGDPYNLQGVILVPSRAAFARNPHYNYTGFSLQNNCFIFNFQIYK
ANVRPTADE
>KALACAFP_01742 Ferredoxin-dependent glutamate synthase 1
MRDKFLSWGIVLVIATWIVALLIRAHYWIPILLSAFYALGVYNAYQTKHAILRNFPVVGY
FRYFFESISPEMQQYFIERETDGKPFPRNQRSAVYRRAKNLSDTVAFGTQLEVNHRKYEG
IKHSIYAKSPAEELPRVWVGGEQCTQPYHASLFNISAMSFGSLSDRAQISLNRGAKKGNF
YHNTGEGGISPYHLEGGDLCWQIGTGYFGCRDDEGKFNPELFSKYSNLPNVKMIEIKLSQ
GAKPGHGGVLPGVKNTPEIAKIRHVTPGMTIISPPSHSAFSDAPGLLRFVQQLRELSGGK
PVGFKLCIGDTKEFEDICVQMNVLKIYPDFITIDGAEGGTGAAPPEFSDGVGMPLEPALI
FVNRTLKNYNLRDKLRVIASGKVLTSLDILRAVAMGADMCNNARGFMFSLGCIQALRCNS
NNCPTGVATQDKMLIKGLDVTDKAERVYHFHKNTLHMCNELIAAAGKSSYEEVDATMFMR
GDEFDHLADLYFPDILGNVKQKARS
>KALACAFP_01743 Threonylcarbamoyladenosine tRNA methylthiotransferase MtaB
MHPLNSGVKMSTFHRTAAFHTLGCKLNFAETSTIARQLTDAGYDKVSFDEKADIYVINTC
SVTENADRECKLHVKRAMKANPEGLVVIVGCYAQLKPEEISQIEGVDLVLGAKEKFNILS
YLDDLEKSESEGIVHSCEIEETDFFIGSYSIGDRTRAFLKVQDGCDYKCTYCTIPLARGI
SRSDTIENVLKNAKEIAARDIKEIVLTGVNIGDYGKGEFGNKRHEHTFLDLISELDQVEG
IERIRISSIEPNLLKDESIELVSKSKSFVPHFHIPLQSGSDDLLKKMKRRYLTKLYNDRV
NKIREVMPHAAIGVDVIVGFPGETEERFMETYNFLNELPITYLHVFTYSERENTEAAEMD
GVVPIPERKKRNKMLRILSEKKKMAFYQTQLGKTLPVLWEHENKDGKMFGFTENYVRVQK
DFDPASVNQIEFLNLEKILSDGTVSVQSSYESFLAKA
>KALACAFP_01744 hypothetical protein
MKDLFIKRFEYYKNLGDKSFEQLSDEQIFWQYNEESNSIAVIVKHIAGNMLSRWTNFLTE
DGEKSWRNRDEEFVNTFKNKQEVLEYWEQGWKCFFNALDQLNDENLSSTIYIRGEAHSVI
DAVFRQLAHYPYHIGQIVFIAKMIKNEDWETLSIARNKSQEFNSAMKNKFSGRDIHPNSS
PVCYQNSPEVRDEFKQ
>KALACAFP_01745 hypothetical protein
MKKNLLFFYLLVSQLFFSQADCSSALQVCGNSNITYSPTGIGAVNENLGGCLTTGEHNSI
WYRITIATGGTLTFDLVPTDPNADYDWAIYGPNVSCGSLGSPIRCNAATVLGIGANTGLN
MTSTLLTAAGGSLTPYCKYMDVLAGQTYYLYIDNWVGAGSNTMAPFSLTWGGTATLASPF
TDPTIQTQPFVPPGVPAANPADPREVIICENPMVFNFNSLSAGIINGNSNFLISYHTSSN
DALSGANPILTPQTISTTATYYYSIHYVDPANPNNPINSCRQVGLFKFKQGTITGTNVSL
YSCNNNNTGVATYDLTSAAVFSDPTAIKKYYNSIADLNAGINEITTPTAFVSAEGTVYVK
IISQYGCTATAEISLKFYPVVVVTEATLRSCFIESKPSTALFNLTIAPVTTQSGTKKYYP
SLADAENGTNEILNPTAYIAPNGVIFIKVINGNGCYGIAKVTLIVLPPTYSTVLEDKIIC
IEDTTTLDAGPGFTGYLWSTGATTQTINNVAVGTYWVDLKTGECVTRQIVKVYPSKQPVI
SVIDIANNTVTVNVTGGTPPYKYSMDAVNWLDSNVFNNVPRGDNHIFVKDAYDCEPIDVV
IVVPNLVNVITPNGDGINDVIDYSALGNKQNLVFNIFDRYGTKIFQADKSNNYKWDGMVA
GKKIPTGTYWYSVTWNEHDKKNTLFKYSGWVMVKNRD
>KALACAFP_01746 hypothetical protein
MKKAFSDEDLIKNLSLYYLNRHLKKKPIEKYHRKIDESSLHDREKYKKKSEILLLNSFMH
HFPEVQFENLTCESPDFIAKFNDKKIGIELTEVINHLEMKKVESNLNKIFRQAEILLEQE
DTTKYRGVYFLEFHTNIKLDTLESHEEIILNIYKSIKRGKPFGCVKSLRKSVHRRNVFIT
YEYNMNLFDELCSEKILELIEKKNEKFPYYDNTVDECWLVIVSDMNSLASRYTFIQDKEH
LQQVKSPFHKIFHLENLCGNITSIK
>KALACAFP_01747 Glycogen phosphorylase
MYTFKIIYHIINIKFIFIINTFAPSQIKLRFMDFKNFKIPFSINPQYSKKVAYFSMEFAI
EQVLKIYSGGLGFLAGSHMRSAYNLKQDLIGIGILWKFGYYDQARNHDQTLQPTWTRKMY
SFLEDTGIKFQIEIHSAPVWVKVWYLDPEIFNTAPMFFLSTDVPENDHVSKTICHKLYDA
NESTKLAQYILLGKGGARLLDEMNIERDVYHLNEAHGLPAAFHLLKKYNGDVKKVKEKLY
FTTHTPEEAGNEKHNLRLCYDMSYFSGFSMEYVKNIEGSDDDRFNHSLCALKMAKVANGV
SQLHGVVSRAMWSKYPGICEIKSITNAQEFKYWSDKPLYNAKDEHNSTLFDYRKKHLKKR
LFEIVADQTGNLFNPNVFTIVWARRFAGYKRADLLLHDKDRFYKLLNHPKYPVQIIWAGK
PYPMDYSAISTFNSLVEESKNHKNMAVLTGYELSLSKSLKQGSDLWLNNPRVPREASGTS
GMTAAMNSSVNLSTDDGWIPEFAKHGENSFVVPKADYNNMSIYEQDNYDLNKLYEILENE
ILPTYYDNPDQWRKIQYNSMNDVKDQFNSDRMADEYYKVLYNYEG
>KALACAFP_01748 hypothetical protein
MSNTKYSEKAQDKVGKVMHEFKEGKLKSSSGKKVTSRKQAVAIGISEAREKGLKVPKEKK
KKD
>KALACAFP_01749 hypothetical protein
METNAFNQKLNRYVLNDQIVYTGFSSFKEAEECAQKKGGTLVEVGFKDGNDNPEICDEAH
LLEKKLHYCVDAGDEYKFIHSSDPGFRKYADELQKIKARQQQSPPDERYLANFEIENAED
PIIVIKNDHFESVTSRERSKYLKHAKVYEIGVSLLKS
>KALACAFP_01750 Prolyl tripeptidyl peptidase
MKKFILTLTVAAAFQSFSAQEITLDKIYSGYYRGKGIAGITSMKNGENYLVIEPTGIAKY
SYKTSQKEGNIVDGQFESYEFSDDESKILLLKESEPIYRHSFLGKFDVKDLKSGKVISLN
DGKNVQEPRFSPDATKVAFISENNLYYQDLNSGKITQITEHGVKNKILNGLADWVYEEEF
GHARLYEWTKNSDAIVFVKLDETEVPEIYIPIYGKSLYPKEMRYKYPKAGEKNSVVSAHI
YQLNDGKKTKVNLENFKNYYIPNVVQTAKPDEIVLITSERVQNASDVLKVNTKTGEVKKL
FTETDEKWIDTDSPTLEFLEDNSFLWGSERDGHRHLYWYDKDGKLKKQVTKGDWEVTDYY
GFNPKSKEIYVQTTEKGSINKVVSKINIENGKAQLISNGEGNNSANFSKNYNYFIETSST
AAKPYTYILKDGNGKVVKELQNNNDQLQKLKADNFVEKEFITIPNEAGDQMNAWVMKPKN
FDKNKKYPLFMFQYSGPGSQQVANSWDNGNTLWFNHLVQKGYIVACVDGRGTGYKGAKFK
KVTYMNLGKYEIEDQIAAAKWFGNQSYIDKTRIGMFGWSFGGYMTSLAMTKGADVFKAGI
AVAPVTNWRYYDTVYTERFMRTPQENPDGYDKNSPTKYANLLKGKFLMIHGTADDNVHFQ
NSMEFSEALIQNKKQFDFMAYPDKNHGIFGGQTRPQLYQKMTDFILENL
>KALACAFP_01751 hypothetical protein
MMEIIWSEETLKNYLKVIDYLFENWTKEVERFENHFNKLTDNLKNHVTICPKSKILNLRK
CIIDENNSLIYQEINDKIFLVTIIDNRSFHFY
>KALACAFP_01752 hypothetical protein
MEITLKDLENNIRTLPENFYEEVNDFIDFLKTKYTRANAEDWSGILSEPQRESIKKGIDD
IENEKTLSHESAQKKIKDYIASKK
>KALACAFP_01753 Dipeptide and tripeptide permease A
MKTKHPKGLPFLFFTEMWERFGYYLILGIFVLYVIEPTGLKGGLGLPDKTADDIFGTYIA
LTYLTPFIGGFLADRVLGYIKSIYLGGVLMAAGYIGMGVFKDLTLFYSSLALIIIGNGFF
KPTISTLLGNLYSEEPYKANKDSGYNIFYMGINIGAFICNIIAAFMRNKFGWGEAFITAG
VGMLIGLIIFTIGRKHYIHAAQMKPVQEGDTKLSEILVKVFLPAIIAGAIGWVIPENIFG
SDNTDAFIFACVPVIYFYASLYFKAKPEEKSSIGALLSVFLISMFFWAVFKQNGTALTRW
ANYYTDRSVPAALEKPLEGIYMVDGKGYEDKEVSVYDDQYQSQKDKDGKTIKETGKDIYF
RNISPEQRADLEKNPDKKVYLYNTELFQSINPFWVIALTPIVVGFWALLRRKGKEPLTPT
KIVLGLFISGLSCLVMVLAVWAGDNGAVKVSPWWLVASYGVITVGELCLSPMGLSFVSKL
SPARITALMMGGFFLANSVGNKLSGILASTWYSYDNKMNYFLVNFALLIFATLLGLSMLK
RLNKIMKEKGH
>KALACAFP_01754 Di-/tripeptide transporter
MDNTEALSPKPDEFVENKNSRHPKGLWVLFGTEMWERFNFYGMRALLTLFMVNSLLIKEA
DAAIIYGGFLALCYLTPLLGGFIADKYIGNRNAILIGGSLMAIGQFLLFISASTFSADLG
SAKMIMWLALFIIIFGNGFFKPNISSMVGSLYPKQEKSKLDSAFTIFYMGINIGAFLGQF
ICPYVGDVKDAATGVRDIFAFKWGFLAASLAMVIGTITFFILKNKYVVTPEGRPIGGLPK
HNTSADFEEGETQTAKFSGKALGITGVLFVILFFAFRYLLVGEFGFNSVEMGQLIKGIIY
PFIYAAGISLAFLIMSSAENKVEKQRIWVIYIVSFFIIFFWAAFEQAGSSLTFIADNQTD
RNIFGWNMPPSMVQIFNGIFVVLLAVPFSLCWDKLRAKGKEPVSPMKQAIGLALIALSYF
IIAHNVKDLGNSGLLAIKWLMLLYFIQTCGELCLSPIGLSLVGKLAPKRFASLLYGVFFI
SNAAGYALAGSLGALIPATGDKFSKAQEIGVNLQDVLDKKVTLTADQAAAFEKAQLPIAN
PTFAGFEIHNLFEFFMVFVVLCGIASVILALISPILKKMMHGVN
>KALACAFP_01755 Di-/tripeptide transporter
MSLTLDEIQDFKGKYPSQIWSLFFSEMWERFCFYGMRGMLVFFMISQLNLHEKEANLQYA
ATQAFVYAFTFIGGLFADKILGFRKSLFWGGLLMIIGSLILAADPHKFFFLGISFTVVGT
GFFKPNISSMVGQLYKPNDSRADAGFSLFYAGINLGALLGGYLCITIGKGEILTSLIPEN
MRWNVAFGLAAIVMVVSLINFIFTQKRLGTIGLQPGHPMAEVKSAPIPKWQEYGVYVLSL
IFIPIIMIMVAKTQYTNYFMYTVGPLTLLYLFYEMTKVTPSERKKLWAALVFILFSILFW
GIYEQSGGSLSIFAAKNLNKDLLGLDPNGVNNSGGAFFIIFLAPLIGLLWIWLNKRKIEP
NTLIKFGLGFIFLGLGYYVLFATRLFVNAAGITSLNFFTLALLIITLGELCLSPIGLSIM
TKLSTKNLQGMMMGMWFLASAYGQYVAGIIGASMATEKKGASNYDAFITYTDGYKQLGLY
AVIAGVVLILISPYVKKLMQDVK
>KALACAFP_01756 Thiol:disulfide interchange protein DsbD
MKKIISIILLFWLNFSFAQVKWMTIDEALKAQKENPKKILIDFYADWCGPCKIMDKKTYG
NQIITDILNQNYYAVKFNAEEKKSFEIFGRLFSNPNIEQKKGRNSLHEFTEYMNVGAVPS
TVFLDENGGPITILQGELSAKELEPYLELISKNLFKKIRTRQQWEDYQKKFKSRIDEI
>KALACAFP_01757 ATP-dependent DNA helicase RecG
MNLETSIEYVKGIGPEKAKLIKNVLGISTVEDFLNFFPIRYLDKSKVHKIAQLKDVSTDV
QLKGKITSVQEIQTGKTKRLSAKFNDDTGTMDLVWFQYSKWMKEQLPINREIYIFGKINV
FNNQFSMPHPEIEIEEKKDTDNRLKPIYPSSEKLTKRGLNQKFFQTILRNICKEIPNLIH
ENFPDYLMKAFKFLSRQHTYLNVHFPKDMEHFEKANYRLKFEESFFFQLGYGLKKLHHKS
HTAGNPFPIVGDHFNNFYENHLPFDLTEAQKRVLKEIRLDMKKPIQMNRLLQGDVGSGKT
MVALLTMLIALDNGFQSCMMAPTEILAQQHYNGIKDLLKETKVNVRLLTGSTKAAERKII
HKELENGELSILVGTHAVLEDKVKFKNLGLAIIDEQHRFGVAQRAKLWAKNKIPPHILVM
TATPIPRTLAMSFYSDLDVSVIDEMPVGRKPIITAHRREKDRAYVYNFCREEIQKGRQVY
FVYPLIEESETLDYKNLMEGLENVMDNFSKYNVTMLHGKMKPDEKDAAMNYFASGKSEIM
VATTVIEVGVNVPNASVMVIESAERFGLSQLHQLRGRVGRGAEQSYCILMTSDKLSSDSR
TRIKTMVETNDGFKISEVDMQLRGPGDILGTQQSGVVDFKRLDLVNDSAIIKTTKNTVEK
ILEADPLLTRPDNQIIKNYYLRNYKGKNKWGKIS
>KALACAFP_01758 hypothetical protein
MNKEYLNVILVDDDEGNQIFFKNIFKDLKVGVKVQIFNNGRDLMNFLNSEDALIPEILFM
KYDIPKKNSLECLEEIKIDFRFDQMVNVIYSDELSVGEEEDVFVKGANVFMKKPDNYADM
KKVLSEIITINWQYHTSGLNKNNFIMKV
>KALACAFP_01759 hypothetical protein
MYVKFDFNALCKKVLDEKLKEHGLKYRLLNFGEVEFYESLTQEQHKIFKKNLEDYGIEII
ESQKTALVQKIKDVIVELVFSNDIIPVKASIYIAEKLNHSYGYLSNLFSEVTYTSIENFI
ILQKIEYAKELIIRNKQSLTEIAHRLNYSSVAHLSTQFKNTTGITPSLFHKIVTKRRKVQ
SMIGNIEMQYE
>KALACAFP_01760 hypothetical protein
MKLIEATEKDIPLIQDLARRSWENAYVGIISNEQIEYMLSEMYSTKEISEHLQNPNYHYY
LILDENNNSFEGFIGYEHGYEEGTTKLHRIYLVPESKGKGFGKGALDFLKSKVSESGDGR
IILNVNKENSAKNFYESQGYRVYNELVLDIGRNFVMDDYQMELLIHK
>KALACAFP_01761 4-hydroxy-tetrahydrodipicolinate synthase
MSILKGVGVALVTPFNEDLSVDFDSLTKLVEYNIENGTNYLVVLGTTAEAATLSEEEKKQ
VIEHVIKVNNKRLPLVLGIGGNNTLEVKKQIEEADLSAFEAVLSVSPYYNKPNQEGLYQH
YKALASTGKNIIIYNVPSRTGQNIEAETTIRLAKEFPNLFLIKEAAPNILQYFDILRKKP
EGFSLVSGDDEFTLPVTLAGGDGVISVIAQAYPKEFSTMVQLAFDGKVKEAYEIHNKLVD
ITRLIFAEGNPCGIKVILTEKGITKNYLRLPLVPASEGLYAKIKAEMANI
>KALACAFP_01762 Mannosylglucosyl-3-phosphoglycerate phosphatase
MKNKFLLIGIALTALSACKTASPLQVANVQTQKNISINNELKNDEEFVKIIEPYKQKLDK
EMNQKISHTNTDLTKQGDNSNLGNLLADYTFDGADEWAKKNLQKNVDAALINIGGIRTTI
GKGDILLKSVFEVMPFENEVIIVKMKGTDLQGLFDYYAKTQVNNPVSHLYIETNNGQLTK
TLINGKAVNPTQDYYIATSDYLALGGDNMKFFAKGESTPTGIKLRDLFIDYFKKNPEVVA
NTDVRLNFIGKK
>KALACAFP_01763 Trifunctional nucleotide phosphoesterase protein YfkN
MDRKKFLKAIGGGTLAMALAPNMMMAEELNILDLKSTKKLTILHTNDQHSRIEPFDASYT
KSPNQGGFARRASLIQQIRNQESNVLLLDSGDIFQGTPYFNFFGGELEFKLMSMMKYDAS
TMGNHDFDNGLDGFLKVLPNAQFPFICSNYDFKNTVLDGKTSQYKIFNKNGIKVGLFGVG
IQLDGLVGKKQYGETVYSDSIEVAQHYSNFLKTEQKCDLVICLSHIGYDYKDEPNKVSDK
ILAAKTENIDIILGGHTHTFLPEPQTFTNRQGKNVLVNQVGWAGLLLGRIDFYFDTDKNV
KHISWNNQVIDSSIIA
>KALACAFP_01764 hypothetical protein
MKKISLISLGILASLQFVNAQNISSKKWTDLFSYNNVLAMKEDNGRLIAAAENGIFYYTV
STGEITKLSKANGLHEVKISAFDYNPQTKIGLVGYQNGALDVIAPDGVTYVVDIPIATGY
NGSKKINHISITGDLAVISVGYGVSIFDLKKKEFKDSAFFLSGGTYEASNEATIFGNKVY
AVSNTGFKSHEMNVTFPVYSTWTVEMAGSYNHIDSEGILSFSSPTTGYLYNGGVPVPLSQ
AFTNVHDVVVNSNNIIVTDQNRVYTFNTNGNFTNTVTFGEECNTATTVGSSVYGGTILSG
IKNESNNSFKPDGPYFNYAYKISLFGENQLLVSSGGRENRFNTPINNLRNPGFYYFNGME
WIYPSYFIGNTTRFNILDVVSDPVNPDDIFFTNYNNSTGRGIYKMKYNSGSKDFTFTKNY
DLGTSDFYTRRPVGLTFDDSNNLFTSIAFSGEGAAQGPLTAVGAYDRATDTFLIKNTTIS
GGAAQKPLYYEGLLWMPLPRVSSFLAYDYKKTINTSDDTEYILNQSNGFASNSNGTVSVA
VDKSGDAWIGSDAGLRILPNAASEIKTPSTATVEPIIIEQNGLGEELFRDSQILQIEVDA
GDHKWVSVDGGGVYYLSPDGQQTIKHFTKENSPLPTNSITDIKVDRKTGKVYFVSYDGIV
TYQGDVADVTSDFGNVVVYPNPVVYTQFKGKVTIKGLAEITNIRIADAAGNVVHSAVARG
GYYEWDLNNQRGVRVASGVYFVLMTNEDGSDKATAKIAVVN
>KALACAFP_01765 DNA repair protein RecO
MNSQNGFLLSYIKYGENDAVLHCFTEEDGFQSYFLKGIYAKRNKKKALLLPLSKFNFSLN
PLKGNGIQTISKFELVKSNDIYMDIKCNSVVFFISDFLNQNLKHENKNPTIFFCLEEFID
ELEHQNYQSHLVFLIKILKIQGVAPLLNEGNFLDPETGTFSQELTHQLFSEDISTIWKAI
LYAENPYVIKVHSTFRKDFLDSVLVYYHYHITDFKTPTSLEVIQQIFE
>KALACAFP_01766 hypothetical protein
MKEKERLSDISWKKWGPYVSNREWGVVREDYSADGDAWNYTTHDTAEAKTYRWGEEGICG
ICDDFQKLVFSVGFWNKKDKMVKERFFGLTNGQGNHGEDVKEYFYYLDSTPTHSYMKMLY
KYPQNAFPYEDLLTVNATRTKEEAEYELLDTGIFDENEYFDIFIEYAKESQNDILVKLTI
INKSENEAPLVILPTVWFRNTWNWGYDDYKPQMTSEEATSIKVNHKDLEIKNVYAKQSVK
VLFCDNETNNERLYQCPNKSKYTKDGINDFAVNGNSQSVNPKDFGTKASFFINEKFKSKE
TKIFEFRISDKELKKPFDDFNDIFESRQKEADEFYAEVQKGIKTEDEKLVQRQAFAGMLW
NKMFYHYNVEKWLKGDPAEITPPKSRQKIRNFEWKHLNNEHIVSMPDKWEYPWYATWDLA
FHTISFSIIDPDFAKHQLKLFLFEWYMHPNGQLPAYEWNFSDVNPPVHAWAVFRVFKIDE
YLKGEPDLEFLESAFQKLLMNFTWWVNKKDSNGNNIFEGGFLGLDNIGVFDRNLPLPNGE
HLEQSDGTSWMAMFALNMMRIALELALYNSVYEEMAMKFFEHFLYIANSLDNMGDEHFSL
WDEEDEFFYDALASSDGNHMYLRMRTVVGLIPMFAVEVIDDEMIENLPNFKKRMEWVLEN
KPELAALVSHWEVKGQDSKHLLSLLRGHRLKRLLHRMLNPDEFLGEFGVRALSKEYEENP
YTLKLNGTDYIVKYTPAESDSGLFGGNSNWRGPIWFPVNFLIIESLQRFFFYYSPDFLVE
YPTGSGNFLNLDQIADELSKRLSKIFLKDENGNRPVNGQYPRFQTDPDFKDYILFYEYFH
GDNGRGVGASHQTGWTGLIAKILMPRFSKKEIAESETEMPDDAK
>KALACAFP_01767 Glucose 1-dehydrogenase
MEISLQNQVAVVTGASSGIGSGIAKSLASAGAVVIVNHSSERSTDEANAVLKEITDAGGK
GITYQCDVSKEDQVVKMFQEVVSEFGTVDILVNNAGIQKDAKFTEMTLDQWNAVIGVNLT
GQFLCAREAIKEFLRRGIDTSRSVACGKIIHISSVHEIIPWAGHANYAASKGAIRMLMQT
LAQEYGADKIRVNSICPGAIQTPINTNAWNTPQALNSLLTLIPYNRIGQPQDIGNLAVFL
ASDLSDYITGASIFVDGGMTTFESFSTGG
>KALACAFP_01768 hypothetical protein
MVSLKFFNEEDFPEVNYTLDELQLQYTSPAKFALARIKERNTDLEFPITIFNDEKPAGFF
VLDFGEDKLDLTDNPNSTLLRSLSVNPALQGKGIGKEAMLQIDDFIRKHFKDCDEIVLAV
NQNNISAYELYVKTGYHYDGKTRIGRSGPQYLMFKKL
>KALACAFP_01769 hypothetical protein
MKKYILILVLMPLLFFSQKKISKEEMEVKKFQKELNAEYLNPKETPLRGDNFTKFKEHPF
FPFNSKYRITAKFVRTENAEPFDLPTSSGKTKSYREYGKAIFKIDGKSYTLTLYQSLDLI
KQEKYRNYLFLPFRDATNEKETYGGGKYMDLTIPKGNMIILDFNKSYQPYCAYNAYDYNC
PIVPDENKLPVEIRAGVMYEDIYHH
>KALACAFP_01770 Cholesterol oxidase
MDRKSFIKNSLLAVGGFYFLQSNLFHAAQPAIKQEKNIDAPIIIIGSGYGGAVSALRLCE
AGKKVVMLEMGMNWGKSGIPYSNLLKPDKSAGWLKTKTIAPFFNIFSLKPFTGVLDRLDF
EHINIWVGRGVGGGSLVNGGMAVTPKESYFKEVFPNLDSDKFYNIYFPRARQELKVNIIS
EEFLKECPFYKFTRVGEEEAHKAGFKTMRIPNVYDFSYMEKEYKNEVPRSAFNTEVIYGN
NHGKNSLDKTYLQKALDTGNLEILDLHSVDEINVNQDKSYTLKVHQIDTLGKTIAEKTFN
CKKLIVAAGTMGTLKLLLKSNAVNNLPIPENLGKNWGNNGNFMTGRNWVKPLSGGTGAKQ
STIPVAGVDNWNDPEHPFFAEIAPLPMGMDVATALYLQINRVDKKGSVYYVDDNLKVNWD
ASNTQKMRENADYFIKKMNRANGGTRAHLLFDNGFGANICYHPLGGCVLGEATNEFGKLK
NHDHLFVLDGSLIPGTIGVNPFVTIVALTEYCIENLIQNNEFA
>KALACAFP_01771 hypothetical protein
MSDTLVKPIIVKELLESLQTKVEEEKQVIVHCCFPASPFLGNLIRIWHSTYLFDNQSDHR
SRLIHAENITIFPNWTPVPFMQDFWFTLIFSGLPTDCKSFDLKEVIPEEGGFFVESIKRN
SSDIYRVKISESYI
>KALACAFP_01772 putative malate:quinone oxidoreductase 1
MSQSLTSRTPKPKYDVVLIGGGIMSATLATLLHEFDPNLEIAIFERLGRFAKESSAAWNN
AGTGHSAFCELNYTPEKPDGSIDISKAESIAEQFEISKQFWSYLITKGYIHEPKDFINSC
PHMSLVFGEKDAEYLRKRHEKMSESVLFKGMEFAADHEKLKEWIPLVMSKRNQSEIMAAT
KMDMGTDVNFGTLTRKMGRHLLEDSNVEVFLYHEVKDIDPKEDGTWEMKVKDRIHNHKQE
VEADFVFIGAGGYALPLLDSSDIKESEGYGGFPVSGEWLVSHNQELVEKHHAKVYTQATV
DAPPMSVPHLDLRIIDGQKALLFGPFAGFSTKFLKEGSYLDLPESVNTKNLRSLFGAWWH
NIPLTKYLIQQVAMTKSQRMQHLREFIKDAKEDDWELKIAGQRVQVIKKDEKEGGKLEFG
TEVVVNKKGTIASLLGASPGASTAVYAMLNVLERCFPEKLHGEWKGKLLEMVPSYGQKLA
DHPELTEKIRKYTKEILELEY
>KALACAFP_01773 hypothetical protein
MKIFNLVSIILAQLLFSQSGNVGINTSNPDNSAILHIENFNGTPATATATISGGVVTAIN
ITNGGSGYKTVPTVNFYDGGSIVNGGSKARATATITSGVVTGITINNGGSGYTSIPSVVI
SGGNKGLLFPSLNIANLSSTTTPVASPADGLIAFNGGTNSNSKALHFFNGTINQWQSTID
AEDTPKIAYIQLTGNLAVLDNAIQGVSARLLPNPLSVSAVSNINGFKVVPNDNAYSLVLP
QGNYLVEVNLNLNSPQENPSGFNGTAPLTGSTYYLMGYFMDFYNDTYNNSTGVFTSGPAS
RKEIPIVSKVSTNHLASWSYYYSVPANANANIIGGLRLYLGRMQGSTFYDLVNVISSESY
IKISKL
>KALACAFP_01774 hypothetical protein
MKKNYIVILLMLVNMVYSQVGIGKTILNSSAVLDISNSTNKGVLLPRVDIVDILNNTTPI
SSPAEGLIVYNKGNTISPGLYIWKNSKWTQIADTYNLVSYLMLQRTTDYSVLGGLANGTF
KNFNDAQFTVVSNDIGASYNTSNGIITLPGNSGYLVNICFDIRDTEESATAGIGNTAVHV
HQYVLKLIDPATNTQYGKSISVNAQSIASNKTHTINLSFSFVTTSATPINLLPAISHAAG
GTYQSGSGGTTLNNGGIIITNAKVDIQRSALNP
>KALACAFP_01775 hypothetical protein
MKKHILTCILFIFTFSLPINAQVGINTSSPNASSILDINSTNKGVLFPQYDLTVLNSTST
PVANPAEGLMIYNKGGVSTYPKGYYIWIKNQWQRAIISGSEPQNMSLVNITVTPPNVLIT
ANNTNSVVPNLVVGSNKITGASLGADKSTITLPAGTYIFRYSVDAVTGTNNTGPANTQYL
SRNFVCTRSYLVNAATNAVITESNKMCQLSDTFTFFQGTFFLKLTAPTTIKQKFEFDTGN
GFTRSDLLIRSSFAINITRMAQ
>KALACAFP_01776 Glycerol-3-phosphate dehydrogenase [NAD(P)+]
MPRKPLFNLCFNIFAVHISIMAKKKTNTESAGPKKNKKDISVGVVGSGSFATAIVKMLVE
NCKVVHWCVRNEFVKGAIELRGHNPTYLTAVNFNLKNLKLTTDINELVSACDIIVLATPS
IYLSDTLDKMNCDYKDKIFVSAIKGIIPKVNDVVAHYLRDEFKIGFRNQAVIAGPCHAEE
VAMERLSYLTIATVEDETSEKLVEIFNSDFIKVHSSKDILGNEYSAILKNIFAIGAGIAS
GLGYGDNFTAVFVSNAIREMETFLEAIYEAPRDVNESAYLGDLLVTAYSLFSRNRSLGNL
IGKGYTVKSAIQSMNMVAEGYYAADSIYKTSKEKGLKLPIIDTIYAILYEGKNAEKQFRK
LTTKLN
>KALACAFP_01777 Pentalenene synthase
MKTMTNEEFYAGLLDLPKPKYPFPDTIHPDFQRLREEYYNWIDTEYIIHSKQAREKHKEH
NLCDIAARGCPFLKSIDDLLPLANYTANGAMMDDYFDRCSRNEMYEITNRIHELLTGNDP
KEPSENGIFHLYWKLRQDALRCDFPEHLYKRFVKSVDRVFKGYAEEKTYYRVNTIPPLPV
YLLIREDTSGVQPYCDYVAMQKDYRQIPDEIFDHPHIKRIQTLCSLLIGIHNDIISLPKE
LHREGDTMNIVKVLQQEYKITIQEAYIKALELHDDYLKEFLVLQNHLPSFDNWKNMIFEY
IQDLGIMVSGVYAWHTDTVRYQNGNYVEGEYTNEK
>KALACAFP_01778 CAI-1 autoinducer synthase
MYFLPEKHGKYPDFLLKRMDDFYANRLHKEWGGEHILRGAAPGEGSINLLSNDYLRLSVD
SQVLASQSGSFDGAAHTPLMSASFIHGEAPQTVLERRLASFFGSESALLCQSGYVANLGL
MQTLVEDMDVPVYIDMMAHMSIWNGIQMGNGKAVPFMHNDISHLEKRISQLGSGIIVVDS
IYSTDGSIAPLRELAEIARTKNCTLIVDESHSFGTHGPNGKGLVEELGINDVVLFRTASL
AKAFASRAGLILCPKEFGDYFNVTSKPQIFSSALMPFDINGLNAVLDLINSETGDERRVR
LHRHSNQLKELLMETGIDVSESESQIIGLKAKSEYKMMLLKQTLDKEGIFGAPFCTPATA
KKRPVLRFSLHSELQADELQHVAVSCKKAFLKHNI
>KALACAFP_01779 hypothetical protein
MKKTLSAMIIAIGVTASAQVGVNTSNPDQSAMLDVSSINKGFLPPRIALNSTTDVITIPS
PATGLFVYNTGAGTLTTKGYYYWDGAKWTRLSIADGGGDFQIGEERGYRFVVPGTFQNNS
GNTSKNQMTGRLATNIGTITRKALSEFVNPADLPLFEGIRLDILGGDNSVLRPRFYNTNT
SNVIISYATLSTSNPLQNSPNMTILPNYYSTPIDGDDWLNTNNTNMEQDLVEILFSDGKY
YRMSIVAYSTDAAYTTVASNTIIGISLKRVQ
>KALACAFP_01780 hypothetical protein
MEKSEPDYKRIYTDLINEKYPERKEEYSSILSKEKLSVLEVITLNKLLFNHEGEDRETSG
FNQNHRAYDKEAILQILDYQKKWKYTNAQLASHFNLSRNTVTKWKRKFIL
>KALACAFP_01781 hypothetical protein
MDLKEINIGAIIESGVVESGIEMDRICNFFNTTEEEILKMYQSDDLEAKMLLRWSKLLDY
DFFRLYSQHLILYAPMSSRDYNHISEKKSASSLPQFRKNIYTKEIIEFILNKISKGEMTK
AQIMNEYKIPKTTLYKWIAKYKK
>KALACAFP_01782 hypothetical protein
MTKKFTTGFAMIASTLLFSQVGIGTPTPQATLDVTGMPTNTTKLDGIIAPRLTGVQLRGK
TYTTAQTGALVYVTAADTAPANQTIDVTATGYYYFNGTKWVATTKDTNIYNSDGALTDYR
KLNFNGKSLSFEGNEQQTNFSDDGLRQIGLTDYAMIQVNSADVNANGLSTNLTLHTFADN
YAEISTSGDSNGLMITANGNVNPSVLEFRTSPGGGLPSQQRLYITGDGSIGINTDNPTEK
FDNNGGNTRLRYLPANGATNAISTTPDGSPSSSQDQTFTATRTVVADANGVLGYVNGLPS
EAGTQKVLVNANVSGTQNVSGGTSVVGQFTVENIDLMNAWTSNVFTVPSGAGGLYMINMQ
TSNNHVVPDNSATSWFVMAYFQKSTDGGANWNIILRDTRSNMSSTTVDNGNALLWTGTLN
AGDKIRPMFLCTATTNNTMVHGSLSITRIFQ
>KALACAFP_01783 HTH-type transcriptional activator RhaR
MNSIDMRKPVLFLVYFLLLFFTVSCSDPAKKQNRTEESLKKEINNLLEAEDIANPKELLN
KAKELKKRAAEIHYDLGVLGCNLIIMNKLSSFGKFKEAIIVSKENEVLIKKIKRDDLSCL
HYTYLGAAYSNLGLVDEGLNYLNEALKYNNKMKDGNKKYLFLGVIYADLAFLEAMRNKSP
VPGLTKKYYQKELEALQKIDDSKDIERRKNSSLAFLYLNLGVTSNREKKTKEAKEYFHKA
LDICKKYNIIKDAPLIVHNEMSWLLYDEKEYDSCIAYAQKGIILEKSDSKPQIRRDLFEV
LYESYSNKGDLQNSAKYTKLYMKLNDSILDAQEIAINDPVKNIVQEKEKDHKSNLINILT
IIGAGILILGILTFLLWRRNQKILHTKYENIISELKNEENKTSVEVMPNQPALNLEKILN
INDNTISTILQKLDKFEKSEKFLKKEMNLSYLANSLDTNPRYLSEIINQYKGKNVNNYLN
GLRIHRITELLYKEPVFREYKITYLAEYCGFASREVFAAAFKKETGVTPSYFINQLTIDE
KNT
>KALACAFP_01784 Murein DD-endopeptidase MepM
MKKFLSSKRNVNLLLGGLLLVVFAQGIFIAKLYSEKDDKNYEVNLVKINTEKDSVDYLKM
KTDLTLVDQTVAQLNSFLKSKDVSSEKVAVLSKDSISNSVYLAKQANRYSQYLMDLQNKL
MQVPLGMPTDGYISSNFGIRKNPIPFKTVFASVKSGAATESKPAAAVASKPEVKAEPVEK
IIEVTDSYGEKRQVKVMVTPKAAPAAPAPTANSSTKAIASNTTKPTEKNNAPAEADQMQF
HKGLDIAVPFGSDVIATAAGTVIFSGQKGGYGNCVIVSHGNGLATLYGHLSQLVAKVNDK
VKVGQVIAKSGNSGRSTGPHLHYEVHKNNTPVNPKLFMNL
>KALACAFP_01785 Aspartate-semialdehyde dehydrogenase
MKKVAVIGATGFVGAQVVKELANRGYEVEAIVRDASKVHENEKVKVKSVDVNNVDELANV
LKESDAVISAFNAGWTNPNLYDDFLKGSENIEKAVEKSGVKRFITVGGAGSLYIDGNQLV
DSPEFPAEYKAGATAARDYLNKIKENKTLDWTFFSPAIEMHQGTAGVRVGKYRTALDNPV
FDENGRSILSVEDVAVVLVDELEQNNHIRERFTAAY
>KALACAFP_01786 Putative HTH-type transcriptional regulator YwnA
MNNTRFATAIHIMTLLAQSPQEWLTSEWIAGSINVNPVIVRKELSILREAGLITSRQGKV
GGSQLTKNADSISISEIYLAVKNTEVLGKKNQNPNPACTVGREINNHLNGLYDEMDQLVL
NFLGNKSLKQFSDQFS
>KALACAFP_01787 hypothetical protein
MKKLLYFLAIFSLLISCVSKKNQVIKQNILTLKDSYCKAPFQYNYVNKFPSYNSDSIIAA
NHDLKGLFSDQSILILNALDNLDEVHQIMELKKDTSLESQVKVLQLKSKINSKITIALTE
LDAVAAEFDCEGERVAQIGNYVDNLNDSRNNKLILYSIVAGAAASVAGGIVQDNGWSNAI
DISGGVLGAGFGLATLNPKGKKVEFIHSRNLLRDIWKQKLESTNFPPFVWYMYTEKKFST
KDGKPIIQNIKKRWLHFQFDNDLKAADKSVIFSDGGFYRSDDLHNRAAMLNQMQSATRTI
NQNINYLLLDLDRLIL
>KALACAFP_01788 FKBP-type 22 kDa peptidyl-prolyl cis-trans isomerase
MGVADMLFKRKKELAEKNLKEGKEYMEEYGKRESVVQLPSGLQYEIITEGDGEKPGPKST
VKCHYHGTTISGKVFDSSVKRGTPASFPLNRVIAGWTEALQLMPVGSKWRLIIPPHLAYG
DQQISKEIGPNSTLVFEVELLEIK
>KALACAFP_01789 hypothetical protein
MPHPQKYNKKYDKLTDEEKELLEISKNSITDFVEQSSSVSDVHYATRNAHAKTYAVAKGE
FLIDKNVPEELQQFFDKEKYDLIIRFSNAHLKINKGKKDIPAYGFAVKIKDESGDLIANY
PLVNFPLFPINSVSTFLKLFTSVNRFFVKKWSSFSLMMQISKVIPSTFTGSFLKNIFKLW
RKRNDFILSFDYHSVGAYRLGENMIKIKLSPKSVDKNFNKKLKTKDALSNYLKTNDFNAD
VLIQICYDLKYQPINKLNVEWKHSPYLKIGEVKIEKNSLLDPNACDNELLSFNPFESKPF
FQPVGKIQKLRDEAYKISLQTRRKINKLLKYK
>KALACAFP_01790 Inner membrane protein alx
MEQNTSILDLHPGLVWGFAITVVIMLLLDLGVFNKKSHEVSSKEATIWSIVWISLSMVFS
GVVYWVYNTDGGAGSHALAVEKFTQYQAAYWIEKALSVDNLFVFILVFGFFKVPKRLHHK
VLFWGIIGALVFRAIFIFAGIGLINLTYLPEMNIFGHAVKINVVMTLFGLFLVYAGIKSW
GEGEDDDNEDFGDTPGAKLVKRFWKVSDNYDGDKFFTIQNGIRMATPLLVVVAVIEFTDV
LFAVDSIPAIFAISNDPFILYTSNIFAILGLRSLYFLLANFIHMFSKLPYGLAIILAFIG
VKMLIAPWIHIPSPISLGIVGGVLVISVLLSVLFPEKVTGDNDDKKIEE
>KALACAFP_01791 Stress response protein SCP2
MAINLQKGQRINLTKENGTTLTQACVGINWGAIEKKGFFGGVTREAVDLDGSCILYDSNK
NATEVIYFGNLKSKNGSVRHSGDDLTGDVNGDDGLDNEVITVDFSNLEPNVEHVALVLNS
YKGQDFGTIPFASIRIYEGTPTNVREVFAKYDIANDASFRGHVAMVMGVFYKRNGEWKFN
AIGDPTADRKLQETIETVKQKYL
>KALACAFP_01792 hypothetical protein
MDDEAVSILSQSKRRLTKLKLLSNFFENVDIISIYIKTDIIHKLFEENKTLDYNKLELFH
LQYTDSLIELLTKIKKKKENDLLAVINEININNQYIEAFEEKKVDSFETDRKIYSGIFSQ
HLRNLYKDLTEDKFTLNWNDVLYFQKRYAAEFYRTDADESKLKAHSVPSYRYQDYSIERK
LLGKLNIQQFKVRFVCGYRIERNEYELFKIFQSNEHFIFNVEEKRMYLIDDELSYLNTSE
NESNQISIINQLKKKNEELEETIHERKRKLPDDVEPVLKDYLRNLESIDIMSKIFDVNEE
TNILRAMLNLNLNN
>KALACAFP_01793 TelA-like protein
MDNQENQPIDPLGSIEPLKTFEPTSMTPPAQPAQNAAPAVLVDRDGNVNLNQLQVEERQK
YETMANAIDETNPGSIVNFGADLQKTLANQSDSFLGNVRRSNSGEVGELINNLLVELNYV
DVDEINNRNPVKGFLSKLPFMKKVMTQVENLFAKYDKIVNNIDQISHKVNAGIITSSKDN
AVLQTIFDSNVNSIKQIEDLVIAGNLRMEKASQELAEMETNVQNYADYQIADKRDFIARL
DRRMADLKVVRLIMMQSLPQIRLVQNNNVSIAEKAQTILTTTLPVWKNQLSLAVAMHRQQ
QNIEIQQKVSSTTEEILRKNAERLGQNSRNVARANEQTIVSAETLRETTNMLISTLNEVK
QIQKQGAENRRKLDQDLQTLEHELKANIRS
>KALACAFP_01794 General stress protein 16U
MAINLQKGQRENINAPKFTVGLGWDINNTSTGTAFDLDASLFLLGENKKLISDNHFIFYN
NLESPDKAVIHSGDNLTGDGAGDDEQIKIDLTKIDAAVKEITVVVTIHDADARKQNFGQV
RNSFIRIFNTDTNEEILKYELDEDFSIETAVEFGRIYNRNGEWKFEAVGSGQREGLEKFV
SIYQ
>KALACAFP_01795 hypothetical protein
MNRRYSLHHIHSADEFTFSPAEYSYFKYGDKSYAEKFAKELFEGFIAENESLLDTDKEIV
VLPSPYMAIPTASNFLCFYFKKYLDFYLFQKGKKSSILSKINRNHTYTTDYGNLSFEDRK
NLIANDTYYLDKDFLRGKLCIFIDDIKITGSHEFTVNKILDEFDVKADFLFMYYAELMNF
NIDPKIENFFNYYAVKNVEHIAEVMVKPSFQFNTRIVKYILGLESSKFEYLSSKVKKEQM
DHLLELAISNNYHLIKEYENNINILTQTELYYGY
>KALACAFP_01796 Phosphoglycolate phosphatase
MKTDIDIHNHCHFSFDLWLTLIKSHPEFKAKRVELFSSFFNVKKPIEEVAKTVKYYDDLC
NTINEVIGGNIDTFEIYLLILGSLNVDVKQLDRTQLNEFYLKSEQLFLEYKPMIIFENLH
QFFDEIKNQGKTINILSNTGFIKGTTMRKFLINENLDQYIDFHIYSDELNCSKPNPLVFQ
EVKNRIKNPDLQMHQILHIGDNPIADYKGARDFGFNAHLLKHQL
>KALACAFP_01797 hypothetical protein
MNGKSFYWAKTCCYHLLNEVPLRLENIFKNVNKNHATFALKIFHKLNQKNKIQMLENHKN
ILKQQINSIH
>KALACAFP_01798 Elongation factor G
MKYNTRNIGIIAHVDAGKTTLTERLLYYTGMIHKIGNVDEGNTTMDKDIQEKNRGITISS
AAISTQWKKDQNVFNINIIDTPGHIDFAVEVERSLRVLDSVVAVFCASSGVQPQTENVWF
QAEKHGISKICFINKMDRIGADFFAVLNEIKAKLNAVPLALQIPIGSEDTFEGVIDLIKQ
KALYWIDENGETIIEKEIPENYKAEANEWRIKLMETLAESDETFFEHFLDSETQISEEMI
VEAIQRTCLSRSLVPVLCGSAFKNKGVQPLLDAIVSYLPAPHQLPSIKGKDAKTEDTIEL
ERNEEETFSGLVFKVIIDKHMGKLAMLRIYSGNITSGDTVLNVRTGENFRISRILQMQSD
KTLTIEEGKAGDIVALTGIKDSKTGDSLSSVEKPVLLESITIPAPVIRVSIEPKTNADEK
SFGLVLAKIQEEDPSLVVERDRQTGETLLSGLGELHLEVTLEKIRLNHGIKINQGKPKVS
YREMLTETRTHREKLVKQNGGNGQFADITFEIGPREDHEVGLEFINQIKGGVIPSEFIPS
VEKGFREAMENGPLSGNPLESMKVTLLDGSTHSNDSHAQDFEVAARDGFRAIGQSCKPKL
MEPIMQVEIQTIEEYTGAVTADINKRRGIITSIDEKSGRKIFAAEVPLASTFGYISDLRT
LTSGRASISMKLSHYALVPDFMANTLVT
>KALACAFP_01799 Bicarbonate transporter BicA
MENKVVLFDFSKKINYKNELLAGFTVAMTMIPESLSFAILAGLSPLTGLYAAFMMGLVTA
ILGGRPGMVSGGAGATIVVLIALIQSHGVQYLFATVVLAGIFQMLVGIFKLGKFVRLIPQ
PVMYGFLNGLAVIIFMAQVEQFKMTEANGVVSWLHGTSLYIMSGLTALTIAIVYFFPKIT
KVVPASLVAILIVFAIVLGFNINTKTVADIAHVSGSLPSFHIPKVPFSLETLKIIFPYAL
IMAGVGLIESLLTLSMVDEITNSKGNANKESVAQGIANMTNGFFGGMGGCAMVAQTLVNL
NAGSRARLSGIIASITILIIILVGAPFIEKIPMAALVGVMMMVAISTFQWVSITIVNKMP
KSDIFVGITVALITIVLHNLALAVLVGVIISALVFAWDNAKRIRAKKYIDENGIKYYEIY
GPLFFGSVTTFIDKFDPTNDPEQVVIDFKESRIVDMSAIDALNKLSKRYAQLNKKLHLKH
LSEDCRKMLKNAEAVIEVNIQEDPTYKVMPEK
>KALACAFP_01800 hypothetical protein
MLYKEIHIGQFIKERVDEQEISMERICNFLKKDDEFIEKVYKSKSIDTDLLLRWSKLLEY
DFFRLYSSHLILYSPPSAVNKSTSQKSEKIPYFRKNIYTQEIKEFIIKKIQSGEMTQSDV
IKEYSIPKSTLHRWLQKNDTN
>KALACAFP_01801 hypothetical protein
MRPNYKKIYLDMLKQDQPEKLQDPKIQSLLKNLKTTEDVLNFNELVFKQSKESLRNNQKL
KTYDKKTMLKLLQYQKKHGFSTSFMSKKYKISRTTLAKWKKTFEEEIL
>KALACAFP_01802 hypothetical protein
MKEWNSMSGKCPKLPTEIPDENTNDEENFQLKT
>KALACAFP_01803 hypothetical protein
MKGWNSTSGKCPKLPTEVPDENTNDEENFQSKT
>KALACAFP_01804 hypothetical protein
MNKILIFIRSSIVLLVFVCSNRAAGQQNQLKQIDDLLVKADNYNKKFQDINELKTAQQAY
SLAQKAGDDNREAKSVYYIARSLFNLGLFKESLSYVEKADSEKHFTKDPIQKVLFTELKA
YLYKSLKLDSQSKKEFTNAFSLLGDNNSNDAFEIRSRIYANLSQNTTNQDSILIYYNLQK
EELKKLPEKKYFGAYCENYNYIGNFYLGNNKLDSAYYYLDKSYQLKQKYKDPVLYEQYYF
LGSYYKQKKEYNKALDYFLKCYENMKKYSSRLEYFRSVYSQLTSTYSSLGNKAKQKEFED
LGKKTDMKILTEQNKNVEHALNIILNDQEKELKKSETTKYIWIFTGILALILIFIFVYRI
LRKNLKHKEILITEVHSTLQEKEEIISQKTVETEELQLRVNDAYNEVIDLAKKNDPSFYF
RFQEVYPDFQKKLLKYSPGLRTSELSLCAYTFLGFNVKDIADYTFKSVNTVRNRKQNLRK
KFNLSGEQDMAIWLRNLTERKN
>KALACAFP_01805 hypothetical protein
MKTTFIFFKNSILLFIFLCSNITLGQENQLKQIDSFLHESEKKHSHYNHLEELQIAKKAN
VLAKKIGDNQRIAESNYIISRALASLELPKESLSYIQKSLNQKYTQKNILLQAKFKEIKA
YDFYVLSLKSQSSQELKSILKLLKNKTDTASARILARIHTNIANQYFDKNSIDSAFIYYR
TAGNFFGKLNEKSAHNTIAEYYIALGNAFSQKKDFDSAFHYYQKSYDLKTKYKDPIIFMQ
YITFGNYYQDQKKYNVALDYYLKALQNIKEYSINITPFNSLNKNIADVYGALGDKEKQSL
FENIYTNKESEIAATRSESMDYALSIIVDDKENKYETSEKKKYIWIFVGIVTLVLFFFFI
YSVLRKNLKQKETIFSEVHGTLQEKEEIISQKTVETQELQLKVNEAYNEVCELAKNNDPN
FYSRFLEVYPDFQKKLLEYSPGLRTSELILCAYTFLGFNIKDIADYTFKSINTVRNRKQN
LRKKFLIPTEQDMGMWLRNVLAKPTGKEE
>KALACAFP_01806 hypothetical protein
MENKYKKVADFEFSEINIGLEETEFIKEYSKLIFNGFFFIKTIESNQEEFRNYLNSIHKP
LEDFDINIPFQSATSDAKDFIYHLINNETLRRISLYFYEDSDFFTIATQYTSLENFRKLP
IAEMNKLKLQRYLFEIAKEGSVYEEWKSSDRLTSKMINDFLVKLFQNDNYRIFNIGDWSG
YDMGFYICFLLIDLDKAQITFFAKDDYD
>KALACAFP_01807 hypothetical protein
MKFNFLRKEKRVVLNYEGAKAYTMTPAEELYSAVVTTGLSNTNYEKGADRLARIQTLIQK
NDPEFVAKLAVYARKDMYLRSIPLVLTTELAKQTSGTDLVSKTVDGVIQRADEITELLAY
YQLANERTETKKLNKLSKQIQKGLVKSFNKFDEYQFAKYNRKAEVTLKDALFLVHPKAKD
ENQQAIFNKIVNDSLETPYTWEVELSMLGQAKFFNEAEKKIAFKNKWEELIFSNKLGYMA
TLRNLRNILEANVSSDAIYKVCSYLSDEKAVRNSKQLPFRFLAAYRELKAIDSKYLSSIL
EALEDAVLVSAKNIKGFGFETSVVIAADVSGSMQQPVSPKSKVLLYDIGLLMSMMLQSQC
KNVISGMFGDRWKRVPMPKNGILRNVDAFYKREGEVGYSTNGYLVIEDLLNRSEKVDKVM
LFTDTQLWNSNGDRNSFESSWNQYKRFNPNAKLYIFDLAGYGKQPLDIKKNDVYLIAGWS
DKIFDVLNALEDRKSAIEMINKVVL
>KALACAFP_01808 hypothetical protein
MLKNVQINAYQTGLVFKNGNLIEILKEGKHWIYGNKSVEVYDMKSLFKANSDDLTLLLKN
ENLKSMLEVVEVKDGEIVLVFENGIFKEVLNVGQYAFWKGILNRDFQKMDLTKVEITEKI
SKTILENMKLKNFTRKFVVTNQYKGLLLIDGKLTKVLEAGTYYFWNNEISVEVKAIDVRM
QQMEIAGQELLTKDKAMLRINFYVRFQVENIEKALMENKEYDKQLYILMQLALREFVGAL
TLDELLLKKDSVGKEILENLGNKAEELGLKASDAGIRDVILTGEMKEIMNQVLIAEKKAQ
ANSIMRREETASTRSLLNTAKLMEENEVLWKLKEMEYMEKIADKIGDITVSGNSNIVSQL
KEIFAK
>KALACAFP_01809 Metallothiol transferase FosB 2
MIKGLYETHIQVSNLEKAVEFYTKVLGLELAHKEESRRIAFLWIGKNKESMLGLWEQREN
LQTRHFAFTADKEDILNNSVEFLKNKNLKPYNFLKDGIEKPMVFAWMPALAIYFNDPDGN
QLEFISILEGEGKPELGVLSYEEWLEKARA
>KALACAFP_01810 Arabinose operon regulatory protein
MKEANTPYHYNSLSEVHRLLGLPKPLHPLISLINNTANTLPTGHLPAIRTSVFYKISLKF
NLTGKLKYGRQYYDFDEGGMFFVSPHQVTADSDHNGDHSGYTLIVHPDFLLTYPLASKIK
QYGFFSYSANEALHLSAKEKETIITLFKNIEEELNERFDDMTQDVIISQIESLLNYSNRF
YRRQFITRKAVNADLLLKTEILLDEYFNTEKSLFKGVPTVQYLADHLNLSPSYLSDMLRS
LTGQNAQQHIQNRLIDKAKERLSTTHLSVSEIAYELGFEHSQSFSRLFKSKTKLSPVEFR
QLFT
>KALACAFP_01811 Cyclopentanol dehydrogenase
MKKVLITGANKGIGLEMARQLSQKGYYVFIGSRNLKSGLDAVELLTSEGLVNIEAIQLDV
TDQESINAARNEIGNKTDMLDILINNAGINGIEFQGDIPLMHTALGTGVDKFKEVYDVNV
FGVIRTTQAFIDLLQKSPTPRIVNVSSSQGSLTLHSDPEYKYYHAKGAVYQSSKSALNMY
TIALAYELRNTDFKVNAVSPPSTATDFNHHLGTGSVEVAAEHILRYALIDNDGPTGKFFC
PDNNPETGEIPW
>KALACAFP_01812 DNA polymerase III PolC-type
MKTTDNILIIDLEATCWNDRPPRGQESEIVEIGVCIMDAKTGKISQNEGILVKPQFSKVS
PFCTELTSITQQMLDDEGILFEDALDILRAEYDSEDLTWASYGNYDLNMLQNQARRFNLD
YPLSDDHINVKTLFGELHPTVRKSVGMARALGELNLTLEGTHHRGVDDAKNIAKILHWCL
QKLST
>KALACAFP_01813 DNA polymerase III PolC-type
MKTTNEILIVDLEATCWENDRIPPGQKTDIIEIGICELNRTTKAISRKQSIYVIPERSKI
NKFCTDLTGITPQLIEEKGIYFEEACEKIRDEYDSALLTWAGFGNFDKEQIMEQCDWFGI
ENPFSENYINVMHQFKNYNGLHKMMGLKRALKFLNMNFEGNHHSGADDAYNAAKILRKIL
E
>KALACAFP_01814 hypothetical protein
MKPNIFFTADHHFGHENIIKFSERPFESLDHMNEELIKRWNEKIGVSDTVYHLGDLSLGK
PDFTKEILDQLNGNIHLIKGNHEGAALTYPKRFDSIRDYHELRIDEPENSNGKQKIILFH
YAMRTWNGSHRGIWQLYGHSHGTLPDDEMALSIDVGVDCHNFYPISYEEVKEIMKKKKWT
PPFAPRN
>KALACAFP_01815 Ribonuclease BN
MLQAEIKSLLKEDISILIKVPNSAKHYLCDCGEASLLTVKEVQSVSAVFISHTHIDHFSN
FDGIFRHQIGSGEKIVICGPKNIHQQIEARLKSYTWNLIDENAIVYEIREIVSREEINVY
KIHPPHWNLELIKTQNFLFENEYVNVDFAILDHKTDSIAYLFKEKDSVTFNENASEFKKG
KWISELKTAFENNDSDKEIQIEETVYRASAFFHLLTRNTGYKLGVIMDHAVCEDNYEKIK
TVFKGADLVYIETFYKDEDQEFAKINYHSFASASGKVMNECEVKEAIPIHFSRRYVESDQ
LEIETAFYKAFQGN
>KALACAFP_01816 hypothetical protein
MKKISTLFKKDINNLGRVINEINPENKWVFGGEAVATQKFDGSACAVINGKLYKRYDAKK
GKIAPDGAIPCQEADLITGHHPHWVACDIDKKEDKYFWEGFAALAELGKVEDGTYELIGE
KIQGNPENIEGHLLVKHGENILSLESLDFEFIKNFLSNPENNMEGIVFHHTSDNRMCKIR
KSDFGVRRKLVKELIV
>KALACAFP_01817 hypothetical protein
MEITKRFLFLDDIRYPIEAYHYTKQDIFLRKDWHIVRNYEQFVNRILEKGLPEMISFDHD
LADEHYLKPDSQEFVEKTGYDCAKWLIEYCMDNYLNLPKFYCHSMNPVGKENIESLLKNF
KNY
>KALACAFP_01818 hypothetical protein
MYFLVQANVYLDPDHYKIFDALEELNIDYHVINIPPTAEKIDFETDRKDVFVYGSVTIAR
LAKQNTDWFPGSFYGGNHLYEVYSKYYGENLLNHKVSVHKISEELIWKKDEIKFIKPYNE
AKIFTGKVFTEAEWKDFVFESLKNQLNRITEDSLIQISEAKRTIKEARLWIVGGQIIDAG
YYKFNDNAPFEEKISEDGLNFANEMIQIFNLEEAFVMDICLTDEGWKIVEINCINSSGFY
PNTNVKSIVKALKIYFSN
>KALACAFP_01819 hypothetical protein
METQQQMWQNMTGKIFQHSITQLVEEAIIREQANGHRLKVCVGSDSHVYGDAINYATAVV
FIREGKGAFTFIRKEREIQNISIKERMLNEVNKSVEIAYTICSILDAYGVEMEVHADINT
DPDFKSNIALKDAMGYILGMGYVFKAKPYAFASSNCADMMV
>KALACAFP_01830 hypothetical protein
MNRQKFIDKFMAAFFILVIIKVIGILAQLFHQSFWSVIGTLVIFAIVAFIIFIVLLRLED
KEKEKNSQSRKGANGGGNFYLEASLFDKIRSKYEDLAQKYIDEKDYKKAAKVYMNLLRDH
YRGAKTLEDGGFYTEAAVIYLKKLKNKSEAANCYEKAKQYRKAIDLYKELEQKEKVGDLY
REINDVKNANTYYQMVVDDYVNNNQMVKGSLIYRKKMEMPDEAQKILLKGWEEDRDAFNC
LNNYFANIFDVKKLDQQIQELYKKTPSEKKITYLEAMKYEFKKDPKLQTTARNIAYEIIA
EKVTTHSEIVNELKHFNPDDEVILKDISRYKTGRNRMFRN
>KALACAFP_01831 hypothetical protein
MELRIQPFPKNNYPRKGLLIKGSSPLTWLHEMEILGIDLDEVQSFPIPSNQPNVLYGCFL
IFKNNAPGEIGKNSYFQCIDNKFFIPENTTFYPKINPEDWQSIDSEFLIMHPEFGLVKLN
EEIDWLSLIQHPKQSEDNIRKPLNGVKIPQKIESYTVEMDDEKVLEALQKPQTEEEWMKS
LPFDLQKVMKGNKKEIEKYLKYIEKYPDRAVDLGVPLDVMGTSRGDGFGKFKFLENTWFG
KLFGGNNSNGTGSTYSEKYRWVFWVFLIAIALFRFFMHLSKDEPAQAPSVASSGKISEVN
KDLMKPVVAYQSGVTDIDMKIDSMYGRKRRELMDEHMKASLNLSERDEGKSYKEYLKKGG
RPINKIQEDIFKFNDKKNSSTDSLKRVYRKKIVKYVAQSEEKYKKKITDSLKKISSGKPA
DQGIVKSIWKKKQVLIEDSLGRLYGTKEYPEPPPVDPDKAKKVETLEKEKPYSKHNISFS
EIIWLIIFMTGVVGLYNFIVKRKSLNIGGNNVPGGIKIFLIIVLVAMLAYIFYPLIEMFG
YNWFVWILIICVVLLLYRLFSEDKTILKSDKDE
>KALACAFP_01832 hypothetical protein
MELREYFQSYENYFWEWTTDEDVPDDTGYNENNLISIPNVGAIAYRPYVIEVLRELKDQG
FPSFGSLLLVLYAIQDGYLNMDGVFYYLKKQNTAFGIDKSADIDLAIRFLENLNSLGSSI
KKGQNKIILLKTIFKNTHNILSSGNSELIIKIFEKRPYKISGSAEKKKLVFPVINNDINA
LAYLQKKFPTAGSIIEAMKGIVDIPELEDEVVEEETTVETDKDFIQELIEEPKTFQVGSL
IKRIWSGLKIPMRHLSPGEQPIGGISDMTNKGELHRMLLSEFANEDEVFMNRVANNEALY
IQREIPPEENVFERIILIDTSLKNWGTPKVLAFASAIAVIKHPKAHSECKVFALGQTNVP
IALDKVEQVIENLNQVSPLLDVSQALETFFDEKHPEKDLEVFFITHEENLANQKVQKVIH
ENRDKLKFIVTTSADGELNFYKYHKGTRKHIQKIVLPLQELWANPPQRKQKRENVSTNGK
RTEVPLNYPILFPAPIKKMATFLYEGEFYILSNKKQLLRTYLSDNYYNKNYYDYYKIHHG
CEVLIEDISVKPKGQFALARNKQHEFILCQYQPDKKLISKLNLNTKEYSELNLTGKNIPP
IFQLIYFNRNFYLHHPTQDWIHEINLEGNISIEQVKNDLEIIKNQTKVDAEIKKLSNSGI
KILNNFSNIGINIEDNLVISNSELNKLYDNSLTFYRNRHQLKIFAEQNKNKFTFSDGSEI
ITDSRGMLTFKSSNKNVPEFYIPSTDYGFLALATHTEFGGSEYYLPTSTLLKVKKMEDMY
AECLKRFIDQILDYGT
>KALACAFP_01833 hypothetical protein
MAKDSSERIKEFWAELPRADEDFLGSIRDWKNVQIALEEDVIWLKGFTDEQAVSPEIQQL
PDFLLYELREGLLFRKNALVPSKKVRTALLWTPIDKALRLTFPPSNQNFFGIDEKVEVRL
KPSEEEQPAAALLSSITEIKDTIIALPKFKLENLDWIVMNEKALFLGMPLLSLPGKTFWA
KDGHLLPTGFDFEFKNLSSLLQRKYNAGQDQWILWNEEGSVLSINKNDFRKLSVSSFRLT
EKAKEWN
>KALACAFP_01834 ATPase RavA
MIQNIEKLNTVLTHVKDTFVGKNDVVDLLGICLLARENAFLYGPPGTAKSAIVRTLAKTV
KDGKNFEYLLTRFTEPNEIFGPFDIRKLKEGELLTNTEGMMPEASMVFLDEIFNANSAIL
NSLLMALNEKIFKRGKETKHLPALMFVGASNVLPEDEALNALFDRFLIRINVDYVNPELL
QQVLLAGRKLENDTETDIPEILSDEIRELQNLCKTVDLKPIYEVYLNTIISLRNTGIAIS
DRRAVKLQNLIAASALICGRNEAILSDLWVLKHIWDTEEQIEILEGIINRTIEKDDNPKS
HPQALQNKTPNPEEVMKDVKILVEKWNNETLSFEEQNVIKDKLRYLQTRCDWIKNPEQKQ
YIQQEIESLWQKILQSV
>KALACAFP_01835 hypothetical protein
MEINSAITVGFIVATHMFLFCIIGYYINMKLFKLDINALTIFMFFSKPLYSYQLKNGIKI
NFGYIPITSYLNYSSDQELSIPESDILMRERRKKGAAFQLVMLFLLTSTISVLSLVLGFN
PVKILLDFWINSYEFIKGNQTESDFLNFIHHQYEVYGKYFFIFFAVMSYFILITAVMIIT
SLWHWFYITLFVLLVISYFVFGLQYLKLPFTFYIDLFLTLTISGFIYFLLLRYFIK
>KALACAFP_01836 hypothetical protein
MMETKSPFLDTLFLLRKDECITIFTDIQEISQKEEQDAADYFESEFEKERLEFLSDQISC
DRETTVWAAKILYHSAQLYLVRKNTAKDLQKLIPEFKGKRDISSLLSADLSLRFLPQVIS
ALQNADPEDSLIKMLENILAQFHYSAIGFDLDLEKINWKEELKDKTYRKLYLERIVEKKA
YQLAEIPYINELLIAEFGMYKDVFWKELKIMNHGN
>KALACAFP_01837 Purine nucleoside phosphorylase DeoD-type
MSIHISANKGEIAKVVLQPGDPLRAQFIAEKYLENAELVSKTRGIFYYTGFYKGKEITVG
ASGMGFPSIGIYSFELFTEYEVDTIIRIGTCGAYNTDLQLFDILNVENAASESTYAKYAW
EIEDEIISHQGNIFNTINQTAEELSLKTKIINVHSSDIFYRKDPNIPAIATKYNCPAVEM
EAFGLFANAQHLGKNAATILTVTDIIPTHEKISADKRERALKPMMELALESAIKSL
>KALACAFP_01838 3'-5' ssDNA/RNA exonuclease TatD
MYTFVDIGINLTNKQFHNEHEEIINRALDNGVEQMILTGTSIRGSKESAEIAEDYPEILF
STAGIHPHDAKSFNNESIHELRKFLKQDQVISVGECGLDFDRDFSPRPIQEKCYRAQLEL
AIEVNKPLFLHERSAFKRFNEITDEYLSKLPKAVIHCFTGSLSEAKIYLDKGFYLGFTGA
ISDERRFKHLEDVIKYVPLDRMMIETDAPFMLPKNMPRMQHRRNEPSFLPYVAQTIAGLK
KISISEVADETTEVARNFFRI
>KALACAFP_01842 hypothetical protein
MKKLIYFLFIFSNLCFGQKQSYEDRKALADSFYNNNEYEHSLQIFDELLGKDSKNHYLLG
RVGLCLYDLKNYQKAKEKFRLAALYCPVDENKTIAGYYANLSSCYSNLKENEKAYQYASK
AYSLDDKSSQILWNAALNALNLGKYDECLNILDNAKIEKSNAFFSLYGQSYLSKGESKKA
IENYENLLQNYEENNDVIKLDLLIQKKNLFNAYMRFLGENSSNSSKYEDKATQLFNDISQ
HKEERINMLKLLLDHKCSWYVNESLRNTNMTKAALNMMTLTSAKEFEKDQIYMSAVDVGW
ISTGAKESLRKKQFEQGYIPPLDSVDGAARILHPVVDGIQGNYFSGVLLKNYKIHTW
>KALACAFP_01843 hypothetical protein
MKHIIFLLILMSIQTCRGQNDKNMTTDKRNDLNEKIIIPNLFDKRYFHGYQLSPDSDYPI
YTFANKDIGSVTVNFINKNIKKQEEWFQFDFKNGLDSGDDPDDKYFNDLNKMIKPKLESH
LDNYYIIAEFVPYKYIKISRDYIDHIYPYKKTYYLYNKEKKSWDFLKEKTVSDGNDEKNI
TKLAELNTMMGIKPANSIVNIAEIHTVNTSISLEKLDGIWSDDCNSNKTIAFISTLESVQ
FSIPNRFSMNAQLKKIDVNKYEFYFTDFPPIIPLPDEMEVWDNMDNKKPVGTIEIINESK
VNLTWFGFYYKKSKKYIQTENPFNKNSNVATIIHCTDK
>KALACAFP_01844 hypothetical protein
MIINFKYLFIVILFTSIINCKGQKEEIPDKNKVSLSHIEKKSNEIFIGKVFFSGDEFNDY
EFIKSDETTIDSISYSIYKNIHNKKYVFSLERLLKTDDVEKYKIIDTVNIKKNVPINGLK
VEKSMIDNAVNLMYDQKLLKSWRFKIKNQDQINWKGTYSVNIDYGKLDGFSEMAILYDIE
INENGCTFSGLGYKTYFTDQCKIEEKNNSLILKYEKNIEGDGFSDHSKIDTLAVLVLKNN
KYYIKSPIIADKNWNYNTELILNKK
>KALACAFP_01845 Murein DD-endopeptidase MepM
MSKKGISQIKGPSEIRLGETAYYEVSRIYDLDDREKVSQARWKLYALDFDQHDNWRELKP
GAGAPKKIGHRIPLTVTKQSLVGSELMLEAFIYEAEKRIPPGLRIKVLPGLEKKITRVEL
FKIDDSPIKEDTVMKYGQTIKVKVYTHNMQDEMVKLSLYEDDADGGGHSLKNKNNLVAQI
TKALNKKGFLWHEFKLNADFSEIANAMMDGTHDKLHEYYVVVETAEHRSVSKNVDVQNPD
YIKVQTVSSGKPFDNEEIYDGGEIEEVVVKGKLKRQYGANPAVDTGNKVVTVFKPDEKKK
DDKCLCKQYDLIWGDKVSCEFRKKVVEICADLWGEKRKIEMANNLMAVFKWESGGTFKTD
APNQANSGGTGLIQFMPSTAKALLGKEVTVETVKNYYGQKYNKKTKRKEDSYLKRVKEFA
DMTAIDQLDYVKKYFEPLRGKTVEFVDFYLQVLFPASSLKEEHIVFASSLDKLTTRISES
EKLKNLRVTSYNQNKGLDINSDGIIWKSEIKTKVLVYITEGLTNKAIKFTCNEKSTHEKI
VASETQWHHPINHPQLRGWYNDWAPERSIHSNNIPGRAKGKHDGLDLYAPAGTQVYACID
GEVNEIYYSESYGNCINIKGNYNGKTYWFFYAHLSSISINAKDKDGNPTKVKAGDSIGKS
GKTGSSATALKPNQVHLHFEVRTTKERTGGRVDPFSHISELNTQVIKNPKRENQP
>KALACAFP_01846 hypothetical protein
MNSTQQTQNKMSEKHLVCQGATCKCKFGTVPDKLMVKTQTKRYINDKEGKKKLTATHKDI
GKTFEKNTFGNCAKMNNNPCQAVVTEWTGFYDKIVIEDNKGKVLLEDSKATCPIGGKDCI
DIINHGQKSEVTTGNFKNANPEVLVEACPFIDFTEVSDNMEMEEEKADYI
>KALACAFP_01847 hypothetical protein
MNETFNERISRNTILEKKPFRKEYEVMQTIYENGEDKTRLSFVAEVERFDAFRYSINRKN
MLINGQSPDFLVEEISVKTGNMFFPLKLETLENGNLKQITNQDEIRTRWHFIKNEFLQYY
SGKGAQEIIKTIENELASKNRIQNRILNSFFYRLYFLPFKDYIKEKNTDFDLYLPVFPFK
NKVKFGVTMKEFKLSENGKWMMQISGECTDSRSFIQMINNRKTTASDEQKCSGKAELVYQ
FNKEDGSVFSINADVVLISDDEKNERQIIFELNPANTK
>KALACAFP_01848 hypothetical protein
MRFKKYFINLLDPKLLVMIFIVLALCVILTMLFSQKAPDFKKKYKSKFYTYVFAFAFVYA
IAALLGYNRLFSDDNLYEFIFYQISSLVLGIVHCSLYRSVFNKFDSKKIGTEYLFALVSV
MYAVIPFSLIYSFLNGPDLVYLMLGHFMIFFIPTFLNDTFNRAMQIPPKIYKTWQFPENY
RELAGVDDEEMRDLVVFTFLMDKDKDASKYSIYRAKGPTRIDFGRLFYSFIMDYNERHTE
NQIQTEDENGLFSWVFFLQPKWYESTKYIDPDLTLYMNGIEENSVIFCMRTTEVMQGSKK
ITDRAPDFEFNQETEKKRNNKTEEEPGMISQE
>KALACAFP_01849 hypothetical protein
MEKLEYIASQIDALKYDIKAEVIINDLLKNHKIDENQYVTQHEGQFSRAYRFDILESEIL
DHEYNDQQTLQLNLSRDSFYDMLPENLTHDTKNDALNKDVDVMIKEYQVQKKQQKAARSF
FQPFENELFSYGVEVEHFEDSFLFELNSHLVPQMFYDFWGIDRDFPALLVSKFIRLLPFS
YRIVGDIEQTCNILSLLLEEDVHISYKGHHKYSDEEQNTELGMSRLGLDLIAGTTYDDYS
NHLDISIGPLKNSSFTDYIHEGKKKKFVEMFYDHFFPIEVEIKTIILLPKEKQDFEFDIS
ESPVLGYNTRI
>KALACAFP_01850 Murein DD-endopeptidase MepS/Murein LD-carboxypeptidase
MIYSKINIFAKTQIIIMRLIKIIYIFIAYSVFYSCTGKKYIKEIPYKYSLSEYLKDKGQE
KKNLDSVYSTIDDNSEGLSDDVLKIKEKYSIILGVMPKEIKDYKLYSYIDEWLGTPYKKQ
TLEKNVGVDGSYFVQALYSDVFDKTLSKTPDGIFRSKEIQLFTGRTFLQEGDILFFRYDK
THPISDVGIYLRNDRIVACTSKGLNIYNFNDEYFQLRYIAAGRLK
>KALACAFP_01851 hypothetical protein
MKKSNRTLFQNVDYRVYICFGILLSASVLLLLYQFTRHVDCDDAKFLVHADDYVVNHVVE
FQDNTKGASSWEWDFGDSTAVDKRQITLHQYKKPGDYIVKLTINGNCVHEKKLTITSISQ
QTGYLPFIISPNVVTVGETVQFDAEKEGGVSWEWSFGETSNTDALDKNPSYRFKTVGEKK
ITLIVNGDLEHTAVKTIYVAPKTINAKQKIDIKSYEFERPHAAFSLPRGEAQKDPLVDML
QYIPVAPKTKSKKDSAIAEKKAPEISNEQFQLLLNQVAAQAKTKDDFKDYLCGNFEVPVV
INDKKLMPFDQFCQNLMGKKIKITALRLNKDSKNCIQNITIQYKVKKMLIWMNE
>KALACAFP_01852 hypothetical protein
MNVLKKFCYLLTAFTLATTAISCSDDNNTIVEEQLTPSQILASTPWATTGAKDKNGKSVA
LNDPNVAGFVGFAYFNGDGNFAIYGLNDVLRSIGTWSVDPAGKKRTITALRPDGTTIFTR
NVDILELNKNVFTYRIHTNASDPSVYYDIIHERVSHAEPANGQRTLASTAWETTDALDKD
GNHVNLNDASVNGFVGYAYFRAGGQYAIYGLNDVLRNQGDWSISPDGKTRTLIARNPDGS
IMFQRDVEILELNDQKFTYRITPNAANPSVFYDIVHEPVDHLEP
>KALACAFP_01853 Sensory/regulatory protein RpfC
MRKLLLLLTLLFISIAFGQQYSSFWYNSESGLPQNSVKDIVKDKYGFIWLATEGGIVRYD
GYSFLSYKNLKLSNLNFTYFKGDISRDYIVNSNIDEQQYALIKNRNITIQTKPVSKNLTK
YVHYKDKNYLNISTVNFTFSESFSIKTKDEMYFFNDGSIIYKKNKTSPEKIISLAFNVKD
YKRLFLHGETIFFRSPGQKNLMVVKNGKLSQLTADPLYNDPQSRIFWQQLNDQVFIVNQG
KIYKSEYINGALKLRLLVHLKNSEIDFGTMSSIYYDKEYNSLYLGTYNQGLCIVKISAFH
IPKTEIPLENRIYYTALPFGENSIINTQGRVFDQNTLLHDYHFSEKDNNFSITYDESGNI
IYPKNNKIYRVTKSSGFKKTDSVTVGKEVLAIFKEKGIYALQLQRNPPYFLNIYTNDQFK
IPEYSLPCQSPINTVRALDKDHLLIGRNNGLFIFSRSKKTLKQISSLTIKNIVTTPDGNF
WIISRGEGFYFLKNNELIKIPYDDNGYISSPHNVLEDKKGFLWIPTNNGLFKVLKSKLLE
YAKNRNTDVFYYRYTKKAGFNSNEFNGTGGLSNVAVLKNGNFVLPSMDGYVFFNPLTTPS
YYPKAENIFIERAKSKGSNYIYFKDKLNLENDFDITSIYIDVPYYANNDNLYIETSLQSD
DQPAKWQRLKDKEYTLSHLSPGDYTLNVRILISPEGKFAYKKVFINIPPLFYQTLWFKIL
ILTFVIGLILFIIILRTRILTEKNNQLKKIVHQKNDELKTTQDKLKNESEYQKNLIQTIN
HDITTPIKYLSAMSQKLSETDNPKLQKQYFNTIYKSSEELYKFTLNLKNYTELFNTESLK
YQEESYFIYDILETKKRLFAEIASQKNTIIINNSSKNIKLNFNESIMAAIIHNLLDNAVK
NTEGGEIILEATSEDDRNIIGISDNGTGMKPELMEYYNHLINNLENKPSSFKNHGLGLHL
VIQLLRKIEGKIVFKNNQPKGTKVEILIQNQS
>KALACAFP_01854 Oxygen regulatory protein NreC
MQKKILIADDHYVVRMGASLLLHSTYEDLEIDFTETYEHVKEKISSQHYDLLMLDIDMPG
SIYLEMVKELKGLDPDLKILMFSAYDEKTAVKYIMEGADGYLNKQQSESVVEAVTMIFRQ
GYYYSQQVAHHLLNNSKDVSPLFNLSKREFQIFKLLAEGNGNLEISNDLDIKMSTVSTFK
KRIYEKLNVKSLAEIIKLYEKYNSGVTR
>KALACAFP_01855 Autoinducer 2 sensor kinase/phosphatase LuxQ
MKLPCLISLVLFFCIDAKNYTSTRYATNNGDIPSTIKRVSHKDLSKKPTDIENIYLQKKL
ERKFNSQNISINDKKHTLTVSPGRYDLVVKFLISEKGKYIYKTIPIEIRPYFYQTFTFKI
TFLLVGIIFILMAIRFRSIFLRKNRVLTKSLHDKNIQLLETNTTLEITQNRLKTESDYQK
KLIESISHDITTPVKFIAMLSQELAESDDTKTQKKYFDSIHKTSEQLYKFTLSLKEYTEL
YKEENTSKQEYKIYDLIEEKRLLFEQIALKKNTMMYNFCDHHISTKINRNILSSVFHNII
DNAVKHTSDGEITIRTKIIDSYVELDITDTGSGMSDEQIQYYTLLSEDSTCGNLIFKNYG
LGLHIVIQLIKKTNSKIYFQKNKTKGTTIKILITYE
>KALACAFP_01856 Oxygen regulatory protein NreC
MNKKILIADDHHVVRIGTAMILEKNFDGLFIDFAETYSEIKQKIIAEKFDLLILDIELPG
SVFKAMIKELKSLSKDLLILVFSSHKETIALQYFEEGANGFLNKLNTPETLVAAIESIFS
TGIYYSPFLMSKLMERNNKKSPEDLLSERELQVFMLLAKGNGNLEIANILEIQESTVGTY
KRRIYNKLNISNLVDLLEIYNGLH
>KALACAFP_01857 hypothetical protein
MKKIIITSVFLFIYSSFSAQKAVIGIGTSSPQAVLDIVSTKNGILIPRQTAAQIQGIQNP
DQSEIVYSLTSDGATINRKGFWFYQSGTWRPLLENIINSNDIVYTIDGILTSDRLMTLNG
KYFNMGPDLFRIIDTVSRIGILTAAPTVTLDVNGDVRVQGLNTAGNVISDAQGVLMHDAE
FFDIGDVKPSYATTDHDGWYLLDGRAVTTLPVAAQNNASSILGITTVLPNAAGRYSMGTA
TTTPGTFTGSNAVTLTRANLPLFNFNYSTNSTGAHTHTMTLDRIRTNTINGGGNNVHDYW
LSGSFVGGANYSRTTGFGGSNHTYSVSSGGSDAPVDIRPSALNANYFVYLGQ
>KALACAFP_01858 hypothetical protein
MQTRIIIKIASLLGVLSIMNINAQVGVGTSAPKAALDVTSTTQGVLIPRLAATQAEAISN
PEIGELVYATTTDGTVIKSQGFWYYDGTTWKPFGASVQPNIDLYNGDGTLTSDRTMTMNG
NNLSFDSNKLTILSTNQRVGIGTNTPQHTLDVSGNTRVRNLSAGNVVATADGTLANGPKV
PYGTVKESLRPTDHNGWYKLDGRAVNTLSAAAQTNAATLGISGNLINAENLLMKQGSTLA
SGGSSNVTLIRANLPNYSMTGSTSTSTDHTHILAASGFNFAPNAAGNAYVLRSGRGTASG
TATITLPSAGAHAHSGVVSSGGSGTPFSIVPESITYTYFIYLGQ
>KALACAFP_01859 hypothetical protein
MRKEVLVLCLLLTGIKTFSQTGINTPTPEAALDIVSDKSGILIPRMTASQIEQVASPTEG
ELVFSTTNTGTTVNLVGFWFYDGTVWKPVVANSSAGINIYNSDGTLTGNRIVSMDSHSLN
VGPDKLFISGDTTGNVGVMTATPTQKLDVNGSMRVRSLPQGSVYSTADGTLTTDASSVYH
YGDMRYSSVTTDHAGWYLLDGRALTSLPANVQTRAASLGITGNLPDAANKYIKQGTPGTT
TGAASVVLTQTNMPTFTLSGTTTTPTHTHTLVSPGETTLRATDILQDPAGSANSYQLAGG
AAAGSITASQNYTSSADGAHSHTVTIPSGGTNTAIPLSPSYIQVNYFIYLGT
>KALACAFP_01860 hypothetical protein
MRQLFIFLLIFLGLQFSAQKVFSVQYSSQADVKVFVTEYESQADLKVYKVEYESQAGKND
GKWFFTQYESQAKKKIFFVEYESQADLKIFFVKYESQAGWARNDKKQLMY
>KALACAFP_01861 hypothetical protein
MRSLYIKLLLFFPVLSLAQIPTIDVPDGKGGYEKNNKVVLQKLSIETKITGRISTNVVTM
VFKNNSGRLRQGRLTFPLPEGVNASGYALDINGKLRDAVPVEKEKAKEVYETIKKRNVDP
GVLEKVEGNNFRTTIYPINANGGVRTVQITYNYELKKSGNNYQYFLPLNVASEIPEFTIK
TTVFQNADAPQLEEKPDGSFDFVKNGNVWVAETHKTKYKPTGNLKINFPQNNENQTVLMQ
NASGDSSYFLANVNINSGERAKKLPNKLAIVWDNSLSGMKREHTKEWSLLEEYFKINKNL
TVRIYFINNTFDEGKSFKINDGNWSELKTYLSQVTYDGGTDFGQLESLKDDEILFFTDGL
SSFGELKLRWEQPVYTISSSNNVNFNQLKYISNKTGGEFLNINENDPKKEVRKLLYQPLK
FLGIESNASLSEVYPSLAQTISQDFVLAGILKGNQTAVKVKFGYGNEVTETRTVTLNAQE
QTVKDWEISKFWAQKKLNELELFEKQNKNEIKNLSRQFGLVSNNMSLMVLENVEDYVRYD
ITPPTELQTQFNEIVKNRRAEKDERVEDLMKDAERMTETLKQWWKTDYENRPKQYPKPTS
HASRRDTLRSQRIEEVVVTGNISESRDEAAEVSESDKAIEEVVMIGYGSQRRDAVTSAVV
ASRESVSNEIVERRVTRTNAVQALQGRVAGVQIGVRSEDEKLSDIINSGRINMKEVKSNA
EYMKFFNDLKDPEAIYQVYLKNRKEYENLPQYYFDISQLLFKNNNKKLGVKILSSIADLE
IEDEELYKLLAYKLKQAEVYDKELFATQKVLEWRPFDPQSYRDYALALEDNQEYQSALDN
LYKVLTQSYTKELANRDDGIEEIIIMEINQLISNYGNKLDLKNINPKIIAELPVNIRVVI
NWNKDDTDIDLWVTDPNKERCMYSHKETAIGGRISDDFTRGFGPEQFLLKKAIKGKYQIQ
TNFFGENQVGIAGPTAIMAEVFINYATGKQERKIVVFQNQKDNKQKGDGILIGEFEF
>KALACAFP_01862 hypothetical protein
MKVFDYQNQDGKFIFISKDFPKSIEEKEVNLPKSIVIDYEIKHNATTHELHIKESRNGNI
LVYDVTNLSHNTLQKLIEDIKKSIRMNNFYLHKHFIPVS
>KALACAFP_01863 hypothetical protein
MKKKLFLASMLMSSLAFSQVGIHTSNPQGSFNVDGAKDNPATGTPNAAQQSNDLTVLNTG
NVGIGTTAPVGKLHLYNPITGSEMGNDYVIDDESPISQIQGLVMRRSNAGNNLAQNDFIG
AMLFNPKIGGTFGYAGAGMAGIYRGNGTTALTALALRVNSNQEAVRIDENANVGIGTSTP
TERLDVAGNARVRTITPVTGSTVVTPVYSDANGVLVKASPSVTYGETTSNSVSLASGATG
TLITGVTQGIYKAVVLTSDACVYVATAEYFVHNYSFNSSFSIRGITGLLSPSTTKGPTFN
ETNQTTTVTTWTGKPACQDGGNSTALNYTVTMPSAGTINVTNNGNVSRAYKIILTRLD
>KALACAFP_01864 hypothetical protein
MYNFTICRVVLFLVIFFSFHNSFAQASESKIDSLTRLIDRGYLTGNFNQQITLKNTTDLY
YLSQEAGFIPGKARSIVEEANMYCNNADFESALKKINEGIDLAKSQNDKNTLCRLSLIYQ
RLLVQLGDFFNAKQILVQSENYNKLVDNSDEKKINTIFILLSKAELLVNNEGISKNMASV
LSYKKQAYSEALSLEDSNIYKKFTLIYALESLAWSTALAEDITSARKYITKIDELLVSYP
NDDFMLRNLIIKGAVENVAENYHPAIKYLSEAISKAKQSHKVYILYEIYPMISASYGQLK
DFENATIYSWRQKHLADSIGIVKEKVKNSSLVSTINLKISEPEKSNKSIYPVLIIVAIFL
LIGGYVLYNKTQSRPVKKQDTLKVMKNADTETSADRQLEISKKMVNLAKADINVFYIEFQ
KVYPTFYQSLKEKYDLNISDLNFCTLIKMNFEIKQIAVYTNSTLRSVESRRYRIMKKMNL
KSQNDLYILLSKL
>KALACAFP_01865 Methionine aminopeptidase 2
MSITNEQELIGMQKVSEAVAYTLKEMINYAQPGMTTKDLDEYGAKILSDFGAKSAPYLTY
GFPGWTCISVNNEFCHGIPTDKRVLEEGDLINIDVSAELDGFWADNGGSFVIGKDIHQHQ
KLVDASKEILQKAIDTIKGGVKIADVGFLMENEAKKRGLKVIKNLAGHGVGRSLHEQPDE
LLNYKNRFDSRRFRKNSVVAIETFISTDSNLAVELKDGWTMVGNKGGYMAQHEHTIVVTD
GKPIILTEMNEILN
>KALACAFP_01866 hypothetical protein
MQRLNIILIFLLLQSCSGNSQTKEIQKKTEIGSQYSIRMIGEKLLVKSPDSAIIYNNSSL
IRNADLFTTYFYRGISKNDFFLVYQNNASTTKTQSTFHLFVNEKDLFLISKEQVDLNADG
IFIVKNYIIPVKVTNMDYETMDEKIFFTNQKNSFLSKQKLKNNIFFQNKNAFEILFNYKA
DDFFMDYPVNTFKIGTLNLLDIKNSNDIAYYLEEAKIYDEAIFILKSIIKKEPTRTVAYL
NLADSYWAINKKDLAKENYKKYVELMKSQNKDLKKIPKQVWERIK
>KALACAFP_01867 hypothetical protein
MKINFYLKERNSIKDSLVLVAISLNGKRPKFSTTLKINPKYWNHNSQRVKANSSNALNFN
KILNTVQSKILDLYTKNFVENDKSKTTKFFDEVRTYLTGKFENSEIDLTVDKAFEKFLEI
RKSNLKEGTVKAYTTLRNHLNAYSVTIGKKNLLFDDLDIRFFDGFMNYLKMTCKQKTNTR
SKQIKNIKAFLKFMYDRNYHTNKIFEKLDREHEKGQFVDFVEADFEKVFNLDLSNDSHLD
ITRRLFCISWSVRKKYFEGMYDPVLGKNEKRKKMALENENTKQGDGVKYFGRGFVQITWK
KNYRRMGEKFGVDLVNSPEKALNHDIAIKIMIYGCEEGKFSGKSLGDYINSEKTDYYNAR
RVINGTDRADIVQEYAKKMEKCLKIKKCKD
>KALACAFP_01868 hypothetical protein
MNTEITVSEIQVTYHPYKMFETKLSMSSDVIEVLRTIWDKGIIEMQEEVKILFVNSSNAV
IGVYNLSKGGMTGSLVDIRLILAVALKCLATGLILVHNHPSGNLTPSSSDLAIVKKLKTA
CKLLDIALLDSIIITKESYTSFNDEGLL
>KALACAFP_01869 hypothetical protein
MKNDLYKHLKFRLDDEHNDFEFEAISVPTYEFIENNLSLVPYEYFGDINEVLGLKVKQIL
LYFNADRLMRVELKYKENKVERLKNKLEEFTITFPSSVTLKLYYHEEENLTILMYQKEVL
NKFYDFGVTKT
>KALACAFP_01870 hypothetical protein
MFTIITTSTFFLSNSIVTWELNKGKLYICEIYSKFNDEAYQKTYVNQILEDDNKAFHDWI
NCEILVPGYLIPCFNKAKGDYLSIKIKGGCIEATEYKQIL
>KALACAFP_01871 hypothetical protein
MYLAYCFFAFLSLSLHNATRNVAEEDGDIPTIYRGTNTVLLNLWFFLTGLIAPIITMFLY
TKWYLAIIYIVAGLLILMVMANNYVYQYHIVRRPPLYIPSRVDVRLSLITSLIGVIFLII
LIA
>KALACAFP_01872 hypothetical protein
MKLKSLLVTIAFVLGVLLAVFGIKFYQESNIEGYNLVNYPVQVVLPEGYKEINPESHLVG
YYNKRQNKLYIAFYDEFGKKTNSNNTATGSNEKH
>KALACAFP_01873 hypothetical protein
MRTTLLLITILVSITTTLKSQVRSKTKTQTVKTSTKHDTKSIGLDYLVHLKTTSTFSGVS
KSLLSKGFYFRIKNNTYNLFTNGKDEIYYFPGQGNDGSGVFYGDIQELKEKIAVQYMFNS
EALYESLIEQSYHYLGAKLYKQHTEGNGNMITIIQTTDFVFMFGENLEKTDDLNYKVFII
SRSSFTE
>KALACAFP_01874 hypothetical protein
MDKKELQIAISKRIIQLREEKNISQSELGALCNMDKSNMSRIESGKTSPSIFTLYTIATK
LEVDFSELFRFLEKSSENSTQ
>KALACAFP_01875 hypothetical protein
MVTITNYTKRKKEDGTAFCVLEINSGIELLKSQTTGQYYTTAKKCYIPATFDEAVCRSLK
GTMMKGDIIKVECEPYQYTIKETGELITLNHRYEYTPDESSQLTHNNYLENYTAPGNLVN
AIQ
>KALACAFP_01876 hypothetical protein
MTNSVLYFPYINLPENSWTIKSILYWDTVGVIVPPSYIETPHNYEQYTGNLLQSNLVTQI
FPNDYINNSEFDQGFINLLENDGFNISEKQQNFEHELVTKVNVMKFGEKLMKKLVELRIA
TKINHQWYLVEYSTANLIMLYLASYIGIKEDFTPSTDKLLDYPSNLTSQNTINKNQIREK
LLEDIIPYPVNPNLDRLKRFKDLYYDELNSFRILLERTISEINNNQDEEFYSIKVEELID
KRDKISSDLKGFKFSLAKFSSIIGLGGATYGAISGNDIATGIGLVQSVLSLAQAFNKPDI
LSQECSYLALIDKNFN
>KALACAFP_01877 hypothetical protein
MLETNIESKFLNLFYHDLQDQILDNDNTLNLFTLKVKNNAFAYDELIEELGDNLCHFALS
RQNVKKLIEEQKFNTLVQTAKSKLRNHNINEGELGEILLYCILESYLKAPKILTKLELKT
ANNDYVKGADGVHLLKVDDKNYQLIFGESKLESNVKNGIYSAFGSIKNFLTKEGKSKYEI
ELLNTNLAKESFDNDSYEILKKIIIPSAKDDETYLDYSFGIFLGFNIEINDEERKMSNSD
FRTCIREKVKTHIQENLTSINFQLQKSEFTGYKFYVYIIPFSDIAEKRKEIIEQITL
>KALACAFP_01878 hypothetical protein
MQLIEKLEKDIFENEYFKSLFEKCIMISSIKNFKSQNEEIKLFTDKEFIDILRFADILSN
SETAKSRNQAYHIISSLNSLYLN
>KALACAFP_01879 hypothetical protein
MKKNIILSFVLGLTFFSIIQAQNDQNKYSEYYFKNLPNSPSTATFLRYGDIQNSEYTGTN
SPQIPLLTAESGTIKIPLILKYISGNGVKVTQEAGSTGLGWDISLPSITQSILGGYSDFG
TEKKYLADFTKSANPFNNYFPHSVQPLPAGFVSQPTKDAYSYYKTIDGFLPLNGNFEDLN
NSFQADTDTSPDIFTCNLFGEKLEFIISNYPTNFVTTFTPTFYCLNKKGYKISYNSNSYF
TIIDPTGTKFYFSRVEDVRTLTSVSKNYFITKITDINNNDINFTYNEYSNVKNLVSIGQK
LNYTYGNQTYHYNSLPLSNSQNFTWIGEFDEQYPGSAMNPFRSSQSVGFMTPPLINWSTT
QNYLLINNISGNFGKINFYYSDRVDFPTQKLDKIEEQNNLNQIVKTVNFNYDYFNSQNSI
TIDQPYQIYSQDRLKKRLKLLSITINNDTPYIFGYNETLLPSKNSMGVDYWGYSNGGFSN
KTLFLNPTDFNYPTAIPLDNNYNNNFKQADINYTQSAVLTKIIYPTKGSSLFEYELNSAN
NLFNQYDYSKLTVGNGLRLKSQTNKDSNDQFI
>KALACAFP_01880 hypothetical protein
MNKFYTGALFLCTILSTSAQEVVWQKDIKSSTQDFLSQVTTTIDQQYLISGSSIQAGDQK
LGAGSKQNNGYDYHFIKLNQQGEEVWEKYFSGQNHDFLSATVATQEGGFLAAGTSYSGKG
LDKKDDSKGGSDIWLIRLNEFGDELWQKTIGGASDEEARAVIQTTDLGFFVAGSFVSAQD
SKMKGYGSKDVLIVRLDKNGKELSQLILGGKGLDEVEKMIPTKDGGALLGIYSRSNAGGS
KKTENFGEGDYWIIKLSKDGKVEWEKNFGGKGDDHLRTLSLTSTGYLIGGESRSERSGNK
SVGIEEGTDLWLISLDERGEEIWQKSYNFKNRDVLMGMSILHASDDKSSKGVLLGGYTQA
EGRIESDDETFWMLYLDYNGNEQWRKYVKGESRKKEERLADIKLNRDGSIVLAGTSAEEL
GKENWKIVKLGDKQIDQLIEKQDIKIYPNPVSDYAYVEIGFDFKEAEILLYDMSGRQLQS
LKTKNKVTKINTQPLIQGAYLITIKTDIGKTANAKLIKK
>KALACAFP_01881 hypothetical protein
MKRGLQWLMIIFSLTVFGQKGTVDTAQIVIPNRYNSVEAQTKPYVIMISADGFRYDYAKK
YNAGNLLKFSNGGVQAKAMIPSYPSITFPNHWSLITGLYPSHHGLIDNYFYDYKRKEAYA
MSDRKNAEDGSWYGGIPLWGLAEKQGMISASLMWVGSASDAGGIRPTYYYPYHEKFTPSE
KVDKVIDWLKLPMDKRPHFISLYFPEVDGSGHHFGPETKETEEAVHLVDKAIGELVQKVN
NLGLKNVNFIFVSDHGMIKVDGGNPLEIPAMLLNKEKFDIYNSQTLLRVYVKNPEEVKAV
YKELKANKTDDYEVYLDKKFPKYLHFATKDDKYNRIGQILLVPKAPKVFLPKGKTTSVGK
HGYNPAIVPEMKATFLAWGSEFKNNLVIDEFANINVYPLVAEILGLKINEPIDGKLKVLK
KTLKENK
>KALACAFP_01882 hypothetical protein
MKIVITGSLGNVARPLAQQLIAEGHDITVISSNESKKNEIEALGAKAAIGSITDLEFLIK
TFEGKDAAFLMTPPNLGFENIVENTINAGKNYTEAIRKTGLKRIVMLSSIGAESPVENGP
IKTLYHIEKLYNGLENTSVTFLRAGYFYINFFNDIPLIKNAGIIGGNYPEDVKVPLVHPI
DIAKAAAEELVKNSDSKNVRYIVSDLRQASDFAKTFGLAIGKPELQWVEFKDEDSLNGML
QAGLPQEIAELYTEMGRGIRTGVVQKDFIEHGAYVDGKVKLEEFAKEFAERFNA
>KALACAFP_01883 putative HTH-type transcriptional regulator YybR
MTAIKESSTIQQNKKYALDSCPVTYVMEKIGGFWKPIILYHLSNGDKRYSELKRAIPAVT
EKMLIQHLKQLEADGLVIRTAKPVIPPHVTYELSKSGKGLIPVIHAMAEWAFKDMNVKIK
>KALACAFP_01884 NADP-dependent alcohol dehydrogenase C 1
MSTFTVKAYGAESKIADLQEININRREVTAKDIEIEILYCGVCHSDLHTARNDWGGSLYP
VVPGHEIVGRITNVGSEVSKFKVGDLAAVGCMVDSCGECESCKHDLEQYCQNGFTGTYNG
KDKHLGGHTFGGYSQKVVVDEHFVLSVPENLDLAAVAPLLCAGITTWSPLRHWNVGPDSK
VAVVGLGGLGHMAIKLAKGLGAEVTLFSRTPGKTEDAKKLGADHVVISTEQAQMDAVKGK
FDVIIDTVPYEHDINPYMQTVALNGTLVLVGFVGEFENEEPSTRPMIFQRRSVAGSLIGG
IAETQELLDFCGKHNIVSDIELIKIQDINEAYERMLKSDVKYRFVIDMQSL
>KALACAFP_01885 Melibiose operon regulatory protein
MQNQEIEIYNSVSEYNKMANHETLHPLVSIIDFSKSDPICQFRRVFGFYTVFLKDIMCGD
MHYGKHSYDYQEGTLVFIAPGQTYGIYNDGKFIQPAGYALIFHPDLIKGTNLGKNIKDYN
FFSYEVHEALHLSEKEREIVLECFKNIKLELEQSIDKHSKSLIVNNIELFLNYCMRFYDR
QFITRDHINQGVIGKFEGLLEAYLKSDKPKSIGFPMVNYFAEQLNLSANYFGDLIKKELG
ISAQEYIHNKLIDVAKDQIFDPSKSISEISYDLGFKYPQHFTRLFKSKVGVSPSEYKTLN
>KALACAFP_01886 Para-nitrobenzyl esterase
MTTQQNIGTHSFHTPFGKILALKENGVIKAKSIRYARSERYKMPVPVETVESEEILDKTP
VCPQNISPLLERLIGKTDLEKFQPDESTQFLTITRPENFSQNEKLPVVVWIHGGSYEIGC
GDLPTSDPSVWVKEQNMMVISVSYRLGLFGFLGGDENRPANLGLFDIMEALRWIQKNIQS
FGGDPENITLFGQSSGGDAIAHLMISEGVDNLFHRAIIHSAPLGFRLKRNKMSLEFFRKT
EFLKDETDPLKMTEGYVNFLPSFRKYGLKTSMPFCTQYGYPPLCTEEESQEKWKENAKKY
DVLMGLNHDETAFYVKTAEQGIYTYLHEKILNRIVRVTTDSIYEKPANMFAENYSEGGGN
IYLFKIHSTIKNNYIGASHCFDLPLIFANETAWKSSELLKDVPWQYMVENGKKLRALWAE
FARKGKISDDSERPEILRLRKV
>KALACAFP_01887 Cytoplasmic alpha-amylase
MNETMIQFFHWYSEGDGKLWKEAEKHAQYLADLGITSVWLPPAYKGATGGHSTGYDAYDL
YDLGEFDQKGTIPTKYGTKEDYIQAIKALKEKNIQVIVDIVLGHKGGGDELESFKAVKVD
EENREKIISDEIEIQSYTKFTFPGRGKKYSDFEWNFTCFSGVDYAEGMDSHIFKIKNEYG
TDWEEMIDDEKGNYDYLMYNDIEHRNPFVREELNNWAKWYFDETDFDGVRLDALKHISFD
FYKEWLTLLRSNSGKNIFAVGEYWAPGYLNLLQKYIEVTEGCMSLFDSSLQNNFHTASKE
GGSYDLRRIFDGSLTQADPLHSVSLVDNHDTQPLQDLEAPVELWFKPLAYAMILLRKDGY
PCVFYPDLYGAHYVDKDREGNDQEIFLDKVDKIEELLKARKDHAYGEQRDYFEDANCLGW
VREGDEEHSGCAVVLSNKDAYEKPMEMGEKYIGKTFYDLLGRFENKVTIDENGWGSFPVP
AGNVSVWVAE
>KALACAFP_01888 DNA polymerase IV
MDFPFPIRKIIHVDMDAFYASVEQHDNPALRGKAIAVGGGHRGVVSAASYEARKFGVRSA
MPSKTAKEKCPHLIFVPPRFPRYKEISRKIREIFYEYTDLVEPLSLDEAYLDVTENKKGI
ESANQIAKEIRQKIFEQTGLTASAGISVNKFLAKVASDINKPNGQKTIHPDKIESFLEEL
PVEKFYGVGKVTANKMFSLGIFKGKDLKKRSLEDLTRLFGKSGAYYYNVVRGIHTSEVKP
HRIQKSVAVERTFFEDLFDEQQINEKLQSLSDELHNRLQKNNILGRTLTLKIKYKDFSLY
TRSITKEEYFSSPEQYFNTGKKLWELRPFDKPVRLLGLSLSQLNTEEKKLISVQLKIPFK
EFEDQ
>KALACAFP_01889 Thiol-disulfide oxidoreductase ResA
MRKLLLFFTLSIFGLGCSQKVPQANKTGFSKEALAQKLEDEEGKTITIQQILDQHKGKVV
VLDFWAGWCRDCLKALPKAKELEENNKNIDFVFLSLDRSKEGFEKSLERFEMKDKENYWF
VSGWKNDFNNYVDLNWIPRYMVIDQKSAIAKYYAISPEDPEIQATIDKLLK
>KALACAFP_01890 Purine nucleoside phosphorylase 1
MLEKIKQTADFIKNIIKETPDFAIVLGSGLGKLQDEVEAIHTLEYSAIPNFPQTTVVGHS
GKLICGILEGKKVLMMSGRFHYYEGHSIETVVFPIRVFHLLGIKNLILSNASGGVNSSFN
IADIAIIKDHINMMPEHPLRGKNIDSFGPRFVDMSEAYSKKMISVAEHAAKENNIKIHKG
IYVALQGPTFETPAEYGMIKAIGGDMVGMSTVPEVIVAKHMGMDVFCISIITDLGGPDIA
FSVSHEEVLNAANKAMPNVITVVKGLVKNYQ
>KALACAFP_01891 Tetraacyldisaccharide 4'-kinase
MKSTYHSKPNPYEISYFCNRMKRWYLYPFSLGYHMVTGIRNTMYDLGILKSTKFKTPIIN
VGNLSVGGSGKSPMVMYLAQFLAKHYRTGVLSRGYGRLTKGYAVTNYESNYKMVGDEAMQ
LFERFKNRFVIAVSEERVPGAQKVISDMDLDVLVLDDAMQHRAIKPGFTIMMTDFNDPYF
KDHLLPAGDLRESRTGVRRANIIMVSKCPDELTEETKQYYISRIRPSHKQKVFFSSIGYD
ENVYGKEKMLPDNNLNYYDILLITGIANPKPLLTHLAKFSQRVKHLKFRDHHNFTDDDIK
KIVAEYKKLGEYKLILTTEKDYVRLKTFDYLRDIVYYWPINVIIDKKEEFNQIILDYVRK
N
>KALACAFP_01892 tRNA pseudouridine synthase A
MRYFIEFSYNGKNYFGYQIQPDAISVQEELEKALSTILREEIKTTGAGRTDTGVHAKKIF
AHFDTEKVLNDDLPRRLNSFLPPDISVKRIFQVKDDFHARFDATYRTYEYYISLEKNPFT
QEFAWQHWKRPLDINKMNEACKILFEYEDFTSFAKLHTDNKTNLCKMYKAEWEQNGSELK
FTVSANRFLRNMVRAIVGTMVEIGSGKMKPEDLRKVIEDKHRNAAGTSAPAHGLYLVDVG
YEFD
>KALACAFP_01893 hypothetical protein
MMSIFIMIGAYRYYAGLAQRFGKTKWHFGLLAIGIYLGFQILFLFCYGIYKGLTNPTALS
NNNNYDYGNFTFVNFISWLFAIAVVYGFHTYLEKKFTKEMVRKPSSEIEEIGNKE
>KALACAFP_01894 hypothetical protein
MDEIEKLAFALNHFAGLTEEDFKLSEDFWLPKNYSKGDFYNLRGTVCTYFGFIVDGVFRS
YTIDEKTGEEKNVFLYSANGFVVSFKSFINQIPCDYHTQALTDASIIYIRYTDLLSLYQQ
SHRWEKFGRLLAQEAFNITMSRIEGFILKSPEERYLDLIKQHPDIFNNVPLYHISSYLGI
QGPSLSRIRKRISGK
>KALACAFP_01895 2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate synthase
MKTNTIVLIHGLFVNNTSWKEWKTYFEAQGYTVHTPANPGHNGDPRDLKKNFPADLKDVG
FDDVVDHLSRFIDTLPEKPIIIGHSFGGLMVQKLIDMGKAVAGVSIDGAPPKNVMAPFST
VKIVWPVVNFFKGNTVFMGSKEWYHKAFFNNYSKEESDKLYETIAAPESRKLARDPLFKS
SAKLDLQKPHEPLLFIAGERDHIFAANFSRKIAGAYKDKNSIVDFKEFPGRSHFIAGEKN
WEEVAGYVLDWIKKVN
>KALACAFP_01896 putative ABC transporter ATP-binding protein
MKKQDTWGIIKRLFFIGMKFRSWFVITLIISIILAIVSTYRPYLTMQVVDNDITGLKDKA
LMMKHIYLLVGLVFAETVLNFFLVYFSNYISQNVIRDIRERLYNKLIYFKTSFFDKTPIG
QLVTRAVGDVETIATVYTDGFLMVFGDILRIIFVLVMMFITNVHLSYITLAILPLMVVIT
RFFQKRLKKAFGDERTWTANQNSFVQERLAGMPIIQVFNRQNSEFKKFDDINITLKDALL
RTVFIFSLFFPVVELISSLFIGFILFYGSYTTIKAGVVIAFIQYISMLIRPLRQIADRFN
NIQRGIVGAERVLGLMDEENSMPNTGKVQKDHFDGKIEFQNVHFAYDEKQEVLKGIDFKV
NPGETVAIVGATGAGKSTIISLITRLYDINSGKILIDDVDLKDYELYCLRSHIGVVLQDV
FLFHGSIFENLAFGDETITLDKIKAGAKEIEVDEFIESLPGGYDYVVSERGSSISLGQRQ
LLSFLRAYLSDPKILILDEATSSIDHESEKLIQRATEKITKNRTSIIIAHRLSTIEKADK
IIVMEHGKIVEEGKHLELLDKNGYYATLYKAQLRHEVEMEEEERKS
>KALACAFP_01897 putative NTE family protein
MKKIFTILSLIMTITLLYSQDSIKIHSSLITKDTKFGLALSGGGAKGFAHIGILKMLDSL
KIKVDYITGTSMGGILGGLYGMGYSGNELKKMVYSTDWKRVLSNKIPYNKVNISEKDEYN
KYIMEFPVIDGLPTLPGSYIEGQYMSEVLNTLTFPAKHINDFSKLRIPVELTSSDIINGG
LVMQKKGSLALAIRSTLAIPAAFAPVYIDGKLLVDGGLDRNFPVQEVKDMGANYIIGGYT
GFRLFTKKEIENPMKMIYQTHAFHSVQDYNQQKKMSDILVDFVTPLNKYTTKDFKNYKEI
IKIGEQEAKKHLPEFIALANEQHKLGIIYDHQLIEEIKKPTVKFTYSEDNGTPINNTAEI
ETINNLMGLKKGVYYDAKTVNEAIDRVFGMRHYEKVYYTYTDSDDGLIMNIFVKRVNPAA
FKLALHYDNEQSVGIIVNYTYRNLEKRFRALATLDISEHFKGRLQFQKFLGNTSHWWISA
EGNTSQLKSNDFILRLINSDDDNVSLSDNYIYRNINFNTAINYTINPNAMISSGIEYNIE
KINHSVDKIGQFITGNFDNKVYQHNDFNLFLKFNQNSLNEKYYPTSGNNLQIISKYYFGN
KYNLYDLENTQPSLYQYLNPSERYYSASKNMISLIVNENYVFPIFKKLSVKANVFLGTHF
SFTPQVENQTPYLFLNQKFYLGGSEYNFNGNNPEFNGFRQKEAPINSLAKLGIDFQYNIY
KKFYLTPSFHYGMGSYYLTPFKESINIFSYGLNLGYQSVLGPININVSKNDVINLWRVYF
SIGFKF
>KALACAFP_01898 Trans-aconitate 2-methyltransferase
MTNKNHWENVYETKNPDQVSWTQKKPQTSLDFIHSFGLKKDAKIIDIGGGDGNLVDFLLE
EGFENITVLDISAKALEKAKKRLGKKAEKVQWITTDITEFAPTETYDIWHDRAAFHFLTT
PEQISKYLEIAKKSINKFMILGTFSKNGPTKCSGLEIKQYDEETMSSQFHENFEKINCII
EDHTTPFDTTQNFIFCAFKKLFPDK
>KALACAFP_01899 hypothetical protein
MTMRTFFVVIMLGLFNILQAQKPEFKAPDYDAIQKNIEDKNSEFYYPNLLKKLKASDTLI
TGDQYRHLYFGQTFQKNYSPYKTGKNFEEMSKFYRGENITDKDLPRGLKLFREALEENPL
DLRAMNYLAYLYHLTKDEAMAKKTSINFHGLLGAILSSGDGLKCETGFHVISVSHEYVLM
NMFELESQAQSYDGKCDYQKFEKDKYKIPGLYFNVSKLYGRMFD
>KALACAFP_01900 hypothetical protein
MKNIQDEFQVFKDELRKLNIEVQKVVKVGNGSMDFHEVFYKSPRYHDVKSVYVQRHNLDN
ILEKFRQAYH
>KALACAFP_01901 Alpha-ketoglutarate permease
MNTTHITTAQRIKAIVGGSIGNLVEWYDWYAYAAFSIYFSHSFFPDSDLNAQLMNTAGIF
AVGFLMRPIGGWMFGSIADKVGRKRAMTLSVLLMSFGSLLIALTPTYDTIGILAPLLLLV
ARLLQGLSVGGEYGVSATYLSEMATSDRRGFYSSFQYVTLIGGQLTALGIQLILQKLLLT
ETQLETWGWRIPFVIGAILSVVALYLRSSLHETEAFEGNEDVKKERKGSIKELLKHPKAL
LTVVGLTLGGTLAFYTYTTYMQKFLVNTVHLTKEQSTLLSFISLFIFACLQPVFGALSDK
IGRRPLLLCFGILGTAFTYPLLNALSTTTSMWGAFFLIMSALIIVSGYTSINAVVKAELF
PSEVRALGVGLPYALTVAIFGGTAEYVALWFKQANVEHYFYWYITICIFFSFLVYARMKD
TKETSTLDKD
>KALACAFP_01902 hypothetical protein
MRKLFLILTLIFLQYTQAQDSIKVEKKTEDMPKEKNPLDIGELKINLNPEKDKWLKFTIS
SQIWLRSIDNNPGTLVNGVAQEHTYDAGIRRMRLIMQSQLTPFYSIFLQMGINNQNFNSG
GGTGTGASGAGKKAPFFFHDAYNELAIIPRNNFQTGKPNKNNIYIGAGLHSWNGVSRMTN
ASTTKMLAADIPVFNFPTIEIADQFARQLGVFVHGEFDRLNYRFSINKPFATKTTPAVGG
PAVDNNQSGKLSFAGYAYYQFFEKEVTATSFLAGNNLASKKILNLGAGFYTNKDATQTQP
SENVFESHNTNIFGADVYSEIPLGEKRKEMGLTLYSVFYNYNFGPDYLRISGIMNPGTPD
PDFKGQKMIEGAGNNRVLMGTGNIWFSQIGFVIPKFSKILKIQPYFNYALKDMRALNQTG
SYYDVGANFYLYGQNARIVAQYSSRPLYDISSKRISDRKGEFLLSLQIVL
>KALACAFP_01903 putative sensor histidine kinase TcrY
MNLSLRFARSFTILVLFVLLTGFGILYFAFERATMRSAILKLEDLNNYVTKKLEQNPNYD
FLKFHHRQTQVKILPGSAPEKEKIIEEKYIWNKSIQSYINKISVTTYPIIHHRKYSITSV
RYITVIENRFLMSLLMVLAWIMVFLIILTIILSVLISKNILEPFYQALDEIKKFSLKDNR
PMNLMKTDTQEFQEMNKFLITMSESSKKDYHLLEELSENTSHELQTPLASIKGKIELLME
HDLSENQLSVLCSMNDEIDRLSSINQSLILLAKLEHFEKSDSAYINLSELLEERISYFED
IIELQNITLVKEIQENVFINFDKNLACIVINNLISNSERHNIRNGKIFIQLTDNHLYISN
TGNIPTISSEELFQRFKRGNPDQNSIGIGLSLVKKILEIYNHEISYQFNNNLHTFSMKFK
N
>KALACAFP_01904 Sensory transduction protein regX3
MKLLVIEDHKDLLDTVIIYFKKEDYICETASDTREALEKIELFEYDCILLDLMLPDGNGL
EILRHIKSYSPETSVIIVSAKNSLDHKLTGLDDGADDYMTKPFSLPELHSRIKAVLRRKM
PENNRFLNFNEIHIDLQSKECKINNNILNLTKKELNLLIYFINNQNRMLSKQSIASHLWG
DYTYSMDNVDFVYQHLKNIRKKITDAGCKDYLQTVYGLGYKWIDR
>KALACAFP_01905 hypothetical protein
MKKYLILLPCFIFSQINAQEPAAVSSDKMNIVKTNVTAYAFRNINLSYERAFTKWLSVNM
SFGAMPEGKVPFINSFLSDEDERRFQNLEVKVFNFTIEPRFYLGAGYGKGFYVAPYYRYS
KITSNTFDFYYDYNFSGTTYQIPLKGFGNANGNSGGVMVGVQFFLTSKQNLVLDLWIAGA
HYGAGKGDFTMTSDVVLTPDMQAQLKQEIENLDIPFVNYTVETNANGARILIDGPWIGFR
SGLSLGFRF
>KALACAFP_01906 hypothetical protein
MIMIKMFKIFTIILFKLIENLTTKTKDITELFKVELFKKNLQKNKNQ
>KALACAFP_01907 hypothetical protein
MKRILFSMLAASGLCTAQTTITKAFNDPVAGETVNNVTINGTVDNSATGANTTFNNASLT
QGAAATTTYSTPTTGDVTTFPSSTLKMVSSGNTFMYKQSTSKLEITGLITPDATLNLSAN
NGTFISYPAAFGYTETDQAQGTFTSTTANGLCKGTINVSADASGTLILGSSTYPNVLRIK
SVQNFSLYLPNDTTFMFPIGTIVNTAYSYYDSAHKFPLLSTTQVIINVPLAGINNQTTNG
AQALNLTTLSTGDLTARKKGLKIYPNPAQDFIEFKGKTENYSTAKIYSLDGKLIKTSDVK
AGKVQISELPPAAYFIEVSAKDNKKPEASKFIKK
>KALACAFP_01908 3,4-dihydroxy-2-butanone 4-phosphate synthase
MEKLIEKFGATPKERVEKALLTLQQGKGILLVDDENRENEGDIIFPASTITEKDMALLIR
ECSGIVCLCISEEKSRHLNLRPMVETNNSKNQTAFTISIEAKEGVESGVSAKDRVTTIRT
AVAENAKAEHIASPGHVFPLVAKKDGVFERRGHTEGSVDLIKMANLGEDAVLCELTNEDG
TMARLPEIVDFAEKKAMTVVTIEDIYSYRKMMISQN
>KALACAFP_01909 hypothetical protein
MAKANKTTETAVSVTDFINSYVEKDEKKADSFELIKLMSKWSGFEPKMWGPTIIGFGGYH
YKYASGHEGDAPIIGFSPRKAEFSLYVYSPTEESKPLLDDLGKFKMGKACIYIKKLSDIN
IDVLEKICTLSIAYINENHECACREK
>KALACAFP_01910 hypothetical protein
MHEQALIPNLFRTEYRKIVSVLCSTFGIDHIEIAEDIVSDTFLTATESWSINGIPENPTA
WLYTVAKNKTKNHLKRDQLFQQKISTEIKYTSSNTEEFDIDLSQKNIIDSQLAMMFTICN
PSISKESQISLALHLLCGFGTQEVADAFLVNKEVVYKRLKRAKEKLKTEGIKIEQPSVSQ
INSNLQTVLTTLYLLFSEGYYSTSQNAILRKDLCEEAIRLTSLLLENPMTNSPSTNALLA
MMYFHSSRFNARISENGENILYEEQDDTLWDHALIGKGIKFLNQSAFGNTLTKFHLEAAI
AYWHTKKKDTGEKWENILQLYNQLLQIEYSPIAALNRTFAFAKVRGKSAAISEAEKLNLM
DNPFYYSLLGHLYTDINDVKAIENFEKALKLSNSSSVSCTLKKYIDQLTEKNQ
>KALACAFP_01911 hypothetical protein
MNEFLIAIHRDIINKDASPSPEQMQASIQPFQDWLGSIAAQNKLVAPPKRWDLGGRVVKS
DTVTNGPYAEIKESIGGMFIIRANDYDEAVEIAKGCPILQWGASVEVRMAIPPVTQ
>KALACAFP_01912 hypothetical protein
MKITVIGGTGLIGSKLVNSLKNLGHEVLAASPNSGVNTLTGEGLDQALENVDVVVDVANS
PSFADDDVMNFFKTSGENLMKAEKKAGVNHHIALSVVGTERLQESGYFRAKQVQEDIIKS
AGIPYSIVHSTQFFEFVGGIVHSSTVDHQILVSPALIQPIASDDVVKAMTEVVIGEPKNS
TVEIGGPDKIKLSDLVKKYTAIMKNPDEVVASPEAKYFGAPLNDATLIPKDDAKLGTIHY
DEWISNPENQR
>KALACAFP_01913 hypothetical protein
MQNKNFERVYKMSFAGVYPHYIEKAEKKGRTKEEVHEIIFWLTGYDEKSFQEILENKTNF
KDFFENAPKINPNVSLIKGVICGYRVEEIEDELMRNIRYLDKLIDELAKGKSMDKILRK
>KALACAFP_01914 Dihydrofolate reductase
MKKIILDLATTLDGFIEGPNGEIDWCIMDDDMDFDGFLSSIDTIFYGRVSYDSWGNYQPG
ENADPEEIKLWEAVHSKEKFVFSSQSREDENATFIHSDITEKVDEIKKQGGKDIWLYGGA
SLIKTFIQLNLIDVYRISVHPIALGNGKPLFEDLKERLHLKLIKTNVFKSGVVQLIYEPE
K
>KALACAFP_01915 hypothetical protein
MENQKDEQILDNGPFYHGTKADLQIGDLLTAGFESNYYPEIIMNHIYFTALKNGAGLAAA
LAKGDGEERIYIVEPMGQFENDPNVTDKKFPGNPTRSYRSQDPVKIVGEITDWIKLTDEE
LQSWKERLAKIRENPDAEIIN
>KALACAFP_01916 hypothetical protein
MNLKTLITHTVQYNNWVVNKYIDWLSTKSDEQLNQEVISSFPTILATLHHIWQTQEYWWS
HIAENNDFNFAETSAKTTKDEIFSGIKNNSEKLMKYVESLSEEDLAKNVKIESQWFQCDF
SKYEYIQHIVIHGTYHRGQIVTMGRNVGITDAPMTDYNFWNIYKDADVAVS
>KALACAFP_01917 N-acetylneuraminate epimerase
MSMKRGAITSAIAGDNIYVSNGYKDSDGNATIIEKYNIKDNRWSIINSSLVPKRFANSET
YDNKIYIFNGWGNSHLEIVDLETHKKTKGAVNRAYTGNAGSAIHNGRIYTFGGSGLNNAA
TTVFSDRFQYYDIASDTWHPLPNMPTAREAKGKIVNDKLYVIGGFNGTSSRLVNVYDLNK
NLWTEQYTMPVGISGHSLAVSGHKIFIVGGSNNQTFLAYFDTETNKLHQLTSNMIPRRHA
AAEIYNNKLYIMGGSTTSSTKSAIKSIQVADISEETLSARDQSN
>KALACAFP_01918 hypothetical protein
MGYILSEVTQKVISRCAKSPGFEQQTKQKTASSKRFSFLNNYSKKKKYHVLVSKFQRRSD
VADFQSVTFPYI
>KALACAFP_01919 hypothetical protein
MKINDFILRYSFANNYNKDGICRIRTFVNSHSKILVLITDLDTKNTSASVTNSIEAICKT
LIEKYRMTETSIFIEHYEPSIGRNHIFDIIKLNKENNTEWESITYERVLELLECDDNEIG
DMTLKNIELLEEIEQLRTLIAPHSELPDQLESQYILRQFEIEKNMISKNSLYELITKNST
ETEFLNLLKNDLSFFAEIYASPNDSYVCFSEFPINNGFVDFMLLTGMSRMDVFLIEVKGA
DFNLLNKGNYKKFNYKIDTAANQIRDRLRYIHENITSFRNLVHDCREKAFNRDKLFNAFI
GPEQDTLVDKNKDINIHNIVIGGRTQNDLEESYKRHNFESTFNLPFKLESWDTFYRKLRR
K
>KALACAFP_01920 60 kDa chaperonin
MAKEIKFDIESRDALKRGVDALANAVKVTLGPKGRNVVIEKSFGAPHVTKDGVSVAKEIE
LEDRVENMGAQMVKEVASKTNDIAGDGTTTATVLAQAIVREGLKNVAAGANPMDLKRGID
KAVTAVVENLKSQSKTVGDSTEMVKQVASVSANNDETIGALIAEAFGKVGKEGVITVEEA
KGIDTTVDVVEGMQFDRGYQSPYFVTNPEKMLAELENPYILLVEKKISSMKELLPVLEPI
AQGGKSLLIISEEVEGEALATLVVNKLRGSLKIAAVKAPGFGDRRKAMLEDIAILTGGQV
ISEEQGFTMENISLDMLGTAEKVSIDKDNTTIVNGGGDESKIKGRVSQIKAQMETSTSDY
DKEKLQERLAKLAGGVAVLYVGAASEVEMKEKKDRVDDALHATRAAVEEGIVAGGGVALV
RAISALENLTGINSDESTGIKIVKRAIEEPLRQIVANAGGEGSVIVAKVAEGSGDFGYNA
KTDEYVNMLEEGIIDPTKVTRVALENAASVSGMLLTTECVITEIKSAEPAIPMGGGMPGM
M
>KALACAFP_01921 hypothetical protein
MRDYKRYDIWKIAHELVKEIYIISESFPKSELFGLTSQIRRASVSIPTNIAEGCGRSTDK
EFARFLEISIGSTNETEYLLFLSCDLGFTTEDKLSSLNPKLNLIRQKLIQLRKKLLNNN
>KALACAFP_01922 10 kDa chaperonin 1
MSVNFKPLADRVLIEPIAAETKTASGIIIPDTAKEKPQEGTVVAVGPGKKDEPTTVKVGD
KVLYGKYSGSELKLEGKDYLIVKEGDLLGIIG
>KALACAFP_01923 hypothetical protein
MRIFLILLIMSSANFFAQKTLTPDNVKIESKYIKDETSNSIWYIENGTHKKEIGKITTEV
KKVDKTTLLIKTSVKMNMSPDIPWVDSTLVKISDFQPVYHSSYNSARDMQLKFGKNKVTG
YYLDKKTQKKDNINESVSTEYFDSNSYPGLLRFLPLKEHYSTEMPIFDYNPAAKKGVVKA
YIEDVNKGELNGRKVWIVKTTDDIQDRKTIVTYYLDTSTREVLKQEIDSNGRKMVMESVK
>KALACAFP_01924 hypothetical protein
MKLKVAALSVFAYVGLTAQNIQNNPGSNHGNKFEQLGTILPTPNIYRTASGAPGQGYWQN
RADYEISAYLDEDKRNLKGSETVTYYNNSPDELEYIWLQLDENQQSTVKKADFPFSSTLP
KASNDQQLRPTELPAKDNGYGVNLEKVTDASGNPLKYTVNKTMMRIDLPKPLKKGEKLVF
KVDWNYNIPNRMKMGGRGGYENFPEDGNDLYTMTQWYPRMCVYSDFHGWQNHQFTGRGEF
ALVFGNFKVSMNVPADHVVGGTGECKNYDQVLTSDQLARYNKSKTSSEPVEIVTLDEAKK
AEKNHSKQRKTWTFEANDVRDFAWTSSRKFVWDGMGVTIPENNNKVMAMSFYPKEAYGLY
RKYSTKAVAHTIKTYSEFTIPYPYPVAQSVEAANGMEYPMICFNFGRTEKDGTYSEGIKN
GMLGVIIHEVGHNFFPMIINSDERQWTWMDEGLNTFVEYLTEEKWDNKFPSKRGPAWTIV
DYMKLPKDQLEPIMSNSENIVQFGPNAYAKPATGLNILRETIMGRELFDKAFKTYAKRWA
FRHPEPADFFRTMEDASGEDLDWFWRGWFYGTDPVDISIDKVTIATPDFETAAREDKETK
YKVDKPLLNEFEDISKIRNKEDKNITFYVDKDKDAQDFYYRYDRGQEKVDTNKEYTLKTE
GTEPLSQKEKDKFKNITAYQIDFNNKGGLVMPIILEFTFEDGSKLTDKSSAQIWRMNEQK
VSKTYYFDKKLKSIQLDPMKETADIDTSNNFWSNSGGTAETSKFQLFKQKEGGNARGASN
GKVNPMQAAGKK
>KALACAFP_01925 hypothetical protein
MMQDFLFYLHLGWEHIISLDALDHQLFVLALIAVYSYKDWKKILILVTAFTIGHSITLAL
SILDIIRINSAWVEFLIPSTIVLTSLDNILMKNKKQTLMKANYYLALIFGLIHGMGFANT
ARVMIAKSQSIAIPLLGFNIGLELGQIAIVFGILILLFILLKIFRVNQKDWILFVSSGVF
ALSLKMALERIPF
>KALACAFP_01926 hypothetical protein
MINFGTNLMNCVMKNFWLFLLPVLFLFSFSEAKHPYHVGSVEINYNSKSKTFEITGRFFL
DDLENALGKKYGQSFHFNDPKYKAQLNEALRKYCSEYFKLKTNNQFLKVDFVGYEEDHES
VNVYLESEGVQNPRKVETAVSFLYNLFDDQINIVHIIVNDVRKSEKLTYPNRYLYQQF
>KALACAFP_01927 hypothetical protein
MKIKHLYSSLAFFAATTIIQAQVGINTANPQSSLDVVGNGSNTSFKDGIMAPRVSKQQLA
SKVAGTYDSAQNGALVYVTDITTPSGVTPSLVQVADINAAGYYYFDGTAWRASSSAPVNI
YNSNGTLTNNRVVTTTGNQLNFIGPNTNIAVATAGTEGRISLTGSTRGSIGLISGTSVLN
LFQDNANVAQITTNGTSTGLNFATLNATPLNFLTSGSSRMIITSGGNVGIGTTSPDTKLH
VVSTVASANRYNIIDATAGTNQYGIIALRNTSALATGNFSLIGFTNSGPTSGGANWALGS
VRTGATLTNGSEEDFYIGNSTGGGLIERMRINPTTGNVGIGTSGATNKLHVNATNPLRLE
GLQPSSGTSGSLTVNSTGVVQLQNSASISAVRATGNISITTNNAFTNTGTATETFDNLNE
FTGNTFTATATGLYKVEFIVNYPQRPSTDDTGDGYLGFAKIVLNGVDYATMNVKVSLPEA
SGAPSYNTCTNSSLVKMTAGNTLTFQGLTFGSSPTAGTPITASFTINIVRID
>KALACAFP_01928 hypothetical protein
MEKNFRLVMLFTVLSVAKLVGQVGISTNNPLATLHVDGAKDNPNMGVPNSAQESNDAVVT
STGQLGVGIIKPTTKFQVVANTANANRFTLIDAPTGTNQYVTLALRNTSPLATGNYSILG
FTNSGPASGGANWGLGTIRTGAVSASGSEEEFFIANSTGVAYNERMRINTIGNVGIGTSS
PNPSAILELSSTTKGFLPTRLTTAQRDAITPKPAGLMIYNTDTNCMEYWNTTMWVGNCAA
PSGTNTITNCTSGALSGTYVQGTPMNAGNTVTITVNVAQTGAWSITSNTVNGVIWSGSGT
FTSTGVQNVTLTASGTPTNSGTFDYTFNLGSSSCTRSITFNGNTPSSMCQFGPDDLPNNS
FVTSNGIQISVSATHTGDKGVNTTGWYGCGPAGAANAVYMSNFWLFGLKNGVHTSTTTTY
SFSRPISNAEVSMSELDVNQSVTITAQDVNGNNVSVVLTKTKDCISYNNTVSGNTVTATN
GRNTSLSIRVGGAYYRKITVVHNGVSGSYRPETNNATAANLTLCNAVAQ
>KALACAFP_01929 Acyl carrier protein phosphodiesterase
MNYLAHSFLTFSDGQIVGQFLEDFIPNRDRFSFPKDIQDGITLHRAIDTFTDSHPAIHEA
KKVFAPLVRLYAGAFVDVAMDYFVANDLSLHSLAQWKAHSLHVYKVLNDHERFLPENFKT
MLVRMEADDWLYNYREDQNIKFSMRNVLNKAKYLDLNIPVFEAFLENKSVLQQCYDDFFP
DLREHAKGINSLLQLEK
>KALACAFP_01930 DNA repair protein RadA
MAKLKTAYFCQNCGAQYPQWMGQCKSCGEWNTLVEEVVEKTSSHKTPPFSKSKQHVINIV
EVETNEEPRIKTPSEELNRVLGGGIVLGSVTLIGGEPGIGKSTLLLQLALKMKKKVFYVS
GEESASQIKMRADRLTDIQNPNCFLFTETSLEKILHEAKKLEPDFVIIDSIQTLQSQLIE
SSPGTVSQIRECSNEIIKYAKENNVPVFLVGHITKDGQIAGPKVLEHMVDVVLNFDGDRN
HLFRLLRANKNRFGSTSEIGIYEMISQGLKEIKNPSEILITKKSEELSGNSVAVTLEGNR
PMLLEIQALVSTAVYGTPQRSSTGFDAKRLNMLLAVLEKRAGFQLGAKDVFLNITGGIKT
DDPALDLAVVASILSSNEDIAISEHYCFAGEIGLSGEIRPIAQAEQRITEAEKLGYEKIF
VSNLNKLPKKKFGIKIEEVSKIEDFHERLF
>KALACAFP_01931 Protein YceI
MKKIFLTFVFALVSVVGFAQTGWAVDPMHSSVNFNIKHMGVSFVQGRFDKFDGKVATKGN
ALDGAEISMMVDVNSINTGVEMRDKHLKSADFFDGEKYPNMTFVTTSITKDKNNSYLLKG
KLTIKDVTKDITVPVTFGGITKNQQGKEIMGIQTTFKVNRLDYNIKYDPTGAGVAKDVDV
NLYFELIKQ
>KALACAFP_01932 CTP synthase
MSKKNTKYIFVTGGVTSSLGKGIVSASLGLLLKSRGFNVTIQKLDPYINIDPGTLNPYEH
GECYVTEDGAETDLDLGHYERYLDAPTSQNNNVTTGKIYQTVIEKERKGDFLGKTVQVIP
HITNEIKRRIKILSKQNYDIIITEIGGTVGDIESLPYIETVRQLKWELGEKNSMVIHLTL
LPYLASSGELKTKPSQHSVRQLMESGIMADVLVCRTEHKIPKDQRAKLAQFCNVPLDNVI
ECKDLETIYEVPMYLQKQNFDDVVLKELDLKSDKDADLKEWKSFLKKFQNPKKSIEIALV
GKYVSLQDSYISIAEAFKHAGADVETEVKVRWVYSGDITEENIKDTLKGVDGILIAPGFG
DRGIEGKVLTARYARENKVPMLGICLGMQIMTIEFARNVLGYSKANSMEFDTSTPDPVIS
IMEEQKNVVDKGGTMRLGAWKCSLKSGSKLNDIYGTKNITERHRHRYEFNSDYIGEFEKN
GFLATGTNPETGLVEALEMPEHPFYVGVQYHPEYKSTVATPHPLFRAFIKACTPK
>KALACAFP_01933 Membrane protein insertase YidC 2
MQQNNGLDKSQMISFAVLCLVLFGFMFYFQNKQSKEEQLKAQQQKTEQVKNAVKQTQASN
INPNVTPNAIQTANLSNKELKIEFNSLGGQVSKVELAEYKAYDHKTDKADLPLYLINKNN
SNYGFQFKDKTGKVINTKDLVFSPTVNGNAVTMTANYNGAVIQFVYTLLPKYTLDFKVRT
QGLAKITSDNKADFIWNYNVRNLEKGRAQEQSHSEFSYAFNNYKDYDYDGRTTMEEEKET
LNWIGVKQQFFSSVIESKTGFTQSKGNQETVEEGEYLKKLNYEGFVQMTGSELNQDFTWY
FMPLDLKLLKSYDKNFDEILPLGWSFIGAMNRYFFMPMYNIIASWGITAGWVIFLMTIIV
KLILSPIMYKQHKLSAMMRVIRPEIDEVNAKLKDADPMKKQQATMEVYRKAGVNQMAGCL
PALVQIPIFYALFRFFPNFIDLRGKGFWFAKDLTAYDDLIKLPFKIPFLGDHLSVFALAC
TVVILIYTVMTSGNMQQPQQEGMPNMKVLMYIFPVTFLFFLNTSASGLSWYYFVSNAINI
LIILVIKYWILDEKKIHAQIQANKEKPKTEGKFQKRMREMMEKAQEQQKVQEQRGKKK
>KALACAFP_01934 Ribonuclease HII
MDLLKKWSFFYVEAGCDEVGRGCLCGPVVAAAVILSDNFNQNLVNDSKKLNFKTRMDLDS
YIKDNVQDYAIAELSAEFIDQHNILNASIHAMHQALDKLTVRPELILVDGNRFHPYNYIP
HECIIQGDAKVLSIAAASILAKNYRDKLMIELHDEHPEYGWNTNFGYATKKHQEALIKFG
PTKYHRRSFRLKYD
>KALACAFP_01935 TonB-dependent receptor SusC
MKKLTTSVLAVVLTSSFVMLSAQQTPNDTLKTTDIREVVVTGALGIKKRQDAVTSSNQVV
NSAEITQANNPNAIQSLTGKVSGLQINTTNNSVNSTTRVVLRGPRSISGNNQALVVIDGV
ISTLGILQNLPPEIIDNMNVIKGMQGAALYGEKGSNGVIVVTTKRGTKSEKLQFSLTNSI
DFSSVYKLPIFQKEYGQGWPGDAFDTTDYGGTNWTPYENSNWGPAYSSSLGGQNLLVGLP
QADNTWFTDTFSPKKNHIAKFFQTGVLLQNGLSVTAGGSDSYVFLSVNRAENDFVVDKDN
LKRNNFILKAGKKIGNFRIDGNVNYLDLRTSQTSAGLYSQLLQTPTNVDITKFRNSLPDA
GHSMYITNPYWLIDNNRFDDKSRTFTGLINLEYKLNDHVSFTYAGTVVSGSSISESHLNA
FNFDRVYRGTDTYLDGHSPSDGTFGVEPIVSNYYKSVGSSFRYYGDLMANFDYDLTNDIN
MKLNVGHNIQDTSGSTTSVGGKNLKIPGWYHINNVLQPDQFYSLDNGKTQVRSYAWFANL
DLSYKDYLFLNSTFRYEKSSLTSINPVDSQGNALPFNNEPFAYYSFGGSFIPTKAFESLK
GKVLNYAKVSLSYSKVGNVQTIGVYGLDRVGAFPTGYPFGDLSSYLPTTSYYSPDVQPEF
FYSKEASLQLGFFNDRITFEGSVFRNDNDNMITSVTTSSASGITSILDNIGNSRNQGFEL
DLGLTPIKTKDFEWKLRGSYSTYRTKIISLADGSPDTPLTVYGRPAVGIYAVVGDDFPMI
KGTKYQRDPNGNIIVDANGNPLSTSTLEVLGKVNPDYILGFSTSFKFKGITLSAVADYRT
GNSFVALSKTTLGFAGNLEQTAGFDRSQGYIIPNSVQLVNGQYVANTTTVGDDPSYFGVN
SYFTQGAFQSVGEEYVVDGTALKVREIALSYDIPKSVLRNTFVNSLTIGVYARNPFVVYA
KDNRNFADPETSSTNGNAAGVALTGQYPTIRNYGFNLNVTF
>KALACAFP_01936 hypothetical protein
MNKNKFLTTLLVVAMGLTVTSCSNDYLDVNDNPNAVQAEKITPDLIFPGAVSTAYRTQAN
TMMQFGNLMMNSWAGNTYSFGGPFAREFNLSTVDNTFYTGIWGLYPRIANFAQIETYPNA
DHKQDYYVAMAKIMKAYYMQYIVDLYGDAPYSEAFKGQDNMTPKYDDDASIYRALITNIN
EAITLIQTAQDTNINNINNGLPTVAVVPGGTDIVFEASTDTEMDQWETFARTIKLRMLLR
MSKVTGEMATFRDAQLQTLAGATFIEDEVTVNPGYTASNDDQMNPYILTWARTSAGTQVQ
NYAVVVASEHMANALEGNVILSDSNYSKFTGLKDPRRSRLFTTVVSVDAAGNPFNGLKGV
RQGAVPGQPGAPISNTNTSKLGIGNFSGAASVASWLDVIDENNERGGVLMSKAESNLLQA
EAALRWPSIFTLITPQAKFNSAILSNGTWLGANASQMNTYITSIASRPGLGWIGTDAQKL
EAIMTQKWIALTNVNPTEMFIEYNRTGYPWTPLAVTAQQPNKPLRLVYPFSEYAANAANV
PNISSAQVFVKNQYTPFWNQN
>KALACAFP_01937 TonB-dependent receptor SusC
MKKLTMGVLSIVLSSSLAVVQAQTQPKKDTIKTQDIEGVVVTALGIKREKKSLGYSSQTL
DAEKVNSVPTNNFINNLSGKVAGMEIKNNGNFGGSSNIVLRGTKSITGDNQALIVLDGVP
IISGNLNSSDASRGRDGFDFGNATADIDPNNIESINVLKGAAATALYGSMASNGAVIITT
KKGKKSKTLGLSLSSTVSVGQMDKKTFPKYQNLYGGGYSGEDSFIHGDVNGDGIEDIISP
TADDASYGPRFDPNLMVYQWDAFVPGDPNYGKATPWVAPKNNPTKFFQNSLSFVNSFNLN
GGDELNMYNLTVTNNYETGILPNSRLNKNMLSGSYSRKFADNFTARTFLTFNDQTTIGRN
SVGYGDNILTGFRQWYPLNVDILHLRDTYFRTKQNYTWNMNNPLNGDLSPAFWNNPYWDR
YENFSSDDKTRLITGAELSYDVTSKLNILGRATIDYTNSKQEIRKAVGSHAEEFGLSQAD
ETSGYWVFDDTILRQTYDLIGRYTWNISDKMNALFVAGGQFMDQHQRSMENSTTGGLIIP
GLYTIANSRAYFPPVETNIRGQKAGVYAQASFDFDKFLFLEGTIRNDTSSALPKANRNYT
YYSLGSSFVFSEFIKTNWLSFGKLRLSYAEVGNDMAFGRPGFFGNRGTVGGLPMADINTT
FVDFETLKPERQKSWEVGLEASMFKRRVSLDVSLYKTNTQDLLFSVPQSPSTTYSFSLIN
AGETENKGIEVALGLVPLKSKDFQWDINVNWAKNRNMVVALNQGRDNLQLASFQETTLNA
TVGDAYGTFRGTGFVYDANGNKVVDEDGHYLVATDKVLGNIQPDWIGGVYNTFRYKNFSL
GFLIDVRKGGSVYSLDQSYGSFTGMYEYTAGLNDLGNPIRNSLADGGGIILPGVKQNGTP
NDVRVDASFAGGAFGTDAGLPQEAFIYDASFVKLREAKISYSLPADLLRNTFIKGMTFSL
LGQNLWIIHKNLPDADPEAGTSSGNIQGFQSGVMPTTRIYSFNVKLDF
>KALACAFP_01938 hypothetical protein
MKKIFSILTIGSLAMLTSCINGDEDFNNNQSQPYEVPAEPLLTNAQKELMDQMETPSVNL
NVFRFFQHYLATTIYRNDARFNFTGTRKVPDNMWLALYTDVLGNINQAKKIIPSEIKPTL
TPQAAWDKQQANKLAILNLMEIYTYQVLVDSFGNVPYSEAAKPETIVLPKYDDAKTIYAD
LIARLNSIIATLDAGYPSFQTGDNIYNGNVADWIIFANSLKLKVGINLADVNPTLAKQAV
ESAFAGGVLLNNATNSLFKYDATSPNFNRLYAEVIASNRNDFVAEKGIVDVMNTLNDPRR
QFYFTTVSGSYVGGTVGLTNNYNDNSHIGNSLLAPNKPGLLFDASEVNFYLAEAAARGYS
VGDTAQKYYEDAIKRSMEQWGVSTSDITTYLANPSVVFSPANWKQSIGQQAWIAMYNRGF
ESWNFYRRLDYPVLTAPNAVPAAAGKVPTRLTYPINEQTVNGTNWSQASSAIGGDKLTTK
VFWDIN
>KALACAFP_01939 Arginine--tRNA ligase
MNIKNIIEEKLSEVILNVYQLKDINLEVQENKTEFEGDFTIVTFPLVKQLKKNPESIAVE
LGEALTEQTELLESFNVIKGFLNVKVKNQFFVDQFRSINNDFDTIEKKNSTVMVEYSSPN
TNKPLHLGHIRNNLLGFSVGQILKEAGYDVIKTQIINDRGIHICKSMLAWEKFGKGETPE
VTDTKGDKFVGNYYVKFDQEYKKEISELVAQGISEEQAKKDAPLMKEAQKMLLDWENGDE
KVRNLWNEMNAWVYKGFNETYKRLGVDFDQVQYESNTYILGKDLIQEGLDKGVLYQKEDG
SVWCDLTEDGLDQKLLLRSDGTSVYMTQDLGTAVERFKQNDIQKLIYTVGNEQDYHFQVL
FKILGKLGYSWADQLYHLSYGMVELPNGKMKSREGTVVDADDLMQEMHSTAKAKTIELGK
LEGLSDEEKEVSYEIIGQAALKYFMLKVDPKKKMLFNPDESIDFNGNTGPFILYTYARIQ
SLLNNGNYEYKEVPEIEANQHEKEVIMLLSNYKGIVQKSAELLSPALVANYIYDLVKAYN
SFYQTNNILKLEDENLKQFRLNLSDLTAKTIKKSLHLLGISTVNRM
>KALACAFP_01940 hypothetical protein
MSIFLCSISCTEDFFENEIPKSEPIAGKTTIGAYQSSLPYNLNVVYFIPSDVSARPEYER
RISEFLLAAQEYYRQNMYNWGYGNRTFGLLKNPTTNRIKINVVSGSKPMASYNYSSGNQI
LSEVNSWFAVHPTDKTSEHTIVFTATPSINTEIPYYGLGRNCFVGDNEYNDYQYFNQNTT
RGNQVKAYMGGLLHELGHGMNLPHDALPKSLQNTPGYGTSLMSWGNQTYGYSSTILSKPT
AAILNNCQLFSTVAKPAGYFYNQNHGMQASVTQRTLSNGRIHVWGNFSVGSPINSLNVYF
MPKDAPYHAVSGTAIQGSNAFYTYLDISDLYLTDRSYTIVVQAQFVDGGSNWQTFPLFNF
VNGTPVIQ
>KALACAFP_01941 hypothetical protein
MKTFFLNILLFNLLLLFTSCEQDLLETEIALKTDTQNSAKVTSGIYQSDQPYNLNVVYFV
PSDVQMRPEYERRISEFILAAQEYYRQNMHNWGYSNRTFGVLKNPLTNRVKITIVHAANP
MSTYSASSYHPILSEVNAWFAAHPSDKTSEHTIVFTAVPTPETPIPFVGNGTSCFVGDNE
AWDYQNFNKNTPEGTTVKWYMGGFLHELGHGLGLPHDALPKSQQNVPGYGTSLMSWGNST
YGYSSTILTKSSCAILNNIQVFATTAKPFYGGNKSFTINQLYHSFENGRIRIWGTYTTSQ
PINAINTYFSPNNQYYAVSSVADGNLVNSFSTYVDISDLYYTNTDYQFIIQAQFPDGGAV
YKVYNFPIVNGIPKMDFQTEVSRTGWTISSSSAYPAYPASFAIDGNLNTYWHTNYSPGVL
QTDPVPGQAQTFPYFYDINMGAADYIWGLVFTQHQGLARNAKNISVYTRASTAEGWTHRG
NYDLKKVAYKQNVLFSQALACRYIRIVFNSSYDGEPYIAMAEIGALK
>KALACAFP_01942 hypothetical protein
MRKHVNFFWETLKETFSEWNNSSAMKDSASLAYYAIFSIPGLLIIIIWIAGYFFGEEAIR
GEISKQISGVMGPEVSKSIEDMIAGALIDKHNVIMKAVGVGALIFGSTTLFFQLQHSLNS
LWDVKSAPKKALVKFLLDRVNSLGMILILGFLLMITMILSSLISVFNKIITRYFGFETYM
LVELVNFAVGFGFVMLLFALMFKVLPDVKVSWKPVWKGAFLTAALFTLGKFLLSLYFGTT
KPTSAFGTAGTIILIMMWINYSCMLIFFGAEYTKVYAYRKGYKISPSKHAKWSDSKLYGE
SLKNQQL
>KALACAFP_01943 Outer membrane protein assembly factor BamA
MKKIQTYFKYLFASGLASATLSCSNTKYLKEGQMLYTGAEINIKNDSLSKQEEKDLKAAL
ESNLTPKPNSTFLGLRPRLFFYNIAKEPKKEKGFNYWLKNKVGEKPVLLGDVDREFNKDI
IQNYSENKGYFNAKATYDTVSKDKRAKVIYNVSPGARYLISDVRFLKDSTIINKEIQTLT
DKTFLKKSNPFDLDVIKAERDRIDNGLKEKGFYYFSPDNIIVQADSTISKKHKVELIVKL
KDNTPALATEQFSIDKVIVFPNYNIRDVKDGKYNVPMNADSLQKYAHEDIYVIDPEHKFK
PKIFDRALYFKKGDLYNRTNHNLTLNRLISLGVFKFVKNQFVVSDSLQHKFDAYYLLTPR
QIQSLRLEALGRTNSANYAGSELNLNWTHRNFFRGAEQFKASIYGAFDVQIGGPENANNI
FRAGANAQLSIPRLVAPFRFNSSSAFVPRTNIILGYEFQNRTQNYTLNTFNASFGYVWKE
NARKEHDLKVIDITYVSPANVTPEYQAKADANIYLQRVVDKQLIFGPIYSYTYTNTMLQK
PNTIYYKGTLDLAGNLTGLLMGANVDKGKQKNIFGIPFSQFAKIENDFRFYHKFTEKTSL
ATRAIAGVAYPYGNSDHIPFSRQFFSGGSNSVRAFRARTLGPGSFDPRTLTPGEFFDQSG
DIKLELNAEYRANLYKFLNVAVFADAGNVWLVNEDPKRPGAKFSKEFLSEIAVGAGFGLR
LDFSILILRLDLAMPLRVPYYEKNERWTFDRIKFGDPSWRKDNLILNIAIGYPF
>KALACAFP_01944 hypothetical protein
MKLKINKKKLLRRILITFISILVFFTLLIFSLRLPVVQNFIKDKLVVYLEKKIKTDVSLE
KVYIGFPNSLVMEKLYLKGQDTDTLLAVRKLDVGLHMWKLLKSTADITSVDMEGVRANVV
RKPDGKFNFDYIIDAFATSDKEESPSKPFIISLDKINLKDIGVTFNDQQSQNDIKLYFKS
FDTRVKTFDLNNNKYAVNDINLDGLKLKLKQDLVKEVSKKVEKKVDSLNDKKPMQIGLRG
IKLTNFDIDYGDDNTKTFAKVLFKELSTKVNKLDLENNSYNVANVYLSGADINANLYLPT
QNANPKNTKEPEVSKATDQEKALSLLLGKIVLNDVKVVYNNTAIAPTKQGMDYNHLNFSK
MNVEVRSFKMQNNTFAGTVNSAEIKEARGLDIQKFNTDFVYNEKEAYLKDLYLQTPKTLL
RDEVVLNYNSIEQLSSNLGAVKLSANIKDSRIGFADILNLVPTLRNTVPFNKYPNAILHV
NANVKGSVNDLLINNLKVSGLDQLRVAASGRIKNAMNPDNLYYDLRITELSSSAKTIFNL
VPKNTIPSNISLPSNMSVKGVAKGTTKVVNANLNLYSTLGNAAVVAQIDMRRKNHELYDV
KANLQGLQIGKIIQNKDIGAVTAQIAAKGESFDFKNAKADLKGYVASAVYKGYRYQNMNL
TGKINRGAYNIVLNSKDPNANLLLTASGVYNEKNPTVKVDGDIIKLDLNKLGFYEKPMIL
AGKIDADFTSLDPDNLNGYLNLKNFAFSDTKEVYPLQEVNLKASSTNDSTHIILNSQIAD
VELKGKYKLTQIFGSLANTVNQYYQFQKPGKAQKIQAGQFFAFRAKIKNDDVIRKFVPDL
KSFETINLVGNYDADSQKIEIDGEIPQLLYGENSIENASLKVTNENQALQYNFNVAALKS
SSFALNKVNITGDVANNVINYNITTKDQKNVTQFLIAGNAKSLNDITEISLNPNGLKLNY
TDWTVAENNKIQISDNGIFADNFRLSNGGSEISLQSESQSPNAPLNVSLKDFKIETITEL
IKKDTVLARGNINGTAQLRNLTKNMTFTSDLKITDLFVYGSPVGNVDAKVNNTSPNLLNA
NIVLSGNNNDVKIVGDYNTSSSSFDMNMAINQLQMKSVQGFSMNAITNTEGYLSGNLKIT
GTTDKPNIVGKVKFNEVGLQIAETGSDFRKLNDEIDFTSRGIEFNNFKINDKDGNSMDID
GQVLTQTYRDFAFNLDVNAKDFKVVNSQKSDDAIMYGILAIDAALHIRGDLDLPKVDGRL
AVADNTDFTFVLPQSTPSMQDREGIVEFIDQDQVVLNKTIKTDSLNSQSRIKGMDVSVNI
EINKDAKLSLLIDKANGDFVKLQGEADLTGGIDPSGKTTLVGVYEVESGSYEMSVSIMKR
KFDIQKGSTITWTGEPTTAIMDITAVYKTEAAPIDLVEQQISGESADVMNQFKQRIPFSA
LLKMKGELLKPQISFDITTDEDNNSVSSTVTDIVEQKLTQLRSQESDMNKQIFALLLLNR
FIGENPFESGAGMSGEMLARQSVSKILSQQLNNLASGLIKGVDLNFDLESSEDYSTGAKN
TRTDLNVDISKKLLNDRLKVSVGSNFGLEGDARQNESTTNIAGDVTVDYSLSKDGRYMLR
AYRKNEYQVALQGQIVETGVGFIITLDYDKFREIFQKSRNKRQRESRENKKNQVVEFK
>KALACAFP_01945 Cbb3-type cytochrome c oxidase subunit CcoP2
MKTRTPISIYILVTVGLTIMAFEMFAHDSGYFSSPFFWGLMLIAIILLLIMNSIGDLIEN
QNFSKLSDEEKAQYLKEKNIPYFQKLWNSAFKKQSATEEKDILIDHGFDGITELDNSLPK
WWIGLFWFGFIFCAVYMTAFAFTDYAHPDAELNAETKQMLASIEEYEKTAPQINLESAKY
SADNIAEGQELFKTNCVTCHGEGGKGGIGPNLTDTYWINIKEKSLFKNVFWMLENGSPNN
PTMRPLIKEGTITGRDAEKIAAYIYHINQETAPITPAQGGAAPQGEVAKWENGNN
>KALACAFP_01946 Cytochrome c oxidase subunit 1 , bacteroid
METQRFNYDNAIVKAFLYATIAFGLVGFLLGLTAALMLFYPELPEFLFGTDDTTIKSLAS
GNIQGLINTQGALGFGRIRMLHTSAVIFAFVCNSFFCGAYYSMQRLLKTRMYSDTLSWIH
FWTWQIMIVSVVITFLMGINTSKEYAEHEWPIDILITISWVVFGINMFGTIAKRRVRHLY
VAIWFYIGTWIAVAMLHIFNNLEVPLSFTGWKSYSIYSGTKDALVQWWYGHNAVAFVLTT
PVLGLMYYFLPKAADRPVFSYKLSIIHFWSLIFVYLWAGPHHLQYTALPAWAQAVGTGFS
IMLIAPSWGGMLNGLLTLRGAWDKVRENPILKFFVVAVTCYGMATFEGPLLATKSLNKIG
HYTDWVIGHVHIGALGWNGFMAFGIVYYLIPVMWRTELWSKKLANLHFWLGTLGIIFYAV
PMYISGFTQGLMWKQFNPDGTLVWKNWLDTVTAIIPYYKMRFLGGVFYLSGAILMVVNVV
KTIKQGSFQKNVPAEAPALANIGSARKEGEGIHLWLERTPKFLSILAFIAVAIGGLVEII
PTLSLKQSVPTITAVKPYSPLELEGRDLYIREGCNSCHSQMIRPFRDEIVRFEGKNGQYS
KAGEFVYDRPFLWGSKRTGPDLHREGGRNPDSWHFKHMYNPRITSAGSIMPRFPWLIANT
LDKTKMVDKMKLMKNYFDVPYTKAEIDSANQWADNQAKGIVKRIYAEANDVKQQVDKDRM
AKGNSFVPLEQREIVAMIAYLQRLGTDIKTTQVQTASTN
>KALACAFP_01947 hypothetical protein
MKICSQNIRKIRRSKDLTQEYMAFEMGISQKAYSDIENAKVKINLEILTKISDILDIKPS
EICSISDKCANEFEDKYHGLLEYMKKNDISIPKEYL
>KALACAFP_01948 hypothetical protein
MKKIFFFLALAVGLVKAQDNSKHVVLISVDGLRPEFYLDAEWSMVNLRQMMKKGAYANGV
RGSFPTVTYPSHTTMVSGVLPAKHGIYYNTPVQPLGITGEWFWFYKDIKVPTIFTAAKEA
GLTTAGVSWPVTVGAPITYNLPEYVYLPKNKGEKKDEVKAMSMESTPKELFQEVQDYAVG
KFAEYGASLDYAVTDQNKARMAAYILKRYKPSFLALHIAATDHFEHEQGREGDKVRSAVV
GADVAIKTLIDAATAAGIQDNTTFIITGDHGFVDIHTQFNPNVMLAKAGLYNNDKKEEWK
AYFQASGGSAFLHLKNPNDKATLNKVNELLNNLPDGYKKLFHVLNKQQVAEAQGDPTASL
ALAAYQGVSFGATATGELLKAADGGTHGYLPTDFKEIQTGFVAFGRNIKEGTVIPLMGQE
DIAPLIAYLLNLNLKTDGVLYPGLLKK
>KALACAFP_01950 2-succinylbenzoate--CoA ligase
MQINFNNLNINQLSFETEFEQKIKKFLEEWFSESETVRVQTSGSTGIPKVFDIEKKKMIN
SAEMTCDFLGLKEGNTALICLPVEYISGKMMIVRSMVKELRLIVVHPSTKPLEHINDEVD
FCAMTPLQVENSLDKLHLIKNLIIGGAAVSESLKTKITQTLQFSNSPTRIFETYGMSETL
SHIALKQIFPLTEDYFTVFENVTISRDERGCLKIFAPNLNAEVLQTNDLVEIKSDNKQFR
FLGRIDNIINSGGAKIFPEQLESLVKKKIPNEVVFLGLNDESLGQKLILVIEGKESENLI
EKISAMPFEKKFHKPKEIIFIEKIPRTPNGKINRIELTKIIGNK
>KALACAFP_01951 hypothetical protein
MKKDIIKIAVLFSAAIVGWIFWVKQSIKDAEIQDKYEQPFFHNNILINGRVGGVSDSGNH
CFGIIYLKDFVSNVKEFNPYKKDIFPYAIKNNEAEIYSWMCLYDVEEGDSIIVNSNDRSI
LVIKKDLREKKEGDLKFVNDEKDYIQQNSKLKFQ
>KALACAFP_01952 Peptidyl-tRNA hydrolase ArfB
MKDFSKELSFKTSRSSGAGGQNVNKVETAVTVLWNVGESEFFNEDQKLLIQNKLKNRINA
EGFLFLTVSESRTQLMNKNKAIEKILEIVDKSLFIPKKRVATKPSKNQKQKRLDTKKKIS
EKKENRKFRY
>KALACAFP_01953 Regulator of nucleoside diphosphate kinase
MSDNIIVTTGIYDAIKDTLRRKKVTVLEEKRLAEELRKAKQVLRRDLPSDVVTVDRKVTI
KDHTQNFEHEYIFVATTKAKPAKNKYSILSDIALATVGYKVGDIIDWPFKDGERKIEILK
VEPWQG
>KALACAFP_01954 hypothetical protein
MIKKLITLGLFSISAMSFAQKVSLMPSVGYAWRTAEMPKGITYEERNYIKGLKKGVNFDI
SAYYHVNHILGVGLKFSNYSASSDGRLTVMDNQGNVVTGNVSTKDNITFFGPALMISNFS
EQTRHKMFVDMGLGVISYTTKTGSVKGTGSNLGAELNFGYQYQVSKNFLIGPKLGLTAGT
LSKMKFNGVTYEFGEEEKEGLHRVSLSAAATFRF
>KALACAFP_01955 Deoxyhypusine synthase-like protein
MNKPITEFIEKYYLHFNAAALVDASKGYVAHLKEGGKMMITLAGAMSTAELGKILAEMIR
QDKVDFISCTGANLEEDLMNLVAHSHYERVPHYRDLTAQDEWDLLERGLNRVTDTCIPEE
EAFRRLQKHIVEIWKDAEAKGERYFPHEFMYKMILSGVLEQYYEIPRENSWMIAAAEKNL
PIVVPGWEDSTMGNIFASYCIKGELKATTMKSGIEYMTYLADWYTKNSGGKGVGFFQIGG
GIAGDFPICVVPMLYQDMEMHDIPFWSYFCQISDSTTSYGSYSGAVPNEKITWGKLDITT
PKFIVESDATICAPLMFSYILEN
>KALACAFP_01956 hypothetical protein
MKKTFFRWLNKVNKAILPKLSNKDPNKLTKFQKGILAYRYFVLVNSLD
>KALACAFP_01957 DNA base-flipping protein
MDEIFKKQVWEITKLVPKGRVTSYGAIAKAVGYPNHSRHVGKAMGGCPKDVPAHRVISSS
GTLSVPEFQKRLEAEGIVVENFRIKNFKKLFWDPLTEL
>KALACAFP_01958 Chaperone protein HtpG
MTKGNINVSVENIFPLIKKFLYSDHEIFLRELISNATDATLKLKHLTSIGEAKVEYGNPK
LEVKIDKENKTLRIIDQGIGMTGEEVQKYINQVAFSGAEEFLEKYKDTAKDSGIIGHFGL
GFYSAFMVAEKVEILTKSYKDEPAVRWICDGSPEFTLEETTDKTDRGTEIILHIAEDSTE
FLDEGKIRELLLKYNKFMPVPIKFGTRTHTLPLPEDAPEDAVAETEEVDNIINNPTPAWT
IAPNELTNEDYMKFYHELYPMQFEEPLFNIHLNVDYPFNLTGILFFPKLSNNLNIEKDKI
QLYQNQVFVTDEVKGIVPDFLMLLRGVIDSPDIPLNVSRSYLQADGAVKKISSYITKKVA
DKMSSLINENCEDYEKKWNDIKIVIEYGIVTEEKFAEKADKFTLYPTTDGKYFLWNELEE
KIKLNQTDKDGNLIVLYASNADEQHSYIQSAKDKGYEVLLLDSPIIPHVIQKLETSKEKI
SFVRVDADHINNLIKKDEPLISKLNETEKESLKKNVEEAINDTKFTVQLEDLDSNDAPFT
ITQPEFMRRMKDMQATGGGGMFGMGGFPEMYNLVVNSNSEFASQILKSENSEEKEGLIKY
ALDLAKLSQNLLKGKDLTDFIQRSYQNLNK
>KALACAFP_01959 Protein RecA
MSNIDDKKKALALVLDKLDKTYGKGTVMTLGENSVDNTIEVIPSGSLGLDIALGVGGYPR
GRIIEIYGPESSGKTTLTLHAIAEAQKAGGIAAFIDAEHAFDRTYAAKLGIDLENLIISQ
PDNGEQALEIADNLIRSGAIDIVVIDSVAALTPKAEIEGEMGDSKMGLHARLMSQALRKL
TATISRTKCTVIFINQLREKIGVMFGNPETTTGGNALKFYASVRVDIRKASAPIKNGDEA
IGSRVKVKIVKNKVAPPFKQAEFDIMYGEGVSKTGEILDQAVELGIVKKSGSWFSYEETK
LGQGRDAVKDVLKDNPELAEELENKIKEELKNKAK
>KALACAFP_01960 hypothetical protein
MNCKCIIWSFLQFEIYKLNLQGFKNLEGLIGYYILMKIRVLCNLKIIR
>KALACAFP_01961 Rubber oxygenase
MEITILQPRFKDSSHFKDFWIKGNGKELIDFSGAQPSFKDFEKFAPYYYHVDEIGDEVAK
DVYLTKKFHEASREIEGYIRNGISENDDVPESVKKLLLQTQKIPDWLDYDLIKSGAELCM
RSNLDSLISLRDYCLMGGYDYAYLNKPLIATEALKKGAVKRLSETLDFWVNVTRYDALEI
HKKGYEFAIKTRLIHSYARLSIKKYYKNWDTENWGEPINSWDMMATYIGFSLVFLHSLKK
LGNTFSPQEEKGIFHLWKYVGYLLGIPENLLPNDKKQATEYFYLWTSIQPPADKDSVLLA
HSLLNESLENPILKYQFQRKNLRYLHICCTWFLLDDDVCRRLQIPDVANRNVFPYTKWFI
NKIYDKTVSRKARIRKGNKDQMKVLTDYLKITQNSNFH
>KALACAFP_01962 Oxygen regulatory protein NreC
MDNSEKKHPLVEVWNTYPGVRKENKAISVIPPIERIIGEMFAIGEFYYYVLNLTNSTISH
HHENILKLHGLEEYPQNLKEIIDLTHPDDIEFIVKAEQKVVEKMMEIGKEHQLYLKPSYC
FRMKTASGNYELFHHQAILTLEDEDRNLVQSINIHTNINHITKENPRTVLIAGFGPRNDF
HQIKIENISSNNHFSGVNLTRRETEILSLIAKGYSGSEISKMLILSEHTVRTHRKNILTK
TNSRNSKELLRKAFEWGLI
>KALACAFP_01963 hypothetical protein
MKTNLLLLFLLGWAGIVFGQEQANGKIDVNANNIFSLSFESDTIKVEKTSKDGYISIPLK
VDIVNPKTWEDYKFYIEVDKEKSTLPVSDYEFEDNTFNFPDLKKSKVITIKLKKDTLWDR
GRQIVLSLKTSKNADDIDKRNIGLKKKIIVLVDDGKDHINLFHEYNILAYVGTNFDIVES
KTKAKNLFFATNIFIPPVERRNKVGFYFSLYGNRTMSDIDSTGNVNRVYKIEPVSETQHN
EYRAQYKMVTSRVSDNIGAYISPLFKLIKSSNKHLSLYYSPSLEFIWRKSTITRDFKDQK
NSEVSLVDGFVPGTVIMDNVSRKIQNEYVFNVGGAGFFLAYQTANVSFRAHASVGYSSYF
YPSNYLIEGNTTEVKRMHDVFFLGRVWLTEANTGITLQAEIMNTAINPRPFFGVTLSKAI
KLDKLGSIFTPLTDR
>KALACAFP_01964 Glyceraldehyde-3-phosphate dehydrogenase A
MSTIKVGINGFGRIGRLVFRAMTERDNIEVVGINDLIDATYMAYMLKYDSVHGIFPGEVS
VEGNDLVVNGKRIRVTAERDPNNLKWNEIGADYIVESTGLFLDKENAAKHINAGAKKVIL
SAPSKDDTPMFVMGVNHKELTDDIKILSNASCTTNCLAPLAKVIHDNFGIVEGLMTTVHA
TTATQKTVDGPSAKDWRGGRAALNNIIPSSTGAAKAVGKVIPSLNGKLTGMSFRVPTVDV
SVVDLTVRIEKAASYEEICSVIKAASEGELKGILGYTEDAVVSQDFVGDKRTSIFDKDAG
IMLSPNFVKLVSWYDNEMGYSNKLVDMLVHAASL
>KALACAFP_01965 ATP-dependent 6-phosphofructokinase 1
MKESAVKKIAVLTSGGDSPGMNAALRAVVRTANYYNIECYGVREGYNGLISGDFLKMGPR
SVKNIINQGGTILKSARSMEFKTKEGRQKAYDNCVKHGVDALVCIGGDGTFTGAKIFNEE
FGIKVIGVPGTIDNDIFGTDNTIGYDTALNTAMEAIDKIRDTATSHNRVFFVEVMGRDAG
FIALNSGLATGALDILIPEKKDSMSDLFANFRNAEKTGKASSIVVVAEGERLANIYELAE
QTKQEFPDYDIRVTILGHIQRGGSPSCADRVLASRLGYGAVVGLMEGQTNVMAGMRSNDI
VYTPIEEAIKKHNEINKDLLLISEILAI
>KALACAFP_01966 hypothetical protein
MTTLLYDGSFDGLFTAIFEVFEYRYQDVEIVSRERFHQENIFAEIHEVITQNDKAERVLN
KLEQNIGKSGIHDLLKVYLSEDTESEQLILSAVKQSIKHPDENILQNYADNDMLKISKIC
KSVSRERHRMTAFVRFEKMQDDVFFAKIDPDFNVLPLIRKHFKDRYQDQKWMIYDLRRNY
GILYDLESCDFFYPDEKLDLNKYQQKFHDEETQYQTLWQRYFTKTNIVERKNLKLHIQHV
PRRYWKYLTEKY
>KALACAFP_01967 hypothetical protein
MNFDRLKEKLEILADAAKYDVSCSSSGGTRKNTKGALGDSSASGICHTYTEDGRCVSLLK
ILLTNHCIYDCAYCVSRSSNDIKRAAFTVEEVVDLTINFYRRNYIEGLFLSSGIFKNADT
TMERLVRVAKKLRLEENFNGYIHLKSIPGASDELMQEAALYADRLSINLEIPTESGLKLL
APEKNRQDMLNPMKYIQNGIAQYKDEKKIFRKVPKFAPAGQSTQMIVGATNENDLQIIKV
ADHFYKNFNLKRVYYSGYVPVLEDKRLPSLTTEVPMLRENRLYQSDWLMRFYGFKAEEIL
DPNMPFLDLEVDPKLSWALRHLHQFPVNLQTADYQMILRIPGIGVKTAQKIVSARRFQVL
TLDHLKKLGAAVNRARYFIDFNTGNAYLKYLTDKNFRKLLIGGSSSKFHNQFSQQLTLF
>KALACAFP_01968 3-hydroxy-3-methylglutaryl-coenzyme A reductase
MNHKPVEGFSKLTKQGKIDWLVNEYLEGNEEYQHILKQYWNENADLQKLHDEFSENTISN
FYMPYGIAPNFLIDGKLFALPMAVEESSVVAAASKAAKFWIDKGGFKTTIINNEKLGHTH
FIFNVESHKLLHFFNFNLKKKLIEATNDITANMRNRGGGILDIKLVDKTAEMPNYYQLKA
SFDTVDSMGANFINSCLEQFGKTLKQEVAVSEDFTQEEKNSLQIVMNILSNFTPDCIVRA
EVSCKIEDLKDDSGISNEEFARKFKQAVTIAEIEPFRATTHNKGIMNGVDAVVIATGNDF
RATEACAHAYAARNGRYSSLTHCTTDNGVFRFWIDLPISVGVVGGLTNLHPLVKFSLALL
GKPSAQELMSILAVSGLAQNFAALRSLVTTGIQKGHMKMHLLNILNQLGATEEEKQHFVT
YFKDKTVSHHEVINEFNRLREK
>KALACAFP_01969 hypothetical protein
MFGIIVSAFMLTFGIFLKLTKNPGFAQNKKLAWVFIGIGAISLVFKIINYK
>KALACAFP_01970 hypothetical protein
MKTITLVFGAVYGMLSVILGAFGAHALKKILSLERLESFETGVRYQMYAAFFLLIIGYIL
KFETSTEKWTSILMIVGTFLFSVSIYFLSLQDYLGANLKFLGPITPLGGLLMILSWGMLI
LYFAKNRI
>KALACAFP_01971 Chloride/fluoride channel protein
MKINRRRRLIRTFDLLDQPIRFNPFVFSRTFFMWAFTGLVGGVIAGLYWIVLEHFTEFLA
EFQGWMVIPTMAVCGLLAGLVIHFFGDPGEIHLIVNNIRFNKGKLEPKNNPSMILSSLFC
VASGGSLGPEAPLVQVTGSTGTWLGKIFRLKGEELRSLSIAGMASGFTALFGAPLGGSLF
SLEILHHKHAVEYYKAIIPALVASCFSYLMFALIIHMGIGATWNLKDYHYSGVYDFAYAT
AFGIVGTLFGWIFIFVVKFFKKIFEYRKLPIYITMMIGGIILGVIAFYLPITRYFGHNEI
NEIINGNFTLDFLIIVLIFKILAIAITVTSGWRGGFIIPLFFVGTTLGLIIHNLFPTVDT
TLAIVSCMAAINACVTRTPMSTTIILGTLTGFTYFVPILFASLTGYFLAPKIPFIGSQSE
KLSEE
>KALACAFP_01972 Succinate--CoA ligase [ADP-forming] subunit beta
MNLHEYQSKEILSKYGVAIQRGYVANNVDEAVAAAEKLTAETGAQGWVVKAQIHAGGRGK
GGGVKFSPNMDKLKENAQNIIGMQLVTPQTSAEGKKVNSVLVAEDVYYPGESETKEFYVS
ILLDRAEGKNTVVYSTEGGMDIEHVAEVTPHLIHKEIIDPALGLQGFQARKIAFNLGLEG
NAFKEFTKFITSLYNAYTGIDASLFEINPVLKTSDNKIIAVDAKVTLDDNSLFRHKDLAE
LRDTREEDPMDVEAGEAGLNFVKLDGNVACMVNGAGLAMATMDIIKLSGGNPANFLDVGG
TADAQRVQTAFGIILRDPNVKAILINIFGGIVRCDRVAQGVVDAYKAMGSLPVPLIVRLQ
GTNAVEAKKLIDESGLPVHSAITLEEAANKVKEVLA
>KALACAFP_01973 Low conductance mechanosensitive channel YnaI
MQKNGLSYFDVVYKVLENWYLKFAELTPKLIVGILVFSFFLITSKYFSQIAVKFFHKFFP
KSKKESSLVTLISVFRFIIMLMGTFIALEIMGFSNFLWKFIGSLGVAGVIAGVALKDLVS
SIFSGMLIGIDKAFKVGDYITIGANSGTVIEIGFLTTKIITDDGKKVYIPNQVVFNAPFS
NITASPQRRIILNFEIPADEDVNKAQIGILEVIKNLENADKLDTAEVIFTDLKQGVFNLQ
AKFWMKVGANMALVKNEALMKIKQRLDSDNIQLVTPTSINITNGDTLINENHD
>KALACAFP_01974 Alkyl hydroperoxide reductase subunit C
MSIKLGDTAPNFQAETSVGDINFYDYLGDSWGILFSHPADYTPVCTTELGYTSKLKSEFE
KRGTKVIALSVDGVEDHLNWIKDINETQNTDVQFPIIADKERKISELYDFIHPNASATTT
VRSLLIIDPEKKVRLIITYPASTGRNFNEIIRVLDSLQLVDSYKVATPVNWENGEDVIVP
PAISTEDARKIFPKGVTEIKPYLRYTPQPNT
>KALACAFP_01975 hypothetical protein
MKKLILTGILAVAGLATTMNAQIQKGNWMVGSSLISSRFGLNTDAGYDIAIQPKGAYFIK
DNVAVGGYVTLGTSKVSKDSGTQFTYAVGGLGRYYLSPGEKGVDNLLNHGRWFFEGNLGI
GGQSTKGGTSTTGLDFGVGPGYSYFITPNIGLEGLVKYAGVTGFGNEGLTSNITFNLGFS
IYIPTSKAKQVVNDVK
>KALACAFP_01976 hypothetical protein
MDKIKDTRSFMRITHRYLGYFLAGIMAIYALSGVLLVYRDTDFLKKEKKYDKVIDKNLSE
KELGKELKIKNLEVEKTEGSILTFKQGTYNTETGEAKYSKKELPFVLDKMTKLHKAQSKD
TLSPLNTFFGISLFFFVISSFWMFNPKSKIFKRGIIFTIIGIVVSIILLFI
>KALACAFP_01977 Ferripyoverdine receptor
MKKQLVTLGLLFTAISLSAQMKNTEADTVRVQTIEDVNLHKTGNPNKARPLSTKSNLTVM
ENPQAMSIVTHEIIEQQQAKQLSDVIRNVNGIYLTSARGGSQDSFGGRGFTFGNDNIFKN
GAKVNSGVFPEVSGLERVEVLKGANAMLYGNVGPGGIVNLITKKPKFEFGGAFGFSAGSW
NSYKPTIDIYGPLSKNIAFRVNGAYEYAESFRDLVQSKKNYFNPSFVFNLSENTQLIVEG
DYLYHNFTPDFGIGSVTDNATGVSRLATEIGRNQFFGANWQYQTNQQASTDVILNHKFNN
NWALNAVASYQNYTKDYFSTERIQWAYNSKNNNFNPSWTRPVGRTYNEQNYTSLQINLNG
EFKTGNIVHKLLVGTDGDYGQADSYTFKLSSTTLGTLLLNDPSTWSNEGAMPTADKTYRR
RIPTRRLGIYTQDLVELTKSLKLLAGVRFSYLTNGESSDKIFLPNNPVAATSAKTEDHAF
SPKVGIVYNPNDNLSVFATYTNSFVPNTGTTVYFEALKPSTVDQYEIGIKKNVFNNAVAI
NLTAYQIINNNTYNTARFKADGTQNSDSNLKEFAGKVRSRGVELDITGNPLTNLSLIGGV
SYNNSVYTETPDVYGYVEDQRLVRTPAVTANASVFYTFTNFAKGLRVGATAFYTGDRKAG
WNDTKNQTQVTRMIDVEGFTTVDLSLGYEWKKFMIQGKVGNLFDVVNYNVHENYSVNPIT
PRNYYFTLTYKL
>KALACAFP_01978 scyllo-inositol 2-dehydrogenase (NADP(+))
MQLVKVGLCAFGMSGKVFHAPFLKEHPGFFMSAVVERSKEDSKEKYPEATIYRSVEEMLK
NADIELVVVNTPVQTHFEYTKMALEAGKNVVVEKPFTVNVSQAEELVKLAEEKGLFLSVY
QNRRFDRDYLQVQKIMSEGNVGNIKEAEIRFDRFRTEPSGKAHKENPEATGSGSLHDLGS
HLVDQAVQYFGFPERLFADVFSMKGKEFANDYFEIILFYQNDLRVRLKSSVFTKEAHYAY
AIHGEKGSFLQERTDNQENELVAGAVPEYGKEWTQPLKEPDGILNYLNENKETQRIFTSS
EPGNYMNYYQQIYEFIVFGYALPSPAEEIIKNMKIIDAAWESSKEGKIVTL
>KALACAFP_01979 Energy-dependent translational throttle protein EttA
MNYVSVENLTKSYGIKVLFENISFHINEGDKIAIVAKNGSGKSTILKILMGKEVADSGTV
NINKDIQVVLFDQEIDFNSDLTIEEFMMTLDSAPIKALKNYHKSLHSTDNDFIEKALAEM
EAHKAWDLENEMKQILSQLKITDLEAKMGTLSGGQIKRVALAKLLTETRAEHRHTLLIMD
EPTNHLDVEMVEWLENYLNKAKITLLLVTHDRYFLDSVCDIIWELEDKNLYIHNGSYATY
LENKMIREDNLNATIDKANNLYRKELEWMRRQPKARTTKSKSRIDSFYETEKVAKTDTRK
QGLELDFEMKRLGKKILELKHIDKSFGNKVLLKDFSYQFQRGEKVGIVGKNGVGKSTLLN
IIQGFEKFDNGEIETGETIHFGYFSQKGLQYKEDERVIDFIKEVAEFYPLANGKSLSASQ
FLRLFLFDDQTQYSPISKLSGGEKRRLHLMYILYQNPNFLIFDEPTNDLDLPTLTVLENF
LQQFQGSLIIVSHDRYFMDRIVDHILAFEGEGKIKDFVGNFSEYREAKSREESLEKSAVQ
KVEPVKEPVSAPNISQNSFKKKKLSFKEQKELETIEKEMPELETKRAEILDSLNNESDYE
KISKLSADLEAISEKLENHEMRWLELQEMLGEG
>KALACAFP_01980 hypothetical protein
MMQINFWAILVAAIVPLIMGFIWYHPKIFGTVWMREAGLSEDKMQGQMIGVFIFSLILSA
LMAFFLQMVTIHQFGAMGMVGGDEMNAKDSYTAFMKDYGMAYRSFGHGALHSFMAGIFFV
FPLIAINAMFERKSWKYTMINTAYWTITITIMGGIICGWYAVDGFYWVTQK
>KALACAFP_01981 hypothetical protein
MSYNLKIYSTVSDLPEYWNTVIGNHNIMLSKEYFHVLEVSSPQNMRCYFVGFFLDNELIG
GALFQYLDFQYHSTFQKNQVWCSIRNFFGRQFSKDVMILGNNMLTGQNGFYFDSSKINLE
QVVPLLDKAVCKMQKEIRKTSLIIYKDYQSNFVTYFNDKAHQAYFKFSVQPTMILKLRKQ
WLNFEDYLNDFSTKYRTRAKSAKKKLQGIEKRELHLREVKKLQKEMNFLYQNVAENAPFN
TFFLAENHFEMMKENLKDNFKIFGYFSEQKLIGFYTLILNNEDIDTYFLGYNKELQKEKQ
LYLNMLLDMVDFSIHHQFKRIIFGRTALEIKSTIGAEPVEIFGLIKHKSFLANQFMKNIF
PSLSPKTEWIQRKPFK
>KALACAFP_01982 Lysozyme M1
MTQRKYSKKTAKIHQKRRKNYFLRRKVVLIILIIALVGTGLYLKQSISYYYALYFNKFKH
KKLHNTEAEALRIQKILSDNLNKTYGFDISHYQNREDINWDSLSIGNRTIPLEFVVMRAT
MGNRNADKHFDEFWEQAKKHELIRGAYHFYRVDEDPVIQANNFLENVKLESGDLPPILDI
EKIPKRKTNKKLLEDLKIWCKIIEETYGEKPIIYTYYHYYKDFLKGEFDDYPLWLANYND
VPTPSPNDDWDFWQFTENGIVHGINAKVDLDIYNGSSWSLKRLTLD
>KALACAFP_01983 NADH dehydrogenase-like protein
METREKIIIIGGGFAGLQLAKTLNNKNKKVIVLDRVNHHMFQPLFYQVACGRIEPSNISF
PFRKIFQRSRNTQFRLTEVKEIDTANNKVITDEADFSYDKLIIATGCKTNFFGNKDLEGR
AFGMKNTQEAISIRNHVLMTFEKLIIEKSRSDDGNWNIVIVGSGPTGVELAGAFAEMKKE
ILPRDYPYMNFDHLKIILISSTEKPLAVMSPEAQEKSEKYLKDLGVTFLSQEYVTDYDGD
KVYMKSGKSIPSNNVIWAAGVTGNVVDGFSQENLMKNRYIVDRYNKVKGYENIYAIGDIA
YMETPKYPQGHPQVANVAINQAKNLGKNLLKKGVNDWVEYEYDDKGSLATIGKHRAVVDL
PYIKFQGFLAWYFWMFLHLMLILSVRNKLAVFFNWMWSYFNKDSSLRLIILPNKKNETLQ
>KALACAFP_01984 tRNA (guanine-N(1)-)-methyltransferase
MRIDIISVLPELMESPFQTSILRRAMDKGLAEVHFHHLRDWATNKHRQIDDEPYGGGAGM
VMMVEPLDKCISELKSQREYDEVIYLTPDGITLNQKIANTLSIKNNLIFLCGHYKGIDQR
VRDLHITKEISIGDYVLTGGELAACVLADSVIRLLPGVLNDEQSALTDSFQDDLLSPPIY
TRPEVYKGLEVPKILLSGNFGKIEEWRHDEAIRITKEKRPDLLGN
>KALACAFP_01985 hypothetical protein
MELFSFYNVENLFLPDPMPKHKLDPTISGLRNWDEKKYQNKLFKISHVFQLMKEENGVLP
FMIGLSEVSGRKVLEDLVKMEPFNSQYGIVHYNSMDERNVDVALLYDMNKIEVVDSQTIT
FFFEIIKKNTENYDTTRDVLYSKVKYKGEVINVFIAHLPSKRKKDINKPKRAFILNEIRG
RILNLVNEEKEHVILCGDFNENPDDENLVKILYDDAHGKVLENPFQQLFSTRNYSTFHYK
SGLLFDQIILSKSFFTKQSALHFQDAEVFRSEKISSRNRKFEGRPFRTYAGTRYLGGYSD
HFPVFVSFKKDGTT
>KALACAFP_01986 Regulatory protein AsnC
MKNSSNTNYHLDSIDKEIIYMLMDNAKTSLAHISKNVGISTTAVHQRIKKLEHAGVIENS
ISFLNPKKIGYKVISYIGVFLDQPSNYPDVVKSLKDINEVVEAHYTTGNYTIFLKVLCKD
NDHLMQILSKLQKLKGVTRTETFISLEQGIYRQLKV
>KALACAFP_01987 Deoxyribose-phosphate aldolase 2
MNIAQYLDSTYLKTPAQSGLSDEETLQIDKDLAQEAIENGIFAVMIRPDYVSEIKKYLLE
RNSNVVVGTVIGFHEGTYSIDEKLAEASKAIADGADELDFVINYNAYLKGNLGLVKEEFV
KCTLLCVQHHKIAKWIIEIAALSDEQIADLTKNISHWAEENFSENDLSKIFVKSSTGFYK
TTGEKPNGATFEGVKIMLDNAGKLPVKAAGGVRTPEDAEKMITMGVKRIGTSSALALIKN
QSASEGY
>KALACAFP_01988 putative tRNA-dihydrouridine synthase
MIKIGNIELPEFPLLLAPMEDVSDPPFRRLCKMHGADLMYSEFISSEGLIRDAIKSRKKL
DIFDYERPVGIQIFGGDEEAMAMSARIVETVNPDLVDINFGCPVKKVVCKGAGAGVLKDI
DLMVRLTKAVVSSTSLPVTVKTRLGWDSTSINIDEVAERLQETGIKALTIHARTRAQMYK
GEADWEHISRIKQNPNIEIPIFGNGDIDSPEKALEYKQKYACDGIMIGRAAIGYPWIFNE
IKHFFKTGEHLQAPEIADRLLAVRQHAEWSAEWKGERLGLIEMRQHYSNYFRGVPHFKDF
RKKFLEVFTLEEMDALIKETQEFYSEYLAQQA
>KALACAFP_01989 hypothetical protein
MGIFSGNAQVFTWKNPNLPQDSLRQDSIRHDSILAAKFEQDIFAKDTLDFVKTSNRVIVD
EAVLARNDKKRFLGELNSKGSIIRGITFGNNQGQSVQSSMDLQISGRLSKDVTILASISD
HNLPIQADGYTQTLEEFDKIYMQLNIKDKSILRAGHLDLVEAKNYFAKYQRRSMGLEFQT
EFGKENKTFVDISAGVARSEFNRIRFQGVEGNQGPYRLTGKNGEQFITLISGSEQVFIDG
ILMKRGENQDYIINYNTGEVTFTSFRPIFQQNFITISYNYTNRNYSRYLFTGKVEHKREK
LKLGLNWFMENDNKNAPLSLNLSPEDEKILAEAGNNPNLMYAPSGVVTEYDVNKILYRLI
QNPNGNYYEFSTDATQTLYTVSFTYFGANLGDYKITQTTNNGRVFEYVGPNQGDYRAVRK
LPSPEKSQVYSLNSEYLLKDGKIGADISLSNYDVNLFSSRDSYQNIGYAWRVFGNKTFSK
NNWKGTPNFEYQYIDSQFHILDRINDVEFSRDFNLTQEFSGRTQNRFIFSFLNKWNNKST
LNYRINYLDEKDSYKGIKNDLDFGWIKGKFFTKGSLSYLNTTATLQDTKFIRGGVSTEYT
GKKGSWALGGSMEHNEKKYNDTQLMDVTSFSWKEIFVQKKIGDSTRTKLLAKVYMRDNDS
VRDNRLQSMNNILGFMAESQIIKTEKTTLNALIHYRKFFYQNQDIDVSRNNDFVVGNILY
NQQLFRNGMRLQAFYELGNGQEAQREFQYIKVTDGQGIYKWTDYNGDGVQQLDEFEIAEY
SDLAQYIRVYTNSVRYIPSNKNKIQLALFVNPSIVFNSENKFLKRWNFNISLNSQNSFYK
KDRVLVLNPFEKNDDQILKNQNILASVQFSPTEKSGWNGNYRFISNDNLVNANFSNEERE
QTSHFLNIGYWFNKEFRVDWENSVHDIQNSSQLFQTRDYRLNNFETKPKATYKFTDAIQA
ELSSAFRQKDRVDGEELLKAFDITGTIQWERRKTTIRGNFSFINNNFTGNNFSIVGNQML
DGLKPGKNQVWSVFIQQAINSFLQLNLNYEGRNSGDRTIHIGSMQVKASF
>KALACAFP_01990 hypothetical protein
MKKIYSFFAAVGMAASFMAQTTVASDNFSYTGALNANGWVSHSGTAGQLTANGSTANLAA
GNSEDVNLAFSTVYTIAPGVVNKADYSATINVPNGTGLTTTGDYFLMLGGTAGASVTFFY
GRLYIKGSATGYTLGVLNNSGGTATPAYGTEIPYGTPANITVTYTIDNSVTPATNAATLQ
INSQPLLTNATGTSAAATQLASVAIREAGNASSGTGNISIDNLVVRTYSSTLAVSDVSKA
KGNLVKNTFVTNEEITFGAQAKDVKVYNMFGQVVKTASVKENESLNVSELQKGSYIVTGT
VNNQPVSQKILKD
>KALACAFP_01991 hypothetical protein
MRKIFTFIGFVSVIAFANAQIVISEIYGGGGNSGSTLKNDYVVLKNIGSATASLTGATLQ
YAPAAGTFTQYHTLPNITLNPGQTYLIQEATGGGGTVDLPTPDFIATTVVNFDGSPNPSV
GIGIAVTSGKIVIANNNVQVTGPTSTNVVDFVGYGTAANQYEGPGPAPSPTTTTAIKRIS
GDTNNNTVDFTTGAANPINSTGGTLAISDVDFNYSKFHFIQNSFVKENEIIFGGEINDVK
VYNMYGQVVKYAPTRSSYSLDVTELPKGNYIVTGTINNEPVSQKILKD
>KALACAFP_01992 hypothetical protein
MKKLSIYFILFLGVAEVSAQKDSIYIEARLSSDKKTLDVNQDLVYYNNSGKDLNTIKLLN
WVSAYNRRGTSLVYRKLEDRNTDLHFAKKEELGKLLNLQIKNPDQEIIVSDISDENFFLP
LKEVLKPGEKIKLHLQYQIQLPDKKFTGYGTSDKSIALKYFFIVPDRFDPDNISKRDYHD
IEESVSFNTYWTVNFDLPVNYFIESNLQQIQMNSFKGYLDSDPEFLISENEYPSIKINTS
DVNTEVKFGYNLRPEEKQNLEFYLPLHLKFIKERIGFIPERIFISDKFRGKEDFFGNNDI
SFWKFRFQLFTDAEKTDLDYFGIIAKKVLDESIITDKQDYHWFKNGLKSYLEIQYLKKFY
PDTKLLGALPETKVFGVKPLKLFHASNVKLIDRYGLAYQYIMSQNLDQKIAEKYTVLSNF
NDMAISSFETGSLFNYSADKMGYENFDQLVQNFIAKNTDKQVDPRDFIKELAEKDKRTSY
LSNFLEHKNRVNFKLRKFKKENDSLNIKIQKNTLANIPVKLQTETQEGDKKEYWVENEEN
EKSKTFSIPALDIYKITLNNDYIFPESKYRDNFLYAKGFFSNAKKIKLKLIKDIPNPEFN
EIYISPRVRFNNTYDKFLIGFNFKNQSFFDQKFLYSITPTYSTGTGKLTGSGAVSYSFLP
AESIFRSLTFGVSGSYFHYDYDLAYRKASLYSTINFRKNPRSTVSRGIALSYNYFERDLS
PAMIAKNDYGKYNLWSAGYGYSDSQSIHEKSLSVSTQWMEDFNKITAEGFYRWEFAPRQK
LSVRLFAGYFVRNETRNNTFNYGISRVSDYSFSYNLLGQSATGGILSQQFILADGGFKSF
IPGSVNKWITSVNLDTSVWKIFHVYADAGIYDNKNQATKFIWDSGVKVRVIPDFLEIYFP
IQSSLGFEPGFKDYAKRIRYTLVLNLSSIINAARRGWY
>KALACAFP_01993 Orotate phosphoribosyltransferase
MESKKEFFLECYKLGIIKFGRFTLKSGIESPFYVDLRPLASDPKILKNLANYLLEMLPLD
NFDLICGVPYAALPMATAMSLESYIPLIIKRKEAKEYGTKKMIEGIYQKGQNCLLVEDVI
TSGKSLIETIAEIEQEDIKVADIVVVLDREQGGKQLLESKGFRVHTLFNISEVCEILQEN
GELSDDEVKRIQDFLQGNHIQFEEKTRSSYEQKLNNAQHSVSKKLLETALAKQSNLIASA
DVTTTQELLDLAEKVGPHVIALKTHIDIISDFEYDKTITPLKALAAKHNFLLMEDRKFAD
IGNTQELQFTSGVFKITDWADFVTSQVIGGFESLDCFKNVGVVAIIGMSSKGTLTTNSYR
EEALKVALSHPNVIGGVSQNPLPEEMLLFTPGVNLADSGDGKGQQYNTPEHVFKTLHSDF
IIVGRGIYKAENPAEAAITYKNEGWNAYLNSLDKKVIQS
>KALACAFP_01994 hypothetical protein
MSLADFVDYADVCVLLIKRKVFFKNKILLSKLRQINLLHEANGKASSNQLVDFSLPI
>KALACAFP_01995 hypothetical protein
MKYSKLNLAKEAIAHKGFVKKIPDIFRMVKMWKKGQYPVKSIDVILPLLGLLYVISPIDL
LPEVAVPVIGVLDDLAILSLAIPKLIREVDKFLLWEAEQKYNSGNMKVIDAEIVK
>KALACAFP_01996 Thiol-disulfide oxidoreductase ResA
MKKNIIYLVLIVIIGVIAFVPGVKEKLQDTFFPIATIENAVHVSDEDYDVELQGINVPNT
NLKNFKGKAVFLNFWGTWCPPCRKEWPSIQKLYDTRKDHVDFVLIAMNDKEDAVRKFLKE
NNYNVPVYIAQSPISEKILPKVFPTTYLLDKNGRILIKEDASRDWNTESTHQFIDNIIK
>KALACAFP_01997 hypothetical protein
MKNYWDKSIFFEEYLEIGKQRLANPASQQETDYKQYYELGLQRIERTLKKYVPDEDQLKE
LESKNFDGKILIISEVWCGDASSTVPALVKFFEGKNEVKIFLRDSDKSLINQFLTNGTES
IPKVIILDKDFNVKNSWGPRPKYGKELLMKYKADPEAYPKDTFYNDLQIYYAKNRGKDAV
QEILELL
>KALACAFP_01998 Chorismate synthase
MLNTLGNLLSLTTFGESHGLAYGGIINNFPAGLAVDFEKVQYELDRRKPGQSAIVTQRKE
SDTVQFLSGIFEGKTTGTPIGFIIENENQKSKDYDHIAKSYRPSHADFTYDQKYGLRDYR
GGGKSSARETMNWVVAGALAKQFLSDIEINAYVSSVGEIFCEKPYQALDFSKTESNEVRC
PDAETAEKMIEKIKEIKKEGNTIGGTITCVIKNVPVGIGEPVFSKLQAELGKAMLNINAA
KGFEYGSGFCGAKMTGKEHNDLFNEDFTTKSNLSGGIQGGISNGMDIYFRVAFKPIATIL
RPQESVDKDGNPVIVEGKGRHDPCVLPRAVPVVESLAAFVLADLFLINKTRNINNF
>KALACAFP_01999 hypothetical protein
MVFILLSTFIIVPTLMGFGKIMENLFGSLLGGIAGKIISGILGISLIWTVLAFFIPLNIY
VEIPTVLLGMIYFFKDKLYLEFYGFSKKDYSLISIVSLIILFCGSFYPYILDHFGYYVPS
IKWLTEFGLIKGISNLDLTLGQMSVWHIFQAGFSNFSDPFLRINSILLIIYTLYIIEKKS
WIQLCFVPVLLLFSQSPSPDLPVIIFSLIILNEIVKENKNTSLLFAFSVFVFAMKPTMIW
LPIVSFLYSIFIIKSNIKNLIPGIVILLLFFIKNIYAFGYPVFPVSIGDLGVRWKPNPEV
LKISSQYAIQKTYDMQYSYEEIQKFSGFDYIKNWLFLDGIKAKINILFIFSLLFFIVFTF
IKKNKIISLICISILIKSILVLLFSAQYRFFIDVFFVIFFVIFINYFNQKKSLVIFSALS
IIFIGFLTLPNILQTYLPSFKLGNFMGKFEKEQFYKPSTYDYNKFQSYKIGNLKFNVSKK
YPYNFDTQLPAISESFIFEDIKANIFPQLIDEKNIKKGFIWKKLNTEEKKEAEKVINSIN
NSYK
>KALACAFP_02000 hypothetical protein
MKSIVLTGLLSVFLLTACKKDDQVAEKSLEQQKVEFQMRQLEIEKQKLAIEKEKMAYEAQ
KKADSTVEAQKAKTAAANNSRPEVIRETHTVYRDRPSQSSGNGTYANNGSSASQGTTTTQ
KKGMSKAAKGTIIGTVGGAAAGAIIAKKNRGLGAVIGGVIGGATGYTIGRAGDRKDGRVQ
PR
>KALACAFP_02001 hypothetical protein
MKKFTVKALLFAGLISVVASCSSNDDLIVSDAQRERLNSKEVSKTKTYQIRYGLLSQSGV
KILSGSYDVGSFVATNTATGETFETYAGGGFQSLPKYYDGVPAGTYTFSAMQGQGGWVGY
GSVTGVVSDSQVDADGYITVYIPIVWEE
>KALACAFP_02002 hypothetical protein
MKKLVLLIIGLGFFAVSCKKQETQVDNNTVNDSMTTANSVSPMDTTASVRDSSMNQNNQN
PNQTTGTSTNRTTVTPSGAVSTDSAR
>KALACAFP_02003 Chondroitin synthase
MNKASILIANYNNGKYFRDCYESIISQSYENWEVIIVDDCSTDDSVQIIEEIIKNDDRFK
LYKNDINKGCGYTKRKCADLATGDFCAYLDPDDALFYYSLECAIDEFNKHNKIIAVYSQL
VFCDEKLNPKEIFSKIKQIHNDKYFFNTPIQLSAFFVFKREAYLQTSGINPELKNAVDQD
LYLKLLEKGDAKFIEEVLYKYRLHSNGISQQRSKQSAKDSFAKVIHEAMKRRGITKIQNK
NVPVHYTNSQEIYNLLDYQTKIPYRLMNKIKATLNI
>KALACAFP_02004 hypothetical protein
MILAVESASSKAYELDLAQQILVVGVVVLVGLLGFAFINSWNKR
>KALACAFP_02005 Beta-agarase D
MKKFYTFLVLLLCLINLGAIPDVYGQTPATLPYSQDFNTANDFTLLNGTQTNKWVYGAFT
GNTGSSIYVSNDNGASNAYTNTTTSTVQAYRDFTIPAGSTIANFSFDWKSGGESTWDYVR
VWVVPATFTPTVGTQIGAGAGRTQLAQLNLQSTWQTFSLVNLNVSAYAGSTMRLVFEWRN
DDSAGIQPAVAIDNVNLSIPTCIMPSGMATSAVGATTATLSWTAPSPVPGNGYEYYLSTT
NTAPTAATVGTANAGTTVTPTVTPATTYYWWVRSVCSGTDKSVWVAGPSFTTTQIPATVP
YIQNFSTGNDLQLNNGTQPNKWFYGSAVGNPVNALYISNDNGVSNAYTISSSSVVQAYRD
IIIPAGTTDAALAFDWKADGENSWDYLRVWLVPTSFVPTAGTQIAAGGGRIQVGGNFGQQ
TTWQNYLNTTLNLSSFAGQTMRLVFEWRNDGSGGTQPPVAIDNINLSIPTCKVPSALAVS
AITTTSATISWTAPTPAPVGGYQYYLSTTNTPPIATTIPTGSSATTTAVLSPLTPNTTYY
FWVRSVCVGSDRSFWVAGPSFTTPQIPTTIPYYQDFSTNNDLGFTSGTQVNKWFYGSAVG
NPAKAIYISNDNGTTNAYTTGSSSVVHAYRDITVAAGTTNVTFSFDWKAAGESSWDYLRV
WLVPVSFMPTAGTQITAGAGRIQVGANYNQQDTWQSYLNATLNISSFAGQTMRLVFEWRN
DGGGGTQPPAAVDNIKIRICSTATPTVTVGTVTHNSAVLTWPQDNGGANYTIRYRPVGTT
TWLTTNVAAAPFPTATNTTTLTNLQSATQYEVEIAAVCNGTTGTYSHNTFLTRCDPTPPN
VTISNITTTSALITWAPLAASSHYFMRYRIVGSGNAGWSANIPLPAAPTNTYSLTGLNVY
TTYEVQIANMCDNETTLNTWSNPKVFTTERTCEIAPPGLTITNLTPTTAVVVWDPFPGAT
YILRYRKVGIPSWTNVPSSTNTVTLTGLIELTQYEMQVVNVCNGTPGTYTQPYIFTTPTV
VYCQMESTASTSEYISKVTVTPNGKPVMENQSLASNYTDYTGVTNKFIELIQGSSNNQIT
IEKKLSGNANAGVAVWIDFNRNGYFDINERVLVSGPNNSDQATGTFSVPTDAFVSMTDFK
YVVMRVALQKDGIPVNCTSFPAGEVEDYTVRISKPIVPNPINQTDILIYPNPVRTVLNVK
NISKRANYKIYNAAGQIVSSGIILNNKIDVHALINGVYVIDIEDSAGLTAQKKFIKE
>KALACAFP_02006 hypothetical protein
MYSKACFKYLLSGLECLKAFLMNNKNLLIDEINSEYRPTHDIHFIHLQSLMFNLSFHGY
>KALACAFP_02007 hypothetical protein
MTFSEALKHKKNILKNSSDFTKTLYDYIIIPAIEEEAEKFINDFRQSPSIFTDENCKVYS
SNSQFKVFLFPKNQN
>KALACAFP_02009 hypothetical protein
MKKILKVVENNRSNSWVRFGNFIIDRVVVYLFFLAFGFFASLTYEILGTEFFINIALELS
SVNKFMDILITTTVYFLYVFLMEYFTKGRTIGKYITGSKVISTDGTQPTLQDYFIRNISR
FVPFDALSFLGGGNGWHDSWSDTRVIHIKNYKAELQAKSEIESIGAKEIA
>KALACAFP_02010 hypothetical protein
MKFIKVLFLLAFINIFGQTNVDNQLAVHNFPKIKSSITMPVTIPLSEVSNMINSSVKELI
YQDDSYTDNNNDQFKVKVWKTRPIRLVGGTNQNILIEVPLKIWAEKGIGTLGVYTYQNTT
FETVMSFNASLTLKNNWTIATNTQPNGFKWVTKPVLDFGRIQIPITSLVEKNLKEQQEKF
CKTIDQQMATQLNFQQYTVMAWNVFSQPFNISQEYNTWLKVTPVNINITPLKFYGNQIDT
NIGIDIYSETFTGTKPESSQPVKTASDFNFIPVLADRFLLQTTANVPFTEATNIARNMFL
NKEYDVRNSKVKIKDIKVYGVDNRVMIEAETEGYVNGKAFISGIPVYDEIKKKIVLSNTK
FNLKTANILQKTATLLFKGKIVKMIEEEYGIPTQDLENSSRKSIEEAFNKEYYKGLKMSG
KVFNLKPTNILLNPSGITAVIDTNASLKLIINGI
>KALACAFP_02011 Dihydroneopterin aldolase
MSKIYLEDVKIYAYHGVLPEENIIGTYYILNAELHTDLWIAAESDDLKDTISYADINEIL
HREMKIKSKLLEHVAGRIIAEIHEKFPEISYIKLKITKTSPPMQGEMKGASIELEKSFKP
DN
>KALACAFP_02012 Quinolinate synthase A
MSTETLEKAKSAIPVRGFLDIKDLVIPQGEELVKAILKLKEEKNAVILAHYYQPGEIQDI
ADFLGDSLQLARQAKDTNADMIVFCGVHFMAEAAKILNPTKKVVLPDTMAGCSLADGCSG
EGLRKMREQYPNALVATYINCNAETKAESDIIVTSSNAETVIEALPKDRPIIFAPDKNLG
RYLSQKTGRDMILWDGSCVVHEAFSMERIAKQLADNPDAKLIAHPESEEAVLKLAHYIGS
TSALLNYVEKDDCQKFIIATEEGILHEMRKRAPHKELIPALVFDETCNCSECFYMKRNTM
EKLYLCMKYELPEILIDEELRLKALKPIEAMLDLSKSIK
>KALACAFP_02013 Guanylate kinase
MNKVIIFSAPSGSGKTTLVKHSLEVFDELQFSISCTTRQPRGSEVHAVDYHFLTPDEFRQ
KISEDAFVEFEEVYTDKYYGTLKSEVEKIWNQGKVVIFDVDVKGGISLKKYFGEQALSIF
IEPPSIEELERRLISRNTDDAETIKTRVAKAEEEMSYAKEFDKIVINSDLDIAKKEIESL
IKNFIGS
>KALACAFP_02014 hypothetical protein
MILSMTGFGRAEDVFEGKKISIDIKSLNSKSFDLNIKIPLRYKEKEFEIRKILNDRIIRG
KVDCYINIENLEETNDVKINKGLIDSYINELRNIASDGPDFEYLKMAVRLPDAITSRPDE
LCEGEWEKLASIVHAAIDRFEEFRKTEGKNLHEELERNIQNIDKYLGEVIPFEEERIVSV
RERYQKSLKEFENVDETRFYQEMAYFTEKLDISEEKVRLTQHLKYYKEVMDNEDFNGKKL
GFISQEIGREINTLGSKANHAEIQKLVVMMKDDLEKIKEQTLNVL
>KALACAFP_02015 tRNA dimethylallyltransferase
MKKKNLISVVGPTGIGKTRLAIDLAKHFDTEIVSCDSRQFFKEMKIGTASPSSEELAEAP
HHFIGNLSVEEYYSIGQYEEDALKKLKELFENHDTVILVGGSMMYEKAVIEGLNDLPEAD
EDNQKKLHEIFEKEGIEKLQEILKELDPEYFTVVDFHNHRRLLRAIDVIWQTNKKYSEQI
AVSQDSRDFNVIRIGIEAPREELYDRINRRVDIMMEKGLLEEAKSLEKFKHLTALNTVGY
AELFKYFDGEWDLDFAVSEIKKNSRRYAKRQLTWYRKADDIHYLPLGYSQEDFDGLIEYI
NEQILK
>KALACAFP_02016 hypothetical protein
MNDTIFYKIQNAYMIPYSEAIDEKIMDTYDKTNETIASSRIYLICRLRVKGFFLKKFSKP
EVLYVGETFDKKNRFSPHKKLLKATTLLKSKDHLVVYFLHIRFSYLGLNEFHNNPLNIFN
ELKDIHSKTSVWLLERLFIKLFNPILNNKHNDENIKEDNLVRKKLIDNSILYVNLDIGMN
ELLFNFTGGRRVENQDIYNFNLKNNEMTFGHPLIE
>KALACAFP_02017 Outer membrane protein OprM
MKKVKNIFLTFILALGSVSCVSKLAYTEPDLELPEKFQYTATADTASVANLEWKQFFSDP
ILQGLIEKGIKNNYDLQIALKQVASSQEKLKQAKYLQYPDVGFGVAAQISKPSKNSMNGQ
SLNLFLGKSYVEDYNAAFNLSWEADIWGKIKNQQEVSKMQYLQTYEATKAIQTQVVAAIA
QGYYNLLMLDKQMEIAKSNLELSTNTLSLTEKLWQSGDTTSLGVQQATAQKQSTELLITQ
LEQNIAIQENALSILVGENPGKISRTIEMSDTSLPQDISAGLPAAMVSRRPDVRQQELVL
LESNAMVGIAQANMYPSLKITANGGVNSFKIDNWFQIPASLFGSVLGGLTQPIFQKRQLK
TDLNVAKIQREKNVLAFRQSVLNAVGEVSDALVSNESLKVQEQKATEQVATLKNGIKSAE
MLYKGGMANYLEVITAQGNSLQAELNLASVKRQRLSSIVDLYRALGGGWK
>KALACAFP_02018 Efflux pump membrane transporter BepE
MLKQFIERPVLSTVISIILLLLGALSLFNLPIALFPDIAPPSVQVTAFYPGANAEVVARS
VATPIEEAVNGVENMTYMTSNSSNDGTMTLSVFFKQGSDADNAAVNVQNRVSKAMSQLPQ
EVVQAGISTQKVQNSMIMFMGLTSDDPKQYDELFLQNYLKINIIPQIQRIPGVAQAQVFG
TRDYSMRLWLKPDRLAANNLSPQEVLNAVRDHNLEAAPGRLGQGSKETYEYILKYKGKLN
KNEDYENIAIKANSDGSFLRLKDVARVEFGSYTYTAANRVDGKPVSGFAIMQTAGSNANE
ILTEIEKQVDQFKTTLPKGVEPIIMYNSKDFLDASIHQVVETLVIAFILVFIVVYIFLQD
FRSTLIPAIAVPVAIIGTFFFLQLFGFSINMLTLFALVLAIGIVVDDAIVVVEAVHSKME
HTGMPVEQATMSSMSEISGAIISITLVMCAVFIPVGFMQGPAGVFYRQFAFTLAIAIMIS
AVNALTLSPALCAMFLNDPQGEHGEHGKKTGFGARFFNAFNVSFNNLTKKYIYSLKFLIK
NKWVAVGGLVLITAASIFLIKKAPSGFIPTEDQGFILYAVNTPPGSSLDRTHRATEQIDK
IINGEKAKNHLWVADGLNFISNANASPYSAGFIKLKDHDQRGEITDPDQIAAGLTGKVSQ
VKDASAFFFNFPTVQGFGNVSGFEFMLQDKTNGSLEQLGTTTQAFIGELMKRPEIAFAFT
TYAAGNPQFTIEVDSDKANQLGVSITELMQTMQIYYGSSFVSDFNRFGKYYRVMAQADIP
YRTDANSLEGIYVKNKSGEMVPVKTLVTLKRAFGPETVTRNNLFNAVTINGTPKPGYSTG
DAIKAVEEVAQKSLPRGYGYEWTGITREEIKTSGQTAFIFMLSILFVYFLLAAQYESYIL
PFAVILTIPTGIFGVFAFTGLAGIDNNIYVQVGLIMLVGLLAKNAILIVEFAVQRRNAGR
SLLESALQASRLRLRPILMTSFAFIVGMLPLVFTQGASAKGNHSIGFSTVGGMLTGVVFG
IFIIPVMFVIFQYLHEKMPSRKKKRLQRQKLEAELLATTH
>KALACAFP_02019 Multidrug efflux pump subunit AcrA
MKIFGKTRIIVLIASIILLQSCSKAAENTNQAPPAPELPVYTVITSPATVYQEFPTALEG
KNNVEIRSQVDGYLDKIYVEEGAYVRAGQPLFKIDSRSYGEQMNMATANLQVANANIQKA
KVEVDRLEPLVAAKVVSEVQLRTAKANYAAAVAAASQAKATVGSARINVGFTTITAPVSG
YIGRIPYKKGSLISRTDPSPLTLLSDISEIYAYFSLSEMDFIAFQNKYPGATLNEKLKNM
PQVDLVIADNSTYPEKGKMSIVDGQFDKTTGAISVRAVFPNANGVLRTGNTGRVRMPQLF
DKTLVIPQESTYEIQDKTYVYVVGKDKKVTGKPVTISGKTNNYYFISDGLSVGDKIVFTG
IGTLKDGVAIQPKTISSDSLLKARPL
>KALACAFP_02020 hypothetical protein
MGLHERRQREKENIRTSILDAAFSLAKTEGWASLSMRKIADAIEYSAPVVYDHFENKEAI
LYEISLNGFHCLHIELLKAQREHDNPEDQLKAIVDAYWKFAFKNKEYYQLMFGLGMQCSG
KGMMKEEFSSFQDMLYDCTYEIIKKNGSNPDNACHMSHALFSAVHGLISIMMMRNDDIPS
TMNKTTLDETVSAFVKSL
>KALACAFP_02021 Thiol-disulfide oxidoreductase ResA
MNTPSNMIELGTKAPFFELPNPSKSNEIQSLDELKGEKGTLVIFMCNHCPFVLHVIDKLH
ELYEDYHERGIEFIAINSNDVEKYPADSPEKMIEFQIERHFDFPYLYDESQTIAKAYDAA
CTPDFFFFDDKLDLIYRGQMDDSRPGNNKDVTGEDLIIAFENLLLGEPQEEIQRPSMGCN
IKWK
>KALACAFP_02022 HTH-type transcriptional activator Btr
MKVTFERVIPDEKSSFRTIHNNSPISEFKWEYHYHPEIELVCVISGSGTRHVGYHKSNYT
NGDLVLIGSNIPHSGFGLNSIDPHEEIVLQFREEILQFPQQEVEARSIKNLLELSKYGIH
FHSKIKKTMLPRLKLMLESEGYKRYLLLLEILFELSKCTDYELLNKEIMPYTIISKNKTR
LENIFTYVEHNYDKEINIEDVAKLANLTLPAFCNFFKKATQITFTEFVNRYRINKACLLM
AQDKSISECSYNCGFNNVTYFNRMFKKYTEKTPSEFIKNFSHNKVNVDLKVEAKSKATF
>KALACAFP_02023 Protein TsgA
MKNFNIKAVLFLNYFVFAILLNSVGTVILQMQQNFGISKSSASVLEGFKDLPIAICSFIL
ASFLPKIGIKNSMLIALFLVSCMCFVMPFSNDFWFFKLLFTIVGISFALIKISVFTSIGL
VTDTDKEHSSFMGYLEGFFMIGVLMGNVLFSLFIDDHNPRSTHWLNVYWVLGTLSTLSFL
FLFFSKLDEHEAKSEKTDLLGDLRNSASLFSYKKVLFFLLCAFLFVLVEQSFQTWTPTFY
KEILKVPTSMSIQAGAVLAGAFALGRFLSGFFSKKFSWIYVVSFCVVGFAISILLVLPLT
HNIHIDTGTTWLNAPLVVYLFPLMGGLLAPIYPSINSVILASIPKYLHSAMSGLIVVFSA
IGGTIGSIITGFVFQEFSGQQAFYLSLIPLSLLIISAIIMNKLKINHKK
>KALACAFP_02024 Periplasmic trehalase
MNKQLYIKEIQTLFDDVQRSKVFEDQKMMTDAVPLFPISLINAKYEKEKNSENFDLKDFV
FSHFDFLGAKISIQREDHLPIEEHIEKLWDELTRTAYEEKGTLLKLPKPYIVPGGRFNEF
FYWDSYFIMLGLQVSGRVEMMENIIENCSYLIQTVGFVPNASRTHFLSRSQPPYFSLMLD
LLFETKKDEAIYIKYYDTLKKEYAFWMNGIEHLENASNINRVVKTINGDILNRYYDAENE
PRPESYLIDIEDSENAGEEFYRNIRSACESGWDFSSRWFADGENIQTIETLNLAEVDLNC
LLWHLEKTLAKSSALQNLSEKENYFKERAAGRRQMIDKYFWDEKSGTYKDYHTKKNTTTP
SEHIAALYPLFLKLASGEQAKSVAKIIEEKFLYQGGLVTTTKKTGQQWDLPNAWAPYQWL
GFKAMKNYGFDELAEKIKNNWCANVERVYNNTGKLMEKYNALDIETVAGGGEYPNQDGFG
WTNGIYLTLKNN
>KALACAFP_02025 Pesticin receptor
MKKRSIFLLAGIATLYFNNTYAQETPQDSTKTASIDQVVITGNSNPKKKIESSTAISTFT
AKEIQKQNPISAAALLQRVPGFAVETSGGEVGNNLFARGIPSAGAYEFVQVQEDGLPVFE
DGALQFANADNFFRVDNSVSRLEALRGGSGSIFANNSPGGLINFITKEGSNDFKGTAKLE
TSTYGLMRTDVNLGGALVEDKLFFNIGGFYRADNGIRKTGFKANNGGQIRMNLKYVFDKG
YAKVYYKKLDDRNTFFLPIPLVQNGNDLKEFSGFDANYGTYSYRTISQLNIPQAGGGFFS
RNLEDGIHPKVDVLGAEFKYDLGNNFSVLNKTRYTNINMNYTGIFPAGGPKDAVKFATDP
VSEGGLGMTGYQYSLVSNGAVVNPQFVQKLGFWAIDKQMNNFVNDLQFNYKFDKGNVTAG
FYKSNWKSHQYWNWSNILTTATDRPELLNLVDTSLAPTDMGYSKTYNGVTDMSFLIRDSQ
IQGSLNDVYLNLDYNITDNLSFNGGIRYSRDFYKGYGVSTTTSNLNNSDLTTDGTHSFYT
TTADDNMAVLGNKYTYWNYDISRVSFTTALNYKINRENAVYARFSNGFRSPNEEAYYNNM
NNLSAIKPVTTNQLEIGYKYYSRTFDVAVIPFYSTLKNLSFTDVYSDGTSENKFANTTNL
GVELEGYARLFNNLLEITFNGTIQSPKYKDFTGRNADGSTFDYDGNTVRRMPKFYFNISP
AVNITKQWRTYVSMNYYGKRFQDEKNAQTLPSFSEFGAGTSYQLGKIRFAVDGTNIFNTI
GITEGDPRAGSPTGDGIIMARPIMGAAVRASITLDF
>KALACAFP_02026 Hydroxyacylglutathione hydrolase GloC
MLQIQGFVFNFASENTYIIYNENKNAWLIDPGNMNDQETKAISNFITENGLKIQKILLTH
AHIDHVLGLQWAFDTFKVPVTMHKDDQDVLDMLQASGMRFGFQINPVKVDIEYVNEGDEL
DLDGEKFKIYHVPGHSPGSVVYHNENQQFMISGDVLFEGSIGRTDLYKGNYEQLIEGIKT
KLFILDGKTQVFSGHGNPTTIGFEKEYNPFFK
>KALACAFP_02027 hypothetical protein
MKTLRIFLLSLGGLVFGQNIQSIQLFNPQTNDETPVINFNQQLVLSFDDLTNASEIYRYT
IKHYNRNWEDDNLFFTEYANGSLNALLDKFQYSFNTLQAYTHYKLIFPNDKIQPKISGNF
EIIVYKDSADKPLFKRRFYLVEDAATLAVGVSRISEARNPNVNQRVEVKAVSKGGDLSSN
VNSMTLNVMQNNNPNMVINNLKPSTTLGNQLLFQQMSLLFPGNNEFYYFDNKNMNLAADM
VRATEVKDGVNNTFLHPVWAFPLNYQYQPDVNGAWYYRRNDIGRERDAEREADYSWVYFS
LDSDPVDKEIYVLGGFNNFKPSKENQMQYDAATKQYVAKIYLKQGFYNYILATKTPDGSL
DFGEINGNFWQTENLYQAFLYYAPFGRNYDGLMGYGEFRTPVR
>KALACAFP_02028 hypothetical protein
MKVLLSSIAKNDIRLLLRVFNAEKGNTGIDFLEDLKESINEISQQTERSEEVSINEMKNF
PVNIHYIFENDEVLFVTAIFKM
>KALACAFP_02029 hypothetical protein
MMNTTAEILKNKIENFSPEVLEAFVKMMEIFETENKSAVPQFQLDEVLYRIQFHNENPGT
KLDFYENISELKKYCA
>KALACAFP_02030 Ferrochelatase
MQKETSNPESRNSKKGILLVNLGSPRSTAVQDVKEYLDEFLMDERVIDYRWIFRALLVQG
IILKTRPPKSAEAYKTVWTDEGSPLIVITEKIQRKLQKLVDVPVEIGMRYAQPSIEAGIQ
KLVDKGVTEIVLFPLYPQYAMSTTETVIEKAEEVRKQKFPKVKINYIQPFYNRDIYINCL
AESIKEKLPENFDALQFSYHGVPERHIYKTDPTKTCNLNDCCSRESNPSHSFCYRHQCFT
TTNLVIEKLNLPKEKTIVSFQSRLGKDKWIEPYTDETLETIPAKGVKNLAIVCPAFVSDC
LETLEEISVEGKEQFLHGGGENFHYIPCLNDEDRWIEVVKTLCEEKLNEFYLV
>KALACAFP_02031 Fe/S biogenesis protein NfuA
MHTILIEPTENPKVMKFVADYNLIPGSLELDRDSDISEIPLAQELFNYPFVERVFITANF
VAVAKQDTIEWEHVAESLKNVIEDELLANPRVYLQKKKEMYQIYAEMTPNPNVMKFVSSK
LLLEGFVEVKSRETADGVPLAEAIFKEFDFASEVFISDNFVAVTRDNSVEWHQVMMAVRG
MIAEYLQNGGKISTLESQKHENPVEKIINRDYTEDEQKISDILNEYVAPAVENDGGKISL
MEYDKEHKTAKMLLQGACSGCPSSTATLKNGIENILKQFVPDLVERVEAVNG
>KALACAFP_02032 Galactoside O-acetyltransferase
MALIKELLGKTPQIGENTFLAETATIIGDVTMGKDCSIWYNAVIRGDVHYIKMGDKVNVQ
DNAMLHCTYQKHPLNIGNNVSIGHNAIVHGCTILDNVLIGMGAIVMDACLVEENSIVGAG
SVVTQGTHIKSGEVWGGVPAKKIKDINAQLLEGEVNRIADNYVKYSSWYKENVKHVEG
>KALACAFP_02033 hypothetical protein
MKNIFLQISAVVFCISLTLVSCNTVKKANANLPKDIAERPADENSQTYDQAQLDKIKGSI
ESEISKEKCTNINEWTFAPMGAKSCGGPQLYIAYPKKLEATILPKINDYTEKVKAFNQKY
NIMSDCMMIEPPTSIKCVNGKAELVH
>KALACAFP_02034 ATP-dependent RecD-like DNA helicase
MNNHFFDLIEHTNRSVFLTGKAGTGKTTFLNDFVKRTRKKHIVVAPTGIAAINAGGVTIH
SMFGLPLRTFLPTTERIDTSLANNIADLMPHFKYRKDKLKLLREVEIIIIDEVSMLRADV
LDMMDFSLRFIRRNNQRFGGVQMLFIGDLYQLPPVVRDEHILKMFYNSPFFFDSLAIKEI
PLITIELTKVYRQTDEEFLDILNAIRDGDIANIDFEHLNERYDPDFEIGNESYVYLCSHN
KMADEINVEKLAEIKVDAKTYEAKLFGEFKENQFPNEQFLELKIGAQIMFIRNDISGEKK
YFNGKLGEISALDENEIKVILDGSEREIVVKREVWEQKKYFLDTEKNIKEEVLGSFEQFP
IKLAWAVTIHKSQGLTFDKVIIDAGKSFTAGQVYVALSRCRTLEGIVLKSKITPEIIFKD
NRILHFHSDTVANDHVENILNKEKYDYSIRKVLRTLDCVWFLKEVEEWNKLSITTKSIDV
FKTNQLYQQLKPEIVNLGKIFEKLERVISQKVNNFIEQKEEWSEIESKTKGAVNFFFTEI
RDKVFNPLKEFYAEIKGSKGLKQYNEEFRVWLEDIEEYLNSLKEIHLLETKLLDEKNDKE
VSMKIAKVPSQVLTFQLFEQGKTISEIAMERGLVKETVIGHLAKFAEQGLLDISRVITTD
KIKAFEEIFYKDPKETLTEWKNVLPNDFEFNEIRILINHFNYQKEKSK
>KALACAFP_02035 hypothetical protein
MKKFYLLFISFILISCSFNEFYKDRESDKKDGEKIPQKFYWELRYGDNKEDIYKLFGEKF
FTVTDKGKLDELLEVTNKIGPVQEYNLVKWETMIVKGTNARSQYFYVYDVKRGSEKTEES
FTLEKDKDGNIQIVGYRVNQNFSNK
>KALACAFP_02036 hypothetical protein
MESKIMYIENKSSGHHGPAWIGFVEFSKSGQTVYFNNKALKKLKNPGIYGNHFDVETGEE
YWVSGVKKNGQDRHWCGGGKIMIDKNSIDEYLKLVDFNNLDEKYFTIIEFAETDKSRFNE
IENTEVEQRNESREASYWDNNRRKIILDNN
>KALACAFP_02037 hypothetical protein
MKNILLCFSVFFLLFSCNKNENFKKNLEKQKESEVQKNKNSKYHTKLDTLVIKTENDIIL
NFEKKKFNKIIDDHPEFFDEMVQSPDTFYTINSLGFGSEAGKDSYYILYAYFLKQRNSVE
KCSEQRKKLIKIYSNINSIFSALTYGGTYFAHQEPRILGYTEYSIYLHSLDNDASFKDPY
DISKQKKLYLQSLRQLVKDETKIDTESTEEQKIDRSKKIDLLVDELDHLITNIFYLRCAQ
HFHYEHY
>KALACAFP_02038 Limonene 1,2-monooxygenase
MKNFEISVLDLAPVKQDKTIHDTFQDSLSLANHTENLNYKRFWLAEHHNMESIASSATSV
LIGFIANGTKKIRVGSGGIMLPNHSSLVIAEQFGTLESLFPGRIDLGLGRAPGTDGLTAQ
ALGRNPAIINEQFPRQILELQKYFSKENRDALVRAIPGEGLDIPMYILGSSTDSAWLAAE
LGLPYAFAGHFAPEQMEMAFSIYREHFEPSKHLDKPYIIACVNGVAAETTEEAHRISTTL
FQAFINIVRNDRKPFAPPVDDMDDIWSPMEKSMVLQKLRYTFIGNQSEIEEKLKNFQEKF
NVDELMINSHIYDHQKRLESYEIIRKAKDSLFN
>KALACAFP_02039 Riboflavin biosynthesis protein RibBA
MSDIKLNTIPEAIEDLKNGKIIIVVDDEDRENEGDFLCAAELTTPEIINFMALHGRGLIC
MPLPEKRCDELGLEIMVSRSSDPKETAFTVSVDLLGNGTSTGISAADRAKTILALMDEKS
KPTDFMRPGHIFPLRAKKGGVLKRAGHTEAAIDLTSLAGLKEGGVICEIMNEDGTMSRLP
ELYAFAQKHDMKIVSIEDLIHYQLKKGNLIERIEERKVKTAYGEFDFFAFRETSNEQIHF
ALTKGTWTVDEPVLVRVQSSDSYFDVLTRLNNGEKPLLEKVTNMVNEAGKGAVIFINNVS
NSENTLRKLQQFLNYQEGQEQHPTLAYNYRDYGIGTQILKNLGINKFKVITQNPNIKPHV
GGYDVEVTEMVQL
>KALACAFP_02040 Methionyl-tRNA formyltransferase
MKSLKVVFLGTPEFAKTSLEAIHNSHHEVVGVVTVADKASGRGQKINQSPVKVFATENNI
PVFQPEKLRNPEFLEELKKLDADVFVVVAFRMMPKVLFEMPKLGTFNLHASLLPDYRGAA
PINYAVINGEEKTGATTFFINEKIDEGNILLQEELEILPDENAGSLHDRLMEMGSKLVVK
TLDGLAENSIVEKPQPHVEHPKNAYKIFKEDTRIDWTKSSKEVHQFILGMSPYPAAFTTL
RIGEEEKGLKVFGGKFEISNHGKTVGSLEISKNDFKIYTKDGVYYPLELQLEGKKRMNIK
DFLNGFRNFEEIKMA
>KALACAFP_02041 ATP-dependent DNA helicase RecQ
MISQQDFQELKFKTLKYFWGYDSFRDSQETIIDSVINEKDNLVLLPTGAGKSLCYQLPAL
LKEGTCLIISPLLALMKDQVNQLKSRGIEAEYLSSELDEYDAETIYGRCKEGLTKMLYIS
PERLTNKQFLQNIEEIQISFIAVDEAHCISEWGQDFRPSYQNIKDFRRNNPKIPCLALTA
TATPKVLEEIKIKLELKNPTVFQKSFKRENIRIFTEEVSDKFQRILDILKYTNEAGIVYV
RTRKEAELLTEFLHKHQLKHVDFFHAGLTTKEKNAKQTIWNNSNSNVLISTNAFGMGIDK
DNVRFVIHYSPSPSIENYYQEIGRSGRDGKDSFAFMLWDKQELSNFDQILKNQIPNKAEF
LKIITYLYSIFQVAEFELPEKVFQLNANGIQNFTKLSAAKIKNVLNFLHNQEIIFFNDHK
SLSSLQLLMQADEIDQLPQKDAYFLELMLRTVSGITTHKVMFSEQQVSNKIGVSLHLIKE
RLKELQQKGYVEYVDGALSSIKFLKPRDERVNNSLYWKLFEHIQKNKIQKWEEMKFYIED
NQFCKMKLILAYFGEKNSKNCGKCSVCEKNKQSIFGKNISNQIVNLLAKKPSTIEELSIQ
LSYHSKENILENLIFLLDSGKVKMLNFRTYMLA
>KALACAFP_02042 Outer membrane porin F
MKLSLAIVALALAVPTVGFAQDSTAVVSNGEYPNTFSSGSANVSPFTNKSKRFNDWAISI
GAGVPLIQSADLTSIKNGNGKNLFGYSAYISIDKAITHAFGINLQYDRGETRQGWFNTKD
AAPANASAYQQVAARTQYDAISLLGDINFSNLLRRVDNHSPYRWALHGYAGIGTIAYRAY
QKDETGQKMVTELKPFQLGSMFAQAGAGVKFKVNRRLDIEGRLMYVVTGDDEFDGGGYKY
SAINQREEQVSDNFFNATLGLSLKLGKHESHLMWHDPLQEIYYKLDVLANKNQDIEVCKK
GDLDNDGVCDDWDRQLDTPAGARVDGAGVALDTDLDGVIDLYDKCVTVPGPVENQGCPTT
PTPNNGNGPVVETETKLEGIEFDLNSDRILPSNTPILNNAVNYINSSSGSYNVIGATDTR
ASEAYNQKLSERRANNVKNYLIQNGVQSGKLNAIGRGEKDLKYPECEPATKCPEWKNRAN
RRVYFEAK
>KALACAFP_02043 Outer membrane porin F
MKLGLLLLATMPIAAYAQDSIAVSSTNEYPNTFSSGSANVQPFNNKARRFRDWSISVGGG
AAFMVHSDLKSITDKKVNWGYNSYVSLDKQITHAVGISLIYQRGETTQKGQLEGAEGIAA
GVAEAKTKYNQIALMGDVNFSNLMRRVDNHSPYRWALHGYAGLGLMNFNTSLHDNDQFRW
STSPARSPLFIKQKMDISSFYYQFGVGLKYNVSKLIDIEARTMYIISGDDEFDGGGWADP
ADYDPASKNAKYNMIDKRRSDNAWTVNLGVSFKLGKHLSHLAWHDPLEEAYYRANVLENK
ETDFVVCEKGDLDNDGVCDDWDRQLDTPAGARVDGAGVALDMDLDGVIDLYDKCVTVPGP
VENNGCPTTPVAPATPDAVEVINKDFEGIEFELNSDKIRPQSFEKLNHAADVIKGLNTND
NFLVIGATDARGSSAYNLTLSQKRANAVVKYLTDKGVSSGMLTAEGRGKTDLKYPECDPA
TKCPEWKNEANRRVYFQAK
>KALACAFP_02044 Bifunctional folate synthesis protein
MSQHKVILLLGSNLGEQKKNIETALEKLKEGGIEILKISEFLTSEPVEFASSNIFCNIAT
IIFTHLSPIQLLDFVKSIEFEMGRINDSKATGGYTDRVIDIDIVKYNDLKFISERLEIPH
KKHLFEREFSKVLLKNLSE
>KALACAFP_02045 Protease 4
MKSFFKNVLANIVAIVILCAVFFFFFIVMLVFSAMGNDKSVVVKKNSVLTINLKTNIIDS
PTEEEGGLFNFNDKNKSVLIYDAIEAIHKAKNDDNIKGISIEADDLNAGITQIDDLRNAI
DDFKKSGKFVYAYGNTVSQASYYLGSVADKYYLNPAGMIELKGLATEVAFFKDFADKYGI
GIQVIRHGKFKSAVEPFLRNDISPENKEQLSTLLNDIWKNTSSRMATSRKIDTAQFRTVV
DSLYGMIPELGLKYKLADKLIQKGEYDELIKSKLSLKQDDRLNKISLGKYIASYSDDEKS
GEKVAVLYASGSINGGDNYNDIHSERYIKYIKDLQENDKVKAVVFRINSPGGSANASDEI
LFELQQLKKKKPLIVSFGDYAASGGYYIAMAADKIYSEPNTLTGSIGVFGVIPYFKDIAN
KNGIRADIVATNANSQYYSSLNGVTPYGVSLITKSVEGTYKRFVHFVTQNRKQTFDQIDN
VGGGRVWSGTRAKQIGLVDELGTLNDAVKFAAQKAGLKSYEVASYPKRMTPFEQIFKDLN
EDDISARVIKNKIGKANYEIFQQVVEERKLQSEVKMEMPYQIKIN
>KALACAFP_02046 hypothetical protein
MGILTWILFGLIAGAIAKMIMPGNQGGGWLITIILGILGAFIGGAIGVYVLHWGDVDSFW
NFRSWILAIGGALILLWIYGMATKRSS
>KALACAFP_02047 Signal recognition particle receptor FtsY
MSWFKNIFKKEEKETLDKGLEKSSQGFFEKMTKAVVGKSKVDDEVLDDLEEVLIASDVGA
STTIKIIEKIEERVARDKYVSIGELDKILREEISNLLLENPHKGTGNIDTTKKPYVIMVV
GVNGVGKTTTIGKLAHQFKSEGKNVVLGAADTFRAAAVDQLVIWSQRVGVPIVKQEMGSD
PASVAFDTVQSAVAQNADVVIIDTAGRLHNKVNLMNELSKIKRVMQKVIPDAPHEILLVL
DGSTGQNAFEQAKQFTAATEVNALAVTKLDGTAKGGVVIGISDQFQIPVKYIGVGEKMQD
LQLFNGTEFVDSFFKKR
>KALACAFP_02048 hypothetical protein
MAKKVVATLQSGQSKKMTKVVKMVKSSKSGAYVFEEKVMNADEVDGYLKK
>KALACAFP_02049 50S ribosomal protein L33 1
MAKKGNRVQVILECTEHKESGMPGMSRYISTKNKKNTTERLELKKYNPVLKKVTVHKEIK
>KALACAFP_02050 50S ribosomal protein L28
MSRICQITGKRAMVGNNVSHANNKTKRRFEINLLEKKFYLPEQDKHVTLKVSAHGLRVIN
KIGIEEAIERATRNGLIKKN
>KALACAFP_02051 Apolipoprotein N-acyltransferase
MKYVLLTLISAMLLSISWPTYGVPFFIFFALVPLLMMEHGISKFSSYKRKSWVVFGLSYL
CFVIWNAVTTGWLYGSKNPDGSHSMMAVLFPVLVNSLLYSLVFQCYHWYKNAQGTYWGLG
FFIAIWMSFEKFHLGWELTWPWLNLGNVFSDYPKLIQWYDTLGATGGSFWILLINVLLFY
TVRTWEAGRKRKDLIKNSSIVAGLIIIPMIISLIKFNNFNEKPIGQVNVLMLQPDLDPYA
EKYSIDSLTIENDLLSLAERNSKGKIDYYIAPETALPGRGSISETAFEKSLILNNIKNFL
SKHPGSVFSTGISSHKFYTNKNNLPKEAYQLNQGLWVESFNTAVQIVPNQKVEVYHKGKL
VPGVEIFPYMSYLKPILGDAMLNLGGTVASLGTDKERVAFSNPFNKGKLAPIICYESIYG
EFTTDYVKKGANFLAIMTNDSWWGVTEGHKQLLSYAKLRAIETRREIARAANSGISAHIN
AKGEILEDTFYGDKTTLFAKVNLYDGMTFYARSGDLLSRFSIFALGFLLFYFLIKWFQRK
TKKA
>KALACAFP_02052 hypothetical protein
MLKKFYKIIIVPYTLFLLYLMFLGMGRFQYDDNLLTVEPIISTINFIKGAISWKDIVIIV
LGNIVMFVPFGFLGWVFPKLNDLKALLFSFISIIFIVEALQYFTRMGIFEIDDIILNTFG
VYLGFLLRKFVEKRLGNWAV
>KALACAFP_02053 Pyrroline-5-carboxylate reductase
MKIAIIGAGNMGLSFSKSFLKYELIKPENLHLITRNQAKFTKISEDFPKSKVSTFEEVKE
LDADLIILAVKPQDFQHVAENFQFTLKENQMVLSIMAGIKIEKIQKLLNHPLVVRAMPNS
PTLLGMGITGYTSAEGISFSQLINIERLLNSTGRSVYLENEELLDGVTALSGSGPAYFYY
IIDAMIKAGIEMGIDENLSKLFVKQTMLGAYHLINNSDKNLEELIQDVASKGGTTEAALK
TFNENNLKEILKNGILNAEKRAKELNG
>KALACAFP_02054 UDP-N-acetylenolpyruvoylglucosamine reductase
MHENFSLKPYNTFGVDAKARYFTEINNVEELKEALNFSVAQHLPLLFLGGGSNILLTKDF
EGLVIKLNLKGIHEDIINENEVLVTAKSGENWHEFVLFCLEKNYGGLENLSLIPGNVGTS
PMQNIGAYGTEIKDVFVNCTVLNLENLQLETFNLEQCQFGYRDSIFKQEGKGKYVILEVI
FKLTRKNHKIKTEYGAIQTELENLEIQNPTIQDVSKAVINIRQSKLPDPKQIGNAGSFFK
NPTIALSQFEDLKQKFENIQGYPNGDCVKVPAGWLIEQCGWKGKQIGNVASHKLQSLVIV
NATGNATGKEIFDFSTEIINSVKEKFGIELEREVNII
>KALACAFP_02055 hypothetical protein
MSAIKNKGLKFFVPVLLLLIFFSCNQATEKKTVTDPNEITFIGLSNIGGSLGSYRIIKIT
KDSIHAEKGIAARKIHQQWHAEIDDNAWKKLVSTIDIKTLNTIKSSPSAQSVDGIDETFQ
IRTPKKSHVYVNSHVDTVHYRQLQNLKDQIQKILPKEYK
>KALACAFP_02056 Aspartate aminotransferase
MPNISNRAQHMPPSPVRKLVPFALKAKQKGIKVYHLNIGQPDIETPETALNALKNIDLKV
LEYALSEGNLEYRKALTEYYHSLGFEDLTTDNFIVTNGGSEALNFAISTLCDDGDEVIIP
EPYYANYNGFTSTFNVHVVAVPSTIDTGFALPPIEEFEKKITKKTRAIVICNPGNPTGYL
YTREELQKLADIAVKHDIVIISDEVYREYVYDGKQQISMLAFPELAENCIIIDSESKRYS
MCGVRIGCMITRSKVIHDAAMLFAQARLSPVLLGQIAATAAHQNDGAYIRAVREEYTHRR
NVLVDLLNAIPGVICPKPKGAFYCVAELPVDDTEKFAQWLLETYSNHNETIMVAPAGGFY
SNPELGKKQVRIAYVLKEEDLRRSAAILKDALEKYKLEFNL
>KALACAFP_02057 hypothetical protein
MNLKLLFGAFNAVALLSASSIAGQNFQQMPISSGLTSDVIANGIGSSSVSTSTDVDGVSF
AFVSRDFQLTAASAPLTYGLPIDGTVNSVVAATPGLSYKLADYSSNNSLKLSNTNDSGTL
VFTTPKAAFKLYMLATSGSGASTVTVTVNFTDTTSQTFTGVAVSDWYNATGFAIQGFGRI
NRTNDTLESGSGINPRLYQIQLLIDAANQMKPIQSVTVTKTSTAQGYTNVFAFSADAYSD
CSAPTLQPVGTLTANSADVSWTVPAGTTAVNYDIYYSTTNAAPTGSTTPSIPGVTGTSTT
IPGLNPNTTYYYWVRTNCSSATSQSVWSFSGTFKTLCGNMTSMFENFDSYATGSIVPDCW
VRLAGTGSQTITSTSPASGTRNIYQNTPSSSTPTYAVLPTFSNVNAGTNQLRFKARVSSG
APGTMMVGYVTNTADASTFVTLQTLTITNTSYASNAEYIVPVPNTVPAGARLAIRSNNDG
KSYYWDDIYWEANTLATSEVDANKKKLMVHPNPFKDVLYVSDIEKVTSVTISDVSGRVLR
TIDNPSKEIDLSLLNSGLYLVNLRLKDGTQYTVKAIKK
>KALACAFP_02058 hypothetical protein
MIKKIFSKAFSAIIFFSAIALVAQQHLQTMPVQSGYTADVIANGLGSSMSSTTVSVDGTY
YNLVTNDFKLTPTSTPPSYGLPATGIINSAISPGLSFQLGNLSGNNSLRLQSNVPGAIDN
SGTLVFTNPVAAVKIYMLATSGQGTSYVTITVNFTDNTTQSFIQEIPFWNSTRTNYAIRG
IGRINRDTDVLQYYPQDPKLYETVHNISAANQTKPIKSITVTKGSNEGVANIFAFSADAY
TDCVEPVLQPAGMITSNSAQISWTVPAGTSAISHDIYYSTSSTPPTSTTVPNYSGVTGTS
YTLGSLLANTKYYYWVRTNCSGLMSQSQWSLSKNFTTLCGVMVLPYTYDFNSFGSTNIIT
CWTKNLSGGTPATGPTGTDYGWYKGIFLNDEQSSNSSAKFNMGSANKIAWLTTPLFDLST
GAYKVKFNYGIKGATSSLPVLMGGDDVVHFLLSNDSGNTWTILKTWDINNNPSNTSSEYF
YNFTTSASPTTKFAFYANTGTTNNPIDYGFFVDDFTVESIAQLGTSEVNNQSKKVIIYPN
PFKDILYLSDTEDLKKVTVADVSGRILKTIDNPEKELNLSELKAGVYLVTILFTDGSKST
VKAIKE
>KALACAFP_02059 hypothetical protein
MQIQAISIEDYISKIPEERQEIFRKIFDTINDNLPKGFRENISYGMVGWGVPLETYPAGY
HCTPGSPLPFIGLASQKNFIAFYHMGMYASPELLNWFVEEFPKHSKRKLDMGKSCVRFKK
MDDIPLELLAEVSKKMTVQDWINCYESNFKK
>KALACAFP_02060 hypothetical protein
MNQILKNNILLKFFALFLLFNLNVSCKNPAISDVKNGDLLFVTAKETGLSGAINNVTQKQ
KNASFDHIGILEKNRDGVFVLHAAPKGGSQKQNLKEFLKDQAGEGQKVIVYRLKPQYQNA
IPGALEKANSMLGKPYNFNYILNENSYYCSDFIERAFRKDAVFKLEPMTFIDPKTGKTNT
FWEEFYQKKNLKVPEGEPGCNPNGLAASDKLERIKELK
>KALACAFP_02061 hypothetical protein
MITPNPGLQVLQSKLNLPKRELILEIELNGKMKFEHLMNTIYNQFGICHRVLSANVEYMN
GRSFGSVQLYINVNSEDFEKLEFYLENNKLLSTTIEYVCRKYS
>KALACAFP_02062 UDP-N-acetylglucosamine 1-carboxyvinyltransferase
MSGTFQIRGGKRLHGEITPQGAKNEALQILCAVLLTDDEVRIKNIPDIHDVNRLIEILGD
FGVKVTKNGHGDYTFKSDKVNFDYIKSNEFKKDGAKLRGSIMLMGPMLARYGEAYMPTPG
GDKIGRRRLDTHFQGLVELGAEFHYDEEEFFYSLKAKELNGKFILLEEASVTGTANIVMA
AVLAKGKTRIYNAACEPYLQQLCKMLNRMGANISGIGSNLLTIEGVDYLHGTEHTMLPDM
VEIGSWIGLAAMTKSEITIKNVNWNQLGVIPNTFRKLGIQLEQSNDDIFIPAQENYRIQK
FIDGSILTISDAPWPGFTPDLLSIILVVATQAKGSLLVHQKMFESRLFFVDKLIDMGAQI
ILCDPHRATVIGLNQETPLRGTTMTSPDIRAGNALLIAALSAEGKSIIHNIEQIDRGYEN
IDGRLKAIGADIERI
>KALACAFP_02063 hypothetical protein
MPEYGRIIQQLVERCKELSTKEERNEMATAIIDFMGQRNPQLRDEENYNHKLWDHLFILA
NYDLDVDSPYPFPTREQLAEKPKRMEYPKLQGDFKFYGKSILQLIDKAIELEPGDEKEAL
IEVIANNMKKSYNVYNKEHVTDDVIFRHLKELSENRLDLTSIETLEKSKIYYTSNNNRNN
NNNKNTNKNQSNNKRRHNNNNHKNRNK
>KALACAFP_02064 Alpha-amylase
MKKTHFLLSFVALGLINSCQNHDEMVVESPKQLEVHNKTVNVTNHDGRPFSTGTSANAKF
VAGPGGSVLMQGFYWDVPDGGNWWNTVKGKITDWSNAGIGAVWLPPASKAQNGAYSMGYD
PTDYYDFGNYNQNGSTETRFGSRTELEALITKAHDENMQVYADIVINHNSGGQSEANPFT
GTNTWTNFTGVASGKFPRTYNNFYKNSFGNNDEGAFGGFPDLCHADPFVQSWLWGRDDSV
GKYYKNVMKFDGWRFDYVKGFGPWVINNWNSNVGGFSVGELWDSNVNTLEWWANNANSSV
FDFAAYYKMDEAFDNGNLNVLNDDMMWKRNPFKAVTFVANHDTDIIYNKMLAYAYILTHE
GYPTIFYRDYEEWLNKERLNNLIWIHNNKATGTTSILYTDNDEYIARRNGYNGNPGLVVY
INNSSSWQERWIQTNWTSQQIKDFTGHSSWYPTTQGDKWVKIQCPPNSYSVWSLNQ
>KALACAFP_02065 hypothetical protein
MEEKWENKHIVFFDGDCGVCNFWVQWILKRDKKDQFMFASLQSDFGQKFLSERGLNTKIF
NTMYLWKPKQYYLEKSKAVLQIANLLGGIYKLSWVGRIIPGFLSDKVYDMISRNRMKLAN
QKCYLPTPSERAKFIEV
>KALACAFP_02066 hypothetical protein
MKKVLTIILVAFIIIQFFPIDKTNPAPTPGMDFLKIKNTPPEIAKIITNSCYDCHSNETT
YPWYSNFAPASWYLKNHIDEGRKHLNFSTFATYEPKQQVDKLEECIEMIEKKEMPLESYF
VGHQDAKITDEQRKILINYFKKEKTETVRKMTL
>KALACAFP_02067 Catalase-peroxidase
MEKDLNDISKCPFHNGTMKKQSVAGGGTKNLDWWPDQLRVDILRQHSSLSNPMDEDFNYA
EAFKSLDLEAVKRDLHALMTDSQDWWPADFGHYGPLFIRMAWHSAGTYRVGDGRGGAGAG
QQRFAPLNSWPDNVNLDKARRLLWPIKQKYGKKISWADLLILTGNVALESMGFKTFGFAG
GREDVWEPDMDVYWGSEKTWLGGDLRYAHGSPGVVEDHAVLPSDDANGDIHSRNLERPLA
AVQMGLIYVNPEGPDGNPDPIAAAKDIRDTFGRMAMNDEETVALIAGGHTFGKTHGAGPA
DHVDKEPEGAGVELQGLGWNSSYKSGKGGDAISSGLEVTWTETPTQWSNYFFKNLFENEW
ELTKSPAGAHQWVAKNGEDIIPDAFDSSKKHKPTMLTTDLSLRLDPVYEKISRRFYENPD
AFADAFARAWYKLTHRDMGPKARYLGPDVPAEELIWQDPIPEVDHVLINNSDVEALKSKI
LNSGLSVSELVSTAWASASTFRGSDKRGGANGARIRLAPQRYWSVNNPTQLQKVLNVLEN
IQKEFNETQTGGKKVSLADLIVLSGSAAVEKAAKDAGHTLIVPFVPGRMDASQEQTDVES
MGYLEPAADGFRNYLKRKFSVSTESLLIDKAQLLNLTAPELTVLIGGMRALDTNFDGSKH
GIFTQNPGVLTNEFFINLLDMNTQWRSVSPDDELYEGTDRKTGEKKWTATRADLVFGSNS
ELRAIAEVYASSDANVKFVNDFVSAWVKVMNSDRFDLQ
>KALACAFP_02068 hypothetical protein
MLLKKQHTMTRKLFPALLLVGSFAYAQIGVNTDSPNATLEVTGNPTDTAKFDGIIAPRIS
GDLLKTKNYTSSQTNALIYVTAPDSAPSGQTLEVTSPGYYYFDGNPSVNRWIKVISSADR
KIRTISSGMVAADDYTLLVSGNIALPAASASNMGKVYNLINDTTGNVTISGTFRINGGNF
SNYGLNNSDMGRAIVVQSTGSAWVLISRY
>KALACAFP_02069 hypothetical protein
MKKPFILCSMIFFSLAYSQVGINNSSPNSSLDITARTPTGTANANVKDGIIVPRVDRARA
QAMGNNTSPAVTESTLIYVNNVSTGTPTGSAANISAIGYYYFDSNALPAPGLWQPLRPSN
FDMFATQLLIPPHNTWAADFSGHSVAGYDANSWWVISKSSSGGVAGTPARMTIVYEYQGT
PLNIANTYPELTVGNNIGTPDVYTANLIGMANNGTAGRTRLTVSVVRAESFSAWGGTYLL
NILLIKKL
>KALACAFP_02070 hypothetical protein
MKNRILLISLLFVFYNFNAQVGINTVSPTATLEITAKNSTGTSATTEGLLIPRVDRQRAQ
SMTAIPVSTLIYVNDFSSGTPTGNAVNIDNNGYYYYDGTVWMKLNTNIYNSNGTLTENRV
VTQNGNTLAFEGTSVNAFSVDGTTLSVDAASNRVGVGTNAPAQGLDIEGTARLSQSVAAN
TPIRLPGTTKPLYVNSTDGTVTHAPIGFTRVSGGFRPSIPFTIATLPVTNTIIRVRFVCH
VDQSDETNNSDTANYAYGDFTIVGTGTADPIRFRDVNIKNFDGTAKTLITNTPTTITWSN
GSTISGNPTITLNQTTGEFRMNAGTVALSYFFEMLGGS
>KALACAFP_02072 GTPase Der
MSNIVAIVGRPNVGKSTLFNRLLERREAIVDSTAGVTRDRHYGKSDWNGVDFTVIDTGGY
DVGTDDIFEEEIRKQVQLAVDEATSIIFMMNVEEGLTDTDYEIYRLLRRSNKPIYIVINK
VDSSKEELPATEFYQLGIDKYYTLSSATGSGTGDLLDDIVKDFPTTEYKDPFEGLPKITI
AGRPNVGKSTLTNALLDVERNIVTDVAGTTRDSIQTLYNKFGYEFVLVDTAGMRKKSKVS
EDLEFYSVMRSIRSIEFSDVVIIMVDATQGWESQDMNIFGLAQKNRKGIVILVNKWDLIE
DKQTNTMRDFEKQIKDKIGQFNDIPILFISALTKQRILKAVEVAMEVYEDRKKKIKTSKL
NEVMLPIFEQTPPPANKGKYIKIKYCVQLPTPSPQFVFFCNLPQYVKEPYKRFTENQLRK
EFGFTGVPIEVYFRQK
>KALACAFP_02073 Uracil phosphoribosyltransferase
MNTIVLSQQFSLVNSWINELRNVEIQNDRLRFRRNMERIGEIAAFEISKGLEQKEIEIQT
PLDLIRAKEIAVQPVITTILRAGVPLFQGILNYFDKADCGFVAAYRKHDANDYFSIKQDY
LTCPSIEGRPLIVADPMLATGASLIEALKDLLTNGKPTQLHIVAAIASKQGVETLEKAYP
NAKIWVGALDENLTSKGYITPGLGDAGDLSYGEKLQR
>KALACAFP_02074 2-(acetamidomethylene)succinate hydrolase
MKSLILLHGALGHNEIFEPLRTELSKYFTIHTPLFSGHGDVEIPENGITIEKYTQELKGF
IEKEKLQNVYIFGHSMGGYVALCYAEQHPSTVHSIMTLGTKFDWTEEQALKESKMLNPDV
IAEKVPKYAELLENQHGSKWKQLLPAIAEMMISLGKNPPLKDNLSTIDVPVQVMVGDKDN
MVTLEESIHVYRSLPNAKLAVLPDTKHPMDKVRPNVLLNAMKDFWNLS
>KALACAFP_02075 Amidophosphoribosyltransferase
MILDLFFPNRCLHCNRIIDAHLLVCNLCFEHIHFTHYTYFEDNFIKEKCKLLFPVENTYA
LMQFEKENVSRKIIHELKYKSREKVGKILADWTTERLDFQNEKPDLLVTVPLHSKKLKER
GYNQLHLFTETLSEFYKIPFDHELIKRNYYSQAQALKNKENRLETENTFSITKHISGKNI
LLIDDVFTTGNTLASIAWEILKAGDNKVSVLVMAIDV
>KALACAFP_02076 HTH-type transcriptional regulator RamB
MNSESDFIKTVFGLKLKQQRQKKNWSLQDLAVKTGLSKSYLNEIENGKKYPKHDKIIQLS
EALSCTFDDLVSTKLDKSLAPFNEILQSDFFKEIPLDLFGINKNNLISIISDAPKKVTAF
INALIEISQNYNLGKERFYFAVLRSFQELYDNYFPEIEEKVVQFARENQVEISKNLQPDV
LENILTGKFNYKIQSEDFQQYGTLDNLRSLFIPEKKLLLLNKKLEQDQKTFIFAKEIGFN
VLELKSRPNTYSWLDFGSFEEILNNFYASYFAGALLISKQKTLEKTSEFFLQHDWDPLNF
ENLIKYFTHSPETFYYRLTNILSSELGIKDLFYLCLVKKKNSDKIQILKELHLNHQQAPH
ANATNEHYCRRWIAVKNLHHLKENETLTDAQISHYKDQGISYLVISTSQKNPFSDGSNRS
YCLGILLNSQTIKKINFIKSSNLKTINVGVTCESCSISDCEVRQAPPIRLEKEYFNLSMK
NAIERIRKEF
>KALACAFP_02077 Malate synthase A
METKTQLKIKAQQQFEEIFSNDLVDFLIELHQNFNKKRIKLLEERKKTQQEFDKGILPKF
LSETEEIRNGNWVCSPLPDDLLDRRVEITGPVDRKMIINALNSGASTFMADFEDSNSPTW
KNCMEGQINLSDAINQQIDFTNEQGKSYELNEKTAVLLVRPRGLHLNEKHLEINGEETSA
SLIDFGIYFFRNAKQLLENGSGPYFYLPKLEHYKEARWWNEVFIFSQNYLGIPQGTIKAT
VLIETIAASFQIDEILFELKEHSSGLNCGRWDYIFSFIKKFRNLPEFIVPDRDQVTMTSP
FMSAYSKRVIEICHKRNVHAIGGMAAQIPIKNDYEANSIAFGKVRSDKEREVKNGHDGTW
VAHPALVSVAKDIFDQFMPSRNQIDKKFNYQITEKDLLEIPKGEITENGVRKNINVGILY
IESWLMGIGAAAIYNLMEDAATAEISRTQIWQWLKNEAVLSDDRTLTRKMVLQWEAEEME
RIEKYVGEERFKNGKFNLAKELFNELIFCENFEEFLTLKAYPFI
>KALACAFP_02078 Isocitrate lyase
MKTKQEQIREIEKDWLENPRWAGIKRPYTAEEVLKLRGSYKLDYTIAAEMAKKFWNKLHH
QDFVAGLGALTGNQAVQEVDAGLEAIYLSGWQVAADANLSGEMYPDQSLYPANSVPSVVK
KINNALLRADQIQSVNGGGEKEYLVPIIADAEAGFGGNLNAYELMKQMIEAGAAAVHFED
QLSSAKKCGHLGGKVLVPTQEAINKLISARLAADVLGVPTLIIARTDADAADLLTSDIDD
RDKKFITGERTSEGFYVVKNGVEQGIDRGLSYAPYADLIWMETSNPDLEQARKFAEGIHS
KYPEKMLAYNCSPSFNWAAKLSVDEMLNFREELAKMGYKFQFITLAGFHALNTAMFELAL
AYKEKGMAGYSELQEREFALQKQGFRAVKHQSFVGTGYFDEIQNIVTNGSSATVAMKDST
ETAQFH
>KALACAFP_02079 hypothetical protein
MSGFKLRDIYLGVNDGKKEALYKNDFENYFVEYNNNYNDILKPEKYLIIGRKGSGKTILA
EYVKKQAVKKNSWYCKIKSYKDFRFQELINFKTNDVSPNEYSAIWRWIILLDIAKLIFED
HTLNDKQGIKKLQDFFKENYNSLDIDDKKILEINKNNKINGSILTEIINISGEKGSEIKF
GDGNYLNYIEDLERVILKILKSSKSKYTLFYDELDDRFQNDEFYRNSLISLIKAVDSLNC
GFLEEKIDFKVVLLIRSDIFAVLNDTDLNKLKVINTLNITWGEKVSSDSPLLHLVVKKAK
KSNLYLNSLSDIRVLKTLFPQDVKKIAPERFILERTFFRPRDIITLLNLIIHKYPESRYF
GWKGLHEIKSSYSEYLFDEVRNEMIGHISQEEIDQGLKLLKNYNQHFFEYSDLRTYYEAN
KTLYSKIDLDKILIEFFKFNVIGNKWFNRFKQKEYYTWAHRDSRAEIDLNKEIVIHLGLR
EHLSM
>KALACAFP_02080 Long-chain acyl-CoA thioesterase FadM
MSLVYEKQIRVTEDHIDGNNHVNNVQYVHWVEEIAGEHWDFVKHRTEYPEDIWMLLDHHI
QYKKQVYLGDIIKIKTYPKAPEGIKQPRKVEFYCNDKLVVDSTTLWVLIDVKTQKIKRLE
SDWLDKL
>KALACAFP_02081 Thiol-disulfide oxidoreductase ResA
MKKIIILFSILFYCLLTAQERYFFIQPDLESKIGKHFPIENYKNQQGENFTSDDLKGKIT
FINFWSTTCEPCIKELPYLNKLKETLGTQVNFLAITHDSKEKVDKFLAKREFNFSHITDS
GQELKSYFPILRNPLTFIIDKNGNVKEITGIVDETKFDTIVKILNE
>KALACAFP_02082 hypothetical protein
MIRITKIFTFETAHVLYNYDGKCKNMHGHSYKLFVTVKGKPINDLENPKNGMVVDFGDIK
TIVKSEIVDVWDHAVLINALSPHKELGEDLEQKGHKVIYCTFQPTCENMLYAIAAKIKSR
LPEGISLAYLKLHETENSYGEWFAEDNQ
>KALACAFP_02083 UDP-2,3-diacylglucosamine hydrolase
MLKTIINLEPGKKVYFASDQHFGAPNPKESKVREERFIRWMDEIKHDAQVLFLMGDLFDF
WHEWKHVIPKGYVRVLGKIAELKDRGIHVYFFVGNHDLWMKDYLEEEIGCTVFYKKQYFE
IAGKQFLLAHGDGLGPGDKGYKRMKKLFTNPVAQWFFKWLHPDIAMKIALYLSQKNKMIS
GDEDKAFLGEDKEFLIIYSKEKLKTQKIDYFIYGHRHLPMVLDLEQKAKYINLGDWISYF
TYGVFETDFELKTFEKSTKKITS
>KALACAFP_02084 hypothetical protein
MENIFDILTEQDFLNASLKTFYHQYENVEIYRKFVDYLKINPKEVDSLTKIPFLPIEMFK
NHQILDKNVTTDLFFQSSGTTQMNLSKHFIADEKIYQESIYKSFKQFIGTPEDFIFLGLL
PSYLEKQNSSLIYMVDYLMKKSGKPENGYFLYNHADLFELLNTLQDKKVILFGVSFALLD
FLDFCSSNTQTLLSSNTLTVIETGGMKGRKEEMTKDELLKILQEGFKTEKIYSEYSMTEL
LSQAYSLGNNEYQCPNWMRIMVRNAEDPFNYEKEGRTGAINIIDLANIHSCSFIATQDLG
KITGDKFQVLGRIDHSDIRGCSLLVS
>KALACAFP_02085 hypothetical protein
MLKIEELVHAFIHSQCDFEKEIVLTNHFQADWEADLLIIDFEGFSHEIEIKLSKSDFKND
FKKSYTNIKTGEKFLKHDKIGCGDYVCNAFSFLLPMGMVEHGLIPEHCGIIEFYHNVDSW
ETEFYPIRKPKRVHEDSYWKLNDKDLFIRKMALNLLQRKMEIKGKHEELIFKNPFDIKKF
K
>KALACAFP_02086 Aquaporin Z 2
MIKKLFAEFFGTFWLVFGGCGSAIFAAGIPDSGIGILGVALAFGLTVLTMAYAVGHISGG
HFNPAVTFGLLAGGKFPAKDLIPYVVAQCIGAIAAAGCLYVILQGAGAFTAEGPGAFATN
FYEMAGYHGRSYSMAAAFLAEFLLTAFFLIIIMGATDKYANGKFAGIAIGFALTLIHLIS
IPITNTSVNPARSLSQAVFVGGNAMSQLWLFWVAPILGGVVGGLIYKFLLQRDSEVVD
>KALACAFP_02087 hypothetical protein
MGRVFCTILVSFTFNFHYSQAAKKVLPCHDLAEVLKVEPTALYKPHLDASKSFGVKLLKD
SKTVQKYISSGKFHKIKKTGKGYRVQKLDYSRAWMVSKGKLMLEKMGARFSKETKGHTFT
VSSITRTLEDQCRLRRVNSNASLGISSHNYGNSFDISYVRFNDVLKYNPKMEAALEKVLK
YYYNLGRIYYIKEKQQSCYHITVRNY
>KALACAFP_02088 hypothetical protein
MTTFNQEQYNLAVEGWMNSCGSYSTIQSLIPTNYVFNLSADQIDWVKERNKCNDFCVDMG
IYNDQVIIILSPLNSDGQKMPVDEYPYSELKELQQDLRLVETEEYTLVKNAVLSKDLRTI
DDDSDMYFPVSNKPIMEQDKAIEAIEMWRNEGMTWFYRECTEFQGARVFRKFYVPSENLS
PPKPGLTNIICSFGLKFSDVYQRVLPTLIFISFYADLENTGSIQTISNTYDWSQPCPPIC
NI
>KALACAFP_02089 hypothetical protein
MEDAFKVILYFNNGFLFISAIIGLLKFKRLKNIEKWYVYYIIFLFFIEAAIKISIYALKL
KNIDFLYPLYVSGELFLLGSLFIRKLNLSKYWYIPIFVLMGYFFFVNKVETNELKKVISN
IVVICFAGYSLLMEIRKSETNNDRFILVDAFIFLYYAVSVFIFFMLKQLKSFSNDEVYMI
WSMNNVLCSFLYVSIIYTFLKLKK
>KALACAFP_02090 Oxygen sensor histidine kinase NreB
MIIVSFILLAYRSFILRIIKEKNAQHEAEVLHQKRLVLENIKAQESERKRIAVMIHDDIG
NRLNILSLWLNNMDTKGDELIKKNISAQMGSLIDSARSISHSLYPVNLESVGLVLYIEEL
IANLSGRINISLNVSPKFQKKDIFIEVQLYRIIQEFTTNVLKHSEASRVWIYIKDNNDNL
AVVISDNGESFEYEEVKKGMGIKNIESRIKSMNAAHKWKNVLGKGSRLIIKIPYNNEFPN
QNSIN
>KALACAFP_02091 Transcriptional regulatory protein DegU
MNSQIKIALIDDEQLILEGVKMLLSSEQNISVVSTSNNGPGFLESLENTSPNDFPDIALV
DVQMQPMNGFELVEILKEKYPDLKIIILSSHYKTTILGYMVKLGVSAFLPKNSNRNAFIE
AITMVYKNGIFFTPEDHQMIFSYMNSPTKKRTLFEMDDELSDREKDVVKLICQEFTNNEI
AEKLFISPRTVESHRQRIVEKIGAKNTVGIVIYAIINNIHPLERI
>KALACAFP_02092 hypothetical protein
MKNNIISVGIFFDGTGNNGMNATSSEKPQKNNESYYSNTTNIYKLFKLFNGDEKIYIEGI
GTVTGAEDSDFAMATCKNPMGSEGYSSDDKLEKAFSFIKGKMYDQTKEYHFYVYGFSRGA
MLARNFCYEVLKPGSKISGTIKMKFLGVFDTVESAAFNDYNVTVLQATERALHLCAVNEC
RYFFPLTGFFEYSKDMEDTKSETGNSVWKEIFIPGAHADVGGGYLEGSQSVYVSPNFLRN
DHLRSYVENVKTTSRDAQGNKIWNSLLQHYKLDEGELFSQAYVARDWVYNELSKVYGKLM
LTETNAQETIFKTDFDESDFIINEEDHPYLIQLSSALEKYSKNLSPDLKPVYNYEKLADY
THISANFGLYHPAILQNSKSDANVEFINNGLNVPSNNNDQFSVNQSKLQSEIHHIEDSVV
DYAYGTNIPNNDNWNRTILIKENFYNKC
>KALACAFP_02093 hypothetical protein
MEYRDNEVYFDTASNNLVKGSFTVNEFSITDGQDPKGHIYVGFTASCGSDGKFIFSIGRK
GSSTVAKWFSERVPANRTTFNHDPGELNFAMIGTLVLEFNGGKICTFYNVALAQGHSGAS
NNWWFGGKQGMYNGSDTAIYGASSNGIVELASFLRGGNSVDHVKVTPKTF
>KALACAFP_02094 putative ABC transporter ATP-binding protein YheS
MLSVQSLGLHHSGNYLFQNVNFTIKKDDKIGLVGKNGAGKSTLLKMLSGEINFYEGNVVT
EGSVTIGFLKQDLDFVKGRTVWAETMQAFEQINAWKNELEDVNHQMATRTDYESDSYTDL
INKMTELNDLLMNHDAYNLEGDMEKVLFGLGFKADDFQKITDEFSGGWRMRIELAKLLLQ
KNDIMLLDEPTNHLDMESIIWLENFLKDYPGAIVLVSHDKQFMTAVCNRTFDINNKKVDD
YKANYSRYLVMREDRREKLIQAKKNQDAEIKQMEDNINKFRASATKASFAQSLIKKLDKI
ERIEVDNEDVSKFNIRFVQSQVPGKIIFEAENLGKAYGQKQIFDDVDFIVQRGDRIALLG
QNGQGKTTLAKILAGDIKDYSGSWNLGHNVNIGYFAQNQEEVLTPNKTVLEEAEDAATEE
TRPRVRDLLGSFLFQGEAVTKKTRVLSGGERNRLALCKLLLRPFNTLIMDEPTNHLDIQS
KEIIKLALQKFEGTLIVISHDREFLQGLCDKIYEFRDGKMKEFLGDINEYLEFRQKESIR
EISAERAKLHNEIPKVEEKKAEEKPAANNPQPATIVSKEQKNIQNKLKKVEEKISELETK
IEEFEASFAKENPSEETLEIYNKTKEELDLALQEWEYLGTQLD
>KALACAFP_02095 hypothetical protein
MILKESRNLKNFISKLLFGIYFLAMFSQSFHSHSSEEVFKNFSFKKSENTFTKNVVKEKA
GDCLACHFLATGHTLVPEEFSFSFENYTHEVKLIIAVQEKIWSQTKFTFQLRGPPAIS
>KALACAFP_02096 putative TonB-dependent receptor
MYFTESTQSIYLTMKLIYSLVLILCGLVFTNAQKTYTVEGTVQDFHDKTMLENAIVKIGD
FTTKTDGKGKFSFDKIPAGKYILIAKHPDCNDYTENIGVNQDLHVTITLEHHVQDIETVT
IHGSHKSNGSLIIKTLDKSEIERNSTDNLGNLLSKISGVATLKTGNNISKPIIHGLYGSR
ISILNNGVKLAEQEWGVEHAPNVDINNFQHIDVIKGASALKYGSDAIGGVVVMEPEIFPK
KDTIKGSVNLSGISNGRGLGIEADVAKVWKNGWAVKSGGSIKKLGDQHAPDYNLMNTGMD
FSSFNFTVQNNTYEKGISFDYYLTNQNIGIYRGSHVGNNEDFYNAITSNIPAYTGNFSYD
INNPRQVIEHHIAKVSAFKRFENIGKLSATYSYQYNHRQEYDIRRGDLADTPSLDLELMT
HQFNINDLLEREKWSLETGIDASFQNNYSDPATKARRLIPNYDKYSAGIYSVFKYKISHD
FNAEGGVRYDFNRYDVTKWYDKSDWENLYADSYPEFYVRTNQNRVLTRPKMNYENFSFNA
GLEYRPNANFDVKFNYAKVGRTPNIAELFSDGLHHSAAVIEIGDLGLKNEQGHQFNLTVD
TKFNVLKGLNISVNPYFFITKNFINEVPTGVQNTIRGVFPVWSYQQIDAKMYGIDLDVNW
KLTDNLTYVGKGSYVYGQDDTHSVPLILMMPPNFSNALQFNKENWNHFYLTLENQTFLRQ
DRFPVYNATIPVYVDGNEVEKTVDFSTPPSGYSLWNIQAGINISKNLSAGLIVNNLFDVS
YRDYLNRMRFFADEAGRNFIVNFRYRF
>KALACAFP_02097 hypothetical protein
MNKLFNTKNIFKLLAVLFIAITVVSCQRDGSAEEDDIPQEELTNVVLLVTEDTPGAITNS
YNYSIGAGGTQTIPLVDGKSYNVEVKFKNGNEDVTQEIIDAKDEHFLIFDFPKSNISITR
EDTSASTGALGKVGLLTKWNVVKVVNSSAPFLKLDLIHAPQSASPAQNGTAWGSVVGGET
DAEATFNLSN
>KALACAFP_02098 hypothetical protein
MKKIISGLLIVITIFSSAQVIVGDALGTASVKTSVLLDFAPNQNKGIILPYVRTLPTTPA
EGTLILDATDPTKARIKYYNGTWVDLSGQDADVTTALATQPTVAQMAEGAGEKVIMGAAS
STANGVLVLESTTKSMVLPIVEDVRNIPTPSPGMMVYVNKTGAKRLAVFNGSKWSYWMP
>KALACAFP_02099 hypothetical protein
MKISTRITRLPISKKSFGFPVVIFLFLSISQNILAQTRVIVNPGLEFGVANGTVQQTDTN
FGFGASFDAGLTVSSPWYTSHPAQAGSCTVGVVGACHPVEVWGTGFGGVPAAQGTNFVEL
NAYVSSMIYQNMYLANGDIINFNFRHRARLDTSERAAMVIEDQNQVNIATIRQTALPSST
AAWSTNSGTYTFTGTSGVYRVGFRAVNTTSPGAGNLLDDIRITLNPLIDLKFSNSLTACE
GLSDGTLFMRISGAVTTATTVAFELINPSNGTAFASDSDITVTGVANSNGTPVVTHTAGS
SMYLVTIPIGNYDGGVTPGYSSPTNDEDGIRMNIASVNDVVYEPNETFKFQIKQQGTNGS
TNNFVSTSSPVYGDTYYGTTNDYFIQRCVCYDDANTTTAGADSKVGISLLQKVSPNDGSW
PASRKSAHLVLESNNKGFVISRMTTAQVNAIVSPQEGMMVYDTMAKCLKLYDGTAWSCFS
TATCP
>KALACAFP_02100 Trigger factor
MKVTAKNHDDVSAILTVTLEKSDYKEKVEKQLINYAKNAQVPGFRKGKVPLSMVRKQYEA
GIAFEEINKQVSDALNNYVNENKLRLVGQPVPQPVNEFDYNADQLEVAFEVGYEPAFTID
LAKYEAPHYKVEASEKEINKSIENMQKRFAEQVPQDKITKDSYIALEVSQVVEEDAEGEH
HHHPKNVTITAENKEAFKLVKSLKMDGSVRVSKETLAGDEELAKELGFSKEEVEHLHHNE
VEVKVKDFYSLNLAELNQELFDKVYGEGNIKSEEELKEKVKSELDEYFQQNADVHFVNKV
LEQVSEKEEVKLPEEFLVKWLLFSNQNIQSADQAKEILEAEKNQLKYQIIEGKLMTDNEI
QLDYADVLGQAEQLVRNQLAIYGIHHLGDEEIQKYAVEMLKDQEQVRQISSEVAMTKLKD
VILEKASKKETKISHDEFLEELKK
>KALACAFP_02101 hypothetical protein
MRKFVIPFFCAVLFSTSVAAQQTTAAPTKTETVKSKLTPKEVVDSYLKALGGKEKLESIK
TTVMENTLTVPGLPAEVTMVTKKMGNKFKSEQSVMGQKMVQFFDGEKGYFDQMGQKHDIP
ADKIAELKKSKVIDALAYDPASYTSVTVEKIDGKDYNVLNSDKGKFYFDNATGLLYKSSG
SEGNATVKSYMTVDGIKFPAEIEAEGNGQKVTIKTTKVTINSGVTDADFK
>KALACAFP_02102 putative zinc protease
MKKMISSFAVIVLMSANVFAQNIPTDPSVKIGTLPNGMKYYIKKNTLPEKKVDFRLAINA
GSILEDENQRGLAHFMEHMNFNGTKNFPDNKLVDFLQSIGVKFGQHLNAYTSFDETVYML
PVPLDKPGNLDAGLKVMEDWAFNATLSDEQINKERGVVLEELRLGLGADKRMSDKYLPKL
LYKSQYADRLPIGKKEVLENFKPDVIRKFHQDWYRPDLMAIVVVGDINVDEVEKKIKDNF
SKYKNPSKPRERKVFDLPNHKETLVAVETDPDATSSMVQFIMKDAEAYQPDVTVEQYNQS
LIENLTSTMLNNRLRELVNSTNPPFTYGSVYHGGTYARSKEGFQGFAMVKEGNQLNALKV
LLEETERAKRFGFTQTELDRAKAQVLSNLERSYNNRDKTESEVLVDEYVRNFLEQEPMPG
IAWEYEDTKKFLPSVTLAQTNDIIKKFVKDDSRVVVITGPKKDNVTMPTEAMVLNTFEGV
KMADLKPYQEKETIKNLVKPFKSEGKIAKTETDAKLGTTTWTLSNGAKVTFKKTDFKDDE
IVFSARSMGGSSLINDADYNKTQFAFPALSEAGVNGYSKADLTNYLAGKQVSVNPAVTGI
FEGVSGKTNQKDLGTAMELMYAYFTGLNYNPDSFNAYKTKQSAMLDNLLANPQFYFSSEH
AKFMNQKNPRFIGIVPMEKDWANTDYKKAYDIYKEKFANAGNFHFYFVGNIDEARFKNEV
LQYIASLPSTGKSGSFKDTGYRQMTGDFTKTYKKGKDPKSMVTISYAGEAPYNEKEALAL
EALGEVATIKVIEKLREDESGIYGGGARGGMYKVPFNSYSFSINFPCGPENAEKLTKSAL
TELQKLIDKGPEQKDLDKYKEGEYNDHKTSLRDNMYWMNALTKNQMDGSDKYEILNYEDK
VKALTVKDLQDVGKKYLTKGRIVATLMPEDGWENAKKEEPKVEAAVIKAGAAN
>KALACAFP_02103 hypothetical protein
MIQIDDKLISEEIFSEEFVCNLTKCKGACCVEGDVGAPLDKDELEILDNIFDKIKPYLTQ
EGIKALEEQGTWTTDPVDGMYVTPMVENRECAYVTFDEKGITKCGIEKAYEDGAIDWQKP
ISCHLYPIRVTEYSSFTALNYHEWNVCSDACVLGKELQVPVYKFLKTPLIRKYGEEFYGV
LSDVAEEWKKEFGA
>KALACAFP_02104 hypothetical protein
MFKLLSKESNIFSIPVYIGFLLLIVIFFNILNFNTYEAIIAGITFLGIALGYFCFHSIAL
NYQTHLPLFLYTFFVFGLYPGNLDIGIAVSLLTNSFLLLLLTSTNEDIRKKSYVLVGAIV
ALNFIFLPTTWPMAVFVIIHVIATSERIVLNLFRFLLGIILIAFSYFSLMFFMNFTTWNI
NYFPFGKIKFVTDYTGLFPLIPIVVMLIYAVYDHFKNYNKKSPISRYKYTFLLVFSVAQL
VTIILYMNKSYEYLLLLAFPSTIIISRMLKFLPKYWMQEVSLWLIIFSLIGFKAGTYFDL
F
>KALACAFP_02105 hypothetical protein
MTSFFLFLSKVFKWSFGFFDAFGNVINWILFIVCCVLFTYWCYVLVVSLGGDKDKDYYSP
TEGKNPYYDPKIYKKEG
>KALACAFP_02106 Universal stress protein A 
MINIVLPVDFGDKTEQLVDGAVKFAKQVNGKIFLIHVAPSDIGFAIGDMGFQYFPEVEEN
EIREELIQLNKIEQRIVSHDIDCEHLLKQGIAKDIILEYANSKNADFIVMGSHGRSGIYD
VFVGSLTKGITKDSRIPVLVLPIHE
>KALACAFP_02107 Fumarylpyruvate hydrolase
MKIICIGRNYSEHAKELGNEVPENPVIFMKPDTAVLKGNDFYIPEFSNDVHYELEVVVKI
SKGGKYIQKETAHKHYEEIGLGIDFTARDLQGELKSKGLPWELAKGFDGSAVVGNFFKKE
NYNLESLNFSLLKNKEKVQDGNTKDMIFPIDDIIAFVSQYFTLRVGDLIFTGTPKGVGKV
EENDILEAYLEDEKILDIRIL
>KALACAFP_02108 hypothetical protein
MSELVKFKFYETALQANRDKQILAESGINSFIANEQLIQSDWLLSQAVGGIQLQVFEEDL
EKAKQTLQDYKDNEEFSLEVEHTVENPDFDFVCPKCGSNHIYRDDSATSFFGVSILTSHK
FVCYYCGNEFMH
>KALACAFP_02109 DNA polymerase III PolC-type
MNLKLHKPLCIFDLETTGTNIGKDRIVEICVLKVNPDASRESKTWKVNPEMPIPRESSEI
HGIYDEDVKDAPTFREIAPKIMEMLSGSDLGGFNSNRFDVPLLAEEFLRVGIDFDLSKFR
LVDAQTIFHKKEPRNLSAAYQFYCGKTLENAHSAEADVMATFEVLDAQVGKYDDIPNEIG
PLSEFTFHNKHADLAGFIGYNEKSEEVFNFGKYKGQCVKVVFQKDLGYFGWLQNAEFPLY
TKKVFTKIQLSSKF
>KALACAFP_02110 hypothetical protein
MFNFVIMNFIKNNLANAITLGNLFSGCVGAIHLILGDYQTTAICIILSLILDFFDGFVAR
ALKANSNLGVQLDSLADMVSFGLVPGLTMYAALEPFGNIFLGTGLPFEIKYLGLFVTLFS
CLRLAIFNLDEDQKYYFKGLNTPSNTILILGLYYAQKEGGAFTFLFENPLYLILITAVCS
WLLVSPIKMIAMKFKSMKLQDNYPKLALLIGAIIILIIFKTVGIPMVIIYYILISIIFQK
QFN
>KALACAFP_02111 Lipoteichoic acid synthase
MKFFKEFRKQEVIVLLYRIFLAYFFYQIARFLFWYFNKGLIKIDSVSDYFSLSYHGTAFD
TTAILYVNALFIFLSIIPIIINTKKGYQKFLFWLYFITNGIAYTMNFGDFVYFKFSQMRL
TSAALQVAQHEDNIFRVFTASMIQNPYVLLWFVVLMWLWVYLYKKVKITEQKPVKLVPYF
IWSVLTLCLVAVLAVGGIRGDFKHSTRPINLVDANRFAKLPAQGNVVLNSTFSFFRTLNT
NNFKEVHFVDEKFIDENIQPYKIYDRKIENKPNIVIFIVESFSREYSGAFNKDKNIKDYV
SYTPFIDSLASQSLIFPNTFANGRQSIHGMSSVLAGIPSLTDAFTSSPYSNQKIQSIVSV
CNEMGYDTSFYHGAPNGSMGFLGFGNILGFKHYFGKTEYNNDNDFDGMWAIWDEPFLQYF
AKNVGKKQPFMATVFTASSHHPFKIPEKYNGKFKKGKNQMHEPIQYTDYAIKKYFETAKK
QPWFNNTIFVFTGDHTNEVYYSEYEKIMNRFAVPLIFYSPNPEYHLKGVNNEFAQQIDIY
PTLADLIGYNKKIRSWGRSLVSEKQYPAIIANSDGTVEQFIIGNYIYRFDGKNVVGIFDK
TDLGLEKNLMDQLKNNPETEKGKQIAKAWYQDYMNRVINRKMY
>KALACAFP_02112 hypothetical protein
MRKLLLTLVLSLFSVMSFAQIEGKWKTIDDETKQAKSLVEIYKKSDGKYYGKISQLLIKP
ENANCVNCKDDRKNKPILGMEIIRGLKKDGNEFTGGTITDPKTGKTYKCTITRNGDNLNV
RGYIGLSLIGRTQIWQKAN
>KALACAFP_02113 2-oxoisovalerate dehydrogenase subunit beta
MAEYTFREVIAQAMSEEMRKDESIYLMGEEVAEYNGAYKASKGMLDEFGAKRVIDTPIAE
LGFAGISVGAAMNGNRPIVEFMTFNFSLVGIDQIINNAAKIRQMSGGQWNCPIVFRGPTA
SAGQLGATHSQAFESWYANCPGLKVIVPSNPYDAKGLLKTAIQDNDPVIFMESEQMYGDK
MEIPEEEYYIPIGKADIKKEGTDVTLVSFGKIMKLAIQAAEDLAKEGISVEVIDLRTVRP
LDYDTVLASVKKTNRLVVLEEAWPFGSVASEITYMVQQKAFDYLDAPIKRITTPDAPAPY
SAALFAEWFPKLEKVKEEIKKAMYVK
>KALACAFP_02114 Low affinity potassium transport system protein kup
MAEVTEGGHHFDIKKLSFIGVLVSLGIVFGDIGTSPLYVMKAIVNARGEGSTMPFNEYIE
GALSCIIWTLTLQTTIKYVIIALRADNKGEGGILALFSLVKNLKKGWLYLIAIVGAAALI
ADGVITPSLTVMSAIEGLEIYNPHTPVVPITIGILIVIFVVQQFGTSFIGKFFGPVMVVW
FLVLGGLGFSHLSENLEILRSFNPYYAYKLIVNSPSAIIILGAVFLCTTGAEALYSDLGH
CGAKNIRVSWGFVKIMLILNYLGQGAWLLTNYNKPGFSAINPFFGIMEEWMIVPGVIMAT
AAAIIASQALITGSFTIFSEAMSLNLWPNQKIDYPSGVKGQMYIPRINWGLLLFCIIVVL
HFKESGKMEAAYGLSITVTMLMTTILLVYWLLKHRVNKLLILVFALVYLAIELGFFSANI
IKFLEGGWITVVLGGFIGICMYAWYNGRSIKTKFIKFIKLENYIPIIKDMKLDETIPKYA
TNLAYLSRAKRNDEIESKIIYSIIKKQPKRADHYFILSITNQEDPYTFKYAVDEVLPGTI
YKINFMLGFKIDRRINDYFDMVLRDLMADGTIPSRSSHPSLRAHNIPPDLKYVIIDNTYI
NDILLTVKEKIILNIYNFVKYIGSDDFKAWGITSHNVVVESAPMTEDCVGKSKIEQCEFI
RHKS
>KALACAFP_02115 Ferric uptake regulation protein
MDTVQKEKNIALIKDVLRNYLLEKGFRNTPERYTILEEIYNMDHHFNVDDLYLLMMQKKY
HVSKATIYNTIEIFLDAGLIRKHQFGEKTLTSSSYEKSYFDKQHDHLVIYKKDSDKEIEE
IIEFCDPRIQGIKEAIEEAFGVKIDSHSLYFYGTKND
>KALACAFP_02116 LPS-assembly protein LptD
MRLIFVLLVFISTLTFAQDQPKPLQKDPYFTPSATPQKNAPPAEKVKHRHSDELRKDEKY
DGNPYFKGNVEFEHQGSVLTADEVIVYEGQNFVKAIGNVKLQNTDGSVITAEEMEYDGNT
QKGIARRNVVLTDPKQTIRTDIMYYDRLSNQAYFNTGGTITDGQSTMYTKSATYFLDTKL
IDFTGKVKIDSKDYIIEGDNIKQNQNTKVAEFFGPTTITNRANPKNRVYTERGTYKMNTK
EAYLNKNSKIFYNDKILTGDDMYYNQLTGFGKATGNVMLDDPKERRWIKGGYGEIFEKKD
SAMITKNPYAVKALEKDSMYFAAEKIISFQRPDSADIKVKKSFLRAFRKARMYKSNAQGR
ADSIAFNETDGIMHMFREPILWSDGKQVTGDKVEAYFDTQKESIDSLKVIGNAFAISKVD
SLNMKDEFNQVKGKLMTVYYGEDNNIKEAKVIGNAQAISYSDDVNGQTKEKERIGISLTS
CGIIDAIFEERALYVVECNIGATSDTYPMSKIEPARRKFPDFNWNTKDRIMKWQDILVDT
PNYPEIKYESDNTLYDKAQEAVEKEKAKEEAKKPKRVRR
>KALACAFP_02117 Acetylornithine aminotransferase
MEMQKDFFIYQAQTTKFAAGFEVDKAEGSYIYGKDGKKYLDFVAGVSANTLGHSHPKIVN
AIKEQAEKYLHVMVYGEYAQEKPVALCKLLAEATPDPLEITYLVNSGAEAIDGSLKLAKR
YTGREEIVSFKNSYHGNTHGALSVSGNETHKREFRPLLPMVSFIEFNNEKDFDKITEKTA
CVILETIQGAAGFLVPNEDYLIKLKRRCEEVGALLILDEIQPGFGRTGKLFSFEHYGIVP
DILVMGKGMGGGVPVGAFMSSKKIMETLAHSPKLGHITTFGGNPLIAASSYATLKEVLES
GLMNEVDEKEKLYRELLVHPKIKNINGKGLMLAVNLGSPEYTLDVAKRCMEKGLIVFWQL
YRNEYLRISPPLTISKDEIREGCQIILDVLNEN
>KALACAFP_02118 hypothetical protein
MAKHKVHYEFPMHCLSEILYEYLATAEGLSEWFADDVTEKGDDFFFSWGGGPAEKATLIR
YKPEGFVRFRWEEDEGTKNFFEMTITIDDITEDLALNITDFCEEGDENENAMYWENLIEN
LRIKLGAA
>KALACAFP_02119 hypothetical protein
MENQYFTSDELQVSNRAFLLGDAVKVSFFVRDAKLIIDEECYFFLMASMRKMRLNIPLTY
TLEFFQSLFQKDVIDGRGIKNGIINFQVFRNSDGITLSKSSVSYFYEVEIMEDVLKVNER
LLELDLIKEINVNNNLLSNIRVHSPENIYGTIYAQENDLDDVILLNPNKRIARATSGNLL
FLENSVIKVPKQTEGAYISPLMENFVTFLHKNNLADIQEHEIIAFESQKAEEILLISDEK
GIFSVGKIRNKTFGNDRFLELVESWKESF
>KALACAFP_02120 N-acetylmuramoyl-L-alanine amidase LytC
MKGTKLFALSIFSIAFLSFTPVDKKLIIIDAGHGGNDMGANRNGIYEKNIVLNIGKEIQK
FNQVQDKYEVILTRDNDTYSQLAERTDLINKLNPEMVISLHVNNSAKPESEQQGQEIYTQ
NTESSKKLAEKISKKFDVQKIEEKNLHILRESKAPTVLVELGFINNTKEREYMTSENGQK
EIAQKFLEVFNEY
>KALACAFP_02121 hypothetical protein
MNYSYKGKILISTPDISGDIFSRSVVLIIEHNEHGAFGLILNKKNSQMSSKFKDFFDFKI
EVYDGGPVENDKVFFIAKGKKVTEVYTEITDEFYLTEDIENIISAVLNKEISIEDVKIFS
GYSGWSPLQLDGEIQRKMWTVVEVYNLDYTLPNDQTLWKSIMQNLGGEFLLWANSPEDIS
LN
>KALACAFP_02122 Pyridoxine/pyridoxamine 5'-phosphate oxidase
MENLHDKRKVYEKSQLIESEIKQNPIEQFRNWFLEASENPAISEANAMAISTMENDGCPR
TRMVLLKAYTYEGFIFYTNYESRKGKAIEKNHKACLHFFWPNLERQIIIKADVERIAENL
SDGYFHSRPKGSQLGAAVSPQSQVIPNREFLEVKLKDLEKEYENSEVPRPENWGGYIAKP
YEIEFWQGRPNRLHDRIIYELVDGLDWKISRLAP
>KALACAFP_02123 DNA-binding protein HU-beta
MNKSELIDAIAKDAGITKVAAKAALESFIGNVTSTLKKKDGKVSLVGFGTFSVAERAARQ
GINPATKKPIKIAAKKVAKFKAGADLSNAVSGAKKK
>KALACAFP_02124 Aspartate 1-decarboxylase
MLIEVFKSKIHRVRVTASDLNYIGSITIDEDLIEAAGLVVGERVYIVNVNNGERFDTYVI
KGKRKSGEVCLNGPAARKVQKDDIIIIIAYAQMTPEEAKTFQPKIVFPDEKTNLLT
>KALACAFP_02125 hypothetical protein
MEKKSKSPLKSILTIVISLAFAGFFLWFALKGLDFKVIQKSLSKANYWWVLFAACFGISA
YWFRAIRWNLMLEPMGHNISNANSLWSISFGYLMNLTIPRSGEVARATALYGVEKVPVDQ
SFGTIILERVVDLVCMIAFLGLTLIFKYEAILSFYENSGINFNPNKVLIGLSILIVGVIL
FFVLRKRLANIPLLGKIINFIDGIFQGLTSIFKLKQKGKFILYTLGIWMSYYFAAYLVCF
ALPETSNFTFADGFLIIVVGTLGMMIPASGGIGAFNLAMKYGFMALFISMGKSAEQGGEI
GLTYSFISLPMQIVIMLVMGLISIPMLAKARNNIVAEKEIY
>KALACAFP_02126 General stress protein 16U
MAINLQKGQRIEIGFTKMTIGLGWDPNEGRGYDFDLDASAIMIDAGRKLVNEEYFVFYNN
LQSPDGALTHTGDDPSGKNSDGDDDEAIIVDLEKVDERVEEILFVVTIEDFERRKQNFGQ
VRNSYIRIIDNISNQEIAKYELDEDFSIETGVEFGRLYKRNGSWKFEASGTGYRADLAFF
LEKYYQGQIIK
>KALACAFP_02127 Stress response protein SCP2
MAINLQKGQTINLRKNELGNNVYDLSTVTIGLGWDVRRQGGFLGSLFGMNDGPDYDLDAV
AFLLDENGKVADLGKTFFSGNGREIVLYQSDVIYFNSMRHPSGKIWLTGDNRTGAGDGDD
EQIIVKLDQLDERYQKIVFVVSIYNGIVNRQHFGMIKNAFIRAVDARGKEITKFSLSGDA
SMNGMCSMIFAEAYRHNGDWKFRAIGEPYQTDNFIEVIVPFMYRK
>KALACAFP_02128 hypothetical protein
MSYIMVDIESDGPIPGDFSMICFGAVLVDDDLETTFYGKLKPISEKFNPDALAVSGFSRE
ETMAFDDPEEVMLKFEEWIKENSKGRPIFISDNNGFDWMFICWYFHHFIGRNPFGYSSRR
LSDLYCGMEKDTFAQWKHLRKTEHTHHPVDDAKGNAEVLLHMKKEMGLKISLK
>KALACAFP_02129 hypothetical protein
MAEELYFIKTNPVTAKINLYNKLCREEDSILQYMQDDKKTSLELIKKKVLDNVDSLSKEE
LLNLFEWFNAKYKTDPEEVKTQLFIHGIDLFYEIPQSSNIQSFQQILSDYEKYSKRNLNY
VFDAENFNRFLVYGILFTGLINKEKGKEHILSDFLKSDYKDLFSYAEDQFKSKNPETLSQ
EDMYNQFVDLYDSTKFYKGPIITLHDF
>KALACAFP_02130 hypothetical protein
MFNFFKKRKPAEKPANTNPVNINSISIPTFGWDIVEKNDGEIVWVNPEQSALISIYFFNI
PPDLPTIKDIDALRSFHRSVADSGGGIIEVSTFNLKGFPSVKTIFKFPQPEKGMSYLASV
TIPFENCSFVIKTQAVEVGTTGIRDAFVLNKFLESGEVTFDDNGLKNWFEDPYDPTFKEG
TRMNKSEKEEYDAEFPEHPLTKVRNMINQAIEEVVFRDELKDLPIFNK
>KALACAFP_02131 hypothetical protein
MLLAILLPFLSFMVRGKILTGIICLILQITLIGWLPAAIWAVLSLNNERADKRNDRLIRA
MKENKR
>KALACAFP_02132 hypothetical protein
MNNIPQRLQNIKKLQAKRFENEDHWDEINDLLIKELDEILLIEPENTSALIDMGAIYSDM
GENETAIEYLKTALRLGSEDKNLYINLAIVMVGLGMHAEEYHEYLEIAEDKKEDPLTFKA
YFDPQSH
>KALACAFP_02133 Oligopeptidase A
MNILTEKFNTPYHSAPFNLIKNEDYLPAFKELIQKSEEEIDAIVNNPASPTFENVIEALA
YSGEQLDTVSNIFFNLNSAETSDELQQIAQEVSPILTEYSSKISQNEALFNKIKKVYDEK
EKYNLNEEQQMLLNETYKGFVRSGALLNEADKEKLKKINMDLSLKSLQFGQNVLASTNNY
FKHITNKADLAGIPEAILEQYAEEAKERNLDGWVVTLQYPSYIPFMTYAENRELRKEIAL
ANGKRSFDGGEFDNQNLIKELLSLKHQKAELLGYKDYADYVLEERMAKSPAKVIDFLNEL
LVKAKPYADKEIEELKSLAKADGIDEMQAYDHAFYAEKLRKAKYDLNDEELKPYFPLNQV
QDAVFGLANTLFGLSFEERNDIPKYHEDVKVYEVFEAGNGKPEDGSNHPEKTFKALLYVD
YFPRKGKRAGAWMTSYKNQYTKDGENSRPHISIVCNFSKPTKDTPSLLTFQEVTTLFHEF
GHALHGMLANTQYPTLSGTSVKWDFVELPSQFLENFCYEPEFLKTFAKHYKTGEILPDEK
IEKIEQSKNFMEGYQTLRQLGFGLLDMNYHTKVGDVESKSVKEFEDEYTKATQLYPVNPE
TAMSPSFSHIFQGGYSAGYYSYKWAEVLDADAFQYFKENGIFNPEIAAKYKVLLSSGGTK
DPMELYKSFRGSEPKVESLLKRAFG
>KALACAFP_02134 hypothetical protein
MKTILKILGVIVLLILAYAVIAMLAFSKDYHFEKSIVINAPKEKVWQHVGSTKAFNEWNP
FAKADPNIQITYSGTPGTVGDSYHWKGNDQVGEGEQTVTAVVPNEKLSSDLHFIKPWEGM
AKGNFILTPEGSGTKVTWAMDNELTTMMKIMKPMMDSQMGKMFGQGLDELKKISEK
>KALACAFP_02135 Transcription elongation factor GreA
MEKIVFEKNHIRNYVKNVIAEKIDKLKNFIEFTLEASRDIKKTPKYDSMREEMQEEIYQM
QKQLAALNDLKINMAKVLNNTTEKVQLGSLVITNKARFYISVSLGEFFFEGDRFYAISPE
SPMAKKMMGMRSGDEFTLNKIHQKIVEVL
>KALACAFP_02136 Putative NAD(P)H nitroreductase YdjA
MNKAEVLKEIIEQRRSIFPKDYTGVEISQEIIDEILKSATFAPNHKRTKPWRFKIFKGEE
KAQLASEMQAIYKASQPEQLFLEKKYNDIGFKINKADAVVSIVVNFSGMVPEWEEIAAVS
MAVQNMYLTCTANGIGCYWSSPKIVEQLKESLTIEENQKCLGLFYMGNV
>KALACAFP_02137 30S ribosomal protein S16
MSVKIRLQRHGKKGKPFFHIVVADSRARRDGRFIEKLGTYNPITNPATIELNVDSAVKWL
NNGAQPTDTARAILSYKGALYKKHLQGGVAKGAFDEAEAEKRFNAWVDAKDAKVQGKVEG
LTKAQADAKKAALEAEAKVNEARIAAAAQAEADAKAAEEAANAPAEEATTEATEGEAPAA
ESTEENTEA
>KALACAFP_02138 Ribosome maturation factor RimM
MRKEDCYLLGKITRRHGLAGNVILKLDTDQPELYNKLESIFVEINGLLVPFFIAKSAWSK
TDALNIAFKNSTEALVDQSLGKNVYLPLSTLPKLSGKQFYYHEVIGFTIFDEENNNCGVI
QSVNDQTAQNYFVTSFGGKEIVIPIIKDWILEVNREEKSIKMQLPEGLIDVFLVPSKKDE
>KALACAFP_02139 hypothetical protein
MKPIILFALILISSLSFSQVKNIIEPEKIENSVQKNHLNKIIFLDKVIALENIKENDLLK
TMTFQEDKDFDIRVFMDNSLVNYLHQIDPILSADELLKKGNYQFNFFVDGKLIYTENLNP
GAGTADSKKIKTTFRIPFISTKNEDLWGRYLWMRFYLANSGIDALEPGNHLLKVEIKPYL
KTPDLKVGNKIADGEIQLIIPKKNISEQQIAIQKILPGSDWQVSKEKFNQEKIRLLNKKI
AENRFREITGIVVIKNEKLLLEEYFNHSGRDSLQDTRSVGKSFSSALMGIAIKDGYIKNE
NQALKEFYDLKQLGNYSSKKDQVTIKSLLTMSSGFNGNDDDYESPGNEENMYPTDNWIKF
ILDLPMTDNTIGKKWSYFTAGVVLTGDILDKSVPKGLKDYADQKLFQPLKISNYKWQFTP
QQKPSLAGGLRMSTLDFAKFGQLYKNNGTWNGKTILDKEWIKKTFTNYFTDTKDFDGYGY
LFWRKIYKVGNKNYEAYQSSGNGGNKIIIFTEIPVVMVITAKAYNKSYAHVQADKIVQEY
LLPAVYE
>KALACAFP_02140 Bifunctional transcriptional activator/DNA repair enzyme AdaA
MNTLRNGEFFGQTNKTLRFDGLTITDTEYTHAFVDWHYHENPYFTFLLQGNMKEGNKKEI
YDCSAGTLLYHHWEDAHYNIKPDIFTRGFHLEISEDWFEKYQILKSKTEGSLNIKNPALK
LLIYNIFKETKMNDHSFELQIHQLLLHLFSQLSDQKSNPEKKPNWVRQIDEILHENFTEK
LSLAELSKTLNIHPMHLSRDFQKHFHCNLGDYIRKLKIEKSLKLLNEYESLSELALECGF
SDQSHFIRCFKDNIGITPLKYRKILK
>KALACAFP_02141 hypothetical protein
MKKTLFTVILTVLSHVFYAQVGINTPNPQATLDVVGQEKNLRKVDGIIAPRLAGNQLKAK
DGLYGSSQIGAIVYATSPASPVSTKTQNVTAVGYYYFDGSVWVAFNTSKNINDATRYLGG
TVYVKFQQQSGGNLSNSKVIGGTENTNYNVGTVSQTSLKGGIDSVIGNGYTISNPRSGIF
DIKFDNPLTQIYGISVNIVDSYGYNDGNQSNIPAGTGSTATEPGMRLLTNDNAQVSYISN
SIIRVKTGNSNGGLDNRSFTFLVTGV
>KALACAFP_02142 Asparagine--tRNA ligase
MKKQTIKEILQDYKKVLHHDITVYGWVRTFRANRFIALNDGSTINNLQIVVDFENFDEEI
INKISTASSLKIVGEVVESQGAGQDVEILAKKITILGDNFTEERDKTILQPKKHTLETLR
EQAHLRFRTNLFGAVFRVRHAVSFAVHAFFNQNQFFYINTPVITGADAEGAGEMFGVTNF
DLNNIPRDEQGDIDFSQDFFGKKTNLTVSGQLEGETAAMGLGRIYTFGPTFRAENSNTTR
HLAEFWMIEPEVAFNNLEDNIDLAEDFLKYVIQYVLDNCKDDLDFLDKRFAEEQKTKAEK
ERAKEGLIEKLQNVVAKRFKRVSYTEAIEILLNSKENKKGKFQYPVEKWGTDLQSEHERY
LVEKHFESPVVLFDYPKEIKAFYMKLNDDNKTVAAMDVLFPGIGEIIGGSEREARLDVLK
QKMADMHVDEHELWWYLDTRKFGSVPHAGFGLGLERLVLFVTGMTNIRDVIPFPRTPKNA
EF
>KALACAFP_02143 hypothetical protein
MSTITIHTENENQINLLKALLKELKINFEINKDEKKLTEWQKEKILKGISDISEGKFSSS
ESVGDKARKCLE
>KALACAFP_02144 hypothetical protein
MFRIIWSHQAETDYIDTLKYWVAHNQSNTYSSKLIIEVEKKEKLIAQNPNIGTPSEIAGV
KYVLIDKNFSLYYRTNEDVVEVLAFWDNRRNPENLSL
>KALACAFP_02145 RNA polymerase sigma-54 factor
MLKQHLQLKLGQKLAPQQIQLMKLIQLHTLEFEEELERELEENPALEIVKEEPKEEDFSS
SLEDAYQDEGTESITTDFDVDQYLYDDEPSYKTASSNYSPDDEEFDNESLLTEGQSLYDY
LTEQIHLSSINPEDLKIAEYIIGNLDTDGYLRREIKSLVDDLAFSQGIYTTKEKVEDILE
NYVQKLDPPGVGARGLQECLLLQIEKKVSSDKSVSLAANILRHQFDALTNKHYNKIIQKY
DIEEEDLKDALEEISKLSPKVGGNFDTQTITINQEIIPDFVIQVKDGQVVPVLNSKNAPT
LRVSEEYKDILTTYSHDKTSSEHKQAALFIKQKLDAAKWYIDAINQRQNTLLQTITAIVK
FQKEYFITGDEKSLKPMILKDVADITGFDISTISRVVKSKYADTPNGIVYLKDLFSDSLT
NDDGEEVSTKEIKTHLQEVISKENKRKPLTDDALVIILKEQGYNIARRTIAKYREQLNIP
VARLRKEL
>KALACAFP_02146 3-[(3aS,4S,7aS)-7a-methyl-1,5-dioxo-octahydro-1H-inden-4-yl]propanoyl:CoA ligase
MHLSYVSGASDIPLLGETIGSNLKHTVEKFPHQEALVSVHQNYRATYQEFYNQTTAVAKA
LIFLGAKAGDRIGIWSTNRYEWVLLQYATARIGVILVNINPAYRTSELIFVINQSEMSHI
FSSQTFKSSDYKKMIADAREYCNTLKSEIFFDDNWEEFLNNGQEISDDTLHSFEEHVQFD
DPVNIQYTSGTTGFPKGVTLSHHNILNNGYFIGIRLHYSHKDRVCIPVPFYHCFGMVIGN
ICCTAHGCCMVIPNDSFDPDITLKVVSDEKCTSLYGVPTMFIAELAVKNFDSFDFSGLRT
GVMAGSVCPPEIMRKVENLMNIKEISICYGMTETSPVSTQTLIGTPFEKQVNTVGTVQDH
LEIKIINENGKIVERGEHGELCTRGYSVMLKYWNDPENTKKVLDDSRWMHTGDMAVMDDE
GYITISGRIKDLIIRGGENISPKEIEDFLYTYPNILDVQIIGVPSEKFGEEVMAWVKVRK
GFQITEEELSEYCKGRIAHYKIPKYWKFVDEFPMTISGKIRKVEMREVSIKELGLENVKE
>KALACAFP_02147 hypothetical protein
MPEFDLDSFKKTWQEQPVQQKYDNNEILQMLNRKSRNYVKYIFWISVAEFLFFSVLGLFY
FFQNDEANSFSKVLERLGAQKTPEVESSFDHAYFAIKILSLLITAYFVFKFYQNYRKIKI
EENLKGLITRIIKFKKTVNAFILISIVLLIAFTFVFTAFIFYALNSQNVQPTTSDLTIVI
SGIIVSMVLSILLIWLYYRLVYGIIIRKLDKNLKQLKEIDSQEI
>KALACAFP_02148 ECF RNA polymerase sigma factor SigG
MASKEKEFAQLIKDNQGLIIKVSRLYTNSLEDEEDLFQEIVLQLWRSYDSFKGNSKISTW
MYRVALNTAITLFRKKSKSLPTNELDINHADFIEDDDEKQQQVSLLYTVIKTLPNVERAI
VMMYLDDLPYKDIAENLGITEVNARVKMNRLKKTLKEQMEKYA
>KALACAFP_02149 hypothetical protein
MDTNFSDDFLVKGKFSIKKTSTQYEGKLTKEQGTQLLIQEKEKLRELQEKLYADGSKSLL
VVLQAMDAAGKDSLIEHVFGGVNPQGCNVTSFKTPSSKEYLHDFLWRHYVALPHKGMIGI
FNRSHYENVLVCKVHPEYNLSEKTWKSVKDFDNTFWENRYESIRNFEKHLSENGTTIVKI
FLNVSKAEQKQRLLDRIDEQEKNWKFSAADLPERALFDKYMECYETAINETSKAHAPWYV
LPADDKWFARVAAIQIIIDTLEKMNLAYPKLSNEDRTELQEAKKHLESE
>KALACAFP_02150 hypothetical protein
MKKLIAGIALFGTFALASAQTITFDQTTFDYGTIKPNSDGTRYFTVTNTGDKPLVVSNVK
ASCGCTTPEFKTDPIMPGKSAKIKVGYNTAINGGFNKMIEVFSNDPANSRTVIYIKGTVD
ANAPDPKPLTAEELKAKAKAEKKATKQAKKVAAAK
>KALACAFP_02151 Valine--tRNA ligase
MQISEKYNPQETEQKWYNYWLENKYFHSEPNDKPPYTVVIPPPNVTGILHMGHMLNNTIQ
DVLVRRARMQGFNACWIPGTDHASIATEAKVVAKLKSEGVNKSDITREEFLKHAWEWTDK
YGGTILEQLKKLGCSCDWDRTRFTMEPKLSQQVIKSFVDLYNKGLIYRGYRMVNWDPEAK
TNISDEEVIFKEQNGKLYFLKYKIEGSEEFLSVATTRPETIFGDTAVCINPNDERYAHLK
GKKVIVPIVDRIIPIIEDEYVDIEFGTGALKITPAHDVNDYEIGQKHHLQMIDALDDDGN
LNEYGLHYAGKNRFEVRKQIAKELEEKGLLLKAEDYVNKVGTSERTGAVIEPKVSVQWFL
KMSEIAKPALDVVMDDEVKFYPEKFKNTYKHWMENIRDWNISRQLWWGQQIPAYYYGDGE
NDFVVAENIEDALALAKEKTGNSNLEISNLKQDQDALDTWFSSWLWPMSVFDGLLDPENK
DINYYYPTSDLVTGPDIIFFWVARMIMGGLEYRKEVPFKNVYFTGIVRDKQRRKMSKSLG
NSPDPLELMDKYGADGVRVGILLSSAAGNDLLFDEDLMLQGRNFMSKIWSAFRLINMWNH
EDKPANATETQAIEWFENKLNKTIVEINDQFEKFRISDALHLIYKLIWDDFCSWYLEAIK
PNYGEGISKEVYHKTVQLFEELMKLLHPFMPFLTEELWQTISERSIEDALMIAQQKKAEA
FNEDIIKNFETASELISGVRNYRQTKGISPKEVVEIYTNASEFSNESVIKKLANVSAIHF
GTKTDKPSFTFLVGATEVSIPLSENLDLGEEKIKTEEELKYLKGFLISVDKKLSNEKFVA
NAKPEVVEVERKKQKDAQDKIAILEEKLKTL
>KALACAFP_02152 hypothetical protein
MTHIENIKKLFSKSFVENPLLESFEVGKIYLSSGKLVACDPLITNDMKPFSTEFPKGDFS
VLLHKERESNCVAYAEIVFSNAEISDWKMATTEGQDVKDLAEEEVFGYPVESGMGCFMDV
ETQNSLNELEQRLYHSKGVDFMGIYEEFFHDYFFDENGAIDQYAFLKPAEEKPGTIFGFE
TGYGEGFYASYIAFDKNNVPVKIITEFIEIS
>KALACAFP_02153 Ribokinase
MNFSSEQPKIIVVGSSSIDLVLETEKVPCPNETVIARNSESYFGGKGANQAVGAARLGAS
VYFIGCVGMDPLGQQIMRNMVGENVNVGFVFETDQEATGTAYVTTSDGNAAIVVVPAANN
YLSIEHVEAADKYFHTADLVLLQLEVSMKVIEYTIKKAKKYGKKVGLYASPAQRLYDDIL
DNIDFMIVKSSELHIVFGEDQREEILKKYFNKVFVRDDINSTVYFDGTEMKYCRNDKDKT
VYKMGMGDAFTSGFAVALCHGNPIEECVKFGNEVSARVSGKKGSQTGLPRISDFFS
>KALACAFP_02154 hypothetical protein
MDFFFYTMEKLRLITQDSVAVVGHLFLPEKSNQKLLLINSATGVKQQVYFSFAKYFAEQG
FTVITYDYRGIGLSKPEKMSGFQASMRIWGSEDYKAVTDYIKINFNDYQKYCLGHSVGAL
ILGMNEDSAMFDEFIFVGTQNAFVGNLKFRTQIEAYLGFGIAQPLTTGLLGYFPAHWFGL
GESLPKNCAYDWRTLILNKKSTNGLLEKINDYSKELTQKVFVIRAEDDIWLTEKGVKSLL
NDTYPNLKPTYRLIKTSESEKGEIGHVNFFRSYNKKLWNIILNELI
>KALACAFP_02155 hypothetical protein
MKNLIDNTVEFVKEKLEGAEAGHDWFHIERVWKLSKKIAETEECSQEVVELAALLHDIAD
PKFHNGDETIALKVSREFLESQNASEEVIEKVLFIIKNISFKNREEAPKDLPIELKIVQD
ADRIDAIGAIGIGRTFNFGGFKNNPMYDPNVEPKLNMSKEEYKKSNGTTINHFYEKLLLL
KDLMNTEKGKEIAGERHDFMLKFLDQFYKEWNVD
>KALACAFP_02156 hypothetical protein
MVFVILLIFWALFFSLILSKIKKGKGAEWAKLFRIITLVFSISFFTYWFIKKSAMGIVKD
SLALQVINKLPQPLDFYVINLNDPDANKAIETKHIGKIRPEYYRIEYLKMEKSNEYWIVG
YLGKKNLVYFTQHSVPNKNIDQIIEVQNYINQSVKLSDIAKKQVEAYNYENIKQGIWVTL
DFLLLFLNLVLLIRRK
>KALACAFP_02157 hypothetical protein
MLNSLKNNDMEKEICTISITTNWLGDEYTFYEDDRIKRVYDNNSLSSDVTEWLEPNQISK
QNKDKLVKNCPEEFKERIMLILDYP
>KALACAFP_02158 hypothetical protein
MKFGQVEDPSKIDFTLPKDHPRTKEILSQNKKGLENISIGCAKWNKTDLKGFYPKGTKDE
LTYYGTQFNSIELNATFYGMPTPEQVQTWKEKTPENFKFFPKITNTVSHFRRLLNIDDVV
TQFATAVLNFDEKLGMVFLQLHDNFKPKDYERLEKFVKNWPKEVPLAIELRNTEWFTDED
ILNTTCELFEAHNITNIIVDTAGRRDMLHMRLTTPNVFIRYVGANAESDYERLDDWLKHL
KQWKKEGLQNLYFFVHQNIEKASPLLSAYFIKKMNDEWKTDLLIPKMATENTGTLF
>KALACAFP_02159 Vitamin B12-dependent ribonucleoside-diphosphate reductase
MEEQGTNIWWLNEESEQMLNRGYLLKGETVEGAIDRITTAAAKRLYKPELQPAFKEMITK
GWISFSSPVWANMGTQRGLPISCFNVHIPDSIEGITHKMGEVIMQTKIGGGTSGYFGELR
NRGTAVTDNGKSSGAVSFMKLFDTAMDVVSQGGVRRGAFAAYLDIDHGDIEEFLSIKDIG
SPIQNLFTGICVPDYWMQDMIDGDMDKRKIWARVLESRQQKGLPYIFFTDNVNRNKPQVY
KDLGLPVNASNLCSEIMLPSSMEESFICCLSSMNLELYDEWKDTDAVKLAIYFLDAVLSE
FIDKTEGNYYLQGARNFAMRHRALGLGVLGYHSYLQKNMIPFESFEATQFNARAFRHIKE
QAEQASRELANIYGEPELLKGYGLRNTTTMAIAPTTSSSAILGQTSPGIEPFASNYYKAG
LAKGNFMRKNKYLARLLEEKGLDNEETWRTIMLNHGSVQHLKELTEEEKAVFKTFKEISP
MEIISQAAQRQQYIDQAQSLNLQIPSTMPVKDVNYLYIEAWKKGVKTLYYQRSSSVSKEM
MVNFVTCSSCEA
>KALACAFP_02160 Ribonucleoside-diphosphate reductase subunit beta
MGIFDKRVSYKPFEYPEVLQFVEAINKSFWVHSEVDFTADVQDFHSQLEPHEKHAVKNAL
LAIAQIEVSVKTFWGNLYNHMPKPELNGLGATFAECEFRHSEAYSRLLEVLGYNEEFTHV
IEIPAVKKRIDFLSNVLKHANSATPKEYVSSLLLFSILIENVSLFSQFAIILSFTRFKGY
MKNVSNIIAWTSVDEQIHANAGIYLINKIREEQPDLLTDSDIEDIYTLVDQSVELEGEIL
DWIFELGELSVFSKEDLLNFMKYRVDDSLKKINMNTKYNVSPEQYRPMVWFEEEVFANSM
DDFFAKRPVDYTKHDKSITANDLF
>KALACAFP_02161 putative ABC transporter ATP-binding protein YknY
MLVIQDLHKSYDTGKSKLHVLKGINLNISEGEFVSIMGSSGSGKSTLLNIIGILDEKDSG
TYELDGVPIEHLSEVKAAEYRSKFLGFIFQSFNLIGYKTALENVALPLYYQNVPRKERNQ
KAMEYLEKVGLAQWANHLPNELSGGQKQRVAIARALITNPKVVLADEPTGALDSKTTHDI
MKLLQDINNEGKTIIVVTHEPDVAAQTKRNVILKDGIIESDEFIKQVVL
>KALACAFP_02162 Macrolide export ATP-binding/permease protein MacB
MFDLDRWQEIFSSIRSNVLRTVLSGFTVALGLFIFIVLFGIGTGLQNAFTEGFARDAQNL
ISIVTGKTTIAYNGLQSDRQITMNNDDYDFLVNVDKEKVGSSTPRYTANLLVKYGKESGN
YQINGARPEEKIIENRKMLEGRYLTPTDLDRKQNVAVIGRMVQRDLIKNASPIGKELNIN
GTMFKVVGVFSDDGGDWDERHITVPITTLQQMKKGSDTVSINYIAYNDKLTPEEAIKYGD
ELKERLKSRKNVSPDDENGVRVWNNAQNMNDTFTFMAVLTAIVGFIGMGTLLAGIIGISN
IMVYIVKERTKEIGVRKAIGAKPRSIVALIVQESVVITVVSGFVGVGLGVLALNLIGDGL
EEYFIKNPSVGWGTIIMAFIALVFSGLIAGFVPAYRASKIKPIEALRTE
>KALACAFP_02163 Macrolide export ATP-binding/permease protein MacB
MNIIFKKDTWQEIYYSLRNNKLRTFLTMIGVGWGMFLYVSLLGAAKGMENGFDKLFSGFA
TNSIFLWAQNTSIPYEGFPKGRQMHLHLTDMDMLKRKISEIDYISPQNARGSFTGTPGEA
MSRNGKNGTYSLTGDFPVGNKISEKKLIFGRYINDADVSGNKNVAVIGEEIYKNFFDAKK
NENPLGKSINIKGIFFNVIGVFRVKKGGGFENDQTVFIPLSTYTKMYNAGDQIDMFAIVS
KPNANVNAVEENVKLELKSKNKVSPEDTNAFGSFNLGKEFKKLTGFLTGMQLLTIIVGTL
TILAGVIAISNILLITVKERTKEIGIRRALGAKPSEVRNQILLESVVITLSSGLLGFMFG
IFVLMILNMATQGQDAFPFYNPTVNYGNVFAALGVMVVLGLIIGMIPAQRAVKIRPIEAL
RTE
>KALACAFP_02164 Macrolide export protein MacA
MKKKFTWKKAIYIVLGLLFAVALFSGIGYLIKSNSKESEAFLTRKPTIQNMDDKVMATGK
IIPKEEIEIKPNIAGIIDKILVDEGDKVTAGQLIATVRIVPNLADVNSAQQNVDNQQLQI
NNAKLNVDNMRKQFEMQERLYKQGVASKQEYLNAQQQLYSTQQALRNAQQALVTAQKTLQ
IAKTGSTPELQSLATTQIRSKASGTVLEVPVKMGSQVIEANSFNAGTTICSIADLNSLIF
QGEIDEAQAGKLKQGMNMNIVIGALQNKTFPGRLTMIAPKGKDNNGTIKFPVEGDVYNPN
NEYIRAGFSANGEIVLNSQKNALLLDESLVQYEKKNGKDVPFVEVKQKDGKFKKEYIKLG
ASDGINVQILPGSPITKDSEIKVWNPSDKDKEELKEKSKK
>KALACAFP_02165 Ferric uptake regulation protein
MRLNRNNNFYICNMAKRNTITKQLILESLKSSKSAVSQEILQKELGETVDRATIYRVLNS
FCEDGIVHKILGDDGKYYFAICVNCSEKKHKHNHFHFRCLTCGKIECLPNEMEVKLPQGY
QSVNFNGFISGYCADCSN
>KALACAFP_02166 Alkyl hydroperoxide reductase subunit F
MKNYFTFATSNKQQATSNKKTMENKFDVIIIGGSYAGLSAGMSLGRSLRKVLIIDSGKPC
NRQTPHSHNFITHDGKTPKEISDLAKEQVEKYETVHFHNGIVIKTVKVSEDFQVETDNGE
NFFAKKLILASGVKDMMPDISGFSECWGISVIHCPYCHGYEVKGEPTGILSNGEMLFEFS
KLVYNLTKDLTLFTNGKADLSNEQIEILNKNKINLVEDEIEAIIHENGQMQKLILKTGNE
VALKALYAKIPFEQNINTEDLGLELTEHGFIKIDHFHKTNVDGVFACGDNVTMMRSVANA
VAQGNFTGAIINKELCDEEFS
>KALACAFP_02167 hypothetical protein
MEFYLLAIATMKEDGIDISHYFRNPAKAFGTEEEIARQFRNVREEIKNYCEKFIKENI
>KALACAFP_02168 Serine hydroxymethyltransferase
MDIIFDLIEKERQRQTHGIEMIASENFVSENVMKAMGSVLTNKYAEGYPGKRYYGGCEVV
DEVETLAINRAKELFGVDYVNVQPHSGSQANAAIYLAVLKPGDKIMGMDLSMGGHLTHGS
AVNFSGIQYEVVSYGVEKETGLIDYNQMREVALRERPKMMIAGFSAYSRDLDYAKFREIA
NEIGATLWADIAHPAGLVAKGLLNNPFEHCHVVTTTTHKTLRGPRGGMIMMGKDFENTYG
HKTPKGEIKMMSQVLDGAVFPGIQGGPLEHVIAGKAVAFGEALDTQFEVYAKQVQSNARA
LAKAMIERGFDIVSGGTDNHLMLVDLRNKNVNGKETEKALVLADITCNKNMVPFDDKSPF
TTSGIRLGTAAITTRGLKENDMDTIAGFISEVVDNIKNEEVIMSVRKKVNELMEGKALFN
Y
>KALACAFP_02169 Regulatory protein RecX
MEKKSYTFDEIKLKLVNYCVYQDRCHAEVEQKMREFLLIEEAKEEIMLYLLKENYLNEER
FTRSYIRGKFYIKHWGKNKIRMNLKQKQISEKLINKCFDEIDEADYEKTIRKIYEDYASK
QKGLKEYQKKSKTIKYLMSRGFEYEKINDIFD
>KALACAFP_02170 UDP-N-acetyl-alpha-D-glucosamine C6 dehydratase
MRRYESLRRKIFGGDNVVNLSDVRYLPRWIILVIDIIILVISLFLSSYIIEKISQKEFIY
HDDKSTVFAAIVLTNVVFMYIFKTYAGIIRHSTFIDLFKLLVSCFCTMFVIGTINIIYFW
ITGGKFILTPYLILYFIVSFMGLFLFRLYVKEFFHIVREYRRSTLKKRILVLGIDEQSIA
IARAILDNPSLPYHVVGFLTQRTDSKRASLLGKPIYAKEKIEKNTKEELVIDGVIIVKEM
MSKDEMNSWVNLFLEKDLSVFKAPSVQKLRDSDLGGSIRNLQIEDLLNRKPIKIESEEVT
SRYFNKNILVTGGAGSIGSEIVRQVAQFNPSLIVVLDQAETPLYDIELEMKEKFPHIRFK
FVLSDVSNKHRVEPLFQAYNFSMVYHAAAYKHVPLVEENPHEGILVNVLGSKIIATLSSK
YKVNRFVMVSTDKAVNPTNVMGASKRAAELFVQSLQNVEGNTTKFITTRFGNVLGSNGSV
IPHFKKQIEAGGPVTITHPEIVRYFMTIPEACELVLQAGTMGKGGEIFVFDMGEPVKILD
LANRMIKLSGFEPNIDIKIIYTGLRPGEKLYEELLSDDAKTLPTHNEKIMISKDPTMEFL
EIDSLVNMITRASLKKDKVEVVRILKIIVPEFRSNNSVYEVLDK
>KALACAFP_02171 hypothetical protein
MKSKVLVIISAFLLVSCKTNPSDLNYMQNIEKVAIDASAKNTNSTIQPGDQLVILITAKD
MDVVKPFNQNYSSSEVVQTNSIAGGNTPNQGMVSVSGPTYIVDANGDIDFPVVGKLSTSD
KTLVEFKNELRDRMTKYIINPTVNVRIVNFKVTVLGEVNRQGDYTIANGQGTILNALGLA
GDLTMYGKRDDILIIRTENGQVTHGKINLHDANLINSPYYNLKQGDAIIVASNKTRDLMA
KQNPNTGLYLTAASIAITAAAVIVSLIKK
>KALACAFP_02172 Tyrosine-protein kinase ptk
MDNQQSPQLPETNHNPNTIDLNETIKPYLRRWPWFILSAILTVIIGYIALKFMVPVYQVQ
TTVLIKDAKNSSSPVSNDLGVLPDLSSFGGMKTNSIANEIEILKSKKLMREVVVNQNLQT
SIIAKGRVSTVELYKETSPIEVKVISEKQSNVGSGGKIQLTIDGEKLILKSDKLPREIVS
AFNKTIGLPFANIIIIKNKDFNANIIKGLDYKNLELDISSIDSKVNSLQGLLNVSLINKD
ATVLNLALKYPQITKAQDILNSLVVVYNNEAILDKNSESNKTLNFIEDRIKKLSGELGDV
ENQKESFKSKNNLTDLETEAKIDLESSAAARAKQLEVDAQLELTNSLIGFVSNQGQYQVL
PANVGLNNPEATAGISTYNQLILQRNRLLESATPENPTVVDVSKQINSMRTSIMQSLQRN
RTGLELARNEYQGEQNKVAGKISKIPAIEKMFRSIERQQQIKENLYLLLLQKREETAIAQ
SITAPKARVIDKAYALGTPVSPKSNAILLAAFFLGLLIPFLIIYLKELLNNKIETKHDLE
KLIHAPVIAELPSLEKGDSEIVKVNDITPMAEAFRILITNMNFMLPKDKKGKVVFVTSTV
KGEGKTFTSVNLALTLANPKKRAIIIGSDIRNPQLQRYNPARKGLAGLTEYLYSDHTKLE
DVIHVSSFNPNLDVIYSGMIPPNPTELLSNGRYEVLIEELKTRYDYIILDTAPLLLVTDT
FLIAELADIIIYVSRSRYTEKALLEFANTNIDQKKIKNVGFVLNDVNRENLGYSNKYGYG
YNSHHEQTWFEKIKNKLS
>KALACAFP_02173 UDP-N-acetyl-D-glucosamine 6-dehydrogenase
MMKTYKIAVIGQGYVGLPLSLEFAGHYPVLGFDINAQRVDQLNEGHDITLEADIEKLNNG
LKKYNETNGSFGYKATSVLSDIAASNVYIVTVPTPIDKYNAPDLNPLLSASKMLGGIIKK
GDIVIYESTVFPGCTEEECVPVLEKFSGLKYNEDFFVGYSPERINPGDKVNTLTSVKKVT
SGSTEEIAEEVDNLYKKIITAGTHKASSLKVAEASKAIENAQRDVNISFVNELALIFDRI
GIDTNDVLEAAGTKYNFLKYKPGLVGGHCISVDPYYLAHKAEQLGYHPDVILSGRRVNDS
IAKFIASKVVKLLITKGGIIKDSQALILGVTFKENCPDVRNTKVVDIYAELKDYGVNVDI
YDPWASKEEVKHEYGIDILDTLIDGKKYDSVIIAVSHNEFLEMDLELLKKDNAVVFDTKA
CLDRNLVDARL
>KALACAFP_02174 L-2-hydroxyglutarate oxidase LhgO
MSYDIIIVGAGLVGLATAYQTKLKNPDSKILILEKENDVAIHQSGHNSGVIHSGIYYKPG
SLKAKNCIEGYHSVINFAEEYGIRYDLCGKIIVATSQEELPLLDNIYKRGIENGLQDLKY
LSREEFREIEPHCEGVRAIKVPQTGIIDYPGVAKKIKELFEELGGEVKFNNEVKNIINKG
SEIIVQTNVSEFKAKKLISCAGLYSDKITKMTNEENDVVIIPFRGEYYKIKDEKKHLVKH
LIYPVPDPNFPFLGVHFTRMIDGNIEAGPNAVLAFKKEGYQFFDFNFNETIQTLFWPGFR
RIVAKYGKTGLGEMHRSLSKSAFTKALQKLLPEIQESDLVTGGAGVRAQACNRDGALIDD
FDIVKNGNIIHVRNAPSPAATSCLSIGNKISELIEF
>KALACAFP_02175 UDP-2-acetamido-2-deoxy-3-oxo-D-glucuronate aminotransferase
MNVQMVDLKSQYEKIRDEINTGIQECIDNTAFINGPAVKEFQQDFEKYLNVKHVIPCANG
TDALQIAMMALDLKPGDEIVCPAFTYVATAEVIGLLGLKPIMVDVDEQTFDIELEGLEKY
LTPNTKAIVPVHLYGQGANMEKILEFAEKHNLFVIEDNAQAIGSDYTFTDGTVKKTGTIG
HIGCTSFFPSKNLGCYGDGGALMTNDDDLASKIRMIANHGQEKKYYHKVLGCNSRLDTIQ
AAILKVKLKNLDQYSAARNKMAAYYDENLKDIAEIQIPERAKNATHVFHQYTLKVKNGKR
DELQKYLAEKNIPSMVYYPLPLYKQEAFQQYVEENYSLPVTEKLCSEVISLPIHTEFNQE
VSDYIISEIKNFFN
>KALACAFP_02176 UDP-2-acetamido-3-amino-2,3-dideoxy-D-glucuronate N-acetyltransferase
MSDFFAHETAVIDEGCKIGAGTKIWHFSHIMPNCVLGEKCNIGQNVVVSPKVILGNNVKV
QNNVSIYEGVTCDDDVFLGPSMVFTNVINPRSAVNRKNEYLKTHVGKGASIGANATIVCG
HNIGKYAFIGAGAVVTKEVPDYALVVGNPARQMGWMSEFGHRLNFDAEGFAVCEESGEKY
KLENNKVSKI
>KALACAFP_02177 Putative 4,5-dihydroxyphthalate dehydrogenase
MSEKIKFAVIGCGHIGKRHAEMVSRNSECELVALIDVKDKSALGIENYDVPFFKSLDDFL
NSGIEVDVVNIASPNGFHFEQAYKVIDAGKHVVVEKPMALNKQHAEKLIFQALHKHKQVF
AVMQNRYSPPSVWIKEMVESGKLGEIYMVQLNCYWNRDNRYYKPESWHGKLELDGGTLFT
QFSHFIDIMYWLFGDITNIQAKFADFNHKDLTDFEDSGFVNFDFVDGGMGSLNYSTSVWN
QNLESSMTIIAENGAVKIGGQYMDKVEVCNIKDYIMPELPPTNPGNDYGAYKGSAANHHY
IIENVVDVLKGRNTITTNALEGLKVVDIIERIYELKKNDTYEL
>KALACAFP_02178 N-acetyl-alpha-D-glucosaminyl L-malate deacetylase 1
MSFKKVLVLAPHTDDGELGAGGFISKLVDEGAEVFYMAFSTAEESVPAGFPKDILKTEVK
AATKVLGIKEENVIIFNYQVRKLNYARQEILEELIRFKREHSDIDLVLIPSINDIHQDHS
TIANEGIRAFKTKSIFSYELIWNNLSFNTQSYVSLSEEHINRKIDALKEYKSQGFRDYLS
ADFIRSLAVARGVQFGVKYAETFEVVRFSIK
>KALACAFP_02179 UDP-3-O-acylglucosamine N-acyltransferase
MMVVLSEIINRLNPEKVIGNIDKEIINAIQLDPNNERDDVLMWVSAKFSEKLKEVKKGVI
ICNNFSEDLINSDCTYLIFENPRLAFQKALSEFFMPKKKTGISKTAIIGENVSIGKNVYI
GEYTIIEDNCTIGDHTVIDHHTAIKKDTIIGENVIIGANNTIGGVGFGYEKDETGQFVFI
PHIGNVIIGNNVEIGNNTCIDRAVLGSTILMENVKVDNLVHIAHGVKVGKNSLVIANAMV
AGSVEIGENTWVAPSSSILNQKKVGNDVTIGLSAVVVKDVENGQTVIGSPAEEISVALNK
KKIMNEKLFK
>KALACAFP_02180 hypothetical protein
MGFKDIINRVKSNLFLQNVAILSSGTIISQLIVIATSPFLSRLYSVEAFGLLSVFSSFAI
FFAVLSTGRYELALGLPKENIKASNIFKLILCIGFTVSLLYFVLIFVLKDLIHLQDNTGF
LNNKQVYLAPVYIFFGALYSALGYWNQRDKKYTKITLANAIQVIGTSVFSLFFGVINYEG
GLILSLILGIIISSLYLLLTDKELLSHLSSFDNKMLKVGKEYKAFPRYMILSDLSLTACQ
QFIPILFSALYNTTIVGFFSMANRMIRLPNIVITSSVGNVFRNDAIDEIRETGNCIHLYQ
STLKKLLIISFPIYLLVFAVSPKLFSLVFGEKWEIAGYFARILSVALFFEFLSAPLNTLF
YVFEKQKILMRLQIINALFVFISIFLGYYLDKSYYLSLILYTVVSVLSSLIFLYFTNNLS
KNASRKA
>KALACAFP_02181 hypothetical protein
MQVEKPNSLQVFFLTLMLYGYELISFFPDLLGIESRPVSIALRVVVLVSGIFVVLKNRMQ
LTKIHYLLFFFWFLYLLRLFYDTALTTKNILAPINDYWSFSVLIIVSMFACTTQFSEKTL
LTVKNYILVILFIVNIWGLYNNITAPQIVPDDILIRADGNSSLNTVSFGKTSTILFFICF
ISLLKYKKNLLSIVFIIGMLLGLYNIFVAGSRGPLIQLIVIISLYTFVHIRQVRLKYVLL
AFIVGIVLLNLFPSYFEASKLVFQRIGETGFTANENDQFRAMLLKSAWNQFLDHPFFGDA
IETSMGNAYPHNIILESFMAMGIVGGLLSIVIFIVNIIIGTKVLKVFAYSFLGGILLMDT
VGSISAGSIVNYLLIWPVLSLSINLSKTNGKK
>KALACAFP_02182 hypothetical protein
MEKNRKKIVMLQDFFGLGYTYQENLLTENYRRLGHEVVVITSTFENVFDYTHEKYDPSKK
KKIEDYHGAKIIRLPYSLNFLNKLRKHSGVYEILAEEKPDLIFAHDIHLNLKEAVEYQKK
FPECKIIMDYHADYTNSAKNWISLNILHKLIRKPFFNRYKKYLHKIYSIVPGSTTFLNEV
YDVPYDSIELLPLGCDYAKCNEVRQNTNISEIRNQFGIKKEDIVIITGGKINQLKRIHLA
VDAVKRLNLKNVHLIVFGKGDVNDEVYYEQMKKNAEGYNVHFTGWIDSHTTYELMAASDI
ALFPCSQSVLWQQSIGMHLPLIAGDFGGQDMSYLNRNNNLIKIDAQDINEEYFSKILLEL
IQTPEKIDLMKKGAEKTAKEFLDYEIIARRTLED
>KALACAFP_02183 GDP-mannose-dependent alpha-(1-6)-phosphatidylinositol monomannoside mannosyltransferase
MIKIFQISSEVNSGSVGRIAEHIGEKIIDNGWESYIAYGRDHNPSKSNVIPIGNKISLIS
HGLKTRLTDRHGFGSVAATKKLIKTIKEINPDLIQLQHLHGYFVNIEILFNFLSEFKKPI
VWTFHDCWSFTGHCAYYEFVDCHKWKTECFKCPQTHDYPQSYIDQSTRNFRDKKRIFNSV
ENLTIVPVSNWIGDQVKESFLKNFRVHTIHNGIDIEKFAPQNAESIKEKYNLKNKFIILG
VASPWSERKGLKYFVELSKNISDDYQIILIGLNDEQIKKLPSNIIGVKRTENIKELAEFY
SVADVFVNPTLEDTFPTTNLEAQSCGTPVITFKTGGAPEAIDENTGIVVEKGNVQGLLDA
IQEIKKNGKQFYTKECRKRAELKFNKNDRFQEYLDLYCDILKLN
>KALACAFP_02184 hypothetical protein
MITKLFTVLSTVLLLTCAGNEKKQNFVSPEIGGIQNPPQILICSDNKSKTFTDFINREKI
QFVQFVNDGQFIDKKVPFTFSKDLLIKELERAYPDPNASGIAYIDIEVPYIDYLKEDVTT
DNYKRSVKLFLDVLDFVKKQRPNVKWGYYGIPYTTYWGRDKKFYDQYKKLDPIIRKSDIL
FPSIYIFYNHVSFSMENEDYIEENAEEMIRIASIYNKKVYPFVMSRYHPSNASIGNQKIN
DSDFRTYITAISNAKYNNKHVDGIVLWNADGYSYRTSEPVLKKELEKNKITNFDTFYDQY
IIGLLSLMKKEVEK
>KALACAFP_02185 hypothetical protein
MEETRPYQICTKTIMDTTDPNIVFNEKGESDYYINYIENILPTWHTDERGLKELEQEAEK
IKKDGKNRDFDCIIGLSGGLDSSYAAYVAKEVMGLRPLIFHVDAGWNTDRAVSNIEKLVN
GLNLDLYTEVINWEEMKDLQVAFLKSQIADQDMPQDIAFFSGLYKFAKKNKIKYVLTGGN
YSTECCREPEEWGAYPGIDKTLILDIHKKFGKRELKTFPIVDIMSYKLYYKYVLGMQVYK
PLNSLPYIKKDVEKMLFDKYGWESFQHKHHESRFTRFFEDYWMPKKFGYQKRKAHFSSLI
LTGQMTREEALDRVSRPELSEEFLQKEFEYVANKLDLTVDELQKLFEGENKTYHDYKNKR
SLIGIGAQAMRKFGLEKRLFR
>KALACAFP_02186 Imidazole glycerol phosphate synthase subunit HisH
MITIIDYGVGNINAFVNVYKRVDVPVKIAKTKDDLEDAQKLILPGVGHFDHAMTQLNNSG
MRDKLDELVLDKKVPVIGICVGMQMMANNSDEGKLDGLKWIDATVKKFDETKINQVTRLP
HMGWNDVKPVKDIELFRGLEKDSIFYFLHTYYFHCNNNEDIMAVTEYGGEFASAAHHENK
YGIQFHPEKSHHYGEILLHNFAKL
>KALACAFP_02187 Imidazole glycerol phosphate synthase subunit HisF
MLRPRIIPSLLIQDNGLVKTVNFKNPKYVGDPINAVRIFNEKEVDELAIFDIDATVKGLE
PNYSLIERIANQSRMPLCYGGGVKTVEQAQKIFGLGIEKIALSSAVLQNPQLITQIADRV
GSQSVIVVLDVKKKLFGGYEVYTHNGKKATGINPFKFVEDAQKLGAGEIIINSIDQDGVM
KGYDLSLIDKVREKISLPLTVLGGAGSLNDIKQVIDKHGIIGVAAGSLFVFKGVYKAVLI
NYPSFEEKEGLRQK
>KALACAFP_02188 Asparagine synthetase [glutamine-hydrolyzing] 1
MCGIAGLIYKDKTPVKEGTLRKMTDKMSHRGPDAEGFFVHENLGFGHRRLSIIDMSESAN
QPFHFNDKHVLVFNGVIYNYIELKEELKEKGYSFNTTSDTEVLVASYDCWGEECVKKFNG
MWAFAIFDSKNNKVFCSRDRFGIKPFYYFSNENKFIFASEIKPILEIEKVEKVNIQILLQ
YLIVNLTGHFNETFFEGILKLPASHNLIYDLKTNEFRIYKYYDIEFKKEINKLNLEESIE
IFEKKFEESIKIRLRSDVKIGSALSGGLDSPYVTTIANKIIDKQNNCGFTAITVGSLDER
DDESKLAKLIAETIHVNHDIVTPKSDEFRHDLENVIFMHEEPFADLSVFMQNFLMKEANK
LGVKVFLDGQGADEILLGYSRYTAAFLRNHDFISNLKFLKKVKSHYDISILEAGKIYFYF
SSYFVRKFRLQRRGAILKNKYLGIINFSKLKKLTKSYKKIFELQKNEIFHFLLPDILRIE
DKNSMLFSIESRLPFLDYTFVETVLSINNNYKIRDGWSKYILRRNLEKFLPDEVTYNSRK
IGLNPPVNHWWPRSQKILETINNSKIIQEISKKKYTFIADRDLEWRLYNIAVWEKLYNMK
L
>KALACAFP_02189 UDP-glucose 4-epimerase
MQIKDKTLLITGGTGSFGTAVLRKFINTDHFKEIRIFSRDEKKQDDMRNQFKNDKLKFYI
GDVRDYKSIEPAMRRVDYVFHAAALKQVPSCEFFPMQAVKTNVEGTQNVIDAAAINKVKK
VICLSTDKAAYPINAMGISKAMMEKVAVAASRNLDETVVCLTRYGNVMASRGSVIPLFVK
QIKNGDPITITDPNMTRFLMSLEEAVDLVLFAFEHGNPGDLFVNKAPAGTIGDLAQALKE
MFKADNPIKIIGTRHGEKLYETLCTREEMIKAEDMGDFYRIPADNRDLNYAQYFSEGTED
ISKIEDYHSHNTHQQDVEGMKQLLMKLPLIRKEVLGEDLMQYPD
>KALACAFP_02190 hypothetical protein
METPQIIKGGKYSDDRGNLFFNNNFNASQIKRIYYIENADTKFVRGWTGHKIEQRWLSAS
QGSFTIRLIKIDHWEKPSENLPILKFELNSGQLDVLHIPKGYVSAIQSREEKSRLLVMAD
YFLGEIADDYRFPIDYFENFK
>KALACAFP_02191 UDP-2-acetamido-2,6-beta-L-arabino-hexul-4-ose reductase
MKKIGITGQNGFVGSHLYNTLGLYPEKFETIHFDRDFFENEEKLDEFVGKCDVIVHLAAM
NRHPDPEVIYNNNLDLVKKLVSSLEKTNSKAHVLFSSSAQEEKDNLYGKSKKEGRELLAE
WAEKSGGKFTGMVIPNVFGPFGKPNYNSFIATFCHKLTHGETPVIDNDGEVKLIYVGELV
QEIINQIERGETKKLYEVQSTSTNKVSEVLQKLENYKQLYFDNGEIPVLETQFDFNLFNT
FRCYFDIKNHYPVKFTQHTDPRGAFVEVIRLGIGGQCSFSTTVPGITRGNHYHTRKIERF
AVIKGKALIQLRKIDTDEVLDFYLDGNEPAYVDMPIWYTHNIKNIGEEELYTIFWINEPF
NPEDADTYFLEV
>KALACAFP_02192 hypothetical protein
MYFLIMALFGYILAYIDPYYSKGFPHYINFFIRGGIFLLSIYFIVKNFHIVQKRKTVIIV
FALFFSFYLFKLYKTIPSFTVPPDVFTGLKNSIYYYGFMVIPLPVIAILSLNYQEIDFKK
FFRIIFFGLLIIFGINFLYTNFVFESYRSNGRSGIFRSYYILVGHYGLSLVIMSLYGYLF
LKAKGYFYALGILLGSFAIFVSAARSPVLALFVILFVFLIAINNRKYWLCFLGAVVLAFV
GLFVIYRTGIGENSIFFERLNGAIFERNASGRSSFFSRGIEIFLNHPLFGGNALFEDGMY
SHNIFVDILMSTGVFGMALFIIYFKFVVQSFIKILKHIYKYKESGVVIFFFLQYFILAQT
SGNLYLSFEFWYFGAAVIGLGYINFTNEEIKSNDSRGNTAGDY
>KALACAFP_02193 UDP-2,3-diacetamido-2,3-dideoxy-D-glucuronate 2-epimerase
MKKLKVMTVVGTRPEIIRLSRVLSALDASEAVEHIIVHTGQNYDYELNQIFFEDLGLRKP
DYFLEAAGKTATETVGNILIKIDPLLEELKLDAFLVLGDTNSCLCAIPAKKRQIPIFHME
AGNRCFDQRVPEETNRKIVDHTSDINLTYSDIAREYLLREGLPADRIIKTGSPMFEVLNH
YLPQIESSDVLTRLNLEEGKYFVVSSHREENINSEKNFNGLIESLNAIAEKFGFPIIVST
HPRTRNMIDKMKVEVRPEIQFLKPLGFHDYNALQMRSYAVLSDSGTISEESSILNFRALN
IRDAHERPEAMEEASVMMVGLSPERILQGLVQLQQQKTGKERNYRPVSDYSMPNVSEKMV
RIILSYTDYVNRVVWSKK
>KALACAFP_02194 hypothetical protein
MNVLFLTLVKIDTLQQRGIYHDLMREFSAHGHNLYIVSPLERRENKKTCIKTDGNTKFLN
VKTLNILKTNFIEKGISTLSIEKLFLRAIKKYFSDVKFDLVIYSTPPITFTNLIKFIKKR
DNAKTYLLLKDIFPQNAVDMQFMSEKGFFYKYFRNKEKELYNISDKIGCMSKANVDFVLR
HNSYIPKEKVEINPNSIQIQGFEEISQEDKNQIKSKYNIPTDKKIFIYGGNLGKPQGIDF
LIKTLDAEKENKKGFFVIVGAGTEYEKIKDWIDKANPKNVLLISFLPKNDYDLLVRVCDV
GLIFLHKDFTIPNYPSRLLSYLEYKIPVIAATDKNTDIGEDIVNNNCGAAVCSDDIESMM
KTVNLFAEMDKAEFEKMRQNSWDFLEREFQAYMSYEKIMKSLN
>KALACAFP_02195 Undecaprenyl phosphate N,N'-diacetylbacillosamine 1-phosphate transferase
MYRNFFKRITDFLVSIIGLLVLSPIFLLVMICLFFANQGQPFFFQKRPGKNGEVFSIIKF
KTMNDKKDKDGNLLSDAERLTPVGIFVRKTSLDEIPQLINVIKGDMSLIGPRPLLVQYLP
IYNNHQARRHEVKPGITGWAQVNGRNAISWKQKFDYDVWYVDNISFLLDIKIIFLTIKKV
FIREGISQEGQATMEFFTNNENE
>KALACAFP_02196 hypothetical protein
MNNILITSAGQRVSLVRAFQKEIKKIDENGKVFTVDLNPVLAPACHVSDGYKQINRVTES
NYIANLLEICKSWDIKIIIPTIDTELLILAKHKSFFLQNGIIPIISSENFIEKCRDKRII
NEFFKEKNIEIPKQFDKDNMSFPLFIKPYDGSLSKDIFLIKEPSELTDYHMQNPKLMFME
YIDQTIYDEYTVDTYYDKKGELKCVVPRKRIFVRAGEVNKGVTQKNEIENYVRQNIPQID
GAVGCLTMQFFFHPGDKRIIAIEINPRFGGGYPLSYLAGANYPGWILKEYLLGENISYFD
GWESNLLMLRYDDEILVHNYEG
>KALACAFP_02197 Phosphoglycolate phosphatase
MKGKYIIFDLDDTLMYEIEYLESAYHEIAELLDIQNKEMLYQDMINWYHDKKDVFGILEE
KYSHAKIDLLDIYRNHFPKIKIAEEVKFVLDYIIGKSYKLGLITDGRSVTQRNKLRALDI
EDLFDKIIISEEFGSSKPDFKNYEGFMGTEDLDYFYIGDNTKKDFIAPNSLGWVTIALKD
AGKNIHKQDFDWSEEHRPQIIINNIKEIISYIN
>KALACAFP_02198 Putative pyridoxal phosphate-dependent aminotransferase EpsN
MSQKIWLSSPHMGGNELKYINEAFAENWVAPLGPNVNGFEEDLEKFLGKNTKIAALSAGT
AALHLALIQCGVQYGDEVICQSMTFSASANPIAYCGANPVFIDSEPETWNMCPVALRNAI
EDRIRNGKKPKAIIVVHLYGMPAKMDEIVSIAKEFDIELIEDAAEALGSTYKGQACGTFG
RFGILSFNGNKIITTSGGGALVCHSQEDKDKIVFLSTQARDNAPHYQHSHIGFNYRMSNI
VAGIGRGQMEVLKNRVEARRSMHDFYVDLFKNIDGVTVFSEPSSDFYSNHWLSAIIVDPS
VTGKTREELRLAFLEDNIESRPLWKPMHLQPIFENAPYYGTNVSGKLFDDGLCLPSGSNL
TEEEKERIAKVISNFFSN
>KALACAFP_02199 Undecaprenyl phosphate N,N'-diacetylbacillosamine 1-phosphate transferase
MNQYRYWKVIFDCFFAAVLIILFLPLLIVLFIVASVDTRSNGIFCQKRIGQYGKLFIIYK
FKTIRDKDEYCSKTGSVLRKYKLDELPQLFNIIKCEMSFVGPRPDIEGYYDKLQGDDRKV
LELKPGITSEASIKYSNEETILKAQNEPLFYNDEVLFPDKVKMNLVYLENMSLSNDFKIL
TKTIFKIFIK
>KALACAFP_02200 dTDP-4-dehydrorhamnose 3,5-epimerase
MKIKETPLKDCYIIEPTIFEDDRGYFFEKFNEKKFEELTGMNGHFVQDNISKSSYGVLRG
LHLQKGEHAQAKLVSCLEGKVWDVAVDLREDSPTFGQWFGIELTEENKLQLYIPRGFGHG
FSVLSETAVFAYKCDNFYNKESEGSVKYNDPELNIDWKIEDKDAVLSEKDQNAPGFKEKN
F
>KALACAFP_02201 Ribosomal protein S12 methylthiotransferase RimO
MRTKSVGKKKINVVTLGCSKNVYDSEVLMSQLKANGKEVVHEDKGDIVVINTCGFIDNAK
EESINTILDYVEAKNRGEVEKVFVTGCLSERYKPDLIREIPDVDQYFGTRDLPILLKHLG
ADYKHELVGERMTTTPKHYAYLKISEGCDRPCSFCAIPLMRGGHVSTPIEKLVTEAQKLA
KKGTKELILIAQDLTYYGLDIYKKRALGDLLKELVKVEGIEWIRLHYAFPSGFPEDVLDI
IREEEKVCNYIDIPLQHINSDLLKSMKRGTTHEKTDALLSKFREKVPDMAIRTTLIVGYP
GETEERFQELKDWVREQRFDRLGCFTYSHEENTSAYVLEDDIPQEIKEARVEEIMELQSQ
ISWEKNQEKIGNIYKCIFDRKEGNYFVGRTEYDSPDVDNTVLVSAENTYISIGDFADVRI
TSAEEFDLYGELT
>KALACAFP_02202 hypothetical protein
MKKILLTATMLVGFAAVSQAQQGRVGINTNTPASTLDVVGTPTDATRPDALLVPRLTEDQ
LAAKNAVYVDGTAGTPSPQNGALVYVTAADGATTAKTANVTAPGIYYFDGSAGQNVWKTW
GTGGSTPPNFQIQKGRLHSANAPIVWAADDYSVVTTGMGNSSQLLLPDATTLPLNSVRCV
SSNGPGNVGWSPSAVAGITRGMQNIPSTVTSGGSFCFIVVDNAGTHNWGILSGR
>KALACAFP_02203 hypothetical protein
MKKIILALFVSAGTLMSAQALSNGEIANTFPNENIFLDASTNNNSTVNDGKGLLFPTTDL
TAFTFKVASLDGINFPSAYDGMVVFNIGSGNTLTNDGVISTPVSRGFYYFDNPNKSTDVT
GGRWLPLGASAKFDVTTAETTTNTLVNGNQVYAKRGQFVASGTSTAPTSYTNAVIIPTTG
SLYRITIFQAGTNNVYDNSVYSYDKTTGNFITGSPSMSVVYPSGTYDYTVEYTK
>KALACAFP_02204 Endolytic peptidoglycan transglycosylase RlpA
MKRFILVIIMMISALGVYSFKNSAIDAKKTSYASYYHDKFNGRKTASGEIFDNAKFTAAN
RTLPFGTNIKVTNLNNGKEVIVRINDRGPYHSSRSLDMSKAAFDEIGDISHGTIPVEYEI
VD
>KALACAFP_02205 Exodeoxyribonuclease
MKLITYNVNGIRAAFTKDFLGWLTTADPDIICIQESKAGNDQIDIESLEKLGYHSYWHSA
VKKGYSGVGIASKIQPNHVEFGCGIESYDNEGRIIRADFDGFSAISVYVPSASNIERLDF
KMQFCHDFLDYIKTLRKDIPNLIISGDFNICHQAIDIHNPVGLKNVSGFLPMEREWMTNF
INECELIDSFRFFNNEPDNYTWWSYRQNSRERNKGWRLDYNFASYTLKDKLRRAVILKEA
VHSDHCPALVELDV
>KALACAFP_02206 hypothetical protein
MKKSFLAIICTTLFLVSCTKDKTKASTEPEKTPIADSTSTSTASPAAKNDLIKSTAKDKN
GKTLEMTFDNAKNTVTVVFEGNTVTLQGQEAGSGMLYKNDQYELSGKGEQVKLAKEGKTI
FEN
>KALACAFP_02207 Transcriptional regulatory protein OmpR
MSEKILWIDDEIDLLKPHIVFLEKKGYQITPVNNVNEALELMDSEKFALTLIDENMPGIS
GLEAIPMIKDKDNSLKIVMVTKSEEEHIMEEAIGSQIADYILKPVNPNQILLSLKKNLQQ
DNLVEQKTILQYQQEFRNLSMELSYLRSYQDWAEYYKKILNWEIKFDKVTDNEFADLLQS
QKEEANIQFAKFIENNYEDWLHNTEKPIMSHTLFKEKVKPEVEKEKVLLLMIDNLRYDQW
KMIEPLFTKYYNKVSEDYYYSILPTATQYARNSFFAGLMPSEIEKRFPDKWFNDNEEGNK
NEFERDFLEDQMKRIGLGSKSMKYLKVLNADFERKIYDDFNQHKNNDLLVIVYNFIDILS
HAKTDNHIVDQLIRDDKTFRSLTLNWFENSSLMKIIKVAAESGFKLVITTDHGTVYVKKP
SKVVGDRETSTNIRYKTGKSLTYDDSDVWAITNPEKLFLPKGNLSSKYIFAKNNIFLAYP
KNYNHFVNYYKETYQHGGISLEECIIPFSILEPK
>KALACAFP_02208 hypothetical protein
MRKFSIFIILFFSLHFSAQALSETQKLESLCKVWGFLKYYHPNVAKGNFNWDQQLFQKIS
ELENINDKNQLNELYSNWLESLGKVDECKECLKEDNKIFFLKNFDLNWINNQEIFTPNVI
QKLQFIQNNRNLGENHYFGKGGRKVYFRNENSYGSKFTSKQISLFELFRYWNYVEYFFPY
KYGTDQNWNDVLTEMIPKFVAITNDENYQLTLAELVTKIDDSHAFLFSRLISLNQYGRKS
IPVEYSYAEGKLVITKINSTTFNEENPLKVGDIIYDINGLTIPQKVNAFGKYIPASNSWG
KIKKAKNLFLMTNGDSIQLKIERDGKNLALQLKTFLLKDIISEKPTQPEKWKFIDDEKKI
GYVNMGVIEKTDLDEMYNTLKSTGSIIFDLRNYPKQTILPLSRMLLPKNTIYYQFNFPDT
NYLSKFYSRKNSIGRNNPDYYKGNVVVLVNENTQSQAETTTMMFKQHPKAKVIGSNTAGA
NGDIIRFNIADLETCFTGLGAYYPDGKETQRIGIIPDIMIKPSVKGIREGRDEVLERALD
YIKNGH
>KALACAFP_02209 hypothetical protein
MQNKLKIINDPVHGFIKIPHEILFDIIEHPYFQRLRRIGQTGLLNLIFPGATHTRFHHAL
GAMHLMFTALETLKQKGVKISEEEEKGAMLAILMHDIGHGPFSHALESMLMDDWHHENLS
LLLMNRLNDQFKGELSVAIEMFQGKYHRKFFNQLISSQLDVDRLDYLKRDSFFTGVSEGS
INTQRIISMMNVCEEGELVIDAKGVYSIENFLTARMFMYWQVYYHKTSALAEFLLVKILE
RAKHLVSLGVDLPATENLKYFLYRGKSAATDEDVERFTQLDDNDVIQAMKNWQNSDDFVL
SYWCRCVTQRNLPKTIISSHSFDPQFIEEKIKKTNEYFGIDNGSELVHEIKRKLLPYNTE
KQPIYLLQKSGEKIRLEDSQDQLLSGLMVNKTTRFILTFPRDISHTIS
>KALACAFP_02210 UDP-3-O-acylglucosamine N-acyltransferase
MEFTASQIASFIDGKIIGDGEALITGVSPIESGETGHLSFIAQDRFSHYLDTSKCSVIIV
SEKLLAKENYNPTIIAVKDAYLSFQVLMNLYQEMQGRKEGIEDGSSIHETAVIGDKVYIG
AFTYVSEKAKIGEGTQIYPQVYIGKGVKVGKNCKIDSGARIYDYCIIGDNCVIHSNTVVG
GDGFGFQPTADGFKKIPQLGNVIIEDDVEIGSNCSIDRATIGSTVIGKGTKIDNLIQIAH
NVKIGQNNVIAAQAGIAGSTTIGDWNQIGGQVGVVGHIKIGNQVRIQAQSGVNSSVNDKE
TLYGSPAISYNDYLRNYVHFRNFTEIVNRINNLENNSKDKTNE
>KALACAFP_02211 UDP-3-O-acyl-N-acetylglucosamine deacetylase
MQKTLQQEVTLSGIGLHTGKEVKLTIKPAKENTGFVFVRTDLEGHPQVEADVNYVVATER
GTTLEKLGVKITTCEHLLAALVGCDVDNAMLEMDASEPPILDGSSKYFVEAIESVGVVEQ
GIAREYLVIKEVLTYNDPATGSEITIIPSDTYEITTMVDFGTKVLGTQNATLKNISEFKE
EISSARTFSFLHELEMLLDHGLIKGGDISNAIVYVDKDLTPDTTEKLKKAFGKDNVSIRP
NGILDNLNLNYPNEAARHKLLDVIGDLALAGVKIKGKVIANKPGHYVNTQFAKKLNRQWK
LQKKKNVPDFDLTKEPVFDINGIMKLMPHRPPFLLIDKILELSDSHVVGLKNVTMNEPFF
VGHFPKEPVMPGVLQVEALAQTGGILVLASVPDPENYSTYFIKIDKVKFKRKVVPGDTII
FKIELIEPIRRGIVHMQGYGYVGDTVAVEAELMAQVAKNKVD
>KALACAFP_02212 Acyl-[acyl-carrier-protein]--UDP-N-acetylglucosamine O-acyltransferase
MIHQLAAVDKRAKISKNVIVEPFTTIAGDVEIGEGTWIGPNVTIMDGARIGKNCRIFPGT
VISAIPQDLKFDGEDTQVIIGDDTTIRECVTVNRGTKALGYTKIGKNCLIMATSHIAHDC
VIGDHVIIVNGCGIAGHVEIGDYTVMGGLSAVHQFGKIGKHVMISGGTLVRKDIPPYVKV
AREPMSYAGINSVGLRRRGFTNEKIFEIQKIYRAIFQMKMNVSQAISHIEKEMLPTAERD
EILQFIQNSPRGIVKGYGTGKE
>KALACAFP_02213 hypothetical protein
MLSVTSLLFGQQMEGLKTEKTTKTSIMERKLPEKSNDSIAKNNLNDILKQQNTSTSIFGT
ANQYNSEVQMNVNKLQNNVNTFNNNTFNRMMPQGQGIQFNKRK
>KALACAFP_02214 Elongation factor P
MATSNDIRKGLCIEYSNDIFKVIEFLHVKPGKGPAFVRTKLKSVTNGKVIDNTFSAGHKI
DEVKVITRKYQYLYDDENGFHFMNNDDFSQLYLNKEMIENSNLMKAGEEVTIILKEADET
PLSAELPQSVYLEVVEADPGVKGNTATNALKNAIVETGARVMVPLFIEPGDKIKVSTEDG
SYLERVKE
>KALACAFP_02215 UDP-3-O-acylglucosamine N-acyltransferase
MTFHQPQKLKTIADLIGAKFIGSEDFEVLGTNEIHMVRPGDIVFVNHPKYYDKALNSAAT
IILIDKEVECPEGKALLVSDDPFRDFNKINTHFTRIYNFTEELHDAEIGEGTKIHHSAVI
GNNVKIGKNTLIFPNVVIGDRTVIGDNVIIQANTVLGGDAFYYRKVNGNFDRLISVGNVV
IENNVEIGNGCTIDRGVTDSTVIGEGSVLDNQIQIGHDTVIGKKCLIASQVGIAGCCVIG
DEVTLWGQVGIASGNKIEGGSVILGKTGVNRDLEKGTYIGMFAEDFKTYLKKEVKLRNLK
>KALACAFP_02216 Succinate--CoA ligase [ADP-forming] subunit alpha
MSILVNKDSKVIVQGFTGNEGTFHAGQMIEYGTNVVGGVTPGKGGSEHLGKPVFNTVADA
VAKAGANVSIIFVPPAFAADAIMEAAEAGIKVIVCITEGIPVADMVKVKSYIADRDCRLI
GPNCPGIITSEEAKIGIMPGFVFKKGKVGIVSKSGTLTYEAADQVVRAGYGISTAIGIGG
DPIIGTTTREALELFINDPETEAVVMIGEIGGGLEAEAARWYKASGSTKPVVGFIAGQTA
PKGRTMGHAGAIVGGAEDTAQAKMEIMRENGINVVDSPADIGATVAKILG
>KALACAFP_02217 hypothetical protein
MKKFLLASALAFSTLSFAQIDLKSTRFGVSVGGNYSGVKNAHNPSGKRFAVQAGVLALIP
LGKSNQFFLQPEVQYFGAGETGKNKDAKGVDGYDAVYANNYLSVPINFKAYFSEAESEFF
GVIGPRFNFLLNQKVKNAPISRPYYDPDYEVPGNPQLNGKASSFNFGVGLGVGYSYKRQL
ELTARYDFGLSDTYPGLKHEPKGSDKSKSEQVLSLSLSYIFK
>KALACAFP_02218 hypothetical protein
MNNIFLITKREFLTQVKKKSFIILTLLAPVLLVAFGAVIGLMFKANESHNIIEVVDKSGL
FKNQLKSDDQLNYVFVSAADEKSKINNLKDNESLDGILILPELKNRNFDDLQQNTRLIIN
SKIGFDTKQKIVSDITDVIKKEKIKQLGIAETQLINLDKSFTLKTINVSENNKEDSDLAF
GVKSGLSILLMYVTFMFIIIYGVRVMRSVLEEKNNRVVEIIISSVKPFELMMGKILGVTM
VALTQFLIWITMSVIGALVLNTGFSLQKNIPGGNEELASKFDIAQIATQVSHSLLELNFP
LIIFVFIVFFLLGYIFYSSIYAAIGSAVDNETETQQFTLFAILPLTLGMYGSFSLMNNPD
GPLGFWLSIIPFTSPVAMIARIPFGVPAWQIALSIALLLGTTIFMIFLAGKIYRVGILMY
GNKATLKEIWKWIKG
>KALACAFP_02219 putative ABC transporter ATP-binding protein YxlF
MLKAEHIRKTYNAGKKVALDDFSIHVPKGSVYGLLGPNGAGKTSFIRIINQITQADSGEV
QINGQKLNPHHIKDIGYMPEERGLYKNMTVGDQLLYFGELKGMSKNDALNEAKKWFDKLH
IDQWWKKKLSELSKGMAQKIQFVVTVLHRPHLLILDEPFSGFDPVNANLIKDQIIELKNN
GTTIILSTHRMESVEEMCDYVALINNSKKIIDGRVFDVREKFKKNIFGITLSEVNDSQLE
GFKNKYEIFNLSHQNNLVSFDLKNEADQNHILLDLVHVGKVRSFDERIPSMNEVFINAVS
NNS
>KALACAFP_02220 hypothetical protein
MKKLLLLFIFLGAFVGFSNNMKAQIKEPSSFSQKSDDGVLVAYPNPAKDFLIIKAKDSNL
RIKSVIFYSILGTQVASYSVNMNSGEINIEKLKPGKYLIRYILSDNTMKVTQIVKQ
>KALACAFP_02221 Delta-aminolevulinic acid dehydratase
MIHSRNRRLRVNESLRSMVRECTLTTNDFVMPIFVMEGENKQEPIPSMPGIFRRSIDLTV
KECKELFSLGVKSVNLYMKVSEHLKDNTGKEAWNKNGLMQNTIRAIKDAVPKMVVMPDVA
LDPYSIYGHDGIIENGKIVNDATNDALARMSVSHAEAGADIVAPSDMMDGRVQVIREALE
ESGFTDVGILSYAAKYASSFYGPFRSALDSAPKDNMEIPKDKKTYQMDFHNSREALNEVF
KDIEEGADIIMIKPGLPYLDIVSKVREAIDLPIAVYNVSGEYAMVKAAAQNGWLDNDKTI
IESLTCFKRAGADMIFTYFAKEAAILLNK
>KALACAFP_02222 hypothetical protein
MENNQQLTELLALDLGIDIANRRPYAKEVFKWQDMDLLPHSSTDTLLCEIYEWNGRNWRT
TNNNLIGYLFSGDQLNMVKNQLINVQKFPALIPDFEFTKDSMIEYGLSLPSLFNIGVNGD
IKNAKDFSVRVNGVTKSRITNIDSPGIEILRNFSEFTQNESKTYRKNIKFNFLSTSLFYA
ESVEINLEKESGVDLEVSFQTQNVEVQANVDTDTKKNFILKYTGNQSPFAAKFTKGKDFD
IS
>KALACAFP_02223 Lipopolysaccharide export system ATP-binding protein LptB
MILRGENLIKEYGPKKVVKGVSVQVQQGEIVGLLGPNGAGKTTSFYMIVGLVKPTSGKIF
LDKQEITTDAMYRRAQKGIGYLAQEASVFRKLSVEENIMGVLQLTKLSKREQQIKCDELI
EEFSLQHVRKNRGDLLSGGERRRTEIARCLATSPNFILLDEPFAGVDPIAVEDIQKIIRS
LVDKNIGILITDHNVQQTLAITNKTYIMFEGRILKEGLPEDLANDPQVREAYLGDNFVYQ
SILDKPKKKKYAYNIWAGNFDSKSHFQGFVDENFAQFDDLRLMHGFEDISFASLANSEIE
HIFNDVVDKNANNSFIFQKKEINSQYSLEQAEAESKAASKQELHYLTTYLYEG
>KALACAFP_02224 Putative multidrug export ATP-binding/permease protein
MAKPFNRTVTLFGIYKQLVPFIRPYRLMIYGTLFLTFLGALAAQVNPLVLKYTVDEVTKL
TLLPHPMSEGIHVLVLISVILLGKELLNIFINFGQKFYGEKIRINVSSVLAQSAIDKILT
YRVAYFNDENHESGKLQIRIDRGIESLTRLVQNFFIDMLPLFSNAIIALIIMYLQNIYVG
IVSTIIVPIYFYISSLQAKKLSGVRRQLRNQREQKTSGLLNLINSIMVIKSFVREKFEGK
KQYDLQMQLMESQMFTRKTNFIYDGLKTFIEQFGVVLIILLTVYLVLDQQMTIGAIMLHI
MLFNNVSAPIRQLHRIYDDMNDAMIYAEGYFDILNADDEKEPNGNFVEKDIKGNFELKNI
NFTYPNGTQALHDVSMTIENGKTTALVGLSGAGKSTVINLLCKFYLPDSGEIVLDHVNLN
DFNNTFLRDDLGLVLQKNHIFQGSIEDNIRYGNMNATFAEIEEAAKKAYLHEQILDLPDQ
YQHDATQLSGGQQQRIAIARLFLKDPPIIFLDEPTASLDAIATEQIKNSLDAIKEGRTVI
IISHSLSQILDSDKIYVMKKGRVVESGTHDELVQINGTYREIFDASARSLNLDKLVNSFK
DN
>KALACAFP_02225 Bifunctional ligase/repressor BirA
MNDHYLKKLDRVTAILTQLQSKPIVRAQDLAQKFEVSVRTIYRDVKTLENAGIPIVGEAG
SGYSLMDGYKLPPVMFTKEEVLSFITAEKLMQKFLHQSLGNHYQTAMEKVRSVLKYSDKN
LIENIEKQIDVYNYHPKTEDNIKNVIPIILESIAEKKQLTMEYKTMDSKISTRTIEAVGV
FFEFNYWYIMAFCTLRNDFRQFRVDRILQIFKTQNPFLQEYGQINDYRKSGNGNKTTVKL
LVEKKIMNHLVNSKKYYGLIDEVDTENGVELTFETEWINDGFPRWLITFADYATILEPEI
LQTKLNDLLIKISGKHK
>KALACAFP_02226 hypothetical protein
MTTTATITKQFMTSEQLLEHWQGHRNLTRRVIEAFPEKELFEFSVGGMRPFAKLAVELIS
IGGPALKGIVNKNMEAYNEEGFNPKTKEDILKKWDEETETINHYFAQISEERFQETFNLF
GQYEFPVYQNILYFVDNEIHHRGQGYVYLRALGIEPPFFWERF
>KALACAFP_02227 hypothetical protein
MNTDIFRLAVVLYVDKNYKIESSTVHKKIIESFFVDSNNKQVTVYTLINEIKNKYDFLDK
KEIHEIVANDPDFNISVHKDELSNINLVQSKYLSLKNKIQKNNIDTFLSGCHETISELQK
IRNEKIKDKLSMREKTVVEQKLIDEKVKNDFIKYQMGGYFYIVLAIFCSFFVALNFFYKE
SSWNYINYVESLSKGFAEKELIEYIFLLPLGFFVFCAVQIYKRLICIKAKKKKKEIFRQK
YNDKIICKFYSNL
>KALACAFP_02228 Cob(I)yrinic acid a,c-diamide adenosyltransferase
MKIYTKTGDKGQTALYGGTRVSKASARVDSYGNIDELNSFIGIAKSHIEDEEVLQQLKKI
QFDLFTVGSEAATPVDKLMLANGKSRLPLIISETEIEELENWMDAFEEKLEPLQFFILPG
GGKSATFLHAARTICRRAERSLVFLNESEEVRPELIKYLNRLSDYLFVLARYISKINNEP
EEYWNPNER
>KALACAFP_02229 Thiamine pyrophosphokinase
MKDKALLFINGDAPKSFPNPEKYGLIACTDGAFHYLKNLDFPLEKLDFISGDFDSHSGKD
ENLYHEKFIYTPDQDKTDFHKALEIIIEKGFKNIDILGGSGGEQDHFLGNLTVAFGFKDI
LNIKFYDEFSEYYFVPKNFAVKNVKDKMISLYPFPSVENITTKGLNWPLTNGNLSITSRI
GTRNFAVEDEVSIEYEKGDLLVFIGRDYL
>KALACAFP_02230 Tyrosine-protein phosphatase
MKIRVICGEIKMKNLIKMSFLLITFLSIYSCKTQHFSTPEYGKNETEKEIRIKKVHNFRT
VENIKNIDGRTLKQGKFYRSGHLFKLKKKSFHEFESLGIKEIIDLRNSKEIAKKPDNLPR
DIVYKNYSAFEDKGDQLDQAKKMVLKGKVNGSDADQRMVDFYKDYVTENPEMIKKIINEI
LESDQPILYHCTAGKDRTGITTALILIILKFDRQTIYNEYLLSNNYRKKLVDKRLKLATD
LHFLYPKMDVKVLEKLSWVESDYLDAAFSEINKKYGSVDAYIQQVLGIPEDKRQEYIQKF
TY
>KALACAFP_02231 Biosynthetic arginine decarboxylase
MKIKYSELIDQTLYFPTEEFNVSENNLLFHDIPLMEVVEKFGTPLKISYLPRISQNIQKA
KSWFREAFEKTEYKKNYTYCYCTKSSHFKFVLEEALKNDISIETSSAYDMDIVKSLYENG
KVDKNIEVICNGFKTDDYLAKISDLINNGFENITPILDNYRELDKLTESIDSTFDIGIRI
ASEEEPKFEFYTSRLGIGYKDIIPYYSQKIAEHPNARLKMLHFFINTGIKDTAYYWNELY
KCLRVYARLKKIAPEVDSLNIGGGFPIKTSLNFDYDYQYMVEEIVSQIKKFCEEEGVEEP
NIYTEFGSFTVGESGANIYKIISQKRQNDREKWNMIDSSFMTTLPDTWAISRHFIMLPLN
RWEDTYERVFLGGLTCDSDDYYNSEQHTNAIYLPVFSDTKPLYIGFFHTGAYQETISGFG
GIHHCLMPQPRHVLIQKDEDGELQYEIFRERQEPEDVLKILGYK
>KALACAFP_02232 2-deoxyglucose-6-phosphate phosphatase
MPLKAVLFDMDGVIVDTEPLHRKAYFKTFNELEIAVSEDLYTSFTGASTKRVCETLIYEF
NLNQTHEEIAKTKRDYFKDYFYNDEEFDLIPGVKELIQHYHENGIKLILASSATMTTINM
VFEKFELEKYFSGKISGADLKESKPHPEVFLLAAEMAGEPVENCMVIEDSTNGILAAHRA
KIFCAAYRSPHSKNQDYTLADTVISDYADLELDKVSKYF
>KALACAFP_02233 N(1)-aminopropylagmatine ureohydrolase
MKTYAGIPEENASLENSKVMLVTVPYDGTSTWGKGADKGPELFLNASENMELYDIETQTE
PYLEGVYLAGEISENSTPEAMTEAVYQKTKELLNNDGKLFTLFGGEHSVSIGSIRAVGEK
FENLTVLQLDAHTDLRPEFHGSTSNHACAVFEANQKHNLVQVGIRSMDIEEAEYLPEGRV
FFAHEIANNENWVNDVLEKVSGNVYITIDLDAFDPSIAPSTGTPEPGGLQWYPTLELLRR
VFEKCNVVAFDIVELMDSPMAKPSAFLAAKLYYKMLAYYHLYNNN
>KALACAFP_02234 Bifunctional transcriptional activator/DNA repair enzyme Ada
MSTQSQIDYNRIAKAIEYIRSNFRLQPSLEEVAEKINLSPTHFQKLFSDWAGTSPKKFLQ
FISLEHAKSLLKEEKASLFDATFETGLSSTSRLHDLFVKIEGMSPAEYKNGGKSLNINYS
FSESPFGKVITASTEKGICYMAFENDTNKALGDLIFKFPNASFFEKQDEFQINALSIFNK
DWTKLNTIKLHLKGTDFQLKVWESLLTIPMGKLSTYGNLAEKIGHSKASRAVGTAIGSNP
VAFLIPCHRVIQSSGNIGGYRWGSERKQLIVGWESSRVYSDSLNTN
>KALACAFP_02235 hypothetical protein
MHRDSYEMTSPLNIKHKTLNCMLNLFEDISDYPLNILPNDGTVHYYGKVFSKQKSDFYYD
YLLNQIPWENDEAIIFGKLILTKRKVAWFGEKPFEYTYSKRTKYAKFWTPELLELKQKCE
EVTGETYNSCLLNLYHDGSEGMAYHSDGEKDLKKHGAIASLTFGAERKFLFKHKTTKEKV
EIFLENGSLLVMKGKTQDHWLHRLPPTTKVKTPRVNLTFRTIEE
>KALACAFP_02236 Cocaine esterase
MKIHFSILFIVFFIFGNSQNNQQPTDTFVKDNFTKKEFYIPMRDGTKLFTIAYIPKDISK
KNKYPFLMQRTCYSIAPYGENEYRTKLGPNQYLMKDKYIFVFQDVRGRYMSEGTFTNMTP
QVDRKTKKDVDESTDTYDTIDWLLKNIKDNNGKVGQYGTSYPGFYTAAGILAQHPALVAS
SPQAPISDFWNDDFLHNGRFMLGYFRTFPVFGVQKTKPENKAWYTDSMIKTTSEDGLKFY
RDMGTLKDGYEKYYKDNFFMTEIMNHPNYDEYWQKRSLLPHLKNVNHAVMTVGGWFDAED
LSGPLNIYKTIEKTSPKAKNTIVMGPFSHGAWAQEQGKHFHNQIYFGDSIATYYQKNIET
KFFNHYLKGNTKQDAGLPEALMYDTGAKQWREFATYPPKEGQKVNFYLSNGTLKNTAGQG
FSEYYSDPDNPVLSSDNLKDFNGFTPKNYMSEDQRFAEGRPDVLTFTTDVLTEDMTFAGE
IMAKLNIASTSTDADFAVKLIDIYPEDFKPAEKKEGVIYGNYHQMVRSEIMPARFRNSRE
KAEALVPNQKTAVNFRLQDVVHTFKKGHKIQIQISSTWFPLFAINPQKFLDNPNFATKED
YTKAFIKVFDDSAIEIEVLK
>KALACAFP_02237 hypothetical protein
MKKILWLLFVFFNFLILNGQKFSISGKVADFEKKPVENATVYLLKQKDSSVINYTPTNKE
GKFSLKINELNEPSILKIDAEKLIPYSKKFDKIDQSITLENIELDKSQVTDIEEVKITVS
PIKIKKDTIEFNANAIKVRPDSNIEELLKNISGVEIDNDGKITMNGKVVDQIMLNGKPFF
DKDGKIALKNIPADIIKNIQFTTTKTKEEELSGKTPKSENTTINFTIDEKKNQGFLSRIT
AGYGSDKRYEGNGFLSYFKNKTKISLVASSNNVNSQGVSSDDGFDSMGKNSRNTGGNNIK
GIQKSTTIGINYSDKLSNEVELDALGMTWTNNNLETASKVSRTTFLPDYALKTNSENQAE
NENEQYNFNSSVKIKPDTLSTIYFSPSFLQSKSTNFRTSKSVTYRDNDLLNTSESTNSSQ
SENNSFSPNLHYSRRFKKKGRTLYASLNTSISENKNNNLVKSKTLFFENGIEDEDKKDIR
DQLSKTLRQNNNYSFNAKYSEPVSDSANISFGLNYNAKNARNSRIVNDFNENTGQYSDYN
IILSNSSEEKNNQLSPGITFELNKKKMNMWASVNVDLTDLKYNSIFNGQHYELDRNFALP
DYNTGLQFRLSQNSRLSIYNSASFTIPASERMIPYVDESNPLITYKGNPDLKNAWSNRTS
FYFNNFNVLKNINYNINFGFTYNNNDTTNFSYYDESGKQFVTYTNISGNKSANIGGGFSK
TFKWGDNRLIINPKTSLNYSYNRGFINGQQFTGNSYTFTPGINLTYDKKDKIIIKPSYNV
NYSFSNYENYSIESIKNTYQTFRLELTNYYLKTNLLFANDFEYNTSSNIAPGFKRDFYYW
NTSVGYSFYNKQFTAKVKVYDVLNQNQSVKRTIAASYVEDREDLILKRYVMFSLTMKLNK
FAGRKM
>KALACAFP_02238 hypothetical protein
MSTLQDKYSSVVSAAQSAGISNLQVQEQDGILYVSGQASNTAAKDAVWNALGAIDSTYSA
SDINIDVQVAGLAAGASLTVATDESNLNIRQEPSTEAAVVGKASKGSSVTLIEQTSDDWW
KVKTADGQEGYAYSRYLKA
>KALACAFP_02239 hypothetical protein
MKKTIAMAALAVAVSFGAISCKKKVSDTNLQTQATTVVTSNPNASVEVKDGVAHLSGTFE
SQEAKDAMIKQLKAIHGVKDVMDMSTVAPAAPAAAPVETQSAVDPAVQQKVQDAVKDFPS
VKVEVVNGELTLTGNVSAADARKIKESVDALKVGKVNYNYTVK
>KALACAFP_02240 C4-dicarboxylate transport protein
MKGQNKLFIAIVIALILGVGIGGFVHVQYPESAEPFSKNIKLLGTVFIRLVQMIIAPLVF
TTLVVGIAKMSDIKMIGRVGTKAMLWFISASLISLFIGLILVNWLEPGHVTKLPIQDAAS
AEDLLKSSKGFSMEDFVKHVIPKSIFEAFATNEVLQIVVFSIMFGVALANLGEEYSQPVI
KLFDIIAHGILKMVGYIMWFAPFGVLGAIAAVVATNGFEIFKVYAIYLRDFFFALAILWL
VLLLVGYLILGNRLFELLRRIKEPLLIAFSTTSSEAVFPKLVEELERFGCNNRVVSFILP
LGYSFNLDGSMMYMTFASIFIAQIYGIEMSIGQQITMLLVLMLTSKGIAGVPRASLVIIV
ATCSMFGIPPEGIALILPIDHFCDMGRSMTNVLGNALATSAVSKWEGQLENHGGKM
>KALACAFP_02241 hypothetical protein
MKKILVLLLGIIAHNLFSQNYSQYVNPFIGTGGHGHTFPGAIVPFGMVQLSPDTRIDGSW
DGCSGYHYSDSVIYGFSHTHLNGTGVSDYGDIMLMPTMGNPSLDNKEYSSKFSHKNEKAS
AGFYSVKLDKNNIDVRLTTTKRVGYHEYTFNNAGNANIILDLNHRDKLLEGEVRIIDDKT
IEVFRRSEAWATNQYIYARIEFSKPMLESKVQQESEPLRGTTQPGNFYHGTQVKIAFSNK
VKKGEKILVKVSISPTGYEGAGKNMLAEGKSNDFEAIRKQAVADWDKELSKIEVKSSDKD
KLTVFYTAMYHVFTQPNINMDVDGKYRGRDNKFYMAKDFGYYSVFSLWDTFRGAHPLMSL
IDRKRTADFINTFIKQYEQGGKLPVWELASNETECMIGYHAVSVIADAMAKGITGFDYEK
AFEASKNSAMLDIFGLNAYKQNNYIAIDDEHESVSKTVEYAYDDWCIAQMAKILGKKEDY
QYFMKRSQNWKNLYNPKNGFMQPRKNGNWYEPFEPREVNNNYTEGNSWHYSYSVQQDIPG
LIAAHGGKEKFEQFIDAIFAAPDKTTGREQVDITGLIGQYAQGNEPSHHIVYLYNYVDKP
EKTNAKIKYILDNDYKNAPDGLIGNEDCGQMSAWYILSSMGIYSVTPGLPEWQTTTPYFD
EIKIHLEDGTTRTITKNTGKAELRKLGFENVKEFKDYKYEELTATPVIAADRIFDLNTKV
TITPLNPNDKIYYMTLDEGDANVRKTFTAYKGPFTITKTTQVSAYAERNGEKSSIVTANF
NRRPNNWAITVNSTANPQYTAGGNLALIDGINGNINWRKGEWLGYQGQNFEAIIDMKSPQ
QITKLSSTYLQDSKAWVLMPKKVEYYASNNGKDYILLKTVDNTVDPKDETIQIKDFSADI
LPTEARYVKVKAYFFGKLPEWHLGAGGDAYIFVDEISIK
>KALACAFP_02242 Iron-sulfur cluster carrier protein
MLTKEKVQNFLKEIEVDDLVTNFQVMGNDVYIDMTAHSPAMHEKKKLEAAMKQAFASEFG
EEVHLKLKIVSPEPSEIQQSQIKGKQIPGIQNIIAIASGKGGVGKSTVSANMAVTLAKMG
FKVGLLDADIYGPSVPTMFDTEGQKPISVEIDGKNLMKPIENYGVKMLSIGYFSGANQAV
VWRGPMASKALNQMIRDAAWGELDFLLIDLPPGTGDIHLSIIQEVPVTGAVIVSTPQHVA
LADVRKGIAMFQMESINIPVLGLIENMAYFTPEELPDNKYYIFGKQGAQYLAEDLGIPVL
GEIPLIQSIREAGDVGRPAALQENSKIAEIYTETARNMVESLVERNKNLPPTEAVKITTM
AGCSPKAKK
>KALACAFP_02243 Fe/S biogenesis protein NfuA
METNITHEETVTKVMEALESIRPFLNKDGGDIELIDVKDNLVYVKLLGNCSGCSLNFSTL
KLGVENTIKQHAPEIEKVISVE
>KALACAFP_02244 Response regulator UvrY
MKNILIADGHYVVRTGTALLLESKLGSSCKIDFAETYNEAKEMVSKKMYDLLIIDIDIPQ
SIFKAMVKELKKKQKQLKILIFSTYEENVGIQYIEEGAAGYLNKGASESEILMVVKSIFE
EGYYYTVNMMKKLVSHSTESHSVERLSKREFQIFKLLAEGNGNIEISNILNLKMSTISTY
KKKIFEKLNVKNVVDLVRIYDDMH
>KALACAFP_02245 hypothetical protein
MFAFSLDTGEETEIITYIDDAKNLESNETNLGYRELRLINVHDVEKLKYEIEKATKLYDN
NGYIHMLDKDKSIVTSTFISKVRIIKSKKNNITLNGYVWHPPKGFLKAWKMYLNNEITEK
NTWKKLDKDELQGWLVFTGCVRRPEIDRENIIIQLDGNNFHNLDELFCTLGEEVNGIAGY
FGRQLSALYDCLCGDFGVKSIAEITWHNHERSKKLLKKNFDKIIDIFNKFNIRIILK
>KALACAFP_02246 NAD-dependent protein deacetylase
MFRGFFVVEKFISFKLYKAMKEQLEEIIHQIYHKEKRNLFTFLTGAGISSDSGIPTYRGI
DGIWVKGTQFHKPEEIDEGFEIDYRNY
>KALACAFP_02247 hypothetical protein
MINNYLLKGSVVAAFFLQGAVFGQTNLIHYWNFNNNASAATIITPTSTLVGGSMAVVTSG
TTEIDFAGGTGQNFNVENLNARNGDASGTHLRYNFPINGNLQFNLPTTGYNNVVVKFTTR
RSGSGAGTQTWSYSTDGTTFQTYQTVSPLDANPQLVTFDFSAIAGVANNPNFKLKVEFSA
GSGGTVGNNRFDNFTVDATAAGGADTTPPTVTYLPANNTNNASTTANPTISFNENIRLAD
NSAINDSNAQNLVDFRLGNSSGAQVPFMTTFANNKITVIPTSGLVPNQAYYLALKPNMVE
DTSDNAVTTSTSATFTTAGTSISLDKNFIKVNENAGTLAFKINVNNPSASSVNLVVKPAP
FGTADSNDFTLANQTITLTPSTTDYTVNIPINDDALEEQQAEYFVVSLENPVGATISGDN
NATVYIVDNDKPAPVPSNQISLNYIGSFDPSGNNNSSTEIVVHDPSTQRLFTISSITDVF
DIINFSNPNTPTVVNTINMAPYGGITSIAVKNGIIAAASPNANPQQNGSVVFFDINGNFL
KQVTVGALPDMVTFSPDGTKVITANEGEPNDAYTVDPEGTISIIDISGGINNLSQSNVTT
LNFNAFDSQVATLAATGLRKVRTNNTLSQDLEPEYVTISADSQKAWVTLQENNAVAEINL
ATKTITSIWGLGKKDMSLPGNGFDASDNNGEVLIANWPVKAYYMPDAVQNFKTGGTNYVI
TANEGDEKDLSGFSERTTVGANNYTLDATLFPQSSILKASYNLGRFRVSNATGNTDGDAE
FEEIAALGARSFSIFNADTKQIVYDSGDRFERYLAANHPLIFNADNESNGAKNRSRAKGP
EPEGIALGTINGQTYAFVTLERTGGVMVYNVTDPNNPTFTDYKNSRMTSAYGGDNGPEGI
IYIAPENTTTGKGYVVIANEISGTLSMYEIASTTLATGEVKAEKATFNVFPNPVTKGNTL
YFNRAQDYELYDMSGKLIGKEKNALTIETSKLSTGVYLVKTSEGHLKRVIVK
>KALACAFP_02248 hypothetical protein
MKEMLKRIFLVAFILLVLVAISGFFYMQKHPLDGKKSTGKNLNFSGKVTK
>KALACAFP_02249 hypothetical protein
MNSIKIILTGATGMVGEGVLMECLENPNVSEVLSVSRKPCGKKHAKLKEYIIPDFLNIGL
NDENLKGYDACFFCAGISSVGMNEEDYTKITYGTTLHFAKAVLNQNPDMVFNYVSGAHTD
KTESGKLMWARVKGRTENALRKLGFRSEYNFRPGFMKPVEGQVNVKWFFKPFIWFFPVLL
PSKSLTLHDVGKAMINAVKKGYPTSTLEIKDIKNLAI
>KALACAFP_02250 Guanosine-5'-triphosphate,3'-diphosphate pyrophosphatase
MKIAAIDIGSNAARLLINEVKFNNKEPEFIKLNLLRIPLRLGMDVFTLGKIGPEREKMVI
DSMKIFSDLMKIYKVEHYRACATSAMRDATNGQDIIREVKETSGIDIEIISGDEEATLVF
ENHVAEGLDKDFAYLYIDVGGGSTELTFYENGKMIYEKSFNIGTIRLLNNLVTPDNWKDM
KEEIRKNINSKRPIVAIGSGGNINKVFSMSKTKDGKPMSLSHLRKVYKEFDGLSVEERMT
KYNMREDRADVLVHALKIFNNVMTWSEINRIFVPKISVADGLIHNIYSKLQHKR
>KALACAFP_02251 Polyphosphate kinase
MSLHFNPRDITWLAFNERVLQEAMDEKVPLHLRIRFLGIFSNNLDEFFRVRVAGLKRAMD
FKEKVIAESFYQPPSKILQKINDIVMRQQQNFDKTWKKILGEMAEHKVFIKTSKNLTAKQ
KEFVRTYFDEVVESNVIPILLHENTPMPYMRDKSLYLGVAMRKKDWQYSSNYAIIEIPSR
FVGRFVLLPTEDPEEKDVMLLEDVITFNLPHIFSYFGYDEFAANAFKVTKDAELDLDNDI
RTNFAEKIEKGLKNRRKGKPTRFVFDKDMDKALLEMLIRKLNLTKKDSIIPGGKIHNFKH
FMDFPDVFETYARPVERTSFTHPAFEHGERVTDVILKHDVLLTFPYHKYNPVIDLLREAA
MDPDVKSIQITAYRLASSSKIINALIYAARNGKEVTVMLELQARFDEESNLEWKEMLEPE
GITVLVGLPNKKVHAKLCVIKKRAHNKTIQYGFISTGNFNEKTARIYGDHLVMTADRGVM
ADINKVFNILKKPKDDFLPVLKTCKNLLVCPQFMREKIVHHIDKEIEEAKAGRRAEMIIK
ANSVSDRALIEKLYEAAQAGVVIRMIVRGIYCAINQKDFKEKIKAISIVDEYLEHARVMY
FYNKGSEDIYISSADWMTRNLDYRIEAAAKITDKNLKKELKDILDIQLKDNVKARILDKK
LGNEYISNNKEECRSQIETYKYLKAKTDKK
>KALACAFP_02252 Chaperone protein DnaK
MSKIIGIDLGTTNSCVAVMEGKDPVVIPNAEGKRTTPSIVAFTEDGERKVGDPAKRQAVT
NPKKTVYSIKRFIGTHFKDDGSEISRVPYEVVKGPNDTVKVKIDDREYTPQEISAMILQK
MKKTAEDYLGQEVTRAVITVPAYFNDAQRQATKEAGEIAGLKVERIINEPTAAALAYGLD
KNHKDQKIAVYDLGGGTFDISILDLGDGVFEVLSTNGDTHLGGDDFDDVIINWMADEFKA
EEGVDLKSDAIALQRLKEAAEKAKIELSSSPQTEINLPYITATATGPKHLVKSLTKAKFE
QLASDLVRRSMEPVAKALKDAGLSTSDIDEVILVGGSTRIPIIQEEVEKFFGKKPSKGVN
PDEVVAIGAAIQGGVLTGDVKDVLLLDVTPLSLGIETMGSVFTKLIEANTTIPTKKSEVF
STASDNQPAVSIRVGQGERPMFNDNKEIGRFDLTDIPPAPRGVPQIEVTFDIDANGILSV
SAKDKGTGKEQTIKIQASSGLSDEEIERMKKEAQENSAADAKRKEEVEIFNKADGLIFQT
EKQLKEFGDKLSADKKAAIEAAHGELKTAFEAKNADDVKAKTEALDAAWMAASEEMYAAG
QGAQGADAGAQNPGGNAGNEDVQDADFEEVK
>KALACAFP_02253 hypothetical protein
MNISAEKNEIIKWINSLENPEIIEEINKISLRKSFDFEKEWQRGISGDEFKKKNQNKLQL
TL
>KALACAFP_02254 Thiol:disulfide interchange protein DsbD
MKFSKIIVILTIFLFQFNFAQEKADVVLNKALTEAKSKNKNVLLVFHASWCKWCHVMEKN
MNLPETKPIFDKKFVTTYVDVQEMGEKKKLENPGGQELMNKYKGENAGLPFWLVLNPKGE
VLADSFNEKNENLGCPSTAEEVAVFIAKLKESSKMNDKELQTIQTVFAKKN
>KALACAFP_02255 hypothetical protein
MMNVQMQTINQKIAIEYLKFFYPTLRPEISQLSVQENFAGAIQATVNYLKDLLQESKINI
IAHHIKLMDWLYRNGNSYVKSMIENLFVRSFESFKKHAKIEHWKLLYQYMPVSFQVIYND
QRKQDKIFFGK
>KALACAFP_02256 hypothetical protein
MKSKIRRISDWKTLKTTTNRHNLEILATHIAVIVGVFIFAACL
>KALACAFP_02257 hypothetical protein
MNYLEAAQEITDVIPDIQSEWKGNRTQNSYSVMQTFTDQIKNMIRQNDRNLLFKSLKKMD
EIYRNGDVVLKNAIENTFIFSLDNSTAFCTEEYRKMIFSHISQDLQRIYAKQIYNHGI
>KALACAFP_02258 hypothetical protein
MDLKTLNRIDKLRRLKSKGPATPKWMKPYHLLLMAFLVVFIFGGIIKVLELNQN
>KALACAFP_02259 hypothetical protein
MKNLVTILLVLFSFTFLHSQNTSIYIVRHAEKDISDANNKNPNLSEVGKQRAEELLKKLK
NVKFSAAYSTPFYRTQQTLQPIAAFNKIEITSYNPSDNKKLVDEILNNYSGKNVIIVGHS
NTILSILEAFGAKKPFETISEDDYSNLFQIIIDKNTVKLQSSKY
>KALACAFP_02260 hypothetical protein
MFSKIVVHRVGNKINGESLILSQEELELDEGMAELLENYFLGSFKSEETFHFYSDSYLVN
NPVYSSVSEIFDDKAKFLWESENIAKHLFEAAENPRVQGGELFIVYFEDEREGTERVDKI
GIFKTEKRESFLKISPNGETFDIEKDQGIGLSKIDKAALIYNNDKETGYVLSVVDNNKNG
DMYYWYEDFLKVKQRDDEYFHTQEALMVYKDYITKQLPQEFEVSKADQADFLNKSINFFK
EKEEFKLDEFANEVLGDEHVIESFNNFKTDYEQDMQINIAEEFPISEAAVKKTQRHFKSI
IKLDKNFHIYIHGDRQKIATGEDEKGKYYMLYFDKEV
>KALACAFP_02261 Kynurenine formamidase
MEPKIIDLSKPIQYNAGDPWFMKVKIKHKSHKKSHWLIRLALGLPAKLFPKNWTGWADDK
IKSMGLHSTTHIDAPWHYGPVVEGKPAKTIDQIPLEWCYGEGIVIDCTHKEDFVAITGDD
LKQDLDKNGITIKPGNIVLIRTDRDKLMGTPDFPNKGTGMSREATEWLIDQGVKVMGIDQ
WGWDLPLKFMAQKAKELNDPEYFWEGHRVGIDKEYLHMEQLTNLSALPPSGFKICVFPLK
IVGGSAAPARVVAIME
>KALACAFP_02262 Phytochrome-like protein cph1
MNFVECHEEPIHIPGYIQSFGYLIGIDAESHSITFFSKNIEDIFNIGNKEILFDKKITDF
PESFNSIIESDIYNSLNRFTQRENETYFDKIFIRDKEYHFSVFRSKAHIFLEFEEVLENP
HKRISNKYDSFYIVDNAQEIWEQLLNTLSRIVNYDRMMVYKFMMDGSGKVIAERRGEDME
SYLGLHYPESDIPRQARELYFKKRKRIFSNVYAETVPLLSKRQEDIDLTYATSRGMSPIH
GQYVKNSGASSSFSVSIIIDDHLWGLVTCQNSEPKHIDLEDRVQAGIFTALASNAYSSFK
SKNELNYRLELNEKSSELKKEFLKYNSLLDSLIENKTEIKDLPEADGLAIVSDETLVTEG
NTPSRKAIGRIIQWAHENTEDNIYMSRNFLRNYGEELELDTNSAGIVIYFIERSKNNMLI
WFRKEFDEHINWAGKPEKKIEVFSQNGEERQIVSPRTSFQIFTENIKGNSKRWNSRNIAA
LQSIRDLILETSHKNYNTIKRLNDELKKVNEELDSFSYTISHDLGTPLTVMKLNAQMLLN
SLTDGSEKSKNKINSIIEEIDNMAEMMHDVLQLSRAKHSEIQLENLPTVNTIQKISENAK
ITYNSPKSEIIIKECPDVLADKTMMHQVFLNIINNAVKYSSHKEQPKIEIEGFEAGDKII
YRIKDNGIGIPEEEKHKMFKIFNRMDNAKKFKGNGVGLSIVHRIMNRIGGNVEYESSEEG
TSFILTFKKP
>KALACAFP_02263 Heme oxygenase
MVSEYLKQNTAEYHDAAEKLFNSEKIFNKTFTLEDYKKIISTNYLMLLHSENRIFDSLSD
KFSEKLQLSNRKKLHLIEKDLESLALKNQSASHELEFSNENEALGAMYVIEGSTLGGNVI
AKQLSKTEGFDNVTFNFFGCYQENTGSMWKNFKEVLDTEVAEESYDEVLSGAKKLYTFLL
NVN
>KALACAFP_02264 Malate dehydrogenase
MKVTVVGAGAVGASCAEYIAMKNFCSEVVLVDIKEGFAEGKAMDLMQTASLNGFDTKITG
TTGDYSKTAGSHVAVITSGIPRKPGMTREELIGINAGIVKEVTENLVKHSPEVIIIVVSN
PMDTMAYLVHKTSGLPKHKIIGMGGALDSARFKYRLAEALEAPISDVDGMVIAAHSDTGM
LPLLSKATRNGVPVTEFLNDEKQKYVIEETKVGGATLTKLLGTSAWYAPGAAVSVMVQAI
ACDQKKMIPCSLMLEGEYGQNDICLGVPAIIGKNGVESIVNVTLTADEQLKFAEAANAVR
EVNGDLKF
>KALACAFP_02265 hypothetical protein
MKDTKSISEYTDEELINNEKKIKILTIMLMTAIVLLFLSTMFLTFKKGFSALTVIPIALL
PILIININNWNKLKKEKADRNL
>KALACAFP_02266 hypothetical protein
MKYLEKIQELLPLGYLYLIILGLLKESILFYQLGINILKYSSITDILISPIADMASSPIL
IIIIISVVLFFFLFQVILVKNSDKNWSKKLLGSYKINQDVDKRTLQKMMIPIFATLIPLE
LLALFVGLGWGEGNIIKKRINTQNLKYNYKIISESGIPTDIYMIDINSSYYFYVAKGDKN
IKIAPVGKINTLELIKKK
>KALACAFP_02267 Proline iminopeptidase
MKTIWLILLLFIIPANISAQHTSANENFFETSDHVKIKFKVSGKGEACIYIPGGPGQGYP
SFELLGGNNLEKNLTLIYMDQRGSGESETSDNYHLDKMVQDIEELRQHLKLNKVFLLAHS
FGGIIAVNYAKKYPQYTKGLILANVTLHFLNNESVKEQIEYGNQLLQQKNRAVHSDSLSM
ELSKISKSLRSKKMGYKFLTDDIETIKEMDKIDSLHPRIIDFGMAVISKPKDFPEYYADY
APMTKTIKTPVLIITGKSDKAVGTQHYKTFQFPDKKVVSIDGGHLLYYEKNREFVNAVVD
FVNKIK
>KALACAFP_02268 hypothetical protein
MTSIFTDKTVKPSDDDLKKALGKNYTFWHELFSFTLQKYPESSFDWHFSGQKFGWGFRIS
DKKRVLVYLLPRDQFFKIGFVFGEKAFEEICNSNISEHIITELKNTKKYAEGRGIRIDVT
DGSLMDDFKKLIEIKIKY
>KALACAFP_02269 Arabinose operon regulatory protein
MKQPIRIKTIQEFHQFRGLPKPQHPLISIVDYSTIKHDVDIQEVSWILDFYSISIKRTSN
AKIKYGQQEYDFDEGVMFFMAPGQVFGVTIDPETHKRAQHTGWILLIHPDFLWNTSLAKN
IKNYDFFDYSVNEALFLSEKEETILHQIIENIQQEYHSNIDKFSQNIIISQIETLLNYAE
RFYQRQFITRKISNHKILDSLEKLLTDYFNNEDLITKGLPSVQFVADQLNVSPSYLTGLL
KVLTGQSTQQHIHEKLIEKAKEKLSTTQLSVSEIAYELGFEHPQSFSKLFKSKTQVSPLE
FRQSFN
>KALACAFP_02270 hypothetical protein
MKIIVTGSLGNISKPLTEELVSKGHDVTVISSNPERKSEIEKLGAKTAIGTMEDVDFLTQ
TFKGADIIYAMEAINHGVFFNHEINFIQENIQIGKNYKEAIEKSGVKNIIHLSSIGAHMK
TGNGILAFHYEIEKVFNELPEDVSIKFMRPVGFYYNMFAFIPTIKSQNLIIQNYGGDEKE
PWVSPKDIASAIAEEMEKPFNGREIRYVASEEISPNEIAETLGEAIGQPDLKWLKISDED
LLNNLINAGMNPQTAKGFVEMNAARKGNILYEDYFKNRPVLGKIKVKDFAKDFAKVYFN
>KALACAFP_02271 Exoenzyme S synthesis regulatory protein ExsA
MKFNNLHSCHLGPEISPEQFIPEHFFLFLLKGSMVSYDGYRHYSMKPGDYCIARKNHLVR
YTKYKEDGAFEKVIIAFDEKFLKKFLERHPYQTEPTDNTDSFLFINEDKLIKNFIQSLEP
YYNGTEQLDDVFVDIKREELLMILLKNNPDLKNIFFNFNVPHKIDLELFMNHNYKFNISL
ERFAFMTGRSLSTFKREFKAIFNTSPGKWLMNRRLQEAYFLLDKEHKKPTDIYVDLGFED
LSHFSYVFKKEFGVSPSEVNKFKV
>KALACAFP_02272 UDP-glucose 4-epimerase
MENTKKTVLVTGGTGFLGVHTVLQMLQQGYEVKTTLRSLSKKENIVKALEEGGITDFSHL
SFIEADLTSDNNWDEAVKDCDYVLHVASPFPAQDPKDENELIIPARDGALRVLKASRDAG
VKRVVLTSSFAAVGYSIDIKDHVFTEEDWTDANAELPAYIKSKTVAEKSAWEFIEKEGNG
LELTVINPVGIFGPSIGGITSASLDVAVSGILNGNLEYTPTFTMGVVDVRDVADIHIKAM
LSPEAAGERFIATSDGVMSFYDVAELFKKERPQYTAKIQKLEPIGQEFYKEMSNKKAKTI
LHWNPRTREEALLASADSLMIK
>KALACAFP_02273 putative oxidoreductase
MNITNNTILITGGGSGIGLEIAKALSPANKIIIVGRNKEKLDAAAKDLENVFTIQADITN
ESDINRLYDEVKTTFGGLNILINNAGHAHYYTISENSDTYSKALAEFTTNYFAPIRLTEK
FLPLLKEQTEAAIVNVSSIVGFVPGSHVPTYSDSKAALHSHTRILRYQLAKDTNVKVFEL
MPPLVNTDFSVEIGGRENGIPASDVANDFVKALQENIYEIRVGNTGLLYDNFFAASEGAF
ATFNN
>KALACAFP_02274 Transcriptional regulator AcuR
MAGRPKIFDEQEAIQKATEVFRNKGYDTASADELLNAMGIGKGSFYLAFKGGKQELYIKS
IEQFSENFYKKLAEGMAKSGNGIEFIKKFFLMQADSSDCEKERGCYLGNSLVQLSEKDED
IKRISAKILRKLQQLFAEEIRKAQETGQIKNAEDPEILAWHLTNLWNGVHVTRRMENSPK
ILRSLIEMNLKMLE
>KALACAFP_02275 Spermine/spermidine acetyltransferase
MIEIKKLEPLTTNPTLNWGFNGYETDKIFAVSAIEIGSSFEFSLREKNQYYKKIWETNSD
DIHELHEIILQGNSFGAFENDELIGWAICDFREWNNSLFIENILIDEKYRGQSIGKLFIK
NINRKARELQCRLVELETQNTNYPAIKFYQNAGFRFTGINTKLYKDSTETALFMSFDILT
>KALACAFP_02276 Alkaline phosphatase PafA
MLRKISIAAATFLSVVTINAQKNKNSQLERPKLVVGLVVDQMRWDYLYRYYSKYGNDGFK
RLLNTGYSLNNVHIPYVPTVTALGHACIYTGSVPAIHGIAGNDWNDKETGQNVYCTTDEN
VKPVGTTNAKVGSHSPKNLWSTTVSDELRLATNFQGKVIGVSLKDRASILPAGHTPNGAF
WFDDSSGDFITSTWYMNDLPQWVKAFNSQNLPDKLVANGWNTLLPINQYTESSPDNSSWE
GLLGSAKTPTFPYSNLAADYQAKKDNIRYTPFGNTLTLKLAEAAVDGEKLGNDDVVDMLA
VNLASTDYAGHKFGPNSIEVEDVYLRLDQDLAQFFSYLDSKVGKGQYTVFLSADHGGAHS
VGFLEEHKISTGFFGEGMEKGINQKLKDKFGVDKLINAVDNYQIYFDRKLLKDNKIELND
VRDFTIKELEKDPTVLYAVSVDEVQEATIPEPIKQRIINGINRQRSGDIQLISHDSMLPP
YSKTGTTHSVWNSYDSHIPLIFMGWGIQHGESNKPYFMTDIAPTVSSLLKIQFPSGNVGN
PITEAIGK
>KALACAFP_02277 Nitrogen fixation regulation protein FixK
MIISENLLFSHGAELQNYNSGEFIFEEGSIPKYYFQIKSGTVKLSSFLEDGKEFIHGIPF
DGHCVAETYLFNNKNYAVNAIAVTDCSVIKLEKKRLIELVLKNPELILNMYSYTADRMHY
RYIVSAPFSFKDPLTKLHLIMNHVKAHFGFKEKFSFLIPYTRQQLASLTGLRIETVIRTI
KKMEKQNLVKIDNSKIYI
>KALACAFP_02278 hypothetical protein
MKFIIKLILLLFLGFQNSFSGQKISDDSLMKKAQLEIYDNPEKAINIGKSLLKKEKDVKK
LIAIYLLLSTANIAKRDFDISLKYILKAKELAQKTNDPKTQTTVLVSVAIQYQQMELFSK
SLETLDEADQYLSKLPDDTREKHFETARINAIRGMIYKSQSNSEIALEKFLKSVEHFEKI
GQKKSTYANMSVVYYNIGYCYLNLNQNDKAEQAFLQSIHYAQENQAKSLEAFALKGMSEL
YKQKREHQMALNLLIKAENLCKNTGDLILNEGIYKEMADNYLAMGNQNLYQVYNKKYFEM
HFQRTQNELNSINQSIDNHNKETFLKSEELKRRHYYLIASVIGFGTLVIAILLILIFKIR
KENKKYHKEIQQMIRS
>KALACAFP_02279 HTH-type transcriptional activator RhaR
MRTDCKKAKKNQPKNIFLKKEMPKKNIQIIFFLLCSAFLSAQSSPDFSILADKAFQKLYQ
NPDDCINYSLSILNSDKNIEHKIVLRNIISQAYAMKGDYVQSVNISTQKEEPDEDKRLSY
FMQTFGDYNLADQYQNLDLYNQSQRIISNLLSDPKLLKSEDKKMRITVAKLYQLQALNFG
ISRNHISMLENLNKSDQYIDYHNEENKIIAIENNIFRSSYLLKKNKTSEARKIIENVILK
LEKEENQPFLLALAYENFSRYYFIKGDYHSSIQQLEKGLANIENLPFNTLKTKIYESLSK
NYFALHNDEKYHEYYKLYSENTAKIDSSTKEGIRYIVKLVESSQNKNIEFQKQNQLKRFW
IIASVFSLIIIGLIIYFLALKTKRKDLKKQFEFFEKQKTRKKTIPLHTDVPKKEEILSID
KSTEKDSNKISKEKEDEILQKLEQWEETDQFLSKNMSLSMLSTQMGVNTKYLSEVINNNK
GKNFNGYINELRINHIAHLLKTDPTYLNYKVSYLAEYSGFSSHSAFTTIFKSVTGMSPNA
YIQEISKSRTS
>KALACAFP_02280 hypothetical protein
MKNIYKISLKVLAAYFLFNCFYSNAQLTVMAVGNYTVGGVSDNGVVSMHTGGGGIFKWDA
VNGLVSIGSLTNGYPQAGRTLVSNDGMKIGSTMTNGATNFNEISTYDVATSTWTNQGGLV
STGWDGSVSSTWGMTPAGNTLVGLGWLTGATAHAVKWTPQGGVVDLGSMVAERSSRANAV
NTDGTVIVGWQDEIDGTRSGAKWVNGVESFITDTSGNNVGEAGAVSADGNTIIGSAMPNP
YVWNSTSGLTYIIHPNSSAFFRGGATGISADGGTVIGFFRPFPGPPMAGEGFIWTMAGGR
VNLNDFSVSLGIATNGVTMSLPLAISQDGKKIAGIGTNSSGQVVAFYLDLTQYLSANDIV
KAEHDISIYPNPVKDILYIKKGKEKIEKAEIYNMVGQKVRTFSSVESQIDVSSLSKGNYV
LNLLFVKGEVSQSFTFIRQ
>KALACAFP_02281 hypothetical protein
MRKITLLFLVFVLFHSILFAQIGIGISSPNTNAVLELSSTNKGLILPRVALTATNNPAPI
STHIAGMTVYNTATNTSSATNAVYPGEYYNDGTKWMRKSTSREVRMLTGGTITDQLSARS
LIVPDASTYAETTLITLPTFTLDRESIVEFNANISATFTQNGSPLTDSSAKLAKTFFVFT
SAPAGIPTDSQFGSCSQSYTNTASVNGNVIGGYYYMTPRSILTLPAGNYTVALKGGGASD
QGYTLIFGEGTADQIQIRATPVK
>KALACAFP_02282 Barstar
MKTIYIDFTDIGDYEDFYAQLKEKLPLPEHFGENLDALYDVLTGDLEMPLHLEFVNMTVD
QLEIFEDLLTTLEDAEEELEDFTFTYFLEQYDDDEEEID
>KALACAFP_02283 hypothetical protein
MKVNNFILFFVCLTFLFSCSEKQQEKIKEKATIVILVQPFKDIKPENVQFVTNEIKKVYP
NVKILQPIDFPTNAYYKDRNRYRADSIIKFLDKRTKNGFVTLALTSKDISVTKGKVKDFG
VMGLGFRPGKACVASSFRLNKENSNEQFFKIAIHELGHTQGLKHCPEKKCFMRDAEGKNP
TNEEVDFCEKCKEILINKNWKFNTI
>KALACAFP_02284 Ribonuclease
MNSKKRSLFFICLGLLFGMSVMYIYNNFIADKKENSTIDSRPRYHAPGELPDGTPDPKYS
DQQRIDQLTEEKTVINYVKQNHKLPDYYITKNKARELGWNPSKGNLCDVLPGKAIGGDKF
SNREGTLPKGENYFEADVNYNCGNRNADRIIFTKNGDVYLTKNHYKSFEKQ
>KALACAFP_02285 NH(3)-dependent NAD(+) synthetase
MQTQKVIDHIVSWLKDYAVKANVKGYVIGVSGGVDSGVVSTLCAMTGLEVLLLEMPIRQK
EDQVNRAQDHIEDLKKKFPNVQGKTINLTPVFESFENIVHDHVEGRWSNNLSLANTRSRF
RMLTLYYFGQLHGLLVCGTGNKVEDFGIGFYTKYGDGGVDVSPIADLYKTEVYELAKALN
LIESIQNAIPTDGLWDADRTDEDQIGASYPELEKIQKEYGTKAVEDYEGRDKEVFMIFDR
MHKAAKHKMVPIPICDVPEEWREN
>KALACAFP_02286 Spermidine N(1)-acetyltransferase
MHLKTNRLILRKFEETDDERMFLLDSNPEVMKYIGMPPVSDINESKKIIEMIRQQYIDNG
VGRLAVVEKDSGLLIGWSGLKLLTQEINGYKNVYDLGYRFLPEFWGKGYALEAAKASLDF
GFNDLNIDTIYAHAHSENEGSNHILRKLGFEQTGEFTEPDGICFWYELKRDKFL
>KALACAFP_02287 Internalin-J
MKKKIFTFLGFLLAVSCFNAQKLTFSDKTFEKTVLANYDLNKDGAIDQSEADKVTNLFVS
NKIQLRSAEDINLFKNVQTIVLDGAIIISLDIKDLNNLTLFSCEACNLLTFKAENLKSLT
SLYLNGNKLTQISLKNTPEINELLLSSNSLTSIDVKPLKKLITLNLENNQIKQLDVSENP
NLENLITNNNPLKEEDIKRGKAAKTTPAPSNSSLPQRPSNAPKN
>KALACAFP_02288 hypothetical protein
MKIFRTIALSLLLVLGLSSCKKESKNQWNVEVKNPAEKVEITDISKEFYDQNISLDQFKA
KFPWFQGTVPDADFGKRRADQGEIKIYKEAIGKIDQKKLQEDLQDLFSHIKYYFPQFKSP
KVFLFSSALQMVQDPIFYDAKGNLLFIDITGFMGDGNPNYKGLELYFQKSMNPNNIVPKV
SQIFAEGFVKESPDHQKFIDQIILNGKIMMLQDAFLPTYPEYLKMNYTQKQYEWAVANEA
NVWNYFVENNLIFGDDHRLADRFIAPGPFSKFYTEIDNESSPQIGIFTGWQICKSYFKQK
PETKLQDFLNMDATVIFNQSGYKPKLD
>KALACAFP_02289 Fluoroquinolones export ATP-binding protein
MNEIINIQNLTFGFSKNKAILKDISLSVPKGSIYGFLGANGAGKSTTMKMLIGNIPDEKK
AIKIFDKNLSEFYPDGFNRVGSLIDTATFYDHLSGWDNLLVVSELRNLPKTECERVLHLV
DLWESRNMKMKKYSLGMKQRLAIAMTLLGKPELLILDEPVNGLDPNGMVEIRELLIKLNK
EEGVTIFISSHLLQEVEKMITHLAIISHGEIRFSGSIKDLNELYRYNHIRIGINNASGFI
SKIPENYSPKIFDENTLEITVESQKDITNLVKHLVNIDAEIFEIKSTAGLEDWFMEITKN
>KALACAFP_02290 Thiol-disulfide oxidoreductase ResA
MKKLLTTTKVEWLKIKGLGLTYLAIILGAFIPLLFFVINPFGRNTVLEDRPPYSMFQVFI
LENVQAFILCMLLIFMIIAASKIAQLDHKNNCWQLIETQPITKAHIYFSKYIVLLILCFL
CIASYFISNFLLSLADFYVHPDPAKILTFDILWALKTFLRMCIAVLGIAALQLCISVVFP
GFIWSFLIGILGLCLNLTSVARSENFTFSPYNSLYIFGNSFEVRNLNRFISFSEYLSIFW
VIVFLIIGYFWYSGKSFKTAFFKDKKKIVFSVLFLMIGSGIFYFLQKPIAYKADKEGVTI
DGELKTILKIDTIKIYSNDFHKKIASIPVKNNKFSWTTTEKIPFDEYLVEYGGKKIPLIF
GSGDWFHLNIECNTSYNKIFLKSNRKADQVYQEDEQLGSAFEKVLNDENASDPQEFYKAA
ETDWKRNVKKLENFADAENHALSGEYKAYKKQLLAIKYLNEINNYRKITSSTDSKFAPPK
EFLDELNENIQRPTYLLSKDDEYLQYKLDQMLDGKKVVSNPDSILFVKLDELPQSLEKDR
LLAKHLNENIELQTDSAARYKIFNSQINKIQNKDYRDRLYASFEQINISKKGVPFPNLVL
LDDKGKTSELSQYRGKYVVIDLWASWCAPCKKIRPVFETRSYQYRYADNIRFISVSIDQD
KTKWANYLKTKPSEVPQYWMPNAEQFMDKYNIQMIPRFVIIDPQGKIFNLNAPFPDEDNF
VEILDKLKKY
>KALACAFP_02291 hypothetical protein
MRKTQITIDVELDENHIPENITWNAQDGGIEKEETKATMISVWDDKAMEALRIDLWTKEM
PVDQMKMFIHQILVSLGNTYQRATGEEDVAQWMEEIAEEFAIKSAIKM
>KALACAFP_02292 Cystathionine beta-lyase
MNFNTKVIHGGQHHESATGSVNVPVFLTSTFAQKSPGVHSGYEYSRAANPTRQALEDSLA
SIENGARGLAFGSGLAAIDCVLKLLNPGDEVVAVDDLYGGTYRMFTRLFEKYQLKFTFVN
FDDVSKIANVITDKTKLIWIETPTNPLMKLVDIKAVVEIAKGKDILVAVDNTFATPYLQR
PIDLGADIVMHSATKYLGGHSDVIAGALVAKDAELGEKLHFIQFASGGILGPHDSYLVLR
GIKTLALRVQRHSENGMAVAKYLESHPAVAEVIYPGLESHPQYELAKSQMKDFGGMVSFT
FKSGKKDDAIKFLEKLKVFTLAESLGGVESLANHPALMTHASIPAEKRAELGITDDLVRL
SVGIEDAEDLIADLERAFS
>KALACAFP_02293 hypothetical protein
MRKIQILVLLILSQIAYSQVKNTDELYKTAKKLDSLIFDIGFNKCDLSHYDSIISDDLEF
YHDKGGITSGKAAFTASIKNNICGGPNKVKRELVPNTMKVYPLYNKNVLYGFIEEGEHDF
FEYFNNKWNKGGHAKFTILWILEGKDWKMKRVLSFDHQ
>KALACAFP_02294 hypothetical protein
MTRKANIQDVRQLSELFDQYRVFYHKDSDIPAAENFLKERIEKEDSEIFVAENDGKLVGF
VQLYPLFSSTRMKRYWLLNDLYVNENHRGKGYSKQLIEEAKELAKSTDACGILLETGKSN
DIGNKLYPACGFEIYDEVNFYEWTNQ
>KALACAFP_02295 hypothetical protein
MTDFQKYVQRYLDNIPSENWLGELKNSEEKTIALYSKLSEEQSLFAYDEGKWTLKELLLH
LSDTERVFQYRILAFARGDQNELPGFDEEIYAKNSFANERSLESLLEEYKLVRKSSQILL
ETMNSSALNNIGTANGNQISAETIGKLIVGHNFHHLNIIEERYLPKL
>KALACAFP_02296 hypothetical protein
MRQLKNKLILISIIIFIASLFFTAFKVIEPKEIKVFSSAELLLLGPISFVGGSVLEFFIW
TANFWLLISIVCVYSKKFFISIVTGIIALSISGSFTFWKEVLVSESGRMGKIYSLEAGYF
LWLASILFITFSSIYLKINKKIKAKNFTNINRNGL
>KALACAFP_02297 hypothetical protein
MSFIKIYVHIVFSTMNRNPYLNTVDLRIKVWKHIKENATEKGIFLDMINGYSDHCHCLVS
LGSNQNIEKIVQLLKGESSHWINKNQLTKDTFSWQDEYFAVSVSESMLESVRNYIKNQEK
HHKRKSFTEEYQEFIDKYNFK
>KALACAFP_02298 Threonylcarbamoyl-AMP synthase
MEKIINILKSGGTILYPTDTIWGIGCDATNIEAVNKIFDIKKREKNKSMIILVESEKRLQ
DLVDVPEMAWEIIDLSEKPVTIVYENPRGLPKELLAEDGSIGIRLVKNDFCKKLITKLNK
PLVSTSANFSGDKSPLKFSDISPEIIDLVDYAVEEDREKVSKYSGSSVIKIWSDNRIKVL
RE
>KALACAFP_02299 Multifunctional CCA protein
MFINLNQNKNLKLFKIISEVADRNNQSVYIVGGYVRDLLMKRKASTDIDFVTEQSGIELA
QSVAKEIDPKMKVSVFKTYGTAMIRYKDLELEFVGARKESYTENSRKPEVEGGTIEDDQK
RRDFTINAMAISLNKDNFGELVDPFNGIGDLENGILRTPLEPAQTYSDDPLRMMRAIRFA
STLQFQIEENSLEAIKQEAERIKIVSMERIMVEFNKIMLSQKPSLGLKLMEQTGLMKLII
PELIDLKGVEEVEGQTHKDNFYHTLEVVDNISENTDNLWLRWSALLHDIGKAPTKKFVEG
TGWTFHGHEFLGSKMVKTLFQRLKLPLGPDMKYVQKMVKLSSRPIALITDDASDSALRRL
LFDAGENLEDLFTLCKADITTKNSKKQEKFKKNFEYVAVKIKEVEEKDQVRNFQPPISGE
EIMEMFNLKPGREIGILKEKVKEAILEGEIGNDSEEARNFVIAEAGKLGLSLA
>KALACAFP_02300 hypothetical protein
MKINRLLTLVFASALLFNVSCSDDDNVTEEMYYGNGFLVANEGNFGKPNAEVTYVSSDLS
IKQDNIFSSNNGGSNLGDVLQSITYSGENAYLLLNNSNKIQVVNRYNFKRTGEITSQLNS
PRYMAFANNNIYVTNDKYGGDKFVSIYKSSDLSFVKKITFTDNVERVVEAGNNIFVQNAS
YGFGNKITYITTSNNEIQSTITLPSGNINKMIESNDMIYAIAAGTSDSYIYQISNTGSIT
KTYTLTGIANATNLEIEKNKIYFTSGLNVYAMDVTATTAPSAPLFTVANSIDPYSNLYGF
SVVNDKIFTSDANGFTQDSKISVYSTSGSLIKSFTAGKGTNAFYWN
>KALACAFP_02301 Vitamin B12 transporter BtuB
MDIKRSLVLLFSSYGCFLFAQEKTIDTVYIFDNQMNKVKLFHKVNTITPKDIEKNTTNLS
ELLRFQSQVYIKENGRGAVSSPSFRGTSAGHTAFVWNGININSNFLGQGDVNNIPLFGYD
QLEVKAGGGSVQYGSSAIGGSIHLNNNLDFNKDFGAALYSEVASFDTYNNFAKASFSNDK
FSFKVSGNYFISQNDYEVREKEYINRNGRYYNTSVNVGASYKIAPHQTISWQNQIFDGSQ
YYPIFVENGNKTKYKAQTLRSLLAWDIHKSKLSNSLKAAYTEDNFQYFGDIDKPKESGAE
GKNYIFKNDFNYFITPKINVNVIGEFQVNKGEGYQSGIGDISRNMGSVAGLVRYFATQDL
RFEAGVKKDFVEDISSPLLYSFSGKWNAMKWYNIGMSVSRNLRIPSFNDLYWEKGGNPDL
LPETSTNLDMDHEFSFGDFKITLSPYYMDVKNYINWLPTPYGYWAAFNTYKAEIYGLESQ
VTFNKNFGKHGFRLNAGYTYSKSINKDTGMQMVYVPIHKAFGNIDYQYNFLRVYVQGLFN
GLTYTTTDEKRADAIDPYFVLNTGISATLLKKYTLGFKVNNITNTVYQTVSYYPMPKRNY
SVYATINF
>KALACAFP_02302 Cytidine deaminase
MKKETQISYEYFKNSSELNDIERKLFERAKQARENAYAPYSQFLVGCAILLENGEIYSGN
NQENAAFPSGLCAERTTLFWVAANFPNVKIKKIFVVGGPKEFHEKNPPIPPCGACRQSLI
EYETKQNENIDLYFSSMNEEVVKVHSIKDLLPFYFDATFL
>KALACAFP_02303 NADPH dehydrogenase
MLYTPVKFRNVELKNRWVMSPMCMYSCENGLANDFHFVHYGSRSQGGTGLIMVEATGIEP
RGRITNHCMGIWNDEQAEKLQRIVEFVHKNSESKIGIQLAHSGRKGSTWNNIQIPVEEGW
ETVAPSPIPYHPTERIPHVLTVEEIKEQVQNFKNAARRAVKAGFEVIEIHGAHGYLVHQF
LSPLSNIRTDEYGGSFENRIRFLLEIVDAVNEELNENVALFVRISGTEYAESGWEISDSV
ELAKILKNHSVDLVDVSSGGNIHGVKIPLFDGYQVPLSSQVRNEAGIKTGAVGLIKKISH
AEEILQKGDADLIFIAREILRNPYIAIQGSFEMKEDCFFPHQYLRARIST
>KALACAFP_02304 hypothetical protein
MKIEDFMLPCPSKKFLGIECFGCGTQRAIVMVFEGKFGEAFHLFPAVYTLLLFFATVFLS
FVDKKRNYGNVLVILAAVNSVIMVVSYFYKHFFINH
>KALACAFP_02305 hypothetical protein
MDQKLPNAQTVLILGIVSVVGSCCCTGLIGIICGLIGLNKYKSDKLLYDANPSQYSDFGN
LNTGRILCIIGLILGILQVLYFIYILATIGWDGYMQQMQDLTKMGRG
>KALACAFP_02306 hypothetical protein
MSNTVNAKLYKVQDFIVKEKDDNEAVIQEIIDSYLKRKENEFIPINLSNSVNIEGWNAKL
YVFTTGIKVPSWYDFLASIVDEESELDNIKVQNSTFVLFVYDHESIFIISRGYHGHSLLD
EYIEPFFGMDVLSKLVNKNSTEIRQLEERGLFGIELGAQRYFRENYSLAFEDDFGKIYKA
MLASINEDDFGKLGIIKKKESTTKLSINGGSSLEISSKFDYEELINRLKKIKELLKLEGV
EFNQFYRLPLSNPINKELNDCLLDYAYECLINNENIDFYNPNLMHYVRSTETEFFNKKDG
NYCEKEYSASSNYIEIMKLLKDNNLIDDTSLETFKESLDKTQGHFRENDSGEFIFPSKLS
YWISGEVEYGGNKYFKLDGSWYVYRDSLDHNLNEYFKDFDFESYAPIIPLESWVKKSEGS
YNESFKNKEGFIIGDRAYLNYIEIADLIRVTDDKIYLYHVKKGLGQDTRVLINQINNSAR
FLSYSEDEESIEGIKSYYKSVSDKHYNGGKIKLKENNRLKQLSEKNFIDLFKSNRKICFV
FAYGSDNVLSIKDEIIASNSRIAKLSLIYIIRDMKRTDYELLFERILLEE
>KALACAFP_02307 Extracellular ribonuclease
MKKSLLLFAFIGFLANAQAPAGYYNAANGLSGAALKTALSTIITNGHQDKGYNGLWTGYK
TTDIDKNYENDGSILDIYSEKPTTTDPYKYTPVTNQCGTYSVEGNCYNREHIVPQSLFNE
ASPMVSDIQFIRATDGKVNGMRSNYPFGKVGTATFTSKNGSKLGNSVSSGYSGTVFEPID
EFKGDVARMIFYFVTRYQSKLSTFSSGNMLGNSTFPGLQTWELNVLLAWHNQDPVSQAEI
NRNNASYTYQGNRNPFIDNPNYVSQIWGSTSGGGTTNPPTGTNCVNENFEAIPTASTSSY
LTRTWTNSGISWTATDARTDQTITTKAITVRDGSLTSGSSANGIGSLTVTTQLKFTGSNG
TFNVKVNGTTVGTIPYNTNVTTTTINNINISGNVVVELENTSTNNRVAIDNLSWTCYSGS
ARQAQNIASEFNETHALQISPNPVSNNEIFVKGETQNIKKAEIYNLQGKMVQAIDQPFKN
TRNSIKIKSLEQGIYLLKLDASTLKFIVR
>KALACAFP_02308 hypothetical protein
MLREPQHDIPNTTRFTHCYAENFILNLSITNIFTNDTDLF
>KALACAFP_02309 hypothetical protein
MIKNLSLKKCFPLLGILGGMLTANAQCNAVTSFSENFDAYSCCTMGVVPTCWDSVLLGGA
SQIISSTAPASGTSQIYQNGYGAGKISIVVMPPVSNINAGTHRLRVKMRANSAGYLEFGY
IKDALPETFVVLQGITITNTSYSDSAAERIFTVPTTVPDGMRLAIRNPGTSFAGHYWDDA
VWEPIPTLGTVETTISSGVKVYPNPFTTVLHISDTKDVKTAIITDAVGRVVKTVEKPATT
VEVNDLQKGVYFVTLYFKNGTEKSFKTIKN
>KALACAFP_02310 hypothetical protein
MIVGGALVYLGRKIKNRKNDSEVFVGEDGNTYKKDEMYFTSDGKVYKNGKELHFKTPETD
NVTDSKSNFKNESIPKNYDAQPKNVEYHHKGVRHH
>KALACAFP_02311 hypothetical protein
MKKYIFILLAAATLGLTSCSPFQVRSDYAETANFTTYKTYKIRIDDLKLNDIDKDRVLNE
LSRQLQSKGLQSGENPDLIVNVKANHKKVTDITNNSPYGMYGWGGPFGWGIGMSRTWTSN
YNEGALIVDLVDAKTNKLVWQGIGSGISVDSPKAKQRQIPEIMAEIMKNYPPQRK
>KALACAFP_02312 hypothetical protein
MALFDIKEGEDFYYNEQGYKVFTEKFHLKRGYCCKSGCRHCPYGYDKKTDTFIKNDKKNK
>KALACAFP_02313 D-cysteine desulfhydrase
MLLQLPTQKIPIQEISINKNIKLFIKREDLIHPHISGNKYWKLFFNINNYLEKNPEKPYI
ITFGGAFSNHISAVSAVGNLAGIPTLGIIRGEELKDKWRDNPTLLFAKRNGMNLQFVTRE
EYRHKEKLTDFLQNEFPDALIIPEGGTNEEALAGVKMMLNDDTKDFDYLCTAVGTGGTIA
GISKYCEDNQKVIGFKAVDDDSLENKILELTLKQNFNLINSCFGGYGKVKDENIRFINDF
KEKYGIPLEPIYTGKMMQRVFELIDEDYFPEDSKILCFHTGGLQGIEGANLLLEKQNRNL
II
>KALACAFP_02314 Exo-glucosaminidase LytG
MKRLFLLVSLLVLSKFSAQSWATEDQYIQKFAKYAVEEMEKYKIPASITLAQGLLETGGG
QSRLAQEGKNHFGIKCKEDWTGKTMKHTDDAPNECFRVYDDPKQSYEDHSVFLATRKYYT
GLFNLDMKDYRAWAHGLKKAGYATNPRYASILIGKIEKYKLYEFDNTSSKEVLYAVLKMY
PDLKDDRSFMAQLEPEKYTKKIKDPVTVEVPYKQTSYAQQQKRVERIKTKAEILNSILIK
SHPNDGLKYIIIPEDTNLKFIANKFKISESKLMKWNELENDVLKKNDIVFLESKNSDGNT
PTYKAESGEDMHDIAQKFGIKLNKLYAKNRMDEGQKPSAGQLIYLIDKKPRN
>KALACAFP_02315 Glutamate-1-semialdehyde 2,1-aminomutase
MKYQRSSALFDEAYKYIPGGVNSPVRAFKSVGGVPVFMKSAKGAYLTDADDNTYIDYINS
WGPAILGHTHPEVLEELKIQAEKGFSFGAPTELETEIAKFIVENVPNIDQIRMVSSGTEA
CMSAIRLARGFTGRDKIVKFEGCYHGHSDSFLIKAGSGAATFGNPNSPGVPAGTAKDTLL
ARYNDFEQVEDLFRHNQGEIAAVIIEPVAGNMGCVLPENEFLQKLRKICDENGALLIFDE
VMTGFRLAFGGAQELFNVKADLVTYGKVIGGGLPVGAFAGRNEIMDHLAPKGGVYQAGTL
SGNPLAMRAGLKTLQIIKNDPEFFNRLVKTTETLDFEIGKILNEKGIAHKINRKGSMMSV
FFHINRVSNFDEAQEANHSLFNNFFHQMLTNGIYLPPSGYETYFISDAIKDKEIDMTLEA
VRKFEYS
>KALACAFP_02316 Arabinose operon regulatory protein
MSHQKDHFPVLRIQEFVEKQSNGCDLLFNELYGERSIIEPHKHDFFIINLFEKGKGTHTI
DFREYPVENHQIHLLFPDQVHHWQIEKETIGYQLMISREWYESFLPSLRFSASYYQYHPV
ISLSEPVYQSLRYEFQMIQNELDLEPIFWELIQKRSELIGLLVSKTAEGAFKDFEMYNSN
PIISKFLNLIDSHFKTERSVSFYAEKLNISANYLNIVCKKNLNVSASSLIQDRILLEAKR
LLKVSEMSVKDIVYDLGFYDHASFSKFFKAQTGMTPSQFKE
>KALACAFP_02317 hypothetical protein
MKKNHLKLIIAALIIGFSFTIYSCSKDDETIATIVPVGIALDPSNFKGEVTNGQVVTLDA
TKVYVLTGSVIIKNGGKLVIPAGTRIVATAGAASYLLVEQGGQLYANGTALSPVSFTSSA
ATPGSWGGVVICGKAPINTGATGISEIGNSTYGGSDPADNSGSLNYVRIEYAGAEFAPGK
KFNGLSLFGVGNGTKADNISLLNGSDDGIELYGGTVIVSNIISAGNADDAFSFTDGWAAV
VTNIYTKRRADGTGNSGIRGVNNATNFDASPRSNPTIKNITVIGGTTGNTNGINLISGTN
AILENIVISNWSTGITIESDPSVTYFNGHKKIVGALFDNTTTKVSLKSTAGANVPIVDTT
FTEKPDAFGAGNGTATPAWAAGWSGL
>KALACAFP_02318 hypothetical protein
MKNLFFYLVLFFSFTVKAQTLTAGNFKVDALSTANHRMDYSYDISGTFFKVDMYVYKNSV
AQENLISYNSKIDESNFEQFTFPPGFRYSTYSLNYYESTTPAKFILVIEAWENPEMPKMT
QTLTYTPPAPQKPDFSIARIQIYRDKFNTNDYSHLFFDSQDTANYPGTAFNKGTKYKFVV
TVYNTGSLTNQNSTLTLIQGLSQSGTYPSGTALKTYDAAVSIANTNIKTVEFYETLISPS
QDYVPAYLAFHIDKNNTADELNENNNIKIQQASLYPTSITIPGKSANLTSIKVFNEKGNL
LKEYSVKKDEKIENKIVEDFGAGNYFIKSENNITRKLKISK
>KALACAFP_02319 hypothetical protein
MKKNHLKLIAAALFIGTSFAIQSCSSSDDDSIPTVSPVGIAQDPSNFKGDVPNGQVVTLD
PSKVYKLTGAVMIKDGGKLIIPAGTRIEATGGTSSFITVEQGGQIFANGTQSAPVVFTSP
AGAPGSWGGLVICGKAPINKGTTATAEVGNATYGGTNPTDNSGSLTYVRVEYAGAIYTAD
KEFNGLSLFGVGNGTKVENVAFVNGSDDGIEFFGGTVNVTNVVSVSNEDDAFDWTEGWNG
TATNIFTKRRANGTGNRGIEADNNSNNHDASPRSNPTIKNATFIGGTSGEADGFKLRVGT
YATIDNVVLSGWATGINIENDASVSYFNGGGKITNIKFDNVTTKASAKSNAGTSVTVLAN
TYTENASATGAGNGTSTPSWASGWSSL
>KALACAFP_02320 hypothetical protein
MNFRKLSIAVLFLTTSGTVLYAQETKKDTAKSEKKIEGVVITGSTKKGAESNIISLQKKS
VEVIERVGSAQLTKQGVGDAATAVTKATGTQKQESSGQIFVRGLGDRYNSTTMNGLPIPS
NDPLYKNIDLGIVKTDMIDYLSLEKVYTPRIWGDMAGANVDIVSKVYTGKPYFKVNLGSS
VNFNAIQKNNFYLQDGPNFFGTDIIKKPSNASVASAGYVFKTSWQNKEQNNPFASSLGID
FGTNFKVGSTGKLSIFGYAAFDNDYGYVKGIAGGAYDGQNTPLKIYNNAEEYRYLTNSTG
LLNLNYKLNSNHNINFTTNYIHTTDQKLGNYQGYNRDYYDNDPLQERYVTNLRRATYKVN
DLFVNQLRGEHTLSEPLKLSWNLGYNRLESKRPDRQQNVTIFDKQMNTSFFASSNPGANN
RYFDNLIENDYVGDIHADYKFSENAKLTLGYSGRYKDSDFRATQYNFRIKLNQGSYFVDP
NNYDTFFNPLNYQIGAFDIVTFRGDVKFDPATALIPQFFTSEIFNNAGYVNFDYKFNEKL
TAQIGVRYDNLSQKMTYNTALLSNGGNLDKNYSKILPSLNVKYALNDFNNFRLSASKTYT
TPLLLEMAPFEYEDIDESSLGNKDVYPSDNYNLDLKWEWFPKKNEVISITAFGKYIKNPI
SRITIASSSNVVSFANVGESARVFGAEIEFRKDLYTKGNSRVYTFLNATYLNTEQDLDSE
KLSKENTYVSGNFLKDKEKMQGASDFLANVNLGWETKWRTGNLDLVVAYSYIGDNIYSLG
FEKRGNMVDKAINTLDATARFKFNNGFGISLQGKNLINPTIKRVQDNEGTELIAKQYKRG
IGLGLGVSYEF
>KALACAFP_02321 Transcriptional regulatory protein WalR
MNQKKILLIDDELDILEILSYNLEKEGYDIYTATNGNEGIDKAKEIIPDLILLDVMMPEK
DGIETCQELRKIKELQKTLIVFLSARSEEFSQLAGFQAGANDYIVKLIKPKILISKVNAL
LQLTSQVSDNAKLIEIGDLVIDKDNFRVSKNGQQFLLPKKEFDLLYLLASNTEKVFKREE
ILEKVWGNDVIVGERTIDVHIRRLREKLGINTIQTLKGIGYKLIV
>KALACAFP_02322 Alkaline phosphatase synthesis sensor protein PhoR
MKFYRLTLVASCLLTLVMFLLVIIFDSLKDIYYKTPFFKLGLFLCLVFIFIVNYIVLELL
FNYYGKKQVRGLSQLLPQEIVHDDDQNITIKELGERFSDLNQQKVTELDMMKEMESYRKE
YIGNVSHELKTPLFSIQGYVETLRDGGVDNLTIRDKYLERIDKSVERLIAIVTDLDMINR
LEAGEINLTVSRFDVNLLIKEIFDLLDLEAEKHNTTLQIQTLHPQIFVEADKQKISQVFI
NLISNAIHYANRQEAKVVVKTSILKNKVLIEVIDNGMGIKSEILPRIFERFYRVETSRSR
REGGSGLGLAIVKHILEAHNENITVESVYLEGTKFSFMLEKSK
>KALACAFP_02323 hypothetical protein
MVYKIRVILDAKEDIFRDIEVKGKQTLWNLHLGIKSAFSLQGDELSTFNLLEDDGTIVKS
VPLEDMSDDGDGEIMSDVYIDEAFENIGDKAQFQYGLLDLWEFFCELVEIIDETKGVNYP
ITVYRFGNVPLKAPSKNGGSGSKKKSAMPLMDDDFNFEDDFAESTTFVDEDDSFDDEEEE
DYNDDIFDEEDDNEDER
>KALACAFP_02324 Alpha-amylase 2
MKKLILLAVIGLGIVSCTTQNRIKHMTDLPKDWKHTTNIYEVNLRQYTQEGTFKAFEKEM
PRLKSMGVKTLWFMPITPIAQQNKKGSLGSQYAASDYTSINPEFGTLDDFKHMVNEAHRL
GFKVLIDWVANHTGWDHVWTKTHPEFYLKDPDGKFHIASGMDDIIELDYKNQEMRLAMIE
AMKYWVKETNIDGFRCDLASWVEVDFWQQARPEVEKIKPLFWLGEFDELESPEYGKVFDA
SYSWKWMHKSADYYKNNEPLQELKDLLIKYSAIGDSSMRAWFTTNHDENSWNGTEYEKYG
VITKPMAVFSATWNGVPLLYSGQELPNMKRLEFFEKDVIKWTNTYQMADFYKTLLNLKSS
NPALRGGDANVTTYLLNTTANDKILAYIRKNGKDEVLVVLNMSKEPVNFKIEDEHVSGAF
INVFDKTKRNFDEGKDFNFKVSDYAVFEK
>KALACAFP_02325 hypothetical protein
MTKKLFMIASMAIFSTAYSQVGINIESPHVSSALDVTSDTKGFLVPRLTTAAITSLSGTA
SEGLIVYDKQQKTFLGWNGTKWVNLGFEGSSGGNLQTGVIFTQGFETSDSVNYTTSGFSP
SSFNFTSGSSTASDAPGSSALFSEGTRGYGYSTSNTSATVSYLEFNTVDASSYTNNITFS
FDVAAFSVGSTTNGMENTDVVTIDISTDGGANYNTKLTLTGGNSSTATNVRWAFTGSGTG
TNSYSSSGITVTSSNTNTGSGVTLTGAQAITKLSVTGIPNSSQLKIRVGVRDNAATELWV
IDNVKLQAF
>KALACAFP_02326 Transcription elongation factor GreB
MLNESLLSMDKSKILEIIRNKITEKIQSFEHLIAETRASNNDTKSSMGDKYETGREMLQQ
EINNLQRQLNETLNQQSILQKITSETSSKVQNGALVKTNKGLFYIAASIGEIVVDNQKIM
TVSVESPLVKAMMGLQSGQNFSINNVNQTIEEIW
>KALACAFP_02327 hypothetical protein
MKIETLESGHFYHIYNRGNNSEMIFFEERNYHYFLQLLNKYIVPIGEIYAYCLLKNHFHF
LIRLKEENKISYDDFVFSTINKPKSIDPSRQFSHFFNAYTQAVNKQYCRTGSLFEKPFER
KRITDEKYLRQAILYIHNNPVKHGLVSKVEYYKWSSYRAILSNNISAVRKKEVLELFGDQ
ENFVFSHNYYDVLNLPY
>KALACAFP_02328 Thymidylate synthase
MQNYLDLLQHILDNGTDKTDRTGTGTRSVFGYQLRYDLSKGFPLVTTKKVHLKSIIYELL
WFLKGDTNIKYLKDNGVSIWDEWADENGDLGPVYGAQWRSWNGADGKVVDQITEVIDQIK
KNPDSRRLIVSAWNVAEIPNMALAPCHALFQFYVADGKLSLQLYQRSADVFLGVPFNIAS
YALLLMMVAQVCDLEVGDYVHSFGDVHIYNNHFEQVQRQLSRDPRPLPTMKLNPEIKDIF
GFDFEDFTLENYDPHPGIKAPVAI
>KALACAFP_02329 hypothetical protein
MEIKISLDEYADIPFIKKLLSQIKGITNIEVSENDKTYSWDEIENSEYFAKVMKQVRMII
KMENSGADR
>KALACAFP_02330 hypothetical protein
MSIGKKQIKLMYEIKTDEIVIKLFWHCKQDPIKLKNILNEKTN
>KALACAFP_02331 hypothetical protein
MKYLKINTQETTDLEALKNAILQMKGVDSVDIIDEENPESELKKAFNKTKEQFKKGDYET
VVNDIFDILTKNNSKK
>KALACAFP_02332 Aminopeptidase N
MKKAILSIALLGGIFFSVNVAAQTDTSGREKVYRATHTKVTELKHTKLKVNFDYQKEQMN
GEEWLTAAPFFYATNELTLDAKGMLIHEVALDNNGKKSPLKYDYKDDVLKITLDKTYQKN
QDYTVYIKYTSRPNEVKQQGSAAINDAKGLYFINAQGKDPDKPTQIWTQGETESSSAWFP
TIDKPNQKTTQEIYMTVPDKYVTLSNGILKDSQKESNGLRTDHWVMDKRHATYLFFMGVG
EYAIVKDKWRNIPVDYYIEKEYEPYAKQIYGNTPEMMEFFSKKMGYDYPWAKYAQISGRD
YVSGAMENTTATLHGSDILQKPGQLIDENTWEDTIAHELFHHWFGDLVTAESWSNLTVNE
SFANYSEYLWNEYKYGKDQADYHQMQDVNMYIHNPADFKKDLVRFDYDSREDVFDLVTYQ
KGGGILHMLRNYLGDEAFFAGMQDYLKTNEYQNAEAHQLRLSFEKVSGKDLNWFFNQWYF
GSGNPKINYSYTFEPVKKQIAVVIEQTQEQPFQFPLAIDVYDNGKPKRYNVWVNAQAKNT
FNFDVSKNADLVNINADGVLLADITDTKTPEQYLMQFTGSKEFKSKYNALNGIKDQVGKN
PTATKLLAAAIKDPFFRTRIKALQLMDLSNAEQLKALGSDVEKLAANDPKTLVQAAAISA
LAKTKDKKYMPIFEKGLNAVSNSVKGNSVGAIIEIDPSRASTLADKIDLEGAPENLLSKL
LPIIVKNKVTSQMSNIAQLAAFYPFIKFQNPELGKAAEEGYNWIMTSDNVKATESITKIL
GQAKGQMGDNPQVKMMISQMLKDGLAKKMELLKQNPQNAASINKQIDAMNKAIEDFK
>KALACAFP_02333 Hydroxymethylglutaryl-CoA synthase
MTFGIEAASYYAPSLYLEIKDLAEKRGIEPAKLEKGLGLHKMGFPDVHEDAATFAAEALL
KLIKDYNINPKEISRIYLGTESALDAAKPTASYAMQMVEKVLEPEFGARCFKNCDVVDMT
FACIGAVDALHNSLDFVRANPDKKAVVIASDYAKYELVSSGEYTQGGGAVAVLVSSNPDL
IEIENDWGIATESVFDFFKPRRHFKKEDLSNSPENYPNTIEIFTDEPVFDGQYSNQCYQD
RIREAYNHYKEITGKNKPYESWKYLIFHLPYAFHGKRVFTEIYSLENGLSYETPEEQKTV
AKSEEYVQFINDKIEKTQRASSEIGNMYTASIFMALLSALQTSFNENEELAGEEIGFLGY
GSGSKSKVFAGKVSQNWKNVVAKWNLFEDLKNRTAIDFETYEKLHRKQLEESVNQNYKGF
GLTSVELESPVLKGARYYDYQK
>KALACAFP_02334 Aerobic C4-dicarboxylate transport protein
MIKKHHMKEVLKNYSGILLLLLGISVGSIIGIVAPQIVDYIKPLGDIFLNLLFVSVVPLV
FFAVSNSIASLEQQSKFGKIMMTMAFTFLFFILTAAVFTICAVYLFPVSGVSGSSEIVEE
AANNDSWGNRIVSFFTVGEFTQLFSRQNMLALLIFAFMTGFAARKAGEKGQPFRQFIASG
YEVMKELLLLIMKIAPIGLGAYFAYQVATLGPQLFGFYAKPLGLYYIAGIVYFLVFFSLY
AFLAKGQNGVKSFWTNAIYPTLTALSTCSSFATMPANLLAASKIGVPSQIANIVIPIGTT
LHKNGSSMSSIIKIYVAFLIIGRDFFDPMNLLLALGITVFVSIVAGGIPNGGYIGEMLMI
SVYKLPQEAIPAVMIIGTLVDPLATVLNAVGQLVASMFVSRFVRV
>KALACAFP_02335 Curved DNA-binding protein
MAYIDYYKILGVDKNATQDDIKKAYRKLARKLHPDLNPDDKEAEKKFKELNEANEVLSNP
ENRAKYDKYGEHWKHGEEYEKAQQQQQSQYQGGNFGGGFSGADFGEGEDFSDFFQSMFGG
AGGGFSRSSRGSASGKFKGQDVHAELNLNLKDAATTHPQTFEINGKKVRITIPAGVYDGQ
QIKLKGHGNPGFNGGPNGDLYITFNIPADPNFERIGDDLKTKVAIDLYTAVLGGDVKVNT
LGGSVNLKVKPETQNGMTVRLKGKGFPVYKKEGQFGDLFVTYEVKLPTNLTDHQKELFEQ
LKNS
>KALACAFP_02336 Chaperone modulatory protein CbpM
MSERISREELVKIYNIEVTFFDELVDSGLLHIETENEIRYLMYEDLPSFERFANWHYDLE
INLPGLEVIDDMLKKMEDLKQKNRELMNKLSAISDKYEEG
>KALACAFP_02337 hypothetical protein
MNEEKIIVLKPRKNDFEEIYFSENQGSLFFSSTTRGKTITTIVVGLILLILFLFKDDFTK
EKFGILYFVSFLFLLCAVFLSVSINKVSRWKKQVNSYLNKLENCNIYEIRFDQNFFTVNI
DGEKETSEWKDFEYFDSTEKYIALEGKHNYMFPKKSMNEKDYSLLKQTLKKNIKE
>KALACAFP_02338 Putative cystathionine beta-synthase
MKYANNILETIGNTPLVKLNKVLGEDFPALVLAKVETFNPGNSVKDRMALKMIEDAEKDG
RLKPGGTIIEGTSGNTGMGLALAAIIKGYKCIFVTNSKQSKEKCDILRAVGAEVIVCPTD
VKPTDPRSYYSVSKRLAKETENGWYVNQYDNLSNRAAHYESTAPEIWEQTEGKLTHFVVG
AGTGGTITGCGKFFKEKNPDIKVIGVDTYGSILKEIHETGEIHLENAYTYITEGIGEDIL
PENYDMSVIDHFEKVTDKDGAVYARKLAKEEGIFCGYSAGSAIASLVQMKDQFTKDDVIV
VLLHDHGSRYVGKIYNDDWMKEMGWLD
>KALACAFP_02339 Lipoprotein-releasing system transmembrane protein LolE
MKFPLYFSRKIAFSKDNKNNLSRVIIFIGRLSVALGIIVSLITVSTGFGSKKAIKERLAD
FSGHITVKSTRSNSSYNTSVLDNQGLNIKKIQELPDVETVQKYAMVTGIMRNEHNFAGII
FKGVGKDFDSLRFKKFLIAGTTPKVTEVGYNNGVTISQKIANDLHLKVKDSIVTVFSKTD
QQPIYRKFEVVGIYKTDIKMIDDQFVIGGINHVRKIQDMKPDEVGGIDIFLKNVNDIDRD
FPEIEKLIGYKNYAEKATEKYPQITDWISIFDTNIALIIIIMLIVVVINIIMVLLILIIE
RTNSIGLLKTLGASNSQIRATFINYTLIIMIPGLLYGNAIGLGLILIQKFFGVIKLNPEN
YYVSTVPVDLNPIAIISISIGILIISALALIIPSYLISKISPVKAIKYN
>KALACAFP_02340 hypothetical protein
MNLDFKIKNLVLICLIFLGVFNQYYSQTQDKANFKTGADQPELYLPLLKGKTVGVVTNQT
GLMSDRTHVVDFLVKNGIKIKSIFAPEHGFRGDADAGEKVKNGVDVKTRIPIVSLYGNNK
KPKPEQLKGIDVVVFDIQDVGVRFYTYISTLTYLMEAGAENNVEVMVLDRPNPHDGYIDG
PVLRQKWSSFVGMHEVPVVYGLTIGEYGKMVNGEKWLKNSVQAKYTLIPMKNYHKKLRYP
ILDKPSPNLPNDKSINLYPSLCFFEGTQVSVGRGTDLPFQIYGSPWTPNLPYQFTPKPNF
GAKDPFLNGKLCYGENLSNYPNDLREINLEWVIQAYKNYKNPQLDFFLKNLWFDTLAGTD
ELRKQIIAGKSIAEIKASWKPDLNKFEKIRSKYVVYEN
>KALACAFP_02341 hypothetical protein
MKLFGRNHIIISVITFVILFLMNYVGNDQPDKIERALMTSIAGVIGLSIGLFILNKGKND
KTPPQNFD
>KALACAFP_02342 hypothetical protein
MSKIKFITGFLTLFLLGNLKAQEQSETSVYLKGNALFATIGVLNVGVEHQLSKKYTLQGD
IFISPWKSFAGHEFQYYSASVEGRYYFDEAFKHWYLGANIAASAFTLQKWSYWSDGEFIN
EHNGDLLVYSNLYQKGYSLILGVTAGYQFNISDRWNIDIYGTVGTSQDFYKGYDRTTGKR
YDPATGFNKSGEVLPYRGGVMISYKLK
>KALACAFP_02343 Thioredoxin
MKKFISGLFIISSVVAFAQEAIQFQDLPFKDLVAKAKKENKILFIDAYTSWCGPCKMMEK
NTFTKKSVGDYYNANFVNARFDMEKGEGRDIAAKYGVRSYPTYLFLNGDGEIVSQNYGYM
EEGLFLSMAQDINSPNNKKGSLRDRFANGEKDPEFLINIMKLNSASDFDFAKKASERYFE
NKKKAEEFSKDEVGFLLFFLKSADDKNYKEFTDRKAEIIKFLPEETYKEFDNQIKLSKVV
EQSIDQKNKRINDDYFMKTAEPLVGKHDAEVKLNQTKLSYYEQNANFPEYEKAALAYYKN
SESFEPNELLKAAWVFSEHVKTPTSLKKAAEWAEKSVMRGETSENTYILAKLYFLTGNKD
MAKTYAEMSRNMATQAQKDATLAEELLKQIK
>KALACAFP_02344 hypothetical protein
MTQFININEIKMKKKITQQPDYITITKNTLFRKKI
>KALACAFP_02345 Histidine decarboxylase
MLDAYMHSLAEKASLSIGYPFATDFNYEELHSLLRYPLFNLGDPFMESNYGVNSFTMERE
VIDFFADLFHAPKDNYSGYITSGGSESNLYGLYMARELHPNGIVYYSSDSHYSIPKSIRL
LNMKSIEVGSTQNGEIDYDDLFLAVEQNRHLPAIIVANIGTTMTEAKDDLSKIRSILQKL
VVESHYIHCDAALAGAYLPLLEGGSKFDFSNGADSIACSGHKFIGSPIPCGVVVVKKDNK
ERLSHYISYIESVDSTITGTRNGLSSVFLWYAIRHFGKEGLLQRAEECLSLAKYTYHRLL
ENNIDSYYNENAITVLFEKPSELLCQKWQLATKSGFSHLICMPGISKDQIDRFIEDVLNE
RENNKATF
>KALACAFP_02346 hypothetical protein
MQNTAEQLSPKVKHVDPIIVTTPEPWQWDVLAKAFLNDPTLNFWLGEKTNEQTLSEYFEA
MIKDTLASGGTVFASPDQKSVLIWTWLGRDPEDTNEFKKQWHAVLDPEGVKRYYWLYEEG
ELDLDPEKLEKSYEPAYMGVHPDSQGKGYGGHLLRWSLNYFEDKGYEAPYILASTRRSAK
LYCPLVGFHHHKEVFASESDSEPVAVYLKRNK
>KALACAFP_02347 hypothetical protein
MKAKINNFYNFLNELRYRFQNILMLGPESFDEDISLLESIYSINKEQFPFDIKTAFEELY
TENPDKMEMIFWDKLKESYYNYEQFIELDYQYFKNPDLPEKFQNLFYHSKLLSYNYFAYV
SRIYYWYYGRKNEHRSEKEEITVGFLDDYSKIIPDLSESNAMQKIQNYFSLQFEMLENYI
KYIYVKNEFHLEVVELRMSDNSFINKRLKKLANEYYSKLEILTNYKDNITKLAMNLRFNY
PDFLDNKQPTAKKVTKSQESLKFLYPENVFDSLSPYITEEFKESFRKLIFGELANVVKEI
TFRGGSNMLVYFLKQRYDEGHLIADSKEQVSEWIIKNFMFYDEEDYKKFKKDTIQKTLMR
DCKPPKKEVKYLI
>KALACAFP_02348 hypothetical protein
MKQEKFLEIITQLVSAFPSESKTDEKLDLLISKLESKDKDSAESEKDEHLLISEVCELTK
KKRTTIWLWDKKGLLKPVGKSGKSPIYRKSDVLNYIYNSKKTK
>KALACAFP_02349 hypothetical protein
MMALLPRSVNYEHIELSGKEKIEKFDMNIVKFILHSIVFKSVAFNGNTEVVNYFNQSFLS
RNYWVETIGTDYSKYIELLRDEKIIYRTPYQKKTCFGYGLVVPYRYSRIIVEVIQMKGVH
KHQNKKFNSSYTKKYEKPLSDFFVNTDFAIDSDKTENDLFERYFELANYPLKKSHGEPIK
SDLKSYSSYLMALKKMAQFMNGDYIFSRNKTSSNNKKTGKKDYKTKGRLYTSFSYLNKEI
RQNLIYKGGKLIEIDLKNCVPYLLSNLFSVTNIRMTSKRVSRLQSNLSIYMCSEDLKTVM
DREIEDFKNLCIEGTVYDIFIEPLKEKYAEKWSDMFMSYFDKRYVESYEHDRALAKQLFI
MMLFGMISQFTEVQQVFAEKFPILWDILTTKKRQNYKAVAKSLFDLEGSLMIDQVAKPLI
KSHKRKIPVFSVHDCIATTEENIPVVTEKIESVFYSNFGNIPRISID
>KALACAFP_02350 Nucleoid occlusion protein
MGEKNIKNLISSFRPQPFKFMELTLDVIEGDPNQPRKAFGFGAGGDYSRLLKSISHYGIE
DPIKVSEIEEGRFLIMDGHRRFSCAKELELETVPCRVYPKMSEGEFEARRFEMQNNRRSW
KPMEKANAIHKITAEYKDATKKELANLLGISPVHLSHYIGLRDMRVEYLELMSDYNMKEY
QRIAFMQMLPKLRKIKQYEIDNIIKILFKKISDNVMFVANDFKTLSKIFTNASLHEEEIL
NFLTEPLMTVNELSEKSRLSGFSSQIKGLIKELSTKKSLNIRLTEKEQNLLDDLHKLMGT
FTDNAEYFSTEV
>KALACAFP_02351 hypothetical protein
MLNISQQRFKNAIAYYRHSAEDKQENSVAIQRSHIERFAHEHNLEIIHEEVDEGVSGLLA
NRPGFERLFEQWIENPTAPHFEYVLVYDVSRWGRFQDQDQAGHYVYLCKKHSKEVVYVSR
GFPDVSNQLFSSLEISIQRYMAAEYSRQLSEKVFHGCIKVSQQGYSAGGKAAYGMTRQLL
DVNKKPIRILNAREHKQIANERVTFTPKNDETTEIVRKIFDLFVNERFSITEIAEYFNQK
GIFSANTKKWNTSKIIRILTNETYIGTRIYNKTWGRLKQKSVKNKRSEWVVVPNAFEATI
DKEVFNKAQEKIYWLFPSSWRKGIYAIKKAKKNINNDILKWLISKGASEFEANEIILELP
IIFSIKLENTTTVCWCFLISEKIRAYDNVLGISVLYDSKKIIEEIFVFSTQNFTSTNFLI
LMGNSSLYYKTKIETKNLEEVILNLLKQIKESRRWFKNKYKFLENLM
>KALACAFP_02352 hypothetical protein
MDKTYIRWKYNNFNTLRIIMKNINLFLVLTILTSSLASCQTVVNLHNTYPTNTPNTYYKD
IGDKLNPYEGTWVLDDGVSYIKIVLVKKVKFPVWQYFEDCIIGGFQYKKNGVEIINTLID
INSNQSDPIHYPISGNWIGDPSRTPFSQYTSDNSYLKLSIRENDCFSDIYVRRLTLNGQI
AIQIFKRKPMDLHQVCNPVIPQDFHYLIKQ
>KALACAFP_02353 hypothetical protein
MKNKFFLWLSLLITLSIVLYSCRNEDFAKAETDPQRNNANFFKHQSDIYSKAGVDYINIL
EAYNKETDFLSTMPDQRGIPIWDKMQIFDAEGATGLMIPLSYDNETLSSILFANLDEKNS
VLNVKNYDNSILKNLVYNTEIDIKARTQMFYTFMYVDHQTFGTESFTGIPYDMFDGDQHQ
ENSNTYGRVWLNDFKSPSNPHYDTSKMTIMVDICVTSWHCKEGKSWKNCDKCGTCLSYSC
TTIGSGTFDDPIYSPGTGTSPGSGGGGGGSPSPEGIPPVDPCTQSGMPFYRIAPQCAGNN
GGGNLDDEELLPPQSPCETLTKAKQDSKVNNALEELKSKTLLKQEYTYEISRKYNNSTQD
YDYDTNLKIGDGFSVVVSTGEYIKGNAHNHPSDGVRIPSVGDIMWMKICKENIAPSKAVA
YNIIVCSNPINPNDTTKANIYAIATDDYDSIASKIDEMLNRSDLAGKSYDEKRQKLLDED
DRYYAGINENSTELEIKFLQKYGSFGLGLYKFDKTTNKWTKLTYDGNIITLTPCE
>KALACAFP_02354 hypothetical protein
MKKLIFTLMFALPTFYFAQEEKPKESQIAKECDLPKDFKEPIKNNRLKKFVAIDNGVGEK
EVIIIRAQNGFGSGIYTVCVKQQPIQYQKMGTVFMREGKNPFNNAK
>KALACAFP_02355 hypothetical protein
MSKKERRAEEETRNLNEQVRNQRGNPLMQKLVFNYSKIKFTNEVTFKPIQIATAEVYKDR
FEITIYPYSAYSGTYVIVKSQKQGDGILNTVVKVDGGNFSHYNSKKPCFVHISERANILK
IYDENRIGIILKF
>KALACAFP_02356 hypothetical protein
MSILFSTDTVRSLNKRQKLAMLTVVKAISDNATDFTKKINQQKILTKYLAIFELTDVAMS
NYEQHLLRIDLRSLNPNQRDYFIVMGHELLGAIQNRRLEDYNILFEAFQSYGNISSSEFS
GTIERLRGNSY
>KALACAFP_02357 hypothetical protein
MLTNPYFYRARLFPALITSIPMLIFVNKIIAVQYADALKNVYDILPFIAHFGLSGAIIFL
CVQVNRIVAKEIFQRLHFREELLMPTTNHLLISDTHYPTPIKDKIRNKIKKEFKIVLADA
QSETQNENDARKLIVTAVSQIRNVLRGDNLLLQHNIEYGFWRNLIGGSLIAVIFAIAIFW
YGAYNKLEDQIITGIICFILYLIPIVLSRYIIRRYGNYYSKILYEQFLSMK
>KALACAFP_02358 hypothetical protein
MLQWFKKHPEFLRRESNALANDSNYRELFQYRDNLFISHGNIVVRANGLHRFPILVLYSD
ATPYRLPMIFPLERQLSQEEIVELSKLQFSEALENIKSFTKLYYNLRHQNSSGELCTLER
EDLDKPISIYGISTILQRVTDWHIGHITGEYPPDSEDVNFIAHFNNISSDVKFFYSEQFL
DLSLTEGDCYANLFKFIPKDPIFTENKYIYFGCFIDGHKNGIFTQIDIDLTRFGIKDIKT
SLDLYSKTSTVQGLLKDKTLLKASWFHINSEPSPFGTIEELITIIGNGDYQHGLIRLSQS
IHNFKSLDGYFYLGLRFSNRKGINEFQLFKILKKEVSEGYIIGQTDNTQKIKEIFDCYDK
IEAIQSEKLTEESFHQRNSKRADYDILKDESINIFGVGALGSEIADCATKAGIGEIMLVD
NQIMHAHNAVRHLAGMEYIGIPKVLAVWQILNNHNPFIKILPNYGDLYQLDPENLADNSI
TICSIADDNVEGFINQQLILSNKPAFYVRALRGGKTARIFRVVPEKDACFHCLSLYRSEN
EYFIEIPEDAEYPTLKNECNNPIRPASAADLKLIASIASRFIIEHLQSGESENNHWIWST
DTIDGTTINSNSIYSQYIPPHNECVYCNNKQKIQVIISKDCISFMQDLIRKNPTIETGGV
MAGIKDEKGNIVITHVSGPGPKAVMSSTKFEKDIEFCQNFLDEIYQNSNQTTTYVGEWHS
HPSTNNHPSETDVKSLTEIAIEKNYLTDCPVMIIFSNRGNPSCTLHPADKPYYFSDLEIK
>KALACAFP_02359 hypothetical protein
MTIYSFCIVWINSCVLTTITITQNIFMTVAEKIIKPTQAGIFRTVFLYTGQGEATLMVIP
TGQNVNDYMYVLVDSDKDNEENEIDLVYLFKELFSNGGKLSTFINTHPHNDHIGGIKEIY
DEIGFSEVWHSNHKAGGKHKEKYEVFTEVLKKVGKSNEYFLLGTNELNKIRTSENVPTTK
KLGLIDFQVISPAQYLCEDIQEGDADERNKRIHEQCGVIKFTYGTNPKSILMTGDSDKEA
WKEHITEYHKDSLPADVLSASHHGSRTFFKNGKDDKDVYETHIEYIKPSYLIISAPKQSE
SPHEHPHDDAMELYKKHIDEDGILHLGANIESVIVDIDSYGNITVKTDKELIEKYGISEN
GGENEKNDASKNVYIGVQTSRIDNKPMG
>KALACAFP_02360 hypothetical protein
MAKLTNCLDTFSIYVGTYAKYNEGSLYGAWLELSNYSCYDELLKAMHELHQDEQNPEFMY
QDYECSEFFIKQKLISECHLSVNIYEIGKQIDNSDYDFEVIEAYAECMSYSHEDVRDLLN
SLSDSYYGEYSSDEDFAQTTLEQDGSIPENLPSYIYIDWEVTARHLMYDYMSSNGYYFRN
>KALACAFP_02361 Putative transposon Tn552 DNA-invertase bin3
MRARYIRVSTGAQNTARQEERQAKDEKVFIDVVSGSTPFKDREQGRELIKAIEGSKINYV
SVSSIDRLGRNLYDILTTLEFFKEKGVILKVDNLGIESLIKGKENQAFKLIISVMANIAE
MERETILERQREGIALAKAKGIYKGREKGSTESIEDFLSKYKEVIKNLKKGNSIRDTAKI
CSVSIGTVQKVKNNI
>KALACAFP_02362 Tyrosine recombinase XerC
MNIAFFLKEPTKATETMVYVSATLKGQRLKRSTGVKVKPSQWTGTKVRQLAPESAIKNLK
IENTVKILKEIEREYLLKEQPLSKEILEKEFEHKITPVNTTTARKKDVLSVFNEFIDVRK
QSVSENTIKTYKTCKNHLQTFSTEMKFDMSFQNITLNFYDELLAYFIEKNFYNSTIGKYV
TILKTFMNWAGERRFHNNMEFKKFLVFKDDSEKIKLTPEIVEKLRTTDFEDDYSNIVRDI
FIFSSYTGLRFVDIQNMRPEDVTEDFLRLHIKKAKEMLDIPLLDIPKEIIKAHTERYGRL
KIPTNQFCNREIKKLFETIGFDAKIRFVKYSGKNEITVEKNAHDYLTMHYGRVFFITNSL
INGMNEEFIREITGHKDYKSFKKYVQFSREMVADSLHSAWKK
>KALACAFP_02365 hypothetical protein
MSLISKNDLIKASGLSKIGFLKNPVASAVMSIAKINEVNRLYDKLKDKEGKDFFDSFVRE
RNLSYIAFEEDLAKIPKTGPFILVSNHPLGAIDGILMCKILSEVRPDFKVMGNFLLEKIK
PMEPYVISVNPFEKRKDAYNSSSGMRETLKHLQNGGCVGIFPAGEVSNKNNPYGEILDKE
WEKPALKLIKMAKVPVVPMYFHAKNSRLFYQVSKIHPNLQTLMLPAEMMNDREKPIRIRI
GKPIAVKAMDDMETIEELGEFLKRKVYMMKSYYEKRKSLAQSINLQNLSVKFPLLKEENI
VQNIIDETPKEDIIKDINKLKGTDKMFFSNGNYEVYFTNYEEIPSIMREIGRQRELTFRA
VGEGSNLPFDLDEYDKHYHHLFLWDNAEERLVGAYRMALGKEVMKRSGIKGFYTSSLFEF
EQDIHPFFKKVIEMGRAYICQEYQQKPLPLFLLWRGIVHVCLRNPDHKFLMGGVSISNKF
SEFSKSLMIEFMRSNYYDSAVAQYITPRNEYKVKLRDRDKNIFFEEMESDLNKLDKIIDD
LEPELRLPVLIKKYIKQNAKVIAFNVDPNFNDAIDGLMYIRISDLPESTIKPVLEEMSDQ
IRKEQENNPAENQ
>KALACAFP_02366 Lysine-sensitive aspartokinase 3
MKIFKFGGASVKDADSVKNVSMVLKSQGFAKCLLVISAMGKTTNELEKVVELYFKKDNYQ
TEIEKIKRKHIEIADGLFPENHAVFAEINLFFDDIDSFLRRNKSPNYDFVYDQVVSCGEM
ISTKIVSEYLNEIQFTNQWLDARDYVKTDNSYRDGNVDWKKTEEFISNLNKEICYVTQGF
IGSDDNNFTVTLGREGSDYSAAIFAYCLNADAMTIWKDVPGVMTGDPRKFKDVTLLSNIS
YEEAIEMAYYGASVIHPKTLQPLQQKNIPFYVKSFVDPTKEGTKVGASDKNQSEETYILK
ENQTLLKISTRDFSFIAEDHMSLIFGYLSKYKIKVSLMQNSAISLALCLEDKFNTIDELN
EELQKVFKTEVVKNVSLFTVRNAKMDHIDRFYQEKSVLLEQISKNTLQMVTQ
>KALACAFP_02367 Fructose-1,6-bisphosphatase class 1
MSDQPLQTLGEFLIDKQDDFQYSTGEFSRLLSAIRLASKVVNREVNKAGIADIIGKAGNE
NVQGEEQQKLDVIANEIFITALSQREVVCGIASEENDDFIDIKCGENGHLSKYVVLIDPL
DGSSNIDVNVSVGTIFSIYRRVTEPGTPVQLEDFLQKGVNQIAAGYVIYGSSTMIVYTTG
NGVNGFTLDPSLGTYYLSHPNMQFPKTGKIYSINEGNYIKFPQGVKNYLKYCQMEEGDRP
YTSRYIGSLVADFHRNMLKGGIYIYPSYSQAPNGKLRLLYECNPMAFLAEQAGGKATDGF
RRILEVEPTELHQRIPFFCGSIDMVEKAEEFMRIDSVK
>KALACAFP_02368 L-amino acid-D/L-Glu epimerase
MKAEYFRYLLQFKRPSGTSRGVLHEKETFVLEISENGKKGIGECAVFRGLSFDDRPDYEE
KLQWLCENIQQDSEFLKEKLKEFPSIWFGYEQAVLNLKHSGNLYFPSDFTEGKASINING
LIWMGDIHYMEEQIQDKLEKGFHCIKLKIGVDWKSEHEILQKLRQKFSKERLELRVDANG
GFNKDESKVVLQQLADLDIHSIEQPIKAGNWKDMAELCAETPTPIALDEELIGIIDCNEK
KKLLETIQPQYIILKPSLVGGFAGSDEWISLAENQNIGWWITSALESNIGLNAIAQYTYT
KHSKMPQGLGTGGLFTNNFESQLDLRGEQLFFLK
>KALACAFP_02369 hypothetical protein
MAVYILSNRKIIRHKGERVDSFSNDEYSIPSFRIAKCNFDGYKEPTAAAKKKKDYTNRNI
LNYQLFSEPQKQGYQDVLDVLLNEKGIKESSLTANHLGGTQRMFYELYKNMSSTKDRSDV
LIFIHGYAYDFDDELKAILDLKKLFIDNTESPVEHILFVSWPASSNVVPLTYFDDKAASI
NSGASLMRLFYFYTQFLKDIFSNRDLIPCNQRIHIAAHSMGNRVLQSMLYSLKKENILRV
IDQVLLLNSDVSYKVFEDQETSFNKLPLLANRISIYLNRKDLILGISQFTKNILTPRLGK
NGPSNIEPYKDIVSVIDCTFVEDDLLNTFKFEAGNHWGYLSSSSVQNDIFQNLYGVDRNL
IANRLKNNENIFTIVS
>KALACAFP_02370 Glutamine--tRNA ligase
MEEEKKSLNFIEQIIEDDLANGLKRDQIRFRFPPEPNGYLHVGHTKAICINFGLGEKYNA
PVNLRFDDTNPEKEEQEFVDSIMKDVEWLGFKWDKVLYASDYFQQLYDWAVQLIKEGKAY
VDEQPSEVITEQRKNPTEPGVESPYRNRPVEESLDLFERMKNGEFEEGTMSLRAKIDMTS
PNMNMRDPVMYRILKRPHHRTGTAWKIYPMYDWAHGESDYIEQISHSLCSLEFENHRPLY
DWYLDQVYDETKVRNKQREFARMNVSYMITSKRKLQRLIAENVVNGWDDPRMPTISGMRR
KGFTPTSIRNFIEKVGVAKRENLIEIQLLEFCVREDLNKIAKRVMTVVDPIKLVIENYPE
GKEEWLETENNPEQEDAGTREIPFSRELYIEREDFKEEANNKFFRLKLGGEVRLKSAYII
KGERVEKDENGEITTIYATYDEKSKSGSGTEESLRKVKGTIHWVSAKHAIPVEVRNYDRL
FTVEQPDAEKDIDFLNFINPESVTTVQGFAEPSLKDVVVGEPLQFQRIGYFTKDQDSTDT
NFVFNRTVTLKDSYKPE
>KALACAFP_02371 Multidrug resistance protein MdtH
MKLINLYTNSFKGLSQESWMLALVMLINRSGSMVLPFLGVYMTNHLHFSIENTGIVLSFF
GIGSVLGSWLGGFITDKIGEYKVQSFSLLLSVPLFCLIPVFKTEVGVAAIILLQSIVSDS
FRPANSVAITKYAKPENITRAFSLNRMAVNLGFSIGPALGGILSAISYEFLFFSNALAAF
SAGILYIVFFRKRNKIARLKAKKVKEAIEIKKENSPYRDGKFLVYCFFCMLFSICFFQIF
STLTIFYKDVAKLSQQNIGYILGYSGFLIVLLEMGFVQIAEKYFNLAVTMLLGTFICGFS
YAMMAFDHSIVTLIISMTLLCIGEIWTLPFMSTITALRSGDNNKGAYMGLNGISFSIAFI
VTPYLGTMLAEKFGFNALWIGTGVLATVIAIAFYFIIPWMIGDKKEKI
>KALACAFP_02372 Vitamin B12 transporter BtuB
MTKFYFLLSIFSVSFFFSQKKDSATLISEVQIDAYKKSTPFMASTKSVSVVSEQLLSQNT
PERMLESINQIAGARMEERSPGSYRISLRGSTLRSPFGVRNVKVYLDDFILSDASGNTYF
NVISPELIDKMEIYKGPESGDYGAVTGGTILLQTRKSDHLSANVSIGSYGAFNQSFDFSK
QLGKHFVEIFQNYYQTDSYREQSAVARKQFFIKDNFQYSEKALFKAMISYTDLNYETPGG
LTLEQMQANRQQARPATPSLPGAKEQDTGIRNKMLLTGLSHEFNFNQNFSHFILVQGSYV
DFENPFITNFENRFEKNFALRTHFNYEKNWNEISLAYRFGFEGGINDILIKNYDNNKGIE
GNPQNFDQIKYTSGFYFLSQKLDFNEKLFTDISVSLNSNSYQWERLYPRSQDGTIRFKNQ
WLPNFGITYLLGKGFSVRGKIGKGNSAPTNEEIRSSNQEFNVNLVPESGWNKEIGLRKQF
GNSIFVEGNYFDFRMKNAIVRRQNDSGQEYFINSGESVQKGVEILLESKNFNLKNTILSN
FKFRFSGSFYNFKFENYQQNNTDFSGNDLTGVPRTTINSLLNFTLFKKISVDYSHFYTSK
IPLNDANTFWSESSLIGNIQLRFPIDIDNTRLNVFFQIQNLYNTDYVLGFDSNAFGNRFY
NPAAKRNFVTGIQVNF
>KALACAFP_02373 hypothetical protein
MKKLTTLKVLGIIGVSFFLASCEQDGIEDTIQQIQPTEKTELATKTMSAKEEAKFIEENG
LKLIATISMPERRSNKISLQNSTTIQEELTSANLQQLGLTAPKIVTLYKNQYGGNVTGVI
VNDYKTDASLVRPANNGAKAYVKTSLPVINSFNPVQDGSQATYSATTIYNSSSNPLAYSK
TLTFSDQLTLSNSTTVAAGLNVGAKISIMVSSPTGNIGLPGGVSIPLPFVQATAEASVQA
TLSTSKTTTTTTTKGTTISETISPTIPPHKKLYIVAIQKVQKGAISYKIPVSITGSVVTK
QAASYTNRPASFLKTQNLTEQEGTINYGYYSDTKIYVKELNMNEAPPAL
>KALACAFP_02374 Ferredoxin--NADP reductase
MYKAFSYFCDMEILDILIIGGGPIGLNCALEAQKNNLTYLIIEKGTIVNSLYNYPLYMRF
FSTAEKLEIAEIPFISTAPKPGRQEALEYYQGIARQKNINIHLYEKVLKVTKENDVFTIE
TTKGKYSAKNVIISTGFYDIPNFMNIPGENLPKVKHYYTEPYPYAKQKIVVVGSSNSAVD
AALETYRKGAEVTMIIRHSEISKSVKYWVKPDIENRIAEGSIKAYFNSEITEIKENTVIF
KDENGQTNEIENDFVLAMTGYLPDFEFLKNSGIELQGECLNPLYHPETMETNVKNLYLAG
VVCGGKDTHLWFIENSRIHAELILQSILK
>KALACAFP_02375 hypothetical protein
MKKLFTSLLILSIVACEKDPKKPIEDRKDSTQQTAIDSTAVTQNPTNNKDILLTQNNQEI
LQALKNKDYKKLAEYIHPEKGIRFSMYAFVNPKEDKHFSKTDFEKYEPTKTLFTWGAMDG
SGELYKATIDDYLTKWVYSKDFVTGQTSLNEFLGKGNSLNNLKKIYPNADFVENFIKGSE
ANAEMDWKTLRLVFEEYQGKYYLVGVVNDQWTI
>KALACAFP_02376 hypothetical protein
MSSQKKILIITYYWPPAGGPGVQRWLKFAKYLPEFGWKPVIYTPENPSYPLLDESLIKDV
PKDIEIVKTKIWEPYQLAEKLNKSNKKFKAGQFDVGKNQSWKSKLSIWVRGNFFIPDARV
FWVKPSVKFLENYLKENKIDVVVTSGPPHSLHLIGLNLKKKLPHLKWIADFRDPWTEISY
YKHLKLTKNSDKKHRQLESDVFKNADITLATSYTDAENFKKNGANAVCITNGFDESDASK
TAKSSDSQTLKQRFILSYIGVLEQLRNPENLWKTLDDLVKTNADFAENFTLKFAGRIDEK
ILNSIENSALKNHILNLGYLSHDKAIDEMAKSSLLLITNFPNESSKGIIPGKIFEYLATG
KQIISFGPNDADVAEILNETKAGKHFSYSDSETIKNFILEKFELWKNGNLLENTQNIQQF
SRKNLTEKLVEILD
>KALACAFP_02377 hypothetical protein
MAKNKNLIYIAISLVVFIVLAFLYSTPVFTGKQLFQHDIVQYRGGAKELLDYRADTGKET
YWSDSMFGGMPTYQMGSQFKGDIIKKIDSNLNFFPRPVNYLFLLSAGFFLLGMVVLRNWK
YALLGATFFGLSTYFYIAIAAGHNGKINTIEYFAPLLAGILLVYIRKKYIWGFIVTTLFM
GLQVAANHPQMTYYLFLALGFLFLSELIRTIQKKTPMKHFLISSGIIAASCLIGVGMNSQ
RIMANSEYIKETVRGKQILTNDSHTGGNSGMDKESMLMWSYGKLETLNLFIPRLMGGGSQ
EPEGKEMMAKVQELVQENVGSQAEMDRISKGFGNLTYWGDQPGTSGPAYQGAIVCFLAVL
GFFFAWKKYRYWILGASILTILLAWGSNFMPLSDFFIDFVPFYNKFRAPSSILVVVELLF
PLIAIIGLYRFFTDSSLTEEYKKKILLYVSGGALGLVLIMLVFGKSLLGFHTDNEKTYLP
PFLLDYLVDERFKLFKIDAIKAFIYIAIAAGVLFLSLKQKLNQNIALIIIGAVSLFDLWT
VNKRYLNDENYVDKIFAENPFQTESSDLMAEKVQENPNLESILANVNVNKTLETIAEKDK
THYRVFNNILGTFSETNTSYFKSSIGGYHAVKLRRYDDVINEYFQVMDSVKVPNILNLLN
AKYWVVGGPEQPQAIPNPKANGNAWFVSDLKFVDSPNQEIKAIGVIDSKKTAVIASSDKK
YFDGKPVQADSTAFINLTKYQPNELEFRSESKTPQLAVFSEIYYPHGWKVFVDEKEVPYI
KADYLLRAVHVPAGKHHVRMIFEPEVIEKGKWISLLCFGLFILLSGFGIYSIYRKRDKRK
TEK
>KALACAFP_02378 hypothetical protein
MKYIFEFVLATIIIYFVWNILKRIFFKTFHSYMFNNNKKQQPDIQNSNKINKKINWDAET
VDYEEIKENNDKR
>KALACAFP_02379 hypothetical protein
MKNIAALVLISSIALVSCKKETTKVTKFDPKTGKTITVEVPADSVAKVAENPAIKDSAGV
YTQTFKLEKGKTYPLTTYQRDTKTMTDPQGKTLNGTSESTDEMSFTVNDIKGNIYDITLN
LIAKRNSQSADGKTIVVDTKLPIPKEDDLKMIWNINRALTGNKLNMKMDTKGNVISITGF
DPIYTKVSNAVGTIVKDANQKASVVASLKESFNEKVLKDQFNKNLTIIPKKGVKIGEKWT
SSENADPNGKIKVTSNYILKSVGNGIAEISVTGGIPKKTEKQAQGAITHSLSSELAQNGT
IKFDQNTGWITNQNIKVVTTQIETISDGKQSQSMKSVSNSSVMVNPSAK
>KALACAFP_02380 23S rRNA (guanosine-2'-O-)-methyltransferase RlmB
MTDKKDDFIFGLRPVIEAIEAGKTIDKIFVQNALQGPIYAELKTILAKNKIRPNYVPVEK
LNRFTRKNHQGVVAFISDVPFHRVEDIVPQLFEEGKTPFLLILDRLTDVRNFGAICRTAE
CVGIDAVIIPEKGAAPINSDAIKTSAGAIYNIKICKEPNLAHVVDFLQQSGISVYSASEK
ADKMIYDINFTEPCAVVMGNEETGISKEVLHHSDEKIKLPIEGKTQSLNVSVACGAILYE
AVRQKIMKIN
>KALACAFP_02381 hypothetical protein
MNYHFQAHRQVRKNLLTVLQNTSHEDLLFIPDGFNNNIYWNIAHTVATQQLLHYYLSGNP
FRIDKYWIETYKKGTLPNLNVQKSEVEDLEFLLTETSKILMKDYDSDFFSDYTPYTTSFG
MDLKSIQDAIIFNNMHESLHYGYVMSQKRAILGEKGR
>KALACAFP_02382 ATPase RavA
MSEINQAEDIRQLTEQVKEANYFFSLLRQEINKVIIGQEYMIDRLLIGLLGNGHVLLEGV
PGLAKTLAIKTLAEAVHGEFSRIQFTPDLLPADVVGTMIYNIKDNDFSIKKGPVFANFVL
ADEINRAPAKVQSALLEVMQEKQVTIGDETMMLPKPFLVLATQNPIDQEGTYLLPEAQSD
RFMLKCTIDYPDFEDERTIMKMVSTSHQPVIKPVVTLDHIVEAKKLINQIYLDEKIEKYI
LDMVFATRYPENYGLSELKNYISFGASPRASINLAIASRAYAFLRGRAFVIPEDVKALAK
DVLRHRIGLTFEAEAEEISSEEIINRILAKIQAP
>KALACAFP_02383 hypothetical protein
MSEVVIRRAVQEDCAPMLELIKELADYEKALHEVTLTLEQFTEDGFGKSPVWGAFVAEFE
EEIVGISLYYDRYSTWKGRRLYLEDLVVTEKLRGKQIGKKLFEATLEHGKSNLYSGMVFQ
VLNWNEPAINFYKKYNPKFDDEWFNVSIEFNV
>KALACAFP_02384 hypothetical protein
MQIKDIVKKVKQIEIRTRKKTEATLMGQYHSAFKGQGMTFSEVRPYQFGDEIRRIDWNKT
ARFREPFVKVMEEERELTMMLVVDISASMDYGTKTQLKREYVAEIAASLGFSAAGNNDKV
GLILFADKVYKVIPPQKGRKHILSIISNILTADYVPAESKLDKALEYMMGIFKRKSLVFL
FSDFEDQYDSKMLRVASKKHQLLGMRIYDEKDNEIPDVGYTLLYDAETGKQVWANTSSAR
WRYTFAEAQKQKLRTLEEDFANSSASFMNINTGADYSKLLYNYFQKK
>KALACAFP_02385 hypothetical protein
MKKLLFIFCFLICANAFSQILSSSVEKKTIALGEVNHIVITINNLKNEKVSAAPENELLP
FHFEEVKDSISQNPDIYYRRIEFAVFEEGKFTIPELEFKVGEKVLKTIPYEIDVINTAQK
TDQIKDIMNNKNVKLEATDYWELYKFYILAVIAAIALIISIVMFVKYGRKSKDSPVVATN
QTLKELDSLKKKKYVESGNYRSFYVELIDISRNFIAKQYRLPADVLLTDDLIDLMKKNNT
ISQENERVVEDVFLRGDLVKFAKTFPDQQTMEKDFADIRDFVKRSSKDLEFENLRKDV
>KALACAFP_02386 hypothetical protein
MFDFEFYSPWFLLLFALFIPLLFRDASRQKKKGIKVPTVKNMADSGGIQAVMFLLKISKY
IILSALIIAMARPRTFTVSQDRDDTKGIDIMLSVDVSLSMLAKDLTPDRLTALKDIAIKF
VEKRPNDRIGLVTYSGEAFTKVPVTSDHQVVIDELQSLNPLELQPGTAIGEGLAVAVNHL
KNSKAKSKIIILMTDGVNTIENAMPPAIAAELAKNNNIKVYAIGIGTNGYALMPTQTDIF
GDLVFTETEVKIDEPVLKEVAQMTGGKYFRATSNSSLEEVYDEINQLEKSDVKVSKLYNY
QEYFKIFLWIALGMLFVDALLRWVLYKILS
>KALACAFP_02387 hypothetical protein
MDWYLGNYWYLLLLLLLPLLAVFLIRYLKWIKKKREVFADSQFHEHLFEKRSGFTKFFPA
LYLIATLFLIFSIIDLLNGSEEVKSNQKLNNVIFMLDVSNSMNAEDINPSRLTEAKNLMI
QTMQKMKSDKVGIVIFAGQATSIMPLTTDYNSAETYISGVETNSMQIQGTDFLNGMKIAA
DKFKNVSKGARKVVLLSDGEDNEGNDDDAIKLANKEGITITSVGIGTDEGAPVPEYVFGQ
LMGYKTDMNGQTVISKRQTEALKKMAQATGGSYIDGNNINEAPDRIVDTLSKKMGASETL
VKSQNANHYYQYFLGVSIFFFFLIYIFNPKRDFNV
>KALACAFP_02388 Photosystem I assembly protein Ycf3
MNTKIIFLSFITAFMFSGFVFGQENYRTLVYEGNEKFNGKDYDGASSKYMEAIKANGKDF
AAHYNLGNALYKRKKYEEAKAEYEKAQKLSQTIPDKAAALHNLGNTYMQMNQPEKAADYY
KQSLKQNPYSEATRKNYEIAKLKEKEKQQKKNQQNNSGKGGGGKDQQQNDDQKGNPKDQK
QDQGQGQQNQGKSQQGDNPDQSQNNAGKMPKDLENQILNKVNDKEKETAKRILNKNSYSM
PESNEKDW
>KALACAFP_02389 hypothetical protein
MQNRFIYILFIFTSVISYGQVNLSVTPDKTNYNGKDVINLTIVLEMNGSEYNQQTPLRLP
DFSKFNLIGTGSVSNAYVDPETNTVVSQSVTRLALEPKQKGKVRVGSFLITINNKIYKTE
PFDIFVKDVEKKSVASNTSKDVYLNMEIEDREVYQDQPTIAVLKVYSKNMDNFRRVKNIH
LPEQDNLSVYPVSFAKSEIDPADYGNMASQILAVFMLFPNEAGYVEVPGVSASVNSYSNK
NKIVSNKVKINVKKLPEGSPEYFKNAVGNFNVSLYNASKEKAEVKKPINIVVKVSGEGNL
KDMELPKIAASDDYEVFAPKITSKVVVGTTGMKGEILASYVVIPKKAGEIAIKTEEFAFF
DPSSKEYVDLGQQTLALNALSHEQVLESRTTVEKVNEYTNTFLETVNTPVLKTTSFKVKE
KSKFHWNALLINTAILLGLFFSYLLFKTWQKKRRLIKETVPVKSLGSVAETENEIRERLK
TDVNDYFSYLENLKDNEDYQKFFQVVDEMDSEVRSQYFQGSGEDFGKFLESYKGSAIAEE
YRNLAQRIQIEKYAPVKSSEGIEELLKAIVNLYSQISK
>KALACAFP_02390 hypothetical protein
MEIFNDFSIKEIITCFMVLFAVIDIIGSIPIIVSLQQKFGKIDAERAAITAGVIMLVFLF
VGNKILKFIGVDVNSFAIAGAFVIFIIAMEMILGIEINKTAEARAASIVPIAFPLVAGAG
TLTTTLSLKAEFHDINIIFGIILNTIFVYLVLKSATWLEKKMGDATLAILQKVFGIILLA
ISIKLFTANFAQLVQTYINF
>KALACAFP_02391 hypothetical protein
MQKFYKVFLVLFIVFIAINLYALDWQSDVLSEDNLKFVFSIASAVIGLIIVFVMNTWSQI
GAKK
>KALACAFP_02392 Isochorismate synthase EntC
MMYFKLPFDEKLYSTDENSNENFVNFYSFDGTTQINFNGNIVEINPERFDQITISSESLP
EDNNHFSTETQEEYLENLSKVIDVIKNNQLPKLVYSRRKIFTDFNEIDVKESFKNLCQSY
PNAFRYIFINGETSWMGAFSEVLGKFNKETHDFETMSLAGTLPISESWSEKEIEEQKPVT
TYIKNILNNYSENINESKTYDHISGNIKHLRTDFKAKIKPENLDKIIQELHPTPAVCGIP
KEFCKENIQNLEKFPRELYAGYIKIETEKTVQYFVNLRCSKLYKNAVHLFVGGGITAQSS
PEKEWIETELKSEAVLKNLVIS
>KALACAFP_02393 hypothetical protein
MFLKKIIFLLSVITTSFLFAQKKKKVDTVYVYEKVIVYEKVIVYDTVYLIKPLKFKQNGL
LFSELKVEETKFVRNVYKEEIEKQRAINRARRQKIRTFEYGLEAGSGLKISDWGKELSGK
PQFGENIGIWASKRISNTGLSLGLSANVYHWNSSFDLDANKEDTYLNGFYFTDDNQPLLF
QRFNNKHFEYTLQLKLFYEWKNIRPFAGFLVNKNIYKMQFLTPENNVLDKLEDFKSNQTN
IGFSLGLQYRVFRKILLSLDYQQYHMNNVSLKNSSFDFDIFKTNNTFAERKINLGIVYTI
SR
>KALACAFP_02394 ECF RNA polymerase sigma factor SigE
MKKSTSDINWQQIYGDYSPKLLGICRRYIQDIYTAEDIVQDSFITAIQKNHQLADEKALF
GWLKKIVVNNALMHLRKHSKEVFVTTEPSEIPDTYSEMNHPSLDEKHIFIYDFTREQLLS
SIDNLPEHHRSVFNLFFIENYSHAEISSALGITINTSKSHLMRAKKSVQNFLTSHFVNQD
TPKNKKLAQLLVIFGLGGLLWAQTFRSKFADFSISPSKKLEIPENISYINSAFSLTPTGA
WKNKMIMGSTVLVIIAGSVVLLSPKNSLLKNSMNSTETTVKKEKISQNIHLKSENSPVNE
NLSGQNVETSKAQKTEVIPAEKNTEIKSNSKKIIIKDSIKETPQKVIVVKKIIQRDTVFI
EK
>KALACAFP_02395 hypothetical protein
MKTLILPFLFLLTLVISCKTDNLEILQEKTTSYDVYVGGVDEYNACYWKNGQKISLPGGE
NLQGTYITVDNNDVYMLANNIASLGGNNTISSWYFWKNGVRYNVAQYLNVAPNTINDDLS
LQLWNNFTVKDGNIYFSGIIRNPNPTSSADLFQLCSWKNGAKTVLESFSSYNSQSAGAIG
IFNNDTYVATRKINLPTISSWNTGFYKNGTYNLVTNNVLPRRFISDATGMYLLYSDISGS
ISIKNIVTNTNLSIPTNIAQSGITELSWDNSDKYYIGSNFYFKNNNQVQISDANNFNNIG
HFVAKDQNIYMTRYNSSVGGTAVKFYVNNVEVMSLPNTARGCFNSIFVVPN
>KALACAFP_02396 Putative esterase
MYYTKDKTKEEILEFINNWGEETFAKTLDIKFIDIDLENETLTATMPVLPRIHQPFGIMH
GGASCVLAETMGSSLSNIFIDGEKYFGVGTNINSNHLRSKKEGIVTAVARFIRKGKTMHV
SEIEIRDEKGQLINHTTMTNNIINR
>KALACAFP_02397 hypothetical protein
MKKLFGKLMLKMMGWKIVLQGDVNSLNRCILVVAPHTHNMEYILGNFAYWALEKPLKVII
KDAHTKAWYGGLVKGLGGIGIDRSQKNDLVNFVAKQFEKDNFSLVITPEGTRSWVPKWRK
GFYHMALAAKVPIVLAAGDFKRKIIYLGYTIPYERIASVPFTEIMREIEDYYIKNDIVPK
VPENWNPNIMGNDSEAKG
>KALACAFP_02398 hypothetical protein
MNKTLSIGLAGFSFTIEEHAYIKLSDYLNALRSSLDASEADEVMHDIEIRMVEIFRDSLG
KREVINDTDVEKVIAQIGTPEKIEEQEEAYYSEKNNSRKSNTGTEYTDKKQLFRDPERQK
IAGVCAGLAHYVGMDITAMRAIWLGVFVLGIFTAAISSSLIVLLYIILWIVLPKAETAAD
FLKMKGKPMNFDNLKNESNKLVQFANESTQRVGEMYIESKPYINNAGSGVWNVIRYILGG
IFALMSFSCLIGVFVIFGFMGNSDFPPISEMDFYFDDGGMRYVLMAMITLGSLIPAMLFG
LLSIKLISPKTKLRNTGWVIGALILALIAISTYFGISMAKKEMFLKGHKEDTEEVTINTK
SDSIYVDFKQVNIPQNFRGYEDDLYSDKVSVFEKDWIHVEVTRKADVKTPYLIIKKEAKG
YNFPLNVNVPVEVVDNKVILPNYIKYPYAHRFRDYSIDYELVIPAKSVVIPAKRDGIDFD
GDLNGDGINDDDQDKDEHGNIKIEKNKITVNGSTIEYNSNDEDSDSIIINGKKVPSNQAD
QVIDSMKNSIKKMKGNVDIKVNEGKNEISIQTK
>KALACAFP_02399 hypothetical protein
MNTENTKAQMRKGILEFCILSLINHREMYVSDLIDELKKGKLDVVEGTLYPLLTRLKNGE
FLSYRWEESTGGPPRKYYQITEKGKLFLDELQNTWNELTDSVNQITQKN
>KALACAFP_02400 hypothetical protein
MSYKLLLPILLMGNLCFAQHQFELKDASKNYDVKINVENCENNECSGKATIELFDKKTSK
KFQTLSSDDLNFYLNEDQKPTANIIQLYNEQSPLIFDDFNFDGTEDVAIRNGNESGYGGP
SYDVYVFNITKKQLVPSEELTQLAHENLGMFNTDSERKRLITY
>KALACAFP_02401 hypothetical protein
MKIQKEIDFILAVDALKNVQRRNYNADDSRRENTAEHSWQIIILAQILYPYAKNRADIDL
LRVIRMLSIHDLVEIEAGDTFLFDEAAMVGKFEREKISAQNIFGILDEPLRSEFFDLWLE
FEEEKTPDAIFACSIDRIMPFILNSHTSGKSWTEAGVTEKQIRNMLENAISRASDELGEA
FQLLMVKNLETEKVLK
>KALACAFP_02402 putative acyl-CoA thioester hydrolase
MTTEERITASETRIFKAVFPNTTNHYDTLFGGTAMQLMDEVAFITATRFARKRVVTVNSD
KIDFKKPIPAGTIVELIGKVAHVGTTSMKVNVEIYTEQMYSYERERAIVGDFTFVAIDEF
KKPIQVL
>KALACAFP_02403 hypothetical protein
MMISVSKAFYLSVFCLFSLALMKGQNKVPFGVVKAEEGYAMVRVHKEDYRKIIDKIRMKT
GDVFVYVKPAPGETEWIWIKYPEKDDTEKPFVRYDSITKEGMVNKNRVVFVDQLPHFTPS
KSKNGKSLIFTDDTNPKIPGNQRTKVIIDVYPSYAKLKKQEKDANGNIIKIDKVKSWGVG
TELPEDLTEIKSIRVQQPGRGSVFVRDAIKNMFMPTMDFSNIGVTAIDNDHIFLYMINGS
GANRYTTIWTIKQGKVESQIIFKNPE
>KALACAFP_02404 Endonuclease MutS2
MYINKEDLNELEFPQLLAEISPFAYSPKTREKILQLRPMEIDEAELSLKKTSEYLSSFES
SNAIPFDEYEDIESELKLMLIENYRLENSAFIKIKTITEQIGKLQKFFPTMPETFPTLME
EASVLEFKKEIIDKVDKVFNRFGEVKSEASPILKTLRTEIQHAKKAIQENFNRALTTYGQ
SDFLDDIRETIIEDQRVLAVKSGFKKRVAGRVLGISKTGSITYIQPDSVVKHYFKLRENE
EEEKKEIDKILRKLTAELAEFQPQLWRYQVYIFDLDLTRAKAKFAELINGILPKINRHKT
LRLKDAFHPLLFLRNKAENKTIYPQTLTLTEHNRIICISGPNAGGKSITLKTVGLLQLMI
QSGILVPAHPKSEMFFFDKIMTDIGDNQSIENHLSTYSSRLKKMSGIIREADANTLLLID
EFGTGSDPELGGALAESFLEFFYDKKSFAIITTHYTNIKLVVEQLPNAENAAMLFNEETL
EPMYKLEVGQAGSSFTFEVAEKNKIPRFIIHSAKKKVEHDIVNLDKTIVKLQQEKFEVEK
LKTDLAERKESVEDKRDNLQKLNEQLQQKLYNFQKLYEEEHRKLQFGNKIETFIDSYTKG
KSRKDVVKDFVKLLEQEKFRKIGADKDESKRLQVVKRKITQQLKKEDVIEKIAETNEKLE
EKRKTDRALWMKVGQRVRITGSTSVGTIEKISRNKVIVNYGTFKTTIDADELERI
>KALACAFP_02405 hypothetical protein
MKLETERLQLKEINESHVDDILKIRSNEVINQFVQRKSPKNNYDALQFILTIKERTQNNQ
SFYWGISLKDQSNLINPI
>KALACAFP_02406 Uracil-DNA glycosylase
MTWTEILAPIKSTPYFTNLWEKVKQEYATTKVFPPKNQIFRALEITPFDDIEVVIIGQDP
YHNDFQANGLCFSVSEQVAAPPSLKNIFIELKDDLGVVRTSKELDDWGKQGVLLLNATLT
VRAHSPNSHKDLGWEKFTDFIIKEISDKKENVVFVLWGAFAQKKAELIDPAKHFILKSAH
PSPFSVHRGFFGSKPFSKINEYLVSKGKKPISW
>KALACAFP_02407 hypothetical protein
MFHKTIILSLGLLVLINCNAQKEPKTAEKTWTATETPKTQPMKGEKVIYFNEGENKFLKE
YQMNVTFKGISEDSRCPKGVNCIWAGVAVAQVEVMGVATRPMTLNIATMDNKGRNYSKSA
DFNGYTISLAQVDPYPGDAEGAKALQGKYKIGIVIKKAGENSTTK
>KALACAFP_02408 hypothetical protein
MDTALINILCLILLFLGILGTFLPILPGLLLSICGLLIYKFGTNADLPMVYIWAFGILTL
VSVVLSYVIPAKTNQKYGGTRWGSIGSVVGMIIGMFLPIPLGFLIGMFAGVFVGELLHDS
KDMNKALKSTKGAFIGFIYGTGFSFVVGVAMFLVVVLDMLNVI
>KALACAFP_02409 hypothetical protein
MKQNYFFILLCVFTLLTSCAGGDDSPIATENTTPAVAKTGKLTGKVMSQNGTKPIGGASV
FTFDDKYKIYYTTSDAEGNFTLEAPVGNHTIHIQTGNGSNFRTEISATVKDNETLNLDVS
QTKLNQVAKIAYVKGTYDKIEDIIQTLGYTATEINNSDLANLTTIAQYDIIFLNCGSRSS
YTSNPALYTVIDANLATFVANGGSIYASDWDVAYLVGGTTNTNNCSLPGGFVPDSKLCSK
NIGTSGMVAATVNNAGLTSALGFSTLNIDYDLSQWQKIINYDPNYWEVLVKETSSNDPLM
IRSNHFTATGTTTTPIGTTTTFVTVCITLPGNIQISISVPQVLVPYLVALGATVGPCSGS
STSGYIYYTTFHNHASGNIGNAGVILQYVILNL
>KALACAFP_02410 Miniconductance mechanosensitive channel YbdG
MNDQLQDTKSFLQELSEQLYIYISQIAPSGLDWVFHIIVKLALLCAIFLIFDFIFKFIIN
NFFKFFHNQEKYPVIKSIYQSKVSNSLAHLIALLIIGGIHESIFSGALRNTSKFIVRSVN
LGLVMIFAGMLYRGLTAFRNYFTIKQDFYKIMALNAISETMKILGIFIFSIVGICVIFGI
KGTTIVGSLGAITAVLVLVFRDTILGFVTGIHVATSKNMKVGDWVSIPKYSIEGNISDIS
LLTTKITNFDKTVSTIPTYDLLTTEIKNLQVMSESNTRRIKKSIYFNINSFKFLTEEDIE
RLKDINLISEYLEGKSIELRKEKETLKHSDKIINGMQLTNIGVFRYYAQRYIENDPEVDQ
DGAMMVRQLDITPQGLPLEIYCFANDSKWEHFEQIQADIFDHLLVASKEFDLQVMQVSVK
V
>KALACAFP_02411 hypothetical protein
MKKIFLLAVSLYLLNSCTRDFAETNTNPLDIVNTTPEALLPLAIKKGYDASFEYYYDYYR
RIMPWTQTLVPGSCNVPEFMDDGSNMNARKDVFYGDHGSLLTDIIHKIDQMPADEQAKYV
NIKSIATILKVYYAWYVTDVNGSMAYTEAFQARYGGTATPKFETQEQLYDILDSQLNSVY
TAIEGANQSIQVNPGSGDLFFNGDILKWKKVSNSLRLKIASRLMKRNPTKIATIAAQVLS
RDQISSQSEDFSLRSRRFTEHGNFNPNGFFATKPMVDYMRVNKDPRMPIFFQKNSYTKTA
IKRLSDAGLMNSVVIDDSLKRYVGGPISPDQSTSRYYTSARRSLNGTIYDTISKLQYRIW
QPEFLSGTGNAVFPILTYADYSLLKAELQARGIIATGSSVQTLYEEGIKASIDTYNFIAK
EAIVDQYAPTTAGEVTAYLSAPNVQFNPSNALEQIIIQEYLNYFKQPNEVWALIKRTGMP
NTSTALKLEAPTRNGGIPLTMPRRIVLPTPSANNLNYNNQLSALNQMKQDPDFGSSESDI
QGRIWWDKK
>KALACAFP_02412 TonB-dependent receptor SusC
MKLNAKNSSIGAFCFLLGTTAQIHAQKTKTDSTKTTEIKEVVVTALGIKRDQRKLGYAIS
KVESKDISQAGVVNPMEALQGKVPGVQIIAGSGGPQSSAKVQIRGNTSLGKNNQPLVVVD
GVVIDNSVTGADEWGSGYDFGNEMKNLNSDAFESVSVLRGAAASALYGSRASNGVIVITT
KKGRSRNGIGVKVNSSLTTQSVYAGPKLQNEFGAGVGSTFPVDSNGERYIDPNTFFYSYG
PKFDGQPVRDIDGRTVLYNPQPKNYLQMYQVGIDRKNSVELSGGNDKSTFLFNYTNQEAE
GILPRNKFIKNAYFLRATHEFNKYLQLDASFNYTRSYGENPVPQGGNSSPLFSFVYGTPR
SFDANYWSQNYLDPVNGGIKQGNADPYGMAGQYFDIFQNTRSQKENNYIGRLEVKSQLTD
WLNLVVGGNFNNYNFTNESKILGSDPGFKGGGYSILEGRKEQNTVKFLANANFKLTDNLT
MNASIGGESFSSKYKSTRLFTNNGLRIPGVFEIQNSVDVPGTEIVYTDGNVSPKKIQSLY
AFANFAWKDQLFIDITGRNDWSSTLIYPDGHGDVSYFYPSFVANWTFSNSFKLPKWINFG
SLRGSLAWVGRDTFPYNTSAGFYYKGDPSAYNSPDGTRIPLIGFNSRALANANLKNELSR
SIEFGLNMAFLNNRLDFDVSVYKTNTTNQLLTLPMPQESGVDSQQINAGNLQNKGIEIIV
NAVPLKSNDFKWDTSLTFAKNQDKIIELAPGVEEYVLQWAMGRDVKSIAIPGQEYGLIQT
NYAFATYQALDANGNKIDDPRNGMRVLKPNGTYLRSNSYQNQGYVTVGKLTPDFLTSFRN
TFKYKNVALSVLIDARVGGDILSATYNYGVQFGNLPSTLQYRDEDRGGIMYTDANGKTQF
GLIPEGVFAQNTQIKDKQGITRDVGGMTYAEVYQRGWMDPLRTDLYYRNLGSWGNGIREN
AIFENTWVALRELRLTYSFKPELIKPLGINTLNASLIGRNLFYIYNKLPDGINPEGMYNN
NSGSFAEYGGSPMSRYIGFNLDFSF
>KALACAFP_02413 Pyridoxine 5'-phosphate synthase
MTKLSVNINKIATLRNARGGETPSVTEAAIKIQEFGGQGITIHPRPDERHITRKDVYDLK
PLVTTEFNIEGNPHRPFIDMVLEVKPEQVTLVPDADDAITSNAGWDTKKHLDFLTEIIAE
FKNAGIRTSIFLDPTPELVEYAAKTGTDRIELYTEAYAKNYTLNKELALKPYYDTAVVAA
DFGLGLNAGHDLSLENLKYFADNIPNLLEVSIGHALISEALYMGLENTVQAYLKRLAKW
>KALACAFP_02414 Esterase YbfF
MEILHSKIFGENLSSTPLLVFHGLFGMLDNWGSFGKDLGELLPVHLIDLRNHGRSFHSED
MSHDDLANDIANYMNHYGIEKAHVLGHSLGGKAVMQFAMNYPEKVEKLIVVDISPKAYPP
HHQGIIKALETVDFNTVNSRNEVEAVLSQYIPEKSTIQFLTKNLYWDENKKLNWRFNLKT
LSEKYNEFVSNAIKFGVFQGETLFIAGEKSNYILPQDEFAIKQQFPKAKIVTVKNAGHWV
QAENPVDFAEVVKEFLDLN
>KALACAFP_02415 hypothetical protein
MEEKKSKKPFFASFLEKQVEDPEKIKGGSGTITSALQDNTTGALKDSITSALQDNVTKPG
SDNVTMKYPSDGDEDGDAV
>KALACAFP_02416 hypothetical protein
MKKNGGKKPFFASFLEKQIQNPEEIQGGSVPTAPLTDFVTLPTKDTVTTSPTLDNATLPF
KDNVVTLKYPSDNDEIGDLSDPGES
>KALACAFP_02417 hypothetical protein
MKNKNSKKKPFFASFLEKQLQDPEKIKGGGDITLATQDIVTKPAFDGVTKPDQDMAQTQK
YPSDGDDDVQYVDL
>KALACAFP_02418 hypothetical protein
MILCITHSQDYYNIDLFFEYIKTKNIPYFRLNSDRMNHLQKISINENFFELTDESGNKIN
SDKIKGVWHRKAWKISVPEELDEDYEKIFLKEYASLRYNLFTILEDAAWINPFENEKKID
GNKMLQLKIAEKHHLTIPKTIFSNDAEKITAFFHESCNGKMVAKLHGVLSKSMGGEDLVS
TNIIDGDSLEFISDIAYCPMIFQPYIEKEYELRIVYVDGEFFTGKINNSENADWRVAQGN
FFWSAYDLPKNIKASLTSMMKEMGLYLGAIDMIKSRDGNYYFLEVNPQGEWGMLQKELHF
PIAERIADNLIKRMNTNE
>KALACAFP_02419 hypothetical protein
MNKILIITHTGDNFSIEKVTEYIDKNGCEVIRFDVDLYPLKNKLSTTFQDGKWITILETP
EKKYRLDDIAAVWYRRAYNIGDGLRDQLDTKFYGAAMGEIRNTLFGFLESVDVYSLGKPS
VYRRLDSKEEQLKIADKIGLKIPETCVTNNPEEAKQFILKHQNVVAKMQTGFAIYEDGVE
SVVFTNVVNEDKLEELDTLLYCPMQFQKKIEKKKELRVTVVGRDVYAFEIDSQQSEAAKI
DWRKDGVNLIDKWIQTELPAEIEAKLLELLDVYHVDYGAIDIIVSPEDEYYFIEINAAGE
FFWLDNLTDGNLISKSIADVLCDKAPRRNNMVLA
>KALACAFP_02420 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase
MVFVTGATGILGRVIVLELLKKGKNVRAAKRPASNLKEVRHSYTFYTENPDDFFNKIEWV
DVDFDDINALQNALRGVEEVYHCAAKVSFHPKDEKEMYHTNIKGTENLLYACEGSEVKKF
LHVSSVAVLDNFNEKGELDESSDFNPKLEHSAYALSKHLSEMEVWRASAEGMNVIIINPG
MIIGTGNWNQSSGEIFSTFEENSFTFSGGSCYVDVRDVAKVAVELMERNVFAERFLVVAE
NNRYTEIGGQIRKKLGLKEAKVLSRFQLNMGRLANIFFGWLIPKLRMITKSNIESVSSFN
TISNQKIKEKLDYQFIPVSESIDFHLNNYINDKKLKK
>KALACAFP_02421 Long-chain-fatty-acid--CoA ligase FadD15
MNLAEAIIQKNIEKHPVKSAIGFKKKEAGWKELSWKKFGEIIFKTANSLKNAGIQENDKV
AIYSDNSSEWMIFDLASMAIGAITVPIYSTNNAEQAEYIIQDSGAKMILVGDQAQYDACL
ELVQKEESTLETIIVSKKSVWIKKEFNSFYLEDFIAKSPSKLEFCKKEYDDVATLIYTSG
TTGTPKGVMLTHGNFIKAFDAHFEFFKFKNFEEELSLAFLPLSHVFERSWSLLCLYGGAR
VYFLEDPKNIAKTLEDVKPTMMCAVPRFFQKVYAGVLEKAGEGSSLKKKIFNWALETGWQ
TAELRRNEKPLSLGLKIKESIADSLVFSKIKERMGGRLWFLPCGGASLSPEVTRFFESVG
IHITVGYGLTETTATLTLFPLTHFEHGTSGKPLPGVEIRIGESDEIQARGNGIMKGYYNK
PEETEKVFTEDGWFKTGDAGKIDDKGNLIITDRLKDLMKTSNGKYIAPQQIENLLTNNNF
IQQIVLIAEGRQFVSALIVPNFEFLQDFIKKNNIQFTNWEEIVKNEKVHDFYKEKIKELQ
SHLSDFEKVKKFTLMPAEFEISSGEITPTLKVKRNVVLKKYADLIEKMY
>KALACAFP_02422 hypothetical protein
MTIQEFLGKKDFTIHNQTVSESCPSNIALIKYWGKYDNQVPANPSISYTLNHCKTNTTIE
FFANEPFSVQTFLAGNEEVKFAEKIEKYFKNIEQYLPWILQGKYIIKTENTFPHSSGIAS
SASGFGAIAKCLMKLDENFSGQTSEEESLRKASFLARLGSGSACRSLYNGLVVWGESQVK
GSSDFFAVQYPNDEIHEIFKNFNDWVLLIHEGQKSVSSTVGHGLMNTNPYAERRFQEARE
NFAPMKEILKNGDMQSFIKLVEHEALTLHAMMMMSDPAFILMKTGTLEVINKIWDFRRAT
HLPLFFTLDAGANVHLLFPNDGSEEKIKSFIESDLLQHTQNNGVVKDVMKF
>KALACAFP_02423 hypothetical protein
MWTAYLILIVLLLILTILPKIQNSHWIFRVPEFGKIQITFFILFTFALGFVVAENLENFW
YYQAFLAILFVYHGFTLVKYTPLYPVKKYSQSNHSSQKLKFISANVYQFNKEHHHFIKLI
EKYQPDFFLTMESNAEWEKALQPLEKEYIYQHKVPLENTYGMHFYSKTEIKKAQTHFFVA
NDIPTIEVHLETENGYKFVFFGVHPPPPSPTEEETSKERDGDLLSTAKRVTKIEEPVIVV
GDFNNVAWSRSSVLFRKTSHLIDPRIGRSFVSTFHAKYRFLRFPIDLMFHSENIFIKELK
TLENFGSDHLPVYCELFIDHQNDEQKKRIDKATNEEKTEAEEMIQEGKEENGDRDPVVTE
D
>KALACAFP_02424 hypothetical protein
MATVLFGSLCFGQQNENQEVEKTIRNLFLGMKNADTELVKSTFSDTAILQTITKNGLKNE
ELKDFLGSISKYSKNDLDERIVIDVIRTDGDLASVFTPYEFFFKGKFSHCGANSFQLVKQ
NGEWKIQYLIDTRRKDNCKEIK
>KALACAFP_02425 hypothetical protein
MGNKNLILNYIFLGCLIVLFLNDHFFKFQFKSWFTGKLSDIVGIVLLPMLLTYLFPKLKQ
NSVFVAGLFFIFWKSPLSENFINIYNLMSPISIHRVVDYSDVVVLLLLPVPYFLIKNMSL
LEQISVKKINSFAVLLPTLLVLMSTSQPKSYTYSPETGVLTFNNDTRFEVKKTKIDLINE
IRNQNLVIVKDTAYILESSRFIVSRMGKFDQEAIKSDGDIFKVDNADLKEVLLKEIEKRS
DYKIAEIRIGERTVKNLRFSIEPAFNKISPKKFSEIVVHGVQIDKNLDNDKIGERLREIY
KSIITSKFKNF
>KALACAFP_02426 hypothetical protein
MKIHHIAIICSDYEVSKKFYTEVLGLNIIREVYREERQSYKLDLAIGDHYVIELFSFPDP
PKRPSGPEACGLRHLAFSVENVHEKRQELVQKGLICEEIRTDEFTGKEFFFTRDPDQLPL
EFYEM
>KALACAFP_02427 hypothetical protein
MRKNFTDVDLNRSVGNLLRLGVILAVATSLIGFVKLFTEGFKMPKKYTSLDMGTSSEKVW
GQFWDSLCKGEGMAIIQLGILLLIFTPLMRIIFALIGYLKEKDYIYVAISSIVLAIMAVS
FFTGYAH
>KALACAFP_02428 hypothetical protein
MSEIIILFLGAISAGLLGSLTGLGGGVIIIPLLTLGFGVPMHYAIGASLISVIGTSSGAA
VAFVKEGFTNMRVGMFLEIATTSGAIIGALVSGMLNPNTIGIIFASILLLTVILNLKGKP
DHQEPIIKGSLEEKLKLYGTFPDKGVVKSYSARNTVSGFLMMMFAGAMSGLLGIGSGALK
VLAMDNMMKLPFKVSTTTSNFMIGVTAVASALIYFQRGEIIPVIVAPVLIGVVVGSFIGS
KTLMVSKTKKLKVFFAIVITILSVYMMYNGINKSFR
>KALACAFP_02429 hypothetical protein
MYFCIMENQLKLFYIILGATPKGRNIEQHDVFFGIAESLKDLVPDMKDFWKEADGKIHID
CYQEVKFADGYEVEIVEKGRKTTEDQLYFINLGGYKKGFFEEFHEQHLMVGKSMGEIVKK
AKDTEFYHTMGFDGAVSHIDDKHGVDIDDIFNVSDILPEKMKEKYSIVLKKSDVENQENL
MGLGYLKIDKI
>KALACAFP_02430 N5-carboxyaminoimidazole ribonucleotide synthase
MKIGILGGGQLGRMLIQEALKYDDEFYTLDPASDAPCHNISYFTQGNFNDYETVLNFGKD
KDVVTIEIEHVNADALAELENQGIKVVPNSKIIKTIQQKILQKEFYKAHDIPSPEFEVMD
GSSDEIKMPLPFVQKMNTGGYDGKGVQVIRTAEDMKNMWTQDSVIEKLVDIDKELSVIVA
RNENGETKTFPVTEMVADPKLNLLDFNICPVFLSEEIEEQINSITEKFLNAINSPGLFAI
ELFLDKEGKVWVNETAPRLHNSGHQSQEGNANSQFEQMYRVVKNLPLADTDAIIYSGMLN
LVGAEGFSGKVIYEGMEDVLRMPETYVHLYGKTETKPGRKMGHINVLADSREELMEKLVM
VKGMVRVIAE
>KALACAFP_02431 hypothetical protein
MKQIFSLFLIFTSFIIFGQDQKFTDQEIQQKLDSIKAEGNLLFSMENASWNSSDLAREHK
KIAEKLGGYLTYKNNDTVKTVFLNKSQNLIIAEYSFKNDSKKPVKENFKERNLNPTETTL
SNVRAKLISQLSAPKHEVGVPEGFNLNIITIPFNENYKNYIITGASEHGVIPFGNDYLFI
TDKDGNITSNKKFHSRFIPTMTRMQDGNAIASSTHSHIRTNPFISATDICTFKLYAPFSN
LEEFSIYSPALGCYIKYNYKKDTVSKSKDLK
>KALACAFP_02432 hypothetical protein
MIEILENIYYFLSKLLPYSFGIALIGFLMSFIADIAKNIKFKKICFILFLQIFVMGFIMF
ALQEIIIRKIRNEVVEILSDPKTQIITSRNDFEILPNELKKELLKIQDISPNHTGPEDKK
PIEVISPKGIFKIFIGRDSANKNQFWIFTDRYEFGKEQEIGRVTSTLIK
>KALACAFP_02433 putative inner membrane transporter YedA
MKDLKLTFAILTVAIVWGTTFLSIRVAVETIPAWFVAGIRQFLASVIMLLILLYRGEFQW
IGWKNLGYQIVFSLLMLIIANGLTTVAEETLTSSLTSLISATSPIIVFLGSVALGLQKFT
IRALVGVLMCFGGILFIFWDGIKDLANPDYRFGILLLFCAIAGWASGTIYTKKLNIQSKN
ISLNLFYQFAFAGIMQIIFAFLFSENYNFENWSLKSVSAMIYLSVFGSVAAFFAYHYALR
KVSPVQVSILAYVNTIISIFLSWLILDETITMKFIMAAVLIIFGVFVINYNPQMFKKQRI
E
>KALACAFP_02434 Zinc-type alcohol dehydrogenase-like protein
MKAIVLEQFGQPLVVKEIEKPQPKDHEVLVKIKASGLNPLDIKIKNGQAAHAQVTPPMIL
GIDMAGVVEAVGKNVKNFKIGNEVYGMVSGVGNNPGTLAEYIAVDADLLALKPKNISFKE
AAATPLIFITAWEGLIDKMNIQKNQNVLIHAGNGGVGHVAIQIALAKGSKVFTTVKSENI
EAVENYPVEIINTDESSVEKYVQDLTNGIGFDAILDTVGLLDDSFKAVKQYSGHVVSILG
WRTHSLAPLSFRNATYSGVFTLYPLLSGENRKHYGEILQQATQLFENGKLKIMLDDKFYS
LEQANDAFGDIENRNTKGKIVIEID
>KALACAFP_02435 HTH-type transcriptional activator RhaR
MLYFYMIKGYNVVMRKDYLQQPFELDLKQPLGVCPRGEHGVSFFELVYIVSGKGFQHING
NEFSYKKGNLFLLKPEDSHRFTFETKTQLFFIRFNRVFFQNTTIENNFFKRIEQVFSNIN
GFQSFVVDAIEDEIVIEHLMENLFLEMKNKKLYSEEVIQLLVQSVLTVVARNLIQKTSLI
IDEKTEDRAANIIQYVHGNIYEPEKLTSESISNLFGVSKTYIGRYFKNQTGKTLNEYITD
YKIKLIENRLKHSDMRINEIADEFGFTDKSHLNRFFKKRNNISPSAFRKENFTSGL
>KALACAFP_02436 hypothetical protein
MGFGGGKAAAETQIDIQHNFFIFEHLIHIEEW
>KALACAFP_02437 N5-carboxyaminoimidazole ribonucleotide mutase
MVGIIMGSQSDLPIMEQAANFLKSLDIPYELTVVSAHRTPERMFDYAKTAQERGLKVIVA
GAGGAAHLPGMVASCTTLPVIGVPILSSNSIDGWDSVLSILQMPGGIPVATVALNGALNA
GILAAKIIGSGNPQVAEQLQKYQESLKDKVLGTVDDIKAQHPNRYDK
>KALACAFP_02438 hypothetical protein
MHKKLISFFFILFLIHFSKAQNEFITIWHPGLPATTPLIVVDAPSQATSNQIWFPGIGEN
YTITWEEVGYPTHNGTMTDVTSTAQVLIDFGNPINPDPATATYRVKASNGNGVFRQIRFG
VPAIITLPDNLFPIWTIYGSADKILEIEQWGNISWESMNSAFSNCRLIQLTATDSPNLSN
VTDASFMFHNAHNFLGAPSMQNWDTSHIQNFMFMFAHQGDYPAAIDNFDTPYISTWNTSS
AINFNSMFFNRKNFNQPLNTWNTSNATNMGWMFASCLKFNQRLDNWDTSKVTDMSFMFHF
IPVFNQPLKSWNTSNVVNFGHMFHGCTSFNYNLDTWDLTKTTSTDTMFSGASSFNQSLAS
WNLAVLNEASSFLSNSGLSCENYSKSLAGWADNPNTANNVNMGFVIPLQYAANAVNKRNI
LIGKGWSFNGDVPGSCFLATSEVGLRKKGSIYPNPAQDNIHIESIHDAQSFKILDASGRI
VDSGNTDSEMINVSALPKGNYILQIVSRENIENFKFIKK
>KALACAFP_02439 Inner membrane protein YiaA
MKKQRVSNAFVAASWVALGAGMIGFIVGLARAEMLLNEKGYYFTILLYGLFAVVSLQKAV
RDRLENIQVTDIYYGICWFATLSSIVLLAIGLWNATILPSEKGFYAFAFLLALFGAIAVQ
KNTRDNMIQE
>KALACAFP_02440 Adenosylhomocysteinase
METTTQYVPYKVKDISLAEWGRKEITLAEAEMPGLMAIREEYGPSQPLKGARIAGCLHMT
IQTAVLIETLVALGAEVTWSSCNIFSTQDHAAAAIAAAGIPVYAWKGMNAEEFDWCIEQT
LFFGEEKKPLNMILDDGGDLTNMVFDKYPELTKEIKGLSEETTTGVHRLYERMQNGTLVM
PAINVNDSVTKSKFDNKYGCRESAVDAVRRATDVMLAGKRVIVCGFGDVGKGTAASFRGA
GSIVTVTEIDPICALQAAMEGYEVKKLDTVIENADIIITTTGNFNIVQGSHFKKMKDKTI
VCNIGHFDNEIDMAWLNDNYGSTKYEVKPQVDVYNVDGNEIIILAEGRLVNLGCATGHPS
FVMSNSFSNQTLAQIELWNHSDKYGNEVYTLPKHLDEKVAALHLKKLGVELETLTDEQAK
YIGVDVKGPFKPEYYRY
>KALACAFP_02441 hypothetical protein
MPLYRDFSDDNATILVWKYDETEDLDINKLLEPENAEKVKDYHPKKLLEVLMVRQMLKGL
KPHSKILYKDREPFLSPKDAEISITHSFPFAAIAISKNKIGIDIEKFNPKILRVIDKFTY
ENERDFIPLDKEVAFYTIIWSVKESMYKIHHSKHWSLKKNYDVRPFELKHLHHIKCRVYD
DQNSDEFKARVEFFDDYCFTIVEE
>KALACAFP_02442 Inner membrane protein YccS
MNYSAELKKFVTSQYVYSAIRITLATVLPCVVLAHFGILKEYFLFPLGTSFVALTDQPGP
FIRRRNALSFAIICFVFVALIASLVMNIKILVFAELIVFGMFFSLIGVYGQRLAAVGSLS
LVVLAIFIDGHLTGENILKSLLIFASGCTWFLLIFLIVTTIQPYKLASQMIGENYLQLAE
FLKIKANYYQKNPDFDKLTTQVIAKQIGIKNLQEETRETVFKTRTIVNESTTTSRLLMLM
FLNSMDLHEKLMTSESDYQKLQESFDDTTILVNIHDYLNLLAEEITNIGISLQIGTRAKP
MFNLDTELRNLNHNYFDLRNKRISPDNFEDFMILRQILMRINEITKEINEIYKVFSQNVK
LAKSLSTGLDLKKFMPNEEKLNFNVLKNNISLSSSHFRHALRITIALLIGYSFSLFQFLG
IGHTYWILITIVAILKPAYSITKQRNLLRLYGTVAGAVIAYGILHYIHTRQALFTILLLS
MVMCFSFLKGKYFWAVLFMTIYVFLSFNFLSPGNIDVIFKDRIVDTIVAAVITSLVAYVV
LPVWEHTQNLDLMKKSAESNLLYFQSVISKFLEEDYDIEEYKVKRKNAIISLANLSDNFQ
RMISEPKNQQKKLEVVHQFVATSHLITAYTASLSQYVKDDEKYPEIDADGWSRKIEAEMQ
KISKLLNGEEINETLNMESRIEPEDSSLEDLILKRRTELIENEGYDLRDPNKISHLTELK
NIHDVLELIYDVAKEQRKVIENYKTESQTEALESIPQQS
>KALACAFP_02443 hypothetical protein
MNLTTKLLLGIGLSAGFLGYSQDLSLVRPVLTGAPFLRIAPDARAGGMGDQGVVTSPDAF
SQFWNAAKYPFSRTSSSVGINYTPYMGKLTNDVFLLYGAFHKFLGQEERSTISASIYYFN
MGEVDLTQLVGNEVTSMGTSKPNEFSIDVAYGLKLSDSYSMAVTGRFIRSDLAGGFNTDT
TLKPANSFAVDVSGYYTSPRFSSFGGYDGKLNAGFAVQNLGPKLDYTGNEESRSYLPTMA
RLGVGYDMYLDDVNRVGISVEGSKILVPGSEYVGMDPNTRQPIYEVPNVGPIAGIGKSFK
NKNSIMYSGALEYSYDNAFAVRGGYFHESEEQGARQFATAGIGLKYRSFGLDISYLINMS
KINTALDNTLRFGLTWNIGDETSNVDY
>KALACAFP_02444 hypothetical protein
MKQKILLLFLIGFVSTVWAQRINIDWDGSKIQDFGDTKINLPNFKNQGFSFSQNNIFITI
KQKIGEKQLKVSNPVWENVSSRDLFELSKGLLPDYEIKDVAYYYLDGERYASINVALFKN
VKGSVQRLSSFEISETNASNNIGSTLKVGTTGNPLSTGGFYKIKVDKSGVFKITKQFLQD
NGINPSSVNPKNFRIYGNGGIMLPEYNQDVKYSALQENAIQVVGEDDGVWNDNDYALFYA
QGPNGYNLYNTSNGNGYKRVDTRSDRSENLKNIYEDFSYYYINFDKGPGKRIQPVDVNLP
TTPLITRFDNYQVINNDQKNLMKVGRIWVEDTPFTTDKPVTFTTASAIQGGDVIRYRAQV
IGYKSQQNSIAFNINNLNPFTVAIPPVNSSGTNDFYPARYSGTITGLSGTQITFNLKPDI
SVNPNGTFYVDYLEVQYKDNLNFNGSQMNFRDFSLVSGSNTTYGFSLSNASTAEQVWDVT
DITNVNRRVNKAAGNTTFNFAYTASDLNFNNEFVAFKADAAFSPQFVGRINNQNLSGLQN
VDYLIITTPEMMGQAQRLASYHQTKSNFNVQIIDTDKIYNEFGSGSRDLTAIRDFVTKLN
TPLGTLKYVFILGDTSYDYKNRIPNNTNVVSSYQSEESMDVIRSFVTDDYIVMTKPQTNE
FITNNLPDLPVGRIPAANVTEAGNMMDKTLAYYNNLSGQSTPFGEWRMKLDFVVDDDNDG
GTPFHTVMNNSLVTTFEQPSTNLKEYNVRKLYLDAFQAVSTAGGQRYPQVNQAISNDIGN
SLYLFYFGHGGINGWSQERVLTLDEIQNSNNFSNVYSRFPFVSTITCEFTLWDEPDTSSA
GEQFLKLKQGGPASMITSSRAIDVGYGIDFTNLYTQNIFKLTSDDFDTLGYAHLNAKKQK
GAATDHLKVNFLGDPAMKLSRPKRLLNIDAIETPVPGLIRALDFVKIKGHINKPDGTINT
SFNGRVVINIFDKRLNKSTLNNDGNLTPILQYTEEGSAIVKASGTAVNGVFTVEFYVPKD
INYAVGTGRILGYADNKVSDVFNNQAVQVGDINPNGINDNEPPKVKLYMNNTNFADGGIT
DQNPMLLACLTDDTGINSTGSGIGHDITVYLDGQIINTIVLNDFYASGEGNGCLSPSLAD
YQKGNVTYPFRNLAVGQHQLTFKVWDINNNSTTATLNFEVKDQADQHLVINRPLNWPNPF
TNKTYIQFEHNCDDILDVNVQIYTITGKLVRTLSQPVVAEPFLQGFRTPRQAIEWDGRDD
FGATVAKGTYIFKIFAKSQNQEKCKGSATAVEKMVLLK
>KALACAFP_02445 Hercynine oxygenase
MLTFFKKINSLLDLLNNLFFLCTLKIFISTMKKLKLFSLIALSSTLALTSCGGGTSKGGG
TKKFVSKTGWKPNEKQGWFFAGKQQKQKGWPGMVYVEGGTFTMGLVKDDVMHDWNNSPRR
MQVSSFFIGETEITNYEYREYLTWLKYVFPPSDPSFKEIYNGALPDTLLWDNKLSRNDYN
ETYFRSPEFDYYPVVGVSWTQANRYCEWLTDRANEKALMQAGIIAKDLYINESNNQGGTA
FNMDKFKSNDPEMQGYINEKRMQQKNGIKTTNQRLLAANRAPAAAMVQKFRLPTEVEWEY
AALGMAKNREYNQYLGKKPEIQTLVGKKGRDKGMYLENFKMGTGDYSGIAGWKNDGSART
SDVRQYPSNDIGIYGMYGNVSEWTADIYRPIVDEDFSDFNYYRGNMPQAVVRNGDGTYKM
VDENSIKYDTLDDGRLVYRNLPGQFERETIADYRNYRDGDRMSSLDYRSTSDSADSKTNM
YNGPQRRFIVDASGKVILQRDRKERTSAMTNDIRVVKGGSWQDTAYWLDPGQRRYKDENK
AYGWIGFRVAQDAKASDKGRTRR
>KALACAFP_02446 UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase
MNIEQFYPLFLKSGKVTIDSRKIGKDDIFFAFSGENFNAATLAEKAIDEGALAVIVEQQD
FENTDKNIFYVPSTLEFLQDLAVRHREQLDIPIIGLTGSNGKTTTKEIIHAVLSEKFNVQ
YTFGNLNNHIGVPLTILSIKPEHEMAVIEMGANHQKEIEFLSNIAKPNYGYITNFGKAHL
EGFGGFEGVIKGKSELYDYLKNHQQTIVVNENDPIQVQKTENYSPKITFGKENSDYQFEL
FSEEHFVGLQYKGIKAVSKLTGEYNFTNLCAAASLGLHFGIDFEQIKHAIENYTPTNMRS
QVVKKEGRTLVLDTYNANPSSMTASLHNFITFEGSKTIVIGDMLELGEESEKEHKNILKL
AQELGFNEIITVGKNFKHVNSSAKAFENTLELIEYLKQNKILSENILLKGSRGIALERSI
DFI
>KALACAFP_02447 Diadenosine hexaphosphate hydrolase
MYKVFVNEKKLLLSKQSENLEKTLGYEDVTTLEIALDLLENTSVKELNVFGENINEIWAE
FQKLFRIIEAAGGVVNNPEGEILFIKRLGKWDLPKGKMEKGESREESAVREIEEETGLKD
VELVQFINTTYHIYVERNGDKVLKCTHWFEMNFNGEDTSKPQIEEGITEVAWKNTAQIED
EVFPSTFKNIKLIIEEFWATKAK
>KALACAFP_02448 hypothetical protein
MNLEGRKIIVNKSSKELVEILKSPENYKDFMPDGLQKFETREDGFKFGLQGMPEIALKID
EVNDQKAVLKSASSSLDFSLTATLNPLNENQTEVQMFFEGNFNPFIKMMVEKPLQNFINT
LTDKIEAYK
>KALACAFP_02449 Pyrethroid hydrolase
MKTKLIFKKADFILLLLALFISVNFYAQQNKTIKNIVLVHGAFVDGSGWEGIYKILAKKG
YHVSVTQHTLLSFEEDVKAVNRIIDQQDGPCILVGHSYGGAIITIAGNNPKVAGLVYVAA
HAPDEGESEADNGKIYPPAYKSLIKGQDGLDYINPEKFPDDFAGGVAKEKAKFMAVSQTP
TADVAFHAIIKNPAWKVKPSWYVVAKSDKIINPDLERMYAKRAKSTAIEVEGASHCVYIS
HPNEVSNLIISASNLSK
>KALACAFP_02450 Anhydro-N-acetylmuramic acid kinase
MKFHAIGLMSGTSLDGLDICFARFEKQDSWSFEIVKAETVPYPKDWEDQLRNCIDFSAAE
LLELHSEYGFYLGKSVKNFIEKHQIENIDLIASHGHTVFHQPQKKFTLQIGDGRAIKLAT
DLPVIYDFRCQDVLMGGNGAPLVPIGDELLFSQYDACLNLGGFSNISLKINDTRIAFDIA
PVNIVLNKLVQKFNKNFDENGDLARKGKINDDLLLQLNSLPFYQQSHPKSLGIEWCNEKV
FPLFETLETVDIMATFTEHAAQQISKVFNENQLKNVLFTGGGTYNQFLIEKIKAKTNTQI
IIPENEIIEYKEALIFAFMGVLRLNNEINVLSSATGSSHDHSSGVIA
>KALACAFP_02451 hypothetical protein
MIKNISYKYIAYLFSCAIFFILTSCEEDLTKAGGKQSKNFPSQIINNANIIQRDSGFVTL
RAKAPIIEKYELIDSPYTVARKGIDIQFFDKKKPKVPGTIKAKYAKFFDYKQFYEARGNV
RITTNEGQKFAMQSVFWDQRKKQIYTHDTVYVTLEDGSTLISNHGMRAKDDFSEYVFLQN
SGDFTTTKLSESKK
>KALACAFP_02452 hypothetical protein
MKKIFVLSFISVGYFLNAQNLSNSPYATYGIGDVKYDNTIETTSMGGISTAFISDFTSNF
NFANPANNANFELTSIKLEATNENNYFKTDYNNTKSTKHSTYLSNISIAFPLSPKLKMGL
SYQPYSSKSYEIIHTDELKDENGVVYATRANRFKGSGTLNTAQIALGYELTEKFAVGLRA
NYYFGNLYDLNELAQSNAELINGYETKNNVRNFNFTLGASYQNLNTSTDKKLTIGATTTF
GNTSNMTSEYKNSTYFYDATGTTIQSGSESIIEQKTASSKNLLPLQASLGVGYGEENKWF
LSLQGDYKKGESITYFGKSFDLQDSYRISAGGWYLPNYNNFRSYFSRVVYRYGAFYEKGS
LKIAGQNINKFGVSAGVLLPFKNSSITRMSGLELGLEVGKRGTLKNDLINQNYINFRVGF
NFADKWFRKRLYE
>KALACAFP_02453 hypothetical protein
MNWENIAGQENLKKLLRDSIAENRVSHAQLFVGKEGYGTLPMVLAYAKEVLSLENEHAAS
KVEHLNHLDLHFSFPVFTDNKNSLSKNKFEDFREMIMASPYSSYDDWTAFLESENKQLFI
SADEVDDQNQKFSLKSFEGGTKILVVWRADKMNVAASNKFLKFLEEPPAKTIILLTAEST
NDILPTILSRTQIVEVPRINDEDIEAYLKKNFNVSDDKIKEIVHEAQGDLNDALKLLQSG
NKSDEFEKLFVQWVRDAFMVKKKPEFLKSIILWAREIAGWNREKQKNFLNYCSEIFRLAL
LQNYQSESLVYKKIDANGFNWVGFSKFISGANIESILEEISTADLHLTRNGNPKIVWTDL
GIKLSRHIHKNS
>KALACAFP_02454 hypothetical protein
MKKIISIAAILSVFTLNFAQEKEGCCAGKDKKECSVKDKKACGDHHKSCDAKAKTAENTV
KNKKAVKAVKKAA
>KALACAFP_02455 putative HTH-type transcriptional regulator YttP
MISKEENILFAAEILFAEKGFEGTSTREIAKAANVNISMISYYFGSKEKLYEKLVEYRMN
EGQFFSKDIIERTDINDWEKVEKIVDQFANKVRHHKCFYRIMQREQLHAENPQIVEFLKE
TKMGFLTMYSKILESGLKKGIFTKNPPIYLLHSTVSGTLFYAFNAKEMYKEFLNDTNDEE
VFDEKYYTELNTHIKYLLKDLLGYEENK
>KALACAFP_02456 hypothetical protein
MKRINNSVIALALFIGVANANAQEKKTLTLDEAVQLGIQNSKNLKIDVAKIEEATADLLE
AKNRQLPELKVSGSYMYLPLKPNVNIKLPGVSGDGGPEVHQVAYGSANLSVPIYSGGRIK
YGIESAKYLVEASKLSTENNKIAVAYNVAQAYNNLFKANQSIKVLEENLTASQKRDETFL
KMENNGLIARNDRLKANLQTSNIELQLLEAKNNYNIANINMDLLLGLPETTEIEVDQNYI
EEGDEVKPVDFYVNEAKENRKDLQALDKQRQAAALGTKAAKAENLPSVALTGGYVAADIP
KFLTIYNAVNVGVGISYNLSNIWKKNSALKQSQAREMELSATNELLNDNIKLDVNREYQN
TDYSKKRIAVFEKSAEQANENYRITKNKYDNGLATMTELLDADAAQISANVGVINAKADA
ALAYRKLLQTTGTLTIK
>KALACAFP_02457 Multidrug export protein EmrA
MENNNTQATEPKKKKSLVFPIILAVVLIGGGIYGYRAYTYGQYHEETDDAQIASNMAPVI
SKISGYVTEVKVKDNQFVKKGDTLVILDSRDQKMALEQAEAALSTAKSNISNAEATTTAT
SKNIGSSEAAVTTANAQIEAAKVNVWKTSQDLKRYANLVKDHSITEQQYEQALAAKQTAD
KQLQVLIDQRNQIAQQTNIASSQTAASSQQISVAGSVAKQREVDVENAKLNLSYTVIVAP
EDGYVAKVPIQAGQYLQAGSQLFALVKNDQKWVVANFKETQVDKMVEGQKVKIEIDAFPD
QEFEGVVSSFSPATGATFSILPPDNASGNFVKVVQRLPIKIDFVNLDKNIAKKLRTGMNV
KAEVSLK
>KALACAFP_02458 Multidrug export protein EmrB
MQDSLVEYGARRVIITITAILCALLEIVDSTIVNVALNEMKGNLGATLSEVGWVITAYAI
GNVIIVPMTSWLSQQFGRRNYFAASIIIFTVFSFLCGNATNIWELVFFRLMQGIGGGALL
VTSQTIITESYPIEKRSMAQAIYGLGVIIGPTLGPPLGGYIVDNFSWPYIFYINIPIGIA
ATLMTLQFVRSPKYAEKRKVSDVDWIGIALLAITVGSLQFILERGHEEDWFASGMIVAFT
VSAVLGFILFLWRELTFKYPIVELRVLKNGNLRIGTAMSFVLGFGLYGSTFIVPLYTQSI
LGWTALQSGALMIPAALTTAFMMPIIGRLLSKGAKQQILVALGLFVFFVYSFWGYKILTP
DTSKEAFFWMLMVRGAGLGLLFIPITSLSLSTLKGQEIGQGAAFTGMMRQLGGSFGIAAI
TTFIANEGQKYRLNLISHLDENDFAVQQRLQALKGSFIAKGMTPDAAMNAAYKMLDLSVT
KQATVLSYMDVFLYLGVIFLICIPFILFIKERKSKEKIDLSEAMH
>KALACAFP_02459 hypothetical protein
MKKYLLLAGFLVINTLSAQVGINTQNPQTAFHVDGAKDNNTSGTPSAAQQLNDFTSTSSG
SLGIGTSAPTSKMEITSGTANISGLKFRNLTSATPVAATGQNLGVDASGNVITVPTPTTP
NVITEEVSNSTGFSYVVNDLAYTMIPTSQQTLNIPAGGKAVFINFMLGIDYFTFLAGGGA
AYYEARLFVDNVPTNVYLITQERVQGGSQTQYSMSTVKTLTAGAHTVDVRMIRSFNNGVT
SGANMTCRAISMSFNASYINN
>KALACAFP_02460 hypothetical protein
MKKKVTLLCSLIAFGVSFAQVGINTSNPQGAFHIDGAKDNNSTGAPTAAQQLNDLIVTSA
GNVGVGTTAPSSKVEINSGTANTSGLKLTNLTSASPISAGQTIGVDASGNVVTLPNPTAV
GVTPYEVASTTGADFNVDDSSDTLVSGTTQTINIPTGGKALFINFMLGIDFTTVTGTGAG
YFRAMLFIDGVATNTYLIIQEPVGSASASGGQQLSYTLNTVKFLTAGNHTLDIRMRRTAN
NGTAAGTVTGCRPISMSFNASYLN
>KALACAFP_02461 hypothetical protein
MKNRFILFLSVLVSGAFFGQTGQVGINTATPRVHLDARATTGNSAIAFGNTNQTAPAAGA
GAMKYDNSVNNNGIYYSDGVVWQQFLTSGTTSLPKVVAAGRKTVDEIISTNTGDTHPWLF
QNVILNDGNWNSTTNSYTVPQDGLYQMSMGAPLRPSQVNNLSEFTIFVYDSTGTNEVRNF
VFRGIDYSVGGAAFRGGTLTFELKKDQIVKFGSVHCYIGCLGNTVNFTIGAGALFTIVQL
>KALACAFP_02462 hypothetical protein
MHNNRETMKKNFLMLFLLAFGAFSAQVGVGNNNPTVNLDARATTGNSAIAFGNTNQTAPV
AGGGAMKYDTGQLYYSNGTTWIPILEKQAGVFIPRVVASRKKDDTQIMGPTNTNESYVWT
FHETVIDDGNWNDTTSGYVVPTSGFYQVSLFGRIYANATNNSANWTIYVFNGATETRYIV
ATQSILTAGGYTATGGTLALYLTAGQVVKLGSSYCNGCSTPKTYTVTPDAGFTITQLSNS
>KALACAFP_02463 hypothetical protein
MYTVKHDCELLSISIKYFLSVLWGTMDNRKLVMALAAFVYLESVTYSCY
>KALACAFP_02464 hypothetical protein
MKKLLLIFSITCMSTALFSQRVGFRTSNPQAPFHLDTRANNPATGGLPSLPLVYDDFLID
TDGSMNIGPYFAAGMPRSKFFLFFATTGGDNVRIDNLLPAPNPEDIDLLGVVRPGAGFSY
LKREQSLNELDLPRTTVLGLSADVTNFLNGVSAGGAQDMPMTVIKNGIPGLSYNATTHFV
TLPAGTYRFTVVYSASHGGCTLSSYFYDFPLPSSFTRVHSTSDHLTGAGVGSRHTGTITY
ASASLPDGKMILTNLGRGQSGNCGGTGMTLFADGTQFLITRIGD
>KALACAFP_02465 hypothetical protein
MKKKLLLSIFLISALYMQAQVGIHTNNPQGMFHVDAGKDNPATGAPTVAQQANDFVITSP
NGYVGIGTTTPARKLHIVGDGVNDPAQIGGLVAGDPQLDNLLGITSTGLIRSIGSVESLS
IPRPALFVLGTSVTNFLNGVAPGNNQVVNMAMIKNAIPGLTFTAATREIVLPPGTYQFTF
VYEADHNNTGCTLSSYFVDFPNDGTAVRVQSNASHLEGGVSNHGGTISYSVKLVNPTNSF
FIRLGRGQAGNCTGTGMTLVKDSTHLLIYRMGA
>KALACAFP_02466 hypothetical protein
MKSLYISIILLLFSQVKAQQNVIMEALDAPDPVFTITACNVSTIGWLGTGLPAASADIAA
KQEIAVNVIIPGPYAFTTGAVNGVTFSASGTFTTTGVQNVTLTGTGIPVDYTVGNGTFSY
TVTNTTGTNAGSCNFTRKVYVPDQNYTGTIRNDGNHRFLYKVILGPGSDEWLQTNLGSHY
NEVGHPSFNPEMGATNVDDYLAFGSLFQLGRNSDGHELVNWTSATTATGLSTTATPAPNP
TVTPVNSGLFYTSTDGTRNLDGTGNPDPETGNYYGLKVLNLALKKYTVGPGDPCPSGFAV
AQDANYGPANYNAGSTPWLNNPLKLVAPEMFRNAANGALVAYPRRLMRTSRLALFPMDTF
YSSEFVIEGGNIVYGGGGSTEHADRRVSGFNLATGTVFDPRGTLDGYPVRCVKPL
>KALACAFP_02467 hypothetical protein
MKKQLLSIFTLTFGVITFAQVGVHTSTPQASLDITAKNLTGTSVEGLLIPRVDRLKAQSM
IAIPTSTLIYVNSTANGTLAGNAVNIDAVGYYYFNGTAWTKLIPTSAPTSSVNIYNSDGT
LEGNRIVTQGTNFLRFTPTIAHGFSVNGNTFSVDGENNRVGMGTITPQRKVHINGTMQLT
NELNVGGTATVAGSAGTAGQVLVSNGAGTAPSWEATDGIIGNEVLNATAGGALTRSGAGT
AASPYTLGIADGDITTAKIADNSVNYAKINTPFRNITTATDALVATDEGGFIYVMSSTPV
TITVPDTLPNAFHCVIIQQGTGQVTVAGPGLASARGLKTRTQNSAIGIIRKSPVYATVTG
DAVN
>KALACAFP_02468 HTH-type transcriptional activator RhaS
MTKNLLFLIFLYSTMGWAQKSNDPFEQLYMKTLTEVAAKDTPRALKIADSMYAAATTPEH
KGRAFMLSANIYLQQNKNEESIKFAEKAKDILDKSENDELKSKIRGLLASEYRIIGLNNK
SKTYADEGLKLADKINNEQKKAQVKSLFYQELGYYEMEQKNHKNAIHYLNQSLECLSKIP
ADKINLGRTYQLLGQNYLELHDYKNSDSYNLKAIEILPETFVGTALSYIGLGISKTNQKQ
YKEAEKYLLKGLQYAETADHPAAKRTVYDGLAKYYEQTKQYEKASIYRKKFVEVFKKTED
KYKKTVDNDYDKIEKEKEQYIGWNSTKNIIIGVASLLILSLAILFIINRKKHKAEYQKFK
SIIDHYKEKEEYVLESKVVTSEMEENENEEENIYEEIEAENKQNDIAINKETEAKILSEL
EQFEKDEKYNNSFISLSYLATEFNTNIRYISYVVKKHKGTDFKSYINKLRINYIIHKLNT
SEKYRKYKVGALAEECGFSSHSKFTTIFKSITGISPSTFISFIEQEETKKNKN
>KALACAFP_02469 hypothetical protein
MVCVENEIFNCLNDSFLDDLSNEFVMILSKIKENSPDKQLSSFHFIFIPTKIVFFMDQNS
LDKIIQRSLEIREKYHQLEIRQNGKEWTLEQDVLAFLTDAGLVGRDVMSHEKTWTKPNSA
EELEHKLAENIWWLIILADRTGIDIKEALEKFLIKTENILK
>KALACAFP_02470 DNA-3-methyladenine glycosylase 1
MSYCLAIERMQPESRRELHKKYHDNHYGFPIHDDNELFGRLIMEINQAGLSWETILKKEE
SFRLAYDNFDIQKVAVYTEQDRERLLSDPGIIRNKLKVNAAIENAKTIIDLQKEFGSFEK
WLEHHHPKTLPEWMKLFKKTFKFTGGEIVNEFLMSIGYLKGSHDESCSVYHEVLKHEPMW
KKG
>KALACAFP_02471 hypothetical protein
MKYICQCCGEEKEDWPAIAFSAPSPYFHLTEEELEHSELTSDTCIINYPDHTNYFIRVVL
VQEVDDSCQDLEYGVWVSLSEKSFNNYIENYDDKNFEGGCFGWLSNYIPDYEFDEAIPTD
VFIDNKIGRPFIYPHESCEHPFVKDFYSGISKEEAEKRIGVVLNGS
>KALACAFP_02472 hypothetical protein
MKTEALNQILEEDVLSPQSKEKLAALHENISSKEFSDLLDAEGNQYVEFVQEGGGVWGSA
LVGYLYGLEIFGIRFLKVAGTSAGAINTMLIAACKTKEEPKSEIIKDILFNWNFADFMDG
KTYVKTTIHAMLNNKNFLKINLYIAVAILAFFGILAFVLPTKSTWETKILFAIPLFLVIF
GILCLSKLYSDLKKRNSGLNPGNTFLNQMKQVLDGFGITTVAALNKKFVQSGENLNLDYR
YGNGMEYYAIALNSIEEIKVNNKEHIDEIRYRIFYESAVNNEYYKKDPFYLLKSEYIVIT
TDINAKIKVELPTMANLYWSEEEMKHISPAEFVRASMSVPFFFEPMQKRIDKNDDSVKYA
WKFWMNTKQEDINPVGVFIDGGSISNFPIDLFHSADIFYPRLPLFGVQLTSDSDILSEKG
KTSEEILKSPLSFAGNIISTLKGFNDKTFLTKHTFYHLYSIQTVNCGTSNWLNFFMKKEE
KEELFNKGFQAALDFLNRFEWEKYKCERMMLSMKEKKILKEEDTKTVG
>KALACAFP_02473 Cobalt/magnesium transport protein CorA
MPIDTIFRNAQCDWVDVEAPTAEDLKFLHERYEINNLLLEDTLDPNHLPKYEEDGDVKFF
LLRESTELERKNLNTISDISTKIGIFLIDKTIITIHRMKTKSIYETKKQISILQEETTPE
TIALKIALLIMKSFDDESVSLLETMDNIENEIFLKNTNHTNQIKRLYKLKRKSGLNSRVL
TISTDAVDKFRLLGLQDSEVVDLKDKHKDVVADFDHLNLQITNLISMFLALSDQKANQVM
KVLAIYSVYFLPITFIAGVYGMNFDNMPELHHKYGYFFTLGLMALVVICTFIYARRKQW
>KALACAFP_02474 3-oxoacyl-[acyl-carrier-protein] synthase 3
MIKSTIKGIGFHVPDNVVTNDNLAELMTTNDEWITERTGIKERRHRKDRYDSQETTAYLG
FKASEKAIAKAGLTSKDIDYIIFATLSPDYYFPGCGVLLQEMLGCDTIGALDVRNQCSGF
VYAMSVANAFIKSGTYKNILVVGAEIHSFGLDFSDEGRGVSVIFGDGAGAIVLSATEDEN
AGDVLAFNMHSEGKYADELCTQFPGSKFGWSDRMRKDPENVTNKEIYPIMNGNFVFKHAV
TRFPETMMEALDKAGKTIDDVDMFIPHQANLRIAQFVQQKFGLPDEKVFNNIQKYGNTTA
ASIPIALSEAIEQGKIKRGDLVLLSAFGSGFTWGSVLFEY
>KALACAFP_02475 hypothetical protein
MRVKFLTILLLIISASFLKAQVGVNTTTPQKTLHVNGSLQVVNELNVGGDASKAGDAGTA
GQILTSNGAGTAPSWQTLNIHSGTISNAYYVQGTTGLTIPAGTTADVPGVTITLTVPAGR
TQTFLFNILGYAVNPSPGTGKSSQGVFSLLQNGTKISSAYTSNVGNAGGGFVDFPIPVTF
LKAVSLPSGTYTFKVQYKAWAGDQRVNHNPTAYAGYDGDAEAMLTKMQVLVYNN
>KALACAFP_02476 hypothetical protein
MKKKILFGTLLFPLFFCAQVGINNNVPASTLDITAKNATGTSTNVEGLLVPRVDRQKAQS
MASVPVSTLIYVNSIATGTQTGTAVNVDAAGYYYFNGTVWIKLNPSVNIYNSDGTLTGNR
TVTQNANTLAFTGTATNAFSVDGTTLSVDAANDRVGVGTTTPQKTHHVNGSLQVVNELNV
GGTASTAGSAGTTGQLLTSGGSGAAPSWQALNTMSGALFNTYYVQGTTELNVAQGTTADV
PGVTLTVTVPAGHTQTFMFTIMGYAAQTATGASQGVFILLQNGTKISSAYASSSDGSGLS
RLPHPVTFLKSVTLTAGTYTFKVQYDAWVGTQAVNFVPSFYGGYNGDVEAMLTKMQVLVY
NN
>KALACAFP_02477 hypothetical protein
MNNSIGFKIKKLREQKEISQEDLAFQLDISQSYLSKIENGSIEKIDFLFMQRVAEFFKVE
PQYFLEGDTVINDIETSNNSAVGYFRNYTINNNIDGDLFKSFVQNQEQITKQQEQISQLM
EMQNKLIEKLLKN
>KALACAFP_02478 hypothetical protein
MNNSIGFKIKKLREQKEISQEDLAFQLDISQSYLSKIENGSIEKIDFLFMQRVAEFFKVE
PQYFLEGDTIFNVETSNNSAVGNIHMSTINNNIDNDLFKSVMQNQQQISQLMEMQNKLIE
KLLKN
>KALACAFP_02479 hypothetical protein
MKRIFLLAAMAVAGTISAHTSVAEMKAESKVIYNPIKITSSCGYTQYVTVGANDDPLCYL
VDADQMEIDCDSPFENPQYGYNP
>KALACAFP_02480 hypothetical protein
MRYYFSILLLFSFFFACSQQKEEKSFSDLEVLYEYSFTRDTTDVDPSHRSKELMVLDCNP
RSSIYYSRQYVAARKVFEQAGIAAQTSANVEIRTADLPKYKISYSIYRNGSQIYYTGNIF
RDVFTFESTYLKWNTNYDEVKTILGYRCNKATTNFNNRIFTAWYTKDIPISEGPYRFKGL
TGLILEINDEKNYHSFKAIGIEKKQTEIKPLQKGIPVTREQYIKKREEFKSNPYPERKNL
PKERRDQMIESFKKEVPLER
>KALACAFP_02481 hypothetical protein
MMKKTLSAAILLTVTSLCYALLNTPGSTLGIIAKTSLHTSRNGHDLFSSRGGIEKSQPII
LIPHLSIYSGGNVLIN
>KALACAFP_02482 hypothetical protein
MKKALSAAILLTAASFFNAQVGINTPTPSSTLDITAKNSTGTSKNVDGLLVPRVDRERAQ
SMSSIPVSTLIFVDSVVRGTQTGNAVNVDTVGYYYFDGNVWVKLNAGSSGSSVNIYNSDG
TVLTNRTVTQNDKTLTFTGTATNAFSVDGKTFSVDAANDRVGIGTMAPVAKLHVEGIESQ
FTNATSKWALSPEGTSPNSQLSLVDRNNNIRRIIMQENGNVFLGGNMGSVGANATISAVG
GNVGIANTAPTNTLDVNGTARVRTVNSVADNVISTPVHADANGVFVKMNPGTYGSVIASS
SPAITPGATATVISGLALGAIYKAVVSVSNWCTDVAIAEYYIYNGSYPTLTGDDGVVGTT
GSKPTFTQASTVTTHTTWNPIGCQDGSNTTGFNYTISLVGGGTVNITNNGNIVKNYRIVL
TRMN
>KALACAFP_02483 Thioredoxin
MKKLAILSSLFIGAIAFAQGIKFEDTNFKTILAKAKKENKLVFIDAYASWCGPCKLMVKN
VFPQKAVGDYYNSHFVNAKIDMEKGEGIDLAKKYNVKAFPTYLFVDGNGEVVHRTLGYVE
ENDFIQFAKDAGDPSKRIGTLKQRFENGEKDPEFLKNLAELTMYNDSEFAGRVMERYLSG
KTELDRGDVQMLLTGAQNTDSPLYKMFQARKVEITKILPAEKYDAIDKNIKINSIFKKSY
NADTKTWNDSYFMTEAQKFLTKDEAEKILKRAKAGRALKDKDIPTYEKLSLELYKDTSAA
NSEELNSIAWNFFENVNTKSSLEKAVTWAQESVKKNENYANTDTLANLYNKIGDKKNAKL
WAEKSIELAKKEGQDSADTEKLLKTL
>KALACAFP_02484 hypothetical protein
MSKSFYKLLFFIVAALLTFPTHFLHHTKNFKKLFPLAEINIYKIPLPEKDYAKTVAAITV
SPENSTIKSEKRSTEISIAKNIAIIILAAALVGLFVYCKSKQKKQFSKFRNIIRNHYVQI
NKENNSEPVKEVAEPDFSNISVEEVFKKKDDHKKRNESLMTSETETKLLELLNDFEKGSL
YNNKNMSLPFLAGELNTNTKYLSYIINQHKSADFKTYINRLRINYIIDKLINEEKYRQYK
ISILADECGFSSHSKFAAVFKAETDFSPSSYIKLLDSENQSDKHVHFQENN
>KALACAFP_02485 hypothetical protein
MRTTLTVVMASVLSNLAYSQVGINTADPITSLDVVAKTNDGSSAEGILPPRLTGDQIKAG
DNQYFPQHAGVIVYATAPVGVPSTKTINITSVGLYYFDGAVWVKMMQGDGRNFSTQAAGD
IKHSIQPIDHNGWYLLDGRDVSTLPAGAMNAAVSLGFPSKLPNAADRVLKTKNNVEILGS
VGGSNTLQIEKENLPSVNFTGTISGNTNAAGVHTHTMSGTAISAGAHTHSVSGTAASAGA
HAHGPTSGGGFLLGGTNAGNNGTGNYQGNGSPGAWGNVGIGGTTANAGAHTHSVTGTGAN
AGAHTHNLDVDAANAGNHTHTVTGTATVSSGGTGEALDNKSAYLVVNTFIYLGE
>KALACAFP_02486 hypothetical protein
MKKLLLGAVVGSLFLASCAQNKEKREEFKDDHDKSAMRNSMGDSAVANSEIGPEIDSTKV
NDTVKTK
>KALACAFP_02487 Thioredoxin-like protein
MENPQMKALWIFFIYLFENKLYLYPKNNTVIKKILFVAFTAIGLLTYAQGIKFEENKLSE
ILAKAKKENKLVFIDSYTSWCAPCKIMAKKIFPLQSVGDYYNSNFINAKFNMEKGEGIAI
AKKYNVKVYPTYLFLDGDGKEIHRTMSSMDEQEFIQLGKDALDPSKQITTLKRRFDAGEK
DPELLKSLIQLTNDDDAYNPKVFKRYFTVKPEIDKEDAMMLFTSINGTDDSRYQLLQENK
SKIIQLISQENFDEYNKFVILKGIRKKAYEKSKKLDEKVFLAEAQKFFGKEEAEKILFNE
KISESLENKNYAAYEKMVLDKYKDNYSNEEPLELAYVAQNFLNHIKTRSSLEKALLWSSD
AAKRNPHSMTFFTLAGLYNKLGDKTNAKIYAEKALEEAKKAKYQSEDLNADIQKLLDSLK
>KALACAFP_02488 hypothetical protein
MNFKNHTPKQSIMKKFLLIAVGLGIFAVSCGTKESSMSTSSKDSTAVDNTTQSVSPATTD
TMTTKTTNPDSIKIKTDSAATTPVK
>KALACAFP_02489 1-pyrroline-5-carboxylate dehydrogenase
MSKAISQVPFAVNEPVNSYAPGTPEVKSLIAQYKKMWAEKIEIPMIINGKEVKTNEKVQL
QSPQDHAHDFGFYYKGTMQHVDDAINAALAAKQEWNELGWEQRAAIFLKAADLLAGPYRD
VINAATMIGQSKNVHQAEIDSACELIDFLRFNVEFMTEMYSEQPVSDSGIWNRVEYRPLE
GFCFAVTPFNFTAISGNLPTCMAMLGNVVVWKPSDKQVYSAKVIMDVLTEAGLPAGVINM
IFTDGKDTAEKVLAHRDFAGLHFTGSTKVFQGMWKMIGDNIHNYRTYPRIVGETGGKDFV
IAHPSANVEAVATALVRGAFEYQGQKCSAASRAYIPQSLWADVKKVMETQINSIKIGSPE
DPSNFVNAVIDKNSFEKCKGYIDRANASSEANVAIGGKTDDSKGWFVHPTVIETTNPQYE
SMVEEIFGPILSVFVYEDKDWKETLQLVDSSSPYSLTGSVFAQDRYAINEAFKALENASG
NFYINDKPTGAVVGQQPFGGGRASGTNDKAGSKMNLLRWTSVRSIKETFVSPKDYRYPYL
G
>KALACAFP_02490 hypothetical protein
MENSDLEIISHLNPSKIVKIMRDPEASAKAVHLVYTSDAETAGIIRKKTGKKYSYYKDGE
KIKDKDEISRINKLVIPPAWENVWICALDNGHLQATGFDVKKRKQYRYHPLWNALRNHTK
FYRMLQFGYALPNIRLHVEQDLALRNFEKRKILALIVSLMQRTNIRIGNNAYEKLYGSFG
LTTLKVKHVKINGQKITFSFKGKKGVMHNVDLKSRRLARLVQKCKDIPGKELFQYYDDEG
NRHSIDSGMVNEYIKEISGEDFTAKDFRTWSGTVSALIAFKEIGYAETHAEYKKKVKEAL
EIVASHLGNTSTVCRKYYVHPLVINLYENNTIKKYLDELEEIEQNDGKAGLTQEEKLVLK
ILENEKM
>KALACAFP_02491 hypothetical protein
MKKWSLYSIMILCLLTLTSCEAIETIFKAGMWWGIILVVGVLAIILWLFSRGKNS
>KALACAFP_02492 hypothetical protein
MESQSYQNHRKFYPPHHFIYLPLLILLEVFGIWKIFNDEPNKLIWILFSIVIFLLFYLAI
MIRQHYALGLQNRLVRLEFKQRYFELFGQRSDEVESKLGFDQIAALRFAYDDEFKELLYK
ALHENISGNEIKKSIKNWRADHHRI
>KALACAFP_02493 Aminopeptidase
MTSKEKVAALREEMQKNNVDAFIVYSADPHMSEYLPEEWQERAWLSGFLGSAGFVVVTKD
KAGLWTDGRYYTQAAIELEGSGIDLFKDGLEGTPNYIDWIISEIPANGKVAVNALATSHA
NWELLSQKFNPKHITLVDLPLLKEIWKDRGTPSKNPIFVHPVERAGKSVTDKIAAIRQKM
EEQEATVHIISSLDDVAWTLNLRGSDVESNPVFLGYIIITKNDAILFTGLEKLEVEARKS
MDDSFVKMMPYEEFSNHLKTFRNEKILVSPNSNQSIFEALKSENQFIKAPVPGNLMKAQK
NETELEGFRKVMVRDGVAMVKFLYWLTHNAGKEAMNEYSIGEKLRGFRAEGENFVGESFG
SIVGYKDNGAIMHYSAKSEGSKDVTNDASILVDSGGQYLEGTTDITRTLALGAVSDEFKR
NSTLVLQGMIRLSMVKFPKGTRGVQLDAIARLPLWMSGKDYNHGTGHGVGSFMNVHEGPQ
NIRKDMNPQELLVGMVCSNEPGFYVEGEYGIRHENLIAVKESEKTAFGTFYEFETLTFCP
FFKDTIVKEILSEEEIAWLNNYHKTCEEKIAPYLEGEVKNWFLELVSPL
>KALACAFP_02494 hypothetical protein
MKKKIIILMCFCSLLHTTYAQVGINTSNPQATFHIDGQKNNPSTGVPNIAQQSDDIVGTS
TGNLGLGTTAPTAKLEIQTGGTTAAPISGIKVVDGSQTDKYVLTTDASGSALWKPITLTT
IMGVFPSNVGAGNYTFKTTALWDKTNAFITLPPGSWRVDVTQLLRITGDALTGDQYMWLR
FSFTDDNTPLNPTLTNDFSNNARYISAQISGPTVVMTNVYKYALAQGSVLINNSSGANKT
YYLIVGSTTSSFTSTATWLERVGANIWGENIITAIPISQ
>KALACAFP_02495 tRNA modification GTPase MnmE
MNNDTICALATANGVGALGIIRVSGNEALPIVQKSFPAKNLEKQKSHTIHYGYFVDGEEA
IDEVMLSIFLAPKSFTTENSVEIAFHGSPHIGKRILETLIKNGARMAKAGEFTLRAFING
RIDLSQAEAIADVIASENEASRKVAINQLKGGITNEISLLRTDLLNFVSLIELELDFAEE
DVEFADRTALVQLLNKIELKLNSLIESFQYGNAIKNGTAVAIIGKPNAGKSTLLNALLKE
ERAIVSNIAGTTRDTIEEVLHIKGHAFRLIDTAGLRETMDEIEAIGVKKAKEKVENANVL
VYLADAGTEDFSEDIEMIKSLLRDDLKLIICATKIDEVIPTQYEKVEEIFRNEISQEFDF
IKISAVENQNIQDLKNELSSYVEQLKTEENNVVITNQRHFEALRKSLAAVHKVKEAITFQ
ISTELLAYELRNALEHLGEISGEVTNDEVLGNIFSKFCIGK
>KALACAFP_02496 Tyrosine recombinase XerC
MLITLKQKKLKDGRISLYIEYYKGSNTDSNGKRIHIRDFEYLKIYLYENPKSASEKKANK
ENEKLAEDILAIRKTEYVQGKFDIKNTSKGKRRFLEYFEEKTEEKSSSVNNYGNWYSTLH
HLKKILPKNLLFEEIDPTVIKRVKDYFDKDAKTKSDLPLSLNSKYSYFNKFKACLRSAFD
EGYLTINYASKVKSFEQAESQREYLTFNELQSLAKTECKYPVLKRAFLFSCLSGLRWSDI
NMLIWSEVRDEGEMSRVNFRQEKTDSVEYLYISVQARALLGERQDQQDRVFRGLKYGVTY
NTEIVRWCNRAGIPKHITFHSARHTNAVLLLENGADIYTVSKRLGHREIRTTAIYAKIVD
QKMKEAAEIIPELIIKIDNF
>KALACAFP_02497 hypothetical protein
MENDRILSKLNRIEKYIIGLKDILNTDELSDYTGFKKSYIYKLVHHNLIPYSKPNGKKLF
FDRKKIDIWLLSNSFKSSQEIERNALDFIVKHNKMK
>KALACAFP_02498 hypothetical protein
MKTKILLLSLALCACIFSAQMPKWTVGNSLIDFSGTSPTIINSLGINTGDLWSVNGFYDE
NNNLLFNRTGGGINQNTSFAQEMGIIRVPGSCNRFYLIGIPPAPVGGTTSLYYSMIEVSN
GSVNYVPGYYMVNLGSMNTLMGSIAISKLKADNTRFLFATAGESRRFRISNTGITYEATI
ISNINDISDEADLYEDPVSGNMKLALATYAGFKVYNLNNQGGYISTWSVPSSFGVQNVRG
LEFIDSNRLLVSQNNNVALKRGLAVINMASGSISYIPGSQQYLDSHIEKAIDGKFYTTSG
EFPPYKLASVDIVNLTATEVVTLPAIGRYHVRALPEQVDNENYFTVNHKQDLASYDSPVD
TGLEPNPSANTWINIYQSPDIWNRVTNSGLNLIHENPGYSGPGSNVMRFRVHNQSCHTSS
PSYARLYWTMGSTGETWPDSWIGVGVGNIGGIAAGGELNIPYTGFNPSNIYVPGYGFKIP
ALAPGEEYIIDAKWHPVNPSIYGANADNVICFLGRIDDPNDPMHNEQVGPIEPNVVNNNN
IVTRNTRLVNLSGVYPFSGSGFFIGNYFNDEHHFDIRFERVKDSGIPFENAGNVTIKLDP
RIWQRWIEGGKQGEGIQILNYDQHEILVTNISKAILKNIRLQAKESLPVTVNFNLVNMNI
NTLQEYDFAVSQVASDKPSEQYGSVCHFLVDINREDQNEEYLEKQSGNSYSLFSDDLKLS
PNPVSDIAFLSFTLKNDAKITAKITDWHGKEIKSLISSELKKGKNSIQFSTAGLPQGSYM
VNISSGLENKSLQLMVRH
>KALACAFP_02499 DNA polymerase III subunit alpha
MFLNCHSFHSLRYGTLSVEQLVKQAYEQDIKTLVLTDINTVTAIYDFKKECENYHIKPIA
GVEIRKEDRLLYIAIAKEFSGIGEVNVMLTDYHCHGRELSQTAPEFKDIFVVYPLDQIPS
ILKANELIGIREDELTLLIRPELALLIPKMVILHPVSFSTKKEYSLHRILRAIDKNILLS
KLSDQDIARPSEYFTSENTILEAFRQYPRIIENTKKILEACSFDFEFKKVRNKQCYTQSK
ESDLKLLTRLAYIGLKRRYGTDHKIAGKRIEKELAVINELNFCSYFLITWDIVRYSNSLG
FMHVGRGSGANSIVSYCLGITDICPLELDLYFERFLNLNRMTPPDFDIDWSWQNRDTILE
YIFKRYGKDHVAFCGTNVEFKHKSRFREVGKAFGLPKEELDELTKKPMETHESNSVIQTI
HKYVKLLESFPNQRSMHACGILISEDPITNYSALEIPPKGFPIVQFDMNVAEDIGLEKFD
ILSQRGLGTINDTVNLIKKTRGINVDIRDTTLSKDEEKANEYLAVGKTIGCFYIESPAMR
GLLRRLKCSDYRTLVAASSIIRPGVAQSGMMREYIFRHNHPDQFEYFHSVFQEHLKETYG
IMVYQEDVIKIAQYFGGLSLADGDILRRAMSGKGRSIKKLQEVKANFFNSCRDKGHSQEL
TAEAYRQIESFAGYSFCKAHSASYAVESYQSLYLKVYYPLEFMVSVINNQGGFYRTEVYI
HEAKMSGGNIQVPCVNTSEFQTILKGKSIYLGLMLLEGLETRITNTIVEERERNGNYTSL
EDFIRRIPIGIETVQTLIFVGAFRFTGKPKNELLVEARILLVNFKPENRGMLLFEEAVPQ
HRLPRLKRENFEDAFDEIELIGFPVSCTPFDLLQTKYRGSVFVKDLLQYHKKQVKMLAYL
IARKHVPTKKGTMYFGTWIDVNGHYFDTAHFPDSLKKYDFQGGGCYLLLGTVEVDFHFPS
ITIHKMAKMPMIPDPRYAYDKDKQYDIHRHIKEDVSMTFREPYPQAHEIGLPRQMFGTQT
KS
>KALACAFP_02500 DNA polymerase IV
MNRAIVHMDLDTFFVSCERRNNSQLQGIPLIIGGGDRGVVASCSYEARKFGVRSAMPIRM
AQRLCPDARIIRGDYELYSNLSHTVTEIIREKVPVMEKASVDEFYLDLSGMDKFFGCYQW
TQEIASAVTKETGLPISFALSTNKTVSKIGTGESKPVGRLEIKDMEVKPFLNPLSIKKIP
MVGDKTFQLLSRIGIRTIHTLSEMPVLVLQQMIGVNGKELWKKANGIDENPVIPYSERKS
ISTERTFSNNTMDIIELKRLISGMAEQLAYQLRQEKWLTSTVIIKIRYANFDTETKQCKV
AYTAADHTLSRVALELFNKVYTRRMRLRLVGLRFTGLVHGSHQMNLFEDTEEQMRLYQTM
DYLKNRFGTGAVGKASGFDFGK
>KALACAFP_02501 hypothetical protein
MSVFAENIRFLRDQEKISQQKLADALFITRERYAKYEDGRSEPPIEILLRISRYHKVSID
LLVSIDIRKYPLDSLVNLPDNKILLPVVIDPEGNKYIEIVPQKASMGYLKGFSDPEYIES
LPRIQLPFLGHGIFRGFMADGDSMPPFADGTCVIGEYVETLDDLKKGKEYMFITQQGYTF
KTFVKKNTRSITVVADNTFYDPYDIPLKDMIQIWRYVRGILPQDYKPHYLPDHVKLKDLV
DEAKRSISNLETKLFHLNNNE
>KALACAFP_02502 hypothetical protein
MDQLSLFDAKEFYEFPKDLIEYQEDFLSRAEADMLKDQLLHTVPWEQRTQKMYDKMVLTP
RLTAWYGERNKSYNPEENSLPTDSWIPELLLLKERIEKEFGYRFNGVLLNLYRDNNDSVD
KESRYGKRPVIASISLGQTRNFDFRKMDHHQSKYSLPLPHDSLLIMKGDMQEHWEPWYC
>KALACAFP_02503 hypothetical protein
MVILTSCNTNDDETILEGKQAAAVDRQGWTQTSVLLAGLNNPEDTSFMRSELNKLINFWG
IPVQMMFVNDPVDPNGSMNAISYDNGSMIYYGYTFYNDAKSKAGNIGNVFILGHEYGHQI
QYKFQLPQIITENTSRGIELEADGLSGYYLGRNQVSFQQVAIAANYAAAIGDFNITDPSH
HGIPSQRRSAVRLGYLLSANALTPQQFDMYFKYYYFGVLNGQYKIKDNSSISIDPELDQN
ISKHLEEIQRIKNGEMSYEEYRNLK
>KALACAFP_02504 hypothetical protein
MKKQLLIIFALILGITINAQIGINTPFPVSTLYINAKNPTGTSTNVDGLVIPRVDRQRAQ
SMVGIVVSTMIYVNNAATGSQAGNAVNIDTVGFYYFDGNVWQKFITTATTQKIFAYIGKN
QAQLMQQGDIVWQTKTGVNADLISVSGSNITLPPNKTFLLHGNVSWLYSSTVPDGEAWMR
FHFLDATTGNRVGVVNITGYQEASTESVKDAGISLATSVIQTGNTPVTVKLTTFGPSYTY
GLFPNDPLGKTPATYILIQEL
>KALACAFP_02505 hypothetical protein
MRNNMYTLLLLFLFTSINAQEYSKLISEADKLYETKDYKMSTDLYNKAFKIESKNPNHLY
NGACASSLAGNTKKAFK
>KALACAFP_02506 hypothetical protein
MNLSIEQGWTNLKHLNSDTDLENLHSKKEWGKTIKKLEKKLELMEANYDKPLQAELLTIL
DEDQKYRIQINETQKKFAQDSKEMQDLWKLTIQKDSINVLKVKKILDEKGWVGKDKVGAQ
ANSALFLVIQHSDLETQKKYLPMMKEAVTKGNANPGSLALLIDRIEIREGRKQIYGSQIG
T
>KALACAFP_02507 DNA-invertase hin
MASLAEYERELIRERINAGLQSARIKGRAGGRPIEW
>KALACAFP_02508 hypothetical protein
MRPNYKKIYYDLLKEKQPEKLDDPKILHLLNNLNTMEDVLKINALVSDSSKKNLKKNQQL
KNYDKKTVLRLLHYQKKHNLSDNFMSKKLKMSRTTIAKWRKIFGHEV
>KALACAFP_02509 hypothetical protein
MLSIGITAPEDKIRITTILRCTIEIPKENDWPPPPPQLVTVNTQSYFNSDRGWNNDKKLL
CISYYGNKKSLPRILLMTDYW
>KALACAFP_02510 Iron transporter MagA
MNGLLWSICLLCLTTLGIMFLLKKLKQPYLIAYIMAGIVLGPHVSGVFTEPDEIELVGEI
GIMLLMFFLGMEIDVPDNRSLLVKPVIAQSIKILLSIICAFSVGYIIGLSLNSIILIAVL
FVFNSTAVVSEFLKKHHTLKTTFGIMILNMLIFQDLLLAPVLMMLKVWNKDDSSFVNSML
PILVCIAIFFVLKKIRTAQEIKLPEFFKTIENDHDLQVFSGLLICLGFGLLAETAGLSSA
LGSFIAGVLVGRIKTFHWLEHSLIPFKIFFVTLFFVSIGLRIDISYLYFNFRFILLGAFF
VLISNSIMSAIIFRLLRYNWKDSWYGGALLSQTGEFGILALSIAYKTGIIEYSLYKDGLG
ITCLSLLLFTIWISVLKKLIERKSVIPH
>KALACAFP_02511 18 kDa heat shock protein
MSIVKRNNGSLLPANRTLFDDFFSRELFNWGNNNFSSTLSTLPSVNIKENPENFEVEVAA
PGMEKQDFQITLDGNFLTISSAKKNQQEENNDNYTRREFSYQSFQRSFELAKNVVDEDRI
EAKYENGVLKLIIPKTEDAKKKAPRLIEIQ
>KALACAFP_02512 Response regulator UvrY
MVNKILIADDHHVVRVGTSIIVKETFPEVSIDFATTYDEVKEKLEAENYDLIILDIDMPG
TIYKSMVKEIKMLREEILILIFSFYEEDIALQYYKEGVHGFLSKLCDPNDIVSAISSICE
KGHYYSSYIINQMIENKNSPVETLSQRELEIFKLLAQGNGNLEIANLLNIEESTIATHKR
KLYKKLKISNLVELIRIYNTLH
>KALACAFP_02513 hypothetical protein
MIINETLLLEYGADYNHYKDNDIIFHARSQPHLFSQVAGA
>KALACAFP_02514 D-alanyl-D-alanine carboxypeptidase
MHILKNLQAIFLIMLASVNVCAQNIQQKIKNTVDSIYAANLKAVGFAVYVEAPDQKLSFG
YATGYENRDTKHKLSMDQPVLIASTTKPYVAASILRLVEKGKLDIEQPIKDYLSQRSETE
LTQAGYNTSRITIKNLLSHTSGIRDYVDAEYFKFIGEHPKYIWTRDEQIAKATRLGKPLS
QPGEGFKYADINYVLLTEIIENITHLPYYLSIRKLLSYKNNGLLITRFAKFEKERKNTPE
QAHQYWDEFGWDTYNLDPSWDLYGGGGIITNVKEMSSYFQQLFNGKIIKNKRVLALMTQD
VLPNLEVNYCLGIRKITYAGILGYNHGGGLGTDLIYIPELNASIAIAVLEASHRPIAVEI
SKEIVKLLKYNMQDIVETSQAL
>KALACAFP_02515 HTH-type transcriptional activator RhaR
MIDKSVKKKELHYYKSISDLCRGLGVASPLHPLIVSVNHADIPSESEVQYLVHDFYMVSY
KSNLKGKLKYGQSYYDFDEGGLIFVAPGQALSVIDDEVCSGRSLFIHPDFFAGHPLARLI
TKFGFFSYNINEALHLSEKERNKVLIIFENIKEEIEMVIDDTSQELIISYFEVLLNYSNR
YYKRQFITRKAISSPLIERFETLLNNYYEDEQSIQKGIPSVNYFSALLNVSYGYLGDMLR
NMTGMNTQQHIHAKLIEVAKQKLSTSELTAAEIAYELGFEYPQSFNKLFKNKTGLTPLQF
REHLN
>KALACAFP_02516 putative oxidoreductase
MSTIFITGASSGLGKATAKLLASKGWNVIATMRHPEKETELNVIKNIHLLQLDVTDLSSI
EKAVAAAVQIRPVDVVFNNAGYGLTGPLEGYRDDQITRQFDTNVLGVIRVTEAFLPHLRE
KRSGLIISITSIGGLVAFPFASIYHATKWAIEGWSESLSFELAAHNIQIKTISPGGIATD
FMSRSLDFGKHEAYAEQFDKFLASFENNESPLQFSTAESIAAIVYEAITDGKDQLRYLAG
NDAISTYQQRLDIGQEKFRKLIAKGLVG
>KALACAFP_02517 Serine 3-dehydrogenase
MNKTILITGTSSGFGAATANYFAAKGWNVIATMRDTTKNGNLEKSGNIFVTQLDVQDKNS
IDKAIVEGINHFGSIDVVVNNAGYGLFGIFESASREAIQTQFDVNVFGAMDVTRAILPYF
RSNRSGTIINISSGAGAIGFPMASVYSSSKFALEGWTEGLRYELVSLGITAKIIEPGGAM
QTGFMSRVGGESAGLNLIEDYLPFLEQIGKVYGGMQGTADADAVEKVVHAIYEAATDGTD
RLRYSPTDDIKPILNARRNTSEEEYQTFTNSIFLAK
>KALACAFP_02518 hypothetical protein
MRKWLREIDITQYPNFYQEERKRLIEEDFEDEDPILIQGCKNIWCFGMRINGELAFINFI
QTENL
>KALACAFP_02519 hypothetical protein
MPDKTSVVVGDQVLYTVKVKNDGPSGVENATFTFSLPSGFNHQNVVFQGNGCGSQGAVII
YNSQTGKYTSKLNLPSGCEITYIFTAGVTATTSGTNQQAEATILRPNDVTDPDATNTSLN
IPPADPHFFSA
>KALACAFP_02520 hypothetical protein
MKNKTITSLFLVLGTMTFAQVGFNTPEPKVTVDIVAKSATGTTTNPEGLLIPRVDRQKAQ
SMKEIPVSTLIFVDNVTTGSTTGIATNIYQVGFYYFDGERWVRLNFDPVLYAPINLYNTD
GTLEADRVVTQNDKKLAFTSTANNAFSIDGDTFSVDAKADRVGIGTIAPAERLDISGAVS
VRGRAAIDKTSAGTFDYGLGQTRILSWGDTTSGVIGFWTGAGGKPTSEKMRIHSDGNVGI
NTNAPKAKLDIIGSTFGLRNSVGSWDNIWFDVNNTSAPSINASGAETGLQFKVGKNATGT
YGDENQSLITVATMSPDGNIGIGTVSPANSAILELNATNKGFLPPRLTTAQRDALNPKPA
GLMVYNVNTNCMEFWNSASWVSTCAITAPPVGVVTTLNCGGATHNGTILTGTNASVSSVI
PYDGGNGGTYGGQTIASTGVTGLTATLTAGNFDNGAGSLTYTITGTPSGAGTANFVINIG
GQACTLSRTVSAAPGSVLNLNCGGATNNGTLTSETLAAGVSSIISYTGGNGGTHNGQVVN
STGVVGLTATLAAGNFANGSGNLTYTITGTPTTAGTAYFTINIGGQTCILSRIVNAPTGV
ITNLDCASVTRNGNLQLGAVASNVSFEIPYTGGNGGAHNGQTVTSTGVTGLTATLSAGNF
NATGTLTYIITGTPSAAGTANFAINIGGKTCIISVGVLAPCTAEGVYAYPHDVRKYYRCI
RIGGDLYRYIYTCPNGSVFDPIKKICVAQ
>KALACAFP_02521 hypothetical protein
MRNIRNLPTGNYRNGHGSKKIKSSFGESEIKVPRDREGNFEPALVPKRHNIIDGLENIII
SFYAKGMSVSDIEEQIREMYDFEVSTSTISRITNAIASEVVNWQNRPLEDLYLIVWMDGI
VFKVRENSKVINKTVYLAVGLNRDGRKEVLGMWLAKNESSAFWMGVLMDLKARGVEDILI
TATDNLNGFTQTIRSVFPESQTQICVVHQIRNACKYVVWKDRKEFPADMKHIYTAPTKQA
TEAALGDFADKWESKYSYAIQSWRNNWDELTVFFEFPLEIRKIIYTINLIENLNGKIRKY
TKNKMSFPTDDAVIKSVDGIKRSC
>KALACAFP_02522 hypothetical protein
MMDKEELLNNKDFYKSFKNREDLISFFKEMHKRAVEHMLDAELDSHLDNEKH
>KALACAFP_02523 hypothetical protein
MKKILLFLIGMLTFNSCTRPQNELNQYFFDINQEVSIAVDEHQPERIKAIYDRELKKYKE
FKTNQYLISSKFVELSLYQNNYNKKKQLLLYKLIQINNGQYNYISIVCNYHLSIQYENTS
PELSLEFLNKAICLDEKSKKKYFLPHLYHQKGRYYYKSKDYNKALIYFNKSLKALDKNNI
LFIASMHNNFALCYYKLGKTNLAIKETNRAIQLLKEKKNKVAEDDLFLYYILGNLGDYYM
ELKNYDKAKELYNAEFNFDKSGNFLNEIMGPSKRLFNLLTLTNDHQGLKELIVYLIKKEE
ELVTIQDKIQANKFIQIYYANHNDFQNLKIFSEKGIKLNDQYKAQVEKSHMETSDLLNQY
IIKNVNQKYDYEKKRSFLLKLVFFLSIILSATIIIYIITHNKKERELMENQKIILEDNKK
LLEQDLEIQDQKLKNLYLRLNLKMETEKAFLESLKNLKKLRIQEPEQILKDLLLKVTNLL
DIDKRDYDLLTESSLQNEHFIKKLSLQFSRLTKYELKLCVYFRLELSSKEIASFENTTPN
TIRVYKTKIKTKIGLDKNSSLDQFLKSV
>KALACAFP_02524 hypothetical protein
MKKITVFCFILVSLFGCSQVGINTPNPLASLDVTSKNPTGNSSNIDELLIHYVEGN
>KALACAFP_02525 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MKTKIALITGASRGIGRNAALKIAEKGLDIIITYNNRKEEAETVVKQIKMKGRHAVAYQL
NTKDFKSFDQFVKDVTSYLQQHRGSPAIDYLINNAGTALNSLISQTTEDQIDDIIDIHFK
GMFLLTQKMLPYLNDGGGIVNISSGLARIALPSSSVYGSIKAAVEMMTRYMAKELGNRKI
KANVVAPGAVETDFGDGRIRDDKELNKIIASRIALGRVGIPDDIGGVIAFLCTEEARWIN
GQRIEVAGGMCL
>KALACAFP_02526 hypothetical protein
MKKSTLFCFMVASLSGYSQVGINTSSPLAILHVDGSKDNPSTGTPSANAQANDFVVSSLG
NIGVGTISPANKIDVLATAGTGDVIGMRLRANSNNALTGQSILIGFHPNTVLGGNAPWGI
GAQFLASATGQGSADFIFKSSNGAAYSNRMIIKNNGNVGIGLDSPSSRLEVSSGLAGASG
LKFTNMNSASTATANAATLGVDATGNVVIQDVQKARFKGSVSTASFPGNSNSDSGPFTQL
SYTENFDEGNNFAINTFTAPRTGFYIVNANVSLSRTSDWNTSRNELYLDARVNGTLVLAN
SNIFSVSAASSEAGPTISINGILQMIAGQQLAVFGWMQNNNILRPILGGRSYLSIAEL
>KALACAFP_02527 hypothetical protein
MKKITIFCFMLVSLLVYSQVGINTTNPAASLDITAKNPTGNTSNIDGIIVPRVDRERAQS
MTTPTVSTLIYVNDASTGTAAGTAIDINTVGFYYFDGTKWTAINTTATNNDWKTIGNAGT
NPANNFIGTTDNQNLIFKRNNADAGFLGNLNTAFGLNSLPFTSSAIQNTAFGINALGNSA
GPASSAFGHQALAANTTGGNNSAFGWQALNANTTGTSNTAFGSRALASTISGGFNTAVGH
LSMQTITTGGFNTALGYASLNNLTSGTANVGIGHNAGNEGTGGVSLTSGDGNIIVGRQAG
LPNGNNQMNIGSIIFGTNINGTLANRTGNIGIGTVNPQGTFHVDGAKDNPITGAPTTVQQ
ENDVVVSPTGDVGVGTTSPTTTLEVITRKVNSGNVGIRFAGYNATPAINQNVLIGFNPNT
AAGGYAHWAIGSQFFTGTSLGEADFIFKSSNGGGYSDRVIIKNNGNVGIGIIAPTAKLHV
SGTTILEGATSVTGAANLFGTTSPLQMNGISGNSGQVLVSNGTGTPAWKNVVQSSFTAAF
DLSYPIGYYERTANFILPAITGPADSGKLFYIKNVGLAPIDAAVAAGNSIFGPNNGSVSI
PVNGTVGYVAYYVSAGSRGWIAVSKTW
>KALACAFP_02528 hypothetical protein
MSFESSVMYIPNKKIVFKGYSQRDQEERLRRYCENYHIIIGEIIYEDYSAKAFNRPEWIK
LLETLKKRSSKTNLLLFTKWDRFSRNAGDAYQMINLLKKYNVEPQAIEQPLDLSIPENKM
M
>KALACAFP_02529 hypothetical protein
MMNKSGGKQIKISAFLAGLRNPAYCGKIYIEQYNEEEAHFVPSIHEPLISEELFEKVQSV
MDGNVNPARPNAKILCDENLPLRGFLVCPECHHLITGSASTGRTGQKYYYYHCKSSCGYR
YKSEIVNNKFIQLLEALEMRESIKKYLRKVLKQNFEKFISNPQHERKTILSEIDCLNSRL
KSARTKLLEDVIDNDEYLEIKADCKDQIDKLESKLSKVKDKKKIDFPKLLDQALSNLVNL
SKVYADGDIEVKRKIVGSIFPEKLEFFENHYRTTKANVLLSYIYHINNELGVRKNRKESE
LSPLSGLVPDKKQLENQLNKLLDNEESSL
>KALACAFP_02530 Octaprenyl diphosphate synthase
MKNYSVENNSEKIGINLLIDDLPHKTSNLEWWYFHAHVEDDAGKAFAFFCSFFRIARDFN
VFPFEFTHSLTWSLVDIEDQKYHSETSHDDKILSKISDDLKEKKELKPIDNAFKEIIDKG
NFPAPDFLMKKSVVTSNNELKLNYDLGHLEKDEKGNYLVKIGNQIGNSNVNFCFTPLKNP
VHHGENGLVKSSMNAANNMHYYFIPENAVEGNITLNNKTFRVKGSGWYDHEFSESYNPAQ
KVEQNTSKHWMWFAIQFDNHCQLTFYSLTDKNTTQSDRLIVWIDEKGESFTLKDDNIVIE
IIDYYISKKTCAKYPVEWQVKIPAWNLDFNVKAELSDQEVMTFLYAPGFWEGRAKVSGTL
ENEKITGNAFVEITTDKGWNNMNDLLDQAAEEVLDIIHEVVPYPHEKEKIKKLMKDYYSS
YLNAVPSEILHEALIKPLLEMLDRKGKGWRSHLLRLLVGLCEGNISQYDPFVALVQLIHC
SSLIIDDVQDQSPLRRGDASCHVIYGIPAAINSGTFGYFVGEILIRNMTHLSDSKMKKVY
EAYFDTMRLCHAGQALDIRTFTDLLPQAFETGDTYSISESMREIHILKTGVPIKMMANII
TILEDLSLEKHKAICHYGEAFGLAYQIIDDVRDLNGSFKGSKVELEDIREGKVTLPLIKA
IELSQPEIRLKMKNLWSKPNKSSQDIHDIADWIISSGALTQCRKDAINLIDEKWIEIDKI
FPDSHYKLMIRAMSNYFLNL
>KALACAFP_02531 hypothetical protein
MYVLIDGATFSSAALFTAALKSQRKATKFIGRETAGGEEGCNGMVIQEFTLPNTKVLIDF
PWMCVESVAHNPTHGRGILPDYEVNYDPLDVVINKDRDLEKVMELIREDGKNE
>KALACAFP_02532 Non-heme chloroperoxidase
MSTLTLKDGTEIFYKDQGEGPTLMFHHGWPLSSDDWDAQVIFFLQRGYRVVTHDRRGHGR
SSQNIYGHTIEQYAADAAELVEFLDLKDVVHIGHSTGGGEVIRYVNKYAKGRAKKAVLIS
AVPPIMVASESNPDGVPMEVFDNIRNQTLNNRQQFYIDLTIPFYGYNREGADVKEGIQRN
WWRQGMMGGIVAHYDGIKAFSETDFREDLQAVDIPVLVLHGEDDQIVPYQNAALKSIKLL
KNGTIKTYPGFPHGMPTTEAATINKDLLKFIEE
>KALACAFP_02533 hypothetical protein
MDNSDDTKSVSASSESIGIQEKLALFLALIAGYIDATGLIKWKTYVSFMSGNTTQLGAAL
STDKPGVIITSVTVIACFLSGIYTGTCLSLWKRIKNKALIFYIVSGILIFYTIADYFYTL
NILSSIGIIGFSMGLMNTIVTSVGNQKVNTDFVTGTLNSLARNVAMLSMTDDKVAKVEYK
SNAIHLLFLWVGFLSGAFIAPFLLDFLRNWTFILPALLLMICGLLISRINSKN
>KALACAFP_02534 Oxalate decarboxylase OxdD
MKTTSLSFKYELEKKEPRTNDGGTTRGASVTDFPASIGIAGVSMRLQPGSMRELHWHANA
AEWAYVISGTVRTTIIHPDGHSYTDNFEPGDVWYFPKGYGHSIQATGTEECHFILIFDNG
NFSEDHTFSVTDFVSSVPPEIVAQNLGLTLEEVAALPQKEAYFAAGIVPDEMSFNAEARP
NESDIELTSFHRYPLHSQQPRIVPGGGLQRLVTSKEFPISSTMSGSILELQPGALREMHW
HPNADEWQYFISGQAEMSVFLAESTCVTEQFNAGDVGYVPMGAGHYIKNTGDTVCRILIG
FNSGKYESIDLSEWLAGNPKDVVITNFGLKEGEIEKFPTEKVFIQPKK
>KALACAFP_02535 hypothetical protein
MEIIQTPENALSHSTVTAIINAPIEKVNIADWLLNLPDAEYQRCSTQHIGAAISTTYDGE
PVSLNVETIGDALMVQHYVAVEHRPDYCRMLSISDSITKGGRTKVQVLWELKATKIDDNT
TLYTNEIHATATPEMFEYLKEHNVNLADAAASRQAASDAHNHEETPNFAKSIENKALTGK
YNQPF
>KALACAFP_02536 hypothetical protein
MHLTKRNNFSNSYKSKIMETQGASVVITHHVLDGKQAEYEKWLDEILPVSKSALGFIDWQ
IVRPIPNLTFVYTVIIRFDTIDHLRSWMESDARRKLIEKAHPLFTKEDNYEIKSGLDFLF
YGEKTDKVPVRWKQYLATWSAIYPLSLLMQLVLLPGLRFVNIPANRYFDTLVSTGCLVFL
VIYVVMPNYTKLIRKWLYK
>KALACAFP_02537 Autoinducer 2 sensor kinase/phosphatase LuxQ
MGNKRFSYFIIISFIIGTFLLIIVQINSAKNTKELIKNNNTLLNELRSSNHLREIDRDIL
GVESRIRASIATNDTTHLNGVDQKIDEVENFLDSLSKDNTDPEEQKLIHRLSELALEKKL
VKEKLLLRYNTIGDMDDQTSIANPRARKISNEITNITAKIYKSRRLQMVELSQQSAEMGK
KAKLYDISLLALLVLSGGIVGFHILRQFKRQRLLIQELDISEKKASVAAQTKENFLANMS
HEIRTPLSGILGFTNLLQKRPLDETSKEFVSSIQRSGENLMTIINDILDLSKIEAGMMRI
TPGIFSINGLIDSVETLFLERAKEKGLIISSTVDPSIPDTLTGDATRLTQILVNLIGNAI
KFTHHGKIDIEVYNKSQTEKNIVLGFKISDTGIGIDKEKLGEVFERFNQGEDSITRNFGG
TGLGLSIVKNLVILQDGSIEVSSEPGKGTTFDFYIPYGISEEQLTTITTANTDYFKDKTN
TPLRVLVVDDNAINQSLMKHLLLQWNINFDIVSNGLEAVEQLVNQTYDLVLMDIQMPKMD
GYAATQQIREVLKLDIPIIAMTAHALAGEREKCLSRGMNEYISKPIKEEELFKLIANFGL
QKTESSKITAETTPVTFQYIDLSYMQSISGGNKSFEQTVTKQFIDNIPPHLEQLSTAYEN
QDFTTVKLRAHDLKSSVAIMGLLPILEEKLTALERSTEKNTTAQNDLENVKNILNFALDE
AKQFLKQL
>KALACAFP_02538 Transcriptional regulatory protein YpdB
MKALIVDDNEIARTTLAHLAKQIPNLTIVNEYSNAIEAYNHLQTNHVDLIFLDIEMPEMT
GIELTKNLSGKDVIIIFTSSNKEYALEAFELNIADYILKPVMPARFLQAVSKAQSIFESK
KEDVEVTKDEFLFVRDSNITRRLKLDDIFYAEAMGDYVKFYTREKMFAIHGKMKTAEERL
PKDAFIRVHRSYIVSVGKIDTLQDGGIMINGKFIPVADAYRKALNARMNVF
>KALACAFP_02539 DNA protection during starvation protein 2
MKTNIGITEKNTEAVAEQLAKLLADETVLYIKTRNAHWNVNGENFHANHIFFEEQYKQLD
ELIDSVAERMRKIGHYAPATMKIYLELTHLTEYSERTNDGPGFMKDLLKDHESIIDFLRG
NITPFAEKYKDYGTSDFITGVMETHEEMAWMIRSYFR
>KALACAFP_02540 hypothetical protein
MSKKTLLSIIFLSVINTVYSQIGINTSTPQSTLDINAKNPTGTTTNTDGMLIPRVDRQRA
QNMGTVEVSTIIYVNDYTTGSQTAKAQNIDANGFYYFNGSVWEKINKTLLSYPIGSITQS
FKSADYSGWYLLNGRAISTLPAAAQVAAASLGLTTTLFDATDRTLKTKNATENIGDTGGS
DSFTILQSNLPNINLTTTVSGTALSAGSHTHGSDTGGSFLYGGTSNGNNGTGHGGNISPT
LFGGVGIGITNVSGNHAHSFSGTTSTTLGSGQSINNRSAYVVVNSFIYLGQ
>KALACAFP_02541 hypothetical protein
MKKIYVSSIIFLSIVNIAYGQVGFNISAPQSTLDIKAINPTGAFTNADGILVPRVDRQRA
QNMASIETSTIIYVNNAATGSQTGKAQNIDNTGFYYYNGSIWEKLFFTDKSSLVGNVKYS
IKTTDHDGWYLLDGRAVSTFPATVQAKAQALGFTTNIPNASDKVLKSKNTAESLGTIGGS
NLFAISQSNLPNITLTSNTSGTTTASGAHAHGTAVGSAYLLSGTSYSNNGQGYGNAGSGA
WGGVNWRANTAAAGAHAHTFSGVASTPLGGGGQSIDNRAPYLSVNTFIYLGE
>KALACAFP_02542 hypothetical protein
MKRLYTTALLLIGSFVFSQVGINSVEPKATLDIGAKNATGTVTDTDGILIPHTDRLRAQN
MATVATSTMIYVNDISTGTNTGKAIHIDATGFYYFDGNVWQKLAFNNNSYSLGDIQYSAR
AADHEGWYLLDGRSIASLPANAQSAAASLGLAGNLFDASDKTLKTKSTAESIGTVGGANS
FTISQSNLPNISLAGSTSITINSAGSHAHGPDKGTGFLITGLAGGGYGGGDAGSWGGTGV
ASTTGAAGAHTHTLSQAIPVALGGSNQPIDNRSAYLALNTFIYLGE
>KALACAFP_02543 putative sensor histidine kinase pdtaS
MKAKYLFCFLLSFSLLGYGQTSIKNNYDIKKNRLLIKATAMYIHSVNQGFIDMDSAVVLA
CTANKFPVSMSFDEGYNDGSYLPGGKMVDENNIDTAKDILKQLKKTDKIRLLLHLGSHYL
FKTGEKKEDLQQSLFFIQQAIELSNAMGIPKWKQQSNILLGKYYVQANNPVESKKIFAKV
VIESRNFNDRKSLAEALSNQGTYLSLDDPDKEKALSESMILYRSVGEKELEIELLMKLLT
VHFWKGNIDLAEKELLQASALQKKIGFKHLHYTSAPLAFIYSVKYNLNKSLFYSINSIET
MEATNDMICADNFYLRLGNIYEKMEHTKEALELYKKSFDVGTKNINSGSWYKSFPLTIQL
FIKDKRYKEALDYLKKADTYPPNTAIDIFYLSQTRASLYEKIGNNVLAEKYYLEMARNAE
NMMSTRTSRNVAIGYSQVSLFYAKTGKPDQAKFYADKALDVSKKTNQNFTIQELDLSLFK
IDSLKGNYLSAIGHYQDYNKVNDSLYNVSKNREIEELKIQYETLKKEDNIKTLEMQSKLQ
QSKLHRSRLLINLSIGSILLLVVIIGLLYNSYKVKQKNNKELMIKENEISQQNIKLQHLL
EDKEWLIKEIHHRVKNNLQTVISLLNSQSAYIDDDLALSTIKNSQHRIHAMSLIHQKLYM
SENISTINMPIYINELVEYLKDSFNLKQNIRFKINIDEIELDVSQAIPLGLIINEAVTNS
IKYAFPDNSQGIISISLITKDTDHYLLTIADNGTGIILDPDKKTKNSFGMSLIRGLSDDL
DGKFSIENSNGTLLQLSFEKNEQTRKHTI
>KALACAFP_02544 DNA-binding transcriptional activator HyfR
MELEKNEIDKKKKILIVEDQFIEAHDLQLILEKAQYEVIGIARSVVQALTFIDEEKPDLV
FVDIFLKGTETGIDLAKKLHEKHIGFIFLSANSSRSVLEEAKKTQPYGFIVKPFREQDVL
ITLEIAFYRHNHGIESQMQQENILRESIDAISCQPVKWEQALLQLARLFQTYIPFDYLQL
EPVHNGYSPTGLLRKDFENYEIIDADKIAKISGKNKSEIDEIQSGSPKHEFPKVYYDQSF
REIFQNSGFVRLIAATFGIRSFMVLPVRMGEDVFNFSFFSRNSDAYNNEHLQLLTKLESK
LAKLVSNLHNTKKKQPNIITNKKVDIDQMSNGFSSMVGNSQKMISVFDYIKRVAPSDTSV
LIMGESGTGKEKVAQSIHNLSPRKNKPLVVINCGAIPNNLAESLLFGHEKGAFTGAFEKR
IGKFEAADGGTVFLDEIGEMPMDIQVKLLRVLQEKEIERIGSSSPVKLNVRIIAATNRNL
EDEVAAGRFRLDLYYRLHVFPITVPPLRERREDIPVLVAHFITIFSKTLGIDEPAVSDHA
LTQMKAYDWPGNVRELEHVIHRSMLMKDGNLIKDIILPNFPKNQGEEKTQEFSIKTIHEN
ERDYINYILKTCRGKVSGAGGAAEILNIPASTLYSKMKKLGIKNNPLL
>KALACAFP_02545 HTH-type transcriptional activator Btr
MIITENNKRLLTPKQIRFPSSDRDEEFGCINIRRVPSEYFADLTWFEPNCFTLTFAVDAS
GQYKTKANTYDIVPGTFFFSRPETFRLMEWTGLHEIYHVCFSEHFLQKYAGVELFKTFPF
LFLENYAPKYGNQEIIDDFRIIFEEIAHEYQENFSISKNIIANLLTQLLLKIKRNFWTEY
DMNADRKKNHDIVRKFIIHLEDHYQQIQQGTASIQLRVNDYAKKQGIHENYLSNIVKEKT
GKTVSHWISEKTILISKRLLENFSFSIKEISYRLGFPYISYFTIFFKKHTGFTPTEFRKM
IA
>KALACAFP_02546 HTH-type transcriptional activator RhaR
MKPQLTEIRKFTDSLAFMNLPVFTYIERDDFAIVRVEELGMKIPHNSPVFRPDHFNIIVV
PDGSATYLINDTIFEISSHQILFIRPDTFLSYRWLHVGRAYMISFSASFFLQFWASGINE
IQRLDNSKGYITNLTEKMMKNVEQICQNIYKETTSQIPYKYELITNLILNLLLLIRRQQQ
TKQQEVPVNTSNPYVTQFFLDLENNFSTIISGETKVLLRAKDYANRQNLNENYLSKTVCT
HSGKTVSQWIHEKLINEIKFLLKYTDKSMREIASLYGFHDLNYFYNYFKRHTKNAPGLFR
KSFTT
>KALACAFP_02547 Pyrethroid hydrolase
MKIYRLSRSFAIIALLIISFFSIAWIPENRHNNVESSTKAKPTIVLVHGAFADGSSWSKV
IPILQKEGFRTVAVQNPLTSLQDDVAFVNRILEEIDGSVVLVGHSWAGMVITEAGNNPKV
KSLVYVAAYAPDANESISDLSKEAYEIKKFPPVPGRDNPKISNGYIQLREETVIKHFAHD
LPIEEAKILAAVQGRFHTGNPTAKISKPAWKDKPSFYIVADEDHIISPLMEQEMARKIKA
TTYHLKASHAVMLSKPQEVAKVIIKASEGIE
>KALACAFP_02548 2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate synthase
MIKIVKFNSLQSAYMETAKQKSNIIVFIHGLFLNNESWTEWKNYFEAIGYTVYAPAYPGH
TGNPVSLRANIDPELITAGFTDVMNVMNSFVDSLSEKPIVIGHSMGGLVAQKLAEAGKAV
ACVSIDGAPPKNVMPPFTTIKTTWPALNIFKNNSHAYLGTRKWYRKSFFNTVSEEESNSF
YEKHAVPESRKIVKESAFSSASKINFKKPHVPLLFISGEMDAFFPPGFIKKIAGMYSDKN
SIVQFKMFEKRSHFICGEKNWMQVADYINIWLCDVLNKIK
>KALACAFP_02549 Haloalkane dehalogenase
MIFSMKNNIYYRKIKIDTIDIFYREAGSKENPVLLLLHGFPSSSHMYRDLIRELSGTFYI
IAPDYPGFGQSSTPEIKDFTFSFHNLSVVMEAFIDALELKDINLFVQDYGGPIGFRIALR
RPGLIKSFIIQNANAYEEGLGEALAPLAAYIENNSDEAEQGARAFLKPEATQWQYLEGAS
QPEKVSPDSYSMDQFYLQRPGNDLIQLALFRDYGNNMALYPEWQHYLKTNQPKTLVVWGK
NDKMFVEAGGEAYRKDLPDAEIHQLEGGHFLLEEHSEKVARLVEKFLMN
>KALACAFP_02550 Putative monooxygenase
MEKEVIVKWKIEETKIDEILTLLPTLAEETKKEEGNVHYAIYQSETDPNELILHERYRSP
EAQEAHRNSKHYQSIVVEKIMPYLIEREVNVVKKII
>KALACAFP_02551 Putative cysteine protease YraA
MKKVLIIVSNTNAIGPNNRRTGNFLPEVAHPYAEFQRANYHVDFASLSGDTPYLDDLESA
ADPDNLAFLTGKGWVDMRKAVKLETVDVSQYDAIFIPGGLAPLVDMADAPLIKKVVKETY
ERGAVVGAVCHGPVSLLNVKLSDGSYLVNGKNISSFTTEEEDGYARADVPFDLQTALTEQ
GAIYHTVEPWQPFSITDGNLVTGQNPASGKGVGEKMVKLLEGA
>KALACAFP_02552 putative oxidoreductase
MENNIINKVIVITGASSGLGEATAMHLAERGAKVILGARRTDLLENLVNNISAMGGIADF
RQTDVTKKEEVQALVDFAVNNYGKIDVIINNAGIMPIAPISELRTDEWDSMIDINIKGVL
YGIAAALPFFQKQKSGHIINLGSVAGIKVFSPGGTVYSGTKFAVRAISDGLRHEVGADIR
VTTIEPGAIESELKNSTKHETSSVIVNEFYKQAIPASSVARAIAYAIEQPADVDINEIVI
RPTVQEF
>KALACAFP_02553 hypothetical protein
MKLFISSRKTIFSVIIFGIFALASQVSLSGQKSSEPISGKEKPTIILVHGAFADGSSWSK
VIPILQKQGYNTISVQNPLTSLADDVSFVNRAIAEVDGPVVLVGHSWAGVVITEAGNDPK
VKSLVYVAAYAPDVNESALGLTKDAHEVRKLPAVPGLDNPIITDGYIRLREETVVKHFAQ
DLPESEAKVVAAVQGRFHTSTLTATVTKPAWKTKPSFYVVADNDHIISPLMEQEMAKKIG
AETYHVKSSHVAMLARPEEVSKIIIKAAQK
>KALACAFP_02554 hypothetical protein
MIEELKRIENLILKAKGHKILNLTEDLECKEYFGFNFQAGQLTIKFRKAKITPKKVGHFV
TLWKRNAEKVTEPFNINDHFDFYLVFTEYENDMGFFLFPKQILMERQILSTDQKEGKRGF
RVYPKWTKTENKQAEKTQSWQIKYFIDLANSELKNVEKFNSILLI
>KALACAFP_02555 Penicillin-binding protein 4*
MQKLILFFTAILLINCSYAQTLEDKADSLILSEFKEANGPGGVFMIARKGQPIYKKAFGM
ANLELEVKMTPDNVFQIGSMTKQFTAIAVLMLEEQGKLTVNDPISKYIPDYPNGANITIH
QLLNHTSGIKDFTKMKALGDIAQKEMTPKQMVDFFKNEPVDFIPGEKFEYNNSGYVVLGY
LIELVSGQSYEDFIVKNIFEKLGMSHSYYATDRKIIKNRAYGYHKKSFGYVNKTVINFSV
PFSSGSLMSTLDDMLKWQNALNRNQLLGSKETQKAFIKYQLNNGQEVEYGYGWHLKNMEG
TATREHGGSVFGFKSMGVYIPNKDIYVLGFSNCDCNSPTQLVRDLAKLTVKLDKPTK
>KALACAFP_02556 Linear gramicidin synthase subunit D
MKKELTAVNFHYANDFFEHNFLENADDIVKQIEKIAEEYPEKVAITNGSEKTTYEKLNQK
ANQLAYYLQTQNIEKGALIGVCIPQSTSRIIAFLAILKTGATYLPIDGELPQARIRMMID
DSKIKLMLSVDQYLDKVSNDQIQSIALDSLFSDESFQKISTENLLIDIVPENSAYVIYTS
GSTGMPKGVIISHQSFYNFVQYQAELLGLSADNITLQFASPSFDAAVIDIWTPLIKGATM
HLYPNNKIVGEPLLDFIVTHNIDTVPLMPPMVLASLPLNKPLGNLQTVAIGGEACSENTV
KAWYKKIRLINSYGPTEATVAVSNYEFKEEINPKIIGAAMPFVDIFLLDESLKPVTDGTV
GEIYIGGSQLALGYLHRDEDTKKSFIQAPEWLSDQLNNKKLYKTGDMALRREDGNLEFYG
RKDDQVKIRGYRIELAEIEYHISKLPQVTQSAVKVQRKENGLPVLISFIQLATDEDQAKV
LQNIKAKLQQVMPAYMLPDKIFIVDQMPLNHAGKIDKTLLEIPENQTKNSNLPKWKEDNL
TQVVTHIWKDLLSLEDINEEDDFFELGGHSLLLAQLHMLLPEPVRNLISLPELYIYTTIS
AFVKEVETRMVKTEISQKSKAEIMIRELIKDSELHIDFNISESPDPNILKNPKSIFLTGT
TGFVGSHLLEELLLQTSANIYCLVRASSSGEGLERIKATFKKFKLSWSVDYDNRVIAMIG
DLSLPHFGMEHENYNFITNHIEVIYHSGSSVSYVQPYSLIKKSNIDGLHNIIDLAVTGKI
KFLMLLSSMGVFSWGRPFTKKTWMYEDDSIDQNMEAVSRDLGYIKSKWVMESIAEKARQK
GLPITNFRLGFAVCHSTSGATVMNQWWGSLIRSCVELNSFPLVMGLKDELTTVDYMCKAI
MHISKKKEAVGLNFHLSPLPENDVSLTDFCAKINEYYDIDLKGMEYHQWLRQWKYDSNLP
IYPLLSLFTEDVHEGKSLVEAYENTYYYDRSNTKQFLADTDLVPPVFNKKLMTPYLEFMG
ILSVKAVKENY
>KALACAFP_02557 hypothetical protein
MMTSKLAHYRRKKGLSQEQLAVVSGVSARTIQRIESGKVEAHPATLKMLADALEMKSEEL
TVKEEVLLPSETNNENKVKPIFHILALIGLCFPIFNIILPLLFWFLKKDESPAYDLEGKL
VVNFQITISIVFVPAIIFMIFVFSVGFPLVIIIYFYALIMCLINIFRTINKQESRYPLTC
QFLK
>KALACAFP_02558 Beta-lactamase
MKKLLALAFWIWMLPLYGQNNSHIRHLNGKKIDAKILDQQLARLVDSAKIAGLQVTIVNH
NKVVYSSSFGFKDIENKKKLNDSTVMYAASLTKPVSAYIFMRLVDKGIFNLDQPVYTYLK
KPIREYAKWKDLADDPASFNRITPRMLLSHSSGLPVLRQLYDNKVNLIAKPGEKFYYSNE
GINLLGFMIEEFTGKKLEVIAREEAFDPLQMNHTGMIWEKKFEDNFSYAYFKDGKKYGSE
RRESSRAAGSMSTTANDYAQFVINLMKKKGLSSKSYRQMFLPQIMVKSKRGFGPLKDSIT
NENDTIRLAWGLGIGLFESPFGKAFFHTGHGDANQNFAVAYPKAGTAVIILSNSENFEKH
NAQILKLCIGDTYSPLTWLGHLD
>KALACAFP_02559 hypothetical protein
MRSLLITIVLLVQCAFCYGQCPEAVSTCEKLLQGGLYSFTGMTNTGSFSQDLRTYYLSEQ
FKTDMKNGKWGGSLTIPVKGVPFTLGASDSEEKFQQFRSMIMSETTLNISSDYYQTTFAS
IPNTNLYEAFNQCIQTICNENQVGFLPVKELITEDYVVFTIHYRPQVSTDPLPKVEYFKV
ENALSVSNVPVKDQVLSQTTIISARRDPEKDILLTLQTDRGTVSRKIDAENSLSSNKELP
IGTVITSFLTFEEFNFASKNNLKSPGELWTAEKSKWAPCDGRSIANSGYSRITSKAFTPD
LRGQFMRGLNSFDPVKGPVLRAESERDPDSNRAVGSYQEDAFQGHKHFQAENLMKSRNND
DIPNMPDKRPYWDNIPNSAGIYDAGYGKPRLSTETRPKNVAVYYYIKIN
>KALACAFP_02560 Spore coat protein SA
MKLKMNKNINSDVEDKAKRQAENSKKHIVKNSKPEIVFISTFPPKVCGIATYTQDLIQSL
QSKFGESFTPVICPMETEEENYQYEEHIKYRLNTSDAVSYLEIADQINKNNNIRLVMLQH
EFGFFNEAKNGLPLFLRNLKKDVIITFHTVLPKPDQELKEKVEEIAAFSKSIIVMTGISA
LILSTDYDIPADKITVIPHGTHLLPFTNKISLKEKYGLKDKKVLSTFGLLGSGKNLETTL
EALPEIISRNPDVIFLILGKTHPVIVKNEGEEYREFLYQTIKKHHLERHTRFINEYLPLD
ELLEYLQLTDVYLFTSKDRNQAVSGTFSYAISCGCPIVSTPIPHALEVLKEDTGIIIDFE
APKQLAAAVNTLLENETKREKLRSKSLEKMAPTAWENSSILHSMLFDKFGDDKIKFHYTL
PNINLGHIKNMTTDFGMIQFSKISKPDIDSGYTLDDNARAMIAICRDFEVRREESNLELI
SIYLNFIAFCQQKDGSFLNYVDEQRKFTPQNDDVNLEDSNGRAIWSLGYLISLKEILPLE
FSEIAEEIIQKNLICAQKTHSTRAMAFIIKGLYYQNSGSNIPLLKELADRLVKMYQHEAK
EDWHWFESYMTYGNSLLPEALLCAWLAAKDDMYKQIAHESFRFLLSKIMVGDDIKVISNK
GWLQKENTEKNTSAGGEQPIDVAYTILALSTFYNVFNDEKYLKMMRNSFNWFLGKNHLNQ
IIYNPVTGGCYDGLEEKNINLNQGAESTVSYLMARHCF
>KALACAFP_02561 Beta-1,4-mannooligosaccharide phosphorylase
MVLIKKEGIILKKTELSFECEGVLNPAVISENGKIHIFYRAVAKGNFSSVGYCLLSDPLT
VEKRSDIPIIIPEFEHEKHGIEDPRIVKIDDTFYLTYTSYDGINALGTLATSQDLKSWKK
TGIVVPKIPYDEFKLLSESESLIPEKYQRYNQFQLNHNTDEDIFLWDKNLIFFPRRINGK
LYFLHRIRPDIQIASVENIEDLTPDFWKDYFLHFKDHVLLSPKHDHEISYIGGGCPPIET
EYGWLMIYHGVHDTIDGYVYGACAALLELNNPEKEITRLSYPLFKPEEKWELKGEVNNVC
FPTGTVVKNDTLYIYYGAADERIAVASLSISKLLKELMRDVV
>KALACAFP_02562 hypothetical protein
MSKEKDSKKKSDKTPPLKSAKEKREDKINKRIDKENESRNAST
>KALACAFP_02563 HTH-type transcriptional activator RhaR
MVVQQELEKLKIRNAVVELGLVEILDDISPEQRNLLKKNLLKTGLELLDDKKSILIEKIK
NAVIEMIHYCESLPKENFSDYISEKLGYDYTYLANTFSEVKGMTLQHFIIINKVEKVKEL
LLYDELNLTEISYKLNYSSVAHLSNQFKKITGLSPSFYKQLKQKRFRNLEDL
>KALACAFP_02564 hypothetical protein
MRKPILIICLILSKLLFSQEPEYSDIKCNYLTTFLTDTTDVNTKREELTGLWIGKNSSIF
KSDQKAKYDSLTKESVKKSIANPVNGKIIIDFSRIPRAHFIPEVFKIGEKLEVYDKILGV
YYKFETDQKIKWTLVNETKKISTYTCRKAVGKYRNKNIIAWYTEEIPISEGPYTFKGLPG
LVIEAYDEKDFFHFTLVRLKNLSEIIAPIRNMVSTDYQGFIKKRNDFQKDPAGAYFAATG
NQVPKDDVERVTKLHRKYNNHLD
>KALACAFP_02565 Sodium-potassium/proton antiporter ChaA
MKKKNYIGMWTYLVPIFAWLSYFGNSLFSSGYYSVILALFLMGSVLAAVYHSEVIAHRLG
EPFGTLLLAFAITVIEVGLIISIMMGAKGLETITLARDTVFAAVMIILNGIIGTCIIMGS
LRYREQSFTLQGVSTALITLTSVVIFVLILPNYTVSHLGGEYTSFQLLFIAVICLGLYLG
FTMMQTLRHRSFFISPKDKLSEKILTKKDPEKLSKKELYIRCLLLVLCLGIVVLLAKLLS
KDVEHIVVSAGAPKSLVGIIIAGIVLLPEGLAALRAAKVDQIQTSLNLAFGSALASIGLS
IPAIAIISVITGIRMSLGIDIKSTILLGLSLFIITVSLATGRTNIMQGVVLIGIFLIYLF
ITIVP
>KALACAFP_02566 hypothetical protein
MIIRNIFVDFAHKPNCLQNADDFLNYEQMQTPAFTPKPYLKPSKSQPDQHVRIAYFIMIH
HKPEVFRAMFQKIYSKDQFYLIHIDRKAEEEVTEEIQLYISQFPNVYILESINIVAGGFS
MIQAELDAMEFLLNIAGEWDYFINLSGEDYPLKSQQIIREFLTVNNGRNYIFYYDQKFYR
PDTLQRIQNHFTELTHKVSSMIYKRKFMLGVTPYIGGKWFVLTRETCIFMTNNKRVMDFE
DYYLHTLLPAESFFQTVLMNTAFNDVIVNDDKRAIIEKTFFNKKQNVETFIESLKSSNYL
FIRKINDSTDEKILNYIKESYLLPLQEINEIERELKRNDDQNN
>KALACAFP_02567 ATP-dependent RNA helicase RhlE
MSQKNRNSGIFTMSFKNLNLINPIIRAVTEAGYSKPTEIQYTAIPHILEGKDIIGCAQTG
TGKTAAFAMPVLQLLKKHTPDHKEIRTLILTPTRELAVQIEENFKVYSKYLPLSQLSIFG
GVSIGGQLAALRKRVDILIATPGRLLDLVNQRHIDLSKIEILILDEADRMLDMGFINDVK
KVLKLIPQKRQTLFFSATMPSDIRSFAYTMLNNPVEINVTPVSSTAKTIQQSVYFVEKKD
KTDLLINILQDESILRSLVFTRTKHGANKLVKQLEDTGIFAAAIHGNKSQVARQKALEDF
KSSKIRVLVATDIAARGIDIDELPYVVNYELPNIPETYVHRIGRTGRAGTEGNAISFCDH
EERSDLKNIQKLIGFSMPVIQQHKTFQYQN
>KALACAFP_02568 Cold shock-like protein CspC
MQQGTVKFFNEAKGFGFITPADGEKDIFVHSSGLSTRSIQENDKVTFEVQKGEKGLNAVN
VKLA
>KALACAFP_02569 hypothetical protein
MPNYRQLLETAGASLTLTNVLAALGITALFGSGLFIHDLYQRYKNYVVKADQSADFLLTG
GILSPGNNAAINIEDQLETLRQMTEIRNDRQDDTRAKLTFLGRFFSRFLREGHSNIDDII
ARNINSIALVPGYATDEEIEIALQRAILGGTRTRGYLTTLARRIGGPIYRLLG
>KALACAFP_02570 hypothetical protein
MIKHYLRLAGSAQLISVQTRGFVSIPWFSKNYQQVTSALKNPDKVAPDGRLKAVVSTSHY
TPDKVGFGVHAATIFIYIIFRDLGQQKVGREFGLPYAVEILDSPRNFKNNRRFGVIDQNY
WILHQGKGATLPDNVVICIGAWMYPVPRAVIQELLAKIRETFFSRN
>KALACAFP_02571 hypothetical protein
MADTVNNQTTDAVTQTNVTVLGESPAQAMSMLYQMATHASGISIQNSVTNQQNLNQLNPA
IVADAIKILKG
>KALACAFP_02572 hypothetical protein
MDENNSEAKETKAVATTPAEKAVEFVNAEVLSPPTASPMGGVAKVMIEQSAGMMVQDLQS
FLKGFEQVGLIALSRLANNLLTYGSPSGPKSKKNKDGNGSSNGGDKSIEEDQEFGAGNGN
NEMMRELFKIVSDYAEAKTKISGAIYNPSILYPADPSGTQNPPPYTDFSAVAEDPEKKNE
>KALACAFP_02573 hypothetical protein
MNYSNETKPAKILNLRSLKEINESLYLERNSDNAYFSAKKPENNSDRAVFSLATSDINIQ
PLVRQVICTNKGKRYNNYQSFVVEPKDKSMGIAIIMLKLEEHQTFFCNVRILPLNTLSDI
AEPEIDSKLLTVNLEKSKCVLKTDITITASNTGEAMYSVHDVDVNGISDLVTPSEIVELK
RELEFQGSKLIAHYFQEILSIVVNENPSNTGKLPVIPDEYILNLPPDQLKEMISANAISG
CIAIEIIGSNVIQDLNRDWTAAGAFIGYLI
>KALACAFP_02574 hypothetical protein
MRRPIHQRVKPPVPVVPDPEPIMKELLAAEDAILEADDELIDEENTILDQEDVMPFVITH
EDEIINYIKDKATKETLKSLAPLLEKLEEAVKQQQAYQQVTPVAATAASPIPLSYEDQLK
KLQEASKGKIKEKELKIAERMNKLQARFANIRK
>KALACAFP_02575 hypothetical protein
MIHNQNHINTEVVGMAPTVPTAISMQVNAHSTGLMYEQSVLNQHRDSLIGLSNSVMGIKK
IGSKKLKKELMMLRKSRFDF
>KALACAFP_02576 hypothetical protein
MATTVNPQITDAVTQSNVKVVGEAPAMALGNVYQTAAHSTGIMFENAVNTQNQQNILGQA
ATTQGVMQIYSMDTVADAISIAKMLNPNT
>KALACAFP_02577 hypothetical protein
MATVVNEQITDAVTQTNVKVVAESPAMALGNVYQTAAHSTGIMFENAVNIQNQQNILTHA
ATTQGTMQIYSVDTISDALSIAKMLNP
>KALACAFP_02578 hypothetical protein
MATVVNEQITDAVTQSNVKVVAEAPAIALGNVYQTAAHSTGIMFENAVNTQNQQNILGQA
ATTQGVMQIYSLDTVADAISIARMLNPNS
>KALACAFP_02579 hypothetical protein
MATVVNEQITDAVTQTNVKVVAEAPAIALGNVYQTAAHSTGIMFENAVNNQNQQNILGQA
ATTQGVMQIYSLDTVADAISIAQMLNPS
>KALACAFP_02580 hypothetical protein
MRVFLYGVLLRSAQYAYQKSWEKEKKYIREYRGTPIMNAVHGVWKKLDLSIDKRKHFYSE
IQLVGKVESGLDARAFYEFLKANSIKTVPMSIRGGNNQILGPRTQGGRATAIFGGPVETS
HDDKTMMLINFAKQGHFFEGGYVMIRVFEEDGKVYSEFIGFGKNNFAGFNEQLGSKLFKG
MMSFNILLFNFRRYTE
>KALACAFP_02581 Oxygen regulatory protein NreC
MENLKIKIGIVDDDLLFVQLLENYINTSEHYEVVLTSTGGHHFLNETETDLPDILLLDLR
MSNGDGLEVLSALSQKNAETKIIVLSSFYRRSFMGQMLKMGAHAFLPKEIEMEELLKVIQ
AVYHHGHYFSDEQIDVMRSQLSNKLPEFHSYSKDALTEREIDVLKLVCQQLSTKEIADIL
FISPKTVETHKTNLMIKTCVKNMAGLVIYAVQNNIVDANEIVLFDK
>KALACAFP_02582 Oxygen sensor histidine kinase NreB
MSRGENESVVTLWIWIGIGLLFLTTLFITLLIASYTKSVKKNKQKVMQMVRNTQSECWEN
TLYLQEKDRERLAEELHDNIISRLNLIRLNAHYKNMNELNLDLKNSMQLIRELTHNLTPP
DLSEIDLTDLLIDYLEQVKTNIKVDFYPLIVNENSINNQIKLNTFRIVQELINNTLKHAN
ASLIKVYLRISRQYLILIVEDNGSGFNAKNQATGIGLRSIQLRTKQIKAHYKLKTQPQRG
TKYIFFVNTIQQ
>KALACAFP_02583 hypothetical protein
MPTYNELSFYLQFTINLTLLTGVALFLKRGKQVKKLLLIFLLGEFALELSDLVFRLLKVN
TVNIYIYPISQCFGLLMMTEIYNKYFFKIPRSLKWIIYAFAGLSLIINFTYQQNTESVTF
YSNIITNIFICSFAAVYFLNVIRKSRIDKTLFIVNVFIFLFFSIESIISTTFNFLINNHL
EWVAPVWLFRGVLLWFFYIAFINLGCRAGKMKVW
>KALACAFP_02584 hypothetical protein
MQIDTIYQAIKNWKILIDSYKNGNDESGKEIMKFLNQGSHFSVEGTEIKEWKKRLENESD
KAIHVYMGIDNNILKFFLIDSKSDADADFSYIVVKEFNRIPPESPVNTSAELVSGPPITS
ESAIYRNFRFNMYCSAWLTAQKAEPFRIIYVPFDDYERMQLTDDQSCTSFFGLTNETEEN
NPIEDYHIEIITVKDIGVNSISQTAENYSTPRPPFTANDPIGDYQLLLKSDAHV
>KALACAFP_02585 hypothetical protein
MKKFYTGAFFLCTILGVSAQEVVWQKDIKSSTQDFLSQVTTTIDQQYLISGSSIQAGGQK
MGAGSKQNNGYDYHFIKLNQQGEEVWEKYFSGQNHDFLSATVATQEGGFLAAGTSYSGKG
LDKKDDSKGGTDIWLIRLNEFGDELWQKTIGTQADEEARAVIQTTDFGFFVAGSFVSAQD
SKMKGYGSKDVLIVRLDKNGKELSQLILGGKGLDEVEKMIPTKDGGALLGVYSRSSEFRG
SGSGVQNSDNKTSNPASRYPKSTNNFGEGDYWIIKLSKDGKVEWEKNFGGKGDDHLRTLA
LTSTGYLIGGESRSERSGNKSVGIEEGTDLWLISLDERGEEIWQKSYNFKNRDVLMGMSV
ISGMMEDGSGKSKGILLGGYTQAEGRIENDDETFWMLYLDQNGNEQWRKHVKGETRKKEE
RLSDIKLNRDGSIILAGTSAEELGKENWKIVKLGDKQINQLIEKQDIKIYPNPVSDYAYV
EIGFDFKEAEILLYDMSGRQLQSLKTKNKVTKINIQPLIQGAYLITIKTDTNKTANAKLI
KK
>KALACAFP_02586 hypothetical protein
MKNVINILITIVFISFNLKAQTIITPEPTSSSLQNYVNASVSPAMGIPSINIPLYQLETS
DANLPLSLSLSYHPYNAKAIVPASEVGAGWSLFKGSMISKETYSKNNEYTEINDLTKLNA
DRFYYSIPGHSGKFIIYKDPLSGYLKLQNLTGEKIKIDFTRDESSTKLIINSFKITDDKG
YQYLFDNYNISSWSQPGIPYGVKTQRSSYVITSVKKADNTDIIIYSYDIKTRYIDNTPNI
PKYKLCKLNTITTSKGKIKFEYDYDLYLDNTNNYNNDFYTINNISLVSNSGKMISKYKFI
KGNIPGLVTTYSFDTPIATLGSKLGLYRLQKLDSNNVLEEQTEFFYNETGSDTQYGYSEN
PDLYGDDICSNENPYMSPKKEVIGLLQKIIFPTGGSVVYDFEASEVYTDRTTEDYTTSNI
FSEPLFQYYDISDSLDFDTNISRTYTFNVSGASNKTYPVKIGKGLDGLDYGLTTTHGDPY
PFSFSVLNSNNVTMQVENSPCNNIFTKMYKLPPGTYTIKINLWGGTGNFAIIQLKSLPKP
YKNYDPLQIGARIKRITYFDHDDNIQKEKVYEYNLFTDPLTSSGYQFADENTSLAADLDG
FVLYRNVREKEISGNQSNGYIDYYFDTPEDYKDLSGNIIYYYYNLTSQGILKKKNTYNSQ
NQLIETSEYDYTFEEVPGAESQNMGYFTSVPSWIQYIKDTSISYLGQSFNKTMKETTFSP
NNFQEILSKITTNNGDINEVSTKYAQDLSDSHLITANMISVPLQVETKSNGITLSKATTV
YGNSSHFYPTALESTDLDQISETQITYDLYDNKGNLVQTTDKSGNSVTTIWGYYQTLPIA
QIVGVKYNDISSLSVVTAAISASNSDADNPANEGALLTALQNLRLASQLQGYSMTVNTYD
PLVGITNTISSNGIKKSYEYDAAGRLLKVKNSDGQVLKENQYNYKH
>KALACAFP_02587 hypothetical protein
MKRKLKILSLLFVAGLSYAQTSGLSTSENYIYTKNCLNEDCSKKTEAVEYSDGLGRSKQV
INIKGSPNGKDIVTPVEYDNFGRQLKSYLPIPQSGTQNGAIYTDPKSNASQTYGTDLYFY
AESVLENSPSAKLLSQTKPGIDYQGHSQNYEYEMNIANDVKKYIVSTSWTDKATNNTISI
SGTYNAGELIKTSVTNEDGNKTIEFKNGKGQTILVRKKVSGTQNADTYYIYNKYEQLVYV
IPPLASALPSISTTTLDDLCYQYKYDSKSRQVEKKLPGKGWEYMVYDKTNQLVMSQDANL
KAQGKWLLTKYDQYGRVVLTGVTNNTGTRLTLQTALTAAAYTFEIRSVGSFTVSGMPIYY
TNRTLPGNLAQVLTVNYYDTYPAGSPARPSQILGKNTIGDNMGDVVNTKNLPTASYVKNI
EDDNWTKNYIWYDIKARAIGTHSINHLGGYTKTESSLDFAGVSQLSKVYHKRLSSDNEKV
ITQTFEYDSQNRLKKQWHQVDSNPQELLSENTYNDLSQLINKKVGNNLQSIDYIYNLRGA
TIKMNDPANLGTDLFGYSLSYYNPSSSSVGKYNGSISEVSWKTAQDNMLRKYTYQYDALN
RLKKGVYSEPNSSIPENEFFNESAEYDLGGNITSLQRNAKGQFSSTAELIDNLTYTYSGN
RLNTVSDISANYRGYPDTSGNLISYDDNGNMTDHIDKGILKIDYNILDLPVYVKFNEFAA
PDRNNKIYVNTTYVYRADGTKVRKIHNYKDPSYNSALGNKTTDYLDGFQYEYDWNPLAGT
SPTNNFQLKFVPTSEGYYNFENNKYIYNYTDHLGNVRLSYTKNGSGTEIIEENNFYPFGL
IHEGYNQTVGNLSYNYGYNGKELQKEMGWSDYGTRMYMSDIARWGVIDPLAESSRRFSPY
NYALNNPVMFIDPDGRKAISPDARLEMIGGISTGGAAEYLATGGRAEWGSFDKFIIPYDY
TKDWKSGGGGGGSFKSGTTVGGIMAALGINMDGSLKSYEQVIGGLNLWQQLVIAGFKNPE
KTKASYKDLGALLTNIPSLTELYRITEAEFIEDTKGKHPAETVDKYVYLTMSKIDNILFF
AYTLGHEMNHVFDNRFFQNEFIEITKFGDKTSIPFRTTFGLYKESNGLGWEMQFGNSKLC
GLTGFEAASFYYGPSGWGLYNQETVDRLSPYINRLNRARAIIYSTKKNNLK
>KALACAFP_02588 hypothetical protein
MIYKIIKIYFTFVMLFITTKFYTQIRITWELDSKKENAEVTVYNDSDKNIAIPLDTLSLQ
GYYSDSDRITEKNWNKDYPFFALTLNIYENSKKRIKTNSGAPYFDMSKFEEIKNKKDSIQ
NEYNFVIKQWQAKNKIQKDFTAQINYYLLKKILLIKSKDKIKFSVIYNLRNITNTENGLH
DSYQLEFGKNYFASLTLNINSLIYKYLTKDQKQELKKYELFEGKIESNKIELKD
>KALACAFP_02589 5-methylcytosine-specific restriction enzyme B
MNFTELINEQDIWEEWRGNYKNFVPKFIEEAKANKNWQEWDEEVFYEFFMRSSDQCVSSL
KQGYFNNAEKEAIKEDWAELSPLLAQISLSQDKPLFETYHQIKTLIRKNTGTNKKAATNR
LIASLQPKLLCTVVNEERLRHLIHLLNTKLEDFNLEIKADWFENSYYLFQEFKKRMGSES
GYEIMTYPWQLYDYLLDQSNFPGEKNNDMSESNIESRIDLLKYKKQIILQGPPGTGKTRE
AKLIAKELLGVSSLKELEEHEQFKLVQFHPSYTYEDFVRGIVAKPNEEGEGVIYAAENKT
LGKFAEEARNNFLAHLGKTKNKINFQNKLNVLLEKINTEINKGSVYYFGEKSTAQIISIK
EDGLIYNFQDREEIKYKILFSDMEKVYNNWNEISKPIDLRDQEAKLGLTMKGKYPYYYMI
QQQLISINVNKNNPFIPEDLKNYVLIIDEINRANLSSVLGELIYALEYRGETVDSMYEVG
SRELMLPPNLYIIGTMNTADRSVGHIDYAIRRRFAFVDVLPTDLVELGNDFKSDLFKKVK
ALFTRDNFTSHSSNLSGEFNPKDVSLGHSYFIQHYEKDENGENIKESPIDFSFRLEYEIK
PILLEYVKDGILMGNVEGQKIEDYIKAL
>KALACAFP_02590 hypothetical protein
MGIVLKEHRSHSLSIYYENFPENISSSDALLFAQKDDLNTINTRQFKTERGKDYHCYEVK
IQDDTITVFSNYFVGVDWFWQQGNRTIRVEPKINSTVYKCFENLTTLEDEYLIEKENEAA
EKNIFNDLYEKEIDCIAMLMEIMSYPEVAKETEKLVLIDWDSAQIKITQKQDLLTPFLIV
RFLKIVQDIVRKGLKKSYYKVEENLRSRTKGKVLIAKNIKQNVFKNRFTDTLCEYQVFGE
NSIENRFLKKVFSFCVQYVENDSSYFKNKQNIHWILNYIRPAFDQIGDEVNLHDVKNLKH
NPFFKEYKEAVKVGELILKKFSYNITKTVQQETFTPPFWIDMPKMFELYVYVKLLKDNPG
ISAEQLHYQFSTYGNSLDFLICSDLTKIVVDAKYKLQYNYKTIHDDIRQVAGYARLKKVK
AQKPQIDDEEISCLIIYPNPDTQEDVSLHIETLLRENNELKTYHKVYKIGIPLPLLK
>KALACAFP_02591 Undecaprenyl phosphate-alpha-4-amino-4-deoxy-L-arabinose arabinosyl transferase
MNKMLLISPRQLLFLYIGFALVYISGLFIPLMENDSAQHASMAMRMVLNNDFFTIYKGEN
PYLDKPHLHFWLAAISMKIFGINHIAYRIPALLALLLGVYSTKKLAYLLYKNENTSHLAS
LIFLSAQTIILSAHDVRTDAVLTGFIIFSIWQFVKFIQSQSVTYAILAGLGTALAFSSKG
LMAFVIIGLCIFSYLLYSKEWKKFFNLKIFFALIFFIIGITPVLYAYQHQFGEEGIKFIL
FNQSLNRLTANGFKETSPDYFFFFHTLLWAFLPFSLAFYFGVFEKTAFFIKNKFKKIEGV
EFLTLGGFWMVMLIFSVSKFKLPHYLNGLIAVLAILTSAYLFDIYRRNCIKKIKILYIIQ
LVVILSAFVGTGLLTYFFTGIHNIVFYLLFCLVMMYLLVKIFTKEDLFKKYVFISLIFSI
GVNIYLNTQFYPVLTQYQGSLKMAEFVNKNKIDKEKILMLKGYEPWAFDFYTRRNTPRVD
ENTLKKGDYLVIYNEHLNLVKKNYQFIDTENHYRITRLSLKFLNPKTRPEQYEKISLIQI
LD
>KALACAFP_02592 Dodecaprenyl-phosphate galacturonate synthase
MDYKKFYSLVIPMYNEEGNAGLIIDRIFETMKGYRYELILVDDNSKDKTVKEIIEKNDPN
VVLIQLKRNYGQSSAMMAGFDYASGDYIITLDGDLQNDPADIPAMVDLLERGNYDLVVGK
RQKRKDSSLKTIPSKIANFIIKSSTKLNISDQGCALKVFRYETAKDLTLYGENHRFISLM
AHLNGASIAEIPVRHHARQFGVSKYRINRTFKVINDLLLILFNQKYLSKPIYLFGNIGLA
AFTLGMIINAYLFIVKLMGHHIGGRPLLVLGVLLVFVGIQMFTTGIVVDMLMKTYYESQN
KRPFNVRKITDFGKNRFKEKEDFHQWSESAH
>KALACAFP_02593 hypothetical protein
MGKTDSRKKKIFINGLKVLISIAFLYFVFKKIPFREVAKIWSTVHVLYVIFGAFFFLASQ
ILSVKRLDFYLKANSFNLSFRSNLELYFLGMFYNFFIPGGIGGDAYKVYILNKKLGWELK
KITSAIFNDRLSGLLAICVLILIFSLFLLPLQWIGLMVIMMIAGFSLTYFLVKKLFPVYT
PIFFKTFFISIVIQLLQVICFLFLIKSLGLNENYLIYMIVFLGSSILSLISFAGIGVREF
LFLQASGYFNFNASVSVSASLLFTVITAFFSLFGLVIMFTKRVDEIKENKEFT
>KALACAFP_02594 Trans-aconitate 2-methyltransferase
MPWNPEVYNQFKNIRFKPFFDLADLISEENPMKAIDLGCGTGEQTAILSEKFPKATFIGI
DSSSEMLEKSKALENERLQFRQATTEEVLESDENWDLIFSNAALQWSDNHQDLFPKLISK
LNTHGQLAIQMPYQPGNILNQILFELADEEPFKTQLNSWNRPSAVLTIDEYAQILFDNGI
ENLNLFQKVYPIIAEDHETLFNFISGSALIPYLERLDEEQQSVFTAEFKKRIAASFPKLP
AIYSFKRILLYGRKIIK
>KALACAFP_02595 Leucine-responsive regulatory protein
MATENYTPDEKDLSILRILQKDAKLSVRDVANKINLSPTPTHERIKRMEKLGIIKEYTTV
VDRKKVNKGMMVICMIALNVHNKKTAGKFIEEVGKLNEVVEFYNISGDFDFMLKILAPNM
DEFHEFFVNKLSEIEGIGQTKSIFVMNSIKESAQIL
>KALACAFP_02596 Multidrug resistance protein Stp
MDRKNLILILASAGTFVEALDIAIINLTIPSIQEQFGIGAETVQWLQTLYVLFFGGFLII
GGKLSDQIGRKKIFLLGCLIFMLTSLGAGLSTNFETLAIFRALQGLGAAFIMPSAMSIVT
NTFTGDQERNRAIGIFSSFAAIGSGSGLSLGGIISTYLSWHWVFLINVPILFITLIFAYQ
YLPKDEKSGKSQKTDVASGILLVLGLLSLTYGTHELIHIKEQTFMVVASLILSVLLLALV
FYRLKSVSQPLIDLKLFKHQSLLVSNFAFVALGAFFIGFLFLISLMLQKDMNHSAASAGL
LLVPFSVMSALVAKFVLPHISRRLNSTQMGIFGWIFMLTGALSLLISVYFGHPLPLVLLG
AACISGVGMTFCFTALSVLGIQDVEPSSYGVASSLSSTSYFLGAGIGLSFMTLMSQIFPS
EWAVGNLSLLILIGYSVAALGMLFYFIVKNVKVKQTEMAVS
>KALACAFP_02597 hypothetical protein
MPVLFYFSDMKIQIISDLHQEFGYTDLSFDKADVVVLAGDVNLGTKGIDWIKTKIQDKPV
IYVLGNHEYYKGSYPKTLNKIKESAQDSNVFVLEDDFVDIDGIRFHGATLWTDFSIFGDP
RYYGFVCQNGMNDFKQIRRDPSYSKMRSIDIFKIHQISRAWLQESLENSKGLKNIVVTHH
APSLQSTPAHFKEDPLTSAYVSNLEDFILEHRPLYWIHGHIHTPSRYKIGETEVICNPHG
YVVDEYNGYEKELIIEV
>KALACAFP_02598 hypothetical protein
MKKLFSSIAVLVGLLAFAQEKKDTIRKETQIEGITVTARKPTVESKVDRTVFNVANSSIL
AGNTTWDVLRMTPLVSIDNNDAVKAEGESVTVYINDRKSVFTGKELKEYLKTIPADNLMK
IEVITSPSSRYETAGSVINIVLKKRDDEGIKGSVTFNNRQQQKNSQYTNLNLNYHKKSFT
QTLIGSYSDNSYLQKSALQSTSYADNSVTEINTVSVGRSKSPSLSSTSEFELNDKNTAGL
ILEYYQGNSTNSAEANGITHIDNIFNRSYTQNQWASGLSRTLGTNIFYKFYDKEKNRILD
INLGSNYYGQSEDNNFVKNQLISNNSTLYETRVLSDSENRNYYVKIDYTQPLGKEWGTLE
VGGKMDFNNNVIPNDLSATQMDGLSTHDIFHYEDNINSLYANYSKTFFKKLETRIGLRYE
HIDYKMRQDVAGASRKDSYGAFLPNLLLKYSFSEKYDLSLTYNRNLWRPWYAEFNPFMVP
NDNGFYSRGNMELEPNPSHRLYMKLGLFKKYFISARYMYTDQDYWTSYIFETNPTDPTKN
KTITQPDNFKGRVQKYYLFANTNQTFLKNKLTVNVGFGWYYMDNSDFNLKNNLENARDYL
SYWGGSTNISYTNLFNKNINLSAWVEISNQNNGNSYANRTNVFHNISVTKIFPKTQMEAS
LQLMNIFQRPNFDATTYNQTGTLRNSMQWDWYGVSLSFVKRFGNQKVKENTKTDVEKNAG
GGK
>KALACAFP_02599 Adenosine monophosphate-protein transferase SoFic
MLVASISEKIGEINANHLYKPTTELRKKNQIKTIQSSLEIEGNTLTEEQITALLENKRVI
APAKDILEVQNAIKVYDDLKIFDPKKIKDLQLAHSILMKDLVSSAGKFRTTNVGIVKGSQ
VEHLAPGGSMIKGLMNDLFIYLKNDNDLILIKSCVFHYEFEFIHPFIDGNGRMGRLWQTL
ILMQQYPVFEYLPVESLIKQNQQEYYNKLSESDKMGQSTPFIEFMLGIILESLKHVLQSQ
NINLSTKDRIFLCKEKMGDKKFSRKDYLQNFKNISAPTASRDLKWAVDENILIKSGEQRL
TEYQFKE
>KALACAFP_02600 Beta-glucosidase BoGH3A
MFKKTAIVSLITLISASYMAQNTTALPVYLDDSKPVEQRVQDALSRMTLEEKIAMLHAQS
KFSSAGVPRLGIPEFWTTDGPHGVRPEVMWDEWNQAGWTNDSIIAYPALTALSATWNKKM
SWNYGKALGEEARYRKKDILLGPGVNIYRTPLNGRNFEYMGEDPYLTSKMVVPYIKGVQS
NGVATSVKHFALNNQEMFRHTSNVKIDDRTLYEIYLPAFKAAVTEGDSWTIMGAYDMYKG
QYASQNQYLLNDILKKEWNYKGVVVSDWGAVNSTEQAIHNGLDLEFGSWTNGLSEGNSNA
YDNYYLAKPYLKLIKEGKVGTQELDDKVTRILRLAYKTTMNKNKPFGNIASEEHKAVAKE
IGEEGIVLLKNQGNVLPIDINKAKKIAVIGENAIKIMTIGGGSSSLKVKYETLPLDGIKA
RFGKQADVQYARGYVGDIGGEYNGVKSGQNLKDDRSPGEILNEAVELAKKSDYVIFIGGL
NKADFQDSEGNDRKSYELPYNQNNVISALAKANKNLAVVLVSGNAVAMPWVKEVPTIVQA
WYLGSEAGNSIASILAGDTNPSGKLPFTFPVKLEDNAAHQLGEYPGNKEELAAGKGKDQN
NPINIAYNEGILVGYRWHDTKKIKPLFSFGHGLSYTTFEFGKAKADKTTMTQDDKITISV
TVKNTGKRAGAEVAQLYISDLKSSVQRPAKELKGFEKVFLNPGEEKEVTFSIDKTALSFF
DADKHDWVAEPGDFEAQIGNSSDAIKTKVKFTLK
>KALACAFP_02601 Putative ring-cleaving dioxygenase MhqE
MENRILGLHHITAIADNAKRNLDFYTQVLGVRLVKKTVNFDDPGTYHFYFGNEEGTPGTI
LTFFPWEGIGKGTNGSGLATHIGYSVPKGSLEFWKNRLQQFNINVEEGEIFGEKLISFQD
PDGLQLQFIESATPDNRKVWTTDDIKDENALKGFHNITLTLRKADPTIKVLTDIFGYDLQ
KQEGERYRFATDAIETANLVDIIENDKISAGRNAAGTNHHVAFRVKNDNVLMEFREKVLS
AGLNITPKIDRDYFYSLYFREPGGVLFEIATDNPGFTVDEPLNELGTSLKLPKQHEGLRE
KIEEVLPKLS
>KALACAFP_02602 hypothetical protein
METTKVLMGNVRGEIQLFSDDNKAGKMDISVIGKKLTVYHTEVNEEYEGRGFAKILLEKL
VSYARENDLKILALCPYVHAQFKRHPEEYQDVWLKEEE
>KALACAFP_02603 Putative ring-cleaving dioxygenase MhqO
MSLITGLHHVTAITGDSQENIDFYTGVLGLRLVKKTVNFDYSDVYHFYFGDEFGTPGTIM
TTFPYGKGLVNGRHGKGMLNTTAFSVSMDALDYWMNRLNQFNIPFKQPQQRFSGEVFIYL
EDFDGLGLELVFNDKDNRKGYYNGFIPKDFAIKGIHHVEIWLDAYERTAALLTTQMDHKL
IAESSDRFRFATEDVPGKYVDLLCTPNALKGLAGRGTVHHVAFATPNAETQLEMVEKLNK
LGLEHTEVKDRKYFTSVYFKEPGGVLFEIATSGPGFDVDEEFASLGEQLSLPKQFEEKRE
HLVEVLPKINYPTEKFR
>KALACAFP_02604 hypothetical protein
MSHTLDIKTGGKSLNEAEKVLIMIHGRGGSAQDIVSLSQHLNVKDYALLAPQATNGTWYP
FSFMAPVEQNEPWLSSAVETVEKTVQTALDAGIKSENIYFFGFSQGACLTLEFLARNAQK
FGGAAAIIGGVIGEKIDRENYKGDFAQTPIFLGTSNPDFHVPVERVYATANILKEMNADV
TEKVYANFGHSINQEEIEWANALIFK
>KALACAFP_02605 hypothetical protein
MKITRIFSDEKGESHFEDVEIPLLDQGEIGFLSEGIDVKKLQFRKVSADYDYDFHHAPQK
QYIILLDGGVEIETSLGEIRQFQTGEILLVEDISGKGHKTKNLEKRERMSLFIHV
>KALACAFP_02606 hypothetical protein
MKTLNFLVIGKNQEILDVLKRIIENNEGWKAEIQSDENFCYEYIKEKQVDIVLLSSGLEE
QFEKDIKVFCENLDKEVKVIDHYGGGSGLLKNEVYALFPNLQS
>KALACAFP_02607 hypothetical protein
MSENIIENVTRFINLSENEEKFFTDLLTLQTFPKKTVLLREGEICQFEGYIQKGCVRVYY
LDDNGFEVTILFAIEDWWISDIASFQEQKPSRLYIETLEDSEIYMLNPTTKEKLLTEIPK
FERVFRMLVQRNLSTLQSRLVNTISKSASDRYLEFIKVYPSIPQRVAQYYIASYLGVSKE
FVSTIRKRLASKEK
>KALACAFP_02608 Quercetin 2,3-dioxygenase
MDRKDFLKKGLLGTGMFVASASLGNAMKNEIDEIEPLEPIGYNHLPNPDSKIKDNSVIHK
ADSRGKADHGWLVSNHTFSFANYYNPERMHFGVLRVLNDDKVDAGRGFGTHPHDNMEIIS
IPLEGDLEHKDSMGNSAIIKSGDIQVMSAGTGIMHSEFNKNQDQLVKFLQIWVYPNKRNV
TPRYDQITLDKTKSKNKFQQILSPNANDEGVWIHQDAWFHLGNFENNIETNYHIRKKGNG
VYAFIIKGSAEIEGQKLEERDGFGVWDISDIQIKTTSENTEILLMDVPMTM
>KALACAFP_02609 DNA topoisomerase 3
MKLCIAEKPSVARDIAKVLGATTPKQGYMEGNGYCVTWTFGHLCTLKEPHDYGPQYKSWN
LFLLPIIPNNFGIKLIPNKGVENQFKVIERLVGECDEVINCGDAGQEGELIQRWVLQKAK
CTKPIQRLWISSLTEEAIKEGFASLKPAEDYKNLYLAGNARAIGDWLLGINATRLFTKKF
GGNKAVLSIGRVQTPTLAMLVQRQKEIDAFTVEEYWELKTKYRDVIFNAAIDRLKTLDRA
EKGLEYLKENLFEIVSFEIKEGKEKNPRLFDLTGLQVEANKKYGYSAENTLNYIQSLYEK
KHVTYPRVDTTYLSESLYPKIEGILRKMTFYQDLVTPLLQEPIPKSKAVFDDTKVTDHHA
IIPTEVPPSQNLSREEKLIYDLIAKRFISVFYPECKISNTLVEAKVGTIPFKTSGKQILE
PGWRAVYAKEPKEESTDKEKDKEEEQTIPEFTVGETGPHDPMIHQGKTSPPKPYTEATLL
RAMETAGKQVEDEELRELLKNNGIGRPSTRANIIETLFKRKYIEKKRKNLIATQTGIQLI
DTIEDELLKSPELTGEWESKLRRIEKGEYEANQFKEELIQMVTELTNKVVYGKGKVITLE
EEKTETKEKKKREPAPKKELQSWEETQCPKCKEHHLMKGKTAVGCSDFKNCGFKVTFEIF
GKKISDKQLMDLVLKGKTSKLKGFTTHPESLAEGVLALDENFQIVLS
>KALACAFP_02610 hypothetical protein
MTPQKKQLITDSFSRSETLKFYKAELLEVETDFISMKIPKMDVMTRKAGMFNGAMIASLV
DVSSGYAAVSHYDEDCYVVTVELKVNYLRPAMGDALVSKSYVVKGGAKISVIRTEIYTVD
ENSGSESHVATSLVTMMKIK
>KALACAFP_02611 putative RNA polymerase sigma factor FecI
MEQFKAIYSEYKHRVYFFVKKYVQRDEDVEDIVQDIFVHIWKYAEKNNSKVPLEAIIFKT
CKQEVANFYRKNKMIMVSSDNIVNVDEDETIDEIFTEEQISQIEALLDKLPQQTKKLFIQ
NKIENLSYSQLAKENNISKTAIGKQINKAISFLKVNLQ
>KALACAFP_02612 hypothetical protein
MHFRVFSLKDFFVIANMNSEKDFEETWKETSKGQNTIDDITDKRIWDGINHKIKKKKSGR
KLYWIAAVLVPLFALMLIFKPSEDSKRNLEAKYVFETFGVKKNFKLPDGSWVELEPNSKL
TLSEKFGEKNREVMFAGQGRFNVAKDKTKPFRINAGEFFVQVLGTQFFLDQRSEEKKVEL
FEGKVKVEHADKITYLLPKEIWRTDEKNGDFHFYTPEKQKDFTFTNINYSEAIKQLEETY
DIKIVYPAEFKNKKVSGAFTGNLNEVVSVISFPFSLKAEKINEKEIILK
>KALACAFP_02613 TonB-dependent receptor SusC
MKKTAISIAMLGILCSSQVILASEIHTHLQSSYTAGMPLTKVLEKLSKTTKTQFFYSVSD
LQDILVDDKKIDYKSLRQTLSYLQKNYPIEFNVQNNIVSARRTADKKIVMNDVMSKTFAP
KTDTIHEKEKKIDEVVLIGYGKQNKKDISGAIASIGEKELKSVASGNFGDMIAGKATGIQ
VAQSNATPGASPTIRVRGIGTLTAGANPLIVVDGFPLTEGTNLNSIDPNSIATIDILKDA
ASTAIYGSRGANGVILIQTKEGKKGKLEYTLDSYYGIQMRSDNEKFVNAYDMATYMKEAR
DNNYLSKGSNRSASDDNATRIGKGASLRELIPDYLVPYLNKQPGLIDTDWYNTVLKPAPI
SNTALNILGGTEKTKFAFTGSYLNQKGLLIGTGYEKYSGNINLVTNISDKLKFGVSMSPS
YSKGELFDMVNGGRTYNLLQMATTMYPFFAPRDASGNLIISQQIKANIPYDGALVENPVA
VAEMTKRKYTMFKTFGNIFGEWNFLKDFRYKVSAGGDYTSYEYNFFDPSTVGSYRTAAPD
ATTASRTEYITKNYLIENLLTFDKRLEKHSFNVIAGQSFQKEQSNQVTTLAANFPDNSLT
NISGGTSFKIDVTDYTWALLSYFGRFNYSYDSKYSVMASYRRDGSSRFGVNTKWGNFYAL
SLAWTLSNESFFPKNKFLDPLKFRFSLGTNGNNQIPNFGAISLMTQENYVFGGVLAPGYR
AFTAPNADLSWEKSESTNFGVDFGLFNKYVNVSADYYILNRKGLLLDVPVPQQSGYSTSL
QNIGAIRNQGLELQVSLRPVRFGENLEYSNNFSFSANTNKVLALANNQTQIVAGANNFAV
TKVGGSIAEMYGYNILGIYKTQAEIDNSPHIAGTLVGDYIMEDLNKDGKIDANDKKSFGS
GIPKYVMGFTNSFKYKNFELNFTLYSELGRKIYNGDQVSITESGEGFGIANQYYFDNRYN
PVTNPNGTYAMPNMNFSNNRKEARTSNIFFKNGDYVRLRSLRLAYNLPESLLSALKIRSI
QLYFIGNNLLTFTSYKGQNLDANSDTILTQGYDNGYYPVARTYSFGMNMKF
>KALACAFP_02614 SusD-like protein
MKRIYIPLLSIFLLQSCSSDVLDTYPETIKQTANFYQDQAQLEQGVNSVYGSLQYNGQYQ
LAMLAIGEIPSDNTYDEVPANDSFTYGEFDFFTIQPNNSLISNTWRDHYIGIQQANIVLN
RIGAVPMDQNLKNSRIGEVKFLRALMYFDLVRIFGDVPLVTKETTNVNEYFGQGRTPVET
VYTFIESELKESLNLLPATQSQKGRVTKGAALGILAKVLITRNKFSEALPYLQQVETLGY
SLLPDVTKIFDVTNKNNAEIIFDVQFASGLNGNTEGSQAYQMFSPSGFVSGAKGHNLPTK
QVYNIFTAGDTRRDAYIGLTPNGIPYTKKLSKPTTAPADGGSNIVVLRLAEVYLLMAECY
AQTNDFTNANLYLNKIKTRAGISTVNLSGQALLDEIDLERRKELVGEGHRWFDLVRTGKA
ISVMTTYFQNTPGYNTATIKSYNLLMPVPQDQVNTDPSIKQNPGY
>KALACAFP_02615 Glycerophosphodiester phosphodiesterase
MENILNKNKKLFILFIFFISVTAYAQISLKKFPDDKVMVVAHRADWREAPENSVMAVKKA
MEKGVNMVEIDLALTKDNVLVLMHDYTIDRTTTGKGKPSDYTLEEIKKFNLRDGLGVPTQ
MKIPTLEEILDITHGKIFINLDKAFDYFDLVYPILKKRNMLDEVLFKGTAGYEEFNSKYG
KFKNEIHFMPIVRLSENEGWDKINTYFKNYKVYGFELTLGADESHLIDFKKIMEKGARVW
VNALWPQLSAGHNDDLILENPNAYEWYLKNNINMIQTDRPKELIEYLKKTKKYSPDK
>KALACAFP_02616 hypothetical protein
MEWLLHAKAHKHSKNKTMNLIIRLLVTAIVAYLLTKILPGVHFEGFSGAIIFAIVLGILN
LILKPILSILGLPLTIITLGLFALVINAVIILIADYFIDSMKVDGFWWALIFSVLLSIIT
SLANSMFSDGD
>KALACAFP_02617 Dipeptidyl-peptidase 5
MYFHKKLNINMKLKYSLLALAAPLLMNAQQLMTPEILWTLKKVGVQAVSPDQSSLIYKVG
QVDLKTEKTKNENYFLNVLNNQSTKIDLGKKALIQWDKNGIYAQEGDKIFLSKDSGKTWT
EFYTIGEADNIVISPDGKKIAFSKQVLVEKVMGKDKFSDTPKTTAQIYTDLNHRHWDYFN
EGKYNHVFVVNTSAAVDSAKDLLEGKTWDSPQRPFGGAEDFIWSPDSAQLLYVTKAKSGK
EYATSTNTDIFAYDMASGTTKNLTETNKGYDVNPKFSPDGKSLIWQSMARDGYEADKNDI
KILDWKSGKTTNLTSGWDESVSGDVFWGGDSKTIYFTAALRGTKQLFSLDPKNAKVQQIT
RGDFDVNEIFADQKNTLLVGRTDINHATDIFSVNIKNGEMKQVTEANKEMYSKLAQGKSE
LKMVKTSDGKEMGVWFHYPPNFDPNKKYPTLVYCQGGPQSALTQFFSTRWNFALMAANGY
IVVAPNRRGMPGWGTKWNEEISKDWGGQPMRDYLAATDFAKTLPYVDGERVAAVGASYGG
YSVYMLAGIHENRFKTFIAHDGLFDMKSWYLTTEELWFANWDLGSPWEKPQPKAYTECNP
SNFVEKWNKPIMVIQGGIDYRVPYEQGQEAFQAAKLRGLKTKFVYFPNENHWVLHPQNGL
VWQREFFDWLKETL
>KALACAFP_02618 hypothetical protein
MQNRISSFPPIIDNNSKILILGSIPGVKSLEKQQYYAHPQNKFWKIIFELLNEKFTEDYA
ERINILKKHHIALWDVIDSCERKGSLDSEIRNEEANQIAELLENHPHIEAIFCNGGKSYK
NLHKILGKNFRIPVFLMPSTSPLHTVSFEKKIEEWKTVLDFL
>KALACAFP_02619 N-acetylhexosamine 1-kinase
MEIDHIVYKFINTENYTITPVTNGLINTTYIVENRDSDQKFILQKINNQVFKDANTIIIN
HLQINCLLQSNGYQLDIIHPISSSTQEFLIHDENEQSWRMQSYIENSFTFITVPSVQTAF
EAAKTFSYFLNIINTGDLIEIKETLSNFLNFEKRVADYKNSLKNTDPQLIENAKKEIEIT
DQFLSLPDKWIEMVKTNQLPKRIIHADTKISNILFDEDHHALAVIDLDTVMISTILYDFG
TMIQSYTNTTNEDDGSAENNFNPEIYEAVKEGFLFHLKEKLTPEESENLDYAAQVAIYIQ
EIRFLTDYLNGSTYYSTKYPEHNLDRTRNQLELLKGLNEYLGLRV
>KALACAFP_02620 hypothetical protein
MNSKKTLLILAGGLGTRYKGLKQVDGILENGSPILEYSIYDALEAGFNKIAVVINQFIPE
SYIERLEKISKMEKFELKWIYQEMEKFVPKEIDISSREKPWGTGHATLCAKEMIKEPFVI
INADDFYGKEAFQLASREMDLGNISEFQFELIAYPVETTLSENGTVARGVCALDSESYLL
KIKEQTSLRKENSRIIYTENETDIEIKNQTLVSMNFFVFHPSIFNSLENYFIEFIKSNPL
PKEEFYIPFAIQKMITTKKVKVLVKSSPSQWMGMTYPNDKIILKNYLEKQIQRNRYPANL
WK
>KALACAFP_02621 Alpha-N-acetylgalactosaminidase
MTTRRNFIKTAAMASFGALVLPNSLFAYSENFRYDKKIRVGFIGVGFRGQEHVKLLAKRD
DVEIIAFADPNKIMLARSQKILKDNNKPAAQEFSNGEHDYKNLLKLKNIDAVVIATPWEW
HLTQGVEAMRNKKIVGMEVGGAMKLEDCWEFVKAYEETKVPIFMMENVCYRRDIMAVLNM
VRKGMFGELVHGRGGYQHDLRGVLFNDGITAYNSGVEFGAKGFSEAKWRTEHYVKRNGEL
YPTHGLGPVSVMMNVNRGNRLTRLSSFSSKSLGLHKYIVEHAKGGENHPNAKVKFKQGDV
VTTQIACENGETILLTHDTSLQRPYDLGFRVQGTEGLWQDFGSGGLNQGHIYFEKLMNHN
DQWDNSEKWLSENDHPMWKKFENKATGAGHGGMDFFVMNTFIECIKRNIEFPLDVYDLAT
LYSITPLSEESIAKGGQVIDIPDFTKGQWKNRKPVFGMTDEF
>KALACAFP_02622 hypothetical protein
MSKYSLEAFVNETKENPQERDYFELEKPQLLEINLNNQSVWTKIGSMVGYIGNINFEKQG
MLSGGLGNLLKKAISGEGTRLMKAEGTGKLYVADSGKKVRILYLNNESICVNGNDVLAHE
QSIKNDITMLKSVAGMMSGGLFQVKLSGTGHIAITTHGDPLTLMVTPDAPVFTDPNATVA
WSGNLSPELKTNVSFKSLIGRGSGEEFQMKFSGSGWVLIQPYEEVYTIEK
>KALACAFP_02623 S-adenosylmethionine:tRNA ribosyltransferase-isomerase
MKTSDFNFDLPAELLAEHPSEHRDEARLMVLDRKTQTIEHKLFKDVVDYFSEEDLFIFNN
TKVFPARLYGNKEKTGAKIEVFLLRELDKETRVWDVLVDPARKIRIGNKLFFTEDESLVA
EVIDNTTSRGRTLRFLFDGSYEEFRAKLKELGETPLPKYIKRAVEPEDAERYQTIYAKIE
GAVAAPTAGLHFSKHLMKRLEIKGINFAEITLHVGLGTFNPIEVEDLSKHKMESEEVFID
ERNAEIINKAVDGNRRVCAVGTTTMRALETSVSSNKKISAFHGWTNKFIYPPHDFGVANS
MITNFHTPKSTLIMMIAAFAGRDFIMHAYEEAVKEKYKFYSYGDAMLIL
>KALACAFP_02624 hypothetical protein
MRQNDLLTRTFAFGVNCLKFLRTLPNDPESKLIRFQLGKSATSIGANYEESQAGSSKADF
KNKVKIALREARESNFWLRVLEKLDGYNSEEFKNLLNESAELKNILAAIVNNTKL
>KALACAFP_02625 Dual-specificity RNA methyltransferase RlmN
MKDIRTLSLDQLKEYFMSLGEKPFRAKQVYDWLWSKNLHSIDEMTNLSKTLRERIAEEYT
INPVSVDQLQRSTDGTIKNGVKLHDGLMVESVLIPTETRTTACVSSQVGCSLNCEFCATA
RLKRMRNLEVAEIVDQVALIDSQSKMYFDRPLSNIVFMGMGEPMMNYKNVVEAIRKITQP
EGLGMSPRRITVSTSGIPKMIKMLADEDLRVKLALSLHSAIESKRNEIMPFSDKFPLTEI
MEALQYWYKKTGSVVTFEYCVWKDINDKDEDIKALIKYCKQIPSKVNLIQYNPIGDGKYD
QCNKQAEENYIRQLENAGIVCVVRKSRGGDIDAACGQLANKASD
>KALACAFP_02626 hypothetical protein
MDYFMDENGLESVYSWAIPIHATIILAEMIYSHVSEAKLYDKKDVATSVYLALMNFGLDL
VMKAFAMGVMFFFYNHRLFSWDFTIWYWLICFVVTDFAYYVLHYVDHHSRAFWAVHITHH
NSEYFNLTTGFRSPVLQPLYRYLYFSPLAFLGFNPWHIMVVYAIGQVYGTWVHTQTVKSM
GILEYVLVTPSHHRVHHACNIKYLDRNMGMCLIIWDKIFGTFEKEDPNVPVKYGIYPKMP
DNKPDTVLLYEWRKIWKDIKQPGLKFSDRINYIFNSPGWRHDGTGKTVRQYQKDYWAKKN
KKKEDIQKKSA
>KALACAFP_02627 hypothetical protein
MKKLSLIIAITISTFSFSQQSDQLKIRKHRISYLNEKIQETSGLNFFDGKLYTFNDSGNA
PELFELNKTTGEIISILKINAKNKDWEALTNDGKNVYIGDFGNNGGTRKDLEIYKIPFEN
NSLKNDSVKIISFEYPEQAEFVPKYLETNYDAEAMIYLNGKIHLFTKEWGAKSTTHYTIN
PEISEKQKAEKVESFKTNFVITDASYFDKKLYLVGYTKKTEVFLDIFNESEPGIFFKENP
RHYYLGSSLSIGQIEGIAVDETGVYISGEKFHSPLGSTKPSLYFIPKEKLKD
>KALACAFP_02628 All-trans-nonaprenyl-diphosphate synthase (geranyl-diphosphate specific)
MANTVEEIKRPINEEMKLFEQKFYESMQSKVPLLDKVTRFIVTTKGKQMRPMFVFLCAKL
IGDVNEKTYRGASMIELIHTATLVHDDVVDESFKRRNFFSINALWKNKIAVLVGDYLLSK
SVLLSTDHKDYDLLGVISRTIREMSEGELLQLEKARKLDITEDVYYEIIRQKTATLIAAC
CEIGVLSNNADEVLAKKMMDFGTYTGMAFQIKDDLFDYLTSNVIGKPVGIDIKEQKMTLP
LIHTLKTAGEADKKYYFNTIKRYNNDQKRVKELINFVKSSGGLDYAFGVMKNFQQKAKDI
LDEFPDSEAKRSLHIMLDYVIERKF
>KALACAFP_02629 hypothetical protein
MEKKSSHILNASSNLLGFSLVIITSLKISKISQSTYLDEFASVASVCFAISCFFSFLSIR
SADKKRGNKFEDIADYLFLIALFCIVLAVVIVTVKII
>KALACAFP_02630 Pyruvate dehydrogenase E1 component subunit beta
MAMQTTYIETQQISFQDFKNQILEDYKLGRISREMSYLGRREVLTGKAKFGIFGDGKELP
QLAMAKVFRNGDFRSGYYRDQTFALAVDALSVESFFAQLYADTSVEREPASAGRQMNGHF
ATRSLNEDGSWKDLTAQKNISSDISPTAGQMPRLLGLAQASKIYKSVKFDGSEKFSKEGN
EIAFGTIGDASTAEGHFWETLNAACALQVPMIVSIWDDGYGISVPTKNQRAKADIAEMLS
GFQRKEGENQGCEIIQVKAWDYPSLLDAYARAEQFARMESVPVVVHVIEVTQPQGHSTSG
SHERYKNEERLAWESQFDGLVKFREWILNYSIEIEGKEEIIASAEELDAIDEEAKKTVKA
GQKNAWDSYQKTITDLVHSVLPLVENLKGQNAEIENYINQFNKLVSKAKKDVFHLVRKSL
LATRGTDSAERSQLMQKYNEIFEVEKDNYSSHLYSQSQWKAENVKEIKPIYSDSSEDVDG
RVVVRNNFDKIFEKYPETLVFGEDAGNIGDVNQGLEGMQEKYGDVRVADTGIREATILGQ
GIGMAMRGLRPIAEIQYLDYILYCLQGMSDDLATVQYRTKGGQKSPVIIRTRGHRLEGVW
HSGSPMAGILNLSKGILVLVPRNLTKAAGFYNTMLQSDDPAVIVECLNGYRLKEKQPDNL
GEFTVPVGKIEVTKEGKDVTLVTYGSTWRIVMEAAEELEKLGISAEVIDVQSLIPFDLTH
EIAESVKKTNRLVVIDEDVEGGTSAFILQQILEKQKAFRFLDSDPLTIAANDHRPAYASD
GDYFSKPSADDMVERIYAMFNETNPQKYPAIF
>KALACAFP_02631 hypothetical protein
MNKDLEKLAPSKQSAAKNLFAAFEILKQEGGQLLGKQVIDRIRDKNDLTDWEKEVYEKTG
YIRWESILHFYTIDAIKAGYLRKNKGIWYLTEEGEKAISLGPAKILETASKLYRTWAADK
KEGKYLNNNNSNDEPIELEENKTQSQKANLDLLEEQAIAGIKDFIRNKNAYEFQDMVAAL
LRAMGYHTPFISPKGKDGGLDIIAYNDPLGATTPRLKVQVKHRPDSSVPVDDIRSLTGLL
NKDGDIGLFVTSGAFTSESERSARESHRHIKLLDINNFIELWQEFYNKMEDEDKNMLPLH
PIYFLGSNE
>KALACAFP_02632 putative HTH-type transcriptional regulator YybR
MKKNELMQYSCPLGKAMSALGSKWKPIIVLVIKDRKLRFGELAVRIHVISRKVLTDQLRE
MEADGLVIREEFKEIPPRVEYSLTEKGLALLPILYLLEEWETKYHVYDPDKVKECGVNSK
KIKKTVV
>KALACAFP_02633 NADH oxidase
MSTESLFKPFQYKNLQLKNRIVMAPMTRAQSDNGVPTQQIAEYYARRAASEVGLILSEGT
VINRPASKNMQNIPDFYGNEALNGWKNVIDAVHENGGKMGPQIWHVGDTRNSPDYPLEDM
EKASTMTLEDIKDTIAQFAASAKAAKDLGFDVVEIHGAHGYLIDQFFWEVTNTRTDEYGG
KNIKERSRFAVDVVKAIRAAVGEDFTIIIRLSQWKQQDYSSKLANTPEEMEDWLLPLKEA
GVDIFHCSQRRFWEPEFEGSDLNFAGWAKKITGQPTITVGSVGLKGDVMGAFAGQGTEKE
DLAELTRRLERGDFDLVAVGRALLQDPEWAKKIKEQNIEAISDFKAESLGVLY
>KALACAFP_02634 Aminopeptidase C
MKNTKIVSLLFVLSAGSMMFAQDDLINKLKNNQSQNANFQFTTLKDVGATSVKNQGSSGT
CWSYSGNSFLESEMQRMGKKPVDLAEIYTARNSYHDKAKLYVLNNGAINWGDGGELHDVI
NMYKKYGAVPQDAYTGLKQGQTINNFSEMQGKLKPVLDSLVQASQKGKLTDNWMSAVDAI
LDQYLGKVPANFTYEGKNYTPQTFAKEVVGINPEDYVEISSYKDYPYYQKFVVPIPDNWS
HDSDWNVPMKDLTAIIDNAVNKGYSVGWATDVSEPYFSYKNGVAYVPDMDLDQITAENKG
TLFTEPKKDKAITEDMRQKALNNLSTTDDHGMHIVGLAKDQTGKEYYMVKNSWGVTNDFE
GYLYATKPYIEYKSTAILVHKDALPKSIKKQLKPTKNIGL
>KALACAFP_02635 hypothetical protein
MNEKAFYIKKFEALKIFFFIKVFHTERIHARIFPDCFLIQCLDDKFYGLLNGFSMFKSPT
ATLAPIGAFV
>KALACAFP_02636 ECF RNA polymerase sigma factor SigE
MEHQLLIECQRNDRNAQRKVYEKMAGKLYSVCKGYLKNDEDIEEVLADTFYKIFTKINQL
QNHDIFEAWARKIAVNECLQKLRANKALHISLEENHMAASDSALENISFEKDILSLLNFL
PEGCRAIFNLFAIEGYPHKEIAVMLSISEGTSKSQLNFARKKLQELLVNQNI
>KALACAFP_02637 TonB-dependent receptor SusC
MENNHNIDKTFNEASKTLEEPATFPGFEKVWNTIEEKLDKKQEKKKIFPIWLPYGIAASL
LIASGVFYFNNQKENTEIAKPAIAETVVESKMPATATSGNILKIDSTVKANIQSESLPAA
PAKIASHTFPKMVTSPVVVAPVQPSYDDVSDAVYDKISDTLQSKNLEEVRIAMGLKKDKV
SMINAERLASSEKKKISDLNAIADTAELIEPIDVFDLKQQAREPEILAYNKKYKKSQKPV
AATSAFGEKIGRNSYLNSIQGATPGVNVSSISGKPGSGKVDILISCQNSAKPEMNPLVVI
DGQVSDMETLKKLDPKKIENISVIKKEKAAGLFSGKAQNGLLVVITKDISKKEKRKLKKL
LKKELPQK
>KALACAFP_02638 Alpha-agarase
MRKTCITITALVFLAGCKTKNVSEASNESKPLSIKKDKDQDGIPNKLDQCPEIAGSIENN
GCPWPETDGDGVIDKDDACPTVAGPAENNGCPWPDTDGDGILDKDDACPTVPGLPEYNGC
PKPKSVTAMEVESSFSVGDYSYQSRGKVYNNRIRTQKTGKKVIKKQRDYSNEEYDALVEN
PFELAQNQPVSTFSIDVDNASYSNVRRMIDYGSVDKNAVRIEEMINYFKYNYPQPKNNQP
FSINTELSSAPWNPDHQLLKIGLKGKDIPMDNLPTSNIVFLIDVSGSMNEENKLPLLKSS
FKILLEQLRPQDKVAMVVYAGSAGVVLPPTSAAEKGKIIEALGRLQAGGSTAGGAGIELA
YKLAEENFVKNGNNRVILATDGDFNVGVSSKASLEELIEEKRKSGVFLTCLGYGMGNYKD
NKMETLADKGNGNYAYIDDLKEANKFLGREFAGSIYTIAKDVKIQIEFNPKYVKSYRLIG
YENRKLRNEDFTNDKIDAGELGSGHTVTALYEVIPVNASSEFLPKQSKLKYSSTSKTQKF
GDELATIKFRYKKPAGMKSSEMIQIVKNSAVSKAKASRDFKFASSVAWFGLVLRNSKLIK
KKNLTDIENLAKQNVGNDSEGYRAGFVKMIQDYKNIK
>KALACAFP_02639 hypothetical protein
MQLSEAKEKYIQTWGTFATNWGINRTMAQVHALLLASGKPLSTDEVMEQLEISRGNANMN
LRALMDWGIVKKEFVKGERKEYFVAEKDVWFLFKQITKERRKREIEPVISFLEELKNIED
NDSEEAKEFIKLMDDFSSVTGKINNIMDLAIKSDDHWLVGKITNLLK
>KALACAFP_02640 hypothetical protein
MFNIVSYVIFLTISSYITIDVGRRCYNAGKSYLDYLIHDSDLCLTINRILLGCYYLINLG
YIAISLTTWDRVDSMEEVFTVTAFRIGSIALILCALHYMNIFALYFLRKNLTIK
>KALACAFP_02641 hypothetical protein
MTATILTTATTYNFQAYMMYLPIVITLTVFVSQFLFKNSKTFMIDIFHQKEDIAMATNSL
FKIGFYLLNIGFALCIIEFFQIESVERLVVELSQKVGGFSIYLGVMMLLNLLLFLKGRKH
AMNKEKQMQHENTDI
>KALACAFP_02642 hypothetical protein
MKTFFKYDYYFQLSILVAYVLGWISIELFNINWGNYFLLFYYIVGGSQLISYLLRLMMRY
PKNWIYVMYGIFIIPVWLILLYQTQIRIVNGFFFYILFSSFFYSPVLALVYIFYTYRMNI
LYNSNKN
>KALACAFP_02643 hypothetical protein
MNHLELIKKVEWKDLKSLSIKEMLIENNISLPWLIISLFLAYKNYYWAALPFSGFYFLTA
LRQVHNGFHNSLGTGKFLTWLSLYLNSMSMMTSIHAVKFNHIRHHKFCLSEEDYEGKSAS
MKWYEAILYGPKHMFLIHWITFKKANKNYRKNMILELISISVFVMIVFYFRINFLLYHIA
VMFFGEFLMAFFAVWTVHHDTHENPNIARTQRGFWKNKLTFSMFYHMEHHLFPAVPTIKL
PKLAERIDQVLPELNKRQTF
>KALACAFP_02644 hypothetical protein
MNFLKAEWRKLAIINYEINPETLIKYLPKGTELDFYQGKCYVSLVGFMFLNTKLLGLPIL
FHRNFEEVNLRFYVKKKEGNEWKRGVVFIKEIVPKPALSFVANSVYKENYKTMPMKNFIN
EKDGELLIKYSWKDKSWHSIEITAENERLKMETNAEFEFITEHYFGFTKKGNKTSEYEVC
HPKWDYYFIKDYQLEIDFEKIYGKDFGFLNHQKPISIMLAEGSEIEVKTKKYLA
>KALACAFP_02645 Epimerase family protein
MKIIIAAGTGFLGKNLEKYFTEKGNEVYILTRSPKRNNEMYWNAKTLGEWKNILENADIL
INLAGKSVDCRYTEKNKKEIYSSRIDSTKVLQQAIDDCRNKPKVWLNASSATIYVHSETQ
LNTEENGIIGDDFSMNICKSWEKEFFKAKTENLRKVALRTSIVLGNNGGAFPKLKMITKF
GLGGKQGRGNQNVSWIHIDDFCKAIQFIIDHENISGKINITAPNPLSNKEFMMKLRKEMK
AQFGLNAPVWQLEIASIFLKTETELLLKSRNVYPDKLMKSGFEFSYLEIDSAFKNLI
>KALACAFP_02646 hypothetical protein
MLIRQKTKTLFLSSLLISTAFFSQAHNVSKGYQKPTDPLVVQNLENWQDLKFGLFMHWGT
YSQWGIVESWSLCPEDESWTQRKPEHGKSYYEYVKNYENLQATFNPTQFNPQKWADAVKK
AGMKYVVFTTKHHDGFAMFDTQQSDYKITSSKTPFSKNPKADVAKEIFNTFRKEGFKIGA
YFSKPDWHSDDYWWSYFPPKDRNVNYDPKKYPERWDNFKKFTFNQLNEITSNYGKIDILW
LDGGWVRPFNTIDSNVEWQRTIKVEQDIDMDKIGTMARKNQPGIIIVDRTVPGKWENYVT
PEQAVPEHPLSIPWESCITMGDSFSYVPNDNYKSSQKIIETLVKIISRGGNYLMNIAPGP
NGDYDPIVYERLKEISGWMNSNQSAVFATRSVAPYHDGNFYYTQSKDGKTVNIFHLDEKA
DYQSPSTLSFLIPENFKPKSLKVLGLSNKIQWKKSGNSIEINLPKERNQLKYATVIQITQ
>KALACAFP_02647 Xylan 1,4-beta-xylosidase
MCFKFRFKIIAISLLSSIFISAQKPLYKDPKQPVEARVQDLLNRMTPEEKFWQCFMIPGD
LDNVPKGQYSHGIFGLQVSAGNQGGGVAGQMLKYNANEDAERLAKKINAIQKYFVEESRL
GVPIIPFDEALHGLMREGATAFPQAIGLAATFNPDLMKEVSTAIAKESKLRGIRQILTPV
VNLASDVRWGRTEETYGEDPFLTSVMGVNFVSSFENQGIITTPKHFLANVGEGGRDSYPI
HWSKRYLEETHLIPFQKAFKQGKSRSVMTSYNLLDGRPSTANHWLLTEKLKNEWNFKGFV
ISDASAVGGANVLHFTAKDYDDASAQAMNAGLDVIFQTEYNHYKLFIPPFLDGRISKERI
DDAVARVLRAKFELGLFENPYVSNKDIQELKRINHKPLAEKTAIESFVLLQNNNQTLPIL
ENFKKILVVGTDAVDARLGGYSGPGNKKVNILDGIKNFVKNKNIEVNYSKGIDWNLKSFT
TVPSEFLSSENQKGLKGNYFSNSDLKGNPAFEKQDEQLNFKWTLYSPNPEKLQPDNYSVR
WTGKLEAPDSGKYKLGLRGNDGFRLYVNGKLWIDHWEKLSYSTQTVDLDFIKGQKYDITV
EFHENRGEANIELIWNYGLNDGQKDFNDALQLAQNADYIIVTAGIHEGEFQDRSSLSLPG
NQEKFIQEVSKLNKPTTVVLVGGSAIKTTDWKDKVGAILDVWYPGEEGGNAVAKVLFGAE
NPSGKLPITFPVEEGQLPLTYNHHPTGRGNDYHDLSGEPLYPFGFGLSYTSFEISDLKLN
KTKFTENETIVATITVKNTGSKAGSEVVQLYVKDLLASVSRPVIELKGLKKIALKPGESK
QISIEVPVQELKFLDEKMNWIVEKGTYRIMVGNSSKNLPLKQNVEIE
>KALACAFP_02648 hypothetical protein
MLRLNDLCFKDKINLGMISVILTLNLNEFN
>KALACAFP_02649 hypothetical protein
MKKLIISMIVLLGLSMNVSAQQRPPAPPHPSKSELIAMKSRELDRRYNEEKKLILNHPLA
TKKMKRDQLKALNEKYQSQKRLLKKM
>KALACAFP_02650 Dihydrolipoyl dehydrogenase
MNYDIIVIGSGPGGYVTAIRAAQLGFKTAIIEKENLGGICLNWGCIPTKALLKSAQVFHY
INHAEEYGLNKVEASFEFPNVIQRSRGVASKMSKGIEFLMKKNKIDVILGTAKVQKGKKV
SVTDKDGKVTEYTGTHIIIATGARSRELPNLPQDGKKVIGYRQALSLPEQPKSMIVVGSG
AIGVEFADFYNTMGTKVTVVEFMPNIVPVEDEEISKHLEKSLKKSGIEIMTNASVESVDT
SGAGVKANVKTANGNITLEADILLSAVGIAANIENIGLEEVGIQTDKGRVLVNEWYETSV
PGYYAIGDIIPTQALAHVASAEGITCVEKIKGMHVEKIDYGNIPGCTYCHPEVASVGLTE
KQAKEKGYEIKVGKFPLSASGKATANGNTDGFVKVIFDAKYGEWLGCHMIGEGVTDMVAE
AVVARKLETTGHEIIKSIHPHPTVSEAIMEAAAAAYGEVIHI
>KALACAFP_02651 hypothetical protein
MFKKLAAEALGLGDIGKIIPSQDYDKVDSDDYILSEDNEKIFFLIKSKRDEYCFTNRALI
HIDGASALDKKRVLRRYEYYQFPFSNIALQTAGTIDLDVEISFNIGNVPLMISVTKSQVD
QLKDLYKALLAIQQEVHHNHSLLNFANDSLQKAVTTVASGKQENVSKSQELQNINEYIFN
WNKNSFNTYNQKDFSAIFEKYINN
>KALACAFP_02652 hypothetical protein
MKKITLLLLILCFNALFSQKEEMFKETYFPVKYVLKSSKDTIKTKILNIGFYSNEEFSPA
TYIKQMTVLDPSGNKVKVPENNILYLEIVDLKKVKRKFVDAKSIISKDLGLVQIIYSGKK
TDWYRKSSYSGSIYTYKTDDVDYLKFHKDKSMMEIHFDIPGAKYQIKEKFYNYPDLALLI
DNMVEDTDLLKVLKLYDKK
>KALACAFP_02653 hypothetical protein
MKYFDFHCHPVLKQLFNDNPNIDAFIYRSDVAAIPKACSDLPSIIETQTHQSQLSEFNDE
VILGAVLYSVEKNVAETVIPLRGYLKKASQFKLSEQLLKDIVSNKNRPFSDFLMKRTLDK
YLEASSSFHILTKDSFKSPLPKNKVNVFFTIEGCHSLVDSPNFCNASNKYKPGDILSNLD
KVLSKISIISINITHLQQSSLCNQAFGMQVANASAFFPSGNGFENDGRTVVQGIFDRKIC
IDVKHMSYKSRKDLMSEIDSKKYKNIQPLVCTHAGFTGMPFKDWAGHIQLKKPASGALYL
EITKPFNAKINPGRPGFPTFNASTINLFDEEIVWIVKNGGVIGISMDRRILGYVDKFDDD
PTGITDMERIVDKEFFSKTEWDSLGIKNENIGKVIDDDNCLFMNELEENTESSLPRRDEY
FYDHLLNHIKHYFQVCKDNGIPIQTAQKQITIGTDYDGLINPFLNMPTVKRMADVRSYIS
MNLKYFLRDLKDSKKWADELNIDTFMEDLFYNNGYRFLKSRF
>KALACAFP_02654 putative NTE family protein
MNFEKVGLVLSGGGAKGIAHAGVLKFLKEKNINVDVLSCCSAGSIVGCLYAVGKTPEEIL
EFFNSVYFFNWKHFTFNQPGLVSSVIFRNYLNPIFGDMKLGDLDKEVKIVATELVGGTEK
IFDKDFKIMDAIIASCSIPGITTPYIIGEEMYCDGGVLNNFPADIIRDDCDKLIGVFVSP
PHDIKIDDLKSIKAIVSRSYDLLSYRIEKIKFEYCDWFISSQELSTYGTFERRKDRLEQI
FNIGYNAAKESFNESSFYIQLKQSGT
>KALACAFP_02655 hypothetical protein
MIKKIILGALCVAQFSLVFANNVDRNPGITSKNSTEFQQKVPKTVIIKTKKFKIRIDQQP
NGKYLYQSWPANAKITSKPSMIISDGQIVPDGSGGNYYYEFTNKGYTYHVWRNYLTEGTM
PPYTLMVSDQNGKTIVDQGAQVVKK
>KALACAFP_02656 hypothetical protein
MELTFHGWMIPALIALLCVLFYKFILRIFFGLIIVPQDKIGLVTKKFVLVGKQELPEGRI
IATNGEAGFQAQTLAPGVYFGKWIWQYSIDFQSFTVIPTGKIGLLLAKDGMELETGRILG
RKVDCDSFQDAEAFLRNGGRKGRQTAIIAPGSYRINTLLFEVELTDMTQIPDNAVGIITT
MEGSPLEEGQIAGKIINDHNKFQDVDTFLNNGGYKGLQEQVILAGSYFLNPWFTKVEMVK
MTEIPIGHVGVIISYVGEDGKDLSGVDFKHGNIVEKGHKGVWAEPIGPGKYPINPYIMKV
ELVPTTNLVLNWAYERSESHQLDKNLSTITVRSKDGFPFNLDVSQIIHIPTYEAPKVIAR
FGNMINLVSQVLEPTIGNYFRNSAQDSDVIAFLGTRKERQQSAKDHISSVLEQYNVNAVD
TLIGAIVPPESLMKTLTDRKLAEEQKITYETEMLAQETRQALEKETAVADMQKEIVKADQ
GVLIAERIADASVKKATGDANSVRLQANAEGDRLKLLATGEAEKTRLLAKAEAEKIELLA
KASAEQISLTGNAEAEKILAIGKSNAESYKLSVEAMGGNNFTQLKIMENIASQNVRIMPE
VLIGGSGDAANGGISGLLGLQLLEQVQKKNIETVSVIDEKPDNNS
>KALACAFP_02657 putative ABC transporter ATP-binding protein YxlF
MSLQINNLTKKFGEQTALNNINISIENNEIIGLLGPNGAGKSTLMKSIVGALKIDEGEII
FNDKNITEHEIESKKRIGFLPENNPLYLEMYVKEYLQFVANIHKIPESRVDEVIELVGIT
PEKSKKIGQLSKGYKQRVGLAQAIIHQPDLLILDEPTNGLDPNQIIEIRNVVKEIGQQKT
VLLSTHIMQEVEALCSRVILIHKGNILQDCPIDEFKGKFESLEEAFASYTA
>KALACAFP_02658 hypothetical protein
MRKIILLFTCMFGISVFSQIKVLKNESLVEIGKDNSVGLYKKENNFTINYQDLNTSNLNT
FRSFSFQNLNGDVSGLYELITNGFINTPESNIVLELPNDIIELHYEKNYGQPTVQFIQYI
NKNKKYVGKSQFLTRKQVDKIFGKANGKSALYDKPATMHNINAAKSSSTASTAAPASNGK
DKKARK
>KALACAFP_02659 hypothetical protein
MKKCILALILLNSFYYEVSAQVGINTPTPTATLDVNGNMVLRKANSALSNKGYSCIVRDD
NTGELKVIASPSGNTLPLNYITYTLNNVNGDWVNDYDTKISSSEYTVAIIGSNYTSSNNG
LTAAVGTDFNPMNVFAFNSGNTWHLSADYKGATSSGGNGTWEIRCLVINNTLVKTLPNVI
QNLGGSKDASATSSPSGL
>KALACAFP_02660 hypothetical protein
MGRVHLVSVRIITADIKRLVQFFEDATGITAKWATDDFAELSSESFTLAIGSTRTLAFFG
EGVAEPATNKSMIIEFLVENVDDNYEIIKGLTSEIVQKPTTMPWGNRSLLFRDPDGNLIN
FFTPVSEVAKKKFA
>KALACAFP_02661 Mycothiol S-conjugate amidase
MFKKIILVFILGFYTVFCSAQQVRPSKSSEIYRELKTLKHLPKVLYLAAHPDDENTGLLS
WLINDQNVETGYLSLTRGDGGQNLLGTEQGAALGLIRTHELLEARKLDGAQQFFTRAIDF
GFSKNTTDTFKQWDEDSIIADVVWVIRKFRPDVIICRFPPNAAAGHGQHAASAVVAEKAF
KLAGNKTAFPNQLKYVNTWQPKRVLWNTFRFGGVDTTSENQLKVTVGQYDAQLGMGYGEL
AGLSRSLHKSQGAGTQSVAGIRTEYFAHVGGEPAKASLFDGVVKTWTSQGNADIDQSLDK
IISAFNFNNPDLSLPALLALRKKVMALQDSDLKKDKIKSLDHIIFSCAGFMGEVVTNQAE
AVAGDSYNFRLNLISRATNPVVLEDVQWLNKLENFNRKLSKDSLITIQHDIEIPADAALT
EPYWLAKSPTNAATFSVPNDTLIGLPEAESPLNVLLGLKIGSEKFQVKLPLSFKKLDPVR
GDVVEALRIVPALELKFTQPLYLVKENEDLHLSLNFKVNSNKQFNNGKVNLMYNGERLGG
ADLKSMNGKDFTIDYVIPKTKLASIKSNQLQLDANFVADGVTYNKKQILIQYPHLPSLQY
FAPATVTVMKGDIQSKVKKVGYVQGAGDFIPEFLRIAGVQVDVLKDKDFYGNLDESAGNG
SQNKLSQYDAIVLGVRANNTEKKLGRWMPYLWSYVKAGGNLVMQYNTNQDTTVDKLGMYN
FNIANKRVTEENAAVTFLNQNHKLLNFPNKITADDFKGWVQERGAYFPAQWDAAYEPLFE
MHDTSEEPLQGSTLYAKYGKGNFIYTPLAFFRQLPAGNVGAARLFLNFLSAQKN
>KALACAFP_02662 hypothetical protein
MNNQLKNWNTWYLLLAAALVLQIVFYYLFTKFWA
>KALACAFP_02663 Sodium/glucose cotransporter
MSTIDWTVLIVTLVAVVVYGVLIGRGQKNNESYLKADNKMPWYIVLIGIMATQASAITFL
SAPGQAYTDGMRFVQYYFGLPLAMIVICITFIPIFQRLNVYTAYEYLENRFDKKTRVLTS
LLFLFSRGLSTGISIYAPSIILSSVLNWNIYLTNVLTGGILLIYTYIGGAKAIAHTQKLQ
FLIILATMAFAGYLLIQNMPNGIGFNDALYLAGKSGKLNVITTEFDWKDKYNIWSGLIGG
FFLALSYFGTDQSQVGRYITAKDNTNAKMGLLLNGLVKIPMQFSILLIGALLFAFFSLKP
APIYFNERSYQYLKETKPEQAAVFEKEHQDLQLKFNAESKEILKLKETQSPQLKKTIQDF
KNTQTQVKALHSRVEEAINNSNYNAEKTDTNYIFLYFVKNTLPVGMIGLLFAVIFLASWG
SISAALNSLAACSLKDVHLIFSKEIPDEKTELKYSRLHTLAWGIFSIGVAMFATQMGSLI
EAVNVLGSLFYGPILGIFLVAFYYKKIDGKNVFIAAILSEIAVIAVYQFDIVSFLWLNVI
GAAAVIIFSAIGLLFYKQKAVNS
>KALACAFP_02664 hypothetical protein
MKTMIKSATVLFAAMTISVNAFAQDTKKPASPPATATGKIKDATITIAYSSPSVKGRTIW
GGLEAYDKVWRAGANEATTFETDKDITVQGKPLPAGKYSFFLIPKKSGTWTAIFNKEPKQ
WGAYKYEQAKDALRVDVKTKALPATQETLVYKINNNGFTMDWDKISVPVEIK
>KALACAFP_02665 hypothetical protein
MELRPELIRDFFAVINKKYGSVENFFRLK
>KALACAFP_02666 hypothetical protein
MKNNILFLMFLVAGNALVTGQVGILTSNPQGSLHIDGAKDNPATGTPTAIQQVNDVIITP
EGSVGVGTIAPDSSSSVEVRTTNKGFLPPRMTNAQRDAIALPATGLMIYSTTSKCLQTNI
GTPAAPSWGCVAVQGSVGAPVVQVNSYTPNTAAGSAASEICLGSICVRHNGAAIEGSILL
RSNTGASIPSSSIAGFQVATSGINMGDTEIVTLTTSYTQFYRGGASGGEFINYQVCTGTG
ENYRIFLTMVAPVLNPGAGNGMYLLNLEKIR
>KALACAFP_02667 hypothetical protein
MKKINLLLFLLSAQLFFTQIGINTSNPKSTLDIAAKTTDGSRPEGLVAPRLTGDQIKGGD
TQYTTDQKGNIVYATSAVSTVSPKTINITEEGYYFFDGNIWQKINQDTNIYKNNGTLASN
RVVTMADKTLSFTSSATTGTSHFQVDGTTLNVDAVNNNVGIGTTTPSTRLDINNGSTPGA
IKIVDGTQAEGKVLVSDASGIGTWRDTTGAALIIDSTTGSNVNFAGGTMKYLGASAVVTI
PGYYIVSPHLIADKSPSGCGNFIAYNLSQSPTAAINNAFPAPDVHMPAGPTINDFIYTSN
IAYLTAGTYYMRVRDANLCTTNTARSTFSQNSFTLTLLK
>KALACAFP_02668 hypothetical protein
MMKQNYFNVLLILSSIGMYGQTAGNVGIKTSTPTNALTVNGNSSIGSGYTTIAAPANGAI
IQGNVGVGTSKPVNNLTVSGNTSIGTGYAATAAPANGAIIQGNVGVGTSKPVNDLTVSGN
TSIGAGYAAIAAPANGAIIQGNVGVGTSAPAAKLDVIGKIKITDGTQGAGKVLVSDANGV
GSWRDTSATAIVINSTTGFSADFAGDQLTYLGAKATVTVPGYYIVSTRLISDKTPIGCGA
YIAYNLNKSATANISPAFPIQDIHMSAGPNGWDHLYTSNIAYLTAGTYYMRVRDANRCTT
NVSRHTVGENSFTLTLLK
>KALACAFP_02669 hypothetical protein
MKKLLLPFLIPCGVFAQVGINTPTPSATFDVAAKNATGTTTAVDGILIPRVDRQRAQNMT
GITPSTLIFVNDITTGTQTGSAINIDNPGFYFFNGTDWVKLNTNIYNSDGTLTGNRTVTQ
AGNTLAFNGTATNAFSVNGTTFSVDAANNRVGIGTDTPTAKMEIASGTDGSSGLKFSNIN
NTTPPVSNTSPLGIDANGNVVVQSSLTTSFRSFNINASTPTSSSVAIGSLEFRYPSTTCT
NTDSYVQVRTTTGTNNTGIIHGIYRTAQNGSGFINSVPLTITPTFANIGAGIPANANPAL
IPINCGQDGHAQFTFFSYIDKTFYRVSFHIADGDSLGFGALGYIFVEFQR
>KALACAFP_02670 hypothetical protein
MKKRFFLSLLIACISANAQDLTSYNKLYTKTYLETAPKDFNKALSIADSLYKTSQTPYFQ
AKSLMLTASLYRQSGDVKKSVLYAERSALIVDGTDDSNWKCRIYLFLASQYRILELYNQS
KKYSEKGLEISKTISDTLIAHNIQGMALQEMAYYEIDRKKYKKSIQYIQRSQAHFNNIKK
DKDFFTSTNEQLLGLSYYHLKNIETSLFHYEKALNLVKDVPENQLTGYIYNGLANVYLEK
NDLIKAKKYLDLAQKVADKAEHLELKKEVYSTVEQYYIKTKDIEKLKDLGLKKDTLDRKI
TSKTRQFIDESYTNLDKKIIKAEKKSTQKNYLIIITGLLVILILALYIRSKIQQRKNIEK
FKEILRRSNEKPKLAEPIVVKEVKIEDTDIESSEATVLMTSETEEKLLAKLNKFEKSNLF
NNKNISLPFLAGRFETNTKYLSYVINTHKEKDFNNYINELRINYIIEKLKNEPQYRNYKM
ASLAEEIGFSSHSKFSKVFKKVTSLSPSLFIKYLQDETQSKKD
>KALACAFP_02671 Glucose 1-dehydrogenase
MSTHDVKGKIVLIAGGGKNLGGLLSKDFAAKGAKLAIHYNSESSKAESEKTLAEVQALGA
EAFLFQGDLTKVENITRFFDETIAKFGGVDIAINTVGMVLKKPFTETTEEEYDLMFGINS
KSAYFFLQEAGKKLNDNGKICTIVTSLLAAYTGLYSTYAGAKAPVEHFTRAASKEFGSRG
ISVTAVAPGPMDTPFFYGQESADAVAYHKSASALGGLTNIKDIAPLVEFLVTDGWWITGQ
TIFANGGYTTR
>KALACAFP_02672 H(+)/Cl(-) exchange transporter ClcA
MNLHNRKKYLSFLKFKRDFQKYGLEKARSYELVLHWLHNRLSRSQFLLLSGIVVGCSAGL
AGVILKTLVHNIHHFISSKVHFEYQMLFYLVFPFLGIVLTSIVVITIFKGQDRKGIGAIL
YEIAQNSSIVSSVKMYSQIVQSAITVGLGGSAGLESPIAVTGAAIGSNYAQTYRLGYKER
TLLLAAGATAGIASAFNAPIAGIMFAFEILLTGVVFTDFIPLVVAAVCGSLLSRILLQED
ILFRFYTRESFNYKNVPYYLILGIVTGLYARYFVIISQKVEHFLKKLSLTRLRKAMLGGA
VLSFLCVLFPPLFGEGYDTIKAFTNGNTQRIIENSFFRYFEIREWTIILYLLLVCLLKAF
ATSFTIFSGGNGGNFAPSLFAGGTVGYLFALICQQIGFTEVPVTNLVLVGMAGAMSGVLY
APLTAIFLIAESSFGYDLFIPLMIASVISYLIAKWFSPISPELQSMADQGKIFTDKHDRN
LLSALHSEDFIDYNSQTINENISVSEMFELFKKSNKNIFAVVDDKRALRGMFSIDDIRPY
LFGDHDVPKNIIQIMKAPPAVFHKEDKPLEILQVFDDTGVWNLPVVDEENRFVGFISKSS
ILMGYRQLLKEYSE
>KALACAFP_02673 Na(+)/H(+) antiporter NhaP
MELFLIFSILITLAAFFSFINIKFLKLPSGISLMLMGVLVATGVIVTGYFSVGFTEMIRE
KLSLIDFSEFLLGILLSFLLFAGSMHVSIPDLKKSAKSIISFATIGTLISTVVVGYSLFY
LLSAFNQPIPLIYCLLFGALISPTDPIAVMGILKKTNLSKNIETNIVGESLFNDGIGVVI
FATILKIASDGAENFGIADIGILFIQEAVGGIFMGLIIGFIGYKLMKSIDHFQTEILISL
AMVMGGYSLCHSIHVSGPLAMVVAGLMTGNRGKELAMSDITKDYLGKFWEVTDEILNAVL
FMLIGLEIVIVSFDLSYLTIGIITALIIIIARFVSLYIPAVLFRFKKVFGTKSLFIMTWG
GLRGGISIALALSLPQNPYKNILVSITFVIVIFSILIQGITVEKVIKRLTP
>KALACAFP_02674 hypothetical protein
MKKIYFLSVMFLVLSCTGTTRNTLQFTKQDYPGEWPFAVDEMEVYCSGYSEIYGKASNGK
VYALNGSAKGVSYHDPSVSKIKNFDTKTKALDYAKEYIIDVINLNP
>KALACAFP_02675 Arsenical-resistance protein Acr3
MQPKLKFLDRYLTLWIFLAMAIGVGLGFLFPGISKITDSLSVGTTNIPLAIGLILMMYPP
LAKVDYSLLPTAFKDKKVISISLLLNWVIGPVLMFVLAILFLRNEPNYMIGLILIGLARC
IAMVIVWNDLAKGNREYAALLVALNSIFQVFTYSFFVWLFINVLPGKLGLANFNVSVSMK
DVTESVLIYLGIPFLAGFLSRYFLVKLKGIEWYNRKFVPRISPITLYALLFTIVLMFSLK
GEKIVELPMDVIKVAIPLVVYFVIMFFVSFFINKSLKVPYDKNASIAFTATGNNFELAIA
VAIAVFGINSPQAFVGVIGPLVEVPVLILLVRASLWMKKRYY
>KALACAFP_02676 Phosphinothricin N-acetyltransferase
MEITAIVKEHYPNISRIYKEGIETGHATFETTVPEWEDWDKSKLKHSRLAAIVDDTVVGW
AALSPVSNRCVYEGVAEVSIYISNMHKGKGIGTALISKLIDDSEANGIWTLQSGMFPENE
ATVALHQRFDFRLVGYREKIGKLGNTWRDTIIMERRSKTIGIN
>KALACAFP_02677 hypothetical protein
MNQNILKTIESISIDTVSEERKTVLQPLTDYIQKKIDAGHTIRLNFICTHNSRRSHLSQI
WAQTMAYHFGITNVFCYSGGTEATAMFPKVAETLGTQGFTIQKLSEAENPVYAVKYAENE
APVICFSKEYSNEFNPRNKFGAIMTCNNADEGCPLVIGAEARFPITYDDPKASDNTPQQT
QVYTERSLQIATEMFYIFSQISK
>KALACAFP_02678 hypothetical protein
MKIALFSDIHANLPALEAFFEDIEKRNPDSIYCLGDLVGYNIWPNEVVNEIRKRKIPTIA
GNYDFGIGRMSNDCGCAYKTDSEKDNGNISISFTNAMMKNDERAYLRTLPAHIKVEFQLN
EDKLNLLLAHGSPRKINEYLFEDREEKSTLRIMEQADADIMCFGHTHKPYHRILNSGTED
LPYYRHAINIGSVGKPKDNDVRGGYVMLTINENSSVLSKDSIGVEFIRFDYDFEKAAKAV
EDSPLPNEYAENLRKGY
>KALACAFP_02679 hypothetical protein
MKLSEIKGILPTLENVEFQLENGTLVPEHFHLTEVGQINKKFIDCGGVIRDEKAVNFQLW
NADDYEHRLKPGKLLHIISLSEEKLGIEDAEIEVEYQSDTIGKYDLEFNGKVFILKSKRT
ACLAQDACGIPSEKQKKNLSELAGNQNTSCTPGGGCC
>KALACAFP_02680 HTH-type transcriptional repressor CzrA
MGATKTDHFTDHQNQIAVIAKALGHPARIAIIEHLLKVNTCITGDIVNELPLAQPTVSQH
LKELKNAGLIKGSIEGNSVCYCIDENTFDILREYFSKIIFTVTNQKCC
>KALACAFP_02681 Cyclopentanol dehydrogenase
MKTLKDKRVIILGGSSGLGLATAQAAAADGAEVIIVSSNQQRIDKALASLPENSKGFAVS
LDKEENIKSFFNNIGNFDHLIYTAGENISMSMVDDTDIEKSKDFFTIRFWGAFAAIKYGR
PYINDGGSINLMSGNFGQRPAAGYSLGATICGAMDAFTRAMAVELAPIRINNIAAGVIDT
DLWGNLSKDDKENFFGHLEKTLLLKRVGQPMDVAEAFVFLMKQEYITGQSLVIDGGAVLV
>KALACAFP_02682 hypothetical protein
MEYSKINNPKVLAALLDWQKGDSAKWLSHFSKNATLLDDGHPRDFIKFSTEAIGKEHFIS
IDKVENNSMDIYGKFHSDTWGDFKTYFKFRIGEDGKFDQLMIGQAHY
>KALACAFP_02683 Enoyl-[acyl-carrier-protein] reductase [NADPH] FabL
MNTLENKVALITGSGRGLGKAIAERYAALGANIVLNYSKDKSSTDQVESNINAMGVKVIS
IQADVSKVEDIKRLFEEAKKAFGKIDIVVANAGIEMVETPVTEFTEEQFDRLFSINTKGA
YFTMQQAALTIEDNGRIIYIASSTTAFPVPGMAVYGGSKTTPRYLVDVLSKEIGHRGVTV
NSIIPFAVDHSGIFTEEGSYPDLRKSLLESCPMGRLAEVEDVANAAEFFASGLSSFVNGQ
HLLVNGGANQ
>KALACAFP_02684 Arabinose operon regulatory protein
MANSERIESNSLFQLYQALNLSVELFDLAEGFTVFNLNEIGFELPYVSDSFRPNFFSFLF
VKNGNGKYTIDEQTFEVEPHSIYFTNPSNYRTFSWNKIDDVLLITFDETFLKKYIGEEVY
TDFPFLLTEIVRPKVVTDTFFREVEAVNSLILDEYRKNTIYKYRVIGHLLAVLLFKIKEH
IWTDYNPIYEGNRSSQIIISFKRILERHYRDLSSGKIDVVFRVQDYATALNLHPNYLSSV
IKSKTGKNITAWIAEKTLTEAKSLLQNDDIPIKEITYKLGFTETAHFSNFFKKYEGMSPI
SYRKSHHP
>KALACAFP_02685 General stress protein 14
MKKILIIITHPDMDNSVINKRWLTELEKYPEKFHVHQLHKVYPDQKFDIAAEQKLIEEHD
HIIFQFPYYWYYAPALLKKWLDEVLTHGWAYGSSSGFKFGGKKVALAISLGLKEEHLQRG
TPLKFNLEDLTHPYEALFDWIKADYQPYFAYYGMTFEPSEEWVERSVPLYLDFLDRFNSD
KKDTNVA
>KALACAFP_02686 Exoenzyme S synthesis regulatory protein ExsA
MNNLNCSKIIKENPRVLSWNKDIQVMHYQTHQEIIRANMCVHMNMISIVMHGTKEILGCG
MKRIVPSGSGFFMKKGSYLVSDKIEDEEKGYESIIIFFSDAWLQSQIDTIFDCKNTAETK
VEDCLNADIALLEEDELMNSVIAQFKSYFEVNQDKERLQVLLPFKMRELFQILISAPNGY
HFEKRLRSLDNHQNPDLVILMENNYKENISLEQYAFLANCSLSTFKRKFVQTFKTNPGRW
IMQRRLEESYELLKNSEKNITEIAYEVGFETPAHFIASFKQKYRNTPKQLQQQL
>KALACAFP_02687 hypothetical protein
MKLYYFADPMCSWCYGFSPVVKKLKENYPNIDLQIISGGFAPGSKQKVTKEYKDFLEYHW
RNVNLRSGQYFDHSMKFVNENFHYDTEPSSRALVVVQMFLPEKDFEFLSLMQKSFYVEGK
DITNDEVLADLAEEIGVEKSVFLESFHSEEIKLKTAQGFQFSKQLRVQGFPTLLTLENGA
VKVLTHGFQPYESLKNIVEESLKTMLIPESNSGQFCSDISCGC
>KALACAFP_02688 putative Nudix hydrolase NudL
MKKQSFSSSIKKLQENLQKALPGKKAHRIMEAVSAKYLGLNPTEETRKSAVLMLLYPIDN
EIHFPLILRNSYEGFHSDEVGFPGGRFEISDENLIQTALRETQEEIGINPGEIQVLGTLT
DIFIGPSDFNVLPVVGYLPYRPDFVPDSREVQQIFDLKLDYFSDPNIVGCSEISIPGDLV
ITPYYEVNGHKVWGATAKIILELLYVLNNSLSTKKD
>KALACAFP_02689 NADH oxidase
MSVSDLFKPLTLLHGPAMRNRFMLAPLTNQQSEFNGKASEYDQFWMQQLSQGGYSLIQTC
ATHVEAEGIAFARQLGIFSDDHLPGLSQMAATIREGGALSAVQLHHAGHRANPLLGGIPS
PASSFTIPGVNAISTEEVERIRDSFIAAAKRAERAGFDGVAVHGAFGWILSEFMSPYLND
RTDKYGGSLENRARLTIEVIEGIRKACGPDFQIGWRLSIERYGLVLEELREITAEILDKE
LIDYLDLALWDSAQIVQEGKFRGKTMLSVFTELPRKGVRLGVAGKIMTAQRAGELLDEGS
DFVLIARAGILQRDFPLQVKANPFYESPKTPVPAEYLRQRGLSERFINHLRGWQTFVTRG
SI
>KALACAFP_02690 HTH-type transcriptional regulator BetI
MGSKERIQRFKDDSREKILAAALNIAKNEGWQALSMRKIADQIEYTAPFIYEYFVNKEAI
LFALTKRGYAILTKVIIEARNKNENADDKLEAMWIAYWDFAFTHKELYRLMYGVDMVCFT
SECAMPEVENLYDILSDVITIYFDEKNVSEERVRIKYYTYWSMIHGLISINLIHLNGRIS
YDLNRQILRDAIQSITKSIKK
>KALACAFP_02691 Multidrug export protein AcrE
MNAIHHFSPSDIIKKFNSARHFLIVVFTAAILVSCENKSEKTTADAPPNVPVGSVSESSE
TTFVEYPASVQGSVDVEIRPQVSGYIQRVLVNEGAYVSAGQTLFQINSQPFVEALNNAKA
NLHASEAAILNAKLEIDKLTPLVQNKVVADFQLKTAKTAYKIAQANAEQARASVASAQIN
LGYTNVKAPVSGYIGLIPKKQGSLVSPADQEALTQLSDIRDVHVYFALAEKDFTVFNTNY
EGKTPAERIKNLPFVELVLSDNSVYPIKGKVDMINGQFDKNTGAITFRASFPNPNGNLRS
GNTGKLRLGLNHNNAILVPQSATVEMQDKVFVFLVDKSNKVTKTPLDVIGKSGTNYLIKQ
GLNQGDQIVLSGLDRLQEGQVINPQKTARIAQLNNKK
>KALACAFP_02692 Efflux pump membrane transporter BepE
MFKIFIKRPVLATVISVIMVIMGVISLIKLPVQQFPDIAPPSVMVSALYPGANAETVLRS
VAPSLEESINGVEDMTYMSSTASNDGTLSISVYFKLGTDPDQAAINVQNRVSQALSRLPA
EVVQQGITTSKQHVTFMMGIGLYTEDESKYDQTFVGNYAEINILPELKRIPGVGSASLYG
GQKDYSMRVWLNPSKMSSYKVSTSEVMKAIQDKSLEAAPGKFGQHSKEVFEYVIKYKGKL
TKPDQYENIVIRSNSDGSVLRLKDVAKVELGSFSYNSLTRLSGKKGVVLGILQLSGANSN
ETQIAIKEAMDKASKSFPKGIKHEIFFSTKRALDQSIDQVKSTLIEAFILVFIVVYLFLQ
DFRSTLIPAIAVPVALLGTFFFMQLFGFSINLLTLFALILAIGIVVDDAIVVVEAVHAKM
EHENLKPKKATHAAMHEISGAIISITLVMAAVFLPVGSMEGSTGLFYRQFAFTMAIAIVI
SAINALTLSPALAALFLKGVHPVQNEEHKALAKKSFKEKFFIGFNSSFNALTKRYVGGLK
FLIRHKWLSLGGLALISLATVLMVRSIPSGFIPTEDQNFVAIAVNTPSGTTLDGTQKVMK
VAETKMKALEATRFVTAISGFDALTNSMSPSKGIIYVQLKANKERGDFKNIDKLMDEIRS
QLGTINGGNFFVFSFPTVPGFSNVEALDIVLQDKSGGNLDKFSGISQEFIKELIKRPEIE
VAFTSFNADYPQLQLDIDDDKADQLGVSVKDILETMQVYFGSAQASDFNRFGKYYRVVVQ
ADVQDRADPSAIDRVFVKNKNGEMVPINTLVKLSRIYGSETVSRYNMFNSISVNAIPKAG
YSSGAAINAVKEVVEKQLPTGYSYEFSGQTREEIASGGQSTIIFILCMVFVYFLLAAQYE
SYILPLAVMLSIPVGVFGVFAAIGLTGIANSIYIQVALVMLIGLLAKNAILIVEFAVQKR
KAGKSLTEAAIEAAKLRLRPIIMTSLAFVVGLIPMMYATGPSAQGNHSISIGAAGGMISG
VVLGLLIIPVLFVVFRFLQEKLSQNSQEDEYDDVVEEPVK
>KALACAFP_02693 Outer membrane protein OprM
MCAFLVGCTVSKDISLPDVAPNSFRTDAVEQDSVNIGSVPFKDFIKDETVQNLIDTALIK
NYDMQIALKNIDAAELLYKQSKLGNLPEVKAMVSASSNRPSDNSMNGFTLSQFMGTNHIE
DYNAGVSVLWEADIWGKIRNRKAGALASFLQTEEAKKAIQTRLVANIAQGYYNLLMLDEQ
LEIAKKNLELNENTLKIVNLQFNSGQVTSLAVQQTQAQKLNAEKLIPKLEQQITLQENAL
SVLIGTLPKAINRKSSLDRMIIPENLNTGFPSQMLSFRPDIKSAEFALNVANAKVGIATA
NLYPSLTISASGGINSFKASNWFNIPASLFGMVAGGITQPIFQRGELKTNVELAKIDREK
VVIHFRQSVLNAVGEVSDELVKIEKLKEEYSIAEKRVQTLQQASKNADLLFKSGMANYLE
VITAQGNLLQGELDLVNIKTLQLNAVVGLYRSLGGGWK
>KALACAFP_02694 tRNA-specific adenosine deaminase
MNNYNQYMLECIELAKQALEKGNPPVGSVLVFEDKIIGRGIESGKSSGDITQHAEILAVK
DALKNGYREILDKSVMYSTHEPCIMCSYLIRHHKIAKLVFGVSVPFVGGQSSEFKILETE
NVPKWGNKPEIESGILQNECEILNEKFTEYLSKQK
>KALACAFP_02695 HTH-type transcriptional activator Btr
MLSQSVYTLVNEQNGNLAFKLFEFDNNSYFDHIQRNNYFTLILITSGEGTATVDLCDYSF
KENTLFAFYPYQPFMLQSAKPIMGISIQFHHDFFCIYRHHKEIAANGILFNNVYQQPFIV
LNEFSKNSILNLINGITNELKNDAFRKDEVLISYLKILLVTATRIKLEQQTIQNSETVNI
KQQFIIQNLKNAIEDHFRTKHSASDYADLLNQTPASLARITKNHFNKTLSDLITERIIVE
AKRELYLTDKTIKEIAYELGYEDEYYFSRLFKNKTDISPQIYRNTIGFNRGAES
>KALACAFP_02696 hypothetical protein
MKIIHSLAGYIPTSLQCKLNFYTMKKTAIIILSDPKSGSEEALGRVFNALASAYEFKHAG
EDVKIIFQGTGIRWPEQLEKADHPVHGLYNEVKDYVHGLSKGCVAVFGTEVSGYELLNEN
EVPGTPGLPSFINLRNDGYDILIF
>KALACAFP_02697 NADPH dehydrogenase
MSVSDLFKPLTFLHGPVMRNRFMMAPLTSQQSDFDGTASKYDQFWMEQLAQSGYGLIQTS
ASTVEAGAIAFERQLGIHSDKHLPGLTKMATAIREGGALSAVQLHHAGHRAVPSLGGIPA
PASSKTLKDIKAISTEEVERIRDSFIEAAKRAQLAGFDGVSVHGAFGWILSEFLSPNLND
RKDKYGGSVENRARFTIEVIEGIRKACGNNFQIGWRLSIERYGLRLEELREITAKIFDKE
LIDYLDLALWDSAQLVREGAFQGKTMLSVFTELPRKGVRLGAAGKIMSAQRAGELLDEGC
DFVLIARAGILQRDFPLQVKANPMYDSPKLPVTADFLREGGLSERFIETMRGWQTFVKPG
S
>KALACAFP_02698 Acetyl-CoA acetyltransferase
MNEVFIVSAKRTPVGGFLGNLAEFSATQLGALAIKNAYESISLDPEWISSVYMGNVLSAG
LGQSPARQAAVFSQIPYDKDATTINKVCSSGIKATILGAQQIQTGLDEIVVTGGMESMSN
VPHYAFLRKALKLGDAQLIDGLTKDGLWDVYNDFHMGSAGELGVKKYGLTREELDNYALE
SYRKAREATEKGKFRNELIEISISSKKEKIIIDRDEDIYKLIPEKVSQLKPVFESDGSLT
AANSSNLNDGAAALILASADAIKKYNLQPLAKIVSYADAAQAPEWFTTSPSVAITKALRL
ANLNLSEIDYVEINEAYASVVLSNQQILGLDPEKINLYGGAVALGHPIGASGARIIVTLL
SILEQEKGKYGVASICNGGGGASAIVIQNLNI
>KALACAFP_02699 hypothetical protein
MNDLLKFAIEGHGGLENWNKFNKVSAHINVEGLTWERKQQPGILKDANVQVDLKQQKVSF
VSVKEEWETIFEPHLVYTKATHGEILEELSNPRESFEKYTRDTPWSRLQAFYFAGYAMWT
YFNAPFCFNDPEYEVTEIEPWEEDGETYRRLQVIFPEHVATHSRVQTFYIDKNGLIKRHD
YNVEISGNAAGAHYLYEYQTVQGIQFPTKRRVFIRQEDNTSLQPEPILVSINFSNISLT
>KALACAFP_02700 6-phosphogluconate dehydrogenase, NADP(+)-dependent, decarboxylating
MEKYNYGVIGLGVMGRNLLYNIADNGFSTVGFDLDEEKVKELHNGATPGTSVRGTASLED
FVSALESPRKIILMVPAGKPVDAVLESITPLLNPEDIVIDAGNSYFKDTERRIADLAAKN
LHFMGMGVSGGEQGARRGPSIMPGGDWEAFNLVKPMLELISAKVNDEPCTAYMGKGSAGH
YVKMVHNGIEYAIMQLITEAYDLLRKGANLNNDQLYEVFKKWNEGEMNSFLIEITRDIFL
QKDDFTGGFLVDQILDKAGAKGTGKWTSEQAMEIGVSIPTIDIAVTSRILSAYKDERVKA
SQLYAKGEMKRPENIELFIKEVGDSLYLATLISYAQGLALLVKASTEYQFEIPLKDVVKI
WRGGCIIRSVLLEKFYMAYSKDHKLSNILLDQKISEIVKDKISSLRKTASFAASNGIPSL
GIQTALGYFEAYTTESLPVNLLQAQRDYFGAHTYQRIDREGIFHSSWQNLNN
>KALACAFP_02701 Glucose-6-phosphate 1-dehydrogenase
MGDNTILHPTTVVIFGATGDLAKRKLFPAFYNLYVDGRMPKGFNILALGRAENTDEKFRA
YIKENLESFSRRSVTPEDWAGFQAHISYFQHQLDEEKSYQNLYQKLESFDKVYGMRGNRL
FYLSIAPNFVSVISNHIKNTSIASDPAKDRIIIEKPFGHNKESAIELNNLLSQTFQEEQI
YRIDHYLGKETVQNILAFRFGNSIFEPLWNHRHIESVQVTVAEEVGVETRAGFYEQTGAL
RDMIQNHLLQILCMVAMEPPVSLESGEIRDRKVDVLKSIRKISPDKVDHYAVRGQYGRGK
VKGLKVNGYRQEEGIAPDSNTETFVAIKFYLDNERWENVPFYVRTGKKMKEKHSYITIQF
KPLPHSTFSETTSLLSANRLIINIQPQMDIRLQFMSKKPGLSLELKPVEMIFDNFACHTD
TPEAYETLLLEALVGDLTLFMRSDQVEEAWDVVKTIQETWEETKDSSFPNYEAGSWGPDD
SNALLERQGHQWI
>KALACAFP_02702 6-phosphogluconolactonase
MDITIFNDLDVLYKNAADLFVELSEKAIQKHGRFVVALSGGSSPKAIFSLLATPEYVEKI
EWSKFYFFWVDERWVSLDDEKSNFKMTLETLLDKIPVSENQVFPMYKDGIEPENYAKVYE
EQIRNVLGENGIFDFILLGMGDDGHTASLFPGEKVLEEKEKWVDAYYLKPQEMYRITLTE
PIINKAENILIVTFGKSKKHALNEVLNGKYNPQLYPLQLIEKRNGVKIFTDEEAGV
>KALACAFP_02703 hypothetical protein
MQKLFFKTAVTAAVLCLSSMALAQQKYSVSGTVKDHKNGELLIGVTIKVSEDPSISVIAN
EYGFYSLSLPAGSYTLIVSYPGYRDFELPVKVEQNTKLDLPLDQEEKEDEKVGKIDEVVI
SGIKKDKNLTSAQMGTETLSIKNIEKLPVLFGEKDVMKTIQLLPGIKSNGEGSSGFSVRG
GATDQNLILLDEAPVYNASHLLGFFSTFNSDALKDASIIKGNSPAQYGGRLSSVMDVKMK
DGNNKDYNVNGGIGLISSRLSVEGPIQKEKSSFIVSGRRTYADLFLKASDDYKDSKLYFY
DLNLKANYQINENNRLYLSGYFGRDVLGLGDTFSTDWGNTTATLRWNSIISSKLFSNTSL
IYSNYNYKLSLKSNDNTFGLDSQIEDWNLKQDFTWFAGNKHSVRFGLQSIHHTITPSSAS
GTSVSSFPRNPRKSWENAVYINDDFKATDKLTVNYGLRLSTFSILGGDTYNTYDNGVITD
SRFLEKGKFGKTYFNLEPRITANYRINEVSSIKAGYSRNTQNLHLLSNSSSGNPTDQWIG
SSYSVKPEIADQISAGYSRNFNNNNYELNAEIYYKSMQNQIDFKNGAQITFDTAADVESE
LLYGKGRAYGLELIAKKKSGRLTGWISYTLSKTERKINGINDNDWYNARMDKTHDLSIVA
TYELNKKWSLSGLFLYSTGNAVTFPTGKYELNGQTIFQYSSRNADRMPAYHRMDLSATYE
PESTKRFKGSWSFGIYNIYGRENAYTITFEDNPNNPGTTRAMQTSLFRWVPNITYNFKF
>KALACAFP_02704 hypothetical protein
MKNIIFIILSLFLLTSCEKEIDLDLDDKSGNIVIEGNITNQPGPYIVRITKSVAFTQNNQ
YPAVADAQVVVSDNTGQTETLQYVGDGKYITTAFTGVTGRTYTLKIQAEGKQYTAQSTMP
EVVNFDGLTQDSFTFGSETTYTLLPVFTDPAVLGNRYLFNFTINNMTKKTFEVFSDNVNN
GMVNQRPLFLPNEDNDDDPTDHKVVPGDTVYVEMQSIDHNIFTYYSALLQISEDGGPGGG
VTPSNPPSNIDNGALGYFSAHTVQKRSIIIQ
>KALACAFP_02705 hypothetical protein
MENFLLLYSHCIIVNGASRAIICDLQRGSIYPIPLVFASLFKDERYIDIVKTMEELDDEG
REILKEYFDFLEEKELAFYCSQQELNCFPKMSNEWLFPAHISHCVLDGQSSLSYFDEDFL
KQLEILCCNFIQFRFFREADWDELHRILALINNSQIKSIEIIVPYKTTDTEFYKKVEDFV
EQNGKISNLTITGAAKTHIYKEGMHGMGYILQTKTLVDSQSHCGIVDSSLFSINIPTFTE
SLHYNSCLNRKISIDINGNIKNCPSMPQTFGNVKNTNLEHALQHQDFKKYWDLSKDKIEI
CKDCEFRYICTDCRAYTERTHTKDGMDVSKPLKCGYNPYTCQWEDWVTDAQKEKTIKYYE
ILNPLNGFV
>KALACAFP_02706 hypothetical protein
MTEEDKIKEKIKTWIEENRDKLPLNIDSWNIQVFKREKTSRPKTISLGKYNAEIIRSDPF
YKPYSKTSIL
>KALACAFP_02707 hypothetical protein
MYLIQSNSDDKSTNDIIDWILFLNENRNDLFRLNDTIIVDNFTYQLSYKNGEHFNINNNL
ETLKIKSFWYRRGRFSYNDSILKTNNLLSQQLMNGIQSNFHRENKHINNCLYHILRKKGN
INTFNDNFTNKIANLSAAMEIGLNIPDVLVTNNTADLINFSLIHEKIITKDIEMNAIKAS
YNENYNIVIEPSVKILRREDILPKNKKTKGTFSLYQQYIEKKYELRIFYLKGKFYPMAIF
SQASEKTKIDFRNYDKERPNRCVPYKLPQEIEQKLICFMQSIDMNSGSIDMIYTPEGEYV
FLEVNPVGQFQWLSKSCNYDIEREIALDLINETND
>KALACAFP_02708 hypothetical protein
MKLESLKSSKFEAMSNEKMGMIKGGFISATNSRDVNTGAPVPDRQEITEVKNIHGVVTGY
IYGCTEYQINGVWLSPIAH
>KALACAFP_02709 hypothetical protein
MKLESLTSEKLEPLTNNQMSKIRGAGNVATNSGIFMNNGHPEFSSHDVNVYNDSTGQLLT
QVFWGEDGTKHVISVTLGK
>KALACAFP_02710 hypothetical protein
MAVRKEQKPNLNNMKLESLKSSKFEAMTNSQMSMIKGGYTERTGSGSLIGLPGGGIRTAS
SDTLIWDDNGKGLQHVSFVDSETGLQMSYYA
>KALACAFP_02711 Sensory transduction protein LytR
MKTKIQACIIDDEKDGRDYISLLLQNEFPEIQIAFQAASVEDAYIYLTKNSPDILFLDIQ
LKDGNAFDLLSKFKEIQSEIIFITAFENFAIQAIKNGATDYLLKPIKKIDFVTAVNKALN
NIKKTKNLVNNPGQNKIALPTAQGFTLIDIADIVHCEADSNYTIFHLNNKTKILISKTLS
EFEKHLLEYNFFRIHHKHLINLSHLKEYIKGKGGQVMMTDNSVLEVSVRKKNDFLLRIEY
RD
>KALACAFP_02712 Sensor histidine kinase YehU
MKNVYHFAVFIFIIFFQSLFFAQIPGMINYNQEDGLNCTVTYRLIQDEQGFLWIGSDNGF
FRFDGIEFKNYNAKQGLKNIEVLGVLTLKNKILIIPFLNNIAYLEKGAIYNTDTDPELRK
IKTGTGGFEAYYNKQRDESFILNTTDLSCIYKYKNGKVQTIPLYINPDKNRFSLIDFDTN
SFELLLSDQNNNIFSYNILKKKKHVFIIKLEKKEWLVQLKNNILISINKNGNKIFLYRRK
GDTFNKIHTLELEKEHDIHDIHIDDNERLLVSLNSGGILFFNQPITNFSPSKKPYLFLQD
YVINDILIDKDKNIWFSSRDNGIFFISKNFFANYINYFSEIKNSANITSIAANSNSVFLG
YNVSKAAIYSPNKKYTEFVLDHSQKNEHRAIFANDKTVLFGQTQRVSQMNLSNFKSFTPK
SLQTFNIKNIVPYLDNEVLICNSSNVSRYNYQLKKIVDTLFNERSYTALSYQPDSLFVGS
FKDLYKVNVKNKQKKLFLEGYYFTDLKKLKDNLYAGATNLHGIVIFNNHKILKQITQADG
LVTNQIKKIDIEKPNILWASTNTGLIRIELTKNKPKINLFTQTDGLPSDKVAGCVIKKDT
LYIGTSKGLGILSIKELLTQQKFINKKVIINSVIIGAREYFDISNNLTTESPHNDIIFNL
SFPDFTSQGKISYKYKMEGLNDNWNISNSSKIIYNSLPPGKYIFKVFGLGHGGKQSYTYA
SMPIEIKPRFWQTWWFKAAAALLMILPIVIVINITLHKQRDKKLKKIIHEKKIAELELQA
IKAQINPHFIYNCLNSIQFLLYKKDYNETENYLDIFSQMIRKTLHYSEKTFMSVQEETEY
LSLYLNMEKLRLKDQLEYTITVSERVNPEWQIPSLLVQPFVENAIKHGISGLKDRKGKID
IAFDYSDSTLSIAIEDNGVGIQNKQETMAKNNSFGVKLSQKRIDTFKQLFDTNVVLEINS
LSEKTYGTQIKLYISPYENKNTGLHH
>KALACAFP_02713 Exoenzyme S synthesis regulatory protein ExsA
MESPAEILPGVIFYSYLSSERKEKACVWNHHTLVLQVSGQMVLETSDQNISISAGDVLLV
HKNQLGTLTKTPGPNGHYETIVISLQEDLMRQIALEDKMEVHGKYTGPPNLCLPNNAFLT
GYFQSIVPYARSSGTEMTDELGLLKVKEGIKLILIAVPELHNFLFDFSEPYKIDLERFML
SNYHFNVPVEKLAQLTGRSLSGFKRDFQKIFGMPPRKWLQDKRLNEARHLLESKNKKPSS
IYLDLGFESLSHFSYAFKKKFGRAPTEGLVNTD
>KALACAFP_02714 General stress protein 69
MSEISKIQLGQNGPMVSKLGLGCMRMSSVWGGPTPDETESIATIHQALDSGINFLNTGDF
YGAGHNEMLIGKALKGRRDEAFISVKFGAIFHNGQWIGLDLRPVAIKNFVNYSLTRLGIE
TIDLYQPCRMDDSVPIEDIIGTIAGLVEEGKVRHIGVSEITADQLRKANSVYPISALEIG
YSLADRQIENDLLPAAKELGISVVAFTNTAEGLLTGDLQAPLPVDDYRNHFSRFQGDNLI
HNLEKVAVLKEMAHVKNVTPTQLAIAWVKEQGDHIMPLVSMSRRSRLPENIPAMEIVFTP
DEMNILNTTFAIGAIKGGTYLQR
>KALACAFP_02715 putative HTH-type transcriptional regulator YybR
MKNKIAPAEIDQQCGVDYAFKRIGGKYKGRILWHLNSKEVLRYGELRRTLPDITTKMLTQ
TLRELEDDRLITRKVYHEVPPKVEYALSETGMELIPFIKHLHHWGNKQLAKEVISCEK
>KALACAFP_02716 2-haloacrylate reductase
MQQSDKNKSHFGKDKIMKAVRQHEFGGPEVLIYEDAPVPELNKGEVRVKVKAIGLNPPDW
YLRDGYKMLPPEWQPKVPFPIILGTDISGVIESVADDVKEFSVGDEVYSMVRFPSYGPSQ
AYAEYVNVPVSELAVKPAGVDHIHAAGAPMSLLTAWQFMIEVGHDEQNPLQPNKHMPVPL
EGKTVLINGAGGGVGHFAVQIAKWKGARVIAVASGRQEELVRELGADEFIDYTKTNADEI
LKDIDLVIDAVGGPKTGRFLKTLKSGGSLFPIFPLGFSDRDEAERLGVSVSATQVRSNGK
QLSELATLLDQGIIRVVIDSTFPLAEARQSHERAARGHIQGKIVLTVDQ
>KALACAFP_02717 hypothetical protein
MKKTLTEDKIQLKELIDQVSILGDQKDFNNQVQLFTENALSETRAEGKVIMELKGRDVMA
KAFAEFLKDVETVYHFNGQSLFTIKGDEATGTCYCLITLISNQKDKKIRTTIGAVYNDHY
VLHDHQWLIDKRIGDFLWQEKCEIHSSEL
>KALACAFP_02718 hypothetical protein
MNKQSKSKKTVNILKVIFQVLLFFILGWAGMMKFFNSDDLPFPWIKDHPQLVLITGVFDI
LGSIGIVLSPIFGLKSKITVLSSIGIIFLMLSAIVFHVLRHETGDITFNLLMMAMAGFII
WAETKNN
>KALACAFP_02719 putative HTH-type transcriptional regulator YtcD
MLSNGGCPKTMLSIQDALEAVEGRWKLLILFSLSEKPKRFKEISREVRGITDKTLSKELK
SLEANKLLRREVFSTFPPRVEYSITEHGLSLGKVLDELHFWGLLHRSIVLNDN
>KALACAFP_02720 hypothetical protein
MICFLSAYKSFSTYIVFALVNLLFFLIKTHTDKINPFPQTENTFSHVQEIINQNLFLMVF
HT
>KALACAFP_02721 hypothetical protein
MLDIFKKHITKFAQVSDDEFEEIKKFFDTKEVAKKENLLEEGQICRHYYFVLSGLLRKFY
INEKGTEQTTEFAIETWWLTDNFAYENQVRTEFYIQAVEKSIVLYITQDKQEKLLKEFPV
MERYFRFIYQRAYAAAQKRIKFLFSFSKEEFYFQAVRNHPEFVQRVPQYLIASYLGFTPE
YLSEIRKRLLS
>KALACAFP_02722 Alkyl hydroperoxide reductase AhpD
MQKRFNIKEVSPNALKAMVGLEIYLSQASISKTTKELIKIRASQINGCAYCINTHTQDAI
KNGETSQRIFLLNVWRETEDIFTEEEKVVLAITEEITLIHQNGLSDETYSNALQFFSETQ
IADIITAVITINLWNRVVLSTHLLIGQSLA
>KALACAFP_02723 hypothetical protein
MKKYCNLIIVSLLLSSLSYAQVGVGTEMPSAGLDVVSKGNTNATKALEINNSANTEMVTV
LDNGNMGIGNVAPTRKLDINNGTTAGAIKIVDGTQGAGRVLTSDANGVGTWSPTPATSLY
FLSSNIYAGTTEPSDFTGTVNPVAGASVPNTTAARFLVNPSSAVLNLGPPTTYTTGSTGL
SYRIPVSGMYRITLYVDSGYPATGTPGSNGGRIDVTAYRGTVIYKYNRDFVTSNNAGTMI
NIWQLEAGDVVVPISVGIPAPGTSQFVETTFTVERVN
>KALACAFP_02724 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MTTQKNKSDLMGKIALVTGGTKGIGLAIANRLAESGAKVIVTARHQPKENLEHYFIASDL
TKAEDVSRLTEQITEKFGTVDILIDNIGGLTTPGGGFSALTDKHWEDEIQFNLLAAIRLD
RAILPKMIDQKSGVIIHISTGSSKLPIWDINMAYAVSKAALNSYSKALSTEVARHGIRVL
TVLPGAVKTPMMVEFVEGIAKSAGISVEEATTGLFSKIGGVPLERMGEPEEIAELVNFLA
SPAASYMTGSTYAVDGGSTPTV
>KALACAFP_02725 HTH-type transcriptional repressor ComR
MKRLFQIFLYLCFRKLLMARNIEFNEEVAIQKAMNVFWEKGYYATSMRDLTDAMKINSSS
LYNTIGDKHQLFLKCIDHYIEVKKKNLTERIIEGKSPLRILEDFLHDSVTAIANDSNPCM
VVKTAFEVAQKDKTVQLLLQKDTTFTHSFLVDLIEKAVASKEMNIHTTPAILADFLISSF
SGWYEMYLINKDPQQIKSIAGYIIKQILK
>KALACAFP_02727 hypothetical protein
MKSRILLLFAFCALISCKREPKNSSAESISISNLVEYKEQNGVLHLKSGNFNYNFKQNQV
PFKKIILLNASMAGYISALGAENLVVGVSSPEYIYSEKIQSLLKEGKIQNVGNEQKYDVE
KIISLQPDAIFTNHIASFDNTYQLLKNNGIQVIFLDEYMEQKPLEKTAYIKLFGKLFGKE
KEAETQYLEVEKNYNALKQLALQAKEKPTVLASEMYGDIWYLPGGKTSVAHFISDANAHY
ILKGNAEEKAVTMSFEEVFAKSDAVQYWVNAGNHVSKKEMLVMNPFYAKLNVFNKGKIYV
ITGRERAKANDFFESGIIRSDLVLKDYIKIFHPELLPDYQLTYMKELQ
>KALACAFP_02728 Biosynthetic peptidoglycan transglycosylase
MWKRIKQIIFILLILNVVFIIWGRFFNPPITITQIGGLFEYGRLQRDYISYDEMGDKVKK
AVIVSEDQKFFSHNGFDYTAIEKAMKHNEKGKKIRGGSTISQQTAKNVFLWQGRSWLRKG
LEAIYTFIIEKVWSKDIILERYLNSIEMGQGVFGVEAASQYYFGKSAKNLTTSEAAWIAA
ILPNPKKYDPKNPSAYLRKKHNWIMRQMRNVSLK
>KALACAFP_02729 hypothetical protein
MKLFTSSTNFDSVLKKYFSFRNETLSLEPFAEFMDSVKRADFKDVLLFFQNNKELTENFK
YYLHHIFLGRSFNLSLTEANVLSENAFVPELKKRILNKILPPVVNEKTVWYMIDNVSVRP
RKDLEYLHNLPENEIDELFKILGISDFIINPNIKKEMIFSMNILSWRVTGAAMEVEVVRM
APEYRNFDNPFLALQNELEDLADELERNPDLQLDSKNSRYKQIKIYVEQCLEFVNISFKN
SSKYGISGKINQSLLKIRQQIQRIYEIVQLLVIDREEDILTNSKNLVFNILNYKSHKNNI
SDLINDSTRLISHLITNHTAETGAHYITSTRKEYMRMFYKASGGGIIVGALCVLKMLYGY
VPGSDFSHAFLYSMNYAMGFIMIYLMGFTLATKQPAMTAATMTKVLADEGNNKSNHTEFA
HLVSKLFRSQFIAFIGNVLLAFPVALLIIYGLDVFFSENLAVERSDKLLKDLNPFESKAI
LHASIAGFYLFISGIISGNIGNNSVFYQIPERIAKNLSIRRFFGKKFAKGLSKYYAKNWP
GIISNFWFGVFLGATAPVGLFFGLDLDIRHITFAAGNFAIGLYGKDFSVDSYTFWLSFGT
VFLIGFFNFLVSFSLSMFLAFRSRKLNFGQVSEIYKEIFRYFIKHPFKFFFPLRSRLDKK
ADDLMSSTIPTKSEDH
>KALACAFP_02730 hypothetical protein
MKINLDFFTRTNKPESRNPKPGTQFMKKNKKREFQSSELVKSFARIHGFEHKLIAFEIKD
FLEEYLDESLFCEIKSVNIEEQTVIIKINSPLLKHDFQMRKSFFLKKFQDKFGAEKFNDL
QIL
>KALACAFP_02731 hypothetical protein
MQESGFEDEDFGVGISRFDNSNEEWTMNFRYNLDTYTTQMSYKNLDIYKISFNLFLKAHK
ASFLLPKYELFELGSQLRRSSDSVITNIVEGYGRSVYKNDYIRFLVFSHASNDETINHLD
KIIALYPEFSAEFGILKQEYDLLGGKINNYKKWVKENWIENKP
>KALACAFP_02732 DNA replication and repair protein RecF
MIIKKLSLYNFKNHSEKKFEFSPQINCFVGNNGVGKTNILDALHYLSVGKSFLGNTDINN
IKADEDFFTIDAEVQNEESEDIIKISQPKEAKKIIKKNDKNYDRLADHIGYLPSVMISPY
DSNLISDSGESRRKFLDSMISQTDSEYLFDLIQYQKTIQQRNALLKYFSKNRIWDKDSLD
IYDDPITRFGTKIFIKRRNFVEKLNPIVQNFYQIISGGKESVSVIYESHLFEDFDQNQPE
KKFYDLLKESLERDRMLTYTSKGIHKDDLLFEMDSVLIKKIGSQGQQKSFLISLKLAQMS
LIKELTKKTPILLLDDIFDKLDDHRVSQLIELVNQENFGQIFITDTHRERTESVVKKINE
ESIIFEV
>KALACAFP_02733 hypothetical protein
MNFLKILKKSVIDSQFYVSLMGTLFAVFFMEEQNTFRFPTVVLIFITYFSGYLYTKYQYT
RHFFKILILNVITGVISAVLIIHNHNEVRLIKWFIIVFLGLLYNSFFLEVYIRKIPFLKV
FYVGLIWALVNCWLTLPEFSFPIFFISFFFITALVLPFDIRDMKSDTVETFPKLVGVQNT
KYIAYLMVFVSNILSIFYLDLNYSIAFFLAGIITYILIYFSENEKNDAYFSFGVETCSAL
PFLFLLIMKYF
>KALACAFP_02734 hypothetical protein
MKRFSKIFVVLLLLLNFSAVFAQKYYDEQWKKVAENSQKGAYKSNLPIILDIQKQAMKEN
NTLQLIQSLKAEFSIVNQTRDDEENNSASQFFSKLQGVEKQLKGEEKIVYEVLLNGFFMD
YYNRNLWKINGRTNLNSQDVSQIETWSKLDFKNYLTQSFKELDQRKGEMKKVSLAKYQEL
FSNTKDISFFPTLADWYDLKKVDFLSNNGIFTKNELTENQKQINSIFDELIAQNSGNPKL
YFMHQKLQENCNFSQCKDKLDQLKNLVKSNVEGDYKVLIMEDVMNELTGKKKEKEALEIA
AQAKSQYPKSPFIENIKNKEEQIKLSSLNIKYEQQTQGNLPIHFVAEYKNLSEFSLNIYE
VKEDIKSFLQYSRNSYADIFGKVKKNLVRKETYQLSDPKDYQLHKTSLEIKPLPSGIYMV
EYLVNEGNNEKNQNFYFFVSNNKIIYQSKGDRKYSDNELKLVNSENGKPVINENITFYEF
VANTTLNKTDGKTNDKGVFKFPATSNKEYYRTFLIQQPKSNDFQIMQVYGDDYDTDYDLN
EKSRSKAQIFIDRAIYRPGQTVYFKVINTKINKEIESVNSGLKQKITLMDANGQEVSSQN
FTTNEFGSYHGSFILPKGKLNGMFVLKTDGEQEQYKNFRVEEYKRPKFEVTFEPIKSEYK
YGQTIELKGKAMMFSGVALSNTKVSYEIKKHNIRWKYFWWYPQDDDNENSILGETQTNEK
GEFVIRLELKKDEKLDGIQIDNYEINASVTDINGETQSADTQLKVASVSHYIKADEIKDA
FSDENVKVKVETKNYNEQNLKKPYQVKLSRLQAPDRIFRNNFKQAVQDLPKFSKEEFVSK
FPHDFYDKNDEIKNWKTSSVIVNGAQKSEESLDLGKLEAGDYQLELYNFEGKDTIKTAQY
FSVWDKNSLKPNQKTFLTALQPKNEFSRGERAKVYVYSAISDALVNVFVQDGSGKTISEV
QKFKNGVLEYMVDIPKDKAVTALNLQFQLVAYNDIQTETINVKIKNIEQPLKIETITFRD
KLEPNSKEKWSVKVLGSEKEKINAEVLANMYDMSLDQFAANNFTWENLYLPYSSITMYDV
RQNLLTEYYQKRIKYFDGNYVEVPQFNWFDRNGLMMLQGKAAGIKIRGVANPAPAAPVAM
ADSAVSQNLEEVVVTGYKAKKEMAVTNSNVADAEGGLDEDAQELEKVPVRQNLTETAFFY
PDLKTDSEGNVSFEFTSPEALTKWKLMFLAHTKDARAATLEKEVVTQKEFSVTPNYPRFL
REGDELNLQSKLSNLTSKKLNGSASLQILDAFTNEDISTKFGLNSATQNFDINENGNSAL
TWKLKVPNNVSSIILKVVAKAGNYSDGEQQAVAVLPNRMLVTDALPVFVKEGETKTFVLD
NLKNANSTTISNVANTLELTTNPIWEIMFALPSLKNDQNNSADVIFNKWFADVLASEIFK
ANPKMKTVFEEYQNKGLLNSNLEKNQELKQLLLEETPWVLESKNEQEQMAKLSLLFDTNT
MRNAMQSDWEDFRKLQNPDGGFSWYQGYPSSYSTSLYLLKNLGKINSWLKDNVKDYQSPG
QKELVKNLIQYVDNEVNKYWDVKKENVWTNWTLDYLDTRNYWEKEYPLKGKGATLKTLVK
QKAKTAKLTDFTFFGLHRAALLMSDYGLKDVSDKLMNYLKETSTDTKTQGVYWKQNLDDW
GWFSSKVVNQAGALEAFNKLKPNDQKFIEDMKIWLITQKEVNSWGSSRGTSEVIFTILNS
GKSWTSAESNKATIVWGGKELQPQTQATGYVKSTMKTDVVDKNLATVTVTKPGPGIVQGG
LFWQYYEDLDKIKSSENYISVTKELYKKIKTVNGEELQKISPETPLKIGDKVTVRMILNT
DRPMEFIHIKDMRAAGFEPVDVLSGYQWKNNLGYYQSTKDASTNFYIQSMPKGKYVFEYD
YIANASGKFSNGITTIQNYYAPQMNAHTKGSNVQIAE
>KALACAFP_02735 hypothetical protein
MENVFDAKDAQNYIDRINNLTPETHGLWGKMTVDQMLAHCNVSYEMVYEPEKHKKPGSIA
KFILKTFVKSKVVGDKAYPQNGPTAPQFIVSERKNFEEEKKRLIGFIQKTQQLGASAFDG
KESFSFGKLKAQEWNNMFAKHLNHHLAQFGV
>KALACAFP_02736 hypothetical protein
MKKILLFFILVSNFAFAQMPDISNVWLNSSKPYTGTIGNKNQEIKLKINISEQNKKNDQE
YFVSGYTLVDKNYTKFEGKLTITKYKDAKKKGTVYGEYELAEENKGKHSGLFKGKFIYTF
KWNKNTEKVEAQYIDLIGDWKSYDGTLDFKTRIKNQ
>KALACAFP_02737 hypothetical protein
MLRRILAVIAGIIVGSIGIWLIERVGHSLYPLPAGLKPTDMEGFKTYVENLPFMGKFIVI
LGYALGALLSGFVATKVANNNKPTAAIICGIIFMFFTIYNMVVLPTPAWFWVLGIAVWGL
VLAGYKLALNTNKA
>KALACAFP_02738 hypothetical protein
MKLGAFSVSLSVKDLQKSKDFYEKLGFSCMAGAMEHNYLIMKNGEHIIGLFQAMFDGNML
TFNPGWDQNAQNLETFDDVRVIQKHLKEQGIEVQKETDETSSGPAHIYLKDPDGNMILID
QHR
>KALACAFP_02739 hypothetical protein
MKILKWTIIVLASILIFWLVTAFFISGDCKYEKSITINAPVEKVWQNTNTLKAMDQWSPW
NDIDPNMKKDWTGTTGQPGEKVCWKSQKKEAGEGCQEVKKVDNAQKRIDTEIVFLTPYKS
EANAYVTVVPEGNGSKATWGFTSTIPYPFTVMKLFMNLEEAIGKDYQEGLTRLKNLSEKQ
>KALACAFP_02740 hypothetical protein
MASVNVYLTFNGNCREAFDFYKSVFGGEYPYIGTFGEMPPMEGQETKEEDKNKIMHVSLP
ISKETVLMGSDAGCDWTSQFKAGNNFSISINAESKEEAEKLFAGLSAGGMVTMPMADTFW
GAYFGMFTDKFGINWMVNYDDPAKMQQHP
>KALACAFP_02741 hypothetical protein
MKFTIEQIKTEHQKVKSGADFPRYIQALKDLGVSYYTSYISDNNIDYFDSQNQLTATTRG
KDEAVRSVSGIVNLDQFKSRLKLHQQGGTDYATFCHDCAENGIEGWNMDLNKMTCSYFDK
TGNEVLIEQVPTL
>KALACAFP_02742 hypothetical protein
MVRSFLAVMIFGLAVTATYAQKSDLGAWYMYFGNNKISKKLNFHNEIQYRNFDAGGDLEQ
LLIRTGIGYDLTENNNNILLGYGFILSKPYINGEKTENIEHRIFQQYITKQKFGRFNIQH
RYRLEERFLQDDFRMRFRYLLGFNIPINNKEMLPKTFYGSVYNEIFLHFDSPVFDRNRVY
GALGYVINKNMRIEAGYMNQIQENKNRGQIQIGFYNNISFTKND
>KALACAFP_02743 hypothetical protein
MHSGKKFGAGEFIFWTRRSIYGLLVLSAIPTILYYCGWTFLSFPWQPIAIMGTAVAFIVG
FKNNASYGRLWEARQIYGGIINDSRSFGYMLRDSLKNPDEVKDMFLRHYAWLTALRFQLR
EPRAWENMTTAQFDEYSKKYEIPERLSKLEDELKKYLSGDELQYILTKKNRATQLMAVQS
KVLSEAYAKGEIKDCQWMQVNQQLVKFTDNQGKAERIKNFPYPRNFSSITTYLLLLFIAF
VPFGLLKEFDKLGDGTMVEGFTLWFNIPFSLLVTWCFHTLDSVGEASVNPFEGSPNDVPI
TQISRTIEIDMRDMLDETNLPPVITAKNNIVL
>KALACAFP_02744 Sodium, potassium, lithium and rubidium/H(+) antiporter
MIHNYVIISIAVLLSVMILVMIGQKLRVAYPIFLVIAGLLISLIPGMPHIEIEPDLVFLI
FLPPILFEAAWFTSWQDFHKWRKQIFSMAFGLVFLTSMVVAYLSSSIIPGLTVAMGFLLG
GVNSPPDAVAATSVLKHMKIPKKITTILEGESLINDASSLIVFKFALAAVISGQFIFGEA
VKDFFSMAIGGIAVGVGSGLLFGTLLKIIPSNSNIDTIITLIVPYVMYVAAEHFHFSGVL
SVVTGGLLMSYNSHCYLSHTSRIQSGNVWSVLIFLMNTIIFILIGLELPVVVAAMKDYTI
TEGIFYSIVIGGAIIFTRILYSYALMYFPRFCSKEIRLKTPKPDWREPFIISFAAMRGVV
SLAAALSIPAFLPNGEAFPHRNIILFVTFVIILITLVGQGLLLTPILKLLKIDDAGSELP
EEKQEVILMRKLKETALQKLDSDFSELAQRNSLVQHQKHKLENEMMMMADKAQCMASTGD
YVTAMSENKDVMRQVIQAQRNELHRLKREKIFDDHVMRTIEMQLDFDEAKITGFSHG
>KALACAFP_02745 hypothetical protein
MSNPIIVEYKVNAPIERVWKALTDKTEMRSWYFDIPDFELETGKVFNFYEPGDEKKYHHQ
AEVVEIIPEQKLKHTWTYPEFSNEKTMVTWELQPQGNETLVKLTHDGIDNFSDLGENFSQ
NAFTEGWNGIIGQSLKPYLENKS
>KALACAFP_02746 hypothetical protein
MTKFTSLRPVLWTERLDETIGFYTQFLGFILQEKNDDWQWASLEKDGVQIMLSKPNEIEN
FNGIGFTGSFYFNVNNVDELWEDLKTKAKICYEIETFDWEMREFAIYDNNGYILQFGQHI
NEISKAE
>KALACAFP_02747 hypothetical protein
MKKNIIAGFAAVLLLASCKNDKKVLDSLADYNNSMEQKGYHFGDKLALPKEVTDDAASIT
ISFGDKETSNLTIDPKFFTLGDNAVTFNVKTKGGETLTQDATINVFAKNPEKNIAYQVVA
EYPHDPKNFVQGFQIEGNTIYESDGQNGSSQILKYTLGTTTPLASTKQAQEDFSEGSTIV
GDKVYQLTWQSKKGYIYDKNSLKLLKEFPYPNVLGEGWGLTYDGKDLIASDGSKLLYFLD
PNNPSKLVKYIAVAGSSQAYDQLNELEYHNGFIYANVWQKPIILKIDPANGEVVGTFDFT
DIAKQNTKGSDDVLNGIAFKGDNMLVTGKNWSKIYEVAIK
>KALACAFP_02748 hypothetical protein
MLADDYGNLYLYTNKNFSFTKYDSLGKQIGKMMLTVPYKVQSVQNPLSVPLFSENAQELK
FVDQNLNEIQRVDFKQKFGFIKMAYAEDLQQLWLLDDSTKRLIQYNFRNETTINSYPFDA
SFDDLMDLLVYENKVYILTRTYIRVYSLKFEKIFEAPIDKGKRFRRENEFILVITNNSIL
KYVPEKEMVKIFDDPDAQIVDKNTLSYFEIKANNVYLYNLETSKETQPKTDPQPEQKTTE
KEVEKVEEKTAEPDSPEGKLEKKTKEIENDNPAKSSLQNLIEDASEVQSAGVQ
>KALACAFP_02749 Deoxyadenosine/deoxycytidine kinase
MHIAVTGNIGAGKTTLTTMLAKHYGWDAQFEDVDHNPYLEDFYADMSKWSFALQIYFLGS
RFRQVKEIRESGKSIIQDRTIYEDAHIFAENLNDMGLLSDRDFNNYASVFSLMKSFVSAP
DLLIYLKSDVPNLVKKIYKRGREYEASISIEYLSKLNQKYEKWISDYTEGKLLIIEVDDL
DFVEKPEDFGFILEKIEAELNGLF
>KALACAFP_02750 Regulatory protein Spx
MLVKVLHNGNCSKSNAVLEYLDENGVPFEIINMVEDPLSILEIKTVLKKLNQSVFHIIRK
TEKLYLENFASKNLSEEEWIKILSENPSLIQRPILIKGSVAMLGRPIENVKYFIEK
>KALACAFP_02751 hypothetical protein
MDILQGNQHASPEDFYNSLREKLEDHHDFPEDYLFKFIIPTDQSKLTEIYRVFDGIKFTL
GNRESKNGKYTACNINAFVLDANQVVNIYKEVAKIEGVILL
>KALACAFP_02752 hypothetical protein
MKKYIIAAALLIGTGAVINTTMQSCTTLATTDLGLSIIKKFLLNGIDKGVNIYSNKQAFL
QNNMVDKALPKQLRDINSMLEKVAPSLVAKEREYIADAAVYTVNISKPILVNAVNTLNAQ
DVTRIIQGEKGTATLILKEKTSQQLIAAIAPKVDEQLNKYGIVKSINTALSGSNLLGSLL
GGNKTSVNAGGLSQLASEQLVNGMFNIIEDYEQQNSKALLGPLGK
>KALACAFP_02753 TonB-dependent receptor SusC
MKQSDLKYSCLIAVLYFGMNVNAQVTPKDSTTKEQKIEEVVLIGYGTQKKENVTGSIGVV
SAKDLADKPNANPISSIQGKLSGVQILNSGSPGGSPRIDIRGISSMSGKPVFIVDGTITD
DISFLGPQDIESMSVLKDPSSLAIYGARAANGAVIIKTKTGRGKKPVFNFNSYLGFKTVT
NIPKMANSDQYIELYNEKLINDTGSSNGSISRAQFPADTDWFKEIFRTSVINSNDFSASG
SLGKLNYYGSIGYLQDQGNLAAGRGINSGSEFNRLNTKLNLSYKITDNITIGDNFTFSKM
RTDLAQNPLLDAYNSPPIFPVMNPNTGNYQYFTGYSIPNSRAKLDLYRSQIRQERLLNNV
WGEYKFLNDFTLRVSYTTDNTNSNQYEFTPTFTYVPVDQQKASVLITRDSRNRNYVWDNT
LTWKKAFGGHNIELLAGFSRTRNSFTPIYGSALNVNYDGTNGSLQIANGTDGFYVSNYDV
IRGNLPDEYRIESFFGRLNYDYKGKYLINASLRRDGTSKYSSDDRYHFFPAVSAGWVISK
ESFMSEQNIFNLLKLRGSWGRLGNPDVQRAYTLNTSIINAGAYFGNNGNPAQTIDTIIDP
SIGWEISTGRDIGLEMAFLNNKLKVEATYFDKDTKDVVYGVVQGTVSGASNWNNYITNAY
SFNNRGFEASVNYDAKISENVRLGVYGNITTLKNEITSVFSGSYLETGASLFGNSIIRLQ
EGQAVGSYYGYQVAGVFQTDAEAAASGQNGGLAKAGWFKFADLDGNGIIDARDKTFLGSP
VPKGTYGFGVNMNVYDFDFAIDFQGVFGNKIYNYNREQRFGNENWDLDFYNNRWHGAGTS
NSYSMTTNNQSVILPSSFYVEDGSYFRIRNIQVGYTLPKVFSKSLSITRLRLYVSAQNPW
TSFKYHGFSPEILNTDRVQMGIDNNIYPISAIYTFGMNLTF
>KALACAFP_02754 SusD-like protein
MKKIFLSIALLSVIVSCNDYLDIQQEGRTEASSFFKTQDDALQATSAIYSFLRSWENSAF
PYQFVFGVPADDVIKGSNPGDASFINAYDNFSYTVSDEGVRGYWIGQWQAVNRCNQVITN
VPNIDMDSTLRGRLVAEAKMLRAYFYFNLVRIYGGVPIFDGIQQNYNIPRNSVEEVYNFI
IADLTSAAEVLPQTYGAADLGRVTKGAALGLLSKVYLYKKDWQKAYDTSNQVIAMGYALD
PDFNHLFRPAGEFGSESVFEVNCQCSAQYGGSQYAEVQGVRNQFGWGFFTPSQALENAFE
PGDIRKEYTILRNGEVTPEGDLIAMQDPNSVTTFNQKIYVPTSLNNSACGYGSIQNIRIL
RFAEILLINAEAANELGNTGTAVTNLNKVRTRAQLPNTTASTQGALRTAIWHERRVELAL
EGDRFVDLVRTGQAATVLASYGFKANKNEVFPIPLDAMNQSNGTYTQNPGY
>KALACAFP_02755 hypothetical protein
MKRIVLSIAAASLLAASCKNSQTVKPSDSQVQVVKNDITDQQLMDRVQKDALKYFWDYAE
PHSMLGRERYHEDNIYPDNDKHVVTTGGSGFGLATILVGVERGFVPRKEAVKRLTTMMDF
LAKADRHKGAWSHWINGETGKTVPFGKKDNGGDLVETAFLTSGILMVREYFKNGNAEEKA
LAQKCDELWKGIQWNWYTKGGQKVLYWHWSPEYQWEMNFPLEGYNECLITYILAASSPTY
PIDAETYYKGWTRNGTYLSDKEKYGLPMYVKHNGAEEYGGPLFWAHYSYIGLDPTNLSDK
LIKNYFDLNKNQVLIDYKYCVENPKQWKGYGPNYWGLTASYSRNEDGSVGYNAHFPQNDH
GIITPTAALSSFPYSPKESMDFLRFIYTQKPEFIGSAGPYDATSINYNNWTTPRYLAIDQ
GTIAPMIENYRTGFLWKLFMNAPEIQQGLKKLSFKSEKYNIK
>KALACAFP_02756 hypothetical protein
MKLKLNHLPLLLLPFSLSVHAQEIKAELNKEVKKQEKISYVLDYPQKVKGNVPLIVFLHG
SGERGSDLEMVKAHSPFTYKNLIKEPVAILAPQCPENMWWDTVTVYHLIKEIQKKYKIDA
SRIYLTGLSMGGWGTWKLAMEHPELFAAVAPVCAPADRVMEANVDQYKNLPIKIFHGGND
DIVSPINSINMYQAVKKINPTVTLTIFPDDNHNSWDSTYSDPKLYEWMLSQKKEK
>KALACAFP_02757 Beta-glucosidase BoGH3B
MKKLIVIATLALSPVFSAQEMVTKPVQSYQTAQYQAKKKAFVDNLLSKMTLDEKIGQLNL
PSSGDFTTGLAQSSDIGKKIEKGLVGGLFNIKGADKIKAVQKVAVEKSRLKIPLIFGMDV
IHGYETTFPIPLGLAASWDMNLVQQSARIAAKEASSDGINWTFSPMVDISREPRWGRVSE
GSGEDPYLGSEVAKNMVYGYQGKDLSVGNTILACVKHFALYGAGEAGRDYNTVDMSHVRM
FNEYFPPYKAAVDAGVASVMASFNEVDGVPATGNRWLQTEVLRNRWNFKGFVVTDYTGIN
EMVDHGMGDLQQVSALALKAGIDMDMVGEGFLTTLKKSLDEGKVSQADIDMAARRILEAK
YDLGLFTDPYKYGDAKLAAKEVFNMENRNIARSVAAQSMVLMKNDNQVLPLKKSGTVAVI
GPLVNNSLNMPGTWSVAAQHDKAVNLMQGLQANYGKDVKFISAKGANIDYDAKLEDIYAA
HGKKTDRDNRSKEALLKEAVDVANKADVIVLAIGESAEMSGESSSRTEITIPQSQVDLLN
ELKKTGKPIAMVLFTGRPLALTNVKDTPDAILNAWFAGSEAGNAIADVLFGKVNPSGKLP
MTFPRSLGQVPIYYNAKNTGRPLDQKLVDKCEYQRFRSNYMDECNTPLYPFGFGLSYSKF
NYSDITISNANPKGNQTIQASVTVTNSGNYDGAEVVQLYIRDMVGSITRPVKELKGFQKI
MLKKGESKKVTFDITPENLKFYNGDLKYDWEPGEFDIMIGTNSEEVKHSKINWSK
>KALACAFP_02758 hypothetical protein
MKKTILFGAILIGSLASAQMRMGGGTDSFGCPSDGGYSYSVILNDCIQIFNQKIIMKQVG
APQGQPISKTCVIFSKNKKQAETFLPGQKQSIILRKMGNYWTNGIYQLIPTANGGYALKQ
DGDVIFQSNI
>KALACAFP_02759 Adenylosuccinate lyase
MNSYKNPLEERYSSEEMLFNFSHNNKFRTWRQLWIALAEIEKDLGLEITDEQIAELKANA
ENIDYDKAAEYEKKFRHDVMAHVHTYGDVAPSAKGIIHLGATSAFVGDNTDLIQIRDGLL
ILKKKLVNVIKSLADFAIQYKDLPTLGFTHFQPAQLTTVGKRATLWLQSLVLDIEELDFF
LETLRFRGVKGTTGTAASFLELFNGDYSKVKHLDKELSKRFGFEKVFGVSGQTYDRKIDA
KVVALLGNIAQSAHKFTNDLRLLQNLKEIEEPFEKNQIGSSAMAYKRNPMRSERIGALAK
YVMSLTTSSAMVASTQWFERTLDDSANKRLTIPQAFLAVDAILLIWNNIMNGIVVYPNRI
NKHIEEELPFMATEYIIMEEVKAGGDRQEIHEVIRVHSMEASKKVKEEGKENDLIERILN
DDSLKLDKSKLKEVLDPKNFIGFAPIQTEEFIANEVQPIIDANKDLIGLEADLKV
>KALACAFP_02760 hypothetical protein
MQSPSTKKTGNFILYMKKILLIISLIPILSFSQQKEVLKYFKSKDSLVGVKNQDGKIIVP
AQFKVFSYLKDGELVKEETIYFDGDKNNEKPGKNEWGYVYDRKGNFLYRPFFYDNGADYF
SEGVRRFVKNGKVGFVDRNGTVIIQAEHDFVSPFNYGYTAFCDGCDWEKTEDEHKAMVGG
TWGVMNFKGEIIQPVSKSENTIEIDGKYFPNPFRYNEKEKNILQFFEKQNKQLSDIYYVN
HYNKLSENEKKLFFEIVERPKENFPFYQINSYDYRKMEAGLSDFKFLVSEDGKNVFALEF
ENEKIPFEKWLKKEIKEAENFQKEHPDNPNKLSK
>KALACAFP_02761 Phosphoribosylformylglycinamidine synthase
MSQNKRIFVEKRGIFDVESPKIFDEVKAVAPSIQNVKVYNVYDIFGLNDGEFEKVVNSTF
VDPVTDILHTENPAKGINFGMEFLPGQYDQRADSAQQCIALLTENEKSKVRSGKLIEFEG
VSESDLVKIKDLLINKVESQEKDLSILDIPAEEVPSKVIVHENFNSFNSDELEQFYNSHG
FALGLDDLKFIQEYFKSEQRNPTETELKVLDTYWSDHCRHTTFETELSNIEFEGQFKHTL
ETIFNDYIEKRKFLGRELKPISLMDLATVCGRYFHKTGNLENLVVSDEINACTIQIEAEY
DGKKEPWYLLFKNETHNHPTEIEPFGGASTCLGGAIRDPLSGRSYVFQAMRLTGAADVLE
PVDKTLPGKLPQKTITKQAANGYSSYGNQIGLATTMVSEIYDEGYKAKRMEVGFVAGAVP
VDWVRREKPEAGDSIIILGGATGRDGVGGASGSSKEQDETSIHTMSSEVQKGNAVEERKI
QRLFRNPEVTRLIKKSNDFGAGGVSVAIGEIADSLEVNLDVLPLKYEGLNGTELAISESQ
ERMAVVVEPKDKEQFIKFCEAENIVAVEVAKVTDSGRMQMFWKGDKIVDLSRAFLDTNGC
SKSQEVKITHLNEVKEETPSFNEENFLKILSDKNVASQKGLLEMFDSSIGATTVAMPLGG
KYQQTLMEGSVQTLPIIGAKNIETVSLASWGFDAEISKQNSLLGSSYAVVESVAKIVAMG
GDYKNIRFSFQEYFEKLGQNPEKWGKPLASLLGAYDAQINFGLAAIGGKDSMSGTYQDLN
VPPTLISFACANGEKKNIISPEFKNEGNKVYFFNHVAQENGLPNYDALKNIYELIFENIK
AGKIVSVKTVKEGGVAVALAKMSFGNRLGAEITVDENVLLTKNIGSLIIESKEELSYVNL
QLIGKVVADEVLTINQQPTTINKLLAANTDTFENLFPTVEKEKLTVEIDEKLNSINPRNI
IIKKHGIAQPKVFAPVFPGTNCEYETLNAFAKEGAVISSLPLKNINHQLLDESIDAWVEE
IKTSQILAFSGGFSAGDEPDGSAKFIVNVLKNEKMRNAVHELLDRDGMIIGICNGFQALV
KSGLLPYGRIKDLDENSPTLAHNAIRRHISQMVNVRVVNDESPWLKGMKDQVFTIPVSHG
EGRFMASETEIQKLYENGQIATQYLDLEGNIAHGMPFNPNNSLFGIEGITSPDGKIFGRM
GHPERFAEGLMKNIPTANYHNVFKNGVEYFK
>KALACAFP_02762 hypothetical protein
MKKIIANKKMTVINGSHFSNLEGFYEEVSTVFMKDADWKVGTLDGFNDVLYGIETDITWK
NSQKSKEDLGFNVTKEFYENKIRQGKPFNVQLIQQKLDKMIDGNGQTLFEILIEIIESHK
NITLILD
>KALACAFP_02763 hypothetical protein
MPKLFSYGTLQKEQVQIETFGRFLQGEKDILTGYKLEMLEITDPEVLRKSNQKYHPILAF
SGNAEDEVEGVLFEVTDEEILQADEYEVDDYKRIETVFKSGKTGFIYVGK
>KALACAFP_02764 Undecaprenol kinase
MRKPPIHKSFFNAFRGVFLMIKHERNFQIELLAFFVNLFLIFYLKLSAIDTILILIASFG
VLSAEIFNTAIEKICDIIQPEFDKRIGFIKDISAGAVLLMTAASVVVGVLVYWKYVFN
>KALACAFP_02765 hypothetical protein
MKKNILITLSVFISGFVFSQDYKQKIAKATCDCVAKVKSENKNSKNLEAQLGICMLKASS
PYAAELKRDYNIDVSKADAFDDNNKAMDDFAGAIGIAMVSECSDVFLEIMNSKEGAQEGE
VQLLISGTITKIEKENFVIFHVVGDNKNLTKLYWISNIESNLDLPKEYNSLINKKVSISY
YTSEIFDAKINDYKNVNIISGLKTD
>KALACAFP_02766 DNA polymerase III subunit beta
MKFIISSGELQKALQTVSGVISSSQSRPILENYLFELDGNNVTITASDGETTLVTSLEVK
SDDAGKFAVPAKIFQDFIKTYGEQPLTLAVKDNAEGTGSQLEILDEKDNFAVALDNADDY
PELPEFDASQSVTMSAGVLSEALTNTLFATSNDSLRPVMTGVLFQFGENETNFVSTDSHR
LVVYKRTDLMNAEPMEFIMPKKPLNIFKNILASSNDDVTIDFNENMAKFTFGKHIWICRL
IDGKYPNYTAVIPKENPNVLTINRNLLLGAIKRASIMSNKSTNQVRFKLSANILHLHAED
TEYANKADMQIPCDYNGEDINIGFSSKFLTEMLTILSSDDITMKMSQPNRPGIIEPLDGL
EENENILMLSMPVIGL
>KALACAFP_02767 Phenylalanine--tRNA ligase beta subunit
MKISNNWLKDFIKTELKTERIGEFLTDIGLEVEGIDKFESIKGSLEGIVVGKVLTCEKHP
NADKLRKTTVDVGNGKVLNIVCGAPNVEAGQTVPVAVVGTKIYDKSGNFFEIKEAKIRGE
VSQGMICAEDELGLSDDHGGIMVLDEEKYELGKNFADYFELTNDEVFEIGLTPNRTDAMS
HYGVARDLFAYLSTNKQKSEFEKVSSDVLNNEGTHDFTLEVEDAELCPRYIGAVIENVKV
ADSPAWLKDRLKAIGLSPINNIVDITNYVLHGYGQPLHAFDADKIEDKKVKVGTVKEGTK
FTTLDGIERTLNGSEIMIKDGKDNPMCIAGVFGGANSGVSDETKTIFLESAYFNPVAVRK
GAKFHGLNTDASFRFERGVDPNITRTAITKAITLIQELAEGKLVGDLLEEYPKKIEDNYV
IIRFSKIEQILGTKIHREKVKEILKALDIQVLNEIQNGLEISVPAYRADVTREIDVIEEI
LRIYGYNKIDAPQKISFTPVKLTAQDQDELENNWARTLQGLGFNEVMNNSLTSVKDETDA
VKLLNPLSNDLAFMRKSLLEGLLQNAIYNINRKNQDIKFFEFGKIYHKKEKYEERKQLAI
LVSGRDVAENWLQPKSATSFYNLKAYVKVLLEKLAIDYKEVALSDERFSDALAYEVDGKA
LVRIGKVSSQLLKDFDIDQECFYAEIELEFAQQLRSKNELKFKDIPKFNKIRRDLALLID
KHINYEDLYQTAKNNKSPYIKNINLFDVYEGKNLPEGKKSYAMSFELLNEEKTLEEKEIA
AVMDSLVKSFQKEFNAELRG
>KALACAFP_02768 hypothetical protein
MKNLFLSICAAGILASCGTMSSSSASKVGKAQPSLAGTKWALADNVKGKIPTLNIEGEKI
SGNAGCNNYFGTAKVDPSTGNFSAGQMGSTRMACDNMNVEKNFMDMMGKANKYVVSGSTL
ELYQDNLLLLKFNKAE
>KALACAFP_02769 hypothetical protein
MKLPKFLLADNSEFPEDLFVVHTEYPRFILNVEEEEVEWLDDLEGDDEETMADEATKVVE
AAFKWCDEELAKYDDEEED
>KALACAFP_02770 hypothetical protein
MKFKEKYIQISLVIITLVMTILRFLLNEKGRTNPDSIRYMRFAHNLPEIDNTTTPLGYPA
AIKFFTFFGTDEFWSSKIIGIAAFLFIIFFTWKKKFFFKESIVACALFSFLSIFSYTMSE
ALILPFVILFLYVSSLIINGKLEKGKAIFYLSLSLIALYNIRYSSLFIIGGTGLYGLIFW
KRNYAKTFIISGAIGFVFVVLYKFLFIDYFNENYIKDALITGLHPTSQLLKELFQGLCTT
FNPFIHIANPGGGVINYAIYGIGFLNIILIIYLFIKYKLSDAEFFFVFVSISGIVCSYFV
QYFYPVNAIDYRLMAPFSFPIWLIYFKKLFQILDVKTYAVGILSIMSGIVFTWLSKGNYL
ENRKEMTEFLQSENLDKVPLKFYLETTEDLEKIQVAELISTINPNINLTFKPKDTLQKAT
LTRYKVLQKIKIDKNKYQ
>KALACAFP_02771 3-hydroxybutyryl-CoA dehydrogenase
MIQNIVVIGAGTMGNGIAHTFAQSGFKVNLVDVSQEALDRGLKTITTNLDRIIAKGNLTE
EQKAETLGNISTFTELKNAVGNADLIVEAATENQDLKLKIFGQMDEFAPENCILATNTSS
ISITKIAAATKRADKVIGMHFMNPVPIMKLVEIIKGYSTSKETFDSIYEMSKTLGKVPVE
VNDYPGFVANRILMPMINESIETLYNGVAGVEEIDTVMKLGMAHPMGPLQLADFIGLDVC
LAILNVMYDGFKNPKYAPNPLLVNMVMAGKLGVKSGEGFYDYSESKKAEKVAKMFLK
>KALACAFP_02772 hypothetical protein
MKKILFALGLFLSTFFFAQKSENYLQIGYASICCGTPSDKPVMDFVSQFQKKNKIKELEI
YKQSGLGREGEYNLYIGIDKLSKTQKANFIKGLKGAIDAQNSARRQNRDGIVNFNEAELV
KKADLSNARNLNIYKK
>KALACAFP_02773 Extended-spectrum beta-lactamase PER-1
MKKIGLFLLLISAFTFAQKSALDQKISSIIKNKKATVGVSVLGFENGFIYNKNGDKKLPM
QSVFKFHIAAAVLDFVDKGKLSLDQKIVLDKSNLLENTWSPLRDKYPNGGVEVPLSEIIE
FTVAKSDNNGCDILLKLIGGTQTVQKFIDSKGIKGFQIKYNEEEMHKDWNTQYQNYSTTA
SAVQTLKKFYDGKLLSKKSTDYLMKIMISTSTGLNKIVEQLPKNTVVARKTGASGKNKDG
LTGAENEIAIITLPNGKHYALAVFVSNSTETDAVNCKMISDISKTVWDYFNK
>KALACAFP_02774 hypothetical protein
METQSPFEQFDELRIDNAGKLFLTEAARWTTFLAILGYIGIGFMVIAALFMMTVGASMSS
YKSIMPMGGGLLFSLIYLAFAALYFFPVNYLYKFSSNMKSALRSNNQAELTKAFEYLKSH
YKFIGILTIIVFGLYILAIFGAMIAGISGIR
>KALACAFP_02775 Endoglucanase C307
MKRAILLSAFLLSQFGTSQLLKTNGQKIVNDKGENIQLRGLGLGGWMLQEGYMLKTADFA
GPQYKIKQKIAELIGEDGMNEFYKAYLKNGITKQDIDFLKKAGFNSIRLPMHYNLYTLPI
EKEPVKGQNTWLEEGFKMTDDLLKWCADNKMYLILDLHAAPGGQGNDVNISDNDKSKPSL
WESEDNQKKTIALWKKLAERYKNEPWIGGYDLINEPNINFTGKNPNGTDEMSNAPLWKLQ
KDITDAIRQVDKKHIIIIEGNGWGNNYNGLTPLWDNNLVFSFHKYWNYNDDATLKFALDL
REKHNIPIWLGETGENSNVWFTELIQLLDKHNIGYAFWPMKKIDNIAGITNVKITPEYQK
LLDYWKNGGEKPSKEFAKKTLMQIAENYKFSNVEIKNDIIDAMFRQTTDGSTKPFKNLQA
PGKIFATDYDLGKMGSAYLDKDFINLWVSDPAKRSEWNSGNQLRNDGVDIYKSKDNQYYI
GKTETGEWLQYTFNAKADKAYTFDIRYASNNDAKIRIEDASGKQLASVSLSSTGGNETWK
TASVKAINLKKGENKIRIIFENDGVNLNYFEIK
>KALACAFP_02776 scyllo-inositol 2-dehydrogenase (NAD(+))
MLKAGLVGAGHLGKIHLRLLNQSDKYEFVGFHDKDVENGKKLEAEFGYKYFENFDELLDQ
IDMLDIVTPTIYHYDYALKAIEKGLHFFIEKPVTQTLEQAEEILRKCQENGIKAQVGHVE
RYNPAFIATKEFINNPMFIEIHRLAEFNPRGTDVSVVLDLMIHDLDILLSIVKSKVKNIH
ASGVCVVSKTPDISNARIEFENGCVANLTTSRISMKAMRKSRFFQKDAYISVDFLGKKAE
VIRMKDAPENPTPFDMIIENAEGEKNQILFEYPNIQPNNAILDELNSFADSITEDKHVEV
SIEDGTEALKVALEIMKLIS
>KALACAFP_02777 Protein-L-isoaspartate O-methyltransferase
MHDSFVHKGKRKILVDYLRNRIGISDENVLSAMNEVPRHLFIESIFEDFAYEDRAFPILA
HQTISHPSTVAEQSELLQVKAGEKVLEIGTGCGYQTAVLLAMKALVYTVERQKDLFDFSK
KKFREMHLYPKFQSFGDGFAGLPTFAPFDKIIVTCGASILPTELLKQLKVGGKMVIPLGP
TDQQVLYRFTKVSQTEFEKEEFGAYKFVPMLGNTNQ
>KALACAFP_02778 hypothetical protein
MSSEIQQYNSSQTESDQEICSRLAEIIDENLPNAESKIWHAHPVWFLEENPIVGYSKQKK
GIRLMFWSGKSFNEDLLNVHGGKFQDASVFYNDLSEINEDDIKRCLKKSEKIQWDYKNLV
KRKGELIQLNIH
>KALACAFP_02779 hypothetical protein
MDTNRFKSSHDFSNIQKNLHNNPGYSVESYSQQVKDYINDMKSQNKEVTKQGFMTHAQKS
AKEVWEEIQEMASEAWEKHNESDKKQ
>KALACAFP_02780 Glyoxylate/hydroxypyruvate reductase B
MKVFINKRIPEIGIKMLEEAGLEVFIPEYDLSNAEWLSYCKSHDVILSVGTDFKYDKDFF
NECPNIKAIALYSVGFDHVDIKEANRLKIPVGNTPDVLSKATSDVAFLLMQSVARRASYN
FEKVKSGSWDSFDPLHALGQELYGKTLGIFGLGRIGFEMAKKSKAAFDMNIIYHNRHRNE
EAENELNAKYVSFDELIAESDVLSIHANFKPEQNELFNSSVFEKMKPDAIFVNTARGGFH
HQKDLYEALISKQIWGAGLDVTNPEPIFKDDPILELSNVCVLPHIGSATIEARNGMAKLA
AENLIAFSKNEKMLHCANPEIYS
>KALACAFP_02781 hypothetical protein
MVPENSPKEQDRKLEQMDYNPNEDIFRQEKHIPLDGDGVPFEDEEIDEDKIDKGLDIPGV
EDDDEMEDIGSEDEENNYWSLSDNEDDHEEENDDVLT
>KALACAFP_02782 Urocanate hydratase
MTFQEQIQQGIPNQLPAAKPYETNINHAPKRKEILGEEEKKLALKNALRYFEPKFHAELL
PEFKEELEKYGRIYMYRFRPDYEMKARPISEYPGKSEQAKAIMLMIQNNLDYAVAQHPHE
LITYGGNGAVFSNWAQYLLTMKYLSEMTDEQTLVMYSGHPMGLFPSHKDAPRVVVTNGMM
IPNYSKPDDWEKFNALGVTQYGQMTAGSYMYIGPQGIVHGTTITVLNAFRKINKEPQGGL
FVTSGLGGMSGAQPKAGNIAGCVTVCAEVNPKITKIRHEQKWVNEIHENLDELVARVRKA
QENKETVSLAYLGNVVEVWEKFDQEDLRIDIGSDQTSLHNPWAGGYYPVGQSFEESNTMM
AENPELFKEKVQETLRRHAEAINKHTEKGTYFFDYGNAFLLEASRAGADVMAENPTLGRE
FRYPSYVQDIMGPMCFDYGFGPFRWVCTSGKPEDLQKTDDIACQILEKIQQNSPEEIQQQ
MKDNIQWIKGAQENKLVVGSQARILYADAEGRMKIAEAFNKAIKNGEIGPVVLGRDHHDV
SGTDSPYRETSNIYDGSRFTADMAIHNVIGDSFRGATWVSIHNGGGVGWGEVINGGFGML
LDGSDDADRRLKSMLFWDVNNGISRRSWARNEGAIFAIKRAMEVEPKLKVTLPNFVDESL
F
>KALACAFP_02783 Endonuclease NucS
MTENQIRDLLVQNLSLINPYYIFLDKEAYLPNNIGTRSFIDILAINNENKYVIIEVKKSN
ASSREAIHELYKYLEAVKQNLAVKSDEIELVIVSTEWKELLVPYSSFINSTDLKSYGYQL
FINEEGISVKKIDTNATQEDRILSAIQMARYYLDEASLQEGIREHINFFQNRDINNFILI
ILKSPENYSDLVLKSIQNFEISMYNEIRTENLDPNLNFEYMIYSINQTLSLNSSTEILLK
HYSSPEIIEEIEEIKNLEETFYTKMEMLNQMIINQMPFPKCDYVEIGTPAKYVKFIEDEK
WQLIEIKKYGALLDNIFLTNDIIEQEIIASGTTKERYTSTLDLMNTANLARVKKEIKNVL
SDNIVWRNHILEILEQLTYEKEHIKYAHISIYNPMNIIYSIYLLFNQQMGLRYIPSYQIE
VLLNNNEERLYVGHLDGNLRQTTMDNILQKFWNSEAIEYLLTLNWGGYFNRNLELCEFIG
LEYKTMLIKAYQESTTHFKYRNYKFIEVDNFDPLENIINKLSNDLHLVPNIFSFFNEHKV
KNGYWEFNR
>KALACAFP_02784 hypothetical protein
MKIALTKLSTKDLATLAQRIISNSQSGKYPVITNHPLAVALQTSYMEYDKVYTKQTFSGK
GKDVASADRERDVAYSNLKVFLNGYRQLPSAPNVQLAEDLYGVFKTFGLDIDRLSYSSQT
AQMKKLIETLELPENQQKMAALSINTAFAEMKTKQEDFEAIFAQQAEANADLRQMTSASA
IRKNLEKILKSYLNLITAMKDVPGWELLYSDVNELVKAAKNSSVPKGSQDNGSPIVKKVD
>KALACAFP_02785 putative thiol peroxidase
MYPKLIFSALLFVSVFIFAQNAKTANTVLMGGKPVQTYAKLPAVNKPAPKFTLTDVTMKD
QTLDSYKGKYLILNIFPSVDTGVCSASVRHFNEDAANIPNTVVLCISKDLPFAQKRFCGA
EGIKNVVMLSDFRSDFGKTYGVEITDSAMKGLLSRAVVVIDPSGKIIYEEQVADISHEPN
YEAAIKAVKN
>KALACAFP_02786 NADP-dependent glyceraldehyde-3-phosphate dehydrogenase
MDSVNTPSFHEIFKSENEIPEEYKVPEIHQRVYLLNGELVEWNGDVQNIYSPVCIPTENG
LERKLLGSIPNISPKEAMEVLEASVKAYNNGLGEWPTMSVEGRIKCMQKFVYLMIQQRDL
VIKLLMWEIGKTLADATKEFDRTVDYINQTIDALKDLDRESSRFQQAEGTIAQIRRAPLG
VVLSMGPFNYPLNEIFTTLIPALIMGNTILFKLPKHGVLAHYPLLKAFQEAFPKGTVNTL
YGKGSEIITPIMESGKVQVLAFIGSSKVANGLKKLHPKVNRLRAILSLDAKNAAIVTKNA
DLDVAVSECILGSLSFNGQRCTALKLIFVQKDVAEEFTKKLSTAVSAMKAGLPWEKDVKI
TPLPEVNKPPYLKECIDDALAKGAKIMNENGGFTEESFVFPAVVYPVNSDMKLYHEEQFG
PLIPVVPFDEIEEPIDYQVNADHGMQVSIFSEDPVEVAKLIDPFVNLVSRVNINCQAQRG
PDVFPFTGRKDSAEGTLSVFDALRSFSIRSLVAAKITDSNKNLLNTIVRDHDSNFLSTDY
IF
>KALACAFP_02787 Thermolysin
MKKNFTHVKALAFAVALVISPASLLQAQNQRNNTEISVQNLPEISKNSVMGNFQANFSGQ
DIPAGFLITHLGEWLGTDSDHTYKLVKESTDELGIKHFVYQHYFKGVKVGDELILLHEKN
GKLTYVNGEISDKINVQVGNSISEMEAEKIAALDMKAVGNTKFSDYEQLITKVDNGRGIE
LHSVSKIEGFSLKPLNAFIYYIDNSTKNIVKKVSKNYEVDTPSNSLTLYKGTQPITVDSY
NGNYRLKDNARNIHTLDGTNLDGNYDPTTGELSGGQEYTNATPDFTATNTKPAVEVQWAM
EKAHDYYISRHNRNSYDGNGSILRNYYHFDFGIFGNTPGYGLNAAAIDASGIVCMVYGDG
AYPPYASGVVANPVVGIDVAGHEYSHLIIGRNGLGGLNYQGESGAINESIADMMGAAIEF
YSGINANWTIGEGILNPAVLPPGYFRSLSNPNSGPAAVGGQQPDTYMGTYWASTANPSDS
NDHGGVHTNSGVGNYWFYLLSSGGSGTNDIGNAFNVTGITIQKAEKIIYRALTNYMTPNS
TYMDAYNATKQAVTDLYGASGNEQLQNVRAWYAVGIGNGVLATNEVANGGENQFTIYPNP
VKGGMFTIENNKNDSTFEIYDVSGKLVKHADKLSKGTNKININGLEKGIYIVKINSNGTS
VSKKLIVE
>KALACAFP_02788 ECF RNA polymerase sigma factor SigG
MISLEQEFLEKIEKHKGIIFKISKMYMDEKDDRDDLFQEITYQIWKAYPNFKGHSEFSTW
MYRIALNTAIIFLKNEKKRSFIKNEDFSEYKITQDEFDHEKEEKLNAMYGAIHQLNPIDK
AFIFYYLENFSGKEIAEQMGISEGNVRVKMNRAKNKLKDILNSK
>KALACAFP_02789 hypothetical protein
MNIDELKNTWSEDRDDETPEISTEQKNKINFPLEKMRKNMRMEFWSTVGIFIFAFALIAL
CEAPFKFKFYITILIASMVFVTFFFFSQFFKLYKEMTNPVMKTYDGLKDLLHQLYLNKQY
YFSFYVAFAPFLVCELIIVLEFIPYPKPPSNLKIASIIIGALVVTMISLFFLGKFWFQKF
YGKYIQQIEGLLIELKK
>KALACAFP_02790 hypothetical protein
MTLYYHDDLKMINLYFLTKIISILIIKLFNLAVEKPNVQKNYFILFLLLIITSCGSIRRH
NEQKASCIPPEKLKEDVDFAYSKLKEMHPQLYWYISQKDLDHKFDSLKKTITEPLTPLQF
YFKLQPVIADIREGHLSLRIPRKKFTKKEIKGLEHKKGMFSRFEYYVKDDHLFIVENKDS
IENIKPGTEILTINDIPVSEYLKKYRQLVSSDGFNTTFQPYFLKDWFFYFYVAENGFTDH
AKIETLYNGERKVYYLKRESKSENDLKNDKEQKKRTAEKKVNDYVAFNNSYNRNFKFLGK
DSSIAYIKVKSFSRDYSEKFYKETFEKIKNAKSSYLIIDVRNNYGGSLDEINNLYSYLTS
SPYVLIKPSQVTSKISPLKTSYFRKSNILQYAYKGLTYPTFFFAQTFSTYKKDGKVYYKM
KADKVAKPNKDTFNGKIFVLINGGSFSASSIITSKLKNDKRVVLVGEETGGANDGTVAGF
YSFQKLPNSKIDLPIGLLLVQPNITFSNTKKGVVPNVTVTETLQDVIDKNDPQMDWVLSE
IEREKNLHK
>KALACAFP_02791 hypothetical protein
MIYILIAAAVFIVLLYLIITNRSVFGAEAKGKRLERMHQSRHYKDNQFQNLSYTPSLAEG
YTFPKVLYDFFFKKKNPLLKPLNNIPSIHTDLKNIPKNQDVFVWLGHSSYYIQTDGVSFL
IDPVLSLYGSPFKFFNKAFTGADIFKPEDIPVLDYLVITHDHYDHLDYPTIKAIKNRVNT
VILPLGVGAHLERWGYRPDQLIEEEWGDNAVLKSEIKITFTPARHFSGRKVKRNVTLWTS
YVLETPTKKIFLGGDSGYDTHFKMIGDKYGPFDYAIIENGQYNQAWKYIHALPEDVIQAS
IDVNAKNIIPVHSSKFALALHAWNEPLEKVTSLGKEKNLTILTPMIGEPLDLNKTDHQFK
AWWKE
>KALACAFP_02792 hypothetical protein
MENIKFEVSPYQDELQMLIDGKRVGYMSIEIDGRLLIVYYTKLDKEREGHGYAKMLLDEL
VRYAEEKDLLVDPECDFVRQQFENHPSRYKDIWHA
>KALACAFP_02793 hypothetical protein
MDEILVIKVNSEPGYFKYFKLFGKHLLNLLFKFHFKFVILKGEKFSEIID
>KALACAFP_02794 hypothetical protein
MKKLLLIAMLVGTFGVSYAQSDYYNDYRRSITDVNWQNVIADLVLTTVQANQIYALNDRY
RDYNSWNRIYVHNPDRWREDRYVELERILGRDKYVKFKTKYYKGQNPVAYYNRNKNNDKR
YKHMDKKIKVHKQKHGNGHH
>KALACAFP_02795 HTH-type transcriptional activator RhaS
MESKETIKGFYERNAQNKGLQCIKTPGVGHFNVFSRENCSSITPYSRRDYYKISLIIGKG
KLHYADKWIYVDKPALLFSNPVVPYSWEAENKDQKGFFCLFTDQFLHTGNRFGTLQDSPL
FKIGGTPVFFIDEQQQGIVSDIFFKMMTEIQSDYLHKYDMLRAYLHLLIHETMKMHPAEN
FEPYQNASQRVASLFMELLERQFPIDSPERYLRLKTPTDYAENLSIHVNSLNRSVKEITG
KTTTQQITSRIIQEANALLMHTDWNVSEIAYGLGFEEPAYFTNYFKKQTGLTPNAIRTSV
V
>KALACAFP_02796 General stress protein 69
MKFRKLGNTGEQLSAIGLGCMGMSFAYGPTDEQESIHTLHRALDLGVNFWDTADMYANGE
NEKLISKVLVPNRDKIFIATKFGFRFKDGKASHSGAPGTYFDGSPEWIKKAVDLSLQRLK
IDEIDLYYAHRVDPNIPVEETVGAMADLVKAGKVKYLGLSEASAESIRKANKIHPITALQ
SEYSLLTKDVEKEILPTIRELGITLVPYSPLARGLFSNITEVQNFGNEDFRKSLPRYQEE
YLENNRSLAKEFNDFAQSKGVKGTQLALAWVLNQGDDIIPIPGTKRIKYLEENIAAINIE
LSSSDLETIDSILKKYPNTGERYNEGSMKLVNN
>KALACAFP_02797 Multidrug resistance protein D
MVTLKEKNKLIATVLAFAVIPMSGLATDIYLPSMPSMATELRQPESNIQLTLSIFLISYG
LTQFFAGSIVDSFGRYKVSMISLALFVVSFLITATTQNIFVIYAMRVLQGILSGFAVVSK
RAFFVDVYEGDERKHYLSIMTIVWSVGPIIAPFIGGYLQKSFGWQSNFYVLAGYSLLLLL
LEFIFSGETLKKRNPFHFEFLLKEYNSMFKAKDFFYGMIMCGLSYSMIMFFNLCGSFIIE
HKMGYSEVVAGYVSLILGFAWMTGGFLGKALINKAFLPKIRYANFIQLILIILMFVASYF
SSNIYSLVAFAFLIHVTAGFIFNNYFSYCIGRFPNSAGIAGGLTGGIAFIITSAISYGIV
AMIRPQMQLEVAEGYFVLGILGLFILSMIKLRKAHA
>KALACAFP_02798 hypothetical protein
MKTKTTKIIYWSGAIFMSVWFGASGFFELTKNPVVWDITLQLGYPSHFIYILGVFKLAGI
LVLLLPNRLLRLKEWVFAGMFFDIIFAFFSKIAVIGFASAIDAIVAFTVLSVTYFMFRKL
YTPELIFGEE
>KALACAFP_02799 hypothetical protein
MILKNLIGTAAFVALMFTVSAFVYTNKSEKPQQNNPTEANGFAVLELFTSEGCSSCPPAD
QLMGEIEKLYKDQPVYILAYHVDYWNNLGWKDKFSSVENSQRQQYYSRTLRSQVYTPQLV
VNGKKEFVGSDRNNVEDAIENALFNSKNLHIDLSANSSEKEINVNYKTVENNSQNKLLIT
LVEKKSATNVQKGENEGRHLQHWQIVHQQNQISLKNSSEGTTSFKLPENFNTNDWEVIGM
IQNTKTGEILGSAKAIF
>KALACAFP_02800 Sensory transduction protein LytR
MNIIIIEDEFRAAKSLQNLISELKPESKITGVYDSIEMSIEALSKGSMPDLIFMDIHLSD
GLSFEIFKQVDITCPVVFCTAFDQYMLDAFKSKGVDYVLKPFSREDISEALRKVDELKKF
FQKNELPELESLLQKIAQPQAASKSNFLVFKNQKYTTIQTENIAYFYIHNEITHLVTFDK
EQFQLSQSLGQVAEQVSEKQFFRINRQYLINFKAIKEMEHYFQRKILVKLTIETPEKLLI
NKEKTHSFFTWLEDR
>KALACAFP_02801 Sensor histidine kinase YehU
MQQQKLKISPAVIWVSSIFLGALSSVPQLASHAFNWKEAVVNSAITAAFSIMMWYLNIYM
LNRNSGRKRQHISYSRLMIVLAFGMVIMFGLAWIQQLILSHINFGPAMLMVEVRGILINL
VCYMFLTLLQNNYTGQQIQLELEKVKSDNLGAQFELLKQQINPHFLFNSLNTLKSMAETN
DSETVDFVMKLSDFYRFTLESRKLDLITVQEEMKIVDSYLFLQKARFGEGITFTNELNSE
VLKTLIPPFTLQLLVENCIKHNIVSQSKPLHIKIYNSEDKIIIENPIQKKMATEDSLGVG
LDNVKLRYKHLLEKEIEINSDEKIFQIKLPFIHEYHHH
>KALACAFP_02802 hypothetical protein
MKKILFIIMSVCALFTACKIDEPDKDLKRIVFDPGDLKFISNSLNPKKETMSALYGNQEA
LQSLATENNQPKANSEFKLVTWKYHENPQYIGGTITGELLSVETIHSDKNGTISYQLKDQ
VRTENNPSNKEERIKYFMSYKPVVRP
>KALACAFP_02803 hypothetical protein
METVKKKRNPIAIVFLVVLGIFGGLQFFNQPLEGKSVTKQIEAPREVISILENSCFNCHS
NQQNLSWYDKIAPISWAVNKDVKRARQVLNFSEWNYSAGEHQGKMYAILNMMQSGKMPLH
EYTILHSSAKVTQKDIDIIKKYTLSLSGVDTAKKEEKNIHQNINLPENNTSSKFPVSPNG
VKYTDDFKNWKVISMSTLFDNSIRVIYGNDIAVKAVETDNFHPWPDGSIVVKSVWKQEEL
SNGEIRPGEFVNAQFMVKDSKKYTDTEGWGFAKFSGNELHPTGKTASFAKESCIACHRQL
GEKTGYLFDVPMKVNTERLIKNLQK
>KALACAFP_02804 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MNTFNNKLAIVTGGNSGIGYATAKELIAEGAKVIITGRRKEAVEKAAGELGAIPFVADQA
NLDDIDALKKEVENQYGKVDILFINAGITGTLGSIENMNPENFDNVMNINFRGAYFTLSK
FIPLLNDGASVVFLSSNVATTYRPNSSIYQASKAGLNSIAKTAAVELAPRKIRVNIVSPG
PTKTEIMTKAGLDEKTLEGLDAWLTDQIPLKKMGTAEDVAKAVVYLSNNNVASFMTGTEI
LIDGGMIL
>KALACAFP_02805 putative HTH-type transcriptional regulator YybR
MERDQTEELRALQDTLYFIGGKWRIPVINSICNGNRRFREIERSIPGITTRMLSKELKDM
EMNKLVKRTVYPETPVLIEYEPTEYCRTFGKIIAEMINWGREHRKVIVEG
>KALACAFP_02806 hypothetical protein
MVENEIRAMLERYFDVLQTQDLNEFDKVFNSNSVLYSAQDGNFVVRPFDEYREMVKNRKS
PVEMGSGRKDEVVFLDILSDTMAFAKVRLQLFDNIMVDYLNLVKVDGNWSIVSKLFYREG
PAS
>KALACAFP_02807 HTH-type transcriptional regulator MetR
MEIRHLKLIKAIVEEGGITKASDKLHLTQSALSHQLKEAEQKLGTDIFTRNNKKLILTEA
GEKLYHTANEIINKLHDTQNEINNLIHGDVGSINFCSECYSGYHWLAPLLKKFQDSYPKI
DLNIVVEITGNPLKGILERTLDIAIISDPAKNENVEFLELFEDEIVLIVSENHRLASKEY
VSPNDFIDENLIIHSLPIDKVTLYDQFLKPENITPKKITPIPLTEASLSMVKAEMGVMTM
SEWSAKQYLKNDPSLKTVRIGKKGLKRIQYIAILKALKHPQYFNSFIDYLKAEIHNTQ
>KALACAFP_02808 Isocitrate dehydrogenase [NADP]
MSDKSKIYYTLTDEAPMLATHSFLPIVKAFTKSANIEIAVPDISLAGRILANFPEFLKDD
QKIGDALAELGQLATQPDANIIKLPNISASVPQLDEAIAELQSKGFAVPNYPAEPKNDEE
KAIKAKYAKVLGSAVNPVLREGNSDRRAPKAVKNYAKANPHRMGDWASDSKTDVAHMDNG
DFYGTETSTTVENATKFKIVFKGNDGAETLLKDFANLQAGEVIDSSVMNLNALKAFVQKA
IEEAKNKNVLLSAHLKATMMKISDPIIFGAIVETFFKDVFTKYAETFKSLDVNPNNGLAD
LFEKIKGNAQEADIKADIEAALANGPRVAMVNSDKGITNFHVPSDIIVDASMAALVRGGG
KMWNKEGKEEDTVCIIPDRSYAGFYQSVIDDMKAHGKLDPTTMGSVPNVGLMAQKAEEYG
SHDKTFQATADGTIEVQDENGNVLLSQKVEKGDIFRMCQTKDAPIQDWVKLAVNRSRLSD
TPAIFWLDKGRAHDREIIKKVEKYLKDYDTTGLDIKILDVKDAMTETLKRAREGKDTISV
SGNVLRDYLTDLFPILELGTSAKMLSIVPLMNGGGLFETGAGGSAPKHIEQFLEEGYLRW
DSLGEFLALQASLEHLAQTQGNTKSQVLADTLDEANAKFLATDKSPARKVGQIDNRGSHF
YLAMYWAEALANQTKDADLAAKFAPIAQALQENEAVINQELIAAQGKPQNIDGYYKTDTY
KTYAAMRPSTVLNEIIDGI
>KALACAFP_02809 putative thiol peroxidase
MSTTITLKGNEVHTIGVLPSVGTTIRDFALVDSGLHVKTLDNFDGKKKVFNIFPSIDTPT
CASSARKFNEEASSLDNTVVINVSRDLPFALGRFCAAEGLSNVETLSDFRGSFGDDYEVT
IADSPMKGLLSRAVIVTDADNKVIYTEQVSEIADEPNYEAALAALK
>KALACAFP_02810 hypothetical protein
MKRSGTADLPLHYGKVPPWLYERMSILGLSIVEVILMDYGKDEVLRRLADPFWFQSFGAV
MGMDWHSSGITTSVMGALKRSVNPNSQSLGLYICGGKGKFSRDTPSELIQIADKTGLNGN
ELVRASKLSAKVDNTAIQDGYQLYLHNFILSDNGNWSVVQQGMHESDGTARRYHWHSGNI
KSFVEEPHTGINGISRGQILNLTDSEASENRKGILDISHTDSAEIMSDFARLILPNHHDV
QASDVDLRRLGALLYVTREQQPQNFEDLLMLEGVGPRTMQSLALVSEVIHGAPSRFKDPA
RFSFAHGGKDGHPFPVPTKVYDESIQILKSGIEKSKLGNSDKLKTLNKLHQIVEATEKDF
TPNFDIQEVIEEERQNSWRFGGKTVFGDAQKPSNPKPIQLSLF
>KALACAFP_02811 hypothetical protein
MFNISFIISHKNSILELQKNIDLMSSKALEICYDFPFFLSEELEEIFQAHEKVVFQKGEF
ILEEGKTANEYYILERGLARSFVNDFNGNEVTTHFFVENEVIIEVSSLFQRIPTQENIVC
ISDCECWKFSFETFQELFHKIPNLREWGRAWMSQQLFVYKQRSVEMFTLSATKRYLNLLE
QKPHVIQFAPLKQIASYLGVTDTSLSRIRKELVSHPKKV
>KALACAFP_02812 hypothetical protein
MTINQIYVNLPVKDVQKTREFWTKLGFSINEQFSDEKAICVIMKEDHIYAMFLNEEFFMT
FTDRPIAKGDTTQTLLAIGVNSREEVENMVNTAIENGGSKYSEAQDHGWMYQNAFSDLNG
HQWEVMFADMSKLPTE
>KALACAFP_02813 hypothetical protein
MKINQIFVNLPVKDIQKTKEFWTAIGFSVNEQISDERAVCIVLNDNISVMFLTEEFFQTF
SERPVPKGDTTQVLVAIGLDSREEVDQVVNTAVANGAYQHEEPQDHGWMYQNSFWDINGH
GWNVIFADPSQIPAE
>KALACAFP_02814 hypothetical protein
MKNEIEIVKVQIFSNYKVISMNIEGITNEEAMTFPNGETNCMNWVLGHLIYIRNPLLNIL
GEKAVWDGDRFSCYNRGEIPLERKDEFVSFEELKSYLKQSQDRLEAKLDSIESFNSENIK
DISTLCLHEIYHSGQMGYLRRILGKPGAIK
>KALACAFP_02815 hypothetical protein
MDTPKSKKLDIIIPAFRGHSQSFLMVLDGISEEDALKRIEGRTNHIVWMAGNFLDMRYGL
GAVLGLQEEFEFKDFFFQGKALDESFTYPTIQQLKEAFHKISPLVYQKLLEASDEELDKA
FPMGMNIDFFPETVLNFVGMCIGREDYLCGQMGLMRRILGYEGMKYDFDKDLKY
>KALACAFP_02816 AB hydrolase superfamily protein YvaM
MNPVEKGYKQVNGIRMYYEIYGSGEPLVLIHGGGSSILFDYKEVISRLENQFQLIGIDLQ
NHGMSEHRDIPETFEQDARDVAALLKEINVRKASFWGFSNGGSTVMQLAHLFPEIVEKLV
VASAFYKRAGMMDGFFESMMEATLESMPEPLKINFLNLNPDFSKLENMFDKDSKRMQTFE
DWSDDVLKGIKSPTLFISGDKDVMKPEHVVEMWRLVEGSQLMILPATHGSYMMADFGGNV
DEKLIDLTVSEVEKFLRN
>KALACAFP_02817 hypothetical protein
MAKLNPYLNFDGKAEEAFNFYKSVFGGEFLGEIHKMGNAPGTENLSEEEKNRVMHIALPI
GNDLLMASDIVPSFGQKLNVGNNNYVSIFPESKEEADRLFKGLSEGGNIEMPIEDQFWGD
YFGSFQDKYGVHWMVNYNEEYTK
>KALACAFP_02818 hypothetical protein
MEPINIDITILAPVQKVWDYYNDPKHITKWNFAHESWQCPRSENDLKVGGRFKNRMEAKD
GSFGFDFEGIYDEVIPNEKIKYHMEDGRNVDVNFDKIDENTTKVRIAFDPEKQNTVEMQR
DGWYAILNNFHKYVENH
>KALACAFP_02819 hypothetical protein
MINLVIMAKCLSSICAVSHVVQGDFLQGVIAMPARRALEKEKIDSLEKLSNYSEEEIMQL
HGFGKNAMEKLKIYMKENHVSFKN
>KALACAFP_02820 hypothetical protein
MNNDIFPCLWFDEDAKEAAEFYSKVFDGKITADTPVVMNVDLFGQKLMLLNGGPQFKKNP
SVSFMVICETEDEVQKYWDQLLDGGMALMPLDSYSWSKKYGWIQDKYGVTWQLFLGEKRT
EQKIIPTLMFINENNGKAMEAMELYTKTFPNSKIGNILKYGEGSEGHPIQEPDENIQHAH
FEIDGYSFFCMDNSYDHQFNFNEGISMVVMTDDQEQTDRYWNTLTSDGGRESMCGWLKDK
YGFSWQIVPKKLIQLMSDPDQEKAQNVVQAMMKMQKIIIKDLEDAYNS
>KALACAFP_02821 General stress protein 39
MKTQNKSKSKSKVPKEGLFPEIIRENYQGSQKLLNKKAVISGGDSGIGQAVAVHFAREGA
DVAIIYKESDDDAGETKKLVEKEGRKCIVIKGDLTKKAFRTKCSEKVKKEWGNLDILINN
AGIHTSKDSLEKITDEQIQKTFDTNIISMISFTRNFLPMMNEGGRIICTTSVTAYRGSDH
LIDYAATKGAILSFIRSLSTNLAEKKILVNGIAPGPIWTPLVKETFKDISTFGKDTPLKR
AGQPSEVAPAYVFLASEDANYITGEVIHINGGDFVGG
>KALACAFP_02822 hypothetical protein
MKKLSFEIQISAPPEKVWSVLWDEISYRQWTTAFTEGSFYQGTLEEGSLVKFFDPNNNGM
YSRVVKNIANTEMKFLHLGEIYDGIEVPQQWGEATEAYILDENEEGTQLIIKIQTPEEFK
EFFEEKFPKALGIIKNLSENQF
>KALACAFP_02823 hypothetical protein
METLSYEKIINAPKQKVWDVLWGDDTYSEWTKFFGPGSKMKSDWKVGGKTYFMNSEGEGM
VSTIDSLEEPNQIIFKHLGMVDKEGNEDTQSKEVMEWSGSFEKYILIDFDGQTKLHAEVQ
VEKDWKDHLNNGFIQGLEVVKNLAEK
>KALACAFP_02824 hypothetical protein
MKLLTILFITFILALLGTKIFQGDWNFLFSGNLGMAVFIIFTGLSHFKFQKGMEMMIPDF
IPAKIFWVYCTGFIEIAAGIGLMIPSIRELTAFLLIIFYVLVFVANINSSKKNINIFKAD
YTGPGMNYLYRERIPMQIILIAWTWYFGIYLS
>KALACAFP_02825 hypothetical protein
MKKHNFVILFVLLSSLMPLSGKATKFSTVKNSSTTIANVLNKKGDKQPSGDTKPNKADKN
KSKFTGEFTTDFTAKNGLIYVNAELNGKPASFVLDSGLGSDLILNSNSKLLEDLKESDVC
ISGMGSGKCRQIETSWVSTFNWKGIMVSDVDVVAMPLSNLGGNDNFAGIIGFNMFKNYQL
TFDYQHHNLKVSTNKNLEKEIKENGKLLSTIPFEMKEHMPVFDVEINGKTYKMGLDTGAS
VNVINIKYFDGFTNSLTKIQEVSMKGFGGESKVKRGSIKETRIGGLTYDNMDYNFENASL
NNLNKEYKYGIDGLIGYDFLKKYITVVDFNSKEIRIYEGSKN
>KALACAFP_02826 ECF RNA polymerase sigma factor SigR
MPQKEKENIISQTVSKYGGRLMSYIRPKVKNTEDAEDILQEVWYQFSSLTNLSEIVNVGG
WLYRVTANKITDKYRKKKTENLEDFVYEDEDGDFSIKDILLMDESAGPEVKMFQDEIWKK
LFEALEELPEKQRLAYVENELNDKTLQEIADEQGENIKTIISRKNYAVKHLRNRLRKLYE
DLNS
>KALACAFP_02827 hypothetical protein
MNHKHKKGWIFLIVCPPLIFLGVTWIVMALWNHLLPEILGVKSITYWQAMGILVLSKILF
GGFHFGKGMRDFKEKKMMRERMMNLTPEEREKFKEVWKDRCSGGFFNRHNKTNE
>KALACAFP_02828 hypothetical protein
MKNSALKGALGALAVVGIAFIAKKAVQRKRFVKGIFEEYGIKERSPFGLADKIREMNEEQ
YQELKGKFKKEFASKCHSRFEKKEDIVEA
>KALACAFP_02829 Chaperone protein DnaJ
MKDYYYFLGISHDASEEDIKKAYRKLSLKYHPDKNENDDFFADRFREIQEAYETLSDKSR
RHSYDQNLENHQKSFRYNVPPSIKTFTANKIHAKKGEEIIINWQTQNADVVKVLPFGLEK
PYGERTFKITEFKDGKFQILLHATNSLLHKTVVQGITITEVFENNTEKFKDKAEELFKSQ
PRTAANPHGQPKVARIVVGVIFLILAIYFLIKSLS
>KALACAFP_02830 Glycine dehydrogenase (decarboxylating)
MNTEQFVSRHISLNEADKQAMLEKVGVSSIEELISQTIPSSIRLEKDLEISEPLSEYEML
IHSKELASKNTDYTSYIGFGYHNTLLPSAIQRNIFENPSWYTAYTPYQAEIAQGRLEALL
NFQTVVCDLTGFALANASLLDESTAAAEAMHMFFNNRTKDQKKAGANKFFVSDLVLPQTI
AVLKTKAEGLEIEIVEGDHKTHQLDASYYGVLLQYPGKNGIVLDYTEDIVEYKKLDLQVA
VACDPMALVKLKSPASMGADCAVGTTQRFGIPLGYGGPHAAFFSCKEDYKRDIPGRIIGV
SQDMYGRRALRMALQTREQHIKREKATSNICTAQVLLAVMAGMYAVYHGPKGLNYIADQI
HFKANALKGGLKALGYEIVEEPIFDTVKIVMNEDEKGRLMRMMLDHRLNLNYFTEGIVSV
AINESTTLEKLNVLMASFAQFKDKQTFKLEIKEGYSIPEENLRKDEILTEEVFNKYHTET
ELMRYIKRLERKDLSLTHSMISLGSCTMKLNAATQMLPLSWENWGAVHPFVPVDQAGGYQ
EMIRELEKDLAEITGFAGTSLQPNSGAQGEYAGLMVIREYHISRGEGHRNVVLIPQSAHG
TNPASAAMAGMKIVVVKNLESGEIDFEDLKAKAEQHSENLSCVMITYPSTYGFFDANIKE
ITALIHQHGGQVYMDGANMNAQVGYTSPGNIGADVCHLNLHKTFAIPHGGGGPGVGPICV
AKHLVPFLPSNANIRIGAKEAIDGISAAPYGSGLILNISYAYIKMLGTSGLKKATEHAIL
NANYLKEILAEHFPILYSNTQGRVAHECIVDFRQFKSLGIEVADVAKRLMDYGFHAPTVS
FPVAGTLMIEPTESESKAEIDRFAEALIAIKQEIDEIANGEADPANNVLKNAPHTEQLVI
SDSWDKPYSREKAAYPLEWVRDHKFFASVSRVDEAYGDRNLVCTCEPIEAYM
>KALACAFP_02831 hypothetical protein
MRIEQQIQNYITTQPESKNSELQTLHHLILTAMPECKLWFLDGKNDEGKVVSNPNIGYGV
HMMKYANGSTKEFYKIGLSANTTGISVYIMGIDDKKFLAETYGKRLGKASVTGYCIKFKT
LKDIDIDVLEEAIKYANEQ
>KALACAFP_02832 hypothetical protein
MKFFNIFLISILLISCSKKYTGEVSFKNCKINYPLHDEKKESRIYNGHNIPNQWEYESAM
RKMALCLCEKYLQKPDTEIKEKIIEIYKYKFEFYNKENTFKKVNFDSILVNRKDIFNSEI
LID
>KALACAFP_02833 hypothetical protein
MKEDLLHNLEIINQRIKNACEKAGRNADEVKLLLATKTVSAERIKLALENSETLIAENKV
QELKEKYEDLKDIPHENHFIGHLQTNKIKDILKYDVRCIQSLDRLDLAEKLHQRLAMEGK
TMDVLIQVNTSDEESKFGIHPDFAIDLVKKVSEFDTLKIKGLMTIGLFSAETEKVRTCFK
ILKNLQQEIIQQNIPNVEMKELSMGMSGDLETAIEEGSTIVRVGTAVFGARIYPDSYYWN
ENSKNL
>KALACAFP_02834 Proteasome-associated ATPase
MNLYNLIIQDKEEVTLNDVFLAPNNKEQLVQLIKENTYSRELQEYGLPVNNKVLLQGSSG
CGKTMTAKAVANALGKNIIILNLSNIVSSRIGETSQNIKMIFDKAARERSVLFLDELDQI
GKARGSDDKDVGEMRRLVNTLIQLIDYYPENALLLCATNHPEIIDPALIRRFQLKINYEM
PSKDFLDRFYDNLLSKFPEDLRKIERKYEVSFAEAKDHTFTVVKGNLIQKLEAQHQTQS
>KALACAFP_02835 hypothetical protein
MNESDFNLKHQNQNTESKIVASLERISQAFRVLLWQESKEYALSPIQVQVLIFLLNHSNE
KRKVSYLADEFNMTKATISETVKSLEQKNLITKEYEPHDTRSYIIHLTQKGKEIADKTSY
FTREISAPIQNLDEESKENMLQSLFDIIHHLNKTGVITIQRMCTTCVYFRPSAEGKEPVC
GLLEKVLYSEDLRIDCPEHQMKA
>KALACAFP_02836 hypothetical protein
MQVAVWDTYVTKKDGTVMHFDIIAPTEIKETDVIYGYGKDYLKGKGQESQELSAKECSFC
HIETVLPQWEADINEKGYTIIEMENCN
>KALACAFP_02837 hypothetical protein
MKKSVFYHAGCPVCVSAEHDIISLIGLDNVEIVHLGDNKERIAEAEKAGIQSVPALVTPT
GNVLHINFGASMEEVKG
>KALACAFP_02838 Formamidopyrimidine-DNA glycosylase
MKENLQKLVGKKVIEAHGNAKIDHPILKGKILKEIRTFGKQTYLVFDDIAVRIHLLMFGS
YSVDEQTKPDRQLRLALIFKGSGMYFYTCSVKLVDSEFLAAIDWEADVMSDEWNPKKAEK
KLKSKPEMMVCDALMNQDIFSGVGNIIKNEVLFRIEVQPESLLGNMPAKKIKELIAEARN
YSFDFLKWKREFTLKKHWLAHTKSVCPKCGEKLIKKQTGLGKRRSFYCEKDQKLY
>KALACAFP_02839 hypothetical protein
MKIFLNLPKRTQMKNLLFLLFPICLFSQDNCFDDGQKHYRSGNFLFIKDTEELILFNNPK
HIKFQENKSNISYQKDEILEYTGYDTIPNFWEKRKAEYEKKYAEFNTYFSDQFKYIQLQK
EKNISYAIAENRFGYWLLEIKNKTPKAYYIGFNKNTYINKNQKEIFIKDNKLSIDGSFIA
IAESWGRPGHPEIEAVKDFLTFQIDLNDIKKDSDDDGYNDFFENLIFLNPNSKDTDGDKI
SDFEDLNPRYKSENTKFTKLFEEIIEKDGYQNIQENHYTFETYESDCEYFQKVNPGKRRV
LIFPEEKARKLNSDYKPGLFSTYYGRIKKDPDGKTFYIPYHESSSGGKIIAVYENGTWSL
STERGYVI
>KALACAFP_02840 hypothetical protein
MSELLQQILGSSIVTALFTAIIAYFFHKRTERHNAILKREFEALAKKDTSYFEWRKNTVE
LLGQVYIHLNRLKLAFQNKYSKIKDYDPFYEDEIIYQSNKHIRDLLINNGHFLPPELLDE
ATKLVEHFDVWLTKYHQTRIVQKDFHSKQIYVGPDGFRFPENAEKMFKDKYVEMFNELHK
>KALACAFP_02841 Deoxyguanosinetriphosphate triphosphohydrolase
MNLNQIFTNQRTGNNPQTKASRTDFQRDFDRIIFSSAFRRLQNKTQVFPLPGSVFVHNRL
THSLEVSSVGRSLGSVMGEFIHDQFNSDLTEDAKSFYLHNLGNVIAAACLCHDVGNPAFG
HSGEDAIASYFEKNEKDLKPKFNEKEWADLVNFEGNANAIRVLAHQQQGKDAGGTQLTFA
TLASIAKYPCEAIAKQKGIIHRKKFGFFQNEKEIFLEIAKGTNLISESEEPHIFKRHPFV
WLVEAADDICYNIIDMEDAHRLGIVSTSDCENLFFELVKSETDDIKRVKDKLASIGNDNE
RISYLRAKVINALINKSIETYKLNFEKILEGNLDKALLDIYKSENDSLKEIEKFSIAKIY
NHKAVVEIENAGYNVMYELLNHFIPSILKSKDERKSYDKMALKLLPQQFVYEDGTDYEKV
LGVIDFVSGMTDNYATDLYRKIKGIDIGMTV
>KALACAFP_02842 Putative monooxygenase
MWNKNRITDLLGIEYPIFQGPFGGGLSTVELTSTVSNLGGLGGFGAYTLSPEEIYEIDKQ
IKLKTDKPYNLNLWVNDHDIIDQEHTENQYKKTVEIFKPYYDSLGIEVPALPPSFESRFQ
NQLQVVFDIKPKVFSFMFGLLDQDIIERLKSQGTIVVGNATTLNEAIALENLGVDAIVVS
GFESGGHRPSFLDKAELSTTGTFALIQLVKDKVKTPLVAAGGIANGRGITAAMTLGAEAA
QIGTAFLATEESGALPIHKEFLFSDAARSTTLSRAYTGRLGRGITTEITRKLLTATDQTL
PFPLQTTFIASIRKAALEQKKHELVFFWSGQIAPILKHKNASVLMKSLIEEANELMG
>KALACAFP_02843 hypothetical protein
MKVLLLLTSLLIFPVGSFAQKIKVMKTDTVQETEIRNAIEQYYFKGIYEGNTELLKQVFH
KDALLFGDIKGVPYYKTAAQYIEGVGSRVSPEKSGKDFKPTIISIDVINTIATAKLNVKM
YDFNYYNFITFHKIDGKWLIVNKTLTDVEL
>KALACAFP_02844 Dihydroanticapsin 7-dehydrogenase
MKKQTVIVTGASSGIGLEIARYFLDRGDNVVINSQTESKLQQVYNELGAGENLAMVAGSV
ADKAVGEKLAKTAIEKFGSIDVLVNNAGIYENKPFLEVTEEYLDKFLTTNLKGTFFTTQS
VIPQMQKQKDGVIINIGTPLVYHAIAQSPSTAPISSKGAIHALTLQLAAEFGKDNIRVNV
VAPGLIRTPMHDESIDNNAGIHLINRIGEPQEIAQMVHAIAKNTFISGAIINADGGMGAG
HNL
>KALACAFP_02845 putative tautomerase
MPFIKVDVLREDLNREKKQQLIREISKAVTTVLNKDPHLTHIVINEIEDDNWGYAGEQVS
VLKEQGFSTEKK
>KALACAFP_02846 Protein YceI
MDTKNFKVNSEKSLVEWIGRKVTGAHNGTIEVKEGTFAFEDNTLSSGKFVIDTRSIKILD
IDDAETNAQFAGHLASDDFFNSDQFPDAIFEITHAEPGDNNSYYVTGDLTIKGITHSITT
TLQIVKTDNAAVLDTKIVIDRTKFNIKFRSSNFFTNLGDTLIYNNFDLNIHLVAEAQ
>KALACAFP_02847 hypothetical protein
MVDAKNILKEHISKFVSLPEEQFDYVFGHFNLINLKKGQSLITEGDFVDHEYFVTDGCLK
AFYLNDSMKMFILQFAMPNWWVTDFDALYSKNRATINVDCITNATILSISNEDREKICRE
IHEVEHFFRWRTNKGYVATQKRLLSFMNNDAKFRYEELLSLYPQLYNLVPKHLIAAYLGV
TRETLSRLHQ
>KALACAFP_02848 hypothetical protein
MKKTTTILLIAGIGMTKISAQIGVNTSNPQTAFHVDGAKDNPATGAPTAAQQTNDVAVTQ
QGRLGVGTIAPTNSLEVDSRVASTSGVKMTRLPNASVLATDANGNVISGVTEDAGVSVTK
LRLAVATPSLVLNSASNNYSFRYNSTSTGGTWQIRINNGATRQFNIWDTEYNGQAGTGVS
DTVWQLRTVKNLTPGTWTALDDNIAGGANEYNVYHVYDLSVGTILRLTVTLSSVSGIRES
MILEEF
>KALACAFP_02849 hypothetical protein
MKKKIIILLITSLGAIKTTAQVGVNTENPQASFHIDGAKDNVTTGVPTAAQQANDVAVTS
AGNVGIGTSAPDASAALEIRSANQGLLPPRVTLISETDNLTITNPATGLSVYSFQNGTLE
AGLYTNIGTPAAPQWKRAGETVNNNIGSKIYKTVYRGRNVSPYTKPNLQVPEMNLMFRFA
VVAGDMRLQVRMINPPTQAGVWVRLLGHWQGEDLNFHGSYANQIQFTAANYSTWTPFGGI
WNGEWGYYYLIYTDEQRSGTDNPYDRAMNLYGIDSFGYYNAQTQKEIYSLAAEVF
>KALACAFP_02850 hypothetical protein
MQKTKLIETRKRKNISQEKMADILCMDVSNYNRREKGTAKISLQEWQKIADTLQVPLDEI
YENEESLIFIFNDNATGNGNIVSNNYNIPVSMWESQKKYIEKLEAEIESLKAMLHKK
>KALACAFP_02851 hypothetical protein
MKKTLLLGALFIAGVVSAFPFRTSCGTIVMVNGASGSLSHIENICESINLAVCGTYADVV
LYTH
>KALACAFP_02852 hypothetical protein
MKKNLIFFILLSLKLISQTSFNVIYEADYKLQYKMLNINNAKLEEAAFALLINEKESYFK
NMNKYVGDSLRYEKKLDDNSSNGKYFTPFRENIGTTDGKIYVTVPISYKNFKYEETNDIT
WNLINEYKTIGKYKTQKATTKKYGRTWIAWFAKDIPFPFGPYKFNKLPGLILEVYDEKND
YHYTLYKFGKRKYLCKSANMNTGATLVEKSRIFDYQRKEIGDQNQFNDVIEDKETLNMLR
KKSAERAKQFNPIELSIY
>KALACAFP_02853 hypothetical protein
MALDNLISLTFSESDLTTIDQALSSIENILLGKTINLTPEQRQQYGRIAEQNKLFVNMSK
NYMEQYPQFVPVFLDKAEFDRDYSARQQIESRLQRLSSITEQLSDTKVLLDHDNYHNSIT
FYRNMKFLAGENVPGTNVIYEDMKQFFVPPTTSSPSTDTTTPPTDGSVIRQ
>KALACAFP_02854 Autoinducer 2 sensor kinase/phosphatase LuxQ
MKFYYFILIFSSLIVHGQRYASQWYGMDQGLPQNSIKDIAKDKDGFIWLSTDGGILRYDG
TSFLLHNDFKISSLSFKDFLRYGNDGFICFNNGEKEGVLISGRTVKVLPEDKLVRTYALK
GAYQSKRFCKNSLIEYFFPDVDCYYIKTDSGTYFFDNKNIEYQARNGKKKLIQQNFHHPY
LKQSFEQNGVIYIADPQNRRTMILRNGTVSYDNQPSLYNDPKTKIYWHQDNKQVFVINND
NIYVSKIVNGKPTLSFLMQYKDVEKLFLYCMFYDEEANKMYFGNVVNGLNIVNLSNFYVS
QKNIPYTGEVCYEALPFTKNSVITKDGIEYYKDKVNKWYSARVKYDKRFLIYDDSQNLLY
LEFNKLHRRYRSTQYQKRDSISFPGKSVEGLYKIGKKYVISIPDYNWNYHLTIFTDDTFK
NPKNVFKFKSNINFVTEYNSDMMYVGTSNGIYLLSLSKNKVVKYLAKDLPIKEIQRTKDG
NFWFTTYNKGLYLLKDDEVIRMPEDKNGYIASAHHILEDNHGMFWISSNNGLFKVSKKSL
LDYAQDKNSKVTYYRYTKENGFLNNEFNGSSNPSGNILENGEFVFPSMEGFVFFKPGEIK
SHYPKSDQLYIERAKIGKDIVGFKDTLRLKSDYKNVDIFLDIPYYYDIENIYLEAKLENS
GNNKWEEVRKDKKYTLGSVDPGNYTLLIRFLVADGKFVYKKIFLEIKPFFYQTMLFKILV
MLLIVTAIVLIIQMRTNFLRIKNKKLQSNLHNRNLELKETSDTLEMTKNKLKNEAEYQQK
IMESISHDITTPVRFIALLSQKLSEAEDAKIQKKYFDGIYKTSEQLFKFTLGLKEYTELY
KEENVFDDEAHSLYELAEDKKLLFEEVASDNNTTITNLCDPELKIRTNHNILSAILHNLI
DNAVKNTTDGKIEITSDVKGNELEINISDTGKGMSQSQIEYYSHVFESMETENFVFKNYG
LGLHMVIQLSKKINAKISFHENSPKGTIVKIFLKLH
>KALACAFP_02855 Transcriptional activator protein ExaE
MNKKILIADDHYVVRLGTALILESQFAKISIDYAESYDEVKNKLNAERFDLIILDIEMPG
STFKKMIKELKMIQEDLMIMIFSSYKESVAIEYIQEGAEGYLNKLSSEKTLIKAVQSIFE
DGYYYPFKLVKQLSARPQKEEVESILSEREFQVFKLLVEGNGNLEIANILQIQMTTASTY
KRRIYAKLGVNNLIDLLKIYNSQNQEK
>KALACAFP_02856 Modulator of FtsH protease HflK
MAYLGIIIFIGLVTLFASFFTVKQETAAIVERLGKFHSVRHAGLQLKIPYLDRISKRMNL
RIQQLDVMIDTKTLDNVFVKMKISVQFQVIRTQVGDAYYRLESPHDQITSYVFDVVRAEV
PKLKLDDVFLKKDDIAIAVKAELQEAMQSYGYDIIKALVTDIDPDEQVKHAMNRINAAER
EKTAAEYESEAQRIRIVAVAKAEAESKKLQGQGIADQRREIAKGLEESVRMLNNVDINSH
EASALIVVTQHYDTLHSVGANNRSNLVLLPNSPTAASGMLNDLVAAMTTANTVGEMTKGK
YPPPPKEHEH
>KALACAFP_02857 hypothetical protein
MKTIITAVKSAFPVLAVFALTQCKAPANASNGNEKTLIVGPQTADCTGVAPMKCLQVKEK
PTENWTNFYSNIEGFTYEPGYEYVLQVKTEKIENPPADGSSIKYTLVKQVSKTKK
>KALACAFP_02858 hypothetical protein
MDNQVETENYKVEKFSPWAGYIEDHELIERIKDSDFAKRQIDEGRDYCYFLDKKYYTSNT
ENNEYVCMAYTLNEPSNLERASVMDIVVEENEVYNIHRISVLRDGVLIDKIPDMKVKVLD
SENQSSGGILSSNKKINITIKDLRLYDILILEDSRVKAFTDRDFLRKEFSKYVWVSPDNY
WAYGSFRFTFINDREQTIAYKKTFFRDENGNVLEPEINYLQKGEKFVFEEKNYINPVDAN
REIFPYIDFATDTNWKDLSNYIAPIYEEIFNKAFLPEYAPNLVEKLEAISDLDEKIQFAI
EYVQNNIYYIFNADEMNGHKPQEPAITYENKQGDCKAKSVLLKVILDYIGVDSSIVLVNF
HTDFYIKYYLPSLLTFNHVIVKINHKGEEYFIDATIRDEFGLLENRGFIYFMHYLEVKPN
QELKERKSYKFPYYCIDEKVDFNVQDTTGKLVLTTVYKGNRANAMRRYFKNTNKREVVDS
WNNFLFYSLNYSGDRNGTDIRNIFKDASIDIVSDDKQLNEFKIQYKSTIENPYYTDPKNN
RFLMYFDRNVVKASARDYMHKDLPFWHNFDREKYEINLYTDQKIDTEEKYTAQESTIKNP
YFDFTSRKKITKNGASVFIEYNPLTNLEIPQSEFENFRTNHHTVADSNFGLGIDIIEPGL
MNRLKFSFKKKFK
>KALACAFP_02859 hypothetical protein
MSERIKTFKEFYQFYLTEHSKMGTRIFHFTGTLLVFVVIGYVISSGKERFLWYIPIFGYG
FAWFSHALIEKNKPATFKYPIWSLISDFRLFFELLIGKQKFRGISVKKPVE
>KALACAFP_02860 putative amino acid permease YhdG
MSQLFRRKIYSDSDTSTHLLRVLGVWDIVFFGIAAIIGAGSFSSLGEAVFRGGPGVILLY
LICGFACGFTALCYAEFASRIPTAGSAYTYAYASFGELIAWIIGWALIMEYSFGNIYVAF
SWSDYFTSFLERLGMHIPDYLTCSYTEARKAFMNGSENTELLNAWKNAPLIGNLKFIVDI
PALVINGLITWLCYVGVKESKNFNNALVILKLAVIVLVILVGFAYINTDNWTPVNPQTHV
TSFMPNGFSGVMSAVSGVFFAYIGFDALSVLSEETKDPQKTLPKGMILSLVLCTFIYIAL
TLVLTGMVDYRKFDGVGDPLSFIFEKTNANVAWMELVVSFVAIVAITTVLLVFQMGQPRI
WYAMSRDGLMPQKFQTVHPKYKTPSFATIITGIVVGIPILFTDKTFILDFTSIGTIFAFV
LVCAGVLMLPAKEKIKGRFHLPYINGKIIFPVIFIGTLIVFYIFEPQFFQDLMDWKDPKE
GEFRASIFFFILINLVLCVFTFIKNFSLIPLIGLSSCLYLLTGMSHENWFWFGLWFAIGL
VIYFCYGYRNSKLRRA
>KALACAFP_02861 Lipopolysaccharide assembly protein B
MNSKKILLATAVLYFGISDAQQSQYFTQKENYRFNLAENLYQTKIYNASQYEYARQYFYN
QNLSRSRKEAAQFFDNVIGVILQKNHAEEGLTAFMKEYPNSAYFAQANLPLADYYLAKKD
FPKALETLKKVNQYQLSKEENTQYILKLGYAKFMMGDSKGATDALEEAYKTADESQKGDI
AYMLGHLYYSNRQNDKAFQYFDSVKDQPKYSKLVRPYYVQMYYNDKDYDKAISEGTALLN
EDISDAYKAEVHKIIGESYFMKGDYDSAYPHLKDYLSVQQNPSENDLYEMGFVAAQLKKY
DEAVSYYNQLLNSNSALAQNAYYQLGNAYLAVDKKQEALSAFRSSYQMDYDAKVKKLAHE
QYAKLSYDIGNPFESASTVIQNYINENQNDPNASEMRSLLVKSYLYSGNYKETLNAIDKL
QDSTPEINKVDQEVSYLLGTEEFNKGNYDEAEQYFLRSLGFNINKEFNNRALYWLGQVYY
QKGNYPSAIARYEKLLNENFPEKQQLPYDLGYAYFKSKKFDQAETYFKQYLTNPKPEFKN
DAELRLADINYANNNLNEAIAIYDKNEDATDYTLYQKGMALGFKGDTQAKITNLKNLLSK
YPGSDYYDDAQYEIGTAYAAQDDFANSNDFFNKVIKTSSDSDLVANASIYRAQNYIDQNQ
SDKALSELKALGEHYKNSIYAEKIVQAAKPIFTKNGDVAGYESFAKSIGVNVDASEIDEI
NLSTAKQYFAKKDYKNAISYYEKYLTQNPTGEGLYQAKYELGESYYQTKNTTKALLVLME
VANLANDYQDDAQTRLAQIYVAQGDNNEAKKYLENIKNSSNVNIKNYANVELMKIYGDEK
NFSEAEKLADAVIANNKNSAAVIETAKVIKARSLMNSGKDKDAQTAYASLEKSSNTAVAA
EALYAKAFYQNKGKAFKSSNETIFKLANNYSSEEYWGAKALVLMAKNYIGLKDNYQASYT
CDQIIENYKDFPEIVAEAKEVKKQIKK
>KALACAFP_02862 hypothetical protein
MKYILPIIFLGVSSVAFSQIKEEKLILNKKREPEVKKIEKKKTSVETIKNYPPEEKSQNP
VKYTITDVPAVSDFKTSTIQGQDVTPKFEGSAQNNYIQFGMGNYGKILGDANISKTLENK
IEVGVDAHFLSTQGLKKEYAWDSKQSSTTLGAFLNSYGDKGKFNLNAEYGLNSYNYYGIY
ALEPGDVDLDQRINQFKVNGYYDFYSNEILNDVRVKSSFLKDHFDAQENQVSILANLSKH
AVEIGKSGINLNADLGVGLEAVKSEFAIRDKNNSNFVNTSLAPKVTFRKGESYLMLGSSF
SFLNSKNQNDLMAEQMKNNKTYWFPQAEFQYAAAKEFKFYGGVDGGLKLNTYADLLQQNP
FILSDQYLKPTETKYHFYVGLRGDIDEMFKYDVSAGYGKMKDIMFFKANSIFDTDYTLNR
SAYNFANTFSAVYDDGNVGDIKGSLQYFPLANLVLDGEVKFTKFDLKNYEDIYNVPLVTA
TIGAKYTMLDQKLLLGFKGIFASDRTTNSFMIEGVGSPMMYQSTEDTNDKVGGYADLNLS
AEYKIHKNFSIFALGNNLLSSKYQTYKGYKVLGAQVLGGVKITF
>KALACAFP_02864 hypothetical protein
MIKKILFMLAFAGIMITHAQTGNIGIDTALPTTKLDINGGVTYREGSPITVNGATVVIPD
LSFSQYRLTGTPSSAFTITGPTTSDGTTAIIAGARLIIVNATSQPGVLNSFSILPGLAQE
FTYSNGSWTAIRNPSGPIGLFAKSAGTQVITGAQVINDWVVTTNNFATAWNGSIFTVPAS
MQGWYSISAGYSTAASYAGGIRTPHQHVLIRVNGITVAQASTAVVITGGLVNGNAPGSGT
ANASINYYLNAGDQISIIGNHLSYLVSNNASTPASAESLFTYLSILKQ
>KALACAFP_02865 hypothetical protein
MINKLKHFTLGVSLLFIFACQNNDSISTDSPRIENTAHAATAKVTVDNPYELAGIRHNAF
LDYLKTQPNAVNVDQIVDLSINFSNQNNFHPLTYVTKNEIIASVNPSVTQPFMVSLDNLY
SQGKISSVVYAQLQNLGNILNNVNEQDGIDGLVQNIENLEQTCLLLDLNDTDKPVLLSVL
SVAKYSSHYWRTIYFPTQGASKIGAFLKALLNVAAVIGADAIGAAAGAAIGAGVAAVTAG
VTAPIVVPGMAVAVAGAASGLIAKDPPVK
>KALACAFP_02866 hypothetical protein
MRKNVSILMFIASGIFLLIHAQVGISNSNPQGTFHVDGAKDNPAVGVPTIAEQANDVVVT
STGRVGVGTTLPTEMLDIVGRGRIRTMDMVAGTNAVTPVYTDSNGVLVKASPSAAYGAVL
SSFAGNVASGATATLITGIPDGSFYKAVVIVGDGCGNATVAEYYVINSSASSLFSINGLG
GNQGSGNTDKSPKFTQISRYTITTAWTDVVGCADGGNPTALNYTLTMPAVGTINVINNGN
VTRGYQIVLTRF
>KALACAFP_02867 Histidine protein kinase DivJ
MRFKICCTKSFLLNIFLFVFLKSHGQYISSWYTTDNGLPQNSIKDIVKDKYGFIWLSTDA
GLVQYDGLSFTVFNKLPITNLHFRNFYGDVRNDSIIVYNNYEENKVLIRNKKIEVIPKDN
SDGIFIKEKDNFLKRITKNEIESKYYSKTKYLIKISSGEYTFYNDEIGYTDKKEKQKKVP
IHISEVYNVFFDGETLFMTDPEKRKTYRIYKGEVTPIDKPSLLNAPESKIYWQQLTNQTF
IVNNDRIYLVQKYNNELHFKFLVQYENFGNQLFTSLFYDEDFNRLYLGSTIKGLNIVQLT
QFYTARKKIPFVDDVSNSSLPFSKNSVIDPLGYEVNKYGLVQDHHFGLNEKYFMFYDKSG
NILYKNDNTIIRRFKNSGYRKSDTISFTGLKSFFKSSNLYAISTTDLVYSYLHIFQNEDF
KKADYNFRFTGFVNSFLKYNDDVLIGCSNGLYTASLKHNKIKLIAKGINVKNVFQTRDGQ
TWVTTNKDGFFLFKNNKLIKMPLDQEMYLHTAHYIVDDRQDYYWISSNNGLFKVARKQLL
QYADNPKTSVFYYRFTKTEGLSTNEFNGGSMPEAYSLENGDFVFPSIEGFVFFDPKKIPV
YYPDRKNIYIERARINNADIIRFDRHLVLENDYKTADIFIDIPYYSNSCNLRIEAKTEGE
NPDWERIKINNERKYIINNLGPGYYILKFRIQVSSNGDYEYRTVSFEIKPLFYQTNAFKI
ALLFLLILGLTGIIHTRTRFLQTKNKALKKTVSSISTELKETSEHLETVKNDMQKESDYQ
KRFIEAISHDISTPVKFIAMLSQKLIEVDETDLQKEYFDSIHQSSEELYNFTMHLKQYSD
LFRDKNIFENDEYCINEIFNLKKKLFQEISKEKNNIIHIEEGNEVYCKINKNTMSCIVHN
LIDNAVKYTTTGKINLSANNKAGKITIKISDTGNGMSPEQLTYYNELYKTSSDDDIIRFK
NYGLGLHMVIYLIKKIKAEIAFSNNEPKGTTITIDIKNNIDE
>KALACAFP_02868 Oxygen regulatory protein NreC
MNKRILIADDHYVVRTGTAAILRSAYPNLTIDSSAEYGHVKESLQANRYDLILLDIDMPG
SRFTEMIPELKAIQSDVKILIFSAYDQDIALQYIRKGAEGYLNKRGGEDDIEKAVKTILQ
TGYFYPPDLIPFIVKDVDISNSIKKLTSREYQVFELLAKGNGNLEISNILGIQINTISTF
KKKIFEKLKVNNIVELSKVYQNLH
>KALACAFP_02869 hypothetical protein
MRKITLHFFCACIAGITIHGQVGVGTSNPHPSALLDLDASNKGLLLPRIALLSTTDIATI
PNPAKGLMVYAVQNSGTGITAIQKDTLYKFDGTQWKALTTREKFISNEIPRIVAVGRKTT
VETCVGVTNGVFNLNQRSSTLITAAGGFTAPQAGYYMFSVKIVQLMAPSPSQPFNVSPYI
QAPNLATYSYLYRGSGVSAQPASVLGVIHLTQGQVTQGFKWFFGTNTCTAEGRIQGQEVT
WEYLGNPL
>KALACAFP_02870 hypothetical protein
MSQVGIGTATPASSSILEMSSTKKGFLITRASLVSKTDIITVANPSMGMLVLASQSSGTG
ENAIYEGRLYKFNGTAWDELVEEGEIASGSLYPELVAVGNKTTITTTCTGAVMGNFQLTT
LKNIKTTINANGSIQANKKGYYIWSVSIRQYMLQSAYSPFLLPGMLNYAFRDGNSTTRAW
QTTVFTGSVYLEQGEISEPFQWHLGGTCVAADRIGEQQVVWQYIGE
>KALACAFP_02871 hypothetical protein
MKKNIFCLLIGLVTITIKSQVGIGTAAPHPSSILELSSPDKALILPRISLTSTTDITTVA
NPVKGLLVYNLSDSGAGTGRVYKDLIYLYDGVVWQALMDYKLATNTINMPTLYSRGRKTT
VTTCTGVSGGNFTLDLRDNNMGVSGTITADKAGFYKFTAGIVQYFQLEFIPLLVTPSGTF
SYNFRGATGYQDRKVTTSGVIFLTQGQSTPPFFWGLGGFNECNATHRIKGQEVIWTYLGN
L
>KALACAFP_02872 hypothetical protein
MKKIKNMGLSNLGIFHTAIGVIALVAGIVSLVKNGKIDLSQLSGKIYFYGTVITSVTALG
LSKNGGFNVGHIFSLFILILVVIAFVLAKRNSGNRARYFENFFLSFSFFLSLVPTVNETF
TRVPLGHPLAKSPADPLIGKTLLVLFILFIIGSVFQFTKQRKNNRMTQA
>KALACAFP_02873 hypothetical protein
MSTTDFLQKIIKPFAGLTEEDISVSLPFWRTRKIPKGDFFNMQNIVCKDLGIVVKGIFRV
YYYDNETSEEKNMFFFSEEQFIVSFRSFLYQCPCVYFIEALEDAEVLYVSYEDLQHLYTH
HKSWERFGRMLAEHFFHQSQGRTEYLLLFNNEKRYLNLLAEHPKIVERIAGFHIASYLGI
KNQSLSRIKKRIASNNSDLNLRSE
>KALACAFP_02874 hypothetical protein
MKFKIKKTPPKPLKKTTLNRFLRKRMIIYVLPNVFFNFIIAYASFNELGYTHFFAGNQCL
ARLTLPMAIFLPVVLTIDIIKRITDAAEQHAIEFAVDDQLNLKKLMTRLSILHGLITGSL
VFLSLMFAQFILSEYYKLDATAMAVLVGILAGLLSVLFTYLPVWRLRKYLYRTVASLDTN
>KALACAFP_02875 hypothetical protein
MIKRKLMMVERIMYVDSETPVNVVYTAKIKGEISEENFSVALHKIQQKHPLLRVSIDHKS
AKYPFFVEEKEISPIPLRIVERKTDQDWLLESENEWYRIFEDKKKPMAQIVWVKGSTASE
ILWVMPHCICDGTTGITLLREVLALLDDTSIELNSYEGFDSVNDFLPADFNLKKKKRKAR
FYLMMAKLFFLIQRKSKDRNLGKNYAIHRKLDAETTKIITGKCKANGISVHALLCSAFIQ
AFKETQGRNAKGKVISPVDVRHFIPEIQQDHIFAFAPTVELSLKKGTQDLVENAKYIKKD
LVEKIEKTETRELLWMGENMHPVVDRMISMLKSSKGGHDVTLSNMGKIDIPGEYKNFQLE
TIFSPTVAFPWLNSNTLVTTTYNQQMDFTLMSNEDFLPKEEAKKIKDKAIELLIS
>KALACAFP_02876 hypothetical protein
MKRRLLFGERMLLGDGTEPFNTVIPFRLKGIFLIENIQYTLSRLQVKHPWLKAIIKHDEK
NIPWFEVQEKTIPIPIRIIPRTGNNDWLEESQKEWHTTFKSTEEPLLRVVWLKGEEFSDI
LFVFHHCLCDGGSAMTLLDEFLKILNDPTYDIGMENPILGIHDVVPDEILNSRGQKLKAK
MIGRLAATAIKVIPVNKKTTDRQSDYLLNWKFNKETSHELITYCKSQKVTVNTFLSAAVL
KAFQKIRREKAFNKVSCPVDIRRFANQIKDDHIFAFGLMIVVSLKKKLSFKENLKLMQET
VEKKTSKLNPYITMMVMESAHDALSNFTKLLKNGKSSNDCMFSNLGRIQIAHQYKEFTLE
NVFSPSVIGPLGNTTTMVASTFRGEMNFSFMGSEGYLPHSEALAIREEITKIVKHQLESV
AIL
>KALACAFP_02877 4'-demethylrebeccamycin synthase
MAKFVFIVPPLTGHVNPTLSIGATLLERGHQVAWISLDQQLQHKLPEGGELLLIQYDQTD
EEKRDSENYLDIISKKVVYGIDSIKFLYEDVLIPLNRHCYNGIIPLLKAYQPDLVIGDHQ
LFAASIAAKKLGLPYATTVTAPAAIKIMSELPKVHEWEEKQIIALQKELGVEENRALDCS
DLLTLVLTSRYFFGEMDLPTNFQFTGPVLTERRISCEFDWEKFNNSSKKKILVSIGTTFD
HEHKKAFFQKVIDAFKDEELTVVVVSDPELFDHWPEHFMVYQQVPQLELLPHLDGVVCHG
GHNTVSEALSNGLPLVVIPIAYDQSHVAGRVVRTGAGERLNFNRFKAHHLNEAVHNILTN
PEYKKAAETVRESFLEAGGTTTAAYLLELALIPTSEPEKPQSKFLFVIPPFFGHISPTLS
VGASLIARGHEVKWFGITPLDNKHIPEGGSYFYPEQDLIPYQDEIAKILKRQDDGPSCSG
PEVMKLALEETYVPFAKMMMPGLETLTKEWQPDVIVNDCITFGGALFAHKNNIPCVTTTP
VPPDVMGDTANSAPKIFEWQQNLIKQLQKEVGIEDDGIFIHSHHLNLIFTSQKFADFDEV
PAHMEFVGPVKGRPNPAPFDWDKLNASTTPKIFVSLGTLLVDIRKAFFEKIIAAFAGQPV
TVIAATPPEIFEEWPSNFIVSSFVPQSALMPHMDAVICHGGFNTVNDTFTNGLPMLITPI
AYDHFHIAKLIEKAGCGISIRYKRLRVDALRQAVFELLENPVYRNAARQVQASLINAGGN
DRAVELLENFVEQSTLIPV
>KALACAFP_02878 Dihydrolipoyllysine-residue acetyltransferase component of acetoin cleaving system
MPIISVNDKKVHIQELNKGAEQTVVLIHGMFSNLSIYYFNIAPILAKHFHVVMFDLKSHG
MSERFTDGYDLENMSSDVLALMDALHIEKAHLVGYSFGGLISLKTALKAPNRINQLVVIE
APDPQDEKARNIIDEYSKEFLEHYVANFTDTTKVQMGKRQMEKNHRMYEFLFNQTSIKAD
MIKEKHFLSEVDFSELKPSTLLMYGEDSNCRPTGEWLNTQIENSELRLIQGDHNIPIQEP
VLIAETIAHFLSKSLKTLTQNHG
>KALACAFP_02879 Acyl carrier protein
MDTINTTEKLNHEELFTLLKGFITEVIGEEFVEEMDITPESSFTKDLEMDSIEIVSFSEK
IKAHFGEQIDFTGWLSSMDLDQLIDLDLSMIINYIYECQ
>KALACAFP_02880 Polyketide synthase PksN
MKKTDVAVIGLSCVFPGAQDADTFWQNIVNKVDSTQLAPADRIDPVHFSDSTNPVDRFYC
QRGGFISDYEFNPTAFGILPLAVEGTEPDHLLTLDLVQKALDDAGIFKKNISLEKTGIII
GKGNYTGPGATRAIEIVRTGEQISSLLKELLPEISSADIEKVKHAFQERKGRFAADTAMG
LIPNLVASLVANRFNLGGAAFTVDAACASALLAVDHAVQELQRGRSDIMIAGGVHTGQNA
AFWSIFAQLGAMSRQQQIKPFSSDADGLLIGEGCGFIILKRLEDAVRDQDKIYAVIKGVG
ISSDGNGTSVMSPAVKGQLKALQQAWANADLDENQIGYLEAHGTGTPLGDKTELQTLAQF
FGKEEGTKIAGIGSVKSNIGHAMPAAGIAGLIKTCLALHHDTLPPTLYCENPTSEMQNTR
FEPIQEAKNWSKTGLPKVAAVNAFGFGGINAHVVLEGYEMPKKDEVLILARPTHEELLTA
LQNNETAVGEGNFRVAIFEPTPARIEKATKIVAKNNPWRNKQDIWYTNTPLLQNGEKVAF
VFPGLDGLAKGEVESVSRYFNINAPIETEGEGLLNDALHIFNNCSILDNSLKKLGIVPDM
NAGHSLGEWLAGYSSELAEVNSVKALIDVLNPETFELKDSKFIAIGAGIETIKPIISAIK
NVYISNDNCPNQVILCGSNAALDELVPVLKSKQIFHQILPFQSGFHSPFIADKLDVILAG
MEKAQFQQTKIPLWSATTLEPYPADQESIRKLSAEHLVEPVRFRELTDKLYEEGARFFIQ
VGTGGLIGFIDDTLKGKAFSTIASSVATRSALAQFQRVVAALFVEGKTVALDFLDIQNQS
KKPSGKGIKLKLGSPIIRDFTEIKNLAKSIDTSKQKVSAAVAKSGHPLVQAFQDNISDMI
KMQEEVLTLFQDRPNIPIPNVVLPKVQTPISKNFEKTLYITLETHPYLIDHSLLRQPKGW
TEVADMEPVIPMTMIFEQLAEIAQAEIEGSQVHKIMNISVFQWMNVAKPFEKTVKGEWKS
TNHAYLDIENFANAEVVLTSTARPNPTFNLSIGEILPIERTPEEIYEMHMFHGEKYQGIT
EVSKVGTKGIIGKIKGNGGKGSLLDNAGQLFGLWLQLTLTKDRIAFPVKIKDIELFGDLY
DQDGIFECTCSLTEMNDEFAIGDILLTRNEKVWCKISGWQNRRLEIDAALWNVSMSPLHN
RLSEEIAPEVFFFHQAYSRVASWDFILKRYFNQNEKKHHQKLLPNKRKSYMVSRVALKDA
VRNLLKKEKNHPCFPITFEIGKDEIGKPFLIGDSTENIHISLAHKGKDAVGIAKSGKPVG
IDMEIIEERSSGFYDLVFTDNELTLLKGKDQAEWTTKFWVAKEAYGKFAGTGLKGNPKNF
EVEKITEDSLWINQTEIKTIKHKNYIIGWTL
>KALACAFP_02881 Phenolphthiocerol synthesis polyketide synthase type I Pks15/1
MCYHISLPILFQIINVMKNVTIIGLTPFEKPDVNLMLALHQAGAFPILSLGHELAIAQEA
LDQINNTNIPSYGVYFPNDSLISLQISEKVTAAILPFGTSMNLLPNLPVIYQVCSLEEAL
KAEQSGATGIIIKGNEAGGLVGYESTFVLFQRIIKEIRSIPVWLQGGIGLHTAAAAKALG
ATGIVLDSQLALFPESFVSKEIKELCSKLNGTETKIIANHRVLVRPNSPTLSENITTEEL
REYFKDLDINKSYIPMGQDISLAIDFYEDFKNLKKLVFGFKEAMYGHLKQAKALLVINQD
NILAKDLGLKYPIAQGPMTRVSDVPEFANAVAEAGALPFVALSLLKGNQAKSLVFDTKNL
AGEKTWGVGILGFAPQELRDEQTSYILEAKPPVVLIAGGRPAQAKVFEKAGIKTFLHVPS
PALLDIFLKEGATNFIFEGRECGGHVGPLSSTVLWEKQIERILKEDHPENISVFFAGGIH
NDFSTAFVSIMAAPLAARGVKIGVLMGTAYLYTQEAVECGAIQEEFQLQAMQAKETVLLE
TAPGHETRCLDTAFAKYFNEEKAKLITAGTDKKEVWEKLEKLNVGRLRIAAKGVERQGDQ
LINIPKEDQLDLGMYMIGQIATMHDKVISLNELHENVSINNQKYIQEAELSEEPVSVEKP
LDIAIIGMECIFPDAKNLEEYWKNIILGKDSVTEVPDERWNKELYYHPDSNEADVSHSKW
GGFIPKIDFDPLEFGIPPQSLAAIEPTQLLTLLVAKRAMEDAGYDKHANRENISVIIGAE
GGNDLANSYSFRGFYKQVFGELHEEVKEAFPHTTEDSFPGILANVIAGRITNRLDLGGRN
YTVDAACASSLAALELACQELVLGKSDMVLAGGADLHNGINDYLMFSSTHALSRKGRCAT
FDNEADGIALGEGVAILVLKRYEDAIKDGDRIYSVIKGVGGSSDGKALGLTAPRKIGQVR
ALERAYSQAGISPSSVGLVEAHGTGTVVGDKTELSALTNLFSRAGAVPGQTHLGSVKTQI
GHTKCAAGLAGLIKASLAVYHGVKPPTLHLQQPNAYYKAETSPFAFNSETGLWADKNRYA
GISAFGFGGTNFHTVIANHPKEDDSAVLQSWPSELFVFRGDTYEEAKIQLNQIKSLLEIN
DSIALKDIAYSLAIHSEKQVQLSIVADTAEHLMMNIELALSGIESKNTFTVNKKEGKVAF
LFPGQGSQRINMARDLFVAFPEMRKLIDSYPELEKVIFPSKTFDELTLKQQKETIKDTRL
AQPLLGIVDLALAKFLQSIGIVPDMLAGHSYGELPALCFAGVFEEEKLVDLSIQRAKSIL
NSVEGGDPGSMIAVSSTRENLQPILEQVEGCYPVNYNAPTQCVVAGSTEAINTLMEILKQ
EKISAKKLEVACAFHSPLLAKSKGLYESVLKDVPFNEMQIPVWSNTTAEIYPANVSDIKE
RLTDHLVQPVRFVEELQAMYNDGARIFIEVGPGKVLTGLTKSCLEKDHLTLFVEDNNSNK
LTHLLSTLAQYLGTGRNFNIAKLFDGRNVKLIQIDQPELYKKSPAIWRVNGQAAYPTTGS
LPANGALPIINPLQMNNFTNTQNPPVENQSNTERMLQEYLNSMKLMIQAQRDVMLTFLGQ
HPQVHQAPVVYNAPVQNIPTQNIQAPVVSMPNNDGAEKTVIIPVKQSPVKDIKTLLLQVV
SDKTGYPHEMLGMEMDLEADLSIDSIKRVEIIGTLKAELGSFSSNNANEDTIMEQLAGIK
TLNGLVSWLTEYSGANTRSSEKNVCAQTAPPKAQNQAVFSLEELQTAILNIVSDKTGYPK
EMLGLDLDLEADLSIDSIKRMEIIGDLKTKIGFGSDMEQADDVMEKLAAIKTLNGLASWI
NEMNGNSTPEPEQNPLSRLRFDLTPTNVSLIENNEILQGKRFAITQNDNSQTLAIKNELE
KHGAIAELTDSDKDLKDFDGLIILDLFSSSIKHNIIDHVDLIKKMDLDKAKWIYLISDIP
AHVQELTDTTLLRHYKGHPGLFKSLAREFEQTNCRLISLTSPQQIDQIAEITLKEILSTD
KPSEVIYKNDQRHKVDIIPSPLSTGLSEAQIQLDQDSVVLVLGGAQGITSELAKHMSKAY
PCTYILVGRSADPRNLTTNSELEAFKTKEEIRAYLIKSGTFTSPSEIEKETIKVYKNNQI
LRTIRDMEQLGNTIVYQSLDLCDENGLSELINSIYEKYNRLDGVIHGAGLLEDKLFKQKT
TSSFGRVFDTKVKPLRVLAEQLRTDCQFVVLFSSIASVYGNKGQTDYAAANSVLDDYANA
LNKKLKGKVISINWGPWKGAGMVSPTLETEYERRGISLIPLEQGKEIFLNEIKYGTESQV
LIMSGTNW
>KALACAFP_02882 hypothetical protein
MKLNQFFNKKNILKILKILIIILTKVICLNSEVYKNK
>KALACAFP_02883 hypothetical protein
MKILKKIILIVLWQIHILNYAQIGINTPNPQALFHVDGAKDNPSVGAPSPTQQLNDFSVN
SSGYVGIGTVNPTANLEINSPTTNAVRIVDTTQGLGKVLTSDSNGYARWTTPSTSFAKLA
TLPTTLITTPTIDDPSLAGTQFIAYSGAFISLTPGKYQIYFTMWCSPGGPNLADSSVNDG
FASVFFSTSSTTNIPPAYLTSIKSVIIPRLYNLQAPASDYYGSGNVAVDITGNTTLYLWV
YMSGGNWTAPTGNSIRFRFDPGSYGPYVQMYAIPFEVQ
>KALACAFP_02884 hypothetical protein
MKELIEKINAEFEAFTTEANQQAEKGNKAAGTRARKSALELSKLFKDFRKVSVEESKK
>KALACAFP_02885 hypothetical protein
MKISEIKERKIIHRPTLSFDGYGKRIYHAYEYYLSYNPGFKGNETQRLFAKWIDMAIFTL
IFFFICNKILIVSILLSVPCVIIAGTVTEFYFGTTLGKKIFRMKVIDDDGNYPGFSKSLA
RNLLCLANFYPVFSEYTTKTVAMGWRRGTQMNFSMHLNNKICKTYIVKESKIPEIKELLE
ADSNKKSLPE
>KALACAFP_02886 hypothetical protein
MSNTLDLLETNDFQTEPINLNGIITLIDSETKELVNLVEISSLPEVSPPVTSPPVPPVLV
TPDNIMYFEKDSRFFKRDYRGVINPEWFGTGKTHVEIQAAIDIARPNDTILIKGEYKCSD
QITINKTLTFMGQNHINGNDVGGNENSRIYFVDFENSLVDSCIESDTNLNIKNLAIFGSE
IEGKTGVKVTNGALTLDSATIQVFETGVEVTAGYYNKFLNSSIVSCQTCLVLNNCYNTNA
TSLSIGAGYAEHAPNSKGIVLTDGTNLNMFGGSIEGFSEIGIDLSASRVSCFGTYFEGIF
DEENENTCIKIQNNNCRVTAVSCHVYLTAGKANSFVHIPSTVASAHIHSKNNYFEYEPVN
DWYTAVYRLAATNFTNYNIDISGDNYQNDLVTGSSYISITSSLLEKGKGIVQITYPSGHQ
LAGIHLTNLNAISPYQYTDDISKLQNGTITTFRNNGGIDDDPLDLHTEPYGYNPYTVVLE
NGAWKKIPKI
>KALACAFP_02887 General stress protein 13
MNTINYIQQTLNISEKSINATLQLLAEDCTIPFISRYRKDKTGNLDETQIEQISKISKQF
EEILKRKETILKSVEEQNALTPEFRQRIEESFDIQELEDLYLPFKKRKKTKADAAKEKGL
EPLAKMIMSQKVQDLEFLASKYVNEQVSSEEEALQGARDIMAEWINENMYVRKNLRRLFQ
RKAVVTSKVVKAKKDEEDAQKFSQYFEWEENLNRTPSHRLLAMLRAEAEGFVKTNVGIDK
EEAIDFIENAIIKSNNETAEQISLAIKDSYKRLLEPAISNETLQEAKQKADKKAIEIFSE
NLTQLLLAPPLGEKRILAIDPGYKSGCKVVCLDEKGDLLHNETLYPHAPQNDTGMAMKKI
RSMVNAYQIEAISIGNGTASRETEFFIKKIAFDKPLQVFVVSEAGASVYSASKIARDEFP
TYDVTVRGAVSIGRRLSDPLAELVKIDPKSIGVGQYQHDVDQGQLKNELDSTVMKCVNSV
GINLNTASKSLLSYVSGIGEKMAENIVNYRAENGAFEDRKQLKKVPRLGEKAFQQAAAFV
RINNAKNPLDNSAVHPEAYGIVEKMAKDLGIKPHELIANKEKITQINPEKYTTEDIGILG
IKDILKELEKPGLDPRKAAKVFEFDPNVKSIKDLKIGMILPGIVNNITAFGCFVDLGIKE
SGLVHISQLKEGFVSDVNEVVKLHQHVQVKVTEVDEARKRVQLSMIL
>KALACAFP_02888 Protein YceI
MKKLSVIALVAVGLLAASCNKEKSADKAATTTEQTVAEGKGEVLAVDAATSVVNWKAFHK
GGFAPRWGTISVKSGELNVENGQVAAGNFIIDMNSIKVDPASVTEKDKKPADLEAHLKNP
DFFDTAKNPTSDFKITSVADLKEAPKDAVAGANKTVSGNLTLSGKTVNVTFPAKVDVVDN
SASIQAKFTVNRADWGIKFGTSEADPAEWGISKDIEIAVDVKAKK
>KALACAFP_02889 hypothetical protein
MTIQDLAGSYSVQGSNQEETDHISYHGILTLSIDENNRIMAQWMIGDHIQNGTGFYKDEI
LVINFNYEGDDHKIYKGVAVYRCLSKDVLDGFWSEKHGNPLYLGSEYCVRIKNSSILN
>KALACAFP_02890 GTP-binding protein TypA/BipA
MQNIRNIAIIAHVDHGKTTLVDKIIHATNIFRENQESGELIMDNNDLERERGITILSKNI
SVTYKDTKINVIDTPGHADFGGEVERVLKMADGVILLVDAFEGPMPQTRFVLQKALELGL
RPLVVINKVDKPNCRPDEVHDQVFDLFFNLDATEEQLDFPTFYGSSKQGWFNTSLEQTEN
IFPLLDGILQYVPEPKITEGNLQMQITSLDYSSFLGRIAIGKVTRGELKESQWIGLAQAD
GKIAKGKIKELYVFEGLGKKKVTEVQAGDICAVVGFDAFQIGDSFVDLENPEPLPRTAID
EPTLNMTFSINNSPFFGKDGKYVTSNHLKERLTKELEKNLALRVQQTDDANTFLVFGRGI
LHLSVLIETMRREGYEMTIGQPQVILREIDGVNCEPYESLVVDVPEEYASRVIDLATQRK
GDLHIMETKGEMQHMEFEIPSRGLIGLRSQMLTATAGEAIMAHRFTEYKPFKGAIPGRNN
GVLISKTQGPATEYSINKLQDRGKFFVDPGEEIYAGMIIGEQNKPGDLVVNIVEAKQLNN
MRAAGKDKDTGVAPKILFSLEECMEYIQGDEAIEVTPNFIRMRKKILSEEDRKRVERQAK
A
>KALACAFP_02891 hypothetical protein
MNLTIMKKLFRQCLNNYKLFLLTLLLWLPFTVQATMSIVAVDPVTGKVGSAGFTCICNFN
LRNYIALVVPGKGTFNAQASTSLGTYPNTQTYLTSGYNAFELLNANIAYKGDINVTQILA
ATLNPGTGLNTGSSPNAFAFTGNGNGNVNYYRYGQNFAIAGNILISKAVLDDAYNAFLNT
PGELEDKLMAALLAAKRPGADSRCLSADTSSHVAYISVAKPNDPIDHGFLELQYINPCGV
NKEPVDILNTMFINWKRANAGLPPISIPVLNITSITTNRQPSGDRGYTLDGDRMIDARAK
LLNADNFGMYGYTQAKVNITDAFAVQGSMTQAALNNLSTDMLFIGSFNKTILGAANGFTP
NEINEVYNWSLGNNKTVFLFESGADWSSFFSKWGYEVTPEVSNPNKQFAANSTLDVSKKI
FNGPFRNVAGFNQGGGLQGYFSKMPSNAIVLAVNNSNKPVLVFDCNTKDIICADTDAVTA
LGGITAGNVVTNDNDRFLANLINLALEIKNNQITLPACGSAAKQAQIPDEKPTSAILSDN
SEEMKVYPNPAGNSFTIDLHIFKNQKLNIDLYNQNYILLRTKSVLKKEDKQTVKIDAHDL
PEGVLYVVVSDQENKKVTQKLIIKH
>KALACAFP_02892 hypothetical protein
MNFQPLKLTLISSFLIASVASCTVQKTSQPSVSKKTTVKAPVNISKTKDSVTVKSAKPPI
EEIFRTNLPEIKREFRGAWVASVANINWPSRNNLTVDEQKAEAINMLNMLKNNNFNAVIF
QVRPSADALYTSNLEPWSYFLTGETGRSPYPNYDPLQFWIDEAHKRGLELHVWLNPYRAH
HTNGGSPNSLSMANKLSDIVVRLKNGMYWFDPSNPKTQGHVSNVVKDIVKRYDIDAVHFD
DYFYPYATYNKGADFPDNASWNEYVRNGGTLTRADWRRDNVNKFVERIYKEIHAEKNYVK
FGISPFGIWKPGYPAGIVGSSQYDELFADAKLWLNKGWVDYFSPQLYWPIDSQGQGFAAL
LNWWESENTIKRHLWPGLNTVEIKVSDRPTEIKNQIDLSRQILGKDAGEIHWSIAGLTKN
ANMLPTLKNGPYKEKALVPKTPWLKAIPLQTPTLFITDNGSFAKTNWSVKNIGDVFQWVL
FTQYNGIWETEILTLDQLSKDIPKFKDGKTLNAIAIKAIDRLGNESDYLAKKVK
>KALACAFP_02893 putative bacterial non-heme ferritin
MNTNRLSATMEKALSDQMNKEILASHVFLSYGIWADDKGYQGIANFLYRHAQEERNHSIK
FMEYVLNRGGKPKVDAIPAPPADPESLSACFEGVFKHEVDNTTSIYRLVDLAMEEKDWAT
WNFMQWFVQEQIEEETLAQNLLDKLKIAGGDRATDESLFTLDKTLQEAPNDVPLAQEATG
DNP
>KALACAFP_02894 Ribosome-binding ATPase YchF
MKCGIVGLPNVGKSTLFNCLSNAKAQSANYPFCTIEPNLGTVSVPDHRLFELEKIVKPER
VLPAVVEIVDIAGLVKGASKGEGLGNQFLANIRECEAIIHVLRCFDNGNIVHVEGSVDPL
RDKEIIDIELQLKDLETVGKAVEKAKKFIKSGKKEDILTYETLQNLQKFLEDGKNAREFA
TDDFTKTIIGDVQLLTNKPVLYVCNVDENSIKNGNEWIGKIEEMAKNEGAEVVVLAAQIE
ADINELETYEEREIFLEELGLTEPGVNRLIRKAYDLLKLQTYFTAGVKEVRAWTIGQGWT
APQAAGVIHTDFEKGFIRAEVIKYADYMNYGSEAKVKEAGKLSVEGKEYVVQDGDIMHFR
FNV
>KALACAFP_02895 HTH-type transcriptional activator RhaS
MEKTAHTSYTSLEDFYQEMTEKLGKDLESIFPKGLHKDIGHFNVFDIAQTIEKARLTSEM
PYNRRKYYKISLIRGKNRAEYADKIISVKKNALLFATPKVPYHWVPEDPNQSGSFCVFTE
DFFIKNKSHNTLEDLPIFQPGNIPIFEIDDELADEIEQLFTKIKKEIESEYIFKYDLIRN
YVLELIHYGQKLQPAATLSTSNDASLRVVSLFIELLERQFPIESTENRLQLKTAKDYADR
LAVHVNYLNKKLKESTGKTTTEFIADRLIQEAKILLRQTKWNVSEISYALGFEEIAHFSN
FFKKKTTFTPLEFRS
>KALACAFP_02896 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MSTKTKIALVTGGSRGLGRNSAIKIAQKGLDVIITYRSNKEEADKVVEEIQRLGQKAIAY
QLDTKDIKNFDAFVKQVGDHLEENTGSRNIDYLINNAGTSLHASISDVTEEQLDDVVDIH
FKGIFFLTQKFLPFINNGGGIVNISSGLARFATPGYAVYGGIKAGIEMLTKYMAKELGSR
QIKANVVAPGAIETDFGGGAVRDLKEVNNTIASVTALGRAGVPDDIGGVVAFLCTEDARW
INGQRIEVSGGMFL
>KALACAFP_02897 Methionine aminotransferase
MIQLPLSKLSNVGTTIFSQMTQLANENEAINLSQGFPDFMPDAELLDHVDHFIKKGFNQY
APMGGMMVLKEEIARKIENSHQAIYHPDTEITVTAGGTQAIFTAIATFVKKDDEVIIFEP
AYDCYEPTVELFGGIVKRFEMKAPDYEIDWNVVKNLVSDKTKMIILNNPNNPSGKILKEN
DIQELIKIVEGTSILILSDEVYENIVFDGKQHLSICKYPELKNRSLLVASFGKLFHVTGW
KVGYCAAPKMLTDEFRKVHQFNVFSVNTPIQMALAEYMKNPDHYNYLNQFFQEKRNFLRQ
GLASTSFELLDCEGTYFQALKYDKISDKNDFDFASELTITHKVASVPFSSFYKNKLNENV
IRLCFAKKQETLERAIENLSKL
>KALACAFP_02898 hypothetical protein
MKKVILSLITISIALSSCRNESDLSSMEDQKAMIKPNLSSMSLKDKRIYLESILMNTAKD
IISESQKDAKSRSVVYAELEKNIDGDDNALIDVFYKQIPALNNDADFKNSLLAFNDLEGS
KYFPQIFVYNYNRLKAAGKIGKSNPILAVFYTGDEKSASAKAYKLNAAGNWEFVKMVDEK
AVENEEVWVFSLNETFVNTIDLSILPKEAVPPRTSKTLPVEQKGDDRCKDGTHYWPYFEY
MTIREHNESFLAGKSDIWTKTYTGWNTPNSVNPCNSSLPKLMWTNNPDGEVFIWKYMRYM
IPNTAVKVVCGYAGSWDPGPANVGGWQGDALNYVIFEKDTWPTGEKSADINNNGFNASYR
YRSADNYYDKGIILHWSSTGPHMNGYSRDISGQIKFNSRL
>KALACAFP_02899 hypothetical protein
MVRMYFLSLYLFLGSFMFQAQDIPPCSDFNDTSNPYGNWAPAAAPNGNVSVGVGTANTFD
GSQFLILKDLSGGSWYQNWKDYQYLGKRFLGQCLYFDFYIENDSGYGMPYHPNITLSDGT
NSATFVANITVTPGSGWVRIKAPIQLSSGGVLPSNSDGAWTMSPVNAAVFDNIIMNSQVL
GISPDMTSTQQEIVYFDNICVKPCEGCNECNSNFKIQTTTSTSGNFTIAQIFLESINSPS
LYKVDWGDGTIGDVMTSHTYVSPGSYKVCVTQYENDKPKCTTCVEICIPKPFQASKMAGN
SGLTSPLKEIAAIAKAETGTPNEVKEYSLVPNPAQNYVDVQTNLAKKGNVSVKIIDVSGK
VVMHVSETVESGRQSIKLNTEKLIQGTYIVEIKSESKTSSQKLLISK
>KALACAFP_02900 hypothetical protein
MKKSLLHAKNLIAAAMIFSTGLVNAQQWLITGNSGTSNLNYVGTTGVAPLFLRVNGSSSN
PGQASLTGSGSFVVDGANNSNTINSKGSLVAGLGHVLGTSAESSLVAGWENNLSASGGAN
IVVGQQNTVLNGAGKSVALGWKNIIRNANQFAIGVGIDLANFYSGGFGVDLAATGDRSFV
IGSGTGGVKLTNNVPRSIMFGMSPTSTMLIVDQSVGVRTNAPTANFHTVGTVRHQGLPSG
TGRALVVDNDGNVMVATSIITRQANNEADLQHQIDELKNEIKELKDLLKQNKMSVDLSSD
SNEPKLFQNAPNPARGGETVIKYYLPNISKEASIGIYNISGQLIKTILLKDKGNGSISLS
GIQGGSYVYNLTVDGKNIESKKMLIQN
>KALACAFP_02901 Sensory transduction protein LytR
MKNNLNACIINAHDDGDYISLLLKNQFPEFEISFQTDNMEHASDYLSKNVPDLLFVDFQL
VDKTAFELLLKIKKNSSQIIFITDSEKSAIQAIKNGIPDYLLKPINELDFVLTVNKAIEN
FRKNNFSLANNPVQNKINLPTLQGFKRVNVDEIIRCEAYSNYTFIYLLDKSKVMVSKTLY
DFEKNLSGYNFFRIHHKHLINLEHLKEYIKGKGGQVVMADNSVLDVSIRKKNDFLHKIA
>KALACAFP_02902 DNA gyrase subunit B
MSQEINPIYSEDNIRTLDWQEHIRLRPGMYIGKLGDGSSADDGIYILLKEILDNSIDEFR
MKAGKRIEIKVDDGKVTIRDFGRGIPLGKVVDAVSKMNTGGKYDSKAFKKSVGLNGVGTK
AVNALSDYFRVRSFRDGKMKMAEFSRGLITENFDEKETSDRNGTEISFIPDAEIFLHFKF
RKEYIERMLRNYAYLNPGLKILFNGETFFSENGLKDLLDEELENETLYPIVHLRDNDIEV
AITHTDKSQTETYFSFVNGQNTTQGGTHLNAFREAYVKTIREFFNKNFDASDVRKSIVAA
VSINVEEPVFESQTKTKLGSNDIGPNGPTVRTFIIDFLKSKLDNFLHQNPEVAEAIQRKI
LISERERKELSGIQKLARERAKKVSLHNKKLRDCRQHYNDQKNERKGETQIFITEGDSAS
GSITKSRDVETQAVFSLKGKPLNCYGLTKKVVYENEEFNLLQAALNIEESLEDLRYNQVI
IATDADVDGMHIRLLMITFFLQFFPDLIKNGHLYILQTPLFRVRNKKETRYCYSEQERIK
ALNELGKNPEITRFKGLGEISPDEFKHFIGKDIRLEPVVVGKDQTIDQLLEFYMGKNTPD
RQTFILENLVVEDPDIDKKEILSEVIDEN
>KALACAFP_02903 hypothetical protein
MRLSNRNKTSVYSFVNTLLLMFLAAGVGAYLLEEYRFNILGKESILLIIVPIMFLGFFYL
NGRQIFEYDSDGEAIHFRNRNIIPFLSKPLSDEFPKYKLLKFEVIDLFFMKRLYITISSK
NSGSTILKYEISYLTRKEINDLKFSLNKVIKANNEKKS
>KALACAFP_02904 DNA gyrase subunit A
MTEEYSHEGESLKKVSGLYKDWFLDYASYVILDRAIPSVYDGFKPVQRRIMHSMRELEDG
RYNKVANIVGNTMKYHPHGDASITDAMVGIGQRELLIDTQGNWGNIYTGDSAAAARYIEA
RLTPFALEVVFNPKTTEWAKSYDGRNNEPIDLPVKFPLLLAQGVEGIGVGLSTKILPHNF
NELINASVAYLKGKKFELFPDFLTAGYLDVSEYNDGHRGGKVRARAKISPVDKHTLIITE
LPFSKNTGDLIDSILKANEKGKIKIKKIEDNTSDKVEILIHLPNDSSPDKTIDALYAFTD
CQVTISPNACVIVGDKPMFLNVSEILRMNTDHTVSLLKKELEIELHELQESWHFSSLERI
FIENRIYHDIEEVKTWEDVLKTIDVGLKPHTGHLLRAVTEEDILRLTEIRIKRISRFDLD
KFKENIAALEGKIEQVKYNLANLVQYAIDYYLNIQKKYGKDKQRKTELRIFDTIDATKVA
VANEKFYANFEEGFIGTSLRKDQYLFDCSDIDDIITFRKDGSMKVVKVEAKTFIGKDILH
VAVWKKNDKRTVYNMIYREGKEGPYYMKRFSVTGVTRNTDYPLASDKKGSEVLYFSANPN
GEAETVTVLLKPNPRIRKNKMDVDFSELAIKGRDSKGNLVTKYAVKKVDLKEEGVSTLAP
RRIWFDDTVRRLNADGRGTLLGSFKGDDKILTINTNGEAKLVSFDLGNRFDDEYLVLEKW
KPEQPVTCIYFDGEKDIYFIKRFLFENTPNIQTFMPSEHPKSFIENVIVANGATAEIIFA
KDKGKDRDPETVHIDEFITVKGIKAIGNQFTKFKVKTINVNIPEPEEEEPEVYEDPEPMS
GMDEDGMIGDLFQSDENTDN
>KALACAFP_02905 Rhomboid protease GluP
MNILILIIAITAIISFIAPNGSSNFEKYKFSVGAILNRKEYIRLLSAGFLHADIFHLVFN
MLTLYFFGPIVIQGFGNVGFLIIYFGSILLGNIFSLFIYQKQPWYSAIGASGGVSGILFA
SIAMLPNLGIYLFFIPIPIPGFIFGLIYFGYSVYMMLNPRQHDNIGHAAHLGGAFFGLVY
AVANQPQAAMANSLYIGIMALPLLYLSYEIFVRKRIG
>KALACAFP_02906 hypothetical protein
MEIKTHHFNNTKIAEVISDGIIINSAQDGLDLLGNIYYQDFDKIIMYEKNMTPEFFDLKT
KIAGDILQKFSNYRVRLAIVGDFSKYESKSIKDFIFESNKTKHIHFVENIAEALEKLSI
>KALACAFP_02907 Release factor glutamine methyltransferase
MTISAFKNYFKTELSNLYTDSESAFLSSIFIHKIVGFDSFQQRRFADQELLIDDEKQLRQ
IISELKTNKPYQQILGETDFYGMTFFVNENVLIPRPETEELLEFAIKKIHHSALTIDKLK
ILDIGTGSGIIPLVLKKYFPQAEVTSIDFSEKALEIAKKNADFHQLEINFIHNDYLNFDF
NQNFDIIISNPPYIGIEEEHEIADSVKEFEPKMALFSPTSDALIFYRKIAEDSKKYLNKN
GLLFLEINQKLGPETLELYTNDFSEALLIKDLSENDRFIFGRK
>KALACAFP_02908 hypothetical protein
MKIVTSPAKLMNVENSTDLLKATTPKFIDDAAFIQSYLKQKSPKYLSELMEISTKLADEN
WERNQKWKAKPTAKESAPAMFAFTGEVYRGLDAKTLEKSAIDYLQKNYRMLSGLYGLLKP
SDKVMLYRLEMGRPFEFDTYKNLYEFWRKKITEQLNSEMKKNEILLHLASSEYGKVIDRK
RLNHKVIDFDFYELKDGKLKTIVVYTKHARGLMVRFCAETNAQTLDDVKAFNYEGYLIDE
EKSTDTKLVFTR
>KALACAFP_02909 hypothetical protein
MSLNGKYSIGIVLTFALLAMTMLYIFPFLNSLFETKTLTAEKFFYSRVALWFVLIITFLY
SFLIEKNSFLLWKERKYSFLFYIGSVISLYFICAFGGAFLNVLVKIATQEKFSGKLLQMT
SLFKNNYLLIIFTCLTAGVVEELLMRGYIQTRVEKNLCKSVFWNYNFRHPFWNSSQHLRN
DWSGLGAFLYRRRFCDVL
>KALACAFP_02910 Threonylcarbamoyl-AMP synthase
MAKILKIYPENPQENLINEVIKTLNNGGLIIYPSDTVYALGCNIFDLKAMEKLAQIKKIK
LEKAQFSIICNDLSHLSDFTRPIETSVFRFLKSHLPGPFTFILDANKSLPLAYKNHKTIG
IRVPDHPIPQLIVEKLGHPIASTSIKDDDEIIEYSTDPELIAEKYDHLVDIVIDSGYGDN
VASTIVDLTSGEPEVIRQGKGNI
>KALACAFP_02911 hypothetical protein
MKTILIFVSLNYGKNIENLPGKSTGKSYQ
>KALACAFP_02915 hypothetical protein
MEPRINLFEKGKKAITPIFGISQYLKHCSLDRHLIELIDFRISQINQCAYCLDMHSKELR
AMGETEQRLYGLSAWRETPYYTERERAAFEYAEAVNTFHVSDEVYENTKKQFSEEEILDL
TLAVNAINVWNRFNIAFQQVPGDYKVGMFG
>KALACAFP_02916 hypothetical protein
MKRYNLLIVLLLFIFNVTTAQKKGSPAADFSAVREAKTKIENTVPLVIKHLQQISEKESD
PNILANGKTALAKEYGKVELEWRLYRGNMNNCILNNSSKKAKKCMEYHNTMFRDTMINYN
NYITNLTRKNGYLGVEGDTKFELNPAETATKLNEAYFNANDAAGRMKGAQKTDFVGQTMA
DDYKLTPFNQLAP
>KALACAFP_02917 Methicillin resistance regulatory protein MecI
MKIQTLTKAEEQVMQYLWKLEKGFLKDVLDLFPEPKPHTNTVSTILKVLKDKEFVDYNVY
GRQHEYFPLISKEQYSGKTMKSLVKNYFKGSYKSAVSFLVEKNEMTVEDLEMLLDELKKK
N
>KALACAFP_02918 hypothetical protein
METVLLYFGKVILCSGVMFLYYQLSLKDKTFHHYNRFYLLSAMLISLLLPLIKVEDFAIE
VSNDIYRLIDTVQNFKTTKNINNDHIYLRIIFSALGLVSFYFLGRFIYGIFRIQQLKNQF
QKESFDGINFYHTNLTEAPFSYFKNLFWKNSITLNSDVGKQILKHEMVHIEQKHSFDKIF
IEIITSVFWFNPFFHIIKKEISLIHEYLADKKAVKQSDTKAFAQMLLASHFSGTQLPATS
PFLSSNLKKRLKMLQKPQTKFGYARRIFALPVVFSVAFAYLVNAKNQEIKATNVEIEKAV
SQIKKENKIEKDTITPNASKNIVVAPKVYKREHDDRKIADLSKKIQEKSQALKNLKPESS
EYNKNLEEIGKLSGEIGKIASSEDFLKRAMVIRMDGKDVNINEYFKSKEWNDKVKNLEDL
NVEIPEIPEMHFDFPDAPAPPPGAPNAPMAPKVKVYSYRGMNDMRWSPEADMAYKSAGRA
QESAATAKKRAKLDKERARLEEKRAKLEGERAKLEVERRALDGNRRVYIYSNSMNKPMKV
NNVRVMKMDNNAMGGPGMKKISGDLSNMKLYIDGKEVTRQEIDALDPNKIKNMNINKRTT
DGDSSGEIRIETKK
>KALACAFP_02919 hypothetical protein
MKNNILLFLLLSVCTNAQINRFFYEYKFIPDSNDKADVKKEMMLLDIDKNGSNYYSRDKF
VADSTSMAEVQKQIKGGSGNINISRRDSPGQVNYKVTKSYPDFKTYLFTRVSMDQYKVKE
DQKPEWKILPEKQKVGEYNAQKATTTYGGREWIAWFSTDIPFQDGPYKFYGLPGLIVKLE
DTTGSHIMTLVGNKKIQTEVSIGEVDMPGNVRLMGIGGKEIEVTKDQYKKLWKDYVNDPS
KNMREMMMRNGGGDNTRVAFKMRTQDGKEISDSNQVFREMEKRTKETLAKNNNPIEPDLT
K
>KALACAFP_02920 hypothetical protein
MKKLVIFLAFFLGMAINAQNQRFVYEYKFVSDSTKKDESKTELMFLDVAKKGSKFFSRNL
FVSDSLLQVQNKGGNRDFSKIKFGMIGFKVEKSYPDYKVIFFNRLDMDEYKVYDERKLNW
KILPDKEKIGEFNAQKAIADFAGRKWIAWFVSDIPIQDGPYKFHGLPGLIVKIEDETKSH
SFVLKEIKNLKQNEEWISEEKKQRLGTLITLSQEKYKKQFLDNRNNPTKGIRQLMASGRK
VMMTDENGKQMDVEEMLRNQERKVKEENAKNNNLLELDLLK
>KALACAFP_02921 Transaldolase
MKFFIDTANLEQIREAKDLGILDGVTTNPSLMAKEGIQGAEAIKNHYKAICEIVDGDISA
EVLSTTYEEMIKEGEELAAIHPNIVVKIPMIKDGIKALKYFSDKGIKTNCTLIFSAGQAL
LAAKAGATYVSPFLGRLDDISTDGLNLIQEIRLIFDNYMYETEILAASIRHSMHIIDCAK
IGADVITSPLPPILSLLKHPLTDSGLAQFIADSQKLS
>KALACAFP_02922 hypothetical protein
MEKTVLPQKNLQGIWEFITGYEPAFFDVQIGDRWHFQYNVNPSNPAVGKVDMFRAGTLYK
SGSFIQREFQDPGPHDYDLEINLEGIFRSYKITTISETRLTLQSPAPYRYPATFDKVQSK
S
>KALACAFP_02923 hypothetical protein
MRNINVRIFFYFKKVFFNDLKSLGYLRNDIAKSLIYKN
>KALACAFP_02924 hypothetical protein
MNHHFTAQLEIIGINPFVFIPEEILNHIFEQSGRNKSPIPVKGTVNGKEFQQNLMKYLGE
WRLYINLTMLKDSPKRIGEQIEVFVEYDDSDRTIPIHPQLEKAINESSVALQNFESLIPS
RRLELIRYINNLKTEESIQRNIEKIIRHLHGETDFFGKKIN
>KALACAFP_02925 hypothetical protein
MKMIKISIKSLFLGLIFIGGASAINAQTTPTDSAKNTTTTAATTQATGNPTIDGLKKQIE
ANPKDTDALAKLATAYQEASDWTNAIDTWKKISVLLPDWAPSYYSQAYAYQSAKDDANAK
LAYEKYVATVKPEEVEQNKKNLAYAYFYIAFAEQQSNPDKAKEHIAKSLQYDPTNQDAIK
LSKVLNS
>KALACAFP_02926 Peptidase E
MNIILASTSTLFGGEYLEYLREELIKLYDGIDEIIFVPFARPGGISHDDYTSKARSFFET
INIKVKGLHEFENKIEALHHAKGFFTGGGNTFLLVKTLHEEGLMSALKQNVETGKPYLGC
SAGSNIGGQNMKTTNDMPIVYPPSFDCMGLVPFNINPHYLDPNPELKHNGETRETRIKEF
LTQNDLKVVGLREGNWIRRIGDRITVEGSELTRIFEKSKEPYEIEAGSEL
>KALACAFP_02927 D-alanyl-D-alanine carboxypeptidase DacC
MKKAFAILTLSTQIFFAQNISQKLDAATKNLMDSSGAISSSLSFYVSDENGNFIYEYQGN
KGLSTASTQKIFTAAAALETLGKNYTYTTTSSYSGTVSGGVLKGNLFISSNGDPTLGSWR
YDAYKPENFRQKLIEAIKKSGITKISGDVIIDDSYFDHQTIPGGWPWDDLGNYYGAGVWG
INWRENQFDININGKDFKGFSYPLEGVNWLNDLKVGGSSDQSLIFTAPHSNVALINGTLP
SKTVTVSGSTPNPPLQLGVEVKQWLKESGIDFSGKVVTNSQLEIEGKKVLEAPKENVIFT
YQSPTLDKIIYWFLRKSINLYGETLIKTLGKEKKGNPSFKSGVAFLKEFWKSKGINTNMI
NFADGSGLSPQNYVSSKAEVQALLYAKKQPWFESYYDGFPTQDNGMKMKSGTMRDTKSFA
GYHTSKDGKKYVFSIIINNYQGSGSSELQKILNVLK
>KALACAFP_02928 Sporulation kinase E
MRKSIFARLNNWIIFTLMTIVVLTIVIASTVIVSFLRKEEVKRVDILVSALKFQQEVTNP
NLEVQALLLQIYSSNTTIPLIILDQDDQIIEHKNLPQDIGNDPIKIKALAKKMAKSYAPI
EIEIVKGNKQIVYYDNSPLLNNLQYSPYILGFFILSYFGFSFWFFRTIKKTDEGYLWAGL
AKETAHQIGTPLSSMIGWMEIMKLDTPDSEGVREIEKDIERLRTISERFSKIGSVPELND
KNFNATIRENYDYLKTRISRKINFGLHLPNYEISVPHNKILMSWVIENLVKNAVDAMKGE
GSISISVFERNKNILVEVQDNGSGMTKQQARNAFKPGYSTKKRGWGLGLSLAKRVIQEYH
NGDIKIVQTEIGKGTTFRIMIKKA
>KALACAFP_02929 hypothetical protein
MKKIALSLGVLTAFMVNAQSIKTTIDLVNVKDDKVAVTMEFPKMKSGDVKFHFPKTVPGT
YSVDDYGRFVEGIKFLDNKGKEIAFTKVNDNTYSLKNAQNLSKVTYLVNDSFDDELDNSK
HKAVFSPSGTDIEAGKIYLINTHGFIGYIDNMQDVPYQLVIQKPNDFYGTTALVDQDKSE
STDTYTLANYAKVTDSPLMYTKPDYITFNAGGMDLVLGVYSPTGKYKAADFKENLEKMVI
AQKKFLGDMNTNKKYAIMLYLSGGEGPQIKGFGALEHHESTSVVLPEMMPKEAIDKTITD
VVSHEFFHTVNPLKTHSEEIHYFDYADPKMSQHLWMYEGGTEYFANLFQIQEGLITKDEF
LQRMNEKITNSKNYNDTMPFTVMSKNVLKDEYKDQYRNVYEKGALLAMCLDIELRKLSNG
EMGYRDMIRKLSQRFGENKPFKDDKLVDELVAVTGYPQVKDFYNKYIAGDQPTPYAQYLS
MVGVELKSQETPPIFWFIKDPQQTGYDDKDNAFVFDESSALSPFSKSIGFKITDKIVALD
GKTINIQNIQEFIGYAKTIKEGQNVTVTVLRKNGDKTDRIDLKGKAVLDKMTVETLQFKP
NPTPAEQKLQDQWLTGKK
>KALACAFP_02930 hypothetical protein
MKKLSYTLLFASGLVFGQFFEKDKVYTKQDTLKGSNTEFRNFWDVKKYDLSVEPDFAQKS
IKGNNTISFEIIKDVTNPTFQIDLQQPMKADKVEASFPIANYQQDGDFIWIKTNKNFKKG
EKYTINITYSGNPTIAKRAPWDGGWVFTTDEKGNPWMSVADEGIGASIWLPTKDIWSDEP
DNGVIMKIITPKDLVGVGNGRLIDKKAEGDKMAYTWEVKNPINAYSIIPNIGKYVNFKDK
YKGEKGNLDLDYWVLDYNLDKAKKQFQQVKPMLSAFEYWFGPYPFYEDSYKLVDSPYLGM
EHQSNVAYGNGYQNGYLGNDLSGTGVGLNWDYIIVHESGHEWFANNITAKDQADMWVHEG
FTMYSEVLFTEKFMDKKSADTYMQGIHKTVDNDIPIIGKYGVRNEGSGDMYPKGASMLHT
IRQVINNDEKFRQILRGLNKDFYHQTVTTQQVEDYISKKSGIDFSSVFNQYLRSTKVPTL
EYSQKGEELKFRYTDIVKNLKLPVRIDGEQTITPTEQWQTVKLKKGTPVQFNKNYFIHYK
KVQ
>KALACAFP_02931 hypothetical protein
MANIEFGVYSKKVPVNLNIRFYHNKIDINAKTNIFIFDSDFKFKKISKGKKSSRSVDIVN
ADVREKTDKLKRNVFDRFIEDFPKGNKIDSDWLIKIINDFHERPEGEDDPRYYFYPFAKQ
FIKESETKINPRTGTLLDHKTITRHYYTLGLINDFQDYLGQKLRITDIGLDFHNKFIYYM
KEVCTSYSNTTIDKQLTTVKQYIREAEQKGYKINPEIKSRNFTIKKDETIDTYLNEEEID
LIFNYDLSGNEELNEVRDLFITGLWTGLRISDLKRINSFDISNNRIKIVETEKTGSFVEI
PIHPHLKQIIEKREGVLPKVTQHKFNEDVKVLCELVGITEVILGGLKNPETNRKEKGYYP
KFKLISSHTCRRSFVSNHYGKLDDKTVMAITGHKSHSTFLDYVKTSKREHAEKLEKYWTE
QEETKKAKRTQVKPKKK
>KALACAFP_02932 hypothetical protein
MSNNSNNGSNSTLLVQMTKEELIRDFEQVVRKVVNQMQVEQQALKNEKLTYTRDETAEIL
NVSLTTLHNWNKQGVFKPSAKVGKKVYYSKNDIQAKLKIN
>KALACAFP_02933 hypothetical protein
MNKYYILVPKSLNLEQRLSKFPPDFELSRDYCHYFISELIKQVSNQNNSDEFKDFKTAIS
HFISRCAGINQSIYRNSKLHIDYLYQNFGGEGRVLWKNNYKPGSCYSYYLPRHFWGDGEL
ELICISEKTLVDKVKRLNKPQIDNTVRKHLNFTLQYFDTNRIELDAESALNELYQDYGRT
GDYAKYLKNAVMIMNLKNEGYNFHYNPETDGRLHTALSQFPKIGRKYLKYDGEHIAEVDL
SSSVPFFLSYLLSLPTSSKSATLSVQLPYSENILYHYMLVESLVSPSVREIADFRQLVLN
NKLYGEFMISFTGLQNFDFGFKNMFGRAFDGDEEELRKYTKKRFLSMLFASPGEYMQEQA
VFYRKFPTIHQLIKKFKQSKFRGVPRSERHKRFSHLLFQLESHFMLNIIAREINNRFRRT
IPFFTLHDCLMVRESDLEQVYELMHEIFVREIGYAPNMIKKV
>KALACAFP_02934 hypothetical protein
MKNTLFTLVAITFSSLAYSQIGINTPNPQGVFHIDGAKDNPVTGVPSATQQANDITVLNS
GFVGIGTTLPKQKLHITELNTTSGILNSFVSGIALTGIGYGFDGSGPGFYLENTNAPVGQ
RLLKLNYSLNSTEPVLNFQGVSDDAGSVGAQMLSITRSGKLGINSVNNPQNNLTVNGNAS
VGNAYTNVVAPINGAVIQGNVGIGTAAPNSKLDLGTSLGTNETDFAGKKLAVYNNAGGTD
FYGLGISSGLLQFHAASTAAEAPSMVLTSGGNVGIGTNSPSQKLHVIGNILASGTITPSD
IRIKKDITDNVYGLKQILTLRTINYKYKNEELGKDKKIGFIAQEVKATMPELIITANDEM
NTLGVNYAEITVVLTKAIQEQQKEIEFLKKEIEILKKAK
>KALACAFP_02935 hypothetical protein
MEKIILPQKNLQGIWEFVTGYEPAYFNVQVGDTWHFQYNINPSFPAEGKLEMFRADGALY
NSGVFKQYEIQNPGPSGYELEIYMENLGASYTIQNISESSLFLQSVSPYRYPGNFKKVQQ
>KALACAFP_02936 hypothetical protein
MKHLLLLTILGLTALTVTACKQPGKVKAFTAENSVNTDNIVKSVYTDDEFGESDMEVTIN
HSKNTATIHLEGQTYQLKKSNDLPNYTAENDEYRYTDINGEITLLRKDFDMVVFHHEREP
DGQKTSKMSLY
>KALACAFP_02937 hypothetical protein
MKKYFITLLAMLLSNTAFSQVGIYTPNPQGILHIDGAKDNPIMAIPNGIQAANDVVITST
GNVGIGTINPNGALQFRNNENSRKIVLYQNAVNNDHQFYGFGVNSGILRYQVNSIASSHV
FYAGANDTTSNELMRIKGNGNVGIGTDTPNSKLELNSGTSNVSGLTFTNLTSASPVSNGA
TLGVNAEGEVVTVQGSSFTPAFGRLVLSGGTIAIPLTAPNYNILSVEITEPGTYQINYTV
RGQMLNTGGNTSGQGFATAFLSTAPTAGTIISNTEILIYNVSTVQDGGSATGMFITTINT
PTTYYLGVRAGGIGDAQIINNSNGRTSISYIKLSP
>KALACAFP_02938 hypothetical protein
MFNFLLECFDEVNIIDSLATQEIRGEEKTDIELGKSPHYWREIKNSKSSSYYYDLRKSYN
NLLRKYNLDTIKLELRDLLVAKFQSLIGGSRDVE
>KALACAFP_02939 hypothetical protein
MRKILLSICVISITMNSCTNANNEEDLVQKTNLENNNLNSSNKSYNLEVENLAKKIVIAS
SKIMLDDYIIETNEQRFKDDLEKGIVFKSEHVTPEEMGEVFQNYFGIDKNATVDFLNVFI
ENRELISKTDREVLQEAIANEAEIYNSTASSGSKLIFGALVSIINPKGCGWGVAAGVLDT
GLSAAATAIFSPTGVGAAIGAVSTAGYYASTVAQAVRCHK
>KALACAFP_02940 hypothetical protein
MKKLSFKATMVALSLTFTIISCSNSSDEDNTTPNNQQPATTQYFHPPIWIQGIWGVTNGT
TSNKLYKFTADDFILLVTGVSEQSMTGTIKSTPNGGSVDETVNSGTQYNFTVKYNITTTT
QSFEFRKVSATQIQWKDNSNGTWFDLVKMKI
>KALACAFP_02941 hypothetical protein
MKKILLGLTVSMTLQLSAQTKTFSYNMVQITKNMNVTELATRKTKIVINKSKNTISVIDS
EFPTPYVFKIDSYCDITTPSINCMIRDKQNKLNFFSYNKNRLEIMNLTGDGTRYINIKP
>KALACAFP_02942 hypothetical protein
MKKILLSSLLFTVLLSCEKSKPTREPDPYIDSIQARMKANERIQFEEIDRKLEAHAKAQK
QYIFVRLLVEEDYGMDTRRANFVSGIQDITHDLSEDEKAQMEDLIISNYLSSPDAQIRNG
RVKKKEMFVFGSYAEASEKRNTFLITE
>KALACAFP_02943 Sec-independent protein translocase protein TatCy
MSEGKDMSFWGHIGELRGHLIRSIIAIIIAAVAIGFNINWIMDHIFFGPTRNDFPTFELV
NHFSRMVLGENSIHLPKDFPVRASKLYQQFNVMMAVSIFGGIVAAFPYLVWELWRFISPA
LHPKERKNSIFIINSVWILFMTGVLCGYFLILPFAVNFGVIFKISDIIIPLYDLSDYTTL
FLQVVLGMGVIFLFPILIYFLTTIGILTPMFMRTYRRHAIVLIMVVAAIITPADVLSMMM
AAFPLLLLYEFSILMCSYTYKKVQKAAGNLPAVQK
>KALACAFP_02944 Arabinose 5-phosphate isomerase KdsD
MERANIISIAKTTLEIEISELEKLKNRLDDQFVKAVEIIHSAKGKLIVVGIGKSAHVANK
IVATLNSTGTPSQFLHASEAIHGDLGVIQRQDVVLCISNSGNSPEIVNLVPYLKDYSSAL
IGMTGNKNSKLAEFSEVILDTHVDMEACPNKLAPTSSTTLQMALGDALAVTLMEMNDFKA
NDFAKFHPGGSLGKNLISKVDDFLSSQKPQVTENDTVKDVIISISGSRHGITVVTNEDEI
IGVITDGDLRRMLMKGDDISKVLAKDIMSARPKTIERTALAKEAMKILKENNIGQLVVTE
DGKYFGIIDLHKLLDEGIN
>KALACAFP_02945 ATP-dependent DNA helicase RecQ
MSAKKANLSGELKKYFGFSTFKGQQEQIIENLLEGKDIFVLMPTGGGKSLCYQLPALISE
GTAIVVSPLIALMKNQVDAVNGLSSDDGVAHVLNSSLNKTQTKQVFDDIKSGKTKLLYVA
PESLIKDDYLEFLKEVKISFFAIDEAHCISEWGHDFRPEYRNLKLIIDKIADVPVIALTA
TATPKVQDDIQKTLGMANALVFKESFNRPNLYYEVRPKVNVDKEIVKFINQHKTKSGIVY
CLSRRKVEEFAQLLQVNGINALPYHAGLDQKVRITNQDKFLMEEVDVIVATIAFGMGIDK
PDVRFVIHYDFPKSLESYYQETGRAGRDGGEGHCLAFYDPKDIEKLEKFLAQKPVSEREI
GLQLLNEVVGYAETSMSRRQYILYYFGENFDPVNGDGAKMCDNSSNPPKLKDATDDLKKV
LELIKDTGEKFKSKDLISVIAGKENAVTKSYKLEQSSYFGFGKEEKDNHWKTILRQATVQ
NFLQKDIETYGVLKIAEKGKLVLDGKLEHSFLIAEDREFDLTQTKAESDQIQMQSAGGLD
QNLFTLLKDLRKKVAKKHGIPPYTVFMDPSLEDMTVQYPITVDEITKIYGVGEGKAKKYG
KEFADFIHKYVEDNNIERTQDMVLKQVANKSSHKVFIIQSTDKKIDLEDIARAKNLSMDE
LLKEMESIVYQGTKLNIDYYIEDNFDEDIVDGFMEFMTESESDSMKVLLDEFGDELSDEE
VRMLRIKFISDVAN
>KALACAFP_02946 N-acetylgalactosamine-N,N'-diacetylbacillosaminyl-diphospho-undecaprenol 4-alpha-N-acetylgalactosaminyltransferase
MKKISVIFILPDLETGGAERIVTTIANHLSRDRFEPKILLLRKKGGYLNFLKKDVEIIDI
NTERIRHSLKPILGEIYRRKPDIVFSGFGEVNAYLSLFIKLFPRTKFIARETNVVSQHVT
RKEIKFFYNFYNNYDKIIAQSDDMMRDLTRNFKIKSDKIIKINNPVDFDFIEEKMAFSPK
PECFKYNYKNVVAIGNLSARKGFDNLLKVFARLKNENILLHILGDGKDREVLHQMKDFLG
LKNIVFHGRQENPYQFLKYADLFILSSRYEGFPNVLLEAGACGTYSLANNCPGGINEIIQ
NNINGEISDIDNPEDFSQKIMRILHGSYDKDSIKNSIKSRFSKNIILDRYEKVLLDLMKK
>KALACAFP_02947 hypothetical protein
MKKIPQIGCACEKPSSHYTEYRSSELGIDHTNGRYAEVTIQQCKLCQRIWIHYFVEFESF
SKSGRWYKGIVSKKDRPNITPENAVEYLEGLEWYVYGGSYFESTGTIGQGKVNVDL
>KALACAFP_02948 Dihydrolipoyl dehydrogenase
MSQFDVTVIGSGPGGYVAAIRAAQLGFTTAIIEKYPTLGGTCLNVGCIPSKALLDSSEHF
ENAKHNFAGHGIIINEPQADIARMIERKNEVVKQNTDGINYLMNKNKITVFEGVGSFESA
TQIKVTKNDGSTETIESKYTIIATGSKPSSLPFITLDKERVITSTEALNLKEIPKHLVVI
GGGVIGLELGSVYLRLGAQVTVVEFMDKIIPTMDGALSKELTKVLKKQGMKFMLSTAVSA
VERNGDSVKITAKDKKGEEVVVEGDYCLVSVGRRPYTDGLGLEKAGVELDERGRVKTNDH
LQTNVANIYAIGDVIKGAMLAHKAEEEGVFVAETLAGQKPHINYNLIPGVVYTWPEVAGV
GKTEEQLKEEGVAYKVGSFPMRALGRSRASGDVDGLVKIIADEKTDEVLGMHIVGARAAD
LIAEGVIAMEFRASAEDIARSSHAHPTYAEAIKEAALDATAKRPIHM
>KALACAFP_02949 hypothetical protein
MINCIMKNIFISLFFFVGINSFAQEAGSVGELLKNEASKTEMQSPKSGNNRNNNSNNSGF
RNPNKQPDMGRNPNYQWNQRNGYAEVFLRIPEYGFFTVELGDQSISNSSGKYRFFDLQSG
RIPIAIYNDGFLVYRTTLMVQNNNRLVLDFFTNKGLFLLDSYPVKNQSYGFNDWDDVWNN
FYGNPSGNYFNVMDDNTFRQFFEMLNKNAKFDDNRLSLINQQMRSSMFTSKQVYELVKLM
SFDKNKLQLAKSMYSRCVDKDRYFIVYDAFDFESSRRDLSEFITKTR
>KALACAFP_02950 Conserved virulence factor B
MLLGKTQTLKISEKNSSGWILTDESGEKAFLPKIFAQDEKEIGDEIEVFVYQDDNKLKAT
TEIPLAEVGEFAVMSCVQSLPSGAFMDWGIIKDLFIPYKQQKTKIIEGKRYLVHIYIDDE
LELITGTTKFKRNPQYQDLPFKKGDKVDLIMMNESELGWNVVINKKYIGLIYTSDVFKKL
YPLSEESGYIKAIREDGKIDVSLQPEGFENIDEFKQKILDKLEENYGLLYLSDKSSPEEI
KDEVQMSKKNFKKAIGGLYKDKIIDISEDKIKLL
>KALACAFP_02951 hypothetical protein
MRKIFFLFTVLCCGFFFSQKKLSQNNEYFFYENKGQIIDQDGKENLDVKYLFHSAGLNVQ
LKKNGFSYDVYEIKKTVNPNSSKFKKDQSLNAKTYFKDEFLYENQFHRIDIELLNSNKNV
SIIAEGKSSDYDNYYNIPNKSKGITNVHRFQKVLYKNIYPNIDLVFFKPKDTLKPIEYNF
IINPGGRISDIKMKFNGAATSIKDNKLLMKVRFGEMYENIPNSWILGSKKENIDVSFRDL
GDQTFGFNAPINSSNKTIVIDPVPTRVWGSYAGGFGEDYGKIKTDSQSTGYIFGATASPT
NISTSGAYQQNLTGGFDAFLMKITKNGQKLWSTYFGTIKDDSFNDVAFDENFNIYAGGEI
LRQASNQDVVLVKFDTNGVLLYQKDFIGNSPEDFYTISYNNNQVFLGGQTMSADFPSLNA
PQPAKLSPNGYTDGFITTVDALTGNTLRSTFFGVADHSTSIFNIFSSTGDLEVIGATRSP
NIPMVNPFQSTFAGVTDGLYLKFSKTTGTLLRSSYFGNSIQDYVWEARIINNTLILAGEF
PDLTGPVYGPAGIWKIDLNTNAVTKTNLPFQYQVQLTAHIDSTGNVFFAGLCHHLHQTDI
ATPNAYMEDTGPYLKTFMIKYDSNIVKQWGTFYGGNGGTQLGYVTKDNEGYIYFTGMSSN
NTTGIATPGTFQQQGGHPSNDIFIAKFQDCTSSAVVSSNSPVCINSTIQLNATGGATYNW
TGPNGFTSTQQNPTIPNATAANAGTYACQVAGSGACDGTFTVNVVVGDNVAPVPNIATLA
DITGDCHTVVSTIPTATDNCAGTITATTTDPLSYSLPGTYVIHWTYNDGNGNVSTQNQNV
IVTAPALPTTANPQQIFCASNHPTVSNIQITGQNIKWYDAAGNILAPTTALVNGQTYYAS
QTINGCESNKTAIQVTINETPKPTGNSAQDFCASSSPTLANLVVTGTSLIFYDAAGNVLP
LTTPLVHGVTYFVTQTLNNCESEKLAIAVTLSTNNVPANDYSTTLCNATTGGSMIVNLTS
YQSNIIANPGSYTFVYTDDLGNPIPNPSNYTLNVGSTVIHVKVLTPDGCFKIIRLSLTLN
PKPEFSLPEKIDFCKGKTVTLDAGSGYSSYVWSTGETTQSITISTPGNYSVTVTNSFGCQ
NTDNTEVSYTVLPEIVAVHINNNSATVILSGTGNFEYSLDNFTWQDSNIFTNLNIGEYIV
YVRTKGGCIIGQKPFSIFNIPNAITPNGDGFNDKWKIAGLENYPGTEVNVYDRRGLPVFK
QIISKKPMEWDGKLNGTPIPTGNYWYTIKVSDGRVYTGWLLIKNRE
>KALACAFP_02952 hypothetical protein
MSNQAKKDQTQELIKETAKNLFFVKGKFDATTQEIADAAGVNRTLINYYFRSRDNLIQII
FDEAQKVEHEKSEIIMNSDLPFKEKIGQFIEGSLSTSLQYPYLETYIVSQINKGNCHKKD
IEEGELKKLYTDIEAEMELGKIEKMKPIQFVLNMVSLLVFPSAVRPLLMENLMINEEEFD
KIISERKDIILNMLFKN
>KALACAFP_02953 hypothetical protein
MERQRITAKLKIGIAAAFMISGFLQAQQSFTVEQSLDYAINNNVDVKKARIDQIKASQKV
KETTGIGLPQISAQGTYNYYLKIPVQLLPAEIAGGTPGTYIPVQFGLKQTVGAGITLKQL
LFNGSYLVGLQSAKAYKETSALAEEKTEISIKEGIMVSYAAIISTDENIKTLEDNMRIAE
KTLNDTKETYKVGLTEEQNVEQLEYSYKNLQTNKENLKRTRTKLLMALKYLMGYPLDQEM
ELSTTLDEMVQKNQVLVDQNKDIDISNHIDLRLKNNALKVSELQLKYQKSLSLPSLSGFA
STNYNGNSNSFTFFDKDQQWFNTSIVGLQLDIPIFSGLQRHWQTQQAKLDVTKAQLDKEN
TERSLKNEYYGKSVDYNNAFESYKTAQDQIKLSSSIYRKEQIKFKEGLGSSFDLQNSETQ
LYNSQSQLYESAINLIQAKVALDKAKGEL
>KALACAFP_02954 Macrolide export protein MacA
MKKIFLPLALLLTLAACKKEGATQDKTLEALIKTKDVKGLQAYKDRQKAKMDSLNNIMSE
VDKNLTALGVSQTLGYVSVQKLELTSFSHNVEIQGNVTTDQDVNVQSQFNGTLTLYVKEG
QRVNKGQVIGRIADGGLNDQHKQALIQVSAANSQLQQVKSQANLSRITYEKQSALWKQKI
GSEYQYLQAKTNYESAQKQIAAAQSQVAATQKAADAIRANLVKTTIVAPFSGVIDKVITQ
NGQAVSAAPATDIVKLISLGIMRVEAKVPETYLANVKPGTSVDINFPALNKSVKSSVRLV
GNYIDPATRTFLIQIPVSNDGGYIKPNLLAQIKIQDYVNPSALQIPAQYIYEDAAHKSYV
FIATNVNGENAIARKVYIETGQKSENSVEITKGLKAGDTVITDGSKNLTEGQKIKIS
>KALACAFP_02955 Efflux pump membrane transporter BepG
MGENKHHEKESFFSSWAVDNRTTVYVLTFIIVILGIFAYTSMPRESFPEVVENKIYISSI
YPGNSAEDVEKLITKELEDKFKNVSGVDKVTSNSFQDYCLITVEFDEKVPLPEAKQRIKD
KVDEAKGDQDWPTVDSGSKVEPSVFDLNISEEIPILNINLKGNYPKFTLRQFADDIKDDL
EDIPEVKEATVLGVDDNEVEVALDIFKMNAAGVSFDQVINAIRNENITISGGNLITEGNR
ENVRIKGQISNPSDVNNFVVKPGVKIMDIAKVEFKEKEKTTYARESGKDVVMINLKKRSG
TNMIAAIEQAKEKIKKAQETYLPKDLDISLTSDQSTDVEHQVNELANHILIGILLVMCVL
SFSMGLKNALFVGTAIPLSMLIAFAVLSAFGVTLNTMVLFAMVMGLGMLVDDGIVVVDNV
YANMEKGYKRREASKYGIGEIAFPVITSTLTTVCAFLPMLMWPGIMGEFMKYFPITISVT
LLASLFVALVINASMTGGGMTLDNKNITPSQAKKYTIIFAILAVVFGVLRLVTGIEFFLA
IVTLSVLAIAAIWLYKGFFHDRIEHFQYTFFPNLAKKYQKFLRNLLQGKKPRYWFLGVIG
VLIFSFFLYGVMMGIGRSKVLFFPENIPKQVIVYMEYPQGTDIAKTNTATKQVEARILNV
LKQYKDKKTGENFLVESMVTQVGKGAINPQVDAGSEADTPFKSKTTITFVEFAKRHGVDT
GEVMEQIRKAIPNIPGFTFTVEKDANGPPVGYPVSIELKGDDYDQLLTEAKNMITYVNKQ
GISGIEKLQSDINKESPELIIDIDREAAGNMGVTTAYTGITLRRALFGQDISTFKDVKDD
YDISVRLQQDQRRNTSLLFNQPITLQGQTGPILVPMSTFSTMKEENTFNKIKRKDNTRTI
MVYSNVLKGYNANEIVQKIQASLKNYKTPEGITYSFGGEQEEQGKNMNFLLFALFLAMAL
VTSIIVFQFNSLSKTLIIMTTIFLSFAGVFLGLAIFGMDFVILMTMMGIISLAGVVVKNG
IVLMDFFVLKLDEMVHKKGVETHDDLELEEVKEIIIESGKERLRPVLLTATTAILGLIPL
AVGLNFDVFSFLTTLNPHFSVGGDNVMFWGPLAWTIIFGLSFATFLTLIIVPVMFYIISK
RKINSRRKYVAKHAHDAEREAEEQERLKKLYPQEFEEYHKKKEDDLGLES
>KALACAFP_02956 Chaperone protein DnaJ
MKKLGEYRKLLEVDKTVTLKELKTIYRNTMKDTHPDKFINDEAGKLEAEEKSKSVIEAYH
FLVSINPETQEKYKEEYTETVTKSNIQDFYLEKSVLTVQHLNGNIYEYIGVPRNTYIKMV
NADSPSRFARRHIYGSFVYRKAGEVMAE
>KALACAFP_02957 hypothetical protein
MKPLRHNNHILENLSNKFFNNSLPEDWFIDKPENDYGIDYITNIVVNNEVTGLNFSVQLK
SKEIDTNKNTVNIQFKTSTLNFFRARLEPVMIIVYVKQDIEAYWQWFEDIEFNHEDLENK
ENIYLKVSKENKLTEINWNDIISKVQKHFGIKSLFESFTKLEYESLDKIEIIAWKNYLTQ
NFSDAIFYFKKALKIENLQDKASILHALSQSLYSMYNYEEALLYINQCLEIEESENLFLT
KACILAEQGISTSNQHKLLDAKEIFRNILNTNNKFTYHYNYANTLSNLQEFEEAIKHYKL
SLKLNPNYAEAWKNLGTAYYYLGNHEEELVCYDKALEINPNLVEALFSKGVTLLNIFKDY
TSAKELMYKSIESGEESLIKNFPRGYYALSLVNYRLNNISEALKFIDKGLDAIPNDGYLI
NLKLDIIDSKINEKIIEESYLNKFFELLLRFEDIRAIYYITLINNYSDNQILQLLQKYIY
IFRFITLDNLEDSKISLKENLSFLKYYSYYQEYRSKCSIFSYYEHLDYDQFKINESFLPL
LELTFAFSYCEALDYILNNENSENKNVIKILHKELLKSINLINILIPLSHPTFSKEEKIN
ILSQTIIEYKMILFREISRQHGFLCGSFGLTKIGVEDLMPEKFSDEIIESIIKVANSKLH
LLSEK
>KALACAFP_02958 5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase
MQTHILGYPRIGSNRELKKACEQYWTGKIDVNDLLEVGKTITQNNWKLQQEVGIDLIPCN
DFSYYDQVLDMTLTVGAIPERYQEIAFKKSETDLYFAMARGFQKEGLDITAMEMTKWFDT
NYHYIVPEFQKNQEFTLFSNKIIKEFINAKQAGINAKPVIIGLLTYLLLGKEKEEGFDKL
DLAQNLLPVYIQILKELENHGAEYIQFDEPFLALDLNEKAKETYQFIYAEIRKQFPKLKF
IVTTYFEGLKDNLSLATSLPIDVLHIDLVRCPEQLDEVLKTIPETLSLSLGIVDGRNIWK
NDFQKSLHFIEKAVQRIGSERIFIAPSCSLLHAPFDLDSEKNEDILSPEIKQWMAFAKQK
VYEIVDLKKLASENPDYNALQALAENKKAIENRKTSTLIHNQDVKNRVDVTTEEDAQRNS
PFTIRKQTQQEVLKLPLFPTTTIGSFPQTKEVRNWRAKFKKRELNAEQYDTLLKQETERT
IRWQEEIGIDVLVHGEFERNDMVEYFGEQLAGFAFTQNGWVQSYGSRCVKPPVIFGDVHR
PNPMTVYWSKYAQSLTQKWVKGMLTGPVTILQWSFVRDDQPRSLTCKQIALAIRDEVNDL
EKVGIRIIQIDEPAIREGLPLRKSDWQNYLKWAVEAFRISASGVEDATQIHTHMCYSEFN
DIIQNIADMDADVITIECSRSQMELLNAFADFKYPNEIGPGVYDIHSPRVPSKEEMVELL
KKAQAVIPAQQLWVNPDCGLKTRHWDETEKALIAMVEASREASEEFLKKEKLKY
>KALACAFP_02959 hypothetical protein
MIDINHPESEFIFQAGTFTDRIRNYCRKYILETFEERKITFQDMKIEGLILQEFSEIHFK
ENFISISLLINDLNTEIEKLESINIISEDGNCTVCNTKLTTFDTLIKEKDFRFITICKKC
PSEIYNILNKLDWLTGAAFI
>KALACAFP_02960 hypothetical protein
MYNPTRRNRNMGTENQGFGQNNRLKISTPYGTLKSFYERIEKYQKEVRIINDHEFLFVIE
ETRENSFHSCSVEDLEKIIEHIPKEDYGDLKFIILRQPKRKEEIISPVWGRLIYSFEIEK
EYFPAIILDSIDLNKKLIWSKKLTVEDQKEFIRLKEDGYIFEENTRNFIAELKLYSSRNT
QLYRTLLHEFGHYVHYLEVVERPGNEDEDYEEKEARDDYYMSIPKVEKEKFAHQYADRLK
NKLIEDKIIPFDRIELNTNLTNTFHK
>KALACAFP_02961 hypothetical protein
MKLLFSLSLSLLLSINVFGQKTEKPTSKDKAAIEHFKNDYKKKNYKKFSGNISVKDNQVL
FDTKIIYYDKSDKITKLILQEGLVYPQLLTDFQIDKFENEDSDRTQKRFVRLQKNWKDSF
EVNNIKLSNASELLFLSSDVKVKRFKISCKDPKFPNIMVYYFELTDKNATDKTPLEEFIK
NSKLTYIYQKTE
>KALACAFP_02962 GDP-mannose pyrophosphatase NudK
MQNPKIDILNTEILSDNWYTLKKVTFNLIKKDGTTEKQSREAYDRGNGAVILLYNTTSNT
VILTRQFRLPTFINGNPSGMMIEACAGLLDNDNPEECIKRETEEETGYKISKVEKIFEAY
MSPGSVTEILHFFIAEYSTEMKVANGGGLAEEGENIEVLELPFDEALSMIDKGDIKDAKT
IMLLQYIRIKNIL
>KALACAFP_02963 Epimerase family protein
MKEIVLITGAGGMIARELSKRLEKDYTVRFLTRKKQHSNEFEWDVRKGTIDEAVLENVSH
VIHLAGANISEKRWTTERKEELISSRVDSAQLILKTLRKKKIKLKSFITASGINYYGTKT
TDTIFTEKDAPGNDFLSEVVVLWERAADNFKEQNLAERVVKIRTAVVLSEKDGALKKMIP
TIKMGIGSPLGSGKQFMPWVHIKDICSIYEFALKNSDLDGAYNATAPEHITNEDLTKNIA
KILRKPLFMPNVPRFVLKLIFGELADALLEGSRASSQKIQDAGFQFEFPRLEMALEDLLK
NN
>KALACAFP_02964 hypothetical protein
MNCLECGEKIMGRSDKKFCNDACRNAYNNKQNKDSNNLMRNINNKLRKNYRILVEVNIDG
KTKIAKSKLDGLGFDFDFFTNLKVYKNGSEYKFIYDYGYKMLDDDFVLIVKNKA
>KALACAFP_02965 hypothetical protein
MKKTLKRTFRVSKYVIYKETLVDYKEHFWSFLGAFFGIGIIAFIQSHTLSATENIFLIGS
FGASSVLIYGAIQSPLAQPRNLVGGHVISALVGVTVYKIVPDIIWLSAPLAVAFSIVLMQ
YTKTLHPPGGATALIAVSSTGKIPELGYWYVVSPVLTGCIILLIAALFFNNITSNRSYPT
HNRLKRLLKKKHAHPHKMKK
>KALACAFP_02966 Arginase
MKGKITLFEFPFNLGLTKKEHEIEPGVRKLPDWLKKLGFHERISPEHIYRLESPAYAMNF
DQETGVKNPEQIVEYAKKQSELILKNSDKNTFNIILGGDCSILIGTAIALKKLGSFGLFY
LDGHTDYIPARLSPSGGAAGMDLAIVCGLGHEKLTNIDNQKPYFLAENVFCVGNAETDDE
EYVGEIINSKINYFDLYKVRKNGFRKTSEDFLALINEKNLDGFFIHFDVDVLNDKIMPCV
DSRMEDGIDYDNLKEILQPLIHNEKCFGIEITILDPDYDPNGEYTLPFIENLIKIINNED
>KALACAFP_02967 Single-stranded DNA-binding protein
MSLRNKVTLIGYTGKEVEMMSFESGNVKASVSLATSDHYTNAKGEKVEETQWHNLVAFGK
TAEIFQKYVTKGKEIAVEGKLTYRSYDDKDGVKRYITEIRVDEILLLGSK
>KALACAFP_02968 ATP-dependent DNA helicase UvrD2
MMKVKVFKIRLPEEFLYEDQKTLDSFLESNDIIKVETAFVQDENYWSVVLYFDELKIVQN
TVKDPKTAKYSAEIETLNADEEKILYALKEWRSEKAKEQNLPSYFIATNKELMSVAKYKP
AKKEELRDIKGFGKHKIENYGEEILEILDSI
>KALACAFP_02969 Histidine--tRNA ligase
MKPSLAKGTRDFTALEVARRRYIINTLQKNFELFGFQPLETPSFENLSTLTGKYGEEGDR
LIFKILNSGDYTSKVNQEDWENKNHQKLTSQISDKALRYDLTVPFARFVAMNHGQLTFPY
KRYQIQPVWRADRPQKGRFREFYQCDADVVGSESLLQEVELIQLYLKSFSDLKVSVTIHI
NNRKILSGLAEYAGITDKLIDFTVALDKLDKIGKDGVVKELLERGISQESIDKLDFLFTQ
SDDALENLLQLKEKFTGNEIGLKGVEELEFVITQSLNLGVDIQNLVFDITLARGLDYYTG
AIFEVKADEVQMGSIGGGGRYDNLTEVFGVKNIPGIGISFGLDRIYLVIEELGLFPEEAT
SKVEYLFANFGGDEMLEALKLIKQLREKGISAEIYPENAKLGKQFTYAEKKGIKNLVFLG
EEEIKNKKVTYKDLEAGEQKTVSLEEFLNN
>KALACAFP_02970 putative chromate transport protein
MKNTEDLKEIARLFLKLGIIGFGGPAAHISMMQEEVVTKRKWLTQQHFLDLIGATNLIPG
PNSTEMAIHIGREKAGWKGLLIAGICFIFPAVFITGIFAWLYKEYGLLPEVQPFIYGIKP
AIIAVILGAIFPLAKKSVKSVKLAILGIIVLVGLLLQYNEIFLLFGTGILAVLIFFIQNK
NSEGLKNLIPVISLQHSGNDILSAANIKLFLIFLKVGAILYGSGYVLFAFLDAELVSEGL
ISRKQLIDAIAVGQFTPGPVFSSVTFIGYQINGFTGAVVSTIGIFLPSFLFVALLNPLVK
KMRNSKIFSIFLDAVNVASVAIIIAVCIHMGMDTITDWRTSLIAVVCIVLSFGYKKINSA
LIVLAGSGMGYLLTFL
>KALACAFP_02971 hypothetical protein
MSKNISKDIIEKWLKGWSLSRNLPLPVTYKSGFKVDVGDEKQKSRYIFAEANTDFFQLAQ
SIHEPWVFLKVCTSFDDLKNKIPERWQLQPQGYMMSCFHRMNIIEVTLHKGYKMEFENYN
STFVIKILTENGEPASIGRVVLVDNLAIYDRISTEADHRRKGLATFLMKELEKIALSKGI
THNFLVATEDGKALYQSLGWNVYSLYTSIVIPS
>KALACAFP_02972 hypothetical protein
MSEKSRLDEIKDELEKLDINPTIFARKEIRALPEVLSEDEKIVYLVEGRNKLTNHHIILV
ATDRRLIFVDKEFFYGLKVEDFSYDKISSIQYEKELMLASIDIQTSDNIVEIDGVGKYYA
ELFCEKTRDFMSRPKEYFQAAKEPTVLDQLEQLGRLKESGILTEEEFSEQKKKLLEKL
>KALACAFP_02973 Ubiquinone biosynthesis O-methyltransferase
MENYLEINKNSWNAKVEPHLKSDFYFVDEFLKGRTSLNSIELELLGDVKDKTILHLQCHF
GQDSISLSRLGAKVTGIDLSDKAIETARDLALKTGTDTQFICTDLYNLPNVLDEKFDVVF
TSYGTIGWLPDLNEWAKIINHFLKPDGKFIMAEFHPVVWMFDDDFEEVKYNYFNEKPIVE
TYEGTYADTSADIVQDYVMWNHSLEEVLQNLIENDICIEKFKEYNWSPYPCFKHVEEFEK
GKWRIPKFGNKIPLVFALETQKKSS
>KALACAFP_02974 hypothetical protein
MGNKTKGLLALLGLGALAYWKYKNSSPEEQQAVKDKINNAKDNLNKWGNDLKDKANNVAS
QVQEKVDGMKEKAEETVNQN
>KALACAFP_02975 Isoaspartyl peptidase/L-asparaginase
MKVIIHGGFFSESDQSHEVKVAKQNSLKNIAQKAFEYLQNNSAFDTVAYAVSLLENDELY
NAGIGSQIQSDGVIRMSAAIMDGETQKLSGVINIQDVKNPIFVAKELMKEDDRVLGGNGA
KKYANEHGFENFSTEIPQRRKEYEAKLNNGGKGTVGCVAIDKNSKLAVATSTGGKGFEIP
GRISDSATVAGNYANSFCAVSCTGVGEDIVSNATATKIVTRVTDGMSLEKAFTKTFEELK
TIDGFAGAIAIDKNGNIYHQDSYPTMVFASFDGENFEVFN
>KALACAFP_02976 Cyanophycinase
MMKPVGKLIVIGGAVNKGSFTETDFDQNIEKNLNFFERGILRKIINESKNKEDSVIEIIT
TASQIPQIVGTEYKKAFEFLGAKNVNILDIHNREEANSDAMVARANAADVVMFTGGDQLR
LTSILGGTRFHDTILLKYQEQDFIYSGTSAGAAAASENMIYQGSSSEALLKGEIKTTQGL
GLIDNVIIDTHFVQRGRIGRLFQAVVNNPRTLGIGLGEDTGLFIHNDVMTAVGSGLVILV
DGRFIKDTNLTNINLGEPISIDNLTVHVMSMNDHYDLITKTLTIENSQFNPIPQDR
>KALACAFP_02977 Cyanophycin synthetase
MKIEKIQALRGPNIWSIRRKKLIQMRLDLEEMENFPTNKIEGFRERIEKLIPSLYTHRCS
EGVEGGFFHRVETGTWMGHVIEHIALEIQTLAGMDVGFGRTRETKTPGIYNVVFNYIEEN
AGIYAAEQAVKIAEALTNGEEYDLNACIQKLKEIREKVRLGPSTGSIVEEAVSRKIPWIR
LGTNSLVQLGYGVNQQRFQATITGKTSSIAVDIACNKELTKRMLHDAAIPVPIGELITEE
EELDKVIKKIGYPIVLKPLDGNHGKGSSINVNDWEAAKIGFHHAQKYSRKVIIEKFITGY
DFRVLVINNKMVAAARRVPAHVVGDGELSLQQLIEKENKDPRRGYGHENVLTEIEIDKDT
TELLEKLHYTLETVPQKGEVVYLKSTANLSTGGTSIDVTDMVHPENITMAERISKIIGLD
VCGIDIMAENLTQPLKESGGAIIEVNAAPGFRMHLAPSEGLPRNVAAPVVDMLYPPGKPF
TIPIIAVTGTNGKTTTTRLISHIVKSNGYRVGFTTSDGIYIQNTMLTKGDTTGPLSAEFI
LKDPTVEFAVLETARGGILRSGLGFSQCDIGVLTNIEEDHLGMNDIHSLKDLTRVKRVIL
DSVKKNGWSVLNADNEYSMKIVNDLDSNVAIFSMNENNPHMLKFAKEGKITCVYEEGFVT
IKKGDWKIRIGKAKDFPITMEGKAKFMIENVLAASLASYLYGFGIEDISNSLRTFIPSAQ
LTPGRLNVFKFKNFKVLIDFAHNPSGYEAIEDYLKNVEANKKIGIISGVGDRRDSDIREC
GKIAGRMFDHIIIRNEKHLRGRKEEEINGLIIEGLQSAGKDVSYEIIPKEIEALKHAMGM
AEEGTFITALSDVISNAIDLVQEYQARELLEDDKV
>KALACAFP_02978 hypothetical protein
MISKYRKQFNQEFSQEKYERFKEILKEKSGLEPAFRISESPLFLSKEFEHKLLDASESII
DQIKALPAETLQKAIPDNCRVPNDTGKPHFFTIDFGVCKNENGEIEPQLIELQAFPSLYA
FQKVFEDTFCEIYPFLTEIKNKMPHEEFKNYMKELIIGNENLENVILLEIYPEKQKTVID
FILTEKLLGIKTVCLTKIKKEGKKLFYENNGKLTEIKRIYNRVIFDELDRIPDLKTELDF
REDIDVKWITHPNWFFKISKFLLPLLQHQFVPKSYFLHEFPDSENLENFVLKPLFSFAGS
GVNLNPTKEITDAIEDKENYILQRKVNYEPIFEDINGEFSKAEIRLLYIWRENDERPILL
ENLGRMTKAAMVNVDFNKKDAIWIGSSNAFFVEE
>KALACAFP_02979 hypothetical protein
MKDIRIALLDMNNNQVNQGFKNIKEISEAFQQSSEENVSIKTFDVRYKNEMPNIEDFDIF
ISSGGPGNPHREGHEWEDKFAGFLDQVFEHNKYNEDKKYLFLICHSFQLASIHWELGNIC
KRKSYSFGVMPIHKTEEGEQEFLFKNLPDPFYAVDSRAYQFIEPNHDRFEELGMKIVAIE
KFRPHINLERAVMAIRFSEEIFGTQFHPEANPAGMVESLKDEKYKTAMIENYGMEKYLET
VDRMDDEDKIILTQAQILPRFLRFAKKNVLKQVEAMV
>KALACAFP_02980 Putative glutamate--cysteine ligase 2
MHQFTIGIEEEYQIIDVESRDLISHVSKIIEGGKAVLSENLKHEMHESMIEMETGICQNI
QEARAELTNLRRHLIKTAHDQNLRVSGGGTHPFSHWSANTITQGERYIKIVDDMGDVARE
NLIFGLHVHIGIPNREEGVRIQNVMRYFLPHVYALSTNSPFWIGRYTGFKSYRQEIFVKF
PRTGIPSYFNSLAEFDSYVDLLVKTGTIDNAKKIWWDLRVHPFYPTIEFRICDMPLRIDE
TVCLAAIMQALVAKIYKLHQQNLSFRSYRRLLLNENKWRASKSGIEAHLIDFGKEESVPY
PHLLKELLEFIDDVVDDLGCRTEVEYAWKILENGTGADRQLQIFKETGDLTKVVDYMISE
TEYGITHGELTS
>KALACAFP_02981 hypothetical protein
MAKKVGILFGMEDTFPWAFIDKVNELGGGEIIAEPVTIDKLEQGTDYGYAVIIDRISQDV
PFYRAYLKNAALNGTYVINNPFWWSADEKFFNNALMSKLGIPLPKTVLLPSHERPTNTSE
TSFRNLRFPHDWDYIFNYVGFPAYMKPHDGGGWRNVYRVENPEDLWNKLGETEQLVMMVQ
EEIIFDDYYRVYCLGKKYVHIMPYEPRNAHHLRYATTHQTQGEELEKLLKTIHDYTITMN
EALGYDFNTVEFAVRDGIPYAIDFCNPAPDADRNSVGEENFAWIVEHAAKLAIEKAKEYV
PGKPNISWGTFVKDSVK
>KALACAFP_02982 hypothetical protein
MPQIEHTDYYSHILGTSLKVEVTGHYGYPIVMFPTSQGQYTQNHDFHLNGSINWFIEQGK
VKLYNIQTIDSWSFYDEKISPQQRIKNYELYVQFLIKEFIPYIQKLHDTHRVAVAGASFG
GYHAANFAFRFPDVVSHLFCLSGAFSIRNFMDGYSDELVYFNCPREFVKNDEAWKYKHMH
IVLSTSDQDICRDKNLEMADILSSKGIDFWYDERKWINHDWPLWRMVFPTFIGAFFS
>KALACAFP_02983 L-arginine-specific L-amino acid ligase
MEEKIIVCISCYYKGYDFMDEMKKLGNKIILVTSENLKEKNWPWHAIDEVFYMPELQPSV
WNLEHLIQGFSHLMQTRKVDAVVALDDYDVEKAALIRETFRIPGMGQTTHRYFRDKLAMR
QKAKDSGISVPEFTAVFNNDEVNRFVEHIPAPWVLKPRSEASASGIKKLKSKDELWDALN
ALGEERHLFLLESFKPGDVYHVDSLTFNKEIVFTSASKYLAPPMQVSHEGGVFRSKTLGR
YSDEFKALEEANAKVLSSFGLINGATHTEFIRGKEDGKWYFLETSSRVGGAHIPDLVEAS
SNINIWREWAKIEDALLKQKKYEVAKPTGYYSGLIVALIKDKEPDYNQFECEEVVKFLPI
DYHVGIVYKSNDSSVVQDRLDYAAAKIHSDMLNILPPKSKPTS
>KALACAFP_02984 Cytosol aminopeptidase
MKLVNKKNKNYTQVFHVFTEEEWTKTSKNFNKNISTFFTGKKNEVFVNAQEEGIAYFIGL
GKSMLQNFEIQQVANKFSQTQKKNLQAVPTLVLADFMNEKQFEEFVKGLLIGTYNYPFEK
THSFWNAKFELHFENLSQKKLDYINQKALALTNGQIACQDWLNKPANLKKPDIFSTYLKN
LAKKHSLKYTSFNRKKCEELGLGAYLSVNQGSAYDAAFTILEYKTTVKNAATFGLVGKCV
LFDTGGISLKDHTNMHYMKSDMGGATAVLGTLIYAAEMQLPVNIVAILPITDNAISENAF
LPSDVITAYNGKTIEVLNTDAEGRMILADGLSYMAKNFKTDFLIDLATLTGSSVRMFGDT
CGALFSNNEELKNLLIKTGDKTNQRLWNLPLWDVWKDDIQSDVADLKNISMKPIGDCIVA
AKFLEQFIESHPKWAHLDIAGVAFGSVGYAKEKAATGFGVQLLADLIENYH
>KALACAFP_02985 Carbohydrate acetyl esterase/feruloyl esterase
MMRFELYSEEIDDRTVYITGNFNNWNPKDYNFQLKRLDPNNYYIEINDEILPDVIEYKFT
KGGWENVELDIYGNITPNRKASKAAGKTADTVEKWRLNWGPFKKEFFPIAEIISEEFYIP
QLDRYRKVWALLPYDYYVSEKTYPVLYLQDAQNLFNEGSGYGNWEIDKKLSILVEYGRGD
VIVIAIEHGSEERIKEYIFDNDNVANGSEGKKYIRFITDTLKPYVDENYRTKRDRENTGI
GGSSLGALISIYSGFLYPEVYSKLLIFSPSLWVEPNNNFPIMNFRVPYKTKIYLYGGAQE
GSKMVKRIRIFEEYLKRWEKKNLFDFEFKTSINPEGTHSEFYWSQEFPRAIEWLFYNNRE
NPVEVKPQQNSIKN
>KALACAFP_02986 1,4-alpha-glucan branching enzyme GlgB
MNSVKTYTLFTDHDIYLFKEGKHYKLFDKFGAHSVEKDGVKGVYFSVWAPNAKKVSVIGN
FNNWNHTDHILFPRWDESGIWEGFIAGLTWGTLYKYAVETARGEILEKSDPYALSWEQNL
QAASMVSTTWYEWDDKEWLENRWKKNTLNAPISVYEMHLASWVREGDDPKRFLNYRDIAK
KLVPYIKEMSFTHVEFMPVMEYPYDPSWGYQITGFYAATSRFGSPQDLMFLINELHKNGI
GVILDWVPSHFPGDANGLHRFDGSYLYEHEDPRKGFHPDWKSYIFNYGRNEVKSFLISNA
MFWLGRYHADGLRVDAVTSMLHLDYSRNEGEWEPNIYGGNVNLEAQTFLQEFNTAVYKEF
GDNIITIAEESSDFPMLTKPVHDGGVGFGMKWMMGWMHDTLDYFKEDPINRKFFHHKLTF
ASMYMYNENYMMPLSHDEVVHGKASLIYKMTGDEWQKFANLRALYVYMFTHPGAKLLFMG
DEFGQTSEWNFTQSLDWHLLEYPVHKGLQTLVKDLNHLYRNETALYENQFNPDGFEWIEA
DDIENSVYIYLRKGKKKDDVFMVILNLTPRVIDYKIGVNAGTHWEVVLNSDDKRYAGSGV
NADIFSEQFEEYKNHPKSISINLPPLAGIILKRKDRNYKQNRIKQHKR
>KALACAFP_02987 Glycogen synthase
MIVYHLSTECYPVAKVGGLADVVGALPKYQNKIKGVDAKVVMPWYNKSFIYDHEFDIVFD
GFIHQGPNMLQVQVMKENTNALGFELYMVKIPGLLDRDNPYGYQDESFQFLAFQHGVLHW
LSAMKIRPDILHCHDYHTGLVPFMIEYCPEFSFLKGVKTIGTIHNGEYQGMMSWEMANYM
PAFDAYKWGMMDWNGLINPLASMIKCATAFTTVSQGYLEELYISFRGLESLVRDEFGKAY
GIINGIDAEVWNPETDPMLDFNFNSKNAVAQKKKNKEKLCKEYGLKPELPLFAFIGRFAT
EKGADLLPDIVWRSIKQSYGALNIMILGSGNSYIENKLKEYDYTYSNFALDLGYKEHLSH
KIYASADFLLMPSRVEPCGLNQMYSMRYGTIPIVRYTGGLRDTVEDISTGGAGINFTYPG
ADDVIHAMNRAMSIYNEKDVMENLIHANMSFDFAWEKSAEKYIALYNN
>KALACAFP_02988 hypothetical protein
MLKKFSFLFLLIMIFSCKKEEGNYVGGYYWIYSYGLKDMRAAEATEGISEKWKIKYADVG
GCVVGYDIQKKADASNKKTYAAIAKRYGKDWKKKYNKDLEDFMMKKVDVMDVLITNKLFR
DELKKYYIEIDDVDKDVKEINENLYKVVVYNQKMKAENKECFAVNVNTEDRTVKLIDKNA
R
>KALACAFP_02989 Glucose-1-phosphate adenylyltransferase
MKRNVISIVLGGGRGTRLFPLTYSRSKPAVPIAGKYRLVDIPISNCLNSGLNKILVLTQF
NSASLNSHIKNSYHFDIFSKGFVDILAAEQNVENDNWYQGTADAVRQSMKHLEKYDYDYI
LILSGDQLYQMDFREMLDFHIEKGGDVTIATIPVNAKDATGFGILSSDDEGNITSFVEKP
SYEMLEGLKSEVSENNKHKGKEYLASMGIYIFTKSILKKMFDEGAGDDFGKDIIPSSIGK
YTTLSYQFEGYWTDIGTIESFYEANIDLCQDFPQFNLFSSSPIYTRARMLPPSKINGSYV
SKAVFGDGCIIMADKIENSVIGNRTRIDKGSTIVNSYVMGADFYQNTAEIVINDQKGLPN
MGIGKYCYIEKAILDKNCYIGDNVRIIGGKHLADGDYGTHSVQDGIVVVKKGAVLTPGTH
IG
>KALACAFP_02990 hypothetical protein
MSKLFYKIFLISIIFISTFYKSQIVTVRGVVKDSLNINNFISISVNDTINKFRDKVFKDE
TFKNKNWNKYDELVKKFSTFPDYPDGNYNITAKLTDTLYFHKRDYITQKYKVADIINKNI
KVILKPRPCIPYKKCDQKVPSRLYAFVGKKIDVSYVDQSKYCGISLDSEYKAEYEIEQEL
NEHYPNSKIIFTAYDHNSMYEYDFSNYDNVLLFIEEYCDELVKDHFFPVYKTTDGRWASP
IKLRDEHYYNSDKFKPININFEKSVSFDLLTTNSNPSEEQIAQLKQFKFPEKYYKIENGK
AIPIAGRYVEDLVELWKEISEKNKTK
>KALACAFP_02991 hypothetical protein
MRFFKIIAVIIVLLVGAYAASMYYFVDESKNFKIEKEIDYPVEKVFNQFNNLQNFTRWNN
FFTSSQSVDIDYYTPYEGQGSSISYADQKNDTDGEMFIRYENPNKTLRYQLFEERNENPT
VVDVQFKPVSATRTKITWVVHTPKLSVLRRVENFWTEDRFAENIDKSMANLKNVLSNKVE
KDNQMAAIKYDSLMVENEESKLLLGINVSTSNKKDALYKNIVMNYNKVYNYVTMDLGKRE
DEIGFTTLITDADNYKDKEVSYYLGIPLSKKFGVTDNNFSFRTINASQVYVMYYKGTYEG
RIKAVQQLIQKAKKDEMRFGDIGQTFLERPMEGQPVNMKLSLSVYK
>KALACAFP_02992 2-oxoglutarate dehydrogenase E1 component
MDRFSFLNAAHSQLIEDLYQQYLKYPDSLEPSWKAFFQGFDFALENYGDDENIQYIQAPA
NVVPAVQQATQAAANGEVPEHIKKEFKVVNLIEAYRTRGHLFTKTNPVRERRHYTPTLDI
ENFGLSKEDLNTKFNCAVETGMKEPATLQELITHLENIYCDSIGVEYTYINNVEEKDFIK
KWLQVNENHPNLSANEKTEILLKLNQAVAFENYLHTKFVGQKRFSLEGGETLIPALDQLI
SRSSQLGVDEVVLGMAHRGRLNVLTNIFGKSYKQIFSEFEGKEFEEDVFSGDVKYHLGSS
KKIKTASGEEVSINLTPNPSHLETVAALVEGICRAKVDDKYKGDYSKILPIVIHGDGAIA
GQGIAYEVAQMMTLEGYRTGGTVHIVVNNQVSFTTNYMDARSSTYCTDIAKVTESPVMHV
NADDAEAVVHAIHFAADFRAKFGKDVYIDLLGYRKYGHNEGDEPRFTQPNLYKTISKHPN
PREIYKDKLINDSVISNDVLKTMETDFKALLDKDFDASKEIEKNVMDLFMAEDWTNYPIG
KRGAVQLPVDTKYDLAKLKELAIKMSTLPADKKFINKITRLFENRIKAIEGNSLDWALGE
WLAYATLLTEGHNIRISGEDVERGTFSHRHAVVKTEDTEEEYIPLRHVSENRFDVYNSHL
SEYGVLGFDYGYAMASPNTLTVWEAQFGDFVNGAQIIVDQYLAAAEEKWKIQDGLVMLLP
HGSEGQGAEHSSARLERFLTLCANENMVVANITSPANYFHLLRRQLKWAFRKPLVVMSPK
SLLRHPKVVSPLEDFANGSFQPILDDPAADPKKVEKLVLCSGKLYFELLAKKEELNAENI
ALVRFEQLYPLQTDAIEAIFNKYENRKELVWAQEEPENMGAWSYILRNFRDTGIQVIAPV
PSGAPAPGSHKMFEKNQNAVINRVFDRNDAPIKRPVTA
>KALACAFP_02993 Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex
MSVLEMKVPSPGESITEVEIATWLVKDGDYVEKDQPIAEVDSDKATLELPAEQSGIITLK
AEEGDVVQVGQVVCLIDMDAPKPAGGSAPAAEAPKKEEAPKAAEPAKQEAPKPAAQPVAA
AATQTYATGAPSPAAKKILDEKGIDAGQVSGSGRDGRITKTDAELAAVPAMGGSALSATG
SRSTTTTKLSVLRRKVAQRLVSVKNETAMLTTFNEVDMSEIFRIRKQYKDEFAQKHGIGL
GFMSFFTKAVTRALQMYPDVNASIDGDFKINYDFCDISVAVSGPKGLMVPVLRNAENMTF
RGVEANIKNLAERVRDGKITVDEMTGGTFTITNGGVFGSMLSTPIINPPQSAILGMHNII
QRPVAVDGQVVIRPMMYVAMSYDHRIIDGRESVGFLVAVKEGIDNPVEILMGGDERKALE
L
>KALACAFP_02994 Protein ApaG
MFSKMTSNIKVSVIPEYDSKNSYPSENRYVFKYNITIENDGSFPIKILKRKWLIFDVGFG
YTEIIGDGVIGLTPEIPSGENFAYFSNVMLRSGVGNMSGKYLVKNMETQENFEIDIPKFN
LLSEVLSN
>KALACAFP_02995 putative ATP-dependent helicase DinG 
MDFCALDFETATHERNSACELGICIVQDSKIVETKTWLIKPPSFPYFNPFNVDVHGILPD
HVKDAPTFDEIWYEVEEMMYGTLMIAHNAGFDAGVLRGCLNHYGMFTPKLNYLCSIQLAK
KTWNYLPKYGLKHLAEYHQIKFNHHRAGDDAEVCAKISLLAFEKLFLTSNEEVADYMKPK
IKKL
>KALACAFP_02996 N-acetylglucosaminyl-diphospho-decaprenol L-rhamnosyltransferase
MSKKLAVVILNWNGKSWLEKFLPGVIRFSQDADIYVIDNLSTDDSVAFLQNNFPSVKIIE
NDKNYGFAGGYNEGLKQIDHEFYCLLNSDVEVTENWIESILSLFEKDSAISAIQPKILSF
NNKKYFEFAGAAGGLIDNLGYPYCRGRIFDDLEEDKGQYNDETEIFWASGCCFFIRSKDF
WEQKGFDERFFAHQEEIDLCWRLINSGKKIFYTGKSKVYHVGGGTLNKQSAQKTYLNIRN
NLSMLLKNLPFPKLIVLIFFRLCLDGIAGIYFGLKQGFPHLWAVVRAHFAFYGQAAETWR
RRQNYQKEVFYQSKWLIFKHFLKR
>KALACAFP_02997 Lipid A biosynthesis palmitoleoyltransferase
MNFLIKILFLISKLPLKILYIFSDIIFFLNYYIVGYRKNVITQNLKNSFPEKSDAEIAKI
RKKFYLNFSDYLVETIKSFSISETESRVRMQHINQEVFHEAKAEGKNIILLAGHVFNWEW
INALARIIPQDHCHPVYRKVNSDFWENQMKKVRNKFGNEALEAKEVILNIVRSKNDGSSA
YMFVADQTPHFAHITYGLEFLNQRTPVFTGYDRLATRMDLAFIYCEMKKVKRGYYQVNYH
RIYPDGEKFVEHEVVKKFHKLLENTLHKRPDNYLWSHRKWKYQDSIKNFDSQKI
>KALACAFP_02998 hypothetical protein
MKKLLLTAFLGLGFFAFSQELKDKPDVREKDKALLVKTDHAELDAKKKAAEEKAKLPKPY
NPKADAGKDIQNLIAKAKKEKKNIMIQAGGNWCIWCLRFNQFVQTTPELKAIVDKNYVYY
HLNYSPDNKNEKIFAEYGNPGDKFGYPVFIILDKNGKMIHVQQSDVLEEGKGYSLQKVKD
FFNQWTPKS
>KALACAFP_02999 50S ribosomal protein L9
MEIILKKDVENLGLEFDTVNVKPGYARNFLIPQGIALLATPKNKAALEATLEARKEEEAK
LIAAANAVVEQLKKTSITIPAKVGSGDKLFGSINNADLSAALEKAGVSVEKKYIKIPGNT
IKRTGRITANIRLHRNVEYNFDFDIVSDAPVEAAPAKKEEAKSEEA
>KALACAFP_03000 30S ribosomal protein S18
MAIDEMAKQASAGGESEVKFLTPLDINTKSEKKYCRFKKFGIKHVDYKDADFLLQFVNEQ
GKILPRRYTGTSLKYQRKVSAAIKRARHLALMPYVADLLK
>KALACAFP_03001 30S ribosomal protein S6
MNNYETVFILTPVLSDAQVEEAVKKFEDLLKEKNCEIVAKENWGLKKLAYPIQLKKNGFY
TLIEFKGEGTIVADLELAFKRDERVIRYLTTKLDKHAIEYAVTRRTKVKSAKA
>KALACAFP_03002 H(+)/Cl(-) exchange transporter ClcA
MLKFFNLIRRSLKKSFDNIRNEQLKYNLLQAIPFWIGSVITGFFAVMYAKLFAWGENLLH
FIINWHAWMIFIIAPIGFVVSWWLVKEFAPNAKGSGIPQVMAAVELANPKEHRKIRSLLS
LKIIVFKIISSVVLVIGGGAIGREGPTIQIAGSVFRKVNEYLPEWWPKISKKNMIMTGAA
AGLAAAFNTPLGGIVFAVEELSKTHINYFKTALFTAVIIAGLTAQTLAGSYLYLGYPKTN
DVSLMVMFPIILVAGTAGILASQLSVTMLKITDWKKRKLKTDKANVLFLVISALIIASIA
FFINREILGSGKEIMERILFTNDKHEDWYVPILRMLGPALSFTSGGAGGIFAPALTAGAS
IGSVISGAIHLSPNETNVVVLAGMVAFLTGITRAPFTSAIVVLEMTDRHSLIFHLMLAGM
VSSIASILVSRHSLYDVIKVNLLEEIRSEK
>KALACAFP_03003 hypothetical protein
MDFGEELNVKLFRFSEEQKKQIFKLYDKLCEFYKVSVIDIKDSPLFQFKPIVENKKFVPE
ICYLIESEGGSVFYLYIVTRLITYHKKYGNTEIEVLEIWGLKELDENYENISIYKKTFAD
HIVGFFNIFDIHTKDDSEFDKKFCILGKNKNKTLQFLNSKRRKELIKKFPDEDFKLEVKN
NILSFGLQKELTNSRALQISKFLKEM
>KALACAFP_03004 Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex
MAEYKLLLPSMGEGVMEATIITWLFNEGDNVKEDDSVVEIATDKVDSDVPTPVSGKIVKI
LKQKDEVAKVGEAIAILEIEGEGGNTASEEVKTETPAAAPDTDTLKTIEEPLKVAASTQE
FSGDLYLSPLVKSIAQQENISETELKTIKGSGLEGRITKEDILAYVNNRGNQPAPQAAPV
QQVVSAPQPVATSAPASTISVAAGDEIIPMDRMRKIIAENMVKAKQIAPHVTSFIETDVT
NVVKWRNKNKAVFEKREGEKLTFMPIFVKAVVKAIQDFPMINVSINGDNIIKKKNINIGM
ATALPDGNLIVPVIKNADQLSLSGLAKAINDLAYRARNKKLRPEDTQGATYTISNVGSFG
NLMGTPIIPQPQVAILAIGAIVKKPAVLETADGDVIAIRNLMFMSHSYDHRVVDGSLGGM
MLKHVHDYLENWDLNTEI
>KALACAFP_03005 Adenosyl-chloride synthase
MSIITLTSDFGNLDYRVSAVKGKILSLNPEVNVVDITHEIQAFNLIQTSYIVRNAYKYFP
KGTIHILSVDSFHHKSRKNILYKANGHYFLAADNGLLSLIFFDIKPEAMYEITLNNRFDD
IVNFTSTDVFVPAAVHLANGGLPEVIGRKIKHTKELLFPKPVYNESEKMIIGEVMYIDNF
GNIISNISKDFFESTGRGNENFTIKFRNLSLSRVFSSHTEVVSDWARETEFHGQSAAIFN
DSQLLELTIYKGSKKNGAKSLFGLNVGENIYIEFS
>KALACAFP_03006 PhoH-like protein
MFELTYDLEDVDVKIFYGVNNQYFNLIKSSFPTLKITGRDHFIFAMGNQEALDILKQKLD
DIVKFISKNNSIELKDVENILNLKDENEKQLVFDQDIIVKGVNGKIIKAKTTNLKKLVKE
TEKKDMVFAIGPAGTGKTYTSVALAAKALRDKEVKRIVLTRPAVEAGESLGFLPGDLKEK
LDPYLQPLYDALRDMIPHEKLEGFIEKKVIEVAPLAFMRGRTLDDAFVILDEAQNTTHSQ
MKMFLTRMGMNAKFIITGDPSQVDLPPKQQSGLKEAMRILHGVKEIGFVHLTEEDVVRHP
VVRKIILAYNDEEKRLRNE
>KALACAFP_03007 hypothetical protein
MKKILLLAAVAVMGMSINAQEFRFGPKVGFAMSTIKVDDKQDDLYERKMDPKYTFYVGGM
AEYKISDKFGIQGEVLYSPLGGKERIEESEGDVYVGEQTKVTFGTLSIPVSAKYFITEGF
SVSAGMNFGIILTAKQKTVIGTNLPIDIEIDGGEGEHDIKDDVKSLNLAPFVGVEYMFEN
GFFIDGRYNLGVSNLSNDGSGGKITNSFAQIGVGFKFGGN
>KALACAFP_03008 hypothetical protein
MKKLLLLGAFALLGGMAQAQEGFRLGGHVGAPLGDASDAASVTIGIDAAYMWHITKGLDI
GATTGYSHFFGKDNVDDFGFVPIAASGKYTFSKVPLFVGLDLGAAISTRDYINSGLYVAP
RVGYQMKNIELYLGFQTISSKYKDHGPYWYDNGRHNFGAVNFGVNFFLK
>KALACAFP_03009 hypothetical protein
MKKVLLAGAIALFGLSNAQIAKGTAYLSGSVGYSQEETNSGNNKTENFNVIPTFGYFVGT
NLAVGLGVGYQTQKETNIATTQLPGATIVSTNEVKEPAFVVAPFVRKYWNLSDKLYIFGQ
LAVPMQFGKTEIDNTSVTTAGSSTTTTTTSSEAKYTQVGVTVKPGLDYFLNKNWSIEATI
GEFGYNNYKPKDGEATNNYNFGLNLSSVTFGVKYVFAK
>KALACAFP_03010 hypothetical protein
MKKLLLAGAITLFGLSNAQIKKGTVYISGQVNYTQEEDKNRDFTEKNFKIIPTAGIFIAP
NLAVGTGLGYTNKKTEYHDIYSDGFFTSSFESTGKTDAIVVAPFIRKYWTLSDKLYFFGQ
LEIPMEFGKINQDASVTYIDGMSGFIAQQTFSVERKYTSIGVNVKPGLDYFLNKNWSIEA
TIGEFGYQNFKYKNETDTDLKNYNFGLNLSSISFGVKYVFAK
>KALACAFP_03011 hypothetical protein
MKKLLLAGAVALFGLSNAQMTKGDWVISGNTGAGFNNVTTTIKANGQSVDGPKVSTFSVT
PSVGYFVIDKLAVGIDLGFLTATTKYEGLKSTTTSFSVMPTATYYFTNSSKLVPFLGAGI
GYASAKNKGEADFMGISDETTTDGLAWKVKGGVTYMATQSLGINLGVSYDQFSNKETIMN
TDVKTNVKTFGVNVGFSYFIKGKAQKSDK
>KALACAFP_03012 hypothetical protein
MKKILFASALALFTVANAQTTFGLKGGFALSKLTSNEDLDAFEGVNGGLKSKAGFYVGAL
VEHKFNNKFAVQGEVQYANLGGKAEVSMSGITVTENFNLNRIVIPVSARYYATPDLAVYA
GPFVSIKTGTKVNIDVSGGMADPQLLNEAENFLEESFDNGLKSAEFGLFLGADYNVYKGL
FVDARYSFGLSNMIKDPVADEKMKMNFFQIGIGYKFK
>KALACAFP_03013 Signal recognition particle protein
MFNSLQDKLDKALHNISGRGKITEINVAETVKEIRRALVDADVNYKVAKDLTKRVQDKAL
GQNVLTSLTPGQLMTKIVHDELVDLMGGSQEGINLSGKPSVILIAGLQGSGKTTFSGKLA
NYLKTKRNKKPLLVACDVYRPAAIDQLKVLGGQIGVPVFTEEGSTNPSTIAENAINFAKS
NGHDIVIVDTAGRLAIDEQMMNEIKTVHSTIKPNETLFVVDSMTGQDAVNTAKAFNDTLN
FDGVVLTKLDGDTRGGAALTIRSVVEKPIKFISTGEKMEALDLFYPERMADRILGMGDVV
SLVERAQEQFDEEEAKKLHKKIAKNEFGFDDFLKQINQIKKMGNMKDLMGMIPGVGKAIK
DVEISDDAFKHIEAIIYSMTPEERRRPSIINTQRKNRIAKGAGRKIEDVNQLMKQFDQMG
KMMKMMQGPQGKQMMQMMSKMPNMPGMGGMFGK
>KALACAFP_03014 hypothetical protein
MLGKNKFEMKANPNILVTVLFFLTFLIHFSLWKFVFHLDEIVIVKFYLFLSVMFMLMITL
IVLINKVVPEFLGLSVIGLILLKFALMYLIRKKLNFEVIPGYKFHFIIPYFVLTTLLTYY
AIKLINHDKKQ
>KALACAFP_03015 ATP synthase subunit a
MFKKFAVLFYSIFVLNLVSAQHGEATAEAAPATELSEKDKVSKENKEFIAHHLLDAHDFT
LMVDKEGHHIGFPLPVIFYDNGIHAFMSNKEGFMHGEPTEVDGNFYKLHHEKIYKTDANG
TLEIDEEGHPKAEKVLDLSITKSVLIIIMVSIFMLVLFTGMARSYKKSQVPTGAARFLEP
LVIFVRDEIAIPNIGHKYKRFIGYLLTVFFFILFLNVLGLMPFGINVTGNITMTFLLAIL
TYLITTFSANKDYWKHIFWMPGVPVPMKIIMLPIELLGTITKPFALMIRLFANMTAGHIV
VMSLIGLIYVFKNFVAGVAFPFLTLVIYLLEVLVAFLQAYIFTMLSALFIGMAVQEHEHE
HHAAH
>KALACAFP_03016 ATP synthase subunit c
MEIPKIVGAGIVVLGVGIGLGKIGAAALEAIARQPEQSGKIQTAMLIAAALVEGVAFAAL
FAVN
>KALACAFP_03017 ATP synthase subunit b
MELIHQFSSGLFIIQSVIFLALLFLLGKFAWKPILKSINDRETSIVDALNQATLARKEME
TLKEDNERIIREAKIERDAILKEAREIKDRIVGEAKDAAKAEGDKLIEAAKQTINAEKNA
AMADIKTQIGTLSVNIAESILKQKLDNSEAQNELVQNYLNKSNLN
>KALACAFP_03018 ATP synthase subunit delta
MLTSKVAKRYAQGLLDFTNESGQTATVFSEMKDVVKIMNESQDLNKFFHTPYIDSKKKIE
VAKEIFKSLSVSSQNMITLVIRQGRENQLKNIAQEFINKVEDINGVQRITLTTATEISKE
NINQILRSTNLVKADSNFDLKLNVNPKILGGYILRVGDQLVDASVKSKLNQIKKDFQLN
>KALACAFP_03019 ATP synthase subunit alpha
MAEINPAEVSAILKQQLANFDTQSNVEEVGTVLTIGDGIARVYGLENVQYGELVKFSSDV
EGIVLNLEEDNVGVALLGESKLVKEGDTVRRTNRISSIKVGEGMLGRVVDTLGNPIDGKG
PITGDLYEMPLERKAPGVIFRQPVTEPLQTGIVAIDSMIPVGRGQRELIIGDRQTGKTTV
AIDTIINQKEFYDAGKPVYCIYVAIGQKASTVAQIVKTLSDKGALAYTVIVAANASDPVP
MQVYSAMAGASIGEFFRDTGRPALIVYDDLSKQAVAYRELSLLLRRPPGREAYPGDVFYL
HSRLLERAAKVIADDKIASQMNDLPESLRPIVKGGGSLTALPIIETQAGDVSAYIPTNVI
SITDGQIFLESDLFNSGVRPAINVGISVSRVGGNAQIKSMKKVSGTLKLDQAQYKELEAF
AKFGSDLDASTLAVISKGERNVEILKQPVNSPLPVDSQVAMIYAGTENLLRNVPIRKVKE
FQIEYIEFLRSKHPDTMAAIKAGKIDDSITGVLKQAANDLASKYN
>KALACAFP_03020 ATP synthase gamma chain
MANLKEIRGRITSISSTMQITRAMKMVSAAKLKKAQDAIVMLRPYSEKLQELIQNVNSSS
DPDQISVYAQKREVKRVLFIAITSNRGLAGAFNSSIVKELNAQFQNKSQYEVEVLSIGKK
AFDAVRKTRTVYSNESAVYDNLNFDTVANVSEAVMTSFREGKFDEVYLIYNKFVNAATQE
VTTEQLLPISMPETTEPQIETDYIFEPNRTEILDNLIPKSIKTQVFKAVLDSVASEHGAR
MTAMHKATDNAQALKNDLVIFYNKARQAAITNEILEIVSGAEALKNS
>KALACAFP_03021 Magnesium and cobalt efflux protein CorC
MDSDIVRLLLALLLVLLNGFFVAAEFSIVKVRYSQIQLKAAEGNSMAKQAEHIIKHLDEY
LSATQLGITLASLALGWVGESALHHVIENIFNYLGFSMSEATVTSVSVIISFVLITVMHI
VFGELIPKSIAIRKSEATTMATAIPLRVFYTVFKPFIWLMNLMSNTFLRLVKIHPASEHE
IHSTEELQLLVKQSADSGEIEEENYEIIKNAFDFTDHSAKQIMVPRQNITSIDFEEDLNE
IINKIMDSGYSRIPVYVDSIDNVIGVLYTKEIIREFVKRKGELNHEDLKELMRDAFFVVG
SKKISDLLKIFQQKKQHLAIVIDEFGGTEGIITLEDILEELVGEIQDEEDDEDKIVDKIG
DNTYWVQATQPLDEINEFLPKKLPLPEESEYNTLAGFILHALEDIPEENQEFDLENYHFK
ILKMNNKSVELVELVYEEPNIVNDLAERIGEV
>KALACAFP_03022 ATP-dependent Clp protease adapter protein ClpS
MNFYNSIKDYEDPKRQYEEEVLVLDDTDEIYKLVLHNDDVHTFDYVIDCLIEICKHTLEQ
AEQCTILVHFKGKCTVKTGSMDVLKPMHEKLLSRELTSEIV
>KALACAFP_03023 hypothetical protein
MKIKINSLILGCVLSCSALMGQESSLEAPARRWITENSRSLGVQNFSQLKLNYVRKGNTG
ETLRFQQMIKNVPVFQSEIVVHFNKEGKITYTSTESLRKNVQDINTVPTFQASEAIKKAH
TASHSKGDITYEESKLYVYVTEQGDTKLVHRVLTNSYENPGSWETIVDAQTGDIISVKDI
SLHHKDKDSEKEKKNKKKKEAKKNVLVTGSAYIFDPDPLSKMHVAYGGQYVDGSDATNAS
LDGARTLVTIPELELTAGVYKLKGTYVEIKELEAPNKGLFTQASNQFLFNRNNDGFEAAN
AYWHLDNNLRYINLTLGIPCVPSVNGGILAFDPHGENGADNSHYDPNIQVLVFGEGGVDD
AEDADVVLHELGHGVHDWITGGNGSQVQGLGEGSGDYWAQSYSRSLNQWQSTDAAYHWMF
SWDGHNPFWAGRVTNYAAAYPSGLTGAIHTDGQIWASALMRIYNKIGKEKTDRVFLEGLS
MTGSSTNQQNAAIAVRQAAIDMLGTFGFTCSDITDITTEFTATGYVLPAYNCQLSVDDVS
KKEIIAIYPNPVSDVLNISMKISKEEKVEIFNMEGRRVLETTIGNGRNAINVSHLQVGDY
IVKIKGLELSTKFIKK
>KALACAFP_03024 Uridine kinase
MLVIGIAGGTGSGKTTVVDKILQQLDIEGMNILSQDNYYHDNHNLTLTEREALNYDHPKS
IDFDLLIQHVKALKNHEPIEQPIYSFVTHSRTGDHVTVEPKNVLVVEGILVLTNKELLKE
FDLKVFVHADSDERLIRRIRRDTQERGRDLGEVLHRYQTTLKPMHQEFIEPSKNEADLII
PNMRQNSVAIDFLTTVIKNSLRKH
>KALACAFP_03025 hypothetical protein
MKENKLIKDIQPKSETFKLIQKYLLNKYTITICMFLVWMIFFDKTSFLVINELNGEINKY
EDQLQYYKTEYEKNDAFYKKLMNNKSEKEKYARENYFMKKPNEEIFILVVDSTNVAKK
>KALACAFP_03026 Methylmalonyl-CoA mutase large subunit
MSNTAWENLVKKQLKTEDIDSVLTRENLEGIDVKPFYDAVKRPLVNLPKIEESTHLVARY
HESLEEDVFAFILDHNVENLEQKTIFIDNVDLAGHISPKEEDQYFSLIDVFDEKEAMIND
QLVKELLAKEFRRNICIDISLHQNAGAAIYQQLGIALAKTKELVEVYGSEILNKLIFRIA
VGGNYFFEMAKLRAFKMVFNQLSKEYNLDEIPYIFAETSLRNKAISDSENNLIRSTLELA
SAMIGGADAVFSNNYLVDRSTENSEEISFKQQIVLAYESIINVFEDASNGSYYVEDITQQ
IAEKSWNLFIEIEEAGGYLELLKQGIVQKKIYDHAIEEQKWVEEGKIKLIGVNLYPKLDV
KKSAEELYNEKEIKTVRWAEMFE
>KALACAFP_03027 hypothetical protein
MKEKLVDLFEYTYHFNKEMIKIISENLEKVDEKTMSLINHTLNAQQIWNARILGEKTFEV
WQINPFESLEGINDQNFKTSVQIVGNSDLDQRINYQNSRGTKFENSIFEMLFHAVNHSTY
HRGQINSLLKQNGIEPILTDYIFYKR
>KALACAFP_03028 hypothetical protein
MLSPVEASHTRKKSVGHKTILNKEIQKYINANLNTDLHSLLLKKSPFPEVSMQEIVQQIK
GKQVAQKKFPFLLKDEIIFPPQLNLEQSSSEKTALYKSGIVKGKKFIDLTSGFGIDAYYL
SQNFEEITLVEQNLELLEIVEHNWNILGKKATFINQKLEDFLEENQEKFDVVYLDPARRD
DHKNKVFLLEDLSPNIIEIQEKLLSISNEVVIKLSPLIDLKYLISVLPNVFRIDIIALKN
DVKEVVVFLSNENSGEIICNCLNLESGESIFTFTFGEEEKAVAAYSEPEKFIYIPNHSIL
KAGVFNLISEKFSLKKLHPNTHLYTSEEKLDDFPGRILEMEVIDAKHIKNKSQFNIISKN
YPLKPEEIKKKYSLKDGGESYLIFTQSKKGKIILKSV
>KALACAFP_03029 hypothetical protein
MKKLVICLALATVAVSCKKIQAGGNKNVIKLEEGADRYSEDVQGGGEAHGHGHETAAEHT
EKATAEKHEAEAPKTDSATATAKPAEAQTPKAEH
>KALACAFP_03030 Succinyl-diaminopimelate desuccinylase
MQETLNYINENKQRFVDELFELLRIPSISADPAYKNDVLKCADVVAEHLKNAGADHVEVC
QTKGYPIVFGEKILDKNLPTVLVYGHYDVQPADPLELWTKPPFEPYIEKTELHPEGAIFA
RGSADDKGQFFMHLKAFEAMMKTNALPCNVKFILEGEEEVGSVSLGDFVNENKEKLSCDC
ILISDTHIYSNEQPTVTTGLRGLSYVEVEVEGPNRDLHSGLYGGAVPNPIHVLSRMIAKL
IDEDGHITIDGFYDNVETVSDADRADMNKLKDNPEEFKKSIGLSGVEGEKGYTTLERTSI
RPTLDCNGIWGGYTGEGAKTVIPSKAFAKISMRLVPYQTPEEITEKFTAYFKKIAPANVK
VKVTPHHGGMPYVLPTDTKEFLAAKQAMESAFGKEVLPYRGGGSIPITAMFEQVLGAKSV
LMGFGLDSDAIHSPNEHYGLFNFYKGIESIPLFFENYAK
>KALACAFP_03031 hypothetical protein
MKKLLLSLGLFTFLIGNAQMNYSFESSQGYTLGNISGQNSWGATAAANIAVVSAEQANPG
TQSLKITGNNGTNHAVAGPISPTTTVNGPIVTVLFNAYFTPSVPAGDECDFFFSPQSPSQ
STINARMRFDFQNNILVVDMDPTTLQLGYIDTGANFTRSAWNTYKIQLDFANNEAKYYQN
GTLIYTGEVVGGTMVGNLAITNDNYNSSAYFDGIQVISGVLGTSDVKKLSYKMYPNPTSD
FAIIETPDKINSIEVYDFSGKKLDAPFVNNKVDLRGLAAGVYILNINTPKGKVTDRIVKK
>KALACAFP_03032 Hemagglutinin A
MIIAQNTIMKTFLLIGAFVGINSQMNAQTTIFNETFETNSPTVNDWSFLDNDGDSQNWTI
DDEPANTDPWGYTGRIYVSLSAGTTPDNVLISPVINLPAGATTLSYQVGGFFPSLPEEHY
AVYVLPSNAVFTGSEAPVFEETLTAAEASMAATRTADISAIAGQDVKIYFRHYGTNNQLA
IILDNVKITQNVLATSEVSHAEKIGLYPNPVSDFINLKTQSKIIYSEVYDMSGRKINIEL
NDNKLDVRNLQSGNYIIKIGTKEGITSQKFIKK
>KALACAFP_03033 hypothetical protein
MKKILFLTALLGILQLKAQTVVFSQTSSGTTGIISDAIANGSFVASADDFTLTNQTTVTK
VKVEGFQNAGTLAAIEATGLMMYIYADNAGKPAGIPNNPAVAPIAQIDIAKGAPGYSLVK
SGTYNFTFSVDVTAALSSPLVLQPGTVYWLVFIAKTNLSDFTSSASTRFNWFAGQANGNM
AKLVDPGNAFGVGATSWSTISTLTNQPAYNGLAFSIEGNNAVLGTTEVFSNIKEIAVSPN
PTSDYLFIKAKSKVNKIEVFDFAGRKMNVSSNEERVDVRGLQTGNYIIKVETKEGITSQK
FIKK
>KALACAFP_03034 putative oxidoreductase
MIENKVAYITGGTKGIGLGIAKILLENGVSVAFSGRKRDDVEKAEQDLKQYSANVLGIVS
DVRSLESEEEAVKYIKEKFGRLDFVIANAGVGIFKPVDQLTADDWNDMIETNLTGVFYTL
KASVEELKKTEGYYITISSLAGANFFENGAGYNASKFGVVGFTQAAMIDLRKYNIKSTVI
MPGSVATNFNGNIPSEKDAWKIQPEDMGNLVLDILKMNPRVLPSKIEFRATKPA
>KALACAFP_03035 Electron transfer flavoprotein subunit beta
MKILVCISSVPDTTSKINFTADKSAFDKNGIQWVINPLDEFALTKAVKLQESQGATVTVI
NVGDATTEPVIRKALAIGANDAVRVNLDPKDSYSTAKEIAAVAQNGGYDLILCGKESIDY
NGGSVPGMVAQLLGKPFVNASVGLDVNGSEATAVREIEGGKETISVKLPAVIAGQKGLVD
EKDLIIPNMRGIMSARTKPLQVVEPTSSEVKVQGVSYDSVPPRAAVKLVSPDNLDELVRL
LHEEAKVI
>KALACAFP_03036 Electron transfer flavoprotein subunit alpha
MAVFVYAENINGVYKKAAFEAVAYAKAIADQAGETVTAISVNPTDSSDLLYKYGASNVIN
IKDEGLKSFSAKAYAQAVSEVANGNIIVFPHTTDASSIAPMLAVMNGHSLITNALAAPES
LSPFQVKRKAFSGKGFMHAKAEGAGVIITVSQNAFGVKENPVSGSEEVKNLSVANEDTKV
ISHEQSSGKLDLKEAEIVVSAGRGMKGPENWGMIEELANVLGAATACSKPVSDIGWRPHT
EHVGQTGKAISPNLYIAVGISGAIQHLAGVNSSKTIVVINNDAEAPFFKSADYGVVGDAF
QIIPALTEKIKAIKG
>KALACAFP_03037 hypothetical protein
MDYKQLIIRGISYSQTQSGAYALLLEHEETHIKLPVVIGNFEAQSISLGLEKDIHPPRPL
THDLFTKFIVSANYELVSVIIYQIVDGVFFSNINFKNKSNDEELILDARTSDAVAMAVRF
DAPIFTTQQVLNEAGILLELEDVSKEEQPFSETVPAEDNLKSLSMEELQKLLEDAVKEED
YDTALEIQEEIKRRKKNID
>KALACAFP_03038 Nucleoside permease NupG
MNLKLRLTILSFLQFFVWGAWLITMANFWFGTKHWDGAQFGAVFGTMGIASIFMPTLTGI
IADRWVNAERIFSVLQILYGIVLFFLPHTSSPGSFYYVMLVAMCFYMPTIALANSISYTV
LKNSNLDVVKDFPPIRVWGTIGFIVAMWVTNLTGNKATEGQFYIGGIAAVVLGIYALTLP
KCPPQRLIDKNAPLVEQLGLNAFKLFGNYKMALFFGFSMLLGAALQLTNAYGDVFLSEFS
HFPKYAESFVVQRSTIVMSISQVSETLFILAIPFFLKRYGIKKVMLISMFAWVLRFGFFA
YGSPEGYGVSLIILSCIVYGMAFDFFNISGSLFVETTTDKKIRSSAQGLFMMMTNGFGAY
FGSNIAGWAIDKFFTHKFTNAAQLSAYLDTTPNNPTFLEILKNTFNSAINADGTLSSAVL
LRDWPNIWIAFAAYALILAVLFAILFKHKHDPKELADIKH
>KALACAFP_03039 ECF RNA polymerase sigma factor SigW
MRNLEENFKLAKKQDRRGQKALYDMFSARMLAIANSYTNNLHDAEDILMNAFMKCFSRID
ECREWKSFPFWLRKIVVNDAISFIRKNKNLLYVDVEIADDYSEDDFGENLEEINIEEIFS
KIPDGYRVIFNLYVFEEKKHQEIAEILNISEGTSKSQLSKAKKWIADYLKTKENEKRNTE
SIKI
>KALACAFP_03040 hypothetical protein
MKKEILNQLKSDYDKREIKPSADLWDRIEQGMDKAPVLSPKKSFEWIKYAAVILLLVSFG
VVFYFNSNSTEKNRNTFAEKHQLEKNIEKENLDIEIINSTINKTENNIAVSHEINKQQTQ
PENTIKIVHENSLPETNHYQSLSKEENQIINKDNFNTNPVAQEKIITQNIERPFVAERKK
TNYIKADELLLGREFDKTREESQDHHKTFGVVDMGKIKIKSPNSFKILGMTVFSDSLESK
>KALACAFP_03041 hypothetical protein
MKKKIALMTAVMAFSYTFAQENPHLKSYSEKIDSIVVSEKSKMNAELDDVDRNFKDKKIT
AEEKQKQRADIASRYEEMINEKVDAQQSELENATKSMVRSAVLGKKDSLYHGKNQLELGL
GGVKMKINKDKTPKDYLRTWELAVSLTGANLTEKNEFFKFYNKESDVRSTIINSSQFVLR
YENQLGGFTSPVFYRIGLGVRSDRYVPKYGKAFMQQDKTLFVDEFTRGNLKRTYLGNAYI
FVPVDLKFVLNPKYVVHEGVKYLDNKKSQLNIVAGIYGGVRTQSVIYNKYSTEDSKRIVE
KERVMQGVNNFVFGGKFGIGYGGINLFIQKDFTPLFNNDAQLKKKYGLQIGIEIANVNF
>KALACAFP_03042 hypothetical protein
MKNIQLLGLILVVVGSFLPLVHVPVIGNWSYWKLDHYLAIACWVLSAGALFAIVNNSGKM
ARIFAILLILLFLFTLFAVKVQALQYFSFMPFKSWQEKLAGIVKLRWGWIVEFLGAFIII
FAKNNNK
>KALACAFP_03043 hypothetical protein
MNFLKIFSAAVLVLGASQMNAQKKGTATPKKEVPQQKKQVDNPTKCSNIKEGTFLRTNYP
KNLWYMTVKDNVQTEYYNGGKDYVKSSMVFLDDCNYKLIVLEKTEKNNPIKVDDVFTNKV
VATQDNYIKIESKIAGDKYDLILIKLKENIK
>KALACAFP_03044 Acetyl-CoA acetyltransferase
MKEVFIVSAVRTPMGSFMGSLSTVPATKLGSVAVKGALDKIGLDPKQVQEIYMGNVLQAG
EGQAPARQVALGAGLSNETPSTTVNKVCASGMKAVTMAAQAIKAGDADVIVAGGMENMSS
VPHYYNARNATKLGDVKMLDGMVLDGLTDVYNKVHMGVCAEKCATDYSISREDQDNFAIE
SYKRSAKAWSEGKFAEEVVPVSIPQRKGDPVVFAEDEEYKAVNFDRIPTLPTVFKKEEGT
VTAANASTLNDGASALILVSKEKMEELGLKPLARIVSYADAAQAPEDFTTAPSKALPIAL
KKAGLSLTDIDFFEFNEAFSVVGLANNKILGLDASKVNVNGGAVAIGHPLGSSGSRIIVT
LINVLKQNNGKYGAAAICNGGGGASAIVIENM
>KALACAFP_03045 hypothetical protein
MSEIENQQPQNIKNNPKIMKAWAVYDWANSVYSLVITSTIFPIYYSILTTAYEKKEYVAE
TKSWIDVPVRHLIKIFGKEYQPDAVYGYSLTISFFIVVLLSPFLSSLADTIGNKKSFLQF
FCYLGATSCMGLAMFTGMHNVFLGLLFSITASVGFWGSLVFYNSFLPDIATRDKQDALSA
RGYVYGYIGSVVLVIICLVLIQVVGKGNPEKQLLFTRISFLLTGAWWFGFSQYTFKHLPQ
FGDVKEKLPKDLVLLNYKNIFKKHEEQGGFFEVLKDNLSFYKDIAKESFHELFKVGNELF
KDKNLKFFLSSFFFYSVGMQTIFLMATLFGKSEINLAQDKLIATLLVIQIEAIIGAVIFS
RLSRKIGNKNVISIAVVLWIVACIWAYFLNKENPTVEYQFYGVAAVVGLVMGGLQAMSRS
TYSKLLPEDSMENTTFFSFYDVLEKIAIIIGTFIFATLIEQFNNMRFAALSMTLFFGAGL
ILIRFVKISIQKEKKD
>KALACAFP_03046 hypothetical protein
MIKKLLILSILQCGIFGFAQNMRPIAQKVSEFHTQKKNFEKYDVFEVNKTSEKLAEYKRA
ATDITVINVDSKQLKKIVHDKPEFLEISFPFDGKEITLELYKNQIFTNDFKVTTNKGEIV
NYTPGAYYQGIVKGDNQSVVAFSFFNDDIVGVASTLELGNIIVGKVKNSTDFVSYSDSKL
TGINPFVCGVDELAENQKQKISFDPNTQKNAGKVATQNCVRIYYEICYTPYLNNGSDTTV
TTNWLTAIHNNISTLYMNDDIRIALNEVYIWTTQDPYTGTPNANLASFRTNRQTFNGDLA
HLVNQPSTTSVAYINSLCTTSRHAYSGASQTYNNVPVYSWTIEAMTHEMGHSLGSPHTHA
CAWNGNSTAIDGCGTQAGYPEGTCPIGPIPSSTVKGTIMSYCHLLSGVGISFANGFGPQP
AALIRNTVDSKACLGTNCTTACSTTISGLSVSNITQSSASASFTDATSTSWKYKLTKFDG
TSVTTGNTTTQSFNFSNLQPATYYLLSVGTDCSAGYQRTQLFLTDADWCSGTLFTDTGGT
TENYGDNQTIVKTFYPSSGALTMNFTEFAMEQDYDFMYIYNGPSTSSPMFANGNALTGST
LPGSFTSTHPSGAITVRFVSDPAVNESGWKANFSCAVLAVEDVNTKDNSVSIYPNPARNL
ITISSKEALKSFKIYDEAGRLIKSESSLKGTKFEVNISSMQTGNYVVTVETEKQKVTKKL
IKQ
>KALACAFP_03047 hypothetical protein
MTNPLFYAKIILFGEYGMIEDSQGLVVPYSFYKGALKFSDLDSEFEKKSNQHLHKYADFL
SVLDLSDDFKLDIESFKNDIRNGLFFDSNIPQGYGVGSSGALVAAIFEKYSVNKLNPENI
SKDNLKHLKAVFGEMESYFHGKSSGMDPLICYMNLPILIENRENLDKVAIPEGEEGKGAI
FLIDSGITGETGPMIQIFFEKMKTEGFRKTLKEEFIRYNNACIDSFLKKDMNPFFRNLKK
LSHWAYEHFRPMIPESIFNIWKKGLDSNAYYLKLCGSGGGGYILGFTKDYEKAEKMLDGF
HKEVIYRF
>KALACAFP_03048 hypothetical protein
MNSEKEPFQQKNYIQKSFFYRFSQFVGFLLGARFFVAILLTFALYVSTFFLFNQDETFRK
FVFDFKVHGIIFCTVLTILAGGIINQFYDFEKDHIVKPFRTRIQSFIKQKYFLYAYLFLS
ILSLGVAWTISHRVFVFFVVYQFFMWFYSHKLSRILILNNLTFVSLTLYPFFGMMVYYET
FSKKVLLMAIFLFLILLCIDIVKDTLTKSVDKAFGYITIPNYFKNKNTKIIIVSLLMITM
GVSMKLILRTGISGFMAYYFAGGLFVFILCIYLLLNDSRRSKFITLNILRFWVFVGIIAM
LLNGLEGKL
>KALACAFP_03049 Proline dehydrogenase
MPIFNDTKVAFADKSDAQLKKAYWMFKLIEQPALTSLGTSVLNFTIHNNFPFVTGIVKNT
LFEQFCGGETREESMKVVKQLFKRGVGSIFDYSIEGKEDEATFDAVCQEIKDIVRFSVGN
PAIPFIVFKPTAFGRIDLYEAVGKNAELTSSQKEEWERVVKRFDEVCKLCHENDKKVMVD
AEETWMQDAADHLCEEMMEKYNQEKPIVWNTIQMYRTGRLEYMEEHLQRAREKGYFIGYK
IVRGAYMEKERARATEKGYADPIQPTKDASDKNYNAGIDFVMNHLDKVSAFFGTHNEISS
ELVMDKMKAAGLQNDNPHVYFGQLYGMSDNITFYLSDKGYNVAKYLPYGPVKDVVPYLTR
RAQENTSVAGQTGRELGLIKKELERRKNR
>KALACAFP_03050 hypothetical protein
MSLNERISKVIEYSKLTPSEFADEIDVQRSSISHITSGRNKPSLEFIIKIKSRFPEILWD
WLVNGDGEMLKSELPETVKPIDEIAEISEEEKLKPTSLPDLFTMMNDDEDFGAEETKVEP
AKISPRESFIPHQSTAQEKIIDSQRLEKSNDQIINQVIGNQTSKIKRIVLFYENGKFESF
EP
>KALACAFP_03051 hypothetical protein
MLILFFPQKWLNLTLVNYYTMNFQQIYQPNPDFPNRYISPEKLFSYLQTNLSDYIQEIGK
SYLEKPIYKLSVGTGNINVLAWSQMHGNESNATHAMLDLLMTLDKAPELKEELFSKITLD
FIFMLNPDGSERWTRLNAIDIDLNRDFHNENSKEIKFLKSMAASKKYDYALNLHEQRTIF
TTDGVHPATLSFLAPSENVERTVTDNRKKCMAVIANVYHHLKEMIPNQIGRYSDEFYPTS
TGDNFIKAGMPTILFEGGHFVDDYTRKGTRKYYTIALYYALKAISELNSGIDGWETYLDI
PENRETHYDIVYRNVKLNTDHECILDVAVQYREIKEEGKDEISFVPFVMEVGEVKQRKGW
LEIDCTGKKFVSANKYPKLDAEVNFTIED
>KALACAFP_03052 hypothetical protein
MKFKAILFAAAVSVSTFAFAQEAKKFGPPAGNALVGDTYGGGVATKVESKAISVDKLSKK
LKKENKKVENVAVKGKVTDVCEKKGCWLTIQTEDNSQFFVKMKDYAFFVPTALKGKTVVL
DGTAERKVTSVDEQKHYAEDAKKPQAEIDAITTPKEEIRFVANGIKVVN
>KALACAFP_03053 Serine/threonine exchanger SteT
MQKKLKLWDAIMLVMGSMIGSGIFIVSADMMRNLGSGFWLIIVWVITGIMTVAAAISYGE
LSAIFPKAGGQYTYLKEIFGKRMGFLYGWGLFTVIQTGTIAAVAMAFGKFTAYLVPALND
AAPIFQSGEFKITWIQILAIGTIILLTYFNTRGVESGKILQNIFTGSKIIALVGLIAAGF
ILVDISHLAENFSLGYDSFNNLKKDALGNFLKEGWEPIGGMTLLGGIAAAMVGSVFSSVA
WESVTFVSGEIENPKKNVVKSMIYGTTAVMILYIAVNYVYLNALDRDSIAFAENDRVAVA
ASHFIFGSAGTAIIAVLVMVSTFGCNNGLILAGARVFQTMAKDGMFFKQAEKNNQNDVPA
NALWMQGIWASILCLSGQYGNLLDMISFVIVLFYMITVFGVIYLRFKQPNLERPYKTWLY
PLTPVIYLLIGTGFCILLLIYKQQYTWPGFLMVLLGLPVYYFINRNKKIQE
>KALACAFP_03054 hypothetical protein
MDTPNYRMPFVPSTLMTEGGSIDTCDMGESIAHNIMLLITTKKGENRYDENYGNDVWNLE
FDNGVTSAVWETVFIKSLKRQIQEYEPRIVQPQIDAHIQFVEHSYDTKEHTEIKKKVKIA
INAKMEATGERFSFSTELFLSPMSID
>KALACAFP_03055 hypothetical protein
MNLDQNIYSKESVKARMLQNATKVWGLKSPQSLDPFVKLLIDAFSTEIFKANNEIQTVNA
RILEKLAKLLTPSIYTHPIPAHAIAFTQPYESSEVLLEHTEFFFRKQMTSTVKSESDKQI
NIPFTPVGNIRINRAQTSIMFVGNTCYSVDDRLNKIPIARFQGKPEDYRKVTIGINVSKY
DNENFPKYISIYCSNPAFEHLDFVYKLLPYITVSSSGNPLFVKEGLTYLKNNQTDGYEQM
FREQSIQNKLIEDVKSIYHHKFIEISGLSDSLFSEPGKLPENLDFVDYKDEITKHIDGKR
YLWLTFEFPPQFSAEILDNFSFVLNAFPIYNRGWKKTEYSLDIMGNNIPLVTDEGEHFLY
VDEVQDGDGRRYTEIPFTPSDDLRKGLYTVRKGGMERFTNRNAVDMIANVLELTRDEIAA
FSLLNRDNVKGVLSEMSDKMKSMVQKVNNAKRSIKQELNYVIMEPVDKTDHTYASFWVTH
STLANHMRPGTELSNQLKSQTLILLTETIGGAEEQKGTDSIQAYKYALTTRDKIISLEDV
KNYCRMVLKDEVKDVRVKRGTMISNKPKEGFIRTVEVEIVPQNYSFYGRAYWENMANILR
NQIISKAIDGIEYLVKITNEDTDFYEN
>KALACAFP_03056 UvrABC system protein A
MSKSTEYIEVYGAREHNLKNINVKIPRNELVVITGLSGSGKSSLAFDTIFAEGQRRYIET
FSAYARQFLGGLERPDVDKIEGLSPVIAIEQKTTNKNPRSTVGTVTELYDFLRLLFARVS
DAYSQTTGKKLVSYTEDQILDTIKENYKGEKIMLMAPVVRSRKGHYHELFVQMAKKGYGQ
ARIDGELQDIEYDLKLDRYKTHDIDIVIDRWIIGETASESRMEKSLRTAMEMGEGLIGIQ
KLGSTDIEYFSKNLMDAETGHSLALPEPNTFSFNSPKGSCPNCKGLGTIKKINTDYFVEN
PKLSINQGGLLPLEDIKSNKWILSQIKNILEIFGLGFTTPLQDIPEEALDYIYNGCHKEF
NKDLKYAGITKKIKISFDGLIPFMEEIIEERESYEAILLERHFTTEETCPECGGTRLQPS
SLSFKIDGKNIAEVNGLSLSDLKEWLADVKDKFSEKNAIIAHEILKEIETRLQFLLDVGL
DYLSLSRSSKTLSGGESQRIRLATQIGSQLVNVLYILDEPSIGLHQRDNERLIASLKNLR
DIGNSVLVVEHDKDMILEADEVLDIGPRAGKFGGEILWQGKPKDLLKADTITAQYINGKR
KIAIPEKRREGNGKNILLKGATGNNLKNVTLDIPLGKLVVVSGISGSGKSSLINGTLYPI
LNKHFYRAVQEPLPYKKIEGLDNIDKIVDVDQTPIGRTPRSNPATYTGMFTDIRNLFAEL
PESKIRGYKPGRFSFNVKGGRCETCQGGGLKVIEMNFLPDVYVHCETCNGKRFNRETLEV
RYKGKSISDVLDMTIDEAVEFFQPIPKIFARVKTLQDVGLGYITLGQQSTTLSGGEAQRI
KLATELAKRQTGNTLYILDEPTTGLHFEDVKILMDAINKLVELGNSFIIIEHNMDVIKLA
DHIIDVGPEGGKHGGQIIAQGTPEEIVKSKKSLTGKFLKRELE
>KALACAFP_03057 hypothetical protein
MNTLAQKDGRNSKYFEIQEDGVFVKNNFAKEINEYKVYFQDIQYDETVFRKKKDPVLIGI
VISMIFNSILFTIVINESYELSYSLGMIVFVIALIPSLIVTALCNNEFKRENSKSLTASK
PLVFSYAKKEMKEVDDFISNIKESKKQFFLKAYYKVDNLIPVHVQISRIHWLYESNYINE
SDAKFIIDELESKRIIEGL
>KALACAFP_03058 hypothetical protein
MKNKVQIFIASIFVCGCMAVVNTAKAQTSNNMIQEVQLNKNDAFNEIRNLLMANFDFTNS
DYKQGVVNSEVKFDIAENGKIVNVHSKGDCKNVSKEIEKVLSSLQYRVDSKKINQNMIAS
TYVMPVRVDINNR
>KALACAFP_03059 hypothetical protein
MKNLKKLNKEELKAVNGGAPKKYCVYCEWMNAVVCSEIPISQCP
>KALACAFP_03060 hypothetical protein
MKNLFLLLSVFLLFTGCIKNQNRPKDQEAKAEITKKVNALYTLDRSNDRYTPPKDLFSTE
LEKLLNECTKITIADTEKIKKSDHPTDMPRMLVSYLMTNLQDTATEFKIKKINVNGSTAE
VFTEFYYENDPKLTQHVKITLINKDGWKIENVIYNKDSNLKSTLESFIKYSKESN
>KALACAFP_03061 hypothetical protein
MNPILDVVLRSLCVYLFMVIAIRIFGKNQLSQLNAGDVVLLLLISNAVQNAMVGPDTSLQ
GGLIAALVLFIANFIVKRFMFSNRKFETLLEDDPVILVRDGKVDEMALDKVKISKNELEE
AIREHGVDSIENVKLSILEVDGNISVISEDENNKQTHYSRIKRKYKRKYH
>KALACAFP_03062 Putative phosphinothricin acetyltransferase YwnH
MNYELREMLPGDETRVLEIYRQGVDGGMATFETTIPTAEAWNMEYFNDCRWILENENNEV
VGWCALKPVSKRECYKGVAEVSIYFDNNYQGKGLGSVLLKKMILDSENHGFWTLQANIFM
ENEVSLKFHQKNGFRTVGIRKKLAKLNGQWKDIILLEKRSEMIS
>KALACAFP_03063 hypothetical protein
MKILTKVIGLFLMVFSFAYSQAAPIQKHHHHGPKHHYHRSHRPHYREVYSYHRPVKHYYK
RHYYRPVRHRYYAHRPYRVYHSRPVVIVNL
>KALACAFP_03064 hypothetical protein
MKGLMKIVGVTTVMLMLTSCIVHEHHGRRGLPPGHAKRVYIYEKRGHGHGHGHHRGHGHH
R
>KALACAFP_03065 hypothetical protein
MKLRKKIKSPEKYRAFVLYFFNENDTNIFKNKSIKLL
>KALACAFP_03066 hypothetical protein
MSVLSITFHCTKNNIEEWENYIDETLVLMTENLMDVNKYILSEVHSDYIEEGKNYNLLLI
FDNDELREDFIKSEMLNIAERIEKKFGQDVMIFNTYLNPKRSRM
>KALACAFP_03067 DNA gyrase subunit A
MQKEGERLIPINIVDEMKSSYIDYSMSVIVSRALPDVRDGLKPVHRRVLYGMYGLGVFSN
RKYLKSARIVGDVLGKYHPHGDSSVYDAMVRMAQDWSLRYPQVDGQGNFGSMDGDPPAAM
RYTEARLKKISDEVLSDLDKETVDFQNNFDDSLTEPTVLPSKIPNLLVNGTSGIAVGMAT
NMAPHNLTESVNAICAYIDNREITIDELMHHIIAPDFPTGGIIYGYDGVRDAFHTGRGRV
VLRAKVAFEEIGNRNAIIVTEIPYQVNKAEMIARTAELVKDEKITGIYEIRDESDRRGLR
IVYELKNDAIPNVVLNLLYKYTSLQTSFSVNNIALVHGRPEQLNLKDIIHHFVEHRHEVI
VRRTQFELRKAKERAHILEGFMKVIGTQDALDKAISIIRHSANPQAAKEGLITEFELSEI
QAQAILDLRLARLTGMELDKIRDEYDTIMKEIADLEDILANEPRRFQIIKDELIEVKEKY
GDERRTEIDYSGGEMSIEDIIPNESVVLTISHAGYIKRTSLSEYKIQSRGGVGNRAATTR
DEDFLEYIVSATNHQYMLFFTEKGRCYWLRVFEIPEGSKTAKGRAVQNLINIEPDDKIKA
YIRTNNLKDSEYVNQMSVVMVTKNGTIKKTSLEAYSRPRVNGVNAIEIRDNDQLLSAYLT
NGTSQIMIATKNGKCIRFPEEKVREVGRGSIGVRGIAMEDNDEVIGMIVVNDVENETVLV
VSEKGYGKRTAVEDYRITNRGGKGVITLNITEKTGNLIAIQNVTDEDGLMIINKSGVAIR
MNMDEMRVMGRNTQGVRMINLKKNDEIAAIAKVEMDKDVEDDSEENAEGTETVTDNQENN
TEAPQTENENSTEETENSDSEE
>KALACAFP_03068 Beta-barrel assembly-enhancing protease
MKKLILGMAIVASAFAFGQKGDVNAQLQEANKAAMDAYNAKNYAVAGPKFMEVYNLLKTN
GQDNKVYMYYAGLNYALANNIDQATKIYTDLINSGYTGVETNYTAKDKKTGQVASYDKAT
WELLKKSGGDYSDFKTEQTPSVESDLYETLSTLLLNAKKNDEALAIIEKGLAKFPNNAKL
KEYQGTALYASGNTDKFMQNLKEQLAKNPNDATNWYNLGVLQSKNPATANEAMASFQKAI
ELKPDFSNAYQNLVYTAIGDDEKAVSEINTLRKTKPDDATKLIDARKERFNKALPLAEKW
YQAVPNDINAVQMLKEIYSITKNTAKFNEMKAKEAELQAKQPK
>KALACAFP_03069 1,4-dihydroxy-2-naphthoyl-CoA synthase
MIEWKTAKEYEDITYKKCNGVARIAFNRPEIRNAFRPKTTSELYDAFYDAYEDSSIGVVL
LSGEGPSPKDGGWAFCSGGDQKARGHQGYVGEDGRHRLNILEVQRLIRFMPKVVIAVVPG
WAVGGGHSLHVVCDLTLASEEHAIFKQTDADVTSFDGGYGSAYLAKMVGQKKAREIFFLG
RNYSAQEAFEMGMVNKVVPHAELEDTAYEWAQEILAKSPTSIRMLKFAMNLTDDGMVGQQ
VFAGEATRLAYMTEEAKEGRNAFLEKRKPDFGENQWIS
>KALACAFP_03070 1,4-dihydroxy-2-naphthoate octaprenyltransferase
MSDWIKAARLRTLPLSLSGIIMGAFIAKWRLYGEGGTWDWKIFALALLVTLLYQILSNYA
NDYGDGIKGTDAKRATEAEARAVASGKITAKQMRNAVILFSILSLVATVALLYVAFFPKY
MNEFYIFIGLGVACILAAIGYTVGKKPYGYMGLGDLFVFIFFGLVSVCGSYFLFTKSFSW
DMLLPGTAIGMMSMAVLNLNNMRDIESDRLSGKNSFALRIGFKNAMIYEMVLLQLPLILI
LMFLGVNGFFQTQNYYVFIVMILLLPLMKLRRKIMAVKEPKELDPFLKQVGIMTFMIAVL
TAFGLNFFN
>KALACAFP_03071 hypothetical protein
MSSNVYVEAQMLIRKPIEDVFNAFINPEVTTNFWFTKSTGKLEEGKTVTWEWEMYGVKTD
VKVLQVVQNQLIKTKWGNPSTNVDYEFKEIEKGTLVIIKSYGFSQTGEDLLKIINDNTGG
FTTVLDGCKAYLEHGINLRLIEDKFPSN
>KALACAFP_03072 Hydroxyacylglutathione hydrolase
MKIQYLGQNCFLFTYKNKNILSDPFYNYKKAESGFDISAQKIDYILLTHAHGDHIADVEE
VLQYHPEATIIAVPEICGYFKNAKNTDDVNLGGSAKIEDLKISMVPAHHTSSFPDGSYGG
VPVGYIFRLPEGKNLYLAGDTGVMADMELFPRLFGKIDLSILPIGSHYTMCPRKAAFAAA
ELLKTPKVIGCHFDTFPAIEINHESALKHFADKNVELVLPKLGEAFEF
>KALACAFP_03073 hypothetical protein
MEMLKSLETKKDNFQITSLQLKPIKNGKLPKSHRYDQLPLLRSHPGGFSGAGCLGLAGAK
IGIFYKLENIIKEK
>KALACAFP_03074 hypothetical protein
MTKSPSTLGIILFIATMIVFFVVYYFFSGINYFDISLKANAFVLPVLYAGTAFWSVKSYW
NNHRVVSFKQAFKRAFVPMFVGGILSIFSIYAYLNFVDTDAKKLLNYQYVTRQKAELDKE
YTSARKILKHQKDIDELDQKYKERLQSFTPEAVKGKDMLTASHFSGYFAAILIFYVVLSL
FFGAFFRTKTIYQETENQE
>KALACAFP_03075 Dodecaprenyl-phosphate galacturonate synthase
MNLSIVIPLLNEEASLEELFSRIDNVCKSNNLSYEIWFVDDGSTDLSWSIIENLKVQHPQ
IHGIKFSKNYGKSQALHAAFERTNGDVIITMDADLQDFPEEIPELYNMVINDNYDIVSGW
KKKRFDNVMTKNVPSKLFNAAARKVSGVYLHDFNCGLKAYKKQVVKTIDVYGDMHRYIPV
LAANAGFRKITEKEVQHQARPYGTSKFGTERFIRGFLDLVTLWFVSRFGGRPMHFFGAVG
TLMFIFGFLSALWLGISKLIDVSRGIYGHLITNNPWFFIALTMMIMGTLLFIAGFLGEMI
IRTNREHKNYNIDEVI
>KALACAFP_03076 hypothetical protein
MEDNLPKIYSKKTILGFSIFLSTLFGGVLLYQNLIDAKKKKEAYIVLGISILLTIITIAI
VNIPEEPKSSLAYLCGLGGGSLLSYYFVPKYFPNEEEYPKKPIWKPLIIALIIVVIFVTL
IVYGASIENG
>KALACAFP_03077 hypothetical protein
MNTKSCLNCGHSISDEFCPHCGQKADTARITPYSLIKNDILGSIWHVEAKFFQTLKDIII
RPGKTAMDYISGKRIRYNNFISLLLILFGFNVLGLHFYEKFAPQEDVAEFSDLRAFFSKY
SKTILFIIIPVLGINAYFLFKRLKLNIAEHFIIATVSLLGILIIFLLDDIVSLIGLWKPV
SGIFNIIDKIIFGLFILFPAITYWNAFKNLYSKSGLLWRVSVLYVLMGIESFTIIIILYK
IF
>KALACAFP_03078 hypothetical protein
MKNILYALMLVALVSCGKVSPKGNIERKDVDVSEFVNLDLDGKFRVFYGRGTKNFVEIET
YPNVADNLDVDVKDKTLSIKEKRGTKGVDFYNITIYSKYNLEKVAISDSVEMNISSEIKT
DNFRLNLKNNATFMGSVNTRRAEVEMQNRSRANFLGQTKDAVIKISDTASLIAPYWKIDN
LKIDSKNGNYAEVNVKDSLKGHVQNTAKFIYYNDPIRAFKIDKDTRVENKKLD
>KALACAFP_03079 DNA gyrase subunit B
MEEKKYTASSIQTLEEMEHVRLRPQMYFEDCFKENNLNSLVFGALCHAIDEYFDNNCNEI
IINADGNSFNVKYNAGMSLEKSWDLTKAECIMTKIGACSNEKKHLEVGDEFCRVGMTTIN
GVSEKCELKTIWNKQKAHFIFEKGKTVFKEISKTDIFEDATTISFEIDKEIFGNFVFELN
DLQLKINSLKEKLPNLKIELLN
>KALACAFP_03080 Phosphoglucomutase
MTTLEKAKLWLSDTFDKETRDAVQLLIDSNSPDLEDSFYRELEFGTGGMRGIMGVGTNRL
NKYTLGQATQGLANYMLKQFKGEEISVAIAYDVRNNSREFGKLVADVLTANGIKVLLFKN
HRPTPELSFTVRDKKCNGGIVLTASHNPPEYNGYKVYWNDGAQIVPPHDEAIINEVYSVK
FDEIKFNGNDDLIEWIGEEQDEVYIDACIENSTYQDVGKGNLNIVFTSIHGTTYTTVPKA
LEKAGFKKIDLVREQMIPSGNFPTVDSPNPEEPAALEMAMDLAKITNADIVIGTDPDGDR
LGIAVRNLDGEIQLLNGNQTNTILTYYILNEWRKQERITGKEFIGSTIVTSDIFFDIAQR
FGVDCKVGLTGFKWIGKMIRDFEGKEKFICGGEESFGFMTGDFVRDKDSCGSIVLACEIA
AWCKANGRTMYQYLIEIYQELGMYYEGLVNLVRKGKDGAEEIENMMKNFRENPPKELAGS
PVEEVKDFKEQTNFIVSQNDKKVMNDIPKSNVLIYYTQDGTKVCVRPSGTEPKIKFYISV
KDSITSEADFRDKLNSLDEKINQVKKDLQLT
>KALACAFP_03081 Aspartate aminotransferase
MKVSKLAANLIGSEIVKIGNEVNDLKAKGAEIANLTIGDLNSNIYPIPAKLKEEIQKAYQ
NNLTNYPPANGLLSLRKEVSKDLKTRWNLDYSPEDILITAGSRPLIYAVYKTIVDEGDKV
VYPIPSWNNNHYAYLTSADAVEVKTTPENNFLPTADDLRPHLSGAVLVALCSPLNPTGTM
FTKEQLSEICELILEENKKRSENEKPLYLMYDQIYSNLTFGAEHVDPVSLFPEMKEYTIY
IDGISKCLAATGVRVGWGFGPSHILDKMKALLTHVGAWAPKPEQEATAKYYENPEEVNAF
VEDFKEKLETSLKVLHSGIQDLKGKGLAVDSIEPMGALYLTIKLDYIGKTKPDGTVIENS
SDLVFYLINEAGVALVPFSAFGEEKSEPWFRASVGGLAIGEITAMMPKLETALNNLK
>KALACAFP_03082 hypothetical protein
MSESIVGKKTFEFAIQIVNFYKKFSIEKKEYILSKQILRSETSVGANVREALNAQSKMDF
IHKLSISQKECDETIYWLELLFATEYISKEEFESLKGQAQEILKIIRSIIITTKNKTHNS
>KALACAFP_03083 8-amino-3,8-dideoxy-manno-octulosonate cytidylyltransferase
MKIIAVIPARYEASRFPAKLMQMLGEKTVITTTYQNVVETGLFDEVFVATDSEIIFDEIV
KNGGKAVMTGQHETGSDRIAEAVQNIDCDIVINVQGDEPFLKLEPLQQLIEVFHNDENQE
ISLASLKIKLTEKEEIENPNNVKVITDNNGFALYFSRSVIPFHREISYDVSYFKHIGVYA
FRKHALIQFSKLEMKPLEISEKIECIRYLEYGMKIKMIETNFIGVGIDTPEDLEKARKII
SE
>KALACAFP_03084 hypothetical protein
MKKLVLVFVLIFSQSIFAQTAKEIIDKNIELSGGLTNWKLLNSVLLQGKVILGVKDEYPI
KIYQQRPNLTKTLITINGKDTAVEGYDGTRGYAMNYATNKLQEYPGYVPESFDNDFIDWE
NKGFEAKYLGKEKIGNIYCHKVELTKNVNKNIYYFDTKNYMLLREIKKDETLDYFDYKKV
GNLSMPFRIESSSTKKDGDYVMLINKIDINKVFPANTFRF
>KALACAFP_03085 Glutathione peroxidase  BsaA
MKKIFLLALSFVAFLQSCMNQKSEVSKAKTTELMGKSIYDFKVDALEEGKQINFADFKGK
KILIVNTASECGFTPQYADLEKVSEEYKDKLVVIGFPANNFGGQEPGSNKEIGAFCQKNY
GVTFPMAAKVSVKGDDTAPIFKYLTEKDLNGVKNTTILWNFTKFLVDENGKLIDSFVSTT
KPTDEAITKYLK
>KALACAFP_03086 hypothetical protein
MKALVIGATGATGKDLVNQLLTDKDFEEIDVFVRKPLDIQNNKLKVHVVNFENPDEWKNM
VKGDVAFSCLGTTLKTAGSKEAQRKVDFDYQYEFAKAAKENNVEDYILVSAYGADPKSKI
FYSKMKGELEEAVKQLHFNKITIFKPGMLERKDSDRSGEVLGSRIIKFANKLGLLESQKP
LPTDILAKAMIKSSKIKSNGYSSIKLGNIFCFAEKTNE
>KALACAFP_03087 hypothetical protein
MDANEILDYCLAKKGVTESFPFDSETLVLKVGTKMFLLMSLEKQPLGINVKTDPEWSSEL
REQYPQITGAYHMNKTHWNSVMVDGLKRDLTLKMIDQSYELVFKSLTKKIQNEINNS
>KALACAFP_03088 Beta-barrel assembly-enhancing protease
MRKVLISAIYFLSIGAIAQTKEETKTWELLLNNKRTEARNFYDKNLKDKKLNGFESLFLD
ALIDEEMGEMIFDETFLKNFVNLKEDESLLYPIFKKSFVLSDNENSSMDDNTYKKVDFLA
QDPIYGQNISILEYKATLDRVRNNPKSADDYLAKIKRIDKWQFAGVFENLNGSGLYNEYE
PETHANNDKLFNANSFGNIGWYNRKFPSNDAFEFFMNESEYGRGIMYAQSFIENPAERKI
LFEVDTNTEFRLFLNDVEVLSSTSDGYSNLGAHMVEVNLPKGMNRLLLKFDMKESKNAFM
VIPFDTNFQKISDLKYFDTYQNYQKSSLTQLQAKELPLKFERLLKEKVAQNPNSFFYKYL
LAAGYLNNYQNDQAKEIIDELLKTYPKASLVQGLLSSYYTNLDDKEKINEVFKNIELNDA
EYFLVPVLKMTNSDGFQDMSIQDLEKNRDILLKTKAKALGGFFDMMIALRNRDMDKAKMH
IANLKKGFANNEKFFVVFTALEDMDKKDQSSTIKKFEEFYAQKSSPDVMSGLYSLYQKSN
RVEDQKKILKKYMEMFPSVNSFRSQYLDLLDDNVQNPEYGTELENALGNYPYSYSLLAAK
AEYLAKQNKKAEAVKFAKLSLSHNTENETMHKLVRDIDNTQDEISLVAVKDLYKIASERK
NKAPKGKKGVTTLLDEYIVNVYPEGGFKKRSTYLYEITSEKGIEEMKEYYVNYYDDVIKS
EIVKPNGSIVPGEKSEDQIVFTNLAVGDIVVIQKESLERSGGRFYKDFNLSSYFNSEYPV
VESIFTVITPESMNYQVKSNNKEVPSTKKKIGDKVFQTWKLTDLPEVNLDEYFGPSFYDA
TISVTANSIKTWQEISSWYADLTRKSLVSDKVVEKAFKEIFPSGVSGMNDTQKAEKIYNY
IEKNVTYSSVDFRQSGYIPQKPSKTLVTKLGDCKDLSTLFVILGNQAGLKSNLVLVQTND
NSVQRLILPNLSFNHCIVKVNLDGKETFLEMTDKYLPFNSVVKGNYKAKGLVIYTDKSAS
GNSDLIDISIDNNTKTSFKTISEVNINGDLQNFSTKQFVMGETKSYYNDFFQDSQTEDFR
KKNLEEEFGSVLDKVISVKSVKLLDGKDLTAKPLSYEVQFNINDKPQSVGSLKIMKIPFV
TKPFTKEVVATENRSTDIQYTKYEKQNDYFEEVYLNIPEGMKFIEIPENKTLAYNGFNYS
INYNLEKNNRLKITRKADTPWDNIKKEQYPEFKKFVEDAINAENQILGYK
>KALACAFP_03089 Riboflavin biosynthesis protein RibF
MKVFKNFTDYSSQKPLALSLGMFDGVHLGHKSIIDELTKVGAENNLETAVLTFWPHPRFV
FNPNEDLKLLNTLEEKKFLMEKYGIDNLFLKEFDEEFRNLTGEEFVRQILIERLNVKYLI
IGYDHSFGKNKSGNFELLQKLSKELDFEVEQMEAINIHENNISSTKIRNALLAGNIKDAN
EMLGYSYSVSGTVAHGKKIGRTIGYPTANIETDSIKLLPKKGAYIVEVFVKNQQYKGMLS
IGTNPTVNGEKLTVEVYILDFEGDIYDEKITVKFRDFLHDEIKFEGLEKLIERLDEDKRL
TEEFNF
>KALACAFP_03090 ATP synthase subunit beta
MANQIKGKISQIIGPVIDVVFTDVEAVPSIYDALEITKENGEKVVLEVEQHIGEDTVRCI
AMDATDGLKRGQEVIGYGNPITMPIGEAVNGRLFNVVGDAIDGLQNISKEGGLPIHRPAP
KFDQLSTSAEVLFTGIKVIDLIEPYAKGGKIGLFGGAGVGKTVLIQELINNIAKGHGGLS
VFAGVGERTREGNDLLREMLESGIIKYGEDFMHSMENGGWDLSKVDLEAMKDSKAAFVFG
QMNEPPGARARVALSGLTLAEYYRDGGESGQGRDVLFFVDNIFRFTQAGSEVSALLGRMP
SAVGYQPTLASEMGAMQERITSTKNGSITSVQAVYVPADDLTDPAPATTFAHLDATTVLD
RKIASLGIYPAVDPLASTSRILAPEIIGEEHYNCAQRVKEILQRYKALQDIIAILGMEEL
SEEDKLVVYRARKVQRFLSQPFHVAEQFTGIPGSLVDIKDTIKGFNMIMDGELDHLPEAA
FNLKGTIEEAIEAGQKMLADNA
>KALACAFP_03091 ATP synthase epsilon chain
MNIKILTPEYVVFEGEVDSVLLPGKNGEFHIMQNHAGIVSSLVGGKVKLYAKSVDEAYTK
YFTKENEKDSVFSYPIKSGVVEFNHNKGIILCE
>KALACAFP_03092 hypothetical protein
MKKYLIILFTVLGMLFNAQNIKTKRGIVTIDGIHVAKISNKSDEYIFMDLKETPIYTIEF
VDKSIVDSVRDSYIKLNRIYNKDKTLELDYISPSAFSGEEKSAVYTSVKSLKIIDNKGIN
IKNLDDLFSKTPKRNLDAKTKEAYSVRSKIDKLNITVNNVGEILSNGRPVGYFTNLPVSF
GSEDTVMDKTFVDIEIYDANSKYIGRYITTTKQLKTAGGKTFTMYREMSGRASILKFPTY
KAIAERLAIMDPNFIKPQGKVVAGPVLKDGIEK
>KALACAFP_03093 hypothetical protein
MKDLLLITPPFTQLNTPYPATAYIKGFLNTKNISSYQIDLGIEVILDLFSKDGIQRIFDK
KIDIQNVSENAQRIFALRDEYIKTIDQVISFLQGKTPTLARQICSMNFLPEASRFNQLDD
MEFAFGNMGLQDKAKHLATLYLEDLSDYIIENIDSDFGFSRYAEKLGKSANSFDELYLKL
SENQTFIDDFTLKILKEKIDIVQPKLVCFSIPFPGNLYSAFRCAKFIKENYPHIKIAMGG
GFPNTELREVKDTRVFEFFDFITLDDGELPIELLYEHICHSEPSEEPEFKRTFLIENQKV
TYKNNSKRHDYKQVDIGTPDYIDLQLDKYISVIEIANPMHSLWSDGRWNKLTMAHGCYWG
KCTFCDISLDYIKIYEPISAKILVDRMEELIQTTGETGFHFVDEAAPPALMREVALEILR
RNLVVTWWTNIRFEKSFTKDLCFLLKLSGCVAVSGGLEVASDRLLQLIDKGISVEQVAQV
TRNFTEAGIMIHAYLMYGYPTQTIQETVDSLEMVRQMFEMGILQSGFWHQFAMTAHSPVG
LNPEEFGVIPIKQEILFANNDVDFKDKTGIDHGKFSFGLKKSLFNYMHEINFDLSLQEWF
DFKIPRTTIHPDYIHDCLLEDEDFKFKGNSKIVFLTKNVIAENRVKTKKQYVYPYTKITV
HLKTNIVSIDLEQEQAEWLMKMFEENSPENPKKITLQQVKTNFEENFEDFELFWFSKPMQ
QLKENGVILSL
>KALACAFP_03094 hypothetical protein
MKLKGYALGIISAVSYGLIPIFIVPVKQAHFSLDITLFYRFLFSALMIGGYLLYSKESFS
INKKEGLILAVLGMCYALSSEFLFLGYDFLTAGIASTVLFIYPVIVALIMFFFYKEKLNF
ISILSLLLAFAGVIVLCLKGKGLEINYIGLGIVMLSSLFYALYIIIVNKSNIKVSGFKLS
FYSMLFTSGFFMIKALLGKESFAIPSITLFFSFVVFAFLTTVVSTLCLVFAIKSIGSTPA
AILGALEPVVAVLVSVLIFNEKFTFNLFLGITLILVGVILNVLAGSKKNVHS
>KALACAFP_03095 Putative pyridoxal phosphate-dependent acyltransferase
MLDIFERIKDNPGPLGQFADYGEGYFIFPRLEGPIGPRMKFQGKEVIFWSANDYLGLCNH
PEVLEADAKAAAEYGMFYPMGARAMSGETEQHLQLERELADFVQKESAYLLNFGYQGMVS
TIDALVGRNDVIVYDVDSHACIVDGVRLHAGKRFTYKHNNIESLEKNLQRATKVAQENGG
GILVITEGVFGMRGQQGKLKEICELKSKYKFRLLVDDAHGFGTLGKTGAGAGEEQECQDQ
IDVYFSTFAKSMAGFGAFIAGDKEIIRYLKFNLRSQIFAKSLTMPMVIGGLKRLELLRTR
PEIKAKLWENTNKLQNGLKERGFNIGDTNTCVTPVMMQGTPVEATLLVKDLRENYRIFTS
VVVYPVIPKGMILLRLIPTASHTDSEINETLAAFEAIHDKLVSGYYKEQEQKLLQEQGLS
FKPI
>KALACAFP_03096 Putative cystathionine beta-synthase
MSNVYDNILGLIGNTPMVKLNTVTKDIPATVYAKLESYNPGHSTKDRIALHIIENAEKKG
LLNKDSVVVETTSGNTGFSLAMVCIIKGYKCILAVSDKTKPEKIAYLKALGATVYVCPAN
VPADDPRSYYEVAKRIASETPNSVYINQYFNELNIDAHYQTTGPEIWEQTEGKITHLFAC
TGTGGTLSGSAKFLKEKNPDIKIIGVDADGSILKSYHETGEIHKEDVHPYQIEGMGKNLI
PSALLFDKVDEFVRVNDEMSAYRTREVALKEAIMGGYTTGAVTQALLQYAQSHEFSENDM
VVLIYPDHGSRYITKVYSDKWMAEQGFVNNCVHNYDEVFKTEIIK
>KALACAFP_03097 hypothetical protein
MKNWTFRQWNTVLGWVVFVIAFFTYLSTIEPNFSFWDCGEYISSAVKLEVTHAPGAALFQ
IVGAVAAIFALGKGENYSIVINAMSALFSAFTILFLFWTITHFVRRLLNKDFDEITKHQE
ISILFAGVVGALCFTFSDTFWFSAVEGEVYSMASMFIALLVWLITKWENEYAAPDNERWI
VLIFFILGLSVGVHMMCMLAIPAVCLVYYARNYQFTWKNFIWANVITLVILAIVFKGIFP
LIMTLFGKLEIFFVNGLGLPFHSGTIVAFILMVAICYFLISYARKMKKNVYQTVALSVVF
MMIGFSCWMVIPIRANANPPMNLNDPDNAIGMLDYYNREQYGDWPTIYGQNYTAFLDANG
IEKNEDGSFKTTKTGEIYEKDEKTGTYRKTGDRFNYVFNKAHVGFMPRMFNEDKDVMANY
ISMYGAPDFSFNYGNEDVADSPEAKQLFEELRQKYQDGSITAADYLKVKPYNLINVQKPS
LSQNLDYFFTFQNGYYFVRYLMWNFVGRQNDLEGNMESTRGNWISGISFIDDALWGNQEK
MPAKFKNESTVKFFFLPLLLGLIGFFFQLNKDFGRFYALLSLFVLTSLGIIFYTGVKPFE
PRERDYAMVGSFYAFAIWIGLGAGAILWFLQSKIKSNAANIVAGVILLGVPFMMGFQNYN
VHNRHDRYTSYDYGYSVLKSLPKNDILFVYGDNDTYPVWAIQETERFRDDVKVVNFTLAS
TPWNIDQIKRRTYNAAPVPGVLTHDDYRDGTNDQIYMMKKDDWEGLFSMLKEQGAPETEF
AEFRKYLTQDSMTLKEAVNFLKYKSPAKDELLKMYFGEEKYEKYNILPVTKFILPVNKAN
ALQAGIINQADLPNTVNQIMINYKGNTLYKNNLIMLDILANFDWKRPINFSSGGIYDSEN
VFYLDEYLQFDGFSYRLIPIHTPQTPDGELGRVDANSLYNVVKNFRWGNFKNLNTHFDET
ATSNIMSYRSSASRAAAALATMGQKGKAIELLDLASKEIPAEKYNDPRSLSSMVYGYIVS
GQEKKGLQLAEVLKKGIFEEYDYYMSLSKADQSYLRKQIRTKPMEYSLVVSAVTDAYTRI
GQKEKAYDYLVRSIEPIDKKFNTFVEGLKEMGKEKAMSESEEVQKITPFYQYLFDVMEPF
DSTYSKEKESQITNAIIKATQ
>KALACAFP_03098 hypothetical protein
MGETKNNKIPIYAVLFTVVFKLLFLLTHYIQEDAFITWRVAQNLLDYGVIGFNGATKISA
STTHLYVFVSYLFNLIFGKEHFIIPILIFNSILFSIGTLLLSHLVLKNIWHKAIFIFLIG
ILPPAIKISILGMEYGILFFLEMALLYYGFNKGKKWAFIILPILILFTRIDTVIFLGIVF
LVDLFWTKKIRWNYILGGILGISVALAFNWFYFGEIVNNTIIAKKLAYDKHFTFAQNLEY
FKLNFGNFWGMLKLPGDFNPLTILLLIFELLCFIYLIRQRKNRNYFLWMIFIFGWVKQLI
FLSQKSLFDWYYWVPQILLFVPILIFVLEQKVKRNLWLSLLIIIYILPMLAFQTIHSIAT
GNGEWNYRRTIGLFLNQYEKDKNQWILLEPAGYVPYFSGLKTIDEVGLVDKEVQEEIKKD
KPNFWINTVKKRKPKYLLSYDDLYQRKDAEYFKAHYKLLKEFRVKDHLKSNHKILEKIYI
LKPSGTDYNLYERID
>KALACAFP_03099 hypothetical protein
MKYCAFLRGVNVKGTNMKMAEVCQVFKDAGMEDVVSILASGNIVFSSGKKEDELKKILEK
SMSEHFSYEAYLFVKSQKETENFWNGNPFEKNENLHSYAFVGNDGIENILMQEFQNASKT
EDEDAKIVNNIFYWQVPKGNTLDSTFGKILGRKSLKDQFTSRNINTFEKIIKKM
>KALACAFP_03100 hypothetical protein
MMKNFLLIPLIAFSSSLFSQTASDLKFTTTVPDAENHWVVFQKSEEANDYNVGFIYFDES
AGYSLRSLGTLVEENGKLKYREDQETKNAVFIKRLENLEYQYAVISPKLLKDFNLPPQPE
WLKSYLSTASKNEKNLNRASMMNGVGFSKMALPRLENLYKSNFKTDKLYFELAFAYNALG
EFSKAEKICSEAINNKIFDDLINKEYVYSLLHQEKVSEADVFLTKNLDRYKNKSYKYEAM
MNMIVVSAQLKNIPLAKKWLELFKNSNDPDTAEYIKKFEELIAAKENG
>KALACAFP_03101 2-dehydro-3-deoxyphosphooctonate aldolase
MIQYLDNIHHKDSKNFFLIAGPCIIEGEDMALRIAEKVVELTDKYNIPYIFKGSFKKANR
SRVDSFTTIGEEKSLEILKKVGETFNIPTTTDIHENEHAALAAQYVDVLQIPAFLVRQTD
LLVAAAKTGKCVTLKKGQFLSPESMKFAVQKITDSDNQKVAIIERGNSFGYTDLIVDYRG
IPTMREYAPVILDVTHSLQQPNQSSGVTGGRPDLIETVAKAGIAVGADGIFIETHPTPET
ALSDGANMLRLDLLEDLLQKLTRIREAIL
>KALACAFP_03102 hypothetical protein
MKKLVLPLSLMVPMLVFSQARKKKDTTAKVNTIEEVVFQKKTTGKTNDITTVKISAKDAQ
NVASISGGIEGIIKTLPSVNSNTELSSQYMVRGGNYDENLIYINDIEIYRPFLIRNSQQE
GLSIINPDMVSTVNFSAGGFEPRYGDKMSSALNIYYREPEKFEVDGEASLIGGRLTTGFG
AGKDSDGDKKFTALFSGRYRNTNLVLNTLKEDTDFNPKYMDFQTYLNYHFSPKFSMSFIG
YYSKNDYEMIPKERSVDFGSLNQPLNLTVNYAGREDDKYKNMMGTYSMNFKPSEKWRFTL
DAFAYQNREREYYSIASAYILQTFDPITGAPVTSYDTGGQIEHARNDLFVRTYGAQFRTR
FSPNVNTDIELGFKYEKENLKDLTNEWKLVDSAGYSLPHAEFVDPRNPGDLELMYNISGQ
NHIQPTRMSAYAQYSQKFFWGSSKVFVNAGARVAHWSFNNETIFSPRAQFAFKPDWDTDM
LFRLSGGVYYQAPFYKEIKDLDGNFNSDIKSQRSIQAILANDYEFYFDDRPFKLTTELYY
KKMNNLIPYYMDNVRIRYSGKNNASGYAYGIDTRLFGEFVPGVDSWLSASYARVFENIDG
KGDIPRPTDQRFRFAMFYQDYMPRFPQMRVNLTLVYAMGLPTGAPVLTDPYQYQKTLPSY
KRVDLGLSYAFIDPKEKKGGYGFWGNFDELTLGVQVFNAFNIRNTVSNQWITDSNTNLMY
PVPVRLTGRFFNVKLEFKIK
>KALACAFP_03103 hypothetical protein
MKKILAILFSVFYFGFSSGAVFSVHYCMEEFASISQKVDDICSKCGVKTKKDCCKTEIKV
VKVDDSQKSDFLKIDFAKQITEVQQHEFLFVDKSFSATKFTQIQINAPPENRPVPIFIHH
CNFRI
>KALACAFP_03104 hypothetical protein
MKKYIITAALSLFSIISLSAQSKKDAQVSKLYQNYIAIKSALASDDADKTSKAAVEFIKT
ASAVDYKVVSEGNLNILRKDATAISEARNITAQRETFYNLSDNMIGLTKEFKLSENPIYV
QYCPMADGSWLSDEKKIVNPYYGSSMLSCGSVKSEIK
>KALACAFP_03105 Copper resistance protein A
MKKIIMFLLFLFSVFTFAQTTKTFYTCPMHPEVVSSKPGDCPKCGMTLVKKTVIIKPKVV
AKPQVKPLPKTEVKSTESKNKAKTKVKAKIKVEKKPDVKKINKSKETNIVKPVLNSKKQN
QIKSEISSDSKPEPQSQPQKYTCPMHPEIISDHPGKCPKCGMDLVEIEDHSKHQAEPEPQ
NSVLKRNSENGKVSFGGKTVRYDLYVKDTIVNFTGKTRRAIAVNGKLQAPTLYFTEGDTA
EIYLHNMLKENTGFHWHGVILPNEHDGVPYLTTKPVKPGETHLYKFRVSQNGTYWYHSHE
ALQEQIGMNGILVFQKREGEPKVNYTKEIPVLLGDWSDEDPMQIARRLHMANTDWYAIKK
NAVQSYWEAIKSGNFGTKALNEWKRMEAMDVSDVYYDKFLINGLPSSDYSHLKKGDKVRL
RVANGGSSTYFWLNFGGGKIKVIANDGNDVVPVEVDRLIVGVSETYDIEVTIPEDKSFEF
RATSEDRIGHASLWLGSGEKMNAPDLPRLKLFEGMKMMNGMMEMSGNMKPMNMTMSNQMM
DMNEVMYPELPESQRKMTMKHMNEMMGIKTEEEDHSNHSGMNMTEEKSIKRLSYNILKSP
EKTILPTENVRELKFRLEGNMNHYLWTLDNKTVTETDKILVKKGEILRITMYNNSMMRHP
MHLHGHDFRLINSKGEYSPLKNVVDIMPMETNTIEFAANQDGDWFFHCHILYHMMAGMGR
IFSYENSKPNPQLPDRKLAWKNFLKDNRMISSMAMLDINSNKIHAETMTMFGPRWANLNE
FHTNWDFNHFDGNFKVGRFLGKFQWALPYAGFRIQKNHEIMERQMMEDMGMDFHGKKTWF
GQQKASKTRGAFVVGMQYLLPMLITADASVDQNGKVLLEFSREDIPLSRRLRGNFTVNSD
GEFNTGLRYILQKWLSVSGNYDNEFGWGAGITLTY
>KALACAFP_03106 hypothetical protein
MEIYFLIGGVILFWILINLIFYFYFKYTRKIFFNFIKDRKYSIVKNVETETESYQKIGAK
ITYRKCDIIFLEDEIFLLSFNKAIIQLSKGIDIFPGVMHKFTYYSKRKVKDRLEIANFDK
SFKANLNFKNKDFDLEEYLNKFL
>KALACAFP_03107 RNA polymerase sigma factor SigA
MRQLKITKQVTNRETASLDKYLQEIGKVELITADEEVELAQRIRAGDRAALEKLIKANLR
FVVSVSKQYQNQGLSLPDLINEGNLGLMKAAKRYDETRGFKFISYAVWWIRQSILQALAE
QSRIVRLPLNKIGSINKINKAYAHLEQENERPPSPEELAEVLDMSEEDIKESMKNSGRHL
SMDAPLVEGEDSNLYDVLRSGESPSPDKDLMLESLQIEIERALNTLTPREADLVRLYFGL
NGKHPMTLEEIGETFDLTRERVRQIKEKAIKRLKHNTRSKILKSYLGK
>KALACAFP_03108 hypothetical protein
MKSMYSKILILAFMASSLYSYAWGLTGHRIIAEIAENHLSGKARREIKKMMGRERLAYWA
NWPDFVKSDTTGVWKEASSWHYVNIDPQTDFKAFEQNLKAQAGPSLYTQIKILSSQIKDE
KTSEKDRKIALIFLIHIMGDLAQPLHVGRAEDLGGNKINVTYFGDKTNLHSVWDSKLVDS
QKYSYTEYAKLLDIKTNDEVKQIQTGTLEDWLYDSHKIANKIYAQTPNDSKLSYDYQYKF
NDTMERQLLYGGLRLAKLLNDLF
>KALACAFP_03109 hypothetical protein
MYENNIVEMNYNKLQTDFKAEAVAVNLLKYHRAVSNIFIERIGINDRAYLKDIKSISSNY
LGFDEEVFTIETYREGIYDYLPEGLFHPPSLGASRKNVESVVREIRKQKRVEEDARKFFR
PFELEIFFTEISALLKESDFEISSDTDALLDTVSELWPLINMLDKQNAYIFIYILPFFHQ
IRGDKKWFERCMTAFLHVPVEVTFLPNIIDGIEENDDSMLLGNSRLGVTYIPSGRHMDGQ
RNWVVNIGPIPYSDMKKYIDGNPFRKVLQALYDYFLPISVDVVENFITEKKEYSFALEDD
ERNANRLGYSTFL
>KALACAFP_03110 hypothetical protein
MEVSSVKGIFLRYILMPLFAVIMMVILGAIRRNKPAIKIKTIIIYVLLCSLCLAIPGVFG
FAGNLFNPYWYLIAQIVYLILGIIHVNLSDKYFKKHLNSLTKSILFESILSLTCIGFGGY
LFYLIFNWMSKGTGYPIMAATSMFIFIVPLVFHYCYIQLISIPVDIYKTWRYSPDQKLPD
FEGADFDRLMVLNVELSKNLEDANRFRIKAKTLPTGVTFGDWFYRVVDDYNHKNPNSIIH
LSDQAREPYYWIFYTKKSFFSFRKYIDFDQDIMENSIAENDVVICKRVIQHEEEGIRKPQ
SHTV
>KALACAFP_03111 hypothetical protein
MIQPIKHFAINWVDGMKVSQRHLNDQDNFLIDTIRDSNSLAITTYNYGLLPISNEFTDRT
IFDVHNTATNDVQLVIKHCSAITMAGYRIELNDRRVSVKSLAKSMNEEQADGEYYILISV
NPFDKVPFGDIDPEEIPPRHPNTQSNHHIELLPVTSLNSSYSGGNYLIIGKVDLKGNIAQ
VDSNFIPPCTSIQSHPALLDYYNNYAKSIGNLQQYAFKIIQKTSHKNQNTALAQNVKFLC
NTMINTFGDMYFQFRNITPYQPPVFLIESFAKLALRLYNATQVLVPAELEEMLNYSLEWS
EIAPHTLLNQLSIVAETNYDHHNCGEPLLYIQQMLRSLETIFSKLSELDYIGQRKENIIV
NEQEVSNNNNPKRGWSVLD
>KALACAFP_03112 putative cysteine desulfurase
MNTDKIRQDIKGLSDGKIFLNNAGSSLMPQVVLDSMINYLHQEEQFGGYEVANRNAELLE
QFYDETAKLINCKSSNVAFATSATDAYAKALSSIVFKERDVIITTVDDYISNQIVFISLQ
KKLNVKVIRTKNLSDNELDLEDLEHLIKEYRPKLVAVTHIPTNSGLIQNVESVGKICRQY
DVLYLVDACQSVGQLEVDVEKIGCDFLTATGRKFMRGPRGTGFLYVSDKVLEQNYAPLLL
DMRGANWSEFDDYELFKTAKRFEHWEISYASLLGLMEATKYANAVGMQEIENYNRKLSEK
LRQNLKNSRFNVWDWGNNLSSIVTFSGPDGDLENIQKVLKENNVFFSVTYKNSALIDFTN
KNINGIVRLSPHYFNTVDEIEKVSEILKNSLK
>KALACAFP_03113 Iron-dependent repressor IdeR
MKTTLTEENYLKALFHLVDNENKVTINELSKFLSVKMPSVNNMMKKFAEKSWVIYETYKP
LIVTEKGRREAALVVRKHRLTEMFLVKKMNFGWENVHEIAEQLEHVHSTIFFDKMDEILD
HPKFDPHGEPIPDKDGNIIAQDLQKLSNCEIGETVIFASVTLSDDAFLNYLTERKLLLNK
KIKIIKIENFDQSITVEVDGKQEILSLKATDKILVKK
>KALACAFP_03114 Low specificity L-threonine aldolase
MKFSFKNDYSEGCHPNILQALLRHNLDQQAGYGEDEYSLQAKELIKEKIKKSDSDIYFVS
GGTQANLIVISSVLRPYQCAVSASTGHILNNETGAIEATGHKILSIEKEDGKLTAEDIIP
VLESHKNVPHQVMPKLVYISNSTELGTIYTLKELEKLSAFCKENDLYLFMDGARMGHGLT
SEISDLTLEKVAELTDVFYLGGTKNGALIGEAIVINNQELQPDFAFNIKQKGALLAKGRL
LGIQFLELMKNDLYFELAKHANQQAMKIKNAMKERGVEFLSDTYTNQIFPILRNDLIQKL
SEKFEFYVWKKIDENFSAIRLITSWNTEDEPVNDFIEILKSEL
>KALACAFP_03115 hypothetical protein
MKINFLFIPNLLSYRNSITNLALSKFDLTITNKDMKKLILLSSLSVFLLNCNKKKEVSST
DKAPADTTMATQPVVDTLGAKSFCYMGVTGKDTVYVTIDDNLGTITGKMATKNSEKDSNK
GDLTGFKSGDTLKLTYEFASEGKTGNKNDIYFIQTKDGLNEGIGERDAETGTKYANEKKI
KYEGGRSLKVADCNTVAKALK
>KALACAFP_03116 hypothetical protein
MSKKKLTAEQNEELLKVLKTRFEKNMSRHQGLNWDKIQAKLEKSPEKLWSLNEMEETEGD
PDVVGYDKKTDEYIFFDCSPESPKRRSLCYDYQAWEARKANKPESNVIDKAAEMGIELLT
EDQYRQLQELGKFDLKTSSWVKTPANIRELGGAIFCDRRYNTIFTYHNGADSYYAARGFR
GCLKV
>KALACAFP_03117 hypothetical protein
METPNKSQKRNKIIYWIFTLWMSLGMISTAIVQLMKNKDELANFTNLGYPAYLMTIIGVW
KILGVIATLIPKTPLLKEWAYAGFFFLMSGAVASHIIVGDPIGKTFPPFLLLVLVLISWY
FRPADRKISNIQTT
>KALACAFP_03118 hypothetical protein
MNPKVDFFFDKAKQWQKEFEKLRTIALDTELEEDLKWGCPCYTYQGKNIFLIHGFKEYCA
LLFFKGALMKDPENILIQQTENVQAARQIRFTDVKQIIDLKKVLKDYMFEAAEIEESGAK
VEMKKTREFEMPDEFQKKLDENHELKEAFEALTPGRQRAYLLHFSSAKQSKTRESRIEKY
IPEILNGKGLND
>KALACAFP_03119 hypothetical protein
MELKTKIHAEDGKQEIFITREFDLPVDLLFKAYTDAEIVEQWMGTKVLKLENKQHGSYQF
ETSNQHGDVVFRANGTIHEVIHNQNITRTFQMENTPFPVQFDYIEFEKLSDDTSKITIHT
IYKSVDFRDQMLKLPFAQGINMAHNRLQEVVSKEVKS
>KALACAFP_03120 Transcriptional repressor SdpR
MNLRRDVFQAIADPTRRSILMLVATQSMTAGAIASNFDTARPTVSKHLQILTECELLKPE
QNGREIIYHLNPNKMKEIADFIEPFRKMWDDRFNALENIMKNYQTKNNKYGT
>KALACAFP_03121 putative Hsp20 family chaperone
MKTLEKINTFPSLKSIVEDFWNTDGFLSQPLFSKSMYPTVNIIDKDKAYELKVSAPGFKK
EDFKVANENGLLTISAKKSSEHTEEKENYLRKEFSTSSFSRSFRLPDNISEDQIKATYQD
GLLNISLTKANPQKGEVKEIKID
>KALACAFP_03122 hypothetical protein
MMIITPKCDASQLNKINLQKAYNNQIELASFFPILKKRDLIFVFNRKQIGWETGKGRVMK
IISNCNYCHRSKVIVVLILDN
>KALACAFP_03123 Beta-1,4-mannooligosaccharide phosphorylase
MIKVKKEGVILEKTNHGFESSGVSNPAILSENGTVHMFYRAVSKDNYSSIGHCRLKKQVT
VEDRKEIPILFPQYEYEKKGIEDPRIVKIEDTYYLTYTAYDGINALGALATSKDLVTWEK
RGLIVPQYSYEEFRYLAESQGELNEKYFRFNGKYIVPKKFGKKVLLWDKNVILFPRRING
KFYFLHRIKPDIQIVFVEDLSELTHNFWDNFFLMFSDHLLISPKYDHEVSYLGGGCPPVE
TTEGWLLIYHGVHDTVDGYVYCVCAALLDLEDPTHEIARLPYPLFKPEYDYERCGLTNNI
CFPSGALVCEDTLYIYYGAADERVACASVCLSELLKELITYKNLPNEK
>KALACAFP_03124 Spore coat protein SA
MKNRLNMKKRLRDASFANAVLKKKVPQWLMITTFPPRECGIATYTQDLIKAINDKFTESF
DIKICALENEAHEYNGDVNYILETANPESYRELTENINLSDQIELVILQHEFGLFRNNEK
ELLQFLNSVNKALAVVFHTVLPKPEKEIKQYIQTIAALADKLIVMTNSAREILENDYEIA
KDKITVISHGTHLVEHINKNTLKKKYGYQNRKILSTFGLLSSGKSIETTLHALPSIVEQH
PDVLFLIIGKTHPCVVQHEGEKYRQSLELLVDNLQLNSNVAFVNEYLPLEALLEYLQLTD
VYLFTSKDPNQAVSGTFSYAISCGCPIISTPIPHALEVLQNGTGIIIDFENPLQLSQQVN
KLLNDEELRNNISLNGLHQMAPTAWENSAIAHVQQFRKILDFNVKLQYKIPEINLNHIKK
MTTSFGIIQFSVINHPDKDSGYTVDDNARALIAMCQHYKIFGTASDLKYITIYFNFISYS
FQEGCFLNYINFQKEFTAQNSDCNLEDSFGRAIWALGYLLSLQDMIPEDLIRKAQVLFNK
AVLQASDIHSTRAMAFIIKGLYYAGLKNNSLQNRLAIEELADRLVQMYRHETDDTWQWYE
SYLTYANSVIPEAMLMAWLTIRKSVYRSIATASFDFLISKIFSQDAIKVISNKGWMHNNR
EIDAAHKGGEQPIDVAYTIIALNEFYTVFKIENYKQKMFVAFEWFLGNNHLNQIVYNPCT
GGCYDGVEDTYINLNQGAESTISYLMARLVMEKYAVPVKSYAAKRNKTERAFH
>KALACAFP_03125 Osmotically-inducible protein Y
MKTNAELQRDVQKALQWEPLLHSAEIGVTAKDGIVSLTGVVDSYAKKMEAENAAKRVSGL
KALVENIEVKFPNSLYKTDAEVAKEVLNALKANYSIPDDNIKVKVEDGKVTLEGELPWNY
QKEEAGQAIKYLIGVKGVINNIKIKSEVDDEIQKKDIEDALRRSTIDDSEIKVSVSGTTV
TLTGTANSWYQKEEAGRIAWKTPGIWNVRNELEIDYEYFL
>KALACAFP_03126 hypothetical protein
MKKLISILLLSLYLVSTTELYQLLKIPTLIEHYWEHKALNPEMTLTAFLKTHYDHPVKDK
DYSKDQKLPFIIHSAPLALVFTMSQGFHFEAGNEQFRQIKSHKIPSYDEDFCYRGFLNSV
WEPPRHTFS
>KALACAFP_03127 Disulfide bond reductase DsbH
MKTILSAILMVVFSIGIQAQSRLENAKKQAAENNELILLNFSGSDWCIPCIKLHKNIIET
EDFKKLETENVIVYINADFPRNKKNQLSPDLKKENASLADQYNPKGLFPYTLLLSPEGKI
LKSWEGLPSENVLAFSKEIRDIKDHQKQ
>KALACAFP_03128 FAD:protein FMN transferase
MLREFKRPQKLMGNAFEITVVSDDEKAANQHIDDAIQEIRRIEKLLTTFNEESQTCLINQ
NAGIQPVKVDREVFDLIDRSIRISSITDGYFDISYGGIDKSFWNFDREMKHLPDPALVKE
HLKLVNYKNILLDRENQTVFLKEKGMRIGFGGIGKGYAAEMAKRLLQEKGVSSGIVNASG
DLTTWGNQANGKPWTIGIADPDNAKLPFSYMNITDMAVATSGNYEKFVIIDGKKYSHTIN
PKTGMPVSGIKSVTIFCPNAEIADAMATPVGIMGTDAALHLINQINHLECIIIDDQDNIY
SSQNINLK
>KALACAFP_03129 hypothetical protein
MKNSTKNNSVIQYVFGQLYPSSTPAFLLVPRKKSSVQAGLQRSATSGIFSIKTMAVVSAI
MIIPFLHSCTVVKEYEKNKLNDAEMVLGNRTIEKTELSFQSYREGSSGANAGKVGGGCGC
N
>KALACAFP_03130 hypothetical protein
MKKIIISILALFGFLNAEAQENTNNEQPKKLSLDEANLVSSYYRQDGNNSAVTGGIGSEK
LTDISNTIDVTMVKYDKKERKNKFNFSVGIDHYTSASSDMIDLKANSSASHADNRIYPAL
SWSRENESKGTTLMAGVSFSTEYDYQSYGANIGFAQKTANRMGEFTAKFQAYIDQVKLIA
PIELRQGGVTDGEHESYGTSGRNTFALSLSYTQIINQNFQVEFLADGVQQTGYLSLPFHR
VYFADNSVHQETLPDRRFKLPLGARANYFLGDRVILRAYYRYYTDDWGLKSNTFSLETPV
KISPFISVSPFYRYYSQTSAKYFAPYQQHTAFDDYYTSNYDLSKFDSHFYGAGIRFSPKN
GLFGIERLNMLEIRYGHYTKSVGMKSDIISLNLRFK
>KALACAFP_03131 hypothetical protein
MKLLTMILTALICSNVFYGQIKADSSVSEDHISEYKDNIYKPNYKKLIVPTVFIGYGVIS
LTSDALKDLNRSTKYEIGEHQPKKIKLDNYTQYLPAAMVYGYNLTGIKGKHNFKERTIIY
GTSQLISAAFVLPLKHIIKEERPDGSNSLSFPSGHTATAFSSAHFLFREYQDENFWMAIS
GYPVAVFTGVYRTLNDKHWVGDVVAGAGFGILSTELAYWLFPIINRMFNKKDAKSFALIY
PVAEPKNFGAGFVLNF
>KALACAFP_03132 hypothetical protein
MYHQLEKHYVNRVGWLRAAVLGANDGLLSTTSIVIGVAAANTERNTIILAALAGMIAGAM
SMAAGEYVSVSSQEDTEKADLLREKRELEEIPEIELKELAKIYEKRGVSKETALQVATEL
TEHDALGAHAHDELGINEITQAKPFLAAIASFGSFALGALLPFAVSLLAPIKQMVYFQYG
FSIIFLMILGAISARTGGSKTGIAVLRICFWGTVAMGITALIGHFFGVTVA
>KALACAFP_03133 hypothetical protein
MKISAGILVFKKEKNDNLYFLVHPGGPFWKNKDEGAWSIPKGEALPDENLLERALTEFKE
ETGKTIEGKFIELSPVKQKSGKKIYAWAVEGEIEMSDLQSNTIMIEWPPKAGKMLEIPEV
DAWEWFSSEEAKKRINPAQAGFIDELEKLLNN
>KALACAFP_03134 Ribonuclease
MESISLKSLGGAETVTGSKHLLKTPKLTVLIDCGLFQGTKFLREQNWENLNTDVSEIDAI
ILTHAHLDHCGYIPLIVKNGFKGKIYMTEPTRELTKLILLDSAKLQEEDAEKANRHHYSK
HHPAKPLYTINDAEKSFRQFFTVAENREIKLSNHIHIRFKQCGHILGACSVEVTCYDKII
IFSGDIGRNHSFVLPAPDFFTQADFLVMESTYGDRLHDSANLYDELEHWINLTVKNKGNI
IIPSFAVGRAQEIIYILYQLKEQNRIPKNLPIILDSPMAAAATDIVLEYADYTNIDQQKW
IEILDTITINRDYEQTEVIVHDKQSKIIIAGSGMITGGRVLEYLKHDIGNSKNTVFIVGF
QAEGTRGRALLNKSYELKMHGKYYRVKANIVEITGLSAHADQSELIDWIKKYQNPPKQIM
LVHGEPSPLEALRVKIQSELQIPVKIMRKDEEITLF
>KALACAFP_03135 hypothetical protein
MKVIIYNINQEDKKLLALANRKKHKITIITSPLDETTVYFADSKDVVILTDHISPEIIEL
LSSLNIKYLLFDSDELSPAETSLIKNKGFTFIQIKNSDQKPKAFQIIDILDEWEKSDKDH
SERK
>KALACAFP_03136 Transcriptional activator protein Anr
MEKIRILIIEDNDDIRESTAEILGLANYEVFQALNGKQGIELAIKHIPDIILCDIMMPEL
DGYGVLHLLSKRDDTALIPFIFITAKTDRAEIRKGIEMGADDYLTKPFDDIELLNAIESR
LKKKERQTKIYSENLTQMTNLFQDSHGLDELKKSFDERKIKLMKKKQVIYYEGDTANAIY
LILSGSVKTTKMTDEGKELMTGVFQAEDYFGITSLFTGREYKETAEVLEDATLCSVPREV
IDQLLYKYPDVANKFIKILAQNIVNHEEQLLQLAYFSVRKRMAEVLIKLHTKHPDNQGFE
ISRENLASMAGMAIETVSRILSDFKEEGLIDRNASKIIILDMTRLQKLKN
>KALACAFP_03137 Sensor protein FixL
MESAKLLRAIIETAIDGIITIDSKGKIESLNPSALKIFGYKEEELIGKNISVLMPEPDKS
RHDGYLHRYQDTGEKKIIGKGREVRGLKKDGSQFPFRLAVSEVQYEDRIIYTGFIHDLSK
EKEAEEFLKKYASELEELVEHRTRSLKQMLYELEEAKEEANISLEKEKHLNKMKSRFVSM
ASHEFRTPLSSMQLSVVLIEKYLQISDNTQILKHLQKIKNAIASLNGILNDFLSLEKLEA
GIIAPNFGVFDVIKFSEELTEELQLITKDDQIIIYQHTGSESEINLDQNLLRNCLMNLIS
NAIKYSGENTLIEFSTEINEKYYLFTVKDNGIGIPEQDHAALFQPFFRAHNTGNIPGTGL
GLNIVLRYVNLMDGKVSFESKSNVGTTFTLLFNKKF
>KALACAFP_03138 hypothetical protein
MRSILVPTDYSKPAKNAAYYALHVANALKANIELCHAFSLPFENPMLGQTAWALYEYPAL
QEENSEGLKKLVKKLEKKEKTLWGDEAFPFHPAISYTCEAGDAINIINNTAEKNQTLMIV
MGMQGAGMFTRFIFGSNTLKMIEFTKHPLLIIPDGFEYKKPEKIAFATDLDKKDIKTAQS
LLKLARYFDAEVLITHIIQSTNEVLQDKEYEHKKELFLKDLDGKICYNCIYSENIDYGLD
ILKDKDIDMMALGHHHQGFFSRITTRSHAEKQAAHMEIPLLILPEGGHIYF
>KALACAFP_03139 hypothetical protein
MKALLNYISIFFCILMLKGQDLKTNTEITSLLNDKVTLEKLHYPKSVVRFYSQNQSDYAW
IMPSRAEQTWTAMLLLDCAYQLGLSSSDYHLQNLSFENLGVLKHPPENISPKDKAMQDIL
ITDALISLINNLHFGKYNPFYTASQFDKGFINGFYSVEALSYARGQNDFIKAILQARPKI
QAYTDFQNYLNKLYANNPENHTEEIKKILINMERLRWLNTENESYILVNIPSYTLEFYSK
NKKFESKVIVGKPSTKSPVLVSDINYFTTAPDWKVPQSIFVKEMLPKIISDSKYLENHHY
AVYNQFGGMVTITPSKLREIRRNPYKYSVRQSSGCDNALGSVVFRFPNSYGVYLHDTSQK
QLFNKTERALSHGCIRVEKAQELASLLLKNDGAEDKIPALQTAMQKYDHKDFVLKQPVPI
NIAYLTCMIKDGKPVFYNDIYHLDADLENKFNLNKQ
>KALACAFP_03140 hypothetical protein
MKKLQHILLIFLLLLVTSCGSTQIVNSWRDPDKHIHPGDWKKVLVVALLKNETNRRKAED
EMVKYLHGKGIPSYQYLDGKINQYDEEALRNTIKKDGFDAAITVRLIDVDKEKVFIPEQH
YMYPLYYDDFSKYYFRNRLFFYTPGYYTVTKKFIIETVIYSIQDDKIIWSGITETYDPHG
VKRLTDDIAETIRKKMLKEGFIEEK
>KALACAFP_03141 hypothetical protein
MKTNAELQKDVQDAIKWEPLLHSEEIGVAAKDGVVSLTGTVDSYAKKVQAEKAASNVSGV
KVLVENIKVKFPDPRSKTDNEIAREIVAAFESNTVIPEEKIHVKVEDGWVDLDGELAWDY
LREITENSIQFLPGVKGIFNNITIKSDIQNTIEKKDVEEALRRSSIDSKEINVSVSGTTV
TLTGAVHSWSQKKEAERIAWKTPGIEHVNNELAVDFEYDF
>KALACAFP_03142 putative phospholipid ABC transporter permease protein MlaE
METFFKKNFTLVGKIASFSARFFKEIFRSGFEYKEFIRQCFVVGYQSLPLVTITGFIMGL
VLTIQSRPAMSRFGAESLIPSMVSLSLIREIAPVITALICAGRVSSGIGAELGSMKVTEQ
IDAMEVSAINPYRYLVVTRTLATMLMIPVLAIYADLIGIAGGFVGVNIHNDHNIQYYFSH
VFESLEYVDLLPATVKTFFFGFFIGIIGCYEGFNASGGTKSVGKAANSAVVSASLIIFII
DLIAVQLTDLFFEL
>KALACAFP_03143 putative ribonucleotide transport ATP-binding protein mkl
MKTIEQNITPGYQNPLDKSFIEFKNVYKAYGDNKVLNGISFTIKKGENLVILGRSGSGKS
VAVKCLVGLTKVDQGEIIISGEDITKLNEEGLNRIRMKIGFLFQNGALYDSMTVRQNLAF
TLQHNNKSLNENEVEAAIKEALQNVGLEEAIDKMPAELSGGMRKRIGLARALIIKPQIII
YDEPTGGLDTITAREIIELIRSIKLKYNATSIIITHDLTCAKYTGDRIIILKDGVIKAEG
SYKDIENSEDDWVKSFFEQ
>KALACAFP_03144 hypothetical protein
MKNESSNQWKLGIFVATGIILFIVAIYFIGVNRNLFGSNFVLRSEFENVSGLKQGSNVRL
SGINVGTVGKIDFISDSLVVVKLIIKKDVQKYIKTDAVASIATDGLVGDKVLIISPGNSS
GTVVKENDIIASYKAPEIEDVLSSIKKSADNTKIITDELVTFSRKMNNKDGLLMKILTNK
DFALRIDRTLENLQMSSEDLARFTPVLNNRNGTIAKIFTDKKMADNISNSINDLQKTSGE
LSAFAAKINNKNNVLSKIVSDDSLAVSLEKTLLHLEKSSNDLNAFTSKINNDENVVSKLI
NNPELGRSVDSTLINIEKGVAELREIEKAAKNNFLLRGYFNKEKRKAKKLKQ
>KALACAFP_03145 Sodium-dependent dicarboxylate transporter SdcS
MPTYFQIHKKEISLFSGLFLSLSGFIINPFSLSYQANQVLSVAILMIIWWVFEAVPMAIT
ALLPIILFPAFGIVSLKKVAENYADPIVFLFMGGFFIALAIEKWNLHKRIALGIIRLTGT
NGNRIILGFIIATGFLSLWLSNTATTMMMYPLAVSVIQVVENHNKNVKNIKNFSLALMLS
IAYASNFALGTVIATPPNVAYVGYIKDRFNFTISFSDWMMLFLPLTLLLLFMLYGLLVKI
LYPNNIKHSNEASNAIKKAQLRLGVMNRAEMRVLSIFGLTVLLWITKDLINDWQHYILLD
DTAIAVLGASLLFLLPSGQKTGNKSERLMAWSDTRKMAWDILLLFGGGIALANALEASHL
VQEFASGLSTVTTTNLFLLILIVSAVSIFLSEVISNLALVLILSPVITSLALSLGINPLL
LGIPMTLSASCASMLPMGTPPNAIIFAKGDVKIQYMMRTGLILNVLCVIVISLLCWLFIP
MMEGLKL
>KALACAFP_03146 Calcium-transporting ATPase 1
MHDFKISGLTDQQVISSRKEYGYNRLEYKKENPFFRSLKGIIKEPMVILLLVASFLYFIN
NQFDDGLFLAFAIILVSAISLYQESRSRNALEKLKTFTQPSCKVIRNGDVQQIKTEDVVV
GDSIMIEEGDLITADGIIVHSNDFSVNESILTGESFSVYKDKNSEDHLVYSGTIVASGLA
IATVTEIGNKTKLGKIGKSLENIKDEKSPLEVQINDFVKKMVIVGSVVFAAVWVMNYLRS
HEVIDSLLKALTLAMSILPEEIPVAFTTFMALGSWRLMKMGIIVKQMKTIETLGSASIIC
TDKTGTLTENEMTLANLFVISTQKELQPDEISTAEEKKLLEIAMWASEPIPFDPMEKALH
ETYGKHFSEDMRPYFKMIHEYPLDGKPPMMTHIFEDQTGKRIIAAKGAPEAFMEISNLNP
EEKENIRTAIKHFTTQGYRVLGVGVADFSGNNFPEHQQEFIFDYKGLVAFYDPPKKNMQE
VLKDFYQAGISVKIITGDNSDTTMAIARQIGFQGHEKSITGEELMKMQDAEFQDCVKKIN
IFTRMFPEAKLRIIKALKAEKEIVAMTGDGVNDGPALKAAHIGIAMGKKGTEIAKQAASL
ILVDDDLAKMTLAISMGRKIYSNLKKAIQYIISIHIPIILTVFIPLTFGWIYPNILTPLH
VIFLELIMGPTCSIIYENEPVEKNIMRQKPRPFTTTFFNAKELITSIIQGLCITAGVLFI
YQYAVAEGFNENIVRTMVFSTLITANIFLTLINRSFYYSIITTLKYRNNLVPLIISVTIL
IVAVMIYIEPLAAFFGFEPLHSSQLLTCCSVGFLSVIWYEMVKLIKRIKFNQEK
>KALACAFP_03147 hypothetical protein
MNISYYDFKNLPNQEQCNVVMNEGRVMNETISDTLKYVLYEVSYFTVEIIYNMKNNKIEG
MNVFQNKSAYSN
>KALACAFP_03148 Exodeoxyribonuclease III
MKIATYNVNGVNGRLPVLLQWLKEAEPDIVCLQELKAPQERFPIKEINDAGYQAIWKGQK
SWNGVAILSKNHEIVEVQNTLPGDDEDVQSRYIEAIIDQMVICCLYLPNGNPYPGPKFDY
KLSWIKRLKKRTDELIKMELPAIIIGDFNIIPTAMDVYKPERWENDALYRIEVRKAYEDL
MKKGWLDSLRTLYPDEVIYTFWDYLYKAYDRNAGIRLDHILLSPYLTSRLKSGGVDKHVR
GWEKSSDHAPVWIELLK
>KALACAFP_03149 hypothetical protein
MNYNEAQQYKKEALQKADESVLQNFHIIITPAITDESAKYIEDFLKNPDKFNDESCKKYS
SDGEFEVVSFKKENE
>KALACAFP_03150 hypothetical protein
METKTPTKNATAKKPAATKTASKATAKTPAKKNAAKELKDLFEDSLKDIYWAEKALVKAL
PTMMKNATDAKLKAAIEKHIAETETHVQRLEQCFSALGKKAQAKKCDAMQGLLDEGKSIM
QETEPGAVRDVGIIAAAQKVEHYEIATYGTLAAYAKVLKEDECLKNLLATLNEEKKCDES
LTKVADTALNTQAM
>KALACAFP_03151 Carboxylesterase NlhH
MRTTFIKGIALSAMTFFSLNSNAFAQQNPASQDPNISKEIRAFLKVLNSGDGKPLETLSP
KDARLVLVGAQKSVNFDYSDIEESERTITQDGQTIKIHIVKPKGAKAGLPVFMFFHGGGW
VLGDYPTHKRLVRDLVVNSGAVAVFPDYTPSPEARFPVAINQAYAATKWVAQNGKEIGVN
ASKLAVVGNSVGGNMAAVVALIAKDKNGPKISQQILLWPVTDADFSRESYTKFAQERFLT
TPLMKWMWDNYLPDLNERKNKYASPLQASLEELKDLPPALVQVAENDILHDEGVAYGRKL
DEAGVPTTVTEYKGFIHDYGMLNPLAHIPAVKESVLDAASTLKRALFSK
>KALACAFP_03152 hypothetical protein
MKQRIAGAFIMGFITTGIISFTLISINVGYIENFFEKWLKSWAMAYIIIIPVIFFIGPKV
QQFVAYLFRKNNQQ
>KALACAFP_03153 Oxalate-binding protein
MKFLNKLIIKAIYILCIAIYFIPVKSFSQQTGITRTNLQRYDLQASGYETIQARIDFETG
TSFGMHSHPGEEVIYVLEGTFEYQIEGEKPVILKGGEVLFIPAGKNHSAKNIGNSKASEL
ATYIVQKGKQLLVMKK
>KALACAFP_03154 Soluble epoxide hydrolase
MKTINNLSRLLFTGALMVQFAIASAQNKTELKNDETIRPFKVNISDAEVKDLRQRILQTR
WPSKELVNDEKQGAKLAKMQELAQYWGTSYDWKKAEARLNSYPQFKTKIDGIDIHFIHVK
SKHKNAMPLILSHGWPGSVFEFMGVIEPLTNPTAYGGKAEDAFDIVIPSLPGFGFSGKPA
VEGWGNDRIAKAWIVLMKRLGYKNYVAQGGDWGAGIVHSMALQAPQGLLAIHSNLPATLP
NEAGMALGGNTVPESFSQKERAAFEQLNNAIKTGGFIYKTTMEGRPQGVSYSISDSPVGL
AGWIFLHPGFDEWSFGKDPKQLPTRDQVLDDISLYWLTNSASSAAQIYWENRNISIISAG
MMQSDKITIPVAVTTFPKDVYASPESWAKRAYKNLVYFHEVDRGGHFAAWEHPQLFSEEL
RAAFKSVR
>KALACAFP_03155 Aliphatic nitrilase
MKNSNKTVKVAAVQISPVLYSKQGTIDKIINKILELGEKGVEFATFPETIIPYYPYFSFI
QAPYAMAQEHLKLLEESIVVPSADTDAIGKAAKEANMVVSIGVNERDGGTIYNTQLLFDS
DGTLIQRRRKLTPTYHERMVWGQGDASGLRAVDSAVGRIGQLACWEHYNPLFRYAMIADG
EQIHSAMYPGSFLGPLHSEQTEINVRQHAMESACFVVCATGWLDEEQQKQIAQDTGGPIG
PISGGCFTAIINPEGQIIGEPIKSGEGEVIADIDLSKIDSRKRLMDAKGHYSRPELVSLV
IDRTPASQVHDISIDGQISASAQIISE
>KALACAFP_03156 HTH-type transcriptional regulator TtgR
MGKAEKTKQLIIEKSALLFNKKGIAGTSLSDILEVTKLAKGSLYVHFENKEAISHAVVEY
YIDKQLKLMDAALAGSGSVKKRLFDYFEVFLNPEIPPFEGGCPFLNLGMEVDDTNDVSRR
KIKKTIDTIHKKIRTTIQEGIDSEEFSNEWNAEEFAIKAYAMIEGAIMMKKITGSAKQMK
TIEKLLKMEVEENLL
>KALACAFP_03157 Organic hydroperoxide resistance protein OhrB
MENATQNEKVIYTGSTITIGGRGGSAKSTDGKLNVKLTAPGAIGEGTNPEQLFAAGWSAC
FIGAMGKAAAAKDIKFPADATVHAEVDLVLSETDGYSLKARLNISLPGIDNETAKSVAEA
AHSLCPYSKMVKGNIKVETIIL
>KALACAFP_03158 hypothetical protein
MFLADLEILLNCSTKVLVRCNDPNDNDVQTDKLDSETDILYGEVLFNLVKNN
>KALACAFP_03159 hypothetical protein
MENQQEISVLNDLLHITNDRIQGFAKVEGKIWENYPDVKDEYARMISFSKVMKNELINLI
TERGGNAQDSPSVAGALHRTWIDIKNSFMSANVESTLGNVVFGEKAAIEAYENALSSGDL
SSESSKTVADQLKHIRDSYHQFKNIEEYKKKD
>KALACAFP_03160 hypothetical protein
MKNLKKLNRTELKTINGNGILDNVIGVVNGVGTVAGNTVTGLGGVVNGVGTGVVTTVGGA
VAGLGGVVETTLCQVQCVINGVVTIKVLACGSTC
>KALACAFP_03161 Putative bifunctional phosphatase/peptidyl-prolyl cis-trans isomerase
MDTFNAENPTPIKAVFFDIDGTLISFKTNKIPDSTKKAIENLRRKGIKVIVATGRSINTL
AHISHIEFDGFITFNGGYCATTDGEILSKNIIDPNDIKNLINYAENFPLSYSLMYEDKVE
INDATPEVVGMYAHVNLPVPPIHDKENIDIENVFQANIFLGPDAEKEFMETVMPNSVASR
WTPLFADVNPGGISKKVGVQTFCDHFGIDVSETMSFGDGGNDIFMLKFTKIGIAMGNANE
NVKEIADYITEDVDNNGIEKALLHFGLI
>KALACAFP_03162 hypothetical protein
MRSILWLVAVICIVVWLLGMLGIVPGMSTGYLVHVLLVIAIIVILYNIITGRKPLD
>KALACAFP_03163 HTH-type transcriptional activator RhaS
MKHYKTITELHAGNLWDPPQHPLLGLVGCLSTCTLGNQEFTADCYIIAFKKIKSGIFMYG
RTPYDHDNGCLFFTKPRQVIEMKDLKFEENGFMLMIDPDYLNGHELFKTIDQYGFFDYEV
TEAIHLSPKEEQIILELHEKIQNEYFNNPDEYSREIILSHVSSILKYSQRFYKRQFIDRA
QITGKTTSKFNDVLKKYINEGNLENKGLPNVSYIAEQLAISPRYLSDLLKQESGKTAIEL
IHIFLISEAKNLLRIGEKGVTEIAYELGFENASYFTRLFKKQTGMKPLEFRKTNLN
>KALACAFP_03164 Dihydrolipoyllysine-residue acetyltransferase component of acetoin cleaving system
MNSNALTSATQFAPINGHNIAYRKFGKGMPMFFTNRFRGIMDTWDPLFLDKLAENNTIIL
LDYPGIGSSEGELPLHIAEVAATVPQLADFLEIEKFNILGWSYGGLVAQTVMFQNQDRVL
KTVLIGTNPPGENEIPIEEVFYDHALKPVNDLDDEYYLFFEPALEASKIAAVESHNRISQ
RLDVSLIPSTMDIFQRYFSGTASFKEDKLNFREAYKTLKTPVLVVSGDHDISFATDNWFP
LLQNAPSMQHIILHGSGHGPQHQFPELTADYINLFLASN
>KALACAFP_03165 putative oxidoreductase
MAKTVFITGASRGFGKLWTEAFLKRGDKVAASARNIAALDDLVEKYGDNILPVQLDVTNK
EQVQQAVDTIQQHFGGIDILINNAGYGLFGTVEETTEEQARAQMETNFFGLLWVTQAVLP
VMRAQKSGHIIQVSSFLGIKTLPMLGLYNASKFAVEGLSETIASEVAHLGIKFTLIEPNG
FATEWAGSSATQTTSDIADYNPVREGFAATGENGELWGDPNATIEPILKVVDSENPPLRL
LLGKIAYQFVHEMYNNRLKDIEEWKEVSIAAHGH
>KALACAFP_03166 Pyridoxal 4-dehydrogenase
MKSHILTEKHRLGLGGVAIGTAFEKLTDGESYEVLQKAWDLGIRYYDTSPWYGLTKSERR
FGNFLHGQNRDEFVFSTKVGRLFVEVPENEVPPTMWKAPLNYDFEHNYTADAIKRSIEES
LERTRLSHIDIVYVHDLSEDQVGDRYPYFLKQAREGAFKVLSELRNQGVIKAWGMGVNKI
EPILDCLDSADPDICLSATQYSILDHEDAVDRLLPAVKKAGVKLVSGAGYNSGFIAGRNR
YNYVDVIPKGMTEKLNKINEIAKKYNTTAVHAALQFVLAADEFASIIPGASRPEQVEDNV
NALNEKIPTDFWNELKSEGLIYEKAQTPA
>KALACAFP_03167 NADH dehydrogenase-like protein
MKKHIVIVGGGFAGINLVKSLVNDNRFQITLVDKNNYHFFPPLIYQVATSFIQASNISYP
FRRLFSNYENVHFHMGKLVKVDSETDSIETDTGRIRYDYLVLALGTETNFFGMENVQKCA
LPMKSIEEALYLRNYMLLTLEEAARNKDAKEAEKLQNIVIAGGGPTGVELAGMMAEMGRY
IAQKEYPEIKLRFSNIYLIDALPSLLSPMSKLAQEAAYNKLEKLGVKIILNVAVKDYVDN
KVILADGKTIETETLIWTSGVIGREVPGIPEESVGKGRRLLVDAYNKVQGTKNIYALGDI
ALQLTEEKYPKGHPQLAQVAIQHAKNFAKNLKRIEDGKVLIPFKYNDKGSMAIISKYNAV
VDLPKFSFKGFFAWLTWLFIHIIPLVGFQNKVRLALDWLRLFITNNPSIRLILQPKRNNI
>KALACAFP_03168 hypothetical protein
MKKTLLPLSLSLGIFAFSQEIKTEAPAVDTTKAWSIQGQNTLMLNQSAFSNWVGGGANNV
GWLAGVNYNLTYEKGKDLWENIIILGYGQNNTKGIGTRKTQDVINLSTNYGREFAKHWYI
SGGASLQTQFAAGYADGNNPEAAKISNFMAPGYFNIGAGVTYRPNDNLTVTLRPANARWT
FVLDEDLQHAGTYGLKNDGDSSLFQFGFLGTAIYKLKIMENITLTNTGSVFSNYLDHPER
LVLSYSGVLNMKINKFISTNITLDLLYDHNQIRRTQLKQTLGVGFAYNIEKGKKRSDNKD
NQSWFKK
>KALACAFP_03169 hypothetical protein
MKTKKILSPILGEHIGTKGVSKGIENAAKYVAVGFLALFALGLFTTSQKINAG
>KALACAFP_03170 hypothetical protein
MLSVFLLKLDWKELLMGHEEWSFLLEIILRTFIMFITIIIGLRVLGKRGVKQLSLFELVV
IIGLGSAAGDPMFNKDVGIVSSIIVFLVIIVLYSVVTYFIGKSKGFEKLVEGKSICLVEN
GEFAIENFKKENLGSDEFFAELRLKSISQLGQIEKAIEEISGEISVFYYENENVKYGLPI
MPDSLNHTLKNITQEGYYSCIFCGHTEEKQIGNAGICPKCEKDEWVHSSNKRRIT
>KALACAFP_03171 hypothetical protein
MKKKLLFGIMIIPLFTYAQVGINNTSPASTLDITAKNATGTSTNVDGLLVPRVDRQKAQS
MTSIPISTLIFVNDVSTGTQTGTAIDMDAMGYYFYNGTSWTKLNPNVTIYNSDETLTSNR
TVKQNTNTLAFKGTVKNLFSVDGNTFSVDAANDRVGIGTDSPTSKLEINSGVANDSGMKF
SNINSSSPISNGKALAVDATGKVVTISTSAPLATIVANNTAPNTGSGTNSSWTYTYNHSG
GLAYITAMATCWANGATPSNGTALSFTMTNSAGTVVVNRVSHLPAAVPINVRISMPPFFH
AVNLPAGTYTIRIFKEAAHPLTLVDAADVASITILTF
>KALACAFP_03172 Adenosylmethionine-8-amino-7-oxononanoate aminotransferase
MNLSERDQAVNWHPYTQMKTAGNAIPIVKGQGVYLFDDQGKKYIDAVSSWWVTLHGHSHP
YIAQKVFEQLTTLEQVIFAGFTHEPAIRLSENLLKLLPENQQKVFYSDNGSTAVEVALKM
CIQFAYNQGKEKTKILAFENAYHGDTFGAMSVSGRSVWTKPFGEMLFEVIFIDTPTSENL
ENLKKIIKNNADDIACFIYEPLVQGAAGMLMHNPEDLSELMKFCREQEILMIQDEVFTGF
GRTGKLFAADYFSEKPDIMCFSKGLTGGTMPMGITTCSKEIFNAFLSEDKYKTLFHGHSF
TANPLACTAALASMELLLNEETQEKINLISKKHSEFSRTLEINPKVENIRQMGTILAWDF
KTEHGTSYFNTIGKLLYEEFLNKGIIMRPLGNVMYLVPPYCITSQELDFIYLAILEVLEG
V
>KALACAFP_03173 Biotin synthase
MDKKNQIRNDWTKEEIEEIYNLPLLELIYKAATVHREWHNPEEVQMSTLLSIKTGGCPED
CSYCGQAARYHTNIKVQALLPTEQVIEHAKKAKEGGSSRFCMAAAWREVRNNRDFDRVID
MVKGVNELGMEVCCTLGMLTEEQAVRLQEAGLYAYNHNLDTSEQYYEEIISTRTFDNRIN
TINNVRKAGITVCSGGIIGLGETHKDRISMLLTLATMPKHPESVPINALARVEGTPLQDN
EKTNTWEMVRMIATARIVMPSSMVRLSAGRIEMTEFEQGWCFMAGANSIFTGERETLLVT
PNPGVSEDMQMLQTLGLKPMMREKTMC
>KALACAFP_03174 ATP-dependent dethiobiotin synthetase BioD
MIDRFLLRRNDNDNGYKKMNTKPETQNPEQRLLFVTGIGTEIGKTVCSAVLTKYFKADYW
KPVQSGDLHHSDSMKITDWVGENVVCHPETYRFQLAASPHQSAFEENKVINLNQFKIPKT
QNNLIIEGAGGLMVPLNDQDFMIDLIEKLSIPVALVVRNYLGCINHSLLSILALNQRKIK
LEYLILNGNFPPDSERIICKNIQPETKIIRIPDIEDITPETIENTTKQLEKIE
>KALACAFP_03175 8-amino-7-oxononanoate synthase
MLNDFHHFQEALEKRKESGTLRILRQKEQGIDFYSNDYLGLAGNKDFQKVLLKNISENPQ
LLSGSTGSRLISGNSTMVTETENFIAKEHQYQSALLFPSGYSANLALFSTLPNRHDTIIV
DEQIHRSVHDACKMSLAKKLKFKHNDPEHLEQILKRQDGSCYVGIESLYSMDGDMAPVKE
IIEIIEKYKAKLIVDEAHAFGVFGYGLVDKFQLQEKVLATVVTYGKALGTHGAAILTHDI
VKSYLINFASPFIYSTSAHDFLWMSVKKGYDFLNMNSELSIKLKENIKIFRDQHLKSPSA
ENSPIQAIIVPDNHQLKALKETLLVNGFLTYAVFSPTVKEGTERLRICLHSFNTEEEILE
LTRIIKKFV
>KALACAFP_03176 hypothetical protein
MEFYNLLEKIVQHHLTHAKWLNTLSFMENAGARKISACEHPSKVDLIQLKHAAEEHRHAY
YLKKQIGKISPESCKTYEKDELLASVATRQYLHSLDIKACKYLQKTFSLTKEELKYAAYL
FVTYAIEVRADELYPVYQEILTKTSSKVMVKSIILEEEGHLEEMINQLNEFSDDWETHAE
TVLAIEKDLHEQWINAISKEVLELHYA
>KALACAFP_03177 HTH-type transcriptional regulatory protein GabR
MNSPVEIPYQSFIKINRNSEVAIYMQVTNQLINAIQRGFLPFGTKLPGTRALSQLLQVHR
NTIVAVYDELFAQGWVESLPNKGTFVIRKNDEKPVSFNDFNQINLKNYPKTTGFTFKTSN
ILDNPFERSDCEFVFNDGVPDIRLTQIDQHSRIYSSTLKRRAHKISHYNQDGSEFFKKNL
SQYLNLSRGLPISTHNILITRSTEMSIYIVSEILLSENDTVLIGALSYFSVNMIFQKTGV
KIVTIPIDDEGIDVEEVRKICQKQKIRMLYLTPHHHYPTTVTLSAQRRLELLNLANEFGF
IILEDDYDYDFHYDKSPILPLASADTNGMVIYIGSFGKSLAPGFRTGFIVAPENLMTEMR
KYLGIIDRQGDILMEHVLGEMIAEGEINRYLKKSVKVYQERLDYFVRLVEENLGNYLQFK
KPSGGLAIWAEWKIPINLMQLSRNCGQNNLFIPKTLLYQNKDLTAMRLGFGNFNFDEMEK
SIEIFSKTVKRMS
>KALACAFP_03178 hypothetical protein
MVFFKSNSQKPLKLITFTNKGIYCPQGKFYIDPWRPVDLAVITHGHADHARWGMKKYLCH
HFTKPILHQRIGQDIECQSVEYGDVINMNGVKLSLHPAGHIIGSAQIRLEYKGYVSVVSG
DYKVQDDGLSTPFELVRCNEFVTESTFGLPIYNWLEVDDLNKKLQSWVLKNKENDKTSVF
IGYSLGKAQRIMKAVEGLGKIHVHYSIGKLNEAFENVGIQLPDYEIPDFRESVKHVQGEI
VIVPPALLDSNVIKKVPNAATAICSGWMQVRGARRWRSADAGFPMSDHADWKGLLQAIKA
TEAEIVHVTHGQTEIFSKYLNEIGIKSDVVETLYGDDDEEVTEKEIIENPES
>KALACAFP_03179 DNA ligase B
MKNFADLINALESTNKTNAKIDAIIDYLERAPDEDKVWFIALFTGKRPRRNVNTNYMKEW
ALEITKLPFWLFQESYSSVGDLGETLSLILPPPTKKIERTLSQWMNDIIDLKNKTDLEKK
EFVLNSWNGLDYTERLIFNKLLGGSFRIGVSDKTLINALTKFSDQESSTLMHSLMGKWLP
DEISFKELISAEKINPDNSKPYPFCLAYPLEKELEELGTPDEWLIEYKWDGIRGQIIKRN
DEVFIWSRGEELITEQFPEIAEAVQQMQGNFVIDGEILAVKEGKVLNFNELQKRLNRKTL
TKKMLSEIPIEVFVYDLLELENNDLREKSISARRAMLEELLLNENPQNIKISQVIDFEKW
EELDQIRENSREINSEGLMLKQKNSPYHSGRKKGDWWKWKINPLTIDAVLIYAQKGSGRR
SAYYTDYTFAVKNGDSLVTIAKAYSGLTDKEIMEVSKFVNKNAIEKFGPVRTVKAELVFE
IAFEGIGFSNRHKSGVALRFPRIVRWRKDKTVEEIDDLDEIKKLIQ
>KALACAFP_03180 ATP-dependent RNA helicase SrmB
MSNFENTSGFRVIHEWMADKGISPFKFQTDTWQKFGNGYSGMVVAPTGFGKTFSVFLALI
ADFLNQPEKYKKGLKMLWITPLRSLSKDIAKAMQEAIDEIGLDWSVGVRNGDTDPKVRQQ
QVKSMPEILVVTPESLHLLLGQKNNARFFNEMKCVVVDEWHELLGSKRGVMVELGISQLK
KYVPKIKIWGITATIGNIDEAMDVLIPYDIKKTKITAKEHKKIDILSVFPDEVEILPWAG
HLGAKLADKIVPIILESKSTIVFTNTRSQSEMWYQLLLNAYPDFAGQIAIHHSSIDAHLR
IWIEENLSSGKLKAVVSTSSLDLGIDFKPVDTVIQVGSAKGVARFLQRAGRSGHSPFETS
KIYCVPTHSLELIEVAALKEAVKQKVIEPREPQVLCFDVLVQFLMTLAVGDGFYAEELHE
RIKKVYAFQEMTEEEWKSILDFLTIGGSVLKSYEEFHKIVIMEDGLYKVTSRKIAMLHRM
NMGVIVSDAMLKVKFISGGYIGMVEEYFISKLKKDEKFILAGRVLEVAMIKDMTVYVRAA
KGKAFVPSYLGGRLPLSSNLGHFLREKLSGALNPKASEKELKFLHPLLANQEERSHIPRE
DEFLVELIKNREGYHLFMYPFEGRLVHEVMAALVAYRISKLAPISFSMAMNDYGFELFSD
KEIPLNEENLDKILTRENLMTDVISSINSAEMARRKFRDIAVISGMVIQNYAGKQRSNKS
LQSSAGLIFKVLEDYDSNHFLVRQAYTEVFNAQLQEQRLVEAFMRIEKSKIILKYANTFT
PLSFPIKVDSLRQTLSSEGLDSRIQRMLEQAKKWRGM
>KALACAFP_03181 hypothetical protein
MKLVTKNINIQNETFTLTNQRAVFWKKEKALILSDLHIGKTAHFRKNGIALANHIMKNDL
ERLSILIEYFQPEKFIVVGDLLHAGDNSDVDEFCEWRNQYPDLQFYLIEGNHDKISKKLE
SKLCLNLKVEVLEIDNFIFIHDFEKNQPKFQITGHIHPGFVINSPVKNIKLPCFAISPDQ
LLLPAFSEFTGLDTKNLPKKGRFYVFTDSEIYEI
>KALACAFP_03182 Spermidine/spermine N(1)-acetyltransferase
MSAIIINKANPEDLEILQKLGRETFYETFAKSNSEEAMQKYLDESFATEKIKTELNNPDS
QFFIAWEEDNPIGYLKLNSGKAQTELQDELSLEIERIYVKAEYHGKKIGQLLYDKSLEIA
RQQYKKYIWLGVWEENVRAVNFYKKNGFVEFDKHIFRLGDDEQTDLMMKKTLD
>KALACAFP_03183 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase
MIKINEKHQFPVEETLFVFALDSEAGEVFNDKNKLITGIGKVNAAMELTKEIHRRKPKLI
VNLGSAGSKNFHKGEVICCTKFIQRDMDVRGLGFGLYETPLSGIPPILEYGLRKNDLPEG
ICGSGDSFEMNHSETDYNIVDMEAYPLALIAMKEKIPFLCLKYISDDAGSEAADDWTVQV
HLAAEAFDKILFS
>KALACAFP_03184 hypothetical protein
MKIEIWSDVMCPFCYIGKNNFEQALEKLPFKDEVQVEWKSFQLDPTLDPKETKNTIEYFK
EKKGFPEAQAQQMIGQVQQMGKGAGIDFNFDKALITNTFSAHKLLHLAKKFNKSNEMEEA
LFIAHFIDGKNVGDLQTLISIAESLGIDSTETEKVLTSEEFDYDVNQDIMEARNNGVSGV
PFFILNGKYAVSGAQPVELFASALQQTYDETVSPLKKDSDNGASCDTEGCEI
>KALACAFP_03185 putative quorum-quenching lactonase YtnP
MKIIPLKEGNFSTNETKDFTLLTNENVETAKGIKMSVQPFLIITHKDIILLDAGIGWKND
NGKTVISAILEKENIHPNQVTKVLLSHLHKDHIETVISRTENGFQATFPNAEIYIQKREL
AFAMENTGSYSFDFDTLEKLIELENIVWMDDNKGNITDEISFEVVGGHTPFMQVFWIREN
DETVFYGADDLPQESYLKYHLAYKSDFDGRKAMELRLKWQKEAIENHWKVLLYHDLDKAI
LEF
>KALACAFP_03186 hypothetical protein
MRNDKPGFNLDDINQKIFVQDEILTLAKENSPRLLNKFRLVDPDFFGKLSAIQPNLKNSE
LIFCIYLKLNLTTKEIATYTFVTPKAIQNRKNRLRKKLSIPSEVDIYKWFNDL
>KALACAFP_03187 2-hydroxy-3-oxopropionate reductase
MEKVGFIGLGNMGHPMAKNLEKAGFYLSVYNRTAEKAEDFKEKSKVCSTVSELVQNSDII
FTMLTNDTAVKAVYEEIFTQNITGKLFIDMSTISPEASREMADAIKIKEGRFIDAPVAGS
TKPAAEGTLIILAGGEEKDIERAKPYLQKLGKVIKHLGKNGKGIAAKLSVNYFISIIYQG
LAETILFSDKLGIDRKDMLEIINESASGSGATKVKTPLLIDDQYEPAFALDLMLKDILLA
KNAGADFPLSKTLIETYQSAHDAGFGKDDVIGIINYLKK
>KALACAFP_03188 Chloramphenicol acetyltransferase 3
MKVIDIASWKRKEHFEFFSKMKSPYFGFTTEVECTKAYEKAKENGHSFFAYYLHKSMVAV
NSVEELKLRIVGDQVILYDEVHGGSTIGRADGTFGFSFFHYSEDFETFNQGLQKEIKSVQ
NSTGLGISNDVLPINHIRHTTIPWNSFSALLHPTNFDPKECIPKITFGKFNIRDGKKFLP
VSVEAHHGLADGIHLAKYIEEFQRQLDM
>KALACAFP_03189 Transcriptional regulator AcuR
MKKSEATRLTILQKAFELIYENGYQTTSVDEIIATTQVTKGAFYYHFKTKDEMGLAIIRE
LMIPNFKNTFIEPFQDSVNPLDTIYNLMYNLLMENEALKVEYGCPASNFTQEMAPWNIDF
TKALNELSLQWEKAMIDAIEKGRKNGVIKSSVNAKEVAVFTLSGYWGVRNLGKLENSKSV
YLVYLKGLKSYFDSLK
>KALACAFP_03190 hypothetical protein
MYQTLTFLHSLFRWLVLLSLVYSIFIAYKGYFSDKKFSKTDDSVRHWTATIAHIQLILGI
TLYSQSPIIRYFWNNFNEAKESFDLLFFGLIHIFLMLFSIVLITIGSAVSKRKNTDKEKF
KTMLIYFIIALLIIFIAIPWPFSPFANRPYFR
>KALACAFP_03191 hypothetical protein
MIDLFKTKIGRLRIIAILEGISLLTLVFIAVPMKYGFDNPAFVKMMGPIHGSLFLLFLFN
TLSVGVEQKWKFKEITWKVLLACIIPFGTFYIDRKILNKL
>KALACAFP_03192 Thiosulfate sulfurtransferase PspE
MKNIVIFLGIVLVIYVVYRIYKYQTLDNGLDQLIKNGAVILDVRTEKEYETGHIAGSQNI
SLGTIRERYVELDPDKTYITVCSHGLRSVKVENILKEKGFRKVYNGGAWSDLQKSFNLKV
SEK
>KALACAFP_03193 hypothetical protein
MSTENLTNQDAIKKIKELSENAKICMFCTELDVVPINSRPMTLQETDNEGNLWFISSDTS
NKNFEIKDDRRVQLFFMNNGDYQYLSVYGDATIYKDRSTIEDKWSPMAKAWFEDGKDDPT
VSIIRVAPKQTYYWDTKAGKLVSLFNFVANAVTGNTTDNSDGVEGNATV
>KALACAFP_03194 Putative monooxygenase YdhR
MEKVILYVDFQHQGPFGKEMAENLQTLAESINEEPGFIWKMWTENEKNKEVGGVYLFDNR
KSAEIYLEKHMVRLSQWGYEDVTYKIFEINEQLTKINHSPILY
>KALACAFP_03195 hypothetical protein
MSKKTSFIYRNSLSIVLLILMICCLAAQFLTGWKTENKELAENGKAMLSLGQYVYSGHFI
QATFENWESEFLQMMLYVLLTISLRQKGSSESKSLDEKEDVDKDPEPHPNAPWPVKKGGI
WLKIYKHSLSLAFAFLFLASFSLHFYGSLKDYNEEQISKNKPTTTASHYITDSRFWFESF
QNWQSEFLAVASLVILSIWLREKGSPQSKPVNMSHDEMP
>KALACAFP_03196 General stress protein 39
MGKLKLENKSVLITGADSGIGKAVALLFARHGANIAIIYHSNTDDAEETKSEIENLGKKC
IIFKGDINDYEFCEETAKQTASEFGGIDILINNAGMQFPSDNIENLEEKNIRKTFDSNIV
GMILLTKIVFPYLKEGSSIVNTTSAVAYQGHPELLDYSATKGAIVSFTRSLALQAKPKGI
RINAVAPGPVATPLTEKTFGEKEEDENKPPLERNASPEEVATSFLFLVSDDAAQITGQVF
HPNGGLIVNG
>KALACAFP_03197 Nicotinamide-nucleotide amidohydrolase PncC
MEFQKNLLEYISQSLLTTGETISVVESVTSGCLQLAFSQMPNASLFYKGGMTAYTLPEKV
RLLNVNKAEAEECDCVSENIVETMALNVAQLFESDWSIATTGYCTPIRNSSYKIFAYFSF
AYKGEIIMTKKLELHPKTQALNAQLYYTEFILGCFKSEINQLLILK
>KALACAFP_03198 Catalase HPII
MKAPKKTNKKLDQLESHSTSNDQEKLTTNQGLKINNNQDSLKAGDRGPTLLEDFILREKI
THFDHERIPERVVHARGSGAHGVFKLNKSLAKYTKAKFLTEVGKETPVFVRFSTVAGNRG
STDLARDVRGFAIKFYTDEGNYDLVGNNMPVFFIQDAMKFPDLVHAVKPEPHNEIPQAAS
AHDTFWDFISLMPESMHMIMWLMSDRAIPRSFSRMEGFGVHSFKFINDEGKAHFVKFHFK
PKLGVHSVAWDEAQRISGVDPDFHKRDLWESIENGIFPEWDFGVQLIPEEDEDKYDFDLL
DPTKIVPEEEVPVQLVGTLTLNKNPENFFAETEQVAFHPGHIVPGIDFTNDPLLQGRLFS
YTDTQLIRLGGPNFHEIPINRSVNTVHNNQRDGYMRQQIPKGKVSYEPNSIGGGCPFQAM
MSEGGFASQEARVSGAKVRERSRSFVDHYSQAKLFYNSQSTPEKIHLQNALIFELSKVTI
PAIRERVVGQLAFIDKSLAWRVAEKIGVTVKELEFPNQSIPADANPADLQSEEREPNTKI
SKALSMQNTVKDTILGRKIGFIMGNGVDAEAVNDLKLKLEAEGAVVEIIAPSLAPVKTSD
GSSLTPKHSLSSTASVCFDALFIGTGEDSTKELLTPENKPLVLRFINEAYKHCKAIYFGD
GTEALYMSSNVGLKKHEDPAIITWENKKSPEKFIEAIAKHRVWELELERNAQN
>KALACAFP_03199 cAMP-activated global transcriptional regulator CRP
MKTISCMNIEPELLYSFGAEVKTYQPGELIYREGDHVVYYYQILKGKLKLNNYNEEGKEF
IHNILGEHQSFGDSMLFLEKFYVMNAVCLSTCEIIRLPKSSFMDMLEKHPHVSLEMNACL
SQKLYFKAIMLQSMSSQNPALRLKGLLDYLKSYHDGDCGQCFQVELTRQQIANLTGLRVE
TVIRALKKMEKEGNLKIENRKILY
>KALACAFP_03200 cAMP-activated global transcriptional regulator CRP
MVIKEEILHSVGASIKTYKPTEIIFSEGDPANYYYQIITGDVKLNNYNKDGKESIQTLLE
AGQSIGESMLFINKPYPMNAIAITNCEILRLPRHIFLDLLKLYPEISRDINTFLSQRIYY
ALVMKQNLNTHNPVSKLKTLMDYLKSFQKEQAPYSFLVPLTRQQMAGLTGLCVETAIRTI
KVMERNKILKIKDRKILY
>KALACAFP_03201 hypothetical protein
MKYVLTLTILGFIVLSCKKSADTSTTSASDTTIVADSTIAPVPADTISVDSTATNRTDTA
DTTKVTK
>KALACAFP_03202 hypothetical protein
MITHKLSKDQTLNGWINGFIGVLLFSGSLPATKLAVTEMNPIFVTIARAGIAGVLALFVL
LIYKEKRPAKDQIFSLVLVSIGCVIGFPLLSSLALQYLTSAHSIVFLGMLPLMTAIFGVF
RGGERPHPVFWFFSIIGSLLVIGFAVSQGISASPIGDILMLLGVILCGLGYAEGAKLSKT
LGGWQVISWALVLALPLMMPLFFIYFPKNIETVSFQGWFGLGYIALFSMFIGFIFWYKGL
AQGGITTVGQLQLLQPFFGLALAAYFLNEQVSLGMLGITVGVILCVAGTKKFTK
>KALACAFP_03203 HTH-type transcriptional regulator NorG
MNKEYLYTEIANGIASQIRNGILKSGDKLPSVRKLCKEHQISMNTAKRVFLELESQSLVD
SKPQSGYFVSNILSVELPLPEVSKPSLIANNEEPNELINKVYENIGKKEVTLFSIGIPSG
DLLPQAKLKKEIINATRTLKEGGTEYEEIQGNLKLRRMISMRSLQWGGNFHENDLVTTNG
GMNALSFCLMALGKPGDTIAIESPCYPGILQLANGLGLKVLELPTHPTTGIEIDALKKVI
PKIDLCLLIPNYNAPLGSCMPDENKKEVVKILSENGIPLIEDDVYGDLYFGSDRPKCCKS
FDKEGNVLYCSSISKTLAPGYRVGWIAPGKYKDKILKLKFLHSTSSISIVNEAVANFLKS
GKYEKHLQQMRKSLQNNYQNYVQTIAEAFPQGTKTSRPQGGLSLWVEFDKNIKTTQLYDL
AIKENISIAPGRMFTLQDQFENCMRLCIGLPWSEETQAKLKQLGNLAKRV
>KALACAFP_03204 Fumarate and nitrate reduction regulatory protein
MKNINNYLAKVLSVPVEKVNMCSLHYEVKKIPKNQFLLQYGEICRYIYFVEKGLIKMYSI
DKNGKEHIIQFAPESWLISDRSSLYFNEKSVYYIEAVEDSEVLLLHPDFISKLVGEFPNS
LEKSDILLQKHIKSLQDRINSLLAETAEERYMKFIKMYPDLLLRVPQWMIASYLGITPES
LSRVRKELARKNFVPDNK
>KALACAFP_03205 hypothetical protein
MSFFDKIFSGKGEESEKKSFWKKIESEEDLQKAIESSFHNRIAIFKHSTSCFISKTVLKN
FEKEIENLDQKVELYYLDLLAHRSLSNKIAEDFGVRHESPQLIVIENGKAISNASHQHIS
ADQIV
>KALACAFP_03206 hypothetical protein
MQIFNNGIPRNMPTFQKLIVNFECDFNDEKENLLKTLDEYRNTFKQGKLPDHHVLFGKMT
EKDWGFLEYKHLHHHLKQFNV
>KALACAFP_03207 Putative metal-dependent hydrolase YfiT
MSNLENKKFPIGQFEQPENICDIKLDEYINVIKDFPGRLKNLIENFTDDQLDTQYREGGW
TVRQLVNHIADSHINSFIRLKLALTEDNPTIRPYDEAKWAELQDSRNMPIKPAMRMIKGT
HQRWTTLLKTMTNKQFERTFHHPEQNKDYDLRSYLAVYAWHCNHHFAHIENLKKEKGW
>KALACAFP_03208 Nicotinamidase
MKKALIIVDVQNDFCEGGALAVPEANEVIPYINALMEENEYDQIVLTQDWHPANHKSFAS
NNGKNVGESIILNGVPQFMWPDHCIQGTFGAEFHKDLNRDKVTHIIQKGKNTEIDSYSGF
QDNNHFMKTGLDDFLKYHDIQLLEIVGLAMDYCVKFTCLDAVANGYITCLHFNGTRAVNV
KPDNGRDAIYEMIQKGVTVLG
>KALACAFP_03209 Ribosomal large subunit pseudouridine synthase B
MSRDNNNSERPKRPRISTKKNSGNSRASSSGNSSESKPFKKSFPKAGERNSEHRGSNTKF
GQKPFKKTERSFDRQDDDQHSKSERKPYITNNSEERKPFGKSAPKRGGKSFDSRDKYERG
SLKYGRRPAAAGEERQDRAKSFVQKRKFNKIDKDIHKDTIRLNKYIANSGICSRREADDL
IVQGLVEVNGKVVTEMGYQVEKTDKVVFDGQNITPEKPVYVLLNKPKGYISTTKDDKARK
TVMDLVANASPYRLFPVGRLDRSTTGVILLTNDGHMTKKLTHPSFDARKIYHVTLDKKLT
HEDMKLIAEGIRLDEGVAVVDQISFIEGKPKNEIGIEIHIGWNRVIRRIFQRLGYEVEAL
DRVMFAGLTKKNIKRGHWRILTELEVNNLKML
>KALACAFP_03210 3-dehydroquinate synthase
MQDSITINFTENLKMITIVDDNFSQLNDFLHEKSFSKIFILVDENTHEYCLPTLLGNMQT
DLGFEILEVEAGEEMKNIQTVNQLWEILTEMQADRKALMINLGGGVITDMGGFVASTYKR
GISFINIPTTLLSMCDASIGGKTGIDLMNYKNMIGTFTFPEHIFVYPKFLETLPFKELRS
GFAEMLKHGLIADKAHWESLTQIHKLDIDGVIPHIQTSMDIKQNVVEEDFHEKNIRKTLN
FGHTIGHAIESLYLSQGNPILHGEAVAMGMISEAYLAYLEGLISEEDSTLIIENIQKYYP
YLDISDFKDEDIFDLLLNDKKNVDSNINFSLLSGIGSCAFDHKCSKKNITASLKFYRELN
DA
>KALACAFP_03211 hypothetical protein
MKKLILGIAVAASSLAFAQETTTTTASSSSPVRFGIKGGMNVSSLSNDAGLDDSKSKIGF
NGGVFANIPVASSFSIQPEVLYNNLGSKVTLTDVNIGGNNYTAEYARHLDYISVPLMFQY
NFVPNFYLEAGPEFSFMIDARDKYKNTKNGSTTGAESYSLNKDDFNKFNLGIGIGAGYYF
TDNIGLTARYVAGTTDIYKNNNGDAVRNNNFQVGLAFKF
>KALACAFP_03212 hypothetical protein
MKKLFLGLALVAASFTFAQKKGTSPISYGLKAGMNVSSFSKDSGSDVQESKVGFYAGGFA
NIPLSAQFSVQPELLYSGLGAKKVETFSGQSQNTTFNSTRKSTASLDYLTVPVMFQYNAT
PKLYLEAGPEFGFMLSAKEKVSTTMVAMTGNSSSTTTTETSGKIDKKDLKTFNFGLGLGA
GYYFTPNIGVTLRYVAGLTDVVKNRPSGSDAVKNNVLQVGVAYKF
>KALACAFP_03213 hypothetical protein
MKKLFLGFAIALSSLTFAQENAKTSSPSSPVRFGVKAGLNISSINEDGFKAKAGIYGGVF
ANIPVASSFSVQPEVLYNGMGAKAESNSDVKLNLDYISVPVMFQYNVLPELYLEAGPQFS
FAINRKIKGNGGSLDVNDSIKGFDLGIGLGAGYYIVDGFGVTARFVAGVTDIAEDNPGDA
VRNSVFQVGVAYKF
>KALACAFP_03214 hypothetical protein
MNKLFLGLALVAGSLVAAQETVVVETATITPVPEKPHARVGIKGGANASQFSDQKLSLNN
QKVGFHAGVFVNVPLSNKISVQPEVLYNQMGAKTITSSSEITSPTTTTKTVSDVKNYLNY
ISVPLMFQFRPGSFYMEAGPQFSYFLNGKNEGETTITKTTGSSTSTETISNSGSVNKDIV
RKFDIGLALGLGLDITHNLGINARYINSLTHTYNNYIMPGVEYNSKTNRVFQLGLNYKF
>KALACAFP_03215 Amidophosphoribosyltransferase
MKSLDIHKSEYLKQFETQTYGRNLFRTQEEERLDAPNEECGIFGMYSDNDLDTFSLSQFG
LFALQHRGQEACGISVLKNGRITNMKDEGLVLDVYKEIHDPEAFMGNSAIGHTRYTTAGD
KKKYNFQPFFAKNEYDQIILSIAHNGNLTNAKELKAELEAEGVVFRATSDSEVILRLIQK
NLDLGLRSAIKATMEKIEGAYSVVGMTRNKFFAFRDFNGIRPLVLGAIDEKSYVVASESV
ALDAVGAQYVRDILPGEIVYTNENEPGKLHSYMADEMKGKQRICSFEYIYFARPDSYLEN
INVYEIREKSGEKIWHQAPVEADVVIGVPDSGVPAAIGFAKASGIPFRPVLIKNRYIGRS
FIVPTQEMRERVVNLKLNPIISEIKDKRVVIIDDSIVRGTTSKRLVKILKDAGVKEIHFR
SVSPPIIAPCYLGIDTPSKDDLISANMTTEELRAYLGVDSLEFLSVENLKEILGSSNHCF
GCFTEEYPVEKGEEVELFN
>KALACAFP_03216 Phosphoribosylaminoimidazole-succinocarboxamide synthase
MEKKEMLYEGKAKQVFATDNPDQVIVRFKDDATAFNAQKRGSVDLKGEMNNAITTLIFEY
LNEKGIKTHFIKQLNEREQLVRKVSIIPLEMVVRNYSAGSMAQRLGVEEGIKSPVTIFDI
CYKKDELGDPLINDHHAVFLGAATYEELDEMYELTSDINEILIDLFDKMNIILVDFKIEL
GKTSDGEIILADEISPDTCRLWDKDTMKKLDKDRFRRDLGEVTEAYVEIYNRLKAVLAK
>KALACAFP_03217 hypothetical protein
MIFIKLILAHLLGDFVLQPNSWVADKENRKLKSKYLYLHVLIHTALSFIFLWDVQLWWVA
VLVGVSHFIIDACKLSFQTVKNKKGWFFIDQALHVLVIAGISFYFNEFNFEFLKDQETLK
IIMAALFLTSPASIFIKILLSSWTPVPETAGNIQTESLSSAGKYIGILERLLVFAFILVD
HWEGVGFMVAAKSVFRFSDLAQAKQRKLTEYVLIGTLLSFGMAVLTGILIK
>KALACAFP_03218 hypothetical protein
MIAVITGDIINSQHAETEVWITRLKNLLENWGSAPKTWEIYRGDEFQFKCNIDDVFWHFL
AIKSLIRSQENLDVRIAIGIGEENFSSEKITESNGTAYVYSGRLLNDLKNDGHTVSIKTS
NDSVDRDLNILLKWSSKDFDNWTMATAEIIHEMIMNKDITQEDLAKKFAISQSSVSQRLK
RANYDLIVETNLYFKKKISEL
>KALACAFP_03219 Extracellular ribonuclease
MKKLLFPLLLISSYFAAQIPAGYYDGTAGLTGYALKSKLHDIISAKNINWHYGDLTNYYN
QTDLDKYYDHDATNTTILLDIYSEIPTGPDSYEYTTANIIGSAGSEGLGWNREHMMPQST
FYSNYPMYSDMFYVVPTDARINQLRSNYPYGIVGSTIYYTFTNTSRIGNCAIPGVTYTGR
VYEPINEFKGDVARSLLYFAVRYEGKLGTFNFNNNANPASDTNPLDGTEERSYDPAYIAM
LLQWHNQDPVSQREIDRNNVVYTLQKNRNPFIDNPAWVNTIWGQTPDAAAPETPTNVAVT
QNSAYFATLSWAPSSSTDVIGYKIYQNGTLVGATKNTTFSIDHLTPSTTYNFTVKAYDNG
YLLSPDSNTVSTTTMTSDIYAKDLFVSKYLEGTSNNKGLEITNKTGHPVNLNDYRLSIQF
PSGGNYYFPDPYELEGIVQNNETFVVLHPDANFSCYTINQAKFVTAAPQMTFSGSQYLEL
RYKNSTVDAIGISSTNNSSTLGNVSLYRKASVNQPTTSFNISEWDSYASNYCQNLGTLSA
SDVILAGNEFKIYPNPVYDHIFVNGKVENVKSAQILDFSGKLIYSENLPFKNKKTIAVQN
LTAGSYLLKLDERVYQFIKK
>KALACAFP_03220 Acyl-CoA dehydrogenase
MNTETIDNIKMIAETAKEFAEKNIRPNIMEWDESQTFPKDLFHQLGEMGFMGIVIPEQYG
GSGLGYHEYVTILDEISQVDPSIGLSVAAHNSLCTNHIYEFGNEEQRNKWLPQLASGKVI
GAWGLTEHNTGSDSGGMSTTAVKDGDEWIINGAKNFITHAISGDIAVVMTRTGEKGAKNN
STAFVLEKGMAGFTSGKKENKLGMRASETAELIFDNVRVPDSHRLGEVGEGFKQAMKILD
GGRISIAALSLGTARGAYKAALKYAKERHQFGKSISEFQAINFMLADMATEIDAAELLIH
RASTLKNAKQKMTREGAMAKLYASEACVRISNNAVQIFGGYGYTKDFPAEKFYRDSKLCT
IGEGTSEIQRLVIGRDITK
>KALACAFP_03221 hypothetical protein
MIKQALLGEFLYEAESTRKLLQAIPDSALDFKPSEINWTTGQLASHIAEVYNWFDSTFNE
DVFDMGTYQYDKGDISKAENIVAKFEENVAKAKQVLENSDENTYFNEWRMEMGGNTLFPP
MPRIQVIRSFLYNHLYHHRGELVVYLRSTGNKVPGLYGPTADDKF
>KALACAFP_03222 Chitinase A1
MFFIIKFLLALIFHNQKRIYMKKQLSMIGMLLITGISFAQTDRLWSESSRKTTSEIFENK
TNIINPKVYSLNINGLKNALANAPKRLAAGEKSEIIISFPNSEGKMENFKVRENSNFDPE
LAAKYPDIKSYVGEGLNDPNSTVYFSVSPLGLSSMEIYGDKSAVFIEPYTKDLSTYVVYK
KSDKKDDLNKFECTVIDVAQKGVANTNVAARPNADDAKLRTFRLALSSTGEYTAYFGGTK
ANALAAMNNTMTRVNGVFEKDFAARMVLIANNDAVIYTSASSDPYSPAAQMNNWNSQLQS
TLTSVIGEANYDIGHLFGASGGGGNAGCIGCVCTNGSKGSGYTSPADAIPSGDNFDIDYV
AHEMGHQFGGNHTFSMSNEGTGANMEPGSGSTIMGYAGITSQDIQPHSDAFFHAISIQQI
TNNIKAKTCPVSTNTGNSIPTANAGLDYTIPKGTPFMLTGTGTDANGDSLTYIWEQMDNA
SSSQTGASSAASATKASGPTFRSWTPIASPTRYFPRMASILTGATTTAGSEITVEALSNV
ARSYNFRFTVRDNRAGGSGNNSDDALITVNGTAGPFSVSSQNSATTYTGGTSQTITWNVA
GTTANGVNAANVDILWSTDSGTTWSTLLAGTPNDGSQAVTIPNSATTTGRIMVKGSNHIF
FDVNNANITVNAGSGGTDTVAPTAPVLAASGTTSTSTNLSWSGATDNVAVTGYDVYQGAS
LIGSTASTSYTVTSLTPSTTYSFSVKAKDAAGNVSPSSNTVSVTTLAGSTVTYCSASATN
TGDERIGNVKFGTINNTSTGTAGYEDFTSVSTNVTRGSAYTISVTPVWTSTVYSEAYAVY
IDYNKDGDFTDSGELAWSKAGSTTTPATGSITIPAAASLGTTRMRVMMKYSSVPTSSCGS
YTYGQVEDYTLNIVSSGKGEILDIKDLLTDIKLYPNPAKDILNISNTTSEDYKIFDMGGK
LISSGKLQRGSVNVSGLIKGAYMIQIGEITKRFIKN
>KALACAFP_03223 hypothetical protein
MDKIDSLNQVAEFHTTFKAPILETPQIPSPERCNLRVELLQEELNELKQAIADNDIVEIA
DALCDLQYVLSGAVLEFGLGNKFVELFNEVQRSNMSKACDNEEQAQETVEFYKEKEVESF
YEKSGEKYNVYRQVDHKVLKNKYYSPADLKTIIEK
>KALACAFP_03224 hypothetical protein
MKKIITNIAVVSCMAFTAQQVNAQKVVVNREVETTNDGKMLLGNQLRDQFLKAPYADWYV
KEHDEYAVDQKAITELRKDKINSYNIIVFMGTWCEDSHRDFPRLMRILDELKYPENKLTI
IALNRKKESPNGDEGLFNIQKVPTIIVQKYGKEIGRIVEMPKSGYIERDLAEILKKDDKS
VIDEIFKK
>KALACAFP_03225 hypothetical protein
MKNFRIILIPFFAGVLVMVLLFFGLKSCLNFGKKTEQSDYYILTNQISKMNKMVVIEQNT
SSMQKTKMGYEFFGKEVSSNSIITYTKTNAQVSYDLNKMKLEVDSINKKLIIKELPDADI
RITPSVEIQSLDDSFINRISEKDIKNVTQKAKETAIKSVNQNQLRTEGRKQLMENLDNIF
VLAKALNYTIEDQTGKLGVLGL
>KALACAFP_03226 hypothetical protein
MDSKGNKKGKESANTAETKRQNQDFPNIPASSKKTNPPDISKEDVQKSSKNKSGKTDNTK
E
>KALACAFP_03227 3-isopropylmalate dehydrogenase
MNKNQFKIAVLPGDGIGPEVIGESIKILNAIAEAFHYTFEFTYGLMGAEAIYQTGNPLPD
ETLKICKESDAVLFGAIGDPAFDNNPDAKVRPEQGLLKLRKELGLFANIRPLKMYSSLIE
KSPLKKEIIEGTDIQIFRELVSGIYFGEKFTEENGEYAYDVCKYSREDIIPIVHMAFQEA
QKRRKKLTLIDKANVLDTSRLWRKVCKEIASEYPDVELDFMFVDNAAMQLILNPKQFDVI
VTENMFGDIISDEASVIGGSIGLLPSASIGESNALFEPIHGSYPQAKGKGIANPIASILS
TAMMLDYLKLEQAAEKLRKSVEYAIENKYVTVDLKAEQPYSTSEVGSFIADYIKFSEKSY
YNFENVKIGKSTIV
>KALACAFP_03228 3-isopropylmalate dehydratase small subunit
MQKLVIIKSQAIPLPMENIDTDQIIPARFLKSIDKNGFGDNLFRDWRYNVHTNEPNPDFV
LNNPKYSGEILVAGNNFGCGSSREHAAWSLTDFGFKVVVSSFYADIFKGNALNNGLLPVK
VSEGFLKEILNGITENPEKEITVDVENQTITFDNTTENFELDSYKKICLMNGYDDIDFLI
SKKQAIKEFELKTQKVYEQKSI
>KALACAFP_03229 3-isopropylmalate dehydratase large subunit
MNNDKKTLFDKVWDAHVVETIPDGPQIIYIDKHLIHEVTSPQAFAELEARNLEVFRPKQI
VATADHNVPTLDQDKPIRDESSRNQVEQLTENCQKNNIELYGLGHQYQGIVHIIAPELGI
TQPGMSIVCGDSHTSTHGAFGAIAFGIGTSQVAQVFASQCLLLNKPKSMRITVNGKLNKN
VQPKDVILYIISRVGTDGGTGYFCEYAGNVFEEMSMEGRMTVCNMSIEMGARGGMIAPDE
TTFNYVKGRTFAPNGEDWEEKLDYWKTLKTDDEAVFDAEFSFDASEIYPMITYGTNPGMG
ISINQNIPSPQNESEEKALKYMGLKAGQALSDIKVNYVFIGSCTNARIEDFRSAANYIKG
KSKSEHVQALIVPGSQQVVKQIFEEGLDKIFNEAGFQIRQPGCSACLAMNDDKIPEGEYC
VSTSNRNFEGRQGQGARTILASPLTAAKVAIEGKISVFEN
>KALACAFP_03230 2-isopropylmalate synthase
MKSEKIEIFDTTLRDGEQVPGCKLNTEQKLIIAEKLDELGVDVIEAGFPISSPGDFHSVS
EISKLVKNAKVCGLTRANQKDIDTAAEALRYAKRPRIHTGIGTSDSHIKYKFNSNREDII
ERAVQAVKYAKTFVEDVEFYAEDAGRTDNEYLARVCEEVIKAGATVLNIPDTTGYCLPEE
YGEKIKYLRENVSGIDKAILSCHCHNDLGLATANSISGVINGARQIECTINGLGERAGNT
ALEEVVMILKQHRNLQLYTDINSRMLNSMSILVSDLMGMPVQPNKAIVGANAFAHSSGIH
QDGVIKNRETYEIIDPEEVGVNASTIVLTARSGRSALAYRFKHIGFDVTKNELDFLYQEF
LKIADMKKEVNNDDLSSIIEKVTRKIG
>KALACAFP_03231 hypothetical protein
MAELQKDFLFVLIKSLTTSEKRQFKLYVNRLGINVDAKFLLLFSEMDKMKEYDENIILDK
KISTKQQLSNLKAHLYKQILVSLRMNPSHQNYRIQLREQLDFANILYQKGLYKQALKILD
KTKHAALDLDEKSIASEIIDLEKVIESQFITRSIEGRADELINQSTEISKQNHYATELSN
LSLKLYSEMLTHGYVKNDEDRAEIMEIFNAQIQKINFEKLNFTEKLWYFKAHVWKNQLLQ
EYKYTLKYAFQWVDLFHKNPEMIVSHPVWYIKGNTYLLKILFLYGNIDILEDSFKQFNET
VSDSSFTQNENIQSLVFLTHYNTLMNIHFVKGEFFSGTKLIPEIELKMEKLRDKIDDHHF
MILYLKMAAMFFGSKKFKESVQYSRKVIESKGNVQEDLLFHTRILILMAKHESGNDEDYD
EFIKTTLKFARKMKKPDEFHFESITFFKNLNNLTPDKQVEAFKEFDKKLEIFSGNEYYRR
SLLYIDIHGWVKSKVRNVDVIEIIKEKVRYKRKN
>KALACAFP_03232 Threonine--tRNA ligase
MIKITLPDNSVKEFEAGVTPLDVAKSISEGLARNTISAVVNDKQVETTTPITTDSTVQLL
TWNDDLGKKAFWHSSAHLLAQAILEFYPNAKLTIGPAIESGFYYDVDFGDESLSEKDFEK
IEKKVLENAKKASTFSLYPVSKEEALKVYADNPYKVELISNLNDGEITFVTHDDFTDLCR
GGHIPNTSIVKAVKILNAAGAYWRGNEKNPQLTRVYGISFPKQKDLSEYLERLEEAKRRD
HRKLGKELGIFAFSEKVGAGLPLWLPKGTALRRKLENFLSAAQKKGGYEFVMTPHIGAKE
LYVTSGHWDKYGADSFQPIKTPNEGEEFMLKPMNCPHHCEIYKTSQWSYRDLPKRYAEFG
TVYRYEQSGELHGLTRVRGFTQDDAHLFCTPDQLLGEFEAVIDLVLYVFKSLGFEDFVTQ
VSLRDPDNREKYIGSDENWEKAENAIITAAKNKNLTTVIEYGEAAFYGPKLDFMVKDALG
RKWQLGTIQVDYNLPERFDLHYIGNDNEKHRPVMIHRAPFGSMERFIAILLENTAGDFPL
WLSPDQFIILPISEKYVDYAKKVSQFLENHDISGQIDDRNEKTGKKIRDAELNKIPFMLV
VGENEEKDGTISVRRRGEGDLGVMNMEDFVAYFKKEAAI
>KALACAFP_03233 Translation initiation factor IF-3
MINEKIRVREIRLVGDNVEPGVYPIDKARQIAEEQELDLVVISDKAEPFIARILDYKKFL
YEQKKKQKELKAKQVKVVVKEIRFGPQTDEHDYEFKKKHAEKFLEEGSKLKTYVFFKGRS
IIFKDQGEILLLKLAQELEHVGKVDQLPKLEGKRMIMMMSPKKPAK
>KALACAFP_03234 Non-heme chloroperoxidase
MSTLKLKDGTEIYYKDWGTGQPIVFHHGWPLSADDWDAQMIFFVQQGYRVIAHDRRGHGR
SSQTTSGHEMETYAADVAELTEFLDLKDAIHVGHSTGGGEVIRYVNKYGKNRVAKAVLIS
AVPPVMVKSETNPDGVPIEIFNDIRNQTMNNRQQFYIDLTFPFYGYNREGAEIKEGVQRN
WWRQGMMGSILAHYECVKAFSETDFIEDLKAVDVPVLVLHGEDDQIVPYQNAALKSAKLL
KNGKLITYPGFPHGMPTTHADVINKDLLEFFKS
>KALACAFP_03235 50S ribosomal protein L35
MPKLKTKSGAKKRFALTGSGKIKRKNAYKSHILTKKETKQKRNLTTTSYVAKVDEKSVQR
QLAIK
>KALACAFP_03236 50S ribosomal protein L20
MPRSVNAVASRARRKKIFKQAKGFFGRRKNVWTVAKNAVEKAMQYAYRGRKEKKRNFRAL
WITRINAGTREHGMSYSQFMGALKKNNIELNRKVLADLAMNHPEAFKAVVDQVK
>KALACAFP_03237 Aminopeptidase YwaD
MKKLTTLLLFSLATYGFQAQSFIQAYQNRANMVSQTNITTILQEFEILGVKTTGSAANTN
ALNWLKAKYQSYGYTAGQITEDPFTFGGNISSKNLVITKTGTVYPNTYVIICGHYDTING
PGVSDNGSGTSIILEAARILKDIPTEYSIKFIHFSGEEQGLQGSAHYADNVVFQNNVRLL
NVKLVINIDQVGGKIGNTNNAIKCESDQAGLSGNNAQSLTFTQQLATCTTLYSPLQTVMS
NAYSSDYVPFEQNGDIITGFYENVRSYNEHTSNDTFANVDPTYVFNVGKAAVGALQHFAV
ATSVLGTNETVANTLESVRVYPNPAKDILNVELPKDIKNFSLEITDLNGRLVLNKENETK
INVSGLTNGAYLCTIKANDKTAVRKIIIGK
>KALACAFP_03238 Aminopeptidase YwaD
MKKLTTLLLFSLSTLSLNAQNFIQAYQTRANMVTQSNITTNLQQFENLGVKTTGSVANNN
AFNWLKDKYLAFGYSASQITEDPFTYNNKSSKNLIITKTGTVYPNKFVIICGHFDTINGP
GVNDNGSGTSIILEAARILKNVPTEYSIKFIHFSGEEQGLLGSAHYVDNVVYQNNVKQLD
IKLVFNLDQVGGVMGNNNNTIYCDEDQDGLSSNNAASAVITQELRNCTQLYSPLLTDVDP
AEDTDYISFEEKGEVITGFFEKIRSYYPHTANDTFANTDPVYIFNVGKAAVGALQHFAVA
SSSILATEEANVNALESVKIYPNPAKDFLNIELPRDIKDFNFEVTDLLGRVLIKDKNNTH
INVEGLAKGAYIGKLTSKDHVAVRKILIK
>KALACAFP_03239 Phosphoribosyl-AMP cyclohydrolase
MKINFDKSNGLIPVIIQDNNSLQVLMLGYMNEEAFEKTKKEGRVTFFSRSKNRLWTKGEE
SGNFLTVKSMTIDCDQDTLLIKVNPKNVVCHTGSFSCFGEKNCKGFLYELEEKISQRIDE
ETENSYTYSLYQKGINKIAQKVGEEAVELVIEAKDNNNDLFKNEAADLLFHFLILLKSKN
MTLENIEEVLMSRDRKAC
>KALACAFP_03240 Imidazole glycerol phosphate synthase subunit HisF
MLKKRIIPCLDIKDGTTVKGINFKGLRNAGNPIDLAKQYESDGADELIFLDITATIEKRK
TFVELVKNIAKELSIPFTVGGGISTVEDVRKLLQAGADKISINSSAVKNPNLISQLAKEF
GNQCIVVAIDTKFSNNSDWVYIKGGREKTELNTLEWAKKAEELGAGELLLTSMDGDGTKK
GFDIRITKSISENVNIPVIASGGAGNTGDFENIFNETKATGALAASIFHFGEIKILDLKR
ELKSKNLAIR
>KALACAFP_03241 1-(5-phosphoribosyl)-5-[(5-phosphoribosylamino)methylideneamino] imidazole-4-carboxamide isomerase
MKIIPAIDIIDGKCVRLTKGDYHTKKIYNQNPVEVAKEFESFGIQFLHLVDLDGAKSRNI
VNQKVLENIARETSLQVDFGGGLKSLQDIEIAFNSGARQITIGSIAVQDPEFCFDLIEKY
GSEKIILGADCYDRKIKTSGWLEESNEDVIDFILQYHKKGVKNVICTDISKDGMLEGPSI
DLYKDILNQTSVKLTASGGISKMEDVYRMKEIGCSGTIIGKAIYEGRINLKEIQKFITNA
>KALACAFP_03242 Imidazole glycerol phosphate synthase subunit HisH
MIAIIKYNGGNVNSVQNALDRLQTESVITDDFEIVQKADKVIFPGVGEASSTMKNLNKKG
LNDLIPTLTQPVLGICLGMQLMCKNNEEGNTTGMGIFDINIKKFPRENLVPHMGWNTISG
FKSSVFSGVEEKSDVYFVHSFYCELSEYTTSVCDYILPFSASLQKDNFFAMQFHPEKSGR
IGNELLKNFLKL
>KALACAFP_03243 Histidine biosynthesis bifunctional protein HisB
MKKVLFIDRDGTLIIEPTTNFQVDSLEKLEFYPGVFQNLSKIAKELDFELVMVTNQDGLG
TESFPFEDFIKPHEKMLEAFENEGIFFSEILIDRSFEHEKLPTRKPGTGMLGKYIYGNYD
LENSFVIGDRSTDIQLAKNLGTKAIFINNIHNENADLTTQDWSEIYSYLKQIPRKSKIVR
KTNETEVEIEINLDGNGNSEISTGLHFFDHMLEQISKHGNLDLKIKVKGDLQVDEHHTIE
DTGIVLGEAILKALGSKKGIERYGFLLPMDDCLSQVAVDFGGRPWLVWNVDFNREKIGDV
PTEMFYHFFKSFTDSAKCNVNIKAEGKNEHHKIESVFKAFAKTIKMAVKQTDQNFNLPST
KGRL
>KALACAFP_03244 Histidinol-phosphate aminotransferase
MKEFNINQLVRKNILELQPYISFRDHNEFEKPVLLDANESPFGEFNRYPDSTQKKIKQKL
SELKNISPDQIAVGNGSDELIDLIIKVFCEPKKDSILMMNPSFAMYGFYASVNENRVIKL
DLNENFEMIKDEFLKTIKQGQLKIFFLCSPNNPTGNSVDDIEFYVKNFNGIIVIDEAYIE
FSGRKSSIKLLEKYPNLIVLQTFSKAWGMAGARVGVAYASKEIIKLINTVKAPYNVNSLS
LDLLLKNIDNQEILNQNLENTLIEKSWLKNELQKIKYINKVYPSDANFFLIEFKNVEKVY
QKLLEKEILTSKRTPQIPDCIRINVGNREENIQLVTVLKEMES
>KALACAFP_03245 Histidinol dehydrogenase
MQISKYPQKNEWSELIKRPILKREKLSEIIVDIFNQVEKKGEQALLEFNKKFDGAEVKNI
RVSKEEIENAEQLLSRELKNAIHQAKENITQFHTSQITDIKKIETSDNVICWRENRAIEK
VGIYIPGGTAPLFSTVLMLAIPAQLAGCKEIILCSPSDKNGNINPAILYTAQLCGVSKIF
KVGGAQAIAAMTLGTENIPNVYKIFGPGNQYVVAAKEYAQTYNVAIDMPAGPSEVLVIAD
EQAIPEFCAADLLSQAEHGNDSQVIFISTDVKIFNETIKETEKQIKELPRNDFARQSLKN
SHFLLLNSIDEALEFSNLYAPEHLILAIENFEKYIPEIQNAGSVFLGNYSCESAGDYASG
TNHTLPTNGFAKNYSGVSLDSFVKKITFQHLSEKGLQNLGKTIEIMAEAEGLFAHKNAVS
IRLKQEK
>KALACAFP_03246 ATP phosphoribosyltransferase
MLRLNQNKMSKLKIAIQKSGRLYEESLQLLKDCGIFINNGKDQLKVSVDNFPMEIMYLRN
SDIPQYLEDGVVDIAIVGENILVEKQKDIKIIQKLGFSNCRVSLAIPKDVETDSLAYFQG
KKIATSYPNTLKNFLQNNQISADIHVISGSVEIAPNIGLADGICDIVSSGSTLFKNGLKE
TVTLLKSEAVLAKSSKLFKEKELILDKFLFRIKAVLKAKNSKYILMNVPDNKIQEVSDVL
PVLKSPTVIPLAEEGWSSIHSVIDEERFWEVIDELKDKGAQDILIIPIDKMVI
>KALACAFP_03247 D-inositol 3-phosphate glycosyltransferase
MKIAFDAKRFFHNTSGLGNYSRDLVRILAKYFPENDYILLNKNKSERGADILENTNVQFV
ETSKGTMSRQFKMGKDAQKQNADIFHGLSGELPLKWDKKPIKKIVTIHDLIFVRYPQYYS
FFDRKIHLWKFKKAANSADKIIAISEQTKRDIIQFLKVPESKIEVIYQGCHKAFKEQQSE
EFIEQIIKKFNLPERYILNVGTIEERKNLLNLVKALKDTQIPLVVVGKKTKYFQKIANFI
QKNKLEKQIHFLEGVSMDELAVIYKLADIFVYPSFFEGFGIPVIEALFSKTVTITSNTSC
LPEAGGPDSVYVDPQNYLDIQSKIQFLWNNESERKRRADKGFDFVQKFNDEPIANELMNL
YRKIIS
>KALACAFP_03248 Peptidoglycan-N-acetylmuramic acid deacetylase PdaA
MVLLSFDIEEFDMPLEYKGEIPFEKQISLSQTGLERILDILKKHSVKATFFSTVVFAENS
KNLIGRLLNEGHELASHTWFHSDFEEKHLKESKDRLEELFSTKVTGLRMPRMMPVSKNAV
ENAGYSYNSSINPTFLPGRYNNLKISRTYFKEGKVTQIPASVSPNFRIPLFWLSFHNFPL
SFYKKLASDTLKKDNYLNIYFHPWEFAEIKDETFKLPGFTVKNTGKDMINRFDEFVSWLK
SENYSFGTFQEFQKQIES
>KALACAFP_03249 putative glycosyltransferase
MKKISIVIPAHNEEGNVALVHEKIKEVFSGLHDYDFEIIFVNDGSRDSTQQKLEELSAQY
DEVKFIEFSRNFGHQPAVKAGLDHAHGNAVISMDGDLQHPPELIPHMIKKWEEGYDVVYT
IRTYPKQISYFKRKTSDFFYKMLSSLSDVDLTKGGGSDFRLLDANAVEVMRSFTEDDLFL
RGLTSWMGFRQTGIEFTANERIAGESSYNLKKMVTFAFTGITAFSVKPLYIAAYLGFLFS
ALSVVGYVGYVIYSFVVETEISGWASLIMTIVFFGGLQLIIMGIMGIYLGKIFKQVKERP
NYIIKNKNF
>KALACAFP_03250 hypothetical protein
MKEKFLKILLNPKYIFGVYLIISVVTAISKYFRGDYAINNYLIFKSVFFNTVNQKNLFIH
YPDLFFDLNHYGVFFSALIAPFAVMPDWLGISLWNLANTFIFVYGIYKLPFSDSKKAIFG
ILCLQEYITAALSLQFNVALTGLLLLSAVYIYERKEVKSVTAILVGVFVKIYGIVGLTQF
FFIKNKAKFILSGLIIAVLFFVLPMAYSSPKFVIQCYSDWFQSIVEKNNENQVLGNMQDI
SLMGFFRRILGDASISNLVFLAFGLPFFALPYIRIKQYQHYAFQLMILASSLLFLVLFSS
SSESPTYIIAVVGVLVWFFLQKERTPFVIGLLIFVIIFTCFSTSDLFPKFVKENYIKKYS
LKAVPCIVVWLRVTYELLTKDFEKNYSLNK
>KALACAFP_03251 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase
MSLQQTIENIWDNRDLLQNEDSQKAIREVISLLDSGELRVAEPTENGWQVNEWVKKAVVM
YFPIQKMETIEVGPFEFHDKIPLKRNYAEKGVRVVPHAIAREGSFVASGVIMMPSYVNIG
AYVDSGTMVDTWATVGSCAQIGKNVHLSGGVGIGGVLEPLQAAPVIIEDDCFIGSRCIVV
EGVHVEKEAVLGANVVLTASTKIIDVTGPEPIEIKGRVPARSVVIPGSYTKQYPAGEYQV
PCALIIGQRKESTDKKTSLNDALRENNVAV
>KALACAFP_03252 Murein DD-endopeptidase MepS/Murein LD-carboxypeptidase
MKTEIFGKPYSMKQLSVLLIASSLIISCGSSKSVATKKNTNTKTITKSENLRNLDSKFDG
TVSKSINEILKDAEKYIGTPYKFGGNTSSGFDCSGFTVKVFEENDFKLPRRSSDQAEAGE
KIDIKEVKPGDLLFFATAGGSRVSHVGIVHDIGNDGEVKFIHASTSKGVIISSLNEKYWN
KAYLHAQRVL
>KALACAFP_03253 hypothetical protein
MATYESLIKIKGAVGDLVFYELNGKNVVRKKSGFNKTAFKKSPTYEKVRQNSSEFGHCSK
VGKMIRQALVPYIKKAGDPLLYQKFAKVMTEIKDLDTVSERGKRTVKNGLSTEKGKEILK
NFQFGNYSHIGNEASISSDLWEVKLNLNKEIQADEVSLVMLKIDFDNYLTESFEDKKAWN
KEEISFQKHYSDDDFVLYFIAIYNEKKIVRMGFL
>KALACAFP_03254 hypothetical protein
MKKLFLLLLTAFLFIGCSKDEDTIYDFIGTWSGTYEGSDKGDWNIVVATDGKVTGTMHSD
QTNENYYISGHLTESGDLAASIGSPADGEFKGSLTREKTGSGGWTNSVPTPAIAGTWKGE
KNSK
>KALACAFP_03255 hypothetical protein
MELVSKIIYWASYAYYLYVFGYASLFKVFQKESMMKSMQSLGFNKTWTMLIGAGELIGVI
LIVIGLFKPQFRNLGVLFLFPFAIGAFTTHMAHGEYNHYYNSLIMCILSVVLLFLDNKFK
IIIQ
>KALACAFP_03256 putative HTH-type transcriptional regulator YybR
METRKENSTNNINLTYLNNFCGISYTLAMIGGRWKINILAYLLKDQKLRFGELKNKLEGI
SERMLIKSLKELENNGLINKIIYQQYPRKVEYELTELGHSLNEIIKSMDEWGESRYDKNI
KPQHISRDLG
>KALACAFP_03258 hypothetical protein
MKTNFLSPMTLALIVCGFFQSTAQIGINTSNPQASLDVLSKGNTGATKAMRINNSGNTEI
VTVTDAGRVGIGTSAPQHTLHSIGTLRFEGVNAGQASGMVLTSNDNLGTATWQRAASNVV
TGTLGGGYNLPFAQTSTMSYTGSSITLPPGKWMLTISLLLIPSGTLGANDWMFVRSTFSE
QNLTTIGDVGVQSPDVIRPTLMSFQVVGPYTGGQKYNVATGTIQINNTSGTTKTYRYIVG
ATQASGTVAGAQLSGVGGSWSENAIYAIATN
>KALACAFP_03259 Solvent efflux pump outer membrane protein SrpC
MKSLLNIIKGITFSVAILALVSSCMARKEYQRPNNVVDEKLFRTDMLPSDSTNIANVSWK
EIFTDPILQGHISKALENNLDIRIALQSITSAEAYLKQSKAAYEPTVTVGPGYTFQTQSL
NTQTGQLFGQRRYINQLDITASVAFEADIWGKLKAQEKAQLATYLGTVAAHKAVKSDLVA
SIASAYYQLLTFDEQKKIITETIKVREQNLETTKALKTAGTLTEVAVQQSEALVYNAKSL
LIDIDTQIQLLENTMSLLMGEPSHSIERSTLESQNVPSDLKLGYPAQLLANRPDVMRAEY
NLMNAFELTNAAKAQFYPTLRITGSGGLQSMDIDHLFSVNSLFASVVGGLAQPILNRRTI
KTNYEVSLANQETAYLNFRKTVLTAGKEVSDAIRVFSVQDQYIDLKQKELMNYKNSVDYS
QELVNYGMANYLEVLNASVNSLNAELNIANAQYSKMKAAVELYQALGGGWK
>KALACAFP_03260 Efflux pump membrane transporter BepE
MIKNFINRPVLSTVISILIVILGVLGLISLPVTQYPDIAPPTVSVSTNYTGANAETVMKS
VVVPLEEQINGVEGMDYITSSAGNDGSAQIQVFFKQGIDPDIAAVNVQNRVARATPLLPA
EVTRSGVVTQKQQTSALMYMSFYSENKDLDDVYLQNFLNINIIPNLKRINGVGDANVFGG
KNYSMRVWLDPAKMAAYGVTPTDVTNAINEQSREAAAGSIGQNSGSSFEYIIKYVGKFND
KGQYDNIIIKSLGDGQNLMLKDVAKVELAGQSYTGIGENGNNPSISMGIFQTPGSNAQEI
IKNIKEYLKSAEGSFPQGIKYTFNFDTNEFLEASIEKVVHTLIEAFILVFIVVYIFLQDF
RSTLIPAIAVPVSIVGAFFFLNLFGYSLNLLTLFALVLAIGIVVDDAIVVVEAVHAKMEH
GISDAKKATVEAMDEITGAIISITLVMASVFIPVTFITGPTGVFYQQFGITLIVAIIISA
VNALTLSPVLCSLFLKPHDAHHKEYKNLNFLQKFFYKFNIAFKTTTDRYGRGFVFLLRHK
WVTLVIFAITGAILYWASTSMKKGFVPTEDRGIIFTDVQLPPGASMERTYNALKTLQANA
LKVPGVQNVTISTGRGFLSGNGSNNGLAFVKLKPFDERKKDGQTSEDITKKLFGISGKVP
DAKIVFFQPPSVPGFGNSAGFEMVLLDKSGGEYADLDAKTNEFIAKLMERPEIEFAQTSF
NTKYPQYEMQINVPLAKQLGVSVSDILSTMQGYIGGIYTADFTKYGKQFRVMVQALPENR
QNIDNLNELYVKTGSGIMSPISQFVTLKKAYGPQSVSRYNLFTSVKITGSNSAGFSSGDA
ITAVQAVAKETLNQNYDVEFTGLTREELNSGSQTVLIFALSLVFVYFILSAQYESYILPL
IVVISLPLGVMGAYFGQKIMGLENNIYFQIALIMLVGLLAKNAILIVEFAVQRRHHGESI
VMAAINAAKARLRPILMTSFAFIFGLLPLVLASGIGAVGNRSIATGAAIGLLIGTILGLF
VIPVLFVIFEYLQEKVKPLKKEEINLAE
>KALACAFP_03261 Efflux pump periplasmic linker BepF
MNNKLVILSIAALSLTACKKEAPKQDGPKPYPVVQVESKNIVGYQTFPATIQGRVNNDVR
AKIQGYITQVLVDEGQYVTKGQPLFRLETNILNENAAASKAGIGAAESNIAAAQAAVNAA
NVEVNKLKPLVQKNIISNVQLQTAQANLAQAQAQLQQARAAKSQAVANYKGVEANIEYSI
IRAPISGVIGKLPLKVGSLVGPTDQTPLTTISDTSQIYAYFSMNEKEYFDFLEKSPGMSM
PDKIKNLPMVELQLANGSLYPEKGKIEAITGQIDPTTGTIQFRVGFTNAQKLLSNGNSGT
IRFPQYYDNVLVVPESATYEQQGIVYVYKVEKDTAKNVVINVIDRIDNMALIKSGVNKGE
VIVAAGIGGLKPGTAVIKKPVKMDSLVQSIKPKF
>KALACAFP_03262 hypothetical protein
MHKSIEIDEKIFQDAVKFYGTVFSLPPLASKIYAYLLFDYDKVGITFDEFVEVLSASKSS
VSTSISLLLNAELIVDHNKMDERKRYFFINEEYKKIRFEKIVQKMQDELKLLDDLDNFKK
NHDDGYNERIEAYKALLNKNIKNIQESLNKL
>KALACAFP_03263 hypothetical protein
MNSEIKLRKAEIEDRDIIWNILQQAIERRRKDGSTQWQQGYPNLDTVESDIAKGFGYVMT
VDGEIAVYAALILNDEPAYSTIEGAWLSNGEFVVVHRVAVDEKFAGQGMVKKLFDHIEEF
TKSHGIQSVKVDTNYDNIAMLKILESKGYSYCGEVFLAGGMRKAFEKIII
>KALACAFP_03264 hypothetical protein
MERSTRVSVFESDKPSEIQLIKSKLEDAQITNSVENNYLTFTTTPTATSLKVMVDLEDEK
KAFEIIDAYLQQNENQ
>KALACAFP_03265 putative L-lysine-epsilon aminotransferase
MTGLLIQSPLRFLFNMEQTIDIQANKVKETVGRHVLADGFDFVMDIEKSHGSWLYDKLTN
KEYLDMFSMFASASVGYNHPYIVEKSAWLGKMAVNKPTLADVYSEEYAHFLEVFERVVIP
EELQYAFFIEGGTLGVENAMKACFDWKTRKNFEKGLNIEAGICIHFRQAFHGRSGYTLSL
TNTADPRKYQYFPMFDWPRIINPKLTFPITEENLEETIKNEKLALLHIEESILMHPDKVA
CIIIEPIQAEGGDNHFRDEFFVELRKLCDQNEVLLIFDEVQTGIGITGKMWAFQHFTAKP
DIISFGKKAQVCGVLANKEKFDEVPDNVFRESSRINSTFGGNFIDMLRFQLIMEVIEKEN
LVENARVVGDYLLEGLKKLAEKYPEKLLNARGRGLMCAIDLPTHEERNALRDELWNDGMI
ILACGDLSLRFRPHLNVTKEEIQLALDKIENNINKI
>KALACAFP_03266 Succinate-semialdehyde dehydrogenase [NADP(+)]
MSKKVKDFGIEKTLKNLGIKDENKGTSVGGKYFASGKTIESYSPVDGNLIAKIKTSGESD
YDKVIETAEKAFKEFRMIPAPKRGEIVRQLGQKLREYKDDLGKLVSYEMGKSLQEGLGEV
QEMIDICDFAVGVSRQLHGYTMHSERPGHRMYEQYHPLGIVGIITAFNFPVAVWSWNTAL
AWICGNVTIWKPSEKTPLCAIACQNIMAEVLKENNLPEGISSVLVADHEIGQKLVDDKRV
SLVSFTGSTRVGRMVSTNVAQRFGKSILELGGNNAIIISQDADIDMSIIGAVFGAVGTAG
QRCTSTRRLIIHESVYDEVKKRLVKAYGQLKIGNPLDETNHVGPLIDTDAVNQYQESIKK
CKKEGGKFIVEGEVLKGKGYESGCYVKPCIAEVKNSYEIVQHETFAPILYLIKYKTLEEA
IAIQNDVPQGLSSAIMTQNLREAELFLSQAGSDCGIANVNIGTSGAEIGGAFGGEKETGG
GRESGSDVWKYYMRRQTNTINYTTQLPLAQGIKFDL
>KALACAFP_03267 hypothetical protein
MKSEKTQNSPENKGKKSFVIRIDESTYKLLEKWANDEFRSVNGQIEYLLHQSLVNSGRKK
KE
>KALACAFP_03268 hypothetical protein
MEKVLKPMSGYLTLVICLGLFAASIYLFVIGVDNNITFVVIALLAFILSCFFLKGLMIIQ
PNHSRVLNFFGKYVGTVKDNGLFFINPLYSSQKISLRSENLQGQTLKVNDKMGNPIEIAV
VIVWKVGDTYKAAFDVERYSDFVKMQSEAAVRHLAMSFPYDNLEDDHAPITLREGGDKIN
AILEQELTDRLSKAGITIQEARISHLAYASEIAGAMLQRQQATAIVAARTKIVEGAVGMV
DLALKKLSEENIVELDDERKAAMVSNLMVVLCGEKAAQPILNAGTLYN
>KALACAFP_03269 Cytochrome c biogenesis protein CcsA
MKKLQDILISTRTMAVLLLVYAFAMAYATFLENDYGTPTAKALIYEAKWFELIMFLLILN
FIGNIGRYRLWRREKWPVLVFHLAFILIFIGGAITRYISFEGTMHIREGETSNEIVTDKN
FFKIQIEEKGDVLNYQDVPYLMSPLHKDFSATYDFHGKEVKVFAKEYVQRKKDSLIADPN
GAEYLHLVSTGQTGRQNIYIKPGETKSVNGTLVTFNRAIEGAVEFKNEGGKLFIKTPVDA
SYMTMATQATGNTVKDEFQPLALRSLYSINELKLVVPEGLKKGKLMAFEGDRKKDANVPD
MLTVEIQGPKTKQLVDLSVEKGNPNAYKQVTMDGLNIMVGFGPKIYNTPFALKLDDFVME
TYPGSSSPSAYESHVKIVDEGKETPYKIYMNHVLNHKGYRFFQSSFDPDRMGTVLSVNHD
FWGTLISYIGYTFLFLGMFVMFFWKGTHFWKLNKILADVNKKRGAAVLLLFLSLGLQAQK
IETHGTTDGSREHIHVEGEAHNHAPAPESAQVQQAPQQNSLAAPLSKMRSISADEIIARN
KISKEHADKFGYLLVQNFEGRIVPINTEALDVLRKLYKKDEFKGTDGKSLTANQWFLSIN
TDTPSWTMVPMIKIGSKGGDELKNKTKANDEGYTSLMNLFPADANGNLTYILEHDYNTAF
RKKPAEQTNYDKEVISVNERVQIFNEFFSGQFMRIVPVKNDANHTWHSWLDQKFEPDMES
QQVMGPYFAEVLQAQKTGDWSKADAELAKLSAYQQKWGKAVVPSKSKVDLEVFMNEVNLN
FKLLIFYTLIGGLLLILGFVELFKPNKVLNKIIKAIIYLGVAGYILHFLGLVARWYISGH
APWSNGYEAIIFISWVGITAGLILYRNSNALIPAAGFMVAVIMMGFAHGGSALDPQITPL
VPVLKSYWLIVHVAIITSSYGFFALSMIIAVISLVFYIISNKETYKIHHDTTLKELSIVS
EMSLTIGLFALTVGNFLGGIWANESWGRYWSWDPKETWAFISIMVYAFVLHMRLVPGLRS
RWAFHVATMFAFCSMVMTYFGVNYYLSGLHSYAAGDPVPVPAWVYIGLGTMALLSAVSYF
KFKALNKK
>KALACAFP_03270 hypothetical protein
MNDLLYKNISRHIQLSEEEFQRFSKPFQLKNFKKKEVVLQEGEYCSFEGFVLNGCFKVYF
LNEDGSEQTLYFAVEGWWITDLDSLINNVPSTLNIEALEDSEVLMISKKEKEDLYEAMPK
IEKLFRIMNQQSSIALQRRILSLMNKTADKRYHEFLEKYPTLEQRLTQQQVASYLGISHE
FLSKIRKKIALGK
>KALACAFP_03271 Streptothricin hydrolase
MKNVFKSTLIICLTLISLFINAQKRKNMENTALLIIDVQNDYFKGGNMPLVGAEEAGKNT
QKVLEYFRKNNLPVINIKHIATNDGATFFLPDTKGAEINSLVEPKNGEKVMVKHYPNSFR
ETELLAYLQSKQIKNLVITGMMTDVCVESTTRAAFDLGFTNTIIGDATATRDREVNGQVV
KAAEVQRSFLAGISALGNLYAQIVNTNDFLNGK
>KALACAFP_03272 DNA translocase SpoIIIE
MDKNTQNKQQDSPEKGKILSKPRIFFGLTFILFSVVLTFSFVSYLMNWKADQSQAGTMLD
KSIKSSNLFGKLGDWLGNIFIFESIGVASFIIAFLFLVFGTIILKKKIFKPWKTVGHSLF
FICWLPIFMGAITKGQGVLGGVYGYQIMDSLNAIIGTVGLWLVLAASVALYFILEFNLRP
SSIKSKLNDINENTIGRVKSMMPSSDENFEADEELIEEAANAEENPSKITVTEVVEKPTV
KMTEPEHVSIPKGFPEVPVSTNLDPIVTPNQTSFEEENKDDFSQSLNINLNTKPSIPTSS
PEQAFDIKPSNNAQENIKFNVEVAPVVDVLDDTEKKSQELIEKHGLYDHKLDLAKFQMPT
VDLLKDYGSEEISINKEELEENKNKIVGLLKNFNVGIAEIKATIGPTVTLYEIVPEAGIR
VAAIKKLQDDIALNLSALGIRIIAPMPGKGTIGIEVPRKNPTMVSMRSVIASQKFQNTDM
DLPVVFGKTISNEIFMADLSKMPHLLMAGATGQGKSVGINAILTSLLYKKHPSELKFVMV
DPKKVELSLYSKIERHYLAKLPDAEEAIITDTNKVINTLNSLCIEMDTRYDLLKNAFCKN
LKEYNKKFTERKLNPENGHRYLPYIVLVVDEFADLIMTAGKEVELPIARLAQLARAVGIH
LIVATQRPSVNVITGMIKANFPARAAFRVISSVDSRTILDSPGADQLIGKGDMLYFNGNE
ILRLQCAFVDTPEVERLAEFIGEQKGYSSAFLLPEYVSEDATSTVGTFDPNEKDALFEEA
ARIIVSTQQGSTSMLQRQLKLGYNRAGRIMDQLEASGIVGGFNGAKAREVLISDLHSLEQ
FLEDLRK
>KALACAFP_03273 hypothetical protein
MKNIISKVIVSGLVVGAVGITNAQKIDAKAKKILDDITANYNSKKNSYFKFSFGSGTNGQ
VSKTEPGIYYAAGDKYKLKIMETEQIFDGNKIYNINTEDMEVTVAKPNGSGSMFSPINYL
SSYRNDYNVTYNGKKNVNGVNADFIKLVPVKSNGIKYVYIFVDSVKKQMVKLEQHGNNKD
VAVIAIKEYKENQDLDPNMFVFDKNKFKNYLITEL
>KALACAFP_03274 hypothetical protein
MLKILDRYIIKTFFGPFFFIFSVLFFIFIVNIIWVQLGQFMGKGLSYWQILKLLFYLGVS
VISMVLPLTILLASIMSFGEFGERYELAAMKAAGISLTRVMLPLLGVTAVLSIMLYFFSN
NIIPDFQRKAKNMLFNIAQTKPALNFTPGQFIDQIPGYMVKFDRIHGENGENIDGVFVHK
KATTYENQQSIVAEKGKFIPAANKNYLKLVLYNGYVYEDNFAGKADNVRLKQPDQAIKFD
TLVSHFDVSEIINKAIEEEKITDDYRFQTFNELNKTIDKTKKDNDKFFSNVNNDVLSQTN
AVVSYMDAAQNRAKTKPKQQIKLDTVKGDKKLEIINNAYNRLDNLRSTVDAKNNELDPGI
KYYGKVVIYQQRIVTYSFTCIIFFLIGASLGSIIRKGGMGLPVIIAIVIFIIFYVINVGT
ENMAWSGKINPYLAAWIPNIVLFPFGVWMTYKALTDSQLFDAEKYKALFKPITRLLVKTK
EHKRYQ
>KALACAFP_03275 hypothetical protein
MKNTILILSLISIISCKKQEVKDAQNTSNDSLTTQKVSGDVKDTTGKTIDDIKKEYSETS
ALLASKKLDSTHFNYVCEDGMSGDVIFYYQDKNLKAVKNIYSEYSHFSSVTEYYVDKENV
YFILKQDTSWNFDINAPKKADGNAETKDDITESRIYLANSKPIQCLEKKYSIRSAGNNPD
PNKIENKEVKCDISKLMTTYESIIKNKDKKGKVNQCL
>KALACAFP_03276 Ribosome-recycling factor
MEELDLIVESVKEDMEAALKHLDHAFQRIRAGRASTNMVQDVMVEYYGALTPINQVANVS
IPDAMTISIQPWDSKAINDIEKAIINSNLGFAPSNNGINIILNVPPLTEERRRELAKQAK
GETEDTKIVVRNARQNGLKELKKLEGVSEDVIKGVEADIQVLTDKYVKLCEEHLKVKEAE
IMKV
>KALACAFP_03277 Uridylate kinase
MKYKRILLKLSGEALMGNRQYGIDNERLQEYAAEIKKVVDKGCEVAIVIGGGNIFRGVAG
AAKGMDRVQGDYMGMLATVINGMALQGALEDAGIRTRLQSAIEMDKVAEPFIKRRAVRHL
EKGRVVIFGAGTGNPYFTTDTAATLRAIEIGADVILKGTRVDGIYDSDPEKNADAVKYNS
LSFDEVYAKNLKVMDMTAFTLSHENKLPIIVFDMNKEGNLEKIVDGENVGTLVDL
>KALACAFP_03278 hypothetical protein
MKKIVIFSLFLSGIVSYAQTGTNVYPFLNIPVSARQAALGGDAISIRDRDVSFAIANPSL
LNKDSDNQLSVNATAYLADSKYGTIAYAKDFDNGHMATINARYMSYGDIPRTDESGFENG
TFNASDVAIGAGYAYQFEEDWTIGGGINFITSKIDNYTSSAISGNAGVTYHNKKNKETAS
LVFRNFGYQFKSFNGTRENLPFRVDLGYTRILKAIPLAITITAHDLQEFNISSQYNVNGQ
EVNVGRKIADHFSVGAELFPEKGFNIRLGYNVKRGNELAVADQRNFSGLSAGFGIKIARF
RIDYAHVRYHNSTNVNQIGVSIDLTSHAGY
>KALACAFP_03279 Cytidylate kinase
MKKPVIAIDGYSSTGKSSISKVIAEKLGLIHLDTGALYRGVTWFALQNCLNEDGSINLDH
LFSSFDQIELEFKNDHGELILFLNHIDISKAIRTNEVSDNVSFVAKQKEVRDFLLHSQRS
LAEKGGIIMDGRDIGTVVLPNADYKFFLTASIDERTKRRYNELISLGIEADEQQVKENLI
ERDKIDSEREIAPLKQAEDAIVIDNTHLTKQETIESILSHIQNI
>KALACAFP_03280 hypothetical protein
MSRKNNTAGILAGLLAGAAAGVILGMLYAPEEGKETRKKIKNKANDLKDQAKNKYGEVSE
KVKDQYSNISSTFKETASSVAHTVKDGYDKYKDQIVSKTADVVKNVESELNDLKK
>KALACAFP_03281 hypothetical protein
MIETIKEYASKRIDLLKIEATEKSSLSAGMITYFVVLLVAFGFFIILFNFGIAFLIGRAL
GDHSYGFLIVAAFYLLIMILVVIFKKRIVNYVADQVIKFLNH
>KALACAFP_03282 hypothetical protein
MGRKYESLEELRRKKKLLKEEIDGLEDLLTFKNTKESLSAFTNGLTDQYLQEKVDDDGEE
KVVLRKDVIAKQITTEIKDAFINKNTAMGIANSAFKGNAMDALIKLGVTAIVGNYAKKNM
SSSNWKKKVLGAALIYLAPIALKFIRKKLENYQKNKSVSSMEQLI
>KALACAFP_03283 23S rRNA (guanosine-2'-O-)-methyltransferase RlmB
MFLVEGNKIICELYNSNFKIKEIFSTDPQKLGRSDVPVTHISENELKKISFLQHPKDSVA
VCHINTEKKSEDKNIQLILDGIQDPGNLGTIIRLADWFGIEQIICSEDTVDFYNPKVIQA
TMGSFTRVNIVYTNLVEYLSKTENVNIGTDMEGENIYTFQKPEKINLILGNEGNGMRPET
EELLQKSIMIPRFGKSQSTESLNVSMAAGIILGQLFRV
>KALACAFP_03284 Outer membrane protein assembly factor BamA
MSCKHYKNSPQKYYKIISFATFVGFLYACSTTKKVPDGEYLLVKNNFEFEDKKEPFDSEL
KGYVQQKPNKRQFLFMPLSLWLYNAANPKYDTLLNEYMTYPNELRDQKLRDSLFIKYNMK
SSVGKSLFFDRLYHSWGSAPVILDQTKTEKGAESIEKRLTYRGYWDAEVKFKHDLDSAAK
KAAVTYFITHKDPTYIKEYYYNITDPKVKNIYQQKLHESLVRQGQILDQTVLEKEVTRIN
DLMRDYGYYKFNSLGDEIYFVADSLKSRKQVPLTLEIHKDSLDTPYKMATIGNIDVAIVD
EMNDYPKNTTKDSLRGIRFHKVNNQYKDRAIWRAITVGPKQVYDQKKLDLTKRNILSMNN
FSILKARDSLRHGGGTIPNDSIVDVMYILKPLPKYELKVGTDINYSQVLNLGISPSVDLT
TRNIFGGAENLSTSLSGTFGSIRSTKDISKRVLAYELSAQASLNFPRLLLPFDYYKLLPK
RYSPTSSIVLGASVQNNIGLGRVNFNTGLNYLATVNDKVSHRLTIFNTQLSLTKNKDAYY
DYFVNDNEIRQEIFDNYFLVRPNIAQQFSSGQLTIDQVSQRITEDLDYQQGLDQAGIDRY
TAFIGTLVNKDRQTQDVLISSLIYNFVYNEIGKKDYPNAFYFNGKVELAGNIFSIFNQKR
NDGGIVTSPERTIFGIPYAQFVKFDFDVRKYFKFSKNTLVLRQFVGVGIPYGNSSNMPVI
RSYFNGGSNDIRAWVAFGGLGPADSQVDERVRTYMTDNLKLTTNIEFRVPFNDMYEGALF
TDIGNTWSLKNYNDGYGDEFKFNKFLSQVGVGSGFGLRVNVAYITLRLDLAYKMYDPNKP
EGDRWRLKYFQPFKPTLNIAFGYPF
>KALACAFP_03285 hypothetical protein
MRIVKNIFNLTFISVEIGILLICLANAWVFALTDGRTYTKISKIPPREVALVLGTSPKMR
SGQSNPYFTKRMDATALLYHHGKIKKIIVSGEKSKGYDEPAAMKNYLIYQEGVPEDIIIE
DPRGFNTYKSILRCKDVYKKDNVIIVSQGFHNLRALLFARNNNMNALGFDAQDVMKPESY
YRNQFREILARTVAVVYFALGISPD
>KALACAFP_03286 1,2-phenylacetyl-CoA epoxidase, subunit E
MEQQIYKGKLTQFHWLKITKKEELTKNTFSLEFEIPENLKENFKFDAGQFVSVKFQSNGV
DVINDYSMTSAPYEQKIALGIKVNSPDGPTSHLIKNYNIGDHLLVSEPSGRFTIVSKPSE
FRTIVGFAAGIGITPILSHFKNILYNEPRTRLFLFYGNKTYEDLIYREELDNLARNCGER
LQIFYFFSQEKTSNSFFHGRLDDKKLGLIINQILHLDDTDEESTIWDAVDEVLICGKGEM
IKTLANACYHHGIPKKNIHFELFEEYNDDIYPIEKEFPLIENIEVEFKMLGKEYRTELPD
NKEKLLQQLLIQNFSVPYSCKSGICGSCECILEEGEVELLENEYLTEREERKHHILACMS
IPKSKKIKLNFDLS
>KALACAFP_03287 Thioredoxin
MKKIILSTLVVFTLASCKKENQKIEENTAASDSISTPAPIAAALKMVTPQQASEFLNKKN
DTLYVTNFFATWCGPCVREIPHFKNKIQELNGKPVKITFVSLDQKEVWNSEVPRFVDEQG
IRNQTVLLDGQLLDGNFFKNNFKQWDGGAIPFTFMRKGDKTDETLGMISEEQLNEKINAL
LQ
>KALACAFP_03288 Hemin transport system permease protein HmuU
MLFYNRLQTIIMSKKFKILCLLLLIAIILTAVFNLNTGFLNLHLQDFFTESSNSQIAEIR
INRVLVMLLAGISIPTSGFLMQEYFQNPLAGPDILGITSVASLSVAFYIFFSYNITLPDL
LQNSFLSFAAIGGSFLLMLVLLSMSNKFQDKSYLIIFGFLVSAFAGAIVSLLQFYAENQS
LKNYILWSFGANNMVSRNQIYVLTILVLTGSFICFKTIKPLIGNSLGNSYAQSLGVNLNR
LKFLIIAASSLLSASITAFLGPILFIGIIVPHFCRLIYNPAKLWQQWILNMFLGMLIMLL
FSIVAEKTQVPLNVISSIFGIPVILMMLLKQNKV
>KALACAFP_03289 hypothetical protein
MTENELSKIVFETGLKIHKKLGAGLFEYVYEECLFYELTKVGLLVEKQKLLPIVYEELKI
ENAFRLDMIVENKLILEIKTVEYINSIHKAQLLTYLKMTNCKLGLLLNFQSDVFKNGVTR
IVNFL
>KALACAFP_03290 putative siderophore transport system ATP-binding protein YusV
MHLQINQANIGYNKSLISNINTNLNLGEVCLLIGNNGVGKTTLIKSILHQIPVLGGEIFI
NDKNVKNLSVKEIAENIAVVFSKSVIPQNYTVEDLISLGKYIYYPFYFELKKEDREEVSE
IITALDLDQYKHTLLRNLSDGNLQKAFIGRALTQNSPIIILDEPTTHLDEKNKIIILKTL
RKLAQEQNKLILFSSHDWRLAKEFADKIWYVKDSQLYSGMVEDVLLQHDELMNPSLFQMN
ENFVAPKIIAPDFYKEMLYSLLQKNINKDLSSFNFEFQNDFWLISNDSIKQQCESFGEII
NFVKTIY
>KALACAFP_03291 Transcriptional regulator SlyA
MDNNKDKIENVDLILKQTWLAVSKMYTELAQEHDSTAVQALTLLKIDPKEGTRSTNLGPK
MAIEPTSLTRIIKLLEDNGYIYKEKTTTDKREVIIKLTDKGLNSRNLSKEVVVNFNKRVM
EKIAPEKLETFKEVMTEIMKIATDLNNRK
>KALACAFP_03292 putative 3-hydroxyacyl-CoA dehydrogenase
MKRRIKHVTVLGSGIMGSGIAAHFANIGVEVSLLDIVPFELTEAEQKKGLTKDDKAVRNR
IASENFEKLKKASPALLYSPKFADRITIGNFDDDLPKIKNTDWIIEVVVERLDIKKSVYE
KIEQFRKPGTLISSNTSGIPIHLLTEGRSEDFKHYFAGTHFFNPVRYLPLLEIIPTNDTL
PEIIDFYMNYGAKFLGKTTVLAKDTPAFIANRIGVFSMMDLLHNVQKLGLTVSEVDKLTG
PVIGRPKSATFRTADVVGLDTLVMVANGVRQSGAEANDFNDVFALPDYIQKMVDNKWLGS
KTEQGFYKKVKNAEGKSEIHGLNLDTLEYELQGKSSFPTLELTKNIDKPIDRFKVLIGGK
DKAGELYRKSLGALFAYVSHKVPEISDEVYKIDDAMRAGFGWENGPFEIWDAVGVQKGIE
LAKEAGYEVSDWVKNVETFYKVNDEGQSIYVDKNSGEYNKIPGQDAFIILDNIRKNKTLW
SNSGAAIENLGDGIINFEIRSKMNSLGGEVLDGLNRAIDLAEKEYDGLVIGNQGTNFSVG
ANLAMILMMAIEQDWDDLNMAIAYFQKSMMRVRYSSIPVVVAPHGMTLGGGCEMTMHADR
VVAAAETYIGLVETGVGVIPGGGGTKELTLRTSREFHSDDVKNNRLREAFMNIAMGKVAT
SAYEAYDMGILEKGKDIVSVSKNRQIAEAKKVAKLLAEQGYTQPIEQKVKVLGKDALGMF
YVGTDQMLTGHYISEHDKKIADKLANVMVGGNLSEPTVVTEQYLLNLERETFLQLCGERK
TLERIQYMLQNGKPLRN
>KALACAFP_03293 hypothetical protein
MDDHINFMANTYTQIYIQIVFAVKGRQNLISKENREELHKFIAGIVSNRNQKLFAVFAMP
DHVHILVSMSPTGSISDLVRDIKAGSSKFINEKGWTKGKFSWQEGYGAFSYSKSSVDSVV
KYILNQEEHHKKKTFQEEYLDFMEKFEIEYDPKYLFEWMEN
>KALACAFP_03294 3-ketoacyl-CoA thiolase
MKTAYIVKGFRTAVGKAPKGSLRFTRPDVMAATVIEKLMAELPQLDKNRIDDLIVGNAMP
EAEQGLNVARLISLMGLNTDKVPGVTVNRYCASGSEAIAIASAKIQAGMADCIIAGGTES
MSYIPMGGYKPVPETDMAKTNPDYYWGMGYTAEEVAKQYNITREEQDQFAFESHMKALKA
NAEGRFKNQIVPIPVEYNFLDENQKMQTKKFDFSVDEGPRADTSLAGLAKLRPVFANGGS
VTAGNSSQMSDGAAFVMVMSEEMVKELGLEPEARLVAYAAAGLEPRIMGMGPIYAIPKAL
KQAGLELKDIELIELNEAFASQSVAIKKELGLNPDILNVNGGAIALGHPLGCTGTKLTVQ
LLDEMRKRGNKYGMVSMCVGTGQGAASIFELL
>KALACAFP_03295 hypothetical protein
MSMELSKLTLDLTDTFSTYEKYGLKSQMDRCSISIPSNIAEGSSRTNKSFSHFLDISLGS
SFELQTQILLANHRKYLSDEKCEIFESKIEEFQRATMVFQNMLNRSDE
>KALACAFP_03296 putative acyl-CoA dehydrogenase
MGNILKGGEFLIREIPANEIFSLEELSEEQKMLRDSAKEFIDREVVPQHDRFEKKDYALT
EETMRKLGEMGLLGITVPEQYGGLGMGFVSTMLACDYVSGGNGSLATAYGAHTGIGTLPV
LLYGTEELKNKYLPDLATGTKFGAYCLTEPDAGSDANSGKTRAKLSEDGKHYIINGQKMW
ISNAGFADTFTLFAKIDDDKNITGFIINKSELENPESLTFGEEEHKLGIRSSSTRQVFFN
DMKIPVGNMLGERNNGFKIALNALNVGRIKLAAANLDGQRRILNHSIQYSNERKQFGVSI
STFGAIRKKIAEMATGVFVSEAGSYRLAKNVEDKIAELVAGGMDHQQAELKGVEEFAVEA
SILKVFVSDLTQNTADEGIQIYGGMGFSEDTPMESAWRDARIGRIYEGTNEINRLLAVGM
LIKRAMKGELDLLSPAMAISKELMGIPSFEVPDYSAFMSEEKAIIANLKKVFLMVSGAAL
QKYMMDIEKQQHLLLNASEILNQIYMAESAVLRAEKHFSADSVEAAMAQLNLYKAVEKIV
VAAKEGIVSFAEGDEQRMMLSGLRRFTKYTNNPNVVALTEKVAAHFIGKGHY
>KALACAFP_03297 hypothetical protein
MKKNLLALLILLINFNTYAQTQTISFETSEGYSLGDIHSQNEWERFSMTPPFSSEIMNTG
AATHGNNYLKIEGRGNNRYVQQTFTGYNKTEYSFDFKIDTLNESQYLIGFKKSGMFSHFA
GFYILPDGNVHTAPFSPVSTGFTATPGQWNNYKVVVDLTARTVEYFINNLSVGIITISDA
QVTDFNMINFSFSDWQNPGTNLSCSVDNIKITNAGGTLGTSEVSSKSFINIFPNPTPDFI
NIKAEDKIDSVEIFDLSGKLILKDHKGKNRIEVSTLENGIYMVKINTAKGSITRKIIKN
>KALACAFP_03298 hypothetical protein
MKKTLLTICFLGAVAVSAFPFRTSCGSVVNVSEGITFYTDDTLQEALASLDRFLCNSNTQ
ASQIVVYGH
>KALACAFP_03299 hypothetical protein
MKYYLIIMIFLFTKVSSQIKFNVEYEADYELNYKDYNTSNAVTNKTTFALLLNKNESYFK
NMNKYIKDSLVYEKSIILSGNAYKDMKMTGKYYTEFPETIGITSSKIYVSLVAFDSYFKY
EEDNNINWQLQNDFKTIGKYKVQKATAKKYGRMWIAWFAKDIPFPFGPYKFSGLPGLILE
VYDDKNDYHYSLYKFGKRKYVCNSANMYKNAKLVDKSKIFDYKRRSLLDINKYKQMIDDP
EVIQTITKRAPVVAKTYNPIELSIY
>KALACAFP_03300 hypothetical protein
MGKFIITKRNNNEYQFNLKAVNGQVILTSQGYASKPSCENGIDSVKKNSRDNSNFERNKA
KDERWYFNLKATNGQIIGTSQMYESENGMENGIESVQNNAPNATVEDETIN
>KALACAFP_03301 hypothetical protein
MLGHFLFLYSTLHTMTKEELLHKAIKIADKAHKGQTDKYHAPYIAHVMRVMEYGKTMDEK
IVGVLHDVVEDHPVDFSLDYLRSEGFPEYIIFAISCLTKFDPEEDYDDFVKRTERSPLAV
AVKLNDLRDNMDLRRVNRELLPKDIKRFNKYLKAYRYLIDKY
>KALACAFP_03302 Protease HtpX
MTNNLPPISSAYRSKLMSAIFSISIFFVIYFILILISLLMIFLLGYGAVKIIMFHANYFT
VLAALGLFSIGLVVFYFLIKFIFIRNHYSNRHLIEIDRGHQPELFAIIDEIVQETKVQKP
KRVFLSPEVNASVSYNSAFWSMFLPVKKNLTIGMGLINSTTVGELKTVLAHEFGHFSQRS
MKIGGYVNQAEKIIFDTVYNNKEYENSLMNGSGHWAFQLTGIVSVGFINVFQYILKIFSD
FLFKNNASLRREMEFHADAVATYVTNPREQVSSLLRLDLSSVAFNSSFMFYAESEEKYLP
ENLFENQTSLMKVFSERNNHPFENDLPKVDLEDQTRYNKSRIEIEDQWSFHPETDKRIEK
IWKNETKNRPENNELAKNIIRGFDDICKALTKKYLTLYSVKNVGEVIENNERFLELYHEK
YPYQVMSSSFNGYYERHNPVLEDVDSIINISSDSAKNEDWFNDKKVSLVHEKAGIEADLY
TLNQLAANPKIIKTFKCDGRLYKAKEAKILIPRFTKIFEDLKAELLENDKKIFNYYYNIA
DDYDKEILKSKYKKFAVLDSEYEIFQNSINNFVPHTRFMSVTLPFEEIRKYRAVLIKNEK
PFKEVLTHFLEESAYKDFLTIENKNLLKEFINSEYIYFNNNKYLEKEVSALYSVVNEYQA
MISKIYIDCKEELLDFQTRLEKS
>KALACAFP_03303 hypothetical protein
MKLFLGLSLFLSITFFKAQEHISSFNAVTLTYKFHPKFFLYAEGQLRGNEEYSYPDYYEA
KGGLGYYLTKNHKPFVGIGRYVNYKNHSLSREELRVWLQDVIDVKKGIVKFENRFRAEKS
WFYEPKTDKSSQRMRYRYRLNISVPLNAKEVKKGTVFANAYDEIFLVSPMKPTFARNRVY
GGFGYQIDDYFGIATGYLWQREFEAAGNKNLHFVYLALNINIDGTNHPVKTYDYPGAD
>KALACAFP_03304 Vitamin B12 transporter BtuB
MTKKIGSIFFLGALFFAQAQEKSTDIETIEIQGKLISIPYKIANQNITVITREEIENSPA
TSIDEILQQIPGMDIRRRGANGVQSDLGFRGSSFEQILLLLNGIRMNDSQTGHNSMNLPI
DLDDVERIEVIKGPGARRFGQNAFAGVINVITKIHIGKKVKISAEAGDYESYGFGLNAQL
GNEKFSNSLQANSNSSQGYMYNTDYEIRNVFYQSKLNIKEGDIRLQAGFSEKKFGANGFY
SSPKATEQYEETQASVVSIAHQQTFGNLKLHSNIYWRRGQDMYLFNREKPEIYRNMHIGN
NVGGEVNSSYQWGLGTTGVGLELRKEFLASNNLGDRNRFVSQVFFEHHFSLLDKKLNINP
GISWANYSKEGNFFYPGLDVGYNFNVNNKIYGNISKVSRVPTFTDLYYVSKTEQGNPDLQ
PENAVSAEVGYQFQNKGILAKISGFLRNSDNSIDWIKKTLDDPIWYAQNVGKIETKGIEV
ELNHRIFNWLKYTAGYTYLENKFTASDEFVSRYVLDNLKHQIIAKLETKLVKNFTAELVY
RYNERVNLGSYNLLDGKLNFVKKDFSLYILINNITNTSYTETFGVQMPKRWFHVGFSYNI
KY
>KALACAFP_03305 UvrABC system protein A
MANTTDIDIKKQIFVKNAHLNNLKHIDVLIPKNKLIVITGVSGSGKSSLAFDTIYAEGQR
RYVESLSSYARQFLGKLEKPKVDDIKGLAPSIAIQQKVISSNPRSTVGTSTEIYDYMKLL
FARIGKTFSPVSGEEVKKDSVSDVVDFIKTSKKDTSFLLTAPLEYDIANFGENLNVLKLA
GFTRLEINGNVAGIEDLESFGFTPEKGMEINLVIDRFSYEEDESFLQRLADSIQMAFYEG
RGYCSLKDVDTGKIKEFSNKFELDGIEFLEPNVHFFSFNNPYGACPTCEGYGKVIGIDED
LVVPNKTLSIFEDAVVSWKGESMSEWKKAFIKKAKDFPIHKPYHQLSKEQKSYLWKGDGS
SSFPSINNFFKMLEENLYKIQYRVMLSRYRGKTLCPTCEGLRLREETSWVKIDGHNIQSM
IELPLDELSPLVNSLKLSEHDQEIAKRLLYEITTRLEFLLKVGLGYLTLNRTSNTLSGGE
SQRINLATSLGSSLVGSIYILDEPSIGLHSRDTENLIEVLMNLRDLGNTVIVVEHDEDVM
KAADYIIDIGPEAGYLGGELVFAGDYKDLKDADTLTSKYLTGRLEIEVPKKRRGAKEWIN
IKGARQNNLKNIDVDVPLENLVVISGVSGSGKSTLMKEILTNDIQIQLGMGGKKGDYDSV
DFPKKLIKNIELIDQNPIGKSSRSNPVTYLKAYDDIRDLFAKQKVAKMMGYKPKHFSFNV
DGGRCDECKGEGVINVSMQFMADIELECEVCKGTRFKSEILEVRYDEKNISDILHMTVDN
ALEFFKDNHEEKIVTKLRPLQEVGLGYLQLGQSSSTLSGGEAQRVKLASFLVKGVTTDKT
LFIFDEPSTGLHFHDIQKLLKSLQALIDLGHSVIVIEHQPDIIKCADYIIDIGPEAGKHG
GEVVFAGTPEDLVKNKKSHTAKYIKEKLGK
>KALACAFP_03306 hypothetical protein
MKINKVAVIGGTGKSGKYLVQHLLDKNYSIKLLLRNPDNFTLQNPLIEVVKGDARNFESI
KDLVQGCDVVISTLGQPKGEKSIFSDAAKNIINAMNSNGIKRYIVTTGLSVNTSKDHKNG
KVKMATDWMYQNYPETTTDKQKEYEILAESNLDWTLVRLPLINLTTESFKTETSLEDCKG
ENISATDLSEFLVSQIGDRSYIKESPFLYNF
>KALACAFP_03308 Bifunctional transcriptional activator/DNA repair enzyme AdaA
MEKKDNSPLKITTISELHQILNVPKPLHPLISLVDNTEISVDKTYLDRSFTLSFFKISYK
FSENGKMGYGQGYYDFNEGGMMFTAPNQVLSTEEDSEYHGYTLFIHQDFLRNYPLAKNIK
KYGFFSYDTNEALHLSDKEKTLIVGLLNNINDELNTAIDEISQDVIISYIEVLLNYSNRF
YKRQFITRKVVNNDLLSKMEHLLEDYFNQQKTLTKGLPTVEFLASELNLSPHYLSDMLRN
LTGQNAQQHIHEKLIEKAKEYLTTTSFSVSEVAYQLGFEHSQSFNKLFKKKTNMTPLSYK
QSFN
>KALACAFP_03309 Dihydroanticapsin 7-dehydrogenase
MKTIFITGASTGLGKAAAKLFQSRGWNVIATMRNPQAETELTQLENVTLLPLDVTSMEQI
QSNVKKALEISDIDVVFNNAGYGLIGPLEALEDDQILKQLDTNLLGVIRVTKEFIPYFRE
KKSGMFITTTSIGGLLAFPLSSTYHATKWALEGWSESLSFELNKFGIDIKTVSPGGIKTD
FISRSLDTGTKPEYQEMIDSMFSNTESIMEGASEPETIAEVVYEAATDGKKQLRYIAGED
AKALYAQRLEMGAEAFREEFGKQFI
>KALACAFP_03310 hypothetical protein
MKMKQIWGNLAITDIEQTTKFYTALGFKPNGEMNSKELISFSCGENNFIINFFLKDVLEN
NTKTQFSDLKNGNEIIFSLSAESRDQVNEWVEIVKNAGGKISVEPYEIGEGYTFVFSDPD
GHKFNVLYWPGM
>KALACAFP_03311 Inner membrane transport protein YdhC
MRNLDTNHKGFSTFLALGLIPLSGFATDIYLPSLPSMAKDLHVSSAAIQLSLVLFMFSNG
ISQIFIGSIIDSFGRYKVAVASLAVFSITSFMIALVPNIYLIYVMRIIQGIAIAFIVVGK
RAYFVDLYSGEKLKNYISLFSIIWASAPILAPFLGGYLQDLFGWRSNFYFLGILSLAFLV
LELIYSGETLKYYHPFKVKTITETYVGKIKTPDFTLGIIILGISFGLVVVYSLSSPFIIE
RVLGYSSVATGYSSLLSGLSLMTGGIIAKSMINKPLAQKVITAISIQIILVVLMIGTVPF
GTNIFTLVGFTIGIHMAGGFTFNVVYAYCLSRFTKNAGIASGLTGGVLYIISSLVSYSFA
NLYAVKSQVLLGVANITLIMILIVVFIFFNKYRKLALQLDK
>KALACAFP_03312 Fatty acid metabolism regulator protein
MSKAERTKQFIIETAAPIINKKGMAGTSMSDIMEATKLAKGGIYGNFESKDEICKEAYSY
LSSTLAGRLNEAVTKGKTAKEKLDNLLDVYENKSLSGGCPILNFGIEADDTHPEIKQRVN
QSISSARNRIAGILEFGISNNEVSKDIDVKVFSTKAFAMIEGAIMCRRIMDNDEVISTII
ETIKKDFESYLI
>KALACAFP_03313 hypothetical protein
MINYKILTFIFLTAALASCNGQNGKSKKMENKTSNPLLCDPATGICEVPGEKTEIGDINV
KANEKPVKVIYFTDPICSSCWGIEPQLRKLKLEYGNNVDIEYRMGGLLPDWSYNSGGISK
PSDVAHHWDEVSHYYDMPIDGDVWLQDPLDSSYPPSIAFKAAQMQDKTKAIEFMRELREM
VFLKKINIAKWDNIAAAAKKVGLNADQLKSDYEGKGKELFQEDLKLAREMGVRGFPTMFF
TNGAGSKEIVYGSKPYAFYETAILRVNSETKKSEYSKTWESLFAKYNSLTAKEFSELSGT
PRKESEQLLNELAAKGTLEKLTTKNGSIWTLKS
>KALACAFP_03314 putative HTH-type transcriptional regulator YtcD
MKKEANVNTTLICKNRMNAIKDAMEILSGKWKFHILGTLMQGEKMRFMDLLREIDGIAAK
MLSKELQDMEINHLINRTVLNTKPVTVEYEVTEYGKTIEPIIDEIAKWGIEYRRSLYQK
>KALACAFP_03315 hypothetical protein
MIYAFDTYYFEDYANTICIAFENWNSENEAEIFSEKTNITSEYESGAFYKRELPCILSLL
KKIQLTTGDIIIVDGYVTLNDEGKIGLGGYLYEALDQKYPVIGIAKNEFNSPDSRRRSIY
RGESKTPLFLTAIGMDVDEIKPKVEAMHGAFRIPALLKKLDQLTRI
>KALACAFP_03316 hypothetical protein
MKQNVKSIRPFIGSENFEESRNFYKDLGFEEVILDTKLSVFKKQEIAFYLQDAYVKDWID
NTMLFIEVENVEAFWQELLGLNLTEKYKSARLTPIRTMDWGKECFVHDPAGILWHFGEFF
NK
>KALACAFP_03317 hypothetical protein
MIREARLEDIPQIQKVRNSVKENTLSDPNLVTDKDCEEFLFERGKGWVYEIDDQIVGFSI
VDLKEKNIWALFLDPGFEKQGIGRKLHDTMLDWYFEQTKETVWLGTAPKTRAENFYRKSG
WKETGTHGKGEIKFEMTYNNWKNK
>KALACAFP_03318 Bacterial leucyl aminopeptidase
MKKLFIPLFSIALLVSCGTAKTSTDAANTTSSVVKGDKAFLSAYKEIKADDLKKNLYVIA
SDEMGGRDTGSPGQKKAGEYMVNYYKSLGIGYPKALGSYYQKVPSDYMKQRGGETLPDSE
NILAFIEGSEKPEEVVVISGHYDHVGTKNGVVYNGADDDGSGTVAVMEIAKAFQAAKKAG
KGPKRSILFLHVTGEEHGLFGSEFYTDNPVFPLANTIVDLNIDMIGRDDPENRGKQYVYV
IGSEMLSSQLKVINEAANKKTNNLELNYKYDDPNDPQRLYYRSDHYNFAKNNIPVAFFFD
GIHEDYHKPTDDVEKIDYKLLEKRTQLVFTTAWELANRPERIVVDHK
>KALACAFP_03319 hypothetical protein
MSKNKSFLKFYFIAFFCIYPIKNFAQKSTPEIDRIIKIIEENYITNNVDKDQLLDYTYDL
YYLSKKANFPDGKAYSIFEQTRIYFFNGDLENSLKKINEGIALAKSRKDYDMLCRLLLVY
QSTLLKLNYLNEAQYILKKCEEYNELNVAKENARINDVYILLAKADVLVDEQGRSDEMAT
VISLKKKAYSLAQQLSESDKYKGITIIYALESLTFSLAVSGDVFSARNYIVQIDKLLKVY
PNKYSLIQSFIIKGAIESNEKKYAQAISYFNRAAEIAANNKNIYELYEIYPMMSASYSEM
KDFKNASEYLWKFKHLSDSITQVMKKSENNKLIAEINKNIQKRDEKKLEQVKIDFALVFA
LFAMILSVFVLIVYKKKQKGSQTYNEFGNGNFLQNTEEKKKPEIDPEIIKELLLLVKNDI
DTFYIEFPKIYPDFYQSLQKEYPSLTISDYSFCALVKMNFTVKEISLYTKLSLRSVEGRK
YRIMKKMKVSNQNELYIVLSSIS
>KALACAFP_03320 hypothetical protein
MKKNVLLLLALFPLFAAAQVGVNTADPAATLDVVAKNATGTTTNVDGLTVPKVDRERAQS
MAGTPVSTLIYVDNVSTGSTIGSTVNVDKVGFYYFDGSVWVKFSNTSIDSANIYNTNGIL
TGNRIVSQEGNTLAFTGSAENAFSVDGNTFSVDAANNRIGIGIINPTEKLDILGNTRIRE
LQNGQNFDDFSRLVVAKTDGTLGYAQNSNVSFQSFQLRIPPHNSTVVDFTNHANTAYDAD
NWWVISKSSVAPGTNTPARMTIVYEYQGGAFPDPAQIFPQLTAGNNSSYPDVFAPAFINL
ATVGGKTRLTVSVARADHSGLQWGGTFLLNVLLGVKGAISAPPAPGTISALNCAGATHNG
TLTANSSASGVSSVISYTGGNGGFYNSQSISSTGVTGLTATLSGGNFATGSGNLTYTITG
TPSAAGTASFAITIGGRSCTITRTVGAPVAGAIASLNCAGATHNGTLSAGVAASGVNSVI
SYTGGNGGTHAAQSVTSTGVTGLTATVSAGSFANGNGTLTYTITGTPSGSGTASFAINIG
GKTCTITRTVTASVLPACTAEGYYANPNDPHQYYRCVQQSTQFIRYQYTCPNGNIYVAAP
NGAQGKCVAP
>KALACAFP_03321 hypothetical protein
MGRFKILKTFSLFLVFFIFPMDGYAQDHRKEIDSISKLLLNNYAKGDQNPNLTLKHVTSL
YYLSKEAKFYQGQVGAIFEEARIYYFNGHFDSALAKISEGIDLTKAKGDDTMLCRFLLVY
QKVLLQLDHLSAATQILKEAERYNEKVTSKEDKLINDIYILSSQADLLILNKNPSDIEKI
IQLKNQAYSKSLKISNSNYLKKATILYSLESLTASLAHFGKVAEARNFMAIIDQHLSTFP
DDAFTIQSLIIKGMIESAAKNPEKAVGYYTQASIKAQKNNNTYKEYEIYAMISASYAEMK
DFEKATSFSKKYKHLIDSIDIVKKKSGDVNFINKINQKVSSKKTVSDNNLYFIIFLVAAI
ILVILFFLYKIRWKKKNTEYPPSISDVSVDTPSEVKQNQENLQHNTSENVKELVVLAKED
INAFYIEFQKVYPDFYKTLAEKYPELNISDINFCTLMKMNFGIKEISQYNNSTIRAAEAR
RYRIIKKMELNNQNELYMILSNIN
>KALACAFP_03322 Methionine aminotransferase
MGNIYGFNHYSFFTEMSELATRNNSFDLSLGLPDFDIDERLRDYLKESADLNTHNYEPLA
GNPLLIENVIKFNLKRPNRIRLNENEVTIVPCATFALYTSLKSILNQGDEVIVIQPSYYT
YGPSIVMNGGIPIYYDLDNDFAINWEKFQNCISEKTKAIIVNSPQNPTGKIWRQNDWNQL
YELIKNQDIYLISEEIYDTYCYDGVEHYSSFLHPELKKKTFCIFSFGKMFHATGWKVSYL
LTSEDLTAKFRCHQQYISYSASSPCQYAIAKYLEVFDPSVNQAEMQRKRNIFNELIKETP
FIVEQKAEGAVFQVVNFRNISKTMTDVEFSRWLTVEKKVACLPLSAFYNSRQDSDYVRFS
FAKKDELIFDALEYLRKNL
>KALACAFP_03323 Putative K(+)-stimulated pyrophosphate-energized sodium pump
MDLFVLVPIFGVVALLYTFLQSNWVTKQDAGDEKMKVISGHIADGAMAFLKAEYRILTYF
VAIVAILLAVMGMSNANSHWAIGVAFVFGAIFSASAGFIGMKIATKANVRTAQAAKTSLS
KALKVSFAGGSVMGMGVAGLAVLGLGGLYLIIKQIFAPHATVDSHEMERTIEILTGFSLG
AESIALFARVGGGIYTKAADVGADLVGKVEAGIPEDDPRNPATIADNVGDNVGDVAGMGA
DLFGSYVATVLATMVLGRETVSEDSFGGFAPILLPMLIAGTGIIFSMIGTLFVRINDNED
SSTSSVQNALNLGNWGSIVITAIASYFLVTYLLPDKMVLRGQEFSKMGVFGAIMVGLVVG
TLMSIITEYYTAMGKRPVSSIVRQSSTGHATNIIGGLSVGMESTLLPIIVLAGGIYGSYL
CAGLYGVAIAAAGMMATTAMQLAIDAFGPIADNAGGIAEMSELPKEVREKTDILDAVGNT
TAATGKGFAIASAALTALALFAAFVGIAGIDGIDIYRADVLAGLFVGGMIPFIFSSLAIT
AVGQAAMAMVEEVRRQFREIPGILEGKAQPEYEKCVAISTDASIKKMMLPGAIAIISPLL
IGFIFGPEVLGGFLAGATVSGVLMGMFQNNAGGAWDNAKKSFEKGVDINGQTYYKGSEPH
KASVTGDTVGDPFKDTSGPSMNILIKLMSIVSLVIAPTLAVLHKDKIEANRKAKIEALTG
VAGVKSVEVTAGVVDLAPKEIKGHLNESGDFVYDTGTIQEVELKGGKKISIGEGSQLYQM
YNLIKNKDQKVLDPNTWYTIENLYFQTGSSDLKPGSEVQLLNLVEILNTYPNLKVKLGGY
TDNTGNEESNQKLSNLRAQTAKLKLLELGIAGDRVEAEGYGSQYPVCEANDTDECKAKNR
RIDVRVLAL
>KALACAFP_03324 Inorganic pyrophosphatase
MIPNFKAHPWHGISAGEDAPNVVNVFVEIVPSDTIKYEVDKETGFLKVDRPQKFSNIIPA
LYGFVPRTYCDSAVMNLAIERGATDVTMGDHDPLDICVLSSHNIHAGGLLMEAIPIGGFK
MIDGGEADDKIVAVMIGDHAFGHFRDIAELPEAEVKRLMHYFLTYKNLPDEPAKCRIQEV
YGAEHAKHVIRASQQDYANKYGG
>KALACAFP_03325 hypothetical protein
MTSFSGYLPYAFALIIAIPFLVLLRQFVFTYIKLKEQEIKLLSIKSNSENKTQSYERMTL
FLERLKPSNLIQKFDKGLAVHEFIFLTEKSINEEFEYNSSQQLYLTKNSWKNIVDSKNAV
IDLLHKTYEGLSSSPNLDEFKTVFIMNYMNSEDYISATIEDLRREILIIA
>KALACAFP_03326 hypothetical protein
MSSNIKTCIAFIVNSKRYSSKFKQNKLDLNNNETFVYHFKKNHRKFDLYLRTFKGDIDIF
YEIFWKKTYDQHLNFLQEKPKVIVDLGAHIGLTSIYLSLKYPDAKIIAVEASPENFLLLK
ENTSSFKNIECVNAAIYFEDGTVNFGSEELSYNQRISDSGAEIKAISVESLMKEHQLNEI
NLLKIDIEGGEVELLSKNNSWLEKVENIIIEIHQDYTQEHLNKDLQPFGFTIELNKNAVL
FADKKQ
>KALACAFP_03327 hypothetical protein
MIRRLKYNEIDFDKYSDCLENSEQRKYSATKIFLDITSDKQWELLVYGDYEAVMPVPFMK
KLGIKLVINPKLCQQLGVFSKTDNVEINDQFLQFFRKKYNIWYYAFNDGNKFSEPLQLRK
NFLIEPEKYEIIRQKYSPKRKRKLRLDEEVSAHSKVIETKIKDAETFISANFIGAKDNKG
KAHFLEIFTNLENSGHLKIVAFVYQEKIINTIAVYFDEKTVALLGTFNDKDYVKLSGAST
IIDYVIAQNIAQKIFDFEGSEVPAIEEFFRGFRPELKMYPVIANSKKDVIRKTLKLS
>KALACAFP_03328 hypothetical protein
MSIKFLAEDDRPREKFLLKGKNSLSDSELLAIIMGSGSRDETAVELARRILSSVNNNWHQ
LSLLSIKDLMKFKGVGEVKAISITTALEIGRRRASQEIPEKPVISNSHNAYQIFRNHLSD
LRTEEFWAAFLNQSNKVIHLAQLTQGGINQSIVDVRILFKTALDHFSTGVVIAHNHPSGN
LKPSREDIEITQKIREAGKLLNIQLLDHLIITQNSYFSFSDDGLL
>KALACAFP_03329 hypothetical protein
MMKYFIFLFLFIISCSKIESQSGNLVDYLPKSKILEIKDYIKGKNYNQDLAVFINFKVHS
GKYRYFVYDLKNDKILQKAVVAHGSGSVVKNSQNLQFSNIDGSFQSSLGKYEIKESYSGK
FGKSYRLNGLDPTNSNAMSRAIVLHSYGCIPDKESTDPACLSLGCPMLSQNAFNQTAKYI
DQSKQSIILYAFY
>KALACAFP_03330 Lipoprotein-releasing system ATP-binding protein LolD
MIKARNIHKSYGNLEVLKGVDIHIKVGEVVSIVGESGAGKSTLLQILGTLDQPTASNKFN
TEITIAGESFINMNDKQLSKFRNQNIGFVFQFHQLLPEFTALENVLLPTKIAGANEKEAL
EKAYALFEDLRIEQRLHHKPNQMSGGEAQRVAVARALINSPKIIFADEPTGNLDSRNADD
LHRLFFDLRDKYNQTFVIVTHNPNLAEITDRKLVMKDGMIID
>KALACAFP_03331 Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex
MTFEFDVSESQISNLESQISNQYYNMAEVITMPRLSDTMTEGKVAKWHKKVGDKVKEGDI
LAEIETDKAVQDFESEVEGTLLYVGVEEGGAAAVDSVLAIIGNEGEDISGLTGGAAAPAA
GGSEEKKSEEESKTENSSTSVEQTSAEVPAGVEVITMPRLSDTMTEGKVAKWHKNVGDTV
KEGDLLAEIETDKAVQDFESEFNGVLLKQGVEEGGAAPVDSVLAIIGPEGTDVSGVGAPK
AAAAQSTEKPAEQKAEAPKQESNNQQPATGNNERVAISPLAKKMAQDKGVDIHSVQGSGE
NGRIVKKDIENYQPSQVKPAASAPAASAAAQVALSFIQGEDTETPNSQVRNIIAKRLSES
KFTAPHYYLMVEINMDKAIVARNEINSLPDTKISFNDMIIKATAIALRKHPQVNSSWAGD
KIIHRGNINIGVAVAIPDGLVVPVLKNTDQMNYTQISAAVKDMAARAKSKGLKANEMEGS
TFSISNLGMFGIETFTSIINQPNSAILSVGAIIEKPIVKDGQIVVGNIMKLSLACDHRVV
DGATGAQFLQTLKTYLESPLTLLL
>KALACAFP_03332 Acetoin:2,6-dichlorophenolindophenol oxidoreductase subunit alpha
MKEFSKEVYLKWYEDMTMWRRFEDKCRSLYLKQKIRGFLHLYNGQEAIPAGFTHAMDLTK
DSMITAYRCHIHPMAMGVDPKRIMAELCGKATGTSGGMGGSMHIFSKEHRFYGGHGIVGG
QIPLGAGIAFADQYFDRKAVNICFFGDGAARQGSLHETFNMAMNWKLPVVFVVENNQYAM
GTSVKRTANHEDIYKLGLGYEMPCLAVDAMDPEKVAEAAYEAIERARRGDGPTFIEARTY
RYRGHSMSDAEPYRSKDEVALHKNDDPIELIKQRILSNNWATEEELEATDNKSRDFVEEC
IEFMENSPYPDAEKIYEYVYAQQDYPFLDKLEN
>KALACAFP_03333 hypothetical protein
MEEKQPSLLHKISKVISDFFNPLVSLFIFFVYMSVRNYTLKDSLLYFLPILLMIILPVII
WLVWNVKTGRYTNMDVSNRIQRKTLYIFIAGCVVSYLLFNYFQNGYVDFVMLFILILLFS
MQISNYFIKSSMHTAFNIFVAALFFALDTTMGFVWLGISFLVGITRIILKRHTPREVFMG
AGIAFVVSFIYLYCNIQFQH
>KALACAFP_03334 Penicillinase repressor
MKINHLTPAEENLMKLFWKLESFYLKDIMEQHSEPKPHQNTVSTYLKILVEKGYLSTEKE
GRIFKYTVLVPLEEYRKFLLKEISHHFFNDSGKEILEFLFNENLISQEDLRGYFDLKIEM
KPAKIKEPKHEYANEVLNPKKDKKSKDKKKKKKKDQPK
>KALACAFP_03335 hypothetical protein
MKTKFQETLSRANEVIFRYPIVLVMALLAAIGAICMFENNRERELFFVFSKFTICACLGI
SLMFALKMLSQRIGKELLLQLFGIIFLVGFYFVLPGKEKDFTEVYGYIIAITVLLTHLFV
SFIPFLGQNVELKFWQYNKNLFVNIFLTAVFTGVLTGGVELAILAVDKLFDFNFDDRLYT
DTLYVLAIFGSCFIFLLFNDKGLNNLEKDRDYPIVLKFFTQFILIPLLLIYVVILYFYSI
KILINWQLPRGWVSYLILAYSIVGILALLLVHPLKNENTKSWVRIFSKAFYYTIIPLIIL
LFVAIFTRILEYGYTEPRYFVLLLALWLLSIVVYFIFVKKGTIKFIPISLFAFGVFALIF
PYLNAFSVSKRSQKAELSKILNEKQLLNNGKIDFKKKVADTISIEIADKFQYLSERKEGD
FLSELLDKKEQNDLNKNIEKGEFYSIRYHIQDQFTNINTTSKNDPEETQRLSITSEKQTT
EIGDYQYFMSFSRYDQEPKKLNEDQFKFIDELTDKSSLKLILNDTDEVDFGPQIVKLFGE
HKDKKNIVKVPEIAMESDLGKYHVKLVFQQITKEKYPYNKRSNIYYQEAYLLIKLK
>KALACAFP_03336 hypothetical protein
MRRHLLALTLMFCGLLFNAQIIYNGQNIQQDKRYWSDNGQYYLLFQKDGNLVLYNRSARP
LWESKTTNRGTQAIFQSDGNLVVYAPGNRPIFSSNTNGKRATKLSVQNDGNLVIYNRSSP
VWASNTSNDDSNNNGGGNGWGFRGGGVNPGFAFYKNSKIYSANRNYYLVFQNDGNLVFSR
NNGEAIWASGTDNKGSRAEFQQDGNLVVYDSYNKAVWSSNTQNRGATRLAVQDDGNLVVY
QNSTPLWSSER
>KALACAFP_03337 hypothetical protein
MNIFVSNINYATKDYELQDLFSEFGEVSSVKIITDKETGRSRGFGFIEMEDSEGQQAIEA
LNQKEFNGKTLNVSEAKPREEKPRRTFSNNGGGNRGGGYGGNNRSGGGYGGGNNRGGGGY
SGGGNGGKRW
>KALACAFP_03338 hypothetical protein
MKQHTTNFINTFIEVAEDCPVSEAQIPPEKKEKTLANLQYEQIVKNPYKYSSDDVIFDCY
AFKNDISKSEKHETREKFFSKGQPCLRCSPLAKKYGFGIHHNDKGKVAIYPLESKEYQEF
LHDHSIMKVKAMRSKKK
>KALACAFP_03339 putative acyl-CoA thioester hydrolase
MNYHTRKWVKPEDLNPNHSLFGGRLLQWIDEEAALYAIIQLENTKVVTKFISEINFVSSA
KQGDIVEIGIEVIKFGSTSITLACEVRNKMTHQTIITVDRIVMVNLDEEGNPAPHGKTKV
EFVKDRLNNQQPL
>KALACAFP_03340 HTH-type transcriptional activator RhaR
MKIFIKNMVCDRCVAAVSTIFSDSNIKVKSIHLGEVETEAEVSEKDLQSLEKLLEKTGFE
RIKDSAHQLIEKIKNLIIVKISELDIDENFLLSEFLSLNLHKDYSSLSKTFSQNENITLE
QFFILQKIEKVKELLLYNEFNLTEIAGKLGYKSVQHLSSQFRNSTGFTPTEFKKLKVHNR
KPLDQV
>KALACAFP_03341 Silver exporting P-type ATPase
MEQQYKILGMTCSGCQKKISEKLNSIKGIKAEINLENNTATIHSEKRIDINTLNKALEEI
GNYKLEDPAQPEKAFVKPQDRVSPSSVYYCPMECEGEKVYFQQGKRCPVCNMYLVPIEEK
QAKDPNFKPTYSSTHLPENFKDNVGKYYCPMFCEGDKIYDEKGDCPVCHMHLEPITEDLV
KNSVSHSHHHIHDHSHHHEAPKVTDEMAGKYYCPMYCEGDKVYDRNVGCPVCGMDLVKYP
EKKVAKYTCPMHPEIVRDEPGSCPICGMDLVRMPDAHDDEEDETYNVLKRKFIISLVFTI
PVFMLSMGGMFINFSFSHQIQGFIELILTLPVLFYSGWFLMKRGWVSFKTWNLNMFSLIA
LGVAAAFIFSIISLIFPDMIPHEIRGHNHEIPLYFEAVCVILTLVILGQLMEAAAHKKTG
NAIRELMNLSPDEANLIVNGEEKKVLLSQVKIGDLLKVKPGEKIPVDGKITEGNSYVDES
MITGEPIPVEKTVNDRVSSGTINGNQVFIMKAEKVGDETLLSQIIKMVNEASRSKAPIQK
LTDKVSKIFVPAVILIAILTFVLWQFFGPEGKRSLFAFVNAVAVLIVACPCALGLATPMS
LMVGIGKGAKNGILIKNAEALEEMHKVNVLITDKTGTLTEGKPSVEYIETVNNDQNLLLK
LAYSLNQNSEHPLSNAVIKKAKDENILPEKVENFENISGKGVKGNINGKTVFLGNESLLN
SNKISIPESLKQKAVEVQSKAHTISYVAQENEALGFISFTDKIKESSKKAVQQLLNEGIE
IIMMTGDNEHTAKAVAEALGIKNFKANSHPEDKLNEVKKLQQQGKIVAMTGDGINDSPAL
AQANIGIAMGTGTDIAIESAEITLLKGDILGVAKAKLLSEKLLKNIKENLFFAFIYNVLG
VPIAAGLLYPFFGILLSPMIAAAAMSFSSLSVILNSLRLNSVDLDVK
>KALACAFP_03342 hypothetical protein
MEKENLYIGCSGFYNNDWKGSLYPEDAKSKDFLTLYSQTFNCVEINSTFYRKPTAKTLLK
WVDETPANFKFFIKIPKTISHEKRLKDCKEEITEFCEHVQTHLKEKLSGFLYQFPPSFKN
TQDNIDLILNNIDFNYLNVIEFRHESWWKEEIFNLLKKNDIIFSGVSFPGNLPEDVIVNH
SEILYYRLHGKPILYKSEYSKEFLQDLAEKIKANKKKAFIFFNNTWGNAAIHNSLFLKKI
LE
>KALACAFP_03343 Chitin disaccharide deacetylase
MRKNFAEKSKNKAFLGMFALMSATSILFNGCNRKIDKKESEILIPNGHPIAKKVPKIDNE
DVTSDKRVIYLTFDDGPNQGTENLLRILNKRKVCATAFLVGKHAYGSKKQKNDLELLRKD
PLVELANHSFTHAHNKYTDFYKNPESVVNDFNIAKDSLKLYDKIARTPGRNIWRLNNISV
TDLKSSTEAANKLKQAGYKVIGWDLEWKPTNKMVLKGKHEEMLKKVDSIFFNDLEKTSRH
LVFLTHDQYLTDTDSVNELDLFIEKLQKSNRFIFRKISEYPKINEVLN
>KALACAFP_03344 hypothetical protein
MNIQENYNDIKSQLPGNVQLVAVSKTHPVSAIQEVYDLGQRVFGENKVQELTEKYPLLPK
DIQWHLIGHLQTNKVKYIAEFVNTIQSVDSEKLLKEINKEAAKYNRTIKVLLQIKIAEED
SKFGLEINEAKDLFQKYLDGEFSSIEITGLMGMATFTDDENQIRKEFLVLKRVFDELNQL
KTLETLSMGMSDDFPIAIDCGANSVRVGSAIFGRRDYSK
>KALACAFP_03345 Nitrogen regulation protein NR(I)
MQKILIVEDEKAISGVLHSILSDELTDYEFVIAEDGLEGYKQVEKEDFALVISDIKMPKL
SGTELLKQSLALKPESTFIMISGHADIDSAVSCLKDGAYDFISKPIDINRLITSVKNALV
KETLKKENKNLQTENKTLKKKVSKKYQMIGESAGLKKIQDMIEKVAVSDARVLITGPNGA
GKELVAHAIHNQSDRAKGPMIEVNCAAIPSELIESELFGHVKGSFTGAIKDKQGKFEQAT
GGTIFLDEIGDMSLIAQAKVLRVLQESKVSPVGSDKEIKVDVRVLAATNKDMQKEIEAGR
FREDLYHRLSVIEIYVPPLDERKEDIRSLVEHFAGMIADEHGTAVKKFDDKAIDALKALS
WTGNIRELRNVVERLIILGGNTVSAEDVASFVRK
>KALACAFP_03346 Multidrug resistance protein NorM
MNFLHKNYTKECLTLALPVMLTQVGQVSVNLFDNIIVGKLLGADALASVSLGNAVFFSMF
VLALGFSFAIPPLVSEAHSQHDHKTINSVFSHGFIINISVGIVLMGILFLGTPLLYHSGQ
PAKIIPDTVDFLTIMAISIVPFMAFQTLREVSEGLSYTIGVTKATIIANVINIVLNYVFI
KGLFGIPPMGVKGSALASLIARIFMVVFLYFVLLNEKKTKRYIKDFTLKMEVFSKNMFDK
MIRLGLPTALQMFFEVTAFAGAAFICGLISAHDIASHQIALSMASFTFNLCIGFSVASTV
MIGRKLGEQNFVELRKVGINNLKIAFIFMAICGIVFILGRNILPTFFTKKEEVEVITLAS
KLMIIAALFQLSDGIQVTALGMLRGLQDVKIPSIYTFIAYWIITIPLGYFFCVTLKMGAF
GMWIALGLGLTVSAVFLVKRFLNMSAKRIKQNL
>KALACAFP_03347 hypothetical protein
MKFFTFFRLACIFLLLVSCKEKRFLNNHEVILVTNFINGDEKLREEAKIFESKNRIKFDE
SNKIYLRFISKYEKIDTVKSTHFYPALIIDGYYLYSFKNIKTNKVAAFGTGVNAQTGQVK
QFKKVIWINEHSLKSN
>KALACAFP_03348 Putative phosphinothricin acetyltransferase YwnH
MQELIFKNATLKDLPKIVEIYNSTILSRMVTADTENVSVESRLQWFHEHNPETRPLWVVE
DEESKIIGWVSFSSFYGRPAYNGTVELSIYMHESSRGKGYGKKVLQYCIDNAEKFGVKTL
LGFIFLHNEPSLKLFRHFGFEDWGVFPDVAVLDGVERTLVILGKRIANGKL
>KALACAFP_03349 hypothetical protein
MLRTNPQFLDYLEELYNKPENKKNIVLKSFEKGEKILTQNEVSNKIMLIKNGITKCYFVE
ENDKEYIVEFLGKGEIIGEIEVIKNVSCLCSIEAMTEVTVYSMTIPYFQFLIKNDLSLNN
LLLDVFVERIVNTSSRASYQQLYTTEHTLSQLLELKSKEMEISKEDMAAYLGITVRSLNR
ALKEIKQSNNEE
>KALACAFP_03350 Pyrophosphatase PpaX
MNNNITTIAFDADDTLWINEPYFQEAEKEFCILLEDYLPQHSVSQELFKTEMKNLHLYGY
GVKGFMLCMIETVSIISNNTASLELINKTIEIGHELLQKPVELLDGVTETLENLKGKYRL
VVATKGDLLDQERKLKKSGLQEYFHHIEIMSDKKESDYQKLLKHLDCRTEHFLMLGNSIK
SDILPVLEIGGFAAHIPYHVTWNHEQHDLQIEHPNFMELKNIKGILDFL
>KALACAFP_03351 hypothetical protein
MNEFFFIFNFKKITLKILIILICLPCFIFGQLSPKVKTFYDQLSMSKRAEGKNIGFAGSE
SDLYKIHEEMAKIATDEEVEYIAFNGNPVTKYYATNILFERKSKSLEKLFQYYLKSKDSV
SVLRGCVGETDHLSSKIYTRLNFEKQIIKQTEFEKKWRDSMIINKQPMPDDYFDLFNTKT
SWTIKEIDSLINTLDQIVLNDHKSPKYLVEIICGYHLSESLKVPYFEKIAYFEEKYNSEY
IRKYMKFCRSGIREPMEY
>KALACAFP_03352 Dipeptidyl aminopeptidase BIII
MKIKLTICLLAFLNFYDAQESITYQKPSAEILKLADYERPPSVLMNNKKDWIVFTYRPTY
KTLEDLSQQEMKLGGLRINPVTNISSSATYSNNIKVRKINDKTEVQVKNLPSNPKITYTS
FSPDEKKLAFTNTTNKGVELWVIDLETATAKKITSDNLNANLGSPYVWYKDSQNLLIKTL
PQNRATLIDSSKDLPTGPIVSTADGKVSQNRTYQDLLKNPQDEKNFEILTSSDIYNVDLN
GNLKKVKDQDLYSGLSFSPDGNYLMATTIKKPFSYIIPLNRFPMTTTVYDMNGNVVKTVN
EVPLNEVMPKGFSSVRTGKRDMGWRSDLPATLVYAEALDGGDQSKTADYRDEIFTWDAPF
SNAPKSFFKTKQRYGGTSWTNDHYAIVSEGWYDTRNTKSFLVDLDNGESKVIDDRNYQDV
YSDPGNFNTTKNQYGRYVVDMKGGKSYLIGAGFTKDGQHPFIDEMDMKTLKKKRLYTSNL
KNAKEEIIDILNPSKGEILTTQQSPSQYPNYFKKNIKSNKTEAVTNFVNPFESIKDVYKE
VITYKRNDGVTLTGTLYLPANYDRKAKKEKLPLLIWAYPTEYKDKNTAGQNTQNPNDFTF
PYYGSFVYWTTKGYAVLDDAAFPIIGEGKTEPNDTFIPQLVANAEAAINAVDQLGYIDRK
KVAVGGHSYGAFMTANLLTHSNLFACGIARSGAYNRTLTPFGFQSEQRNYWDVPEIYNTM
SPFMNADKMKTPLLLIHGDADNNPGTFTLQTERYFQALKNLGAPVKMVLLPKEAHGYVAK
ENILHLLWEQDQFLEKCLKK
>KALACAFP_03353 hypothetical protein
MNYSNSNSTVLKDIILLIVRVFIGFAMLSHGFPKLQTLLEGGKIEFFDFLGLGPQITLIL
TVFSEFVCSILLILGLFTRVALGFLVFTMIIAGFVVLSAEPFAKQELSFIYLSVYLLLIV
FGAGKISVDYMIEKRKRANDW
>KALACAFP_03354 GTPase Era
MHKAGFVNIVGKPNAGKSTLLNQLMGEKLAIVTQKAQTTRHRIFGIYNEDDLQIVFSDTP
GVLDPKYGLQEKMMDFVKDSLQDADVFLFIVDVTDKAEPSEFLIDKLNKIPVPVLLLLNK
VDQTDQEGLEKLVGEWHERIPKAEILPISALNAFNTDIILPKLKSMLPENPPYYDKDQYT
DKPERFFVNEAIREKILLNYDKEIPYSVEVVTEQFKEKEGIIFIDSIIYVERDTQKGIII
GHKGEAIKKVGTEARQDLEKFFNKKIHLNLFVKVKKDWRKNDRDLKNFGYR
>KALACAFP_03355 L-ribulose 3-epimerase
MNIKFGASLLSWITPVWSPEAGKYAIEKTAGAGFDLIEILLPASMEFNTDEVKKQLKNNN
LEAVCSLNLPKEAHIAHYPKVAENLMKQAINKTSELETDFLGGVLHGGIGVFSGNILTEN
EEEIITEVWSNVADYAKEKGVNIGIEPINRYETYVCNTAENVLDLISKTGKDNLFLHLDT
FHMNIEENNFYDPIILAGNKLKHLHMTDSHRGMLGEGTVNWNELFKALKEINFEGNLVLE
NFSSSVPGMQQMVSLWQKSPHDAEELALGSLKFMKNHSN
>KALACAFP_03356 Maltoporin
MKNQILKGCFLMILILSQRGYAQIIITNKKFSFGTTGRIGAGYSPNADGRTGRQLNLANQ
GSLGGRMDQGDYVDFLPAFHFTPVVGDSAKKTKIDMQARLSFYSGGTFLGNVDTKSNQGM
IVALPEAFVEARNIMGSDWDVWAGSRWLRFDDVHIADYFYFDDHSATGWGVRHKNTRFSM
FFPAAIDTAASNSTPYSYTNIISGGKHLIYRQREVFVLEQTIPFKNNDHKVKLLAEFHAV
DKSGKHSVENYPSDYGWVLGAKLNSNLKTRLPGSFNQISLRYGAGIANGGDGGNTQTWRT
YGAPNEVTRTYKGAYSLTAVEHFLLNLSDRWSLNGYAVYTQSKGGADSDNKAIDYYKREI
FNKKSEFNTGVRATYYFNNWFHILSELHYAQRKDGTQDPASMVKFVLAPTIVPTAERSVW
ARPHIRLIAEISRYNDQAMNTLYSPFLQQSGSKRIGTYLGVRTEWWVF
>KALACAFP_03357 L-fucose-proton symporter
MKSAKFTEKKYLVVLAFVISLFFFWAIALTMGDVLNKHFQNVLHISKSKSGLVQLSIFGA
YALMGIPAGLFMKKFGYKMGVILGLTLFAGGCFLFVPASNMASFDFFRFALFILALGMAT
LETVAHPFLASLGDERTSDQRVNFAQSFNGLGAIVGPLLGGFFIFGGAGEDNSLDSVKSL
YTWIGIVVLVLAIIFSFIKVPDLKDPHTEEMEILEHATGEDHHADQVDAAAPLWKQRHFV
FAVVAQFFNIAAQGGTWAFFINYGVEKMHLQETQASYYFSLSMAMMMVGRFIGTFLMRYI
APNKVLAIFTACNIVLCLIISQSFGWVSFVSLIMLNLFLSVMYPTIFSLGLKKLGGKVQQ
ASSFLVMAMFGGAFFTPIMGKIAETDVAHAYLLPIICYVIIVLFALKLYKPKTLK
>KALACAFP_03358 Fructokinase
MINNKKYVVCFGEVLWDIFPEGSRAGGAPFNAAYNIHKMGIDVKMLSRIGSDELGQKLIE
QIQGWGITTEFIQIDNENPTSTVIAKIDEHNEATYEIINHVAWDYIELQPEHIELVSNAD
AFIFGSLSARNEKTRQTLLQLLDHAKLKIFDVNFRPPFIDVELIKTLLHKADIVKMNKAE
LRQIMLFLSEEYKSEDESVVFIQNHFNINEIILTKGSKGARYFVGNKNYGFPAVPITIAD
TVGSGDAFLSGFISKRIQGESPEEIMNQAISLGAFITSKSGACPDYAYSEFENFRIQNSI
>KALACAFP_03359 HTH-type transcriptional regulator KdgR
MKRASIKDIARIAEVSVATVSYVLNKKEGSRISEATKKKIHDVAKSINYTPNKIAKSLKM
SKSKLIGLIVADISNDFYSNIARNIEDQAMKLGYTLLIGSSDENPEKFRKLTELFSEQQV
DGMIIAPVVDSDDAINKLIGEEYPIVTIDRYLKNVSLPGVMINNSEISEYICDQLVEKNF
DEIIYVGYDTKLPHLLDRQDGFDKRISASKIKSKRILIGIHNITEEVHSKLRENLNLNKK
TAIYFSSNKLGIAGLRYLNDNNIRVPEDVSVIAFDETEAYHLFPTDIDFVQQPLIDMAKE
SVKLLDSQINNYTPNGKRVIFHAKYMGRNSVK
>KALACAFP_03360 hypothetical protein
MTINDILNNIHPLPESSANKLKKYITEVSYPKNFCLMEAHKIVPYIYFIKRGIVRAYATT
EDKDITFWFGKEGETIVSMKSYVEDKPGYENIELLEDCELYKLETENLRKLFNEDIHIAN
WGRKFAERELVKTEELIISRQFKPALERYKDLMRDKADLIKRVQLGHIASYLGISQVSLS
RIRAEIK
>KALACAFP_03361 Multidrug resistance protein YkkD
MNWIILIVAGLFEVAFASCLGKVKETSGTTMYFWFAGFLISLTISMLLLIKATQTLPIGT
AYAVWTGIGAVGTVLMGIFFFKDPVSFWRIFFIVTLIGSVVGLKAVSSH
>KALACAFP_03362 hypothetical protein
MKKALLLLFTSSILWAQNIPELFNTNWYISQMVIGGQTTITPVMDFTVQPSTFAVVSGNN
VFTSKYFNVSGIGITFSTIDDTFMKSNSGSCTIADYSGTNMTAVQGYDQKNCDFYGLPSI
GNAFSYEIVPNGSGKTLIVTNISNGNKIYYNSFILRTKENETKSAFSVFPNPVKESLTID
NLGNGLSVKVFNMLGQLMYEGKTTDRKIKIDAQKFSTGEYILTIQNHKSYKFIKE
>KALACAFP_03363 Demethylrebeccamycin-D-glucose O-methyltransferase
MLIKMSIWARPLIYKFFKGDQFFDPIDGRSYRKFLPYGYGNQRENALSPGTLSLERHRQM
WLYLQNETDFFIKNYKVLHIAPEQEFLRKFKKMRNLDYISADLFSPIVDVKADILDLPFA
DESFDIIFCNHVLEHIEDDAKAISELYRVLKPGGWGILQVPMKNSLEKTYEDFTIKDPKE
RQKHFGQYDHVRWYGMDYFDRLRKAGFETEPNFYSQNFTEEEIKKYGLRKNEILPVVYKK
>KALACAFP_03364 Methionine aminopeptidase 1
MIQLKTIDELRLMKESARLVSKTLGMLAKEIKPGITTLHLDKLAHDFIKDHGAEPAFLGY
GGFPYSLCISPNDQVVHGFPNNDVVKEGDVLSVDCGVILNGFVGDHAYTFEIGEVNPETK
KLLKVAKESLYKGIEQCIRGKRIGDISYAIQRHCEKEGYGVVKELVGHGLGRKMHEDPQV
PNYGRQGSGKVIKDGLAIAIEPMINLGTEKVKFHNDGWTVTTLDNQPSAHFEHDVAVING
KPVLLSTFQYIYDALGIESDEEKAFQLDF
>KALACAFP_03365 hypothetical protein
MPSILALFLFVSLHFKNIFEMMSNKKIAVDFDGTIVDDAYPAIGKPKIFAFETLRRLQGE
GYRLILWTYRHGKTLDEAVEFCKQNGIEFYAVNSSFEGEVFDSETQSRKLDADWFIDDRN
LGGFPGWGEIYNIIQERIEFRVEGKEVLAYSKLKKEKKRGLFW
>KALACAFP_03366 Putative acyl-[acyl-carrier-protein] desaturase DesA1
MYQALVRKEVMGILEKEVGSFLDKFLTPIEKIWQPSDYLPDPSSDNFRYDLDEIQTFARE
MPYDLFVTLIGDCITEEALPSYESWLMGVDGIDQEKKEVGWANWIRAWTAEENRHGDLLS
KYLYLCGRVNMREVEITTQYLINDGFDLGTSMDPYRNFVYTSFQETATNISHRRVGTLAK
QSGNGKLAKMCGVIAADEARHAKAYKHFVAKILEIDPSEMILAFEDMMRKKIVMPAHMMR
QSGQMAGELWGHFSDAAQRCMVYTGQDYINILKDLLDEWKIEHVKGLTEKAEKAQEYLMK
LPGRLQKITDRISTPDLQFQFNWVKS
>KALACAFP_03367 2,3-bisphosphoglycerate-independent phosphoglycerate mutase
MSKKAILAILDGWGLGMNPDVSAIDKANTPFIDSCYQKFPHTTLEASGLAVGLPVGQMGN
SEVGHMNLGAGRVVYQNLVKLNMAVENGTLGQEKVIQDAFEYAKRENKKVHFIGLVSNGG
VHSHINHLKGLLTAAKEFGLNENVFVHAFTDGRDCDPHSGKGFIEELQKHMEATTGKLAT
VVGRYYAMDRDKRWERVKIAYDALVEGVGDQTTDALPAIQKSYDENITDEFMKPIIMIDS
TAIGNVVPVAKIVDNDVVICFNFRTDRGREITEVLSQKDFPEYFMRKLNLYYVTLTNYDK
TFQNVHVVFDEEVLHDTMGEILEKNHKTQIRIAETEKYPHVTFFFSGGRETEFVGEKRLL
CPSPKDVPTYDLKPEMSAYDITNAIVPELENETADFICLNFANTDMVGHTGVFEAAVKAA
ETVDKCIEKVAMTAYEHGYAVFILADHGNSDVMINPDGTPNTQHSTNLVPFIVMDKDHTW
NLKSGKLGDVAPTILKVMGIPIPEVMTGDILVS
>KALACAFP_03368 hypothetical protein
MRFLILLFPFFLFAQQKITPTVIDNRLEKSNALLFEGQTDNMIKLNLSILEDSKRINYPK
GKVYACYNLALAFSMQYRYNKSNYYLKLMESEFKNLDDEDEEISMNLLYSMNYKGIKMYD
EALKKLRKNIVLANNIKVDSTRYSSNAMTLVEMAKNYIEKKSYDSATYYGKRVIEEVKKP
KNLNSGLNTSLKIALLILAEAKVKENKIDSAEFYIKSAQSVLIVLGNNEFRTFKLLGEIN
EAKKQYDSAIMDYKKAIDLAAKVKNLKKLLELYSLMSGIYEKTGEKDNEKKYALKYNTLN
DSLKIIEEANLKDTVDLLVEEKQKPMEDRNNLLLYIIFAAGIVSIIFIFLVNKRIRKKNK
ILNVKEQETKVLTQKLNVAFEEVILLAKNNDPEFMTRFQEVYPNFFPKLLQIEPQLQNSE
LKFCALLFLNFSTKDIATYTFVQPQSIQIRKNRLRKRLNISSGEDLYIWMKNVNSN
>KALACAFP_03369 hypothetical protein
MDLRDQLKNLFPDHEEQDFKMPEEQFKQKEPLVCKFEKKGRNGKPVTIVEGWEGSEEDLK
KISKKIKTTLGIGGSEKDGTIIIQGDNRDKIMDILKEMGYKTKRVGG
>KALACAFP_03370 Internalin-A
MKKLFLSIFILILSEAKAQIDPVKYPTYTNVEEAFKSGKTVYSMSFREKGIFNLPVEIQQ
LNAIFFLNLMGNKFEKMDESIFALKELTILNVNENNIKFIPDEIAELQKLESFSINLNEL
TNINPNIAKLQKLKVIHLDANNLNVFPEALMKIPSLEEINLQGNQISFIAEDLDQIKNLK
SLNLALNQINDLGNLTFPKQLKYLELQQNSISKLPENLFQSKNLEFLNVSQNNIKEISPK
VKGLKNIVSMNLANNDLKDLPTEFSQLKNLKTLILTGNPMDKSTIEKLKTIMPQTQIYF
>KALACAFP_03371 hypothetical protein
MKRKLLTIAALAMISSSLFNAQTFIFNKNSSWKYNDSNTALAAQWKDTTYDVSAWSQGNG
PLGYGDPVTTTTATGLVTAYFAKDFTVNLNDLSSTMELGIMRDDGIVVYLNGEEVVRDNM
PAGTIDFTTWSSTTIDSSAESVYNVFSIPKSKFVNGNNRISIELHNRGAASSDLRIDAYL
KTVVTTTPVACNSTHISCFTSIVPTAQTNKLIIPTEHKYQLILKEGDNYTEGGGLVGGLN
DFTGYVPKNGSATNGYLSVNHETNPGGVTMAEINYNGTTKLWQLTKSRAVSFSAPSLVQT
IRNCSGGVTPWGTIVTAEEQTTSSDVNADGMKDYGWLVEIDPATAQVISQNADGSKGKLW
QMGIMNHENVVVNNAGTVAYYGEDGGTHMVYKYVMDTPNDLSSGNLYALKLDQGLSGGDP
VATTATWVQIPNKTKADQNNTAALAQSLGGTSFNGVEDIEISPLDGKVYFTAKGLNKVYR
LQDNGTTASQVETFVGGLTTNYSFDTAQGTKTEAWGDGNDNLTFDELGNLWVLQDGGKNY
IWVVAPDHTQANPKVRLFASMPAGSEPTGLTFTPDHKFGFFSIQHPDSTISTDIDATGNT
IDYRGKSATIVVALKNNLGTAGSLGTVDTKAENTVTVAPNPTSGIVKINSPKGLKDIVVT
AYSIDGKIVFTQKYSGTNKSLDLDFTNQLEASRVLVLNIEAEGGFQQTVKLLKK
>KALACAFP_03372 Cytochrome c551 peroxidase
MKFYPLILIFLFIGFAIMSFNPVYKGVENENNVVNKGLADFKTKLDQLKSDVYQFSEEKI
PLEQLQESLKNTRNSFKEIEFYIAYHYPEFTKTHLNAAPLFHIEAAGTSAYTLPPEGLQV
LDELIFSDEAAEEKEKIKAITDFLYNSYASFYLSSVKNGLSKGNNKTLPLRIELIRMYSL
GVTGFDTPGSLNVSEEAKHVFSGMKKYINDDPYFKNYNIQKANAILTDGIGYLSKNTDFE
TFDRIEFYKKYIQPLYEEFGKWDGRSDDLKEFSGWNVNNKNFFSSDFLDPYFYTLLKKEE
DNADLRALGKEIFYDQNLSDNGKMSCATCHLPENAFTDLKSKSPSNVEGKTVLRNSPSLY
NAVFAKRFFYDLRAFYLEQQAEHVIYNEDEFNTSYESIIKKLKTKPEYKKAFKTAFKNGN
ISKENFSKALSSYVASLYSYESDFDKFMRNEKEISVDAKKGFNLFMGKANCATCHFAPNF
SGLVPPFFNENESEVLGIPTKPINQKPIELDADKGRINSPVKKENSWIYENSFKTVTVRN
IALTKPYFHNGAFNTLEEVMDFYNEGGGEGLGLKMKNQTLAPDKLNLTQPEIKQIIAFLN
ALTDVSKR
>KALACAFP_03373 Uridine phosphorylase
MLNKLAASELVLNDDGSVYHLNLLPEDIAEKIILVGDPDRVAKVSKYFDTVEIKKNKREF
YTHTGTLRGERITVISTGIGTENIDIVMNELDALVNIDLKNKEFKKEHSSLQLFRMGTCG
SVNPDVQVDNMLVTQNVVGLDGLMHFYQDYEFENEFSKNFLDKFPYPKIKPMLYFADWSE
ELGTLYKDAKYHGNTATFPGFYAPQGRQLRLKALDDRFLETLNDLGITNFEMETSAIYAL
SKLLGHKAITVNNVIANRRRGEFSADHHASERNLIEWVLDRIIK
>KALACAFP_03374 Autotransporter adhesin UpaG
MQKKSKLQFGLIILLLINFNFVFAQVGIGTPDPATSAMLEINSKNKGVLFPSIALTSVTD
NVTVPTPANGLIVWNNGQGGLTDTGFYYWNNLKWNMLSIASTNSGNGINGSSSGWNTTGT
NSGTYAGANTTLALGTNTLDDLVFKVNSNIMGRLGVYNSISFGVGANASQNGIALGTSST
AYQGISIGNNASVTANESVGLGELSNVSGFRSIALGYNAKVTVNESSAVGNNSTASGFQS
TAVGYNAKTTANESSALGNNSLAAGFQSIALGYNAKTNANSETAIGYGSLTNGQNSTAIG
SGASATGQNSTAIGYNATTSQYNAIVLGDSNANVGIGTSTPNVNTKLDVYGQYKLGERGT
VNKNQISFETWPGVSVNNLPSGKSTTMNIIIPPALIPTSTRATIVVTPAGDFAGNATFSI
SNPRMTSTSNITINLTNISGNAESLNSSHFYVTINEF
>KALACAFP_03375 DNA-3-methyladenine glycosylase 1
MEKIRCGWSEKDDLYKKYHDEEWGKPVYDDETIFEFLILESFQAGLSWYTILNKRENFRK
AFDHFNYKKIAKYSEAKIEELMQNPGIIRNRLKILATINNAQKFMEVQKEFGSFSKYIWD
FVGGKPVDNKPKTLKDIPATTEISDSLAKDLKKRGFKFMGSTVVYAHMQATGMVNDHVEN
CFIR
>KALACAFP_03376 hypothetical protein
MNNSEYNKAENAVNNTENSLQNAADKAKWKVEDLADKARDYINEKRNNDEEAQQEDWLDR
VKANVSETWEDIKDKANDAWEKTKDAAEDVKAEWNKKTN
>KALACAFP_03377 Enoyl-[acyl-carrier-protein] reductase [NADH] FabI
MSYGLLKGKKGIIFGALNEQSIAWKVAERCHEEGAEFILSNAPIAMRMGELNALAEKTGS
EIVGADATSIEDLEKLFDAAVAKFGKIDFILHSIGMSVNVRKGKHYTEMNYDWLEKGWDV
SSVSFHKVMRVAWEKDCMNEWGSILALTYIAAQRTFPDYNDMSDNKAYLESIARTFGNYW
GERKVRVNTVSQSPTPTTAGSGVKGFGGFLGYAEDMSPLGNATALDCANYCVTLFSDLTK
KVTMQNLFHDGGFSSTGVTQKVISKYDTE
>KALACAFP_03378 Glucuronoxylanase XynC
MKKLIVSCFVIGMAFNANAQNYWKKNAGKTAKVILTNSKTNEKMVDKGMVKFEKMDQPKE
VDACIFVDPDFKYQKLIGIGGAITDASAETFYKLPKNKQKEIIEAYYGKNGLGYTVVRTN
MNSCDFSSDSYTYVQENDNSLKSFNVAHDEKYKIPMIKEAQKAIGKDFTFYFSPWSPPAW
MKSNKNMLKGGRLENAFYQTWADYYIKFIKEYEKRGINIWGLTVQNEPMATQTWESCIYT
AEEEGAFLKNNLGPTLWKNGFKDKKVMIWDHNRDLIYQRATTTLSDPETSKYASGIGYHW
YETWNNKTQLFDNLSETQRAFPDKFLAFTEGCKEQFDMTKIYDVKLGELYGRNMLNDFNK
GTALWTDWNVLLDETGGPNHVGNFCFAPIIADTKTGEVHYTYEYYYVGHVSKFIKPNAQR
IGTSSNRAALTSTTFMNENGQLVTVIMNDSDNDIDANLWIEGMAAKLSAPAHSIQTVIL
>KALACAFP_03379 Beta-glucanase
MKLQAIITILIGGTLLFSVSNCASNKPDSNRKLIWSDEFNGKGLPDSTKWNYDVGGSGFG
NEEAQFYTKDRLENARLEKGNLVIEARREDWENKKYTSARLLTKGKFSFQYGTVEVRAKL
PKGRGTWPAIWMMSENMKKWPDDGELDIMEHVGFNQGYIHASVHTKKYNHIIGTQKTDTL
IVKDASEKFHVYKADWTPEKIDVYIDDQKFFTYENKEKTYEAWPFDQPYFIILNLAVGGF
WGGKEGIDDTIFPQKYEIDYVRVYQNK
>KALACAFP_03380 Beta-glucosidase BoGH3B
MKRVYFLLAITAFGMNAFGQKTIDQKVSELLSKMTLEEKVGQLVQYSGFEYATGPQNSNS
ATVLNEIKQGKVGSMLNVAGAEETRKFQELALKSRLRIPLLFGQDVIHGYRTTFPVNLGQ
AASWDLGLIEKSERIAATEASAYGIHWTFAPMVDIARDPRWGRVMEGSGEDTYLGTQIGL
ARIRGFQGKGLGNLDAIMACAKHFAAYGAAVGGRDYNSVDMSLRQLNETYLPPFKAAAEA
GVATFMNSFNDINGVPATANKYILRDLLKGKWNYKGFVVSDWGSIGEMVPHGYAKDNKDA
AEKAINAGSDMDMESRAYMAELPKLVQEGKVDPKLIDDAARRILVKKFEMGLFDDPYRFS
SEKRQKEQLNNQEHRKFGREFGSKSIVLLKNQKNILPLSRSTKTVALIGPFAKETSANHG
FWSIAFKDDNQRIVTQFDGIKNQLDKNSTLLYAKGANVDDQDKSMFAEAVETAKKADVVI
MTLGEGHAMSGEAKSRSNLHFTGVQEDLLKEIAKTGKPIVLMINAGRPLVFDWAADNIPA
IMYTWWLGTEAGNSIADVLFGTVNPGGKLPMTFPRTEGQVPIYYNHYNTGRPAKNNTDRN
YVSAYIDLDNDPKFPFGFGLSYTQFKYSDMILSSTNLKGNQTLNISVNVSNTGNYDGEEV
VQLYIRDLFGKVVRPVKELKGFQKVFIKKGESKTVNFTLTPENLKFYDDQLNYDWESGDF
DIMIGTDSQNVQTKRINWSK
>KALACAFP_03381 Glucuronoxylanase XynC
MISQYSYSFVLRGAALCGVALLSFFNCSSTSSDLANGDSGNNGGGNTSGDPVQVWLTKGD
QSVKLQQQSTVYFSGTSSTGTTIEVDASQVFQNIDGFGYTLTGGSVQVINQLNAAKKQEL
LNDLFGSSGIGVNYLRISIGASDLNSEVFSYDDMPAGQTDPTLAQFSLTKDQAVIQMLKD
ILIINPNIKILATPWSPPVWMKDNGSSIGGSLKPEFYGVYAQYFVKYIQAMQAQGIKIDA
ITPQNEPLHPGNNPSMYMTATDQATFIKTHLGPAFQAANITTKIIAYDHNCDNPAYPLTV
LNDSAANPYVDGSAFHLYAGDISALSTVHNLFPNKNVYFTEQWTSSTGNFGGDLDWHVKN
VIIGSMRNWSKTALEWNVANDASFGPHTPGGCTQCKGAVTITGGSGYEKNVAYYIIAHAS
KFVPVNSQRIASTQSDNLSTVAFKTPAGKTVLIVQNGNSTDKAFSIKYNQKTAPVTISGS
STATYIF
>KALACAFP_03382 hypothetical protein
MITKYINKTLLLGASVFFLASCTPDTVDGDGNGLSQDAVDGSFKVAKTAENRYRLTTNAN
NYITTKWNIDDEGFNIGKNIQDIFLPDKGTYIIEHQAIGKGGVVAGTGTETITVPTDDPV
AGNIIQGGRFDSADDIAKWTIHTISPSGAQWVFANGKATIVASGSNQQAIYQAVNVVAGQ
KYAIDMVASSDTALEDTWFEVYMLNSIPVSGQDVSGAVYRNINTWDGCGKSAFKGRVSTI
GCNGDKNGGIYTATTTGTVYLVIKCGGKTVNSLSIDKVELRRTQ
>KALACAFP_03383 SusD-like protein
MKNKIIKISIAASLLLGTGLISIACNTDNLEDVKNLGAFDTNNFFRNEQECFFALVGTYD
PLRKYAGGFENMVTFFNAGSDDFYAGGGSATDGAGIQGLSNYQLNPNTMPASYWRDYYQG
ISRANILIEKIPQASMSDAIKNRFTGEAKTLRALYYFELLRMFGNIPLILKEIKATDDYY
NIPQATKTEVYTQIEADLLDAIPKLPMTVSGDQKGRLTQGAAKALLGKVYLYENKKAEAA
AQFADVNGTPGGTSQYGYKLVSDFASLWVTDNKFTTESIIEVMHTNKGNSDWSFWGQGND
EGNSINIMVAPRGYSKKTDDAPDVVAGWAFNPVTTDLYNFMQGDPRMDATILNVKVLKQQ
NKADYSPAYMDSGYFLNKYMPTKDEVTTLPGASELNYRQNYIYIRLADTYLMEAEALNGT
GSRAQALLDAVRTRVGLASIPVSMQAIKDERRRELAGEGHRWFDLVRWGEAPAKLGSRGF
IAGKNEILPIPYTELTGTILKQNPNY
>KALACAFP_03384 TonB-dependent receptor SusC
MNVKISRSLGMVAVLYFTANFNAQNTTKDTVSKETKIEEVVMIGYGTQKKSNVTGAISSI
KASDIENIPAGKPEQVLQGRAAGVNVITNSGQPGSSATIRVRGITSYYSNNDPLWVVDGI
VVDGIGWLNQSDIESIEVLKDGASSAIYGVSAARGVILVTTKKGKKGRLNLSYNGSYGTA
RASRKLDLLDATQYATILNEAYVNGGQNPVFQNPQSLGKGTDWQDVIFGTGERSNHEISI
SGGNEKSTFYGSFGYFDQTGIVMSDISYYKRLTGRLNSTHKLTDWLTVGQTFAYTHTKSQ
GINSNGEFGGPLSSAVNLDPTTPIVVTDPALANSSTYSNPNIVRDPYGNPYGISTLVGQE
MSNPMAFRYTQLGNSGWSDDFIANIFAEVKFLKDFTFKSSINGKKSYWGNQSFTPLFYLN
PNYSNLNFNSLSRTTQQKLEWSLENTINWQKKFGEHSLNILAGTGYYEYNIGFGQTVTHT
NLPISNYQDASFNYFIPQDQKNLNAWDYVNTHKASYFGRVVYDYANKYLFTGTIRRDGSS
KFPNANHWGTFPAFSVGWNVDKENFWPENKIINTLKLRGGYGVLGNDGIGDFLFASFYVP
GANYTNGSNVIMPGYIPNTLANPDLKWESTSQLNVAADIRFLNNFNLTVDYYKKKTSDIL
RQIQIPGYVGVTVAPTANIGDMENEGVEVELGYKKSWTDFGVSVNGNFAYLKNTVTSLER
GRDYLDGPGFQSMGPVSRIQVGESYGSFYGYKTLGIFQNQEQVNAYRNANGQMILPDAKP
GDFIWQDTNGDGKISDADKVNLGNSVPKYTFGLTVNLNYKNWDLMVFAQGQAGNKIFQGL
RRLDILNANYQTAILDRWTGEGTSNTTPRVTTNDTNHNYTWMSDYYLQKGDYVRVKLVQL
GYTLPQTMTQNFGVSKVRFYVTGENLFTFTKYTGYDPEIAAGDSFGIDRAYYPQAKTFLF
GANVTF
>KALACAFP_03385 hypothetical protein
MTTKHYNISLPLKLTFLIFSMVLNCMGIVILQLSEAKITYEKLGFLESFKDIPIAFISLF
VVNFISKIGAKKALILALTIVGICSLILPFVEVFWFYKLWFAIIGTCFAIGKICVFGIIR
NNISDEKSLAKTMNNVEASFMIGIFVVNTGFGWLISSQYSQFWKFGFLSISVLSAITIFL
FSRLNISEPIKEEKVNIIEDLSGFINPLVIIFLAVIFSIVFVEQSFNSWLPSFYKNHLKV
NSFFALQASSFLALFSYIGRTVTANIIQRFSLSKYYILCLSLIIFVLIIIAGIQFLDMDN
SKILLYLFPVIGLFLSPLYPVINSKMIAQIDKTKANLFTSLIVIFSSLGSSVSSIIMSIL
FGNQLLSYYSVYILLAVIVLFTISLIYFKLADKTFRK
>KALACAFP_03386 hypothetical protein
MKIKNEKNKETLQELIDTKDFVAHVSVDCTIFGFHNNILKVLLLKYHDLDLWSLPGGFVF
NDEDLREAAARVLHERTHLKDIFLKQFHTFGRIDRTENNVHQILLNNKGIEVPKDHWIFQ
RFITVGYCSLIDFSIANTFPDAFNETCEWFEVNKLPKMAFDHDRIIETGLEYLRMNINTE
VAASNLLPEKFTMKDLQSLYETILGQQFRRNNFQRKILSLNILERLEKLYDGSANKAPYL
YKFKNRIYNPTNQYPISNEEEN
>KALACAFP_03387 Acyl-CoA dehydrogenase
MSYYSLTSIPDYYGIDALLTEEHKLIRQSIREWVESFVMPKIDQAAQNHTDLPGLMRELG
KIGALGPYIPVEYGGSGLDQISYGLIMQELERGDSAVRSAASVQSSLVMFPINEFGSEEQ
KRKYLPKLASGEMIGSFGLTEPNHGSDPGSMESNFKDMGDHYLLNGAKMWITNSPLCDIA
VVWAKNEEGKVQGLIVERGMEGFTTPETHNKWSLRASKTGELVFNNVKVPKENLLPGVSG
LKGPLSCLNSARYGISWGVIGAAIDCYCTAVQYSKERKQFGKPIGSYQLQQKKLAEFLTE
ITKAQLLCLQLGNLKNDHKATPAQISMAKRNNVKMAIDIARESRQILGGMGIMGEFPMMR
HAANLESVITYEGTHDVHLLITGMDITGINAF
>KALACAFP_03388 hypothetical protein
MKFLNKIIHELLAQNTDLSAFNIVLPGKRPIVFIRQILEENNYSGFLPNFFTIEELIVDI
ADKQPIQGISLWLFAFDVYKSLNLIPNDDFADFLKWFPTLQKDWDDILKFSENDQVVLQY
MFDEERIKDWAQNLGEDDDVPRKKFLNFWKNMNVFLPVLKQKLKEKNWATSGMIHETAKA
EIVNFAKNTQELFVFCGFNAFTPVEEKLVRNLLQWDKGQCFFQADRYYFDDERQEAGKFL
RNHKTWKEFNDHRFFEWIEDDFNQPKNIKVYEVSGNITQTKILPEIFKEIENKTYSNTAV
VLLDENLLPASLDVMYSVQNLNITMGFPLKNLSFSNAVKQLFYLQKQLEKNKSSYYYRDI
FPILEELPKSAEDELIINQFKSKIEERNIVYISKKLLHELLHNLSYYHLLQKADSTNVYL
DSLIAFCRQIKWLEIDDIQYENVSHFENAFRMIKNQLSPYQFEIKMETLEILINQHINSE
SIDFQGEPLKGLQIMGLLETRLLNFENVIMLSVNEGKLPLGNSQNTYIPFDIRKFFDLHT
FLENDSIYAYHFYRLIQDAKNVHLLFNALSSGVNTGEKSRFITQIEMESSHQIEHLIIEN
SSEPIIIQPIEISKTDIVLERLQKWKEKVSASHLTSYLYNPIDFYLSKILNTSESDEIEE
ELSVKNYGNLVHYTLQEIYEVLKGKVLKENDLKESIKAIDQYIEIAIEKLKHQPEFYEKG
MNFIHKAIAKKVIESILYHDLELVKKGNKLEILDIEKRFENVDFYLDENDKISFFGFIDR
IDRLNGTLRIIDYKTAKIKNLVVKIDENNVDEYFHNSDRKQALQLCIYQYVVQNLPEFWG
LPIETGIWSFAEAKKGVVSLQFEKGNIDDAMKSIKSLIQEILNPDVNFIEEIKSYSN
>KALACAFP_03389 hypothetical protein
MKWIFVACFLVSNVLLGQKIFWEEGNKLNWNNFKSKINRKGGDNVVAYTNCGWIYSYEKS
SNPKAPIKIEVQTVFNEDKSWKDTKRINDYVLLHEQKHFDAAEIFARKLRKEISEKIKTS
SDFDKYFKGIYSKILRQYQDFQRAYDGETKNGMVEEKQSEYNRIIAEELENYKSYKTS
>KALACAFP_03390 hypothetical protein
MKKLLYFGFSTLVLGLSITSCNDDDDYQTIESIDKVKIDSVRIVNDTMDVFTVQSIKTYS
TYPSHCEGFYGYDYIHTDSSTRTVTAYKYITNGPCAQGSYTAPGQINFSPQQVGTYTFKF
WNGGSNWITKTIVVE
>KALACAFP_03391 Ribosomal RNA small subunit methyltransferase G
MSTTLLLKYFPDLTENQIEQFNKLEDLYQEWNEKINVISRKDMESLYEKHILHSLGIAKV
MEFEPGTRVLDIGTGGGFPGIPLAILFPESTFTLIDSIGKKISVVNAVAEGVGLKNVTAI
HGRAEKLKEKFHFVVSRAVTQMPEFLRWLKGKFEKEQFNPKHNGILYLKGGDLAEELAGI
KCEIFNLKNYFDEEFFDTKKVVYVSKGNFNS
>KALACAFP_03392 Aspartate aminotransferase
MSKLSDRVKRLGYSQTFVMSNKAREMKANGIDVISLTLGEPDFDVPDNIKQAAFDAINQN
YSHYSPVPGFLELREAISYKLKRDNNLEYKPTQICVSNGAKQAILNVLAALLNDGDEVIL
PNPYWVSYDEMVKMMGGTSVMLPTSYVTDFKVTAEQLEEAITDKTKAVLFSSPCNPSGGY
YTYDELKSLARVIAKYPHVTVISDEIYEYINYETTTTSIAQFPEVYEQTAVINGMSKAFA
MTGWRIGYSACPEWLAKACEKIQGQMTSGANTMAQRASIVALKTDPSEYKYMIDAFKKRR
DLVYDLIKEIPGFKVVLPKAAFYFFPDISHYIGKTLDGTEIKDSDDFAMFLLEKAHVGCV
GGVSFGSPECIRFSYAASEEDLIEAMKRIKNLLDKFN
>KALACAFP_03393 hypothetical protein
MNFLKKITIATSIAAASYCGYAYGQDFQWKEATSNGYSYKYVTNDPTSARYYTLKNGLTV
ILSPTKKDPRIQTFIATKAGSKTDPSDHTGLAHYLEHMLFKGTDQFGSKDWAKEKPLLDQ
IDALYEKYNQTKDEAKRKEIYKEIDKISGEASKYAIANEYDKMMSGMGADGTNAFTSFEQ
TVYTEDIPANVADKFLTVQAERFRQPILRLFHTELEAVYEEKNRGLDNDPRKVYEAMFAA
IFPNNNYGKQTTIGTVEHLKNPSLKAIREYFNNYYVPNNMGIIMSGDFNPDEMIAKIDKA
FSYMKSKPVPEYKVGTEAPITAPIIREVYGPNPENITIGFRFPGATTKDARMLNFIGSML
TNGQAGLIDLDLIKKQKLLSAYAFPYVLKDYSVLLLQGNPTEGQSLDDVKTLLLQEIDKL
RKGEFSDDLLQSIVNNEKKNVIQKYEKYNSRAESLMDEFTSDVDHKTQLAYIDEISKITK
KDIMDFASKYLLDNNYVAVYKRKGEDKNIVKVDKPAITPVSVNREDQSPFLKKVNEMPES
PIAPVWLDYNKDIAKNKLGSVDVLSVKNTDNSLFRLYYYFDSGKWNNKILPLAAEYLQYL
GTKNKSSEDISKEFYKLASSFNVSAGNEETYVTLEGLNENFDKTVALFEDLIKNCQPDQK
ALDAYKTRVKKSRANAKQNKGTIMTGLRSYAQYGPQNPFNNTFSDAELDALKAEDLVNVL
HDLFNFKHKVLYYGPKSGNEVTASLTPIHKVSNSLKDMPKSKTFTQIPTDKNKVLFAHYD
MVQAEIFWVRNGDPYNVNTTPTVSLFNNYFGGGMGSVVFQTIRESKALAYSTYSYFSLPS
KKEDKDMIMAYVGTQADKFNESTVAMNELLTTLPKSDQLFETAKSGLKKSIASERITQDG
IIFSYLRAQKLGNNTDIRKNVYEQAPKLSFTDINNFHDKEMKGKNYTYCLVASQDKVSEA
DMKKLGEVKKLNLTEIFGY
>KALACAFP_03394 putative peroxiredoxin
MSLVGKKFPNVTVDAMSEMGDDLRINIFEEATTNQQKVLLFWYPKDFTFVCPTELHAFQE
ALGEFEKRNTKVIGASCDTNEVHFAWLNVSKDNGGIEGVTYPLLADTHRQLANILGIVDQ
DFEYNEEGEEVFTGSNVTYRATYLVDETGKIFHESVNDMPLGRNVKEYLRLIDAYTHVQK
HGEVCPANWEEGKEAMKADRNSTAEYLAKN
>KALACAFP_03395 Thioredoxin 2
MYTELTEDTLQNIVNDNEKVVVQYGATWCGNCRIMKPKFKKLASENDGIPFLYVDAEKLP
ESRKLAKVDNLPTFAIFKNGELVNQVQTNQAESLINLFNEL
>KALACAFP_03396 hypothetical protein
MKLPVIRQFYQNQTPENLEKTLEVLESFCEFRGTSEEDLNVAGELITNICGALEVHANVQ
NGMSEKDALNSFAQKVLGSIDK
>KALACAFP_03397 hypothetical protein
MMTDVLVAHSSDVEKASFYKKTYLHVALSILAFIGVETILLKIVPERLIIAMFAQRFAWL
LIIGVFWLASILATKWSLSQSKQIQYFGLAFYVLLEAVIFLPLIYIAVVYSGAQVIYQAA
MLTIAMFAGISAVAFTSKRDFSFLRNIIIIGGFISLGLIVAGMIFGFNLGLWFSVGMVIL
ASATILYQTSKLKDSYSTNQYVGASLQLFASIMLLFWYILSILMSRRN
>KALACAFP_03398 hypothetical protein
MKVKILGFLLISQFYLSQNIIQADIQGKKLDYFVQLENKLGSKIYKTDEEHISSGEVLQP
VIFERKEKDIPNLLVFYTPNKKDSTISEILYEWDVYNFDKGDNVKKTLSFNKAMIKKYYQ
LVDEVSKKYGKSIQKGNLEKLELLNAEDGLERSDNWEINKNLKINSYIILSEYYEKNGMV
TTTPTHKIRLYVTNGDENEKDILSEEKIKLFNDEFLKFIDKLKTSDFNEVRNFLSEKIRS
STTDEVLKNLIKNTHFEKKVEIFMTGYQIINDGNQYPMLQYKYVEDDFPPNEIITVLFEE
NGKILGIKPVKKIE
>KALACAFP_03399 hypothetical protein
MKKLLLIFAVAAFQLGFSQQKGNVRIVESKKIEFTSELSKDKIDLYNQSFSKFVAALKAS
DRQAISNLLSDKVKDVVTENVIQQLSGGISFERKTEVYKSGYQKLLDNETYPGIQYKYVD
DSSNPPRDIITVIFENDGKILGVKPEYSK
>KALACAFP_03400 hypothetical protein
MNIENQVLGLTRLSDYIKEFLAKNPENYSENDSDFELLLKKSEIENPWFTLENQKFALQQ
WADLLTEENINNWIKEYSISKISKRVGLILAGNIPLVGFHDVMSVVLSNHIPVIKLSSKD
RYMIPFLLKKWKEFSDNQVEFEFVERLENFDAVIATGSNNTARYLEYYFKNHLNIIRKNR
TSIAVLKGDETTEELQLLAKDIFQYFGLGCRNVTRLFIPQDFVIDKLFENFLNYQDIINH
NKYANNYEYNRAVYLLNQEKFWDNNFVMMKEDEKLFSPLSVINFSRYSSLDEVKNFIAEN
EENIQCVVAKEELGLNSVKLGEAQNPGLDVYADNVDTMKFLSVI
>KALACAFP_03401 Ferredoxin
MAIKITDECINCGACEPECPNNAIYEGAVDWKASEGTELKGTVTLTSGLTVDADAPQEPV
SDDVYFIVTDKCTECKGFHEEPQCAAVCPVDCCVPDEDHVESEEALLNKKAFLHGE
>KALACAFP_03402 Phosphoserine aminotransferase
MSKKHNFSAGPCILPQEVFEKSAQAILDFNGIGLSLLEISHRSKDFVAVMDEARAIVKRL
MNLGDDYEVLYLGGGASLQFAMVPYNLLKVGGKAAYLDTGTWAAGAIKEAKKLGTVDVVG
SSKEENYSFIPKGYTVGSEYDYFHCTSNNTIYGTQMKSFPEVDTLMVCDMSSDIFSRQLD
FSKFDLIYAGAQKNMGPAGVTLVVVKKEILGKTGRENMLSMLDYSQHIAKESMYNTPPVF
PVYASLLTLQHLENNGGIAAAEGRNEAKAKLLYDEIDSNPLFETFCVKEDRSLMNVSFKL
IDESKKEEFDNAWKAAGISGLNGHRSLGGYRASLYNALPIESVQVLVDVMKSIK
>KALACAFP_03403 Hydroxypyruvate reductase
MKVLANDGISKAGEQALKDAGIEVLDNRVAQDHVINFINENNVDVLLVRSATKVKQDVID
ACPSLKIIGRGGIGMDNIDVEYAKSKGIKVINTPTASSKSVAELVFGHFFSLARFLHESN
RLMPLEGETHFNAMKKSFSKAYELSGKTLGVIGFGSIGQEVVKMGIALGMKVKVLTRKPK
TEVLTLSFFDGQSVNFEITSTNDMDAFLKDADFISINTPKTNEYIIDTPQFEKMKDGVYI
VNTARGGVINEVALIDFIESEKVAGAALDVFEKEPNPEVLILMNPALSLSPHVGGNTVDA
QEKIGVELAEQIIKLKKETIQ
>KALACAFP_03404 hypothetical protein
MPVFKPFRGIRPHKDYESTFPTHPLDNFTQEEIAEKAQVENTYINMIKPYVVSKSKDIDR
NLRKIRSTFEELLDENKLVQDNSAYYLYEQIYPSKQVFRGLLGLASIEDFWSGKIKRHES
TIPQKKEKLAHYLEKVNLQAEPVLLTYPANSKIELLMNHEEKNVPIFNHVDSKGIRHKIW
RIDNRLKLQQFKEVIDQIDSFYIADGHHRIGSTALNAKYHKDKNKRHNGTELYNFVYSFI
VSNQSIKIHDYNRVVTDLNGLSSEVFLKELEKYFLIHEKGETAYYPSQKFHLSMYLDGKF
YSLHVKHDLRSKEMSLDNLDHHLLDKYIFKDILKIEDPDSSEKISYIKGTSTIEGINQIK
EKIDSGEGKVGFGIFPVSFNDMIKISDLKLSMPPKCTFIEPKLVTALLMYDMKP
>KALACAFP_03405 Aminopeptidase S
MKKIFIIIPLFLGGFLFSQKKPQKKPAKKTTVAAKFNYHDEFKKISDEIMTNGTAYNNLG
ELTKGIGSRFSATPGYTKAVEWAEKKFKEIGIEMIWRQEAKAPVWIRGKESLQIKAGNGD
WKNIRMLSFGNSEGTGGKDLTGEIVLINSTSELNALSVGQLKDKIVFVNLPMDPKIINTS
DSYLITAKSKLISASVIAKTGAKALIIRSLTTANDDIPHAKMIYYEPDDKVKIPALSIGV
RSADELEKLLKKQKVIAKLNMTAESKGDTTNPNIIAEIPGKKDSKVILLGAQLDSWDFGE
GAIDDGTGVVQCIEVLRTLKALGFENNHTIRVVLFANSENGGQGREMYAAYVKKKEEKHI
FALGTDAGGYSPRGFSLDMSPQRRRLIFPWKEYFLPYGVYDFDQTDAIQDVSPLKKLDIP
LAELVVDTQRYFDYHHSVEDTFDKVNKRELLLGAVAMTQMIFMIDKNW
>KALACAFP_03406 Aminopeptidase YwaD
MKKILGTSLLLLSITIFGQTKQDSIQFAEISKEILNNGKSYTELKDLTKNIGHRLSGSEA
YEKSVKWAEQKLREAGADKVWLQEVMIPVWVRGKESLQIKTQDGKWRNLKMLSLGNSEGT
GGKDISGEIIMVKSLEEYEKLPNEKVKDKIVFFNYPFSQTFIETFKGYGDAAKYRVNAAS
LAAKKGGKFAIIRSLSSAFDDVPHTGAMRYENDNKIPAVAIGNTTADELEVLLKSQKITA
KLNSNCGMKGEKLSHSVIGEITGKKDKNVIVVGGHLDSWDVGEGAHDDGAGIVQSIEVLR
TFKKMGIPNNHTIRVVCFANEENGLKGGIQYGKTAKDNNEKHLFAIESDAGGFAPRGVSL
EMDDEKRKQIKSWSNLFFPYGVYHFEGTYSGADISPLHAMGVPTAELVPDSQRYFDIHHT
VEDTFDKVNRRELLLGAVAMTQLIYMIDKNW
>KALACAFP_03407 hypothetical protein
MKKLTSVDLSRLHHAEFGQFIVRLFEDFSNSGLNANTDEDFKRMFTNIQAQIPVYTAALD
QIKANDESARMADADKIRDADLRALRDALKPYRNAKTQTEKDAYNTVKLLLNEYKNVQHA
SYEEETSKLNILVEKLLSSEYSFHVSALGIVKFANHLSDSNAAFNTIFARRTYQTSQQPT
FDVKALRKILTHDYKQMTNYIVTLANVKDQVFYKDVLTVINNVRNYFSNIILSRNGIKKK
V
>KALACAFP_03408 hypothetical protein
MMKNLMETMFRNQEDSMKMKVWSIILLIGFALLSVLVFVSKISFNNIMIYLIAFAAYIGF
SFMFINSLMEKHSVMQSKKRMNRHS
>KALACAFP_03409 hypothetical protein
MKNIFCSFFAFCSILISAQGKRFFENGEVQLRNPVEKINLNYANELPFVKVTINGKMYNF
LFDSGAPTVISQTIYKELNLEKKHRSKVKDSQKNKHEQIFTELPEMTIDHVVFKKIGAIV
LDLSSAELGCLKVDGLIGANQMAKLFWRINYSENSLEATKDLSLFDLSGYDITIPFLTQT
QKTPMIETKILDKNIKLTFDTGASGRLRIADQNFDSKKATRAVETFGTSAVGAFGAGKPV
AGYIFRAEDMTLGNKNFPNQLIATGGSDLIGNEFFKDFAFIFDWKNSKIYMKRIKETPAK
LETFGFSYRFIDLKPVVTFVFKEDNFPLKIGDSIISINNINLENLDQDGACHYTLNRIER
DQETIDIKIKRDGKILDVTMKKKEYLQ
>KALACAFP_03410 hypothetical protein
MKEKIILLGIFCNVFLIHAQIGINTSQPTGIFHVNGANSSLDINPDNDVVISQPDGNLAL
GHTNPTVKLDIKTAGTQASPIFGFKLWDGNQADNKVLYSDANGVGTWKELSLFTGQNIVG
TFSWLNNTAIGNTNWNRIASLTIPPGTHMIYLKIHILNNANSGFVRTYVGTKNIGTNNSN
PQDTPILGSTNFQPLMGRDFEITQAFVYTNGTNSNITLYYVFQSDSTSISRSVYTFNNAA
TFNGVNLIENYFFSTPVN
>KALACAFP_03411 hypothetical protein
MKIKSLLFLFVLLSLVTFAQTKVSPDNANIKKSLTYFTNSIKTKNIDQAVSCIYPKFFTV
IPKDKMTQLLNMTYNNPFMKIDMQDFKFGNIEKPELIKGEYFSITNYSFTMKCNVSSLDA
DMKKKINGALTNKYGKNNVKYLANEGAYLINATMKACAISKDRKYWKFVILEKEFKRDLV
KVLPQKILDKI
>KALACAFP_03412 putative peptidyl-prolyl cis-trans isomerase
MKLFNKNIILAAASISLMSCTPIYKKMNVDKETYEGLNDGLYANLQTTKGNMIVKFEDKK
APVTVANFIGLAEGKIDNKAKAKGVPYYDGTIFHRVIKDFMIQGGDPQGTGMGDPGYKFE
DEKNDLHHTGKGVLSMANSGPNTNGSQFFITEVATPWLDGRHTIFGKVVKGEDVIDAIAN
VEKGAQDKPKTDIVLEKVSIFSKGDEYKNYDAAKTFTEGKAKIAENNKAYLAKEEAEKKK
KEEEFKANQEKMVENLKAGMQKTESGLYYKITKTTDGKAPKAGDNVSVHYAGKLVDGTEF
DSSFKRNEPIEIPIGMGRVIKGWDEGILLLKEGETATLLIPPAMGYGERGAGGVIPPNAW
LIFDVELVKVK
>KALACAFP_03413 hypothetical protein
MKKILFISVLGLLSCSKNAQTHPPVGGVLSKNDLEVSRNRMKNLNTQERMQIQEWINDQP
VKFYPTQLNYWVNAEGFDQRQRRQDNSFISYSYDLYDFDQTKIYDKPFERRDARFGHFDE
LKAVEDALRFIHDGEEVTLLVPSSLAYGTYGDEKKIDNDIPLIIKLKAL
>KALACAFP_03414 Branched-chain-amino-acid aminotransferase 2
MIIQKTENSRISTFDPNNFSFGNTFIDHMIICEYENGKWGDVKLVPYGPLMFTPAMMGVN
YGQACFEGMKAYKDKDGQVFLFRPEKNFERINKSAKRLAMPEVTEEMFLDGLKALVDIDR
DWIPSGEGMSLYIRPLIFATEEALKARVANKYMFAIVATPAKSYYTEPVSVKISDHYSRA
ASGGVGSAKAAGNYAASFYPTQLAIEEGYEQIIWTDDSTHEYFEESGTMNVFVRINDTIY
TPPTSEKILDGVTRDSFIQLARRRGIEVKIEPIKVKDVVEAQRNGTLKEVWGVGTAVVTT
VFQALGYNGEKLALPRLSDEESYAVILKNDLVDIQTNHAEDPFGWRVLVDHVLETV
>KALACAFP_03415 tRNA 5-methylaminomethyl-2-thiouridine biosynthesis bifunctional protein MnmC
MKREIKTTNDGSKTLFINDLNENYHSHHGALQEAEHVFIKNGLNLINDYEINILELGFGT
GLNVLVTINEYLKTDKNHIINYFTLEKYPINESEINDLAYFELFDNEEFKNIYQKIHQAD
WEKPVEIINGFNLKKIQCDFFDLKDIDLPKINLVYYDCFGARVQPDLWEKPLFEMVSDKM
AVNGLLTTYSSKGSVRRILQELNFQVEKKQGPPGKREMINAVKL
>KALACAFP_03416 hypothetical protein
MIDKINIRVYACAVKDKKVLTLFEEYAGEPLMKFPGGGLEYGEGLIECLHREFDEELNVK
IEVVEHLYTQENFLVSRFRENEQLLTIYYIVNIVNEEDFLILDPCIEKTEWMDIDTPHNP
FPLPIDKIVFDKLKEKFL
>KALACAFP_03417 hypothetical protein
MNFSKIICLFLFFFGVSAFGQKDSVYAKPLSQYPPELLKTDEFGKKYYYDERQKMKVYEI
NGETVIVMDELVLINKPKFNNQLDRNYYFFLNKKLYRVYPLFLTALQQYRDIQKEMTDLD
SKAKRRYIKDRQNMLADQYEKQLRDLTTTEGQVFAKLMNRATGKNVYEIIKELRGGWSAF
WWNVKGKMADIDLKDKYDPYQNRTDEYLESLLQSNWNSGYLQPYPGASEFKVTRK
>KALACAFP_03418 Putative aminopeptidase YsdC
MKFEKKSLKFLEKYLNTSSPTGYEQEGQKIWMDYIRPYVDKIEVDHYGTCYGIINPDAEF
KVVIEAHADEISWYVNYITDDGLIYVIRNGGSDQLIAPSKVVHIHGENGIVKGVFGWPAI
HTRANQNEPIPKIENIFIDCGATTKKEVEEMGIYVGCMITYPDEFFEMNDRYFVCRALDN
RIGGFMIAEVARLLKENKKTIPFGLYITNSVQEEVGLYGADMIADTIKPNIAIVTDVTHD
TTTPMIEKKKEGDQKCGAGPVVFFAPSVHHTIRELIIDTAKAKKIPYQRAAASRATGTDT
DAFAHSNGGVPSALISLPLRYMHTTVEMVSKEDVGNVIKLIYETVLKIKPEMKLKYH
>KALACAFP_03419 Ribulose-phosphate 3-epimerase
MKTKLIAPSLLSADFGNLQRDIEMLNNSQADWFHVDVMDGRFVPNISFGFPVMKTVQQHA
KKFVDVHLMIVEPEKYVEEFINHGADLVSVHYEACTHLHRTIHHIQSLGAKAGVVLNPST
PVLMLEDIIADVDLVLLMSVNPGFGGQKFIENTYKKIAETKDLILSNNSTALIEIDGGVN
LDNAAKLFEAGADVLVAGNAVFSAESPEKTIELLKI
>KALACAFP_03420 hypothetical protein
MTTILLIITATVTALIAGLFYAYSCSVVLGLGKLSDSEYLKSMQSINREILNPVFFLSFM
GTAFLLPISTFLYRGQNLVFILLLMATLAYLIGVFGVTMFGNVPLNDQLDKFDIVNSSAE
AIKEMRNNFERKWNFLNNIRTVFSVITIVLTVCACIWNKAD
>KALACAFP_03421 hypothetical protein
MLFFSAFLILVRKRRKVKGKFICILSLGLVLAAGKIHAQKENSDSKKMEWFQDAKLGVFI
HWGIYAVDGIPESWSFFNNYTNQENYMKQLNGFSAAQYKPDEWVKLIKDSGAKYAVITTK
HHDGIALWNSKAEKATTIPKNSLAQKDVLTPFVSELKKQGLKTGLYFSLPDWIHPYYDIN
TKIKKRYQIKNDPQRWQNFVTYYQGQLNELSSQYSPDLIWFDGDWEHSSEEWKAEQTLKN
LRKYNPNIIINSRLNNHGDYETPEQGIPVIKPHYEYWELCYTMNDAWGYQPFDTNYKTPN
MMVRALADVINMGGNLLLDVGPKADGTIPEKQVEILKALGRWTSKHPDAIYGTRSGLPFE
NFKGKSAFSKDGKKLFLFLEEAKDFTKIYGLHSTPVSGRILGDRNGKVDFKKDNQGNLMI
NFSQVNFDQDVTVVELSFNEKIKFNENSKEENQSLSQILENPNVKLAAFEIAERLHAGNN
IFNNSGLTEDGLDMKIQKTSKTNPEVMNWISKHAEALFETEKGLPDGHFSGNTVLSKDKQ
TLYIFVEGTPTGPIALKGIKNGIARIRIVGEGTLLTHQIFNKLYWSTTPGIIYIDVPKEK
LDKNMTVVAVLLDKPIELHREKVGAIENNL
>KALACAFP_03422 Nucleoside diphosphate kinase
MSNITFTMIKPDAVADGHIGAILGKIAEGGFKIKALKLTQLTVADAKKFYEVHAERPFYG
ELVDFMSSGPIVAAVLEKDNAVEDFRTLIGATNPAEAAEGTIRKMFARSIGENAVHGSDS
DENALIEAKFHFSGREIF
>KALACAFP_03423 Small ribosomal subunit biogenesis GTPase RsgA
MKGKIIKSTGSWYQVLELETDKIFEARIRGKFKLIKTRLTNPLAVGDFVEFQLEQDDIAW
ITKIEPRRNYLIRKSVNLSKEAHIIASNIDLACFIFTLKHPETSLGFLDRFLACCEAYNI
IPLILFNKIDVLHEEEIEIVKDIEFLYSEIGYDSLEISSYSRLNLDQLQELLKDKTSVFF
GHSGCGKSTLVNALQPGLNLKTSEISDTHLKGKHTTTFAQMHFWDFGGNVIDTPGVREFA
MIDIEKEEVQHYFPEIFKKREECKFHNCLHINEPKCAVIDALETGEIQHSRYSTYIKLME
EAEENSQK
>KALACAFP_03424 Phospho-2-dehydro-3-deoxyheptonate aldolase
MNLKDLKNEWINEFSQPLMIAGPCSAESEAQMLETARRIKETHANVPIFRAGIWKPRTKP
NGFEGVGVIGLNWLKKVKEEYGFKTATEVANAHHVFAALEADVDILWIGARSTVNPFTVQ
EIAMALRGTDKPVIVKNPVNPDLALWIGALERLLGQGITNLGVIHRGFSTYQKTKYRNNP
NWQIALDFKSQFPNIPMLIDPSHICGNRTGLADITQEALNVGYQGAIIETHSNPDEAWSD
ASQQITPEVLAELIGNLKMRSTDLAGFEGDMGRHRTLISDIDFQLIELLSQRMKISEKIG
KLKKENDIAIFQPERWKVITEYATQKAKETGMSQEFIEKVFKTIHEESIEVQNNIMIDR
>KALACAFP_03425 hypothetical protein
MVQEVEIKKTTKPLSKQIVSSGISISSLMNKEEKPEEEESTVVKTEDLPQNHFTETDLQM
EWNLLLKQLQTKDTFVFNAIKTFKMLKSDENKITVLYPSDSAKVEFDKVSRAFFNHFKTK
VHNFAIEIEYKRDFENLKVEVMTKRKIFEKFIDKNPLLKDLDDLMRFDLT
>KALACAFP_03426 DNA polymerase III subunit tau
MENFIVSARKYRPQEFDTVVGQSHITDTLEHAIGENQLAQALLFCGPRGVGKTTCARILA
RKINEKDGSVSEDGFAYNIYELDAASNNSVDDIRELIDQVRFAPQVGKYKVYIIDEVHML
SSAAFNAFLKTLEEPPAHAIFILATTEKHKIIPTILSRCQIYDFKRITIEDIQGHLRNIA
QKENIQYEDDALYLIAQKADGALRDALSIFDRLSTFSQKNITLAKAAEVLNILDYDQYLK
VVDLAKENKIPEVLFAFNEIVKKGFDPHIFIAGLGNHFRDLMMAQNASTIDLIEVGEQTK
SKFVQQAQNWNAQQLIDAIEICNHADINYKNSKNPRLTVEIALMQLASLTANSDVSKKKS
L
>KALACAFP_03427 hypothetical protein
MPRKVVQGPIRDKEKTKQKLLAAVGKILRTKGYSGLKVSKIAAVAGFDKKLIYEYFGSTE
KLIDEYIKSQDYWSKMNQDNIHVDFSDGGKELSKVAILNQFEHIKKNKELQKIILWGLSE
NKPILKKIADEREEIGELLFTNIVDPHFKDKSTRYRAIAALLVSGAYYLNLYTGYNASKF
CGIDLKTDEGRKEIEKAIIEIIDFAYEEK
>KALACAFP_03428 8-amino-7-oxononanoate synthase/2-amino-3-ketobutyrate coenzyme A ligase
MDINFSTATFKDFENIPGYDMMQRAEIYYDFLDYMKSNGHRYRLRNNTGCSSVMNVGTEN
ATHEYISFVTSDYLGFTQHPKVKQAAIEGIEKYGTGTAATPLIGGYYLYHNELEAKIASF
FGRSQDEAVIFTTGYTANSATLQILLQKEDIAIIDMAVHASVYEGCILTNRKTFPHNNLE
ALENILKTSESMYRTKLVVIDGVYSQDGDTAPIEEIYKLVKKYNAYLMIDDVHGVGILGK
TGRGTIEDTGLLDKIDIITGTFSKTFGSLGGYVITNEKLATFIRFQSRQQIFSATMPPSS
MGIVKAIELIDEEPQWRAKLWENINYFKKGLNDLGLETGTTCSAVIPVKIGDPHVTGDVG
KLLIERGIYTNPIIYPAVARKDARIRMSIMATHKREHLDKTLNAFEDIDKKLHIAKK
>KALACAFP_03429 Oxygen regulatory protein NreC
MEIVETLNKTLLQKNSGQNCLLDIEVYKAIAFTYSQTENSIAVLSDMQLNKSWVYSSKTS
SELGINFHENPVLIDSIWEEEILKKIHPDDKLKKYIHELRFFKLLKSMKINERQDFSVLS
RIRMKDKDEAYRFIQHRMFYFYSPYNLKLRFALCLYNFALDQSPQLPSEFLIINSTKGEV
VVEDKLVYKKILSPRELEVLKYVGEGFTSKEIADSLSISINTVNRHRQNILEKLKVKNSI
MAFSESLQVK
>KALACAFP_03430 hypothetical protein
MSRIFLSLFALLIFNKNFGQTLEKMSWFNEPEKWEIKNNKLTMLVTPQSDYWRISHYGFT
VDDAPFLYTTYGGEFEAKVKISGNYKARFDQMGLMLRIDKENYIKAGIEFVDGKYNLSTV
VTHKTSDWSVITLDKTPSEVWIKAVRRLDAVEVFYSFDDKNYVMMRNAHLQDNSPVMVGL
MAACPDGNGFSAVFENFKVKHLPDERRLKWLKNNQ
>KALACAFP_03431 hypothetical protein
MRKENYNHLVGKTRREIVKEIGCPFNGFNYFRSITWTYEVGKTWLGKKIILSLTFKDEKV
SEIMLFKSFGKY
>KALACAFP_03432 hypothetical protein
MIFEDEHSVMQDKHNLSYVTNVINFHGDKSFILNSLQKIKNNTLCKIKRKTINKLIKEYT
HHLNQYIENEDINSKPENYELSPVYARQSYDKVLKEDEYLQKVLTFLMNQ
>KALACAFP_03433 Sodium, potassium, lithium and rubidium/H(+) antiporter
MIQDFPFYLSLIVAIVLLIMLANKIKVAYPVLLVIAGLLISFIPNIPMIRIDPELIFIIF
LPPLLYEAAWAISWKELWKWRRIIGSFAFVVVFLTATTVAFVANHFIPGFSLALGFLLGG
IVSPPDAVSASAILKFVKVPKRMESILEGESLLNDASSLIIFRFAMIAVATGQFIWQEAI
FSFSWMVVGGIGVGVLVGWLFMKGQKILPTDANMDTILTIVAPYVMYIAAEEVHSSGVLA
VVSGGLLLSNNRHNFLSTSSRLRGINVWESLAFVLNGLVFILIGLDLPEITSGLEGVSIS
AAIGYGLLVTAVLVIVRIISAYGAVIITLVARNYIPVADKRSPGFKAPVLLGWTGMRGVV
SLAAALSIPVKLYEGGPDFPQRNLILFITFIVILTTLVVQGLTLPYLIRKMHMPSYNDHL
PDDEADDLIRREMAKLTLQHLSDNYGEMLEKSPFLQQIHDKWKGKIDEDSDIKISPEIKM
AYLDILNRQRAWLIEQNHDKNQHFDEDLIRKHLMQIDLEEERVLLIH
>KALACAFP_03434 hypothetical protein
MQGIVFATVYNTRHTLFTLFNNPNTQNIMNVADLKIKNLVEYRNQIFTITEIFQNNEKDY
FVKIENDVHSFSVPARSIKPIQITAEWLEKFGFSRTYSSDQRIRYERPEPFIKYDIDLDS
RKLVDGLKIYGNSIKCKYIHEFQNIFSCLFGKEPAAMNYGLISTES
>KALACAFP_03435 hypothetical protein
MHSISKKIKILQQAVVEKSSFINEEIGRSAQIRFSCCNCGQENVVKITPYESGFPVFQLY
NNDLVLSKNELLSHKMITETQKNVLHFGELTVNNLPTLYFGAHCISCDAKYIGVFSYGEK
QPGLTVLTVSGVWHYEEVI
>KALACAFP_03436 hypothetical protein
MKNLFKYFLFLNITLFSMACSSDRDIFPDETPSEVTTVFYKNANELAATYDPSGAVNQTM
RDQIYDLYKQGKWSELETLFKNNNLNGGWPPASGGFNIIDDVAFTAGQKYDRYSNAVGSY
SGTGVPTLGGSFTSPIINGYVYTFGQRALNQPENSYDFYYEIEVLNNLLNFKGQTADVIP
WFNQVGRGKQTMWKIPIDPATGYQKTWNKLAQEGYIKVTIKKSPSGHYPGSVGTVIQ
>KALACAFP_03437 hypothetical protein
MKKKILLILGHPSKNSFCNALLDAYKKGAERAGAECKIIYISDLQFNVNLSDGYRNAEAM
ALEEDLVNSQKLIQWANHVVMAFPNWWGFMPAVTKGFIDRIFLPDFAFKHHSGKIFPEKL
LKGKSMRLLVTMDTPKWWFYLIYRASQYQILKKIVFGYVGFDPIKFSTFGFMRKSTEKQR
KKWLQKVMDLGRQFK
>KALACAFP_03438 hypothetical protein
MEMQPEIEIYLESIKAFCPAITSDELLEFSEKVSVQEMSKKDFFLEAGKVQKTIGFISKG
LVRSFFIDRNGDEITVGFYPEGEYATHYPAFVVQQPSKYYIQCLEPTTFVNLTYEDMQWR
YKESVIFERYGRFVAEAVLHQQQARIESFIFQTAEERYLDFIKRYPTLFNRISLSHLCSF
LGIERQTLTRIRQKIAHR
>KALACAFP_03439 hypothetical protein
MIINKILNVDDYYFDVFMSISESLTGFSVNELQSTGLAEIYYKHILGQIEAATFTEFLNI
SKNILENSYTQDQLNNAIAAEIFANASTEDIANSIITLWYLGTWEGAYVNDLSYKEGLVW
NVMHSHPPGAKQPGYKSWGVKPVNSNI
>KALACAFP_03440 Fructose dehydrogenase large subunit
MIQQDKPQQKKDVIIVGTGIAGSLIAKLLTDHVFDTQKGKMIHRAEIDEIKTYKELSVLM
YEAGLEAGLELDSVSSMTTYNEYIRTFYMQEAKVPNSPYPNLKQAPSPDVLDMEPITPPF
PDKKGYLVQFGPMPFASDAIRIGGGTTLHWLGTTPRMLPNDFRLKEKYGRAMDWPLDYDI
LKPYYEMAEFEIGVSGNVSKQEYPISESMEDYYGKDYVFPMEEIPQSYMDQRIIDGLAGT
SVQLNFENIPLTMVPSPQGRNSTPNPAYGTSKIIKAESSDSGYTLSLNNIENEEYKALGS
VWNPYMGERCEGNASCVPICPVQAKYNALKTLKKALYKVNKNDNLQRNPHIQVQAQSVVY
RLSVDQADKDRISKVHLRRYISKEKTDFIEEVIDTSDTIVILAANAFENPKILLNSKYTV
IENGQKVEKTVANRSDQVGRNLMDHMVMLTWGLFPEPVYPYRGPGSTTNISSFRDGNFRS
EFSAWISPLDNWGWSWPAFSPGSDISEFLGQGYFGAELKEALADRLSRQVLFHFEIEQLP
NPNNRVTINNEYLDVLGIPRPVINYELTDYEMRAMEQAKLASDQMFARLGVEDFTKYNAT
DNNTFIYNNVRYSYNGAGHIVGTHRMGSTPEDSVTNSYCKSWDHPNLYIVGAGSMTTLGT
SNPTLTLSAVTIRSVESILSDLENNFKTKKK
>KALACAFP_03441 hypothetical protein
MRQKLIRKIEPQDTLLKSSFAKNTIVAEAISLQSLLFDSTISKEDWIEGLKHHSKTLTSL
LLNNQIEEFNQYLQSQFGGEISELKPTAKLSKTKASAVKQGLVEMDYRPILQDLLQTAIL
IEHSTIPPYLTALYSIKDGTNILASQIIRSVAVEEMLHMIMVCNVMNAVSIQPSVNRPQN
YPTYPMKLPMNVDFFVGLETFSSNSIATFIAIESPSNPLVKAPKYDHQVETSALLSKSAV
QENNFWTLENMKDFMMKNVQTIGEYYDVLFFYIVVFQIIAYYKANGKLPQTFEELNTGGI
FTGDLAKQIRPEQYYGSGGKLHFVEDLSGVIAVFQEIKGQGEGADDSIFDVDPSQFEEGA
ELAHYFRFKEVFHEHFYVGGNYEPFMDENGMMPVTTPPTGKPLPVDWNAAYPMKPNPKMA
DYQSNPQLYAQGKAFNQTYKNLLDAIQAAVEGNAKELEKSIMYMYALKEQAIGLMSQPLN
SSQNAGPTFEYPTT
>KALACAFP_03442 hypothetical protein
MLKRKKEIIQDLNARLLKASPEEKKGYLAQLMDGYSKLLIDDPVRPFREENLQEIANNVD
YGILAALNGTWVSYNANYNKNIDRHSLGSGIHTTIMPSPGTNPGTIPGKFSFDSEEYIEK
LTFEIVPGGVRNRGGASELFCGAVKYEQTIKSVNKVEGQQDLQYMGIHEENGMYLWLSDV
YNYAATEETIKRDRGIHAFSEEDYQNYGYKGEYRDQPLVEVKDEHGNSSYILLSELKEGQ
QYYEIIPAQEIKPMDGITGPYFIPDYSISRSGVIPHGSTVTLLGDIAPSGSNYLINGAPQ
FPYGDATWQPNHLSISPTMGGAGASVTNPINLDQPAPAWVHETLTDQNDPGSNKIYTQRI
LADDLYPYSVRPDMRLRDTLSGQNVANYVLIQMSSKMKTGAQGGILNVPFVNRFVPTVEV
DFRLWIETVIEDGKEILQLQYEQIIFFEFDFGNDGGTTSWPHIQVNTLRKIEDIPADQRK
IIEEQFFNAPSAMSMTTPASITDIVNPPSGCPYHKE
>KALACAFP_03443 Cytochrome c551 peroxidase
MKNALSWIFVLFLVVSLLNNCLNNTVQKEIRQKEGFIANLRKLYSSGDSSSWPKPILDPE
TRETFSEIGHLPETEFPKDNLYSEDKALLGKVLFFDPRLSKSNQIACASCHDPELGWCDN
RTFSFGHDRQLGSRNAMTILNVAYARSLFWDGRAGSLEEQSQIPIQDEREMGEHIDMAAG
KIARIKGYEILFEKAFGDKTVTKDRISKAIATFERTVKSSSSKFDQFIDGKSDVYTNDEV
MGLHLFRTKAQCMNCHNSGYFSNQKFENVGTSLLGEKGEDLGMFLVTKNPADAGKFRVPS
LREVAKTGPWMHNGSMLTLADVIQFYSKGNPEHGQKRSTVHQGIALASEKSGMVRMLELT
DEEISQLEAFLRTLSSKTERITPPELPK
>KALACAFP_03444 hypothetical protein
MDNAVPMTFANEWYSLYPVNNTLSNNKSMGPLTSVIISNGGNNTYVQGDWNRSEANFYAQ
>KALACAFP_03445 Sensory transduction protein LytR
MMKKQLTACIIDDEQHGRDYVALLLENEFPEVEVVFQGASVEEAYSYLIKTTPDILFLDI
QLGDSNVFELLSMFKEIESEIIFITAYENFAIQAIKNGATDYLLKPIKKLDFIVAVNKAL
ENIKKNTVLPVNNTQYDKISLPTLQGFKLVNISEIIRCEADSNYTTFYFTDKTKITVCKT
LLEFEAFLAEYNFFRIHHKYLINLAQLKEYIKGKGGQVIMNDNSVLDVSVRRKNEFLQKL
QVRD
>KALACAFP_03446 Sensor histidine kinase YehU
MKKIYKYFLFIFSLFSSLYCSQIPGLINYNEDDGLNSYYTYSISQDNKGFIWIGSDNGFF
RFDGKDFVQYTKKNGLKNVDILACRPLSNGEIFIAPFLNDFAYLKNGKIINSDQNKELKK
LQLQFKDNPIIFNIKDSMILYSSRNPQKIFIYKNEKVKSIPLYYQSKSKPDKVVGFGFES
DPSLLFLSSPDKKIIAYNIFTKKETVCNLSLTEKEGILVDKKDFVIVQNGKKVDIYQLEN
QFYFRKIHSYTSEEDIYHISIDKDNRLWICLQKGGILFFNQDLHLRKKLPSPVKLLSDYI
INGLLVDADHNIWMTTKNSGLFFIAEKFFKNYINLPVKNNSSYITAISDNGKDIFLGYNE
AKGGIFHSNKITDITIEENRKLEHKGIFSKGNIIIFGLAKDVFIYNTITKTKKLIHEWNL
KNIIPYTDHSVLFCVSDALVEYNFVKNTYSELVKERTYTALPYDRDSLFVGDFKDLFKFN
IKTKKKTLFLGDYYFTDIKKLGSNLFVGATNLQGIVIFNNQKILHKVSEENGLITDQIKK
IQVESPNVFWASSNSGLSRVEMKGNSFKIDNFTQTDGLPSNIVAGCVIRKDTIYVGTSKG
LGIFSIKKLLTQQKFINKKVIINSVVIGGKEFFDLNEKLTGESPNNDVIFNLSFPDYASQ
GKIHYKYKIEGLNKSWYTGNSSKIIFNSLPPGKYIFKVFGIGYNGKQSHTSTDLSFEIKP
KFWQTWWFTALLILFGGIIIFLIINLYFQKRRNKKVRELVYEKKIAELELQAIKAQINPH
FIYNCLNSIQFLLYKKDYQETENYLDVFSQMIRKTLHYSEKTFMTIKDEAEYLSLYLNME
KLRLKDKFDYSITVSDKVNQEWTIPSLLIQPFVENAIKHGISGLKDRKGNIQILFDYADS
VLCITIEDNGVGIQNIEGLPSKTNSFGVKLSQKRIETFKQLFKVDIHLEINNLSENNKQG
TQIKIHIHNDEKTTNSLHHR
>KALACAFP_03447 hypothetical protein
MKKSLLLLSLMVSLGINSQIVNIPDTNFKAKLLSSSPSNTVAKDLSGSYFAIDANGDGEI
ETTEAEQVGELVLIDNNILNYQGILFFSNVKKMEIENGSGLPVIPLDISNLNFLTDVEVR
LFSIFPVFSGTPSLKNVNITITNDAPQFSNNAINAFNNTLTSLESLNSLEKVSLASSGNQ
IGFPLTLNLSNHSNLKEVNINNIELNKLDLSHCNLLNLINIVASSSPYFEELDISYSPLI
TNLTSYSHVKKLLASNCLSLQKIFLQKAQNLYLNNCPQLNEIEIRELGKDAATNPIEAIN
CPNIKTLSLGYQYPSFDATPFTNLEYLTLNTFSFFPSDPTFNEELQNLMLNNNANLKILN
ISNYKILNDLNINGLAKLEQIICGVGYNPMTQQLPSFSDFLQSLNIQNCPLLATLILSDH
KGLKTAVIKNCPKLISFSLGSSNPTPDSLESLEIDNCTLLNNVAVSRSHLTNLKILNCPA
LKELYAEYNLLNSIDLTNSTASITHLFLSNNNLTSFNNALSFPNLEMLFLSGNRIENLDL
SNHSKINYLEYRATSGFTPGSPINSPTFLKTVNLNGCSNIESVDLESSVLDKLFLKNGRN
EFLSIINSPTLQYICCDASQISDIQSLVNQNGYTNCIVTSDCNIGPVLSTAENSSNPATI
KIHPNPTKGDVTINADSKIKSVEVYDAQGRIIQKQMGINSQEAKVSIHSSTSGMYIFKIT
TEKEVITKKVIKN
>KALACAFP_03448 hypothetical protein
MTTFVIEYYSNEGYADLQTLNLMNNYARFLKQPLTLGMFVPIDAEGKVLKEPKNYKSWKS
LEHNNRKDNDNSPNTSFEEYRIYQKAEENCLFEGFEVAYNGYSVVRIVASYDHSIELSFN
TNDLTSQTLNDVESLTAFHEIYLNSNALKMIGIRK
>KALACAFP_03449 HTH-type transcriptional regulator DegA
MNKKSATIYDISKKLNVSVATVSRALNDHPRISEATKDLVRKTAKEMNYKQNNLAKALKS
GETKNVGIIVPFVNTNFFSSVIRGIEEELSPFGYHVIICQSHEDVNIEKRHLNTLLNAQV
DGIFMSVSKTTIDTEHIQNILDTTNTPIIFFDRKKDIPGISTVTIDDYRGGYMATEHLIK
EGYKNICHFSGDLNLEIYQNRLNGYKQALIDHNLPVKEENIITTGSSIDAGIEAIKTLWD
KKSIPDAIFSSSDFAALGACQELKKRKIKIPQEVAVIGFSNEPFTQFMELPMSSVDQTPV
TMGKMAGQVFLEGIKESGSGVSTEKKVVLTPEIYIRKSSKRK
>KALACAFP_03450 hypothetical protein
MVKVILISLFVVAALVLAFVFYQKKMRYNLVTISENKVYNSGAVPPEKLASFVSDHKIKT
VIDLRDGLVQTKLNPETKKQVNDEEFAADKIAGLHYFNLPTDQIPEDSTVQKFLKIMDDP
KNYPVLIHCHHGVGRSRLFSSIYRIEYEHFTNEKARANAREFWEFGTNFSKDSQKGIYLT
NYKKRGQK
>KALACAFP_03451 Altronate dehydratase
MQKKVLKVNPKDNVVVALVDLAQGETVTLGDLTYEIIKDTKAKHKFAAVDFEDGDHIIMY
GVIVGKANQTIRKGEVITTENVKHQSAKVEGKTATLGWTPPNVDKWKDRTFMGYHREDGQ
VGTENVWLFFPLVFCENKNIETLKDIFERELLHEKASKHQLLLRSLLNGGETSDVAVEEE
EDTRIFKNIDVRFITHQGGCGGIRQDAEALGRLFAGYVNNPNVAGATVLSLGCQNLQVQI
FMDALHALAPNNKKPIVVYEQQKSGTIDEMLTGVIKDSYEGIKKANEIERKPAPITKLNI
GLECGGSDGFSGISANPVLGEVSDIMAAVGGTTMLAEFPELCGVEQELVNRCINDEDGVK
FLKLMQDFEKSVVAAGSGFDMNPSPGNIKDGLITDAMKSAGAAKKGGAAPIVEVLDFTEY
ATKPGLNLLCTPGNDAECTTALVGSGATVVLFTTGLGTPMGNPISPVVKISSNTVLAEKM
SDIIDFNAGTVISGDQTIPEAADELLEYIIKVASGEVKTKADLLNQNDFIPWRRGVSL
>KALACAFP_03452 Altronate oxidoreductase
MENQIKQKLNRELIGSQEKLPIKIVQFGGGNFMRGFTDYVIDKLNKEAGFNAGIVNVQPT
PGGSVHKLEEQDNLYTLFSRGIKKGEIIDTKQVISAIQKSINPYTNYDEFLALAKEEELE
FIFSNTTETGIAYDESENNYAGPHKNFPAKLTVLLHERFKHFNGAADKGLRIIPCELIED
NAFALKEIILKYAQLWNLDSNFMQWIEQNNYFHNTLVDRIVPGYPKDDVQTYEDQLDYED
QMMVVSETFLLFVIQEAGNLNERIPFDTIDEQILVVDDIQPYRLRKVRILNGGHTLMLAP
AMLSGKETVKESIDDVFIGKFLSETIFNEVNPTLGLDETELKDFAEEVFDRFRNPFIKHY
QASIALYFVSKFKVRILPSLLKYVEINQRLPLNLTFSLASLIRFYQGSFGEKVLPINDEE
AIIARFKEIWATEDYEKVAELALSETTFWDTDLTKVNGLKDAVAKALWEIDHNDIETAYH
NFIQFYS
>KALACAFP_03453 Hexuronate transporter
MSSVKSPKPSTFRWTICFLLFIATTINYLDRQVLSLTWKDFIAPEFHWNNNDYGNITALF
SIFYAIGMLFAGKFVDWLDTKKGFLWAIGIWSVGAVLHAFCGIATSGILTGNWLAGFNGS
KELISTVSDTSAIISTSVTLFIFARFVLAIGEAGNFPAAIKTTAEYFPKKDRAFSTSIWN
AGATVGALAAPITIPFIAKSMGWEWAFIIIGALGFLWMGLWVFYYKKPHLHHKVNEHELT
YINQDQDDAPKEDTSIPEKKFTFRECFSYRQTWAFAFGKFMTDGVWWFFLFWTPAYLSSV
YKMDSTQSAFPLFVLYMITLLSIIGGWLPKYFVEKKGMNAYTGRMKAMLIFAFFPLLALL
AQPLGTITYWIPVLIIGIAGAAHQAWSANIFSTVGDMFPKKAIATITGIGGMAGGIGSFL
INKSSGLLFDHAHKAWTTVDGIPLLEKYPQYINERLPEGFFEQLEKSGAVVSDGIDKGYM
IIFSICAVAYLIAWVVMKSLVPKYKVISK
>KALACAFP_03454 KHG/KDPG aldolase
MTKIQSVTNTITNQGVLPLYYNADETVTLEILRALYKAGIRAVEYTSRGEAALSNFTKMV
EIRNAEMPEMLLGIGTIKNVQQAEEYYKVGADFFISPGFVAEVAEFLIPKDLLYSPGCMT
PTEIIEAENSGVTFVKLFPGNALGTGFMSAIKDVFPNLKFMPTGGVDTTKESIESWFKAG
VSAVGMGSKLVSKELMLAKDYLTIENETKKVLEIIQTLK
>KALACAFP_03455 2-dehydro-3-deoxygluconokinase
MSNKIVTFGEVIMRLSPPGNRTMKQSHEMEFFFGGTELNVASSLATMGCDVRHISSVSDD
FVGESAVSFIKSFGIDTTFINKNDHPLGLYFLEVGSSVRASRIAYNRLNGSFANIKSEQI
DWKKALEGCQYFHWTGISPGISESAYESLKKGLQTARELGIEVTTDPAYRSNLWKYGKNG
NEVLKELVSYSTIFIGGVNEINEILGTQFSSDKEGFIEACKELKQQIPSIHKIFDKIRIG
VTASSQQTQGRALVEDNYFETELLEVNPVVDRIGTGDAFAAGLIYGLINFDDEKALKFAN
AACAIKHTIPGDINYCSVEDILEVMNGDSGGRIKR
>KALACAFP_03456 Uronate isomerase
MKPFITDQFLLQNKYAEELYFKYAEKQPIIDYHNHLIPKDIAEDTVFENISKVWIAGDHY
KWRAMRTMGVNEKFITGDASDKEKFEAWAKTVPYTLRNPLYHWTHLELKRYFGIDELLNA
DNASEIYENITAQLQTPEKSTRGLLKMMNVESLCTTEDPTDLLNYHQDLAKSDFSIKVST
AFRPDKAILIENHNFADYISKLGESAGIEINSYQTLCDALIKRIEYFHENGCRLCDHGLN
NISFEEFTEAEVSAIFNDKIAGKVIAEKQVNQFKTAILLFLGEAYHKFGWVQQFHLGALR
NNNERMHRILGPDTGWDSIGDFVQAETLSKLLNALDGKDKLTKTILYNLNPADNEIFATM
IGNFNDGSIKGKVQFGSGWWFLDQKDGMIKQMNALSNMGLISCFVGMLTDSRSFLSYPRH
EYFRRVLCNLFGEEMKNGELPDDIELIGKTISDICYHNAKNYFDF
>KALACAFP_03457 Gluconate 5-dehydrogenase
MNLFDLSGKVAVVTGGTHGLGMAMAEGLAAAGAELAITSTTPSKLEEALNYYHSKGYKAT
GYIFDVTDELEAAQKVALMEATHGKIDILVNNAGIIKRIPAIDMEVEDFRKVIDVDLTGP
FIMSKLIGKHMIKRKSGKIINICSMMSELGRDNVVAYASAKGGLKMLTKNLATEWAKHNI
QVNGIGPGYFATSQTEPIRVDGHPFNDFIISRTPEGRWGNPEDLAGTAIFLASDASRFIN
GQIIYVDGGILATIGKPANE
>KALACAFP_03458 4-deoxy-L-threo-5-hexosulose-uronate ketol-isomerase
MTQSEFRYAHHPEDVKKYTTEDLRREFLIHDLFNEDKVKLVYSMYDRLIVGGIMPSTQAL
KLEPTDDLKAQHFLDRRELGIINVGGAGKITVDGEVYELGNKEALYIGKGAKEIVFEKSG
DAQPYFYINSAPAHHTYPTKKITKNEAEIVELGEEKYANKRTINKLIVNSVLETCQLQMG
MTELQPGSVWNTMPAHTHTRRMEAYFYFDLEEGQTVSHFMGQPHETRHIFMTNRQAVLSP
EWSIHSGVGTSNYTFIWGMAGENMDYGDMDGIKTNELK
>KALACAFP_03459 TonB-dependent receptor SusC
MDKKVQSIKWLYLTFFLLPVLAMAQETETKKDKETNIDEVVLVGYNKVSKKDVTNAVSSV
KGEALKDMPVNSAAEAIQGRLAGVQVQSSEGKPGGDIDITIRGGTSITGSNAPLYIVDGI
QMDNAMSILSPKEIESIEVLKDASSTSIYGSRGANGVVLITTKSGRKKAVTTINYNGFTG
VRKIMNTLPVLDPYEFVMYQYELYKKNGIQTDIDAFDQRYGSTFQELDKYKTIQKRDWQD
ELFGKEAFNFTHNLSVNGGSDKSAFAFTLNHVDEDGIMLGSGFKRSMANFKYDYDISKKL
KFGVNARYGRSLTTGVGTSSTGSQSNNRLRNSVRYQPFEGGSNVPIDEFDPSYATNTNLV
NPLILNDNEVRDNRINDLLLNAYINYNITKDLTFRSVVGYVQRDISTNQFWGTVTAQARA
NADMPIVQLDRSQTRRITNTNTLNYTKKFGQHKLDILLGQEIVQTDGESSNTYVKWFPKS
ILPEEAFANIGAATPPAGLIQDAPRTAVLAPDRLASFFGRVNYIFANKYIVTASVRADGS
NVFMKGNQWGYFPAASLAWKLKEEKFLKDVNWLDELKLRVGYGLSGNNRITSYLWANFYN
INANNGYVFGTSVTPGAAVSTTQANPDVKWEATVSKNAGIDFEFFNGRLYGSADAYITDT
KDLLVLAKVPFPGYSNQFQNSGKTRNKGLEFTVGGVVVNKENFTWKMDANISTNKNTILS
LGSSVRQGVDSYLVQSGGIGGFDFIAKVGSPVGTYYGYVTEGRYEIGDFNYNPTTQVYTL
KAGVPSSSAIALGAKAVQPGDLKLKDLNGDGQITDADRTELGSAQPKFYGGFNQTFRYRN
FDMSLFFNFSVGNKVYNANKIENTTQYLYRDNNMAAEVADRWRWFDSNGVKVNDPTALAA
LNANTTMWTPPTGQYILHSYGIEDGSFLRLNNVTIGYTLPKGSLEMIGVKNFRLYATVNN
LFVITGYSGYDPEASTRRNPLTPGVDYAAYPRSRFFVTGVDITF
>KALACAFP_03460 SusD-like protein
MKKNKSIFIITCLAGALFFTSCSDFLNPENLSSISEAQQFDSTADTFSALVGVYSQLGGD
DGYGQRLSLIIPQSGDDFRTSGSYNCNDRRGVATFGACPTNTELNNPFAKLYTGIERANL
VIKNIPLSPVYQNGTVDDKKLMDRYLGEALTLRAQYYYELIRNWGDVPFYLVPASDVTEQ
NQPKTDRDVIYEQIIEDLAKASALVPWRSEGGTTSNRISKGAIKGLRARIALARAGWSLR
RSPQVMAQGSNPTKYYQIAYDECKDIMDHSGEHSLNPSYENVFRALHSNSQDATNEVIFA
VGAFGGGTRTDSKIGYYNGLKHDDNSNWKGGGGINALPIYFYEFTKYDLRRDMNVGIFKI
NNSNQAELVASNSWTDSKYRKSWTNITGPSQTLAVDWPLLRLSDVMLMFAEADNELHGGP
SQEAINAVRAVRSRAYAGNLGQIGTIPTDKVGFFNYIVKERLLELGSEGIRKYDLIRWNL
IASKIAETKQKLTDFINGVGAYANVPSDIYYKNSVYDPTKTAQQNVSAIDVYTIGSDKSE
VFYLPTQSATIPAGYKKIAWRSGILPTYVNDPSAGYAQYFEPNKRELLPIYFEFIQNNPA
LTQDYGY
>KALACAFP_03461 Pectinesterase A
MKTFTFIKNLKLFSILSMLWISLLSFKTNDRIIVVSKDGKGNFTTVQQAIDAVENGSSTR
TKIFIKSGIYKEKITVPETKGAILMEGENPENTMITYDDFASKKNSEGKDIGTTNSSTIF
IYSNDFTAKNISFENSSGRVGQAVAVLTSGDRIAFENCRFLGNQDTLYLKGAQDLTDKTK
PSRNYFKNCYIEGTTDYIFGAGTAVFENCTIYSKETASYITAASTPQENEFGFVFINSKI
TGNAKENSVYLGRPWRPFAKTVYIDCEMNAAIKTEGWHNWNKPDAEKTTFYAESNSKGVG
ANSSKRVSWSYQLTQEERKKYTKNTILKGKDHWNVTKLF
>KALACAFP_03462 hypothetical protein
MKKRFTRLFTIAILCGISTWADAQNVLSFPGAEGFGRYTTGGRGGKVFFVTKLADDGSEG
TLRYALDQKGARYIVFKTGGTIYLESPLRIKEGDVTIAGQTAPGDGITVANYETFVAADN
VVIRYMRFRMGDQKKFEGDAFGARFIKNLMVDHCSMSWSTDETVSIYVNENTTLQWCIIA
ESLRNSAHQKGAHGYGGIAGGKFASFHHNMYAHHDSRNPRLGEYAGSKFALTDLTDFRNN
VIYNWGHNNIYGGEGMNANIVNNYYKPGPATTIRNRIVAIDKNEKPETEVYNIWGKYYVN
GNVVEGSPEVTKDNWAKGVFAQMKPSYHLTEKDKNSIKINQPHDIQNNVKTQSPKEAYEK
ILQLGGASLVRDAVDLHVLRDVQNGSFTYKGSKGSINGIIDSQQDVGGFPNLKTGKPLPD
SDNDGMPDQWEIKNKLNPKTANANGRDLDKNYDNIEVYFNDLVKKITEKQNH
>KALACAFP_03463 hypothetical protein
MKNNMKFNLFKILIAGVFVTSNFSAQTSVIEKIKKNPKAPFSYAELSVKEGGQWEGNKYV
GGTFKNVQELTLPSEHTDHSYDIRYEGIGLENNQIGYRLYLDWRNATDIFGKKVNTLVLP
EVGQDGFESYHHDAPWGQDILNSGRTIGIGSYGRYDEQNDFVETFKIVKNTAVKIVNEKD
QSYATIDYKGWKTWGDAVDLQSRLTIFNKDRFVKVDLNLNTAFSGLCTGIVAIKNIPFKQ
GISKNKKWGYIATYGQQTLAKKEDNLGMAVFYPLEIFDKYVKTKSTHTVVFKKTKSVSYY
FLGAWSQEPNGLTTEEAFYQDLDKKLDILDKNNQL
>KALACAFP_03464 Unsaturated rhamnogalacturonyl hydrolase YteR
MNFINNNIKAYTFAILGSGMFLACAQTKSAATSKPATEISKSGKVVPVNLKWSERMMLSE
MHRFPESWMLDFSKSPKWTYPSAIVLDGAEKLYEKTGKKEYYDYVSSFGEKLIQEDGTIL
TYELDKYNIDLLNSGNVLLYLYEKEKKEKYLKALKMLRSQIDGQPRTSEGGFWHKKIYPY
QMWLDGLYMGQPFYAHYTKDFAIGEEAAKAYNDVVLQFDLIQKHLVDKKTGLLYHAWDES
KEQAWANKETGVSPNFWGRAMGWYGMAMVDVLDYLPKDHPGRAKLISYLKSYTDAIIKVQ
DKENGLWYQVLDKAGQKGNYTEATASSMFVYTIIKSVNNGYLPKSYKSYAKKGYDGIIKN
LITVDENGVVNLNKCCAVAGLGGKPYRDGSYEYYVNEEIRSNDAKGTGPFILASIEFEK
>KALACAFP_03465 Non-reducing end alpha-L-arabinofuranosidase BoGH43B
MKRQILNIITISLFSVASTYLQAQEKSYVSEVWTSDQGKNYKNPVLYADYSDPDAIRVGE
DYYMTASSFNEAPGLPILHSKDMVNWKLVNYAIQDIVPAEHFSTPKRGDGVWAPSMRFHK
GEFYIYWGDPDFGIYMVKTKDPLGQWEKPVLVMEGKGLIDSCPFWDEDGNAYLVHGWAGS
RAGVKSILTLNKMNPEGTKVLDKGVHVFDGHDAHPTVEGPKMYKRNGYYYIFAPAGGVAT
GWQLVLRSKNIYGPYEEKVVLEQGSTKINGPHQGAWVDTPSGEDWFYHFQDVDADGRIVH
LQPMKWEKDWPVIGIDNNKNGIGEPVLTYKKPNVGQTYPLITPPETDEFDGEKLGIQWQW
SANENIVWSSKLPGQKFLRLFSIKVPEGEKNLWNVPNLLTQKFPAPNFAASTKVKLTPED
AKEGKTAGLLVMGLDHESIVITNKPDGFYLQLRRAEKADKGGEEKVLFETKLKGNEAYLK
VNVNEPNGLCQFSYSENGKNFTKIGDVFQAKPGKWIGAKVGLYSVSTTKASRGGYADFDW
FRITKN
>KALACAFP_03466 Exo-poly-alpha-D-galacturonosidase
MKKSFKMIGLAAAMMFSGQIYAQNLDIYKNIEFKMPQVAETSFAANTVSITQYGGVAGGN
VKNTEAFKKAIEDLSKKGGGKLVVPRGMWLTGPIELKSNINLHVEEGAFIIFSKDKNDYP
LVDVSFEGLNTIRCQSPISARNATNIAITGKGVIDGSGDVWRAIKKGKVSESEWKNIVKS
GGILSSDGKTWYPSESYKKGFESSSSFNVPDKISKEELKSVKDFLRPVMVSLIGCDKVLL
DGPTFQNSPAWNLHPLMCSNVILRNLTVRNPWFSQNGDGVDLESCKNVLIYDNTFDVGDD
AICIKSGKNEDGRKRGMPTENVIIKNNVVYHGHGGFVVGSEMSGGARNIHVSDCTFIGTD
IGLRFKTTRGRGGIVENIYLKNIDMINIPAQVIGFNMFYEGASPVLEDGQKQEGNKAPEK
VYPVTEETPIFRNIFFKNINAVNSDEAITLFGLAEMNLKNIVIEDSQFETKKALTIVDAN
GIQLKNVKLKYSEGTGATIYNSKNINLSTVKFESANKPFVKVLGNKTGAVLLPKEVTSDK
NLLSIGTDVAKNVVK
>KALACAFP_03467 Carboxylesterase NlhH
MIFNRKHTYISIFFVGTMAFGQVNRPNATPYTNEATYEKLKKKYPFITPIDRPVPQNINI
DKDVEYANINGLSLKADVYYPLDKSKKYPGIAMIHGGGWISGSKENEKFMAMELASKGYV
VIAIGYRLADVAKYPAGVEDIEKGIQWLQKNHVKYSLNKKKMVVLGESAGAQIATLVGVK
KKNKINAIVNIDGIVSFIHPEAEESTYASFWLSGDRNINLKNWTEASPLEYVDKNTPPTL
FINSSQPRFHAGRDDMMKKLKSYNILTEFHEIKDSPHSFWSAEPWFTETLNYTLDFLNKV
LK
>KALACAFP_03468 Pectinesterase A
MKKLFLILLISTANFLFAGNDPYIKITVAKDGSGDFTTIQKAINSIRDLGPAEALVFIKS
GTYHEKVVIPSSKHKITLEGENKDHTIITNNDFSGKLDSFNEKMTTFNSYTLLVMGDDIK
ISNLTIQNSSCNEGQAVSLHVEGDRFVIKNSKILGCQDTIYSATNHSRQYFENCYIEGTT
DFIFGQATVVFKNCIIKSLADSYITAAATEADRQYGFVFFDCQLIAKEDITKVYLGRPWR
PYAKTVFINTEMGKHILPEGWNPWKGDKMFPDKEKTAYYAEFGSKGEGGNISKRVSWSHQ
LTKKDLKNYTLENIFDDWNPNK
>KALACAFP_03469 Rhamnogalacturonan acetylesterase RhgT
MKKILLILYIFLTTFLFGQQKPTLFLIGDSTMANKENPDKNPEHGWGQVLPQFLTTGIEV
QNHAMNGRSSKSFRTEGRWDKVMKQLKKGDFVIIQFGHNDQKLKDSTKFTNPYTQYRANL
ERYVNEARAKGATPILMTSIVRRNFNENGTLIDTHKEYPLVVRMVANDLKVPFVDMQLLT
EQLEISYGPEKSKQLHLHFKEGEVEYYPKGKDDDTHLSKMGAELVAKLALKDLKSLKIGL
EKYIK
>KALACAFP_03470 hypothetical protein
MNFKKEPFFDGNSEWEDLGGGVSRQFVGYNSQVMMVIVKFEKDSIGALHQHFHSQITYVA
SGKFEVTVDGEVKILQQGDGFFAQPNIFHGVKCLEEGQLIDAFTPFREDFLNS
>KALACAFP_03471 hypothetical protein
MLVDREGASSYNYLCFKAQENHRFSTKFFAISNFIADEILAP
>KALACAFP_03472 Acetylxylan esterase
MKKSLFILLISFLAQLSAQEKITLWPKGQMPNSKGLSLKTEEKDGRIVQIKETELFAFLP
PKEERKPMAVIVIPGGGYYKLTYDLGGYQIAKWFNTQGISAFVLNYRLPTSPDVIQKEIA
PLQDVQAAVKYLRKNAGQYGISPEQIGVIGTSAGGHLAATVSNISTDYTELKGDWENFST
IPNFAILVSPVIDFGEFAHVGSRNSLLGENASPEKIKEYSMQNRVTEKTPPTILFHAQND
KTVPVMNSILYYQQMIKNKVKGALFIFPEGEHKIGITNKSELTDNWKKLCSDWLKTIGNK
>KALACAFP_03473 hypothetical protein
MLKIIQHKIFLLACGTVISVSVQAQQNLKLIYNKPAENWNEALPIGNGRLGAMVFGGAVQ
EHLQLNEETIWAGEPGNNVPKNTFDSIQKIRKLLNENQFQEAQNVSNRTYPRQAPKDLNY
GMPYQTMGDLFLDFKGHENFKNYNRTLDIEKAISTVSYEVNGVTFKREIFSSFADNVIII
KLSSSKKGSLNFSINASTPHLKKSIFTEQNQLVINGTSGSVDNKIGKINFKTIAFPVVKG
GKLTSTKDKLDVSGADEVVIYVSIATNFKKYNDISGNPDARVSEYLKFALNKKYDAELKA
HIEKYQKYFKRVSLDLGTTEQAKKTTDIRIKEFGNSQDPDLVALYFQFGRYLLISSSQPG
TQPANLQGIWNYQLNPAWDSKYTVNINTEMNYWPAENTNLSEMHEPLFDMIQDLSVTGQE
SAQEMYHARGWNMHHNTDLWRITGVVDGGFYGMWPMGGAWLTQHLWNHYLYTGDKEFLKK
YYSALKGAALFYLDVLQQDPSKKYLVVSPSMSPENTYFKSVGITAGTTMDNQLVFDVFNN
FINASKILNEDKNLSDEVKSALDQLPPMQIGQHAQLQEWLKDMDRTDDQHRHISHLYGLF
PSGQISPFRNPDLTEAAKNSMTYRGDKSTGWSMGWKVNWWARLLDGNRAFKLISDQLTPA
PMEQQGQSGGTYPNLLDAHPPFQIDGNFGCTSGIAEMLLQSYDGYLYILPALPDALPNGS
VKGLKARGGFEVDIEWKNSKLTKLTIKSNLGGNCRVRIAKNIQIKTKANLQLVKGENPNP
YYQVNAIKKPLISEKAQLKGYSLPETHVFDFHTEKGGSYIFETK
>KALACAFP_03474 hypothetical protein
MNLKIYTLAFGLIVISLSAQVKKDTLAEKMLLYQLPIGGWGKQLNDKSVVNYNLPIDKNL
LKKIKETGDDHATIDNNATSREINGLIKAYNETKNPQYLKSAEKGISYLLLMQYSNGGFP
QYYPNTGLYRKQVTYNDNAMINALSVLYNVAEGKNGFDVVDLKLKEKSKIAVQKGIECIL
KTQVLQKGNPTIWADQYNEITLQPDKARAFEPISLATGESVGIVRFLMMQPVTPEIEKSV
KSAINWFKQNKIEGYSYNVTKQNGKTVRVLAEEKNSVIWARFYDVNTNKPIFGDRDGSVK
YNYNEVSEERRNGYSWFGDFADKLINKEFPKWLEKNKLVQ
>KALACAFP_03475 hypothetical protein
MRKGLIMMINKKRIFLFFCAIDCILNVNTLSAQTSVQVKNTLDFSRNEVVAVPVSALKSF
LNKNKESDLRIKDSSNKYLPIQWIDYDGDGKGDELLFLATIDAKKTNIYTIVSDAKIRLP
ETEVTTYSRLVPERADDYTWENDKVAFRVYGPKGQKEALAGVKGSTLSSGVDIWLKRTDQ
PIINKWYKGYLTDPMFYHKDTRGEGYDPYQVGDSRGTGGIGIWKDDKLQVSQNFISSKTI
AEGPLRTVFELTYAPWSEFGVKETKRISLDIGSNFSKFESTFEAEKPVPNYTIGITLHKN
EGEAKLNDKTGYYLHWEKIDDAFVGEGIVVNPAVIEKSIAFKSEIPDQSNLLVVTKPQQK
LTYYAGFAWQKSGQIQNQKDWENILQKQSQIIENPLLVKVK
>KALACAFP_03476 Putative 3-methyladenine DNA glycosylase
MKLQYPYYLNQDVIFLAKDLLGKVLFTKINDEVTAGIIVETEAYFGVQDKASHAYGNRRT
GRTEVLYNEGGVSYVYLCYGIHYLFNIVTGVKDDPHAVLVRGIEPLVGKEIMEMRRKMPF
TKAAISAGPGSAAKALGIDRSFNNKDLTGEEIWIEDHGIRYHDDEIAAGPRIGVAYAQED
AFLPWRFFVKGNKYVSKPNTVNPEK
>KALACAFP_03477 Putative non-heme bromoperoxidase BpoC
MKSIRKTSITGVLCLTLFSTTLAMSCREESEITTIQEIQTNHQNAKTRFVNVKGTQFAYR
VLGKDGGVPLVLFPGLGGSMDDWDPAVTDGLAKKYKVIIFDNKGVAASKGTTPDNIQAMA
DDAIDFIEALHLNKVNIMGFSMGGFIAQRVVLTKPALINKVILTGTGPKGAIGLSNLPNI
VASTAGLSPEESFLKFGFTQSPESIAAGKAAYARIQSRTVDRDLALSDATSASQFTAVLG
WAQPNADALNEIKNIKKPVLIVHGENDLPVSIQNAHNMSQNLENSELLIFPDSGHASFFQ
NHDAFVTKAVQFLDK
>KALACAFP_03478 hypothetical protein
MKKSILTLLAVVALAACKKNESTAVDHSTDSTATAAPVDSGMTTSDSATTTANTTTSTAL
SDQDKKFADGAAKGGLMEVMMGELAATNATNSTVKALGKMMVDDHSKANEELKKWASTVG
YTLPTGLDAEKQKEYDNLKAKKGADFDRAYADLMVSDHKKDIAEFKKEASDGSEASLKSF
AGKTVPTLEHHLMESEKAKNAVK
>KALACAFP_03479 hypothetical protein
MDMLSLFNNDEYYQFPEELLDYTEHFLSEKEATELEEKLLKTVPWKQRTQKMYDKTVLTP
RLTAWYGDDTKLYQLGGNEFAVNPWTSELLSLKQKIENLSGCTFNSVLLNLYRDGNDSVA
WHRDKESELGNRPMIASVSLGEVRNFDFRKVDNHQLKYSLPLRHGSLLIMKGNLQLHWEH
RIAKSAKPMKPRINLTFRLIKEL
>KALACAFP_03480 putative HTH-type transcriptional regulator YtcD
MEEIICSANDKNKKQIMAVHDAMDVLNGKWKISIISSVCYYNQRRFSDILNDVQGISNKM
LSKELKELEMNKLVKRNVLDTQPVTVMYQLTEYGKTLQTIIDTLADWGTEHRKVIIGK
>KALACAFP_03481 Dihydroanticapsin 7-dehydrogenase
MNFTNKNVIITGGTTGIGLATAKAFITAGANVWITGRNTENLEKAAQKIDSPKLKTLVSD
TSNMEGIAALEKAFAESGNQLDVLFLNAGIATFTPIEQTSETDFDAQFNTNVKGHYFTLQ
KLLPYLTEGSSVIFTSSTVATASQMYASVYSATKGALNKIAQIAANELAERKIRVNIVSP
GPTQTEGFDKAVPDEAVKKQFASTTALQRMGDPDEIAKTVLFLASDNASFITGTELLVDG
GYIGYALK
>KALACAFP_03482 Exo-poly-alpha-D-galacturonosidase
MKKYALFFLLLLITIPFSAQYKPWTSAEQPLKEIQALKKQIVKPNFRKKDYLITDFGAIG
DGKTKNTEAFKKAIEKCNADGGGRVVVPKGVFLTGAIYLKSNVNLYVSEGSTILFSQDSN
DYPIVFTRWEGMECMNYSSLIYAYEEENIAVTGKGTLDGNADLDHWWFWCGATKYGYNES
RPGRQNPARAKLHEYMAQRKLARERIFGDGYYLRPNFVQPYRCKNFYMADVLVKNSPMWN
LNPVLCENVLIERVKVISHGPNNDGCDPEACKNVWIKDCYFDTGDDCIAIKSGRDEDGRD
IGRPAENHIIENCEMKDGHGGVVIGSEIAGGAKNIYAIGNLMDSKNLDRALRIKTSSSRG
GIIENVFFYNTKVGAFQEAAVRFNMHYEKPGNFIPTIRNIWVENLTVEKGGKYAVFSDAY
ESSPVTDFTMINAKMNGIEIPYKVDYMKNVKLKNVTVNGKPLTELKN
>KALACAFP_03483 hypothetical protein
MRKKTIFAGLIVLSAFSLSFSQSKHWQNNERELHYKEDKGDFLLVNGKYRFNRALYGNNL
ASRVEAGDLPEFALYLPGMGGNLQFVIQKGNSIKKLIQAEKIETRYRPGSMLYNIKDPIL
GFGSLKLTVLAQSKEEGLVLKMETDNVDPSTKIYAVYGGASGTTFSRNGDIGADPESGFY
LLPEYCLNNQFQINKNQFQLNYLNKKKETQTVTGNFSNTGSLQVTDAETLEKLSDFSQNK
ADKSPIIYAAYSAQKNPFYIQIKKGKSDKNFSDEELKNIFNEAEQSRLNLTSRVQLKTPD
SDLNSFGATLAVAADGIWESPTYLHGAVAWRMRLNAWRGGYVADALNWHERAKEHFESYA
NSQVLKPDFAPVEMDTLLHLARHAEKMGNSVFSSGYISRNPNNNTKPHHYDMNLVFFDQM
FTHFNYTGDIEFLKKMWPTMVRHMDWEKRNFKRGDLYDAYAAIWASDALQYSGGKVTHTS
AYNYRANLEMAKLAKIIGENPQPYEKEAESILNAMKTQLWLKKNGHFAEYKDSLGNQILH
DKPGIWSIYHVSDAYILNEFEDYQNLQYINNHIPKIPVKVKGETDKNYYTLSTTNWQPYD
WSINNVALAENLQTALAYWQAGRNEDAFQLWKGNLAESMYYGISPGNFEQLSHYDAFRGE
LYRDFADPIGVAARTLTEGLFGVYPKLLENKILLKPGFPKDWNFAELKLPDWEFKFNQNS
KKAEYFFKSNYSKPVALEMQIPVNHTQIQSVKVNGKKVDWKIKPNSILQPFAQFETPAGK
DFKVEINYSGEELKIEKTDYTSYISENLQLNFGLKKKIKQVFDPQELIKNSPSMEGWPKV
GAVNNQFELIKEERKGTFFVQLEQNGTTWWQPVNVDIQYPLEAKWVNKKLEIQSKSENSI
NGKLNIKGLHKTFSTQKNQNTSIEIPEIFLTKGTNSLELEYNGIKQNIEITDWEIDNKGD
FNPISLASKYNEKVTGIFNQKYLSPRLNVPTLQLPWQGIGNWCYPLITAQIDDSGLMNKR
KNDKVDFLGIPFLINNEDKNIVFTSQWDNFPKSVEIPVSGKGKKIYFLMAGSTNPMQSQI
INGKITIQYVDGSTTELELKNPINWWPIEQDLFDDNYAFEIPYDKIPYRVKLKTGEVYKG
GSLTQYSGIKGFTDRAVEGGAATILDLPINPNKELKTIQLTAVSNDVVIGMMSATVLK
>KALACAFP_03484 hypothetical protein
MKKLVIYLSLFCIGFSSLNAQKIDRKRVVQRHNIVNNKIDTLSSLTVGNGKFAYTVDITG
MQSFPEYYKNGVSLGTQSEWGWNSFPNTKNYTFDETLKPYDFNNDGRKALYSVQIKEPER
NKKAVEYFRVNQHRLQLGNIGIELYKKDGQKAKISDLQNINQKFDLWTGIITSEFTLEGI
PVKVWTASFQNSDKIGVKIESDLIAQNKLKVFAHYPSPTGQFLDDAAFYGNENDHSTKII
SSSSSHGLIEHKLQTADYFTQLYFTEGKLREAGKHYFVYEPSSKAKTIELSVEFSAKNQK
TTKSLFADAEKESTSGWKSFWESGAAVDFEGSTDPRANELERRVVLSEYLTKVQCGGSNP
PQETGLTFNSWYGKPHTEMHWWHGVHYALWGRPEILEKQLDYYFRSFEKAKKLAERQGYK
GVRWIKMSDNEGNESPSSVAAFLIWEQPHLIYMTELLYRNNKDKKVLEKYKDLVFATAEF
MADFATYDKEKNRYNLGKGVIPAQEVFPAKDTYNPTYEVAYWDWALKVAQQWKERLGQPR
DKKWDDVISKLAPLPVQDGVYLSTESAKDSFTFPKWMTDHPSVLGALGMVPESPKLDKKI
MKNTLDIVWERWNWEHTWGWDFPMTAMTAARLGLPNKALDALFMKIQTNTYLKNGHNYQD
GRLRIYLPGNGGVLTTVAMMLEGWDNSQGQFPGFPKDGSWKIKAEGFKKMP
>KALACAFP_03485 HTH-type transcriptional repressor YtrA
MAETFEININEHSRVPKYKQIVDSILNGIDGGEIQIGEKIPSINELSESCFLSRDTVEKA
YKELRKRQIIESVKGKGYYISRVNKNDIINIFFLINKPSTYKMMIYNYFVNAIGTKGNVE
MYIYHCDETLFINSLKKNLGGFDYYVIMPHFRDEQSKHTSSTREVLDMIEKIPKNKLLML
DNTKPNISGEYGSIYQDFEHDIYNALKEGLDKIKKYEKIILVYPDRSIHPYPFRIVRGFE
KFCKDFKLDYEILDEIYPDMELQKDIFITIRERDLVNLVKQIRQNNMKLGEDIGIISYNE
TPLKELLGITVITTDFKAMGESAAYMILKNKKESVNNVFKFIQRDSL
>KALACAFP_03486 hypothetical protein
MIKKLIFALSFLMAVTISAQKTNDKDAVTAAAEKLRLAMISGEKPALESLILPELTYGHS
GGHIDDAAEFVEKLVSKKSDFVTIDITNQTISITGNTAIVRHHFYATTADAGKAPGDVTL
DILLVWVKVKKDWKLLARQAVKSEKKK
>KALACAFP_03487 L-lactate dehydrogenase
MAFPFDTRYASLELLIERAKKRMPRFAFEYLDGGCNENINRDRNTDELRDVLLRPRYLNN
NFAEANMETELFGVKYSAPFGISPVGLQGLMWPNAPEILAKAAFKHNIPFILSTVTTSSI
ERIAELTEGKAWYQLYHPREEWLRDDILDRCEASGYDVLCILADVPTFGYRAKEIRNGLA
MPPQLNFRNVSQALVKPQWCMEMLKHGIPSFKTMEKYMDKNMNVKQLGQFMNSTFSGRLN
PDRIKAIRDKWKGKLVIKGVASDEDAEEAVRLGFDGMIISNHGGRQLDAGESTIAVVKEI
SEKYKNQIKIMMDSGVRTGPDVARALSCGAEFTFMGRTFMYAVGALGDKGGDHIIEMLKM
QFRQVMEQVCCEKPGDLQNFRVK
>KALACAFP_03488 Rhamnulokinase
MSKKKVTIVFDIGKTNKKFFLFDKNYKEVVREYTELPLTTDEDGYPTEDLAALQNWIKDN
FNAILDNEKYEVKAINFSTYGASFVHLDQKGNVLTPLYNYTKPMDEEILDLFYEKHGDKL
KIARETASPQSGMLNSGLQLFWLKYKHPETFKKIRYSLHLPQYLSYLFTGICVSEFTSIG
CHTNLWDYDKADYHDWVYEEGIDALLGPIVPTSASINTSYRNKKIKIGVGIHDSSSALLP
YILSKKEPFLLLSTGTWSISLNPFNDESLTDEDIENNCLNYMRIDGKRVKASRFFMGNEY
KIQVEKLCDYYGKEYGFHREVQFDQDLYLRLMKNKAVYFRFEGIALKRKMISETDLNSFQ
TFEEAYHQLMIELMDLQIHTIKNAIGNSEIENIYIDGGFTDNDVFMKLMSHHFQHYNVMS
THSPLGSALGASMVISNKKIDETFLQQHYQMKVLQPLILNL
>KALACAFP_03489 Xylose isomerase
MIIGKDIIEQYNKNEVENFNLDFDFLQNKLTKTGANVTEIVNKIADFQVAIPSWALGAGG
TRFGRFSYGGEPSSLEQKLDDVGLIHALTHSAGAVSLHIPWDIPSDVAAIKEKAASHGLI
FDAMNSNTFQDQPGAEQSYKFGSLNSVNEDSRAYAVEHNKEVIRIGKELGSKSLTVWLAD
GASFPGQLNFQTALSNTEKSLKEIYAGMPEDWRLFIEYKPYEPNFYSTTIQDWGTSFMLA
NACGERAYTLVDLGHHLPNTNIEQIVATLMYKGKLGGFHFNDSKYGDDDLTVGSIKPYAL
FLIFNELVYGMENNPQNPYPAWMIDASHNIKDPLEDLIQSLEAILIAYAQALLVNQKALK
DAQLNNDVVRAQEILQNAYRTDVRPLLRAARLQTGAALDPISAYRNLKVRENLISERGLN
VKATGL
>KALACAFP_03490 Diacetyl reductase [(S)-acetoin forming]
MEKVKTFKYVDYLWDENKAAALGDDQVALFLYRSNILGADLRITNYGGGNTSCKTIEKDP
LTNEEVEVMWVKGSGGDIGTLTRKGIAGLYTERLRNLKNIYQGLADEDRMVGLFNHCIFD
LDSKAPSIDTPLHGLLPFKHIDHLHPDALIAVAAAKDSEKITKEIWGDTMGWVPWQRPGF
DLGLQLEKCLNDNPGIRGIVLGSHGLFTWGDTSYECYINSLEVIEMASEYIAKKIEENGQ
VFGGQKVESLPADERKNKAAQIMPLLRGLASSESRMVGHFTDSDTVLEYINSNDLERLAP
LGTSCPDHFLRTKIQPLVLTLDKNEDLSDSKAILEKLTPLFEQYRQQYKEYYETCKHPNS
PAMRDPNPVIIIYPGVGMFSFSKDKQTTRVASEFYVNAINVMRGAEAISEYTSLPRQEAF
DIEYWLLEEAKLQRMPKEKPLSRKIAVVTGAGGGIGQAIADKMVQEGAVVVFTDLNQEAV
EAVTAKYNKDQAVAVTCDVTNEEAIANAFKETVLAFGGVDIIVHSAGLAISKSLEDTTTK
DWDLLEDVLVKGQFLMVKNGVEIIKKQGLGGDIVNIASKNGLVAGPNNVAYGTAKAAQQH
MTRLLAAELAADKIRVNVVNPDGVIVGSKIWEGSWAEGRAKANGISVEELPAFYAKRNLL
NEIILPEDIANGVFACIAILDKSTGNIINVDGGMANAFPR
>KALACAFP_03491 hypothetical protein
MKNIINNKSILIKKLVVIPSFVIAGLFINSCSSDFLDQPAYNITDTNTVFESLDTADLFV
QGCYRGLVPTEMYYQLGAGDTVTHSSEDGSTNNSKYNICNYQYDAYTPNTVTGIYAAMYA
GIEKTNIAITRLSLMEPSAKRNSLLAEVKAIRAFCYHNLIRVYGDVPAVWIPLEDADPND
PNTLYPKRTSRDVIYDRVIADMQESVNDLPATGTTTERLTKAAGNGLLARIALYAAGYSL
RWDLNTGSAGTMSRRSDNARVQQLYQIADNACAAVINGGTASLVQAQGGKSGFEALWFNF
DQRKFAVTNPEMLWHIAEYGANTNSAFGVYAMEGSRGGTYGSRKALQFILPSYYLSFNPG
DTRRDVSCTSYSIYFLNGGAATDTWVNVGTTFSCIMSGKFRMGWCVAPQAADARNLNIPI
LRYADVLLMYAETQNYLNGGPTAAGTAALMQVRNRAGIGNIPAPTGQQAFESAIVQERKW
EFAGEFNLRTDLIRMNRLASEIDATRQAMKNLSNKSGAYANTPALRLYKFEKNAQVYGDP
FLALKYIEITNPAEIAIVQNVPTSAANYAAYQTALASIVTAHGQTVVAGDKWYPTRMFEA
YTSTFNGNARKAVGFTSGFNALQIGNIIYTKPTGSAENGGTYPNWIEGGGDGLFYGFVPN
KTELLPFAAASAGHPLVDNPNLTQLPGY
>KALACAFP_03492 TonB-dependent receptor SusC
MSLKNTNKNLKPLIAPLFLLASGFVFGQTTTKDSAKTKDIEEVVVIGYGKVKKSDLTGSV
SSVSAKDLAATPAMNALQALQGRAAGLNIVTAGGAPGAGANVTLRGGASITQGTEPLYIV
DGFQLDNALNVINPNDIESIDVLKGASAIAIYGARGSNGIIVIKTKTGKKGRTTVNYNSF
MSFDMLSKKLDMVSKSEEYVKYQYELAQLAGKTTQWSNVFDNSLGTDTPGFYTGVFGRIN
SRYASAPALDWQEKMLGGTGTTQNQNVNISVGNEKTQAYISYNYNKQDGLLQNYSETRNS
LRANINSELYKGIRVDFSSMFNSNSTNGGGAYSGMKKILLQPITGGTKFTQDELFNTQTY
GDYSGLDSSFDTENPYIETQASTSNRRFRSFVANAGIEFDFLKNFTFRTAGSYNWNNSKS
TSFSDANSRAYLTDPVNTGINGSIGNSENYRYQITNTLTYNKTFAEKHKVTVLVGQEAVY
QEAESSSMRLIKFPLFNYGLDDITNATVADKNVDHSSYAMSSFFGRVNYSYDDRYLLTAT
FRRDGSSKFGSNKKWGNFPSVAAAWRVSQESFWQNSKINNIFNDLKLRFEYGITGNNDIG
NSLYTTNLVLTTYPSNNDPNNPALTTSSTVGNKNLQWEEMKATNIGVDMAFFNSRIRLTS
EFYNNDVNKMLLPVGLPVSTGYTTRYENIAVMRNRGMEFTLNTINVKSGAFRWSTDANIG
FNKSKVLALDGRDNRPFSVGGSRSGMVTYYAKVGEQLGDMYGYVYQGVYTTDDFIQGPNG
TLTLKPGVVKPATGTPKPGDMKFAADNEAGDQFTRKLVKIGNGTPDFIGGISNNFTYKGF
DLAVFMKFSVGGDIYNATKQSLSPYAMFQNVPSEFGNNYYRLIDPNTGQATTNLERLKEL
NPDENSRLWSLSNTNTANIAYPSSYYVEDGSYLRIAQLTLGYSFNKEFLQRIAVTNARIY
VTVNNVATITGYSGYDPEVSAATGVAITPGYDTSSYPRSRSYVLGINLTF
>KALACAFP_03493 L-rhamnose-proton symporter
MNALLGVFFHFLGGFSSGSFYLPYKKVKGWSWETYWLIGGIVSWIIVPPLAAFLTIPNFW
EIIQNESSSILGLTFLFGALWGIGGFTYGLGVRYLGVALGSSIILGLCMVFGSLVPSIYY
EFSPQTGKDNIGLMLSSKWGQMVLLGLFVCVIGIIISGKAGMMKEKELQTDSLDPHGTQV
KTEYKFGLGLIVSIISGVLSACFNFGLEAGKPMATVANELWKNANPGQGEFLFQNNVTYV
VVLWGGMAVNLIGCLYLAIKNKSYTDYTKRNVPVLSNLIFCAMAGTMWFLQFFFYGMGES
KMGNGASSWILHMAFIILIANLWGIIIKEWKGVSKKTTTTIAIGMTVMFISILIVGYGNS
LR
>KALACAFP_03494 Unsaturated rhamnogalacturonyl hydrolase YteR
MKKVIMRSAVFILIFGALSSCSVQKQASAKNNNLPDKKEVLEVSRRANQYFMNKWPDTGK
EIVGKKVWPSNLWTRAVYYEGLMALYKVDPKKEYYDYAISWSENHKWNMMRDTYTRNADN
QACGQTYLDLYEIDGKKNPERIKFVKASMDSMIASKKSDDWWWIDALQMGMPIFTKLGRI
TGEQKYFDKNYEMYAFTKYKHGGNGLYNPKDKLWWRDKSFVPPYKEPNGEDCYWSRGNGW
VVAALARTLEDTPKSDAHYQEYLQDYKDLLSALPPIQREDGFWNVSLHDPTNFGGKEMTG
TALFVYGMAYGINKGLIDREKYLPVVIKAWNAIVKDSVQPNGFLGWVQGTGKEPKDGQPL
AIDKQPDFEDYGLGCLLLAASEVYQLK
>KALACAFP_03495 putative rhamnogalacturonan acetylesterase YesY
MKFKIIIPLLLAVFLGVSFQKLQDKPVLYIIGDSTVQNGSGKGSDSLWGWGSFMNLYLNT
NKIEIQNHAKGGRSSRTFITEGRWDSIMKTIKKGDYVLMQFGHNDGGELADTLRARGTIK
GIGEESKDIYNPIHKVNETVYTYGHYMRKYAQEAKAKGAIPIIVSPIPRNDFDKSGKIKK
DQYGIWAQQVAQQTGAYFIDLNKMVIEKYQEMGQEKVKAFFPKDHTHTNKEGAVLNAELV
TKGIKDLKSCELKKYIK
>KALACAFP_03496 Rhamnogalacturonan endolyase YesW
MNIKFNLIILTVLFSQSISAQRQMEYLKRGIVAIPAESGIFVSWRLLGTEPQNTHFDLYR
IENNSTKKLNEKPLLNETSFLDKTADKRKNYTYFVKSNTKNQEIDQDSAKYTASQKPYFS
IPLKTPAGYTPNDISVADLDGDGEYEIILHQTGQSRDNSQKGITDPPVIQAYKLNGKFLW
EINLGKNIREGAHYTQFLVYDLDQDGKAEVVMKTADGSKDGKGKVIGDATKNYVNENGFI
LSGPEYLTVFNGETGEEINTVNYQVPRFAGSLNPTDEQMTETWGDAKGNRIDRFLGAVAY
LDGKNPSVIMSRGYYTRTAIAAWDYKDKKLSLRWLFDTESSEENKKFRGQGNHNLSIADV
DNDGKDEIVFGAMTVDDNGKVLNSTGFGHGDALHVGDLDPSHPGLEIFDIQERFDDAGAH
FRDGATGKVLWKLPSLIYSKQGKFQGPGRGLSLNIDPRHEGSECWAAGAGVKGLYDAKGN
KISNKNPAVNMGIYWDGDFLSEILDGTTVSKWNWKNEKSNLIFDAKDFQCESNNGTKKNP
SLVADLFGDWREELIYRTSDNQELRIFSSTIPTKHRLYTLMHNPQYRLSIVWQNVGYNQP
PHTDYYLDESVKEVPKPNIYTEK
>KALACAFP_03497 hypothetical protein
MKIKNIICLSVICLAFGNLSAQNPWPPTTNTAQPWTRWWWMGNAVDEKGLDKQLTTLHKA
GFGGVEIVPIYGAKGFENQYINYLSPEWMKMLQFTTNKAKSMNMGVDMAVGTGWPIGGPQ
VDEQDAATKMIVQTYTISSGEKFSEKIVLKDEKLKNLKRIKLNIVTAYNEKNEAIVLTEK
ITSDGSLNWKPDSGKWTVYAVFTGKTLQKVKRAAPGGEGYTLDHFSPDATKDYLKTFDKA
FGNSNYGVRSFFNDSYEVFNADWTPDFTNEFKKRRGYDLSPYIKYLVSDEDNEITTRIKS
DYRETLSELILNNFADNFTSWADSKNSKNTNQAHGSPGNLLDLYAAVDIPESETFGSTVF
DIPGLRRDSADVQKSDIPDINMLKFASSAANVTGKPLISNETFTWLTEHFKTSWSQAKPE
VEQVFLSGINHVFYHGTTYTPADVPFPGWLFYASVNFVPENSLWPHLKGLNSYIERTQSV
LQSGKSDNEVLMYWPIYDQWANPKGKDMAFKVHNVEKWLQPTPFYQDLTKLSKIGYSLDM
ISDKMIGESTFQNQRIQTTDKGSSYQVLIIPELKYLPETTLNHILKLAENGASVVFQNEP
KDIPGYFEVEKRRNELTSLWNKIPFQNQGETMKIATFGKGKIILSFDVAKGLEYLRIERE
KLTETGLKFVRRTFDGGKYYFIVNHTSKEINQFVPMNYTGKQTTIMNPENGDFGVAEVQN
NLVKIQLKPGESLVLKTVENPDKSIPKWKYIEKTDSPIILNQPWHLSFKEGGPELPKSRN
LKKLEPWTNFSEDPATQSFSGTGVYTTTLNLNKKNADDYLLKFDKLYESAKVIVNGQDAG
IVWSIPFEINIGKYLKKGKNTIQIEVCNLMANRIRYMDQNKIQWRNYHEINFVNIDYKAF
DASNWKVQPSGLDGQIQLMPLHYSK
>KALACAFP_03498 Rhamnogalacturonan acetylesterase RhgT
MIFVCSLMFAQQTTFKFDFGGSRVENGYIPITKNSKFDRKTGYGFMDISGLKSVDNGGNA
LTGDYITSDKPFYFSVVIPEGNYDIKLNLGDTNGTSETTVRVENRRLMLDNVKTKEGEIL
EKTITVHVKDSIIRNHDGEKIGIVKLKPRERKYLHWDNLLTIEFNDKAPKVCSLIIQPNK
TAKTIYLTGDSTVVDAQYEPWASWGQMLPYFFVPEKVVIANYAESGETLKAFEDRHRIDK
IWKKLRPGDYLFIQFGHNDQKYGNSEKSGYRKRLKEWIDKAKQWGAIPVLVTSMNRHVFD
ENNKIVNTLDDFPEAMREVAKEENIFLIDLNAMSKTLFEAMGPENSKKAFVYYPANSYPN
QPNALADDTHFNTYGAYELAKCVVKSMVDQKLPLSKFVSKNYKGFDLNKPDAVEKFYWPE
SIFMESLKPDGN
>KALACAFP_03499 Beta-galactosidase
MNYSSKIFFLLCLCSQLLHSQSKEIQFLSGKDAEHTEAWDFWINGGRKSGNWSKIQVPSQ
WEQQGFGSYNYGRDYVTYGKNFKFNDEVGVYKHKFSVSNSWKGKSVNIVFEGSMTDTEVK
INGKPAGATHQGAFYEFKYDISDKLIFGKENILEVKVSKMSADKSVNNAERLADYWVLGG
IFRPVYLEATPRENISWTAIDAKADGTFRSNIHLKGIESSNNLKVELFDSNNTLVAESQV
NIEKGDTLKQLQFSVKNPKLWTAETPNLYKAKFTLNKNKRRIYQTEEKFGFRTIEIRKDD
GIYINGTKIKMKGINRHVWWPETGRSVTENIDLMDVQLIKEMNMNAVRCSHYPPNRSFLK
ICDSLGLYVLDELAGWQKKYSTEIGKKLVREMVTRDANHPSIIFWSNGNEGGHNFDLDAE
FAKYDLSNRPVIHAHHKPGNAFNGIDCNHYEDYYSTQKILNGENIYMPTEFLHAQDDGGG
GTSLADYWELHWNSKKGAGGFIWAFADEGLVRTDFNNQIDVNAINAPDGVVGPHREKEGS
FYAIREIYSPVKIDLKTISNDFNGSIPVENRYHFTNLNECQFEWKLIQFKTPFSSESGFE
SIKTGKAESPNIKPTEKGNVNLNLPQNWKESDALSLTAIDPFGKEMYTWTWKIASNLEIS
KQFQKNLTKEFPVSVAENDSLFILKSDEKEFSIGKKDGLLKSVILDKKGKKMTFRNGPVF
MNGKVELSSIKSFAEGKNQFIEAYYKNGNKIIWKLNPDGILELNYEYALSGDYPFAGVSF
DYPENYVINAKWLGKGPYHVWKNRTQGQTYNVWQNLKNSTRTGFSSWIYPEFKGYFDDIS
WLQLDTAEGKITIGTKEEKMFVRLFDFYGIYGAEGYPKLPTGNISFLDAIPPLGTVLAFN
INDKTESLGPESELNHLNGTFKRTLYFYFGLPDLGDEKKQFTMPEVNILTD
>KALACAFP_03500 Exo-poly-alpha-D-galacturonosidase
MKFQNKSSLLFSLLILFFFSSGVKSQDKFPDGTLIPKWFKENKPTDINKLGKKYILTDFG
VKNDSTVLQTKQVQAVIDEAAKNGGGVIIVPKGTFLISSVFFKQGTHLHLEKGAVLKGSD
DISDYPVVTTRMEGQTVKYFPALINADGLDGFTISGKGTLNGNGLRFWKAFWKRREWNPK
CTNMDEMRPRIIYISNSKNVQIEDITVKNSPFWSTHYYKSQFVKLLNLTILAPKEPVKAP
STDAVDIDACSDFLIKNCYMSVNDDAIALKGGKGPKADKDPNNGENRNIIIEDNTFGFCH
SALTCGSESIHNYNIIFRNSTVKDASRLLHLKMRPDTPQHYEYITLDNIKGNVKTFLFVK
GWNQFFDLKGEEAPKRRLANNIVLKNIDISCQTAFDIEKSDLYQLKDFTFENVKIKALKP
EEQNLNAIENLKKTNVTVTKIASLNQSYDKKDDSDEGKK
>KALACAFP_03501 Germacrene A synthase
MREELIVPKCHYPWPTVNSPIANAFDDEEKDWYDSDYTFISEEGIKRCKPQFLSRVATYM
NPTCDSIERMRPCARLMIYITLFDDFFGLTPRNELKIMADRVYEIMMGDEPSPGEIGILR
QMAQARKEWIVNGMPRFWIERVSKNFYEFIMYGMAEEIPFKQAEKRTYPLLPHYLSFRKY
SIGMWPYGDLIDPCVNFALPVHIYNHPVVQRCRELLSLIIVIQNDFASLKKELEIEAECL
NIIFILSHQYNLSYQDACTEAMKLHDAYANELDELHRSLPDFGPFQKEAYNHIYHIKLQI
SGCANWYYNSGTNRYEPKGFIVPKYGREGDEIFIPHSIFVKK
>KALACAFP_03502 Germacrene A synthase
MNPEEYKSKNYLPLGHYPWPDLINPHAEQMGKDMDGWIDNDYTFLTEKQRKTYKKMKLHM
CTARMWPDLTYEQSIPCNRFMLQYVALDDQVENSSLEEIQQLRIRCVDILKGAQPKPEEN
ALYHHMALIRDEFRALMPDIWVERFIYYFYQSFRYGIELEYPYKIAQRPPSLTLFKTIRE
YSVLMRPYLIFGEIESGLVLPEHIFEHIVFQKMISHMTLVVAWQNDIHSLPKEMAKGTEV
FNLVFVLQQEYNLSLEDACAEALNIHHKELEKALTLHAEYREFGEYQEHVDKFVYYAGVG
LQGVNSFYLETERYKHGGEGFAWPEMSNTDKIQL
>KALACAFP_03503 Germacrene A synthase
MNHENFDPLELLNSQFRYPFPTLKNPHADQLQEITENQWIDGEYLWLYEQNPDLRKKYKK
TKTAHIAAQWFPTASMERFRPICRLMLWTLYNDDLYEESEPEDIEFVHARSIAVLNGEIT
AAESGIPLGGMLASLREELLQFIPQESISRFTQMISRYFKGLETELKYKKNKMFPSVAEC
IALRENSICLYPFLQLTEVETGIILPPEIHEHPVICRLQTLACHLVTFFNEVQSVMKDEA
TDSIYYNIVKVIQHEKNISLKEACLEDLRLHNEDLKEFVKLQSSLPDFGIWQDAVVNWVH
YMSMVLSGWKNISTKLGRYNAMEFPEAKELKERLNQI
>KALACAFP_03504 HTH-type transcriptional activator HxlR
MRKTTSTNAINEKLIIDGCGMARALSIVGGRWKPAILCRLKHNTMRYGELKKSIEGISER
MLVTQLRELEEDQIIERIVYPEVPPRVEYRLTDLGKTMNPMLEAMSDWGNMHREKVGDKA
PASVDI
>KALACAFP_03505 Cyclic-di-GMP-binding biofilm dispersal mediator protein
MKNLSNKIAVVTGGSRGIGAAITRKLAAEGAHVIFTYQNSAEKAEALADDIKNNGGNAIA
FAADSSNPSDLQNVIEKTVQQFGKIDILVNNAGIYVGKPFENYTAEDYQSTMDVNVRAVF
LGSQEAVKHMPQGGRIISIGSNMAENSIGPQTTLYTMSKSALQGFTRGLARDLGPKKITV
NLVQPGPINTDMNPDNTEFADFLRTRMATGEYGKSEDIANAVAFLASEESGFITGSFVTV
DGGFNA
>KALACAFP_03506 hypothetical protein
MSTVLFMVPYQAQTYSIFELDSITEMYKTKGDIEKAVDFNQNALKQYRKNDNREGIIAVN
INLGNLLCTLNQYKESISYLEEAKSEISKTKNPYLYARLYNEFGRDYSLLGLFGKGNENL
DKAIGYALKVSNQKKKKHQLYFSYTWKWYNFEYMKKMDSVYSMQKKCLEIIQEPIIYVKA
AGRFIDEKKHLDSAEYYLNKAIPLFEKSPADQKALTLLLFGDLYTEKKEYQKALDYYFQS
LAISQKMKRRDHIRNGYERISKTFKALNNQEKADEYYKNYSFLNDSINAGEKRVLHAIVE
KLDEEKKQEESNKTRLFILICVISAVFVGLLYFLRKAYLEKQKKKDNLIEQKDELIEKKD
QLIEKHSQETSQLKKKINTKFPQLIKLAKNNDPFFIVRFKEVYPEFYEKLMSQYPDLTDS
DLKICAFIRLNLTNKEIGQYENVTLRAVETRKYRLKKKLGIAPETDLIKWIQEF
>KALACAFP_03507 hypothetical protein
MKKHVIILPALLVSAFAYSQVGINTPDPKADLDIVGNTLGLKSSANSGSWDNIWLQVDSR
KAAVNASGAEDGLQFNVGSNNKGTYGDDQTLKTVATMTHNGNLGIGTTTPQNRIDLGSDA
PGATNNPAGKKLAVYNTSTASSFYGLGVSSYTLQIHAGSPADGEPGMVLTQSGNVGIGAP
SPSSSAILELASTNKGFLPPRMTTAQRDAVNPKPAGLMIYNTTVNIMQYWNGSSWINYQ
>KALACAFP_03508 hypothetical protein
MINNNVNINRMKKNIIILSLLLVSASFYSQVGIKTPDPKASLDIVGNTLGMKTGANSGSW
ENIWLQVDNRKASINASSAEDGLQFNVGSNGKGTYGDDQVLRTVATMTSDGNLGIGTTTP
QNRIDLGSDAPGATNNPAGKKLAVYNTSTASSFYGLGVSSNTLQIHAGSAADGEPGMVLT
RNGNAGIGAPSPNSAALLELNSINKGFLPPRMTTAQRDAINPKLAGLTIYNTSLNCMQYW
NTQAWKGSCGTTPPTPDLSANCTGWRLPYKTNNQSATGTVKGTSLTATFSDYGNVKHSTN
GPNRCGISLTPADIYWLGDDRSQNTKMKIRFSRGVTNFKVIQAGTHARETFTFTLKYKGV
AVSPTVTVSPVGGCNDQFQITKPASNQVEVKSLNNWNWTVDGTGIIYNIGGVWFDEIDIT
ALETTNQQNGSSFNFCVGDVL
>KALACAFP_03509 hypothetical protein
MFKNFTTLSVAAALLSYGIASAQSVGVNMDKPGSTLDVNGSLAAKYTAVTAATYAMTSAD
FHISYNGTANATFTLPVAIAGEGNFKGRMYTIKNNTAFTITVNPAASETINGNASMTVSP
NQSLQLISTGLTGAASTWDISGNNSSVTTAVTASNGLTAVGTDVRLGGTLSQNTSINYGD
KSLYLSSNVNNFGLTSIGNVNAGTSAAALLQFTNNSTGTLNMFLNSSTRTADGGANAATI
NNTGGPLTVAGNNNIAQLKLSTAGGGEYFFNGTRRLQIDGDGSINTYGASSNFFNSVNGP
LSLRGNNSFAQFNVGFNGLQYYYNGGNWMNVDGNGDIYMNRPEISETSGGNRISATAGHL
DLSGYNTLNPAQPTQIYLGTNGFKYRYNGNTPMWIDGNGTVYAAGGFVNTSDMRLKTQIK
EINYGLKTILALEPKQYEISDNTEIKNGKPAVDPELNTQHKIGFLAQDLYKLVPEAVHKP
KDDSKEAWAVDYAVLVPALTKAIQEQQAEIEHQKIKIKKMELEMQAVKKKLGL
>KALACAFP_03510 Transcriptional regulatory protein UhpA
MNKRVLIADDHLVVRLGISVALQAEYPDLIIDMAESYEEVMVSLQNHNYFLVILDISMAG
IQSTRIISELKNIQKDVKILIFTSYDQNIGLQYIRKGAEGYLHKKCNEQELKNGIKNMFE
KGCHYPSQLIPELVKSSRETPVLESLTKREYQIFELLAEGGGNLEISNQLGIKETTVSTI
KRNIFKKIKIQNIAELIEMHSNLH
>KALACAFP_03511 hypothetical protein
MKKINKFAQTVSFVALLSATVIKAQSLTETKLGEIFPEDIQWSSFPAFPPEARLSVLVGD
PKNAESYTVRVKVPAGLKLMPHIHPENRIYTVISGVFYIGIGKEFDPSKLKAYPPGSVIT
LPGNTPHFHWAKSGEYVTQVSATGPLGINYIHSEDDPRNK
>KALACAFP_03512 SusD-like protein
MKTTYNKNISFFPLNFKTFGKALIWGTLTLGAISCEKDLMLEPENNITQTSFYTTELQIQ
QALSGVYSAMINSSSRGGFDVNFYLLASEVRSNNFNAISQNGNRDYYAINRFQDTSSTEE
VEVLWEDAYQLISYANNILARIDAVPFNDPAVREQYRSETRFLRAYAYFELMRNFGKVPL
IDHPVSPEEAATIPRKDLTSLYNFITSEIEASVAGLKNVYDTGNKGRITKSAAHAMLGRM
YLTGYGYPLNNSSYLQKAKEHLYAVIQVEGQYVTFAANYADLFKSVNDNKYHIFEIQHIS
GGLSQGSYLPSYVSPTFGSADPLYNAQGSLYSSAELGVSQSLINAYEPGDLRRPLTVKTQ
FIAQNGQPDNANYFVKFREPGIALTNRYDWPINFPVIRYEDVLLMYAEVLNNEGNTGLAV
PYVNRIRQRAGLAPLSTSISGSDFTTALRKERRIEFAGEGVYWHDLVRWNIAADVINQAA
ADLNYNFTITTKDYLYQIPLSQIQVAGYEQNP
>KALACAFP_03513 TonB-dependent receptor SusC
MKNSIIILGLLISTTGLVFGQEKQVTGIILGQDEKPLQNAVVKLNNTSQEVATDTDGAFS
IKVSEEVNKPVLAISHEGYLNKTVDISNQENVKITLQPTPDNKVNNIEEVVVIAYGTQKR
GEVTGSVGRVDAQSFKDRPIARVDQALTGQIAGVKTRSTTGKPGEPLEIRVRGTASISAS
NSPVYVVDGMVVDDMANISPDDIQSIEVLKDAASTAMYGSRGSNGVVIVTTKKGTSGKPS
FSFSQYYGVQTIEKKLDIMNSSEWIDFATEAINKRWVALAPGNSASDSYAVRANYFGLAN
ATDYNLANINYMIDPRWGTNQVANIDWQDAFYRPAAIQSYQLAVRGGSKNVKYMISGAYF
DQEGLAINTGFNRFNLSAVIDVNISDKWKAGIALRPSYSQSYGATVDGKDNLAHKMLSMV
PVAEVSAGLYTNFWKNTRYRWAGSTQSPIGVMEETTNNTNEFRLLSSLYVSYDILPDLNI
KISGGATNNFNLNNGYTPTFDLITNIPGQVSIASRRTVNYNRYLGEALLSYKKSFGEHDI
NAIAGYSAENYRTTTQYNRNKGFPNDDLETFNFTQSASVLNSEYTAAEWMLISMFGRVNY
DYKEKYMVSASIRRDGSSRFGWNNLWGTFAAFGAGWKVDNEEFLKDVKWLNNLKFRYSWG
ENGNNSIGDYRAFGTLSGGNYSFGGSLSNGLIPNTIPNPDLTWEKTQSSDFGFELGLFNR
IDFTADYYIKKTKDLLLEQPIPAVTGYTTMWKNVGSVQNKGLELELTTKNLTGAFRWNTS
ANIAFNNNKVLQLGTDNAPIYTGFSNSTNIIKVGEELNSFYLYEAIGVLSTADINNASVA
KTTGAIAGDVKYRDVNGDGVINEEDRHIIGGPTPDYYWGFTNTFSYKNFDLSIFFQGQKG
GYSYALLGRAIDRTGMGTTVNAMGNWVNRWRSDENPGDGKTPRLDGTTGSLLDTRWLYDA
TYIQLKNVTLGYNFDQDLASKLKISNLRVYISLENVWRKDHYYGGYNPESVQSDGTDYGA
YPNAKVYMMGINFNF
>KALACAFP_03514 Putative acetyltransferase EpsM
MYLYGASGHGKVVAEVAEECGYNIDAYIDENPSKDKLLSYPVLNEIPQQEIEILISIGHN
RIRKRIVAQNEQFSYATLIHPKSIISKRVKIGEGTVVMPGATINAIVKVGKHCIVNTNAS
IDHDCILEDFVHISPNVGLGGNVYVGEGTHVGIGVNVIQGITIGKWCTIGAGAVIISDVP
DGCTVVGNPGRIIKSKSLKI
>KALACAFP_03515 N,N'-diacetylbacillosaminyl-diphospho-undecaprenol alpha-1,3-N-acetylgalactosaminyltransferase
MTKNEKVIRTSTVPLSLNLLLKGQLKFLNEFYEIVGISSEGELLDEVKQREGIKTIKVNM
ERGISPLKDLSSLYKLYKILKTEKPVIVHSITPKAGLLTMLSGKMAGVPIRIHTFTGLIF
PTRKGPVQKLLINMDRLLCSAATHVYPEGEGVKKDLINYKITSKYLRVIGNGNVNGIDLN
HFSSEQISEEQKKLLRKELNIEDSDFVFVFVGRLLGDKGINELVEAFTLLNNKDSERRSK
LLLVGPLEHELDPVRPDILEEIKNNPDIISVGFQSDVRPYFAISHALAFPSYREGFPNVV
MQAGAMGLPSIVSDINGCNEIIMEDQNGVIVPVKNSEKLSQAMERIKSDTAYYQKLKTNA
RPMIESRYEQSEVWNAVLAEYKKLIKEREYRV
>KALACAFP_03516 Putative teichuronic acid biosynthesis glycosyltransferase TuaG
MKNERIAVVTPVYNGAETIEKSIRSLLDQTFDSWVNVIVNDGSTDETRKILEKYQNDERF
YIINLENNVGRGAARKIALEKVKEIDAKYMCMLDADDLYYSDKLKWQYDYMELHPDIALL
SCSIGYIDHDNKLVGVLETFDKEQIMEFDHYINYKAVPHACSIIRLSEIGEVTFDEKLLL
GQDQDFMIRMLIKKKYAFIPKIGYLYNRADSFSFKKYKKSLHLAFYAKKKLQLGALDLLK
IYIINQVKIMYVGILCLVGKEKIYLNKIGRPTLQNELQEHQTKLRMKV
>KALACAFP_03517 N-acetyl-alpha-D-glucosaminyl L-malate synthase
MKILFVEAVQNYGGARKSTVELAGRLQENGHGVKIIDFWGTCEPFVQAMEKRNISYSILD
KRQTPFILASSNKIKMLSNYMKYLQLLSAYRKKIKLLINDFQPDLVIVNNTKTLSILSKS
GSYKIAFFARGWFLPRTVNRFNTILIKKLTDIYIGVSQSTRQAIFSGGFAALEDIYTVPN
AIDYTGFLNDFKDRENIPNWSDDQADRPFVIMHCGGFLPSKGQHITIEIAKKLKRDKVRF
KILLVGIIYQGDASQKYYDKILKQIEEEQLQEYFEIVLNKSDVLEYFGKMDVLLHPSSTE
GLPRVVMEAMALGKPVIGNAVGGMTDYILHGFTGYLTNFNSIEDYIKYCGLLQKDKELYG
FISNNASGLIGKCYTTDNQIEQLLKIKVK
>KALACAFP_03518 hypothetical protein
MNISFLEAVQIFGVRKSAIKLERRLREEGSPKVNFCYNVQSYSEKDTGSNLHEAKSNFEY
ETIDDFKEINFS
>KALACAFP_03519 Ribosomal protein S6--L-glutamate ligase
MKIGIHHRKGSFSDRWIEYLEEKKIPYVILNAFDNDIIKQIKDNGITHFMWHFNQNYFED
MLQARTLFRSINQIGIKTFPNEESYWHFDDKVSQKYLLEALDIPLVKSDVFYHQNEAEKY
IENTSFPKVFKLKGGAGSINVKLVKTKQQAKKLVKQAFGRGFDAFDSWTVFTDTIERFRR
QKTLHNFLRIIKWGGKGIFVDKQYKVFPKQRNYVYFQEFIPNLSYDIRLIVIGNKCYYLK
RNTRNNDFRASGSGMLEFAPGKFNLEAVDIAFKAARQLNMICVAYDFIFDENDQPLVVEI
SYGFQPYVYDQCLGFYDKDLKWNKTDVNLEYEIVHSFLNAYS
>KALACAFP_03520 Putative O-antigen transporter
MINRIKKIFNTKDKKALLENFVSLSALQLIGMVLPLITLPYILRVIGFEKYGVIVFSASL
IAYFTALTDYSFKITATRDVAIYRDSPKKLNIIYSKVLTIKALFLLLSWLVIALVVYFYP
PFYENRVIYFYTSLLLLGYALFPEWFFQGIEKMRYITYLNLGIKLFFTLCVFIFIKKESD
FWIYPLLQSAGYIGAALVGQYLLIKKYKLKFIFLPYKTVIKTIKVNSPIFINQFVPTLYN
NTSTFVLGIFGTAQLVGIYQAILTIINLIVALIEILSRVFFPFLNRRKDAFQWYKKMMLI
MITVMVIGVLAFNKVIFWYLNVSYDNAFWILLILAIGLFGYTLYNVFGLNYFIVHRQDKL
VMKNTLFASLLGFVLAYPLIHFYSVLGAAINLSLARCVMGGGLYYKFFNRKK
>KALACAFP_03521 hypothetical protein
MKKVIFLFFALMYFLGNSQQYVQDRFSGYATVKSQYFKTTKDLTSYLPKGYSKNGDTDYT
DYIQKGINENTVLIMPDFPVLVNENGLALKSNQKILFQKNSKLIMKPNAKDRNGILNLFN
IQNVTIYYPTLIGDKHKHLSTTGEWGMGIYILSGSNIKIIGASIESCWGDGICIGGRNNI
SSSDITLKNTILKDNRRNGLTIGGVTNLVVENAYIANTSGHNPQAGIDVEPDSNNYEVKN
VKLTNIETQNNGNYGIVISPGSIVGKQQKAISIAINNFKDNGSKIGFGMAVTRDKPNAGF
PQLSGNISVNNFSSQNNATAKFRSFKGAPHQVNVNIDLQKINPASKNANGFGQKFKNNDE
TITLK
>KALACAFP_03522 hypothetical protein
MEVNKSFKLVLFAFSFLFFFIGFLIYGKVNNASYQDVYFLPVGLGFFTLFISNIFVKLKS
YFIFWIITIQQLIRYIVIPCLFLTTDKLRFGSTTINEPYAVAMMLVELLFVLIAYHICTY
SKEIKAEKNQLKFLPLNTVNTGLFVLFILIIALNRSFLQKLSFVWDISTYLKLKLSGDLE
AISPLVSIMFPVMRAYIVLFIFSAIDSFKIKQGTKLALSILVVLMNATIIVGISRFSIVY
ATFPLVLLLIYFYPVYRKRILTYTSVFFGIILLLASVAKFSENTKKADVGGFFSLHDLNA
YFGGVANYAIGYDSYKKNQVNPFEKYYYFVSDITQNIPVLSRFSNDNYKTNIKFNNEIYG
AGRSRDQIVPVSVAGLYHFSIYFFYIYIFILTLLAFRFERKAYSTNSAVLFFLYIILAFG
CATSMMINIGSISATLFINLVVFIPFFTMINKLNVTK
>KALACAFP_03523 UDP-N-acetyl-D-glucosamine 6-dehydrogenase
MEKQYKIAVIGLGYVGLPLARLFATRFPVVGFDINQKRIGELKTGTDSTLEVENDVLESV
LIQENPFHQTDKNGLFCSHDISDIQDANIYIITVPTPVDQHNRPDLTPLYKASETVGKVL
SKNDIVIYESTVYPGATEEECIPVLEKVSGLKFNQDFFAGYSPERINPGDKEHTVEKILK
VTSGSTPEIGEIVDGLYKSVIIAGTHLAPTIKIAEAAKVIENSQRDINIAFVNELAKIFN
LLEIDTHAVLKAAGTKWNFLPFKPGLVGGHCIGVDPYYLAQKAQENGYHPEIILAGRRLN
DSMGQYVASQLVKTMIKKKININDARVLNLGITFKENCPDVRNTKAVDVIQGLEDYALQV
TTFDPWADPAEVQHEYGLTVVNEVPEEKFDAIILTVAHNEFRNLDLRKYLKEEGVIYDVK
GVLEVCDSRL
>KALACAFP_03524 UDP-N-acetylglucosamine 4-epimerase
MQKILITGGAGFIGSNLTEYFLNKGYYVVCLDNFATGHRHNIEPFLQNPNYKLIEGDIRD
LETCQQAVEDVDYVLHQAALGSVPRSIKNPITSNEVNVSGFLNMLVAARDAKVKRFIYAA
SSSTYGDSASLPKVEDVIGRPLSPYAITKYVNELYADVFGKTYGMECIGLRYFNVFGRRQ
DPNGAYAAVIPLFIKQLINHESPKINGTGDYSRDFTYIDNVIQMNELAMLTENPEAINTV
YNTAVGDRTTLNDLIGYLKQYLSEFDEKIAGIEATYGPNRVGDIPHSLASVEKAGKLLGY
KPTHTIEKGLQEAISWYWENLK
>KALACAFP_03525 Putative tyrosine-protein kinase in cps region
MQQTDFQAKEEKLNIKKTISKYLYKWPWFIASILVFVTGAYIYLRYSVPQYQSKTTLKFD
KKQNDLSSALADLDNLGIGLGNADELKSEAAVVNSRPILTQVVNNLNLNVEYFTAGEIKD
SQLFSKAPITAKILSYKDEKFAPSQCTVTDIKGDQFTLETEKKKKITGKFNMPLQLDFGT
VVLQIKPQFVLKSEYKIVFSSPMDKVKKLEKTIRVNLPDEKAMLMDISLIGSLPEKSEAI
LNEVTKQYNLDGQRDKNLQAENTQKFIDKRLEVITKDLSGVENQKEDFQNRNRIVDLQAQ
AELALQNTSENTKVLLQQQTQLDLLNSLTAEASKNNNQLMPSNLGLNPSLEQSISQYNQL
LITRNKTLRQATNENPAVIEMNREIASLKEVIRDNINEQKATVQKGIAQLQNQISTSNTV
IEKVPGQSKVYRGIERQQNLKEQLFLFLLQKREENAINLSVDVPKAKIVNPAFTEDLPVS
PKKDIIFAGALFLGLLLPFAVFYISFTLDDKIYSRDDIKERSGLGVLVDIPSLKDNENHL
VQKNDFSELAEAFRVLVSNLKFILPIKDSAKVIMVTSSVKGEGKTLVSVNLALTLANKNG
RALLIGSDIRNPQIQRYDNEPTKRKGLTEYLYDDSVDVEELIHTSTTNPACDVIYAGTIP
PNPQELLSNGRYQKLIEQMSSQYAYIIIDSAPLMLVSDTLSIADTADATLYVVRSGESRN
ILINFANDLVKDSKLNNVSFVINDVSKRAGGYGYNYSYGYGYSQTNDKKSWWKKMFKS
>KALACAFP_03526 hypothetical protein
MKKSIITYIILLSVILLSCKPKQNMVYMSKHNMEEEVTKAKYQGLHIQEGDVLLILVSAL
DEIAVKPFNLNTTNKVGSDSGAGMNQYVQPSEYVVNEEGYIYFPVIGSIYCKGMTQVQLK
QDLEARLKKYLTDPMVSITLKNFNVSILGEVKDPGQKESVSQKINVFQALGLAGDMTDFG
DRTNVKLIRTGEDGVDQVVNIDLTRSDIVSSPYYYMKQNDILYVQPDKNKQVQANSNPNR
ALTFQIIGALLTAGTLIIALTRR
>KALACAFP_03527 UDP-N-acetyl-alpha-D-glucosamine C6 dehydratase
MGNVFKITELRYIPRWLVFFIDISIISFSLLISNLILKNLNTEINFIEYHNEKTVAVLAV
NILFMVLFKTYAGIIRHSTFFDFFRIVWSSGSTLVVLLGFNFLAESVWGKSVYVNPVLFF
FFFISTFLMFFFRMATKQLFKMLMDPKDSSSKIRIAVVGVDEESVSLANAIIHNRRHPYQ
LTGFLSTRLDSKKARLLGHTIYNKREFIKANNLSNQIDAVLIKENMPKQEMEEWTNLTLN
KGLKILKAPVINKMNEGGIIGGIRPLQIEDLLNRKPIKIENGEVKKRHFSKSVLVTGGAG
SIGSEIVRQVVQFNPSIIVVVDQAESPLYELELELLERFPEQKFEFVLADISNIYRLEKL
FEDYQFSTVYHAAAYKHVPLIEKNPHEAIFVNIGGTKNLALLSKKYNVNRFVMVSTDKAV
NPTNVMGASKRAAELFVQSLQNSSDNTTKFITTRFGNVLGSNGSVIPHFKKQIEKGGPVT
ITHPEIIRYFMTIPEACELVLQAGTMGQGGEIYVFDMGTPVKILDLAKRMIKLSGYTPDV
DVKIDFIGLRPGEKLYEELLTDNSTTIPTHHEKIMISRDPVMEFEEIEILCNQIMRAAIK
KDRLQVVKILKTIVPEFISNNSEFEVLDKTPEHEVYQ
>KALACAFP_03528 Cyclopentanol dehydrogenase
MNKKVVLITGTNSGFGWLTAHSVAALGHKVYATMRDTATKNADKAQALEQLDNVTVLDVE
LTDEASVKKAIDTIIAEEGKIDVLVNNAGFARNGVAESFTTADVQEIFDINVIGPWRLMK
MVLPSMRKQSEGLIINVTSGFGRFSFPFSTMYSASKFGLEAVSEGLHYEVRPLGIDVAIL
QPGAFPTEMAQKVKFGSDSSVVDGYQAIADFPHKMGKAVGEMFENVKPDPQNVADAVVKL
IGLSKGQRPLRTVVDPTTGEFVQRANEAVEAEYAKTLVKFGMGDLLK
>KALACAFP_03529 hypothetical protein
MEKMIEYILRFGNLNKQQIDFIESKATVLELRKDEYFSEAGKVPKYAGFILEGVFRFCYY
NNKGTEVTHFFVDENNFVNDYQKFTDRATASEYVQAVTDAKLLVFSRKDWEDIANTIIDW
DKIETKILNKCLTEAIERRSPLISEDATTRYLSFIEKFPALVNRIPLSYIASYLGITQQS
LSRIRKNIR
>KALACAFP_03530 hypothetical protein
MNVNVNRAFLKVRTVILLTTVCVIFSLQIKAQAIDRFDLVNRHNIVLKEIDPLAPLSVGN
GDFA
>KALACAFP_03531 hypothetical protein
MFRKLYLSLLLSSCCGMAYAQQLAFPGAEGFGRFASGGRGGSVYHVTNLNDTGAGSFRDA
VSKPDRTIIFDVSGVIRIKEKIAAASGITIAGQTSPGTGITVYGNSISFKSNTIVRYMRF
RGSIDMPQGACTVVADNLKDIIFDHVSIEWGRWDNLHVKNSTHVTFQYCLIGEGIDPQRF
GALLENPVDITVHHSLWTGNQSRNPKAKAKIEYLNNVVYNWGKSAFVGGHSSTDHYQDLV
GNYFIAGPSSTDEFLDMFTATDHVYHKDNYADLNKDGQVNGRLITDEDFIKETATLVKKP
STLSNSVKIDAAADALKIVMAEAGSSLRRDAVDKRIIGYFKSLGKKGQIFKTEAAAGGQP
EIKQKNSKLKDTDSDGIPDNWENKNNLNAADRTDAAILTQTGYTNLENYLNSLVKIVH
>KALACAFP_03532 hypothetical protein
MNNSHTIISTLFFGVMFLPCICFGQQESKQNYTLFNPVPKDLMREMETDRPDVTESPYTV
DAAHFQYETDLVRLTRQKSDEQETRTLLINQGNFKIGLTRTTAIQIGFQTYGNQKEKDLN
SGSVTTSNGFGDITFRIKQNLIGNDKGNFALAVLPYVKFPTSNYEDSRFEGGLIVPMIYK
LPGEWNLGMQVEVDRLKDRDQQTMHTEFLQTLAISHPIIKGVEAIAETYYTYDFKAHEIS
TYLNAAIQMEVAKDFQLDAGINYGLQHHAEKHYFIGASYRY
>KALACAFP_03533 hypothetical protein
MIAYTYILINFFTVVICFLASFDKKILFNRFFGTFLISSTIVAVPFIGWDIWFTEKGVWW
FDTRYTLGFTLAGLPIEEWLFFYCIPFACVFTYYCMDKFFDLKWVNSFNNIIVFTATIFL
TVVGLLYHHKIYTFITVIVTLLTLSYLHFIAKKEWIGQASLVYLILMPGFFAVNGILTGS
IIPSPIVNYNPDSFLGIRMLTIPVEDAVYGYSQFLLNVYFFSLLKKKHREN
>KALACAFP_03534 hypothetical protein
MNLLIVILVFISMEGATWLIHRYIMHGFLWILHRDHHDHSNEGSLERNDLFFVIFATPAI
ALLYVGVRQDFSYVFFIGLGISLYGMAYFFVHDIFIHQRAQLFKKTRNSYLLAIRRAHKQ
HHKHLGKENGECFGFLWVPVKFFKMYMNKK
>KALACAFP_03535 All-trans-phytoene synthase
MKKLFDELSHDVSKRTTQKYSTSFSLGILALSPSIRSAIYAIYGYVRLADEIVDSFHGFD
KEKLLLSLKTETEHALEEGISLNPILQSFQDTVRKYKIERRLIDQFLHSMEMDLQKINYN
SELYKEYIYGSAEVVGLMCLQIFTEGNKQKFEELKPFAMKLGSAFQKVNFLRDLKDDYQV
LGRTYFPGINMSVFDNSVKFEIEKEIESEFKEALIGIKKLPGSSMFGVYLAYRYYLSLFE
KIKRTSSQKIMKKRVRIPNSQKILVAFKSYIRYKSAYL
>KALACAFP_03536 Dehydrosqualene desaturase
MGTEKTKKKIAVIGSGFSGISAAAYAAKSGNEVHVFEKLSQPGGRARQFTTENGYTFDMG
PSWYWMPDIINGFFQDFGREAVDFFKLVSLDPQFEMVFSDETIGVPSKYDEIRELFENIE
KGAGKEYDKFMQSAQFKYQVGMQEFVNKPCHSWLEFVSLKIASSALKLDLLTNFRSYVAR
YFSDPKLKALMEFPVIFLGASPKNIPALYSLMNYGGYALGTWYPMGGFYQLVLAMQKVAE
DQGAVFHFDQTVHKINVKNGKVNSLIINNEEIGFDAVIASSDYHHTETLLSEDLRNYDEE
YWKSRTFAPSCLIYYLGIKGKIDNIKHHTLFFENDLDEHVECIYGTKKWPDKPLFYCCSP
SVTDPGVAPENCENLFLLMPLAPGIEDHEELREKYLKEMLSRIEQHTGTQDIFSRIEYKR
SYCVNDFIADYNAYQGNAYGLANTLSQTAVLKPKIRNMKVDNLFYTGQLTVPGPGVPPSI
ISGKIAAAEVNNPKVKKYEKIV
>KALACAFP_03537 HTH-type transcriptional repressor NicR
MNYELIKEVIELVQQFEIQNENKNHYSNDVNGFKEWIAASAENTDSVKTPDWEGKEKGRS
PESVISTLIVHMNRYAKSYSKSAINDSMFSSQEDFIYLITLKSFGSMSKTELIKANVHDK
PAGIQIINRLIHQGWAEQTDSDTDKRTKVIKITEKGLKTLDDQMDKIRKATQIVTGDLTH
REKMELIFLLSKLNDFHHSIYCKNLEPKELLDIAYDQLSKN
>KALACAFP_03538 putative HTH-type transcriptional regulator YtcD
MAKTEKNQLDNKAFTEDCHKVLMAMSDALYAIGGKWKLMIIIAMARGNKRFTEIQRQVTG
ISARVLSSELKELEMNGFIIKKVENGYPVTIEYELLPYSHTLEEVVGAMTKWGMQHREKI
KAEMASGKSEK
>KALACAFP_03539 hypothetical protein
MTLEILKAKEDLRNLIDEYAYLSDEWKISEVMNLFTPDVTYKVHMNGALVADVSGRENME
QDFNFHASQVKTYFTLNGQHTTKIDGDTATGISFAQIKMIREADGKNVLTDYSVKYDDYY
VKQNEKWFIKDRVAHFLIIETRSIS
>KALACAFP_03540 Bifunctional transcriptional activator/DNA repair enzyme AdaA
MKSANASPQKFNSISELHKALGFPKPVHPLVSLINYADIKTPADELPKALLLNFYKVSYK
KSLTAKIKYGQSHYDFNEGGLSFVSPNQVIQSAGEDKDYSGYTLLFHPDFIRDYPLGAKI
KTFGFFSYSANEALLLSDKEKQTVFSVFDNIKEELTSSMDDFSQDLVVSHIEVLFNYSNR
FYKRQFSTRIDVNNDLLTRMEQILNNYFKEGQPLERGLPTVEYLGEQLHVSPRYLSDMLR
SFTGRSAQQHIHDTLIDKAKEYLTSTNLSVSQIAYEIGFEHSQSFSKLFKKKTNLTPLQF
KQSFH
>KALACAFP_03541 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MQKTIFITGASAGLGKATAKLFQSKGWNVIATMRKPENETELNKLENVTVLKLDVTDLTQ
IEETIKKAITNHSIDVVVNNAGYGLIGALEALTDEQINRQLNTNLLGVIRVTKAFTPYFR
ERKNGMFINITSMFGLIGYPTCSVYAATKFAIDGFSESLAYDLAHFGVKVKTVAPGGIQT
DFTGRSMDGGQHEAYNQLVEKVSEGYSEERVSNFSTPESIAAVIFDAATDNKDQLRYIAG
QDAVSLYTEREEIGAEAQYQKIQKMFAY
>KALACAFP_03542 Xylulose kinase
MLLLGIDIGTSSIKVSIVDAHNKQVLASAQYPESESPIIAVKPGWAEQSPKMWWEHTKMA
ILKCNATGNYNPLDIQSIGIAYQMHGLVVVDKDQKILRNSIIWCDSRAVEIGNKAFAELG
EEYCLQHLLNSPGNFTASKLAWIKENEPDIFEKTDKIMLPGDYISMELTGEVTASAETLS
EGVFYDFVENRLSQKILNYFGFSENIIPEIREVFSVHGTLLASIAAELGLKKGIPVSYKA
GDQPNNALSLNVLQPGEIAATAGTSGVIYGVSDQLIYDDESRINTFAHVNHSESERRLGA
LLCINGTGSMYRWMKNILGENTTYQQLNEEASHIPVGSNNLQVLPFGNGAERMLNNKLIG
TQFINIDLNLHTRAHLVRATQEGIAFAFRYGFDIMKENGMNAKVIKAGRANLFLSDVFVE
AFVNTIGVPLELYKNDGSVGAALGAGIGSGAFANFEEAFENTEPIKTVEPTLNTYEAEYS
KWLESLKSHLSKSK
>KALACAFP_03543 Erythritol/L-threitol dehydrogenase
MNSHKTIPEVMKAIVAYAPHDYRLEEVPVPKPGPGEILVKVKSAGICASDIKCYTGAPLF
WGDENRTAYCEAPVIPGHEFVGEVVELGEGAKELYHLEIGDHAVSEQIVPCGECRYCKNG
HYWMCNVHDIYGFHQRTQGAWAEYMLFPKGAFNFKVPKSIPLHHAAFIEPLACSIHAVER
GDIKYQDTVVIAGCGPLGLGMFAAAKMKSPARIIALDMQDERLELALRSGADIGINVTKE
NAVKKVLELTDGYGCDVYIEATGHPSAVEQGLNMIRKMGTFVEFSVMREKVTVDWTIIGD
TKELNIHGSHLGPNCYPVAIRMLEQGLLPMEEIVTHKFPLTDYQKAIDLVADGLTSVKVT
LEP
>KALACAFP_03544 D-threitol-binding protein
MKKNNLKIVPSKKRVISLSFFVVALIFCMLTSCNDKSKTDAGGKKKYVIGVSYESLQSEF
TINLQKALQAKAKELGVEIIEVDGMGSGEKQVGQVENFITQGVDAIILQPIEKDATVPAV
EMANSAKIPIVVVNAMTANIQKANAYVGSEDVVAGRLEMEEMAKRMGGKGNIVIIHGPWG
NSAEQQRTQGIKEVLKKYPDIKIVFEQTGNWDRAQGLSVMENVLSSGKVVNAVISQNDEM
AIGAYKAIEAAGKQKEILVSGIDAIADALTFVKEGKLACTVFQDAKGQGALSVKIAADLA
AGKKYPHDNFIPFELVTKENLAEFLKKHP
>KALACAFP_03545 Ribose import permease protein RbsC
MNFSQIFNKQSSGYSREPQNLKQFFSTYGIYIALLLIILILSILSPTFLKPGNILNVLRQ
SSINGIISIGMTLIIINGSIDLSVGAIVAVSAVIASSFAHTDSNYPLVVPLIIGIGMGAL
LGAINGFIISRTKIAPFIVTLGMMTAARGIALVYTSGKPEINLSDSYKSIGGGLILGIPT
PVIIFFLISLFGIFLLKYTRFGRQVYATGGNELAAKISGINTKNVVWKVFIIAGALAGLV
GIIVSSRVMAGAPSAGTGYELDAIAAVVIGGTSLKGGYGSILGTLTGVLIIAVMNNGLDI
LGVSSYWQQIVKGAVIVMAAMLDKKK
>KALACAFP_03546 Galactose/methyl galactoside import ATP-binding protein MglA
MNLKANTTELLEMKDIVKSFDGVSVLKKIYFSLKKGEVHALMGENGAGKSTLMKILAGLY
VPDKGQISLNGKQITYKTPQHALETGIAMIYQELNPIGDMTVAENVFLGKEPTFSFLKII
DRKKLNQMTIDLFQDANISIDPNKYMRDLSIAEKQLVEIMKAVSCNASIIIMDEPTSSLS
VREAEKLFAIIKKLKEKDVSIIYISHRMDEIFRVCDSITVMRDGNTIISDSAENFTNESL
IKHMVGRPLGELFPEVSKKPEAETVLEVKNLNLKNKFQNISFKLNKGEILGLAGLVGAGR
TEILETLFGLSKAYSGDIIINGKKVNISSPSSAVANKMAFITEDRKQQGICADSSVNDNM
TISCLKNICYMGEIIDMKTEKKEVNGLISKLNIKTSHRSKPIGLLSGGNQQKVILGRWLL
NGPSIILLDEPTRGIDIGAKQEIYKLIRTLAESGKSIIMISSEIPEIIGLCDRSLVLCNG
NLITTLDRSEITQEKILEAAMTFENRNPEMNLQES
>KALACAFP_03547 hypothetical protein
MMTKKPLLSGLFALGLCLCTQSLTAQNTDSASVEPKYRPFDVSASIKNKHLWRGYIVADV
PVLTASATVTTKDKNLQFGLWSGNGFNGEYKEFCYFLNYHIKNFDITLLDSFNYTGFSDA
KIFDYNKSSTRHFIDVNLAYHFSEKFPLTVSLATVVQGRDTFIDSNGKLKNRFSHYAELD
YKVYEEGDTNVHLYMGGAFSFVTHDTFYSSSPGIVNVGVTVNKKIHFGKYAVPVFVQGMW
NPNHNKATLGLGVQLF
>KALACAFP_03548 Catabolite control protein A
MKNKVQLKDIALAAGVSPALASYVMNGRYENRIKKETADKIRKIAEEMGYVPNQIAKSLK
IKKTFTIGLMLGDIMNPFSYHIARIIEDEAKKYNYTVIFGSCDENKDQSKKLMDTLINRQ
VDGFIIAAAAGTQSQLKSLQQMEIPFILIDRYFPEEKFNYITIDNYGASFQAVDHLAKTG
REKIAIINYESELVHLQNRTKGYVDALKANKIKPKQEWVCNVKMRDNPENIKNEIAEFLK
NRKSIDALFVSTNGLTLQTLKLLNKLEIKVPDDLAIVCFDETDAVELFYSPLTFVKQPMQ
QMGSLAVQTLLKQVEKNDNQLHEIVLETTFVVNKSSGVA
>KALACAFP_03549 hypothetical protein
MPINSVFKNILLLSLIITGITTYSQDLKGSDTEFAIAISNCKPDNTETKVSYMEDDGVLH
SLFSFSGCSHHEKISLKNGKYKIYISKANYQPVIKEIVVSETDRKIDVNASLEPVKTIEG
VTISGVQKRFIKSESDKTTVFVEGNDILSNGSAYEALTKIPGVIVTPNGYIAQNGKISAI
YMDGEPSSISGEDLNNYLNSLPANSIEKIELIYSPGAKFSANTSGGIINIITKSKNTKGI
NGSINTVNTVNHNYKNATSLQLNGKYDAVSWQFLTGYYYNEGDQRTNVKSIYKLQNTTPA
INQEALNLFLYRGTYARTGLKYTFKDKSSINLNYNFWINGHNPSTHVNIFSENYTPEISN
SSLSSTHTKNTSNELILKYKQNLDSLGNNFQLTAYGQEFNSKYFGNVRQFSTTDLYSIIQ
SDKNVQNYYVKNDWEFKIKKYDLNIYFGGRYGDFQAERLGRYNLNNPDPVIFENINFTSE
IPFNYNEKNLAAYISLNKKVKKFEFGGGLRMEYYDIRSKTDPNEYIVKTNYLKFFPNLNI
FYKISTDINVSLNYSKKINQPNYNDLDPNINNFNNSYFQTVGNPFLNPELVDNYQAKISA
FDYAYLSYNYSFERSKNLTVIENDGNSLNSVQTLKSFSNVKTYSLNLGLPIPFALFTKGL
DFFKSGNINPDKVSFLFANFGYNKTVFDDSSTLVPSNKATWNFYAYSQIVLPKNFKFNAY
YSYMSKGVFTIYDIRRPVQSLELTLSNKFFNNSLNCIFSVQNALNNSGLNAMLYNRNLTT
SYNRIDEKRMYRLSLTYTFGKYKTTKNDDVDINTETKSVDSSKSIGK
>KALACAFP_03550 hypothetical protein
MKTIKIEELEERLELGSWNSSNDGKDGEKGKDGESGKDGENGKGGQGGKGGDGANGGRGG
NGGNGGNGGNGGSGGNGGNGGNGGNGGNSK
>KALACAFP_03551 hypothetical protein
MVDKKIITKLLDSLKAEVYNSEILNLEYIYEQFKKNPSIYLFYPYLFTQSFDVKDSKELE
KLSVAGFLYYLSLLQSDYLIDNKREKDSKFIKEKIFLIEALTEQSIKILSDLFEYHSDFW
SFWNKRKKEYHESILEESAGSYDDFDVENYQKIAANKSAFAKVAIDSCYLMGDKKSDDLY
DRLLKSHTFFSIGFQILDDISDIREDFNNNQINYAIYVAKKNNLLIDSEQIESDIKYFYY
SDLILNIFEEAFNYFDLAIESLGSYKDKCELWINVIKYKKLENVQKIQTIKLYQNVNAQL
ANQSAVKINNVGNDLKTSIDTAIDNSINYILSSFNSEYWEDYITQAGVSSYWATSFIGTH
LKPLENEYPEIGKILNKAKNYIRNNKSPLWSFNEQWSVEDADTSNFCFLFLGDELKEESA
GKLEKWFTYQNEDGGFSTYNDDNNLRKYFSQENYFSYDGWTQSHFCVSSVALHVLYDHKD
TYQDRWQKLNSYITDKLKKDSFDSYWWTDEIYSIYYISTISHLVNFPDDVIKNKLKKLSL
CQNENGSFSDFFGENLFYTGLALVSLSTAGLFQKNVENGIMYLLQNQYTDGSWENSNSLK
IPRPEIVTPEISNFDHVKTFGTNVRAMEFKRLFTTSVCLNALYKLKNII
>KALACAFP_03552 hypothetical protein
MEVQTLVLSKYIAATEHDDGIIVFSTKTGKIIKISEIVWEYLNNESIHKLPADIREYLEN
NQILVDAGRDEFTEILNQNEMINSNITTLYEVIQPSAYCQMGCFYCGQNHQNINLNEKNI
LSIVNRIEEKIETNAFKALKIGWFGAEPLIGMASMREITSRLKEICERANIGYSAKIITN
GLKLTETVFTELCNTLFVDSIEITIDGTEDTHNERRNLKNSDKGTFSTIIRNLEKILQLR
SENNYNVKISIRCNVDQVNQDTVIPLINFLNEKQILQHVKFYTAKIHEWGDKSNDEVLTF
DYPNQEIFWLKKLIENEKAVPLLPNRVYNVCLATRKNSFVYDAYGNTFKCTEIPYINNDT
QSEFFLGKLNQDTINDLDFAATWESDIKAGKSYCLTCNFFPVCGGACPKSWMEGNIPCPS
FKYNMPERLRLYYDTIKKN
>KALACAFP_03553 Putative peptide zinc metalloprotease protein YydH
MNIENLIPEIHNSFSVVEKEKGNVLLIITLDKSHNAYLYCDEQVLHILELIDGSNSLLMI
QEKLKAIHDIDLSVEALNDIIFKKLAKLTSDEVYRKSKNSYLLLKITLIKSKYVEFISKY
LSFIFKNKNFVIFSFIFNIIFCVGFLYSGVHNFKLDSQKIYILPLTMAVTLLLHEFGHAI
SCRSYGAKHGDIGFGFYLLTPVLYADVTDVWKLSRKERVIVDIAGMYMESLLVLALIFLY
IITGNPLFYYCSSVIVFNTLVNINPFLRFDGYWILSDITNTYNLRAKANEQLFKFISLKD
VKLTANKAFLVVYGLLSNLFLLWFLYYVSKYMFVDLFKFPLNLYYYIKNWFWQTENHITF
WQISLPLAFYFIVFSQVKSLSRYIKLKTKKA
>KALACAFP_03554 hypothetical protein
MKKEIKIQELEERLELGSWVGGEGGQGGNGGQAGTVSGNGGNGGNGGNGGDGTIGVDIGG
GTKPTTPAPTTTTTTIQPAN
>KALACAFP_03555 hypothetical protein
MKKEIKIQELEERLELGSWVGGEGGSGGQGGNAGTQTGNGGNGGNGGSGGDGTIGIDVGG
SPKPSTPAPTTTTTTIQPAN
>KALACAFP_03556 hypothetical protein
MKKPDSLEKTNEFNIEELEERLELGSWVGGDGGSGGNGGNGCCHNDGCNCGDGPNTGGDG
GSGGNGGNGTIGTSTTTTTTTIQPANIIRSI
>KALACAFP_03557 Swarming motility protein SwrC
MEKGFAGRIAEFFINSKLTILLMVGLMIIGVYSSTLIPREEEPQIIIPMADVMVGYPGAS
PKEVESRVVKPLEKIISNIKGVEHIHSMAMNGQAMIIVQFYVGEDTERSYVKLYDELMKN
KNIFPKGVMEPMVKTRSIDDVPMLGLTLWSDNPNYNDFQLRQIGEELSSEIKKIKDVSLT
KTIGGRNRQLQVILDKDKMAELNVDPLSVMQMIQANNGSSQSGKFDSGDSEYLLTTGQFL
NSAENVENLVIGTSQNMPVYLKQVAAIKDGASDPANYVSFGYGNAVENGKKFKSEYPAVT
VSVSKVKGADAMKISEQILTKVEELKKNLVPNDVHVEVTRNYGETASHKVSELLMHLGVA
ILAVTLLVMLAMGWRGGLVVFFSVPLTFALTLFSYYILGYTLNRITLFALVFVVGIVVDD
SIIIAENMHRHFHMKKLPFKQAAIYAINEVGNPTILATFTVIAAILPMAFVSGMMGPYMS
PMPIGASIAMLLSLFVALTVTPYLGYHLLKVKDEQHHQEEQGLETGRIYKIYKKIEQPLL
DSKSKRWTMMAITVVLLLISIVAFFTKWVAVKMLPFDNKNEIQVVIDMPEGTTLERTSAV
TQDIAQYLKTVPEVVNYQNYIGSSAPITFNGLVRHYDMRGNSNTADIQVNLLHKEDRDAQ
SHDVAKNIRPEIQKIAAKYGANVKIVEVPPGPPVLSTIVAEIYGPDYKGQIKVAKQVEDI
LKKTDDVVDIDWMVEAPQKEFKLVPDKEKAMLNGVAPQQIVGNMTYLMGEYPIGNLYDEK
SNDPVDIVMKLKNADKTNIQEITGLKIKGQMGMVPAGDLVKVEEKELDKTIYRKDQKRVV
YVLADMAGKLESPAYAILGMEEKLKKIQLPNGYSMNELYMNQPEDESNYTVKWDGEWQIT
LEVFRDLGTAFAVVIIIIYMLIVGWFQNFKTPIVMMVAIPLSLIGIVLGHWLLGAFFTAT
SFIGMIALAGVMVRNSVLLIDFIEIRLKEGIPLKQAIIEAGAVRTTPILLTTGAVVIGAV
IILFDPIFQGLAISLVFGAIVSTLLTLIVVPLVYYITEKKKWEKNTLK
>KALACAFP_03558 Multidrug resistance protein MdtA
MKTYLYSTLILSAILMGSCSSDEKKSAQNSDAPIAVTVSRTTAGSEGSSATASGKLVAKN
SVNVSTRMMGYITSMKAEVGQNVSAGQLLVSINAADIQAKGGQASAQISQAQASYNIAKK
DYERFQNLYKSQSASQKELDDMRARYEMAQAGLQAAQQMKNEVNAQYRYTHVTAPISGTI
TEKFAEQGDMASPGMPLLTIESASSLQAQVLVSEQNIAMISNGMPVDVTLKSMNRTVSGT
VSEISKSAANTGGQYMVKINIHNASDLLPGMFVNVQFPFKASGKINQNFQESMMIPKTAL
VENGQLTGVYVVSSQNTAILRWLKTGKTIGDQIEILSGLSSKESYIVSSTGKLYNGAKVQ
VK
>KALACAFP_03559 hypothetical protein
MRKITILILLFTAYSEAFSQEIIPISKADLENKLIDNNLQVKMVKKEAELAKAELLATRA
MYLPNVNASYTFSNTNNPLYAFGSKLNQERITMMDFNPDHLNNPKSISNFATKIEVQQPI
INMDAVYQKKAGQVKADVLNIKTERTKEYVQFELKKSYMMLQLAYKMLETLENAKQTTLA
NKKVIDNYYKNGMIQKSEVLYMDVRISEIESQIQTAKSNIRNASDYVYFLLDENSENKIL
KPTESLEYTEGISNSETRLNQNRKDLQAYYKSLEAYDWLIKSSKAKFLPKLNAFGSFEMY
DHKVAQFNANGYLAGIQLSWNVFDGLKSKSEQEKYKAERSKAQTEIEQYSKQSQLELNKA
SRQIEDAISKVNFTKQAWEQSKEAYRIRKNRYDQGLEKSADLLSAETLMSQKELEYQQAV
FEYNVAWEYQQFLEK
>KALACAFP_03560 hypothetical protein
MKTLLKLVFISVIIVSCGQKKTGTLNIPASVQQNDELPENPLLMNAITSSVQPKEGTMST
LYGNEIAFNYAQKNTGANYPPGTVLYEVTWKQKPDEVWLGGNIPKSIYSVERIVFNDSGV
IYEKYQGKPLKRITGNIADKDSRKDFIISQKMAVSP
>KALACAFP_03561 hypothetical protein
MKNKNIFVLVLFGIFIGLQFFSPEKIDHGTNTPNLMNVPQDVNTILRTSCFDCHSSETHL
RWYDKITPANFLVNSHIKEGREALDFSKWNTWPKAQRISTMYYSMNKILSGEMPIPSYSA
VHSSAKLDDKQIEILKKYVLSLSPRKPAENLQLQSAEQQYNLWIKGELKKSAVKPSPNGL
NYIPDYRNWKAVSTTDRFDNGTMRIIFGNDIAVKAIRNKNTNPWPDGTVFAKTAWKQLIK
QDGSISTGEFLQVEFMVKDAEKYKKTKGWGWGRWKGNDLKPYGETHDFDNECIECHKPMT
NRDYVFTSPLYLISQLTKIKKQ
>KALACAFP_03562 hypothetical protein
MKKFSLYTITFFAVGITVLLISFFSFQHIYSLSKEDLFNAKFEAGKREAREIGKLLEMQL
KQGIPKETVIQNLQNSIVNTDTQSSFICMYNQKGIELCHPNPALVGQIIDKDNSTFTSGS
KHSDFIEILNSGKESTGTRHLVQSRDRRSEIVSVFPVGGSDWMVASHANLEVINEQIRSL
YLNFSIAFLLATLLILVVSFLLIRMIYRKYEAAKNSEINDLNDEINMLTAINTQLNSIHE
RLKLHAALPSQEDPAENSKRRVITYQKDELISLETSEIAYFFLENNIVYIKTTRANQYPI
TSSLDELIKTLDQKMFYRANRQFIINIKAISNILLYGKNQLKIVTMPESKETILISKNRV
AEFKKWLEQ
>KALACAFP_03563 hypothetical protein
MEAHYYNVDIEWKNERKGEMSSPELSQKIEVATPPQFPKGMDGIWSPEHLFTAAVSSCLM
TTFLAIAENSKLEFSNFECKSKGKLEQVEGKFLMTEVILEPIVTIKNESEREKAERVLQK
SEANCLISNSVRSKITMIPQIKLI
>KALACAFP_03564 Thiosulfate sulfurtransferase PspE
MLDAIKNLFGMDKTDYADLVKQGAVIVDVRSKREYEEGHIKNSLNIPVDQLDKNLSKLSK
DKTIITCCASGMRSASAKSILQNNGYKNVHNGGGWMSLNNKI
>KALACAFP_03565 cAMP-activated global transcriptional regulator CRP
MNFHEILDPEFRKEIASSGDLKRFPAGSVILDIDSYVNYIPLVMSGSVKVVRTEEDGREI
LLYYLAPGESCISSILSGLTHDTSKVKAIVEEDAEILMLSLVKAKEWLIKYPEWSTFVFE
LYHKRFEDLVTMVNSIAFQKADTRILYLLNQKSRLYKSKELNVTHQQLADELGITREAVS
RVLKQIETDGKIKLSRNKITLL
>KALACAFP_03566 23S rRNA (uracil(1939)-C(5))-methyltransferase RlmD
MIFTQLRQNVDVKDPVFDQIYPPHVKAVAERHWTPVAIAKKAAEYLVEKPGRKVLDIGAG
AGKFCLVGAASTKGFFYGVEQRASLTRISKKIAEKNNIINVKFINSNINEVSFADYEAFY
FFNSFFENIDTSFPIDDAVIPHRNLYDEYSNYVKEQLHTTPVGTRLVTYWSKWDEIPRSF
ELVDSACNGLLSFWKKTF
>KALACAFP_03567 Aminomethyltransferase
MEVITKIKKTAFNAIHHILGAKMVEYAGYEMPIHYKGVIHEHEVVRNGVGVFDVSHMGEI
SIQGAGSLELIQKITTNDASKLYPGKVQYSCMPNDTGGIIDDLLVYQISKNDYLLVVNAS
NVEKVLDWIRCYNLFGAEVTNISDSVSLLAVQGPKSVEVLQKLTDVNVKEMKSYTFTIGE
FGHIPNALISATGYTGETGFEIYVENRYAAHLWEALFNAGKHEGIEPIGLGARDTLRLEM
GYCLYGNDINDSTSPLEAGLGWITKFNKDFVYSGFLAIQKNKGVSKKLIGFEMEGKGIPR
HGYEIWDCHQQIIGTVTSGALSPTLKKGIGMGYVSVENSLAGNEIFIAIRNKPVKAIVVN
TPFIRK
>KALACAFP_03568 Glycine cleavage system H protein
MKIPENLLYTADHEWVRMENDIAYIGITDFAQRELGDIVYVEIETLGENLKQHEVFGTVE
AVKTVSDLFLPIGGEILEINTKLEANPELVNSDPYGDGWMVKVKVDNLLEAESLLASDSY
ASIIGL
>KALACAFP_03569 Transcriptional activator protein Anr
MISKFIFNNQYLFDELPDRDKELLRQVMQAKNYRKNEAIFTERTTPNGIFYLKSGKVKKY
KVDNDGREQIIYIYNAGEFFGYSAILSDDTYGDTAQAIENSAIAFISKTDFLRILDQSVV
FSRLLLKSLSHEFSVMANLMTVLSQRTVRERVALSLLILHKKYTSNTMDDKVYITLSRAN
LASMVGTANETLARILHDFREDRLIAMEGRKIQIMDVEKLSRIANL
>KALACAFP_03570 hypothetical protein
MFRHKGKGRTYSHNLKLASILSCVAGLVNITGVLAVSTLTTNVTGHFAYFSEQLFLRNFK
MASIYLLYILFFLSGAFISGLIMEWASKHKSHTSYIIPLSIEMMIMLLTSFSSEILPNTP
SVPIIISSALLFAMGLQNALVTRVSQSVVRTTHLTGLFTDLGIELSQFFFHHQKEKKTQL
NRSIFLKLMIISFFFLGGILGSLLYLYFQLKTLLFPLALLLFALWYDTLLFKYYRIKRKT
RES
>KALACAFP_03571 hypothetical protein
MIFMNNSQEILQIYNLDQSNSKVIFEVNKTYFTESMAREFNIFWEILPFLQKYAKKH
>KALACAFP_03572 Quercetin 2,3-dioxygenase
MDSNIRIIEKENGKRLGVAGGNYRIVISGEETDNTYAVIEMTVPPGGGPPPHSHPNTHET
FYVLEGEVEFKTEKGKIIVSKGGFVEIPFGGAIHCFKNTSDSFAKLLCTVMPAGLEKIFE
AVGQPVSEGEFLPVPEMTEERKSLLQHLDEIHGQKTFPPDYLG
>KALACAFP_03573 hypothetical protein
MMEQKHPLPPFTRERISVVMNTNIITQKDNGSGHMAMKTGNLMKTDLCRDGLQA
>KALACAFP_03574 hypothetical protein
MYQPLFEYIERYSNSSLSSEEKEKIESLLLPKKLRKKQYFLEEGNICAYTGFVLKGAIRQ
FSVDSHGIEYILQLALENWWIVDRQSFMNQTPSKYYIEAWENTELLILPRPNLDAFLEIP
SVRDTFWKMSENNHIASQKRVDDAISLSALQRYESFVENHPEMIQRFPLHQIASYLGISR
ETLSRIRKQSFR
>KALACAFP_03575 hypothetical protein
MHTKAFNPENAAILLIDHQTGTMAWTHSHDINLVKQNAIKLAKIAKALHLPVILTSSMED
QIQGPLIPELQEILPEAYEARIKRPGIVNAMHHEGFNEAVKALGRKKLFVAGVTTEICVT
FPVLQMLDEGYEVQVSADASASYTKYGDNLALERMRQAGAIITTVDQIISELAIDWTSPN
GQKLVGILNYH
>KALACAFP_03576 Quercetin 2,3-dioxygenase
MKIIRASEKHTHGNQTFHIEILYPGTNLGKNDTGFFTIGRIDHALFKPPGLVPMHPHQDD
EIFSYIRSGKMVHKDSTGHTEHLNNAYMMLMNAGSGISHEESAEEDVEMLQIFMRPSEND
LPPKVQFHHFENMYSENIWRLAAGNRADSPLKLRVDTNIFDIRLQKNNSVEIPDWNEDVI
NFVYCFNGDIRIGNETITKGDSVILEENLPLEAITESDLVLFQIKKDAQYSDTGMFSGNK
FQ
>KALACAFP_03577 hypothetical protein
MLLSNWILIVQLLNDQISFPVLDKISGRLYIQSQIYIKNDTIKNIKSL
>KALACAFP_03578 ATP-dependent 6-phosphofructokinase isozyme 2
MKKTILTITLNPSVDKSSSVQNIIPEKKLRCNSPKYEAGGGGINVSRALKRLGILSDTFF
TSGGRTGMLLEELLHSEQLDALSFHVAAETRENFTVSDISDKKQYRFGFPGESLTQEEQK
EILNNIDVMNQVPDFIVISGSLPIGVDRKFMKQLINICKTKGSKLIVDSSGKLLKTAVEE
GVFLLKPNIGELASLAGKEKLEDSEIHKTAQLIISQGKAEVVVVSLGSQGAVLFSATEQI
QIKAPAVDVKSTVGAGDSMIAGMLSVLIQRGNYKEVLAMGVACGSATTMAEGSGLFAKEN
VEHLFEEIQKQQIK
>KALACAFP_03579 hypothetical protein
MHFRLHMRSVLYGGNLKLSEVVFPGRLVATLKNFEKK
>KALACAFP_03580 hypothetical protein
MRTKENKQKTESQDISKAQKQKNTELRKKTDSHHQSVGKTPKDDAKHH
>KALACAFP_03581 Osmotically-inducible protein Y
MKTNSELQRDVQEAIEWEPLLKAAEIGVIAKEGIITLTGIVDSYSKKTEAEEAAKKVAGV
KALVENIEVKLPNSWFKTDEEIARDVLNALKSDWTVPDDKIAVKVEDGWVTLEGELSWNY
QREAAKNDIKNLTGVTGISNKIKIKSEIHDEIEQKNVKRALKRSTIDDSNIEVSVSGTTV
TLTGVVDSLYEKEEAGRIAWKTPGIWHVKNQLAVDYEYAL
>KALACAFP_03582 Arylesterase
MKTLILTLSLLCTFAFGQPLSAQSIRTAASAGRSEFIEVEPNVKLHVTDLGVGQPIVLIH
GWPLNDAMYEYQYQYFVEKGFRVIGISMRGFGKSDRPYGKYDFDVFSDDIKVVMEKLKIK
NAVLGGFSMGGAVVLHYMAKYNGAHVSKLALFAAAAPSWKQREGFPYGASDEAAAGLINT
TRTNRQQLIEDFGKAFAATEDGISKGMSQWLADINADASPYATTQSIIALRDLDLRPELS
KINVPVAIFHGTKDKLCDFAFAEQLHKGLKNSYIVKFEKSGHALFIEEMEKFNTELEKFA
KK
>KALACAFP_03583 Regulatory protein PchR
MKISITDKQGSDIITGFAKALGTVMTGRYVYIPKDKGEGFITGFSWNDNQLRVMLRNYFL
HKDIVVECTNGFAEDQDDIIFILNGIFPDSLSSEKQIVPEQPSVTICKQSVTSILDMPSN
TFFRSIVVAVSRNYLQKSFGNINHPLVENILNTQDNFAFDTALSPEMIKVASEMLYPNVP
EIMESHYCKLKCEELLSYIFSLLVQRESVPTSTLHIDDIKAIYSVKIKLQSDLDNPPNIA
VLAKELGMSEPKMRKLFKQTFGKGIFEFFQYNRMQEAARLLKFERLNVSEVGYQLGFTNL
SHFSKVFEQYIGLKPKKYSSGFNS
>KALACAFP_03584 D-xylose dehydrogenase
MKEKIRIGFIGLNPKGQWASTAHLPALELLKDDFEITGVANTSYESAKIAAEAFKIPYAF
ENADALIHSEHIDLVVVTVKVPYHFELVKAALEAGKHVYCEHPLGNGLQESIQLAELAAS
KGVVAVTGLQMTVSPEVRYLEQLISEGYVGKVLSTTLIGSGGHWRDETISENYYLYDKKN
GATMLTIPLAHTLAGVTKVLGGFKEFSSNIINHFKTVTLQDTGHVKDKTADDQIMIIGTL
ENDVAISVHYRGGISKGTNLLWEINGTKGDLQITGALGHGQLTPLTIKGASEAEKEMITL
MPPPELYDSLPADPVSGNIARIYKLLALDIRNNTRTAPTFADGVELYRLLDSIDS
>KALACAFP_03585 Sugar phosphatase YbiV
MKDIKLIVTDMDGTFLNSHYEVSPDFSAVFQELKKRNILFVPASGRQMSGITQYFEDIKN
DIGFIAENGGYVIYKNKELFADKLEHKFIVDITAAIREIPGARAVLSAKKKAYYESDDQQ
FVDYFTRYYTENQKVNDLGEEVDDDVFKIAVYHPEGSEKNLYPFLEKFRENNLEVVVSGK
YWLDIMNKDINKGNALQKLQNLLNISPSQTMSFGDYMNDITMLEKSKYSYAMENAHPSVK
VAASFSTLSNDDFGVLKTISEYLSI
>KALACAFP_03586 Galactose-1-phosphate uridylyltransferase
MESMNTKEINSSFNQKKHPHRRYNPLLDEWILVSPQRANRPWQGQTEKVAEEKLPAHDPN
CYLCSGNLRVNGERNPVYKGVYVFDNDFGSLMKDDIEFSEEQSDFFTLKPERGINRVICF
SENHSLTLPEMEADDIKKVVDVWQEQYEELGSEDYISHVQIFENRGSVMGCSNPHPHGQI
WAQASIPSTVLKTQENMKKYYEKNGSSLLEDYIKKELEVKERIVLENEDFVALVPFWAIW
PYETMVVSKRKAENILQFSDAEKLSFSKILKDLTTKYDNLFEISFPYSAGIHQSPTDGKP
HPEWHFHMHFYPPLLRNAEVKKFMVGYEMLAEPQRDITPEQSAEILQNLSVVHYKSDK
>KALACAFP_03587 Galactokinase
MMEKLINYTTEAFQSVFKSEPESIFLAPGRINIIGEHVDYSDGFVLPAAIDKHICFAVKK
IDDSETCTFFAIDFDDSFSFNINQKQTPVSQVWVNYLLGVFNAIQEKGKKIGGLQIAFSS
TIPMGSGLSSSAALECGFAFILNQIFDLNLTKKDLALIGQKSEHTFVGVKCGIMDQFASV
FGKEHQVIMLDCNSLEHQYFDANLEGYSLVLFDSCVKHTHLTSGYNDRREDVDRGKKKLW
EKFPEIEKFRDFSFSMLEEVRAEIGETSYKRCLYLLKEIKRVEKAAKALSEGDVKYLGEL
LIETHAGLSTEFEVSCKELDFMVEETLKEEGVSGARIMGGGFGGCSINLIKDENVDEVIK
NISTKYKTYYNIEMKVYRVKISDGINEYKRNKFVI
>KALACAFP_03588 1-deoxy-D-xylulose-5-phosphate synthase
MKKYTYTEKKDTRSGFGAGLAELADRNPNVVALCADLIGSLKMEKFIEKAPERFFQIGIA
EANMIGMAAGLATEGKIPFTGTFANFSTGRVYDQIRQSVAYSDKNVKICASHAGLTLGED
GATHQILEDIGLMKMLPGMTVINTCDYNQTKAATIAIADYEGPVYLRFGRPVIPVFTDEN
QTFEIGKAWMVNEGKDVTIIATGHLVWEAIKAGEILEEQGIDAEIINIHTIKPLDAEAIL
KSVKKTGCVVTAEEHNRLGGLGDSVAQLLITEYLAPQEYVAVNDSFGESGTPDQLMEKYG
LTANDIVEATKKVMKRKQID
>KALACAFP_03589 Transketolase
MQHDITKLKNIASQVRRDIVRMVHACQSGHPGGSLGCADFLVALYFDAMKRKEGFDMSGK
GEDVFYLSNGHISPVFYSVLAHAGYFDKSELATFRKLNSRLQGHPTTHEHLPGVRVASGS
LGQGLSVAIGHAVGKKLDKDENLVFTLHGDGELQEGQNWEAIMYASHNKVDNLIATVDYN
GQQIDGPTSKVLSLGNLKTKFEAFDWKVLEVENGNDMEKILNVLDEAKSLTGKGKPICIL
LKTGMGHGVDYMMGSHAWHGKAPNDEQLAKALDQLEETLGDY
>KALACAFP_03590 Transaldolase
MKFFIDTANLAMIEEANALGILDGVTTNPSLMAKEGISGKENILNHYLTICDIVDGDVSA
EVIGITYDEMIKEGEELAALHPQIVVKVPIIKDGIKAIKYFSQKGIRTNCTLIFSAGQAL
LAAKAGATYVSPFLGRLDDVSTDGLNLIEEIRTIYDNFGFETQILAASVRHSMHIINCAK
IGADVVTCPLPPILSLLKHPLTDSGLEQFIKDSQKMK
>KALACAFP_03591 Extracellular xylan exo-alpha-(1->2)-glucuronosidase
MQHFRLYIILFLIIPFTVFAEDGSQLWLRFPAKNGISADKILSKGNNPTLQIAKKELINY
WQGQEIELRTDKSLKNLKGGYTIKSVQNKLVISAEKEIGLLYGVYHILRLQQTKSSITNL
DITEKPSYDVRILNHWDNLDGTIERGYAGHSLWKWEDLPNTISPRYEEYARVNASIGINA
AVLNNVNASPNMLRKDYLEKVKVLADIFRPYGIKVYLSVNFSSPKVLGGLENSDPLNREV
QKWWKDKAAEIYKLIPDFGGFLVKANSEGQPGPQDYGRTHADGANMMADVLKPYGGIVMW
RAFVYSPSKEDRAKQAYLEFVPLDGKFRDNVIIQIKNGPVDFQPREAFNPLFGALRKTPE
MVEFQITQEYLGQANHLVYLAPLFKETLDSDTYSDGKNSTIAKITDGTLRPHTLTAIAGV
ANIGEDKNWTGHHFAQANWYAFGRLAWNHDLTSEQIADEWLKMTFNDDEKFLKPVKEMML
TSRETAVDYMMPLGLHHIFAGGHHYGPEPWGDYKGGRPDWSPVYYHQANQQGIGFDRTKS
GSNAVANYFPPLNDIYGNIKTCPENLILWFHHVPWNYQMKDGKTLWEELSYKYDTGVKNV
REYQKDWDKVQPFVDEERFQHIQAKLKIQARDAVWWKDACLLYFQTFSKMPIPYDIERPV
YELDDLKKIKLNMGHHN
>KALACAFP_03592 Xylosidase/arabinosidase
MKKAKYLFPKDYMADPSVHVFEGKLYIYPSHDWESGMEENDNGDHFDMNDYHVFSLDDVE
NGEITDHGVVLSVKDIPWSGRQLWDCDVAYKNGKYYMYFPLKDKNDIFRIGVAVSDKPYG
PFVPEKHPMMGSYSIDPCIFEENGKHYMYFGGIWGGQLQRYRNNKALESAILPNENEPAI
PSKVVLLSDDMLEFGEEPKDVLILDENGNLLLHGDKHRFFEASWMHKYNGKYYFSYSTGD
THLICYATGDNPYGPFTFQGEILTPVVGWTTHHSIVEFKGKWYLFFHDSVPSEGKTWLRS
MKVIELEYDSDGKIKTIEGLEE
>KALACAFP_03593 Endo-1,4-beta-xylanase A
MKKIIALLGILTLTVSCKTAGTATSDDTLKDAFKNKFYIGTAMSLPQIYEKDVKSVEIIK
KQFSSIVAENCMKSMFLQPEEGKFFFDDADKFVAFGEKNKMFIIGHTLIWHSQLPKWFFV
DKDGKDVSPEVLKQRMKNHITTVVTRYKGRVKGWDVVNEAIMEDGTYRKSKFYEILGEEF
IPLAFQYAHEADPNAELYYNDYNEWHSGKVQTVSKMVQNLKSRGIRIDGVGMQTHVGLDT
PSLDEYEKAIVAYAANGIKVNITEMEISALPSPWGTSANVSDKVEYEAKMNPYTARLPEN
VKTEWENRYLDFFRLFIKHQDKIRRVTLWGTTDAQSWKNDFPVKGRTDYPLLFDRNNQTK
PVVEKIIQLTKEK
>KALACAFP_03594 Inner membrane symporter YicJ
MNNSSQKISVVEKIGYSLGDLAANLVFQTLVTYLAYFYTDIYGLKPEDASIITLTVGLLA
GFVFNPLIGALADRTRTKWGKFRPWILLTAIPLGAAALLAFSTPDFSYKGKMIYAAVTYS
VLLLLYAANNLPYAALSGVITGDMGERNSISSYRFVAVMFAQFFVQVFMLPIILSAGHGD
KAAGIEVVMTWLAIIGTVMLLITFFTTKERVIPKPEQESTLGADLKDLKKNKPWIIMLTV
TALIFITLAMKGGSYVYYFNNYVDEASLQQFISPITNFFNSIGMNFFGEDPRSAGFGLFN
AGGIIMMIVGITFSKKFADKYGKKDAFIASLFISTLFVLAFIFYPPKSVGLMFLSQILHG
FFYGIGTPLLWAMIADVADYSEWKNNRRATAIIFSAMMVGLKVGLSIGSSLVAYIIGQYG
YISSEGAMKVVQPESVSAGAKMLVSVFPSIPFFLACGLLMFYEINKKMEIKIEQDLKERR
KAKD
>KALACAFP_03595 hypothetical protein
MKNRIFFKILILFVGSLCISFIEAKITLPALVSDGMVLQRNQKLNVWGKADAGEKVEVKF
LNKNYKTIADPTGNWKITLPEQKAGGPYTMTINEITLKDILIGDVWLASGQSNMELPMRR
LTPLYADEIKNANNQNIRFFTVPQKYNFKSPQTELDGGKWEATNPQTILNFSGVAYFFAK
ELSQKNKVAIGIIHASLGGSPIQAWMDENSLKKYPEYLDEAKKWQNDELIKSTESTEQAM
SKAWYTELNQSDIGLNQYWENFDLNDSDWKTMQIPGSWEDKEGSFEGSVWFRKEINLTKN
QAGKAAFLNLGRIKDADVTYINGTKVGNVTYEYPPRWYDIPAGVLKEGKNIIAVRITNGS
GKGQFIADKPYYLEIEGNKIDLKTEWKYKIGAKMEKMAPGQTFIRWKPTGLYNAMINPLI
NYNIKGAIWYQGESNTGKPKEYGDLLTTMILDWRNKWNQKDMPFFTVQLANFMEPKTQPV
ESNWAELRDQQRQVSLSVPNTGLAVIIDLGEWNDIHPLNKKSVGDRLALQALKVADKKNI
IADGPMYQSMKVEGNKIILSFKNGTDDFAPVSELKGFAIKGQDGKYEWAKAKIEGNRVIV
WNDTVSSPVSVRYDWADNPDGNLKNKAGLPASPFTTE
>KALACAFP_03596 Non-reducing end beta-L-arabinofuranosidase
MNKTSVILLFGFTTIVFGQVKKNVSYFSLNKVHLSESVFSKAMQTDEKYILSMDADRLLA
PYLKEAGLKPKKENYPNWENTGLDGHIGGHYLSALSLMYASTGDPKVKQRLDYMIDELER
CQNLSGNGYLSGVPNGKKAWKEIADGNIRAATFGLNDRWVPLYNIHKIYSGLRDAYWYAG
SEKAKKMLIKLTDWMADEVSGLSDEQIQDMLRSEHGGLNEVFADVYDITKNPKYLKLAHR
FSHLAILNPLLNGEDKLTGIHANTQIPKVIGFKRIADLENNKEWSNAADFFWTNVTQKRS
AIIGGNSVSEHFNPINDFSGMIKSIEGPETCNTYNMLKLSKELYATNPKSSYIDYYERAL
YNHILSTQNPEKGGFVYFTPMRPGHYRVYSQPETSFWCCVGSGMENHAKYGEMIYAYSDE
DLYVNLFIPSILKWSEKKLVLRQENNFPENPSTKLVFDVASKSNINLKLRAPEWANASQI
TISLNNKNITVPVDAEGYFTIKRKWKKGDVIEMKMPMHLSAEQLPDHSDYFAFKYGPVVL
AAKYGKENQDGLFADDSRGGHIAHGPQIPLNEIPTILGSSDSVLSHLETINGKDLTFRLK
GLYPQNQFNDGLELVPFYKIQEERYIIYFPQANQDKIEMIQKQKIKEEEEIRKLDNITTD
KIQLGEQQPESDHFIDSKDSNTGYMEDRHFREAKGWFSYQMRNKDKNAKYLYLLYFDANN
NRTLNAEINGVKVISKNFEGKLGSSPQILLIPIPESESHKEILNVKFNTNEKSLTPKIIE
VRLLTQMPDKN
>KALACAFP_03597 hypothetical protein
MHKFILMEENYLTYPKHFVAVDCIIFGFDGDDLKILLVQRNFEPKKGEWSLMGGFIDDKE
NSDQAANRVLNTLTGLENIYLEQLNTYTEIDREPTARIMSISYYALINIQDNIQINEKYS
AKWFDFKDRPDLIFDHNVMVKDAVLRLRRRATTRPIGFELLPEKFTMKDLQNLYEAIFDE
KYDKRNFTSKINALDVLVKTNEKDMSSSKKGSFLYTFDEEKYNKKISEGFMFKI
>KALACAFP_03598 hypothetical protein
MMEEKIISLLKITEPFHLLPETVLAEISETLIKTEFSKDTLAYRQEVTEMKGVDIISSGE
YETFFFDAAGNKRCVTRHHSPYCFGGISVVLNRVRALKSAIAKKGTVVYTLPRKEFYELC
DAYEDFFHYFTSDFGKKMLDEEFSHFVKTPATFEESYFAADQLYSRKIESIAYKSIVFCE
ENTPVFEAAKLMAANKVSCIFIKKTGSDEIIGYATDITLRDKVIARCLHSGIAISEVMDN
PIVSISSDAYLYEAVLMMFKTKSRYLLVKNNEEYLGFLSRNRLLSEQAQSPLVFIQSVKQ
AENAEELRKKWKQVPDIINQLLGRGVHGEIASQVITTIADTITVKVIEKVIREIGEPPAK
FAFIVTGSEGRKEQTLSTDQDNGIIYEDKANEQRELVREYFLDFAKKVSDDLNMIGFEYC
KGGFMASNPKWTHSLSHWKRNYSQWIEESVPENAMKFSTFFDFRFIYGDESIVRELKTYI
KEKLVSPNQLFLAHIAKNALQYEPPLTFFKKIKTQTIGKSEVFDIKTAMSPIVDLIRVYA
LKNHLEIENTGERMKKLMEIGIFTQQQYNEIHQSYYYLMALRLKNQATQITIDKKNPDNY
IEISKLTKIERVTLIEIFKTIANFQLGIKVKFTGSL
>KALACAFP_03599 hypothetical protein
MKKYLLFIDTETTGIPKRWDLPYSDTDNWPSAVQVSWILYDEFGNLVKKENFYINTGNLK
ISVASFRVHGITREFLSKNGETRSFVLKKLSEDIREYHPLITGHFTEFDIHTLSCDFYRA
GLENPFQQSHFYCTMLKSKDYVLNPDVDYFRLPQLYDFLFNEKMERSHDAMIDAEMTAKC
FFEIRSRGEISEDELQKIHHEIECKLKFLTNKMK
>KALACAFP_03600 Sodium/glucose cotransporter
MGNLSTIDIIIFLVYFVVVAGYGIWIYNRKKSAATGSKDYFLAEGSLTWWAIGASLIASN
ISAEQFIGMSGEGFFVGIAVAAYEWIAAIALIIIAVWFIPIYLKNKIYTMPQFLETRYNK
SVSLIMAVFWLFLYVIVNLTSILYLGALAIDTLLGGDNLHIIMVGLLLMALLIGLGGMKV
IGYTDVIQVAVLIIGGFATVYMALQIVDQRINGAAVGNAFAGFQTLIHEAPQHFKLILDK
PKTTTTTLAMPENLNVQKYVVLPGLAMYFAGQWIVNLNYWGCNQYITQRALGADLKTART
GILFAGFLKLFMPIIVMLPGIAAYVLYTKGHLPGFNGVKDGAYSAILGFLPTGLKGLAVA
ALTAAIVASLAGKVNSISTIFTLDIYKKYLKADATEIEMVRTGRWAIIVAMAVALAFTWT
DVLGIGGEGGFTFIQKYTGFISPGVFAMFLLGMFWKRTTGTAALVGVLLGFLLAIFFNSF
AVDIFGKETWLYTAFTYEKLENGVVHTITEIPFLINMGWSFVITVAVMVMISLAGPKVNP
KAFAIDVTMFKVDSRTLVMIVVTVLLLTALYVRFW
>KALACAFP_03601 Aldose 1-epimerase
MKIINYNLIIVGLLCIFGCNKKETTNQVQKENMANIQVSDYAVTAKGDSIKKYTLTNKNG
MTLEVINFGGIITSLTAPDKNGKYEDIVLGFTKPEDYFNGNPYYFGALIGRYGNRIANAK
FTLEGKTYDIDKNDGPNSLHGGKEGFHTKFWNIESIKDAKFPTLKLTYTSADGEEGYPGK
LSTTVLYTLTDDNALEISYEATTDKATVVNLTQHSYFNLSGNFTKTITDHELQINADKFL
PVNETLIPTGEQKAVKGSPFDFTVSKPIGKDINSDDDQLKKGKGYDHNWILNGTGMRSIA
KVYHPESGRVMEVLTDEPGVQFYSGNFLDGKFDTKTGGKNEFRTGFCLETQHFPDSPNQS
SFPSTELKPGQKYQTKTIYKFSVKK
>KALACAFP_03602 L-arabinose isomerase
MLTPLNTKEIWFITGSQHLYGPETLAQVAEHSQKIVEAFNQSSLIPVKVIIKPTVKSTEE
IFETLTAANRAENCIGIVTWMHTFSPAKMWIRGLTALQKPMLHLHTQFNQDIPWSTMDMD
FMNLNQAAHGDREFGFMVSRLRKNRKVVVGHWAEERVQKQIGDWSRVAAGWDDWQGAKFA
RFGDNMRYVAVTEGDKVEAETKFGFSVNTWGIGDLVSVVNSIGDGEIKTLMEEYEASYKM
AESLLSGGSHRKSLEAAARIELGLEKFLKDGNFKGFSDTFEDLHGLEQLPGIAVQRLMQK
GYGFAGEGDWKTAALVRAMKTMGQGLEGGNAFMEDYTYHLNPSNPSVLGSHMLEVDPVLA
VDKPSCEIHPLGIGGKADPVRLVFNSRGNIDSLNAALMDFGNHFRLLINKTKALEITEEL
PKLPVARILWKPLPDLYTAAEAWILAGGAHHTCYSENITAEQLEDFAEIAGIESLVIDED
TKIRDFKNTLRWNEIYYR
>KALACAFP_03603 L-ribulose-5-phosphate 4-epimerase
MSIYKELQRECYEANMQLDALKLVVYTFGNVSAVDREKGIFAIKPSGVPYEILKPEDIVI
LDYDANVVEGKLRPSSDTKTHAYLYQNWENIGGISHTHAIYSVAWAQAQMDIPIFGTTHA
DHLTTDIPCAPPMRDDLIEGNYEYNTGIQILDCFKEKKLSYEEVEMVLIGNHGPFTWGKN
ADKAVYNSKVLETIAEMAYRTRQINPDAPRLKDSLIKKHYERKHGKNAYYGQ
>KALACAFP_03604 Ribulokinase
MKKYVIGLDYGTDSVRAVLIDTENGAELATSVSYYQRWKHGKFCQPGENQFRQHPLDHIE
GLQQTISDVVKESGVAPETIVSICVDTTGSSPIPVNKEGIALSLTPGFEENPNAMMVLWK
DHTSINEAEEINQLARNWGGEDYTRFEGGVYSSEWFWAKILHINRQDEKVKNSAYSWMEH
CDYMTFLLSDHQDLETFKRSRCAAGHKAMWHESWNGLPSKEFLKLLDPSLAELRDRLYEK
TYTSDEVAGNLNQEWAAKLGLTTDTVITVGTFDAHSGAVGAKVEENTLIRIMGTSTCDIM
VAPNEIIGDKTVKGICGQVNGSVIPGLIGLEAGQSAFGDVLAWYKDILSWPVHNILLNSN
VIDENQKQLLKEEIENNLIRNLTLEAEKIPLSEALPIALDWINGRRTPDANQELKATISN
LSLGTKAPHIFKALVNAICFGAKKIVDRFEEEGVKIEKVIGIGGVARKSPFIMQTLANVL
NMPIVVAASDQAPALGAAIYAAVSAGIYPNVQEASQKMGSDFEAEYFPQADHVEKYAELM
DEYQILADFTENNIKSKKKLIVDSL
>KALACAFP_03605 Extracellular exo-alpha-L-arabinofuranosidase
MKTKNKIFTLLLSSCVAFSTAQTSKFTLDLDGTSTNIKIQPTMYGIFFEDINFAADGGIY
AELIKNRSFEFDEPLTGWKQKNTQTLSHNLDSGFLTIYSDHSKTNKNYARITVHNDKKYI
LENEGFRGIGLHKDAGYDFSFDLENASGNISVVNASLVDENGTVISTVPIIIKGKGWQKY
KAVFSPSRTVEKAKLQITFTGTGVVNIDMISLFPQDTWKGRKGGLRKDLVQKLYDLQPGF
LRFPGGCIVEGRTLAERYQWKKTLGNVADREYLINKWSSGFPHRLTPDYYQSFGLGFYEY
FQLSEDLGAEPLPILSCGMACQFNTGELVDLEELNPFVQDALDLIEFANGDANTKWGKIR
AEMGHPKAFNMKYIGVGNEQWGEDYIERYKIFEKAIHARYPDIKIISGSGPSPDGDFFDY
GWKELKKLNAQIVDEHYYNSAKWFQENAARYDKYDRNGPKVFAGEYAVQSVKVVSPDNKN
NWESALSEAAFMTGLERNADVVTMTSYAPLFAHADGWQWTPDLIWFNNLQSYATPNYYVQ
KLFSNNKGSDLLRMYHNKKSVSGQDKLYATAVKDNKNDEVIIKIVNTDSKEKTIEINPRN
IKLGQKLMKIILTASALSDENNFKTENIQPVEDNSIIKKGKFSVEIPANSLVVLKIK
>KALACAFP_03606 Xylan 1,4-beta-xylosidase
MNKILLTVSVIIYAFSFGQNYKYPFRNPDLPVEKRIENLLGLLTVDEKIGMMMDNSKAVP
RLEIPAYGWWNEALHGVARAGTATVFPQAIGLAATWDVPEHLKTFEMISDEARAKYNKSF
EEANKTGRYEGLTFWTPNINIFRDPRWGRGQETYGEDPYLTSVLGVAAVKGLQGNDPKYF
KTHACAKHFAVHSGPEWNRHSYNAEISKRDLYETYLPAFKALVLEGNVREVMCAYNAFDG
QPCCANNTLLNEILRGKWKYDGMVVSDCWALADFYQEKYHGTHPDEKTTAADALKHSTDL
ECGDTYNNLNKSLASGLITEKDLDISMRRILKGWFELGMLDPKSSVHWNNIPYSTVDSKE
HKEQALKMAQKSIVLMKNEKNVLPLHKNIKKIAVVGPNADDGIMQLGNYNGTPSSTVTIL
DGIKTKFPNAEIIYEKGTEVADPSSRTSLYQNFVSQKNGEKGMKVEFFNNNEFKEKPVNT
SVNTTRITYSSFGGTQLAPGVARENTSAKISGIFKSSYSGEVIFSAATSDIYTLLIDGKE
IATRKGPDARHPSEFPVKMEKGKEYQIELRHSQKGKYVSIDFDVYRKDPVNFNSVKEKVK
DAEVIVFVGGLSPSLEGEEMMVNAEGFKGGDKTSIELPKVQRELLAELRKTGKPVVFVLC
TGSALGLEQDEKNYDTLVNAWYGGQSSGTAVADVLAGDYNPSGKLPITFYKNLEQLDNAL
SKTSKHQGFENYDMKGRTYRYMTEDPLYAFGHGLSYSKFTYGNAKLNKNSINANENITIT
IPVNNVSERDGEEVVQVYVKRNNDPLAPVKTLRAFEKVLIKAKETKNIQLTVSEDSFKFY
DEKADDLVSKSGDYTIFYGGTSKSSALKSIQLKVK
>KALACAFP_03607 Glucuronoxylanase XynC
MKKIFKRILVMITGIAISVQLNAQNVQAKVKIDKSIAYQKITGFGGFVCSPQFGYNHMTT
TEIQKLWGAGSVGGYNIMRLYIPEQSSNWGVALATAQLAASMGIKIFASPWTMPAEWKTN
NHVNAVYTDTNGIQQIGYLKPEKYQDYALYLNSFVTYLQDNGVTLDYISIQNEPDEMAQY
QGCIWTPTQIANFVKNYGHLINCKVIAPESVGFTDNFANAFLDPAVMANFEVYGGHQYGS
MQSVYKQFQNYNKEIWQTEYLINWNSSSSQTPRDFIWNTDGFTFAKSVNNALLGNVNAWI
HYASKRFYGLMGDGSYGTVAGEMTKRGYILSQYAKNTTGKTRIDAKWETSGGTLEGSSYI
SLDGNQITLVVINSSANTFDLKVDLPFFTASGVQTTTSQSLNMASLPFSFSTASFRPTVQ
VSPSSVMTFVFNKSGDRPVSLMTGGDVHYNKIESQVPTNSAFGTNYQLSGKTVTFYNSTP
LISSNTDANNGYLNLDDRYNKLIFNVLNYTTTNLPTSSNTTLYYVDTNGTVRSHNYGSIA
FPAPGSGSFNLVFDISRTVLPYGCKGIIGLRSGNYSSILTLTLGDVYFNVGNERASKFAA
AYSLTDSNLMDALENEFYTSIDFRDVTGNTSADTWNTASSNRNSIFYVNGSVSNNNVNVV
SGNSCQNLSLSDLGKDFQVPFAFTASSATYTRTFNGYGIVLLPFQSAIPSGVTAYMMQPG
SGTVVCSPISNGVIPANIPVLINATGSKTFTGSGAVSTPKAITVNQINGVYQSIKVAAGG
YVLKTESGVTGFYKVTAGNEPIISSFQGYLTENNTYTDNFLPLSFMTLKVDNATVTKNDI
ILYPNPAKNEIFIDWKWSDGVYSIVDAKGSTVSYNAKLTNGKNRIDISKLPAGMYFIEIS
GLGENIKTKFIKQ
>KALACAFP_03608 hypothetical protein
MNRLPILFFFVLLLGAFGNVQATERFITTEKTNDVILLKDKSVRISLYADAQMDAGIMRA
VKNLQADFQKVTGEQPNILNQISGMTSPLIIIGTVGTKSVIDDLIRQKKIDGKSLIGKTE
KYIIQNISNPFPGVSEAIVIAGSDKRGTIYGIYEVSQQIGVSPWYYWADVPVETKENLYF
KKGIYTDGEPAVEYRGIFLNDEEPSLGGWARATFGGINSKFYEKVFELILRLKGNYLWPA
MWGKAFYDDDALSGPLANEMGIVMGTSHHEPMAQAQTDWHRYIKRNNLPNVWDYSKNPKV
LQEFWKAGIVRSNSWEKLITVGMRGDGDEAMGEGTNISLLEKIVKDQRKIIAEVTGKKAD
KTPQVWALYKEVQDYYDKGMRVPDDVILLFCDDNWGNVRKLPDLSKPLHKGGYGIYYHFD
YVGGPRNSKWINISPIQRVWEQMNLSYEHKVDKVWVVNVGDLKPMEFPISFFLEMAWNPK
QFNAKNLLEYTEKWAAQQFGEKHSKEIARMINLYAKYNRRVTPETLDSKTFSLENYHEFE
TVLNDYRALAVDALRLKDQIPEEYQDAYYQLVLYPIDACSNLYEMYYAVAKNKELAGKND
IQANFYADKVKECFERNAYLDNKYNNEIAKGKWTHMMDQMKIGYKAWFDGKVNVMPDVIY
ISEATATPKDKIFAEENGYVSIEAENFARMNNSDRIHWEVIPDFGKTKSGITTFPQNAYP
KSDENIYLEYDINFKSKGEFEVQLLLAPTLNFNHNKGLRYEISFDGGKPETVNFNGHYRG
ELGKWQSEHIIKSVTKHQISQPGKHTLRFRVLEPGIVLEKILIDTGGLKPSYLGAPQSDY
SEK
>KALACAFP_03609 Retaining alpha-galactosidase
MKKGTLIFLSLIIFCLLSEIKAQVAEISSPDGKLKLNVFSEQGKALYSVSFQGETMLDKS
PLGLITNESDFSKNLKFINSKKDVVSKKYSNKKIKKSEVEYKANTLMVSFMNADQFGLEI
EFQVSDNNIAFRYEIPSMKDRFSAVVESEVTGYRFPTQTTTFLSPMMKPMTGFARTAPSY
ESGYKADAELGIKADYGYVFPGLFHVGSGNWILLSETGVTSLYCASHLSTTSEKNLYQVA
YPNMAENNGFGSSGAALSLPGKTPWRTISIGDSLKPIVETTIPFDVLEPLYEPSQEYQFG
RSTWSWILWQDASMNYDDQVKFIDLASSLQYEFILIDALWDKNIGKERMKQLVQYAKSKN
VGVMLWYNSNGAANDAPMGPRNKMSNAVERKKEMKWLKETGVKGLKVDFFGGDKQETMRL
YEDILSDANDFGLTIIFHGATLPRGWEVMYPNYAGSEAVLASEMLYFSEDVRKQEAFFAT
LHPFIRNTVGSMEFGGTFLNKFLTQSNKDKNKRHTTDGFQLATAVLFQNPVQMFAVMPNN
LADAPKFQIDFMKDVPTLWDETIFIDGYPGKYSVIARRHQDTWYVAGVNAEKTVKKLKLN
LLMLAGKNVELINDDKSGTTFTKQISINKKGVYEIEIQPNGGFVLKN
>KALACAFP_03610 Arabinoxylan arabinofuranohydrolase
MIGCTGILTAQNPIIQTAYTADPAPMVYNDRLYVYTTHDEDDSTWFTMNNWKVFSTNDMV
NWTDHGIILSYNDFDWAKRDAWAAQCIERNGKFFMYVPMISKTNNKGAIGVAVADSPFGP
FHDPLGKPLVQSEWGDIDPTVFIDDNGQAHMYWGNPKLKYVKLNENMISYSGDIVEVPMT
EESFGKREGNPERPTKYEEGPWLYKRKNLYYLFWPGGPLPEFIGYSTSKSPQGPWKYGGI
IMPAEGKSFTNHPGVIDFRGKTYFFYHNGALPGGSGFTRSVSVQELNFNKDGSISPFKMT
NGITDAIGTINPYSFNQAEMIAWSENIKSYQNKTAGVFIKAKKNGAYTSVKNVDFGKDGA
SSFSARVGTTHNSGVTMDVHLDGLNGPVAATIKVPLTGGDDRFETVTTNLSNKITGIHNL
YFVCNGKAEKDIMFFDYWMFSK
>KALACAFP_03611 Arabinoxylan arabinofuranohydrolase
MLKKTVLKYTLNIGLLVTGLLLSAQNPIIQTKFTADPAPMVYRDTVFLYTSHDEDDAFGF
KMKNWLLYTSTDMVNWTDHGIVASLKDFKWTDPENGAWAPQVIERNGKFYMYCPMPGQRG
IGVLVADSPYGPFKDPIGKPLVKNSSDDIDPTVLIDDDGQAYLYWGNPNLWYVKLNKDMI
SVDGSIVKDPSIAKVKGSPDPFHYQEGPWAWKRNGNYYMAYASTCCPEGIGYAMGKSATG
PWEYKGMIMDSDKRSNGNHPGIIDYKGKSYVFGFHYNLGKQTISKHYERRSVCVSEMIYN
ADGTIQKLPFWNPEGVKRIAVLNPYHRVEAETIAYSEGVKTEEMTEWERNNPYDTGKKIT
DRIVVSSINNGDYTKVQGVDFSKGTNLLEISVASINGGTIEIHTDAVDGALLGTVQVTGK
GEGDLFKTIKSPVKNIKGIHDLYFVFKGNKDLFYFDWWKFSSN
>KALACAFP_03612 Alpha-xylosidase BoGH31A
MITRMNVKKIKAYIITVTLVSMMNQNINAQSYKKTDTGLSFSASTMNVEVKFYGPHTVRV
IKYPTGKSFIKNSLSVIKEEQKTKFSVTENKEILSIKTNDLQISVNIKNGEIAYATISGK
QLLKEKGSDIKPFDDAGNPTYSVTQSFQLEKDEPIYGLGILQNGKLSQRNQDIRMVQNNT
WDFVPFFQSVKGYGIFWDNVSPTQFTDTIQKTSFSSEVGEGVDYYFMYGGNADGVVALMR
NLTGNVPMFPLWTYGFWQSKERYKSQTEIVDVVKKYRDSKVPLDGIIQDWQYWGNNYQWN
AMDFISPDFPDAKKMINDIHGMNAHLSVSIWSSFGPMTNPYREMDKKGMLFNFKTWPESG
REVWPPDMNYPSGVRVYDAYNPEARDIYWKYLNKGVFSLGVDSWWMDSTEPDHLSQKPED
LNTKTYLGSFRKVRNAYPLMAVGGVYDHQRATTSDKRVFILTRSAFAGQQRYGANTWSGD
VNSSWESLRNQVPAGLNFTLTGNPNFNSDIGGFFAGTYKKGWNESSGSKNPMFQELYVRW
LQYGTFTPMMRSHGTDVPREIYQFGKKGDVVYDAIEKFIRLRYSMLPYIYSVSWDVSKNQ
SSFMRPLAMDFSSDKKVWDINNEYMFGKAFLVAPVLKAQYTPEKIVKTDENEGWNKKDEI
KKENSVSNIDFTENKTVKVYLPSGTVWYDYWTDVKYNGGQEIEKTVNIQSMPLYVKGGSI
IPFGPDVQYATEKKWDNLILKVYPGSDGDFVLYEDEFDNYNYEKGDYTEIPMYWNDKSHT
LTIEARKGKYKGMIDKRNFAIVLPNGQQKTVDYSGKSMKVVMK
>KALACAFP_03613 Endo-1,4-beta-xylanase Z
MRNSVIFTLGLILSGIGISAQTFDKKAPQGFDVEKKEIPHGKIDTVTYESKTVGTQRKAL
IYTPPGFKKGTQYPVLYLLHGIGGDEKEWFRNGTPQIILDNLYAQGKLTPMLVVLPNGRA
MKDDRATGDIMAKDKVEAFATFEKDLLSDLIPFIEKKYPVKKDRENRAIAGLSMGGGQSL
NFGLGNIDKFAWVGGFSSAPNTKEPQQLLPNPAKAKELKLLWISCGDQDRLMSFSKRTSD
YLTENNIPHIFYVEPGGHDFKVWKNDLYLFSQLLFKNIDQQQISVQLRSE
>KALACAFP_03614 Non-reducing end alpha-L-arabinofuranosidase BoGH43B
MNIKKSFYIVSFYGFIGLNLLSAQINPSQKQQTTAFTNPIIWADAPDLSVTRSGDDFYLI
STTMHLMPGAPVMHSKDLVHWEMSSYVFNTLNDNSKYDLLNGTVYGRGQWASSIRYHEGK
YYVLFSPNDEPFKSYFYVTDNPETGKWKLITRTRHFHDASLFFDDDDKVYVFTSNKVFEL
SSDFKEVIGNPEGTVVFQKDSTETGLLEGNQIIKRNGKYYMMMISWPKGEKRRQEVYRAD
KVTGPYEKKVILEDNFLGFSYAGQGALIDDKNGNWYSLIFQDRGGVGRVPILIPVQWEND
WPVLGDNGKIPLHGEVPLPPFKPKNNIVESDEFSDKKLKIQWQWNHNPVNEAWSLSERKG
FMRLKTSRVVDNMYAAPNTLTQRMTGPKSSAVVALDVKGMKDGDIAGFSAFNGDSGLLSV
VKEGSQKFLTFSTNEVSLDNKTKAILGVKKEEKKRFPLTLDTVYLRIEADFNLGKDLADF
SYSTDQKNWTVIEKGYKMIFDYRRLFMGSKFAIFNYATKSRGGFVDVDFFRISDSSTGK
>KALACAFP_03615 Non-reducing end alpha-L-arabinofuranosidase BoGH43A
MRQRIMNPVFLKKKTMLTAAVALLFFDSISGQTFSDFSYRGNDKIYTNNPLKEDEFYSPI
LQGCYPDPSITRKGDDYYLVNSSFSMFPGVPIFTSKDLVNWKQVGHVLDRPSQLKVEKSG
VSQGIYAPDIKYNKHNDTFYMITTQIASGIGNMVVKTKDPAKGWSEVQKLNFDGIDPSIF
FDDDGKAYIVHNDAPPKVTEQYNGHRVIKMWDYDLEKDQVVAGSDKIIVNGGVDLSQKPI
WIEGPHLYKKNGKYFLMCAEGGTGGNHSEVIFMSDSPKGPFVPAMNNPILTQRYFPKDRK
DKVDWAGHADLVETPNGQYYGVFLAIRPNVNNRVNSGRETFILPVDWSGTYPVFQNGLVP
MKPKLKVPEGVKNQTGQNGFFPNGNFTYSDKLTDKNLDYRWIAMRGPRENFINISKNGVK
INPFETNIKALAPVSALFHRLQHEDFETSVTLDFKPKSEKELAGITCYQSERFNYVFGIT
KKDKDYYIVLERTEKGESKLIASEKISLSKTVRLQVVGEKDEYNFNYSLDGKNFKNLGGS
VSGDILSTDVAGGFTGSLIGLYSTSSNDIVPN
>KALACAFP_03616 putative oxidoreductase UxuB
MNEIFSIKDKVAVITGASGVLGGSLAKSFIEAGAKIVALGRNQQTVGARVKELKDLGGDA
LAVEANVMNIESLESASKKILEKYGKIDILLNIAGGNIPAATLAPDQCFFDMKMEAWNEV
TDLNINGTVYPSYVFGKVMAEQGSGSIVNISSMAAYSAITRVAGYSAAKSAITNFTQWLA
SDLALKYGDKIRVNAIAPGFFIGDQNRAILLNPDGSLTDRSKKVIAKTPMGRFGNADELN
GAVQFLCSDAASFITGALLPIDGGFSAFSGV
>KALACAFP_03617 Mannonate dehydratase
MEKTWRWFGKKDKIKLDMLRQIGVEGIVSALHEIPNGEIWSLEAINDYKNYIESFGLRWS
VVESLAVSEAIKYGGENRDVLIENYIQSLENLGKAGVTTVCYNFMPVLDWARTDLFYQWE
DGSSSLYFDKAKFAYFEIHILQREGAENDYNSEILQKVEQLKNTLTQEDNDDLIDSIIVK
TQGFVNGNIKEGDQNPVAIFKSLLALYDGVDKNQLRENMKYFLEKIMPVCEKWGIQMCVH
PDDPPFSLLGLPRIVTNEEDIDWFLNAVDNPHNGLTFCAGSLSAGLQNDVPKLARKYAYR
TKFVHLRSTNVFENGDFIEAHHLGGRGKLIEVIRIFEKENPDLPMRIDHGRLLTDDIDKG
YNPGYSFLGRMLALGQIEGVMAAIQNEMSN
>KALACAFP_03618 hypothetical protein
MIKYNKKMIAGAIFLSLTFTGCNEILDEEPRTSYTVDYFNTEQGINQGVTSLYRHLRMLY
GNGYFMSNCQNGTDESTFGQQADGNFKELDMSGNGNITPSTFPPSMIWNSVFPYINTANG
IIEKGPSFGISESLISEARFFRAFDYFLLVQTYGGVPLDLGSGELAFNINPSATSVRNTV
PEVYSKAIFPDLKKAIDNLPASPRVTGGVTKNVARLFLAKAYLTYGWWLQNPNDIPTYPE
AARTDPDGHNAQWYFQQAYDIALEGINSPGPYALQPTYYDLNVGSNDRNNECMLYADHTS
SSSYYNESDPIGFGSGWSPDNFAAWMQTWNYTNIKSSKSSTTWDAGSSVQRAATQTLGRP
WVRMCPTIGVIKNTFADKTNDSRYDGTFVTSYRGNWNKEATGLTTIPVLYNANNLPVQPN
DAILTFLNDDSQTPTYPSGAGQSGVGAGTLPGRADWVIAPNGISRMVFPGLWKIGTYRTD
NGNGLGFPNAGLTRPFNAAKFSEFYFIAAEAAVKGASGAMTARDLINVIRARAGKWKFSN
AQNTTYIADNSAAMVAATPSTITIDYILAERSREYYGEFYRWYDLIRTQKWQEYASSYQI
GGSNYGDHTPQTVTRNIQKFHYLRPIPQSQLDAMEVSADIKAKYQNPGY
>KALACAFP_03619 TonB-dependent receptor SusC
MNVFLLNKTNRAALFFAMALLPSGLMYAQSKKDTVTKEKKIEEVVVIGYGTQRKESVTGS
VASVKGDVLREVPSANITQALQGRTAGVDISQSSTKPGAAMQIRIRGTRSLSGDNNPLVV
LDGIPFAGSLSDISSSDIKSIDILKDASATAIYGSRGANGVILVTSNRGTRGQKPRFSYS
TFTGVQTLFSKYPMMDGPTFAKLRADAGIYTNGADESNDTNTDWQSLYYKPAMMTNHDIS
VSGGTEGGNYSAGLSYFKQDALIPLQNYERFSMRLALDQQVGKKFKFGFTTNTNYTKTEG
NGVNSGAVVGYSPLVNPYNADGSLRSLMNTAGGNDNTWIFTRERLNNLDEKYVDESKIFA
SYNNLYGEVSLPLNGLKYRLNVGLDYRTTNSGNYVGVGVFSTNPATASSAGRGNNQNYHW
VLENLLTYDRTFGKHKINAVGLYSAEGNRYISTYMSAKNVPADFFQYYNLGQSPQADISV
NPNDQIYSQTGLISAMGRVMYTFDNKYMLTATLRADGASVLAPGNKWHTYPALSVGWNIT
NESFMKNIKALNLLKIRAGWGQTSNQAVSPYSTLGSLTVVPYNFGTTNGTGVYVNQAPNA
DLGWEYSKTQNYGVDFGLFHNRLTGTVEYYKTHTFDLLSNKSLPASSGLSYVTKNVAETE
NKGWEFSLNGIIFDNPDGFSWDAGVNLYTNKNKILALASGIDRDINNLWFVGHNINALYD
FQYIGLWQAGDPYQSILEPGTPADVIGSIKVLYTGGYNADGTPVRAIGEADRQIFDTAPK
FQGGFNMRFAYKNFELSTVGAFQKGGILISSLYGSASYLNRLTGRGNNVDVDYWTEDNTD
AYYPRPGRHLSGDNPKYSSTLAMFDASYLKLRTITLGYNFDKELLKDMKITALKIYFTVT
NPVVLFSPYHKFSGMDPEPNSVGDQNQAVSGYRPRQLIIGTNNPSTRNYLMGLNLTF
>KALACAFP_03620 Xylose isomerase
MNVLKGTKQFFPGVAPIKFEGKESRNPLAFRHYDAERVVMGKPMKEWMRFAMAWWHTLCA
DGSDPFGGPTIHHPWSQGTDAVSKAKYKMDAGFEFMNKMGFEYYCFHDIDLVDPADNWRD
YEKNLQTIVEYAKEKQKETGIKLLWGTANVFTHERYMNGASTNPNFDVVACAGTQVKNSI
DATIALGGENYVFWGGREGYMSLLNTDMKREKEHLARFLTMSRDYARKQGFQGTFLIEPK
PMEPTKHQYDYDAETVIGFLKNYGLDKDFKLNLEVNHATLAGHTFEHELQAAVDAGMLGS
IDANRGDNQNGWDTDQFPVDYFELAQAWLVILPNGGLGSGGINFDAKIRRNSIDAEDLFI
AHVSGMDAFAKGLLVAADILENSDYKKLRTERYSSFDNGNGKAFEDGKLTLEDLQKIAHE
IGEPQPKSGKQELFEAIVNMHI
>KALACAFP_03621 Xylulose kinase
MYLLGYDIGSSSVKVCLIEASSGKIIASDFSPKKEMKIMAINSGWAEQNPAEWWLNLKLA
HESVMHESGINPEDIKGIGITWQMHGLILVDKDQNLLRPSIIWCDSRAVPYGEKAFKEIG
EEKCLSHLLNSPGNFTASKLAWVKENEPEIFEKIDKIMLPGDYIAMRLSGEIGMTVEGLS
EGIFWDFKNNCISEDVINYYGIPKSFFPEIIPTFGIQSTVSATAAQELGLKEGTPISYRA
GDQPNNALSLNVFNPGEIASTAGTSGVVYGVLDKLEYDTMSRVNTFAHVNHSPEETRLGV
LLCINGTGILNSWLKHNFATSLSSYGDMNDLASLSPIGSKGLSIIPFGNGAERVLENKDT
RCSIHGINFNIHTKGDILRAAQEGIVFSYEYGMNIMRGMGMDIQVVRAGNANMFLSSIFR
QTLSSVSNAVIELYDTDGAVGAARAAGMGIGFYADSNEAFSSLEKLAVIEPEKEKREQYF
EAYSRWHEHLKEIV
>KALACAFP_03622 hypothetical protein
MNQDFIHTYVSVDCVVFGFDHDNRLNILLVQRYIDDVPADKQRKLPGSLIFSNEDVDDAA
HRVLHELTGIKKMVLKQFKCFADPLRASNQSDIKWMGTEYMHNIDRIITVAYLSLCKIDQ
KINSTKYETVDWHPIDQVPALPFDHNKIINESLTEIRRWIETDFSIIFELLPKKFTIRQL
YQLYSALSEKQIDIKNFHKKISSFNYIIPLEEIEKNVSHRAARYYKFDAKIYKKNNTKLI
K
>KALACAFP_03623 hypothetical protein
MEITEYVDFIKEQFKDIAKEYGFSWRQQNSDILFLEKNKCNY
>KALACAFP_03624 hypothetical protein
MEITGYIDFIKEQFKEVATANNMIFENRNAGIVALKNQFLEIYFSTEKYDDGMNAYFRNV
KKGTYYSLYQSIIKKLGNPDFLTEDEITKSIEFNDDNKSLIFNVAIFVKNHCQDLLNGDF
NSLK
>KALACAFP_03625 hypothetical protein
MENGNVIGEKLTGFGKEVHRFEWKHGYRFDPKTKRMLLPSELNRRKLPTLTQFEEYKIVD
>KALACAFP_03626 hypothetical protein
MTKEELIELGYKIVNAEGTEEQIDEYYELFSKNVPHPNGANLFFYPENYNARTDDLSKYN
PSVEEVVELALSYKAKEV
>KALACAFP_03627 hypothetical protein
MSAINFIKMMDSNPNIDYSELYKEYFKQFSKRERIDAFIYSMTLYKVTKGLFISNTELWI
DFTKQDWQEVLIKNTNRPAIPDNPDGRIIDLYEYDDLIILNKFLKINPFSILLENKDKIS
RNNLLNCLKYGYFMSTFFYQSDEFLVEDFEDFSNISYVEVQEYSKNLITQGCEKRLNTPE
ELYSWLEEKIKTFQT
>KALACAFP_03628 hypothetical protein
MNLQYFQNLNDYLIKNKWQNSNVDPSLINGLELKIKKSFPKAYKEFLELTGMHFYPLHNS
NTALGGAFDFLESANADALEQLEDYGLKNLINKEFWVIAESDGVYIHYIFFDEGENPPVY
GLDMEGYTDDNSDPKRYHKKIANSFTEYVESFINQYNHTSDK
>KALACAFP_03629 hypothetical protein
MSLEILNSKGSIGLSGSKLLSENDIQNGLLNKQNFFKTKEKTFDQISAFKDSPFGQYWEK
RLPAFAVSDYGPSRVLNESNFSIIDLSKKLSSALASLYNNSIEENWDDIKFVVYANPDGQ
EVLKQYANPDFKPEDNQVMFLIETDDGKFDFGKIVRVKLGEKAIEKLRFKYPFLGQTDED
HLAEEFLNRSFEIKTDSSLAFSEAEKERKLNAVELKNLLAKAIQYDYKKKKFDDMLLFLI
LLQGEEFLGLNTPKKLLEISQWMRTKKYNEEKYWNALLEKDFTPAFLPDIIAPQNRKSIK
ETIKNEFKQHIDNISKPDKNDAAIDKIFKEILGNVLLYLFDKFSSLLDEGLKILDDLLPE
GEMLNEIYNLNAFLVGLWNGCIEFAAGIVDLVSLIMIIARDGIGFALTDALGEAFEELLN
EIVYNFEDFIKKLWEKFRIAIKEIPNWYLKYGSNQYYRYKELGELMPDIITLLVPALKAG
KASKVAEEISLLKNLSKAEKELALEKQTQKYLEGYYETLRKESDDFSKKLEAKTAESEVK
ESFDNAEKEIDKKLSKQEIEEDPRKILDEKIKERKKFRSTNLNIQRIESHLKYARKSFQR
ERAGLDFRKVRHEWYYGKLSNRIKKVEISLEEVKILAKLKSGKARFTNIANAELEIWFEG
KLLFSKHDYWASASKKDLMNNGKGIERTLEPIQKEMFEDSALDPSRSRIDDSEVKITSLM
DEDIAKIATEHNIDLNKLEIKIRILTTYDPCNVCKREILSRAIVYPKSEIKVVRPMYKNN
KNIIEPVTNNETFVLFLKQNGIKI
>KALACAFP_03630 hypothetical protein
MNDHIIIPENIQEILNSIGNTSLNLAELPMHAHPILPQFNRSIRVLDIDAKSEQEFIYFR
YEQVLKNKETGEEVKISLPAPEWIIYKETASYLLDDSNSPIELPLKEPQGDQTTDKVKVP
SYKYMLWLLKSNKIRFLELLDYYLQLFVENHKDELDKLS
>KALACAFP_03631 hypothetical protein
MSNIGKIIRVNALPPIGERETNVIYQVAEPGGATYTDYAIDVNGDLKTHAVVEGSIPVEL
SDKHVSISNPDLIAEGIASQADYNANTRERLTLKLDIPSVDGNAQDYPKIIGLNDNGEVA
KLPAGDLGKNVANSSLTTVAGAGLTLGANWTLNTFGLYYSITGLSDVSNDSTFNTFLSQN
ASGRVGKTNGKQPFLSLPTTLSTAEKTAWKTAMNGGWTTATMSVASISPPIVDRANKPTW
ITLKGANLNLPPTSFKIELCTESSTDLNPVVVAEIPASQVQLYDNGIDLSFWFNFSTIAE
GKYKIRLWNGVAYYLTGANTMLQIVNSIVPSIPPLTWTYAEYTPGSNTMIGGNSSVTYNS
NPANKAYQGNDLTTVSAGKSSELFGEDDNFYLRIGINITNVQSGADNNTPFVIGLCNNAD
AVALSDLSVIKGRGSINYRGGGISIFPDLSSQGVTFWGIYTGEMQIIRNNGLFTISVTMN
NTTRIYTKSAPVIALSLFAMIGNSPSATSASFNILEQYKF
>KALACAFP_03632 hypothetical protein
MTENESAADPIAENTPTQTLFRFVSLRSPQLSDEKDQDKRFIFFPEQMKSDTAFYEPVTE
GTGPKQKLLRERAEVFKTNADRIESLTDFKAGYPELYTFAIWLAVNKTRCTYEEFEAAKQ
EMLPPGYLIPEIHVLWNNLIYQVVTQENFYLKETLIQMLLALHTLSVTGENDVLLALAAK
VVLPKELMLDDNNILAITSSSKALGSEVMQTLPTDDMKKQQEISAAKTKLSRIELLNRNL
SAVIKQYKKDYETEFKIQNQAHQERIIPILEEYNKAVADSKQEYCSTRPPGTEYNPEDPC
QQLPVVPFPRLPEFEFKFKDEVSAESLVTELKPENLEALLDVLGYTFDPERESSSRSVEE
SINDLESVLEGRNTFGEINTAVDKNVEELNNLIVQSFQGNEEVYKSIGGILIPASKTISV
PFTFQVCPNFIYKGYTLNLALNVPDSSWDVNLLSYALTPNGTPSSIDGVYFVKTRTGNTI
FLNDLYSPGLDFYTIQDSTLRVKVVFANGRVAEFTVPGVTARACNTGDFVLQVEEGEDPV
IIDDENNFIPSGFGFKNIGVADYLKVEQSTHAYVEGEVAHIENVMAREYREKSTRRLRRS
ENTTTTSSDTEREQLTDTTTANRFEMQSEISKMAQEARDMSLSTHFDASWKTGGAGMGAS
FNTGIAANFANHTSKEESTRQATIQAQDITARAMDRIVTKIHEERIEKIIDEFEESNSHG
LDNRKGDKHVVGVYRWVDKLMKNQIYNYGIRTMFEFMIPEPARLHLLGMKEIKDPDQIDL
IKPVDPRAEGDMQISDYSALANEVKLKYWMGKYNAELDEKPMESFSITKAFTGRDPAFSG
KDDEKIQVVNGNGEVLIPEGYTATNVEYVFNTWPHGFYGNHAAFMSIAGKSSSWIMSTAD
TQKSGTIDGLNVKDKLEFSFATGESPIIQGALNITCRLTQKARNAWQQKTFNAIINAYED
ALIAYNNAKAEADNKAVVIKDSNPNFYRQIENTVLRKNCISYMADRATDSTHGYGLSGLT
QGNSFNDYETVLSSKLDKYTAFVKFMEQAFEWDNLSYYLYPYYWGKKQNWVDLYQSENTD
PLFRNFLQSGMARVIVTVRPGFEDAVQFYLATGKIWNGGEVPVIGDELYLSIVDEMKEPK
GKKEGKAWLTRIPTTLNILQAESIGLKVAHALPFTTENPDDFEVPSEVITPGKFNFEKND
NLLGIQPGEEEKIITGDWL
>KALACAFP_03633 hypothetical protein
MKTAYLYVRVSTDEQKRKGYSLPEQEDRLLKYCEQNQIVVKGIFREDFLAKDFNRPEWKK
IIKKLKSNKKRPAENILFIKWDRFSQNIEYAYQMLGILRGLNTKPLAIDQPIDFDVPESI
VMLAVYLSIPEAENNRRGRNASDGIRRSRKMGRWAGRAPMGYINQSTQEGRKIIVPKQPQ
AGLIKWAFEQFVKGTYSINQVRIMTVQKGLQCSKNNFGKYYAILFIAG
>KALACAFP_03634 hypothetical protein
MYDATIEDRTKKPLQITEKDINRITQSFSERMVSINQAIRILRDNDIRINNDEAIIILDF
LYMLAASFKKDTNLELRD
>KALACAFP_03635 hypothetical protein
MKLPSEFEDQYVKDVLYNRSLENLPDEKWEPIEGYESYKISNYGRVKSLARETLSLFGKE
RTLPEMIMKPGFVKHFNKYLNKYFYNINCRLSRDGKKTSKPVSRLVYYHFVEEFDFYDQR
IHIEAKDGNRLHVHSSNLKKNSASERSLKTFRMDKAKNRHVFYQQTVSQYTTEGELVANF
DSFYAAEKAFGIDATAIYHATTKQTLVAGAYRWFLQSNPPKKEDFIVSDKSGKWFNEELW
IRLGKPLIDKKSPPSCMNLSIEDLPNEKWKPIPGFKGRFSISNKGRIKRWGSWNPVGRKF
FQKDSIVPQFVEFKGDTIYSMCVVLDDLYDKKKKSRIEIARFLFHCFVKAIDLNDKTLIV
LNENNPQWELDLSKLVLRSVKDIPKGKKLKSIRILLNSKKTFNDVLWEKLGKPDVKKKNP
PPILNLSLSDLPNEHWKPLPGYEGKYVISNKGRVKRLSGWKMGIQFFAEEQILTINTDKF
KDSLYLCFRLHEQIRRRSMRLHRLLYHCFVEEFDLNDTSMVVVNDNIPLWEMDLSKLSLH
DSNSRLNQKRLIAQNKSGNK
>KALACAFP_03636 hypothetical protein
MKRKITDGVFKNKERSKKKFLDAVGKILKTKGVSALKVNDIAATAGLDKKLIYNYFGGTE
QLIDQYISTQDFWSNVKQEEDSPDIRDGGQAISKELLQSQFDYVFENKELQKIILWGLTE
NRKSLKKLADNREKEGEVIFKNVCDPHFGDKAGRYRAITALLVSGIYYLDIYATTNNNTF
CGLDLKSKEGRQKVKEAISFIIDKAYSDI
>KALACAFP_03637 hypothetical protein
MHVQLVTILDSKLEEVIRKFARMPFQLSAANFSIAAQILEHSSLMLKNYIDLLIALRLLP
EKHEYYKQQIHITHTHSKIHLVSGDINEKILIAIKDRVTLMLHKYSEHELNPVISIYQHY
NSPDELILVTGLSIIDKKASTAISLLHQLSLPVNLFEFNTYRPVYLIELLKSYQKDTNLS
VHRLAAQYGKSYKQVQKDSKSYFGSTLYSFILKLKMLDTVEDIMFTDLSLKEIAYKNDFA
DYGSMYRLFKQYRFSLKQIPRFLEFSTSGIICYVLAAFYYM
>KALACAFP_03638 hypothetical protein
MSLLVLGGIRTLQQILKHSPLKKIFPHLTQILSYFFVLLFCYAAVSKVLDFENFTVQLAQ
SPLLSAYAGIISYTVIIVEIVTVIILCFPQTRLWGLYASLGLMAGFTIYIYLILYYSDFV
PCSCGGILEKLGWTEHLIFNIGCIIIALLAISSFYQRKQISLLKPLFYSALLIIMSTSIV
ILLFITSEHIIKKENNFTRRFLLHPVLEDKTFDLGMNSYYFAGLDGGKIYLGNVTAPLLL
TTVDTSFVNLRSVKVDLDRENYPFRSLQLQVKDSNYYLYDGSIPVIFRGTLGNTIAHTIS
YRDAFFTQLVILDSSYFAIRTQSSHNRQYMLAALNLQQNPKLQMHPSILKKQIDGVFDSD
GKLVTANNSSEILYAYTYRNEFIVLDQRLTILKKLHTIDTTTVAKIQTRRLSDGTHKMSA
PPLKVNGAIAANHNLLFIHSNLKGKHESSQMWKKASVIDIYRTDEQEYVGSFYVDKQGES
ALSYMIADDRYLYVLIRNDLKRYRFREPISKYFKAGNAENLIQSRQKLINLKKK
>KALACAFP_03639 hypothetical protein
MKKLILPVTLLLLGTGAAFATKMNSSKRILVDAYRIDAVSGRCVTANQKCSTVQSDPCTW
NENSSIFLHDAPLTQTMCGDELYKP
>KALACAFP_03640 Dipeptidyl aminopeptidase 4
MQAIKMKKLIWIYVLLFTGISIPAQDRKDTLQSWMSKFYRLTNPVLSEGGKWAAVRKRYD
ISQDTLIVVNTSKPRVPATTLALDGTVSFLKDDGLLISGAGKAKFLDLKSGAVKHYDNIR
SAYPLPKSSQYALLTKDAVLSIYSIDGKLQHRITEIQGLPVTDDKGNLYICKLFENSCEI
WIISGKKQRKLYIIEYAVKEMEVSPSGLQVFVMGQDSKSSDPRMSIIDTQNGRSVSLTAP
RLGDESFFNVTRVQNGKALFIALYGAKKAESELVDIWYGNDDKLDAKKRGSRKGRFWLWK
LGSDHIDPLPDDVYPEIASLNSERYFLAYSTQGHNFITLQPQFMDASIYDAKQKKYSPLG
ALKGVTYGSPEVICSKNGMWILFSEKRKKWTIFDLAKKEKHLIDQTGLRNPVFSDDNRLV
LFESEKGLWEYDIVKKSFFQSHIAGNKAVSMVNVADYKTSYNSQIGIRSFETKKPLLLEI
KERGSDTSYYILKGKNLEVIMPPIKDKVGRLTYNDRLTHFLTLEENFNKPPQLYIKSEGQ
KQLLLDGGSSDSEAPLLKQDIIHYATTDGRSLKGILYYPVGYKPHQKYPMVVYIYQIQSE
KSNEYMIPGYHNSDGLDIRTLIQKGYFVLLPDTAVGPAGPGLSALDCVHKALDAVGQNPN
IDMKKVGLVGHSFGGYETNFIATHSDRFETYISGSGISDITRSYFSYNYHFPGPYYWQYE
TGQFEMNYPFSENKAIYFDNNPIIHVDKVKVPILLWTGKQDENVPWDQTTEFFIGLKRNG
KPVIAIFYPNGRHAFAYNSIEKKDLYIKVMEWWDYFLKDKKNVTWIDKQMKKGAL
>KALACAFP_03641 SusD-like protein
MKSLKIISIPLTAIFFAICSSCEKLIEVDVPDNQIESGLVFENVQTADAALAALYAGLRD
SSPIAGDNSGAILGTYTDDLDFYATANSNGVYDLYRNQHIAANVDIYSFWSGSYQQVYLS
NSIIEGVSGSSSLSVSDKNRIKGEALLARSVLFFYLWQVFGDFPYPVTTNYQVNQTLSKT
PTSEVGLKLENDLNEAIGFLKDEYRNVERIYPNRKVAQLMLAKVYMIQHRWAEAESMLKS
IIQSPLYQFQSDITKVFIKSSSHILWQLKPKNPGDPTRENQTYYFNGVAPYSYALTQNLI
GSFSGNDLRKTSWTALVTVGPNTWYRSDKYKNGANNSTEYSIIFRLEEAYLLLAEALAQQ
NKIVEALPFINATRQRAGLSALSGITKEVLLNELLLENRKEFFTEMGHRFLDLKRFDRLT
DLTSVKTNWKDFHRLWPLPQQDLLLNPQLNPQNAGY
>KALACAFP_03642 TonB-dependent receptor SusC
MKNVFGCIAALFFMDFSVLYAQQQRVSEHTVNFEIGKTSAKDAVQRFFKKSGIPYVYTEE
SLGKYTIEGVKCRDEAAVSCLKRILEGLPFEIFVNEDKVIIIRSKDNKKTADHSQTVYSI
EKDTLKKALSLSAEKEQKIEEVILNGGYYTVKDRERTGSIVKVKAQAIENQPVTNVLSAI
QGRMAGVNITQGSGVPGGGYDIQIRGRNSLRSITNSDIDGNQPLYVVDGVPIGGKMISPY
SGVILPGANINPLNSINPSDIESIEILKDADATAIYGSRGANGVVLITTKKGKSGRLGLD
VNTSYALSHALSNLELMNTAQYLGMRKQAFANDGISTYPAAAYDINGAWNQNRYTDWPKK
LMGNTATLSNTQLSLHGGSSTTTFLLSLGHNEQSTVFMKDFKYVSNTLSNSITHHSEDKR
FQLNISNLFSLQKNNVPRTDMTRQAYFLSPNAPELYHADGGLNWENNTFANPAALFNSTY
SNENKQLLININMGYEILPQLRIKLNGGLNYQDYEETALQPNTMYNPTFALGQSSATSRA
SKSNQDRFSYILEPQVNWTFKKNSHELDALVGGTFQSEINEQGTMTGIGFESNAFIGNIG
AAQTKIISDQLRTEYRYAAVFGRVNYQYRNKYILNITGRRDGSSRFGPNNKFANFGAVGA
AWLFSKENFLSGTKWLSFGKLRGSYGTAGSDNIGDYQYLDTYTVSSSSLYNGITGLTPSR
LYNPDYSWEKTRKLEIALELGFLKNKVNLTAAWYRNRSSSQLVGYQLPAMTGFTSVLANL
DAVVQNTGLEFEASARPLSGKGLQWETSMNISFPRNKLISFPGLEGSTYANQYLIGRPTS
IIKVYHLEGINQTGQYQFTDFNGDGKISSPDDNKVIENIGVKYFGGWNNTLRYKNWDFSF
LIQFVTQRNRNYNNIMPVPGSMNNQPVQVLDVWSPENPNGFYMPYRSGSSASQILFQNSD
AAISDASFIRLKNLQLGYRIPLRDSVLKEVKIYFQGQNLYTWTKYFGIDPEFLFMGFLPP
LRTFSFGAQFNL
>KALACAFP_03643 hypothetical protein
MNKKEKFNEKDPFLLTPQESELLRETVSARIQKMEEKNRWKHLGVAVSLLLLLGIAGFAG
YDRYISPDVYMAQFSPLDMKLADGTVIRLFEGGKLTVEKSFPGETRDVYLEGNAVFRVAK
SKEHPFIVHGTDYATTVLGTVFKVTQQKGAFKVDLYEGKVSVTKNGDKEEIYILSPNETF
TNYGTQKIAAIVPLKQAPLPSAQNEIKAPEIISLQFKECRFADAVKVIEEVYHIKVLFPK
EYSDKLVTTRLTDMSPDIVMQSLALSMRLELQQHGTTYQLEK
>KALACAFP_03644 DNA polymerase III subunit alpha
MFLNCHSYHSLRYGTLPLEELVRQAHESGARELVLTDINTITGIYDFKKECEKYGIKPIA
GVEIRKEDRLLYVAIAREFKGIGEINRMITDYHCEGKDLSETAPVLKNVFIVYPKENIPE
HLRENEFIGIREEELTLLIRPELKKLIHKMVVWHPITFSTKKQYNLHRILRAIDKNILLS
KQQETDYCRYSEVFKPVDSIKRAYESYPEIVDNTCRILSECRFDFEFSTPRNKKYYTRSK
EDDRKLLSRLAFSGLEKRYGSDHKKARERVEKELKVIDQLNFSGYFLVTWDIVRYSNSMG
FMHVGRGSGANSIIAYCLGITDICPLELDLYFERFLNLNRKSPPDFDIDWSWQERDTILQ
YIFDRYGKDYVAFCGTNVEFKYRSIFREVGKVFGLPKEELDDLATKPIESHDQNSVVRLV
QEYGKLLEKFPNQRSMHSCGILISEEPITNFTALEMPPKGFPIVQFDMHVAEDIGFEKFD
ILSQRGLGTINDTVKLIRKNKGTIVDIRDTTLSKNEQKTNEYLAQGRTIGCFYIESPAMR
GLLRRLKCEDYRTLVAASSIIRPGVAQSGMMREYIFRHNNPDKFEYFHQVFKEQLGETYG
IMVYQEDVIKIALYYGGLEAADGDILRRAMSGKGRSLSALQKVKDHFFESCSRQGHPEAL
SKEVYRQIESFAGYSFCKAHSASYAVESYQSLYLKVYYPLEFMVSVINNMGGFYRTEVYV
HEARMSGGIIQNPCVNTSEYQTTLQGNDIYLGFQHLQGLETAIAQGISDERNNNGNYKSL
DDFIRRIPIGVETLQLLIFIGAFRFTGKPKNELLVQARLLQSTFKPESRGLVLIEEPVKE
YQLPQLKREPFEDAFDELELLGFPVSCSPFDLLKTGYRGDVLVKDLLQYHKKQVKMLAYL
ISRKHVPTKKGTMYFGTWIDSNGDYFDTAHFPDNLKTYPFQGGGCYLLLGTVEVDFHFPT
ITIQKMAKMPFIPDPRYAYDKEKQYDIHRQIREDVSMTHREPYPQQHEIGLPRNKMNGLE
>KALACAFP_03645 DNA polymerase IV
MNRAIVHMDMDTFFVSCERLLNSKLNGIPLIIGGGDRGVVASCSYEARKFGVRSAMPIRM
AQRLCPDVKIIKGDHEMYSKLSHTVTEIIQEKVPVMEKASIDEFYLDLSGMDKFYGCYQW
TQEIASTVTRETGLPISFALSTNKTVSKIGTSEAKPVGRLEIKEHEVKPFLNPLSIRKIP
MVGDATFRLLSRIGIRTIQTLSEMPAEVLEQMIGKNGTELWKKANGIDENPVVPYSERKS
ISTERTFSTDTMDVTALRVLISGMAEQLAYQLRKEKWLTSTVVIKIRYANFDTETKQCRV
SYTSADHTLSRVALDLFNKAYTRRMRLRLVGLRFTGLVHGLHQMNLFEDTAEMISLYQSM
DHIKNRFGSQAVGRASGFDFDNKH
>KALACAFP_03646 HTH-type transcriptional regulator Xre
MSIFSDNIRFLRTQKNLSQQEIADDLSMSRVRYSKYEDGRSEAPYEILIRISKYVNISID
LLLTVDIRKYSLENILKLPDNRIVLPVIVDPEGNNFIEIIPHKASMGYLTGYSDPGYIES
LQRISLPFLSNGKYRAFPADGDSMPPFMDGSYIIGKYVEKLQDLKPGKAYIFVTRNEGIT
YKTLMSGNKKSITVCADNSFYDPYEILLSDILEVWLYVWGLLPEDYRKYNSTDSMSVQDM
FLELRKDIKKLNEKL
>KALACAFP_03647 hypothetical protein
MPDGIIKMFSFRKTYDNFFKEVFERYSQMIFSYILEKVGDRVDALDIAQEVFVHLWKYRK
SIKQDGKDRGLIIKACRQEIYKFYKSGYQQMRTQTISLENTESTLIDCSVEELEYKIEKE
ERLEQLYAALELIPARRKEIFLKNKLEGKTRKEIAVEMKMSGSAIGNQIDKAMQFLIGKL
RR
>KALACAFP_03648 Single-stranded DNA-binding protein B
MKRFNTNTGRKVKRNSTSSHYRINREKSGSLKVTETAQDSAEINLHKFTNLKINIMNIIG
RLTKDAKVYTTSKDKQVVNFSLAVNDSYRNKQGERIEQTAFFDCAYWLSTGVAQHLTKGT
LVELSGRVSARAWTNANGEIRAGLNFHTSEIKFYTGSKKSQTSQDTAGSENSNVVAYGIT
DDLPF
>KALACAFP_03649 hypothetical protein
MAHNLNFNERTGRYSFFSVKEKAWHNLGQVVDQYPTSEEAIRHAGLDYEVLKTPLYTKGS
GIIETAGGIEIVSNELHVPDYFANIRTDNNTVLGVVGKDYQIVQNREAFSFFDAIVGSGE
GILYETAGALGQGERIFITAKLPDYIRVGNGDDVTEKYIFLTTSHDGSGSITAAFTPIRI
VCQNTLNASLRNMTNVVRIKHTAGAKQRLEDAHKVMGLANTMSNQLEGIFNNWAKVKIND
SEVRKLIQLALCPNKETFDLLAKGAEDEISTLFKNTVEDAFAYAMTSDTQQMETTKGTLF
GAYNAVTGYYQNVRNYKNDEAKLQSIVLGGTAQAKTQKAFELCTAFALEGTDTLNFN
>KALACAFP_03650 hypothetical protein
MENQFQFRIQNLLSQKGDTISAPTSPMLFAQDMAKLGDEKFNRLARVWFEDETIHQYWEG
DGYTGHDTLIIGTQYKNDMHLGLWVDEGVRGVPVAMAFQSDKEAIITPVYKKKEYHKKLS
EEQIQEIFNYLFDNTHLLEIRQDTDITDESNSNQ
>KALACAFP_03651 hypothetical protein
MITKINWFGIENLMYYKGKNKKMMAPPEALHFAREMTFPNHEAFNRLAKIWFEDKTIFQY
KIDGELTSHEVYMIGDRLSETRLTLTLWVDEGDKGVPVARAYQTKRDIYIMQAYEEKNYY
YKPSKAQIQEIFNYLFDNPNRLEINRFER
>KALACAFP_03652 hypothetical protein
MTRANLHIILSNGKSIICVAENSSAPEQGYIVEQVILPLLSMEDSEKELELLAEHCTMDE
RRANATYRYTIDLTTKEVRLFEENFNYRKEAFHKGKEITHRYNDYLEALDR
>KALACAFP_03653 hypothetical protein
MKQNANEKRYDTREKRIQFLKSKGSIITFKSPFYPRGTANGSRIQIIVERINEQRTGGIK
IVGEFYDSDWYDSFDDLLNAIDWDEMEVMHSF
>KALACAFP_03654 hypothetical protein
MKITDLNGYQIEIPDLNRAIQMAEFFKDAGHSPPHPTDKERQEYWRDFHEKLLKLKVKKV
NQNEQPRQ
>KALACAFP_03655 hypothetical protein
MSNLANKTEYKALNIIARMVKEFERLHYLDMTKIDDFDATLARNLLESIIHSNGFKVNYN
KNTKKPLIKQQ
>KALACAFP_03656 hypothetical protein
MNTQFFNQIGEMNLNGTILLTIAKGVENNLIVSVTLQNDGCGDDAKNIIPPLTLKGTADE
LDSGFFERITTPLQTTSGLLDNMEEYMKKLDETRKNSAMEKEKTDKEKKVQDDKEKKYKE
AMSKADALEKEGKYKEAWTALPKTSEYPDHAEIIRKRQNDFARKFAPSFFDQETAE
>KALACAFP_03657 hypothetical protein
MLLATQLERVFIFKDKDQEITLTDPEPKWSTQAVLNFYSNTYPILTTAKISAPIIKDDTI
QYRFESVIGTKG
>KALACAFP_03658 hypothetical protein
MNYDTCYNGNDTASPKPKAKKTALPIGRIHPMDGKTQRRGRDQKGQTAVRPCLNAPHAFL
RTAFLPRLEETEFVQDSNKMVITERDFYKSLSHLSEHYGMEIIPTQSLSYPMNVAMALRD
AEEKLKSKVKEFGKIRLLKDEEKTYLTIEEHYDTGACLYYIPVVPLYRMLNDSKHRASAI
LLLSVCTYLYHIADIPYYRQEDSYLFWQYDILKDWIMQDEPEENADYMGEIDQAEMIGTY
MEKKIFNLSNLTYFEKRLTSFKAKDLIDWDCLKVAEKAFHLYQQYPNETVFRNISTNEEL
EEEEQDEMVAMDRYVSFYADSKGWLSEQLEQMINNELQEYGELEEPALIKKFDGNPITEG
SLDFEKRLFALMEELAFLLNHY
>KALACAFP_03659 hypothetical protein
MNDITEQFTSLYHPTSALIVYQSVAKYDSANTYIEHFDIDRNGTLVNAHPLTIREAGRLS
KALKIQQEKETFLTPKDIIGKHILYLDAVKSKAVWFTPTKKRQLLFTEKLGIQQGEAFLP
SLLWSADRNHLSVFALISNRRPTLKATLYNAPFFNVYESGNVCMGTVDIRIQKTASLEEF
TTAWEEYFFNSYFSHLMGDYNPIKGNCVSLWEELISTGKAFPKEVLKKSIIPLKSLLQ
>KALACAFP_03660 hypothetical protein
MIPEITKVHFTDTDLINPTNPITINVIGSGGTGSKVLTALLEMHQSLIALGHAGLSVRLW
DDDTITEANIGRQRFASCELGLYKSVALINRANRWTGTNWKAETKKFSWERQNYYPENVE
ADIYISCVDSVKARFEIAYMLTSKRRHNSKLKYLIDFGNSKDSGQVILSTIGNIRQPTSK
KYETVANLPLVTEEFADLLQQSEAEDDTPSCSLAEALEKQDLYINGALAQLGCSLLWGLF
RNGLTFYRGFFLNLKDFRSQPIPLP
>KALACAFP_03661 hypothetical protein
MKRAKIVLAGVALFAVIGGAFAFKASRVPQPLFTENAAGICNVPTTLFLTLTPPTPGQLP
ITTTDLYYTTRLTTSCPLTTWYTIN
>KALACAFP_03662 hypothetical protein
MKRAKIILFATVLLAVVGGTVAFKATRIPQQLYFNNAAGICTLPTTLPLTLQPQIPGQPI
FTVTNLYYTTRLNTSCPLTTWYTIN
>KALACAFP_03663 Dipeptidyl-peptidase 5
MIVTLNRLAKNWHFLLYILSFFCGSAQHKVIEFSDIKNWPVLDYPSLSPDGQYAAYLIRS
DAGPTSRLCVRSFDQSAAFEIENVRDFNFAMNSRFLVYSVEGKESITIVDLNTQNRKEID
SVRSYQFIRDRTNDWLLMLKSGLSNVMAALNLSTGKHFEYDSIASIRFWAEGRRLIVEKK
SDSVVTLEHINLRDGIQRTIWSGKKVQSFESNERTLQFFTRTEDQSGNLYVDVYQLTEQS
VNHLFRRRLDSLNVKVERIQGLSKDSRFLFFYARNPLETNGYTKDTLQRYVRIWSYLDQQ
LKTVRDQTHGRIQYYLYAVSLSDGAVHRIEQPNEQAAEIGPGKILIRKQEGDCHVSDANW
NKACSHGYYLLSTTDFKRSHIPALDNQQVSASPEGKYLLYFDYRLKAYYAYSISTGQIYP
VTKGINGATWTSHASKVVRGVAGWLPDDQLVLLYDRYDIYAFDPTGKKDGYCLTDGIGEK
TKTVFALSFNQTGLRPFKNRNELLLTALNTVNKDNGFYKVTIGGDLQKLSFGPYLFDVSQ
VKSGTDFPPAECNFVPVKAQFADVYLIKRMTASEFGNLYLTKDFIHLKKISDLHPERGFN
WYTSELHSWRRPDSTLAQGILYKPYDFDSTKKYPVIFHYYDRKSDGLHAYITPDALYYGA
SINIPYYVSRGYLVALVDIDFKTGYTGKSALQTLESAAGYFGEFAYVDSTRLGIEGFSFA
GYLTYYLVTHTKKFAAASAGAGLTDLISQFGTLSLNTFSQHELSQYRMGSMLWERPDLFV
ENSPVMVSSNIETPLLMMNTTHDGLIGIGQSIELFTALRRQGKKVWFLEYLEGIHGVGGE
SALDYCVRQQEFFDHYLKGKPMPEWMTKEN
>KALACAFP_03664 Beta-galactosidase
MISVRNFARVLLIATSSTGYCFGQKAKEWRAADVAVKTIWADSVTPGNVYREYPRPQMVR
KGNWTNLNGLWQIAFSDTSAQEPSRYTKEILVPFPVESALSGIKEKLSPNQFLWYRRKFR
HSFQNTDKVLLHFGAVDYKAWVFINGKEVGMHEGGYTSFSFDISKYLVKGDNDIVVKVYD
PTNIGKGPHGKQVLTPGNIYYTASSGIWQTVWVETVPENFINSYTIKSRVDVGTVECSVK
SPEDGVVEVIIKDGNSVVARGRGKSNQQIRIPLVSPKLWWPDAPFLYTLSIKLIGNHKTK
DSVSGYFGFREVSIAKDASGISRIFLNNKYIFNHGVLDQGFWPEGLYTAPTASAMEFDVK
AIKQMGYNTIRKHIKVEPELWYYYADKLGLLVWQDMVNPNQGLPEGAKAAFEKQSVEIVH
QLYNHPSIIMWVVFNERWGQFDQKRVCDMIRSNDPTRIINGHSGEYLYVDNKLRESSKEP
YTGSDVTDVHSYPFPKLGMKLEGKAQVCGEYGGTGVSITGHQWDDLKGWGYIQASVRDLK
LKYSAMIDSVKRLESEGLSGSIYTEPFDVEGEENGLMTYDRKVIKIHPAELWEINRKLTG
EGTQSPFTSVLGSVTYDADIEAKKYEVLSRLYENGRKDSVLLRQLTLRAFRDSNWVKARQ
LTGEYLSIIRDPYSVGNLTFLVFVTVSVKDPGFNVFLNNTQQINATLGANYAEGMIRRWV
YRSEIKPVIDAGHSDSLESMIPVISNKYGVVGAEKLYGELMMYYFGKKNWEKFGKYYSLY
YQTAITRSEYHINNISWPVVEHIEDPLVLQTALVTMKYNIDKFSQDNPYDADTYAGILFK
IGMKNDAIRWAEKAVKLSNNQAQFVTNRDKLRLGQKTW
>KALACAFP_03665 SusD-like protein
MKKTFHYKNNIRVVGLALFLAVTGCTKLVEVDPPLTSISGDVVFTSDATAISAVNAIYTT
MSSQGMNNGLTSLSQFAGLSADEFKVADNVSDQLYTSYYTNSLTSTNTTGNDFWMNIYSS
YLFIVNSSIEGLTDNALVSEAVRNQLLGECFFLRAFSYFYLVNLYGDVPLVLSSDYKKNS
NIGRSPKAKVYDQIVTDLKNAETLLNTNYVDNSKVTSTSKRVVPNKAAAKALLSRVYLYG
KDWGNAENKASEVIEDKGLYDTVPVHAVFLVDSKEVIWQIQSVSDIYTNAAEAYLFKLPP
TGPDPYSYRVYLSENINQYISYDDKRRSWVDSVMVGSLVYYFPVKYKNNESFSPVTEYSV
VMRLAELYLIRSEARTHLNKTIEALSDLNVIRQRAGVASIQSGSQDQILNKILQERRSEL
FTEWGHRWLDLKRTGKATAILQPVKGASWTINDELYPIPQADININLGLRGQQNPGY
>KALACAFP_03666 TonB-dependent receptor SusC
MQTIVKPAQTCLCLLILLLLLLYPDLQMKGYSSTFQDKISISVRDASLADLLRQIAKKAE
TTIWFKNDDVSSYRGISYEAKNKTVDEILHQLLDNKGFLVTDLGNNSFGIKKKTETNLMA
APMDTIALVRGKITDERGTPLIGANILIKGTGKGASTGNDGSFMISNVKISSRTAVVSMV
GYSTIESQIPGSNFLSVSLKAVSSILDEAIIVAYGTKIKRFATENTISIKSKDIENQPVG
NPMLALQGRVPGLMIEQASGFAGSGVKVRLQGQNSISRGNDPFYVIDGVPYQSQLLPNFG
SILGTSGSASAIPGNPLAFINPADIESIDILKDADATAIYGARAANGAILITTKKGKAGT
MHVSLNVQTGYGQVPRRLQLLNTAQYIAMRKETKMNDGQPIGDNDFDINGTWSDKTEHDW
QKELIGGKANYNDAQVSLSGGSSNVQYLVGTGFHRETTVFPTDLADKKINVHFNVSTSSN
DRRFSATFSGSFLNDDNRLPNIDLTKNAMTLAPNAPDLRKPDGSLNWGVNDRGYSTLGTS
HPLAKITALYKSKTDNVIANAALNYNILRTLTFKTNIGYNSLSTDELITNPVSVWAPEYA
VYVTRTASYGNNTVKTWLVEPQLSFEHQFSTSKLSALAGATVQQMNSNRKLINGTGYASD
GVLENVGAATSVSIPPGFTIISRYKYNAGFFRINYNLEDKYILNLSGRRDGSSRYGSANR
FHNFGAVGAAWLFSSEKFFSSLSKVIDFGKIRMSYGITGNDQIGDYTYLSLYNYNTPPVP
YGGGSSLIQNKLSNPYVQWEETKKLSLGLDLGLFSDRILLTGNYFSNRSSNLIYFAQLPS
TAGPRYLDVNLPAVVRNSGLEVLVNTVNISKKDFKWSSTFNITVSRNRLKRFDDLSTSIY
ATDFVIGQPINILKAYAYRGVDSKDGYYRYADQKGDLTDDPNADPANRTVVINRDPKFFG
GFGNTISYKGIQLDFLFQFVKQVAPRYWPEIPGVNMVNQPASLLDRWQKPGDIKPFQKVT
ATDFKTIGAYYNMFNSDAFYVDGSYIRLKNVSLSWTLPASFRKGLSLENGRVFINAQNVL
TITSYKGLDPESQSSVSLPPLRVLTAGFQLTF
>KALACAFP_03667 ECF RNA polymerase sigma factor SigW
MSTKGERYYTYHDDQKILQGIASGEEKALEAAIDRYQPAMIIEAFHLLQDLQEAEDIIQE
IFIRIWENRDAFSKKGYSSIGPYLLRATRNKCLDKIAHNKITNKRKAFFSQNLSPSHQYD
PSEIKELRALLHSAIESLPPKTRNSFKKLYEEELSQKEIARQEDLSLQTVKNTISNALRI
LREKLKPFR
>KALACAFP_03668 hypothetical protein
MENQLEHIRFLVTKEILGTLSQEERNFLMEEVAKNPDAEETREDLLTVAQNPELLAYLHS
ERPAKQSALILDRLFARSRKVRIIYSIAAASAAAIALFFIIPQTLHLKSGKSNPSLVENQ
SVPATGKSVQLSLSAGQTIDLTEDTTEFTIGEQKMKTTGKTLTYQPSGRNEKSYATLNVP
AGKDYILKLPDGSQVHLNSVSSIRFPLAFDENFREIQITGEAYIKVAPSAKAPFRVKLQG
ETIDVLGTEFNVNCYDSLRHTISLVAGKVRVHTEKNHIELTPGLEAVAGEDGFTSRAFDR
YITLGWLDGRYILNNTTLEEVCTIIRRLYGVALQVENKALLQNRFTGRIIKGQPLEQVLR
GLASTSGINYDQDVQGTYHIR
>KALACAFP_03669 hypothetical protein
MVTLNLDHETLIQYLQSADLTLKSMAFQSIFYSYYQREINYAFLLLDEIEDARDIGQLTF
LQFWQLAKYSHIDSFTGYIRRMTHTNCLRTLKERASFKSNQAEYLRNSPAYEKASFDQAP
ELKAAIEKAIDSLRPSHRMAFQLYYIQNMRQKDGAEMMGVTTQNFKNYIHLAVANLRTQL
SSFFDL
>KALACAFP_03670 hypothetical protein
MDKHLFDENRFTEILTRKLSGTALTEEEAYYFKSNLISDDPFVSRRCQEIIAEVTAKQPL
PSTSPAHELDMEKEYEQMLSTLHSKKNTSHKFIIIIVLLIFILLCIAAFFLFLL
>KALACAFP_03671 Adaptive-response sensory-kinase SasA
MVKTTEESCLTEPYQQVSRLMHQGDTFSDLLTTALIDLRQFLELLRNSSDNSSRQIGNIT
YGKVTNMLHMALQMKASIGDPNKDWYEVCVKRECNSKEELESIAGIFSEAAKLKNYHFHY
SISQEIPEWIYTDQILLARILLSWLENIDHFSNAHDRIAMQVFIEHNEYLCIKITDTAGG
LERLEIEQLFSENRLGTNGRAAYGRGLFLYQKMASSLKGKIQITPTISGLEFYLYLPYQK
P
>KALACAFP_03672 hypothetical protein
MFFKFLFGSSDKQTAILKSFDIKTLLHIKRNIVKCSDILQSVTANAKVYKAAGILAKDGQ
GKAIDITDIDQIGLTILLLETTEYLIETRIILLAVKTNNPLSLDDDLFDLKFMIIRLMHL
FEKGAAEREVVMEKARITDVEFVQSDAKKIRYILMTLLQIVIQYAKPEESITTTAFRHDE
FFCFYVTTSLDRQEVSHKTPLSNEAIKKDIRAQFQDGIQLTEKYIELIGGRLGLVESNAE
KNSNEVKFIVELSIFKV
>KALACAFP_03673 hypothetical protein
MVRLIHIFTHLRFSNKSRRLALQELKRMHLIGLLEIKKLAEISNSTTKEMEQIYEKLMIG
KKEKQDPLVSMVQGHTTLLTNCYRRITDLTKDFISTSLLHTSYEANIMADSFHFEHLLDL
VLEAAKPHALEKKLVIYTTIDRNLRTISIDPIKTGSVLIPIIDLGIFYAATGSAIRITAS
KSDRQLSFSIILSVDPNRPHAKEELLSEGTLFEASPIFHLHGIFLVKEELKLHGESFTIT
ESGFRTGKELICITAVMKNQQENTPAGSQQPACNNESGRLFRNGF
>KALACAFP_03674 hypothetical protein
MQYHKVIFFVIIVNLQVSVVHSQTKNLKETYPNTEKHYKSSADNTTCLLDDDHLYGYSDD
SLRLVELSGRAVIHIEPGLKDFVISLSDHKIVIPANEKADIYINSRDFRLISAYLLTGHA
YWIYPHHVYYLSQGTGIYLQQKVYHHDSTPHIFTEYKKWLEGVYLYDDITLEELADEMAG
KYNIQIPIVDPPLKSQRICIGFENSTSLLKLLNRLSLILDIEYALDENNIIRFSVKNRKK
DVGKSKIKSSAQ
>KALACAFP_03675 hypothetical protein
MFFNTFLRGSLFSLLLIILQACNDLRSPRPNSEPTGDTATRIIHNEGGTILVDSLHKNLR
VYLKHHTKLSYPRNNPDVQHVSGEAYIEKDSTPASNGITVVFGETAALLTGYCYFNISPL
TCLKHAHSTTQNKVDLITIFRGYAWVKNHKRPAFYLRENEQALVYPDTIIISSIRKDNHE
KN
>KALACAFP_03676 hypothetical protein
MKRISLTLLLCASLTSCFKMEGSRQIGTSSRIISFPIQQGISATLNTHSGIHYELGGNGV
IYFGGEGQFIIDKESAEGTPLIIDIEGVRLTCEDGEFYLTTYNLVDGPGNGKPGSAKLTV
LQGKVRVQNAGPDIIVEKEGVRIFKDSVSTMINWQPEEHTYWANGFYKFKQVPLYECKGI
LTRWFDLKVGLDANDADSLVRDLYLKPYEEIAQQLHQLEQNNNYTFTFYSKDSITIRHK
>KALACAFP_03677 hypothetical protein
MYTRIINQYMKHCFLWLIAAFLPFLFLGCEKPDLYNTSTAENTPMIAALDNGFRIMINKH
SELRCRARDARVFIKGGAFVKVDSAERAHTPVQIVLGDVELETTDAELNIDSYDLSSGKG
KLTILKGLVKFKNKLIDTSLTSGGFWFGSNRLDSTIDWQPELEIKWLDNLYRFGSLNVHD
LAYGLNLFYRVETDYKEIEEDPSAIFLDVNFDIREPVTVFLERLQKNTEFKIDYTRYYST
VTITKQ
>KALACAFP_03678 hypothetical protein
MIQVCSFRSRNELIPTIAISDVKSVKATLGWLSQFLKNNLPKMKYTPILILFILLTGTAY
SQRPRSLANPEDKKYFLDQLEKIVSNKLSFLKGKVNRNAESFMHHKDTFYLHIPTLPESE
EAMLKELEGRGSTFAFLFWNDLLKEFPEFKVFSLSAPCDRGKTVTVDYNYNKDGTLSIFS
KLQKRWITLQCSSDK
>KALACAFP_03679 hypothetical protein
MKLLFLIVFTLTFNGIQAQKKRSLTNPNDRKYFYEQLKKIWEGTEALGSNTIQDKNDKLT
SDTFPLILDITSPKPIEVDHHFEEFGAHLAYLFWAQLLKDFSQFQFFSLQLTDQRGQKTS
LTFHYLGKKELEYYSRLQQQVVKIKFNEVK
>KALACAFP_03680 hypothetical protein
MNYEEFSAEKCQSLLHIQEQFKEKINLDSYKNWFYDGESELLRLYNSDEDEIYFRYVPIG
TFSLKLRTWMWSWFNTSSIEKSKSQLLAIKEFGVQNNYEKLKEGTFPADEFDGWELSAIC
LHLLNGIGVYKVNSGELEKYMLLMQIENRDSPEVIKFKKQTIECGKHGYSRPAFVCQHLD
LETPKGFEEAFDTEKGMELGEEDDFQAWCSDCEKIRLQHDGWNEESEKHTGITLICENCY
FELKDFNLTR
>KALACAFP_03681 hypothetical protein
MRIQYKEIDIKVSESYLSTKGLSNFIGKEIRINLGGQLQEDYVEVMRYMIDYIIGSHPTI
VENQTIGYYSWLLKFKINEQNQFDLYEVNADGSGFNRGCDLTISVVKSQSELCSKYGLIP
MFPNFNQMVVISDGVYEGKDLEAIRYESPEHMSGWWLIADEYDDNIESLKTVHYHHVAFN
RPDILKYLALPFDYRFLMDNGRVEISQDEEEDPWLINKRL
>KALACAFP_03682 hypothetical protein
MADTSKKIENILKMSEDERYDYFIRKVADFEEIWGLSDNGWALLGDNAGNQILPLWPEKE
FAELCAIDQWKGYKPEVIQLDNFIEKWIPGMLNDKTLINVFLIPNGKGIVISPDDLNSDL
QEELEQYE
>KALACAFP_03683 hypothetical protein
MKIVIIFLASFVFINCEKAIGNKRLNCIDFKIGKFQLINKDSKKKYLIERTKDFQIEQTF
DLSTNKKIRKDRYYKIFWINDCEYSLILDTSKSEHDQIDLYINSKGGYKCSIKKIDNNCA
TVQTNVEGDNFISKVCKI
>KALACAFP_03684 hypothetical protein
MENLAVITTKFVLEDNSPIVSVFKDEEGDWQFFGKEKGILEEDARVIKLEEILRIDKSIG
DILAIKNRSHVWREDAG
>KALACAFP_03685 hypothetical protein
MKYKKINGLIYKFENLGIENSSDGAILIGKAPHIAPEAWLNEIFPVLDSKEIKILEEQLK
TDIPEDYKNFLMNFSNGLIFLSSTLSLYGLRRQLNRRSSVDSRQPYSIITSNIPERPDNA
KNSFFFIGGYNWDGSRLYIDKNTNKVHCCERWDATSRIEWNSFQEMLLTELKRLYSYFDD
EGKEIDEDRSTLPY
>KALACAFP_03686 hypothetical protein
MNSKEFENILKLEPLKRYQYFIKKIADFEELWTIIDEDGSYALSDIDNFTLISFWTAEEF
VISNLNEGWENCKPIKLTLEDLQDDLFDIIASENYLINVFPINGKSGFVVSLNEFRRDLD
EELEKIE
>KALACAFP_03687 hypothetical protein
MKKYIITKAFSFLGLLVAGMSYAQSNDNYVQSITCLNDDCTKKSETITYFDGLGRAKQII
NVKGTPTGKDLVTPVTYDGFGRQVKNILPVPVATQNSLIHSGITNESTANSYYGVSNAFT
EKEIENSPLDRVLQQANPGEAWKMSSGKTQKFKYEANTGNEVKAFFTTTSTNTVNGVSNT
VSALSVSSANSGFYPAGTLYKNTVTDEDGNAVVQYQNGRGQTVLIRRNDGSQNIDTYYVF
NEYNQQAFIIPPKAVKQIEQNNNIITDNILNELCYQYRYDGLDRQVEKKLPGKDWEYSVY
DKQDRLVLTQDGLLRTVNNNFNSKGWIFNKYDESGRVVYTGFYPNSDSRQTIQNQVNTIT
TSSLNNETRITNPIVLSGTNLYYRNLAFPSAGITLLTVNYYDSYPSEAPPIPQTILGQYV
LPQTLDANNDASTNGILTASYVKNIEDNNWTKAYNYYDSMGRLISTSTINHLGGYTKTET
ELDFAGVPQKKNTYHLRKQGETGVTVQERFVYDSQNRLLQHFHQVDSNPEELLAENSYND
LSQLINKKVGAVSGSAPLQSIDYDYNIRGWLTDVNKNQMGVSDLSGKLFSYKIKYTNRDG
IENPDPAQFSGKNVLPKYNGNIAEVDWRAVETLGVNPSATPKRYGYAYDKLDRLTAGFYQ
NPNNPYSKENTESLSYDPNGNIANLYRTSVMEYGGNTATVIDNLDYTYLGNQAIKIQDNS
GNSTGYEGTAGNPIDFDVNGNMKNMIDKSIASIGYNYLNRPNSVNINLGQVTTDIATKYR
ADGIKVRKETTKSSIGIGGTTSSKETTDYLDGFQYYNITGGNDGGGGSESRMITRAFEPQ
AFTPIEIADPTIQPIGGEWTGSLTPTKTPDLQFFPTEEGFYDYVKNQYIYQYKDHLGNVR
VSFARNSAGALTIVDSNDYYPFGMNHLKTGNAYFGQSSFKNYKFGKKELQEFGAYDFEAR
LYWQEVERFGQIDAEAEEMPYISPYAFGLNNPIKFTDPDGNAPEETVENCCQHLKGFALT
VTDNILGTNLRNKYAVNSKEYRDGVNNGHGATIALSAIMAVDGGASIGGGTAGLAVSGAA
SSTGVGSIPGAAGATISGGAILKGTIEVAGAGVILKNTIDHMKSDKNNSSASSNKGRSGK
QARLRELSTDPKLGKADKGWLKSDINKVTKGKRTTIRNPPGKDLAHERGREAAKGYSYEY
SNLQDRVLHRRQHKYDNGGRKNKERPVKKD
>KALACAFP_03688 hypothetical protein
MKKIIIAIGLIATQFCYAQTQDEDFLPKIVPSSPQASELGKYGNVPIGMFTGSPNINLNI
YTLEEGGISVPVNATYNSNGVQVDGVSKQLGIDWNLIAGGVISRQVNDLDDLQFPFYNVN
TNDLCNVNSPEATLISTGTADTEKDIFSFSFSGGAGKFFFDGNSIIQINPSNIKIEKLAS
PNNSTPKFKITDTDGTEYYYGGESAVESSFNRSYCGGVVPPVLNDTSWYLTKIKTVEGQE
VSFSYLKENFQYKQSYYQTAIAGGTSFSLSNAVLQTPCYNELRHEVPFLQEVMINNKKLK
FNYQKIDVNSTESKQLISVEVYNGLSLLKTYTFSYDSFVSPAVSTSLFNAYTNANEKHIF
LKDIKEITPSNESITRYSFDYYSPDELAPRHSFAKDIYGYLNGANNQNIIYNNAVNTDPI
NNTDAVYHAFKNISSNRKPDFEYTRKGMLKNIYYPTKGRTEFIYEANSILRDKTITPPAQ
NLADVTISESVGYGYEAFSQVFTVTGSVTATLYAVAWRDCGEDDPVHPPQVTATIINADT
GAIIKSLSTNETPANTAVNLVAGVNYKIKSKVLRPCLGANAFVQAPAGAPYAIKVNEPAG
GVRVAKTLDYDNSGNIHTKKYYYGTLQNLEQSSGIPATMDPNYMRNVDHTIKDSQEKYVM
YSNFKTSVFSLDGYSIMYPTVIESFGENFERGGIVNEFNAAQDGVPVPICEELIRGTAFT
NSLVAGNPLKKNTIRKEGTGFITLRSEEYLYSRNPVFDKEIDNFVGKLYKRITDTDTSDG
TQMPDQNSYSVNSYQTRSEFNYLSSKKIFEYDTNGLNPIKTELHYFYNNPLHFGITKEKN
IQPDAVVNETSYSYAHEKSNQLMIDRNMIGIPLETTETQTNGSVTKTLEREETIYPTSLP
TTQAGNLVLPLSKKSYDVLSNISSTDVTFDKYDDKGNIVQYTTKDGVPVTIIWGYNKTEP
IVKVEGLTYAQVSALSSTSAIISASDSDASDPTKENLLLDALNGFRKESALAGKQVSTYT
YDPLIGVTSITPPSGIRQIFVYDSFGTLKDGNVRMKNTSGTNIIKTVKKNKYQYKQ
>KALACAFP_03689 hypothetical protein
MKKNYVGAFIICAMTNFYSQQVVWQKDIKSSTQDFLSQVTTTIDGQYLITGSSIQSEKLQ
GDNKQNNGFDYHLIKLNQQGEQVWEKYFVGNNHDYVTATVALQDGGFLLSGTSFSGKNHN
KKEDSKGGSDLWLVRVNEFGDEMWQKTIGTRADEEARSVIQTTDLGFFVAGNVQNSSKGY
GSKDVLVIRLDKDGKELSQVILGSKALDEVTKMIPTKDGGALLGIYSRGNIGGTKKTENY
GEGDFWVIKISKDGKLEWEKNFGGKEDDHLRTLALTSTGYVIGGESRSERSGNKSIGITE
GTDLWIISLDEKGNEQWQKSYNFGGRDILMGMSVLHSSDDKTSKGMLLGGYTQAEGDIKT
DDEKFWMLYLDQDGKEQWRKYVKGESSKREERLSDLKLNRDGSIILAGTSAEELGKENWK
IVKLGDKQIDQLIEKQDIKIYPNPVSDYCYVEIGFDFQDADILLYDMSGRQLQSLKTKNK
VTKINTQSLIQGAYLITIKTDTNKTANAKLIKK
>KALACAFP_03690 hypothetical protein
MRINIKTCSIGKLKLLLFFLITVMFTSSCEKELEIQTNFPFELEVMPVPTELGGEETVEI
LCHIKREGQYNAVQYSIRYFQYEGQGALMFPSYKPFKPNFSYLIPEDTFTLYYKTKSKGS
HEFQIWVYDNFGNEKTMEFSFDF
>KALACAFP_03691 hypothetical protein
MSSAISHAQRLLPGQKGLELSAGIVSGRKPMHDFLFARVGMTINKRKGNYQFLAVEYNHK
KKVFETIGIPIETYTLEGGYILYVLGDWRKTFSVNLGLFAVGGYEVINKSNKLLSNGALI
LNDDRFVYGGGMNLSIETYLGDRVIILLRGHAKYLLGTSVEHVRPGLGLGIRYIF
>KALACAFP_03692 hypothetical protein
MKKIQTTILLILILLLMVPIGLKAQTDTIRVPADTVAAPPDTAYGKIASHELLVTYDKTT
HIIFPSAIRYVDLGSENITAGKAEEAENVLRVKAAVKNFENGCNLSVITEDGKFYNFNVW
FSEYPDVLTLNFASGEHLNKDQVERQGQNTVIFKELGTRQATVPGLVMKTLYQQSKAIIR
HIGSESFGIQILLKGIFTLDGQLYFVLQFKNATHIPFAIDFISFKVLDKKIAKRTVMQER
VIKPLREYLELSQVDGTSVQKNVYLLEQMTIPDDKLLVIEIYEKNGGRHQFLRIENADLV
KARPVKQMHLDFK
>KALACAFP_03693 hypothetical protein
MENNKSTGVFVREASEGRVKEERSPEERRQKLKKLIIYALMAVVCVGCLYLIFRPNKDAK
ELSDAGLNNSVPQADDQVLTGDKEKAYEQELLEKKESERRKAMLSLSDYLNNGTDTSNGY
IEGDAEMENANPTSQGVKNYREIQQTLGSFYQSDPENEKLRRELRELKERNRANDASSQN
TLVQDPVLMMEKSYQMAAKYLPQLMPQKTNTDTVKKATPPTERYVEPVYTAKKNVVSSLY
RANEQSDQDFAASVLQGAEKRFFDGHSSESSFQSQILRNSIRACVHQTKTVTMGSSVSLR
LLEGARIARMTLPAGTLLTAMAKLQDGRLGLQITSVEFKGNIVPVDLSAYDLDGQAGLNL
LYSPDVNAMKEIASGMSTSAGTNIVLSSSTGQQLISDLTKGIVQGTTGYISKRIGTSQVT
VKAGYLLFLVPKK
>KALACAFP_03694 hypothetical protein
MNNKNISKKIKIGNLPSRINAWCNTLNERQRIRLILLLSAIYFLMTVTVLTWIYFDEDEK
KEIVIKHIQNPAPMFRQSLRIVIPPEVDSVSTFKKIDYGKQ
>KALACAFP_03695 hypothetical protein
MKSTQHRDALIDAFQRKGFTNMFMSERDSPGTLKEIIDDYLKSIKDTKAETIPDLWLSTY
LHWNGEDQSYIVCNLWMNLQKENPVISKMITEKKNGQAAPLNKSELINISIDSLPTTKEL
MALVESSYQKKGKSRRL
>KALACAFP_03696 hypothetical protein
MEFKILRNIENSFKQTRLFAFLFAGLCFSVSVFAIWKSYQFAEAQRQKIYVLDKGKSLML
ALSQDAKINRPVEAHEHVKRFHELFFTLAPDKTAIESNMKRAFLLSDQSAFNYYKDLSEK
GYYNSLISGNVQQRIEIDSIQCQFNTYPYAVKTYARQYITRSSNITERSLITSCFLVNSV
KSESNPQGFIIEKFNVLENKDLRVVER
>KALACAFP_03697 hypothetical protein
MVLQIEFESLHQVLRSLYDEMMPLCSQMTGVSRGIAGLGALFYVAYRVWQSLSRAEPVDV
FPLLRPFAVGLCVMFFPIIVLGTINSVLSPVVSGTHQILEGQTLDLQKLQAQKDELEKEA
LLRSPETAFLASDEEFDKKLEELGWSPSDIATMAGMYVERGMYSMQKGIRDWFRELVEIL
FQAAALVVDTIRTFFLIVLSILGPLAFALSIWDGFQSTLTQWISRYVSVYLWLPVADLFS
SMLAKIQVLMVENDIEQLSDPNFIPDGSNSAYIIFMLIGIVGYFTIPTVTGWVIQAGGGV
GNFGRNVNQTAMKAGSLAGGAAGAAAGNAMGRIKGGLMDKE
>KALACAFP_03698 hypothetical protein
MKKLMMMLFAVVLLSISQVKAQFVVTDPGNLISGILNSANEIVQTSSTVSNVVKNFKEVE
KVYSQGKEYYDKLKSVNNLVKDARKVQQTVLMVGDISEMYVTNFKKMLSDPNFSPQEVSA
IAFGYSQLLKESSGLLKDLKQIVSGSGLEMNDKERMDLIDQTYKEVKEYYNLVRYYTNKN
ISVSYLRAKKQNDASRVLKLYGTDKLRYW
>KALACAFP_03699 Type IV secretion system protein virB4
MRNTAKITTLESKFPLMAMEDGFLISKEADITACFKVTLPEIFTAASDEYIIIHSAWQKA
VMTLPEYCIVHKQDWFISEKYKPEMDKEDASFLHRSYQQHFNERPFLNHHCYLFITQSSK
ERMRRQSNFSSLCKGVLIPKEKMNRESAYRFAEAVAQFERIMNDSGFVMLTRMNEEEVLG
TEDKKGLLSEYLTLSTVNTGTLEDLCLGAEEMRIGNKRLCLHTLSDTDDLPSKVGPASVY
DKLSTDRSDCMLSFASPVGLLLSCDHMYNQYLFIDNSEENLRKFERSAKNMHSLSRYSRA
NQINKEWIERYLNEAHSFSLTSIRAHFNVMAWSDEPAELKQIKNDVGSALALMECKPRHN
TVDTATLYWAGIPGNAGDFPSEESFYTFIEPALCFFTAETNYQDSPSPFGIKMSDRLTGK
PVHLDISDLPMKRGIITNRNKFILGPSGSGKSFLTNHMVRQYWEQGTHVLLVDTGNSYQG
LCELIKGKTKGKDGIYFTYTEENPIAFNPFYTDDRVFDIEKKESIKTLILTLWKRDDEPP
TRAEEVALSNAVNLYIEFLKKDTSHQPCFNGFYQFVSEEYSKILEEKRVREKDFDLANFL
NVLEPYYKGGEYDYLLNSDKQLDLLSKRFIVFEIDAIKDHRILFPVVTIIIMEVFINKMR
RLKGIRKMILIEEAWKAIAREGMAEYLKYLVKTVRKFFGEMVIVTQEVDDIIHSPIVKES
IINNSDCKILLDQRKYMNRFDEIQSMLGLTDKQRGEILSINQNNDPRRLYKEVWIGLGGT
HSAVYATEVGLECYLAYTTEEAEKHEVMQLASELGGDVEGAIKRIAAEKKSSG
>KALACAFP_03700 hypothetical protein
MSSYNINKGIGRSVEFQGLKAQYLFVFAGGLLGTLILVMILYMAGVSPYLCISIGCIGSS
CIVWQTFHLNRKYGQHGLMKLAGRKKHPKYITSRKAVYRYFHANMKNQDV
>KALACAFP_03701 hypothetical protein
MDKRKKKSLLTGTMLLATTVLMAQGNGSAGINEATQMVTSYFDPATKLIYAIGAVVGLIG
GVKVYNKFSSGDPDTGKTAGSWFGACIFLIVAATILRSFFL
>KALACAFP_03702 Transcriptional regulatory protein YpdB
MKVYLLEDETNILKHLITLIQEIPYLKIVGYSTTVAQARREIRELEPELILADIKLKDGS
SFEVFRDMDLTVPIIFITAYEQFAVDALNLGAFAYLLKPVDETIFKNSIDRCFLKAEEYR
FTRQQLQLSAGYFTDRNPPLRLALKSTAHTQIVNTHDIIYCHSDKGYTTFYIKGENPLMV
SKVIREYEFLLPPGQFLRCHQSYLINVDCIRKYFQEGYIELIDGTLIPVSARKKILVREF
LHKIG
>KALACAFP_03703 putative sensor-like histidine kinase
MFRYCKPFVLQIFILFFVGTSCQKQAGSNSNSSNGFSNKGSRYYLPLILSEDTLDKEERN
ALVKQELLKLQRSGDTGNPYYHYFKGRELELSEYNDSALYHYRQMVADTSENDLAVLKQF
LLFDAGMGNGRVVNSETVTGILHAIRKAEKHRSIFLYRLYDLLAKSYYTQRNIGPCIEYT
NLYFAHHPLRYSPIIRQRYFDISCMLAFSTGKKEAMRRYLDSARTLAQDIGDSLALMRTY
DYESQISSSEGQFGKAVENSRLLFNYLKSHDILQMYAFNNLATSFEYNGQMDSAIHYYKE
AITWSRQHPNTDLLWVYESLAEVYQKERDYKNATWALDSSIRIFGRNVDNAQAEKIEELR
TQFQTEKKDQSIASLQATGRLNRKIISQQRWFFAGGLVITSMIGLYLYNRYRRKLLQERN
EKLLIENKKLRLEQRVLQLQLNPHFVYNSIANLQGLICSGDKREAAAYLRAFSHVMRSTL
ELNREDVIPLKEEIEALENYIHLQQMRFKEAFEYIIETGDIAMEAVLIPPMLLQPFVENA
IEHGFRNIDYKGNLRLSFIQKEDQLHISIYNNGTGVEKAGTSLKKSLSQSIIKERLDTLF
NQEKRLAYFEARPEIMENGKGYLVNLYLPLLQS
>KALACAFP_03704 hypothetical protein
METLILICLVIVIILLLENNVTFRKRLNKKKDPEKPPVVELDIMGEIGAVSRQLVPKPTV
QSHHEDTEPEVNNFSSEIDGEGVDIQIPQEEPDNVYDEGVDLQEEEEEWSGYGIFEGENG
FATGVTFEELSAVGMIIQQDVLEASDKDIAVRIVHKIQGTELFSLLENSMEGASKRMAEL
LDNRLSEGADSGSSNVRKSDLMDFNIGDFV
>KALACAFP_03705 hypothetical protein
MEDNTKKNVQAFEKSGTSELQSYEEMFLQKDSMKKRGDKSIYVRPEFHERLSRIAYVIGG
DKIPLYAYLDNILVKHFEMFKQEIIRDYNSKIKPIF
>KALACAFP_03706 hypothetical protein
MEREVRKKIIPEIDEQMMMSMMADGVKKEGMQQPGEIPAEQVPEKPAGKERGRGKKGGDG
DYEKIFFKKAETNARDGKSVYIHPDFHEKLTRIVQVIGEDKITIYAYLNNVLEYHFQEFG
DQITGSFNNKYKPIL
>KALACAFP_03707 Iron-sulfur cluster carrier protein
MTREHKTVFVAFSSQKGGVGKSVFTALAASTLHYRLGYNVAVYDCDFPQHSIMKMRSRDL
ASVMENEALKRIAYKQFTTINKKAYPIMQHKAEGVLESAYDFMESSAVPIDVIFFDLPGT
VNTPGILQTLAGMNHIFTPITADRVVMESTLVFTQLMQDVVMKKGDTSLKSINLFWNQVD
GRERSPLYDVYDKLIEELGLTLMSCKITSSMRFRKESEGDAKAVFRSTLLPPDEKLMKGC
RLDQFMNLFLRTIQL
>KALACAFP_03708 hypothetical protein
MMQDNRKKEKKGGRKPKNDPAKFRYSISLNAEEHARFLSLFEKSGMKVKAHFITACIFQK
PIKTIKVDKGVMDYYMRLTNLYGQFRAVGVNYNQIVKLLYRHFSEKKAAAFLFKLEKQTI
EMAALCKEIIRLTQEFEAKNMKKED
>KALACAFP_03709 hypothetical protein
MIAKIGRGESLYGALSYNHVKVQQENGQVLFTHNMMETPDGNYSVSQLSRSFEPYLIANR
NTEKPVLHISLNPDPKDQVSDEKYKMMAQQYMREMGYGNQPFVVFKHTDIERTHIHIVSV
CVDEDGKKISDKFEKRRSMKVCRDMEQKYGLIPAIGKEEPETRVLFRPVDYTEGNLKSQM
ASVLRHLPEYYRFQTLGEYNALLSLFNITTEKVEGELHGKPKHGLIYSALDENGKKSGPP
FKASLFGIIAGLETLEKHFSKSKESLKDSEAKLLISNAIALAMKSSVGELDFKELLASQG
INAVIRRNDAGRVYGMTFIDHNSKTVWNGSRFGKEFSANIFNDLWQNGVKSEMDNPHGTS
ALLPTLSGDFLPAEKPHDLFGFLETIGLEAVYDISGFIETTGSLFPNTHGENYEEFAFQK
QMKKKKRKKRL
>KALACAFP_03710 hypothetical protein
MPSEHQYEFHVIERQSFEDLAVANQFIEEKYFNAEPFWIYSYKHKSLFAEVDKILKKRRS
WDQQRDLYGDQESSCLEVCFDDDNYIDSVKLRIDFGVSYVEVLFELLWLFRTKDLVIIDE
NLRRQPLNFEIIDRVIQSSKRWEKYFWGEVKE
>KALACAFP_03711 hypothetical protein
MLFKETVSKEMWELIQTLMKDEMLKNFLLVGGTALSLKIGHRISVDVDLFTTKSFDAGNM
VEYLKKNYNAEHSRHNNNSIFTFIDDIKVDLITHDYPIIKPIETTDNIRMISNIDIGAMK
LHAMMQSGQRLKDFVDMHFLLEQNPLKEYLNAYEQKYGGNSKLAGYALLHHEDINRAVSI
QLMKGKENSWKTIKDRLQKAVVSPDLKFGEIKSNSIQQSIKKGKGFRR
>KALACAFP_03712 hypothetical protein
MKKVNKNKRVPNIHKRYFWDINVLKQDWDKGYLFVIGRIIERGGQQEVDELIRFYGRDKV
IKALRDEITFLPNYGIDNAIGFFPELKKEEILCYLNRKDKPYHWL
>KALACAFP_03713 hypothetical protein
MSSNDSGGCFIVIAVILAIFGVVLLLGEGCKEFKHEYYNDPGGVIRGIFILAAVAFVIHY
IAKKVKN
>KALACAFP_03714 hypothetical protein
MQGEDDLRGLAKILAFMRAVSILLLLMHLYWYCYSFFLEKKWTLEIIGKILTGFDRTAGL
FSHPLYTKVFAFVLLALSCFGTKGVKNEKITWTKINTVLMIGFVLFFLNTPLLKLHSDTA
AFFYILTLGSGYIALMVSGTWMSRLLKNNLMDDVFNNENESFMQETRCINNEYSVNLPTR
FYYKGKWNKGWISVVNVFRATIVLGTPGSGKSYAIVNNYIKQHIEKGFAIYIYDFKFDDL
STIAYNHLLKHTDKYKVKPKFYVINFDDPRFSHRCNPINPDFMTDISDAYESAYTIMLNL
NKSWILKQGDFFVESPIILLAAIIWFLKIYDNGKYCTFPHAIELLNKKYADVFTILTSYP
ELENYLSPFLDAWEGGAQDQLQGQIASAKIPLSRMISPQLYYVMSGDDFSLDINNPEEPK
VLCVGNNPDRQNIYSAALGLYNSRIVKLINKKGRLKSSVIIDELPTIYFRGLDNLIATAR
SNKVAVCLGFQDFSQLTRDYGDKESKVIQNTVGNIFSGQVVGDTAKSLSERFGKVLQKRQ
SMTINRNDKSTSISTQLDSLIPASKISTLTQGMFVGAVADNFDERIEQKIFHAEIVVDND
KVAAETKAYKKIPQIRSFLNENEEDILKQEIEANYRQIKLDITQIIEKEKERIKNDPNLQ
HLVQQR
>KALACAFP_03715 Type-1 restriction enzyme R protein
MNKEYQIEDNLIELLKGLKYVYRPDIVDRKTLEQNFKTKFEALNRVRLTDNESLRLREEI
INPDVFAASKLLRERQYFQRDDGTPLHYTLVNNREWCKNDFEIINQLRINTENSYQRYDV
LLLINGIPVVQIELKKGDISHRKAMQQIVDYKNEPGNGYGNSLLCFMQLFIVSNGGRTLY
FANNKNQHFAFNADEQFLPVYELADIDNKKINHLHDFTEKFLTKCTLAEMISKYMVLVES
EQKLLVMRPYQIYAVKAIVSCINDNRGNGYIWHTTGSGKTLTSFKASTLLKNNPDIEKCL
FVVDRKDLDRQTREEFNKFQEGSVEENTNTETLVKRLLSTDYANKVIVTTIQKLGLALDG
TQKKNYKERLEPLRNKRIIFIFDECHRSQFGDNHKAIKEFFPNAQLFGFTGTPIFGENAT
YNIREGEYGSYKTTESIFEKQLHAYTITHAIDDKNVLRFHIDYFKGNQDAKPGEAIAQQA
VVEAVLEKHDVATNQRKFNAVLATASINNAIEYYQLFKEVQKKKQTENPAYLPFNIACVF
SPPAQLIAKDGDQQSQKNAADIKQLQEDLNQEKEDNKQNPEEKKKALTEIIADYNKQFNT
SHSINEFDLYYQDVQTRIKNQKYSNKDYPHKNKIDITIVVDMLLTGFDSKYLNTLYVDKN
LKYHGLIQAFSRTNRVLNDTKPYGNILDFRSQQETVNQAIGLFSGVDKGRAKEIWLVDSA
PVVMDKFKEAVEKLSIFMQEHNLLNKPQEVYNLKGDAARIAFVKNFKEVQRLKTQLDQYT
DLEEEQKEKIEAILPSQTLQAFRSSYIETAKQLREKQQKEGDQASLEIQQLDFEFVLFAS
AVIDYDYIMNLIADSTQKKPAKQKMTKTQVIGLLSANSNLMDEQENLTEYINSLDWNSGQ
DVDTLRKGYETFKDDKYNQELADIAHKYGLPATDLKTFVEKIMSRMIFDGEKLTDLLEPL
ELSWKERRKKELALMEDLTPQLKKLAQGREIAGLAAYE
>KALACAFP_03716 hypothetical protein
MKRISELGKIINGLTGKSGEDFGTGKPFVTYKQVFDNSVIDFQKCARVQIGENENQNSLQ
KGDILFTTSSETPSEVGFASVLIDSPKEETYLNSFCFSLRPFSLEETQPQFSRYLFHSSI
FRKAIISLAQGSTRYNISKAGFLNIMVPVPKSKEQQKIASCLSSLDEVIVAHSRKLELLK
DHKKGLMQSLFPQGGEKAPKFRFKEFEKDGEWIERKLEELAKRGSGHTPNKQVSNYYNGG
IKWVSLADSNKLDSRYVYDTKIQISKEGIENSSAVLHPAGTVILSRDAGVGKSAILHSEM
AVSQHFIVWVCDESKLSNWFLYYVFQILKPVFESIAVGSTIKTIGLPYFKELLIIIPSVN
EQLKIASCLFSLDELITAQAEKIEQLKQHKKGLMQGLFPKMND
>KALACAFP_03717 hypothetical protein
MSTITNFATLGEIAQHFRKDLVGDHRPMKDLVLFFAHNGTGKTRLSMEFKQAGKVFDSEG
NVTSRDTLYFNAFTEDLFSWNNDLENDTNRILTLNSDSAFFNGLHELDLDVKIESFFSNY
VDLKFDIDYDKSTVAFSRSIIVDGNEQTIENIKISRGEETLFIWCFFLAICQLAIDKDPA
YSWVKYIYIDDPVSSLDENNAISVACDLCNLLTVEGNDIKTVISTHHSLFFNVLYNEFGR
KVKNKRYFLHCKSANRYALQDTNDTPFFHHIAMLSELKKVVKSNKIYTYHFNSLRSILEK
TATFFGYEKIDKCIDGLEDEVLFERALQLFSHGKYSVFDPVEMGDDNKELFKRILDGFLN
KYEFYFPEIFNEEVRTETELR
>KALACAFP_03718 putative type I restriction enzymeP M protein
MTQKEQQQLGKTLWNIANELRGAMNADDFRDYMLSFLFLRYLSFNYEEAAKKELGSDYPN
LAKDDSRTPLSVWYDANQTDIKEFEKQMRRKVHYVIQPQHLWSNITELARIQDDKLLKTL
EEGFRYIENESFDSAFQGLFSEINLNSEKLGKTNTERNNKLCTIIKKIADGIADFTTDSD
TLGDAYEYLIGQFAAGSGKKAGEFYTPQQISTILSKIVTLDSQDPTTGPKKKFDKILDFA
CGSGSLLLNVRHRIKDNNGAIGKIYGQEKNITTYNLARMNMLLHGMKDTEFEIFHGDTLL
NHWELLNEMNPSKKIEFDAIVANPPFSLRWEPNEILAEDFRFNGYGLAPKSAADFAFLLH
GLHFLGKEGTMAIILPHGVLFRGGTEALIREKLLRDNHIDTIIGLPSNLFYSTGIPVCIL
VLKKCKKYDDVLFINAVEHYKPGKRQNTLREGEDGEPNDIQKIVDTYQFRPAYIEKYARR
VSIEEIEKNGYNLNIARYVSIARDEVQIDLKEVNKNLTSINDSIKTYTDRHNNFLRELGL
DPI
>KALACAFP_03719 hypothetical protein
MGFSKRFHLQQNIDALRIAFTLEKEKRKATTGEKLLLQQYSGFGGLKSILNRAEDLDDIK
SWKSEKELFSLTWELFQLLRDNSVDEKEYRRYVDSMRNSVLTAFYTPPKIIDTISGVIKE
RGVSVQKFLEPSGGIGDFIRSFSEGSEIQATAYEKDLLTGKILRNLYPDSDIRIKGFEEI
PDRELGSYDVIASNIPFGDTSVFDLSYSRSKDPARERAARSIHNYFFIKGSDTLRDGGIL
AFITSQGVLNSPSNQIIREALMKDHKLVSAIRLPNNLFTDYAGTEVGSDLIVLQKHLGKK
SMSHREQDFCKSLTDSDGVSKNLLLDNPGLIVYTKAYKATNPYGQPAMIFEHEGGISGIA
RDLKRMLAEDFLVHLDQELYLGKNSNKSVFQILVSPSNTIIEAEPSPISESVQTSSVKVT
INNKPHAEKQLSIFDLFESPEKLLPVPASRAITKTKKQTTKQKKPVKGYQGDLFSGILQR
PQIPTEHLPPVSKPQNEAKSPEEIIGDLFSGSENPEPGELKETVNPITEPVAYSYSLQPF
HRDNCLVVCNEQVGYLKIIESEKRQAMFQPLALNASQKARAASYIGVRDTYHDLYGKEAE
YRKEYRQERENLNTLYDAFVKKYGYLNAAENIKLIKTDSAGKEIPYLERVVGGVIHRADI
FHQPVSFSTSALVADNPDEALAASLNTYGTVNLGFMSEISGISSEGLKEALHSRIYYNPL
EDSYEIKERWLSGNVVEKAEEVRGYLASNSDNKELIESLKALEESIPIRIGFEELDFNLG
ERWIPADIYSRFASHLFQTEVRIQYVENTDDFSIQNKGWNVHITEKYAIKSDSRTFDGIA
LLKHALVNTTPDITKKVKIGDQEIKVRDMEAIQMAGTKIDEIRTAFTDWLHEQNEEFKEK
LTDTYNNTFNCFVRPQYDGSHQKFPGLDRKALGIEDLYPSQKDAVWMIKMNGGGICDHEV
GAGKTLIMCTAAQEMKRLGFAHKPMILALKANVHEIAETYRKAYPHSRILYPGKEDFTPQ
KRARIFGDIKNNDWDCVILTHDQFGMIPQSPELQKEILQEELDSVEENLSVLQSQGKEVS
RAMLKGLIVRKQNLEVKLKTLEHDIENRKDDMVDFRMMGIDHLFIDESHRFKNLMFNTRH
DRVAGLGNMAGSQKAMNLLFAIRTIQERSGKDLGATFLSGTTISNSLTELYLLFKYLRPK
ALEKQGINCFDAWAAIFARKTTDYEFSVANTIVAKERFRYFIKVPELAQFYAEITDYRTA
KSIGIDRPEKNEILYHIPPTPDQEVFIKKLMEFAKSGDATLLGRAKLSESEEKAKMLIAT
DYARKMSLDMRLISTKYGDHPDNKASHCAANIAKYYKKFDAQKGTQFVFSDLGTYKPGEW
NIYSEIKRKLVEDYGIAANEIRFIQEAKNEKQRKEMIKAVNDGKIRVLFGSTEMLGTGVN
AQKRAVAIHHLDIPWRPSDLAQRDGRAIRTGNEIAKFFADNKVDIFIYAVEKSLDSYKFN
TLYNKQVFIEQLKTNSLGKRTIDEGSMDEKTGMSYSEYVAILSGNTDLLDKAKLEKLIAG
LESERQAFHRSKATSNYRLEYSLTSLESSKSLLDRMQLDWDNFQKRLQRKQDGTIVNPVQ
LIGLSPDPSVKQIGAKLGELVDHARTGGSYEEIGSLYGFTLLVKTGVYQKDGQDDIYINR
FMVQGEGNIKYTYNNGIMASDPKTASLNFLNAINKLPEFIELEQQKISDLEKDIPVYQEV
INGVWKKENKLSELKTELTAVERKIQLSLAPVPTEEKSEENKQQKQGSNSSEDIIRVKGI
HLPRGIL
>KALACAFP_03720 hypothetical protein
METEKKELSYFRLRLQELLDTSYPELRGNTGFIDQRSQDAAFTYQEAFKSGNSIEQCDMV
ADFVLFEGLHFSKFDTIFQVVCEEFDTIMADEELRPFALKMMSVCEPVFGGYELTDDFAY
TTDYDLLYTELIGTIQLWIEDHGLQ
>KALACAFP_03721 DNA topoisomerase 3
MKAVIAEKPSVAREIAFLLGASEKKDGYLEGNGYLITWALGHLVALGMPIDYGLSGFQKE
NLPILPDPFILTVRKLKKDKTYAPDPAALKQLKIIGQVINRADSIIVATDAGREGELIFR
FIYEYLKCNKPFERLWISSLTEKAIRKGFENLKPGSEFEGLYRAAESRSRADWLVGINAS
QALSISAGSGSYSLGRVQTPTLALICTRYFDHKNFTVKDYFQIELDHRKDYTEFKSLSQT
RWDNKKQAEDALRVIGREEKVTITAVEIKAVTEQPPLLFDLTGLQKAANKSLGLSAEETL
EIAQSLYEKQYITYPRTGSNYISEDVWPEIPGLVRTLTDRESFKEALNDIPWGRFNKRIV
NDLKVTDHHGLLITEKLPSDLPARENTIYDMIALRLLEAVSQPCLKELTQAHVQVLHYDF
IVKGSKTIQPGWRSVQGSSSDEVTELVQELPKFQKGEELKIKNAKVLEKKTKPPVLYDEA
ALLTAMETAGKAIENEEERKALQNIGIGTPATRAAIIETLFARNYITREKRSLIPTEKGL
QVYQLVADKKIANAAMTAEWELVLQKIENGEADASMFQKDIEQYTDSITHELLTASIHTD
LQPDLTCPKCKGHRLLIRDTVVKCPGEDCRWLQYRKICGISISLSDIESLVLRGRTSLIK
GMKSAAGKKFDAYIILNEKAESSFEFPQNKGRRK
>KALACAFP_03722 hypothetical protein
MNEEINPKAGVSADGQLSEILLVLDKQQNKIQAVTGIDKDGKLNTVDATKKNQNQFMKID
LNGDAFTNFFSNFFRQLKDPTRFSFFKVPIAEAVETAGKMQKQVDNPDEKNKKILADHEV
KVPEETQKKDQKQTQNTMETTQTTQKAAVTQETSEYRYKPEQIDWETMSNLGLNREKLER
MNLLEPLLKGYKTNELVPVSLNLGSSIIRLDARLSLQESGDGKVVMGIHGIRKEPNLNYP
FFGHEFTPEDKEKLQATGNMGRVVDLTHPKTKEKIPSIISVDRMTNELVALRTDWIKIPD
EIKGVKLNDEQKQSLMKGEPLLVKDMISKKGEPFDATIQFNADKRLVEFLFDRTAAKREQ
VKIGDEYVAPRYFREKELDKEQYEKFKTGQTVYVEGLTDKKGKSYDGYITFNKATGNIDF
SFKNANMLKEKVVPVEGHKTQVAVNSEGKTNEATKNLKEPLKTGQTEPDSKKQQQKQEKP
RNKVKQKL
>KALACAFP_03723 hypothetical protein
MKNFYRTIRTKIKEAEEKLSLSVETVVEDSRNMVILLNEQLQLLKADVQKNGFENDHDEI
EFFREIKPSVCSKLLFYNKLFRIETGRPSELGSVSRKYFKEKLTKAENNYMGALSDSEFY
RYYRSGRRNKDTIYFMRGQIDWEQGLSNRVFEIDIHFSTYYDYEVARILAFDLLYEYLYY
RIETFRNSTEATSIRNPNNNKIQWTESKNALIELIYALHISRSVGHGKLGIRQIATLFQR
MFDVQFGDIHHAFHRMKYRSGPTYLDRLKADLDSYISEHL
>KALACAFP_03724 1,4-dihydroxy-2-naphthoate octaprenyltransferase
MPLITSSNPALTVFRAVIRELHITWEFINNDIWDTILPSLMIFFTGWIYQGRSWSELPLH
FVISLSYAVLYIYTFTIGNQLDGIEEDRINKPYRPLVTGLVTIKATYSRFYIYNSIYALY
GFVLGIFWFSVAWIAVSYYLNLWGGSKHWATKNLVGMTLGTFILFNVQWHIALSPESSIT
TNLQYYFFLMSAWAGLALPIQDLRDIEGDRQAGRKTLPLVVGDHKARILLSIEYLFFLPL
LFLCIMLTVDSLRDIFTEQTDLIIFIIQMGVHWTVAIRVLLYKSPKEDHKTYHIYVLLFV
SAIPLACII
>KALACAFP_03725 Autoinducer 2 sensor kinase/phosphatase LuxQ
MLNGEKIFHLYLLPLYQLAAKIPVTFKNVFIAIRSAGEASVPEKERPILRNFNTGSALMG
IMVIVFGGIMYSLVPSTSFLIALLLETGAFAMLIYLNHRGKFEYAKVGLYAAHSCSAIYF
GAWLGEALPVDMVIVFLFIYLTCSSCLTYKSWKARCGFIAATIVLSMIVYVNRSVQFIPV
QHFPSEYLPLFTILSCGGMLSLIVYVTISMIRQNDKLTKEMEKANLNKTQYLNETSHELR
TPLNSIIGNSQFLLDFKDQLQSLKDGDDLLKILTDVNAAGKIMTDIINNQLDMAKIEAGK
FDETYITSFSLISVFKTCIDYNTTFAKRRNVTIVFDHDEQVNHIQSDELFLIKIVNNLLS
NAIKFTEEGSEVVVSSTLTDGHIVFNFKNCSTISKEKADSFFKEYVSERNAQFVGTGLGL
VITKKLIEQLGGSVTVHRAGAHTSFMVRLPYMPAMMKISSKAITQKEQTVPNEIIFTTVN
ESIQVLGDKRFDQVKILIAEDDPMSCAMLERILLQEGAVVLTTKSAEEAIAHLSDFSPDI
IISDHNMPGMGGMGLLEYIQLQSIPIPVVIASACADKDHCKTFIEAGAVSYVLKPLNNTS
LIATLSDILVKHSVIS
>KALACAFP_03726 hypothetical protein
MEQITKDDLRQFRMLLLNDFEEILKKLSARSGNKPDEKPQEWLRSKSIRNILNISPASLV
NLRISGKVRFRKLMGSYYYNRFDLEKLFEDDTNY
>KALACAFP_03727 hypothetical protein
MIRITETQWINFLKDLSNDSRLNVWHLALLYALVQLAYSQNETKIIHVSGSRLMAMAHIK
TEPTYYKYFKQIQDFGYIKYTPSYHPGYRSTVELLTLKESSSIYTKK
>KALACAFP_03728 Tyrosine recombinase XerD
MVKNRLTFFLKSPKKKGDMLRAVHVRVKIGGIPMETSTKKKWDVRRWDQKVQRAIGTKED
ARTLNFYLDSVVNKVSNFITKEENLNKIITSRCVINYINGNDESTVKVLEEFQKHNDEMY
ALVRNKGKKSKEIDNEQDDNKGFDLDTWKRYVTARSHVQEFIQFKYKRDDLEFRELNYEF
VKDYDFYLKTVRNCANNTTLKYISNFKKIVRIAIKKGIIPGDPFVQFKGKKTKILNRPLT
WAELRSLENKQFSTDRLSRVRDIFVFQCYTGLAYIDIFRLKRTDIKEGIDGKLWIMNRRK
KCRVNTDIPLLPKALELMDKYKDDPECSPRGSILPVKSNQNMNGYLKEIAALCGINSKLS
THKARHTFASTVTLNNGVPINVVKELLGHSSVKQTEHYATTTQESINKEMTVLKQKLSTE
NADEEDIDTLFQNLEKEFKELKKDQSIIGKDRVKVGLYSLQQKITKLRASMDK
>KALACAFP_03730 3-oxoacyl-[acyl-carrier-protein] synthase 3
MTSKIIGVGNYIPSETITNLFFDQHIFLNSEGDLLKENNASITNKLQKITGIVERRYATS
EQVTSDLGLIAAQTAIENAGIDPETLDYIIFAHNFGDVKFGTVQSDTVPSLAARVKHLLK
IKNNFCVAYDVLFGCPGWIEGVIQANAFIRSGIAKRCLVIGAETLSRVVDIHDRDSMIYA
DGAGAVVVETSNDESGIQSHLSASYTYKEKDYLYFGKSYNNESCPDTKYIKMDGRKIYEF
ALIHVPEAMKQCLDNSGYSIDQLSKIIIHQANEKMDEAIVERFYQLYNTPLPPNIMPMVI
DKLGNSSVATIPTLLAMILKGEMEAHSIKKDDIVLFASVGAGMNINAFVYKF
>KALACAFP_03731 Cold shock-like protein CspC
MQEGTVKFFNEAKGFGFISPADGGKDVFVHSSGLISRTIRENDKVVFETQRGEKGLNAIN
VKLA
>KALACAFP_03732 Unsaturated chondroitin disaccharide hydrolase
MTLHKLSIAVFTVLHITFYAQSKKEMSALIRNEFNFAEKQYRFLMKSVPKDKMPQSYNAS
ENRLVTRDISWWCSGFYPGSLWMIYEQTNDPEIKAEAEKRLALIEPNKTFTRDHDLGFMM
FCSFGNAYRITKDPKYKEIILTSAKSLSTRFRPGMQAILSWDKMADFKGPVIIDNMMNLE
MLMWASQNGGDQKIREIAVAHANTTIENHFRPDYSSYHVVDYDVNTGEVLGKKTFQGYSD
SSAWARGQAWALYGYTMMYRFTKDQEYLDQARNIAKFILNNPTLPEDKIPYWDFNDPKIP
NVPKDASAAAIMASALLELGQYTNGDEKKTCVEAAKQMLVSLSGEKYHAKLNENGGFLLM
HSTGGLPLNSEIDVPLIYADYYFLEALKRYKDWYLQ
>KALACAFP_03733 putative oxidoreductase
MKSDNNLQRTLRGKTVVITGGSSGVGRAIAEAFALEGCNIVVAARGKDGLDETVQLCRDL
EVAAVAVPTDVSIASDVQNLANKALQFNGRIDIWVNNAGVMASGKFEEIPMELNEQVIKT
NLFGYMHGAYSVLPIFKRQNEGILINNVSIGGFMPAPYSAVYSSTKFGIRGMMECLHGEI
SDFPDIHICNLYPQIQRSTGNMHSAKYSGLDFKIPPFAADPRDTAAKIVELAKNPKKDLF
PDIASRFLVNIYSLFPKPIINTASAAMRLMMKVKNAPSEPGNVLEPSSEPHRIYGETMLP
VLSRKTKLAALAGLGLGLAYMFLGSKNSNK
>KALACAFP_03734 hypothetical protein
MAHQNFKKEDFVQDPSGDYRVEFREGNIGEGSDLIVERKKEDGDYEVLSAEIKRHNKSIF
VCWSEPFDGRVIFDE
>KALACAFP_03735 hypothetical protein
MQGIEPKFHNSLTERMEYYRYLLQKTTDESDIESCEVIAKGSELCELYEDYLSNKKKLQE
SIKNYKDFHDDLRKTLTIKLRDVKKKARNQTK
>KALACAFP_03736 Carboxy-terminal processing protease CtpB
MRNFFNIQILAVLFLSVLMISCNRTDDEIPDFPEGSTEAVNVWVQDSIRRYYYWADQMPA
KPDYHLPTKDFFKSLLAPQDRFSFIVNTADSSSYPRSVRNMYGFDYTVLQLANGEVVTVI
KLVLKNSPAMNAGLERGMVIKKINGVAITASNAEELTAAIPDQTVIQLTVGNWENGSIIN
EKNITVYYGYSLDQPLMSKIFEQNNKKTAYLYIYDFPDGMTSALNQKFAEFKTEGVQELI
LDLRYNYGGSVSSSAALCSLIPAGISANSPFIIYKGNKNGGEVKRTFSQQISYDSNALDF
SVLHANSLGLNKVYVITSKSTASASEIVINNLKPYLQVIQVGDATLGKDMAGFVVEDRRK
PKKITWQMHPVIYKVFNASGEGNYTNGIAPQIQVNEYSALPLRTLGDPDEVLLSSVLHQI
YSKSIYNGTQPQDVKVLYQSDSPYIGFSN
>KALACAFP_03737 hypothetical protein
MKKIIAMILFAILFSCTDNSTMERFDKAQQAAEVNIKGYSKPDVLQLRLNGKPIEINGKN
SYTDKIETQLMFVLDEGETDELGIYNNETGTQIAKYTITYNNFEDYKNVSFFNLPGIFLQ
TYAIKPQVNLGKVGFEFIFPNLGEFSGTSLDGVKGVLKRENGLVLAEFDNIGKKDFTSVK
IYNFFSTTAPVYLELYKPGTTEPYTGSNTIKVTLKQDIGANMIVLQEKMENGVWVVKGDI
DIADYL
>KALACAFP_03738 hypothetical protein
MKKIILLSVVLLSQAIFAQYPVWSNSFDTAADLQGWTFHDLNGNGNGWVQGQNIYHNGTA
LAYGPSGVLRHSINLVPTGNATGFATENDWIISPQIDLTSAGGTLTLAGYIGRQRSTHVL
VSRDVYIFVSTPQKQVPDLSDFQQMATEAQNSNGAAYRFNATSANLPADLNQYAECLIDI
SAFAGKKIYIGLWSNRISSGAASNSQNININEMTIFASVLKTKDIKETKNLTRIMENPVA
NSLQLQLNPKLKQNNTTVTVYNAAGQKIINTKYSGNINVSELSAGTYFAEVSDGILTERL
KFIKK
>KALACAFP_03739 hypothetical protein
MRKLTLIAAAALSLTACQHDSLADSSNSFDMKSTSAEYITASTLPVTVVNSDITSNTTWS
GVVELDGNIAVRDGATLTILPGTFIKAKPNADGEGRGVLIITKTGQINATGTESQPIIFT
SYNLLDGNEDTTAEAGDFGGVILLGDAPTNVPTTTTVEGLPQNSMFYFGGSNSAHNAGTM
KYVRIEFAGYDFVGANSGNEVNALTLAGVGSGTTLDHIQVSYGQDDSFEFFGGTVNATNL
VSFAAEDDNFDFDNGYTGTITCALALADFNSGHTISGQVSDTNGIELDNNAGGTSTPLLT
HPVINNLTIVGTQTNQLYTSPSPYTGPKYENGIHIRRNGKLTLNDAVITGYPTGIRVEGS
GSELSSASTYSSIKVHGFTTAVTGLGTSGIPAANLVVSATANAFGMSQPFYNNGGWNVSP
RNCGNFQGTWTKYDFSIVD
>KALACAFP_03740 hypothetical protein
MKSLKCGLTVAAIFFTVAAEAQELVQKVSFSVPGGKPLIEALEEFAGKTGMRLAYSKADI
KELKVKGVKCDNVPLNSCLKDLTNGLPVVYRLRGDLISIKYEGSGVSVMGNGKISGKIVD
EIGNPLTGAEVNAAGRNAVTDNNGDFVIELPSGVYTLTIKAPKYNTLRVEKLAVNNNETR
TVSFAMKSVSDNVASIKEVVITGTRKADTQAGLLAQQKKAAQMSDGISAEQISKTPDNDV
GGTLKRVTGITTIDNKYVVVRSMGERWNTAAMDGINLPSTEAYNQNFSFDIIPTSMVESV
VVSKTATPDMNASFAGGYVEVRTKDIPNENFTTVTLGTSYNDISTFKEFLTRKRGRYDYF
GYDDGTRDFPMGLKAMNWENPLFFEQSKQFTNDNFTNYRTKADMGSNMQLALGRTFKLKN
NNKWGFAGALVLRNEQNKLQIDHTGRGNWLDTTYLTSPEAEDYQESPVKFYNFKNQGASY
TYNSTVAGMMNFGLQLGKNRFSFRNSYTHIYDNTVTRITGWNEYSGGSGLPANAELAYNY
FYYGIIPNNDPEQIKTLDRPYTDNANYPVYQTLLQNKLEGNHKIGNIDIDWFAARTSVAS
DTKDYTLHQTFYNFIGNETIAYHQVNNSSSDFARGFIENRETDYNYGASLKFSLDAGNFK
NDIKIGYAGASKSNTNLQQKFLLRVDEKVAGTKILPMPGALSDWFDGSHYVPGGIGWQTR
PLYSDEQYKGKVEQHAGFIMFDNRWKNKLRLVWGLRAEYFQYDLISQQVDPSDPQNVYKT
AVEDKPWQFMPSANFTYSPTNKINVRLAYNRMAIRPQFNERTGLPYFDPIANGLIHNMEM
VSSIVDNYDFKFEWFPGLGEIFSAGLYYKNIDRPIEREGYISNEGNLHLYNGNSKNAKLK
GFEAEVRKNLGFIATDTFLEKLFISGNFTYNDTKVIAFKDKSETTDQDATYEVDRPLYGQ
TPYAYNLGLMYDGERLGISFLYNAKGDQYITVGYGYNGEEIQRPYAVADAQLSYKFLKDR
NLEVKLNARNLFNRVKEFYNNYNSYSVSKGGNLQTEREMLELLPGATDKYDKNIDKILFR
AYSGRIFGVSVNYTF
>KALACAFP_03741 hypothetical protein
MKNLKYKDIEAFVFRLWQREVSEEKISEKETEVLQQWKIEVEKNLDRDHMRESKKRVLFT
LESYFPQAAIISHPNSFRKYTYQIAASILLLMTLGGVFTYHTFFKSDVYFAKSGNQRVFL
ADGSLVTLFPGAELTVEKSFPADTRVVELKGDAIFTVAKSKKHPFIVKADGFSTKVLGTV
FKITQSGREKAVDLYEGKVAVSYTGVPVTYLKPHQKWTNFGVSRTAAIISFKMENKSKKY
LPSLLSLSFNDVTVREVAEIFQKNYNISIIYPKEVADKKITADFTGGSTDENIEALAFIL
GLDVKKEKETTYILKK
>KALACAFP_03742 ECF RNA polymerase sigma factor SigX
MNPTDYTLLKKIKTGDRTAFMTLYERYWDSLYSFVFVRTRNKEVAEELLQNLWVKILENT
ESIQTDEQETAKGYLLRYLHYRVLDYYNSSKITSSNINIDDSEDPVDMIDTEYFEILEES
EISALFTMIDQVVSQLSTTEQKVYDMRIRKNMSVNETAEALGISNKTVSNKLSKTLSEIR
EQLNPEYKSSKKLVALLLFVEMVAQG
>KALACAFP_03743 Autoinducer 2 sensor kinase/phosphatase LuxQ
MQKNILFIFFIVVFFTVRSQKLSIQFFNTDNGLPQNSVKDIIKDKYGFIWMTTENGIVRY
DGTNFLVYKNFPLTSQRFTYFYGHPEKDSVYTTGDYGKTILLHDKLPKVTKIAKNTLFLI
KDNSGHLLYCTNYSGGATAGVKFFMNFKKGRYYLTDTGLGYTHFGSKGEINLPIKPLLNA
VPQVFALNEILFYRDIQSKKVVKIEKGKITGSYQIPLLTDPHSKILWSQANNQVFIMNKS
TMYTCDYENGELKVSRLFKLDKVKDENFISAYYDKSYKKFYLGSSIDGLQIISLPDFTTV
SRPPSEPESNFYALLPYNSSSVITTFGEIYDRNGMVDNKHFKNTSSYFLSYDHSGNIMTQ
KTDEVMVYQKTSSFTHAIPIKDIELSDFFFDDHRYYGLLQEFKNDKTPRFNTFLTIYKDK
SFRFPGKKVFINSEPTKFVRLDQNHIIVGTIKGLYKISLKTNTIYDLTGKDELLIRNIIK
SKDGNIWVMALGKGLFLLKNNHLVKMPLDVNNNISSAHGILEDSKGFFWIPTNNGLYKVP
ERQLLQYARNRKSRVDYYRFAKDSGFNTNEFNGGSNLCGSQLANGDFVLPSLNGLVFFNP
LKVNTYYPKNMYIERASIDNKLQYFKENLYLEQEFSRVDIFIDVPYYSNPDNLVIEAKLD
RMTNAKWEPIGKDGKFSISNLGYGNHTFVVKMLVSDSGKFIYKKINVIIPPYFYQTLWFK
IFTLSISLLLVYLLIRWRISFLKKKNHELEEIVKSRTKTLSDTVDKLEITKIKLHKEVEQ
QKKLIGTITHDITTPVKFIAMTAKEILDTHDLSTPRAEKILNSIYKSSDQLYNFTITLKE
YADIYTHHRSDEKEIYSLYQLIEEKRILFNEIAEKKNTVIRNHADRALLINISKNILSAI
VHNLMDNSVKYTENGIITIESHVEGENINLLITDTGIGMDDKKIEYYTKLQDNIENEKLL
LQKYGMGLHLVLQLLQMIEGKIIFTKNHSKGTSFRLILTNKKR
>KALACAFP_03744 Oxygen regulatory protein NreC
MIKNILIADDHDIVLVGTSIILESRVQNAVIDQAEDYPETLEKIAVKKYDLVILDINMPE
SKNKKMISEIRAIDPDIKILIFSAYEEEIAVQYIKEGANGYVSKLSKSEEISDAVNKVFS
DGYYYPSSIVSQLFNESPMDLIKNLSEREYEIFNLMVKGYGNLEISNKMGIQMPTISTYK
KRIHKKLKTNNIADLIKLYHTYMA
>KALACAFP_03745 hypothetical protein
MSKNFTKVWQAVALLSSSIAFAQAGNIGVNTANPGSTMDINGSVAAKYNAVTAALYNLTA
TDFHVSYNGTANATFNLPAAISGNGNFKGRLYTIKNNTNFTITVNSAAPETINGNASISV
PANQSVQLINTGLTGANPTWELVSTGSTSTTNNITASNGTTLSGTDVRLGGTLSQATNID
TAGNNLSVNGTGKVLVGTNTVPAGASNSKLVIDNGTTNGALQIKDGTQQFGYVLTSDANG
LATWSSTVTTAFANNWTSYTGTLVNPFTASPGGLLQTGISVTIPAKGWYFFRCGVTIQSG
CNDYGFYIDGVGEIWRTYCNVADVQMMSPRDQNRVLYFSTPGTYSIVAVKTNAVVPTGFN
IGNPAFYLDFVKFQN
>KALACAFP_03746 hypothetical protein
MKFILVFFSVFLFAQQKITSENIEGRLKEAEILMISGKADEFIKANLSILEDSKSISYSQ
GNAKVCLNLAYVFNRLNQYEKSIRYLKMMEAENDYKSADEFNRISTNVLYSNNYFGIKMY
DEAITKLKENIRLSENVTVDSTRRYIKTLGLIDMATNYTEKKRYDSATLCVYKAIQELKG
QKIKNTCLGVNLKIALLNLAGIKFKENKVDSTEYYVKASRALPVDLGYNEFVVYKLLGQI
NSSKKNYDSAIINYKKGIELAQKAKNSRKLSELYSLISDAYSKKKEFGNEKAYLNKFVKL
NDSIRETEASNLNETIKLLVKDKQKPLEEKNRYLLYAIILGAIGLVVIVLFVAKKIGKKN
KVLHIKNEENKILNRKINEAFEDVVQLAKNNDPEFSARFQEVYPDFFPKLLQKEPQLLTS
ELKFCALLFLNFSTKDIAEYTFVQPQSVQTRKNRLRKKLNISSEEDIYIWMKNIIR
>KALACAFP_03747 hypothetical protein
MKNLLFLLSISFPILSYSQVGINTPTPKKMLHVNGSLQVTNELSVGGNASTAGSAGTSGQ
ILASTGPGTAPVWNSSNELKGTIAAAYYVQGNDDLTINQGDTGDVPGLTLTITVPAGKTQ
TLLFTIIGYAIRSTVTDGEATQGVFSLVQNNVKISSAFTASGDFGDLDAVPAPVTFLKSV
TLAAGTYTFKVRYTPWKDQQIVNFDPTGYSGYNGDTEAMLSKMQVLVYNN
>KALACAFP_03748 hypothetical protein
MLIFPAKYGADNSLLLPVVFQWYDDKYDTIKNNDKSLSTDSNREQVLHSYDFRSHKKSLK
QPIQLFSEVN
>KALACAFP_03749 hypothetical protein
MKILFFLFPLFLLAQQKITPRYIDSQIKKIETLGREGKSDQYIKGNTLLLKHSKLIKYSR
GIALGYLNLSYSLFFAGNYKKSMEYLKLARKEEFAQNDFTSQLRIKRLFSYNYISVGLYQ
QAISELREIALLSDDAPIDSVRLQAKTSSYIDIGLIHQEKKQFDSATIYIKKGINALQNC
RKLTPRLKVILAWGKLTLIELKIDEKKIDSAKIYLKQLENCAEKLPGNYNFKLFLAKGKV
CEETGNYQQAVRNYAKSVKLVQETKNIVALRDLYQSLSKAYSKNGNPDSATIYLKKFDAI
TDTLTSLSPPAIESTVQELVTQKENEINSKTRYFMYFLYATAVIVIMFFLVLFGKIRRER
KIVMEKEFETMILSQKVNAAFNEVVQLAKKNDPEFLTRFQEVYPNIFPRLLEIEPLLLAS
ELKFCALLFLNFSSKDIAEYTFVKPESVQTRKNRLRKKLNISSDEDLYIWMKNINNSRIH
SLS
>KALACAFP_03750 Bacillolysin
MKNKLIFAIFIPLLVSGVCVNAQRFIDQRITIENGRSSLITFKPGSAAKDLAASDNEKFF
SEIFSLPLGSKMVKTKSAKLFSDFADEKYQLYHNGLKVEFANYTLHYIKGNLVSMNGEMY
DTSDVNTQPDITESEALNNAVKYAGVKVLMSKTQHGKEIGYQPKGELLLIPVQTAGDHYR
LLLSYKFDVFSAEPFLRSYIYVDAKSGEILLDNPIMKHAGDHAHEKELENLPMIGAENQP
KQDLPSIFITGNASTRYSGLKSIETSLVNNKYVLKDDTRGGGVNTYNNNNGFYTNLVKTN
ISDTDNNWTTAEHSANGNDVALDVHWGVEKTYDYFKNTFNRNSYDNQGAVLESYIHVQDP
QAPGSYANAAWTGSEMIYGDGNGTFKPLTAFDVTAHELGHAICQEEAGLVYQKEPGAINE
GLSDIWGAVVENTFAPEKQNFTIGEDIVKVSPYYLRSMSNPNSGLSSQPDTYKGTFWKNA
SSTCIPNNNPNSPGYNDSCGVHYNSGVLNHWFYLLVMGGSGTNDIGSSYNVSGIGFEKAA
KIVYRIETSYLSANSTYSDLTAYGILAVKDLYGVDSPEHIATQNAFYAVGLGQAYAGGGN
PVTDTQAPTAPQLSASSTTQNSTVLSWNGATDNVAVASYDVYRGITLLGTTSASTYTATG
LSPATSYSFTVKAKDAAGNISVASNAVNVTTQAAGTGVSYCSLSASSAADENIGNVKFAN
INNSSTGIAGYENFTSIIGNVVKGTTYPLTITPNWPLIKFSEAYAVYIDFNGDGDFTDGG
ELAWSKAGSTTSPVTGNITIPATAVTGNVRMRVILKYNSVPTSPCGTISYGQVEDYTLKI
TSAGAFNSLISEVSGGTKAISIYPNPVKDVIKINSSSDSEFKYQLIDVLGKVVLSGETSA
QTINVESLLEGVYILSLDNGKEKVTQKIIKK
>KALACAFP_03751 hypothetical protein
MNTKFLFIVMGLISSVIYGQVGINTEDPKASLDVNGNVRIRTATVLPSAQDVKVMVLDDE
NVVNTTDLNNIFERAPTANTIIKGTGGTGFSVLSLSLLNGWQKVSFPTLEIDEGLNFNTS
TQEFTALEKGIYHIYFNIEMASLLSASTLGAGIFKIKSGTNTAVLISEESFLNVSVLSIN
VSSPVRKTQTIVKLDAGDKIVFGIKIPLADISLFNNSKATFTIWRMK
>KALACAFP_03752 hypothetical protein
MSNQAQNITSSPDYKRIYIDIITRKYPEKMRLCNPILSKKKLSFLDIIRLNNLLFNKDCR
KRTLFNQQHRSYDPLAISQILEYQVNNKLNNSQLATHFKLSRNTIAKWKKQKDLF
>KALACAFP_03753 HTH-type transcriptional activator RhaR
MNKQYITYQEKERLKREFVHKYLLLMIIIFLIYMLIYTFIQYNNFLAYYIAGGLVLTSTA
YLIARKSNSLDKFVRCYFILSPIYIIFIMVYFWNVSVMSFVWLLPLPLGVYIFFPTKKDI
IAFTLYGLFIIIAEYIIVYFFSFSLTISRQSIVLTDTLLIVSNILIILLEIYYTDKIRKA
EFFLQFEKKYLVRTKNSESESYHQLFEKIEEVVKGKMLFKDDKFNISKLCIELDVNSKYI
AKALRANNYSNFNTFLNFHRINHVKKLLEESNLQRITLMYIYTEAGFSNQSTFNRVFKQF
ENMTPSEYIAMKHG
>KALACAFP_03754 hypothetical protein
MKKIKLLLPFSVLSVAAFGQVGINTSNPQGIFNIDAAKDNATTGVPTAAQQANDFTVMQN
GSIGIGTTAPHASAILDITSTNKGILAPRMSLSSRTDVTTVPNPAVGLLVYNLGTQPTFT
YKGYVFWNGTEWRSFDNSSLDVGTVGALACNSVSLTPNTYASGVPYTGTMSIPYTGGNGG
VYQSQTIGPVNGLTATLNGGNFANGSGTLNYTISGTPTVSSPSTTTFTITIGGQTCSTTI
GAGSSISVGQEVNWSGEAPANIGSGGLDETASIPTNYLSNYAADVPVMDGMRFDFYFINN
VTGAGTISAIPRLVNVSGGNLKVNFSAMSSVQNYGSNNVLLGPNQFINLDDGIYNGYGLN
MTTSSVPASYTSPSTSHTEIETVDLWVNNHWYRANYYPVIDNNNTTTPSDDIRRIAISIK
RLK
>KALACAFP_03755 hypothetical protein
MKKKNHYQHLMGRDKKQIVYEMGQEFNFYPNNIWTYIIDNGWFGRKTMLLLFFKSEKVYE
IKVKNFYGKIARLSED
>KALACAFP_03756 putative glycosyltransferase EpsJ
MKMKISVVIPVYNAEKYVANAVESALQFQEVCEVLLIEDGSPDNALQVCHDLAEKYDRVR
LFQHPDKKNHGPGESRNLGIKNSTGDFIAFLDADDYYLPNRFNAEKELFKEPKVEGVYGA
LGVQYYTQKAKEQYYSIFKNRLTTVYRKYHPKDVLPGQLNMLGSFGLFTLDALTIRKEAL
LRKIDSLFKPHLRYHEDTEFLFRLSFYLDLYPGILDKAIVVRGVHENNRITKVDTKKINP
ASTRILLWKEIRDWVEKENEIHDDIKLHIRRMHRSFEIANAPTLKKWKMIIKFIFKDYYS
IRSGLYNINFRQ
>KALACAFP_03757 hypothetical protein
MLFKNIHIGELIDKRVKETETSIDRIVNFFQCNEEDITKMYLSKSIDSESLLKWSKLLGY
DFFRIYSQHLLLYSPPSSPDFHQKTKQKETELPTFRKNIYTIEIIEFILELLKSEEKTKK
QIIEEYKIPKTTLYKWIKKYW
>KALACAFP_03758 hypothetical protein
MNNKTVLETANAAISRGDHETFLTFCTDSVQWIFVGDRVLSGKEEVRRYLSETYKIPPKF
DVDLMIAERDYVTAVGKISLSENDKWTEYDYCDVWKFENGLMAELKAFVVEK
>KALACAFP_03759 hypothetical protein
MNYTLELNTQEPGSNIVFNTIVFDAFKVNIIERYLGRMNFNPTLYNVLFKVRTLDNNLIH
KRDGNVRVKIKGEDFDVYQKLVQVLNSYEYKNKLINRQEAEQNYVHFILSLVIANYQLT
>KALACAFP_03760 hypothetical protein
MNNKILRTIKDVSVIGFLLLFPHFVPLPFYSYAVVCFLFIWFLLRNEGNTFQDIGLSGNG
FTGKAVLIGIASALFWLGFMQLAYIPFIKHFFVVPDYTEYNFIRKSISNLLMVIAAALLI
GGFYEEVVFRGYIQNLLEKRFFRKFAVLWSIIITSVLFGLYHWQQDIFGIVSAVLGGLFW
SILYKKFNNNLWITIVSHAIFDTISLILIYIDKFGNWY
>KALACAFP_03761 hypothetical protein
MKVPKSVNAIRRSVMRNLTKNIGKSNFDINNKNDVAIKKILISRPNHRLGNLLLLTPLVQ
EVINTFPDSKIDLFVKGGITPIIYQNYSNIDKIIQLPKKPFSNLLKYIKGWFVIKTKKYD
LVINANFGSSSGRLSTLFANSKYKLFGEFDEAFSTKHPDYHHSAKNTVYNLRQFLLQLGM
PENTGEIPSLDLKLTDAELEAGRKKLADLVKNDKPTICLFTNATGEKCYSEEWWGKFYSQ
LKQEFPDYNIVELLPVENISKLNFTIPFFYSTDIREMGGFIAASALFIAADNGVMHLASA
SGTPTVGLFSVTDERAYQPYGNRSFSVNTGQVDNNAIMNLLRQTINHI
>KALACAFP_03762 3-deoxy-D-manno-octulosonic acid kinase
MKSIFAEDLSQFKYDILRILENFKNDGTLIGNGSRNIIKFFDFNGLILNFKSFKQHNIIN
RHVYKFYRKSKARRSFEYAHLLLSKNYYTPKPIAYVENHDFIGLTSSFYISEQLKDSWTL
TEVLGNHSFPDRERIIKEYTLLLYRLHNDGIQFLDNSPNNFLIRKENDKYCIYMVDLNRM
NFHENIPLDKRLKNFARLTTDPDIIKIIADEYARLSNNSPEYCSKKIIEASNKLLLKRKV
KKVLKLYKRVIKI
>KALACAFP_03763 hypothetical protein
MDKETAIYIRNYFSNLMTDREKFALKHHMYTFKSADNHIMRNLMLEKGWISSDPEVVSLL
QNGYEEFELNVAKRIMTDTPEKVFFNNCPKCNKLARTPYAKQCRHCGYDWH
>KALACAFP_03764 hypothetical protein
MKKPLLSKQTLTSLLFCGLSLSSIDLSAQTLAFPEATGFGRYTTGARGAANPQIYLVTNL
NDSGPGSFRDAVSQPGRFVIFKVGGIVNLQSVVAVAANTTIAGQTAPGEGIVFLGPRVSF
TGANNTIARYLRIRYGGTSQNQDASGIANGANIILDHMTFTWGTDEVFSVNWDNNGTSPD
NITIQNSIIGQGMHRHNHSAGGLMQPPPGGKISLIGNLYICNKTRNNKIKGINEFVNNVV
YNWGNYGNTYGHTQSGEAYIMGGDSAGSSFANIINNYFIGGPNTSSTVTTPFSVGNANFN
LYGSGNYFDNNKNGALDGTLVPQDLTGYPVGDPAAILATPYDYPMKNPTLTAQAAYDKII
SGAGASYPRRDQVDGLMISDLMSKGTTATYVYVQTDLTTQFGFTNGGAGHVYGAPAPLDT
DNDGMPDAWETANGLNPNVFDALAVSTTHAPYLNIEVYINNLPNAIPPDFIIPPTNLNFT
NALTTITPAASSLAVNWSDNAANETNYIVERSTDGTTFSVIATLGANTTTYNDTGLTPNT
PYYYRVKATNATESSVYTSNVSVTTPPIPSAPTKAVNPIPANNNTNVELSSGNLLLKWTG
SPNTTTYTVYFGTDPLNLNNIATVPYSATPSYQLSSLNTTTNYYWRIDASNSLGSVTGDV
WTFRALTPSLVGNWPFAEAPSAGAQIADVSSYANNGTLDVAYDNANVRVAGKENNALDLA
TSPNNMYIASIPHQNQISFDNQSFTVSYWMKAPTSMIPSSSSTSLYVLCKGSFTKNTTTG
ATGKRFNVEIKGGQLRYAIDDDVTKKEITSPIANYFTGNWVHVVIQRDVVAHKMRIYTNG
ALSTEGDETAVTGIGEASDLIIGNIGELEFLSTANAPAPYKGAFDELKMFNYALSATEIY
ALYNQAVLGNEEFSISKNAGTVYPNPVKDQIFIQLPDYKKSTLTATLIDMAGRIIVKEKI
NSNGQGVFNLNIANKKISGNYILNVSGENLNSNFKVIGK
>KALACAFP_03765 Dimodular nonribosomal peptide synthase
MKSLKKHFNEKTVVKQEFSQINTGKNLIFNFEKQVKKNPTAVAIIDGNTKISYLDLDILS
NQLANQLQRKGVQDEEIIAILLPRSAQYIISVLAIIKTGAAYLPLHLSESESRLKHMITE
SACKLVISNRDDFDWKNRVEIVNAAEILHKENSIEEQYTISKDIHPSQLAYVMYTSGSTG
TPKGVCITHYAIASFAADPLWNAENQSKVLFHSHVAFDASTFELWVPLLNGGTIVIAKED
SFNVDYLVKLIAKEKITSIFLTTMLFNLLAQEKGVHLCDVNQILFGGEQCSEDCIDKMRQ
KLPDTDIVHVYGPTETTTFFSAYLIPSDEILTTVPIGKPMDKMCAYILDNDFKPAREREI
GELYISSAGLARGYLNQPGLTADKFLPDPFSLNGARMYRTGDLVYRNENGELVYIGRIDQ
QVKVRGFRVELGEIEKVLQSHPNVSQSSVIAQKSENGNQLLAYIVPDYSVEASSSQLKEE
QILEWEKIYDEVYQDFDLTSENSEFVGWNSSFDGKPIALPHMHEWLNMTLKRIKKLNPEK
VLEIGVGTGMLLKNLYEETEIYWGTDLSEKTIIKLNSFFEKEPVRSTQVKLFHQLADSID
TLPKQMFDTIIINSVCQYFPDVNYFVDVLNKAMDLLSPSGKIFIGDIRDLRLQRHFYTEI
HLHNKKITAEAQLITAIERDMMMESELLISPDFFAVWSKTRSDIGSFETKLKDGIFINEM
SQYRYDAVVYKKSGKEEKSLCCDKKILDWAHCDFQQVENIIKENKTDSLYIKGVPNERIA
AVLRATDKLSNNENLEAIQDAYAQCVKTEPQLAEFQTLAEKNNYEMSVVHPQSGNCAFVD
LVFIHKSLESLSYSKLYQNESLPGNLTTCANYPPISRKINQLLIQIKNHLQKKLPEYMWP
STIIPINKMPLTSRGKINKDSLLALSVYKNSGGRKANTYVEAIVCQLFGEVLGLSEISLD
DHFFEMGGNSLSVIVLLNRFRDVLNIDIPIKIFFENPTPAMLIKKLDFNSEISFQLHKQQ
RPNDIPLSFSQQRLWFLFNLEGANETYNIPMAIKLSGKLSKKDLTNALNDVIERHESLRT
IFYEKEGVPYQKILNDVCTDIEMMNVDKISLQSSINESSGYVFNLSEEIPIKAKLFCVDD
NTHILLVIIHHIAFDGWSLAPFWRDLSIAYSASLNNQTPDWNALPVQYADYAIWQRNTFQ
TEMENNSTIDRQLNYWNKNLDNLPALVSLPCDYFRPAKPAYKGMRKTFVIPSKLHNDLVL
LSNNQNVTLFMTLHAGLCCLLNRFNAGTDIVIGTPVAGRKGSGVRDLIGFFVNNLVLRID
TSGNPSFQNLLKKVKEQDLSAYAHQDIPFERLVQELKQSGTTSWHPLFQIVLAFQNQPQP
QINFSGIDSGFELMENKSCRFDLVINLFAENQTEKDIEGFVEYNTDLFKAATIDHFIESY
ILLLKSIVENPEYKIDELDINSNGLKNLYKKQSVTCEEEHFASLFQNQVSLTPHAVALSH
ENAALTYKDLGSAVNTLARLLISKGIGPEQVVAVSIPRSLDWIIATLAILESGAAYMPID
SQFPEERINYMLEKSRVSLLLTTADLVPVFSFTDKEKLVLDDPETCKTLNSLSNSKIQPS
ELSAPLLVSSPAYVIYTSGSSGTPKPVVVTHSGISQIMDAQKRQFKLNESSRVLLFASQS
FDGFFWELCSLLSGAHLVVANAEQLVAGKTLAETISKNKITHVTLPPAVLNLMDNEKMSD
LKYIIISGEAPGGKLLSKWVHNRTIINGYGPTESTVCTTLSLPLLPNTIPDIGQPIVNTS
VYVLDEFLQPVPPGVCGELYISGSGLARGYLDEPAMTAEKFLPNPFGNPGSRMYRTGDLA
RWTADHHLMFMGRADNQIKIRGFRVEPNEIETALETHPLVKKAAAKPGKDILGNNLLKAY
VTILDDKQDPSTLSPEKLRAFLKKTIPTFMIPAVISIVDDIPLTTNGKINYQALIDNDTE
KQSDKTLPSTTTENKLLILFCQLLDLTDIGIDDNFFELGGHSLLGAKLISEIHKEWSLEL
PIGMLFQYPSISELGKIIDTSFGGKNKIFQTPVSLLKNDAKRADSLFINENIPAYTIDRE
PECILLTGVTGFLGAFLLNSLLEKYSKAVIYCLVRESSLQKAKQRIVQNLSRYNLNHLLK
NNRIKPLCGNLSLDSLGLSSEDFDEMANKLDCIYHCGAKISSVSSYEELKKNNIKGTYEI
IRLASHLKIKPVHYISTLAVAFNNHDPEKILPEDKRLKANEIISNGYTQNKWVEEEMLLS
IHKKGLPISIHRPGRISGSCKTGIGNPNDAFWQLVAAMLKIQAVPVFREEQNLYIDLIPV
DYAANLIVHFSSDRNFSGKTTNLFHQVKFSLILETLRDMGYHLEKIDFQLWKDKLRHFAS
QNENLNSLQKALLLSDSLESIFKFSGVNYSTDRIKKEIQQNKIKLPKVERQLLTSYIKHF
ITTGFFPDPK
>KALACAFP_03766 Ent-copalyl diphosphate synthase
MKTKLNSTVKLLPSSKEDDKLIMQFVDFIINSKLQMSASIYETALVASIKDADNKPLYPE
LLAQMITLQSKEWRNLSIRKESAVSHQAFLCTLVLVNALLKFNTNQEHDECIGKGIQFIQ
KCIPIIKDDTINFVGSEMIIPAQIELLIEQTNGRTDLLHQENIPILKSLLSNYESIRKYK
LDNFSMKRPSATWFSLEALPENLLDINILNHFINKNGQFMSSPSGTAAIYKMNPDPRILK
YFEEAKNATANKGLPITYPMNIFESIWIIGALINSDFSNQFITKNFKPLLDMIEGNFSNN
GTGSAKDFPPDCDDTSRAVFSFSYLNVNSKYTVETLKQWYVENGKYFKTYHHEKDASMSA
NVHALQAFLESNDVSKTEKEHLWDSILTLLENNAIKESPTNIYWTDKWMSSPLYTAEGVI
YTIINYQDQFPQRKTNIHHKAINWILTRQKDSGGFETYAEYGPTMEETAYALIALVHYVR
YYKDQEILQNVEENTAFVQKLRVSIKRGFSFLEKNKEQIMNIDAHPPLWTCKALFTPYKI
SISYVLGAYFLSKHFLSQEELNLQKNSLSA
>KALACAFP_03767 Mycinamicin IV hydroxylase/epoxidase
MKKHFFVAITNEKNEFSVISENAFLPKGWKKISDIGDLETCISFLQNTWENLGNNGRCPV
SFPIHGVDYTRLEINPLQKELLRLKRLLWIRPPYGDSAWLISNYKDVRSILKDHRFSRQQ
CPFHNESRLTPHPLDTSIMGMDQPDHTRIRSVLDSVFNVKTSMDLKGKIEKSAHELVDVL
ETNSQADLVEDFVMPFSGITICELMGVPFEDRTRFRVWLDSFSSTTLLDADQVAKNMEAM
HKYMAELIEIKRKNLGNDLISGLTKANEEGKLSDRELIELITVLLIAGHDTVSAQLMISL
FVILSDTELTRQLKDNPSLSTNAVKELLRYIPVDAYVTFARYAKEDVLMDDGTLIKKGEP
VLPSIISANQDPEVFEEPESLDLNRKKNPHLMLGAGIHNCPGGFLGMIEIEIGICTLFKR
LSKLSLAISPEDIKFREGLQVRSIHQLPVNLN
>KALACAFP_03768 hypothetical protein
MNKSVQDQVYYTEKYMALPTPIFNGKFYSPEMSLLDVAKDKLIRATDALDFPKEQQKEML
KLIEEIWGKYDNYTIGNPPYHSFGSAEGAPIEFQICWDPEGPSFRFGSDSFALDHSTENN
ASEFYNTTRKLSNYEGVNCESSLAMEDYFKNGGRFGIGGHVVQWRKGGKPSFKIYFLHQP
DQGDENLENALKQLNAIEPWEAIKAHFKKLGFSRPMCGALSLDMKDPDKKSRVKMYIAHD
GHTAQEIDEISTIAKNYIPGAFEKAIVSTTGKSRDWEHPPVTYFSFFPGESVPSASLIFI
PLAANLENDAVAIERCNDFLELEGDQKNFVKGMKEVFKAFSHKPLEDSKTLNFLAYIPGK
QFSLNIGPGIFDNLNLQNHDL
>KALACAFP_03769 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MIYNGLKGKVAIVTGGSGGIGRAVVKRLAYEGVSVLFTYFQGKDRADELISELDNRQVNA
ISVDISSLSDIKRMFDLAESEFGGVDILVNNAAHLSTGMIEEITEPDYEYLMNVNVKGSL
FCIQQAIKNLRNKGAIINISSVNTVLPEPAAALYSASKAALEQFSCIAAKEIASREITVN
CISPGPVNTDLLVKHNSQEVLKQIAALTPLGRIGEPEDIAEIVTFLASSGARWITGQNLR
ASGGLV
>KALACAFP_03770 Enterobactin biosynthesis protein YbdZ
MNTEFTYNVVINDEEQYSIWPAHKIPPVGWKIVGKAGSKSECLNLINKKWKDLRPLSLRK
KLLE
>KALACAFP_03771 hypothetical protein
MKKESHQNNICEANDREEELYIPEANLNRIAVIDTVACKIVRYILVDDIPVLPFGSRPTL
LVAIPDGSKIYSDNFGLITSTVSVINRLTETVKSVIINSLPLGIFNSSNGKELYITEENH
RIEVICTETDEIVRCLHFENIPTACACGSNGNLYIGFANGTLGVYNSFSGNMLWQPLFSE
GTRPSVWLTLNADEKKLYAGNADGIEIIDTANWKRIKSIPIREKDAQHKEMPCSFTAFLS
PDGKKLYVTLTSNPGVTVIDMITDKIIKTIETTGLVTGIAFSSTGKRGYFSEIVPGMSVS
KTIEKAVLEASSQRSEITPTGQVTIFDTETDDIIGKPIIIGSAAGIPVLVPYISSYLIF
>KALACAFP_03772 4'-phosphopantetheinyl transferase sfp
MIVLYTFIDEHKHNYLLSRYLDTCSESFKNKIMKLRRWQDIQLSLLGRVLLKDGLNDYYS
IDQFDIDMSSNNKPLLKGENVHFNISHSNDLVVCVIADFPVGIDVEFLNQGINYWDFQSQ
MTLREFYEIQNSEDKIKSLFSYWTKKEAVIKADSRGLTIPLDSFEILNSQCLIDSKKFFV
KEILVHKDYMSNIASEKVEILDKEILFKRVYF
>KALACAFP_03773 hypothetical protein
MEDVEDVVQEILVHLWKHSSSLQDPKTLESIIFKTAQQEVSNFYRKNKMIFSFSDETLIK
DEADSEKTDYEFKKEQLKKIHSLLEDLPEKSKTFFYKNKLEKISYTQIAKENNISKTAVE
KQVNKVIRYIKTNLNLF
>KALACAFP_03774 hypothetical protein
MKDYQKHFEKVWKTVSEEKQEMDAATDSRIWRRIEGTIRRYHQRKYSWMAVAAILVPLFG
MLFFYKDFDLKLKETKNTFPTLVLQTNEASKTFRLSDNSVITLEPYSKLSIDEDFGKKYR
NVKFQGKGFFSIAKDKSKPFIVEARDFNVEVLGTKFLVDEKSEEKKVQLLEGKVKIDHNG
KLTYLLPNENWSSSPTKSDFHYYAVNAMRSFTFENTTFEDAVSEIENTYGTKITYPKKFA
KNEVSGSFSGNLKEILAIINYPFNLKTVFKNENEITLY
>KALACAFP_03775 TonB-dependent receptor SusC
MKKTAISIALLVAVGLPVHNYAQTQAGTPVANNQRQVSLVKILKKLEKSTNTKFFYSASD
FKNIWVDESKINYSALKPSLDYLKKSVPLEYQIQNNTVTFRKLASNNSFTENNIQPKNDT
INQQEKKIEEVVVVGYGTQKKSIITGSVSVVKGSVAEGQPVLSAGNILQGLAPGVTVTTQ
TGAPGGDAGNIRIRGINSFGGSDSNPLFIIDGVAGNINDIDVNMIESISVLKDAASAAIY
GSRAAGGVILVTTKRAKGNKLTAQYRVYTGWQRATAIPKVTDGLTYMKVFNDASMNDNGT
KIYSDDAINAFSEAYNKNPSNYDWQKAILQGSGFLQDHYFSLSAKSGIISVAPSFGYSKQ
EGIIKNTDFTRFTFRNNMDITPNDQWNIRMDLSFVNKDRKQIADEGTIWNYLGRMPTNIP
IYYGNNYSDGWVKINPVGFIENGGNRKQNNIELIGNLSVSYKPTDWLTLKGLVAPRYLTT
NIHLFRKSVPTYYEDGTEAGAANTFTELTESARRQFYGTYQFQANVKKDFGKHSFELLAG
TSRETYNEKILSGYRRDFLYDNYEVLDAGADNETKDNGGSEYEWLLVSAFGRFNYNYNQK
YLFEANVRYDGTSRFIGKNRWAFFPSFSAGWVVSRENFFEGLKGTISQLKLRGSWGKLGN
QNISSSYYPFSEPLSLGSTSMNGVVYQTIQQLIMSNPDLKWEETTMSGVGIDVSLWKKLD
LTFDIYNKKTDGILLRLNTSQLTGLQAPVQNAAVVSNKGWEIGAQYNERWGDFKMNIGFN
LSDVNNKILDMKGQSSGTILRQQVGSSVNSIYGFIADGLYQNQAEIDAGPTQFGTLKPGD
IRYKDIAGAFDANGNPIGDGKITDADRTIIGSTVPRYTYGFNMGLSWKGFRLSGLIQGVG
KVDGYLDSHYVIPAVNSSAVKPWQLDYWSPENTDAQFPRVSLTSTNNTQNSTMWMRSAAY
MRLKNVQIGYELPKSFIENTFLESMYIYLNGQNLLTFTKFYEGYDPEINYNAGSTDGVAL
GGGNYYPQVKTFSFGIDVKF
>KALACAFP_03776 hypothetical protein
MIKKMKNFLKIFLLIIITSCSSSDMDLEPLNGPTSGTFPASYEEGKMGLFAAYRNLSTLD
AASTPMWHVMDNITDIGYARPGTNYTSPITSSLTTTNALAIKPWEVHYQTIARCHAVLDK
LDGIAGITEAQKAELGSELRFIRAYCYSQLIELYGDVPLLKASVTLNNANVPRTPVAEIQ
QFIIDELGAVAPQLPISQSQFGNVRASRIAALMLKARVELYSKQYAAAAVTSKQALDAAA
GVYSLTPFNASVNYAGKDHTVGEPDPSNIFGHSGFSNSKEWIWVAEYNINVPGYLHNQQY
YAASRLGKGVCYWGPTQNLIDSYEMTDGLSILESPLYDETNPFKDRDPRLDMYAVRPHSR
YLGYQFEPNTSFVKINNYWSAGAPTQVANADATNAYRSFSGYLWRKVVDIADFNSTSVSG
NSDLGVGIFRLPELLLIYAEAKIELNQLDNSVYDAINQIRTRAKMPLLNPGMSQAKLRKA
LRYERKVELANDGLRWYDIRRWGIANTVMNGYLYLNRNANNWTKSAITGFDESANPIYNQ
SQASVYFTTQQVVYKINKDEYWPIPQSEMDANPNLKQNPGY
>KALACAFP_03777 hypothetical protein
MKKNISLLLVLLSAVLFGQEKFHAPKLDNEKSWSIILIPDTQNYVKWNQNQPILDLMVRW
IEDNISTLNIKMVCQVGDLVEHNNILNQGYDGDQSADDQWKSIQSILGRLNGKVPYVAAT
GNHDFSINEEGRRFSRYNEFFPSNFNRLNQKYLAQNFFNDAGAPSMENSVLELKGLNGQD
YLFLSLEFAPRNKALEWAKKVLDMPQYKNHKSILITHAFLNEKDKRTDKENSWFMYEPFL
VNNVPQKSKTIALPESNNGEQIWQKLIQPSQNLQLVLSGHISGEGFRVDSNKYGKNVNQM
LFDMQSEGGGHRNGNGGDGWLRIIEFYPDNKTVKVKTYSPLFGISPVTQKNAYKTDSRNE
FVFKFSE
>KALACAFP_03778 Quinone oxidoreductase 1
METNNQSGVIRIKKQGSPSVLEYDVEKIGQPTGNQVLIQQKAIALNFVDVMFRNGSFPLS
NFPATIGVEAAGVIESVGENVTEFAAGDRVGYFFSLGAYAERRLIDASELIKLPEDVSFD
QAAAVMAKGLTARMLIKQTYPVKQGDVILVHAAAGGVGSLVSRWAKALGATVIGTVGSSG
KKDYVLNNGIDHVIALDKEDLIESVKSFTKGNGVDAVFDGVGKATFNPSLEVVKSGGTVV
LFGSSSGTPEINNEILNAKEIKLIRPTLGSYLPDKASVNIAAADMFEALRNGTLGDINPT
IYPLAEAAKAHQDLESGSTKGSIIFHI
>KALACAFP_03779 hypothetical protein
MHQAENIYIDKCSNLFLTFINMFKNFLIFIVLLTINTFPLASVSFEPLYTYIESKSALTL
SDEEKTLIQNTFKPKHLRKRQYLLQEGDICKYMSFIVKGSGRMFSVNEKGQENIMRFAVE
NWWLGDYESYNFSTPSLYNIEVLEDSEVLMVEHGSMQELMKAILAVDLMIKEIDRRGAVA
TQKRIHSSISHSAEERYDTLIKNYPEFLNRFPQSMIASYLGISPETLSRIRKNMLKK
>KALACAFP_03780 hypothetical protein
MNTSSTLLQDSLLLIWNNRNSAERIALMEKIYASDITFYESNDSEPFVGKESIDQLIQTL
QKDWPSGFEFTLTDTPKSNHNVQQISWQLGIPGQQPAATGMDVAIIENGKIKALYLFLRQ
>KALACAFP_03781 hypothetical protein
MEISKAVLLYLKAFLNIIKEKNYERFIMEIINIIQKIEQTNGKYSSLICRNELTLIQLIK
MYFYTDVSLVEVH
>KALACAFP_03782 hypothetical protein
MMKLKNKIRLLKAGIVMLLFVTQLKAQIGIGVQDPINPVEIKTDAGNVIIDKNGRIGVLV
TNPKVAIDLRSGINGSIAVGNTDKTAVQAGAGALRYIASPAIGVKGYLEFSDGTNWISFF
PKGKPRIVVMASKTTQDTYVFESTVPSELGTKSGIVQRRSSYITNWTEKLDSDSGVPTSN
FNPSTGEFIAPRAGVYFATFTFALQSSQVNTGGNNQTEAIWEVRNSSGTITQRVKTNNGY
ASDTGASPNAVPVGSACTVSVYLNKGDKLRPFTWITVAFDGTISQFDTSGNGIYNALTIV
EQ
>KALACAFP_03783 hypothetical protein
MKNRDNMKYRLLAYVLIFSAGKMSGQVGFFTPNPVHPLHIDAGKDNGAIPDATKLSNDVV
ITSGGRLGVGVLNPVTKVDVRSADNEGIIGIGTNTQTAAEAGAGALRYNAGGFLDYSDGE
QWISLPLAPPTKALVNANKSSVQSISSSVSTFISGWTETVDLGTVAGGDFDPANGIFKAP
RDGFYLVSFSITLASGNIPKNTFIETAIESNQNTENIPVFKTVNSYPAFQAGSVSNYISG
NCNAIFNLKKDDTIKFSIKHNIGSARNTLNDARLNNVSISEL
>KALACAFP_03784 hypothetical protein
MTLIQIHKGINKRLILSIFCCCSGFFYAQIGIGTENPKGALHVDGARDNASIGTPTGSQV
ANDLMISKSNGFMGIGVLNPIVKLDMRSSDTENAVGLGATTMAASAAGAGAVRYDVASIP
VGAKIEVSDGSVWNKAYVAPQKAVVVVRKITSQSIPQGSATVITNWNVIRDMSNSFTPGT
GEFTAPRDGTYTFLLTFNFTGTVINDGSRVESQFYNPVTGNILASVYKTFGQSMTGTADD
ANSTRSTQAGGSSTVTLTLAAGTKVVTRLYQNLSSGAVSLRVTSNSSDPANPDDGFNNLT
IIEH
>KALACAFP_03785 hypothetical protein
MDKQISSHTKTRIGQEGKRPDYKRIYTDLINLKYPEKKDVCNQLLSKGSLSTLDIIEINE
ILFSHNSKENREFNQSHRSYSKSTIFQILEYQKKNKLNNSQLARHFKLSRNTIMKWRTQF
LV
>KALACAFP_03786 hypothetical protein
MILDLKNIHIGDLVSKRVEEKRMDALRICKFLKCTGQEWETMQSQKSLDTETLLRLSTLL
EYDFFRVYSQHLILYAPQSNAHYNSVTNAKSLLPYYRKNIYTREIVDFILEQMENGTKTK
RQITEEYKIPKTTLYKWINKYHPIQKQE
>KALACAFP_03787 hypothetical protein
MKKYLTIICSLGFFLANSQIAIGGASVSSSHTQLELRNSGQKVLIFPVAENETILPKYNA
SQPDKYDDDASMEAMLMYNKAESITRVYDGTKWENAFNTKNSSTTWTRASINSTNMTCLS
TSDLFGQLLQLCSSDNLKFSVPGNSSQFSDYLSVVRNSETFRIRQKGLYRINFNVLFSGF
TAGFDFNGARITIVVVVNGVEKAYMSGKASPFINVGTYLASADGVLFLDVNNDITFRLVL
DGSSWSISSYNFGGTPESSVSVERIL
>KALACAFP_03788 hypothetical protein
MAAALMVATFSDAQVMISKIAGSAHPNALLDIKDATKGVIFTRAEDITAFPLYNNTVEDY
FNDEPALEGAVLYNKEDKQYYKYDGTTWIPALQLGGWYNPFLTRRKAGASKTWNCLGIQV
PNPFPPFTPITISTCSVLALFGSNSKQTISLSPVIARSQLLVNNLGTTMPTNGSDNVIQI
PQAGLYHISGVTGFEGFSLGSLGKDATFWVSIDVSYDGGTTWSTLAFEETRLYGGVFIDL
GQGGNKSASVSASVTLPANSRIRLQAAVNTDSVLSTFSNSVDHTETFISIQKLR
>KALACAFP_03789 hypothetical protein
MKKHYFISLFMYGAFWQAQIAIAPDPSDHEPHKNSILDVKSSTPSKAVLLPVVSQITDAA
DPDNDNNYRGAVAYSKTNATVYEHDGTNWSSIYNYVVEIRPQYLAHFSRSSNLNLSCNGG
FLPPYGCTATGIIPLVSNGSLDFQGSFIHLSLASNIVTVNETGVYRITYRSYATFNGLNT
DEIQLRLQKSAVATPTVFSTIDSKSFTSDNDNLGYSPVFNGSIVLQVNAGEKFRLQGFMQ
SGFSPLVNSSTSFQNNNTYGTGELIFEKIVL
>KALACAFP_03790 HTH-type transcriptional activator RhaR
MMLIKKIILFLACTILSFTKAQNYTESQIDAEIKKARILSINKPNKSIELCTKIYRISKD
MGYKKGMLECNNILMAKLYDAGDFKKVVDISREAETLAKEINDNVTLSNTYRLRGASYTE
LGFNDECLKELKKALRTAEKITSKNDKNYLEALIYTGFGSYSAHINAPMDSLIYYAEKSL
KSTMAIYEDKNFVTKKYYNLAVSYMNLGMLSVATNRIKDAEMYLSKSLEISQNEKYLVNK
NIEVTVLNEFAWLYYDQKKYKEAVRYAERAEALEKRISIPYIRRDIYEVYFKSYVELGEK
ETSKKYMNLYTKLNDSLVNVEKKAINTPVKQIMSEQGESYTNNIQRIILIALGLLISVLA
VGWFFWRKNQNKIHEKYKNVIANLKNEADAKQSGFTLAETDDKVAENTLSISEDTTTELL
RKLSKFEKSEKFLKKDTNLSSLSNMLNTNPRYLSEIIKQHRGKNFNNYLNGLRIHYITNK
LYETPVFREYKISYLAEFCGFSSREVFAVIFKKETGVTPSYFINQLKKDNGQPEVV
>KALACAFP_03791 Exoenzyme S synthesis regulatory protein ExsA
MKESSIATCYMSPSPSTEQFIPDHCFMYLISGSMLVYDGHKEYKIRAGDYGIGRRNHLAK
YTKQPDEGAFKKIFILFEQDFLKAFNDTYGFIAEENKTTGAIIPLAKDKLVKNFMESITP
YFNDNGIIDEQFLNVKQTELLLVLLKVNPQLANVFFDFTNPGKINLEEFMNRNYRFNVSI
ERFAYLTGRSLSAFKRDFEKIFHTTPKHWLVQKRLEEAYYLIDKKRKKPSEIYLDLGFEN
FSHFSFAFKKLFGHPPTQLIQKSDMNR
>KALACAFP_03792 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase
MTNSNNGVNVLVTGGSGFIAVHCIIKLLEQGYKVRATLRSLNRQNEVKDMLKKGGISLFE
NLSFIEADLSKDENWDKAVQGCSYVLHVASPTPIVNYKHEDEMINPAKDGVLRVLRAARA
AGVKRVVLTSAYGAVGMGNTNRTTPYTEKDWSNLKGNLHPYQKSKTIAEKAAWEFIHNEG
GGLELSTVNPVAVMGPVLGTDYSHSNQVVRRMLEGEIKACPKVYCCYVDVRDVADLHLLA
MTHPKANGERFLATTGNALSMLDIAQILKKNLGEVAAKVPTKEMPNWIVRIAAKFNPSLR
MLATLLGKYAETSGDKAKQLLNWSPRSNEDAIMATADSMLQLGLIKK
>KALACAFP_03793 putative oxidoreductase
MDLKNSTILITGGSSGIGLEMVKQLSEQDSKIIITGRNLDNLKETKKKFPEVHIFQSDVS
KPQDIEELYKAVTTQFPELNIIINNAGLMRLIDVQDQTLDLENVNREIATNLSGTVQMTH
RFLPHLLRKKSAAIVNVSSAIAFMPFTIAPIYSATKAGIHAYTQALRLQLEETNVKVLEI
IPPGVNTNLQNGWVIQPKESQMMDVDKMVNIIIKGLSKDKTEIMPPLIRVIKLASRLIPG
LLIRFGHGEFKNFKKINHNNQN
>KALACAFP_03794 hypothetical protein
MKKSLLIVILLMVSIVSFAQKLPADKIIGVWQSIDSDTQLKFEFYKSGDKYFGKLLFASN
MYEADGKTFKKDFKNPDKKLRNRSRYGITNITNLTYDEGEYTGGNLYNPEEGRNYRVKAK
LKNENEMEFRGYIGISLLGKTMKFKKVK
>KALACAFP_03795 hypothetical protein
MKNNNDKLSRFWFIVSNALPPIGFFLYFKHRNQYPNKAKSALQSAAIGIPIALVGGYILN
NYILK
>KALACAFP_03796 hypothetical protein
MIKNIISLALLIISVSLSFKHGWDTFNYRNNPESVKIMNELGINESFIPFFGVLAVAIGI
LLLIPRTFFLGNMLNAISILLIMALALRSGNYKMALIEIPFLVMPLLMIWLKYPFKN
>KALACAFP_03797 HTH-type transcriptional activator RhaS
MEKFTPYRIQSIAEIHRLMGYEKPYHPLIGIVDLATLRDNPGINAVIFDLYVIALKRGCD
KLMYGQQKYDFDEGLMAFMSPGQVLRGEEGGVPNNLEGWMLFIHPDFLWNTSLANKIKQY
EFFGYASNEALFLSDKEEKLINLIIDNIKGEYRSNIDKFSQDVIIAQLELLLTYAQRFYE
RQFITRKITNSKILERLESILEDYYRQELTVGLPTVQFVAEKLNISVKYLGSLLKQLTGR
STQEHIHEKIIEKAKEKLSTTNLTVSEIAYELGFEHSQSFSKLFKAKTDQTPLKFRQFFN
>KALACAFP_03798 Diacetyl reductase [(S)-acetoin forming]
MSKLKNKVAVITGGNSGIGLGIAEALKSEGAVGAIVGRNQETLDSSLKLLGDGFIGINAD
VTNVEELERIFKTTSEKFGKIDILVPNAGAGAVGTVANTTEADYDQLMNLNLKAVYFTVQ
KALSYMNDGGSIILIGSNAAHRAYASFTLYGAAKSAVIYLAKGLSSDLLDRKIRANVIIP
GTTDTPAFNKFIPADQVDAVKQQFADVVPAGRIGKPFDIGKAAVFLASEDSSFMLGAELL
VDGGMTYLVK
>KALACAFP_03799 hypothetical protein
MSNFEVFYDYIQKLSGEILSEDEKSVIETHMKPRKFRRKQYFLQEGDVCKYTGFIVKGSA
KTFSVDEEGNENILKLSIENWWLADFESFYQLTPSHYNIEAMEDLEVLQVTNAQVEEFFK
PISAFSAMMEVVKQNHAIANQRRVQAAISYTAEERYADFVRNYPHFLMRFPLNVIASYLG
LSPETLSRLRKKINLK
>KALACAFP_03800 hypothetical protein
MIQRQKFLGWMLMLAVTAIGCQNDQISSTSMAEEVSSKTNANKTAADVSVNAYVDTSSYI
NSGFGFLNPSQIDKNRQAIGGNAYTEVYGFNIPEENRVRGIRWNTDDETTSIWRPQGIAG
FTKNGVRYLLVSWYAKDDAEYKGSRITLIDISPSSSTYLTYRHILLVQPDIPASTTTYSQ
YGSYAPLNVHAGGIAYFKDKIYLSSTNLGVRVFDLNKIIEVSTGDTTNDKCGKDANGNLF
AFNYRYILPQIGYQKINNASPFSTIQVNDEGTQFWTGQYYAGSADASIVPQVFGFPVDAN
GTLQNTGIVAVTPKNSLFTDNHAHGIQGVFRKGNRTWLSCTGSPSNSYGSNARLARYTDG
ADDTVRFRWPYGAESLYYESQYGYLWSLTEFEPNAGAQNGSQVNRCIFAVDFSKYE
>KALACAFP_03801 hypothetical protein
MNISIKKVIDFGHNTERIEFLILSNCNISYYLVSDTTFVTPDKISNKLRHIYWFPSKDVK
RGDEIVLYTKKGINKSESINSGQNTRYIFYWGLESFVWNNSGDSAVLFELNTWKTTKIIN
>KALACAFP_03802 hypothetical protein
MKKALIIGVNYYAHHKSLHGCVDDAYEVKNALERNADFTKNFDVFFDTAVDENTSITKKH
LKHYISELFKDDSEVALFYFSGHGHLEDTGGYLVTSECEDGDDGVSMKEIIDMANNSKAK
NKVIILDCCHSGHLGAANIGNSIFLSEGMTILTASTADQYASEVNGHGLFTNLLVDALNG
GAANILGHITPGSVYAHIDQSLGAWKQRPMFKSNVKNFITLRMLNPSITLPDLRKITELF
NNKAEHKLDPSYEPKSENPDKDNCEKFAIMQKYNRVNLVVPIDAEHMYFAAMESKACKLT
ALGEHYWNLVNQDRI
>KALACAFP_03803 hypothetical protein
MNKTYRLFISHSWAYSDYYDQIMKLLNAQGLDYYDHSVPKHDPIHTNGTDKQLKEAIELK
IKGTSCIIILAGMYATYSKWINKEIELAKAMGKKIIAVQPWGAERTSKVVKDSADIIVGW
NGKSIVDAIKSFG
>KALACAFP_03804 hypothetical protein
MFYTKSYLRNLSESERIGNRTFSQTLNESKSLTHFDIFLSHSYRDKEYIKGLFIELASMG
YTVYVDWIIDPHLSRANVDKETVSLIRRRMQQSKSLIYATSENASVSKWMPWELGYMDGE
THRCAILPITDYEKSTFNGQEFLSVYPYVTKESVSGLVKNNFSSNKILWINENANNYMTM
EKWFK
>KALACAFP_03805 hypothetical protein
MITNGYHYNSFTMSLQIKYSKEIAKELGKVAVYLPGELIEVGDIITFPNGKGGIFSKEAP
LGVFTKISSLNNLNVEYSTQSKPEAKHSYKFSSESSVSRSSSINSEVGLSSNALPNADIE
VVLQFTSEGSIYFHALDCYKTQINDIASLENEIISKSQVLIWENTYLVTSVTYASKALIM
QSRSKNSEITLSGNVNGIKTSGANIGTDAEFNIKSQNGDFFIKDWSNNVSIFMELMKFDK
QIFQAINRNLNPKQIQGRLTPVDINSLLI
>KALACAFP_03806 Transcriptional regulatory protein DegU
MINIVIADDHEMILEGLESVIKNDDNLKIVGRGFNGKEVISLVNTYPVDIVVLDINMPIM
DGIETTKLLKERNPNIKVLILTMHDEIAFIRSIIQARANGYILKNKGKEELLIAIYRILD
GKDYFSDEVTQSIIANLRSDHVVGDIRLTNREKDVLYLIAEGLTTLEISEKLNIASTTVE
THRRNLLEKTGVKNSKALIKFAIQNGYSKPL
>KALACAFP_03807 Signal transduction histidine-protein kinase/phosphatase DegS
MSFFSVLTAQHKIIDSLVLVSQSATSADTIKINANNELAWEFRKTNFTLAKKYALEAYVL
SQKCNYLPGLITSLNRLGTVYIFNKQYSQAENIYLKVLKLETKIGNKYGIGRASNQLSEI
YRNKKNFKKAISYATRALIIFKELNKSSLVALILNNLGLIYQNIGSYEIATKYLLQSLDI
REKLGEENNCGYSYMNLGVLYLTMKNYENAKTYLFKSEKIFIKYRDDYELSKIYNNLGVI
FFETGNDNLAKGYYEKSLGLKKKIGIKNTDSDIYNNLGAFYYRKGIIETANNNFQKSLSI
QNNYISKDQLKDATINLGNLFFQKQDYDGAIKYYQKALKTSKNSPNRIETLNALYNLYLS
YSYKKQYDSAMYYHKDYNSLRNNIDADYKKAIDLKQKYEQKKKENELLIKNQKISKINIE
KLSLENQNKNILIYTLSTIFALAALLFFIFLRWKGEKQKAELALKDKKLEEKKLEELIKN
QELKSINDMIKVQDEERKRISQDLHDRLGSMLSVAKVYYKSGEEQMKKNKKFDFEQFQKA
NILLDEACQEVRKISYEMSSGVLTKFGLIAAVEELLIVIQQTKKMKVEFIASDIENRLDS
NVEIQVYRIIQELLNNILKYSEAKNVTVQILKLSSILNVQVEDDGEGFDKTKRSKGLGLN
NINSRVQSLAGSIDIDSALGRGTSVNIEIPINSYI
>KALACAFP_03808 hypothetical protein
MEEQDNVTNEPVQTQEGDLNTNEPINANGSTENLISNNGSTPTAPVDPPPTTSPQGAGEI
IKPTERIEKNPKKR
>KALACAFP_03809 hypothetical protein
MKIHHQNSLILHIISALKTSLTGRGIRELYNIKINRGYYDSTIEFSKKDGKSINPLDFFM
LGYFVGRDYDV
>KALACAFP_03810 hypothetical protein
MAKTLDDIFNEDDFGLLDSNEKKSVIKTDEDRLIESFEEINSFFEKNKREPSTASIAEYS
LLARLKEFRSNENKIKIVKPFDRFNLLGEVKYEIPSIDEILNDDKLGLLDSDGDNSIFEF
KHTPQIDKRAKAESIAQRKSLSDEEFAKYEMMFQNVHRDLKSGRRKMLPFNDAETNLKQG
NFYLVDGLLAYLELSDAEKTLKENKTGDRIRLDGPTTTIFENGTVSNLLFRSLGKAIQKS
GKLITQPLDDIEKDLAVNAGMMKEEDIESGWIYILKSKSQRPEIKDMGNLFKIGFSTIPV
EKRIKNAVKEATYLYSDVEIVAKYRCYNINTHYLEKLLHRLFAASCLNIDLYSTSGIRIA
PREWFIVPLSVLDEAINLFMIGSIINYEYDIHNEKLTLK
>KALACAFP_03811 hypothetical protein
MEKENNSDYIKPINLVKVEYAQTGQSKKTNEMGMREMQAKVYEARTAKYLLLKAPPASGK
SRALMFIALDKLINQGIKKVIVAVPERSIGNSFSPTELKKYGFYANWEPNQKYNLCTPGS
DAGKVKAFHQFLQSDEKVLICTHATLRFAFEGLDEKKLNDCLITIDEFHHVSADGDNKLG
NVMRNIMANSNAHIVAMTGSYFRGDSVPVLLPEDEEKFVKVTYNYYDQLNGYEYLKSLGI
GYHFYQGRYYKVQPERNMSALEEILDEDLKTIIHIPSVNSAESSKEKYEEVNHVIDCIGD
LEYQDSETGVLFVKSKRSRRILKIADLVNDNQKEREKIVAYLRGVSSPDDIDMIIALGMA
KEGFDWPFCQHALTIGYRGSLTEIIQIIGRATRDSSNKKHAQFTNLIAQPDAVDDDVKLA
VNNMLKAITASLLMEQVLAPNFKFKPMDNDNDDLDNEEEDDKATIKIRGFKTPTSQRAKD
IIESDLNDLKARILQDDTMLKALPGNLEPEVINTVLIPKIIREVYPDLSEDDVEAVRQYV
VVDSVIKNSTVEEQGSKKFIKMAGSFVNIDDINIELIDRVNPFQKAFEILSKSVTTSVLR
AIQDTINITKIEMTEQEAIILWPKINAWVKETGEKPNIQSTNPIEQRLAQALLFIQDAKR
KKMQNG
>KALACAFP_03812 hypothetical protein
MKIQELKEKLTVLTKNFNKENFIFDFLISFGISKNIITRLKKGDSNLSKKEGELLYKNKI
FFKEEFSGNLLDVIDEAAKDDKILKHNPRFILVSDYETIVAIDVKLKINKRFSFSELPDQ
ADFFLPLSGAEIYKVSTNNEADRNAAYKLGQLYDILVQDNPDWVAAGSHQLNIFLSRLLF
CFFAEDTDIFSVKNIFTETLVNNTNEDGSDVDQFLNTLFRKLNSKTGDFPEYLNSFPYVN
GGLFKDDIISPKFSKKARNILVESGELNWSEINPDIFGSMIQAVADPEQRSNLGMHYTSV
ENILKLIKPLFLDELEDEFDKNMDNPKGLRKLIDRISKIKFFDPACGSGNFLIITYKEIR
NLEIKIIQQIIALEKANLFGGQSFVSNIKLSQFYGIEIKDFAHEMAILSLWLAEHQMNLY
FDEKLEGFGKSEPILPLKEAGNIVSGNAARINWEEVCSKNEGDEIYIIGNPPYLGARIQD
EEQKSDMDFIFNSFTKYKDLDYISIWFYKGSKYIDGYNAQLAFVSTNSISQGQQIALLWD
KILRNNIEISFAHTSFKWNNNAKGNAGVTVIIVGLRNVTNKQKYIFTDGVSKPAKNINAY
LLDASNIIIPERMTSISGFKKMNFGNMANDGGGLILSEEERNNLISNLPLSIKFVRKLVG
STEFINGINRYCLWIDDEELEDALKFEIIKNKIEISKTHRLNSRDKGTNKLATRPHQFRD
RNEAFENSIIVPRVSSERRSYIPLGFLDKDSIILDSAMAVYDAQPWLFGILHSKMHMVWV
DAVGGKLETRYRYSAKLCYNTFPFPDVSEKQKLTINEYVFAILDERAKYPEKTMAWLYNP
ETMPKDLKHAHQNLDRAIEEIYRMGNPFTSDAERLEHLFKRYDEMTKKDTLFAKQKKTRK
KKSDLS
>KALACAFP_03813 hypothetical protein
MRNMEKEERIFIRIQKYRKESWKKLCFKKQISLSSLIIDSVENRVFDDERRKILAFIEKQ
DNIFVRIENNINQVARIVNTQKLMNIEALKGFNEKLKTITELKEQQNGIFTKIYSLIAND
NQFR
>KALACAFP_03814 hypothetical protein
MHIFLVSLIDKKVQEAMVKFSNLPIQTSVLTIRSLEELLYHSGIMLKTYIKLLKTLHILS
KDYDHYYRRPLLIKHTLNTVVIENSSAINKDYLQAIQNRVLPYLQDDTSDQPTIIPLHIH
FTTMRETFLFSGISICKRDKTVAYSLLHETAMPNSQIQGYNIPKYLEELWDTYLQNPSIS
LRALCSLHRKSYTGFQKDSKHYLGTTFYHFYQQYKMLEVLDDLMLTDLSIKEIAYKHEFT
DYSLLYKLFHRKYSFPFKDIPRLVVENIMLR
>KALACAFP_03815 hypothetical protein
MKIKQFLKTNVMAIAALVLFTGSIMSFTLMEKKSVLATTYFYNSADISAGAFANPSHWNT
TNASDCETDGERPCSIVVPDGQTLGSVLAGKTNAQVLSMSPNRKP
>KALACAFP_03816 Thiol-disulfide oxidoreductase ResA
MKNIFYRGLLSLVFTLMLTLPAFSQQRKLKIGDPVPSSVWTKPLEVVNHPENTLNLSTDK
NKLILLDFWNTWCSACLKGFPKMEELQKKFGDKIKILAVSNQDRATLEKFFTTKNGQRYK
GVVSVTGDKLFHGLFPHKGVPYIIWIKDGKLLNTTDGAQVSEKTIGEVLGGGNSSLQTVV
QIGRERPLMLSEDFDREKGLSMMNYSLFAKGRIRGMGFGSGFHREGKTIYGRQFTNLSLL
EIFSTLADEIFQKQKESFSEKRRMIEVKNPAALDYIKNAEGGVEDHNLYNYEYIVPLAKA
DSLYPLMLKNLSQFAEYSANIEKRKVKCLVLKRTSTVDKLKTKGSEMTFLFSLSKTDVQN
TSVYALVNSLNAIPSVSLPIIDETGYTGNIDLKIGAISNAASIRKELSKYDLDLVEAERG
LNMLVIRDKYAAESTVNTKKRSGHWPDLPLTNFSSN
>KALACAFP_03817 hypothetical protein
MNQVNRRIVEYIRDEWVIPMNNNSRFAIEHDIDEKTVRRIREDETYQISLNTIMKICDTK
NIKLSDFFKMVGI
>KALACAFP_03818 hypothetical protein
MQVKVYSCSRCVGMSSRLIKYGKTSYGKQRYQCKSCKITSVFEYRYNAYRKDINQKIILL
TKEGLGIRSTARILKISATTLLKRIIVIANNIFQPAIRYYQSYELDEFKLFVRKKSNPMW
LVYAINKTTKHVAGFYIGKRNNKTLNAVVKTLLNSKARIIYTDRLRNYQYLIPKEIHSTK
RFGTNGIERKNLNLRTHLKRLNRKTICFSRSLLILNSILKIYFWKY
>KALACAFP_03819 hypothetical protein
MQNKIIVKISEDDESVGYVYLPNELDEEKKKVKKTINLSDVIDYEGVPIYLDFNEDGVLL
GIEIVG
>KALACAFP_03820 hypothetical protein
MWIDESEGTILHQGVTNRDHVSNMLVINYSTENQCYIFFKKGSRKFDSKSIPEYIIMVI
>KALACAFP_03821 hypothetical protein
MIEPNKISPPVFFLNRPEIFQIRNVEEYRLFLESYCLGKQLDYFHFRVKFDKFLIENNAY
GLKYNEHTNCPNWVTIIRFSSSSDDQMSLSILKSELKEFIEQNKDDKKNSEIFSIT
>KALACAFP_03822 hypothetical protein
MIELVNFIVHLLRRPKMFFIQEVDDFYFMISGYIAGKEKEEYGVFMDEFSKYLSRKYGFK
DGTRYNLIIKSMSVYDDVTLDFLKDEMYYFLNSEEIKTMEFWQFIDVAELKKLSSDIAPL
GADEC
>KALACAFP_03823 hypothetical protein
MKINLKRLPVTKKSCLLVCFFGCMFVFASFTKEDRLRVRAFKENLVSKLTDKKNVDSLHT
DSVKESVKEPLAKNDTEKASRNILDKNNLSDSEKRNKLSFNGDHKVWSNVISYPSKEKEG
TIGTFSDKEEDKISDNFFTIDVSGVNKDNKTAYLEYDLFGLASYQSVPRSINHNVAIGGN
VIIPNARWSRQREAISADLIKNGINTILFTSPSEGVKYKIKNLKIVFDKDTKYSGLIVNP
IVSKDQLYITGNSVATKDLTINGENISVKNGEFEKLIKLSENDKLKGGFSIIENGSTTYY
KIPAEINSFKTLNANYFNAKGLEISQDKEVSIDYEGINIKVEKETSESAYLEVLKLRGKD
FPATSQGLKNVTVGNSAYRLSVVSGKLDKKVKLTIPYDEKRLGLVSPKEIKTFYFDYNEK
QWKIENTAVVDEKLKTVTIETKGDGDYINGIISVPESPQTNAFAPTSISGLKAGDPAAGI
QLMSPPVANQNGSAAISYPVEIPAGRNGMQPSVAISYDSSKGNGWMGEGWDISGISSITL
DTRWGTPTFTSNEESEIYVLDGEMLMYDGDYLPHRQIDDTANNTFNTTRQNRNSSGVKRF
FLRKGNNFTKIERYGTSPSTYRWVITGTDGTKRYYGGDESAVNNTAVLTTEDGNIVQWQI
TKEIDVNNNNIKYYYDNVKHVNFVDENANLNQGKSIHINKITYTGLNDEDGLYSIVFRPE
PVRGVPNTSLRPDMIIDAKQGVKRIEPARLLAINTYYNGSPIRNYTFDYKIGAFYKSLLQ
TISTNGVSYNLNYHNDTGSGGSMLFGNDTNVSAPNTDAFSGAVNSMLTPSKISATNNLEW
GWSLRIGAGLGLLRPHSTGDKNFMINGFGGESYSNVKGSQELIDFNGDGVVDILYRKRNG
DEGLKFFPGSVDSSGNLTFNAAQKDVLNLRSNFSRTIGTTWNAGATVLFNWWKMGFDFTK
SWAQSESETPIYLIDANSDGLPDVVNDGKVWFNKLNSNGQPELVTTSEATENMVITGNTP
IPYTEPEDPADENEEPVKAKNDVVKVWIAPKSGYVKIADNISISGTIDSNAKAVYSIEIR
NPDALPKNGRLYLTTLAGGNSNIPVQIQHYNDYPSTPLGITNASRIYVNSGEKIFFRLHK
KKGINYIVNTRPSVRYTDSNGAFIPDSAEEEQDGFQPNDLKYEDKFLLNNLIKSIKYTKA
GSAKIKIPKFDVSRLNDDVTFSIILSKATVTDPSTDIIEVYKKTYNESAGVVSIAAVDTG
FSIPTDDDWRLKFIVQSDSYMNKELEWKNIEVNSYYNKIVNDVAQYPSYYVKNFSKKFNL
SALGNIPSGSNDYSISVNKSFAFAPVLTGAFTYVIKRNGHVLGKRQVSIATTGITESNMS
GSPISGINPILFYTGNPAQGVSVDQRINILVYCNTYSDRVAYEALKNQLQGNIFNIYYGT
SPQLLGATTETSLNAAEFNGISAVYHNWGQFIYNENKDVKIGNNPLNPPGGPKDIPTGPV
ATSGPDYTLNPTTPKDQYGMLINNDYLDTLFGSFNYDYSSCSGSANATEYGDCVGDILQA
NFQNMSNNILQAYSPIVPMNTYYKKDESGTFVEKWINNQFTEQYSMPTTFRDEENMMPFF
VDDDPDQPNIEVAGNINTRMFAISKKQKSKSKTTNWGLGIPVISNSYTQLRGYGNINTQD
FFDVNGDGYPDMLYRTQSQLSNALGGLKGAQGRNLENSGDSVISNNDSFQKTQTIAFSPS
AIKDIARNTSNNNSDAKPDTSPSWSGGLSFSDYPDSYDKGLEYWIDINGDGLVDRVKEIN
GVYQYKLNYGTGLVNNPYEDFKDLATNSSAPVGSTSVSIGGGLSGMLDTTSTYSAGWGIS
GSVSASSSSGTSKQTFQDINGDGLVDILTVDSGLTVRYNLGNKFSSPVEIRKGANLFGNP
VDFRNEVKTYNGALGLNGGFYVNIPILTIFGATILYFRAGADTSANIGLSVSEINKALRD
VNGDGYPDLVMNTGGGMTVNYSKIKRTNKLASVTEKSTNGTFLIDYGFSKPSYQDPHSRL
VMTQITVADPHIESYSYSMSNTSKNLVTRFSYENSKYDRRERTNYGFAKVTIERMNGSNV
SSKVIQTFYNSNYYNNGLLRTNEVYRGSSLLSSKTENTYKLYKFINNYTQIEEIPSQFES
YDSGGTEGRKMATTLLAATENTSIESSGSIVTNSTMDYNNKGQLAKYKYFSNLPEGNYSS
SISYHTISSLLAKNILNIPSEIKVFDSNNELKRQRNTEVDTSTGDITKVIVKLNSGTNAE
TLMTYDTYGNIKTIHYPNDYSLTYDYDTTLNKYITKVTDSFDVESSSTYDPSWDALLTST
DVTGNQMTYTYDSMGRLTSILAPKEVGVSPYTVKYSYFLSPMIVNNITVNLYGAVTQNFD
PQHPSNPIETITLSDFAGNAVQVKKDIEIDGIEKMSVSGMIITDLLARPVKQYHPTFENK
DDVLNKKLKLTLAQYFTSTEYDELDRVISSIDEVGHATNVKYDIEGDYYKQTAAQMQNGS
VELKSDQLTNAEGKTVFTRNYLGASSPLVTTYNYNSIGELLSTKDAEGIITKYQYDMGGR
RTVEEHPDHGMSRYEYDKAGQMISRTTDNLGSAGLSDPFIHYNYNRNRLVRITYPPLPSG
SPNPNDVFYEYGSTGNETAKLITKQDGTGTTGYAYGNMGELIQESRQVSGYNIPNMNFNT
LYEYDSWNRLKKINYPDFEQVTYLYDLGGNLKKVSSNQYGDYIKDIQYDEYEQRTKIKYG
NDTYSAYTYLPERRLLATHKLQKDSFATYLDASYGYDFVGNILNISATGGTTPNSMGGSY
EYIYAYDAFNRLTSSTGTFLGNIKAGTNIGNMTSSYSTELSYRAANGIDVKRQNHVLDGS
TNPVNTYENIYEYIDGTHKVGMVQDGFTGNEEKFEYDANGNPTLYLTTTDGPKNMFWDEE
DNMKAYYAAEQGFFQYYAYDDKGERTIKYNLDADAALYQNGTIIDPGSMLMTSYKVYPNP
YNVITSDGKYTKHYYEGSKRFASRLGDNPGIFFKQGVAPTKNTVDPQVDFKNYLEKAGVD
AKGIETEFAKSSAQNGLYYLHGDHLGTTSFVTDDNAVPTQFFLNLPFGETFAEQQIQGKY
ENPYKFNAKELDSETSLYYYGARYFNPRLSIWYGVDPIAIWNPVMENEFYGDGDHNAGVY
YHGNLNPYIYTYQNPVKYIDPNGKQVDWQKYWNQAKEFANDAGDVLGQVAHNIAPVRPAT
ASDPKTLGEAWNNLKNAPANIKEIYTNGSLKDKTVVTLSLLALMKGKSPAVPGTALAGFN
LSKYAKYGMCVEFASAFKKAYGGTVLEIKANYMSLIKDGKEIPITQTGMHRVVEKVVDGE
SYIFDNINPKGVLKSEYEQMLEGAHAPGRPISGAELLKNAKKIK
>KALACAFP_03824 hypothetical protein
MNKQIHSKMFSFLILFFSIPISSQLTKSEIQLWEKANPTSKEAVRCKDENLLNFHCGIKG
KLLMKSIEYSRSKYYTLSVVHSSKEDELIWRDSDQKISLSNSTYNKGKEKMEISKRPSIF
SFTEKVNSNREKTENPSIQFEDQNLYELIFIPKKAKAMDLNKIHSYLSIKYGISLEKGKY
YGSDGKVIWDPEKHKDYKYRPTGLGRDDGNELYQKQSSNQADQFLSIGMNDIKRTNAENL
TSIDNNNFVMWSDDNKEMTLEPNGNFDVLKRDWKINFIGSKIPKTDYKVRISKKEINPKS
LPIVYWMLLKKDNGEVKKIQGVEDENYVIFNKVDFITAFENTNSVYFTFATGPKDKKTEG
TAYSGSIKGEDISLDLSKIVLYPNPVKKEQNFTVIFPPMENLVISIYDGGGRLITLDKVS
SNARSYMNHLPVQGSYLINLTQNGKLIKTFKLIVD
>KALACAFP_03825 hypothetical protein
MNLYYFNAKKVTISNFISQYIYIPNVKKFN
>KALACAFP_03826 hypothetical protein
MKLPTELGDEYVNKVLSNLSLKDLPDEEWKLIEGFENYAISNYGRVKSLERSIVNSYGGE
HRLLDRIMKLQVCKYFNKYLKAHFFSVRCNLCLEGRSYGKSVARLVYYHFVEKFNMDDHS
FLISFKDDNRFNVHFNNLEKLTVGKLHSKSLNTGRGKKGNYQQAVSQYTVDGDFVASYEN
IYAASETLGIYPPHILSVLNKKNITAGKFLWFKKEYKPGKKDFIPEGKSKPEKILNTSLW
KRLGQPVIDESNPPACMNLSLKDLPGEYWKPFPDLEPYFAISNKGRIKRLNTWTQSISPT
FWKEHIISLFVQKSGSEKYFLYTKLSCNGKSYNIAIIRMLYYCFIEKFDLKDRNLVIVNK
SDPQWDLDISKLTLQSATNILTQRNKLYATKVRTVLNSKEIFNNSLWEKLGKPRISKKKP
PAIFDLSLRDLPDERWKPLPSFDSKYAISNKGRVKRLSGWGAGIHFYGEEQILSLNVTKD
KYPKLYFNLHRKEDVNPKMLLRLLYYLFVEEFDLSNRTLRIVNENKWLWEIDLSKLSLRP
MIDSFKNKK
>KALACAFP_03827 Tyrosine recombinase XerC
MQTYSLLFYPKKAKNNPKTSTIYLRITVAGRRTEISTGQTVKTSQWSIKSRKVTGNTPKA
QQLNSLLESSRAKLFKCYNALFNEGREITCENLRNKYLGIEERKVSLIEVFKDHNSKMKE
LIGKEFSKGTWERYETSLRHTQAFMKWKYTISDIEVRHINPGFIADYEFYLRTVRNCSNN
SAVKYIKNFQKIINICLDNEWVSKNPFANYKSKIETIDVRFLTDLQLKKIQSKKFISERL
RIVRDIFVFCCYTGLAYIDVKNLTKHKITRGIDGGLWIKIKRTKTKVEASIPILADAQKI
LSRYENHPKCVDENTVLPVLSNQKTNEYLKEIGALCEIDFDITFHTARHTFATTVTLNNG
VPLETVSKMLGHTNIRMTQHYAKIQDKKISEDMLSLRKQLKNKINTRLFL
>KALACAFP_03829 Thioredoxin reductase
MEQNILDCVIVGSGPSGFTAAIYAARADLKPELYTGLEPGGQLTTTTEVDNFPGYPAGIT
GPEMMMDLQKQAERFDTKVHYEMITKVELSKEVGGVHKLYAGNKEILAKTVIISTGATAK
YLGLDDEKKYAGGGVSACATCDGFFYKGKDVVVVGAGDTAAEEATYLAKLCKKVTMLVRK
DVFRASKAMIHRVENTPNIEVKFHHELIGIEGENSLVERAVVINNQTKETSTVDVDGIFI
AIGHKPNTDIFVGQINLDENGYILTEKGSTRTNLPGVFAAGDVQDHIYRQAITAAGSGCM
AAMDAEKYLAELH
>KALACAFP_03830 hypothetical protein
MKELDLILKNIKNKEVLPIYFFHGEEPYFIDLAVKALEHDFLDEDEKAFNQTVVYGKDTS
YQEILSLARQFPMMGDKQVIIVKEAQDLKLTESESNALEMYVQNPVPSTVLVFAHKHKKL
DSRKKVTKSLDRSNALFLSESIKENNLPKWIADECIKLNIKTAPNISHLLAEYLGNDLSR
IANELNKLKIILKEGEILDGNIVENHIGISKEYNVFELQKALGTKNANVAFKIAHFMGKN
PKNNPFVMMLSSLYNYFSNVIIYNTMIGQPPQVIASQMGVNPYFIKDYAESARLYPLKHA
TRVISILREFDMKGKGLGAVNMSEAELIKELVYKIINVDKIKMKV
>KALACAFP_03831 hypothetical protein
MELPKLNFQETFDFKFKRDKDKFFIYDLVRKAYLLLTPEEWVRQHWIHYYLTVKSYSTSA
LITEKKIVLNGLTKRIDLLITEKTEPIILIECKAPQIKLTEKTFEQTARYNSIIGAKEII
LTNGLQHINAHYENEQYRFYK
>KALACAFP_03832 (S)-2-haloacid dehalogenase 4A
MKIKNIIFDFGGVLVDWNPRYFFKEYFNDDEKMEYFLENIAQSEWNEEQDRGRLLSEGTE
IQVKKFPEWEKEIRAYYDNWTIMLRSDIPHNVEVLRKLGNTDYQLYGLTNWSEETFPYAL
ENYDFFQLFDGKIVVSGTEKLIKPDPKIWHVLLERYNLHANESVFIDDNPKNIEMAKSLG
FNTIHVTPKTDLEKELIDLGLQF
>KALACAFP_03833 hypothetical protein
MASGTVFSQNLKTVSYQDGSQKLNGLVTSNAGKKLPGVLILPAWKGIDDEAKTAAIELEK
QGYVAFIADIYGEGNIPTDSDSAAKTSGYYKKNYDAYQKRISLALEQLKKNGAISDKIAV
IGYCFGGTGALESARGNLPVVGVVSIHGSIGKDQTRKNGLISTKILVENPADDKGVTPED
FNNLIKEMNEGNADWQIITYAHSKHTFTDPKSPDYNPVMAKRAWNHTLMFLKEILK
>KALACAFP_03834 hypothetical protein
MKKYKIQKTPFVVPTMDGKLIEEHWGHSTENPNISIAHMVAPPDWSEPHQTPEFDEFTII
ISGKKQFEIDGEIVTLEKGQSILVEKGARVRYSNPFPEQCEYISICLPAFSMELVNREDE
GVD
>KALACAFP_03835 hypothetical protein
MNFSIQTVLENQEYQLIPLQQGDFESLYEVASDPKVWEQHPNKDRYQREVFENFFKGAME
SKGAFKIVEKSTGNVLGSTRFYDFDEKKNSIFIGYTFYGTQSWGKGINPQIKKLMLDYIF
QFVDTVHFHIGKENFRSQIALERIGGKKVAEEEVAYFGEPTRTNFVYEIKKKTI
>KALACAFP_03836 hypothetical protein
MKKLLFALCISASAFSFAQDYSVPAASPRQKVEQQFSMSKITVDYGRPGVKGRKIFGELV
PYGQVWRAGANSSTKITFGQSVNFGGKIVPAGTYGLFIIPTEKEWKVILNKDFQQWGAYT
YDPKQDVVDVTVPVNKLADKQEWFEITLNPTGENSANLVLKWDMAQAEVALKPSSPDAVT
KIADKLKEIKKIEADANKTKS
>KALACAFP_03837 Methylated-DNA--protein-cysteine methyltransferase
MEIHQKTIQTPLGEMIACAVDEGICLLEFTDRKNIEKQFKSLSKALNAEITEKEHEHFKQ
LENELNEYFEGKRSSFEVPLFIKGTEFQEKVWQLLREIPMGEIRTYKQQSEKLGNLKAIR
AVGTANGINKIAILIPCHRVIGSNGELVGYAGGIWRKQKLLELEKAILF
>KALACAFP_03838 hypothetical protein
MKKYLLGICFLSFLSCGDSGDSDNQTFNSSKIQTLTIQDENITNGNASLSEKLDFQFEYN
QNKLVKVWDLHNNYTENLTYNNNSLSAITISGYIYPDLASHQPLNVKRNIVCDANNKIIS
SENPIADFSGNTTYTLFEYPSSDIIIAKYYNKYLNNPGVLKETSKIFLNNGNVTKVQFAY
DNSPVFTKEVRYEYDQKNNPNSLIDRNRILALPEYAFNVFMLQDYSQISKNNVVVKKSYW
IYPSEILLETTNFHYNYQNNDLPGTIYLQYDYPGNTGLKVSAIYGY
>KALACAFP_03839 L-fucose-proton symporter
MNNTQPGNSFSSSKKKNYYFPLILITSLFFFWGFIHNLDPILIKHLRSAFQLSHFQASLV
DSSVFAAYFLLAIPAGLIIQKYGYKTGILVGLFFFAAGCFLFVPAANTISYPFFLAALFI
LSCGLAILETAANPYITILGEPEKATQRLNFAQSFNGLAASIAPIIGGIFILGEEPKSQE
ELAGLDQAAKLAYIQAETSLVKGPYIILGLIILLVMFLFLLIKLPEVAENKEKSTKNFLQ
VLGVKNVGWGVLAQFFYVGAQIYVFSFLLVFAEDAIDMKGQEAKYYAGVAGFLFMIGRFI
GTFFMKYISPQKLLSIYSIISIVLSIWVIVGSGISTLYALVSITFFMSIMFPTIFALGIE
GAGSETKPASSLLIMSIVGGAIIPPIASKITDISGNIHFSYVVPLVCFIIVFLFSLRFRN
KKISSINVEA
>KALACAFP_03840 Altronate dehydratase
MSNLILKINQKDNVLVALQDIHAGTEIIFEGVTYTTLEAIPAKHKFFMNDMKQGDEIFMY
GVLVGKVQYDLSAGTRMTTDNTKHAAEPYYYRDIDYHWTKPDVSRFLHKTFKGYHRSNGD
VGTANYWLFIPTVFCENRNLDIIKESLYNELGYAVDAKYKNYTHQLVEAILKGENIDDID
FSPSSIPAKDRIFKNVDGIKFLNHTGGCGGTRQDADTLSKLLASYADHPNVAGVTLLSLG
CQHLQIDNFKKDLYNRNPDFDKPLLVFEQQKAVSEETMIKNAIFETLKGLLEINKIERKD
APLSKLCVGVKCGGSDGFSGISANPAVGHLADILSVLGAKVLLAEFPELCGVEQELIDRA
ADKETAEKFIKLMTEYDELAHAVGSGFYMNPSPGNIKDGLITDAIKSAGAAKKGGSSPVV
DVLDYTEPAKKPGLSLVCTPGNDVEATTGKAASGATLILFTTGLGTPTGNPVCPVIKVAT
NTALATKMSDIIDIDTGAIVRGEKTIQQMGEDILDFCIEVASGNIIPKAVALNQDDFIPW
KRGVSL
>KALACAFP_03841 4-formylbenzenesulfonate dehydrogenase TsaC1/TsaC2
MFSLKNKKAVVTGGGSGIGQAIAVQLAANGAEVHILEITEQNGQETLEKIQSSGGNAKVY
ACDVSKQKDVLAVFDQIGAINILINNAGIAHIGKADTTSEEDFERIYNVNIKGVYNCLFA
GIPQIRKSGGGVIINMASIAALVGIPDRFAYSTAKGAVKAMTMSVAKDYIHENIRCNSIS
PARVHTPFVDGFLQKNYPDNIEEMFAKLSRTQPIGRMAQPEEIASLALYLCSDEASFITG
VDYPIDGGFTTLNN
>KALACAFP_03842 Ureidoglycolate lyase
MKLIKFGKPGQEKPGVIINEKRYDVSHLVKDYDENFFSGDAIENLKAEINTQNLPEISLD
ERLGSPLARPSKIICVGLNYKDHAAETNAPIPQEPILFFKATTAIVGPNDDLIIPKNSTK
TDWEVELGIVIGKKASYISEENALEHVAGYVLHNDYSERAFQLERNGQWVKGKSCDTFAP
IGPFIATPDEIEDVHNLRLWLKVNGQMLQNGNTSNLIFNIPFLISYISQFMTLLPGDVIS
TGTPAGVGLGQKPEPWYLKPGDVVELGIDGLGSSAQKVKAYDE
>KALACAFP_03843 L-fucose mutarotase
MKRYCLALDLIDDPELIAEYEKYHQNVWPEIKQSILDSGIMNMEIYRLQNRLFMIVEADE
YFSFEAKNEADKNNPKVQEWEQLMWKFQQQLPHSKPGEKWQLMDKIFSL
>KALACAFP_03844 hypothetical protein
MIIDSHVHFWKFDPVRDAWITEDMTTIRKDFLPEDFSLYLKEKSTEGCIAVQADQSDEET
TFLINLAKENSFIKGVVGWIDLTSEKLEESLQNYQSEKLIKGFRHIAEGEEIGFLLQKNV
LNGIATLHQYGYTFDILLRQNQLSDAVKLSEKLPDQPFILDHCGKPDLKTNDLKDWKSNI
SELAKNSNIYCKVSGLLTQGNWDTIDEKSIFKVLDFIFSQFGIKHTVFGSDWPVMLLGGN
YALWLELITKYLTQFSKEEQQLFFAGNAVEFYNL
>KALACAFP_03845 putative oxidoreductase
MNLNLDHKIIIVSGGAKGIGNAITKILAEEKALPIIIGRNKNDNKKAVQEIVDQGGKVDC
VTAELSQPDECKKAIEEVIKKYGKIDGIVNNAGVNDGVGLENGSYEKFIESYHKNVVHYY
LLVHHALPYLKESKGSIVNIGSKTAETGQGGTSGYAAANGARNALTREWAVELLPYSIRV
NAIIVAEAWTPLYQSWISTFENPEEKLSSITSKIPLENRMTTSEEIANMAAFLLSERSSH
TTGQLIHVDGGYVHLDRSLG
>KALACAFP_03846 hypothetical protein
MESATLKNINKILKDAPESILERILGYIEGILEEENTDFKLSDEQKESLRQIKKRSYEQH
TEIDAFLNEMSSKYGI
>KALACAFP_03847 hypothetical protein
MAFKIIISDEAKTDLEHSYLYYQTKVNKKVADNFFKDFKYYF
>KALACAFP_03848 Carbamoyl-phosphate synthase large chain
MAKRTDIKTILVIGSGPIIIGQAAEFDYAGTQACLSLKEEGYKVILINSNPATIMTDVEI
ADKVYIEPISLQFVSHIIRKERPDALLPTLGGQTGLNMAVELEKSGILEECKVEVLGTKL
SAINRAEDRDLFRELMRELNEPVPESDIVNTVEGALNFADDIGYPVIVRPAFTMGGTGGG
IASNEVELKEIAELGLKYSPVTQCLIEKSIAGFKEIEYEVMRDANDNAIVVCNMENIDPV
GVHTGDSIVVAPSQTLSDREYQLLRNASLKIIRALGIEGGCNVQLALDPHSFNYYIIEVN
PRVSRSSALASKATGYPIAKIAAKIAVGLTLDEIMNPVTGKTYACFEPALDYVVTKFPRF
PFDKFETADRRLSTQMKATGEVMAIGRNFEESLQKAIRSLETGIKHIGLKTKQAAALTEE
EIERRIRVCDDERLFIIGDALRRGYDWEQIVEWSKIDKFFIWKIKKLIDFEKAIAENKFN
KETLLEAKKLGFADINIATLWNVTEREVFNFRKENGLMPVYKMVDTCAAEFESETPYFYG
TYEEENESVVTDKEKIIVLGSGPIRIGQGVEFDYATVHSVWAIKEMGYEAIIINNNPETV
STDFSISDKLYFEPLTEEDVMNIIELEKPKGVVVQFGGQTAINLADKLASHGVQILGTSL
EDLDRAENRDKFEKALQEMQIPQPLGKTSTSKEEAIKIANEIGYPVLVRPSYVLGGRAME
IVYTETELAHYMENAVEASPEHPVLVDKYMVGKEVEIDAICDGETVVIPGIMEHIERAGV
HSGDSIAVYPPQNISQSEIDTLVDYTKRLAKGLNVIGLMNIQYVLFEGNVYVIEVNPRSS
RTVPFLSKITEVPMANLATKAILGQKLKDLGYQSGLVPNKEGVFVKVPVFSFSKLTKVDI
SLGPEMKSTGEVMGKDTTLEKALYKGLIAAGRKVPMHGSILFTVADKHKQEAADLAARFH
EVGFRIWATEGTAKFFGEQGIPCKIGYKIGEESVNLIDLIQKGKVQYVVNTMTKGKQSER
DGFQIRRMSVENGVPCLTSMDTVEAILKVIESMSFKMETM
>KALACAFP_03849 Carbamoyl-phosphate synthase small chain
MKKKLILESGEVFHGEGFGAELETAGEVVFNTGMTGYQELISDPSYCGQIVCMTYPLIGN
YGINRDDYESIEPAIKGLIVKEICDLPSNFRTQITLDELFKKKHLSGISGIDTRRLTRIL
RNHGVVKGKIVNEDVDDNAVVSELKSTTFPTNQVEMVSTKTPYANPGRGFKVVLVDFGSK
LGIIRELSQRNCDIIVVSHDVTAEEILLMNPDGVMLSNGPGDPEDNQHALEMIRGLLGKV
PIFGICLGHQLIGLACGAKTFKLKFGHRGGNHPVLDLEKNKVAITSQNHGYAVDQESLKG
TDLIETHIALNDRTNEGLKHKIYPCFSVQYHPEASPGPEDANYLFDDFIHLMEDFKNKKN
Q
>KALACAFP_03850 Aspartate carbamoyltransferase
MFTITELSTERINRILTEALAFANGKTAKIEGEVFCSNLFFEDSTRTKTSFDIAERKLGL
QVVPFDASHSSVNKGESLYDTVKTIESLGVNLVVIRDKKDRYFDELKNIKIPVINGGDGT
GNHPSQCMLDLMTIYQEFGKFEGLKVGIVGDVKHSRVANSNAEALRRLGAKVYFSGPEQW
FDEGALINGTYLNVDELIAEVDVVMLLRIQHERHDAKMSFSASDYHRKYGLTKEREKAMK
KEAIIMHPAPINRGVEIDTDLVECERSRVFKQMENGVFARMAILKEALEKEGYTFK
>KALACAFP_03851 DNA-binding transcriptional activator DecR
MILSIIQEDSTLSVKEISEKIGLTFTPTYERIKQLEKQGIIEKYVGLLNREKLGLNIVVY
CNVRLKEQSKKVLETFEKNIMQHDEVQEIISLSGEYDYMLKIIAKDINSYNDFTVNVISN
IPNIGQYHSSIVLHEVKKSTKLKIDLD
>KALACAFP_03852 Argininosuccinate lyase
MKKIWQKDDNATNILVNKFTVGKDLDFDERLAKYDVKGSIAHCMMLAEVGIITKEESDKI
IFVLAAILQDILDGNFKIDKNAEDIHSQIEAILIEELGDIGKKIHTARSRNDQVLVDVKL
YLLDEIREITVLTDEFFQILIKLADQHKNILLPGYTHLQIAMPSSFGLWLGAYAESLVDD
LEMFFSVKNIINKNPLGSAAGYGSSFPIDRESTTYNLGFQSMNYNSVYAQMTRGKSEKML
SMAMATLAGTLGKFAYDVCLYLSQNFDFISFPKEFTTGSSIMPHKKNPDIFELVRARCNR
IQSLPNEFILLTNNLPSGYHRDMQLTKEILFPAIDSLKECLEILNYTLPNIQVKDGILED
EKYKYLFSVEKINEEVKKGSSFRDAYIKVGQEIENNEFDFEIGNLNHTHQGSIGNLCLDK
IEYQFNKLKNKLLG
>KALACAFP_03853 Acetylornithine deacetylase
MQELKSVYNKEELLNNAVDLLKKLIEIPSFSKDEFNTSVEIENFFKKHQIPTKRFKNNIW
AVNKNFDVFKPSILLNTHHDTVKPNKAYTLDPFLAIEKDGKLFGLGSNDAGASLVSMAQV
FLHFYAQEDLQYNLVIALTAEEEISGFDGIEALFPQLPNIELAIVGEPTQMNLAIAEKGL
LVIDGEMKGTPSHAAHPNDDNSIVKCMEDLQQILSFKFPKVSDYLGEVKVTLSGIHAGVQ
HNVVPESCTFTLDVRVTDEYSNQEAFEIIQSKMKSTLTTRSFRLNSSKIEMDHPFVQAGL
EIGRTTYGSPTSSDQAIIPCTSVKIGPGDSRRSHTADEFIFIDEIAEGIEIYIKILEKIL
>KALACAFP_03854 Acetylglutamate kinase
MKEKLYIIKIGGALIDDEELLNEFLEQFSKIKERKILVHGGGKLATILADKLGVEQKMIN
GRRITDKDTLDIVAMVYAGGINKNIVAKLQQKKCKAIGFSGADANLIKAKKREHAEIDFG
FVGDITEKSVNRKLISKLLKLELVPVFSAITHDKKGHLFNTNADTIASVIAQALSVKYDV
ELLYCFDKEGVLEDVDNPDSVIKNISEEEFSVLKDEGKLHKGILPKLENALGAVKNNVNK
VFLIKETELKNHIENHHAGTEICL
>KALACAFP_03855 N-acetylornithine carbamoyltransferase
MKKFTSVSDVKNLQEIIKKALQIKENPLSETEKGKGKTIGLVFLNSSLRTRLSSQIAAQN
LGLNVLTLNAAQEAWNLEFADGAVMNGDTVEHIKDAIEVLNQYCDIIAVRCFAGMKSKED
DVNESILSQFEQHAKVPVISLESATRHPLQSLADCITITENWHFDKLSVQRKPKVVLTWA
PHIKPIAHAVGNSFAEWMQEMDVDFVITNPEGYDLDENFTKDVKVVHNQEEALKDADFIY
IKNWSSFDDYAAMPEVKENWMLTNEKLANTNQAKVMHCLPVRRNVELSDEVMDGENSIIY
QQAKNRIFSAQAVFSEILDGLNSK
>KALACAFP_03856 Acetylornithine aminotransferase
MNLFNVYPLFNINPVKAQGSFLWDDKGEKYLDFYGGHAVISIGHNHPYYQTQLKNQLDKI
SFYSNSVQNELQTELAEKLGKLSGLEDYNLFLCNSGAEANENALKLASFHNGKSKVLYFS
GSFHGRTSAAVSVTDNPKIVAPVNYDERFIKSEWNNIEQLEAIFEKQGREISSVIIEGIQ
GVGGIMIPTVEFLTKIKELCEKHNSVLILDEVQSGYGRSGYFFAHQEFGIEADIITTAKG
MGNGFPIGGVLIHPKFQASNGLLGTTFGGNHLACVAAIAVLDVMKDENLIENAQKMGEYI
ENELKDFPHIKTIRRKGLMIGVELDRDCSEVRNNLLYNHHIFTGNSNDKAVLRILPALNI
KKEETDLFISALKIVLEEI
>KALACAFP_03857 N-acetyl-gamma-glutamyl-phosphate reductase
MKTVGIVGANGYTGSELVRLLAFHPHVSLRFLYSRSNSGTKISDLYPDLATICGMVLTDQ
PEDVDILFLCLPHKESQNWLVQNGVDDETLVIDLGNDFRLDRSFGNRNFIYGLPEINKKQ
LLGAKSIANPGCFATAIQLALLPLAQKGLLNEVYTTGITGSTGAGQSLQATTHFTWRNDN
ISAYKTLTHQHVDEILQQLVSFNTNEISLNFVSWRGDFARGIFTSSTVKTDVELSDIEQL
YQDFYADEPFVKVSDKAIDLKQVVNTNRCMIHIEKSGNVAVIHSVIDNLLKGASGQAVQN
MNIAMGWEENSGLNLKPIAF
>KALACAFP_03858 Argininosuccinate synthase
MNKKVVLAFSGGLDTSYCAKYLSEILGYDVYAVTVNTGGFSKEEEKELEKRALNLGVKEY
RCVDAQEDYYNSCVKYLIFGNVLKNNTYPLSVSAERTIQAQEIAKCAIEIGADAIAHGST
GAGNDQVRFDLIFQVMCPNVEIITPIRDMSLSREEEIEFLKNYGYEKEFQKAQYSVNKGL
WGTSVGGKETLTSRNYLPEEAFPSQIKEDQPSELEIEFKNGEVVAVNGENFEYSVYAIQK
IEELASAYGIGRDIHVGDTIVGIKGRVGFEAAAASVIIKAHHLLEKHTLSKYQQMMKSQL
SDWYGNWLHEALFLDPVMRNIESFLIDSQKTVSGKVFVTLHPYRFILNGIESEHDLMSDK
FGSYGEANRAWTGEDVKGYTKIVSNSLNIYHQINGEKI
>KALACAFP_03859 hypothetical protein
MEIEISSSIHLMYVSEIQQEMYDSAQRRGTGIAKRSIEYLSKKISEGNAVIASENGEWVG
FCYIETWSHGQFVANSGLIVSPKFRERGAATLIKNKVFQLSRDKYPNAKIFGLTTGLAVM
KINSDLGYKPVIYSELTQDEEFWNGCKNCVNYDILMKKERKNCLCTAMLFVPENITKNGV
AYTQPEIKYNNEQESRLSV
>KALACAFP_03860 hypothetical protein
METHCPKCNSNKIVKSGIVNEKQRFLCKNCNYYFTVKKLGKKIDDYYVTKALQLYLEGLS
FREIERIIGVSHVTISSWIKKYNITRPPHSEFHPVYKILKQNELIEYMSKEENIKNSGLI
ITQFADKYMLIKWERFKK
>KALACAFP_03861 hypothetical protein
MKKILTFIGLALISNSLYSQGSPDYGSGLKLNLNQQGDKYIRFILWDQFWVRNTEMNPGS
MVGGEPTDNSWSLGNRRLRALAYAQISKRYMILAHFGINNQTFINGGGSGTSGTGGYGNG
KKPQMFFHDAWNEYAVILPGEAGKFSLSLGAGLHYYMGLSRMTMASTLNFLTVDSPIFTW
PLIDNSDQFARQLGMFAKGKYGKLEYRFSLNKPFATDLIPTNVTDPAKAVAVDNNGNPNF
SKAGYVEYQFLDEESNLLPFKVGSYLGTKKVFNVGAGFYHQKDGTRTSVNSNIEKHDITL
VAVDAFADIPLGNAKNKMAVSAYAGYYNYQFGPNYIRNLGIMNIAASDPNFIGEKAIAGA
GNLQPTIGTGNIIYAQAGLLLPSQAEKPKIRIQPFAAYTHKNFEAFDKSSSQFDIGANWF
IDGHHAKITTQYSTRPVYTNPMESPKSKGEFIVQFQIYL
>KALACAFP_03862 Proline/betaine transporter
MSENHHDAYENMTEKQKNRTIWSVITASSLGTLIEWYDFYIFGSLAVVLATKFFPADNPT
AAFLSTLATFAAGFVVRPFGALFFGRLGDIIGRKYTFLVTLLIMGFSTFLIGCIPSYETI
GFLAPVLVLILRLLQGLALGGEYGGAATYVAEYAQPHRRGYWTSWIQTTATAGLFISLIV
ILVTKTTLSAEEFDGWGWRVPFWISILMVGVSYVIRRNMKESPLFAKAKSEGKTSKNPLK
ESFGNKFNFKFVLLALFGAAMGQGVIWYTGQFYAMSFLQKVMNVESAQVDSLMATALFLG
TPFFVFFGWLSDKIGRKAVMMTGMLIAILAYRPIYDSMFKSVNLESKTVAANGIIEKRTA
KIHDKITTDSLVTFHKETLYTDGTLIKKDSVVHWSPSGPVMKDGKAEEPKVSKSIKLADN
TKWYLVFLVFIQVLFVTMVYGPIAAFLVEMFPVRIRYTSMSLPYHIGNGVFGGLLPAVAT
YLVTTAKDAGNESWYLQGLWYPIGVATVCLVIGLFYLKNKNNNIHD
>KALACAFP_03863 hypothetical protein
MNGLKKILGILWIAIALVVGYFGITVMGIPKITSGKQEDLVFGIIILFVLMPIISGGLAV
FGYYSLTGEYSDDNV
>KALACAFP_03864 Sensor histidine kinase ResE
MSSFALFTVVLFYLALLFLVAHLAEKKKSKLWINNPYIYALSLAVYCTAWTYYGSIGVAA
TSGLNYLPIYIGPIIVIPAWIYINTRIVRISRVNKISSLADFISLRYGNSRSFSAIITIV
CLLAIVPYIGLQIKAISETFHLVTETPMSKNILTDNATFVVVLIALFSSYYGTRYVDASE
KRLGIISAIALESFLKLFFIIILGLFVIYFVFDGFSDIYEKASKFEDFKAKNTFNGIEGA
LNWMILCMISGTAICILPRQFHTAIVENRQEKHIKTAIWFFPLYLLIFTIFIFPIAWGGR
LIFDGQNVNPEFYSILIPQHFNNTLITVFVFLGGLSSCISMIIISAITLSIMLSNNLIIP
YGLLGKFKSENEIQNTRNITNIRKFSIFALIIMAFAFYKYFILKTSLDSVGLISFVVIAQ
LAPAFFGAIFWRRGSYKGAVAGLLAGLVICYFGLIIPQYYFSYNQEFKGVLRDLYNLFDF
FTIPYLGRIPEIFFWSILVNTGLFTIISVSIKGNYRERNFAELYVDIDKYIQNHENAFIW
RGTAYVSDIKNILERFLGKNKTEQALRIFNLKYNIDSQTETADSRFIKFSENLLAGRIGT
ASAKILIEGVTKEDKISLKEVLNILEESKENITLNKKLTEQSEELQKLSDDLRNANESLI
IKDRQKDDFLDSVAHELRTPITAIRSAGEILADDDDIPLDIKKEFLNNIITESDRLSEII
NDILYLDKLEHGEIALHIKENNIIETYKKALNPLLHLIHQKNIHLSEVNLLNQFIFEYDE
ARMIQLFQNILGNALKFTDEQGTIQTKLSERENQLIITIFNTGKHIPEEDLEMIFDKFYQ
SRNQNILKPTGSGLGLAISKKIVQAQGGTIKAENSGLGVTFTITLPKKIKENKNEVEQNQ
NTI
>KALACAFP_03865 Transcriptional regulatory protein WalR
MKKIIIADDEHKILMSLEYSFKKNGYDVYIARDGTEVLEFLKTMVPDVILLDIMMPNLDG
YSTLKIIKQDEKLKNTKVIFLSAKNNPKDIEKGLEMGADAYVTKPYSIKKLIQQIEEMF
>KALACAFP_03866 Acetyl-coenzyme A synthetase
MRNYQIEDLPHYFEEYKKSIKNPKKFWDKIADQNFVWYQRWNKVVKYDMSEAKITWFKNA
KLNITKNCLDRHLSVRGDKTAIIWEPNDPKEEAQHITYNELYTRVNKTANVLREMGIEKG
DRVCIYLPMIPELAITMLACAKLGAIHSVIFAGFSASAIASRVNDCGAKMIITSDGSYRG
NKVLDLKSIVDEALEKTPSVEKVLVVKRTHNEIKMKEHRDFWMADLYENASPDFVTVIMD
AEDPLFILYTSGSTGKPKGMLHTCAGYMVYTAYTFKNVFNYKENDIYWCTADIGWITGHS
YILYGPLLNGATTVIFEGIPTYPEPDRFWEVIEKHKITQFYTAPTAIRSLAKESAEWVDK
HDLSTLKVIGSVGEPINEEAWHWFNDHVGKKKCPIVDTWWQTETGGIMISPLPFVTPTKP
TYATLPLPGIQPVLMDDKRNEIMGNQVTGNLCIRFPWPGIARTIWGDHQRYKETYFTAFP
GKYFTGDGALRDEVGYYRITGRVDDVIIVSGHNLGTAPIEDSINEHPAVAESAIVGYPHD
IKGNALYGFVILKETGESRQKDNLKKEINQLISDQIGPIAKLDKIQFVSGLPKTRSGKIM
RRILRKIAEGDFSNFGDTSTLLNPEIVEEIKNERID
>KALACAFP_03867 hypothetical protein
MSIERVFKIMFFSKNKKNGLSPVSIDIVIKINLIYSFIFNFLNNFRIQKGRGISEITEIT
FCDFS
>KALACAFP_03868 hypothetical protein
MSNILAGLFEHHSDYKKLETDLENSGFENSDYIVYLDNGQHNAQYLASVAVKDNVQTDNA
KNIFNQNSVLKTFLFENMSIEQAHYDNLKRYIDARCKAEIHNSPDVKIRNSNHGMDSAEV
KF
>KALACAFP_03869 GTP pyrophosphokinase
MSYDLEQENKEILARYKDLISNTYRTLSEENNKLIRKAFDIALDAHKDQRRKSGEPYIYH
PIAVAKIVATEIGLGASSIACALLHDVIEDSDYTYEDLKKIFGEKIANVVNGLTKISIMN
HQNISVQSENYRKLLLTLSEDFRVILIKIADRLHNMRTLESMAPDKQKKIASETVYIYAP
MAHRLGLYNIKSELEDLSLKYNNPEVYNEITEKLELAKESRERYIEEFKKEVSERLNEEG
LNFKIKGRAKAISSIYRKMLKQGVSFEEVFDNYAIRIIYKSDAKNEKFLAWKIYSIVTDV
YHSNPSRMRDWITQPRSTGYESLHLTVLGPDRKWIEVQIRSERMDEIAEKGVAAHYKYKE
GYKQSSEDRNFENWVTEIREVLEQQQNLSTSELLDNIKLNLYSKEVFVFTPKGEIKILPT
NATALDFAFAVHSDLGMKCLGAKINGKLVPISYVLQNGDQVDILSSQNQKPKSDWLEFVV
TSKAKSKIKSYLNSQKNQLVEEGKEILQRKLRHAKINFNDDEVNKLQKFFNLKTSQELYL
KFQSNELDASSLRKYIESKNVFNNLLSRFRKSPTKNTTFVEPKEQNLDMIVFGKDEEKLN
YSYAKCCTVIPGDKIFGFITISDGIKVHSDNCPNAINLRAQYDYRVIPAKWVNAESFKNR
VKIEIEGLDRMGMINDITTVISGAMGMDMKSMSIESNDGIFTGTINLEVKNKSQLEQTFK
KLNDINGISRVRRLQS
>KALACAFP_03870 Na(+)/H(+) antiporter NhaA
MNLTLYFKKFFSSSQSSGIILIFCVLISLLIANSSAAGSFQAFLDKEAGIDIFHLKYPVS
IWINDGLMAVFFLLVGLEIKRELVEGELSSFKNASLPIFAAIGGMVVPAAIYSAFNLGTT
YSNGWGIPMATDIAFSLAIISMLGKKIPNAIKIFLAALAIVDDLGAILVIAIFYTEQIHW
TYIFLSLGITALLFLFNFLKVKKIVFYIVPGLFLWYFLHHSGIHATIAGVLLAFTIPTNV
SDVEISPLEKLEHKLHFPVSFLIMPIFALTNTNITFNEGMISGLTSSLGLGIIGGLILGK
LIGINLFSLLAIKLKLSSLPQNSSWMHMLGVGFLAGIGFTMSIFIALLSFKGEIEIQDEA
KFAILIASFLAAVLGFIILKVSSKNQAIEEEN
>KALACAFP_03871 hypothetical protein
MGIKLPKFILKVQEFFDDIHIPVLGISLWQMFEIYISGIFKGNIGRKAAAISWSFTISLF
PFLLFLLSVLPYMPHYDKLQFYIFEVLMHNVFPSNIEGDVRGYIETNIIPNMKGISNLTI
VLALVFATNGTFSIINGFNENTDEKMTDVKEFILSFFITIGFITIVFLTLFGVYYSEVVL
KLFTPVYDVSWLADNLSKIIGFVSFPLFYFILLALFYWLGTVRITRFRQAVPGAILTTVL
FVVTTYGFAIYVKNIARYNVLYGSIGSMILLMVWVNVNVYLLLFGNELNMAIRKLRIEKL
LSDQLKKEATNYHAQSAEPNLESDEEHIWKFNKEEKKD
>KALACAFP_03872 Ribosomal RNA large subunit methyltransferase H
MQINLLCIGKTDDKEITSLINYYLKRLPKHWNFTIVEIPDVKNAKNLSPDLLKKEEARLF
LNYIDKNDLVVILDEKGKQFTSREFAQKIDVWMNSSVKKIHLLIGGAYGFSEEIYSRANE
KMSLSTMTFTHQMIRLFIVEQIYRADQILQGKPYHND
>KALACAFP_03873 TPR repeat-containing protein YrrB
MKKHLLFLVLAFSSLPFHAQDKKVAEECFQKADYKCAEEQYSKLAQSEKIQQLQSEYYNN
LGTAQRRLGKTSLAFKSYESALKSNPMSAAVYANLGSIHSQKGNKQAALDYLNKGLQLQP
ENAEMYLTRAKVYENLGKKDLAAKDLNQILSFAPDNIYARTGLANLKKNSGDLEGALKDY
NQLLAEKPESLLYSGRADVYYKLKKNKEALADVNKAISIDPKFAQAYVNKALILFDTAKP
KEACASLDKAVSLGYEKPLLFEHYAKCEVKK
>KALACAFP_03874 hypothetical protein
MEEIILEDKKAFLFLNNLGSSSFDQFWMLISSTWIWVPLYIIFCYFLFKNYKLRSLVFIL
IFVAIGVTVSDQVAGIFKHGIERLRPCHDPTLEHHMRIVKCGGQYGFYSAHASNTFFLAT
YLTILLKNNLKWFPYAIFVWAVVVSYSRIYLGVHFPIDILVGAFVGTLLGVIFGALAKKV
INKQKITT
>KALACAFP_03875 Sec-independent protein translocase protein TatB
MELSFGEMALIAVAIVVLFGPDKLPQIARDLGSGVRKMRGAVEDIKTEILKETDNPVSEI
KREIEKVKDAAKDFNPMKDIQKDILTEPQASNEPPKPKPSEDETYEGPVSR
>KALACAFP_03876 Tetracycline resistance protein, class C
MENSRKKAAIGFIFITLLIDITGWGIIIPVVPKLIEELIHGDISEAAKYGGWLGFAYAFT
QFIFSPVVGNLSDKYGRRPIILISLFGFAVDYIFLALAPTIWWLFLGRVIAGITGASVTT
ASAYIADISTDEDRAKNFGLIGAAFGLGFIIGPVLGGVLGHYGARVPFYAAAGLCLLNFL
YGYFILPESLDKDKRREFNWKRANPIGSFKFLGKHPEISGLIVSLILIYIAGHAVQSNWS
FFTMYKFNWTERMVGISLGVVGLLVGIVQGGLIRWTTPRLGEQKSIYYGLALYAVGMLLF
AFATQGWMMFAFLIPYCLGGICGPALQSVITKSVPSNEQGELQGALTSLMSATSIVGPPM
MTNLFYFFTHDEAPFKFSGAPFFLAFILMAISVVITYYAFQKKHPKKDSIE
>KALACAFP_03877 hypothetical protein
MQGKGLITIVAIVLGLICLNELLPTWYASKIEKQATAIAGDNPEKYQKEIAKLSKDTLNL
GFTKLYYTKAKDKEMKLGLDLKGGINVLLEINQRDLVNDLTNYSTNPILIEALNKTDEVQ
KNSTKSYIDNFFDQFDAINKAKGTNLKLADPEIFGNTTLTEVKYNTPDDQVKSIVKRKID
ASVGTAFEVIRTRIDKLGAIQPNVQRVPGTARISVEMPGMKDIDKVKKMLQTSAKLQFWE
VQQVPEIAPYFQTLTSIVAAKGDSMGVAKNVNFMNLIHLDKLRTNGVANVKLSDTAVVNK
ILNSKVAQSLRPANIKYTQFMWGYKPEATDSESLVLYAIRGNINQKAPVDGAVESASIGY
DELSRVVVDMQMDSKGAKEWKTLTEKNVGKPVAVTLDGRVYTAPNVVNAIPNGRTQISGN
FSQEEAKELVDVLGAGKLPAGAKVVQATVVGPSLGQESIDAGLMSFIIAFGIIIVYIIFY
YGGAGVYAVIAMIINLFYIFGIMDSGDFTLTLPGIAGIVLTMAVAVDTNVIIYERTKEEL
FAGKGILEAYKDGFKHALNAIIDGHTTTFLTAVVLFFFGTGPIKGFALTLMIGIAMTLFT
SVLLSRVMIFSRLNKGKGLSVWTPATKNLFRNTWIDFIGKRKYAYIFSAVLTVVCIISIA
THGFKYGIDFTGGRNYVVRFDKNINVNDIEEKLVTTFKTEDGKNSSVEAKTFGNDRQLKI
STDYLIDDESLKADQIIEQKLFEGLKTNLPANMTLKDFKSADKDHAGIISSEKVGPSVAD
DIKIHGIYAVLAALGMIFIYILVRFRKWQFSLGAVASLFHDAVIILGAYSLLHKYMPFNM
EINQDFIAAILTVLGYSINDTVIIFDRIREYLREKKSITLAGLFDDSISSTLGRTFNTSF
TTILVILAIFIFGGDNLRGFMFAMLIGIGFGTYSSIFVASAIAYDFLKTGKEEDVHGKST
TNKEVLASK
>KALACAFP_03878 Aldose sugar dehydrogenase YliI
MKKLLFTASIFSSLFINAQSISLEEFATGLTAPVEIVNANDSRMFVVQQNGIIKIVQPNG
TVNPTNFLNISSKITYGGERGLLGLAFHPQYSTNGYFFVYYNDLDGNVTVARYTRSSNPD
VADPATEKIIINQSKPFDNHNGGSIHFAPDGYLWIVTGDGGSGGDPNNNAQNKNSLLGKL
LRLDINSTGPYNIPPGNPFVGVDGADEVWAYGLRNAWKFNFDTVSGNVMIADVGQGQYEE
INRVPLTQAGVNYGWRCYEGNNAYNTAGCAAQSTMTFPVAVYDHSGGKCSITGGYVYRGA
QFPVLQGKYIFADYCSTQIGILNPNNSITWSPAFSGNNFSTFGVNNQNELFVAAVNNGKI
FRVTTTSLGTQENENLAEIKVYPNPASKKVFIEGLKDKNISVEIINFEGRRILESVKIEN
DNSIDISGIPAGVYFINLKSGNLKSYSQKLIIK
>KALACAFP_03879 hypothetical protein
MNRKVLLVLLYLYALVFSVLKTIRFPNDWSEAHWMLDYRFGFIKRGLAGEIFGWIFEKNE
FNILILSAVILFLLYVSVFIIAVKETFKQENSFYRIFFFLIFFLSQYIVFSAHLIGYLDH
IIFLLTILVIYFIKQKKILLSSAIAAICILIHEVSFFLMLPVSCFALVVTEIGVEKFSLK
NIFSADILKKLVVFLILPFFTAISVTLYQEWNGENYFSVIFNYLKEIPFISEKAADSVAS
AYTKSFTYYFKEESGSFIQRLFFSRATILYGIPILFSLWMIFKEFKLKQNIQLFLLLMVV
SFIPLLLHAIAYDTYRIWSFPFMILLLVFWILSSKITIKKEKTRKLSTLEIIFFSISLGL
VSLIPNVLMDNEVERFSLIVRLIIIVPIFLILYFLKKPQPN
>KALACAFP_03880 Oxygen-independent coproporphyrinogen III oxidase
MNSLIDKYNIPGPRYTSYPTVPYWDETSFSPEQWKQSVIRTFKESNAEEGISIYIHLPFC
EALCTFCACHKRITKQHSVEIPYLESVLKEWQLYLKMFDEKPKLKELHLGGGTPTFFSPE
NLKKLLTGIFETVEIAEHQEFSFEGHPNNTTRGHLQTLFDLGFRRVSFGVQDYDPKVQKA
INRIQPFEKVKEVTEWAREIGYRGISHDLVFGLPHQTWEAMEHTIRKTMELKPDRLAFYS
YAHVPWVKGVGQRGFDENDLPSGEEKRHLYEDGKKLLENLGYIEVGMDHFSLEHDDLYQS
LIHKKLHRNFMGYTSSKTQLMVGLGMSAISDSWYAFAQNVKTVEEYQKMVEEGEIPVVKG
HILNEEDLMVRRHILNLMCQLETTFDVNNSFPELENAFEMLQEMERDELVEINDNQIKIT
EKGRAFTRNVAMVFDLRMMRNKPETRIFSMTI
>KALACAFP_03881 hypothetical protein
MNGFGFNKDLPNDLKSFKDVYIFQGNSVPDGNLNGGLGKWDVLKPGNGTGFKSNGKTNTL
SDRFGLELSFAKKMKELFPNDKIALIKYAREGTSIDSLAKGDFGCWDADFQGLNGLNQYD
NFLKTVKNALSETDIDKDGKKDLIVPSGILWMQGEGDASYDEAIANRYYDHLKILMNQMR
AALLTDDLPVVIGKISDSGKDKSGRVWKMGELVQYAQEKFVLNDKSAAIVRSTKNYGYGD
DPWHYNSAGYIDLGQKFAEEVFRLIINFENKP
>KALACAFP_03882 hypothetical protein
MKKILPFLFSFLGIFSFSQQIESFETILNDKISIRALEIYDNKVWYSGTDSKFGFVDLKN
PKNQKQIRLSEKKLQFRTLAQDKSSFYAINIESPAEFFKIDKKSLTSKIVFTDTVKTAFY
DALHFVNDQVAYTFSDSDKNNQLKLAVFRNGKWSMFKNNISLNEGEAAFAASNTNIASSK
NYLWIATGGKASRILRMNLKDEKFEIFTTPFVQGESSQGMYSIDFSDDKFGIAVGGDYTK
QDANINNIATTNDGGKTWQIQASGKNAGYTTCVKIKPNSKGQEIISVGDQHISYSSDFGK
TWKKISDEKGFFVCEWVDKNTVVFAGNGKVSLMKLKF
>KALACAFP_03883 putative amino acid permease YhdG
MSAYEADIKKSQLKRVLGKWSLTAIGIGAIIGGGIFVLTGTGAYYNAGPALALSFVIAGI
ACVFAALCYAEFASILPVEGSAYAYAYGTVGEIFAWIIGWGLILEYAMGSMTVAVSWSGY
FSKLLKMFGLHLPEYLTTDPQTYIAAGNSGFSMNLPAFFIVLFVISILLRGTKGAAKANN
FIVMLKVSAIIFVIIAGAFFINPENWTPFIPEPTVITENGVSHTAYGFGGVVAGASAIFF
AYVGFDAVSTQAGEAINPKKDVPFAIIASLVICTLLYILVSLVLTGMMHYTDFNPLGKYP
DAIKAPVAYAFDIAGQAWAGYIITIAATVGLISVLMVMIMGQSRIFLGMSKDGLIPKTFS
KVNPETGVPRKNLIILGIVISVIASLTPINELAHMTSFGTLFAFTMVCVAVWVLRVKEPN
LQRNFKVPALPVIACAGIAINIYLIINLSKEAQMYSLAWLAIGFVIYFLYSKKHSKIQNG
GYGETFKAEQEPLEKPDLDL
>KALACAFP_03884 Nicotinamide riboside transporter PnuC
MCEFLFIFEHMNLYDLFVKPYESYTTFQIFLESFAAVFGILSVYFSIKKNIWLYPTGIVS
TLIYVYILFNFGLLGDCMINGYYTVMSVYGWVLWAKSSEDHIHVDVTWASKKEWMYGILL
FALSLILVTVIYYYKPYIDNQFSMEGTNLGLYHLDWGNWLDVITTSIFLVGMWFMAKRRI
ENWIFWIIGDFICMPMMIYKGLGITSVQYLVFTIMAILGYVSWKKSLKKKSL
>KALACAFP_03885 hypothetical protein
MKNLFKIAFSIITIASLTACTVYSDPYASGYGDPYYDNGYYYAPQGYYGGGGYWGNDGYY
YRNDINYYYDNGMPYYYYNYNNSRRKVYIERRSGATTSQRPNNGFRGGVNDGGSGGFRPN
NQYNQDNKGNQRPNNGFRNQGNQGGNNNSGGFRNSSSNTNSNSNSGFRNNSSSNTNSNSG
GFRNNSSNNNSNSNSGGFRNSSESSSPQPQQTSPQPTRSTGGGFR
>KALACAFP_03886 Diaminopimelate epimerase
MEFYKYQGTGNDFVMIDNRDLQFPKEKDIIEKLCDRRFGIGADGLILLENEPNYDFKMVY
YNSDGGESTMCGNGGRCLVAFAFFLDIFEDKCKFIAIDGEHEAEIHNGVVKLKMIDVEAI
SNDGTDTVMNTGSPHYVKYVEDLVNYNVFAEGHGIRNSENYKEKGINVNFVEKITDDEIF
VRTYERGVEDETYSCGTGVTASALTFLQKNNLISVKVKTLGGNLKVHAEKNGNSFQNIWL
EGPAKQVFRGKIDLI
>KALACAFP_03887 Endolytic murein transglycosylase
MKKAILIIILLVLVVGGFFGFRFYKKYYGNNIEKDGYVLIPHNAGFKQILDSAAKYVDNK
ESFESVAKEKGLDKYFKAGRYHFQKGMGNANLVNMIKAGNQTENSFRIGDFGDIYQMVGK
VTKKTEQDSLQFVNDFNAIAVEKGYRNAEDLKKYFFIDTYNFFWTVTPKEFFKKFDDQYN
EFWNSERKAKEQQSGLTRDQIYALASIVYKESGGKKDEMKTIAGLYLNRYRKGMKLQSDP
TVIYAINKQTNFKESIKRVFYKHLSTPSPYNTYANAGIPPGPICIVDKNSVDAVLNAEKN
DYIFMCADPARFGYHKFTASAEQHAINAKAYQEWLNSKNIK
>KALACAFP_03888 hypothetical protein
MNQTEIINIFTKKTLGLTFVLSAAAFAFAQEKVGISGSVVNKNNQPVPYASVTFSNKANK
LFSDAALTDEKGQYSVNLAPGNYDISIEAIDYKKSVLNKQITAAGNIGAFSIDPEVSATN
TKTTEIQGVTITAQSTKPYKVELDKRTYDPSQDIVSKGGNLQDVLSNVPSVSVDTDGTVS
MRGSSNVKFLINGKPSALLGIDDGANALQSIPADQIEKIEVITNPSSKFEASGTAGILNI
ILKKNKKTGFNGSVTGTLGYLPQTNLNTNLSWRKGKFTWFLNGGGGYRESKNTSRNNAWY
TSGPIKQTDNESITNSQNNNYNASGGLTFDITDKTSVNASGTVRTFDNESDGNVTYYDYL
TDNSTAFRQRTNTGRGNNLAFQGDFGLDHKFDDKGQNIALSLSLQRNRSNNDTDIFDTEN
YDFKLRDLVNQKTINKSVIGKADYELPIGENSKIEAGYRLDINTNDYNNDVLETEDLATP
LSYLNKYTYDATYKETFNAFYLQFKSKIGNFGYQLGLRDELSNVDIYYKNLEPNKPALNS
NKNYNNLFPTIYLSYEFAKDNQLLLNYTKRIDRPRSFFMIPNPSYSDNQNIFDGNIDLNP
SYVDSYEFGYSISKKNFTINPTLYYRHTTDDVKMVVYNQFDADIQLNTFHTLPVNLGTDD
RYGLDFNFNWDATKWLRFMGNVDLFGYKTSGTYFDASKMSEPLYFDGSGFSSRARLTSTF
KVDKTFNFQIQGFYRGGQKTQSLDRKDMYAISFGASKTVMKGNGTISFNIQDIFNTRAMQ
STAYGPNYIRDSYMQWQPRQFALSFTYRFKQGEKIEPPKKKKDINSNATGDDQQGGPM
>KALACAFP_03889 Glycerol-3-phosphate cytidylyltransferase
MKTQKIGITFSSFDLLHAGHIKMLEEAKTVCDYLIVGLQIDPSHDRPNKNKPTQTIVERY
IQLKAVNAVDEIIPYYTEEDLEDILKSFVIDVRIIGDDYMDRDFTGKKYCEDKGIEIYYN
KRDHRFSSSDLRKRIYEAEKTKVSKPETVK
>KALACAFP_03890 UDP-glucose 4-epimerase
MAILVTGGLGYIGSHTVVELLNDNFEVVIVDDLSNSERFILKNIEEITGKKPVFYPFDLK
RKELLTQVFDAHQIEGCINFAASKAVGESQLKPVDYYENNLFSVINILQEFKERGISNFI
FSSSCTVYGQADTMPIDENTPLKMPESVYGKTKQMGEEILMDFAKAYHRKISLLRYFNPI
GAHPSAKIGELPIGVPNNLVPYVMQTAAGIREKLSIWGNDYPTEDGTAVRDYIYVVDLAK
AHVAALKRLMNDQSEETKIDIYNLGTGKGSSVLEVVKAFETANNVEVPYQICDRREGDIT
IAYANVNKAERELGWKSETSLEEALRTVWQWQKYLESRTP
>KALACAFP_03891 hypothetical protein
MLHDERILKNKFAYFFTIVFLLGWIIYYSVFAINILLRGYRLAEKYVKFRSFAYFFNFIV
FILLIVTFIHIFKESKKMFTYLNVTSFLIVILGFLSFYMNYGGLWKTYINSFLITLFIFL
IVPTLLINYFRHTPAKNEMEDIGKHND
>KALACAFP_03892 UDP-2-acetamido-2-deoxy-3-oxo-D-glucuronate aminotransferase
MVDLQSQYYKIKNEVDNAVLNVMDSAAFINGPEVKSFQNELESYLEVKNVIPCANGTDAL
QIALMALDLQEGDEIITADFTFAATVEVIHLLKLKSVLVDVDYDTFTISTEAIKKAITPR
TKAIIPVHIFGQCADMEEILKIAEEHNLYVIEDNAQAIGSEYTFSDGTVRQAGTMSTVGT
TSFFPSKNLGCYGDGGAIFTNNDELAHRLRGIVNHGMYERYYHDEVGVNSRLDSIQAAVL
RKKLPHLDTYNEARRKAADYYDEAFAGHENILTPKRAENSTHVFHQYTLRILNGKRNDLQ
KFLTEKDIPAMIYYPVALRKQKAYYQESNDADFVNTDKLLDQVISLPMHTELDDEQLKYI
TDAVLEFMK
>KALACAFP_03893 Subtilisin NAT
MKKILLFCLLAGYSSVFSQTSLVFVYFKDKPNKVAFYANPLSELSQKSLNRRTALGIALN
DQDAPIEQSYIQNIQTLGFTVTDYSKWLNGVAVNATPAQVSTLQAQTYVQSVESFAKNSS
TVPKFKNVNKWDNPNSSTDKNLTVFDYGSGSAQIDQVNLRPLHLAGYTGTGVTIAVIDTG
FPTVDTGSAYSRLWTNSHIKGGYDFVTKSTDIYNASLNNHGSVVLGAIGGYIQNTFVGSA
PDADFYLYRSENAAVEVPEEELYWIEAAEEADRKGVDLITSSLGYATFDDPKYSYTYANM
NGTTSFIARAAEIAVNKGIFVLAAAGNSGVLPWHYILTPADNAKVFTIGSVDSAGASSNF
SSYGPNSAGVVKPDASARGTATTTVMNNTTITVNGTSIATPIAAGGVACLIQAFSTMNRD
LMRDKLRQTASLYPNHTDQMGFGILNFGSLYNNVLNTSDLVKKEKLSIFPNPVKNILNIA
TESEVLSLEVYDNLGRLITKVNDQKSVKVEDFSKGVYYLKIQTKDKVYYEKFIKE
>KALACAFP_03894 hypothetical protein
MLNTKIIGDKIVKARKESNMSQAQLSELLFISPQAIGKWERGESIPDLITFNRLAEILGV
DLNYFSESFHSSANEISSDKLSEKQTDELSFEKEDKKPKWDMSLGNWVDADFSGLKNLNE
KFGASNMQCCKFVGSDLSHLILKNNNVDLCDFSKSEIRNSRIQSSNLANNTFKSCSLNET
EFSKSYVAGCDFTDADFTGVMLKDGGFEKNIIAESIWKRTSFMNTHLADLVFEGKLDDCY
FENCKFTRVTFQHSVLSNTFFKNNNLKKVQFIDCQADRITYEFLKSGKADISGITLLTQ
>KALACAFP_03895 Phosphoenolpyruvate carboxylase
MIHDQRAEKFRQIVENKFQIYNSLFMSLPYDKMTNIGMLLPFLCEESKIGYEAGKTPEEI
VEEFFKNHTGLETEEQKLELLFKIIQYIERQVVLFDSIEDAAFPNLHSESDNGTVTNMYE
RSLQDHKLDKIREKLKDFAVKVVFTAHPTQFYPNSVQRILHDLRNAITTDSITNIDMLLQ
QLGKTPFVNKEKPTPIDEAMSIIYYLRYVYYDTIGELFTKIKSTFGNDHFHLHEDLIQLG
FWPGGDRDGNPFVTADVTKRVAEELHSAILKAYYNNLKTVRRRLSFRGVSDVLTKLSNEL
YSAIFRNEKITAEDIIKRLDEAEKILVEQHNSLFLDLLVNFKDRVKIFGTHFATLDVRQD
SRIHQQVIDTVFAKLNGTHEASFEDKFNQLIQISEKVNPDDFEDIVKDTLLTVSQVAEIQ
QLNGLRGMNRYIISNSDAVKDVMNVYAFFKICGYQDEEIKMDIVPLFETMEGLANAENVM
NELYQNPIYKKHLERRGNHQTIMLGFSDGTKDGGYLKANWEIYKAKEVLTKLSEQNGIKV
VFFDGRGGPPARGGGKTHDFYASQGKTIANNKIELTIQGQTITSIFGNKEQAKYNFEQLL
TAGVENDVFKNSKKDLTEKERALIIELADISYQKYSDLKAHPMFVPYLQEMSTLEYYGKT
NIGSRPSKRGSGNELKFEDLRAIPFVGSWSQLKQNVPGFFGFGFAMQQMKEQGRFDEVRE
LYKGSDFFKTLVLNSMMSMNKTYFPLTYYIKNNPKFGAFWNVLFDEYNLSKNIMLELTGF
KMLQEEDPLSRKSVKIRERIVLPLLSIQQYALMKLQKGEGNKEAYEKLVTRSLFGNINAS
RNSA
>KALACAFP_03896 hypothetical protein
MIDDIMFTFEKNFLRLKNLIELYKSISTGQGRKPTNSLDILRATTVLAHSTLEDYLRNLL
LWKLPSENQEKINNIPLMGTSLIGRPTKFSLGELTLHRGKSIDEVIDASVKEYLNTVSFN
DTSDIVKALTSISITITPEMQNLFPTLNEMIKRRHNIVHRADRDVSVGRGNHRIKSISVQ
KVEKWKKEIDKLVIEINKSFIV
>KALACAFP_03897 hypothetical protein
MGLFIITKRTNGDYQFNLKAANGQIILTSEGYSTKNSCHRGIQSVIENSQIDSQFDRKTS
TNGFYYFILKARNGEIIGVSQMYASEAGRENGIYSVKINAIQSQIADKS
>KALACAFP_03898 hypothetical protein
MKKIFIFLLPILFFTACGDDCYNAPQPIVFEFVNSNGENVLADGTLTTYSIQDENHNAIQ
LTKTSDNMVILENVGAYNGTKNYTFYSNLKVFDFSIQSSEFKGGCDGFQINKLTFTGVNM
QVSDEKGYYKIVLE
>KALACAFP_03899 hypothetical protein
MKLLFPTLLLLSGLVFGQKAVPSDFKKIPEILDNTELLYPFIVPGKKYDYWSVLRNNPDP
DKAIIYESQMPQYMTINDPAPEKGFFQKCLGEDCFSYLIACENSRSAYFSNEQQLRDFIG
CVDNLPEAILIANTYGYTVDTTNKLAGSYKIEEKNISLYLSKTKNCPLTKESFLIKINRK
TGRLEAKSNGIYVKSEDCGVQ
>KALACAFP_03900 Dihydrolipoyl dehydrogenase
MENYDIAVIGSGPGGYVAAIRAAQLGYKTAIIEKYDTLGGTCTNVGCIPTKALLDSTHHF
SEAQHKFNEHGIKLNQIELDFQQMYKRKAEVVSKNTAGLDFLMNKNKITRLKGTAGFVNN
STLKISNENETIDLTAKHYIIATGSKPSTIPGVEIDKQRIITSTEALSLKELPKSMVIIG
GGVIGVEMASIFNRIGTQVTILEYADNLISTMDNELGKNLHKILKKEGIDIRLNLGVYKA
ENLGSSAKVLFKDKDGTENELEAEYVLVAVGRKAFTKGLGLENTGVEVDERGFIKVYENN
QTAVSNIYAIGDVIGGAMLAHKAEEEGVLVAETINGQKHHIHYDRIPGVVYTWPEVASVG
YSEEYLKKNNIPYNVGKFPFSASARARASMDMDGFAKVLVDPKYGEVLGVHVIGARAADL
IAQGVIAQEYEITAEDMFRISYAHPTYSETLKDAYLIASGQGAINI
>KALACAFP_03901 HTH-type transcriptional regulator YodB
MNKKRSDCPISCSLEIWGDKWSLLIIRDLMIKKECTYGDFMKAGEKIASNILASRLHHLL
ENGIIAKKDHPENKLKVLYHLTEKGIDLVPVIVEINLWGDKYMTVPDDRKKLLENIKKDK
EKFIKKAKAYLSS
>KALACAFP_03902 Alcohol dehydrogenase YqhD
MLNFEFKNPTKILFGKGEIAKISKEIPKDAKILMIYGGGSIKNNGVYDQVKDALKDHEVY
EFGGVPANPEYEVLINALSFIEEKDITFLLAVGGGSVIDGTKFLSAAANYDGEPWEILTK
PVRTFEGEGMPFGTVLTLPATGSEMNSGYVISRRETNEKLSTGGPGLFPQFSVLDPEVVK
SIPQRQIVNGITDAYTHVLEQYMTAPSSADLQERIAESILISLQETAPKVLADDFDYDAA
GNFMWCCTMALNGLIQKGVITDWAVHAMGHELTAYFGIDHARTLAIIAPSHYRYNFEAKK
GKLAQYAERVWGIKNGTVEEKAELGIQKLEEFFHSLHIQTKLSEYTEDFNGTAERVEKAF
TERNWLGLGEYKKLTPQDAYKIVEMSY
>KALACAFP_03903 hypothetical protein
MKKQLLLLFAFSALALTSCEDDDIQGYEMDMMKGDWKTSKIEVISGKDDKTVISTDTPIG
CSAKNITYFSTDYSTSYTYFTGVGADCQLNGKSEGTYTYDTETKDLTINYVNDSSRPYKV
VVLTSSEMRVKQMFDNIDQNGDLIIDYTYITYKR
>KALACAFP_03904 hypothetical protein
MKKILSAFLLLTVALFFSQEKKPMFWQDIQNFKKLDQETAPPKDAILLVGSSSFTKWTDV
ANYFPDKTIINRGFGGSRLTDLNDYANDLLNPYQPKQIIIYCGENDFADNDKLKADVVVN
RFKTFYKKIRAKFPDIEVDYISIKYSPSREKLWPQMKIANKKIAAFMKKEPHAEFIDITK
VMQDSNGNVRKDLFVEDMLHMTPEGYQLWTSVMNPYMK
>KALACAFP_03905 ATP-dependent RNA helicase RhlE
MEKLTFADFELPVKILDVLADLELFEPTPIQEKSLKPILSGRDVMGIAQTGTGKTLAYLL
PVLKTWKYNKTGNPTVLVLVPTRELVVQVTEIIEKLTENITARVIGIYGGKNINTQKLLF
NDGCDILVGTPGRVMDLAIDNAISLREVQKLIIDEFDEMLNLGFRPQLTHIFEMMKEKRQ
NILFSATMTEAVDEMLDEYFASPVEISLAKSGTPLEKIEQTGYKVENFNTKINLLEHLLK
TDTDMSKVLIFNNNKRHADLLFTKIDELFPEQFDVIHSNKSQNYRLKAMKRFENEEIRGL
ITTDVMARGLDISDITHVINFETPDVPEQYIHRIGRTGRADKNGKAITFVTKKEEPLILD
IELLMDKELKFIDFPEGVKINPKKIASEEEQIVMKNPAQVKLTEGGGAFHEKKDKNKKEN
WGGPSKRKAPKKFGANRAQQKAISKSKRKK
>KALACAFP_03906 putative protein kinase UbiB
MFDKQQRKLKRSAKLISVLSKYGFKDVLARMKSGNKQVDIPNNTDEIVSKGTVYERIRLV
LEELGPTFVKLGQTFSNREDLLPPELIQELQKLQDKVDMVEMNIEEILENEFNISINEHF
ADIQRDPLATASIAQVYKATLIDGTEVILKIKKPDVQTVIEDDLLLIKDLEKLVSSYSEI
GEKLNLKQAISTFEKSLLEEVSLINEKENILQFRRNFKNNKETYVPKIFEEFSNNNILCM
EFIDGIKVTDKALLLEHNINPVTISEVGLRLFVSQILDYGFFHADPHAGNILVKKDGKVV
FIDFGAVGKIPPNDKEVLENLIVSFVAKNPHKIVRYLKKMAISYQIPDERRFENDVEDIL
DFVHSSSLKDIDPQSIINKMKDVLKDNRLYMPDYFYLLFKGISLIEGVGRTINPDLDIVK
SLHPYTKKIFAKKISPKNILKTGMDRMMNFTDNVDEIPKELRSVLQKLDENKFTVSSEIK
NIEKTNQLIKSSIVNLILAMILGANIIATAIVFVSESGPRIGEMSLMAVLGFIFSILLVI
IILLRITRK
>KALACAFP_03907 hypothetical protein
MTESELKNILKICNKATKAPWRLYIEGRDFTSGSSFIMTGEIENRDYDIEFLKIKKEDQD
FIVMARNVLPQLINEIIKLKFQQ
>KALACAFP_03908 hypothetical protein
MKNLKKISREQLKNIAGSGIIRNCSNECCPKDGRPRCPGLICPAVVCPQYA
>KALACAFP_03909 2-oxoglutaramate amidase
MQIETRTLTTQDYPELVETMKRAYPQMSEYVWSKKSIEKLTKIFPKGQICITVDGKLAAV
ALSIIVNYDEFGDDHTYSDITGNYTFNTHTSTGNVLYGIEVFVDPEYRELRLGRRLYDAR
KELCELLNLRSIILGGRIPNYHKHSDLSPREYIRRVRDKEIYDPVLSFQLSNNFLPIRVL
KKYLPEDESSKENAVLLQWNNIYYSKKPNTMQDSIIRLGLVQWQMRHFKDIDAFYEQVEF
FVDVMGDYKADFVLFPELFNTPLLAPFNKLSERDSMIELAKLTEEIKAKISDLAISYNVN
IISGSMPVFENNDLYNISYLMHRDGRMDEYRKIHITPNERKYYGMKGGNEIKVFDTDCGK
IGLVICYDVEFPELPRILADQGMKILFVPYLTDTQNAYMRVRHCAAARAIENECYVAIAG
CVGNLPGVNNMDIQFGQAAVFTPSDFAFPSNAVKGEATPNTEMTLIVDVDLNLLKDLHHH
GSVQVMKDRRRDLYETYLK
>KALACAFP_03910 GMP synthase [glutamine-hydrolyzing]
MNNGIIILDFGSQYNQLIGRRIREMGVYSEILPFNTPLETILEKQPRGIILSGGPSSVNA
ENAHLVEKELYEQGIPVLGICYGMQLTAHLLGGKVHKGVKGEYGKAHLEIVKESSLLKGV
TDNSIVWMSHFDEVGQLPPGFELNAKSGVIASISNEERKIYCVQFHPEVSHTEEGGKILE
NFVFGICDAEKNWKLTNYIEKTVAEIRERVGDQKVILGLSGGVDSSVAAVLIHRAIGDQL
TCIFVDTGLLRKDEGKKVMDNYGEHFHMNIKLVDASERFLTKLAGVDDPEAKRKIIGNEF
IHVFDEESHKIEGAKFLAQGTIYPDVIESQSVNGPSAVIKSHHNVGGLPEEMDFELLEPL
RELFKDEVRKVGEELGIPHHLVHRHPFPGPGLGIRVLGAVDAEKVRILQEADDIFIEELY
KNDLYEKVSQAFVVLLPVKSVGVMGDERTYEYTAVVRSANTIDFMTATWSKLPYEFLETV
SNRIINEVRGINRVAYDISSKPPATIEWE
>KALACAFP_03911 Phosphoribosylamine--glycine ligase
MRILIIGEGGRESALAAKLQNDPRISKMFFANGNATTDAIGKNVHLSEIKELRDFAIKEK
VDLTIVGPEAPLVAGLKDEFKKHDLKVFGPTQKVASLEGSKAFSKKFMQTYDIKTAKAVV
FDSYNEAKEYVQTQQYPLVIKASGLAGGKGVVICDTLEEAEATIHDFMIRRIYGDAGIRL
VIEEYLQGFEASIIAFSNGEKLFPCVAAKDYKKAGNGDTGPNTGGMGSVAPSPEFTQEHY
ADFEKHILEPTVAGLKGEGFSFKGIIFFGLMVTKNGTYLLEYNMRFGDPETQVLMALMEN
NLLDVINDCMEGRDIELKFKDEKAVCLVMCSGGYPRNIETGFEIVGEDKLKHSKLLYAGA
VKKGDKVVSNGGRVLNIVATGATYEDARKKVYEDASHVHFDYGFYREDIGKF
>KALACAFP_03912 Bifunctional purine biosynthesis protein PurH
MSKKRVLISVSDKSGLIEFAQFLEAQNYELISTGGTFKHLKDAGLNPIQIDEVTNFPEML
DGRVKTLHPKVHGGLLAVRSNAEHMKTVQEHGIGLIDMVIVNLYPFFENVNKDISLHEKV
EFIDIGGPSMLRSAAKNFDSVTVITDVEDYATVKIEMEQNGDTYIETRKKLAGKVFNLTS
AYDAAISRMLLDEDYPTYLNASYKKVSDLRYGENPHQTAAYYVSTFENGAMKDFEQLGGK
ELSFNNLRDMDLCWKVVTEFKEEMACCAVKHSTPCGVAIGTSALGTYQKTFECDPVSIFG
GIVAMNYKIDAATAEELNKTFLEIVMAPEFDEEALEVLRKKKNLRIIKIVNPVSDKQTWV
KIDGGILVQDNDSIFSDDIKVVTETQPTEEQKKALLFSQRVVKYVKSNAIVVSNGIQAFG
IGGGQVNRIWATQQAIERAKEKFTGDLVLASDAFFPFRDVVDFCAQEGITAIIQPGGSVK
DQDSIDAANEHKIPMMFTGIRHFLH
>KALACAFP_03913 Phosphoribosylglycinamide formyltransferase
MPLQSGLVNNSQSLVKVSNLDKAHKIKMKNLVILVSGSGTNLQRIIDTIDSGEIPNAKVS
LVVADRECYGLERAKNHNIDNVLIPRGKNFSSELSKIIPENTDLIVLAGFLSILKPEFCE
NWIGKIINIHPALLPKYGGKGMWGHHVHHAVIDAKEKESGATVHFVTSGIDEGEAILQKS
FEVTEDDTPETVAEKVHKIEYEIFPIAINKVLGN
>KALACAFP_03914 Phosphoribosylformylglycinamidine cyclo-ligase
MSNTYKSAGVDKEEGYKTVDKIKKAVGETHNSNVLNHLGSFGAFYEIGGYKNPVLVSGTD
GVGTKLKVALDSKKYDSIGVDCFAMCANDILCHGAKPLFFLDYLACGKLDSEIAAEIVLG
MVAACKDNNCALIGGETAEMPGMYQPGDYDVAGFCVGIVEKDQIIDGSKIKKGDKIIALP
SSGFHSNGFSLVRKVFPDFEEEFEGKPLYETLLVPTRLYYKDIHKILDEVQVAGIAHITG
GGLYENIPRIIADGLCASIDASKIKIPSIMLELEKRGGVAREEMFGTFNMGVGMIVVVDA
EHAEKVLHLLDDAYEIGEITEGSEKIDLKF
>KALACAFP_03915 Chromate reductase
MKILAIAGTNSESSMNKHLVTYAASIFENAEVEVIDLNPFEMPIYKHEREVTDGVPQEAK
DFAAKIDGANLLLVSLPEHNGTYSTAFKNVFDWVSRIKDRAVWNEVPMLLMSAAPGGRGG
AGVLEAATKRFPLHGGNIVETFSLPFFNDNFDKSAQKISNEEKDNELREKIKKISAIESI
LEK
>KALACAFP_03916 Quercetin 2,3-dioxygenase
MKTVYHKADTRGHANHGWLDSYHTFSFANYQNNERTHFGVLRVLNDDTVTQGMGFGTHPH
RDMEIISIPLEGDLEHKDSMGTTAVIRKGEIQVMSAGTGVMHSEYNNNKDQAVKFLQIWI
FPREAGVEPRYDQKSIKEGEKINGFQQILSPNKNDDGVWIHQDAWFNLANFTKGNGKNYT
LNKKGNGVYVFVLKGSAKVGDRILNERDGLGIWDTQSFNIEAIEDAEILLMEVPMELPSY
LK
>KALACAFP_03917 putative HTH-type transcriptional regulator YtcD
MEKQHNHKDCMQALKPVRDTLDVINGKWKLQIIISLNHGNKRFTEIERSIPKLTSKVLAK
ELKELEQNGLVERVVKDTYPVSIEYYPTDHTKTLHPVVESLKNWGENHRKHIFGSPSEAE
NGQQIDEIVGK
>KALACAFP_03918 FMN-dependent NADH-azoreductase 1
MANILNIKTSITGENSVSNQLSQAVINQLLEKNPESKVVVRDLALEPIPHLEIHHFNASR
LTDEERSEEQKEASKHSDQSLKEIQEADIIVIGVPFYNFTFPSTLKSWIDSISVAGKTFS
YADGTPKGLLENKKIYLNVAAGGVYENGLIENMEHYLRTLFGFIGITDVEVFISQGTMVP
QLKEENFSKAVAKIEELV
>KALACAFP_03919 Glucose/mannose transporter GlcP
MNSRIVQIVIIFLSAFFTGVNFVVFPALGTAFTDASLFELSSSQFGNLFIPQVICIIISC
LGAPFLVNKWGSKIVLVVGLLLMIISTGLLWMLQFFMNDQSLLFPVLMVLVAFTGSGFGL
SITTLNPLAASLFEKDKSSAILILQFLVGLGTSTSPLMMNLIGNVNNWMYVPASIFVLVS
IIFILFLFLKLEKGTFFELPKHFKIPSKLWIFFTAIVLYGFIEGTFGSFGAIILKNQGLD
NNKASLGLSLFWGGIALNRLLFGIFSKNNDLSYLFLFSPLIVAGLLLSLLIYPNISLIVL
MMFLIGFFMGSIFPGSIGWGTVEFPTLSVLVSGFLMAANQIGTGIITNVLGNFSNQTNMI
FQFLIVCMILICILLFFLKRNSKIKEAF
>KALACAFP_03920 6'''-hydroxyparomomycin C oxidase
MYDIIIIGSGAGGATMAYRLADTGKKILVIERGDYVPVEKENWNSVEVFQKNRYTTKELW
LDKYGKEFRPGMHYNVGGNTKFYGAALFRLREDDFKKIKHYGGISPEWPIKYEDLKEYYL
EAEKLFHVHGKRGSDPTEPNESEPYPYEALPHEPRIQEIFDELTDYGLKPFELPIGVNFT
PHKTINAPYTLDRFDGFPDAAERKADAHLCSLAKALEYPNVELMLNTKVIKLNTDESGTR
ISEVVVEHEGETKNLVGNLVILSAGAINSAAILLQSKNEKFPNGLANSSDQVGRNYMFHQ
NSAMVALFTEPNYTKFGKTFGINDFYRAGGEYEFPLGHIQLLGKSDEFQIEADSPVPAPG
FTFELMAKHAVDFWLTSEDLPDPENRVTVEENGQIKISYTPNNEEGHELLKHELIKALKA
SGKFHSFWFKGIYFSKGMSIASPAHQNGTTKMGVDPENSVVDIHCKAHDLENLYIVDGGF
FVSSGAVNPALTIIAMALRVGDHLKKNVLPS
>KALACAFP_03921 hypothetical protein
MRKNLYLIIISFSLVSCYTYQVKKPVDTAIDNNQEFKKSAVIANNAPTQPNNMTGAPQNP
YSPQTPVPVNVQEKLTPKKNVRIDVDGKTYKVIVDRWESDSLVAHPVHNPKKILKFHKNQ
INGEKIAEKRFSQPIADIITVVVYAGIGVLIYSLIR
>KALACAFP_03922 hypothetical protein
MEPPHSSLSRRKKPNLSMAQIINMSMGFLGIQMAFGLQNGNASRILANFGADVHELSWFW
LVAPITGLIVQPIIGHMGDNTWSPLGRRKPYFLIGAVLCAIGLVLLPNAASATQMMAANV
LVMAVIFLAMMDASINVAMEPFRALVGDMLPKHQATIGFSVQTILIGIGAVIGSELPNWL
ANFQKNNIYLDFYLRKYLSFGLPQWVLDLKSVSNAAPKGFVADNVIYAFYIGAAVLIVSI
LYTIITTKEYSPEEFASFEGGKPMVKDQSKLSDIFKDFKNAPSQMKKLGIVQFFSWFALF
TMWVFTTSALATHHFGLSPEDTHSVKFNDAGDLTGSLFGSYNFYAIFFAFALTPIAKFIG
KKQTHALALACGGLGLISMYFIKDIHSLWISMIGLGFAWASILAMPYAMLIDSIPQKKMG
VYMGIFNFFIVIPQIINGIFGGPIVSGIFGKMAIDYIVVGGVCMLLGAVLTLFFVKSEHE
TPKEIEEEIQQVHF
>KALACAFP_03923 hypothetical protein
MKKNKILLILTFILFALSFTPLSAQAKFDKEKIEISKMLDGFNIAAAKADYTAYFNYFAD
ESTFIGTDATEIWDKKAFMVWAKPYFDKKRTWNFTSLKRNIYFSKDGKLAWFDELLDTQM
KICRGSGVVEKIGGQWKVKQYVLSVTVPNDVVDKVVVEKTPIEDALIQQLKAK
>KALACAFP_03924 Cyclomaltodextrinase
MKKIYTIFALSAASVAFSQIQKVEPAFWWKGMKNPELQILVYGKNIANNQIELSDGVQIK
DIQKVENPNYVFVTVNTNEINVPKFKIIAKNGKKNIGSYTYELKQRDPNSVNRESYTSKD
VMYLIMPDRFANGDEKNDSSPNLTEKADRSLPNGRHGGDLRGIINNLDYIQNLGATAVWL
TPVNEDNEKVYSYHGYAQTDLYKIDARYGTNEEYKELSQKLNKRNMKLVMDYVTNHWGIS
HWMIKDLPTKDWIHWFNDGENGFKRSNYKTTTQFDTNASEIDKKVALDGWFDTTMPDINQ
KNPLVLKYLTQNAIWWIEYADLGGFRVDTYPYNDKEAMAKWAKAITDEYPKFNIVGETWL
STAGQISAWQKDSKTGEAANYNSNLPSVMDFMLYGDMPKALKEKEGWDTGMNRIYNSLSS
DFLYPDINNVMVFFENHDTERWNEIFNDDPKAYKLGLTLISTVRGIPQIYYGSEVGMRGD
KNKGGDADIRRDFPGGWKSDKVNAFNPTNQTQEQKEFYQFTQKVLNWRKGKDVIHTGKTK
NFVPQNNVFVYFRYNQKESVMVVLNNNDKEQSLDLKHFAESLNGFTKGKDIISDKEFSLQ
NNLTIPAKNSMIIELK
>KALACAFP_03925 Glucan 1,4-alpha-glucosidase SusB
MKKITMGAVLFSMMFVGVNAQSLKSPDGKFEMNFQLKQGVPYYNLKYNGNVVVEDSKLGL
RLFKDSAIQFASEIVKPEDVKNDLNNGFTKTDEKRDSKNETWQPVLGEKKNYINNYNELA
ITLNQASTDRNIVVKFRLFNDGLGFRYEFPQQKNLNYFIIKEEDSEIDFPTDMKAWWIAA
DYDSQEYLPQTSNISEIPAKWGSAFDSNASQQMVKNAVQSPLMLKKEGKSPLYVNVGEAA
VIDYPASHLEVDAVNFKFKTHLTPDRQGAKGYIQTASVSPWRTIIVSPKAEEVLASKMMF
NLNEPTKYTDTSYIHPTKYMGVWWEMIIGKSQWAYGQPESNVRLGVTDFSKLTPNGKHGA
NNDKVKEYIDFAAENGFGGLLIEGWNIGWEDWFGHSKEYVFDFITPYPDFDIKMLNEYAH
SKGIKLIMHHETSGSATNYERWADKAFQLMNKYGYDAVKTGYVGDIIPRGEHHYSQWTIN
HFYRIAEKANEYKIMVNSHESVRPGGESRTYPNWISAEAARGTEFEAFGGNNPEHQTILP
FTRWMGGPMDYTPGIFQTKLDYYFPGDKRFVKTTLVKQLALYVTMYMPLQMAADLPENYK
KHMDAFQFIKDVAADWDDTKILSAEPGDYIVTARKAKGSENWFVGGITDENKRDYTVDFS
FLDKGKKYEATIYEDGKDADYINNPQSYHIYKKQITSKSKIDFKMARSGGFAVSIKPLK
>KALACAFP_03926 hypothetical protein
MKQLFKILTIAFVSFLVFSCEKDEDQAILNEVSASKLSSDKTAVVLSEIIAGNPAISFTW
QKSQFNIAIVPTQQVEFGIKGQNFKKSVTYDFANDATSGSITHAGLNALMFNLGATPDIV
NNIEVRLKTSAGPAAFYSNVINLTVTPYTPNPDLVYPKINVPGGYAGAAGYADWTPGNSP
NLFSPGKNNEYRGFIFVTAPNSEYKFTINQDWTGDKGDDGTFTGKLVESGEVNIKAITAG
TYYIKADWAANTYSSIKANFGIIGDATPTGWGSDTDFVYNPATKTFVINSIALNTSGSFK
FRANDDWAMKFQPQSSDQTLTSGSGVVTYLSSENTVTGDPNYKVDVAGNYKIELDLHNSA
NYKLTITKL
>KALACAFP_03927 Starch-binding protein SusD
MKPNKNIFKKITIAAAFGLLVISTSCVKDLEQEPRTGVTSTNVFNDFANYPNALAKVYGG
FANGGQESNGGSSDINGIDGNFSQYTRLLYTLQTLPTDEAVIAWNDGTLQTIHKMTWDSS
SEFIAGMYYRIYTEIAFCNEFLRNVTDEKLASNNITGDNLTEAKYMRAEVRYLRALSYYY
ALDLYGNVPFVDESYLPGSITPPQRITRANLFNFVESELLAVANDMKDARTNVYGRADKA
AAWSLLARLYLNAPIYNGSNRNNDVITYCDKVIAAGYSLKPKYADLFLADNDKNNSETIF
PILFDGVHIQTSGGSTYMVHAPVGGSMPSESMFGINGGWGGIRTTKSYVALFTNSSDQRG
NFYTNGQNLEINNLGEFTDGYAFIKYKNLTSTGQFGADSAKNFCDADIPLFRLADIYLMY
AEATLRGGNGNSATALQYINNIRTRAGYTTPLSSINLDFILDERGRELGWEMTRRTDLIR
YGKFTTGAYLWPWKGGIKDGKSVEDFRNLYPIPAKDIVANPNLVQNPGY
>KALACAFP_03928 TonB-dependent receptor SusC
MKNFTTVLKIAPAFLLASTMIHAQTDSTQKEKKIEEVVLIGYGKQKKTDLTGSISSISAK
DFNGGATSPGQLIQGKTPGVAIVGNSGAPGSGTSIRIRGIGSLNGSQSPLIVIDGVPQDF
SGISGAADPLSLINPNDIQSFDILKDASATAIYGNRASNGVILITTKQGSAGKLKVNFST
LASISTKMGNVDVLNADEFRAFVNQNATPSYIARLGNANTNWQNQIYQKAWGTDNNVAVS
GGVKGLPYRLSLGYNEQNGIVRTNSFRRTSAALNLNPKFLDNHLSVNINAKGTFTDNRFP
ATGAIANATYFDPTQPVYSGNSNYGGYYEWLDPASATGLNVNATANPVAQLEAVRDVSSV
WRALGNIQLDYKLHFLPDLHFNVNAGYDYSKGEGATTINPAYKSGIGVLGSYRPYSMEKK
NKLLETYFNYTKNITSLNTNVDFTAGYSYQDFHTTAPLVVTYQGNNQTGGQVNAIDRKLV
LLSFYGRAIFTIANKYIISGSIRRDGSSRFFNGTRDNLWGNFPGISVAWKINEEEFLKDS
GLNTLKLRAGWGKTGNNELGDNYYPAFASYSPSVPGAQYQFGSQYYYMLRPDIYNPNLTW
ETTTTQNLGIDYGFLNNRIFGSIDIFKKKAEKLLVDSPIAAGDLSNHNILNVGTMDTNGI
EGAITVVPVKNENTTWELSFNATHYNSKITNLVSAANNSFFIAVGDITGGVGNKIQAHAV
GYQPYSFLVYQQVYDTNGKPLDGVYVDRNGDGIINSNDMYYYKSTQPDAILGFNTKLNYK
NWDFGFSARAVLGNYVYNNAASNSSLQSASTNSYLQNVYSSTPEYQFSLPRYFSDLFVEN
ASFFRLDNVNLGYNFKDIFSKGSSLKVYGMLQNVFVITKYSGVDPEIFGNIDNGYYQMPK
VYSLGLNFQF
>KALACAFP_03929 Methionine--tRNA ligase
MSNRKMITAALPYANGPVHIGHLAGVYIPADVYARFQRRLGKDVAFICGSDEHGIPITIR
AKKEGVTPQDIVDKYHEIIKKSFADLGISFDEYSRTTSKKHYETSQDFFKVLYEKGKFTE
EVSEQYFDEQANEFLADRYIVGTCPNCGNENAYGDQCERCGTTLSPSELINPKSMLSGNV
PILKATKNWYLPLNEYENFLNEWIIEGHKDDWKPNVYGQVKSWLNEGLKPRAMTRDLNWG
VPVPLPDAEGKVLYVWFDAPIGYISFTKEWAEKNGKNWKDYWQSEGSDLVHFIGKDNIVF
HCIIFPAMMKAHGDFIMPANVPAFEFLNLENDKISTSRNWAVWAHEYVEDFPGQQDVLRY
ALLSSAPETKDNNFTWKDFQTKNNSELVGIFGNFINRVAVLIHKYYDGIVPQGDANSPEL
KEINKSAKEISGFLENYEFRNSLTALMNLARFGNQYLQTEEPWKTIKDNPEKAAQSLFVG
AQIAVALAQLCEPFMPFSSEKLLNMFNVQKQSWSDIETQSVLIETGHKINESSLLFSKIE
DDVIEAQIQKLEDTKQNNKKTNPNANPMKDEITFDDFTKIDLRTATILEAEKVEKADKLL
KLKVDTGVDIRTVVSGIAESFTPEEVIGKQVMILLNLAPRKIRGIESQGMLLLTTKADGK
LSFVTPDETVENGIEIG
>KALACAFP_03930 Release factor glutamine methyltransferase
MKDLMGKAIWDYYHNENPEDLQTETSISELDELPVDYLFRDFEEMNGIEQKALQLAQGKT
LDIGAGAGSHALYLQNERNLEVTALDISPKAIEICKLRGIKKAVAENMLHFSGENFDTIL
LLMNGTGIFQSLTVIDIYLKKLYSLLNKNGQVFIDSTDILYMFDRDEDGGVYIPAEGYYG
ELDYIVHYKGESEDPIKWLYLDFNTLKNAAENNGFKIEKVLQDEDSYLAKLTKK
>KALACAFP_03931 hypothetical protein
MYNKGLFNDWVPKPVQLLMIVLLVIVVLPLGGVYTGNISFMVGGTGELSEYFMFASYATT
IGMGACMPIVLRMKMRFKVRNKMVLLLVLLGLLNCVNATTFSPVVIIGVSLVMGFLKMMV
AIELFLPLMMMIGDRGVFYGVFYTAVLTLTQISSYYAVKVSIVYNWQQFFIVIAILCLVM
ALLCWVLMHNKYFSLKVPLYHIDWMSIILFMSTFMFSAYVLSFGKQQDWLNSTKIINSSI
AAFVSFAVLIVRQFTLKRPYLSLSVFTRSNVLNGLFMLFWLGMFLGTTSIQNIFAVGVLG
YDQLTNAKLSLLMIPGLGAAGMTAIFWFKRQKPLKMFIFSGFSAMIGYALIMYFSMVLEF
NYEYWYLPMFLKGYGMGALFISVWFYTLDKLELNDMLAAIGLVLVWRTFLVVGIFSALMS
WFQYQFQIVSLGDLAVYMDGMTISPQNVMSNMKTIQLNAILAANKKIFGYIILVGFGVLL
YVLTHHFGAKRFEYLRFIRVLNGKSIIAKRRIREREIVEEIKDAAGSAM
>KALACAFP_03932 Multidrug export protein EmrA
MENKEQNTQNTSSAPAQSSVAEKKKQNKRNKIRAIISNIVVFLVIGFGLYWLVREYFHVG
DKTYTEAAQVEEFINPINTRVSAYIKEIKFIEHQKVKKGDTLVILDDREILTQLGQAEAA
YQNALAQRTATSSSVNTVSNNVSVMEANIAGAKARLWNAEQNLNRYKNLLASEAVTRQQY
DQVKTEYDAQKAAYEALANQKQSANLSTTEVKSRLGINDAEIKRTKSALDMAKINLSYTV
ITAPYDGVMGRRTISEGQLIQPGQQVATIVLNGQKWVTANFLESQMPNIKIGEKMMMTAD
ALGGQKFEGVVTAISAATGSRYSNVPTDNSTGNFIKVQQRIPVRIEFTASNKKENVEKLS
AGMNLNVKIN
>KALACAFP_03933 Outer membrane efflux protein BepC
MIMIFPALFFSQEIKQMTANDVAELAVQNHQQLKVSAQNINIAKQNTNIAKLQKLPTITA
SMSQFYLGDMVAIDKDFSNSTTISMPHYGSSCGVQATQLIFKGGLVNKSIELAGLREQLS
KLDLEKNKQDVKFLVISNYLDVYKILNQQEVFQNNKKLAQERLKNIQKFYQQGMVTRNEV
IRGELAIKNLDQGILTLVNNRKILNYNLNIALGLPSDTEIVPVESLENKESGIGMDYYLD
LAHNSNPLMKSAKTNIDAADKNIEIIKTDKMPTLAGFGGYTLQRPITNRTPVLDMYAGGW
QTGISLSYNIDNLYKTKERVKLGKFQKNQASDAMILIQQNIDMSVNAAYVKYQESMQQAE
ILNDAKRLAEENYKITEAKYLNQLAVQAEMIDAQNQKLQSELDYANAEINVLYQYYNLLK
STGTL
>KALACAFP_03934 HTH-type transcriptional activator Btr
MSVLEKFGVEIFTQHNIFERIAVDKPFRPENPAFIFIKTGSIKLRQHFNDLELSENMFMV
TDPQTVYEMISVSDDFQSRMVSYKREFISALSLRFNRLIGYRYFRQQMNRGVPFDPEEME
IVWKTVNFLKYILDTETEILYKKEVVEHLFSVFCYQMAGIISKEDANSMSQMSRQEEIVF
IFLNDLAANHQTERTVEFYAERQSITTRHLSSVVKAITGKSASQMIALIVMNEAKVLLNS
SNKPVSEISSMLGFSDQYSFSHFFKKHLEVSPSQYRNQFEN
>KALACAFP_03935 hypothetical protein
MRKIDLLFAEYGESHRNATNKLIHWICVPLIFWTILGFISLIPSKSICFIYIGCISYISL
AAMVLVTIFYMRLSFLIGLIMVFVMLLMESFAYGINIRFKENSWIVYLAVFIITWILQFV
GHKIEGKKPSFLKDLQFLLIGPIWLLSFILKKLGIRY
>KALACAFP_03936 hypothetical protein
MKKSLFAIIFFPFLMFAQEVPKLTDEMAIKLSEKPLHCINQEYPNKTAHIINNANEVPLS
PKDLHPSFYGCFDWHSSVHGHWMLVRLLKTKPNLSNAKEIEKILDDSFKKENLQTEADYF
TKYQLTGTFERTYGWAWLLKLDEELITWNNPKAKIWHENLKPLTDKILNSWKTFLPKQTY
PNRTGVHPNTAFAMAFAIDWARANKDKDFENQLIEKAKYFYLKDEKTPAYLEPDGSDFFS
PSLEIADLMRRVLPQKEFVQWLNKFYEKRSLENIEKIPVVSDLSDYQTVHLVGLSFSKAW
CMKGIAKSLPDNHPLKKDFQKTATVFLNNGLPLLFQGNYGGDHWLASFAVYALED
>KALACAFP_03937 hypothetical protein
MSILFDKIHENLLMKKLLLPLYCLLLINCSKSDKLANHEVKADLMEMVAPPSSSEDKLIP
ASSAVASPPPPNSISEKTVNENKPNSSQQKTDTISKKIIKNGNMQIQVGDISKAQKQVNE
IIKKNKAYIQKEEFRNTDTDESLDITIRVPHQNFDALINSFSDGIGSVLSKNISSDDVTE
EYTDVSIKLANKKIYLEKYRDMLKNAATTKDMLEIQENIRELEDEIDVSEGRLRFIDDRV
KYSTLNLGLYKEKVRSSATSKIGFGSRFGDSVTEGWNSFVAFFLGVISLWPFFLLIPLVI
FLWKKWRGRKKK
>KALACAFP_03938 hypothetical protein
MSEKKLAGIWIDSEKAVVVKNHDAQNAFKFFLCSPVKAEIQHGNSSENAGNNAERTNKIK
FFKEVEHLLTNSQEVYITGPGKIQEELKHYLHDTAQFKNLAITLDTAQQMSDEQFLETVK
NHFNA
>KALACAFP_03939 Ribosomal RNA small subunit methyltransferase I
MLFLLPAYLSENTPITHFSPVIKDYIMQTDYFFVENEKTARKVVKFFAPEKKQSDLKLFI
LDKYTENADIKEAQELLLKGQDFGLLSEAGLPCIADPGNLIVKWCHEKNIRVIPVSGPSS
IILALISSGFNGQEFTFNGYLPIDKGEKKKQILHLESLVQKTGYSQIFMETPYRNNQLFE
DLTKFLSPNTKLCIAANIDDAEHEFIKTKTIKDWQKQKPELHKIPAVFVLGK
>KALACAFP_03940 Low molecular weight protein-tyrosine-phosphatase YfkJ
MKILMVCLGNICRSPLAEGILKTKVPENFFVDSAGTISMHEGEHPDKRAIKTAANHDIDI
SKQRSRPITKADLEKFDKIYCMDIDVFEDVISKAENEEQRQKISLFMEILGDHENAEVPD
PYWGGMDDFENVFQILDKGCSKIATQLLTHNS
>KALACAFP_03941 Chromosomal replication initiator protein DnaA
MDENLMMIWQKCLQFMRDNLNAAEDNSDLKKLEKSFDLLFDKVQPISLVDNNLTLMVPSD
FYKEYIEDNYLSLLSAALKKNIGKGVKLWYSVMENKPNGLEKPVTMNMKGKTVPTPKVQE
TMPQGFSSNIVNPFVVPGIKKVNIDSNLKSDFSFDNYVEGESNKFAATVARSIAKRPGAT
AFNPLFLYGGYGVGKTHLGQAVGLEVKSQFPDKVVLYLSSEKFIQQFISAAKAHKQTEFA
NFYQMVDVLIIDDIQFLSGKSATQDSFFHIFDYLHQNGKQIILTSDKAPADIMDIQDRIV
SRFKWGLSAEIKSPDYETRKQIIVDKLSRDGIVLTEDMLDFLASEAKTNVRELIGVINSV
IAYSTIYKSDLSLELLKETINKIAANQKKIINIPYIQEVVCDYFGIKREQLLSKTRKREI
ALPRQLAMYFAKEFTNSTFTKIGEEMGGKDHSTVMYACETIKDVSKIDKEVKKYVKELTE
RIKQ
>KALACAFP_03942 Putative esterase
MIHTTHSLRVRYGETDPMKYVYYGNYAEYLEIGRVELFRSIGMSYNEIENQGIWLPVSEY
KIKYLKPAFYDEMLEIHTYVKKIPGVRIEFEYEIFNEEHVKITEAATTLFFLDAKTNKVV
KCPDYLLKLIEENWKG
>KALACAFP_03943 Prephenate dehydratase
MKIAFLGPQASFTQLATAQLFPDEELLPQANILDCFHAVENGEVDKAVVPLENSIEGTVS
MTLDYLYKTPEIKIEAEAVMPIAHHLMVHPDCKIEDIEKIYSHPQALAQSFHFLDDHFKE
VTKQDFSSTAAAAKHVSENVDRNLAAVANQFAANLYGLKIIHRNIQDFEQNHTRFIVISK
KKQAYHHEKLNILGEKSGLLITLPEDHAGGLHQVLSVFAWRKMNLSKIESRTLKTGLGNY
FFFINVVGKWEPVLHENALEELKALDADVDFLGNYKEYLLES
>KALACAFP_03944 hypothetical protein
MKNKIYFFLMILFPMFNNAQVGIKTEDPKSTLDVNGNVSIRQAPQITSLSGFQIMAINQG
SSEVSQFDPSLLTAPNSLNQTVYSARKNNSISLLSLNLFSSWKQINFLTIDKTIGSVSLF
SDADNSYNVPSTGIYLIGYYFRYGAGVQTTLLSGNPGMGILKKALDGVISVLDSREFTGI
NLGLASVTFTEYSMTSIYQLNEGEKLYFGLNNTGALGASLLSSSNASFYIYKISN
>KALACAFP_03945 hypothetical protein
MKTKICSALLALLSIPFFAQSGWVGINTANPQANLDVNGTIKIRETPVAPALPGYEILAV
NKNTGGDFQVAQVSPQLIADFVISQVNSGVSTTVYAAKKSAGISLLSLGLFPTGFRAVNF
TAAERTVGPTSLFTETDHTYTVPSSGTYAVGFTFRYGTGLQAALLSNSPGIGILRTRAGA
ATLIDSRTFSGANLILLSLTISETSINNLYTLQAGDKLTFGLTGSSLLDAGLLGSSVGSF
YVYKVSN
>KALACAFP_03946 hypothetical protein
MTYPLIVILIVVFIIIFYNLNNRIQRLEREISELNRKIQTPGFTQIKEEQHVQPVVSSIK
EEQKITAFEESKVTEEAPVIPEKDWLTPIFDFLKQNALTIIGIFTLVLGIGYFVKYAIDR
NWIGETARVGIGLLVGGAIMLTGHFLRKNYTVFSSIITGGGIAVLYFTTTIAFREYQLFS
QNIAFVITCLITLISIALSYYYKSEVLIIFSLFGGFLAPLMISTGQSNYPFLFTYLTVLN
IGMLIIVFLKNWKSVGWVAFLFTNIYLFYWTAEKTELLSIYFYIITYIIFYAFALQNYIK
KGILPSYDILMLVLTNFTSIIGLVYIFNTLQYEPVIVFPIGFALVNLFLLFKEYSKKNFG
VNYSVFAGISISLITVAIALQFKTHLITSVWAIEATLLLFIWKKTNLNIFKICFYILFPL
VIIAQIMTWAKYVDAKNLAIIFNPVFLTSFVTVITTFTNLILLRKLPDTNKKNTDFFENV
FTIVSYGIIYVALLLEIMYHISDKTWIVIFSIAMLYSLYYIFCILLFRRKLDIHSILETG
LLYLFLLLIIFNTLISGSGIISNFLMGKLHLSFYGMHLLYWIPFIYILVKILPKSDFFTI
VLSYWVVALAFITAVSAELYHIYLIINANGISEVAKLGKHFRILYLPIIWAVLASILIYR
GLKTNTTEYTKIGFVLIAFMILKLYTYDVWEMDNVSRIVAFIILGIILLLSSFLFQRLKN
IIKNMVENKEENNETENTKS
>KALACAFP_03947 hypothetical protein
MKKILYSFLLLSSATLLAQKNPATKFAVANDIVGTVDMFNAHKSAIQSSQVYKTPANLPQ
NLKKYSSIAENGLVEYKIKNGQDNIDRLPLSDLNVQYQIAENTPVYIDGYEFTNTKTLVF
GEILTKMEAKDKDGKRTLFITTK
>KALACAFP_03948 Replication-associated recombination protein A
MNQNIPLAEKLRPKALDDVLGQEHLTGEKGTIRKMLENNSLNSLIFWGPPGTGKTTLAEI
ISEKSGRKFYKLSAVSSGVKDVRDVIEDAKKQNLFSGKSPILFIDEIHRFNKSQQDSLLH
AVEKGWIVLIGATTENPSFEVVSALLSRSQVYILKALSYEKLEELIDIAAQRYNQDEKTD
FKVVEKEAFIQYSGGDARKLINSVELVFNQFKNSKKTEIKNEDVLEVLQETMALYDKNGE
QHYDIISAFIKSMRGSDPNGAVYWLARMIAGGEDIKFIARRMLILAAEDIGLANPNALVI
ANNCFQAVNVIGNPEARIILSETAVYLAVSPKSNSAYMAINEALALVKQTGNLPVPLHLR
NAPTKLMKDLDYGKEYKYAHSFQGNFVDQDFLPQEIKDVKLYEPGNNATEKKIYEELKKK
WNNKY
>KALACAFP_03949 hypothetical protein
MNESIGKNIRKYRELKGFSQEYMANQLDINQASYAKIESNSTKLTVDRLFTISKLLETEI
TDLLDLKNQIVYNQDIKDYSVGHQEVQNLYQTNQEVYEKLIQSKDEQIALLKEMLNKKNK
>KALACAFP_03950 hypothetical protein
MMKKLVSWLSFMTVFCFMLHSCVQDEIYSSTGPTSKEYHSKSFWKEDEKYIKNVMKIYFE
HESEIKKIGGSPAWDYSMSMGKYNETFMAVPIVENGRVINTLVCARFDKKVYFRYENSER
NNKFFNDIIFGKYTNYKIDSQSNKEKDSTNKGVMCGTRSVSMWYPDNESNPNGSGHWETN
YYTNCYSYQDYYDPSWEQGGGGFDYNGGGGSGTDPNNPDTNQNPCEKTKSLTNNPGIQNA
IQNLKNHISSNTGGELGWKFNKVGPPTPTTQNSAHSVVIGDPSSINGAYHNHTGTTLDIF
SATDINTLLEIARYQDIGNTDNAFYGLIAPDDIHYLIYFNGTHADLPASGSYSDIDIDVW
KIYQLRDMWNILNKDTSGIYCNNTTNTLNSKGLEKVFFDTLNKMGISSNKIVLQKIDSNN
NISTVIKNNDGMTIEIPCS
>KALACAFP_03951 hypothetical protein
MKYILIISFLTVFHLYNAQIYPLNTFPDDVPVESYMKDLDNELTPFVGIWKTNYNGNTII
LTIKKEEHKAFKIPQSSYFYYQDALVINYTIQNSNGIMLQNNNNVQHEYDKNAIVSMYVN
NSIVNLYYIGTNCGVGWGTINLKKMNNTQISWSYYPNDTVLTTKNCPGNQDTTIYLPETK
DLIFTKQ
>KALACAFP_03952 Prolipoprotein diacylglyceryl transferase
MSNIFFRIYLVVFAFITQCFFAQNYPDGMSDGTLKVNTTDVPVKIYATTELGDLNVFPDR
KVDGNVLIILNESNFEPAYFNFGTLTLTKLKDAKYQLLDKNFKPITTPATQENIDNFKYA
VKSNKPITAADKVSLETPFKIWDPSKGIQLGPITLHFYSLMFIFAFGFGYILMNRIFKID
NINQKYLEPLFTWTLIGTILGARMGHVIFYQPELFKEDFWSVFLPISTKNGLKFTGFSGL
ASHGATIALIFTTLYYSFKIIKKNPFWVYDRLGIVVSLGGAFVRLGNFFNSEIIGKPVDP
NSPFALLFPQQSSEYGVTVPRYPSQLFEAFGYVCLFILLWILYRKTNKKYQQGWLFGLFF
IILWAIRFFVEFLKEPQGDEFIQLGGLNTGQVLSIPFMIAGVVIMIISKKFKITQAENEK
PE
>KALACAFP_03953 Bifunctional NAD(P)H-hydrate repair enzyme Nnr
MKIFTAEQIRDCDQYTIANEPVASIQLMERAAESCVDWISENCKNHRNFAVFCGNGNNGG
DGFAIAKMLYLKGFDVDVFTHTKAKFSPDAHINFKELKEISGISIKDFKESMGYRFDNRT
VIVDALFGTGLSRNLEGDYKDLVNFLNSKKSIKISIDVPSGLFADTISSADATILKADYT
LSFQFWKKSFLHPETGKYTGKVEILDINLSEDYISETLTNNFVIDDEVVKNIFKPREDFS
HKGSYGKVTIVGGSYGKIGAAVLATKSALKTGAGLTFTLAPKCGYEILQTSCPEAMFIEG
GADYVNDFIIDENSSCGVGPGLGTEAETVKNFLKFLKSYSKSMVIDADALNIISQDKKNL
NLIQKKSIITPHPKEFERLFGETENSFERLELAKEKAHELGIFIVLKDHHTQVITPEGNV
FYNITGNSGLAKGGSGDILTGILTSFLAQHYTEEEAAILGVWFHGKAAEFASEKYSKESM
LPTDVIHEFGNVFTELNEKVQIRL
>KALACAFP_03954 Large-conductance mechanosensitive channel
MGLVKEFKEFAFKGNVLDLAIGVIIGGAFGKIVSSLVEDVITPLLLNPALKAAGAENISK
LSWNGVTYGNFLSAVISFLCIALVLFWIIKGANKIVKKEEAAPAAPTTDQKLLMEIRDLL
KNKNI
>KALACAFP_03955 Large-conductance mechanosensitive channel
MGFLKEFKEFAFKGNVIDLAVGVIIGGAFGKIVSSLVTDVITPLLLTPALKAAGAEDISK
LSWNGVTYGNFLSSLISFFCIALVLFWIIKGANKISKKHEPAPAEPTEDQKLLIEIRDIL
KNKNNS
>KALACAFP_03956 Hydroxypyruvate reductase
MKVLANDGLDQSGIDALTEKGFEVITAKVPQEFLIDYINEHKIRTLLVRSATQVRKDIID
SCPSLEIIGRGGVGMDNIDVDYAREKGIHVINTPSASSESVAELVFAHLFSGARFLQDSN
RKMPVVGDTEFASLKKAYAAGIELKGKTIGIVGMGRIGQEVAKIALGLGMRVIAADNNVG
KASIKVTFYNNQFINVDIETEPLQDVLKHSDFITLHVPAQKDGYMIGKNEFDMMKDGVAV
VNCSRGGVIDETALIEALDSGKVKFAGLDVFINEPTPSKEILNHSKISLTPHTGASTLEA
QDRIGLSLAEQISSILQIQ
>KALACAFP_03957 hypothetical protein
MMELEYKDHISPILKDGIKNYLIDIDGTITEDVPNEEPERMVTCEPFPDALETINKWYDE
GHQICFFTSRTENLKQITIDWLDKHGFKYHSVLCGKPRGGNYHWIDNHLVRATRYKGKFT
DLVEKQVTIEVFKEEE
>KALACAFP_03958 hypothetical protein
MNNLRKFSQTQNRIFILYLSNTSQHMKRTLALIFSSIGWFALIAQFYLMIENRILPIPET
TIRFFSYFTILTNLIVAIYLTSEIFKDNSNRSSGNLTAITIYILIVGVIYQVILRQLWQP
TGLQKIVDELLHSVTPVLTLFYWYLYENKKNLHYKMIPKWTVFPLLYLIFVLIRGHFSNF
YPYFFIDVNALGLAQTLMNAFWILVFFVGLSMLFIRVGRLFNK
>KALACAFP_03959 hypothetical protein
MVFCGGGWAKKALLIIFSLADFADLADIYVYFLDNVQRIFL
>KALACAFP_03960 Isopentenyl-diphosphate Delta-isomerase
MEEFVVLVSPEDQVLGLMEKQQAHVNGLLHRAFSVFLFNSKGEMLLQKRASGKYHSPLKW
TNAVCSHPKNGETYLEGAKRRVKEELGIEAEISEKFSFIYKADVGNGLWEHELDHVFIGV
FEDDFNLNKDEVEEVRYISMQDLDREMIEHPEHFTEWFKIILEEYKHHF
>KALACAFP_03961 hypothetical protein
MKKIILVLSFLVGFFSFAQSIPTKVYDSENYSITFPEVWKLTNDNDIINIFPGTEIGAIT
ISEYHDLNLPKTETKKFILALYKSADDEKKIKTKSGKKGYTEYFYEYFDENEKLFWITKV
FQKDKDLFLISINCGQKYWNGNYMKLFNEAFDSFKIKK
>KALACAFP_03962 Aminomethyltransferase
MKKTALYDKHVSLGAKIVPFAGFEMPVQYSGVTEEHFAVREKAGLFDVSHMGQFFIEGPG
SKDLLQLVTTNNVDALENGKAQYSCLPNENGGIVDDLIVYKMEDDKYFVVVNASNIEKDW
NHISKYNSFGAKMTNASDDMSLLAVQGPKATEILQKLTETNLSEIPYYHFTLGAVAGVND
VIISNTGYTGSGGFEIYFKNENAVQLWDAIIEAGASEGIIPCGLAARDTLRLEKGFCLYG
NDIDDTTSPIEAGLGWITKFDKDFVSKDIFAKQKEEGVTRKLVGFELTDKGVPRHDYPVV
DAEGNVIGKVTSGTQSPMKKIGLGLAYVDKPHFKLGSEIFIQVRNKNIPAKVVKAPFV
>KALACAFP_03963 Regulatory protein Spx
MKKVFYLNTCDTCRKILAQFNLKDWELREIKKQPITKDELEEMFKHTKSYEALFSKKSTQ
IKLRELDIKSLGEKDFKELLLDHYTFLKRPVFLTDDKIFIGNDKENLGNLRAFFNN
>KALACAFP_03964 putative acyl-CoA thioester hydrolase
MRMENKPITFQFISEPSDVNYGGNVHGGSVMKWIDQAGYACATTWSGNYSVTVYVGGIRF
YEPIKIGEIVKVEAQVIYTGSSSMHISINVFSRNLKQPNFDKKTHCIIVFVAVDENGKKL
PVPKWIPETEEEKQQEQYAKRLMELRTQIEDEMKPFL
>KALACAFP_03965 Inosose dehydratase
MQRNEFIKLSSLGLLGLYSCGTSQLLTNKKTLAIQLYTIRDAISENLEKALEKLVNLGFT
ELEIYGYNGSFFGKNRNEFQSILKNIGLKVISSHHTTGILHNDKGTLLNNWEKSVEDLHF
IGAKYMVCSYLFPEERTIENYKKLPELLEKSGEITKNASIQFAYHNHDFEFEKFDETQNV
YDFILENSSSDLVKMELDLYWISKAGIDPLTYFEKYPKRFPLWHVKDMKAGTKDFAEIGN
GTIDFKRIFEAREKAGLKHWFLEQDSSDKDIFESIAISKKYILEQSYFQ
>KALACAFP_03966 hypothetical protein
MKILNLICLFIIVSLSAQTHRFIYELQLKMDSTESDYQKFNMILDINSKDVKFYGRNLLI
ADSLNKKFGNMNNKHVDMTGQIVKRKINTFDNENFINIKFGYYSFKTHDKIAWNISNETK
KVQNYTLQKATATFGDRNWTAWFNKEIPFNEGPFKFSGLPGLVFEIYDTKRNFIYNLVKS
QELANIYPTEDFLESNFANKAIPINEKQKQKLLLEFYNDPFSFERTNFNKNNSNLNINIG
GKEIRSIDELNAQVKSMQEIIRKYNNPVEIDKAIHYKN
>KALACAFP_03967 Chloride/fluoride channel protein
MSKHQRTLSDTSIIQIRIFFRKYPALPYVLKWLCISLIIGALVGTTSAGFLQSLEWATNF
RENHLWLIAFLPVAGFMVGLLYYYFGKDVEAGNNLLIENIHDPKDIIPFKMAPFVYLGTI
ITHFFGGSAGREGTALQMAGAISDQLTKPFRLDKSERKILIISAIAAGFGSVFGTPLAGA
VFGLEVFLIGRIRYNAIFPAFASAILADWATNLWNVKHTHYHIDFIPKLELLPIVYSVLA
GIVFGICAAVFSKSMHWASSLFKSKIHYPPLRPVIGGVLVAAAVFAMGTTRYIGLGIPVI
LESFEKQLPLYDFALKMIFTIVTLSAGFKGGEVTPLFFIGATLGSALALFIPLPFGLLAG
MGFVAVFAGATNTPLACMLMGIELFGAECGIYVAIACVVSYLFSGNNSIYTKQKIGEAKN
RRFENFNDKSFSDL
>KALACAFP_03968 hypothetical protein
MQNNILKNGKKLRKEDLKNIVGGIGGGGSLGTPDLSLCGCSCTGAVTGPKYCVQYIACPQ
VITC
>KALACAFP_03969 Putative metabolite transport protein YjhB
MQELSLSAKARLIFSIPVIIAALGYFVDIYDLLLFGIVRIPSLKALGLNPDVDGTFILNC
QMIGLLIGGVFWGIFGDKKGRLSVLFGSILVYSLANIACGFLPYFPKEHLVYQYAGLRFI
AGIGLAGELGAGITLVSESLPKNLRAIGTSVVAGFGLMGAVVAQLTVELAGGWNISYIIG
GILGILLLFLRISVSESGIYKNIEHESVSKGNFLSFFTNKDRLIRYLKCIAVGLPTWYCI
GILAVLANQFAPELGITDLNPGKAIMWAYVGISVGDLMSGFISHALKSRKMAIFYMLAFT
IIGVAFMLFGNTNTETKYYLFCVWLGLGTGYWAMFVTLAAEQFGTNIRNTATTTVPNMVR
GLVPVMILAFDFFKKDFSVIMSAAIVGIIVFGLAFYSSLTISETHNKDLEFTE
>KALACAFP_03970 hypothetical protein
MSTVREVLVYPNDRETIAHAEARALHILVVFENYQFYSNKKS
>KALACAFP_03971 hypothetical protein
MKNLKKLSRNELKDVTGGRLPRVWIAETSCGVIATTTQDWTPQQAQEWFEKVETINCPPP
THSGPSTNLAGN
>KALACAFP_03972 hypothetical protein
MYCHKKLLQLFIIFYCTSSYAQSEKKDSLRGEFIYQLKAKSDIRTDSRYEELFSLQIGDK
RAFFASTVSLKGDSVMTNSGTTTHNPNGSITLGYKKGTVIPKTNFDFTIIQTNENIQYFD
LAFMTLLTYREPVIKNWKLVDETKVINTITCKKAEVTFKGRNWIAWYSPEIPFPYGPMKF
SGLPGLIIKITDDKGDYDFELVKSVSNSKLKGRLINIKESRYTHAIETTQPKLKEAIKNV
RANAAAVLASQGTTIIKGQEILRQREKKREENQKYANPLELSN
>KALACAFP_03973 Ribonuclease Y
MIEVIIGVVCLVIGAVIGIFFSRSSLNTKAKFIIDDAKKNAENLIEKANVQAESIKKEKN
LQAKEKFLELKSQHDADIQSREKKMQEIEKRIKDKEHKLNDELSKTGKLEKDLDKQIADY
AKKTEILERKQQELDTAMAKKVEVLEKISNYTAEEAKVELVETMKAEAKTRAQAHVQSIM
EEAQMNAKNEARKIVIQTIQRIGTEQAIENSVSVFNIESDEVKGRIIGREGRNIRALEAV
TGVEIIVDDTPEAILLSCFDPVRREIARLSLHRLVTDGRIHPARIEEVVEKTRKQIEEEI
IEVGKRTIIDLGIHGLHPELIKIVGRMKYRSSYGQNLLQHSREVANIAATMAAELGLNVK
LAKRAGLLHDIGKVPEQESELPHALLGMQWAEKYGENAEVINAIGAHHDEVEMTSLLSPI
IQVADAISGARPGARRQVLESYIQRLKDLESAALSFDGVSSAYAIQAGRELRVMVESGKV
NDEVASQLSYDISEKIQNELTYPGQVKVTVIRETRAVNIAR
>KALACAFP_03974 hypothetical protein
MEVRRITINIAGRVYPLNVPAAEEETLRKVGKQIENMIKDFEQNFDVRDKQDALAMCALK
LGTNAEVVSANYEKTIHSTNERLAIINQSLNETGK
>KALACAFP_03975 hypothetical protein
MLLYLLFLLPLQNIGSFIFVSINILLFLLLVRIYKPEMLQDLENNFSELEKKILLLQKNY
KNLTEKFSELHTEHEELKKKYDEERKKSQVLAEEQKNIKLYSAISGNPEHNRLMKNHINR
LVKEIDFCIAQLQNSGL
>KALACAFP_03976 hypothetical protein
MNKFLLKALVLASVNIAVLANAQFRTRNRMDKLEDFDEQKFSWGFYLNGNRLDYRIVLNP
RYGMNNNQNLVTSKESYSFGAGLIAKWRLNDYLDLRLEPGLQFGQRQLTFNTQSNDQYAA
GTLTNPPFTPIPLTENDRVREVKTTLVDVPVLLEFHGNRWYNSRPYVAAGVNYIVNLQSN
SDSTDDNLQQVFRSTTHNFAWSAEMGVQFYFNKFKLTPAIRGTFIMNNEIVADNATTPPY
WTAAMSTLQTRAVFFVLKFE
>KALACAFP_03977 Ubiquinone/menaquinone biosynthesis C-methyltransferase UbiE
MTKDINQVTPYNSEATKKSQVEDMFDNIAPKYDLLNHVLSMKIDVLWRNTLVKWMKNDNP
QEVLDVATGTGDLAITIEKGTGAKVIGLDLSQQMLNVGVIKIKKLKLDGKISMQKGDAEN
LPFEDNRFDAVSVAFGVRNFENLTKGLAELRRVVKDNKSVYILEFSKVEGFLAPFYMFYF
KNILPAIGRLVSKDNRAYTYLPDSVNAFPFGEKMRQILLDTGFKKVEYKKLSLGIATIYK
ATK
>KALACAFP_03978 hypothetical protein
MKNNPSLKGLVIAVVAFVVAFGVYFLFLAKKNYYVVDNPTPNTYYYKINNSSEGTIAAGQ
TVPVDLNKGKNSIKVFDQNKKLLYDSAFEVNKIRGLINIAHQDYYINDQYYGYNLKKDSL
LLALDKVVIDGKTYYGGAKHFNKLFTDDFYYNVDEDYDKIIKNIQQVESRSKIFRKQDYL
NYYKEYYKF
>KALACAFP_03979 3-oxoacyl-[acyl-carrier-protein] synthase 3
MPNTIIIGSGSYLPNRIIGRDYFLGSEFYSEDGEKIDKPVEETIAKFVEITEIENRRFID
EDLSNSKIGYEAAKLAIADAKIDQEELDYIIYASNFGEVTEHGYADFMPTMAARVKNKLG
IKNRKCVTYDMLFGCPGWVEAMILADNLIKANVAKTILVIGGETLSRVTDPHDRNRMIFA
DGAGAVVVKATDEENVGIIAHNTICDNGIELDYLANGPSINKESDQTRLFVRMQGRKIYE
YALKNVPNAIKETIEDAGLSIEDINKILIHQANAKMDYAMIERLHKLYDVKDYDHSISPM
TIQDFGNSSVATIPTMYDLIIKGKMDGQTFKEKGNIVMTSVGAGMNINAIVYRFP
>KALACAFP_03980 3',5'-cyclic adenosine monophosphate phosphodiesterase CpdA
MQRNFLIIAAIFLFLEVYIYQAIRTLTDNFWIRLGYWIVTLTVYGVFAYEITHFQRSDRS
TVRMQIMISVFLVFILPKVFIVLFLLIDDIFRTGSYLVGLTRPSESFFPERRKFLSLVGL
GLGGVLSALFIDGITFGKYRHKVRKVKVKIANLPKSFKGYKIIQISDVHSGSFGDPSKLE
HAINLINEQNPDLVLFTGDMVNNVAEEFKPFIPLFSTIKSKDGKLAVLGNHDYGDYISWP
SPDAKKQNLETLIDYEKQAGFDMLRNENRVIEKNGEKLYILGVENWGLKPFPQYGKLDEA
IKDVPESAAKILMSHDPTHFDYVVKKHPGNVQLTLSGHTHGMQFGLDLKNIKWSPVQYKY
PKWADLYESEGKMLYVNRGFGVLAYPGRVGVLPEITLFELA
>KALACAFP_03981 hypothetical protein
MVLLTFNIINIESDAKNGSQISDDERLKITIDNTKAILRILDIHDIKASFFVEISIAEKL
QNLIKAISSKGHEIAFYNKNSNLQEIEEAKKSIQNLLEKQIKGIRQKDIKLSQESLKLLE
FSYVSNIDNANILFPFKRLKRDTEITEEEGLSIVPESISPYSQLPYNDFVFQILPMKYYQ
NMVFETLKNDEFVLIYLNSWQFTDFSVYPFDLPFYRKISSGKKMEDKLDALLTFINEKEL
ATSRMKDYIF
>KALACAFP_03982 putative epimerase/dehydratase
MESHTEKILITGALGQIGTELTNRLVEIHGADNVVASGLDRWQKGITAAGHYERMDVTNT
QLVRQVIKDYDITTVYHLASLLSGTSEKQPIFAWKLNLEPLLHFCEMAKEGLIQKIFWPS
SIAVFGKGIPKENVEQDVVLNPTTVYGISKMAGEKWCEYYFDKHGVDVRSIRYPGLISWK
TPAGGGTTDYAVEIFYEAIEEGKYTSFISENTGMPMLYMDDAINATLKLMEAPKENLTVR
SSYNLGGMSFTPKELAEEIKKEIPEFEIDYKPDFRQAIADSWPASIDDSVAKKDWGLSYD
FGISEMTKDMIKNLKVKLAKN
>KALACAFP_03983 Gamma-glutamyltranspeptidase
MKKIIIFLILFSHTFSAQYTDINIVKEVKVKNKGVVVSAHPLASEAGSKILKMGGNAYDA
IVATQYALAVVYPQAGNIGGGGFLVGVKNNGEKFSIDYRETAPQKATHSMYIDKNGKANT
DLSQNGRLAVGVPGSVAGFFATLKHCKLSMDQLIQPAIDLAEKGFAITEQEANLLNASKE
YFQKHNTSSIVFVKSVPWKAGDILVQKELAETLKLIQKQGLKGFYEGKTAGLLVAEMKKG
NGIITLEDLKNYKVAERKALEFEYKGNTVVSMPLPSSGGILLAQMLKMAGYENLEKYQQN
STKAVQIMVEAERRAYADRAEHMGDPDFIEDKTSYLISDEYIKNRWKNFSFNKATPSSEV
GKIIKQPKESTETTHISVIDKNGNAAAVTTTLNGLYGSKVMVSGAGFFLNNEMDDFSIKP
GVPNMYGAVGGEANSIQPNKRMLSSMTPTIVLKNGKPYMVVGTPGGTTIPTSVYQSIVDV
VDFKLNANISVNAPKFHHQWLPETVAFEKNFPETTIQELEKLGYKAEKWNQIGRTEMILI
DDNGNIHAVADGRGDDSVAVE
>KALACAFP_03984 C4-dicarboxylate transport protein
MKSKKFHHQLYFQVIIAIVAGILLGKFYPELGEKMKPLGDGFIKLVKMIIAPVIFITLTL
GIAHMTDLKRVGRIAIKSMIYFLTFSTLALIIGLIVGNILQPGHGLNIDPSTLSGDVSQY
QQKAHETTLTGFIMNIIPETLFSPLVGENILQVLLVAILMGVALVLTKEKSHKVTDFLQD
LSTPVFKIVHMLMKLAPIGAFGAMAFTIGKYGLHSVLNLIFLVGTFYITSALFVVLVLGT
VAWYNGFNIFKLMYYLKEELLLVLGTSSSESALPGIMEKLEKAGCSRTIVGLVVPTGYSF
NLDGTNIYMTLASLFIAQALNIHLPIEKQIILLLVAMLSSKGAAGVTGAGFVTLAATLAV
VPEIPIAGMTLILGIDKFMSECRALTNVIGNSVATVVVANWEEQLDKEQLHFCLNHPNEI
EKKLEV
>KALACAFP_03985 Putative lipid kinase BmrU
MLPNQAAFFNFATMEKVAFIINPFSAKKNYQPFLNELKTKVKEPLYYISESILGTDDFIQ
KHFNDVDIFVAIGGDGTISTVARNLIDTEKVLAIFPAGSGNGFSNETQFSKNLDELLEKI
KAKKSRKIDTFTVNDRLSINVSGTGFDGKVVKEFEKTNRGFKNYIKVSLKTFFKYKPIKV
KFFDEQYKQYNGKYLMLNIANTRQFGNNAYIAPQASKSDGLVDMVLVKKFPLTYSPLFAF
RMFTKKLKDDDYITYLPVSEIEFKVNTKNWHLDGEFNKIKSPIHIKVQPSSLNILI
>KALACAFP_03986 hypothetical protein
MKKRGFIWMFAIVFISFGCKETGFENKDSSADISSKFLIDYVIEEDSAKIFDSVMMKYSS
KLLMFPNLKDERLRDSIYSGKKITDYSKNGLKKYLENKKYSFYNNLKCDKKYSNLISRQE
WENISQMNLRMNKNDYLYIQYYESTFLGKRDNYHYNEKVFDLRNNKKMQLSDITSIPRDK
LLQYLKTNLEKTTMMQQMKKYDQEGYRLLANASIPFTHNFYFDDNNLYFHYNMNEITRNY
DIGDLIILIPFEDLKGTLQPEFIERMKIK
>KALACAFP_03987 hypothetical protein
MKNTIAVLAFSSLLVFSACKKTENTASNTDKTEASKPETFAVDSVKVSDSIMLNDSLKLK
FSSRMLVFPTIKDKTLLDSIYFGNKNIQDFSKNGIQALVDKNKNEYFNNVKKDSKDWLSD
VKYSQEWYSDTGMNMKSNISDYLHIEYAWGSYEGGAHDNYGSSERVFDLKNNKKLVLKDI
TTMPENKLQALLMKNINKINGGATDDKGKINNSDMLLVEVIPATENFYFDEKNLYFHYSP
YEITAFAAGDITIPVSWEELKGTLNPEFKERMKIQ
>KALACAFP_03988 hypothetical protein
MKKVLLIAICSVNFIFISAQKHEFLEPPKFNDADLSKQKSALDENAPAEILYKSLHFSVD
YNTGNLIKKAFYRVKIYDKDKAEDWLNLEIPLYQNGGSDQETLSKMKAFTYNLENGATVA
TKVDKSSKYKSKESKYVSITKFAFPNVKNGSIIEYQYEVTSPFLFIVPEILIETDTPSLY
TEYVLDSPSNIAYNVNYTGSLNPKYREVEEKMMYGMSYRTYRFGYDNVKGFKTEKFVNND
RNYRTKISAELHSTNFREVKLYSSSWEQIKQRLYENEDFGGELKKTKLAKENMPANISEI
KDENEKANAIFNYVKNTFTWNKDRGIYVEDGIKKMLETKTGNAAEMNLFLVMMLREAGIK
ADPLVISTVSNGLINIASPNISNMNFVIAAFQTKDGFHLFDATAKQSAMDQLPPRDWNQF
GILISKEKVQQLSMVNAKTSFTYLTVDAKINDDGSISGTYSDKDTGTYAMFAKENYDDNA
EKYKKQYKENFAIDFTNIDSKVLDNGDFESTMKFSSDNLIDKIGKKMIINPMLFLNKNSN
EFDQTEERKYLIDFTSPFTRVKKIVLEIPAGYVIEEMPKNKKIVTDDKEIEYSYVAEQKG
NKIEVISTTKVMSPDYPKEYYPAFKQIWGVASKQENQVISLVKKQ
>KALACAFP_03989 hypothetical protein
MMKILCFGALSIASLYYAQSFPVSAIPENLKKNADAVLRKDFTTIQINKIDDIKYQFYTV
TTVLNKDGDSDALIYIPYEKGNSISDIKVNIYDESGKKIKSYSKSDFGDFANNNQGTFYS
DNRVMALSYTPTQYPYTVEFSYAMGDENTVFLPDFVPFSSTNVSLEEAQMKIVNKSGIEL
KTKIYPSKYNYTSVAESDNGAEKTYIYKNVPAIDDAFLLPQPVKILPKASFALTKFNLEG
KQGSMTNWGDFGSWYYNSILQPVSVSTPAIKAEVASLNLQGTTEEKVKKLYQYMQAKTRY
IFVALGIGGWQPMLPDEVQKKGYGDCKGLTNYMKTLLDEAGIPSYYSVINSGNSPVSFDK
DFPKMGGNHVILMVPTEKGNIWLENTSQQVAFNHLSYSTTDRNVLSIRKNGIELIDTPTY
PAEQNKEKQILKIKLNEDNSILGEGNFSYTGSQYDNSMALINMSPKERNEAMKSFLDVLH
FEKVEMKNFLNDKDNAITKYDLDFKANNYSKNAGSSMIFRAVPIYSDNVYKTEENRELPF
ELRQSFEDEYEINFTIPKNYKVEELPENVTINSEFGTYKLSFAKNGEEVKVNRAIRINKG
LYPKEKYNDYINFRKKTINIDNSKILISKI
>KALACAFP_03990 hypothetical protein
MKNLKSLILVAMTISFDLVHAQVGINTVNPQATLDVVGKPTTPSSLDGIIPPRLTGDQLR
AKTYTTAQTGAVVYVTAADSAPAGQTVNVTVPGFYYFNGTVWGTMTINNIPNGTGNILAI
NGQPQIAQEVSARMDGDFTVPTNPASPTRIGRMTEKLVDNFNTFTGTATNNAFTVNSNGT
YLVNMNFSLQGESPTTPLSGNCYYGLYNVTDNRYVAFNIDTITSLAFGQVTNLSYQVAME
LVTGKTYAFTIEQQHNGGGSPSVVMRGTGTTAGGGIFPMTFFSVIRIK
>KALACAFP_03991 DNA gyrase subunit B
MSQKQYTASSIQALEGMEHVRMRPSMYIGDVGVRGLHHLVYEVVDNSIDEALAGYCDTIF
VSIKEGNGIEVIDNGRGIPVDFHEKEQKSALEVVMTKIGAGGKFDKDSYKVSGGLHGVGV
SCVNALSNEMITTVYRDGNIYQQIYSRGKAQTGVEEIGNSDKRGTKQFFQPDDSIFTELV
YNYDTLASRLRELSYLNKGITITLTDEREKLEDGSFKSEIFHSEGGLKEFVAYIDGNRES
IMENVIFMEGERDDIPVEVAMRYNTSFNENLHSYVNNINTHEGGTHLAGFRRALTRTLKK
YADDLGIPQKEKVEITGDDFREGLTAVVSVKVMEPQFEGQTKTKLGNSEVSGAVDKIVGE
MLSNFLEENPNEAKIIVQKVVLAAKARQAAKKAREMVQRKSPMGGSGLPGKLSDCSSKDP
AESEIFLVEGDSAGGTAKQGRDRFFQAILPLRGKILNVEKSMLHKVYDNEEIKNIYTALG
VSVGTEEDSKALNMAKLRYHKIVIMTDADIDGSHISTLILTFFFRYMKELIENGYIYIAQ
PPLYLLKKGNKKIYAYNEKEREEFTLEMSPDGKGVEVQRYKGLGEMNPEQLWETTLNPEH
RILKQVTIDNAVEADSVFSMLMGDEVPPRREFIEKNAKYAKIDA
>KALACAFP_03992 Putative cytochrome bd menaquinol oxidase subunit I
MDDFLAARAQMAMSLGFHIIFSCVGMVMPFLMAFAHWKYLKTNNEIYKGLTKAWSKGVAI
LFATGAVSGTMLSFELGLLWPTFMKHAGPIFGMPFSLEGTAFFIEAIAIGFFLYGWDKFN
KWFHWFCGFLVGLSGLASGILVVAANAWMNSPAGFDYVDGQYLNIDPIKAMFNEAWFPQA
LHMTVAAFCATGFAVAGVHAYLIMKKKNVEFHTKAFRIAAGFALIGAFGAPLSGDIAAKS
VAERQPIKLAAMEAHFETEKGAAFVIGGIPDEEKGEIKYAVKIPKVLSFLVSNDFNHEVK
GLNDFPRDEWPPIAVVHYAFQMMIFFGVVMIIIGMIYLYAVFFRKQWLNKNWLLKTFLVA
TPFGYIALEAGWTVTEVGRQPWIIYGIMKTVDAVTPMPGIQYSFYFFTAIFVSLSLVIIF
LLTRQISMVPKLYDPTDPQFNAKNKKS
>KALACAFP_03993 Cytochrome bd-I ubiquinol oxidase subunit 2
MIYVVIGFLWLSICLYVILGGADFGAGIVELFTKEKNRSKTKTIMYESIAPVWEANHMWL
IIAIVILFVGFPEIYTTLSTYLHIPLVLMLVGIIARGTAFAFRHYDAVKDDWQTVYTQIF
YFSSLLTPFFLGLIAAATVSHSIDPNAKSFLDLYIFSWLNWFGIAVGLFTVSICAYLASI
FALRETTDRLELNLMIKKSKQTMIFVVITGILVFLTAHFSDIPLLMWVFSKPLGIMATVF
ATICLGLILRAMQTRKLLPVRALAGFQIIMILVAATYQHNPNIILFANGQHLSLLEHVAA
PKTISALGWALMLGSVFILPFLFYLMASFSKQRR
>KALACAFP_03994 hypothetical protein
MCLILILFISFKTFAQTVKSADRYLNAYKKYENATCPIKKNNIKNFVYFSRDRDAIKDHP
FLKNPRFEGAQIMYSWDRLEPEEGKYDFSEIKEDYQYLLSHHKKLFIQLQDTTFDPEMKS
VPKYLLANKYDGGAVIMLKDNGEPDGWTAKRWNPNVQKRFALLLQALGKEFDGKIEGVNL
QESSIGEVKDPTFTPESYAKGIKANMLAMKKAFKKSVTMQYANFMPGESLPENDKGYLRG
LYQYGQQIGVGLGGPDLMVKRKPQLNNTLAMMHEAKYTVPLGIAVQDGNYINDTSNNAIV
SDHKNIVPLLVAFADDFLKVNYMFWVNQEPYFMEDVMPCFTAK
>KALACAFP_03995 hypothetical protein
MKHTFSFRYLKYSVSFLVFLFSMKAYSQKYENPAKKYSNEYKKYENASCPVPPNTIKNFV
YFSRDREAIKDHPFLKIPRFEGAQIMYAWSQLEPEKGKYDFSIIKEDYQYLLSKGKKLFI
QLQDTTFDPNAKAVPKYLLTDEYGGGAVIMLKDNGEPDGWTAKRWNENVRKRFALLLEAL
GKEFDGKIEGINLQETSIGVVKDPTFTPEIYVKSIKANMLALKKAFSKSVTMQYANFMPE
EWLPWTDKGYLRSIYKYGQEIGVGLGAPDLMVKKDGHLNHALAMMHESKYTVPLGIAVQD
GNYTNDDTNSKAYIKHNNMVPMLSAFAKDFLKVNYMFWVDQKPYFMEDVVPCFSSK
>KALACAFP_03996 Lysine--tRNA ligase, heat inducible
MQLSEQEIIRREKLNKLVEMGINAFPADEYVITDTTESIKQDFADNKQVKIAGRLMSRRI
QGKASFAELQDSKGKIQVYFNRDEICTGEDKTLYNEVYKHLLDIGDIIGVEGELFTTQVG
EQTVLVKNFTLLTKALRPLPQAKTDENGVVHDGFTDPELRYRQRYVDLTVNPQVKEIFVK
RTKLFNAMRTFFNDAGYFEVETPILQSIPGGAAAKPFITHHNALDIPLYLRIANELYLKR
LIVGGFDGVYEFSKNFRNEGMDRTHNPEFTAMEIYVAYKDYNWMMDFTEKLLEFCAVQVN
GTTKATFGEHEIDFKAPYPRVSMTEAIQKFTGFDITGKTEEELYDFAKSIGIEVNETMGK
GKLIDEIFGEKCEGNFIQPTFITDYPIEMSPLTKKHRSKEGLTERFELMVCGKEIANAYS
ELNDPIDQRERFEAQMALSERGDDEAMFIDQDFLRALEYGMPPTSGLGIGMDRLIMFLTN
NASIQEVLFFPQMRPEKTVPQIELGEDEKVILEILNSQEEPFSLAEVKERSQLSGKKWDK
ASKNLTKNNLVKVEKIDENLLMKLA
>KALACAFP_03997 Ribosomal RNA large subunit methyltransferase F
MSTEKSSLHTRNLHRDPYDFDQLISCVPELKHYVFTNSYQTATINFSIPKAVKLLNKALL
QHFYNVKDWDIPETNLCPPIPGRADYVHYIADVLAEQQNEIPEGISVKGLDIGTGANLVY
PLIAHRSYGWKMLGTDINENSLKNAHKILLHNPDLLSTIQLKHQPDPNHIFKNIINSEDR
FMFSMCNPPFHDSEEAALKGNIRKTKNLKKSKVDKPLLNFGGQQSELWCEGGELAFITKM
ISESTLYSSQVLWFTCLVSKKDNLFKLTTLLKKLKAIEIKTIDMAQGQKVSRILAWTFIP
QQNRKSWFL
>KALACAFP_03998 Cytochrome c-551
MKKLFLTGCLSLLILSCSKKENTPIESTSETPAVSEPAKSNLSGDQIIETLDCSGCHSVN
ERMIGPSYQEIADKYSDKDIELLASKIIEGGSGVWGGVPMAPHPQVSKEDAKKMVEYILT
QKKK
>KALACAFP_03999 hypothetical protein
MKKVLAIAFIGGLLVVNCSKKPNHDLQDSNTMLPEPDAPTVVDSTAKKADTPAAATPEAP
KTDSAATK
>KALACAFP_04000 hypothetical protein
MIFVSKILFFTSHHGFYTVIILVLVFGLLSFVTKKGWFLIPILPLAILNGISGQFLNAWF
LNKYGTESTAIITSDVETNSTLNDQYIHDYEAIVKKLDGKYINTFFSTTTASIYPIENTI
RIPQVEKPFPVKFIPGYEKNIVILYHQSEDGKILEKYQLQAPINSARIKYEADPTNQEFI
QEYIEALENYLKVYDDEAFKIRLKELQSQRK
>KALACAFP_04001 Anthranilate synthase component 1
MFNKKIKIKTVSKKTLGDLRTPMTIYLQIRDKFRDTILLESSDSKNIDNNFSFIAINAVA
GIEIKNLNEFEIKLPRQEPIKQFIIEHKIADVFQHFSNIFHCEKTNDPVEETAQSLFGYT
SFEAVQFFENISFKAQSPEVEIPILRYRLYQYVIAINHYSDEMYIIENQIEGVKSELYLL
ESLIKNQNSVIYPFEKNGKETSNLTDEEYLELVKTAQKHCMRGDVFQLVLSRRFEQKFKG
DEFNVYRALRNINPSPYLFFFDYGNYKLFGSSPESQLIIKNNKAIIHPIAGTFKRTGHFD
TDLQSIEELKNDPKENAEHTMLVDLARNDLGKLGKNVTVTKLKEIQLFSHVIHMVSEVTA
DLPEKTNPFEMVATTFPQGTLSGAPKHKALQLINTYEKDSRGYYGGCIGMIGLNGTCNQA
IMIRTFLSKNNTLYYQAGAGLVAKSNPESELQEVNNKLNALKKAVEKAGKLVDSY
>KALACAFP_04002 Aminodeoxychorismate synthase component 2
MNNDINPTTNQQISTKVLVFDNYDSFTYNLVQIIERILNSKVDVVRNDEITLEEIGKYDK
IILSPGPGIPEEAGILLDLIKEYASTKSILGVCLGQQAIAEAFGGSLINLTEIFHGVATT
ADLVKNDTKLFKNLSGGLEVGRYHSWAVNPENFPEELEITAVDKDGMIMALQHKKYDVHG
VQFHPESILTPDGETIIRNFLNR
>KALACAFP_04003 hypothetical protein
MTKEAFEKFLNQKEIYLKSSRTKSSDNQVLNIYAYILQHENKDSDWWIEDHGTNDIIRII
QRSDEDIFDRIKEDIFNWSGEQIELFAQTLLSNDFKDYKVNERIRLYLELFEIPRTDYDL
YDIFYSANIDLKLAEKELLIQLAEKLKFSSVEELLNSV
>KALACAFP_04004 Anthranilate phosphoribosyltransferase 2
MKEILQYLFNHHTLSKSEAKATMIEIAQNKFNATEVTAFISVFLMRNITLKELEGFREAL
LQMAVFVNLDAGNAMDIVGTGGDGKDTINISTLASFVVAGAGQKVTKHGNYGASTITGSS
NVLEELGYQFKNNSDQLQQDLEKANICFLHAPYFHPALQSVGTLRKALGLRTFFNLLGPL
VNPAKPQYSMIGVYNLEIARIYQYLLQKDEKDFVLVHGMDGYDEISLTHDSKIITKNGEE
IYSTEDLGFDSISPESIKAGKKTRETAKIFRDILHGKGTEQQNSVVLANAAVALYHTGKY
GSYDDCLLAVQDSLLGGKALRCLERLLE
>KALACAFP_04005 Indole-3-glycerol phosphate synthase
MTILDTIIQRKKEEVALSKSKISVEELKNSEFFEREKFSLKESLKSKTGIIAEFKRQSPS
KGIINNKVSPLEVTTAYENFGASGISILTDKDFFGGSFDDIVEVRNHINIPILRKDFMID
AYQFYEAKSLGADVVLLIAACLSPDQIMEFTELSHELGLEVLLEIHTEEELQHFNEKIDL
VGINNRNLKDFKVDLQHSVQLKNQLPEGVLSVAESGIYSIEDFNYLKTKGFDGFLMGEYF
MKNDNPAEKFKNFTNNIKV
>KALACAFP_04006 N-(5'-phosphoribosyl)anthranilate isomerase
MNSLIENQALKTRLKVCGLTRIGQIHELISMNADFIGFIFYEKSPRYVLNHLSFENISKI
NHKGKVGVFVNETIEKIIETSQKADLNFIQLHGDENENFISELKEKLNPEMRIIKVIRVG
SWRPEVRSEIQTTVNQQHKTSNYFLFDTDSKAFGGTGKQFDWNILNQIEIPLPYFLSGGI
SEENITDIKNLNQKPFAVDINSKFEIEAGVKDLNKIKNLKMP
>KALACAFP_04007 hypothetical protein
MKKYYSKKLKILKLKRMNLQSIRKSMHHAFFPVKFKNEKIEKLHDFISQNDRDAEYWQLN
GLLGEFINIIKNFNQDDVRFFFNTINLWDSYHLVIIADKLLDPTVKASVKYDFGFVYCRI
FCLYEKLDSYYLVDSLEIAVNMYDSKLNLSMLVDLATKINLLFQNKQITKQQLDYNLSFI
NKLQNELQKP
>KALACAFP_04008 Tryptophan synthase beta chain
MNYKNPDEYGYYGEFGGAFIPEMLYPNVEELQKKYLDIIESEDFQREYQDLLKNYVGRST
PLYYAENLSDKYQTQIYLKREDLNHTGAHKINNALGQVLLARHLGKRRIMAETGAGQHGV
ATATACALLGLKCIVYMGEIDIQRQAPNVARMKMLGAEVIAATSGSKTLKDAVNEALKDW
INNPVTTHYVIGSVVGPHPFPDLVARFQSVISKEIKEQLHEQTGRQNPDYVIACVGGGSN
AAGAFYHFVEEENVKLLAAEAGGHGIDSGMSAATTFLGTLGVLHGSKSLVMQTKDGQVIE
PHSISAGLDYPGIGPFHANLFKEKRAEFFSINDDEALKSAFELTKLEGIIPALESAHALA
VLEKKSFDPKDVVVICLSGRGDKDMETYLKKLEDGSLKMEV
>KALACAFP_04009 Tryptophan synthase alpha chain
MNYNNFELPASGIQPKKLNIYFTAGIPQLEDTPEIIKLIQDSGADMMEIGMPYSDPVADG
PVISQAHELALKNGMTISTLFSQLKSIRNEIKIPVILMGYINPVLSFGFENFCKECSESG
VSGLIIPDLPPIEFEKNYRKMLETYNLNFTFLVTPETSDERILYLDSLSSGFLYAVSSSS
TTGNENTELKNEDYLSKLASLPLKNSVMIGFGIKSKEDFENVTEKADGGIIGTAFVKILL
QNRDWKKNAIDFVHSIKA
>KALACAFP_04010 Octanoyltransferase
MNTHQNKVVEFEDLGTKEYQPAWDYQEKLMKDIIDTKIKNRDLPAEQHITTSNHFLLVEH
PHVYTLGKSGHEENMLAGMDQLKEIDATFVKVNRGGDITYHGYGQIVGYPILDLENFFTD
IHKYMRNLEEVIIRTIAEYGLKGERSPGETGVWLDVGKPYARKICAMGVKASRWVTLHGF
ALNVNTDMRYFEYIIPCGIKDKQVTSIKRELERDLTPEEMEDIKAKIRKHFSDVFEAELV
SR
>KALACAFP_04011 Peptide deformylase 1
MKKLSFVFIFFVVLINAQKLTSSEISIINQGDINSALPIYQTTDENQHKTLLSLSTEIDP
LDKNTATLVKRMKESLLSTDGGVGIAAPQVGINRKIIWVQRFDKEEQSLEYFINPVIVWR
SELQNLGPEGDLSIPDFRDQFYRSKVIQLEYVDLKGQKYSEIVEGFTAVIFQHEIDHLFG
ILISDKKEKEKNDSYKKVDAFKKSDSVTR
>KALACAFP_04012 hypothetical protein
MKNIFLTILLVVFCSVNAQKFKAYQFYNQKGKEIKPEKLVRELAEYDVVFFGENHNSSIN
HWLQLKITEALFEKKKGQIILGAEMFERDNQVQLNQYLNGKFDAKTLKDSARLWNNYATD
YKPLVDFAKAKKLNFIATNIPRKYASQTAKEGLESLNNLSEKEKTYIAQLPIKVTLDTPG
YPEMKTMMGDHADGTKVMNFISAQATKDATMAESILKNLEAGKTFIHYNGNYHSKEFGGI
YWYIKQKNPNLKMAVISVFESENPELKVPEKDYIPTDFNLIIPADMTKTF
>KALACAFP_04013 Hemin transport protein HemS
MSTLVNDLKEKWEALKAENPHLRIRNAAAQLGVSEAELLATNVGNGVTVFKPEFKDILTD
AEQLGKVMALTRNDECVHERKGTYLNGDFSSPHAQLFVGEDIDLRIFLNHWKFAFAVIEG
DKKSLQFFGKDGLALHKIYLTKDSNDAAFDAIVEKFKAEDQNETLEFEAVAPKAPEKDDA
EIDVEGFQKAWTELKDTHDFFMMTRKFGVSRTQALRLAPEGFAKKIDSAKVVNVLEDASE
KELPIMIFVGNRGIIQIHTGNVKKTLWHQQWFNVMDPDFNLHLDVTKIAEAWIVKKPTED
GEVTAIEVFNNEGDFIVQFFGKRKPGIPELQEWKDLVADLEK
>KALACAFP_04014 Putative methyltransferase YrhH
MDNENLKILAQNLANPQGEKGIEIGEMMNATNIGMTLESIKTLLIEDNEAVLEIGHGNAD
HVKSIVNKAQNIHYTGIDISETMHYEAKRLNEEFKNQAEFVLYEGKKFPFEDKTFDKIFT
VNTVYFWEEPVDFLNEIHRVLKDNGTFVLTFGQRNFMEKLPFTQFDFILYNTDEMEQTVS
KSHFKRMKISEKEEEVKSKTGNETITRNYTVLTIKK
>KALACAFP_04015 Hemin import ATP-binding protein HmuV
MIKAHQINYKHREFHILNGVDVSLEYGEFLAIVGPNGAGKSSLLSVLANEVKSNQKIVFK
NKNINDWEVQELSKHKAKFSQHNSNDIPLEVQDVVMMGRYPYFDAQPRQEDHDAMNSMMQ
ETDVFHLKEREYNTLSGGEKQRVHLSRVLAQLQNKIAHKLVFLDEPLNNLDVKHQYKALE
TIKNFTKKANSAIVVLHDLNLAAQYADKILLMKSGRVAAYGSPEEVFTAENISEAYNFPC
TICGHPITNNPMIIFG
>KALACAFP_04016 Hemin transport system permease protein HmuU
MKTQSKLYVYITISAILLIMIAVWSLNTGVYDFGGKSAFEILGKVIKGDPTISLSDTYVV
WDVRAARIIMAILIGSMLAVSGTGLQGLFKNPLATGDLIGLTSGATLLAAIAIVLGGHFK
EYLPEAVQFSLVGIAAFIGSFLSMLLVYRISTSGGKTNVVMMLLSGVAITAIGFSITGFL
IYISKDDQLRDLTFWNLGSLAAATWTKNIILTVVLIISYFILLPKGKALNAMMLGEKDAQ
HLGINVERLKKQIIIITALMVGSCVAFSGTIGFVGLIVPYILRLSFKSNYAFILPLSAIC
GSILLLTADTFSRSIVEPSELPIGILTALMGGPIFIAILVKFKKSL
>KALACAFP_04017 Hemin-binding periplasmic protein HmuT
MKKFILAASVLVAVYSCKKAEEAKKENTTEVSSETPKSTHKIVTLNGGITEIVAALGHEK
EIVGTDVTSTYPESLKATAKDLGHVRSMTIEPIMAVSPTLILASDKDINPELMKKIEESK
IQTEIFKQEFTVDGTKKLIADVAKAIGNTDYQKLNDKIDADLKQIQPIAKKPKVLFIYAR
GNMLMVSGKNTPMAALIGLAGGENAVNDFEDFKPLTPEAVVKANPDILFFFTSGLQGAGG
NEGALKMPGVSQTNAGKNKKIIAMDGGLVSGFGPRLGEAAVGLNKLLVENTK
>KALACAFP_04018 hypothetical protein
MKKILFCLLIGTSFISQSCINDNEDPVAVAPSDGARVDPDVGGATQPNQVWFDLSANAEI
LTKRTDWDLAFYSGSAFKVVLNSSIMMAAGKIPDATNIDMVTESNLTSLKNQVQVANFNP
ANEIYIDDVNGNFPAGYTAIGEIKANDAENAVYLVNMGKEIYTGSVPTGSVATGGDSRGW
MKVQIVRTTDGGYKVKYAELGATTHKELTIAKNTAYNYSFVSLKNNKEVFIQPEKKKWDI
CFTVFTNIIAGAGSYIYADFVTTNNVAGVGAYEVLVTSGSGVEAYNNFKTSDIDQSKFVY
NDQRVIGANWRNPVGTNGLEVYGDRFYIIKDPEGFYFKLRFTRLTNTAGERGRPQFEYKP
L
>KALACAFP_04019 Colicin I receptor
MSKIFVSMKKKVLSVLSLSTVLWVNAQEKDTLSQKKIEEVVVTGQYMQQSINKSIYKVEV
IDAQQIKNMAVTNVAEVLNQNLNILIEPNKGSGNSSANIMGLSGEYTKILIDNIPVVSDE
GMGNLVDLTKINVNNIERIEVVKGSMGVEYGNNAVAGVINIITKKNYGKKFTALASVQEE
TVGKDYDWFKKGNGRHIQSLNLGYKINDNWSVAADINHNDFQGYKGVLNGYKYFSENNDG
LRGYDWQPKDQITTNGTIRYSKNNTSFYYKLNFLSEKINYYNPLVNELYLGAGNRTYTSD
DIDYNTKRWIHQFNIQTKLGRINYNGDFSYQSQERKSQKYTYDVPNRQELSRDPEVTFYK
SDVLYSRGMFSNFLDSEKINFQVGYELDRTKGFADATTFESNNNGKNIQRSIFNYANFVS
AEWKINDWVSLRPGVRLALSDQFDSQYNYSATVRLKTTEKSDIRAVFGSANRFPTYDELY
TFVVDNNHDIRGNENLKPETGYSAALFWDYSTTNSSDWKFNYSLSGMYLDVKNRIEDVII
NNSPLQITFLNVDNYKSILFGGGLNIRKGDLTFNAGVSVMGISQVLNTGNITSPDDFNYY
AEANLAANYTLPYTKTLFALYYKYTGTQKRYTHQGNAQDPTDPGQYVLGEIGDFNMMNFT
VSQPFFKNHFEISAGIKNIFDVTNVRNTIQSGDGHNAAANQQNLFYGRSYFARLNYNF
>KALACAFP_04020 hypothetical protein
MKLKLLLGTLMFAAVTAHAQVATLNENFNNFTPGNTTFPQGGWSAVVAAPTATPPPVSPR
MIVAADANDANNKMVQSYAGNNGAAPSYLISPQIVAPAGDKTLTFDTTLVSPSPGPGTIQ
IGLASNPTDMSTFVPVGNPITVATIGTVQNISVNIPASASQYLVFRFTPSATHVAVQIDN
VVYNTSTTLGVSDQLKSKEEIRFAVNSDNTALQFVTRKDPKNIQVYSAGGQKVAEGKLTG
QLFDISTLQTGVYYMLIETAEGNAVKSKFIKK
>KALACAFP_04021 hypothetical protein
MKTKLLFASMLALGVQQTALAQVDANGYTAVNMTMGAGYQNRVFFDLSANSIVSQPANSW
DIAFYRNSAMSFGTRINDAQNIEVYQASNNPNDWNTITTNNVSTYGNPLFNLDNTTALQE
GAFEQGTATYGWGEYNPGNHHVEGKVIFILKYLSSGEYIKFMIDDYFGGYTFKYAKWNAL
SSSWDATVSKTIANGSDDAYFNYFSFATGEKVSNQEPSKANWDLMFTRYWTFYANIMMYR
MAGVIQNSNITVARVQPETQAVATSTLPPSATFSSNITTIGHSWKPTSGAPTSDVVYYIK
QGSEYYRLYFISNEGTATGNMYFKYKNITSTLGVTDVAGKKASFGIYPNPTTADKHVTVL
FDVKEKANNKGSVEVYDLSGKKVYSAELTNQAGFYKQDLNLSHLSSGNYLVKITFGGSTE
TKKLIVK
>KALACAFP_04022 Putative monooxygenase
MNIYVIALFKFNENYLMEAVELFQTLVRETRKEEGCIQYDLIEDKDNKGTFFMVELWESE
EHLNRHSGQDHLLDFRRDASKMLESSTLVYKGFKTL
>KALACAFP_04023 hypothetical protein
MVISRKVQIRLNVFFVTLAVLFIAVFSMYEMGYLDELLTILAKDNYIFYWMMLVGFLAEI
VAGSMGMGYGVICTTTLLFLNIPPHIVSASIHSAESFTTAAGSISHIKLKNVSKSLVKRL
AIPAVIGAIMGAVSLTYLGEYYAKITKTIIAFYTLYLGIQILSNAFKKKQDKKLKRKTNL
TRLGVIGGFIDSFAGGGWGPLVTGTLIKNSFTPRFAVGSSTVAKFILTLTAAITFIFTLG
IQHWNIILGLLIGGIVTAPFSAMLTAKLPVKSMFIVIGLLVIVMSSITIYKSVF
>KALACAFP_04024 Bifunctional enzyme CysN/CysC
MDILRFITAGSVDDGKSTLIGRLLYDSKNILIDQLEVLEKQSKNKNENGVDLAILTDGLR
AEREQGITIDVAYRYFSTPKRKFIIADAPGHIQYTRNMITGASNSQLIVILIDARQGVIE
QTRRHSIITSLLKMKNVVVAINKMDLVEYSEEIFNDIKAQYQLVAEKLGLENVNYFPISA
FHGDNIVAKSENMAWYEGSTLLDFLEDVEINSAKNFDSPRFQVQYVIRPQTDDLHDYRGY
AGEVISGIYTKGDEITVLPQNIQTKISKIETGGKEVDSVFTNQPAVLHIEDDIDISRGDF
LVKNESLPKVENEIEAVVCWLDKKELNEGNKYFIQHKSKILKAIVKEIEYKIDVNTLEKM
PTSESIKLNEVVKVRLKTASPLVFDSFEESNATGNAVLIDETSNSTVGAVMIL
>KALACAFP_04025 Sulfate adenylyltransferase subunit 2
MSTYTLDYLEQLEAESIYIMREIAAQFEKPALLFSGGKDSITLVHLAKKAFTPMKIPFPL
VHIDTGHNFPEALQFRDYLAENIGAELIVRKVEDTIKAKNLTEPKGKFASRNWLQTHTLL
DTIEEFQFDACIGGARRDEEKARAKERFFSVRDEFGQWDPKLQRPELWNIYNGRINKGEN
VRVFPISNWTELDVWNYIKKENIQLPSIYFAHNRDVIEYDGQLIAVSDFIQIDENDTIVN
KKVRYRTVGDMTCTAAVESSAETLDEVVNEITASRISERGETRIDDKVTEAAMEDRKKGG
YF
>KALACAFP_04026 Thioredoxin-dependent 5'-adenylylsulfate reductase
MISKEDADTLKQLSAEEGLKLISSKFPEGVVFSTSLGQEDQVITDIIFRNGLPIKVFTLD
TGRLFYEHYELLSQNNSRYKIQTEVYFPEASDVEKYVNEKGINAFYHSIENRKECCYIRK
VKPLNRALNGAKIWITGLRSEQSENRENMPVIEWDEDRKLFKYNPLIHWSYQNVLDYLDQ
NKVQELSLHKKGFISIGCQPCTRAIVEGENPRAGRWWWENSHKECGLHSH
>KALACAFP_04027 HTH-type transcriptional regulator CymR
MLSKKSQYAFKALSYLVEKRNDGPILISEIAEHKKIPLKFLENILLELKKADILDSKKGK
GGGYFFKENPENVKLAKIIRLVNGPIALLPCVSLNFYEKCDDCSEDHCGLHDVLIEVRDA
SLNILEKRTLMDLVD
>KALACAFP_04028 hypothetical protein
MHIFWLGGWEMGARSDYNDVITSLFRLPASKQNTYFCSMFSKQEAQQLKKEFWTAFGKSF
PRKWILYDTKVKDLSFKFYADNKKVEVSLDIEMKDEVFRNAYYEKIWSLEDILKDFIGDF
TKEEYFTLENGKVIAKIWVEKHGVSIFNKNTWQEIFEFFVEKMDGFERFYYEYEDFIKDV
>KALACAFP_04029 hypothetical protein
MQTVILSTFFSEKIKGKYTPEFIDTIIEKISLNPKASKNIGTTKNLYLYKLGICDLKKHE
YNLIYFFENKNSPIYFITIFKDKESDIINKAIFYLASDAMK
>KALACAFP_04030 3-oxoacyl-[acyl-carrier-protein] reductase FabG
METTKVWFVTGASKGLGLALIKKLLEQNYRVAATTRNVQTLIDEIGNASETFLPLEVSLT
DDENVKSAIEKTVEHFGQLDVVVNNAGYGQLGTLEELSDKEARANFDVNVFGTLNVIRNA
MPHLRNQGSGHIFNISSIGGYSGNFPGWGIYCSTKFAVAGLTEALAEEIKDFGVKATVVY
PGYFRTDFLSKESVRTPENSIPEYEAARNSEQAHLDEINGNQPNDPDKGAEAIIAISEVE
NPPVHFLLGSGTDEYLNNKIQIITGDAEKWSDLTFSTVI
>KALACAFP_04031 Regulatory protein SoxS
MKNTFRFNSLSDFHAFCNLPNPEHPLISLIDYSKVRYPVDDTELKWIQNFYSIGLKRNVN
AKFNYGQQEYDFDSGVLCFVSPLQFLSLEMKPGIEVEPTGYLLLIHPDFLWGTSLAKKIK
SYEFFSYQINEALFLSDKEEKIIVDLFKNIEKEYQTNIDKFTQELIVAQLELFMIYAERF
YERQFFTRKKSSHELLERFEEVLSQYFENGNLIENGIPSVKTIAEQMNISPNYLGTLLRI
HTQQNTQQHIQNKIIDTAKERLSTTNLSVSEIAYELGFEHPQSFSKLFKQKVQQSPGEFR
RLFN
>KALACAFP_04032 hypothetical protein
MKQVKGLEFSDENIQRLFGYEDAESEPIDRLREYYFKNETFARVSADLPIRLLVGHKGIG
KSALFKVSISEDIDKGNLPILIKPDDIAELGNDEDNFLLSIRKWKSGLNQIIGSKVFNEF
GITDKSTLNKLSNYSLKLINFIVESITIATENVDLSTSKKLIVDNFLKTKKIIVYIDDLD
RGWEGKKKDINRLSALLNSIRDLASENPGLCFKVSLRSDVYFLVRTSDESTDKIEGSVVW
YSWSNHEILIMLIKRILTYFEKDFDENILLNTQQYHLAFYLDNVMESKFQGHGKWENKAM
YKILMSLIRKRPRDLVKLCTLAGREAHKAKSNLIKTEHFQNIFEEYSQGRIQDTINEYRT
ELPLIEKLIFGMKPSKKSKIAYVDSFVFTTPELHLKLNNLLQQNRFTFANSKIATAQDLA
HFLYKINFLTARKILADGEIDRKYFEENRYLSNSTVNFGYDWEIHPAYRWALQPDTIDDI
FNKLSPSAD
>KALACAFP_04033 hypothetical protein
MDIQTRKLNLITYLAQLQDESFFDKIEEYILSKLEKEDHTKPFSVEELNKRIDQSLDDSK
NDRIIDSNDLLSEIEQW
>KALACAFP_04034 hypothetical protein
MVVKIFWTDFAKEQLRNIFDYYKLKASPRVAKNLVTGIVEKANTLDFQKEIGQKEELLLS
RKENFRYLIYKNYKIIYWFNETKNRIEISDVFDVRQNPTKIQERQ
>KALACAFP_04035 hypothetical protein
MKKIPFKSPFGILLFVILPLVVILAFSGIRLDLTKEKRYTLSDNTIKVLESVKKPVTVDV
YLEGDFPASFKQLQSETKFMLEEFRKINPKIDFKFIDPIKSKISQDTLMAMGMQPSVLPD
VKDGKVSQIYLFPYAVVKYGDRGVSIPLVVQQTGIDADQQLTKSIENLEYNLVSNIKNIA
VDKRKKIGVLVNQDELSPDEFQGFMHLALENYDAGPIIPKNQTELSLADVPLLKQMNALV
IAKPRKAFTDGEKVILDQYIMNGGKTLWMIDAVNAEMDTLTRSKKVMPFPVDINMTDFFF
NYGIRINPALVKDVKKFALLRLVTGEVGGNPQYTSLPWPYFPLGIAEKNDPITKNINPVK
FEFPTSIDTLGGRKNIKTKVLFESSERTLLKQVPNYVELKEVASVDSLGQMEKPSTPKIY
AVALEGKFNSAYASRIERKSYPNFKSTSPENKMIVIADGDVGRNKVIKGEPLPLGVDLLT
NEQFGNEQFLRNALDYLLDDSNLMELRNRNIEERLLDRQRITEEKNNWQWFNLLLPLAII
GILGGLFFWLRKRKFG
>KALACAFP_04036 hypothetical protein
MFAIFKKELWSYFGNWSAWIIIAAFSLIATLFLFFFENDSNIFDIGMASLQSYFVLVPWL
LMFIIPALSMKTFAEEQQTGTLNWLFSQPLKVSDLVLGKFLSVWVVGILCLIPSLIYLYT
VYVLGVPEGNIDLGMTFGSYFGLIILIAAFSGVGILASSLSQNQIMAYLLGVFMCFIMYF
GIEQLASYKLLGGADFILQNIGFYQHFLGFTRGLIDFKDVAYFVLIIGVTLVLSNHFINK
KK
>KALACAFP_04037 hypothetical protein
MLYTIIKALHIIFMVSYFAGIFYLVRIFVYYKDTDEFAEDKKKILREQYTFMARRLWNII
TVPAGVIMTVCGLVMIFLNLGLMKTPWFHLKLTFLIGLAIYHYWCWKKVLKLKELNGNTL
ETANIKLRQANEIATFILFLVVFTVILKSMVIEYWWQLITGFLVLVFLIMMTVKLVNKKR
K
>KALACAFP_04038 2-amino-3-ketobutyrate coenzyme A ligase
MISKKYLENLQNELQNIENDGLYKRERIITSQQSAEIEANGKKLLNFCANNYLGLSNNPE
VMKASQDMIESHGYGMSSVRFICGTQDIHKQLEQKIAEFLGLEDTILYAACFDANGGVFE
PLFTEEDAIISDELNHASIIDGVRLCKAARYRYKNNNMADLEAQLIAASEKNHRFKIIVT
DGVFSMDGIVADLKGVCDLADKYDALVMVDDSHATGFIGKTGRGTHEANEVMGRVDIITS
TLGKALGGALGGFTSGKKEIIDMLRQRSRPYLFSNSLAPGIVGAALKVLEMISDDTSLRD
KVMENAEYFRTEMKARGFDIPDGDAAIVPVMLYDAPLSQKMAEKLMDEGIYVIGFFYPVV
PKGKARIRVQLSAAHTREHLDKAIAAFEKVGKELGVIS
>KALACAFP_04039 Aminopeptidase N
MRKFYFLVLSVFVFQQMFAQNDNIDKKGLIDKEMKSFTHKMAVGNVNPNTLNYDLQYQRM
DVSLDPSVYNISGSVTSHFKPNQSMSSIYFDLTNTLTVSQVQYHGNTLAFQQLPTKELKI
DFQSALPANVLDSLTITYSGAPATTYNAFSTGSQNTIPILSTLSEPYGAQDWFPTKQSMN
DKIDRFDFKITTPSQYSVAANGKLMSETALPGSQKLTFWRTMYPMASYLVALSITNFVKL
NDTIGNPPFPFVNYIYPASQGNSTIMSNIDWTKQVMNTFETYFGLYPFRNEKYGHMEFQY
NGTCMEHQTMSSMSSWGRSVIAHELAHQWFGDKVTCGVWNDIWLNEGFATFGEHLANEKL
LMTNPQFMSYLLDQKNYITSSPGGSVYVADSNLGNIGSIFSGRLSYSKGGYVLRMLKWIL
GDTAFYQAIQDYHSRPSLAYNYVKTQDLNASLLQSTGINFTEFFNDWIYGEGYPIYDIRW
RQSGGQIIIKAAQTQSSPTVSFYEMPLPIKVNGTGGQVAYFALNNTTNNQYFVQSVAFPV
ASVEFNYEYQILEKNSTVTQDNTLSTSDVNKEEFALYPNPAKNELYVKGIDKPTDFTIYF
TDGKLVRKATYQSAKPINISELVPGTYLFKMKDKNVKFIKK
>KALACAFP_04040 D-alanyl-D-alanine carboxypeptidase DacC
MVNFRKYISSVAVLASGFFLAQSTVSTVLYSQTYDNQKSLNLPSPITSVVEKAILSPKEL
VDINVNTMMTDPVLKNANWGFVVYDPKTKKVISSYNENTPLVPASTTKLLTTETAMSLLG
ENYRWMTQLEYSGSIDENGVLNGNLYIVGSGDPSLGTNKAGAWSYRDIVSDFVGGLSREG
IKKVNGDIIIQTALFKGNISKLPENVVWLENNNYYLPVGSTREINPANEKLIVKKGNNFS
GDKKFFYISPYNQQMVYADKYDGDGILTTKLPDAPAYLANTFRTTLVKSGIAVTGKVTPK
MTDANPENRKLVSAYKSPTLSDIIYYTNQHSDNGLAEALLKTVGFQNLGDQTAESGRRVV
TEHLKSEGFDMMGLNYMDGSGLSRSNNVTPIAQAKFLTSLMDEKYYKTYFNSLPVGGQSG
TLKRMFIGTGNGQVFAKTGTLNKVKTLAGYMKTNSGKTLVFSLMVNNYAGSVDMVKKRME
KILEPALDL
>KALACAFP_04041 Primosomal protein N'
MQYAQIVLPLNLKGSFTYKVPEELQPEIQIGMRVLVPFGGKKIYTGIVFELHDQAPENFV
VKEVISILDDQAIVPQEQINFWNWLSDYYLCGLGEIYRFAFPSSLKLESETYLKLKPNIT
VDFENLDVNEMYLVQALEVRQLINLTDIEAFIPKKDIIKTVNSLIDLQYIEIDEKIAEKY
KAKEVAYVKINDEVLKTQNLTEILLTLKRAQKQKELFLNILEKQTENPDLHIKKSELFED
GYFAGSHFKALADKNLVEEYYMQKDRIESYEGEIEEIEELSETQKIAKTEVDEAFEEGKN
VLLHGVTSSGKTHIYLEKIEECINEGKNVLFLLPEISLTKQITQRLEKKYGRQLGFYHQK
LTDFERVEVWRRIRQNDIKILIGTRNALFLPFQNLGLVVVDEEHDSAYKPREVSPYFNAK
DAALVFGNFYGAKVILGSATPSVESYYNARKDKMAYVFLEERFGNVKLPEYELINFKEAQ
DSKKVSGNFSLRLIDEIKKTLEEKNQAIVLHNRRGYANVVECETCGYVNYCSNCDVVMTY
HKAANEMKCHYCGQRASKPKACPKCHSENLNERGVGVEQIHEEVSKLFPENEVDRMDVDS
MRKKFAYEKLYEKIEDRETDIVVGTQMISKGLDFNHIELVAIPKADSLLYVQDFRAEERA
YQLITQVSGRAGRVSGKGKILIQTFNPDHSVFQLIKMNNPAKVYKYILTERQKFHYPPFT
KLIMIELKHRREDKANRASQFLGSILRKYLPEDCVLGPEKAQIARLNNLYQFQIMLKLPR
GKKYEEYKKLVLISLKEFDEITAYHSIKKDVFVDF
>KALACAFP_04042 hypothetical protein
MVNFVLIAICIIAGMALKATKSIHPDAHKGINTWILYLALPAVSFKYLPKVHWTMEMLFP
VAATFLIAVVCFVFMAIYSKIKGYSGRSRSTLELVSGYSNTSFIGFPLISAFYGESLLSI
AIICDQTMFFSLSTLGIIAAVRGGSRSGKVSAAFIVKRLITFPPLIGCISALVLSRFIDF
TFAEPLFDKLAATLSPLALFSVGLQLKFNGWKKLIPQMSVSLLYKLIIAPAMILGLTLLL
GVKGNVAKITVFETAMPTVVTSSIIAEQFRLNTKLTNLIIGFSIIVGFFTSAIWYEIIEY
FF
>KALACAFP_04043 Exo-beta-D-glucosaminidase
MNKTILFAFFFIQNIFFGQYSERNLSSEKWQFKNSKDKNWLIATVPGTVHLDLMKNNIIP
DPFKDENEKKVQWIENEDWDYQTSFKMSSKELENQNIELVFNGLDTFSKIYLNGKLIQTT
DNMFRKWTIPVKQNVKNGENILQIKFKSAVNVGKELAKKVPFTVPESPRSYVRKAQYQFG
WDWGPRLVTAGIWKDVKLNFWNQAKLENVKIEQKVLTKQKADLNIHAEIIANNNGNYRIL
INGQSQNISLKPGLNTISVPYQIKNPKLWQPNGWGDPNVYELKISLQKDSKRIAEKSERI
GLRTVELIQEKDAKGKSFYFKVNGNPMYAKGTNWIPADSFSPRISKEKYQKLIKDSKEAH
MNMIRVWGGGIYEDDEFYKACDENGILVWQDFMFAGSFYPGDENFQQNVELEVKDQINRL
QNHPSLALWCGNNEIDEAIVNWKFQNQFKYSNEDSLQVWKDYNKIFHEIIPNAIKKYATR
DKTIYWPSSPSIGWGHKESLTEGDSHYWGVWWGEQPFEIYNEKVPRFASEYGFQAMPTLE
TTKSMFSGKPDLSLQNGTIKAHEKHSRGWEIIDNYMKRDYKSPTDFVKYNYISQLLQARG
MQIAIEAHRRAKPYNMGSLYWQLNDCWPVVSWSSIDYLGNWKALHYQIKRSFENQVILTE
EKDGVLNFFAINDELKKFEDVNLEIQVINFKGQILKKISSTPNGKNLIEITILDPVKIKN
LIGNNNKSEVFLRLILKDKNEKIIVENTHFFVKPKELKLSKPTIKIKKISPTEIEISTDV
LAKDVYLIGDTHFSDNFFDLLPKTSKKIKLSKSLEKMEVMSLWDAMN
>KALACAFP_04044 Copper homeostasis protein CutC
MSKIEIACFNPESAIIAFENGADRIELCDGLSEGGITSNFETAKQLREKINIPIFVMIRP
RGGDFTYSDAEFEQMKEELIQLKSLNVDGFVFGILDENDEVNMEQNKVLVELAKPYQCTF
HRAFDRAKDLENSLEKVIECGFKTILTSGQKPNVSEGKENLKKLVELSNGRIEILIGGGL
RSTNIEEIREVTKAGYFHSSAITDGGAFANADEVIALKNK
>KALACAFP_04045 N(4)-(Beta-N-acetylglucosaminyl)-L-asparaginase
MSSRRKFIKNTALASSALLLNPLDLLAKDLPENTHKAVNKPIVLSTWNFGLKANEEAWTI
LGKGGRALDAVEKGVRLVELDPNERSVGYGGRPDRDGRVTLDACIMDENYNIGSVACLEH
IKNPISVARAIMEKTPHVMLVADGALEFALSQGFKKENLLTPESEKEWKEWLKTSQYKPI
VNIENHDTIGMIALDANGNLSGACTTSGMAFKMHGRVGDSPIIGAGLFVDNEVGAATATG
HGEEVIRMVGTHLVVELMRQGKNPQQACKEAVERIVQITKRRNKNLKDIQVGFIALNKKG
EYGSYCIQDGFNFAVYDQKGSRLEKPEFALK
>KALACAFP_04046 Beta-hexosaminidase
MIRAFLLVFVLLSNLFFSQNKLNLIPYPQKVNINDGFFTIPEVIVLNDKLPKNETDYFKN
KVNSGLKFQNTNKSDAHLVYFQLPKSSNSAQNNEFYSLEITPKQISIKSYTPQGYFLALQ
TLIQIIDQYKGTKKIPTMKIEDQPKFAWRGMHLDVCRHFFTVDEVKQYIDYLAMYKLNTF
HWHLTDDQGWRIEIKKYPKLTQIGSKRKESMIGAYVDNTFDGKPYGPYFYTQDQIKDVVK
YAQDRHITVVPEIEMPGHALAALAAYPELACTKGPFETATKWGVFDDVFCPKEETFKFLE
NVLNEVIALFPSQYIHIGGDECPKTRWKECAHCQELIKKNNLKDEHGLQSYFIQKIEKYV
NSKGRKIIGWDEILEGGLAPNAAVMSWTGIKGGVEAAKSGHFAVMTPGSYCYFDHYQGDP
ATEPNAFGGFTPLDKVYSYNPIPEELNAEQAKYILGVQANLWTEYILDFKQVQYMIFPRL
MALSEVGWGTSDPKNYKEFEGRVINQFKVLDKMGVNYAKSIYNVMGKVVPGNNGVAYELS
TSQNPNGIRYTLDGTDPTANSQAYQNPIPVSKSMIIKSAYFENGQLKSAISSQQFTTSKT
TGKNITLEQQPSENYSFGGAFTLIDGIIGNQKQLGKTWLGFQGKDVVATIDLGQKTQFSE
IDFNTLENKGSWIHLAKSAQVFVSDDNKSFKMIKEIGKEEIQKAKGKIQLNVGNQNSKYI
KIKIENAGIIPAGNPGADSKAWLFVDEIGAK
>KALACAFP_04047 hypothetical protein
MRKTILLAGGLLFSVSTQAQILDAIKSAVKDKTGIDLSEPKTTTGSATTATPKTSTTTTS
PINLGNLTSTQISSGLKEALSLGVTEGVKKLAVPDGFFKNEAVKILMPEKLRKIDTTLRA
VGLGSLADQGVKLLNRAAEDAVTEATPIFTKAITSMTITDAKNILLGSDNAATNYLQTKT
QSQLFTAFEPKVKASLGKVGADKVWSGLISKYNALTGQAVTTDLNAYVTTETINGVFKMV
AQKENGIRNTPAMRTTSILQKVFGAQDAK
>KALACAFP_04048 putative succinyl-CoA:3-ketoacid coenzyme A transferase subunit B
MLTKEQIAQRISREVKDGYYVNLGIGIPTLVANYVPDNLSVEFQSENGVLGMGPFPFEGE
EDADIINAGKQTITILPGGSFFDSAFSFGMIRGQKVDLTILGAMEVSENGDIANWKIPGK
MVKGMGGAMDLVASAENIIVAMMHVNKAGESKILKKCTLPLTGVNCVKRVVTELAVLDVT
PAGFKLVERAPGVSVEDIIKATEADLIIDGEIPEMQF
>KALACAFP_04049 Putative multidrug export ATP-binding/permease protein
MKILLYYLKPYKWLIIVSLLLASINQVFSLFAPAITGNILDKLVTHPNFFDKEKLLPRNL
NEYLYGTDIYHGVFYFLGLLVGTAMISRIAKAFQDYVVNVIIQKFGAQIFTDGLKHSMRL
PFQEFEDQRSGETLSILTKVREDTVKFINNFINVFFGILVSIIFVSVYAIRLHWSIMPVY
VVGIILIAVVTNLLSKRIKSIQKNIVKETTNLAGSTTESLRNIEIVKSLGLTNQEVERLN
NNTYKILNLELRKVKSIRSLSFVQGTLVNFLQQTITFTLLLLIFKNIVTPGQYLSLMFYG
FFIFGPMQEIGNIIISYREAQASLNNFDRVMKKEIEPKPVNPKRIGAIEELEFQHVSFQH
QTAHFKALSDISFNVKNGETIAFVGPSGSGKSTLVKLLVGLYRPLEGDIFYNNINGKEFD
FDELRNQIGFVTQDTQLFAGTIKENLLFVNPSATDEDLHLALKKASCTALLERAENGIET
VIGEGGLKLSGGEKQRIAIARALLRKPHLLIFDEATSALDSITEEEITTTIKEISKEKEQ
ITVLIAHRLSTIMHADRIFVLERGQIVETGSHLHLIEEKGLYYAMWRQQIGERKLTAEA
>KALACAFP_04050 Succinyl-CoA:3-ketoacid coenzyme A transferase subunit A
MIDKRVKNAKEAIEGIKDGMTLMLGGFGLCGIPENSINALVESDVKDLTCISNNAGVDDF
GLGLLLHKRQIKKMISSYVGENAEFERQMLSGELEVELTPQGTLAEKCRAAQAGIPAFYT
PAGYGTEVAEGKEVKDFDGKPHILEHAYKADYSIVKAWKGDHAGNLIFKGSARNFNHPMA
GAGKITIAEVEELVAPGELDPNQIHIPGIMIQRIFQGEKFEKRIEQRTVRKRD
>KALACAFP_04051 hypothetical protein
MKQENFNKAGDIFYVICRLSIGLFFFITGFNKLFHPVFQGYMLKTISSLGFSNPQLMANF
VAANEMLWGFLLLIGLFTRFSSLALIVIMLVALVTKDIHSIPTELVPIDPKVGTRPIENY
TWLTYFFYLPQVLYIMILGLFSLYGYKAFGIDRFLKKKVNPYR
>KALACAFP_04052 hypothetical protein
MKHYFFFFCFAVQMAFGQALFPYLQNPTPTSMIVNWKTASNNETTVIYGTSPTNLNVTVT
GTTNIFSDTGYNNNYYYHTAKITSLQPNTKYYYKIKTGANESAVYNFRTLPLPGQAVTAD
GKIRFLIMGDNQIKAEPRYDTLTLNAYKKLKEKFGPNSDPSDNVALTFMVGDQVDVGTLD
HYENVHFKKNTKLSPYLPIQTTVGNHETYGSLGMNSYYAHFYIDEIKYKNISSGNENYYA
QQAGNVLFISLSSEHTGSAQMTWLQQILNEANNDSTVDWIISLSHRPYQAEQYVGDISTW
VRNNAVPLLTASSKYLMHVGAHHHLYHRGQLKDTPNYQIISGGTAWDQYWGMSTEQDFDD
VQKTLTDWTYQIVEVDVNTGKVDVECYSIGGVYHKKYNELVDTFHRYKNQPKPAKPSITN
TFTAPITLPLTLNGSAFSTTNGELLNTTQFLISKAADFSVIEKEFYRDYEDWFGKEGTGT
PDITKNQNANVDITKATIASNSITNGTYYVKVRYRDRNLEWSDWSDAKQFEVTGSVVSNP
TFILNKTEYTQNEPIIATFTDGPGNNQDWVGIYKKGQNPAAVTSQAFVYTNGQTAGTANF
PNGIANKGQYFAGFFANNGYTEITPRKNFYVGPKVVLSTTSDTYPVGGTVTVNFSNGPNL
TKDWIGIYKMGHTPGTVNSTQWSYVTAPSGTLNFTGLAKGYYYAQYFLEDGYTAIGEKVF
FKVGDIVTELWINKPVYTLGENITASWTDSPGIIKDWLGIYPQSVTTPDDNFVSYTYFDG
VTQGTKTIQGTAVPATPGNYYMVMFTNDSYTEVSNRVQFQVAGPTLGTEETKSTEKNVVL
YPNPTKPGEPTFIKSDYPIEKIELLSANGDLLYESKNIHNQRFSLVNENLPKGVYFVKVH
TRKLFTLKLIIQ
>KALACAFP_04053 50S ribosomal protein L19
MDLLKYVQDKYIAKKEFPEFKAGDTITVYYEIKEGQKTRTQFFKGTVIQLRGTGSTKTFT
IRKMSGDVGVERVFPINMPALQKIEVDRRGKVRRSRIYYFRDLRGKKARIKDAAFKK
>KALACAFP_04054 hypothetical protein
MEVGSWGREVYMIMDYELVNIKLKRLREPQPDNTQIYLIFYD
>KALACAFP_04055 4,5:9,10-diseco-3-hydroxy-5,9,17-trioxoandrosta-1(10),2-diene-4-oate hydrolase
MKNFNVAVALLLSIASNLVFSQVKPLDAELTNYQYPYEVHFLQFKSQKNDLKMAYMDVKP
KTSNGKTIMLLHGKNFNGAYWKKTAKDLSDKGFRVIIPDQIGFGKSSKPESYQFSFSQLA
ENTKAVLDELKIDKTIVLGHSMGGMVATRFTLLYPDRVQKLILENPIGLEDYKTFASYQT
IDQAYQSELKNTAETYKNYQLKFYYDNKWKPEYQPWLDLIAGWTLHPDYPKVVWDAALTS
DMIYNQPVCYEFKNIKVPTLLIIGTRDRTAIGKDRAPKELQPKMGQYQELGKKTQQQIPG
SKLVEIENVGHLPHIEVYDKFWNALYDFIK
>KALACAFP_04056 hypothetical protein
MKKKNILKGVLFVGIGASIYGMLATFVKLAYQEGYTTSEVTTSQFLLGLIGLLLLNFIQT
ITSKKALPSPTSKEIRNLMMAGTSLGCTSLFYYIAVQYINVSIAIVLLMQSVWFSVVVES
LITKKLPNIRKVVSVIIVLIGTILATNLINTEIELDVKGIFWGLLAAASYTLTMFTSNTL
ATNLPVLRKSMIMLSGGAVVVFIFLFFAQIGPSHFDGLKSIYLNFTENTEHIHSFRYSIL
WRYGFVLALFGTIIPPILFNIGFPKAGLGLGSIVSSLELPVSVAMAFVLLGEKVIFIQWL
GIALILFAIVLMNLPSQKEYKIAEVS
>KALACAFP_04057 hypothetical protein
MNNICKLAPLLINMKKRTLPLMFAALAVFSSSSLFSQNNETLIKNYISKNKIREYKKSDL
TNFSIDVNDHSESMNGDVVKIQQMYKGLPVYRSLGSVLIKNNQVVLYNDSFEKDYQNVDS
NIPAISKETAFGFASKGTNIEDPSKVKILNFHDADTKDAFAKHQLVYVKKGEDLVLCYEF
TFPERKTSNYWDILVNANTGEIIEKNNLNLSCNFVDHPYGHSHENSLAVFPLGKENYESA
IPKTSVLLSPDNASYNVFPFPIEAPTFGSRSVVTNPWNLTASPEGWHSDGTIHYTTAQGN
NVFAYQDLYDDDFFTGTTVDGGATRNFNFPYTAGALALTNQDAAITNLFYANNMMHDIFY
KFGFTPASKNFQKNNFNLGGTGNDFVNAEAQDGAGTVVTANVQNYNNANFATPQDGGSGR
MQMYVWVNSSQKLFYNAPASATSRTPVSYIAQFGQQITGLPVSGDVKLSPVLDACTALPA
NSLSGFIGLAERGNCDFSIKVENMQNAGAIGAILYNSPTSAAPGNMSGTNANVYIMSELI
DNVEGEYIKSQLANNVPVNVSMSYSTKQDGSFDNGIMIHEYGHGISNRLTGNGYTCLQYT
QSKEQMGEGWSDFFALMLTNKSGDNASVPRGMATYALGEGISGDGLRPAKYSPDFLINDY
TYVDTNGMEFLNGSTMVPDVHSIGFVWATMLWDLNWQYVAKYGYASDVTSNTTNGSSRVL
QLVTDALKLQACSPTFIDGRNAILQAELATTGGVDKCMIWRTFAKRGLGVNASAGSKTNI
NDQVQDFTVPAECVLATDEVKTVKDNISIYPNPAKNEFFINFPSNTLGKVSVEIYDMSGK
LVSSEDKISPDAKKSISTDKLINGTYMVKVKGLGFDATSKVIVKK
>KALACAFP_04058 hypothetical protein
MKKLALPLLFAVSAIFPSVLYGQDNEKLIKDYISQNKIREYKKSDLTNFIIENVDPSKSL
NGNVVKFQQTYNGLPVYNAAGTAIVRDNKITYYIDNFLKDYSSATPNNALISKTAALQKI
SQNLQKQKIENYPILGFSDADPVNQQAAKQRLVYVENGGVLKLVYEFSLPEPDSPNYWDI
LVDATNGNIISKLDLNLSCNFNDDAFSHDHTEIQNNFIGPVNGTQQSFSLLAPDNASYNI
FALPLEAPTFGSRSIVNNPWIITASPEGWHYDGTTRYTYTRGNNVYAYEDTAGTNIIGFS
PDGGAARNFDYPFSINADPSSNLSASVTNLFYMNNKIHDIFYMFGFTPAARNFQQTNFGL
GGLGSDYVNAEAQDGGGINNANFATPADGTKPRMQMYLWSTRNRNFFYNAPSAAVPRQPS
VGTALFGNPLDATGVTGDVQLSSVLDGCTALPAASLAGKIGLVERGTCAFTVKVKNVQNA
GATAAIIYNNTANGSTLSNMSGTDATITIPSVLITNSEGEYIKSQLSASTIVNVTLKNDP
ATSITPDGSFDNGIVTHEYGHGISNRLTGTGSGCLSSSADKEQMGEGWSDFFALMLTNKP
GDNASVPRGTGTYVMGQPITGGGIRPAKYSPDFTINGFTYGDTNGMEYTNTSGQLVPDSH
SIGFIWATMLWDLHWQYVAQYGYSSDVMANTTNGSSRVLQLVTDGLKLQICNPTFIDGRN
AILNADLATTGGVDKCMIWRTFAKRGLGVNASAGSKTNINDQVQDFTVPAECVLATDEVN
TVKNNISIYPNPAKNEFFIKFPSNTLGKVSVEIYDMSGKLVSSEDKISPDAKKSISTDKL
INGTYMVKVKGLGFDATSKVIVRK
>KALACAFP_04059 hypothetical protein
MKKAFLFLLMAFFMSLNFSKAQTPGAGTDFIICIDNSASIGSQAYEEMRISAKKLIEKIL
ACNPKNRVSVVHYGTALLGSSPSHPIIYIESDFTNNIVTAQSFVRRLDVGDHFHEALGLV
GNALDGTPNPDIVSPQTTLHRDPSNSFVFILFTDAGRAGGDLVSGSYLVNYYDTTYADPA
AFKNVTVFKRDRKTKFAVVHVSYDSYSTQAAASIASAGGSYFGTVENNTDDPDFGISPRL
YFGKPSFLLTPDEITEITKGVCENSGGGNIEMYYEPNDCGGFNTVQSVFGTYDLPAGATF
IGLNLSIVSLTTGDEYPVSYNPTLTPPNGFWQWMTAADFSSVPPSALTGQFKFLLTLAYE
VGGQTYYTSSWNTYPFFSYDINFDCMKGVPSTPLLKQKNNNNDFKLDRNADPNHYKKNLV
TVEQKLQLTPNPTNGMFKVVLNKGIETGKLQVLDLNGNTVYNTSFNNEKEVNVDLHSQKE
GIYLVKIVSDKNITYTEKIIKR
>KALACAFP_04060 30S ribosomal protein S1
MSKETNSAEVILNQNVAPEQFDWDSFESGLDADARKEKSDLEEIYNGSLNNLDDNDVLIG
KVVRLTDKEAIVDINFKSEGVISLNEFRYNQGLKVGDEVEVMVDKREDKTGQLQLSHRKA
RTLKAWDKVNELHETGEIVNGFVKSRTKGGMIVDVHGIEAFLPGSQIDVKPIKDYDQFVG
KTMEFKVVKINPEFKNVVVSHKALIEADIEGQKKEIISQLEKGQVLEGTVKNITSYGVFI
DLGGVDGLIHITDLSWSRVNHPSEILEDGQTVKVVILDFDDEKTRIQLGMKQLEAHPWDA
LSADLKVGDKVKGKVVVLADYGAFVEIAPGVEGLIHVSEMSWSTHLRSAGDFVKVGDEVE
AEVLTLDRDERKISLGIKQLSKDPWENIETKYPVGSKHVGTVRNFTNFGVFVELEEGIDG
LIYISDLSWTKKIKHPSEFCAVGDKLDVVVLELDIQARRLSLGHKQLTENPWDAFETKYA
EGTVHTGTAVEVHDKGASVQFEDAEVEAFCPSRLLEKEDGSKIKKGETAEFKVIEFNKEF
KRVVVSHTGIFRDEEKKNAREASNNRSNNVSSSNNEERSTLGDIDALAELKRKMEEGK
>KALACAFP_04061 ATP-dependent RNA helicase DbpA
MELESIYKKLQIQDMNQMQKSTYKATENKQDVVLLSPTGSGKTLAFLFPVLRNLKKNGSG
IQTLILVPARELALQIEQVFKAMGTDFKVSVCYGGHDKKIEVNNLIEAPAVLIGTPGRVV
YHLRNNNFDPKTIQTLVLDEFDKALELGFHDDMEFILNALKNTSQRILTSATAMDEIPQF
TGLKDEKIIDFLKLSEVKPDIQLRKVMTISEEKLDTLFNLICKIGNKRTLIFCNHRDAVD
RISELLREKGIDRETFHGGMEQDERERALLKFRNDSARILITTDLAARGLDVPEVESIVH
YQLPPKEDAFIHRNGRTARMNAKGFAYLIMTEEENFPFIKSNTPEESVAGFNKVPEKTPF
QTIYISAGKKDKVNKVDIVGYLLKKGELQKEDVGLIEVKDTTSYVAVSRNKVNALLKKLS
NEKLKGKKVKMEVAY
>KALACAFP_04062 Gluconolactonase
MKNIFKIGWVGLVLVLVNCKSVNTNSMFYDGVSPEKVSDQFSFTEGPSSDKEGNVYFTDQ
PNDKIYYWDWKTNKIIEFLSKTGRANGTHFDKDDNLITCSDDNGEIWKISKDKKIQVLLK
DFEGKRLNGPNDVWNDEFGGMYFTDPLYEREYWKNFKQEIPHKSLYYRNKDGKISKLDTF
TQPNGIVGSEKFKKLYVSDIDAGKTYVYDILGEGKLSEKRLFCEMGSDGMTLDKNGNLYL
TGKGVHIFSREGKKIYHIPIEEDWTSNVTFGGKNNEILFITASKSVYILPTKVKGVK
>KALACAFP_04063 HTH-type transcriptional repressor BluR
MKINLPDKLYYSIGEVAKAFDVNTSLIRYWEQEFPIIKPKKNKKGNRYFTPEDIKNLQMI
YHLVKEKGYTLDGARVALTTNSKISETVTIIDRLEFVKAELLKLKESLVEKDSE
>KALACAFP_04064 hypothetical protein
MDRLKLNYFRIEIVIYPFKKYTGTNAGREIFNLFTVFFNQRFL
>KALACAFP_04065 hypothetical protein
MGMLLIILFAFQKYTSKNKEDFSNVKFIAENATPMHLTAFDPNDLDEKQWQDLGFTEKQI
STILNYKKIVGGKFISKEQFRKCYAVSGEKFSELESYILLPETNKDTKNNDYKSFPNSFN
SEKAKIIYHNFDPNTLDFNGWKSFGFSDKQSQTILNYRDRILKGSFKNLEDIQKCFVISS
EKFSELKPYIKLNPSTIAQNTDAPKTKVIQEKTDFSKTDLNVITFKQLLEFGLDEKSAGM
IIGFRKKLGGFVNKEQILTTYNIDKELVQKLLSIAPLNTSNVQKYTLIDAPEEWLKNHPY
FKYSADKIIFYRLSEKDEKKIWKLLRTKPEYEARMKLYLK
>KALACAFP_04066 23S rRNA pseudouridine(2604) synthase
MEKTRINKYLSEVGYCSRRAADKLLEEGRIKINGEIPEMGTKVSDEDVIEVDGKPIREPQ
ENHVYIAFNKPVGIVCTTDTKREKNNIIDYINHPKRIFPIGRLDKPSEGLILLTSDGDIV
NKILRSRNNHGKEYIVRVDKPITPKFLDKMRNGVPILDTVTKKCEVEKIDEMNFRIVLTQ
GLNRQIRRMCEYLGYEVKKLKRIRVLNIKLDLPIGKWRDLTDEELSTLNALVEGSSKTFD
>KALACAFP_04067 hypothetical protein
MTKKLLIILGLIVCFKAFSQETESKKQKMDFYFNPSLNIGLNLNKEKEIPNNTQYIQTQP
PNKITYGITAIGGYNFLPNFAIGSGLRYSFIEDNYHLIYFVIQPKFIFAPGDRPFYIDIN
YGKQINNSVVSDAEFWGARLGMQVSYSKRLSQEGGITFERHAIGGANPFFIGLSYGITIF
SNKNYTGYGED
>KALACAFP_04068 tRNA pseudouridine synthase B
MTAEDLQSGHIFLLDKPLDWTSFQAVNKMKYKLKREFNLPKKFKIGHAGTLDPRATGLLI
VCCGKFTKKIPEIQDAPKEYWTEIKIGVQTESYDTEKPEILQQDISSVTEEQIKTALEKF
VGEIDQTPPVFSAIKIDGKRAYDLARAGEEVEMKSRKTTIFYIQDIKIDLPLVSFTVGCS
KGTYIRSLAHDIGQELGVGAYLTQLRRTKIGEYKIEDATSDFLENDFRFESL
>KALACAFP_04069 Undecaprenyl-diphosphatase
MDLIKAIIIAIIEGLTEYLPISSTAHMGFTANLLGLQEDEFLKMFQVSIQFGAILSVVVA
YWKKFFDLKNLQFYFKLGFAVVPALVLGYLFDDKIEAVLGNQIAISSVLVLGGVILLFAD
KWFKNPKIDDEKGITVRNAITIGFWQCLAMMPGTSRSAASIIGGMAQGLTRKAAAEFSFF
LAVPTMLAVTVYSVFLKTWGKETPNPQKGYEMILSSQDHITIFIVGNIVAFIVALIAIKA
FIGVLNKYGFKPWGWYRIFVGVALLIYFYFFQ
>KALACAFP_04070 hypothetical protein
MSKKTNKFSADSFGKDIPEVPQENTFYFGQQNFKWMLIGLAFIVVGFLLMMGSDANTVDG
KFDPNSWNDGIFSIRRIRIAPLFVVIGFAIEVYAILKRK
>KALACAFP_04071 Cell division protein FtsX
MAKSVDEFNKKRLRSSNITVVISIALVLFLLGLMGLILINAQKYSDYIKEQLVVNAYFDE
NYNVKDSAKIAKMEAEVFKEIQTLAPVKKATYISREMAAQEAKKSMGIDTDALFEENIFP
SSIEVALKPEYVDPAKIDGAIKVIKAVPGIIDVKNDSTLMVDVYNNLSRILKWILGFSIL
FLILAVVLINNSIRLKIFSKRFIIKTMQLVGAKRRFILKPFIIEAVILGAIGSVIGLLAL
FGVWYYFTSQIGSAFVQDNNQYFWLVILVLGVGIFITVLSTVIATWRFLRSNVDDLYYS
>KALACAFP_04072 Ribosomal RNA small subunit methyltransferase A
MSVKAKKHLGQHFLTDENIARKIVEGLSFEGYQNVMEVGPGMGVLTKYLLEKDQNIYLAE
IDKESIEYLKKNYAKVTEETFVGDFLKQDFQFTKGEQIAIIGNFPYNISSQILFKIIDHY
GLVPEMVGMFQKEVAERTAAVPRTKDYGILSVLVQAYYDTSYLFTVHENVFNPPPKVKSG
VIRLTRNPKEGLAGNEVLFKQIVKAGFNQRRKKLSNALKILNIPEALKTHEFMDKRAEEL
SVADFISFTQLWKQNL
>KALACAFP_04073 hypothetical protein
MKRYLLLFSFFIVSSSSLFYSQNITPRKPQKEKASALTMKAGAFIDVNAPSYAPTAYTPL
QLVKDVLISSGTNSCVTPNVSNVQVSPNLPASDANRSWGYFHKGTTNFPFTDGIVLTTGY
ANKAGNSYISSTLGDDLSTGSDPDLVAATNPTATLNDAVILEFDFVPTSSQVKFNYLFAS
EEYTGSFPCSFSDAFALLLKPTAGGPYVNMAVLPAPGTGPVSVTNIHPQNSFTGFDMGCG
APNVSFFGGYNTSNIETNFNGRTVPLQATATVIPGQSYHFKMVLADAIDSSYDSAVFLEG
GSFNIGVELLDPTGATLPEEINVCDNVPQVITASVSDPNMTYQWFFNGVAIQGATTPTIT
ATQPGNYEIQVSFPGNPCPGKANIKINGGTTPAAVDATLLLCTTTDVTWFDLTDAMPSIS
TTSGAVFHFYEDQADAIAQNGDYIQDILHYNGNDGQILYVVVSNGGFCSKMIELKLLKEA
TPTAHVVASKLKVCPGEVVDFTATGGTTYQWGNFPGTGNTQSAAVYNTTTFTVYALGPKG
CKSLQPATITVEVVPELTSPLADVEMCVGDRVTLDAGAGPNYSYQWSTGEVTQTINVDEL
GIYTVTIKNGYCEKTFTAHVLAAASPFVTNVDYSNNTLTITAEVPMINNIPQTVEYSVDG
GISWQPSNVFTNLQNNTTYHIQVRTVGTHCVGALEFFTLHISNIITPNQDGVNDTLDLTA
LGDFQNFTGSIYDRYGSEMFRFSKQNPIWNGTVGGKKLPTATYWYKFNFQYPKSKVNMSQ
SGWIMLKNRE
>KALACAFP_04074 hypothetical protein
MLNRRTRSLLLTLFLVLAGSFVFAQNRQSKAVARKPAPESMKAGAFIDVNAAGYPETNFS
ITQLVKDVLISGGSTCSAANVSNVVVSPNLPATDQNRSWGYFNKATTNFPFAKGIVLTTG
YARKTGNTFQSTLSDGLGTGGDIDLATALSVPNSELHDATYIEFDFVPASTKVTFRYLFA
SKEYFSNFTCSISDGFALLLKKVGDPTYTNLAVLPSGEPVSVTNIIPANLPCGPKNAQYF
AGMNNPQIETNFDGRTIPLTATATVIPGQTYHFKMVLADYQDSNFDSAVFLEAGSFDIGV
QILNPAGVALPPSINVCDNAPQTFTASVQGGGATYQWLFNNNPIPGAINASYTATQPGIY
TVQVFLPGNTCPGTASVTIVGGTSPTVQNATLTACYTQGNATFNLTSAQTSISTTPGATF
AYYLLQSDALAGNANTIANTTAFPSAGQTIYVLVKNGFCSKVAELQLVKAPQMTATIAPP
SILTCINSQITLDATTSVYPAGATFSWTTANGNIVSGANTLNPVVNLAGTYTLTISNTYQ
PGNLTCTATANVTVTGDSAPPTTGLTASKVLICSGESVTLTASGGTTYNWVGLPGTGNTQ
TVSPTTTTTYTVTAVGANGCVSQNPATITIQVSQPITVQNATLLECYQTGGINYDLTEAQ
PQITSAGGVTFTYYLTLADANAGNTNNITNPASFNSPGGQTIYVLVVSGGCRYVVTLQLL
ATPETTLTIAPPQQITCTTTQTTLNASASVIPAGSTIAWTTTGGGNIVSGANTLTPVVNA
GGVYTLTVTNVNQPGNLTCTYTANVTVTQNTTLPVATVTSTFPQICPGESVTLTASGGAT
YNWTGLPGNGNTQVVSPTVTTTYTVFAVGANGCVSANPATITIVVGPPVAVLAASKSKIC
AGESVTLTATGGVTYEWVTLPGNGGTQVVSPTTTTTYCVFALGGNGCKVATPTCITIEVV
PAIESTLHDVYVCAGDFGTLDAGAGPNYTYVWNTGATTQTISVNTPGTYTVTISNGVCSK
VFSAQLINPTLPQFTNVVYNNHVLTLSTTNPTGGTLEYSIDGGLTWQASNIFYNVLDNTS
YNLMVRVKDAKCNTSLEYFTFVISNAITPNSDGKNDFIDFTGISKYNNFAASVFDRYGQE
VFKATKTETVWDGRIKSSINIPTATYWYRVQWENPASKKLELRNGWILLKNRD
>KALACAFP_04075 hypothetical protein
MLNYRLKNYFFFLVLLLVSGMVFAQKAKAPRKPIPEKSTSENFKAGLFIDVNTPTYTPSS
YNIEQLVKNVLISGGSSCAVANVTNVTVSPNQLATDTERAWGYFHKGTTNFPFTDGVVLV
TGKARRAGNVFEGGLSDGVPGSTVSDPDLVTAINPLAPLKDAVFIEFDFVPNSTQVKFNY
IFASEEYTSNFPCGVYSDGFALLLKKVGDPTYTNLAVLPGTAGPVSVTNIVPAGNGFSCG
PINEAYFGGMNPDPNIETNFNGRTIPLTAIATVIPGQTYHFKMVLADASDPSYDSAVFLE
GGSFDIGMTIVDGNGNPITNVNMCDNTPQILKAQIASVPGMTFQWYKDDVAIPGATSATY
TATQPGVYTVRTFVGGTQCQNASVTIVGGTTPPAQNATLKLCTTPSVSTFNLNDATPMIT
SSTSAIVRYYINQADAIAQNNSFINPSLLASYNGTDGQILYVVVSNGAFCSKMVTLTLKK
EATPIAQLQATKVRICAGESTTLTASNGATYQWSNITGTGATQTVSPTQTTTYSVYAIGP
QGCKSLQPASITIEVVPAIVSTLKGGMICEGDVITLDAGTGPNYHYTWNTGDLTQTISVG
TPGTYSVTINNGVCTKVFTTQVIQAIIPEIINVNYNENGTMILTASNPSNGPLEYSIDNG
VTWQNSNVFSNVPRNIVVSIRVRVKNTSCVGFLEYFTFVMQNVITPNGDNINDMIDLRGV
LKYKDFKASIFDRYGKEVYKASTLQPYWDGYFQGKRLPTASYWYQVSFEDPASKKPAVKT
GWILLKNLE
>KALACAFP_04076 Chromosome partition protein Smc
MKKYDEKAEILEKIANGITWWIGSIPSLMVHTLFFLISFLLPLLKIVEFDKMLLILTTVV
SLEAIYLAIFIQMSVNKSHEKIEDIQEDIEDIQEDIEEISEDLEEISEDIEEITEDIEDI
QEDIEEINDDEDEEIHSERAKNVILKSNVNSNKNEIKALKDKIDELQNKINELKKE
>KALACAFP_04077 hypothetical protein
MLKFEELKSFLDEKADQYNHPEFIENDPIQIPHRFSLKQDVEIVGFLAATISWGNRKAII
KSAEKMLDIMGNSPYDFVLNHSEKELRSLEGKSIHRTFNGEDFTYFIKQFQRIYKENESL
ENLFKVNDQETNFLHSIERFRSQFLGTEKHRSHKHVSSPYKNSSTKRIIMFLRWMVRKDK
RGVDFGIWESIDQKYLSIPLDVHTGNISRKLRLISRTQNDWKTVEELDLIIRKFDEKDPA
KYDFALFGLGVTKELL
>KALACAFP_04078 Ribonuclease BN
MSTYLTILGFNSAIPTINSSPTAQLLEMEERSFLIDCGEGTQVQLRKAKAKFSRINHIFI
SHLHGDHCFGLPGLIASFRLLGRETPLHVYGPKGIKNMLETIFTITETHRGFEVVYHELD
KDYSEKIYEDNRVEVYTIPLDHRIYCNGYLFKEKPKERHLNMKEIAKYDEIETCDYHHLK
AGKDFVLSDGYVLKNELLTLDPTPSVSYAFCSDTRYLESVIPIIKNVTVLYHESTFLHDL
KEMADYTGHSTALEAATIAQKAQVGKLILGHFSNRYGDLTVFTDEARNIFPNTFLPKALE
AVKIEKNVC
>KALACAFP_04079 Non-canonical purine NTP pyrophosphatase
MELLVATHNVHKKEEIQQILSDEFVVKSLTDYDIHEEIVEDGDSFNANALIKAKYCYEKT
GIPSLGDDSGLVVESLDGRPGIFSARYAGDHDFAKNIEKVVGEMEGIDNRKAYFITVLCY
YDENGPRYFDGRVHGNLLTENKGFKGFGYDPIFVPEGYDMTFAQMEPEDKNKISHRKQAL
DLFLDFLKVKE
>KALACAFP_04080 hypothetical protein
MENSRYPKFTFTWIGGLVLLAGLFVGTMFVSFFNVFWMFIFKENLQYRDWFFMLSNAAGF
LTAIAFFDFFIVRRTTGKKLNFNFSPTNFYTYLLIFPLMIGMMFIAEFITAQIPTTGPFF
GRYYEFFNELMNQLTDDPVVMVITAVICAPIFEEIIFRGIIQKGLMNKGVEPWKAIIFAS
IIFGIVHANPWQFVGAILLGCVLGLVYYKTKSLLLPMLLHAFNNLCSSLLMIYTKNESFA
DYFKVSEWILLAVGIVIFSLFYYLFVKKYKVHYAEI
>KALACAFP_04081 Peptide chain release factor 3
MSDLIKEIQKRKTFGIISHPDAGKTTLTEKLLLFGGAIQEAGAVKSNKIKKGATSDFMEI
ERQRGISVATSVLAFEYRDHKINILDTPGHKDFAEDTYRTLTAVDSVIVVIDVAKGVEEQ
TEKLVQVCRMRNIPMLVFINKLDREGKDAFDLLDEVEQKLGLTVVPLSLPIGMGADFQGI
YNIWENNIQLFLEEKKHKVGEAIKFDDINDPSIDEVIGEKAAQTLREELDLVQSVYPEFN
REDYMKGDLQPVFFGSALNNFGVRELLDAFIDIAPMPQPKESDTRLVKPEENNFTGFVFK
IHANMDPKHRDRLAFVKIVSGTFKRNENYLLVREGKKMKFSSPNAFFADKKEVVDESFPG
DIVGLHDTGSFRIGDTLTGGEKLSFKGIPSFSPEHFRYINNNDPLKAKQLAKGIDQLMDE
GVAQLFTLEMNGRKIIGTVGALQYEVIQYRLEHEYGAKCTYEPLSMHKACWVEADEKSEE
FKEFARLKQRFLARDKYNQLVFLADSSFTIHMTQEKFPNVKLHFISEFQNA
>KALACAFP_04082 hypothetical protein
MKKFILLAAVSSTFIMCKKGEATTSQLENAVNSADSAVSVASEKINNINDKANAALDSAN
VKIKEFENTKNDVKDKIENTSKIVDSLSEKISSVKLETKTEKKDSTKKNEKIVVNVPAPK
VIKETKIVYKDKPKNENYELNVPKNKLLKTGVLELTVDDAETAKEIVKAEVSKYDGFIRS
ENISLNNDEKKIAYLKVKVPIQKFDYLMEDLSYNIGKIENKGVEVSGQDYVQNTMCEVDI
TLYGKSNGLAENEEPKTFGEKSFAAISSGWNVITSIFLFILPLWPLFLILGIGYYFYKKR
NKNIPNNDSH
>KALACAFP_04083 hypothetical protein
MKYLWVTLGVVLLFLGVFIWYKYFFVFGEGVKSGYLNYAIKKGYVFKTYEGKLIQEGFGR
GKTGTVTSYEFEFSVKDPEIFKQLEMNSGKTFDLHYKEYNGALPWRGNTKYVVDKIVNMK
>KALACAFP_04084 Acyl-CoA dehydrogenase
MDFNLSEEQLMIQQAARDFAQNELLPEVIERDRDQKFPTEQVKKMGEMGLLGMMVDPKYG
GAGMDSVSYVLAMEEIAKIDASAAVVMSVNNSLVCAGLEKFASEEQKVKYLTPLASGRVI
GAFALSEPEAGSDATSQKTTAEDKGDYYLLNGIKNWITNGGTASYYIVIAQTDPEKKHKG
INAFIVERGWEGFEIGPKEDKLGIRGSDTHSLMFNNVKVPKENRIGEDGFGFNFAMAVLN
GGRIGIASQALGIASGAYELALKYAKTRKAFKTEIIHHQAIAFKLADMATQITAARMLCL
KAAVEKDAGKDISESGAMAKLYASQVAMDTTIEAVQIHGGYGYVKEYHVERMMRDAKITQ
IYEGTSEIQKIVISRSIAK
>KALACAFP_04085 hypothetical protein
MVANLHFLSKSENRIKSKYSEAKKHLNKGCSKDYANF
>KALACAFP_04086 Long-chain-fatty-acid--CoA ligase FadD15
MTIKRLFDIPQYALEKYPKPDMFVTKYQGEWKKTSTQEFINEGNKISRGLLKLGIKPGDK
IALITTNSRTEWAIMDLGLSQIGVVSVPVYPSISPEDYEFIFTNAEIKYCFVSDKDLLNK
VMKVKHNIPSLQGIFTFDNISGAANWKEILDLGEDDSTQIEVEDLANTINSEDLATIIYT
SGTTGKPKGVMLTHHNIVSNILGSMPRIPKRKSLDYKDTRVLSFLPICHIFERMLFYLFQ
YNGFSIYFAESIEKMGENVKEVKPHYMSVVPRLVEKVYDKIYATGSSAGGLKQKIFFWAL
NLISKKKTVSKPSGLQEIIADKLVFKKWREGLGGEIITLVSGSAALSTRLNLMFQNAGIP
ILEGYGLTETSPVISVNSFEKMKIGTVGLPLDNLDVKIQEDGEITVKGPSIFKGYFKNDE
MTKEVFTEDGYFKTGDIGHVDSDGFLQITDRKKEMFKTSGGKYIAPQTIENLAKASKFIE
QIMVVGDGEKMPTALIQPDFEFAKSWAMRNNLNIGSTPQEIAKSPELKERIEKEMEGINE
HLGNWEKIKKIELTPEVWSIDAGLLTPTLKLKRKAIKEKFIDLYNKMYEHHE
>KALACAFP_04087 Chromosome partition protein Smc
MAKTNDISVEEKLRALYDLQIIDSRLDEIRNTRGELPIEVEDLEIEIEGLEKRAEKFHAD
IKDQDDQIKTKHEVINHAKTLIEKYKSQQDNVRNNKEFEALGKEIEYQELEIQLAEKRIK
EFGAKIGHKNETLSELNTKIDELKNHLKFKKEELDGLISETQKEEEYLIEQSKEYAAKID
ERLLASYNRIRTNSPNGLAVVGLERGAPKGSFFTIPPQKQMEIAQRKKIIIDEHSGKILV
DDELVMEENERMKTVIKF
>KALACAFP_04088 GTP cyclohydrolase 1 type 2 
MKLRSVISKIEERIQIHQAEDFDNVGLLCGSWDRDVSGILVCHDALENVVEEAIHKNCNL
IVCFHPIIFSGLKSLTGKNYVERAVIKAIENKIAIYAVHTAFDNDFFGVNQGICNQLGLK
NLKILQPKKDNLKQLTVFVPKDYSEKVKEALFTAGAGNIGFYDECSFTINGNGTFRPIEG
SNPFSGQQNVRENADEDMISVIFEDYKQGQIVAAMKSAHPYEEVAHQIYSLDNTNHHSGL
GMYGDFEEAMDEKDFLKMVKDKFGLEVIRHSDFNNKKIKRVGVLGGSGASGIRSAISKKC
DAYLTGDVKYHDFFLAESKMLICDIGHFESEQFVTQQLFEILSQKFSTFAISKSIEKTNP
VNYFI
>KALACAFP_04089 hypothetical protein
MIRIFTLMIPIFLYGLSYAQVGINTTTPNGAAVLDIFSNQKGILIPRLSDADRNANLADN
DPLTVPPAGVANASLTNGTLIFNTTSNTFQYWDGAVWRQLFVTTSSQAGNDGVVKVNSGN
ANVKPSINLSASGSGYGPRQQVLYATPLVFAASPTTSWPETTVPFPGVTSNIYLSATGKW
RENEINGQVHIWRLIANVTPGNNSSGSVKATFRNPDSGFEVTSIQFLPSGSSGVGNLLTF
YFYTIADAASLDPGRGYQLFVESDSNCNVLVDSFTRVSLFKD
>KALACAFP_04090 hypothetical protein
MSYFIRKFTLIKSLKTITLNCNNSQLNDEKTFNISENILTIKYSLI
>KALACAFP_04091 pH-gated potassium channel KcsA
MEREHNLVPEDKLWKRHLYRIIYRSDTKLGKLFDIILLSLILISTTIIMMESVPKLDEKF
HYTFIILEWIISLIFTVEYMSRIAIVKNKKHYIFSFFGIIDFLALIPFYLSLFIPVTKYF
LIFRMLRMLRIFRIFNLLDFMNDGYLIVRALKNSSRKIYIFLLFLIIFSVIVGSLMFMVE
GGRPGFETIPQSIYWAVVTVTTVGYGDVSPITPMGKFFAVILMLAGYSIIAVPTGIVTAE
MRNKRQNLEKTCEQCGNEDIDDDARYCKQCGKKLA
>KALACAFP_04092 hypothetical protein
MEPKKKNKPNSLVIILFALVVLMVIVYFILVTFFPAVFSSLNTGDLQPVPNK
>KALACAFP_04093 hypothetical protein
MTKFLLSCLLFLSMTLSAQIDLGAGSTDVGVAPISTYYGYSYVQQIYTKQEINANAAGNI
TGLKFYMDPAMSIASSSQWVVYLGHTTKSSFTSDTDWVPLAQLTQVYSGTVTNANGVIEV
TFATPFPYNNTDNLVLAAEENSSGYDSNDYDEVIYVYPGASNSLLYYKNDYTDPDPASPP
TMDAQLQGYKSVVTILGLTASPIPACPLITYPGNNATFVPLTPTITWNNSSGATSYKVSI
GTTPGGTDVANQVTSATNSFTPATPLAPNTVHYVKVTAVGPGGESAGCSQLSFTSAPPPP
TNDECATAVTLTVNPDLNCGTVTPGYTIGATDSGTIPDPCYGTPDDDVWFKFVATAATHK
ISLLNIQSVGTNADDTDTYFQVFSGGCGALSSILCSDPASGVVTGLTVGETYLVRVYSYY
DNGSNQSFDICVGTFPPPPANDECFGALTASTFPYTYVQNDGAGATNNAGMITACSSNDM
NDGTWFTFVGDGDTFNITVTMPAGSDFDPQIGVFSGSCSALSCENTVDDGGQGGTETVSI
PTLSGNTYYINVGQYSGWSDEPEGAFTINITKGVLATSDVKANKNTIKLYPNPFSDVLNI
SDAANVKSVYISDVAGRLVRQIENPGSVLQLGELKQGMYLVTLNMKDGSKQTIKTIKK
>KALACAFP_04094 hypothetical protein
MIALGIGASAQISLGSGTSTGVMPVLTNWGYTYSQQIFAKSELNAASSGNITGIKFYLGA
SSVITNSTTWKVYIGHTTKTSFSSSSDWIPLASLTQVFDGEISNTGGEVTVTFSTPFAYN
NTDNLVIAVDENKADYDADNYFYTFSGVSNSSIYYRSDTNNPDPTGTLPSASSRSATKSR
ITFLGLSPNAPACPSVSAPVAAATGVSVLPTISWAAAATASSYKINLGTTPGGTDIMNMV
DVGNVTSYTLTTPLNYSTQYYLTVYATNVAGTSAGCTERSFTTGGITCPTVNSPANNATG
LSLQPTISWSASAGASGYRLSVGTTAGGTNIVNNVDLGNVTSYTFSSPLSINTDYYYTVN
AYAGGATSASCTERKFTTIATTPVANDECTGAISLNPGGNFDQNAIVATNVNSTNNTIAT
CQTSSNNNVWYSVVVPASGNITLETKGVTGSTFTDTVMSVYSGTCGALTLIECDDDDSTD
GLFSLISLTGQTPGATLYVSVWKYTGNSSVTDGEFKISAYDASLALATNEVKGDAKNAVK
LYPNPFSEVLNISDAANVKNVLVTDVSGRLVKTVANPGSVLQLGELKQGMYIVTLEMKDG
SKQTIKTIKK
>KALACAFP_04095 hypothetical protein
MKKLNLLFLLLTSIMACQLYWGQSFSVATCSSNVDNITYSVMRSNTTANEKQRMAFIIPA
SQLVDIANGTITSTYFRRATASGSLNAGTTFKIYLKNTTATDFGSAAPDWATETGAATLV
YDSNPQTAVGSTSGYKQFQHSTNFVYTAGSNLAVYTEYVQTTAQASTIYWQYEYSGPCIN
TSNSNTTKYLGTTGTFGATLTSTNYRRPIIAFDATVPPPTTPPSCTTVSAPANAATGVSV
TPTITWAATPITSSYVINMGTTPGGTNIMNGVDVGNVTSYAIPSATPLSYSTQYYVTVFP
KNVIGQATGCTESTFTTLAMPCPTVSSPAAAATGVSTLPTIAWGAVTGATGYRLTVGTTS
GGTDIINNVDLGNVTSYTFSAPLNPTTTYYYTVTAYNATTNSGTACTVRSFTTTATPPPA
NDNCSAAVDLTVNPDLTCGATTPGNTLGASLSMAAAPCNGNPDDDVWFKFVATSTVHVVT
LSNIVSTGTTTASDMYFQVLGGTCGSQTSLLCSDPNTGTVSGLTPGQTYYVRVYTYSGAG
YNASFNICIGTPPPPPANDECANAVALTVNPDLACGATTAGTTLSATNSNIAVTPCTGTA
DDDVWYTFVATSTAHTISLSNVVSTGSSSSTSLYTQLFSGTCGTLTSVACGTTNTTTVGG
LTPGQTYYVRAYNSNGSGYSNSFNICIGTPPPPPANDACSGAVALTVGGNFAANAITSTN
AGAITDGTTSCQTNRGDNVWFSVVVPASGSVTFETQGVTGSGFTDTVLSVHSGTCGSLTS
IACDDDSGVDNFSLVTVTGQTPGATLYVSVWRYTGTAGGGSTTGEFMLSAYDASLLATNE
VAGNKNMIKAYPNPFSEVLNISDAAKVKNVLVNDISGRLVKTIANPGAELHLGELKQGLY
LISLEMKDGSKQTIKAIKK
>KALACAFP_04096 DNA polymerase III subunit alpha
MYLVFDTETTGLPKNFNAPLSDSDNWPRMVQIAWQLHDDDGTLIENQDYIIKPEGYDIPF
NAARIHGITTKIANEEGRDLQEVLEEFSKVLDKVRVVSGHNVEFDYNIVGAEFFRKNIKD
NLQEKPKADTMILGTNFCQLGGGKGGRFKSPKLEELYEKLYNHKFDEAHNAAADVNATAQ
VFFEMMRIGVIPAEVLKISEDQLAYFKTLYPDPIKPFSIVIRRQVADFHNKKKQQDFGSI
DEIDLGKYFNFDNHSVFSTLSATSSINDLINKAIEDNFPAVGMVDLGNMMGAFKFVSAVE
GANGDRAKKHKEYLAKKQEAEEKGEEFNEAEPVSEPLIPVVGCEFYISDRYEQKQFTKDD
PDRRTQVVLLAKDFNGYKNLAKLSSIGFLKGFYFGVPRISRDLIAQYKEGVIALTSGING
DIPDAILNTGEQKGEELFKWWKETFQDDFYVQIQNHKLPEEEHLNDVLLHFADKYNVKIL
AQNETYYTDKGDSNIQDIVSCIKDGEKLSTPVGKGFGKRRGLATGEYYIKNADEIKETFL
AYPDAFEAYEEFFAKFKPYTLKRDVLLPKFDIPAEFIHAEDEVDGGKRGEMAYLTYLTYE
GAKKRYVDTGITDEIKERLDFELEVIANTGYPGYFLIVQDFCNEARKMGVWVGPGRGSAA
GSAVAYCIGITNVDPIKYDLLFERFLNPERVSMPDIDIDFDDEGRDKIIKWVIDKYGQNQ
VAQIITYSVLGGKSAIKDAGRVLDVPIPDTNNIAKLVPSTPGMNIAKALAKYDKLKPEEQ
QLVDEMRFVLDSPTDPRHDVLASARKMEGCIRNTGIHACGVIITPEDVSNLVPVTIAAKD
ADILVSQFDNSVAESAGLLKMDFLGLRTLTIIKDALKLVKERHGVDIDPDLIPLDDTKTY
QLFKEGRTVGIFQYESPGMQKYMRELKPTVFADLIAMNALYRPGPIKYIPNFINRKHGIE
EIVYDLPETEEYLKETYGITVYQEQVMLLSQKLSNFTKGEADTLRKAMGKKQIDVLNKMY
PKFIEGGRKNNLDEGRLEKIWNDWKAFAEYAFNKSHSTCYAFIAYQTAFLKANYPAEYMA
SVMSNNINNTDSITMFMEDCKSMGVDVLGPDVNESQYKFSVNEKGQIRFGLGAIKGIGEG
PSEAITRERENGRFKNIYDFFERIQPSQMNKRVAESLVLAGAFDELDNFHRGQYFDIDMA
GRTNLERLIRYGQSFQESKNEMENSLFADFAEEVQIEQPKLPPCPEWPNMHKLNKEKEII
GFYLSAHPLDEFKYQYQFMQGQLSKKAVLEKEEEVKLVVDEVPILEKDSIDETADLIEIV
SDELLTGEEEIVEEITKKAEPKGVFHFLNLDEVDAYKEQAFANKQEELFEEKKKDWKTIQ
KERENGGGGKEYTVAGLITEYRVQDGFRSGEKVAFVTLEDYSGSYSFRLGDRDYMKLKEK
LEVQRFVILKIKFAQVKDGRVFVNVNDVIELQEAFERFAKSISLVMDVMDFRPEDLTFFR
TVLERNQGNQKLKFYIKNIDDDSRVEHLEVQSMKHSVNLNGDLIKEIQLLNKYDFYLN
>KALACAFP_04097 C5a peptidase
MKKHILLVSTLAISLVSAQSNDELMRKFEKQKNENEQKFDSYISKYNKTSTTAEIEAQRS
NLAGFDPSGKPYFYEATDLDQIKNSNADYLQNGTISGLTGSFNGENIKYTVFDGGRAFGS
HIFFNNAPNRVNNKEASTMNYSAHATAVTSFMGAKDYPYTITFTNGTTRVTNFRGIAQNA
TFDNYAFATTTLPGNSTTSNIFQKILLAQPKISNHSYGTNPGWDQKTVNGSPAWVWSGYY
TSPSTTYDLQGTYFTNDQNYDNIVYNNPSYVIVKSAGNSFGMGPTGNTVPKYYVSNGNTV
EFTATDTVPSNNCSLGYDCIGFGSLAKNIIVVGASDILTATDKRYSAPSDVIKSSYSSAG
PRDDGAIKPDIITTGTDVASASTAENTTGSNLISVGSGTSYSAPIVSGIIGLWMQIYKQL
FPNLELNAASAKTLMVHSASEAGTVGPDPWNGWGYINSKKGAELLVGKSNNTIIFNDEVL
NSGTPNQKVVTASGTEPLKVTISWIDPEYVIPANLTWADAYNNRISRLINDLDLRIIDTT
DNTVYYPWKLNANSPMTPATKADNTVDNVEQVVIDAPVPGRNYRVEITNKGNLVNNSGTS
APQNYSIMVTGYTQQVLATNETSALNNLTIVPTITKDVVNVLKAPKKATFNIYDLSGKKL
NSGTINSDRETLDLSSYTKGIYIIEIKTDKDIISKKIIKE
>KALACAFP_04098 2-oxoisovalerate dehydrogenase subunit beta
MENTLHEKVSQDILLKAYNHMMLAKAMADIYEENRNVTKYVHSTSRGHEAIQLATAYQLK
KEDWVSPYYRDESILLGIGFEPYQLMLQLLAKADDPFSGGRSYYSHPSSRDENKPKIIHQ
SSATGMQTIPTTGVAQGIKYIQDFNLQQFENNPVVVCSLGDNSVTEGEVSEALQFAALHQ
LPIIFLVQDNEWGISVTKEEARTCDAYDFVAGFTGLSRMRVDGTDFVESFEVMKKAVDFV
RNERKPLVVCAKTVLIGHHTSGVRREFYRDEEDLAKHRAKDPGEILRNQLLETGVDEELL
KQITKKARLEAEEAFEKAQNAPDPSPETVMQHIFAPTPITEEVGTREPEGGEKIVMVDAA
IHAIQELMWKHPEALLYGQDVGERIGGVFRETVTLGKKFGSKRVFNTAIQEAYIIGSTTG
MSAVGLKPIVEVQFADYIYPGINQLITEISKSNYLSNGKFPVSNIIRVPIGAYGGGGPYH
SGSVESILANIKGIKIAYPSNAADFKGLLKAAYYDPNPVIMLEHKGLYWSKVPGTEDAKT
IEPAEDYVLPFGKGKVIIEADKEETEKGRTVLVVTYGMGVYWAKEAAKSFNGRVEVIDLR
TLIPLDEELVFERVKAHGKCIVLTEEQLNNSFAEAFAHRISKNCFKYLDAPVETMGSLDT
PAVPINLVLEKEMLPNAEKLAAKIEEMLKN
>KALACAFP_04099 hypothetical protein
MITTKYVNYRQVLNLSGIHLIWISVWCTLIAVLFYFFNWQWMIIPWVPVALIGTAEAFLV
GFKNNQAYDRLWEARKIWGGIVNSSRSFASMVYAFNTENEEVGTFDLEDRRKKIVYRHIA
WLYAFREQLLIPTEWEHISAEEEHSHHHINQKRNRIIKAGFPDYGRTPIFLNKYLSEQEA
ELQSTYKNFATYLVSQQAKDINALKNLGAISDFHQMQLQNSLNEFYGFQGQAERIKKFPS
PRQFASTAFVFNVLFIMLLPLGLVNEFAKLGDWGIWTSIPFCIIIGWVYIIMELVGDYSE
NPFAGLMFDVPILSICRTIEIDLLQMTGETDLPDPISSKNGVLV
>KALACAFP_04100 Leucine-responsive regulatory protein
MALDEIDKKLLLFLQEDSKQTTKELSYKLGLSVTAVYERIRKLENMGVISKYVALLDRHK
VNRDFIVLCHIKLTQHKKEYVLQFEREVMNLQEVTECFHVSGDYDYILKIGVKDMEDYRN
FMLSKLTTLQHIASTHSSFMISEVKNTTAIVL
>KALACAFP_04101 L-methionine gamma-lyase
MKDFNAANEIQDLQYFGEFGGVNPSISDSSTYTFLSAKTMFDTFEGNADGCYLYSRHSSP
MNLYLSQALAKMENTEAANVTASGMGAITSVLLQVCKSGDHIISSRTIYGGTYAFLKNFL
PSFQIDTTFVDINNVESIENAIQKNTKIIYCESVSNPLLEVADLRKLSAICKKHNLKLIV
DNTFSPLSISPIVLGADIVIHSLTKFINGSSDTVGGVYCGTQEFINDTKNVNTGACMLLG
PTMDSLRSSSILKNLRTLHIRMKQHSHNAMYLAERFEKDGLKVSYPGLKSHKNHELMKSM
MHEEYGFGGLLTLDAGTTEKANELMELMQQENLGYLAVSLGFYKTLFSCSGSSTSSEIPE
EERATMGISDGLIRFSIGLDHDIERTYEKMKECMLKTGVLNHETISIF
>KALACAFP_04102 Putative glycosyltransferase EpsH
MKPTISIVVAIFNRKDELFELLNSLTQQTDKEFEIIIVDDGSMIDLKPTIQNFEQFLDIK
YFRKDNSGPGLSRNYGARRAQNEWLVFVDSDVIVEKDYIENIKKDILEIACDAFGGADKA
HKGFNLMQKAISYSMTSVFTTGGIRGSKKSVSKFQPRSFNMGVKKEVFEKVGGFSEMRIG
EDPDLSMTLWENGFKTAFFDNIAVYHKRRVDFGKFSKQVYQFGCARPILNQRHPNYVKIS
FAFPSLFLLGYIIGFLEYFILGRGIILAFYGLYTFMVLFHALFVTKNISIAGMAVISTYI
QMFSYGYGFLKSWILLNIFRMKPEDAFPKHFHRN
>KALACAFP_04103 Fatty acyl-CoA reductase
MKLNNLQQPINSGFNAQSTAQEVINGIDLSGKIAIITGGYAGIGLETTKVLAAAGATIIV
PARDLEKAKKNLQGIENAEIEKLDLIDPESIDSFAEKFISSGRKLDLLINNAGIMWVPLR
RDSRGIESQLATNYLGQFQLTAKLWEALKKADAARVINVSSYGHQMSPFDFEDPNFENRE
YHTLTGYGQSKTASNLFAAALDEKAKKFNVRAYSLHPGSVYGTDLGREEPIDLYIQMGTH
DKNGKIKPEVEAKLKTIPQGAATTIWCATSPLLENIGGVYCENCDIAEVDNGQIEHRYDE
PSTIRGVQPYSIDLDNAERLWKMSEEMIGYKFEVM
>KALACAFP_04104 Exoenzyme S synthesis regulatory protein ExsA
MDFHIKYITPDIKLSTYDDKLFKTETVFEFHMLVWFISGETKIIQADTSYLFKAGDIFLI
PRNHLATIINYPKDGLPHKAVVMHLTKERLKDFYTTLEIKEKNIREEAKIYSFEKHPLLE
SCLASLVPYFDIKDSFPEHIASLKIIEAISILREIDPGIDSVLADFEEPGKIDLVNFMEK
NYMFNMPLERYGYLTGRSLSTFNRDFRKIFQTTPQRWLTQKRLELAFYHLSEKNKKPSDV
FMEVGFEDLSHFSYAFKKQYGFAPSMVK
>KALACAFP_04105 hypothetical protein
MLFIFTKAQMSGNFSLPPDKYKAEVLDKSIQNIYYQLNFISNPKSDSKKDAVCVLQLGEK
FTKFFELNTMKYDSLVEKYSHEDKIGAKEMNLMFAFYSKWKPILLRDLNKNLITIQDKAK
DNYQYSEEQPIINWKLENESKNILGYTCQKATTEFRGRKFTAWYSKDLPINNGPYIFNGL
PGLIMELEDKKNQYHFIAIAMDKKPMQIYLRNEDEIFKVTRKKYREVQKAYHDNPAFFRG
PIYDSEGNEVKQQTKSKPYNPIELE
>KALACAFP_04106 hypothetical protein
MKKFILLSALSFAAFTSAKENVNNSFEIKNEVYKSSQEGKVFRLPYQWVECHSPCGAVYW
LQASNYESPADLLDAQQDLNDIKCGN
>KALACAFP_04107 hypothetical protein
MVKEKLIRARKEKKFSQQDIAEHLNISQTQYLRKEKGEIEIKDEEWERIAKLLDVEIEDI
KEEDNINHKFENITDITNSNIGSNNVYYNVPEYLLKTQQEYIELLKKEIENLKSRIAELE
K
>KALACAFP_04108 hypothetical protein
MKKLFTMCVLLCSVLAVKAQWNSNTDENMKVVDHSISITQSQRMSDGKTYVVYWQSDPAI
PTGYKLRMQILDQNGNRQLGPYGALITDQIMMNGSVELIKTTIDASNNLYVAVNGTGGNH
DSYIFKITPQGNSVWPNGISVGQGDQLSILHLSNDDILVAYKPTNETYLKIKRFNSNGQA
MWSSPVALMSDDPTKQTVASSLFELTNNEFEVVFHKIINSAGDTYLFAQKLDLNGTIMWS
TPKQISTKTTAMFTKYGGVADGNVVYYGITGSSGSGFADYLQRINADGTLPWGADGADFD
INQTNLEMDMKIAHTPGSPNIWAIANYSNSSQTAYGEYVQKFDKNTGARLFTDNAKQVFP
INASSMMHTGNLYLVNDKPYFVVQKNMPPSMFNISLHAVMLNDNGDFAWPQQYLPLATFA
ALKSYVSSLPPVNGQSVIVFNEQKNFDSDKFAYAQNLVLPTLGTSEVNGNHQNINIYPNP
VADVITVKGVKDQKFNIYNLAGQLVKRGEMKENKINVQDLSKGAYILKIGDQNEGYKLIK
K
>KALACAFP_04109 hypothetical protein
MSWDFLEIFDVVTDAVDLFVSGSSSSNTGYDEKSRIKKKSKYFVEKISAGFLLAASVLFF
FVFKDPIPAENYLQTLIVGSLIGLAVSLLFFFILYALEKYYFKSVFQWLFFSCSTILLAI
SVVFCVYFESGLFV
>KALACAFP_04110 Ribosomal RNA large subunit methyltransferase L
MDIENLQIQIKTFFGLEQILAEEIKKLGGRKVEVKNRAVNCEGDLGFLYKINYSARTALK
ILVPIHEFKAFNQHQFYDRLFKFNWEEFMDVDQSFAIDATVNSETFKHSQFVTLKMKDAI
VDYFQEKFKKRPNVETRTPDIKFHLHIDRELITISLDSSGDPLFKRGYRKEQGEAPINEV
LASGMLQLAGWDGKGNFLDPMCGSGTLLIEAAMIALDLPAQIFRKRFAFQNWKNYDAELF
TKIKEFRINRIKEFNGKIVGYDIDARMLNAARMNIEAAEMEDVIEVKKQNFFDSKKELFP
LLMVFNPPYDERISINDDDFYKKIGDTFKTSYPNTLAWLISSDLEAVKKIGLRPSRKIKL
FNGKLETRFLQYEMYEGTKKVHKLEEK
>KALACAFP_04111 dTDP-3-amino-3,4,6-trideoxy-alpha-D-glucopyranose
MEWFESWFDTPYYHLLYSNRDYTEAENFITKLTADLQLPPNSKIIDLACGKGRHSVFLNK
LGYDVLGLDLSRQSIEFDKQFENQTLLFDVHDMRNPIDADPMDAVFNLFTSFGYFDNKND
DKKVFQSVYDVLKPGGFFVLDYLNEEYVRKNIIPESIIKRGDIEFKICKKIEGRHIIKDI
QFEDNGKSFHFFEKVKLHTLEAINSYAADCGFEKIKIWGDYQLNEFNKETSVRCINLFKK
N
>KALACAFP_04112 hypothetical protein
MIAVVLLILSVIAGVFLGKHFGKKEKLAKNLLILSAGFLITICLNEVFPQVYTSEISGSL
GIFVIAGVLLQMILEALTKGFEHGHFHHHSEHNILPVALMVGLFVHAFIEGIPLANEEHE
FSPYLLGIVFHNLPISFILGAFLFNRKNESKAYPSYPSLLIVALFALASPMGMLLGNYFN
PDLQPYFLAIVGGIFLHISSVIIFESNKNHNIDWVKIGLVIVGVSLALIMHLFHEHPHVG
HHH
>KALACAFP_04113 TonB-dependent receptor SusC
MRKNAINLKKVGVIFFLMPGLIYSQNTKEKDTLKEQKIEDVVIVGYKTQKKSSLTAAVSV
ISDKKLKDTNTSDVSSMLQGKAAGAQIMQSGAPGSTATVKIRGTSTINGPTDALWVVDGV
MMNGTPNLDPNQIESINILKDATSTALYGSRGANGIVQVFTKSGTSSGKGTLNVSMNTSF
NTFTNGKFKLMDGEQFYDYFNSLQNVPATAPRGVRAPGYNWLKNGTQTGVAKNYTVDFRG
GSQNSKTYISGNYYDETGTIKGFDYNRLSFRINHEQTVKPWLILKPKVSLSYTTGKDVRA
SLFEMYLNLPWDNPRDANGNYVNPNTSVWYGRDHRNYLYDQQWNYGKNNQLDLVGNMDAE
IKITDYLKFITTNNVTYRNFDSMYYIDPRSISGESNKGELSETYLKDISKFFNQMLRFDK
DFGVHNVNALAAYEYSDRFYKTSTAGVFGVVPGTDIFDTGASSGHKPSGTKFDRAYNALL
FNAEYVYDKKYFVQGSLRSESSSAFGANHRSGLFYSYSAGWNVHKEKFFHVKQINEWKLR
ASSGLVGNTPAPNYGWQDLYALTQKYNGQIGATWSQLGNPDLTWESIVQNNIGTDIRAFD
NRLTINIDYFNNKTKNLLALVTLPALTGVDRQYLNIGDVKNKGWEFNVNYAFIKTKDVTW
DLGFNVSTYQNEVLSTRNNAIQYLNSNGAAIPGYDVTSFYMRKWMGVNPDNGAGLWEVVN
ADGSKSLTSDYNKASLQVVGNATPDYYGSFSTNLTIKNFYMNANVYFSQGGQIYNFYRSF
FDSDGAYPYYNQMVLQNGWNRWEKPGDIATHPVALYDNNNLTNNTSSRYLEDASFVKLRS
IRFGYNFPKSLIEKLNVNTASIFIMGENLFTITKFSGVDPEVGPPDSGTTYSGTAGGIYP
IPRRFSLGFNFSF
>KALACAFP_04114 hypothetical protein
MKKILISLIALSFVSCNTDLSPYDSKESDVILADATGLQTITIGNYALLKGDANAGGFFN
NLYRFNEYSGDNVNISGVTSDNFFYYYNYRNIKNNVRTNITWNSGYKAIVGCNRAIAKFA
EGTDATTDQLLGENYFLRAYVYFSLVNMFGRPYSQGTQNLGVPLKISDDINDIPPRATVG
AVYDQIVSDLKKAELLMNIDKSNVYASKLAAEALLSRVYLYMENNDKAIEYADKVINSGK
YMLLSKTDLPSYSTKVPESNTETIFAFKYNKDGDYADGWSTVGSMYANIQGVGWGEMYAS
STYLDLINQHPEDARLKFIVPKYTTSQVPVVYWVQQETNSAGGANYNYKFQPTFIQGGNT
YFTMNGVNYQVFTEVTPFKTNYYFNNSTGGKTYVYSDFDMDKRNGYPKFFVYKCSQQEGI
AQLWSPVIVRLAEMYLNRAEAYAKKGNTTSALADVNVIRTRAGIPTYSSVPAGQTLLNVV
LDERRLELAFEGQRKFDIFRNKLDMNRQYPGSHLNGSNPFYTVPYTSNRIVEYIPEQQIQ
IQPNLIQNPD
>KALACAFP_04115 hypothetical protein
MLKKSLVAMSISAAFFAQAQDVSVIRNTVDVYSGSPSVGSAKFNAMAGSNGALGGDANSL
LTNPAGLGVAISGEVSGTLSIMSNKNTSSYAGASYGYNINKADLGNVGAVMTFQLMTESA
WKFINIGVNYSNQSIENYIETPGNSNLIYDFDATNSASFGRHAYDRYGYLSKTSVGVGAN
YNNNLYIGAGLNFLNSSIDQSDTAIFNSLSTGGSEYFSKQNTPFYERGNGFSASLGVIGK
LSPNFRLGAALETPMFWNIDRSYNFYNDPIYGDDIAVENRKFTSPLKATVSAAFIASKSF
ALNVDYSLGLTKPKYKEYGDAEAELNDFFKEDYKNLSELKIGAEYRIKQFRLRGGYAYTS
SPFDALTVSRYTDSGDVTDQSYNNLILNDRNALSFGVGYDFKSFYIDASYQNISSKYSNP
FLRGVVDPSNNIESGYYSPNYLISSDAFAVSDVKNVRNNFFLTFGWKF
>KALACAFP_04116 hypothetical protein
MKKNIHKNLLGMLKSKGILAISGGLLLVSCGAQVGGYSETDGVYYDPNKDTLPEGVVISD
RGNRVGEDYDYYQDDSNVIQNAEANSREGRYDEWNNYNWNTTATDSDWGSYAGSETNYYD
NSWGWGYPWGWYGGYSPYWGWNRGWGLGLSWGWGGSWGWGGWNMGWGYSPYWGYYDPFWG
GYYGGYGYPYWGYGGYWGGNYYRPNYRRSGADGRGFNSYNGSFANKYGGNSGFRRSNSNS
GGFRSGNTNTGGFRGSNNNGVRPQGGFRGSNNNGVRPQGGFRNPGTQVRPNYNQQSQSRR
NDGGFRNDGGYRNDGGFRNNGGFNNSNSGGGFRSGGGGFGGGSGGGGGFRSGGGGGGGFR
GGR
>KALACAFP_04117 Proline--tRNA ligase
MAKLTSRSEDYSKWYNELVVKADLAENSGVRGCMVIKPYGYAIWEKMRDEMDRKFKETGH
VNAYFPLFVPKSLFEAEEKNAEGFAKECAVVTHYRLKTDPNNPSKLIVDPDAKLEEELIV
RPTSEAIIWNTYKNWIQSYRDLPILINQWANVVRWEMRTRLFLRTAEFLWQEGHTAHATK
EEAIEEAEKMNNVYADFAENFMAMPVIKGLKTPSERFAGADETYCIEALMQDGKALQAGT
SHFLGQNFAKAFDVKFTNKEGKIEHAWATSWGTSTRLMGALIMTHSDDFGLVLPPTLAPI
QVVIVPIFKGEEQLEQISEVALEIQAKLRAKGISVKFDNDTQNKPGWKFAEYELKGVPVR
IAMGPRDLENRSVEIARRDNLTKEVRSIDGLDSYIEELLKTIQKDIYDKAFEFRNGNITK
VDTYEEFKKVLEEKGGFIYAHWDGTAEEEEQIKDETKATIRCIPLDDDVEEGVSLISGKP
SKRRVLFAKAY
>KALACAFP_04118 Peptidoglycan-binding protein ArfA
MSLNVIDLIKGQLGPALTTQAASQFGESESGISKAIGGLLPAIIGGLANKSDNPGVLDAI
TNASSSGILGNLMGESSNNSIISSLLSSIFGDKLGGLVNTIATYAGISNNSSSSLLNLVT
GATVGSIGKYAADNNLDRSGISSLLNDQKGIVSTLLPAGLSLASLNIGDWAKGYKFDNDN
DTIKTPTSEEPKIEVTRSTTPTGTFPERNNNEGGGSIWKWLLPLLLLIAAGYFLWKQCDK
KTTTTTTTGTDSTGTVQDTATAVSSSDTAAATASTGKVDENIDLNGTALKGYKGGMEDQM
ITFLKSDGYKNAANDEALKDMWYDFDHVNFKSGSGNQLEAGSEGQLQNLVAILKAYPDAK
VKIGGYTDKTGNEAVNLKISTERANYIKDWLAKQGVGGQVLGAEGYGSKFAKVDASASDA
ERASDRKMSVRFAK
>KALACAFP_04119 Divalent metal cation transporter MntH
MNLKLKSAWRKDKTSHSLSEVYSSIKVPQKGSFWRKYLAFAGPGLMVAVGYMDPGNWATD
IAGGAQFGYTLLSVILISNIFAMVLQHLSVKLGVVAERDLAQACRDHFNPTTNFILWVFC
EIAIAACDLAEVIGSAIALNLLFHIPLTWGIVITTVDVLVILLLQSKGFRWIESIVGGLI
FIILACFIYEIIISQPAFKEILGGLAPKAEIIQNPAMLYIAIGILGATVMPHNLYLHSSI
VQTRDYPRNREGKKEAIKFATLDSTVSLMLAFFINAAILILAAATFHTTGNKHVADIHDA
YKMLTPILGASMASIAFAIALLASGQNSTLTGTLAGQIVMEGFLNIKLKPWLRRLITRLI
AVIPALIVTIIYGEQGTTDLLVLSQVILSMQLSFAVVPLVMFTSDKAKMGEFVNKPFLKI
CVWIISFVIIILNLYLLYQTFFGE
>KALACAFP_04120 Protein GrpE
MENQDINEESINNQEETNIQDEATSGDNVTATPSAEELLAEEKDRYIRLYAEFENYKKRT
AKEKMEFFQYANQDMMISMLGVLDDFERALKEIAKNGNTADLQGVELIYQKFKNRLTEKG
LKTMEVKAGDSFNVDFHEAITQIPAPSEDLKGKIVDVIETGYTLGDKVIRFAKVVTGN
>KALACAFP_04121 Chaperone protein DnaJ
MSKRDYYEVLEISKSASVDEIKKAYRKMAIKYHPDKNPGDKEAEEKFKEAAEAYEVLSDE
QKRARYDQFGHAGVGGNGGFGGGGFGGGMNMEDIFSQFGDIFGGGFGGFGGGGGRQQVKG
SNLRIRIRLNLEEMVNGTQKTIKVKKMKMAEGATSKTCPTCGGSGVQMKVMNTMFGQMQT
QTTCGTCQGIGKVADKIPAGANAQGLVKDEEEVTINIPAGARDGIQLNVRGKGNDAPFGG
IPGDLLVIIEEEIDKVIKREGDNLHQELYISFAEAALGTKKEVPTVGGKVKITVDPGTQS
GKILRLAGKGLPSIDSYGKGDMFIHINVWTPQKLTKEQKDFFEKQMSSGEMVAEPSGKEK
TFFEKVKDLFN
>KALACAFP_04122 hypothetical protein
MRSLSIDILKIILAFFVMFLHMHLLRNVYPSLSYVLVNGLFRTAVPVFLIITGYYFYYVD
DIQKLKKWLIRIFILYAIWTVIYISLWKEKDSYIANIIFGFHHLWYLIGTFFSGIVLFAF
RKISVKILFSLILFFFCCGYAIQFLGNAHYFEGKIDSVMNFFPTYRNFLFVCFPFLGIGF
LIKKLQIDIRKKPSLVFVLAAMGLVIFEAFLNYKVFKLNQSESIDLLFSLLIACPAMFLY
CKNIPVKTDSKILASISTAIYLIHPLLMNLIYTSQMRFRNLIFLGALTSVSLLLVFINRK
VKYLL
>KALACAFP_04123 Inner membrane protein YedI
MASGFFAILDDIAALMDDVAVTSKLATQKTAGILGDDLAVNAEKATGFLSSREIPVLWAI
TKGSFINKLIILPIAFLLNWLYKPAIEVILILGGLYLAFEGVEKIIEFLFHRPKKGYEVV
EEITVEEDSEESEKSKIKSAITTDFILSIEIVIIALGTVIQENHPLLTQILTVTFVSFIA
TVGVYGIVALIVRMDDAGFKLIKKSNDKGFFGKLGHFLVKALPIIIKLLGVVGTIALVLV
SGGIFAHNIHYLHELFPTWPSILKEFTLGLVGGLAAVALFTIGKKIYSLRPRK
>KALACAFP_04124 hypothetical protein
MKKLILKYHFFVLGLIGFILNSCNTKFRVWVGTNDEQKIYNLKYGEHKKQKMDVFLPSHY
PENSPVVLIVHGGAWKYGRKEHMIQIQKMLFKNNIPSINMNYRPVSASKKITYREQLEDI
HAVIEKFNSLAQKAELQPNNYILLGESAGGHLALLYGYQNPDQIKKIISLSGPTDFYSPE
YLHSFYSKYSSPTVQKMVGEKFQRKNLSEAFKKASPIANISNVPTLLFQGNQDFLVNQKQ
GLALDSSLTANNVPHKLVFMKNSGHAPRFFSKMKRDSIIYPNILEWIKNE
>KALACAFP_04125 putative membrane protein
MEDYNSWKDLLNPEFYIKLGGFWLILFIIFAETGLFVGFFLPGDSLLFVSGIYAVDIIKE
TFGSTGSDFLDTFILASSVALAAIIGNEVGYYFGRKTGSALYKKQDTMLFKKKYLYQAHD
FFEKNGALAIIMARFLPVVRTFTPIVAGIVKMDKKDFLRDNVIGAVLWSFILIFSGHYLD
KLFIEQFGIDLKKKLELIIIVIVLVTTLPVIFKFLFGKKQDFSKYENHNFDEDEEK
>KALACAFP_04126 Peptide chain release factor 2
MINNDQIKEIQSRIDDLHKYLQIEKKKIEIANDDEKTAAPEFWDNPKEAETFLKQLRSKK
KWVEDYEEINTQFEDLQVLADFAKEDPDSEKELDETFPQLVEKIEDLEFKNMLSNEGDEL
SAVLQITAGAGGTESCDWASMLMRMYTMWAEKQGYKIRELNFQEGDVAGVKTVTLEIDGE
FAFGYLRGENGVHRLVRISPFDSNAKRHTSFVSVYVYPLVDDTIEININPADISFETMRS
SGAGGQNVNKVETAVRLRHAPTGIIIENSESRSQLQNKEKAMQLLRSRLYEMELEERMKA
RNEIEANKMKIEWGSQIRNYVMHPYKLVKDVRSGYETSDVDSVMNGNITPFLKAFLMADG
TAVSDDDMDL
>KALACAFP_04127 hypothetical protein
MDINEINVLLNKRNGNFAQLKKIIVSMNLIPALSKDQFDLLAEKILKQLENNSDYDKVKQ
IVENELTVTYGLCRQEFDSGKITDAFFDWWAKN
>KALACAFP_04128 hypothetical protein
MKNKKYTNLFAILTIPILVFVIFFAGGGHGSYLPMMTIFPFFTFGIVVPEKISSLFFTIG
LLQFAIYGFFMDKFGAKTVLPYIILIHCLLVTITFLLKAHF
>KALACAFP_04129 Gamma-glutamylputrescine oxidoreductase
MNSSVWELETFYRNRDIIIIGAGFTGLWSAISIKEKYPEKSVLVIERNAISLGASTRNAG
FACFGSLTEVIADSEKMGWEKTLELVKIRFEGLQKIQSYFKNNEIDFELNGGFEILNNDE
PLQRIDEVNEKLKSITGIEKTYFLNQNKIKEFGLGKSQFLIENPCEGSLHSGKLMQKLLE
KCYELKIEFLFGTEVENIVENFSEVEVQLSENLSIKSNQIIHCTNAFASKFLNKEEIIPA
RGQIILTEPIENLKLKGTFHYDEGFYYFRNLGNRILLGGGRNQDFKTEETTNFETTEFLQ
NHLENFLKEVILPGQNVGISLRWSGIMAMGSEKTPIVKQVSGRQFCAVRLSGMGVALAPK
IGEIVAEMI
>KALACAFP_04130 ATP-dependent zinc metalloprotease FtsH
MKLIELAKELNVSVEAIKQFIQDFDLELGVCISTNFEVKKDFEKFARENIEFLRSYEKDL
EKTKTLEQIAETINQPKEKVEKAIKESNPNIFDNGFFKSSISSYGIDNKLGGNYQFVYDY
FGHKTSLQHRDFIGYRDLFFYISNILEPFLNPQQIKDWGINKPAGIILYGPPGSGKIFWA
NKIAEIIGYKFKEVKKHYLGTSFVDGNKTDFNDFLSTIMKEDKVLMFLEDFDEIMMARKA
EKDIASCNLETQEVILHYIGKFEQEKLLMVGSANTVSEIDEEILAPGRFDVMIPVFPPNL
AERSEIILYAMTKDLDEDSLLFKILKHNKADKIPFWHGVSSQMKTFSNTMLIDFTQSLKK
RIKNLYQRTRNENLKIDQTILNAALRDSAGKLTEEYLDQIARFLEDVIINNFDQFQYRIQ
SLKTELDAYKVVEEPRRAIGFHHNGEEDSQG
>KALACAFP_04131 putative ABC transporter ATP-binding protein YxlF
MIILVTIYHLHRLLLCKTNYMEKILSVKNLTKKFKRVVVNNISFDVEKGNVYGLLGPNGS
GKSTTFGMLLSTINPTHGEWYWFGKRGTDPDTLKKIGAIIEQPNFYPYLSAETNLKIVAE
IKGTPQQRIDEVLQTVGLLERKKDPFRTYSLGMKQRLAIASAMLNNPEVLILDEPTNGLD
PEGIIQIRDIINSIAKQGITIIIASHLLDEIEKICSHVIVLKEGNSIYCGRVDEMTANNG
YFELKADNNTQLLNALNELQWFTSVHQDGEILKAQIRDDASISASALNQKLVEKGIFLSH
LTKKKLSLESQFLELVKNTN
>KALACAFP_04132 hypothetical protein
MIKLLKLEYYKNLNYKPFKIFTALYFAILIALLFIGLVDLNLFGNPINLKEQGIYNFPEI
WNFTTWIVALLKIFLGLIIVFSISQEFSNRMFKQNTIDGLSRKEFISSKLLTITIFTIIS
TVVVFAITMFLGYQYSTTTESEMVFKEIFFIGNYFVKLFTFFCFLMFLSILLRKSVFVFL
AFFVLWIGEGVLTVIEKFTKVQGLQGPQREHVLQNDFFLTHLLPLESMSNLIPNPMMRLN
LAKMMGLKYEFHYPTESMIACLVWCVIFILGSYWILRKRDW
>KALACAFP_04133 hypothetical protein
MIHFESLFLFFGLKFSFSFDKIIAMKKIFYVPGLISALLLPILFWYYGNQRVHPQYTVMD
LGLPAKHQYNDNFDNTFEPYRNWNYKKIIVKPNTALKNQPYYVSELKKLQARNEKETGIE
FVIGDKNNYQDFIALIDAMKLAKQEAYGVDVGKTDHFFAVHFYKDPNETKREHNSICGGV
VGGEYYEEKPVLNLVRPETLIDHVPKQTYYIIFGFLLFLNISMFSIKENLQLKRTLV
>KALACAFP_04134 hypothetical protein
MKKIYYFPGLISALLVPVLFWYYINPHVDKTVYNVIDFALPIKLAKDKSNFDSTLEPLRK
WSLKKIKVDSGKAKENSKLYVSEIQQLQQNNEKNTAIEFILNEQNTYGDFVSLLNDMAIA
KHESYALDMDKTGNFLVPVIHKSQKIEEEEFECLLCDDVIRDYEDPSITDAILDFIKRQF
YSIFFEDISKLPKGAYYIIFGFLLFLNISMLSIKERFQLQRVLFK
>KALACAFP_04135 Peptide methionine sulfoxide reductase MsrA/MsrB
MKSILILLGVVLGIAVFATSCGDSLKKKSTGIKKENETNMDTKNVKEIYFAGGCFWGTEH
FFQQVRGVVGTEVGYANGNTENPTYEQVVSHTTGFAETVKVKYDPEQVDLKLLIDLYFKT
IDPTSIDKQGNDRGNQYRTGIYSTDKETEAIVKAEVEKLAKNYSKPVVVETIPLKNFYRA
EDYHQDYLDKNPGGYCHIEPGLFEMARNANPLPKKESKDVKYQKQDKEVLKKKLTAEQYN
VTQENGTERPFQNEYWDETREGIYVDITTGEPLFVSTDKFESGCGWPSFSKPITKKLIDE
KLDRTHGMTRVEVRSKTGDAHLGHVFNDGPADKGGLRYCINSASLKFIPKAEMKEKGYGE
YISLLEKDKK
>KALACAFP_04136 Inner membrane protein RclC
MNGTTPMINQRSPTYRLGYYISLFGAALILLWIGIFKFTPTEASAIKPLIENHFLTFFVY
NFVSVQAVSNAIGVIEIIIALLLLFSVKFASLRKYAGIGMIFTFLITLSYLFTTPNIWKV
VDGIPVTDFFIVKDVLFLGFGLMILNGKNE
>KALACAFP_04137 hypothetical protein
MLKKLIHIIFLPCSEATLLMEKRNADDISPKENWKLNLHLKICKWCRAYKEKLEILDDIL
KRKLSQEKEIKINDSEIQGFKEKVFKNLDI
>KALACAFP_04138 ECF RNA polymerase sigma factor SigX
MTKNETLKNWIDQYSGALLRRAVYLLSDKVEAEDVVQEVFISAFSSYDSFEGKSQPLTWL
MTILNRKVADFYRKKYKAEPQIKLDHFFDENGSWKNDDVLNDWDASNKETELLDDKDFNK
TLEDCIEDLPSRWKIPMKMYYLEEKKAPEVSQELNISTTNLWKILQRSRMQLRECLEFNW
FAKS
>KALACAFP_04139 hypothetical protein
MKIPLLWRGAKIQRTFDGVVFNSILLLALIEVKIPQWSGGTKWSRVMRNCNGKQEIAPKK
EKKLESRIMEVYLIQNNRFLLRRKDNVEA
>KALACAFP_04140 Alanine--tRNA ligase
MTSQEIRQKFLDYFKSKDHLIVPSAPIVLKDDPTLMFSNSGMTQFKDFFLGYKTPTAPRI
ADTQKCLRVSGKHNDLDDVGRDTYHHTMFEMLGNWSFGDYFKKDAIAFAWELLTEVYGIP
KENLYVTIFEGDASENLERDQDAYDYWKAVISEDRIINGNKKDNFWEMGASGPCGPCSEI
HVDLRTPEEKAKVSGLELVNNDHPQVVEIWNLVFMQYNRKADGSLENLPAKHIDTGMGFE
RLCMALQGKSSNYDTDVFTPLIAKVEELSGKKYTGILEDEKDIAIRVVVDHIRAVSFAIA
DGQLPSNGGAGYVIRRILRRGISYSYRFLGMKEPFLYKLVAVLQEQMGKFFPELEKQGTL
VTEVIKSEEESFLRTIETGLIRVEKLIQQTIANNAKVLPTEEVFELYDTYGFPDDLTRII
AEEKGLTIDEKGFEQALNEQKQRSKADSAQKVYDWVTLEEREENFVGYDQIEAETYITRY
RKVENKDGEFYQVVLSNSPFYPEGGGQVGDKGVLENATESFEVLETKKENGLIISLINGL
PKDAGAVFYAKVNATDRKNSQANHSVTHLLHEALRDVLGTHVEQKGSYVGPDYLRFDFSH
FNKMTEEELALVEEKVNAKIKESIALQEFRNIPIKEALDRGAMALFGEKYGDSVRMIQFG
SSKELCGGTHVKNTIEIGHFKIVSESSAAAGIRRIEAISGDKSEEYFKNLEKQIAELSQL
LKSKDVVRSIEKLIEENASLKSEVDALKKEKAKGEIGDWKNAYEQKGDKQLLVKKTSLDA
GSVKDIVFQLKREIPTSVTVILSDADGKPMITVGVSDDLAANYQAGAIVKDLAKEIQGGG
GGNPGFATAGGKNIDGLENAYQKALNL
>KALACAFP_04141 hypothetical protein
MEKNYLTGLFGLILLFFSLNMNAQSLKSMDQQKAVLELQTQLKTKQISLEKEKLKNAQIL
QRTNNLNNKSNDTDVTLNSATPNSSVDQAKDAVRALKRTESANRDLDKSNKKIQSLENDI
QRIQAKLQKMNYTVDITTNN
>KALACAFP_04142 hypothetical protein
MKRVLLFIFCWIYAFGFSQSKITSIETVVIQDKSDPRALEILKKVNQLFQENSPKSLDSY
SYKSYEKVSLDIDEDSISHFNQIFESNDFFKKKRKKDSLNNISARKIFSKSKLFLWERAQ
EFLYSKQLGEKINILDNRISGLKQPIYEMIALQQSNRDKLPAQLKQENRGLYRFFLTDTI
EMDGRKNFVIRFREVNYKKLDKKRKYNGAIYIDTETYGIKKIENFSKNKNDGIITSTWIF
FNNKWFLAHETVKLKMSNMAMEEENKEHPEEKHEKKDKRSFGTYAFLTSKYFDFKSPIQI
DKNDFKGYTFSVKNTDGKTLNQYRTDPLTDRERNTYTTIDSLGKIYNIDTKARVLTGLLN
GQIRVGVVDFAVDEIANYNSYEGFRVGLKAKINETFNPYFSPDYYFAYGFKDDKLKYGIG
VDMKTTLDKNSFFRVEYNDDVTASGEFYRRLWNFKMRMANYGNNLNNDRYYHYKSASLSY
LNDVTNGLTLVFAARRNFEEAMFDYSFRNRGAGFDNFSTLFTLKFSPNSTNIMTPQGKSL
IDQKYPELYFNYEQSYKILGGDFNYTRFDALFVHNFKTMLGTTGFRLYGGMVFGNAPIWK
NFTMNGLASPRRDFNFNLTSFLGFATLEGGKYYNDKFIAYYFTHKIPWYFKSVGQNISSF
DFVLRGTIGNMDHPEYHQFKFRPLNHLYQEVGLEWNNFLSTYFNLGLFYRVGYYTTTNFK
QNFAVQFKLKLLEF
>KALACAFP_04143 hypothetical protein
MQKIQIKAEQFFDLLKLKDTSMWEIFAQMVDSNEKEIIFLDNEDKILFNYILPSNLEKLE
EDRKEFSKQFSEKLTNFN
>KALACAFP_04144 Aminopeptidase YwaD
MKKNYILSILSLLIFGWGSAQNYKKPLVSAIKEADLRKDMYELAADQFLGREAGTLDELK
VSMWLADKAKEAGMQPAGDNGTFFQFFDMYRHQVIPQSTLKIGNNQLKLWKDFLVAEPVN
ANIDGEIVYAGNAEPEDLSSLNIKGKILAVNASNKNIDQQMTLFVRRYPGFVRTKYYNKA
YELGAKGIIFITDDISEKSWVEILPQMTRGAYGVEGLREKVTNNIPVLWIKRENANWVKN
NPKISLNLITETYKYPSVNIIGKIEGTDPVLKNEYVLISGHQDHDGIRHPVKNDTIYNGA
DDNASTCVAMLAMARAYKKQPGKRSILFVFHGAEERGLLGSRWHAAHPVVPKEKIVAVLN
GDMIGRNDNNEAALLGGNAPHKNSEELVKMAEEANNESTKFKYLKDWDSPSHAEYFYFRS
DHLPYAKAGIPAIFFTSVLHNQYHTPQDESENINYKKLYKMTEWMYRTSWKVANENERPK
VISNFTLER
>KALACAFP_04145 Dihydropteroate synthase
MSKLSHSQTLKPSNVPTSQPFHSINCNGRLVDLSVPKIMGILNLTPDSFSDGGKFNNEKS
ALQHTEKMLKDGAEIIDLGPQSTRPKAEFLESSEEIRRIGNIISLMKKEFPEALISLDTF
YSETVEFGFNEGIDIINDISGGHYDDKMFDTVAATKLPYVLMHVNPSYETMHDKIKFADI
TLSENQYFSEKTMELLEKGVNDIILDPGFGFGKTVEDQMKMIDEVKYLDFGKFPLLIGIS
RKSFIYKPLGKSSLDINEETQKLHLKVLQQGAKILRVHDVVEAKKTVDAFLNK
>KALACAFP_04146 hypothetical protein
MSKTSVQFEKIIGQCRELFSKKLQDYGAAWRVLRPSSITDQIYIKVNRIRTLQMTDKKMV
DESEEDEFIAIVNYSIIGLIQLEKGFSNDFNENKEEILNLYDKYSTEAKNLMERKNHDYG
EAWRDMRISSITDLIYQKVLRTKQIEDNQGVTIVSEGLDANYFDMLNYAVFCLIKFSEKE
NNVESKTI
>KALACAFP_04147 hypothetical protein
MIKGLLRLVIAVIFILSGFVKAVDLVGFSFKMEEYFAPNVFDMPFLEKFALPLSIFVVVL
ELLLGFMLLLKLKLKFTLSALIALCIFFGFLTFYSAYYNVVTDCGCFGDAIKFTPWQSFI
KDIVLLVGLIIVFILYRKEFKKKDDYTFTSKKDPSGTFKYILLGIFSLVMIYIMSQGIMH
EPLIDFRDYKIGTDIKGEKEKINKNPSEYKTFYSLKNEKTGEVKKVNQDDYIKKTEYWAE
GSPWKIEEGKNESVLIKEGYKSEIVKFKIEDPTGMEVTDEIIHAPKAILVFSYHPKDISP
ELLKQVEAKVKTQGANIVYGVSTEPNTFKTIKNMMMDGTAIKTIARSNPFVLILQNGKIV
DKQPAKDYVK
>KALACAFP_04148 hypothetical protein
MQKSNKSIAGYHLLMILSSVDGEFAPEEGILIQQYLSEEFPFRVNLDNELETIALLKPEE
WKDHFEFHGRCFLDDSTQDEREKFVQFAKTLIKADNKVTDEEHTFYTLLKNLWNIK
>KALACAFP_04149 Chromosome partition protein Smc
MITKIKINGFKSFHNFEMTFTPFTIIAGTNASGKSNLFDALELLSKLADSDNIKKALQSQ
RGDFLELFSMYDRGIYTDKMEFEVEMLVNSKVRDAWGNEAVLKYTRLQYQLKLRRFVNQS
GLEDVELFHEKLINLKHQDDKWIELISKKNREIWRPKVPAGKRGVPYIDSDIVEGMNTVI
VPQDSKGGNKRRFPLNNANRTVLSSFDSIDFPHVLAAKEEMKSWKFLQLNPDDLREPTNK
NNGEDEITISGKNLAAALYRISLKNDFALKEISRKLNKFLPQFVEVKIIDDKENRQFIIK
LTDVDKKEYTSRVLSEGTLRILTLCILEYDDNFGSLLCFEEPENGIHPARISTMLDLLAD
LSTDFSDNELPLKQVIVNTHSSVLIGEFWKNFKEDNNKSLWFSKMVTKVDVYKNEKIKFE
TTKLSPVDKNFIADLFPDKKVSILNVKDYLDNGNFSLDNE
>KALACAFP_04150 hypothetical protein
MSNKQLFIGLISEGSTDTRFLFSVVDRTIKQLVYDFGSNVEIYIEELKKDSGKKFIKQII
DANLAYQKENFINILLVHCDADNKDDSKVLKEKYIPLIENIKSNKDIICKEIIPVIPIYM
IESWMLADIDLFLDEISTHKTKSELGINGNPESFTNPKNKIKEALQIINQEKPKKRRKDL
QISDLYQIIGQKIEIEKLIELNSFKNFYNQISDSLAKLKFIYK
>KALACAFP_04151 Triosephosphate isomerase
MRRKIVAGNWKMNKNVIDAQQLMVQLLSYKNNNTTNCEVWIAPPSLYLMMAKDIFEKDEI
GVFSQDMSEHESGAYTGEISADMLESIDATGSLIGHSERRQYHGETDSHCNRKVKLALDK
GLIPVYCNGETLEQRKAGQHFEVVKNQTEVALFTLSAEEIKKVVIAYEPVWAIGTGETAT
PEQAQEIHAHIRNIIASKYGKEVADEVSILYGGSVKPDNAKEIFSQPDIDGGLIGGAALK
LEDFSKIIEAFN
>KALACAFP_04152 hypothetical protein
MKKFLLPLFALTVLACNDDDNVNNQDINYSKLPQEFPFSTLTTLNGINVINGGFGSGATA
HPTQKGEFYAITDRGPNVAYSNGIKILVPNFTPTIMHFKINADGNIEVIKYIKLKNPSGQ
PITGLPNPVGMGSTGEIAYAADGSVLGTDNYGLDSESIVAAADGTFWVSDEYGPHIVHYS
ADGIELERISPYGVNTGTRKLPAVFAKRRPNRGMEGMCMTPDGKMLVGTMQSTMYVPTKA
LATNTTLTRIVTFDLVSGQTKQYLYKQDGGASDSVCDITPISNTEFLVIERDGKFGSEGG
LKKVYRINLSGASDVSGSDFTAVDGMKINNKTLEQSTWDEINAAGLKPVTKTLAVDLVSK
IGYEHDKFEGIVYLGNNKLAVFNDDDFGVADDGNGNPKTKILPKTGKQDKGTMYIVDIQ
>KALACAFP_04153 ATP-dependent Clp protease proteolytic subunit
MDIKKEFRDFSVKHLGNNGLVTDQYMGMYGPTNLTPYIMEERRLNVAQMDVFSRLMMDRI
IFLGTGIDDQVANIVTAQLLFLESADPSKDIQIYINSPGGSVYAGLGIYDTMQIIKPDVA
TICTGMAASMGAVLLVAGEKGKRSALKHSRVMIHQPSGGAQGVASDMEINLREMLKLKQE
LYEIIAHHSGQAYDWVEKSSDRDYWMTSEEAKGYGMVDEVLQRSAEKK
>KALACAFP_04154 DNA primase
MISKQTIDKIFSTIRVEEIVGEYVQLKRAGSNYKGLSPFHDEKTPSFVVSASKQIWKDFS
TGKGGTAISFLMEIENFTYPEALRHAAKKYGIEIEEDQKDFSEEAKQAHTERDLLYKIHE
VANNYFQEILWDSEEGKSIGLAYFKERELKDDIIRKFQLGYSPEKKNAFTEYALEKGYAK
EILEKSGLSIFPENTPAGVDRFRERVIFPIHSFSGRVLGFGARILKNNVKTAKYLNSPET
EIYHKSNVLYGLNQSKQAISRKNVCLLVEGYMDVISLHMSGIENVVASSGTSLTTEQIKL
IKRLTENVTILFDGDNAGIKASFRSIDMLLTEGMNIRVLLFPDGDDPDSFARKHPQEYVE
KFIENEAMDFIDFKAEILLKEVGNDPIKKAEAIRDIVKSVSFVQNALKREVYLKQVSNKF
GLSEQSLFNELDVQKQITQNQTQKAQARTEAQPAKLEIVHESKEEVDPIIFNVTKLENDL
INHMLNYGDVVLQRTTPDEKKYDITVIEEILHHFEEDDYEFQVELNKKIVEYIKEGIEKE
ELRKGNFFFGLMDEELSKAAVNSMNIYSELNNWETRNIFSPNYGDRIPEQVAGDILIHKF
RYVNFLILKSKRELAECADSDEEKYFDLLKKIQMLTVVSIELTKILNYSAITGIYTDR
>KALACAFP_04155 hypothetical protein
MKKITFQFRKWAFLLIFSFIDCSIFAQERAQEYQLGTNTDFLNQLQSQLNTNGKNDLLTL
QVSDKEALRSIVNYYERSPDGTLHLEGELTGSATGTFSIRIKENKLEGNIMLPKNKEAFI
YKSDTKGNAFIKKIDINKIICVDFHVPAQKLTENKVVRTQKNSVLGNVSSLQSNPGAGGC
LLLDFNGYIVPAGSGWNGGNSFVAAPSGMSDADILEAWELVSEDFRPFNLNVTTDEDVFN
SYAQNKRRRCVITPTSTASSGGAGVALINSFSSTSDLPCWVFTQSAGTYGKIVGEVASHE
LGHTLGLHHDGQAQYTYYGGHGNWAPIMGVSYYKNVTQWSKAEYSNGNNHEDDLSIISSA
TNGVGYRIDNQGDNFTNATTLNTLGEDVLATQNQGVIDHTNDIDVFKFHTYGGDVNLKVQ
ASEIHSNLLLKIALYNSQNVLITSATGHPDNLGDPVVINTNLTTGDYYLAVTGIGEGTPD
TGYTSYASLGYYNISGTLPKIGTLAVDELENATIYPKMVKDEFTIDTKMNGEYEVQVLNS
LGQLLYKKLFSDQIHQIAFADKPVGIYFVILKNKKTGFQKSHSIIKN
>KALACAFP_04156 hypothetical protein
MKKQLIFATWASLLICISVFSNFYAQEKQSYFLGSTAQFEQQLTSSVSEREARALSLAIS
EHETLNATVNYNKINNGSMHLEGEIQGDHPGSFSIVIKENKLNGNILLFKDKKAYTYYSD
NGKAFVKETDINNLVCTDFSKSPSSYKSEKSSSRTTLADINNLQSFPGAAGCILLDFNGH
YMPAGSGWNGGNPINAQPSGMTASAIEEAWEVVAEDYRPFSINVTTNESVYNSYPQNKRM
RAVITTTTQYHTPGLSGVAFVNSFSNAYDNDTPCWVFTWGATMPGKFTGDVASHELGHTF
GLGHDGINGGGYYAGHGNWAPIMGMSDRPVMQWSKGEYTGASNLENDLAIISGAANGVGY
RADNAGGTYPTAVPLTIVGNQITPVKGVIERTGELDIFYFNTTGGNIEISIKAADRHSNL
RPRIRLHGNTALPPILDYTAQSSNLGLPLTFNTNLPAGKYYIIIEGVGDGTANTGYTNYG
SLGAYSIYGKTNSSLLSTKEIKENNAVKIFPNPVKDNLTIDLGSDNDTYEIELVNPVGQS
LYKATTSEKTHKISVSEKPAGKYFIILKNTKTGLRKSYNIIKQ
>KALACAFP_04157 tRNA threonylcarbamoyladenosine biosynthesis protein TsaE
MKMTIQKKEDWQEIVEKILPQLKHNIFLLKGNLGAGKTTFTQFLLKNLESEDEVSSPTYS
IVNEYNTPKGKVYHFDLYRLKNIEEAYDIGIEEYLDNAFLCIIEWPEVYQDELYGLNYHE
MNIINNGDTREISFE
>KALACAFP_04158 Alanine dehydrogenase 2
MSTTNIFTPFTEEELMPKEEKLEVIKKGKQFSIGIPKETSLNERRTCITPDAVQVLVEHG
HELIIESGAGESSFFTDLQYSESGAKITTDPKEAFAQDLILKINPPTEEEIDYMKPNTYL
VSALQINLRDKDYFLKLAEKKVNAIAFEFIVDEYKQLALVRLVGEIAGTVSILYASELLA
LSNGLMLGGITGVRPAEVVVLGAGIVGEFATKAAVGLGASVRVFDNSLSKLRRLHTLVDS
RVPTSIIDPKELGKALRRADVVIGALPRLNMTPIVTEDMVMKMKKGSVIIDITIDNGKVI
ETSELTTMEDPYVIKHGVIHCGLPNLTSRMPRTTTKAISNFFLSYILNYDEEGGFENMLV
RKNEMKQSLYMYKGRHTKKIICDRFGLTYHDINLLIF
>KALACAFP_04159 hypothetical protein
MKKLKFYLIGLVPGLLIVFFILNKKGASCSGYLPNSRVIAETLSKDFKYSDAFKTEMNTL
KIDEKFLKDSIITKGKVDFDRSHAQKKPCPDYLLTYPENNPTYEITFEKCEETVMLNSLK
KLK
>KALACAFP_04160 hypothetical protein
MEGNYYMIHDYLIFIGVFAIFFFLTVSIYLFIQNQKFKVKNAKLSEANKIIQQRLNEVQL
EHIGTKLNPHLFKNILNSVQSHAYQTYMSLDKLANVLDYILYESNNKFVSPKEELNFALS
LIEINKIKVNPLFDFRIKSRINKSDAIYEEKVFAPLISVDLIENAFKHTDFLAQDSFISI
QMELEDGIFTMKVSNKASLKNILEKEKSGFGSQSLDQRLKMIYNNHYSLHKNSKNGIFTA
ELTINLGEFYDKMRYS
>KALACAFP_04161 Transcriptional regulatory protein NatR
MIKCVILDDELLAISYLKLLCEQIDNVEVVKAFNDPKIFLNEIANLDCNVCILDIEMPGM
NGLQVAELISDSKKIIFTTAYKEYAAEAFDLNVVDYVRKPIKKERLIQAFEKAKELIQNS
HKKNFIEWNTNIGKTVIFTDQIVYIKTSEIDSRDKDIILNDGTAIVLKNLSFRNLLEMLP
AKDFAQVNKKEIIAISSIKIFSTNEIITTIAEGEHFLKLQIGETYKGSLMEMFGK
>KALACAFP_04162 Na(+)/H(+)-K(+) antiporter GerN
MNLGKYKNLIFYVSTIAFFSCLMYWFFVEGKTLEIGENIASPKGTGATMWENFADSFMTN
LHHPLALLLAQIVTIIMVAKLFGWICVKLKQPSVIGEMIAGIVLGPSLFGLYFPELSAFI
FPKESLPNLQFLSQIGLILFMYIVGMELDLSVLRKKAHDAVVISHASIIIPFALGVGLSY
FIYKEFAPDGIQFSSFALFIAIAMSITAFPVLARIVQERNLHKTKIGTVVITCAAADDIT
AWCILAAVIAVVKAGSFSGSVFVILMAILYVFIMIKAVRPFLVRIAEAQKGKGFINKALV
AVFFLILIISAYATEVIGIHALFGAFMAGAIMPENVKFRNLFIEKVEDVALVLLLPLFFV
FTGLRTQIGLLNDPHLWKIGGFIILTAVVGKFVGSALTAKFLKISWKDSLTIGALMNTRG
LTELIVLNIGYDLGVLGPELFAMLVIMALFTTFMTGPCLDLINYLFKGKKSMIEDDEHEK
NDPKYRVLLSFETPESGSTLLKLADNLTHKMNGNKSVTAMNIAPVDELHAFDINDFEKEQ
FKDVIETSHDLKLEVTTLFKASTDVESDLTNITNKGNYDLLLIMLGKSMYEGSLLGRLLG
FTTKIINPEKLLNTVKGKGNIFNNSPFDDLTLQVLDKATIPVGVLVEKEFKSADKVFVPI
FNLSDFYLLEYAKRLINNNNSQIIILDVAGQIRNNIEVKELIRSIEQVAPNHITLYNEKK
IEKEFLNSQDLMLISSKSWKNLIDTKDLWLSDIPSTLIISNP
>KALACAFP_04163 Prephenate dehydrogenase
MKISIIGVGLIGGSIALKLRKNGIADFIYGIDNNNDHLNEALDLKIIDAKVDLEYGIKNS
DLVIIAIPVDSARKLLPDVLDLISENQTVMDAGSTKAGIVKAVKNHPKRSRFVAFHPMWG
TENSGPKSAISDSFTGKAGVICNKEESAEDALQIVEKIVESLDMHLIYMNAEDHDVHTAY
ISHISHITSYALANTVLEKEREEETIFQLASSGFSSTVRLAKSHPEMWVPIFKQNKENVL
DVLNEHIAQLRKFKAALEKENFEYLEELISNANKIRGILDK
>KALACAFP_04164 L-serine dehydratase 2
MESISVFEIIKVGIGPSSSHTMGPWNAASAFIRIINRERSIAEVKEVFLEFFGSLAKTGI
GHGTDIAGMLGLSGEDYKTIDTTKIDEKVEKIKNDQILNLGGEKEIPFIYGHHLVLNMQK
SLDFHPNGMIFKAIFEDGTEIVQDFYSVGGGFIMSQEKKSIQKHCVRTLYPCHHASDIVK
YCQKLGLNRVSDLIFINEESWRTQDETRAEALYIWQQIKECIYKGVNKEGILPGGLNVSR
RAAGINRKLLGDKIYKNKDEWFQQVVDAEENFTNINKWISCFALAVNEENASFGRIITAP
TNGASGVIPAVLMYSQAFTEFISDDDIVRFILVAGEIGTLFKKNATISAAMGGCQAEIGV
SSAMAAAGLTEILGGSVGQVLMAAEIAMEHHLGMTCDPIKGLVQIPCIERNTMGAIKAIT
AANIALESDPTKARVTLDEVIQTMWETALSMNDRFKETSEGGLAIAVNVPEC
>KALACAFP_04165 Ammonia channel
MTVGLKWIASFSIITLVAVGGLFWSPIVDFPNTGEFLSEDKIVGADVAWILAAAGLVLLM
TPGLSFFYGGMVGKKNVISTMLQSFIALGVISILWVVVGFSLSFGDSIGFTVDGVHYGII
GNPLSYPFFSRVGVLPHKAMASTIPFILFALFQMKFAVITPALITGSFAERVRFISYLLF
MVLFSIFIYTPLCHMVWHPDGLLNKYFGVKDFAGGTVVHMSAGFAALAGAIVLGNRKNPH
HEPSNISYVILGTGMLWFGWFGFNAGSALSANATAATAFGTTTIASASAMMTWIFFDRIN
KRKISAMGACIGAVVGLVAITPACGFVSVSESLFIGFISAIVSNIMVNWKALKKIDDTLD
VFACHGVGGIMGMILTAIFAHGENASLLHGGFEVFAHHIMALILVSLFAFFGSLMLYKIT
NSIITLRVSEESENLGLDISQHEESLC
>KALACAFP_04166 hypothetical protein
MIIFVKGKASLDAFSYFSSMKIYVVSGLGADFKVLEKLQFPEQHEVIFIDWLIPGQNETF
TQYVERMAEKIDDSEPFYLLGYSFGGIMVQEIHKLKPAQKVVILGSIKSHKEKSKLIRVG
EITRIPKYLPVSLFNDKTTNVYSVVRKLFDPKNPRVLQYFRVRDPYYLKWSIEKISEWKC
EETPDVIQILGDRDIVFPIKNSKPDYIIKGGTHLFPATKYKEVSKILGEVFS
>KALACAFP_04167 hypothetical protein
MTNKIIIIALASSAGAYSQVGINTTNPKGVLDIVSTTSTVVIPRMADPETIAAPVEGMIA
YDKTNKTVRYFDGTSWGTLIYSRKLERSNDGVVKINAGGAGSGTKPNWTNTAANTTRQVT
YALPLIYASSPTTSWSENSLVSDAKIYSGNQFIENGVMGQVHQWRIIINYTKSSNILSQD
IRFILRNPLSGFRSEISGVIPSSKTSGILVYNFTTIADGASLPAPLGTGGGYILEWVASD
TITTLSIDSVTRISFQKN
>KALACAFP_04168 Protein YceI
MKRLLLFAMMCVCMSFVFAQKKGDKVVKVTSSEIRWWGYKVVKTVPTSHSGTVKLKSGKF
TFDKTVLVDGEFVIDMKSIMAGDVSSQDEDMVKLTNDLKSTNFFEVKKFPLAKFHLTKII
PLANSEFNSTVYGDITIKGVRKTITFPANVYITQFTVVIESAKFSLNRRDFKVFYQSSLK
DYFIKNEMDIQFRISTEKLDNENRTPVKKK
>KALACAFP_04169 Protein YceI
MKKIFLLAVLASGLAFGQSKKVVASDIHWWGYKVAKSEASSHDGTVKVKSGDLVMKGNQL
VGGTVVLDMNSINSTDLTGEYQQKLNGHLKNGDFFEVEKFPTATFKITGVKKNNDKIYNS
IVTGNLTVKGKTNVVSFPAKISYSKGVVSLVSNKFTIDRQKFDVAYKSTMQDVFVKDDID
MLVKVTAK
>KALACAFP_04170 Glucokinase
MILNPKFPLYLPGVKNGNNDNVSIIGANLREDITSLGYFVSSNGGLEIKIQNTYPTKEYA
SFTDILKKFIQDNQLENVKRLGIAVPGPVLNGKSSPARLGWHLDVEDFKSDFDFERVNML
NDQESSAYGMGLLEDSDLDPIYTSGHLENGNVAILAPGNGLGEAGYFFDGKYLRPFATEG
GHSEFSPRTTVEVEFYQFLNNIYGIVSWENVLSKTGLFNIYRFLRDVKRHPEPEWLAEKL
AKGNFVQELYKAAVEEDVLICKIALDTFLEFLAREANNLTLKLKATGGLLISGDIPMEIR
EYINKDKFYEKYKISDKMEEMLRNIPIYLIKQNHTALNGIALYTAYYQD
>KALACAFP_04171 hypothetical protein
MKMFKQAILLAGILTAGVVSAQSAQMNNMIKVGANAGLAVPADNVSASVGVDVAYQNLIT
PGFGLGIATGYTHYFGKDNNGYNNNDVGVIPVGALIRIYPKQTGFYFGTDLGYGFLVGDE
KVASNSTLDRPDGGFYIKPEIGYHNRDWNFFVQYQKVFVGDKGDLPNQDYNVGNIGVGFS
YNIPLGK
>KALACAFP_04172 hypothetical protein
MTVPSLINNKHLLWRAGFGAGINQFEDLNNKDIKALLNDLFREETFLYINYDTPDVEIID
YMNDKSPAEKKKEIQRINREQNLELNLNFLDKMVNSKEQMKEKMAFFWHGHFASRVVNPR
FNRQILNVIRKNALGNFRDLLFEVSQAPAMLNFLNNQQNKKDHPNENFAREVMELFTMGR
GNYTEKDIREGARAFTGWGFDKEGNFRERKNLHDEGTKNFLGKTGNFTGSDVLNIILEEK
TTAKFITTKIYKFFVNENVDENIVNKLSDNFYQSGYDIKKLMTEIFSSSWFYDKKNIGNR
IKSPIELMAGMMRTLPMNIQNPENLIVYQKLLGQMLLYPPNVAGWPNGKSWIDSSTLMLR
LQIPQIWSGLRPLEYTPRQDDDIDMGMKSRETALNKTFKNPNITIDWARVEKVFKDKKVE
DYLIQSSKSLDMNSVKNFSDNSVKMNVINLMSTPEYQLM
>KALACAFP_04173 hypothetical protein
MLIKRREFLKISSLATASFLMPNFLKAMTFDEALEPNQKILVVLQFTGGNDGLNTIIPTK
NDIYFKERNSIAIQNSLSLTDEAGINPALSYFKELYDNGELSVMNNVGYPNPDKSHFRSM
DIWHSASRSDEYLETGWLGRFLDEECYRCDHPTQALEVDDMLSLALKGENNKAFAFKDPK
RLYQTSQEKYFKSLYDHHHEDETVSYLYQTLGSTINNADYIFEKSKAKKTEQTYPNSQLG
KDFKTVASLIKSDINTRVYYLSIGSFDTHVNQNERQQKLFNDINEAVKSFVADMKSNGLF
DDILLMTFSEFGRRVAQNASKGTDHGTANQMFFISGGLKKKGILNALPDLTHLNEGDLIY
SEDFRKVYATILKNWLKADSSKVLGWKNGIYDFV
>KALACAFP_04174 hypothetical protein
MKSRILKTLLAIVAPLVIEFIVKKISEKMNKKPTEDKKQIPV
>KALACAFP_04175 hypothetical protein
MSSNKNALIRYKTLDKCLKNKYRKYTLEDLIDECSEALFEFEGKESFVSKRTVQLDLQNM
RSEKFGYEAPIEVYDRKYYRYSDPDYSIHNISVNESDLKAMNNAVQILKQFKDFSMFKEM
NGVIQKLEDSIHATSQKSIIHLDKNEQLKGLEHIDILYDAILHKKVLNITYKSFKARESD
SYVVHPQLLKEFNNRWFLICSNKQYVYNLALDRMENINIEEKIDYVDMNLDGDEYFKDIV
GVTVSPTMSPRNVVFFVDSHNAPYVKTKPLHSSQEIVSESNEGTIFKICVQLNYELERLL
LGFGESLIVHKPRKLRLRLEEKFKAGTKNYENLVVSDED
>KALACAFP_04176 hypothetical protein
MLFEQLEKSAEEIQFKEVIAFIDEHYDFTPTKFTNGNTVNEADQNNGSCKVFSFAKLNDL
SKEETLSLFGAFYREDVLQNPEGKDHQNIRNFMNFGWDGISFEGKALTRK
>KALACAFP_04177 RNA-splicing ligase RtcB
MEFNGNNLIELGYRSAKWFKEAIAHINENQLDENQIKEYLEQFKQPELISLHETPKDFVI
NIRAEHESENDNVEKVINTMKVLMKTPTLVEGAIMPDACPTGPEGQIPVGGVVVAKNAIH
PGFHSADICCSVMLTDFGKADPKEVLDAAHSVTHFGYGGRPRGEQMEMSQELMDAFREND
FLNDEKLISIARSHMGTQGDGNHFLFVGISKNTGNTMLVTHHGSRAPGAALYDKGMKVAN
RFRHEISPETLRENAWIPYETEEGKSYWEALQLIRKWTKENHTSIHDAVLTKMEIEKQDR
YWNEHNFVFKDGDLFYHAKGATPLDDKFMPDITGPRLIPLNMSEPVLIVQGTTNERNLGF
APHGAGRNFSRSQHKKSLAHKTIEEIFAEETKGLDVRFYSNEIDISELPTAYKSAKNVRA
QIEEYGLCEVLDEVMPYGCIMAGDVQKNAPWKKKKKFRKA
>KALACAFP_04178 hypothetical protein
MTPKILEKLKEIEAKRNIEILLAVESGSRAWGFASPDSDYDIRFIYRHEKDWYLSPWDKD
ETIEFMTEDDLDGSGWDLRKTFHLLLKSNAALLSWFYSPIVYVKNDKFYDVFKSLADSCF
SPIAVSYHYLSMSKKYLEACRSDEVKLKSYFYCLRTTLTGKWILEKGTVPPVLFSELLVL
VDDFTKTKIENLIALKATKGESYYHPNDWELFGFLEKMVAENEERAKGLKGGNADKREME
KIFRTILENC
>KALACAFP_04179 hypothetical protein
MKNIVALSPIYTEDSNNLKKASINSPYELNRFNAKWNVPKEFREDVIAVYGEDIYAEIVA
DQCNLILSKPADNWLSRISEEFTKRKISYGQLKDFVHEENIFIKCSDFKSFKAGVFDRVT
NIKGFDSLDLESMVFTSEVVEWELEVRCFVLNNEIKTYSSYWRNNAFDTNLLSEIEQRDL
FEFFNNFIQQYSETLPKAIVIDFGIIQGKGWALIEANPAWCSGLYACDAEKALEVVVESC
VKN
>KALACAFP_04180 hypothetical protein
MNYKIIYNKEKLKQFIDWLPNLLPNEQYYVALLARKKYNPETGLKADKAQLKRFTSTKER
LLQKIKQLELPLGVYESGNMEVSQDNLAIYITPNPRDLHKASLFLMKEISEKLIRNDNAI
HPHSLALNLIQTTTSRKIFFDLDIDFKTGNHQQAIEKFKSDISNCINSDCLTFIKTNGGL
HCLINLPNIAKEYQKIWHQKISQLTCNEYEVTMNGDNVLPVVGGIQGIDFSPYFLD
>KALACAFP_04181 hypothetical protein
MCIPNTELQFCTCVEGNIFDIKDIYIWTLRTFVGLKESDRRGKIMIPVENLGNGITIENV
IARLNTGNIFDFEYIPKERDTLHISFNAKNKSDYKYFSLIYINKIWEQGSNPVFTSISNQ
IAEGEIIIKEKKIYDHPNLKK
>KALACAFP_04182 hypothetical protein
MTIQTLKNKKLLLLQAISGSRSFGLATENSDTDIRGVYYLPKEEFFGLNYIPQISNETND
ITYYEIGRLVELLQKNNPNILEVLASPEDCILQKNPLMDLLKPEDFLSKLCKDTFAGYAI
SQIKKAKGLNKKILNPIDKERKSILDFCYILQNHGSVPLKKWLREFPFSGGVSEGRGGLL
QEKCGLVSLDNTKGMFALFYDESGELKYKGIIQNEEANQVSVSSVPKEEKPLAYLFCNLN
AYSTYCKDYREYWKWVSERNEDRYNVNQQHGQNYDSKNMMHTIRLLQSCEQIFKTNSLNI
RVENRDELLDIKAGNWSYENVMKKAEHLIKSIEYYHSISTLPDFPDLEKTTKILIDIRED
LYK
>KALACAFP_04183 Transcriptional regulator SlyA
MEKLDSIIFYNIDKAIRAYRNFAQRQLKANGFNITIDQWLIIKAILENPGITQHEIGDLV
FKDNASVTRIIDLLVKSEYINRNTNSEDRRKTDLDVTESGKEIIQKVQNLIVNNRKIALK
GVSKEELQIMNSALIKISTNCLNTKK
>KALACAFP_04184 hypothetical protein
MARIFILIFVWILSFLSTVSAQSIQNFSLSGKIDSDKANQMEINLFNSENKLVKTEIADS
KGNFSFNDLASGNYSLKINKNGTEAYKADNISVTGNTTLPSIQLNEKVIEGVTITKTKPY
IERQEGKMILNVENSIASTGNSAFEVLEKAPGVKIDNNDNISLRGKGNLLVQIDGKNTPM
TGTDLANYLRGIPSASVEKVEFITNPSSKYDASGTSIINIKLKKDQRKGTNGSVSTALGT
GRYFKNNNNFSINHRNKNVNIFANYSFAYREFFNHLVLDRNFYDGNNSFEKAYLQDNFLK
MNFRNHIAKAGMDYYMNDKNILGFSVGFISNRFDPKGDNSSTILGSDHLPTGTFTTQNRS
KDHWKNVSFNLNHKYTIDSLGSELTTDFDFINYSNTSLQNFDTRNYDLSGNLSQLDILKG
DISGNLNIYSLKSDFTKALKKDWKLEGGVKTSFVKADNDLKFFDASSGTSILDETKTNHF
IYEENINAVYGNVSKKWKKFSTNFGLRMENTNVKGTQMTTNQVNKKNYTQLFPSAVFSYD
LTDKSNLEINFSRRITRPSYNQLNPFKFYLDPTTYRAGNPDLNPQTTMNYELTYSFSNKY
FATLSYSKTSDNITEVIKPIVENGENITVQTNENLSSASYFGLNVIAPVKMAKWWDMNNS
ANFYYGSYTGNVSGTQINNKGNFTFSLNSINSFKLGNGFTAELTGNYQAREVYAYMDVKP
IWYLNIGAQKKFKNSSTLKLAFNDIFFTSNPKARTTFNNYVENFVVERDTRVVTLSYTYN
FGSGKSGQPRKTGGADDLKQRIGNG
>KALACAFP_04185 Cold shock-like protein CspG
MADSFSKKENFKKKLQKQKEKAQRREERKASNDKGKSLDEMFMYVDANGQLTSTPPDGNT
KAEIDLDNIQLGAAPIETETIKTGIVTFFSEKGYGFITEDKTKENVFFHNNNCIDQIKKG
NRVSFEKEKSPKGFSAIEIRLVK
>KALACAFP_04186 Polyribonucleotide nucleotidyltransferase
MSIPQAFTETITLADGREIIIETGKLAKQADGAVVVKCGGTMLLATVVAAKEANPGVDFL
PLTVDYREKFYAGGRIPGNFFRREAKPSDNEVLTMRLVDRVLRPLFPEDFHAEVQVMISL
ISYDKAVMPEALAGLAASAAIAITDIPFDGPMSEARVIRIDGELSINPSYEDLLKADIDI
MVGATKDSIVMVEGEMKEITEQEMLEAINFAHVEIKKQIEAQERLAEKVGKSLPKREYSH
EVHDEDIRTKVWNECYNKVYEVARTPSNKEERHEKFKAVLDEFLAQYVDNVEELERVTPF
VKVYYHDVEKEAMRQMILEDNIRLDGRDPKTIRPIWSEIDYLPGAHGSAVFTRGETQSLT
AVTLGSIKDANMIDSVITQHDEKFFLHYNFPPFSTGEARPLRGTSRREVGHGNLAQRALT
AVIPAENPYTIRIVSDILESNGSSSMATVCAGTLALMDAGVKITKPVSGIAMGLITDKKS
GKWTVLSDILGDEDHLGDMDFKVTGTADGITACQMDIKIQGLSMDIMEQALMQAKDGRLH
ILNKITETISEPRADVKPHAPKMVVMEIPKDFIGAVIGPGGKIIQQLQKDTDTVIAIEEQ
GEIGRIEIAGTDREKINAAVAKINEITFVPVVGEVYKGKVVKVMDFGAFVAIAKGTEGLL
HISEIEWKRLDKVPYAEGDEVEVKFMGYDDRKKMKLSRKVLLPRPPKPEGKPRPEGQAPA
SEKPADQA
>KALACAFP_04187 30S ribosomal protein S15
MYLNTEKKQEIFAKHGKSAQDTGSAEGQIALFTFRINHLSSHLKSNHKDYNTERSLVKLV
GKRKRLLDYLKNKDIARYRAIIAELGLRK
>KALACAFP_04188 hypothetical protein
MKKIITFTIFIAVLFIGISSLKAQKNADDKIKKVLYFNPEVEPDVEEIKEPTNYAFFSAV
SDNLSERKNKMLRTEIQIPFDSIDKKTIADYCLNNDADFAIVPKVKYFKVGIGKYVFSNQ
VVVSMKLFDAEGNLITETDYDTYRKNVRLLGSTVNSVKIGTNGAIKGILKQLRKLKPSTE
AGF
>KALACAFP_04189 Magnesium transporter MgtE
MNSKDELIFNPADIAETLSELPADERLLAFLKVPKEYKADVFSHLDPDFQEETIRSIGSD
DVSEILNAMTPDDRTALFEDFPDELIKYSINHLNPQERRIALKLLGYDSDSIARLMTPYY
IQIRKEWTIKRCLQQIKKVGSKVETMNYLYVVDERNRLIDDIALGSLLLAEEDTLVSEIT
DNHFVAITTTTSKEDAVTYFEKYDRAALPIITEAGVLVGIVTIDDILDQIEQQNTEDIQK
FGGLEALDVPYTQTSLIEMVKKRGMWLIILFFSEMLTASAMGYFEDEIQKAVVLALFVPL
IISSGGNSGSQAATLIIRAMALQEIGLKDWWYVMKKEIFTGLFLGGILGIIGFLRIMIWH
EAGFFNYGMYWPFVGLSVGVSLVMIVLWGTLSGSMVPFILKKLNLDPATSSAPFVATLVD
VTGLIIYFSVAGLFLTGKLL
>KALACAFP_04190 Vitamin B12-binding protein
MKVVSLVPSITEALFDLGLTENEVIGRTKFCIHPKEKVKNVPRIGGTKNINIDKIRALQP
DLILANKEENIKEQVEALMNDFKVMVTNVETIEDNYYLLKNLGKTFHKEDKAQVFNLKIY
EILNQAKINSNIKVAYLIWKNPYMTIGSDTFIHKILSEIGFENIFKNRTRYPEIQTEDLA
EADVIMLSSEPFPFKEKHIEELKEFYPEKKIMIVDGEAFSWYGTHIAKCGDYFEELIAEM
NLFKHKFH
>KALACAFP_04191 Free methionine-R-sulfoxide reductase
MSELKKRLSSILESPKHNTEEKLEKVCHLLDQEISYFNWTGFYFKNGDKDELKLGPYVGA
PTDHTIIPYGKGICGQVAVSNETFVVPDVHQESNYLSCSIDTKAEIVVPIFKDGKNVGQI
DIDSHTIDPFTKEDRELLEWLCNEVSKIL
>KALACAFP_04192 hypothetical protein
MYQKLTPKQKALTINLDPTIYGTFAEIGAGQETVRHFFRAGGASGTIAKAMSAYDKDFSD
AIYGKEVKNRYVTQNRLRKMLRYEVALIEERISRENNPNRKFFSYANTVTTINFDKTVKG
HGWVGIRFQVKENEDYNEIVIHVKFKENDATLQQETLGNLGVNLIFGAFHYYDNPRNLIE
SLYDDVAKDNLEIDMIDFSGPAFAYVDNRLMSLQLVKNGMTDAVIFNSEGNNMLPADILY
KKNIFAVRGSFRPVTKVNIDMLRNGLDMFLKDAICTPDETEVLIEITISNLRADGDIDER
DFLDRVDILGKLGYTVIISNFSEYYRLIDYFASYTGGNIGVAMGVNNLLMVFEEKYYKNL
SGGILEAFGKFFRNGMRVYLYPYKDPETHELLDSTTLKVEENLKELYKYFKLNDRIVDIK
SYNPEFLEIYSRDILKKIACNMKGWEIQVPEGVAEMIKERGMFGYKEEFSLKQFS
>KALACAFP_04193 Phosphoribosyl 1,2-cyclic phosphate phosphodiesterase
MKLKFLGTGTSHGVPVIGCTCEVCTSKNPKDSRFRSSVMVTTDENRKILIDCGPDFRQQM
LINHEHNVDIALLTHEHNDHVIGLDDMRPLIFKSGKDMPLYCYQRVGHEVKNRFPYAFTD
VRYPGAPAFDLHEIENKPFTVLDTEITPIEVIHYKITVFGYKFKNMAYITDANFISETEK
KKLQNLDVLVLNCIRKFDPHPAHFILPDVIQLFQELKPKKLFLTHISHHLGLHDIEDKQL
PAGMHLAYDGLEINF
>KALACAFP_04195 hypothetical protein
MERGKNLQKELKDNKVVYSYHGVASNALLRKATINDTLNGITSPKATTLISIVEAMEFTM
TDFGKEFDSISYDEIKKFMNENS
>KALACAFP_04196 hypothetical protein
MYHFDELTFEQKEKFKEFKKITSSFEIDVEAWCKITDENPYLWHTDSYFPDNFLDDYILR
NNYNECNGYINELKLLIENRSCTEREILNFISNDKLFIAAAILKSFTLFGHHDGYIFKEF
ELPPHYVCDYLIVGKNSDGYHFLLIEFENIYNNITISDGDFGTTIRKGLNQIDDWKSWMD
KNFLTFSSNLKRFKNKRETLPDEFNDYDSTRFTYCVVAGRREDYKEKTYRKVRELSKQNI
ILTHYDKLLEEAEFLLNSGSY
>KALACAFP_04197 hypothetical protein
MDLVYTITSGYLECQNEKINISFALVFLENGVYKVETLLTDNSIYEKNESNHYYKIVGLT
EKKYKIECQDLFLTRHEGGNNKVTFICEGYIKLHAPERKLYDEEEKDIDRKQNIWYVELE
NFNTKFANSTETKKFIRGAKSDDNFFDFAFDHTETAWVIDGLEGNGNYFKLKLIQNKNSE
NILLDFRNHKEPRSYCILYYEDYLKIKYELISILSFINGARVKIRKEYIGRYHGQSNNQY
TSEIEINYSFIKKNDDQHNSYIPINFHHSFSDEIFREIFFRSFVKFQRINKILDLESLIF
SLNVSSQTIGVEERYFILITALERIAKKYSNHLAVESTGMIDEDIFSNEIKPNLIKAILP
VKSIDEPSWSRMNAIISNLNINHTSTNKSLTNFLEYAKIPINKNVKSLIKRERNLAVHEG
IVGKSHGEMFRNYLKLDHLLRDCILNLIEYFSHRDRRYMYATKEEFEEVNPKNYTKDVDS
YDIR
>KALACAFP_04198 Proteasome-associated ATPase
MAQLDYIKEIAKYGLENDQERLLSVLNDLIEHSKQTKKLNFAIQLQSILKDSLRVQKTSG
LTTVGSETHLTRIEDKELSDLILEKITSDYSLDNIIANNKIHSELEFFIEEHQKIEILRQ
FDLPVSNKLLLYGPSGCGKTLASYVIAGELQKMMVVINLGAIVSSKLGETSKNLSKIFKK
SATEDCIIFLDEFDSLGKIRDYSQDHGEMKRVVNTILQLFDYLPQSSIVIAATNQKDMLD
EALLRRFDNIIGFELPNESEIKKLIDLILVNGNFKFDNKTVANKIIKAAVGLSYYSIQKT
LITAIKRSLFAASEINKVLAAQISTSIWKNLIEVEKHSLNI
>KALACAFP_04199 hypothetical protein
MSKKSHLKFLSEKQLSEIADFKYNYGFDGNNGEKENTSKNYFMLASVLRSNLRKFERDII
RKYEERDHKLEVPIDIDYVEISFQGLFEIKKYFSVYYNDYGLEGVAFYDFAKRGLFAVVN
KEKFQNFINDIINFTQNEIDKKFVKYSANIKYISNFKLLRARDILKFSMEHLGEIVYLSL
IDLPLDSKLKYGILDNLFNYLNKNNIHYYYNVESDRIELHDITPDQIQKIVSNFDIIESA
TCSAFTTVRPGGFNTVRREFGFEISNAEEDLPVVGIIDTGISQDSALATILLNDATFTLA
GSPLVDQAGRRGLGHGTAVGGLVALGKLNHRNNFEGEIKADAKLLSIKISDSGNGFISEL
KLLEMLYSVKSKYPYIRLFTLTTCYSCHMSTNEAFSDYTYALDKFAYETNSLIFICTGNN
EDCIAENTNYDLDYFNNEHTNLSTPADSLNNFVVGASADNLKDGAFLGIASGREFPALYT
RKGHVDLSAIYNLKKNNQNYFRPDVIESGGDIGYYDENTLDWLDEPALTLLSAKSNIGVM
QEVGTSFAAPLTANLAARLIKNYPHLTNESIKALIINGASLNYIQFDNGVSKLLNRVVGH
GVVNELRSLYSDENSATLILEDIISHGKIKIYPINFPDYLISEELGKKSGILKITATLCF
KFLPIKNNQLSYNPIHMAFSIFKNQTADDIMKPDNVLKSKLRNNLSWSENGRFVSKPLPY
SNSQKISLSVNVTDLKKEESTFKLAIHAKLSEQIVGSLPENYPTEFPFSLVLTIEETIKD
SKGKLYDEIQLINDVVVINDLDTILEADDLNV
>KALACAFP_04200 DNA topoisomerase 3
MKAIIAEKPSVAREIAQLLGAHEKKDGYLSGNCYCVTWALGHLITLGMPEDYGIRGFNKA
SLPIFPNPFILTPKKLKKVKGYQPDSSALKQLNTIKQVINQCSSIIVATDAGREGELIFR
YIYHYLQCNKPFERLWISSLTEKAIQEGFKNLQPGDTFDGLYEAAKARSEADWLVGINAT
QALTIAGNQDVYSLGRVQTPTLALICQRFLQHQNFIKQKYFQIQLSHRKEYTDFTSLSLL
QWEEKKQAEQIQKIIEREGRAVVEDVSVKTVQEQSPLLFDLTELQKEANRKLGLSADEVL
QTAQSLYEKQFITYPRTGSKYIPEDVWTDIPELVRILNQTEPFKTAITHLKFGNFNKRIV
NDLKVTDHHGLLITTKTPSALSATEKAIYDMIAYRLLESLSHTCTKQVTQIQIKVHHYEF
QIKGSKILNKGWRVIKGILSDNENSNNKNEVLTELPEFKTGDELKISKTELLEKVTQPPK
LFTEADLLSAMENAGRSIENKEEQKALSNIGIGTPATRASIIETLLSRNYIIRKSKTLHP
TDKGLQVYNFVKDKKIANVQMTAEWELALERIEKGELSKNQFMNDIQHYTTEITNELLSL
HIPQENIPQLKCPKCQQHNLIIKDKIVKCPDEQCGWILFRTICGVQLSSKDLTLLLTQNK
TSLIKDMKSKNGKKFDAYLSIKDDLTVLFEFDND
>KALACAFP_04201 hypothetical protein
MENELINHQEPSELKPSTDTLLVLNIHTNQVEMVKGIDKDGNLQKVPPQEKKDNEPLISV
DKHGDLFSNFFSNFYRQLKNPTHFNFFKVSEYDAVNTAKDLQKYVDEASPAEKEKLKDYE
IHNNNPKNQNTMDNNTENQEYRFQPEQIDWKTMGKFGLNQEKLEKMNAMDALLRGFKTNT
LIPITINLGTAVSKMDVRLSLQTGDTGQVAVHLHGIRKEPSLNNKFLGHQFTDEDKKNLK
ETGNMGRLVDLVNPKTDEIIPSVISRDRLTNELVAYRAEYMKIPDEIKGIRLDEHQKQTL
LEGGPLYLEGMTSKKGELFNATVQFNADKRYVEFLFNNNQTPQQRQQHNQQQTQHTAQEA
PKIFRGKELDDSQYEKFKAGQTVYVDGLTDAKGKTYQGYITFNKETSKTDFSFTHPNKLK
EKAKPTEDHKTQTAGNTQGKTNEATKNVKEPLESKQQQPASQQQEDQQKKVRKPRGRKL
>KALACAFP_04202 hypothetical protein
MNIERTEFIVWMERIMERFDLLKEQMLKNQSRFIEIDGEQLLDNQDVLQLLKISSRSLQR
YRTDKKLPYYTISGKLYYKLSDVHQLIRECLNS
>KALACAFP_04203 hypothetical protein
MGLTEKLFGNGAERFSDCVEIKIAELKEKHKDFLSEEKIDLSTAYMITFGQSGSGRVGFN
RIQDISLEIDSEIDRILHECAQEHLQKL
>KALACAFP_04204 hypothetical protein
MSQLSLFDAEDLYEFPKDLLEYRENFLNREEADLLRNKLLDTAIWEQRTQKMYDKVVLTP
RLTGWYGDSKYSDSEENKKPTNPWTPELFSLKQRIEKEFDCQFNGVLLNLYRDQNDSVAW
HRDKESRYGKRPVIASISLGQTRNFDFRKKDHHSSKYCLPLPHGSLLIMKGDLQENWEHR
IAKSTIRMKERINMTFRLIKS
>KALACAFP_04205 HTH-type transcriptional regulator Xre
MSKFSDNIVFLRGKKNMTQQELADVLILTRSRYVAYEYGRTEPPIEILLRISKFYNISID
LLLTVDVRKFSIEELMELPENRIVLPIKVDQDGNNQIEIIPQKASMGYLNGYGDPEYIEN
LETISLPFLKGGKFRAFPADGDSMPPYKNGTYIVGKYVENLSDLKTDRTYVFITTNDGIS
YKRFQFHEADGIWVKADNQFYEPYKIPLPEIKEIWEFACSITTKEYEPDEFAEHHIQNFI
TEIKTDIKQIKDRIGDKN
>KALACAFP_04206 DNA polymerase IV
MERAIVHMDLDTFFVSCERLKNSELEKKPVIIGGGDRGVVASCSYETRFFGVRSAMPIKM
ALRLCPEAKVIKGDMEMYSNMSHMVTEIIQEKVPVLEKASIDEFYLDLSGMDQFFGCYKW
THEIAESVQKNTGLPISFALSANKTVSKIGTGESKPTGRLEVKQPDIQSFLNPLSVKKIP
MVGDVTFQLLSRLGIRTIQTLSEMPVDVLQQLIGKSGNELWKKAHGIDENPVVPYSERKS
ISTEDTFAQDSIDIQGIQSILSGMVEKLCYQLRAEKWLVSVVVVKLRYSNFDTETKQCRI
PYTSADHTLLRYVLELFKKVYTRRMRIRLVGVKFTGLVHGCHQMDLFEDTEELISLYQTM
DKIKNRFGTSSVGRASGLLK
>KALACAFP_04207 DNA polymerase III subunit alpha
MFLNCHSYHSLRYGTISIKELVKQAVRFNIKTLALTDINTVTGIYDFYKLCRDHNIKPIV
GVEIRVQDELYYICLAKNQKSIAEVNRLLTAYNCEDIEIPKANPDFTDTFVIYPLENIPE
KLADHEFIGIRKNQLNLLIKPELKQFIHKMIILHPVTFTTPEEYELHKIVRAIDHNTLIS
KLTEADYCKDNEMFTDKKELLAQFYHESQIIENTKYIVNSCHFDFDFSTPKNKKHFTDSR
ENDFELLKKLAYEGLSKRYSGDNLQAKARLDKELGVIDQLNFCAYFLITWDIIQYSNRMG
FMHVGRGSGANSIVSYCIGITDICPLELDLYFERFLNLNRKTPPDFDIDWSWQTRDIILE
YIFDKYGKDHVAFCGTNVEFKYRSIFREVGKVFGLPKEELDILATKPIQEHDNNSVFKQV
HYYGKLLEKFPNQRSMHSCGILISEEPITNYSALEMPPKGFPIVQFDMYTAEEIGLEKFD
ILSQRGLGTIDDTVKLIKEKRGIDIDIRDTSLSKDEARCNEFLSSGKTIGCFYIESPAMR
GLLRRLKCDNYKVLVAASSIIRPGVAQSGMMREYIFRHNHPTKFEYFHEVFEKELGETYG
IMVYQEDVIKIALHFGGLSAPDGDVLRRAMSGKGRSLSALQKVKDNFFESCKNLGHPEQL
SMEVYRQIESFAGYSFCKAHSASYAVESYQSLYLKVYYPIEFMVSAINNGGGFYRTEVYI
HEAKMSGATIHNPCVNLSEYQTTVYDSDVYLGLMHIEKLETRLAQLIPEERAQNGEYTSL
ENFVKRIPIGIETLQILIFIGAFRFTGKQKHELLIESRFLLGTHKIAFRHLTLLDEPQKY
YQLPSIERNRFEDAFDEIEIVGFPVSFSPFDLLQTRYRGSVLVKDLLRFHKQQVKMLAYL
ISRKHVPTKKGTMYFGTWIDAQGEYFDTAHFPNSLEEYPFQGGGCYLLLGTVEVDSHFPT
VTIHKMAKMPFIPDPRYSMDEEKSLEAQRNLHEDISMTFRKPYPQEHEIGLPRYKTLYEN
LINITKV
>KALACAFP_04208 hypothetical protein
MIQPVKECAGNNLQNPLSFYYWLKYTGFSCKDKPFPTNIRDLGSIFICAVVFILPFLIRS
GSDSLNSVFATAFTALGASATLITMIIALSLYQKYGMDSKLIEQQTAKVFELIDQIKGKS
LTIHTGEIKYFLRFINIEEDLKNDPVFNRMYPKKIAVNSDDYLLFLQPLRIFMNNYLLPS
EIKSHLKLFDLYAVDEEIEFSYENYVKMSYEHAIDDSFFVMFPAVTVEEFIDRKNMLMKS
IEGWLSKHTSIKLDLEMAKP
>KALACAFP_04209 2-iminobutanoate/2-iminopropanoate deaminase
MNIKITYRNNFSVHYIAALFFIFIVEMNLKSQTPEEIILKKKITLPEVSISLGNYTNLVR
SGNLIYLSGKGPLRSDGKYINGKIGKDLNIDQGYEAARLCGLAQISALKKELGDLSKIKR
IIKVTAFVNSTDSFTDQPKVVNGYSDLMTEIFGNKGIHARSAVGVSSLPSGWPVEVEMIV
EIEP
>KALACAFP_04210 HTH-type transcriptional activator RhaR
MKDLYPTFDINNMSTCHSIKEVFSIDQFSDYLPGNPKTTTVHRHSFYHVTYFISGGGENI
IDFKTYKIMPHSIFFMRPGQVHSWDLDPSVEGYVINFAPTFFDQLQISSSLIDEFPFFNI
FHDEQKVILPDDQKDEINNYFQQIIAESFSEISRNSQISIAATILQICALASREIQNKHY
FTENNFNSLLFKKFVEQIELNFLEFKMPKDYAALLHITPSHLNFVCKQQVNLSAGEIIRN
RIILEAKRLLVNFNLSVSAIAEKLNYHDSSNFVKFFKKATGHTPESFRKQYYGIQH
>KALACAFP_04211 hypothetical protein
MIPQNFKDFLANSENTGLYQAITLLLFMIFFIALIILVLSKSKNYYKEV
>KALACAFP_04212 Cytochrome c oxidase subunit 1 , bacteroid
MELQKFSYDNNIVKAFLYATIIFGLIGFTFGITAALMLFYPELPEFLFGTDDSTIQSLRN
GGIQSLINTHGAFGFGRIRMLHTNTVIFAFVCNSVYTGVYYSLPRLLKTPMASSTLSWIH
FWTWQIMIVATFITFFMGINTSKEYAEHEWPIDILITFSWVIFGVNMFMTIARRRVRHLY
VAIWFYIGTWIGLAMLHILNNLEIPLSFTDWKSYSMYAGVKDALVQWWYGHNAVAFVLTT
PILGLMYYFLPKAAERPVFSYKLSIIHFWSLIFVYIWAGPHHLQYTALPAWAQAVGTGFS
IMLIAPSWGGMLNGLLTLRGAWDKVRENPILKFFVVAVTCYGMVTFEGPLLATKNINKIG
HYTDWVIGHVHLGALGWNGFMAFGMIYYLVPIMWRTKIWSVKIANWHFWLGTLGVIFYAV
PMYISGFTQGLMWKQFNPDGTLMWKNWLDTVTAVIPYYKMRFMGGFFYISGAILMVVNVI
ATIKNGTFQKVVPAEAPALPVIGRYRKEGEGVHLWIERTPYLLSILSLIVLSIGSAVEII
PTLSLNQSVPTISAVKPYSPLELEGRDIYIREGCNACHSQMIRPFRDEIVRFNGKNGEYS
KAGEFVYDRPFLWGSKRTGPDLHREGGKNPSSWHYKHMYNPRSTSAGSIMPRYPWLISND
LDRSKTVDKILFMKTVYNVPYTKTQIDSANTWVDNQAATIVKEIFSEANDLKEAYARRPK
GELERKEIVALISYLQRLGTDIKTTEVKTVSNN
>KALACAFP_04213 hypothetical protein
MKKSYSNLLEAINDLKKDGYTEDFNLRSNCIDCRNGEFEIFHDEFEIDNYYRFDDEDSSA
ENSSILYTVTSEKYQLKGILINSFSIYSNSLTDQMLKKLKFIK
>KALACAFP_04214 hypothetical protein
MRTLILLLCLVGYTLSGQKAKNVSHIIYAVGNIGCENYNNEVLRELGNLSRSSDSTTILF
LGNNVSISDFNQSNGETKKKLDNQLSYFKGNKGNIFFIPGPLDWAAGVKGLEKERHYISA
GLDKNDVFLLKDGCPLKKVVLDRATDLLLVDSNWILADWDKLPNINEECEIKSKTAFYTE
IEDEIVKSQNKTVLIALCHPPMAVGKYNNFLSFGISPQEISNKYYKDFSNKLLTIAQRFK
NVVFVAGHETNLQYIIERQIPIIISGSINLENKANKGLGLQFSSDNPGFAKITTYTDESI
ELAFYSVTNKFISPIFKTEVVAAGSQSVSEEYNEKHTPAYIYKSVYEPKELKHSNLYSFF
WGKHYREDYITPIRAKVALLDTLYGGLEVLRKGGGHQTNSLRLEGRYGNEFNLRSVKKSS
LRFIQYFLFKTQYLDPVWGDTYFVNLLKDYWTTANPFAPLTIATLSDAIGIYHANPELYY
IPKQKALGNYNDEYGENLYYIEEQISNKLAEVKSFGNHNKIIGTSKLIQNLQRKDRAYVD
QSLYIRTRLFDNILGDFDRHSEQWRWAEDKYNDSTFIYSPIPRDRDQAFSDFDGPIFGLI
RALVPSMRFMQRYNGKYKQIRWFNDAGDDLDRMVLRNDKEEDWVREAIYIKEHLTKDVVE
DALNKIPEGVNTKKKEEIKSSLFQRIEGIEQHSRNLYNYLKSFVIITGTEKGDWFVITRQ
PDGVTVIKGYRINDGKKTTLFWDTEYNSKVTKEIWLYGLDSEDIFEVVGEGQSLIPIKII
GGKNNDTYRFSNARKIHVYDQKSEPNTFETKVNKYLTDNYEINNYDFMKGRRDVYTILPS
ISYNPDDGITFGGALRYIKNDLVRNPFTAQHNLSAFYYTATGGGRIEYEGEFARVLGNLN
LGFNAGFSTANYTNNFFGLGNNTVNNSDMEYNRVIMSQRWISPSLLYKGYYGSKIYTAIK
YEYIDVENTPGRYINLADIDADLFNGQEFYSITAGYSYSNFDDFSFPQKGVGLGVITGYS
VNFSKNKKYAFIIPELRLTSRVNKKGSLVVATKIKANYIFNSDFEFFQAVNLGQNEGLRG
FRNQRFSGKSFIYQSTDLRLSLGSLRNGILPLSFGLYAGFDYGRVWVDNEFSNKWHTSQG
GGIFVNVAGLSTANVAYFNSSDGGRLNIRLDFSF
>KALACAFP_04215 putative tautomerase
MPFVNIKLVDGVFTPEQKHELAAAITDVMVKFEGSEAFREVVWVLIEELHTDGWHIGGRP
FEGPRSLMQTLSNSKDIYESIDGSPTTRAEFAKVMPLKQ
>KALACAFP_04216 Zinc-type alcohol dehydrogenase-like protein
MDILKDTMQALILEEFNNEFIMKEMSMPVPIEGQVLVAIKASGINPLDLKIKSGTAAHAK
TVLPAILGIDMAGIVTAVGENVTDYKIGDEVYGMTGGIAGVQGSLAQFAAVDADLLAHKP
SNISFKEAASLPLALITAWEGLVDRAKVDSTKKVLIHGGAGGVGHIAVQLAKSFGATVYA
TGTADSKKQIEQYGAVAIDYVKETVDEYVQQYTDGEGFDIIFDTVGGANLDNSFSAVRQY
TGHVVSILGWGTHSLAPLSFRGATYSGVFTLLPLITGKGRKHHGNILSEATKLIESGHIR
GNTHPGSFTLKDVEQTWKEMSDGIIKGKVVIEID
>KALACAFP_04217 hypothetical protein
MIQSVNGEVNNATLIQSVMSAYCRRLDLQQWEDWRFLMSDDATFEFENVEGQRIAYFNDP
TEFIKVCIDHLKDTVTVHHLHNSEILSMDEGSAEVVWAMEDRLYFSKTDSREESYFHGYG
HYHISFVKNTEKWLISKLKLKRVRMEQQ
>KALACAFP_04218 2-haloacrylate reductase
MILKEQGGISNFSLENAPVPELLPGEVLVQTKAISINPADAIVRENKSVHWIFNGESPMI
LGWDLSGVVIEVGADVKDFKVGDEVFGVIKHPGHGKAYAEYVAAPANHLALKPKNISHIQ
AAASTLAILTVLQPMRMVGVKEGSRILITAAGGGVGHFAVQLAKYYGAYVIALASASKKE
FVMGIGADEFIDYQSQNFEDLTEKVDLAIDGVRTDGHIFRVLNVIKSGGTLISLWSGITS
EERERAEELGVNAFYNAIQSSGKDMKLVAQLLEEGSVIPHISKIFEFEQIPEAHKEIESG
QTTGKIVIKLS
>KALACAFP_04219 1,5-anhydro-D-fructose reductase
MNKIKVGIVGANPERGWASMAHIPALKALPGYEITALSSRNSETVDLLKKAYEVENIYGS
TKELVNSDDVEMVLVAVRVPLHNEIIREVVSGGKNVFSEWPLGKNLQETEELAFLARENN
VKGYIGLQSRSVPAIRFIRDYINQGHLGEVLSTSMIGSGIIYGEYTPMANDYTVDPENGA
GMINVTFGNAVDAMCFVLGEFSELNATTATRRKTTTIVENGQEIPFKIADQVVVSGILEG
GAVASVHFRGGMLSGTNFFWEINGTKGDIQIIADGGSLAVFEPRIMMSTGENGTMEIVEV
PEEYNLVADYGLDYIPSSVGQNYTLLQSGNAPTFEDAVIRHRMISAIEKSALQGTRESYL
>KALACAFP_04220 Exoenzyme S synthesis regulatory protein ExsA
MIHTNIQDSCYVMESLSNEQFIADHIFLYQQSGSLIINDADKEYILNTGDFGLLRKNCLA
KCTTIPTEKGDYKTITLVLDQPFLKEFIKEFRYTEELEGIEDSVVKINSSPLLINYINSL
PPYFNLEGNENQVLLSLKMKEAVLLLIKTDPNLKNILFHFGKPGKIDLEAFMNRNFQFNV
PLERFSYMSGRSIATFKRDFKKVFKVSPGRWLLQKRLEQAHYLITKKGKKPSEIYLEVGF
EDISHFSRSFREKFGAAPVKYLQENVEKMIKFNSRKA
>KALACAFP_04221 3-succinoylsemialdehyde-pyridine dehydrogenase
MYTIKLFNNMKIIDKIYINGLFVKPHGKQVQDLYNPDSGEKIGMVHLGDEVDANLAIDAA
KKAFESFSKSTLQERAEILERLYDVLVANEKELNEAAVQEYGSPISATKGRTQYAAQIFL
DTKAAMENFEFEKQLEFATIINEPLGVIAAITPWNANYTHICGKVAPAIAAGCTIVIKPS
ELSAIQTEILARCFDQAGVPKGVINIVNGTGPEVGTVLNSHPDVAVVTFTGSTQVGRLIS
STAAQTMKRVTLELGGKSPNIILEDADLDKAIPLALLIGFSNSGQACHAGTRILVPEGKL
EQVKDLIKEGMKNIKIGDLWNTQSYIGPLVSKKQYDTVQRYIQSGIDEGAQVLVGGLGHP
EGFKGFYVKPTVFVNVNQDMIIANEEIFGPVLSVITYTTEEEAVKIANSTIYGLSAYISS
QDIEKAKEIARQIVSGRVLINTAVNREAQSPFGGFKQSGIGRTSWTYGIEEYVEPKVIAL
>KALACAFP_04222 HTH-type transcriptional activator RhaS
MDNRITINNILKLSELDSLNTSLIFNTDISELSVIWNIGNEMYVHIDNVCYEISKNSIFF
LNTSHSIENIKVSSAKMLRFSKTLLCSYSKDNEMDLNNLFGLFEKEVKIISMTAEQLIYL
ENSWNFLHNEISLQDRLQNDIVSLLLKRIINLCAQAAGLTGNKKELFEIVSSFNYLVENH
FCEHHDVAFYASKLNKSPKMLSTIFSTAIGCPPKDFIHERIMVDARNQILYTDKSIKEIS
YDLGYDDLQTFSRFFKSKEGIAPLHYREKVKMSVARQI
>KALACAFP_04223 Hydroxyacylglutathione hydrolase
MENNLSRRRFLEAAGILTAGLVFLPHTLLSSVKEEVIIPNLQESPVLTIMRAAATAKITP
TKLRGNVTVLEGSGGNIVMLSGPEGILLVDAGIGVSKANIKTALRAISSKPLKYLVNTHW
HFDHADGNLWIKEEGAVIIAHENTRKHLSKTTRVDDWDYTFPPAPAGAIPSNTFKESKIL
AFNGEKIQMKKYQPSHTDGDISVYFPKADILVVADTWWNGHYPFIDYNTGGSISGMISVA
KENIARITDKTIIVPGHGPIGNKQQMIEYKDMLVDIHRKVSTLKGQGKTLKEIVASKPTA
DYDAKWGGFVINGDTFTYLVYRGIA
>KALACAFP_04224 Carboxylesterase NlhH
MNTLIDFATDPHLDKDVRAFLVKLNSGGTPLEKLEPKAAKQVLVDAQASVKVDLSGIEVS
EKTITQDGHTVSLNIVRPKGVTDKLPVFIFIHGGGWILGDFPTHERMVRDLVVLTGFSGV
FVNYTRTPEAQYPVAINEIYAATKWVSEHGDEINVDGKNLAVVGNSVGGNMTAVTALMAK
EKKGPEIKGLVMMWPIVAADFETESYQKFGKDRFLSTSLMKWMYDFYIPDPSKRKDIHAS
PLQATTEQLSGLPPSLIIVAENDVLRDEGEAFGRKLNEAGVQVTTTRYNGMIHDFGLLNA
LATLPATRAAFEQSAGQLKQFLGKK
>KALACAFP_04225 Inner membrane protein RclC
MKKLLQIISDSQLHLINFLRITIFIVMTWIGGLKAFHYEAEGIVPFVANSPVMSFFYNNS
GEYKNYQNKEGEVIEYNVQWNQINGTYTFSFALGIMIVIIGLLTLLGVWFPKVGFLSGIL
IFCMSQVTLSFLITTPEAYVPNIGSEQYGFPYLAGKGRLVIKDIIMLAGGLIIASDSARK
LLINSQ
>KALACAFP_04226 hypothetical protein
MIERLIRKTTESKWRQGFLGMGHKASAILEKVSYKESDPFILFMDDKLNLPGTEPVGGPH
PHAGFEILTLVLKGNEKDWLTGSFELLTAGSGIIHSEEIKSQQDLRILQVWLALPAEKRW
VEPFWQRILLENVPTLKNENFEIRVYSGSSNGLISPITSITPFILVDFRVKVKQTLTQML
PSNYNGLVYVLEGSIQIGNKIIEAGQVGWFNRTEDIGDSVIEFKSINDDTHFILYAGMPH
NEEVIAHGPFIADVTDDIYSLYEKYRDGKMPHVDNLSDNKKVNR
>KALACAFP_04227 FMN-dependent NADH-azoreductase
MKILRLITSFREEASQSFQLGNAIIEKLEKKHPDSSVRTKNLVKNEIPHFNGIHFASFIT
PTENHTSELQEAVKYSNEAIEELKNADIIVIDVPMYNFTIPSSLKAWIDQIVRVGATFKY
SENGVEGLIQGKKVYLSIATGGIYSDGPMKKFDLTEQYLRNILGFIGITDITVFRVEGIA
IPEVSENALPKAIQTVEQFVF
>KALACAFP_04228 putative HTH-type transcriptional regulator YybR
MITHTQETCSKAKLAIHDTLDIVGGKWKLILIAVLRSGKRGFNELSREAGISPRILSKEL
QELEINGLISRKVCNTKPVTVIYELTPYSDTLADVLTAMENWGYQHRQKILANK
>KALACAFP_04229 Carboxylesterase NlhH
MKTIITKSLTKAAFIVMAGMLINCNGSKESKSVFTNSDETNKKKATPVDFATDPHLDKDV
RAFLVKLNSGGTPLEKLKPKAAKQVLVDAQASVKVDLSGIEVSEKTITQDGHTVSLNIVR
PEGATGKLPVFIFIHGGGWILGDFPTHERMVRDLVVLTGFSGVFVNYTRTPEAQYPVAIN
EIYAATKWVSEHGDEINVDGKNLAVVGNSVGGNMTAVTALMAKEKKGPEIKGLVMMWPIV
DADFETESYQKFGKDRFLSTSLMKWMYDFYIPDPSKRKDIHASPLQATTEQLSGLPPTLI
IVAENDVLRDEGEAFGRKLNEAGVQVTTTRYNGMIHDFGLLNALATLPATRAAFEQSAGQ
LKQFLGKK
>KALACAFP_04230 hypothetical protein
MKNFSVLKKEEVSEANKAIFSNLEKGVGFVPNLYATFAYSESALNTYLTLQSSKSSLKAK
EKEVISLVVSQYNACLYCLSAHTAIAKLNGFTDEQIIDIRKNTISFDSKLNALANLVKGI
VENKGEATDFQKEAFFTNGYTEANLVDVVIAIGDKMMTNYLFALTKVPVDWPEVPTI
>KALACAFP_04231 Bifunctional transcriptional activator/DNA repair enzyme AdaA
MYYNFFNKKRGSHCKLWINDENFGRDFYTNDKSNPLLTIAWNKNKDQSIEIDGVFYHFKR
NTVICLMVNQTFHFEDASEIIAWQFNRDFYCIESHDKEVSCVGFLFYGTAQAMFIEVESE
IERKLDLLLKICQEEFLDVDDIQEDMLRMLFKRLIILVTRLAKKQYVSHELPDHKLNIIR
EYNLLVEKNYKTEHSVKFYAEILNKSPKTLSNIFKIYGDITPSSIIQQRILLEAKRLLLY
TSKSSKEIAYELGFEDISYFSNFFKRLSGLAPSSFKHKNLVKSN
>KALACAFP_04232 Formate hydrogenlyase transcriptional activator
MSLKVLIVEDQFIEANNLQIIIERVGYQVIGLARSVEEALAIIEKEQPDLALVDIKLQDS
VSGIALAPTLNAINIPFIYISANCNHDVIMQAKGTQPYGFIVKPFREKDLLITLEIAMFR
HENSLETAVKKEEQLRLNLLKVIDIKDTLSDKMLAIVKSLQTFISFDYLLTKSIPLSTSA
NFISYLRIGFDEYQFIGTKEFEIITNHTLTDVTKSKIFNEKSTENIIFVEDNFEKMLLKN
PDQKLLADKFNLQSLMVLPLALSDNNIFYLFFYSRKCDAYNSSQIKLLQRLSNPLIAVIE
NLVKSNQSDDKQNVMLNESRGIKKVNAQEPDFFKQIIGKSHLLLNVFDNISHVAPVDTSV
LILGESGTGKERMARCIHELSKRKSQPFVKINCAALPFNLFESELFGHEKGSFTGAIERR
VGKFELANKGTIFLDEIGDMPPELQSKLLRVLQEKEIDRIGGRDPIKVDVRVLAATNREL
EKEVAAGRFRLDLFYRLNVFPVTLPPLRDRKDDIPLLIDHFISIYSKKANKRIKGISKKG
LNEALNYHWPGNIRELENLVERAILLSREEILMRLQIPDNISHQYMIFEESKEFKSIDEN
ERDHILQALEKCRGKVWGANGAAELLGIPPTTLHSKMKKFGIKRSPS
>KALACAFP_04233 putative sensor histidine kinase pdtaS
MIQRYILLVIMILLPSFVPAQKVFVNELVTMHNVYKRISGSDTTAINQLIKIGKWHLKAS
QLIKYSNSTDSVVYYADKVQRLSSSVKYPIGEARSYLLRGRLALQNGDYGKVRYFASQAE
ALFDKAKDKYGKVEALTLSVTAYGEKATPESLGIAYKVLNVYIRNGDKLKQGYILRIIGL
MQLSRTEYKESLESIKKSLKILEENKLSNEELAQSLVHASSASYFMGNIQEALEYSLKAL
NLSEKIDSQSYVTGLAYNGLARIYHTTGDYPKALIHYKKSVEILEKYKADDFSTSAIGNT
AQILLDMGRKQESLFYLKKLQNRITLNAVARSTVILRSIKIYTALGDYEQAEKYVLRAKK
IINDKPFALTTNNLYTPVANYYFKVGQYEKARDYLEKYKMVAKKNQSKITFLQIYKQLYQ
IDSAQSAFIPAIRNLKLAYAYRDSMFGESNRNKMSDLQVKYDVLKKDRDLLLKEEKNKKL
IREAEVQKLLISRSKIIRNFSVAGIFILAVIIGLIYSRYRTNRKMNSILQSQKATIEANN
ITLTQNVAEKEWLLKEIHHRVKNNLQIVMSLLNSQSYFLSDKLSLEVIQKSQHRIQSMSL
IHQKLYMSDNLSEIRMPEYISELVDYLKDSFAVPRIIKLTLKVDNVFMDVSQAVPIGLIL
NESITNSLKYAFSDAGGIIEIVLQNIDGDIFLLEITDDGCGLPEDFTIDNSRSLGMRLIK
GLAADLGGNLTINREKGTQIKIEFSYKRLRYKS
>KALACAFP_04234 HTH-type transcriptional activator RhaR
MINSDYSIDDLHFTTRSIDGGNTIIFNKQMIFSIIYIIKGEGKYQVQHNTISYGSNDIFI
VVPGEEFQVIQTTSDTEILEIKFSDLFINQKKQFDTDRSDRTHILYSANQNLDYIVNIKN
NIILAHQIANCLLSEIREANIVDGEYLKHLVYMILLFLEKEIKKLLPSIAGLTIEQKVIK
MLQYIHLNIFEPKKLTIQELSDKFFISPTYIGKYFKSHTNHNLHHYILQYKLNLIQYRLK
NSNMRVSEIADEFGFSDKSYLNKIFLKYTGISPSQYRINSKNKNFLSNIS
>KALACAFP_04235 hypothetical protein
MNKQQQQVKARKDWLKIYLESGSVTKTALRCGIARSTLHRWIKRYKEEGE
>KALACAFP_04236 hypothetical protein
MTVWRVLFKHKVNPVVKRRKKSDYKRYSKEIPEDRVQPDVTKIRNKAYQFTAIDDCTRIK
VIRVYPNKKAESTIHFLGEILDTFYFPIQHIQTDWGTELPSINVKLMKPKGALLGYLPIS
FARRIPFAVF
>KALACAFP_04237 hypothetical protein
MKSAYLYVRVSTDEQKRKGYSLPEQEDRLLKYCKYNNIEVKGIYREDYSAKNFNRPGWKE
LFSEIKKKSSGEDKNILFIKWDRFSRNVEYVYEMIGLLRKYKTVAMAIEQPIDFSVPEST
VMLAVYLAVPEAENLRRAQNTANGIRRAKLMGRYPSKAPLGFINLTLIDGNSVPQSV
>KALACAFP_04238 hypothetical protein
MNTAQKAPTLNKFTEELENLLKKRIGGSVNFRGIYYQILYASYLILNELRGTSEKSITME
GIEDIDLNTSQNILNGQLYTQVKSSVNKMDAGSFWDLGVLQNFAETFEINPNSKFKLVYN
MEIAKGNLQSLMHKKDLSDFWQTKFITLKYNINYNDLLSNISFEYKTSTELFNDILISLF
KDWGINKGTELQFLRSLFYNVFIWSKNRVTVTNTDIIALFQDIKDSYSKAPINNAILNNW
IIKVSYDITESHNAEDFYDGKAARPAHIKLGLPVKRKIWQKKVYDSVFESDVTVIRSSSG
QGKSTLAWQTGYDQKEKNNYSIYELRSCKDYNEANSIAEFLESRILIGEKPLLIIDGLNT
LVESWFEIVSITRDFHVKYLLTTRQEDWFRFGADISRINLTTVDISLSMAEAKEMFEELK
RKKKIHPDIQKWQPVWEQIHPKGLLIEYTYLLTRGQMIEERLSAQINYLSNSKSAGAKLE
ILRMISLADCLNIKLKTTKLLSYVKTEIGFEQDRGELLNELEKEYFLNFDGHFVEGLHPV
RSQHLKDLLHKNIPIEESLKNLFKIITDDYKQDFFNNIPFLLDQNYKNEFYETLAEIVSE
DSLENIVVAVDGIMHAEPHRYLNENRLEFDEAYNIGGIELFSVASTPFSELNTLEEMSNI
LGEQGANFKRLADLKKRLPKYQFENSDVVLFANALKLNLQKRTSAIISYKGLGFLVKWFS
HLKIAFNIPSINNNISIGELIKMDFSEAKELMSFFKLTDLIGYKDFITKNKETLFSYLKV
STNSIIVEDSGDKINIKYLLFDQDSKHANNLSVSRIEDVFEFFPFYEQYCTEGLMFPFPS
EEMTTTVRDDSRKQMTPASIGNSFDIHLNQIWYNEIQKMYLDSSAYSWQERIINIRKLAL
EWVKIVTRMIDGLLEGNKNKIQKNVTELQHKGELLNNTIKLKKKYPIYKKYNEKNNAVEG
EKEIGSWISSLTNINSQIFNIFLPKKEQDRRVALINFKGVYFDLEALQNAFRIIENKTIA
YFDSESICLEENIHYERLYASILYYLSQIPLEDKMPVPVGRKAVEEWWMKAKNAKLDDLN
HSLTIIEASSDFKFNYPNGIEETDTITYLTIGIIDFDFSDTQSLESLLFSLGILRDLDYQ
FITIISVKDNIAVSGFRINKELINAYDDLITGAENIDINFPALPVAIEEKIIKYLPGVLL
PEKSVNGDLDKKFEILITLWKLSEFKRHLNKNSSIEMKWLKDLNVESEIINSLNSLNISS
QSFTKFVERGLEPNHIYEVESITNELYKQITSHA
>KALACAFP_04239 hypothetical protein
MIISYTKRSKTYQFCKPSADYKNVFTIIVGKNGSGKSRLLNDIISNFIPSHLAKKISTAK
DGFLMRSSEPTKVLAVSTSPYDKFPLTRSLFGLKFPEGNYSYIGIREIRSSDFSLGFISK
IIKELLHVRLSNPEQFHKIIDVLGYLGYNGELQVKFETVISSAQIRRFLESRKTEDDFRH
IFFKNNTARINTGFFETGEKLDFVKLEYLQKIFMSYEFSKYMRSPTVTINADSIELQMDL
EDLLFILEAGLLRLKDVYIRKIENNRIYPINEASSGEQCIFNTFIGIACKIADNSLIVID
EPEISLHPAWQERYITLLMDTFQHYKGCHFIIATHSPQLVSKLSNENCYVLKMDDGELMD
GELIANNSADFQLANVFNTPGFKNEYLGRIAFSIISKVGKTNKFDSEDLENFTIIQSQIK
NMQHNDPIRKLFDLIKDLKRNA
>KALACAFP_04240 hypothetical protein
MPDINQPVVYTPAIKKRILGFLSKSDLKSSDWSDDDIKDIRKFIRDYYRNITRKCFYCRK
EISLRSVDNCHVEHIIPKSEQIQFMFEPRNLCVVCSDCNIIKSKKEVSGQIETVTKNGKL
YTMYPRSSNAFIVVHPHFDNYDDHIHHCGDIYISKSKKGSYTIHICELNRKVHEYGMDSN
PLTQSELFDIFHDIMNSDDVVQQSKYMNKLREHFIKAG
